data_2myt_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2myt _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.8 ttt . . . . . 0 N--CA 1.503 2.183 0 N-CA-C 111.563 0.209 . . . . 0.0 111.563 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.9 164.35 30.33 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 125.061 1.344 . . . . 0.0 112.907 174.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 75.3 mttt -93.75 145.61 24.46 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 124.206 1.002 . . . . 0.0 112.193 177.269 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 21.5 t -129.06 131.57 67.91 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 125.569 1.548 . . . . 0.0 112.318 178.43 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 47.0 tpp -98.35 132.37 43.88 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 168.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 42.6 m-85 -115.61 127.32 55.13 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 124.441 1.096 . . . . 0.0 109.645 173.142 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 5.7 m -149.16 163.94 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 C-N-CA 124.398 1.079 . . . . 0.0 112.891 -169.779 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 47.1 t -132.25 165.52 23.96 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 127.312 2.245 . . . . 0.0 109.384 169.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -52.96 -37.6 61.26 Favored 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 124.547 1.139 . . . . 0.0 112.741 -178.529 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 82.3 mtt180 -141.18 150.73 43.11 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 127.203 2.201 . . . . 0.0 109.822 169.028 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 24.0 t30 -110.15 -27.11 9.31 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 124.341 1.056 . . . . 0.0 113.746 -173.222 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 60.5 m -56.29 126.54 26.69 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 118.769 0.713 . . . . 0.0 110.461 177.662 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 68.3 m 50.36 36.81 13.85 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 124.798 1.239 . . . . 0.0 113.945 -176.459 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -121.98 143.25 49.59 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 125.778 1.631 . . . . 0.0 109.478 171.082 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 15.8 m -97.02 -33.17 11.65 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 114.742 1.386 . . . . 0.0 114.742 -170.334 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 5.2 mt-30 60.75 -55.88 0.09 Allowed 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 128.578 2.751 . . . . 0.0 116.648 171.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 69.86 -42.67 0.52 Allowed 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 127.929 2.492 . . . . 0.0 117.498 169.599 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -59.9 -33.21 71.55 Favored 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 113.858 1.059 . . . . 0.0 113.858 -170.406 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.9 pm0 -61.56 -42.47 98.89 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.658 1.183 . . . . 0.0 112.275 173.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -68.75 -38.95 86.19 Favored Glycine 0 C--N 1.336 0.563 0 O-C-N 121.557 -0.715 . . . . 0.0 111.59 178.607 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -70.05 -41.65 73.91 Favored 'General case' 0 C--O 1.221 -0.414 0 O-C-N 121.834 -0.804 . . . . 0.0 111.258 175.865 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -60.16 -41.9 93.79 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 119.467 1.031 . . . . 0.0 113.008 -175.736 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 10.3 pttp -76.78 -29.28 55.99 Favored 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 113.502 0.927 . . . . 0.0 113.502 173.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 83.7 m -71.66 -31.29 66.65 Favored 'General case' 0 N--CA 1.485 1.281 0 O-C-N 121.585 -0.697 . . . . 0.0 111.842 175.241 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 78.2 mt -91.57 -30.82 16.17 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 125.923 1.689 . . . . 0.0 114.123 179.827 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -142.89 26.36 2.22 Favored Glycine 0 N--CA 1.475 1.292 0 N-CA-C 118.233 2.053 . . . . 0.0 118.233 -169.086 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -66.27 -20.3 66.07 Favored 'General case' 0 CA--C 1.547 0.833 0 CA-C-N 122.016 2.908 . . . . 0.0 114.952 -178.578 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -76.4 -4.18 79.21 Favored Glycine 0 CA--C 1.541 1.675 0 O-C-N 121.235 -0.916 . . . . 0.0 113.757 169.368 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -118.11 -40.94 2.91 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 127.178 2.191 . . . . 0.0 112.513 -175.536 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 29.4 pt -141.38 154.93 20.56 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 C-N-CA 125.919 1.687 . . . . 0.0 112.168 -175.103 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -97.3 137.53 36.17 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 123.872 0.869 . . . . 0.0 109.702 169.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 84.0 t -122.14 140.22 46.71 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 CA-C-N 118.996 0.817 . . . . 0.0 111.542 -178.769 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 20.4 m -135.68 151.2 49.95 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 124.923 1.289 . . . . 0.0 109.31 173.331 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 77.9 p -133.06 147.73 52.2 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 122.308 1.051 . . . . 0.0 110.913 168.32 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 88.7 p -144.2 157.9 44.03 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 114.066 -1.425 . . . . 0.0 112.461 -174.478 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -79.07 167.67 52.72 Favored Glycine 0 CA--C 1.527 0.818 0 N-CA-C 111.166 -0.774 . . . . 0.0 111.166 169.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 9.2 mp -100.91 -16.91 17.05 Favored 'General case' 0 N--CA 1.484 1.237 0 CA-C-N 120.27 2.035 . . . . 0.0 112.164 169.559 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -138.36 170.02 16.75 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 129.587 3.155 . . . . 0.0 107.095 172.331 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 69.0 m -57.46 110.17 0.82 Allowed 'General case' 0 N--CA 1.48 1.061 0 CA-C-N 119.759 1.163 . . . . 0.0 111.112 -178.461 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 91.2 p -158.51 175.02 14.21 Favored 'General case' 0 N--CA 1.478 0.966 0 N-CA-C 115.673 1.731 . . . . 0.0 115.673 -169.145 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 15.3 tpt180 -139.79 145.01 37.67 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 128.398 2.679 . . . . 0.0 108.852 171.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 35.5 m -56.21 163.98 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 CA-C-O 122.761 1.267 . . . . 0.0 111.155 169.598 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 1.6 t-80 -48.86 127.05 14.09 Favored Pre-proline 0 C--N 1.323 -0.543 0 CA-C-N 114.05 -1.432 . . . . 0.0 112.965 172.354 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_exo -60.64 -28.68 86.99 Favored 'Trans proline' 0 CA--C 1.542 0.907 0 CA-C-N 120.54 1.229 . . . . 0.0 111.904 171.497 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 88.6 m -65.6 -29.72 70.35 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 125.213 1.405 . . . . 0.0 112.238 173.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.32 -39.69 87.96 Favored 'General case' 0 N--CA 1.471 0.582 0 O-C-N 121.108 -0.995 . . . . 0.0 112.089 -175.714 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.9 mp -57.83 -56.03 18.09 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 -177.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.53 -33.62 76.33 Favored 'General case' 0 CA--C 1.542 0.656 0 N-CA-C 113.378 0.881 . . . . 0.0 113.378 -178.004 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -79.95 -21.19 44.07 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 114.13 1.159 . . . . 0.0 114.13 178.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -90.74 -28.01 18.57 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 118.96 0.8 . . . . 0.0 110.306 172.092 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -66.07 -13.12 59.47 Favored 'General case' 0 CA--C 1.543 0.692 0 O-C-N 120.641 -1.287 . . . . 0.0 113.247 171.248 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 13.3 mt-10 -61.41 -27.49 68.58 Favored 'General case' 0 N--CA 1.48 1.059 0 CA-C-N 120.233 1.378 . . . . 0.0 110.464 168.665 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 35.7 t -96.45 -2.29 10.4 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.032 0 C-N-CA 127.581 2.353 . . . . 0.0 111.135 176.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 78.93 21.26 68.66 Favored Glycine 0 CA--C 1.538 1.53 0 C-N-CA 125.35 1.452 . . . . 0.0 114.742 -176.606 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 77.8 mt -83.6 131.07 34.71 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 C-N-CA 124.798 1.239 . . . . 0.0 112.006 -171.436 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 19.4 t0 -96.06 107.14 19.41 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 112.895 0.702 . . . . 0.0 112.895 -178.616 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 15.6 pt -142.68 23.06 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.208 0 C-N-CA 125.302 1.441 . . . . 0.0 114.369 -177.286 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 95.2 p -48.15 -37.34 15.34 Favored 'General case' 0 N--CA 1.483 1.201 0 N-CA-C 116.567 2.062 . . . . 0.0 116.567 -169.341 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -142.97 40.04 1.28 Allowed Glycine 0 N--CA 1.474 1.179 0 C-N-CA 125.358 1.456 . . . . 0.0 113.01 -179.371 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 24.3 pt20 -66.5 -34.68 78.45 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 115.637 1.717 . . . . 0.0 115.637 -169.529 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 68.0 p -93.65 104.17 16.29 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 121.211 0.529 . . . . 0.0 111.352 173.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 95.9 p -108.94 -23.55 11.66 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 125.473 1.509 . . . . 0.0 114.278 178.316 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -145.46 155.34 53.53 Favored Pre-proline 0 CA--C 1.544 0.722 0 C-N-CA 124.722 1.209 . . . . 0.0 111.046 -171.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -74.37 155.13 46.07 Favored 'Trans proline' 0 CA--C 1.538 0.714 0 C-N-CA 122.561 2.174 . . . . 0.0 112.657 173.257 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 5.6 tt -54.44 -38.65 41.77 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 126.171 1.788 . . . . 0.0 111.615 179.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -68.34 -8.6 41.37 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 124.56 1.144 . . . . 0.0 113.763 178.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 -79.92 -21.73 43.54 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 124.085 0.954 . . . . 0.0 112.824 170.71 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 84.6 m-85 -93.62 -176.73 4.17 Favored 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 126.444 1.897 . . . . 0.0 111.879 -179.354 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 7.0 t30 -113.84 129.19 56.62 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 125.783 1.633 . . . . 0.0 109.695 171.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -69.38 -36.9 77.26 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 113.918 1.081 . . . . 0.0 113.918 -175.517 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . 0.272 0.0 OUTLIER -72.07 -7.82 51.11 Favored 'General case' 0 CA--C 1.544 0.744 0 N-CA-C 114.562 1.319 . . . . 0.0 114.562 -173.077 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -65.1 -26.35 68.18 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 123.664 0.786 . . . . 0.0 110.449 168.295 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 55.5 m-85 -108.4 120.75 43.31 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 125.834 1.654 . . . . 0.0 111.44 -173.307 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -74.0 -20.87 60.19 Favored 'General case' 0 CA--C 1.545 0.776 0 CA-C-O 122.195 0.998 . . . . 0.0 112.473 177.55 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 92.3 t -133.95 137.84 51.5 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 C-N-CA 127.381 2.272 . . . . 0.0 108.891 -173.407 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 63.0 t -133.91 118.61 29.65 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 169.685 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 44.8 mm -103.09 113.16 39.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 C-N-CA 123.818 0.847 . . . . 0.0 109.299 -177.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 15.5 m -92.78 114.12 26.59 Favored 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 169.531 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 90.7 mt -86.79 -3.16 59.02 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 125.644 1.577 . . . . 0.0 115.217 -169.548 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 77.5 m -130.34 40.32 3.54 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 125.359 1.463 . . . . 0.0 110.553 -169.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 80.51 -131.72 10.7 Favored Glycine 0 CA--C 1.532 1.109 0 C-N-CA 124.371 0.986 . . . . 0.0 111.174 -169.49 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 93.3 p -63.71 154.49 32.98 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 124.015 0.926 . . . . 0.0 113.479 176.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -75.35 -51.42 7.43 Favored Glycine 0 CA--C 1.534 1.269 0 O-C-N 121.739 -0.601 . . . . 0.0 112.339 176.009 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . 0.273 7.7 p 48.97 -47.54 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.677 1 C-N-CA 132.148 4.179 . . . . 0.0 119.021 169.883 . . . . . . . . 3 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 63.1 t30 -85.9 15.95 4.51 Favored 'General case' 0 CA--C 1.556 1.202 0 C-N-CA 126.734 2.014 . . . . 0.0 112.761 -179.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -122.87 160.45 49.13 Favored Pre-proline 0 CA--C 1.55 0.98 0 C-N-CA 127.589 2.356 . . . . 0.0 112.598 179.605 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -63.34 151.61 84.04 Favored 'Trans proline' 0 CA--C 1.546 1.084 0 C-N-CA 122.774 2.316 . . . . 0.0 113.948 178.721 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_exo -58.82 -27.05 82.8 Favored 'Trans proline' 0 C--N 1.352 0.728 0 C-N-CA 123.609 2.873 . . . . 0.0 115.309 -177.108 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -61.72 -21.24 64.32 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 113.74 1.015 . . . . 0.0 113.74 177.763 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 92.7 m95 -83.73 -28.95 27.88 Favored 'General case' 0 N--CA 1.474 0.733 0 O-C-N 120.83 -1.168 . . . . 0.0 113.318 177.32 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 6.4 m -82.88 -13.37 12.08 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.315 0 N-CA-C 113.36 0.874 . . . . 0.0 113.36 174.41 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -95.31 1.46 54.42 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 114.603 1.334 . . . . 0.0 114.603 -179.33 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 85.6 mm-40 -66.39 156.31 34.94 Favored 'General case' 0 N--CA 1.481 1.081 0 O-C-N 120.83 -1.169 . . . . 0.0 111.596 172.005 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -59.49 -42.54 92.37 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 114.196 1.184 . . . . 0.0 114.196 -168.183 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 16.3 mm -113.21 55.44 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 C-N-CA 125.083 1.353 . . . . 0.0 109.276 177.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 25.1 t80 -74.66 109.19 7.93 Favored 'General case' 0 CA--C 1.536 0.414 0 O-C-N 120.565 -1.334 . . . . 0.0 107.675 169.009 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 13.8 mt-10 -110.95 131.36 55.12 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 114.432 1.271 . . . . 0.0 114.432 176.657 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 12.5 p-10 -94.74 104.69 16.61 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 126.128 1.771 . . . . 0.0 110.053 169.214 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 34.2 m0 -93.35 124.56 37.42 Favored 'General case' 0 N--CA 1.464 0.236 0 C-N-CA 124.183 0.993 . . . . 0.0 109.089 174.703 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 32.5 mt-30 -91.95 42.3 1.1 Allowed 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 124.012 0.925 . . . . 0.0 111.574 -173.324 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 76.1 mt -81.28 164.07 22.5 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 125.271 1.428 . . . . 0.0 112.695 -178.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -87.2 163.74 16.75 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 124.901 1.28 . . . . 0.0 111.221 169.106 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -108.3 139.6 20.91 Favored Pre-proline 0 N--CA 1.474 0.755 0 O-C-N 121.33 -0.856 . . . . 0.0 110.526 169.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_exo -59.9 -17.13 42.27 Favored 'Trans proline' 0 CA--C 1.545 1.028 0 C-N-CA 123.006 2.471 . . . . 0.0 116.392 176.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -54.41 135.44 45.28 Favored 'General case' 0 CA--C 1.546 0.816 0 CA-C-N 120.13 1.332 . . . . 0.0 113.924 178.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 76.54 6.74 84.86 Favored Glycine 0 CA--C 1.538 1.48 0 C-N-CA 124.461 1.029 . . . . 0.0 115.007 178.453 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 -138.05 170.47 15.98 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 125.473 1.509 . . . . 0.0 113.033 -179.459 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 26.4 p -68.07 168.56 11.77 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 117.461 2.393 . . . . 0.0 117.461 -168.524 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 25.0 tp -60.18 -30.09 69.13 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 125.097 1.359 . . . . 0.0 112.483 169.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -65.58 -31.54 72.64 Favored 'General case' 0 CA--C 1.539 0.523 0 O-C-N 121.038 -1.039 . . . . 0.0 111.259 171.684 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 11.4 t -74.16 -38.52 48.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 CA-C-O 118.154 -0.927 . . . . 0.0 112.14 171.104 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 17.1 m-85 -56.25 -44.08 79.33 Favored 'General case' 0 N--CA 1.482 1.134 0 CA-C-N 120.698 1.59 . . . . 0.0 111.74 169.588 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -69.49 -37.5 77.26 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 124.351 1.06 . . . . 0.0 112.408 178.182 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 21.6 m -60.46 -48.04 83.48 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 124.507 1.123 . . . . 0.0 111.201 170.362 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 75.1 t -65.52 -43.52 94.28 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 CA-C-O 118.181 -0.914 . . . . 0.0 110.236 179.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 16.8 mtp180 -53.5 -45.48 69.69 Favored 'General case' 0 N--CA 1.481 1.118 0 CA-C-N 119.914 1.234 . . . . 0.0 112.716 172.091 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -60.57 -51.34 59.34 Favored Glycine 0 CA--C 1.538 1.482 0 CA-C-N 119.431 1.014 . . . . 0.0 113.218 176.432 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 58.9 mm-40 -63.37 -45.09 92.76 Favored 'General case' 0 N--CA 1.472 0.653 0 O-C-N 121.978 -0.719 . . . . 0.0 111.912 178.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 50.5 t -63.83 -41.72 93.48 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 C-N-CA 124.881 1.272 . . . . 0.0 111.237 177.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 78.1 tttt -56.77 -48.02 78.83 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 119.832 1.196 . . . . 0.0 110.425 178.407 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -64.35 -42.31 96.29 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 112.641 0.608 . . . . 0.0 112.641 177.523 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 16.6 mmm180 -61.14 -45.59 94.03 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.393 0.677 . . . . 0.0 112.696 175.144 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 79.3 t -69.45 -41.05 80.55 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 C-N-CA 124.5 1.12 . . . . 0.0 111.157 -179.392 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -62.51 -40.0 95.32 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 118.875 0.761 . . . . 0.0 111.647 172.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 13.0 m-80 -64.02 -46.11 85.95 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-N 118.782 0.719 . . . . 0.0 112.236 174.123 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -54.05 -54.78 34.53 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 124.734 1.213 . . . . 0.0 110.499 175.272 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 91.4 mt -59.88 -45.11 95.41 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 CA-C-O 119.024 -0.512 . . . . 0.0 110.393 179.255 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -68.83 -10.77 58.67 Favored 'General case' 0 CA--C 1.548 0.871 0 N-CA-C 115.245 1.572 . . . . 0.0 115.245 -179.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 21.4 ptmt -102.49 -24.18 13.84 Favored 'General case' 0 N--CA 1.479 1.01 0 N-CA-C 113.91 1.078 . . . . 0.0 113.91 171.271 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 14.7 pt -96.65 -7.97 9.4 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 N-CA-C 114.435 1.272 . . . . 0.0 114.435 176.179 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 83.4 p . . . . . 0 C--O 1.255 1.35 0 C-N-CA 125.075 1.35 . . . . 0.0 114.269 173.526 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.1 ttp . . . . . 0 N--CA 1.502 2.172 0 N-CA-C 112.087 0.403 . . . . 0.0 112.087 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 3.3 mptp? -86.03 159.91 19.46 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 124.602 1.161 . . . . 0.0 113.113 171.003 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 79.3 mttt -112.14 113.21 25.34 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 125.816 1.646 . . . . 0.0 106.577 167.671 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 18.9 t -102.91 132.5 48.95 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 C-N-CA 125.793 1.637 . . . . 0.0 113.579 -178.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 36.6 tpp -107.05 119.86 40.53 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.567 0.747 . . . . 0.0 109.266 168.552 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 60.1 m-85 -97.16 125.08 41.42 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.232 1.013 . . . . 0.0 109.533 171.476 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -140.99 147.78 22.25 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 N-CA-C 114.179 1.177 . . . . 0.0 114.179 -168.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 52.7 t -157.55 164.72 37.03 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 126.189 1.795 . . . . 0.0 112.417 172.298 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 53.4 mtmt -75.08 154.92 37.67 Favored 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 125.753 1.621 . . . . 0.0 112.628 171.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 6.4 tmm_? 49.3 84.45 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 127.377 2.271 . . . . 0.0 112.661 175.618 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 30.2 t-20 -79.69 -25.27 41.26 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 124.62 1.168 . . . . 0.0 113.132 -171.738 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 78.2 p -58.3 141.68 50.29 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.208 1.003 . . . . 0.0 111.567 170.092 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 66.9 m 56.23 -4.26 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.325 0 N-CA-C 116.647 2.091 . . . . 0.0 116.647 -170.598 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 58.8 ttm-85 -92.37 138.57 31.41 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 124.886 1.274 . . . . 0.0 113.372 -170.131 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 45.5 m -96.17 -38.16 10.26 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 114.578 1.325 . . . . 0.0 114.578 -176.64 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 60.82 -46.75 0.11 Allowed 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 127.622 2.369 . . . . 0.0 116.271 -177.132 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' MET . . . . . 0.402 ' HG2' ' SD ' ' A' ' 50' ' ' MET . 0.0 OUTLIER 66.67 -50.54 0.45 Allowed 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 127.771 2.429 . . . . 0.0 116.579 169.619 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -56.17 -37.13 69.13 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 115.584 1.698 . . . . 0.0 115.584 -169.132 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.89 -34.94 77.62 Favored 'General case' 0 N--CA 1.476 0.864 0 O-C-N 121.412 -0.805 . . . . 0.0 112.774 -177.162 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -69.87 -42.83 68.53 Favored Glycine 0 N--CA 1.468 0.813 0 C-N-CA 123.692 0.663 . . . . 0.0 111.764 176.371 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -64.39 -36.94 85.79 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 117.884 0.842 . . . . 0.0 111.313 170.79 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -65.32 -39.12 92.03 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 119.449 1.022 . . . . 0.0 112.663 179.586 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 23.7 mtpp -62.05 -46.62 88.33 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 123.314 0.645 . . . . 0.0 110.978 169.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 69.6 m -68.15 -38.09 81.75 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 123.12 0.568 . . . . 0.0 112.245 -174.448 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 47.7 mt -85.49 -35.46 21.16 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 125.416 1.487 . . . . 0.0 113.362 -179.445 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -117.29 5.15 17.68 Favored Glycine 0 CA--C 1.528 0.867 0 N-CA-C 118.214 2.046 . . . . 0.0 118.214 -168.737 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -60.81 139.48 57.92 Favored 'General case' 0 CA--C 1.545 0.784 0 CA-C-N 122.064 2.932 . . . . 0.0 111.959 177.316 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 88.68 -21.38 26.56 Favored Glycine 0 CA--C 1.54 1.649 0 C-N-CA 124.797 1.189 . . . . 0.0 113.233 -169.206 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 72.4 mttt -101.77 -42.22 6.25 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 126.302 1.841 . . . . 0.0 112.015 169.531 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 36.0 pt -135.12 146.11 30.92 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 C-N-CA 124.676 1.19 . . . . 0.0 113.126 -178.566 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -98.58 145.77 26.49 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 126.685 1.994 . . . . 0.0 108.337 169.197 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 71.3 t -141.38 139.01 32.9 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 O-C-N 121.781 -0.575 . . . . 0.0 112.435 -169.696 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 31.7 m -136.9 159.2 42.57 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 126.198 1.799 . . . . 0.0 108.745 169.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 26.5 p -133.98 148.55 51.15 Favored 'General case' 0 CA--C 1.515 -0.368 0 CA-C-O 121.742 0.782 . . . . 0.0 111.896 168.086 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 59.9 p -147.58 153.81 39.89 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 114.806 -1.088 . . . . 0.0 113.312 176.212 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -83.22 152.97 30.1 Favored Glycine 0 N--CA 1.473 1.138 0 O-C-N 121.735 -0.603 . . . . 0.0 111.987 173.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.4 mp -76.23 -20.43 57.45 Favored 'General case' 0 N--CA 1.481 1.088 0 CA-C-N 119.126 1.463 . . . . 0.0 113.973 176.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -138.31 -52.42 0.6 Allowed 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.934 0.893 . . . . 0.0 113.31 177.226 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 50.2 p -98.93 150.57 21.8 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 115.106 1.521 . . . . 0.0 115.106 -172.403 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 80.5 p -84.81 149.21 25.87 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 125.818 1.647 . . . . 0.0 114.23 -174.497 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 13.2 tpt180 57.61 137.58 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 129.483 3.113 . . . . 0.0 116.045 -178.662 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 15.6 m -67.49 156.48 6.79 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.354 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 168.695 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . 0.437 ' CE1' ' HB ' ' A' ' 45' ' ' THR 0.255 0.0 OUTLIER -68.19 140.18 92.98 Favored Pre-proline 0 CA--C 1.546 0.793 0 C-N-CA 118.188 -1.405 . . . . 0.0 110.943 178.08 . . . . . . . . 4 4 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -63.81 -31.01 68.69 Favored 'Trans proline' 0 CA--C 1.539 0.732 0 C-N-CA 123.254 2.636 . . . . 0.0 114.84 -168.291 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.437 ' HB ' ' CE1' ' A' ' 43' ' ' HIS . 51.7 m -65.46 -24.64 67.22 Favored 'General case' 0 N--CA 1.48 1.062 0 O-C-N 121.404 -0.81 . . . . 0.0 111.787 -176.334 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -50.51 -48.44 57.05 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.11 0.964 . . . . 0.0 111.67 169.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 4.7 mp -55.39 -53.26 37.61 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 CA-C-N 119.433 1.015 . . . . 0.0 111.015 -176.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -62.81 -25.55 68.3 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 113.648 0.981 . . . . 0.0 113.648 -177.709 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -81.08 -35.19 32.05 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 123.644 0.778 . . . . 0.0 112.808 174.859 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' MET . . . . . 0.402 ' SD ' ' HG2' ' A' ' 17' ' ' MET . 4.5 mmt -72.49 -29.76 63.93 Favored 'General case' 0 N--CA 1.473 0.707 0 O-C-N 121.129 -0.982 . . . . 0.0 111.13 172.219 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -67.41 -9.08 38.2 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 125.339 1.456 . . . . 0.0 113.816 172.189 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -69.02 -29.74 67.96 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-N 120.325 1.421 . . . . 0.0 110.857 169.526 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . 0.295 2.2 p -109.66 8.25 8.95 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.815 0 C-N-CA 127.189 2.196 . . . . 0.0 111.955 -172.475 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 85.84 14.08 68.2 Favored Glycine 0 CA--C 1.538 1.497 0 C-N-CA 124.855 1.217 . . . . 0.0 115.369 171.673 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -76.19 138.39 20.83 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 C-N-CA 124.625 1.17 . . . . 0.0 109.698 -178.335 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 19.6 t0 -110.55 104.37 13.08 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 124.272 1.029 . . . . 0.0 111.767 175.088 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 21.4 pt -133.75 6.33 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.248 0 N-CA-C 116.289 1.959 . . . . 0.0 116.289 -175.727 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 72.3 m -60.21 -31.43 70.16 Favored 'General case' 0 N--CA 1.483 1.214 0 CA-C-N 120.438 1.472 . . . . 0.0 111.662 175.207 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -79.35 14.78 14.65 Favored Glycine 0 CA--C 1.539 1.559 0 C-N-CA 126.193 1.854 . . . . 0.0 115.934 175.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 70.6 mt-30 -62.38 157.21 20.46 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 119.434 1.617 . . . . 0.0 110.429 169.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 7.6 t -74.86 172.89 11.4 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 121.538 0.685 . . . . 0.0 112.061 169.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 73.4 m -118.09 -18.53 9.36 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 125.098 1.359 . . . . 0.0 114.211 -174.185 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 27.3 m-20 -86.11 158.68 55.29 Favored Pre-proline 0 CA--C 1.55 0.949 0 N-CA-C 114.691 1.367 . . . . 0.0 114.691 -169.703 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -63.98 160.91 35.38 Favored 'Trans proline' 0 C--N 1.353 0.787 0 C-N-CA 124.001 3.134 . . . . 0.0 114.371 172.268 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 8.4 tt -51.5 -36.47 17.93 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 C-N-CA 125.622 1.569 . . . . 0.0 112.103 173.092 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 17.8 mt-10 -65.0 -16.77 63.81 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.598 1.159 . . . . 0.0 112.825 -177.511 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -83.26 -8.18 59.49 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 124.815 1.246 . . . . 0.0 113.565 -178.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 69.7 m-85 -116.77 -175.44 2.77 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 126.221 1.808 . . . . 0.0 112.614 -172.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 11.2 t30 -120.69 125.81 48.61 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 125.603 1.561 . . . . 0.0 110.026 177.613 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -69.13 -35.4 76.34 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 114.021 1.119 . . . . 0.0 114.021 -173.363 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . 0.275 0.0 OUTLIER -71.92 -5.21 33.01 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 114.329 1.233 . . . . 0.0 114.329 -174.15 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -70.42 -25.73 63.34 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 122.968 0.507 . . . . 0.0 109.949 168.446 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 80.1 m-85 -99.23 148.67 23.88 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 126.473 1.909 . . . . 0.0 111.644 -179.205 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -107.04 -17.92 14.05 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 124.342 1.057 . . . . 0.0 112.176 176.011 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 71.7 t -129.94 137.81 55.64 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 C-N-CA 126.89 2.076 . . . . 0.0 107.959 177.454 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 60.2 t -132.93 123.46 48.48 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 169.591 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 41.5 mm -108.35 104.13 16.6 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 C-N-CA 124.496 1.119 . . . . 0.0 108.883 -176.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 3.6 m -81.78 107.48 14.54 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 169.646 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 75.4 mt -75.71 -18.72 59.51 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 114.945 1.461 . . . . 0.0 114.945 -170.062 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 28.7 p -136.66 30.81 2.83 Favored 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 114.935 1.457 . . . . 0.0 114.935 -168.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 152.03 -172.67 31.32 Favored Glycine 0 CA--C 1.532 1.096 0 N-CA-C 115.246 0.858 . . . . 0.0 115.246 177.685 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 97.0 p -79.01 160.64 27.08 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 125.295 1.438 . . . . 0.0 112.681 176.63 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -81.12 49.96 4.09 Favored Glycine 0 CA--C 1.534 1.267 0 C-N-CA 124.861 1.22 . . . . 0.0 114.951 -171.047 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 24.8 t -104.06 -33.17 3.01 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 CA-C-N 117.864 0.832 . . . . 0.0 112.88 -172.455 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 17.9 t-20 -84.84 -21.91 29.66 Favored 'General case' 0 CA--C 1.55 0.945 0 N-CA-C 113.865 1.061 . . . . 0.0 113.865 -179.239 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -82.42 160.49 62.02 Favored Pre-proline 0 CA--C 1.553 1.085 0 C-N-CA 124.0 0.92 . . . . 0.0 112.55 170.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_exo -61.47 149.75 88.23 Favored 'Trans proline' 0 CA--C 1.543 0.97 0 C-N-CA 122.79 2.327 . . . . 0.0 112.786 176.428 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -62.56 -29.04 77.87 Favored 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 122.95 2.433 . . . . 0.0 114.008 -170.356 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -60.64 -19.59 58.53 Favored 'General case' 0 CA--C 1.544 0.748 0 O-C-N 120.849 -1.157 . . . . 0.0 113.989 177.425 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 84.1 m95 -82.98 -14.71 53.53 Favored 'General case' 0 CA--C 1.542 0.662 0 O-C-N 120.659 -1.276 . . . . 0.0 113.324 175.667 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 14.5 m -93.49 -13.21 8.59 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.209 0 N-CA-C 113.729 1.011 . . . . 0.0 113.729 169.756 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 59.1 p -88.27 -5.46 58.35 Favored 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 114.48 1.289 . . . . 0.0 114.48 179.382 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 55.1 mm-40 -67.87 149.58 49.66 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-O 121.982 0.896 . . . . 0.0 110.275 169.63 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -53.88 -42.48 68.7 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 115.127 1.528 . . . . 0.0 115.127 -167.516 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 19.8 mm -117.44 63.83 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 C-N-CA 124.982 1.313 . . . . 0.0 109.232 179.21 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 33.0 t80 -76.11 111.86 11.96 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 168.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 9.0 mt-10 -108.97 130.92 55.47 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 114.15 1.167 . . . . 0.0 114.15 175.011 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 11.7 p-10 -93.89 109.7 21.4 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 125.016 1.326 . . . . 0.0 109.31 168.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 27.5 m0 -101.7 158.33 16.18 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.568 1.147 . . . . 0.0 108.943 169.627 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 8.3 mm-40 -128.41 65.84 1.39 Allowed 'General case' 0 CA--C 1.537 0.477 0 CA-C-O 122.875 1.321 . . . . 0.0 108.265 173.36 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 14.1 tp -77.11 150.63 35.61 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 126.608 1.963 . . . . 0.0 110.992 -174.344 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 29.4 tp10 -64.32 -43.01 96.01 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 113.681 0.993 . . . . 0.0 113.681 178.572 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 8.4 t0 62.88 126.39 0.02 OUTLIER Pre-proline 0 CA--C 1.558 1.257 0 C-N-CA 127.283 2.233 . . . . 0.0 113.596 -169.659 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_exo -62.61 -12.18 27.03 Favored 'Trans proline' 0 CA--C 1.55 1.301 0 C-N-CA 121.997 1.798 . . . . 0.0 114.499 172.189 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 8.6 t0 -23.99 107.47 0.03 OUTLIER 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 128.31 2.644 . . . . 0.0 116.068 169.629 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 72.16 10.59 74.08 Favored Glycine 0 CA--C 1.537 1.448 0 N-CA-C 116.379 1.312 . . . . 0.0 116.379 169.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 13.2 pt20 -128.73 166.5 18.84 Favored 'General case' 0 CA--C 1.545 0.753 0 CA-C-N 119.159 1.48 . . . . 0.0 113.999 -175.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 49.6 m -58.14 160.1 5.27 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 126.447 1.899 . . . . 0.0 115.63 -169.24 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 20.3 tp -59.41 -32.6 70.33 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.917 1.287 . . . . 0.0 113.069 178.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -61.76 -32.19 72.43 Favored 'General case' 0 N--CA 1.473 0.716 0 O-C-N 120.808 -1.183 . . . . 0.0 112.091 172.481 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 6.4 t -74.02 -37.62 47.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 CA-C-O 118.461 -0.78 . . . . 0.0 110.891 172.748 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 17.5 m-85 -57.08 -48.08 79.47 Favored 'General case' 0 N--CA 1.478 0.972 0 CA-C-N 120.273 1.397 . . . . 0.0 112.119 169.68 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 48.4 mtt-85 -60.12 -48.64 80.88 Favored 'General case' 0 N--CA 1.484 1.253 0 CA-C-N 119.185 0.902 . . . . 0.0 111.326 178.117 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 83.4 m -62.5 -46.13 89.85 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.884 0.873 . . . . 0.0 111.179 179.739 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 96.6 t -74.45 -41.19 49.58 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 CA-C-O 117.586 -1.197 . . . . 0.0 110.83 -175.307 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . 0.304 24.6 ptt85 -64.04 -28.65 69.94 Favored 'General case' 0 N--CA 1.483 1.225 0 CA-C-N 121.638 2.017 . . . . 0.0 113.12 177.487 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -65.15 -46.68 87.11 Favored Glycine 0 CA--C 1.542 1.772 0 CA-C-N 119.356 0.98 . . . . 0.0 112.938 169.279 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 15.0 mm100 -65.75 -41.32 92.25 Favored 'General case' 0 N--CA 1.475 0.824 0 O-C-N 121.387 -1.067 . . . . 0.0 112.151 177.014 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 77.7 t -60.82 -43.8 96.25 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 C-N-CA 125.416 1.487 . . . . 0.0 110.714 173.095 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 82.0 tttt -53.98 -49.68 68.24 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 119.205 0.911 . . . . 0.0 110.231 179.039 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -62.43 -41.65 98.88 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 112.742 0.645 . . . . 0.0 112.742 178.5 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 14.8 mtp85 -64.03 -43.6 95.08 Favored 'General case' 0 N--CA 1.479 1.01 0 N-CA-C 113.135 0.791 . . . . 0.0 113.135 176.024 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 94.2 t -70.91 -38.06 70.78 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 C-N-CA 123.181 0.592 . . . . 0.0 110.762 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -60.2 -38.52 83.56 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 118.613 0.642 . . . . 0.0 111.214 169.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 7.9 m-80 -62.48 -48.69 78.5 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 119.283 0.947 . . . . 0.0 112.153 174.112 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -52.89 -56.55 15.05 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.576 1.151 . . . . 0.0 110.699 174.076 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 85.4 mt -61.37 -42.15 92.59 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 O-C-N 122.017 -0.427 . . . . 0.0 111.08 -179.196 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -70.13 -13.18 62.08 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 114.755 1.391 . . . . 0.0 114.755 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -99.69 -28.5 13.15 Favored 'General case' 0 N--CA 1.479 0.998 0 N-CA-C 113.723 1.009 . . . . 0.0 113.723 172.24 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 19.1 pt -94.37 -21.43 5.84 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 N-CA-C 114.423 1.268 . . . . 0.0 114.423 177.755 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 66.6 m . . . . . 0 C--O 1.254 1.326 0 C-N-CA 125.074 1.35 . . . . 0.0 111.886 -174.085 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.8 ttt . . . . . 0 N--CA 1.503 2.196 0 N-CA-C 111.787 0.291 . . . . 0.0 111.787 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.67 161.3 30.92 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 126.336 1.855 . . . . 0.0 112.358 177.819 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 32.6 ttmt -114.5 116.49 28.91 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 107.136 -1.431 . . . . 0.0 107.136 167.73 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 16.0 t -106.17 134.6 47.27 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 C-N-CA 124.604 1.162 . . . . 0.0 114.085 -178.251 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 40.6 tpp -103.1 128.1 50.12 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 168.355 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 70.3 m-85 -108.97 131.8 54.71 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.984 0.914 . . . . 0.0 109.381 170.007 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.6 m -148.11 158.8 7.8 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.239 0 C-N-CA 124.179 0.992 . . . . 0.0 113.616 -171.666 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 35.1 t -152.31 156.48 39.72 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 126.941 2.096 . . . . 0.0 110.657 179.315 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 61.3 mtpt -72.62 138.83 47.0 Favored 'General case' 0 N--CA 1.484 1.275 0 C-N-CA 123.911 0.884 . . . . 0.0 110.42 169.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 69.9 mtp180 52.73 49.62 19.9 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 125.427 1.491 . . . . 0.0 113.571 -170.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -57.61 -26.51 61.64 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 115.134 1.531 . . . . 0.0 115.134 -176.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 77.1 p -80.2 -31.11 38.73 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 124.169 0.988 . . . . 0.0 112.857 176.725 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 16.4 m -77.79 -9.04 58.82 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.681 1.192 . . . . 0.0 112.79 173.743 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 74.6 mtt180 -131.5 157.96 42.16 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 125.491 1.516 . . . . 0.0 113.381 -169.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 71.0 m -105.22 129.74 53.53 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.979 0.912 . . . . 0.0 109.701 169.76 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 4.1 mp0 -98.67 -29.7 12.88 Favored 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 113.436 0.902 . . . . 0.0 113.436 -169.653 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' MET . . . . . 0.422 ' HG2' ' SD ' ' A' ' 50' ' ' MET . 0.0 OUTLIER 67.1 -43.63 0.44 Allowed 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 127.104 2.162 . . . . 0.0 115.35 172.904 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -66.16 -32.64 74.2 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 114.073 1.138 . . . . 0.0 114.073 -169.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.2 pm0 -62.76 -37.14 85.45 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 119.032 0.833 . . . . 0.0 111.565 172.266 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -62.77 -61.82 6.11 Favored Glycine 0 C--N 1.336 0.548 0 N-CA-C 110.688 -0.965 . . . . 0.0 110.688 177.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -59.55 -33.09 70.97 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 117.584 0.692 . . . . 0.0 112.768 -179.449 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -67.56 -25.87 66.02 Favored 'General case' 0 CA--C 1.539 0.554 0 O-C-N 121.289 -0.882 . . . . 0.0 112.612 177.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 23.4 mtpp -77.57 -44.09 29.62 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.719 0.808 . . . . 0.0 110.665 169.464 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -67.31 -38.58 85.19 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 123.424 0.69 . . . . 0.0 112.738 -175.875 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 55.6 mt -93.21 -27.65 16.74 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 125.388 1.475 . . . . 0.0 112.774 -178.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -111.72 -4.93 26.16 Favored Glycine 0 N--CA 1.471 1.006 0 N-CA-C 117.556 1.782 . . . . 0.0 117.556 -169.058 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -62.84 139.54 58.72 Favored 'General case' 0 CA--C 1.545 0.78 0 CA-C-N 121.42 2.61 . . . . 0.0 112.327 178.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 86.41 -22.1 14.59 Favored Glycine 0 CA--C 1.541 1.671 0 C-N-CA 125.114 1.34 . . . . 0.0 113.437 -169.327 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 63.5 mttp -96.67 -44.28 7.18 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 125.981 1.712 . . . . 0.0 111.686 169.813 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 46.0 pt -141.18 157.01 22.17 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 C-N-CA 125.182 1.393 . . . . 0.0 113.009 -174.354 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -101.25 144.91 29.53 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 127.12 2.168 . . . . 0.0 108.796 169.405 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 73.7 t -140.3 137.6 37.11 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 C-N-CA 123.675 0.79 . . . . 0.0 111.578 -171.578 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 54.1 m -145.28 150.68 37.09 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 124.11 0.964 . . . . 0.0 110.852 177.738 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 93.5 p -133.21 137.98 46.35 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 124.52 1.128 . . . . 0.0 109.012 166.684 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 88.2 p -119.35 -70.05 0.81 Allowed 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 114.259 1.207 . . . . 0.0 114.259 -168.337 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 130.07 154.49 8.08 Favored Glycine 0 N--CA 1.465 0.597 0 C-N-CA 125.716 1.626 . . . . 0.0 113.346 173.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 10.3 mp -89.36 -13.21 38.35 Favored 'General case' 0 N--CA 1.474 0.754 0 O-C-N 121.797 -0.825 . . . . 0.0 113.173 -178.118 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -140.96 -57.06 0.5 Allowed 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 124.282 1.033 . . . . 0.0 112.444 179.322 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 39.7 m -108.44 155.91 20.05 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 124.714 1.206 . . . . 0.0 111.405 178.094 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 95.9 p -90.86 14.58 13.29 Favored 'General case' 0 N--CA 1.478 0.957 0 N-CA-C 116.694 2.109 . . . . 0.0 116.694 -170.042 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 64.3 ttt180 -130.87 157.12 43.77 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 125.541 1.536 . . . . 0.0 111.871 -177.075 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 24.1 m -111.77 165.27 6.95 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 C-N-CA 126.6 1.96 . . . . 0.0 109.55 170.765 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 5.1 t-80 -50.98 131.65 30.06 Favored Pre-proline 0 CA--C 1.532 0.275 0 CA-C-O 118.19 -0.91 . . . . 0.0 113.231 -170.698 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_exo -57.57 -27.94 78.99 Favored 'Trans proline' 0 CA--C 1.548 1.218 0 CA-C-N 120.612 1.254 . . . . 0.0 112.361 173.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 46.1 m -63.93 -32.5 74.05 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 126.08 1.752 . . . . 0.0 112.986 172.192 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -55.12 -45.23 75.55 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 123.977 0.911 . . . . 0.0 110.97 178.753 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.4 mp -53.95 -51.7 43.15 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 C-N-CA 124.09 0.956 . . . . 0.0 109.483 -176.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.4 -32.3 73.7 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 113.147 0.795 . . . . 0.0 113.147 -179.587 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -80.1 -30.15 39.11 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 113.452 0.908 . . . . 0.0 113.452 178.545 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' MET . . . . . 0.422 ' SD ' ' HG2' ' A' ' 17' ' ' MET . 3.2 mmt -76.91 -30.77 56.29 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.42 0.688 . . . . 0.0 110.851 170.712 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -68.58 -13.25 62.21 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 124.41 1.084 . . . . 0.0 113.323 172.508 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -63.94 -29.71 70.85 Favored 'General case' 0 N--CA 1.481 1.124 0 CA-C-N 120.706 1.594 . . . . 0.0 110.695 168.705 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 61.5 t -91.62 -7.68 10.56 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.903 0 C-N-CA 126.896 2.078 . . . . 0.0 111.058 173.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 83.54 21.75 57.58 Favored Glycine 0 CA--C 1.539 1.56 0 C-N-CA 125.434 1.492 . . . . 0.0 114.447 -177.71 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 31.9 mt -88.82 135.73 25.08 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 C-N-CA 124.595 1.158 . . . . 0.0 111.505 -172.188 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 18.6 t0 -94.39 120.19 34.26 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 123.582 0.753 . . . . 0.0 112.332 171.492 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 9.2 pt -134.67 -1.94 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.358 0 N-CA-C 116.094 1.887 . . . . 0.0 116.094 179.257 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 83.5 p -73.28 -21.9 60.49 Favored 'General case' 0 N--CA 1.481 1.092 0 N-CA-C 115.175 1.546 . . . . 0.0 115.175 -169.638 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -78.44 0.86 73.87 Favored Glycine 0 CA--C 1.54 1.604 0 N-CA-C 116.39 1.316 . . . . 0.0 116.39 -173.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 33.4 mt-30 -78.65 -11.98 60.0 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 115.304 1.594 . . . . 0.0 115.304 -171.345 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 42.8 p -63.94 115.42 4.86 Favored 'General case' 0 N--CA 1.477 0.883 0 CA-C-N 119.537 1.062 . . . . 0.0 113.56 -169.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 89.2 p -152.35 -77.86 0.12 Allowed 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.765 1.226 . . . . 0.0 112.708 177.762 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -146.43 159.26 45.43 Favored Pre-proline 0 CA--C 1.554 1.112 0 C-N-CA 124.41 1.084 . . . . 0.0 113.522 -171.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_endo -61.71 161.04 26.24 Favored 'Trans proline' 0 C--N 1.352 0.742 0 C-N-CA 124.174 3.249 . . . . 0.0 114.133 169.745 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 11.6 tt -51.32 -35.68 16.28 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.128 0 C-N-CA 125.824 1.65 . . . . 0.0 112.444 172.484 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 17.5 mt-10 -64.42 -17.77 64.1 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 123.779 0.832 . . . . 0.0 112.961 -177.718 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -84.69 -10.67 57.07 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 124.792 1.237 . . . . 0.0 113.604 -175.898 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 76.6 m-85 -111.5 -168.32 1.29 Allowed 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 125.979 1.711 . . . . 0.0 112.348 -173.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 6.4 t30 -124.39 123.47 40.25 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 126.064 1.745 . . . . 0.0 109.864 178.673 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.81 -33.61 75.98 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 114.187 1.18 . . . . 0.0 114.187 -170.601 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . 0.269 0.0 OUTLIER -71.41 -4.62 27.4 Favored 'General case' 0 CA--C 1.544 0.721 0 N-CA-C 114.212 1.19 . . . . 0.0 114.212 -178.11 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -73.94 -12.33 60.62 Favored 'General case' 0 CA--C 1.549 0.904 0 C-N-CA 123.965 0.906 . . . . 0.0 111.348 168.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 58.3 m-85 -117.22 138.88 51.42 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 127.001 2.12 . . . . 0.0 111.268 179.128 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -90.5 -23.23 21.0 Favored 'General case' 0 N--CA 1.478 0.956 0 CA-C-O 122.207 1.003 . . . . 0.0 112.926 178.349 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 96.5 t -132.28 136.11 56.93 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 C-N-CA 126.988 2.115 . . . . 0.0 108.249 -174.12 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 91.0 t -131.8 125.76 56.04 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 170.104 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 45.1 mm -112.39 105.15 18.23 Favored 'Isoleucine or valine' 0 C--O 1.233 0.237 0 C-N-CA 124.257 1.023 . . . . 0.0 109.354 -176.239 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 24.4 m -86.66 98.79 11.31 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 123.667 0.787 . . . . 0.0 109.117 171.807 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 52.7 mt -69.69 178.62 2.49 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 125.499 1.52 . . . . 0.0 110.966 170.474 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 16.2 m 63.1 19.7 11.82 Favored 'General case' 0 CA--C 1.547 0.841 0 N-CA-C 114.784 1.401 . . . . 0.0 114.784 169.78 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 131.79 -120.43 2.81 Favored Glycine 0 CA--C 1.531 1.048 0 C-N-CA 124.512 1.053 . . . . 0.0 111.971 -172.152 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 9.2 t -135.96 157.99 45.48 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 124.908 1.283 . . . . 0.0 112.82 178.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -74.66 113.93 4.22 Favored Glycine 0 CA--C 1.531 1.087 0 C-N-CA 124.414 1.006 . . . . 0.0 112.261 -179.326 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 11.3 p -139.53 -39.06 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.26 0 N-CA-C 114.594 1.331 . . . . 0.0 114.594 -178.147 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 65.0 t30 -92.43 -15.63 26.92 Favored 'General case' 0 CA--C 1.549 0.911 0 N-CA-C 114.12 1.155 . . . . 0.0 114.12 -177.228 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -71.44 157.13 90.58 Favored Pre-proline 0 CA--C 1.552 1.024 0 O-C-N 121.309 -0.869 . . . . 0.0 111.843 169.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_exo -62.2 149.03 92.1 Favored 'Trans proline' 0 CA--C 1.545 1.047 0 C-N-CA 122.215 1.944 . . . . 0.0 113.352 -177.52 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_exo -57.33 -33.63 96.5 Favored 'Trans proline' 0 C--N 1.351 0.707 0 C-N-CA 122.935 2.423 . . . . 0.0 115.144 -169.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -60.98 -21.4 63.5 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 114.284 1.216 . . . . 0.0 114.284 179.763 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 87.5 m95 -81.51 -22.2 38.1 Favored 'General case' 0 CA--C 1.535 0.388 0 O-C-N 120.637 -1.289 . . . . 0.0 112.663 176.302 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 10.6 m -89.77 -3.16 10.06 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 N-CA-C 113.463 0.912 . . . . 0.0 113.463 172.568 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 59.3 p -103.24 3.8 35.96 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 125.373 1.469 . . . . 0.0 114.888 176.251 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 80.6 mm-40 -66.86 156.66 35.07 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 119.351 0.978 . . . . 0.0 111.973 171.668 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -58.19 -42.01 85.2 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 114.278 1.214 . . . . 0.0 114.278 -167.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 20.1 mm -115.0 59.52 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 C-N-CA 124.822 1.249 . . . . 0.0 108.708 175.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 21.7 t80 -75.6 109.7 9.39 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 169.069 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 13.1 mt-10 -109.18 140.61 42.56 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 114.665 1.357 . . . . 0.0 114.665 174.252 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -98.23 121.05 39.67 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.985 1.314 . . . . 0.0 109.706 169.249 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 24.4 m0 -112.79 105.59 13.75 Favored 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 124.917 1.287 . . . . 0.0 109.063 -177.349 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -85.11 37.21 0.66 Allowed 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 124.933 1.293 . . . . 0.0 112.02 -171.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 73.9 mt -76.17 158.68 31.44 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 126.114 1.766 . . . . 0.0 111.934 178.561 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -81.41 152.08 27.6 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-O 121.559 0.695 . . . . 0.0 112.564 170.639 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 12.5 p-10 -88.02 136.87 31.73 Favored Pre-proline 0 CA--C 1.546 0.808 0 C-N-CA 125.0 1.32 . . . . 0.0 110.987 170.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -82.42 -9.22 11.43 Favored 'Trans proline' 0 CA--C 1.55 1.301 0 C-N-CA 121.57 1.513 . . . . 0.0 114.461 -174.785 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -65.29 146.14 55.32 Favored 'General case' 0 CA--C 1.547 0.837 0 CA-C-N 119.438 1.017 . . . . 0.0 112.47 175.675 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 77.78 5.58 86.54 Favored Glycine 0 CA--C 1.538 1.501 0 C-N-CA 123.829 0.728 . . . . 0.0 114.751 179.449 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -141.9 173.62 11.34 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 126.208 1.803 . . . . 0.0 112.015 178.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 24.4 p -65.78 164.97 13.62 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 116.161 1.911 . . . . 0.0 116.161 -169.274 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 43.7 tp -60.91 -27.91 68.53 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.171 0.988 . . . . 0.0 112.25 171.533 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -66.62 -32.14 73.28 Favored 'General case' 0 CA--C 1.54 0.575 0 O-C-N 120.681 -1.262 . . . . 0.0 111.508 172.597 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 4.4 t -72.49 -36.92 55.72 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 O-C-N 121.108 -0.995 . . . . 0.0 111.841 170.656 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -55.1 -47.57 74.79 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 119.724 1.147 . . . . 0.0 111.471 169.501 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -69.66 -32.59 71.32 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.658 0.783 . . . . 0.0 112.498 178.573 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 42.9 m -62.94 -43.89 97.55 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 123.883 0.873 . . . . 0.0 110.627 169.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 68.8 t -65.7 -41.01 89.53 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 CA-C-O 117.576 -1.202 . . . . 0.0 110.576 175.727 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 24.9 mtm105 -53.98 -49.48 68.71 Favored 'General case' 0 N--CA 1.484 1.24 0 CA-C-N 120.607 1.548 . . . . 0.0 111.592 169.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -59.22 -49.65 76.19 Favored Glycine 0 CA--C 1.538 1.505 0 CA-C-N 119.438 1.017 . . . . 0.0 113.641 179.326 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 56.7 mm-40 -63.58 -44.08 95.12 Favored 'General case' 0 N--CA 1.473 0.708 0 O-C-N 121.996 -0.708 . . . . 0.0 111.988 178.178 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 53.4 t -64.81 -39.71 86.58 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 C-N-CA 124.048 0.939 . . . . 0.0 111.186 176.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 12.3 tmtt? -56.07 -48.83 75.33 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 119.654 1.115 . . . . 0.0 110.312 179.041 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -65.15 -42.62 93.6 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 112.929 0.714 . . . . 0.0 112.929 176.792 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 15.5 mmm180 -62.03 -43.87 97.91 Favored 'General case' 0 N--CA 1.48 1.055 0 O-C-N 121.467 -0.771 . . . . 0.0 112.737 176.536 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 85.6 t -70.38 -37.75 71.75 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 123.776 0.83 . . . . 0.0 111.273 179.082 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 70.6 mt-10 -60.23 -41.91 94.12 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 119.537 1.062 . . . . 0.0 111.6 170.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 15.2 m-80 -63.33 -45.36 91.62 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 118.347 0.521 . . . . 0.0 112.151 175.432 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 8.6 tt -53.19 -55.9 20.63 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 124.604 1.162 . . . . 0.0 110.892 173.642 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 84.2 mt -63.27 -43.0 98.47 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 O-C-N 121.593 -0.692 . . . . 0.0 110.376 -177.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -68.07 -14.02 62.65 Favored 'General case' 0 CA--C 1.546 0.789 0 N-CA-C 114.822 1.415 . . . . 0.0 114.822 178.807 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 20.0 ptmt -102.04 -32.76 10.0 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 113.573 0.953 . . . . 0.0 113.573 174.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 13.5 pt -89.54 -17.3 8.18 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 N-CA-C 114.185 1.18 . . . . 0.0 114.185 -179.529 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 68.8 m . . . . . 0 C--O 1.255 1.365 0 N-CA-C 112.888 0.699 . . . . 0.0 112.888 -179.92 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.8 ttt . . . . . 0 N--CA 1.504 2.259 0 N-CA-C 111.493 0.183 . . . . 0.0 111.493 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 3.0 mptp? -121.91 160.31 25.05 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 125.683 1.593 . . . . 0.0 112.3 175.139 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 33.9 ttmt -111.03 116.92 32.0 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 106.647 -1.612 . . . . 0.0 106.647 167.146 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 16.8 t -104.41 132.05 51.91 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 C-N-CA 124.752 1.221 . . . . 0.0 113.831 -177.719 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 48.5 tpp -100.43 123.4 44.6 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 123.882 0.873 . . . . 0.0 109.137 169.177 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 48.6 m-85 -108.18 121.07 44.09 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 124.574 1.15 . . . . 0.0 109.241 172.178 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 5.1 m -144.14 165.64 13.51 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 C-N-CA 125.009 1.323 . . . . 0.0 112.369 -169.308 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -154.39 148.7 26.04 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 125.999 1.72 . . . . 0.0 110.301 175.165 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 39.5 ttpt -46.3 122.31 3.93 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 125.272 1.429 . . . . 0.0 111.968 175.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . 0.261 91.6 mtt180 52.67 -30.86 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 129.034 2.934 . . . . 0.0 118.896 -174.444 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 5.1 t30 61.81 -19.65 0.04 OUTLIER 'General case' 0 CA--C 1.558 1.261 0 N-CA-C 117.813 2.523 . . . . 0.0 117.813 169.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 75.7 m -50.41 121.27 5.44 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 126.525 1.93 . . . . 0.0 113.157 -177.3 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 66.5 m 51.41 41.07 27.95 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 125.006 1.323 . . . . 0.0 113.096 174.619 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 14.9 ttt180 -126.83 153.18 45.98 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 125.911 1.684 . . . . 0.0 110.023 177.171 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 33.1 m -102.94 126.87 50.28 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 124.062 0.945 . . . . 0.0 110.836 -179.455 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 3.9 mp0 -106.09 -36.16 7.01 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.793 0.837 . . . . 0.0 112.606 -172.523 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 68.78 -48.59 0.57 Allowed 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 126.823 2.049 . . . . 0.0 115.867 169.348 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -59.01 -36.23 74.58 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.59 1.156 . . . . 0.0 113.58 -171.13 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 6.3 pm0 -61.97 -41.63 98.23 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 124.739 1.216 . . . . 0.0 112.499 175.593 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -69.03 -40.23 83.94 Favored Glycine 0 C--N 1.335 0.483 0 N-CA-C 111.54 -0.624 . . . . 0.0 111.54 178.331 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -70.01 -40.41 75.27 Favored 'General case' 0 N--CA 1.468 0.434 0 O-C-N 121.947 -0.737 . . . . 0.0 111.493 177.489 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -60.19 -43.7 95.69 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 119.255 0.934 . . . . 0.0 112.941 -174.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 8.0 pttp -77.19 -26.61 53.05 Favored 'General case' 0 N--CA 1.481 1.115 0 N-CA-C 113.586 0.958 . . . . 0.0 113.586 174.253 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 94.2 m -72.47 -32.85 66.58 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.06 0.544 . . . . 0.0 111.754 174.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 72.3 mt -91.33 -34.36 14.94 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 125.847 1.659 . . . . 0.0 114.598 -179.221 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -135.41 28.04 3.05 Favored Glycine 0 N--CA 1.474 1.175 0 N-CA-C 118.789 2.275 . . . . 0.0 118.789 -168.711 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -65.05 -22.73 67.02 Favored 'General case' 0 CA--C 1.546 0.8 0 CA-C-N 122.108 2.954 . . . . 0.0 115.701 -176.315 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -72.62 -10.92 76.81 Favored Glycine 0 CA--C 1.542 1.77 0 O-C-N 121.209 -0.932 . . . . 0.0 113.868 169.639 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 54.8 mttm -109.56 -39.54 5.13 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 127.251 2.22 . . . . 0.0 112.98 -179.472 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 41.2 pt -145.49 155.43 13.32 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 C-N-CA 124.555 1.142 . . . . 0.0 113.942 -171.174 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -99.43 142.49 30.85 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 126.065 1.746 . . . . 0.0 108.916 169.295 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 97.6 t -130.4 140.11 49.66 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 O-C-N 121.439 -0.788 . . . . 0.0 111.704 -176.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 13.9 m -139.38 153.72 47.71 Favored 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 124.981 1.312 . . . . 0.0 109.698 175.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 91.4 p -128.59 155.58 44.71 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 123.803 0.841 . . . . 0.0 109.742 167.751 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 60.5 p -140.33 161.68 37.11 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 114.824 -1.08 . . . . 0.0 112.149 173.702 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -119.79 101.78 0.86 Allowed Glycine 0 C--N 1.339 0.696 0 N-CA-C 110.343 -1.103 . . . . 0.0 110.343 -169.731 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 10.6 mp -59.63 125.58 24.2 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.734 0.814 . . . . 0.0 109.512 -169.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 68.15 42.05 1.84 Allowed 'General case' 0 CA--C 1.553 1.074 0 C-N-CA 124.716 1.206 . . . . 0.0 113.02 -173.251 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 69.6 m 61.85 54.63 2.82 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 127.724 2.409 . . . . 0.0 113.776 169.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 79.2 p -114.39 164.77 13.5 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 115.587 1.699 . . . . 0.0 115.587 -171.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 22.2 tpt180 -113.38 144.85 42.08 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 126.363 1.865 . . . . 0.0 110.453 177.014 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 16.7 m -68.51 171.56 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.206 0 CA-C-O 122.002 0.906 . . . . 0.0 110.282 169.089 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 1.7 t-80 -59.37 131.02 87.73 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-O 118.431 -0.795 . . . . 0.0 112.659 179.617 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo -60.43 -27.69 85.33 Favored 'Trans proline' 0 CA--C 1.547 1.171 0 C-N-CA 121.35 1.367 . . . . 0.0 111.569 169.607 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 90.0 m -65.83 -30.83 71.51 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 125.278 1.431 . . . . 0.0 112.321 174.341 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -57.52 -39.42 76.5 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.365 1.066 . . . . 0.0 111.532 -175.163 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 2.3 mp -57.12 -60.38 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 C-N-CA 123.665 0.786 . . . . 0.0 109.311 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.19 -31.11 72.18 Favored 'General case' 0 CA--C 1.546 0.808 0 N-CA-C 113.616 0.969 . . . . 0.0 113.616 -177.04 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -81.55 -8.05 59.67 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 114.305 1.224 . . . . 0.0 114.305 177.373 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 41.3 mtt -109.88 -24.02 11.06 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 125.057 1.343 . . . . 0.0 110.211 173.606 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 24.3 mt-10 -64.98 -16.01 62.9 Favored 'General case' 0 CA--C 1.546 0.818 0 O-C-N 120.609 -1.307 . . . . 0.0 111.749 168.694 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 12.3 mt-10 -61.16 -29.33 69.73 Favored 'General case' 0 N--CA 1.482 1.173 0 CA-C-N 119.877 1.217 . . . . 0.0 110.92 169.108 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 48.1 t -92.27 -4.99 10.8 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.981 0 C-N-CA 127.437 2.295 . . . . 0.0 111.118 177.032 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 80.91 17.39 72.63 Favored Glycine 0 CA--C 1.538 1.494 0 C-N-CA 125.223 1.392 . . . . 0.0 114.566 -173.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 78.9 mt -77.64 139.92 17.87 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 C-N-CA 124.309 1.044 . . . . 0.0 111.893 -173.275 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -104.98 104.97 14.81 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.58 1.152 . . . . 0.0 111.761 175.598 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 3.5 pt -131.7 0.84 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 N-CA-C 115.696 1.739 . . . . 0.0 115.696 -178.283 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 93.6 p -70.74 -30.98 67.65 Favored 'General case' 0 N--CA 1.48 1.051 0 CA-C-N 120.012 1.278 . . . . 0.0 113.635 -177.541 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -79.74 13.16 25.26 Favored Glycine 0 CA--C 1.539 1.567 0 C-N-CA 125.743 1.64 . . . . 0.0 115.75 -179.201 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 32.0 mt-30 -80.9 167.98 19.26 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 118.886 1.343 . . . . 0.0 111.868 178.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 3.6 t -71.77 171.64 11.25 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 114.963 1.468 . . . . 0.0 114.963 -178.33 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 48.8 m -125.21 6.07 7.81 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 128.436 2.694 . . . . 0.0 111.66 169.475 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 23.7 m-20 -88.17 155.34 52.08 Favored Pre-proline 0 CA--C 1.546 0.818 0 C-N-CA 124.729 1.212 . . . . 0.0 113.746 179.22 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -78.43 158.78 29.23 Favored 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 123.49 2.793 . . . . 0.0 114.406 -177.685 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 8.5 tt -53.12 -38.98 31.62 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 C-N-CA 124.308 1.043 . . . . 0.0 112.486 174.781 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -70.16 -6.77 36.55 Favored 'General case' 0 CA--C 1.545 0.778 0 N-CA-C 114.116 1.154 . . . . 0.0 114.116 179.11 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -76.42 -15.13 60.0 Favored 'General case' 0 CA--C 1.547 0.83 0 O-C-N 121.429 -0.794 . . . . 0.0 112.569 170.691 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 61.5 m-85 -109.04 -171.61 1.88 Allowed 'General case' 0 CA--C 1.552 1.041 0 C-N-CA 126.921 2.088 . . . . 0.0 111.57 -179.175 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -125.79 126.57 44.76 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 125.337 1.455 . . . . 0.0 110.232 177.397 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.65 -35.88 82.06 Favored 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 113.641 0.978 . . . . 0.0 113.641 -170.1 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . 0.258 0.0 OUTLIER -72.67 -4.88 33.83 Favored 'General case' 0 CA--C 1.547 0.853 0 N-CA-C 113.718 1.007 . . . . 0.0 113.718 -177.559 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -74.47 -12.21 60.43 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 123.982 0.913 . . . . 0.0 111.142 168.588 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 65.7 m-85 -115.28 146.55 41.38 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 127.483 2.313 . . . . 0.0 110.989 178.345 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -105.25 -16.16 14.85 Favored 'General case' 0 N--CA 1.479 1.022 0 CA-C-O 121.97 0.891 . . . . 0.0 112.641 178.148 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 80.3 t -133.17 136.69 54.79 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 C-N-CA 127.306 2.242 . . . . 0.0 107.671 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 60.0 t -132.35 126.9 56.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 N-CA-C 107.999 -1.111 . . . . 0.0 107.999 169.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 43.5 mm -114.31 118.37 58.3 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 C-N-CA 124.635 1.174 . . . . 0.0 108.815 -175.669 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 8.6 t -100.47 116.61 32.81 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 122.934 0.493 . . . . 0.0 111.462 173.672 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 49.9 mt -94.52 -13.38 26.13 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 125.724 1.61 . . . . 0.0 113.71 -172.291 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 1.5 p -156.63 147.45 21.82 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 124.075 0.95 . . . . 0.0 111.412 176.041 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 80.19 179.99 52.94 Favored Glycine 0 CA--C 1.539 1.567 0 C-N-CA 124.53 1.062 . . . . 0.0 114.528 -178.224 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 67.2 m -92.04 3.65 54.79 Favored 'General case' 0 N--CA 1.479 0.993 0 N-CA-C 114.719 1.377 . . . . 0.0 114.719 -170.01 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 79.67 23.59 62.02 Favored Glycine 0 CA--C 1.537 1.414 0 N-CA-C 115.164 0.826 . . . . 0.0 115.164 178.673 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 14.3 t -106.46 -12.0 10.09 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.374 0 C-N-CA 124.323 1.049 . . . . 0.0 112.855 -179.318 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 12.9 t-20 -81.35 6.62 13.79 Favored 'General case' 0 CA--C 1.552 1.023 0 C-N-CA 125.202 1.401 . . . . 0.0 113.397 -179.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -127.97 161.07 58.08 Favored Pre-proline 0 CA--C 1.552 1.032 0 C-N-CA 126.912 2.085 . . . . 0.0 112.058 178.165 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_exo -63.36 148.06 93.08 Favored 'Trans proline' 0 CA--C 1.546 1.11 0 C-N-CA 122.355 2.036 . . . . 0.0 112.773 177.344 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_exo -56.83 -30.61 85.84 Favored 'Trans proline' 0 C--N 1.352 0.733 0 C-N-CA 123.051 2.5 . . . . 0.0 115.286 -174.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -59.77 -20.44 56.65 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 114.237 1.199 . . . . 0.0 114.237 178.458 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 89.1 m95 -81.88 -17.04 48.69 Favored 'General case' 0 CA--C 1.539 0.522 0 O-C-N 120.594 -1.316 . . . . 0.0 113.364 175.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 5.4 m -92.83 -8.38 10.16 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.105 0 CA-C-N 119.404 1.002 . . . . 0.0 113.398 170.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 72.5 p -98.24 -0.46 44.01 Favored 'General case' 0 N--CA 1.479 0.995 0 N-CA-C 114.873 1.434 . . . . 0.0 114.873 179.216 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 73.9 mm-40 -66.01 152.71 44.01 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 119.442 1.019 . . . . 0.0 111.202 169.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -55.38 -43.15 74.88 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 114.634 1.346 . . . . 0.0 114.634 -167.661 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 19.9 mm -114.49 61.15 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 C-N-CA 124.84 1.256 . . . . 0.0 109.003 176.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 41.7 t80 -77.23 108.16 10.14 Favored 'General case' 0 CA--C 1.535 0.393 0 O-C-N 120.639 -1.288 . . . . 0.0 108.22 169.119 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 9.4 mt-10 -108.23 136.86 47.18 Favored 'General case' 0 CA--C 1.545 0.758 0 N-CA-C 114.947 1.462 . . . . 0.0 114.947 177.071 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -91.54 114.1 26.54 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.916 1.287 . . . . 0.0 110.202 169.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 23.1 m0 -111.88 81.97 1.55 Allowed 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 125.047 1.339 . . . . 0.0 109.538 179.579 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 7.5 pt20 -75.88 55.77 0.91 Allowed 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 125.576 1.55 . . . . 0.0 112.279 176.709 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 73.4 mt -86.99 167.19 14.47 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 127.493 2.317 . . . . 0.0 112.481 -178.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -68.68 149.65 48.84 Favored 'General case' 0 CA--C 1.546 0.812 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.99 169.255 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -117.75 142.76 31.2 Favored Pre-proline 0 CA--C 1.553 1.085 0 C-N-CA 125.073 1.349 . . . . 0.0 112.148 175.544 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_exo -75.26 -15.96 19.9 Favored 'Trans proline' 0 CA--C 1.547 1.126 0 N-CA-C 116.929 1.857 . . . . 0.0 116.929 -172.104 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -67.2 141.79 57.2 Favored 'General case' 0 N--CA 1.476 0.837 0 CA-C-N 120.313 1.415 . . . . 0.0 113.334 -170.296 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 77.33 8.59 87.04 Favored Glycine 0 CA--C 1.538 1.527 0 C-N-CA 124.635 1.112 . . . . 0.0 114.901 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 -141.58 164.64 29.68 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 125.033 1.333 . . . . 0.0 113.553 -178.127 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 66.4 m -63.49 164.07 9.96 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 116.161 1.911 . . . . 0.0 116.161 -169.129 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 25.8 tp -57.12 -31.38 65.26 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 125.686 1.594 . . . . 0.0 113.274 176.202 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -62.04 -30.52 71.03 Favored 'General case' 0 CA--C 1.541 0.628 0 O-C-N 121.002 -1.061 . . . . 0.0 111.988 172.662 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 4.2 t -75.89 -38.86 37.08 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 O-C-N 121.122 -0.986 . . . . 0.0 111.388 173.159 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 20.0 m-85 -56.85 -45.31 82.51 Favored 'General case' 0 N--CA 1.481 1.082 0 CA-C-N 120.169 1.349 . . . . 0.0 111.609 169.521 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -67.79 -37.29 81.82 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 124.179 0.991 . . . . 0.0 112.135 178.566 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 70.6 m -67.91 -42.62 80.83 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 123.793 0.837 . . . . 0.0 111.567 174.042 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 53.3 t -66.19 -41.41 89.23 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 CA-C-O 118.387 -0.816 . . . . 0.0 110.142 177.252 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 15.7 mtp180 -52.78 -46.89 67.78 Favored 'General case' 0 N--CA 1.479 1.022 0 CA-C-N 119.755 1.161 . . . . 0.0 112.507 170.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -59.69 -50.56 66.39 Favored Glycine 0 CA--C 1.54 1.6 0 CA-C-N 119.375 0.988 . . . . 0.0 113.427 176.352 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 60.3 mm-40 -65.89 -44.39 85.43 Favored 'General case' 0 N--CA 1.472 0.672 0 O-C-N 121.775 -0.838 . . . . 0.0 112.304 -179.682 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 65.6 t -64.25 -41.43 92.36 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 C-N-CA 124.782 1.233 . . . . 0.0 110.685 176.21 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 80.0 tttt -54.98 -50.06 69.89 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 120.18 1.355 . . . . 0.0 111.068 178.133 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -61.72 -40.67 95.87 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 112.205 0.446 . . . . 0.0 112.205 176.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.89 -35.91 81.96 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 124.354 1.062 . . . . 0.0 113.722 177.133 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 95.2 t -76.24 -40.92 36.64 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 C-N-CA 125.421 1.489 . . . . 0.0 111.284 176.228 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -61.47 -39.6 91.46 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 119.039 0.836 . . . . 0.0 111.39 172.373 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 13.6 m-80 -64.42 -43.57 93.95 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 118.69 0.677 . . . . 0.0 112.611 174.3 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -54.52 -56.58 17.39 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 124.256 1.023 . . . . 0.0 110.442 173.132 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 85.0 mt -61.04 -42.45 93.14 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 CA-C-O 119.166 -0.445 . . . . 0.0 110.532 -178.576 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -73.67 -10.77 60.04 Favored 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 115.073 1.508 . . . . 0.0 115.073 -179.449 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 20.7 ptmt -98.66 -27.16 14.11 Favored 'General case' 0 N--CA 1.479 0.997 0 CA-C-N 119.501 1.046 . . . . 0.0 113.388 169.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 14.3 pt -95.45 -7.6 9.75 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 N-CA-C 114.599 1.333 . . . . 0.0 114.599 176.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 27.3 p . . . . . 0 C--O 1.255 1.391 0 N-CA-C 114.774 1.398 . . . . 0.0 114.774 176.06 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.5 ttt . . . . . 0 N--CA 1.501 2.114 0 N-CA-C 111.725 0.269 . . . . 0.0 111.725 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.5 165.08 28.39 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 125.135 1.374 . . . . 0.0 112.684 175.573 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 67.9 mttt -95.75 145.02 25.64 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.996 0.918 . . . . 0.0 112.333 177.184 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 15.0 t -124.46 134.28 67.13 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 C-N-CA 125.301 1.44 . . . . 0.0 111.884 177.285 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 14.4 tpp -101.02 123.78 45.73 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.087 0.555 . . . . 0.0 109.894 169.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 48.4 m-85 -110.8 99.02 8.02 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 124.533 1.133 . . . . 0.0 110.509 175.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 1.4 m -111.7 165.21 6.94 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 C-N-CA 125.035 1.334 . . . . 0.0 112.042 -173.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 7.8 t -142.44 140.29 31.9 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 125.279 1.432 . . . . 0.0 111.041 179.444 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 37.5 ttmt -66.13 118.56 10.04 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.42 0.688 . . . . 0.0 110.499 175.231 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 28.6 mmt85 45.51 91.48 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 127.441 2.296 . . . . 0.0 113.14 -175.575 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 15.9 m120 -61.36 -17.46 54.04 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 115.839 1.792 . . . . 0.0 115.839 -171.692 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 70.8 m -50.48 138.65 17.04 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.489 1.116 . . . . 0.0 112.212 178.049 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 24.6 p 55.03 -10.62 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.246 0 N-CA-C 118.12 2.637 . . . . 0.0 118.12 -173.707 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 52.3 mtm-85 -93.6 157.22 16.29 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 125.985 1.714 . . . . 0.0 113.789 -174.678 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 5.5 m -113.94 -22.18 10.23 Favored 'General case' 0 N--CA 1.477 0.924 0 N-CA-C 116.457 2.021 . . . . 0.0 116.457 -169.463 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 26.0 mt-30 62.12 -64.0 0.09 Allowed 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 127.078 2.151 . . . . 0.0 116.674 -178.174 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' MET . . . . . 0.4 ' HG2' ' SD ' ' A' ' 50' ' ' MET . 0.0 OUTLIER 74.13 -49.24 0.67 Allowed 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 127.209 2.203 . . . . 0.0 114.344 177.026 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.68 -34.57 74.54 Favored 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 114.602 1.334 . . . . 0.0 114.602 -170.337 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 20.3 pm0 -63.47 -38.18 90.16 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 124.783 1.233 . . . . 0.0 112.138 178.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -72.22 -37.67 59.37 Favored Glycine 0 C--N 1.337 0.593 0 C-N-CA 123.681 0.657 . . . . 0.0 111.794 178.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -73.36 -37.98 65.87 Favored 'General case' 0 N--CA 1.469 0.49 0 O-C-N 121.685 -0.891 . . . . 0.0 111.772 176.819 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -62.74 -35.86 81.15 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 113.403 0.89 . . . . 0.0 113.403 -173.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 6.2 pttp -79.48 -36.36 38.82 Favored 'General case' 0 N--CA 1.479 1.023 0 N-CA-C 113.269 0.84 . . . . 0.0 113.269 170.135 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 39.0 m -69.46 -31.06 69.13 Favored 'General case' 0 N--CA 1.484 1.253 0 O-C-N 121.8 -0.563 . . . . 0.0 111.977 -178.57 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 83.8 mt -91.74 -36.35 13.62 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 125.868 1.667 . . . . 0.0 112.889 174.529 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -104.11 3.03 44.11 Favored Glycine 0 N--CA 1.473 1.13 0 N-CA-C 117.574 1.789 . . . . 0.0 117.574 -169.529 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.49 140.76 58.03 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 121.356 2.578 . . . . 0.0 112.413 178.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 81.31 -11.48 43.89 Favored Glycine 0 CA--C 1.541 1.671 0 C-N-CA 124.783 1.182 . . . . 0.0 114.081 -169.673 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 63.5 mttp -110.01 -44.61 3.75 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 126.089 1.756 . . . . 0.0 111.69 172.771 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 44.5 pt -138.99 159.95 29.67 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 125.903 1.681 . . . . 0.0 112.408 179.497 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -106.52 148.21 28.49 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.092 1.357 . . . . 0.0 110.378 169.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 57.2 t -133.44 139.54 48.81 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 CA-C-N 119.002 0.819 . . . . 0.0 112.483 -177.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 85.9 m -133.14 150.85 52.01 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 125.696 1.598 . . . . 0.0 108.168 169.592 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 10.1 p -90.49 -73.97 0.51 Allowed 'General case' 0 N--CA 1.47 0.534 0 O-C-N 121.589 -0.695 . . . . 0.0 112.759 174.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 9.6 p 66.06 156.57 0.1 Allowed 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 127.925 2.49 . . . . 0.0 113.602 -169.645 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -106.61 156.33 16.2 Favored Glycine 0 N--CA 1.465 0.586 0 O-C-N 121.432 -0.793 . . . . 0.0 112.18 -175.052 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 9.7 mp -99.52 108.97 21.54 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 169.234 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 69.14 64.71 0.28 Allowed 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 126.44 1.896 . . . . 0.0 113.173 -176.661 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 67.5 m 48.51 48.39 19.47 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 126.968 2.107 . . . . 0.0 115.058 169.575 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 58.1 m -129.59 156.63 43.89 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 124.455 1.102 . . . . 0.0 113.172 -172.584 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 59.5 ttt-85 -115.78 153.55 31.23 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 128.232 2.613 . . . . 0.0 109.139 178.619 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 16.2 m -62.98 157.99 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.132 0 O-C-N 122.04 -0.412 . . . . 0.0 111.318 171.33 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . 0.486 ' CE1' ' HB ' ' A' ' 45' ' ' THR . 0.1 OUTLIER -63.74 142.91 98.08 Favored Pre-proline 0 CA--C 1.544 0.712 0 C-N-CA 119.755 -0.778 . . . . 0.0 110.318 174.871 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -60.97 -29.49 88.08 Favored 'Trans proline' 0 CA--C 1.539 0.768 0 C-N-CA 123.266 2.644 . . . . 0.0 114.758 -168.443 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.486 ' HB ' ' CE1' ' A' ' 43' ' ' HIS . 88.7 m -66.17 -22.67 66.37 Favored 'General case' 0 N--CA 1.475 0.813 0 O-C-N 121.273 -0.892 . . . . 0.0 111.924 -178.675 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -52.48 -50.28 63.02 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 118.948 0.795 . . . . 0.0 110.405 169.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 4.5 mp -57.56 -48.64 82.65 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 C-N-CA 123.377 0.671 . . . . 0.0 110.728 -179.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -60.17 -32.42 71.04 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 113.102 0.779 . . . . 0.0 113.102 178.822 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -80.63 -30.43 36.69 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 113.87 1.063 . . . . 0.0 113.87 177.087 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' MET . . . . . 0.4 ' SD ' ' HG2' ' A' ' 17' ' ' MET . 3.6 mmt -73.41 -32.63 64.54 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 118.789 0.722 . . . . 0.0 110.352 170.251 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -67.01 -13.25 61.73 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 124.806 1.242 . . . . 0.0 113.548 174.267 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 58.4 mt-10 -63.11 -27.57 69.47 Favored 'General case' 0 N--CA 1.48 1.073 0 CA-C-N 120.355 1.434 . . . . 0.0 110.666 168.517 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 60.8 t -95.02 -4.51 10.45 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.91 0 C-N-CA 127.041 2.136 . . . . 0.0 111.15 175.465 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 80.29 18.9 70.46 Favored Glycine 0 CA--C 1.539 1.547 0 C-N-CA 125.005 1.288 . . . . 0.0 114.272 -175.649 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 93.2 mt -77.31 132.86 31.92 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 C-N-CA 124.731 1.212 . . . . 0.0 111.28 -174.577 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 19.0 t0 -96.19 104.8 16.78 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.502 0.721 . . . . 0.0 112.627 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 14.1 pt -138.22 17.25 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.365 0 N-CA-C 114.727 1.38 . . . . 0.0 114.727 176.046 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 94.1 p -49.35 -41.73 39.81 Favored 'General case' 0 N--CA 1.484 1.259 0 N-CA-C 116.151 1.908 . . . . 0.0 116.151 -169.798 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -126.98 35.68 2.8 Favored Glycine 0 CA--C 1.534 1.248 0 C-N-CA 125.59 1.567 . . . . 0.0 113.179 -179.293 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 24.0 pt20 -64.88 -33.91 77.13 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 115.56 1.689 . . . . 0.0 115.56 -169.738 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 28.2 p -92.83 106.23 18.23 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 121.559 0.695 . . . . 0.0 111.68 179.633 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 67.4 m -104.57 -28.93 10.98 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 124.521 1.128 . . . . 0.0 113.311 176.469 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -147.75 158.2 43.06 Favored Pre-proline 0 CA--C 1.544 0.737 0 C-N-CA 124.514 1.125 . . . . 0.0 111.997 -176.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -64.49 156.41 60.75 Favored 'Trans proline' 0 CA--C 1.537 0.671 0 C-N-CA 122.42 2.08 . . . . 0.0 112.414 169.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 12.2 tt -50.12 -36.03 12.11 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.181 0 C-N-CA 124.016 0.926 . . . . 0.0 112.098 171.54 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 19.3 mt-10 -63.91 -18.08 63.86 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.153 0.981 . . . . 0.0 113.225 -176.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -85.1 -14.92 45.63 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 124.553 1.141 . . . . 0.0 113.785 -177.059 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -97.06 176.03 6.1 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 126.016 1.727 . . . . 0.0 112.304 -177.081 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 23.6 t30 -99.81 126.95 45.99 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 169.77 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.84 -46.52 74.82 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 112.433 0.531 . . . . 0.0 112.433 -175.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -72.57 -1.0 14.38 Favored 'General case' 0 CA--C 1.546 0.823 0 N-CA-C 114.796 1.406 . . . . 0.0 114.796 -173.169 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -70.24 -17.68 63.13 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 123.668 0.787 . . . . 0.0 110.245 168.255 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 58.6 m-85 -105.53 158.32 16.76 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 128.355 2.662 . . . . 0.0 111.14 174.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -116.94 -12.94 10.66 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 124.781 1.232 . . . . 0.0 112.874 179.465 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 87.3 t -142.54 136.49 27.82 Favored 'Isoleucine or valine' 0 C--O 1.236 0.384 0 C-N-CA 127.86 2.464 . . . . 0.0 107.699 -174.291 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 59.0 t -131.75 133.46 61.31 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 N-CA-C 108.431 -0.952 . . . . 0.0 108.431 169.799 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 43.6 mm -116.41 111.16 34.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 C-N-CA 124.832 1.253 . . . . 0.0 107.916 -177.069 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 4.3 m -95.61 101.36 13.06 Favored 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 123.521 0.728 . . . . 0.0 110.097 176.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 34.1 mt -79.15 176.73 9.4 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 126.495 1.918 . . . . 0.0 110.955 173.445 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 14.8 m 63.2 57.0 1.64 Allowed 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 124.408 1.083 . . . . 0.0 113.422 169.787 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 83.06 -137.14 16.07 Favored Glycine 0 CA--C 1.534 1.268 0 C-N-CA 123.863 0.744 . . . . 0.0 111.706 -171.437 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 98.9 p -83.82 163.29 20.22 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 113.26 0.837 . . . . 0.0 113.26 176.561 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -69.03 -88.85 0.08 OUTLIER Glycine 0 CA--C 1.528 0.892 0 N-CA-C 110.658 -0.977 . . . . 0.0 110.658 169.409 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 98.7 t 63.13 -48.17 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.239 0 C-N-CA 128.054 2.542 . . . . 0.0 116.571 170.139 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 29.3 t-20 -74.98 -30.84 61.3 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 124.883 1.273 . . . . 0.0 113.031 -179.545 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -68.25 146.77 98.15 Favored Pre-proline 0 CA--C 1.555 1.145 0 CA-C-O 118.709 -0.662 . . . . 0.0 112.373 174.412 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_exo -62.05 156.87 47.16 Favored 'Trans proline' 0 CA--C 1.549 1.243 0 C-N-CA 122.775 2.317 . . . . 0.0 115.234 -176.773 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 80.6 Cg_exo -54.3 -36.44 86.7 Favored 'Trans proline' 0 C--N 1.355 0.869 0 C-N-CA 123.984 3.123 . . . . 0.0 115.119 -174.798 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -61.47 -15.86 41.66 Favored 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 115.052 1.501 . . . . 0.0 115.052 178.725 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 82.6 m95 -91.43 -34.51 14.81 Favored 'General case' 0 CA--C 1.539 0.552 0 O-C-N 121.029 -1.044 . . . . 0.0 112.314 172.702 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 6.7 m -84.73 -16.32 10.53 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.186 0 N-CA-C 113.588 0.958 . . . . 0.0 113.588 177.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 1.3 t -78.59 -5.8 53.81 Favored 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 114.627 1.343 . . . . 0.0 114.627 177.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 58.4 mt-30 -71.24 166.23 21.98 Favored 'General case' 0 N--CA 1.478 0.934 0 O-C-N 121.05 -1.031 . . . . 0.0 112.95 -172.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -60.0 -43.52 95.14 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 113.761 1.022 . . . . 0.0 113.761 -168.661 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 10.8 mm -121.23 62.0 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 C-N-CA 124.65 1.18 . . . . 0.0 109.186 176.052 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 17.2 t80 -75.02 113.16 12.02 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 107.394 -1.336 . . . . 0.0 107.394 168.727 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 14.0 mt-10 -108.19 126.72 53.12 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-O 122.26 1.029 . . . . 0.0 113.246 174.224 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -91.4 89.21 7.15 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 125.146 1.378 . . . . 0.0 109.197 176.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 20.4 m0 -81.8 90.97 6.43 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 124.621 1.168 . . . . 0.0 111.405 -173.021 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 70.2 mm-40 -71.55 41.64 0.07 Allowed 'General case' 0 CA--C 1.553 1.062 0 C-N-CA 127.212 2.205 . . . . 0.0 112.345 173.379 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 40.3 mt -84.06 161.94 20.52 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 125.917 1.687 . . . . 0.0 112.156 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -70.94 150.02 46.12 Favored 'General case' 0 CA--C 1.545 0.769 0 CA-C-N 114.757 -1.111 . . . . 0.0 112.222 169.729 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -116.28 142.63 29.67 Favored Pre-proline 0 CA--C 1.552 1.043 0 C-N-CA 124.66 1.184 . . . . 0.0 110.061 169.303 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -63.23 -4.83 7.01 Favored 'Trans proline' 0 CA--C 1.55 1.29 0 C-N-CA 123.107 2.538 . . . . 0.0 116.148 178.701 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -54.18 131.11 40.66 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 115.234 1.568 . . . . 0.0 115.234 -174.814 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 69.52 10.09 62.8 Favored Glycine 0 CA--C 1.538 1.496 0 N-CA-C 115.923 1.129 . . . . 0.0 115.923 175.379 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 16.1 pt20 -134.87 171.24 14.68 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 125.141 1.377 . . . . 0.0 113.909 -175.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 42.7 p -67.26 166.04 15.03 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 116.663 2.097 . . . . 0.0 116.663 -168.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 40.5 tp -57.66 -32.16 67.03 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 124.476 1.11 . . . . 0.0 112.375 172.431 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -62.71 -36.47 83.06 Favored 'General case' 0 CA--C 1.54 0.586 0 O-C-N 121.192 -0.942 . . . . 0.0 111.366 175.531 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 6.2 t -69.29 -40.26 80.01 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 O-C-N 121.482 -0.761 . . . . 0.0 111.477 172.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -53.8 -47.88 70.38 Favored 'General case' 0 N--CA 1.477 0.911 0 CA-C-N 119.298 0.954 . . . . 0.0 112.29 170.089 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 28.6 mmt85 -63.79 -44.41 93.44 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 124.221 1.008 . . . . 0.0 111.884 178.738 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 19.2 m -62.7 -40.99 98.89 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.776 0.831 . . . . 0.0 111.607 174.087 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 52.9 t -66.4 -42.35 90.32 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 CA-C-O 117.546 -1.216 . . . . 0.0 110.712 177.347 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 20.3 mtm105 -54.83 -44.18 73.67 Favored 'General case' 0 N--CA 1.483 1.224 0 CA-C-N 120.539 1.518 . . . . 0.0 111.708 171.647 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -60.4 -51.55 58.11 Favored Glycine 0 CA--C 1.538 1.499 0 CA-C-N 119.115 0.871 . . . . 0.0 113.797 176.411 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 60.2 mm-40 -65.48 -43.63 89.66 Favored 'General case' 0 N--CA 1.476 0.83 0 O-C-N 121.913 -0.757 . . . . 0.0 112.207 -179.426 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 69.3 t -66.58 -40.09 85.47 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 C-N-CA 124.737 1.215 . . . . 0.0 110.883 177.21 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -56.22 -49.48 73.97 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-N 120.163 1.347 . . . . 0.0 110.965 177.241 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -61.48 -41.99 98.11 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 122.92 0.488 . . . . 0.0 112.231 178.037 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -61.45 -42.98 99.6 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 124.824 1.25 . . . . 0.0 113.204 174.619 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 94.8 t -71.84 -39.46 67.81 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 C-N-CA 124.466 1.107 . . . . 0.0 111.663 177.72 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -62.54 -39.04 92.33 Favored 'General case' 0 N--CA 1.469 0.514 0 O-C-N 121.274 -0.891 . . . . 0.0 111.384 172.443 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 12.6 m-80 -63.78 -45.84 87.89 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 118.703 0.683 . . . . 0.0 112.487 173.155 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 9.8 tt -52.19 -54.39 31.5 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.935 1.294 . . . . 0.0 110.775 173.412 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 68.3 mt -63.87 -42.95 97.52 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 O-C-N 121.749 -0.594 . . . . 0.0 110.518 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -67.53 -10.97 56.66 Favored 'General case' 0 CA--C 1.548 0.866 0 N-CA-C 114.921 1.452 . . . . 0.0 114.921 177.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 20.2 ptmt -107.31 -30.93 8.43 Favored 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 113.942 1.089 . . . . 0.0 113.942 174.373 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . 0.263 7.1 pt -95.63 -11.57 8.73 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 N-CA-C 114.576 1.324 . . . . 0.0 114.576 -178.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 65.4 m . . . . . 0 C--O 1.253 1.246 0 C-N-CA 124.805 1.242 . . . . 0.0 112.78 177.846 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.428 ' HA ' ' O ' ' A' ' 29' ' ' LYS . 25.1 ttt . . . . . 0 N--CA 1.504 2.249 0 N-CA-C 112.133 0.42 . . . . 0.0 112.133 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 2.9 mptp? -126.12 158.0 36.61 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 125.729 1.612 . . . . 0.0 113.264 179.301 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 73.8 mttt -105.35 115.2 29.85 Favored 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 125.929 1.692 . . . . 0.0 106.629 167.39 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 10.7 t -105.81 130.89 56.56 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 C-N-CA 125.079 1.351 . . . . 0.0 113.9 178.62 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 48.8 tpp -102.02 125.66 48.76 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 168.677 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 49.8 m-85 -108.62 119.29 39.1 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 124.362 1.065 . . . . 0.0 109.82 171.486 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 3.4 m -140.3 149.74 21.62 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 C-N-CA 124.675 1.19 . . . . 0.0 111.788 -169.386 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 14.9 t -137.15 148.53 46.68 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 125.821 1.648 . . . . 0.0 111.283 -178.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 47.0 pttt -59.51 123.22 16.14 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 123.88 0.872 . . . . 0.0 111.922 177.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 74.5 mtp85 58.27 -33.9 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.784 0 C-N-CA 129.411 3.084 . . . . 0.0 116.718 -169.319 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . 0.412 HD22 ' NE2' ' A' ' 16' ' ' GLN . 17.9 t-20 59.35 -48.82 0.07 Allowed 'General case' 0 CA--C 1.553 1.065 0 C-N-CA 129.382 3.073 . . . . 0.0 117.116 174.61 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 26.2 m -68.76 -8.6 44.64 Favored 'General case' 0 N--CA 1.482 1.167 0 CA-C-N 120.89 1.677 . . . . 0.0 114.023 -176.348 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 84.1 p -100.22 2.54 42.92 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 126.531 1.932 . . . . 0.0 114.506 170.028 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 83.7 mtt85 -140.86 173.83 11.1 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 126.682 1.993 . . . . 0.0 112.928 -169.645 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 35.1 t -114.92 174.9 5.74 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 125.176 1.391 . . . . 0.0 110.252 169.245 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . 0.412 ' NE2' HD22 ' A' ' 11' ' ' ASN . 29.3 mt-30 -141.94 -49.28 0.38 Allowed 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 113.956 1.095 . . . . 0.0 113.956 -170.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 71.67 -46.37 0.64 Allowed 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 126.231 1.812 . . . . 0.0 114.236 173.683 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.19 -32.53 73.18 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 114.258 1.207 . . . . 0.0 114.258 -169.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 7.3 pm0 -63.77 -38.39 90.92 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 123.289 0.635 . . . . 0.0 111.919 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -70.24 -42.84 65.24 Favored Glycine 0 C--N 1.335 0.492 0 C-N-CA 123.715 0.674 . . . . 0.0 111.726 -178.765 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -71.76 -36.25 70.33 Favored 'General case' 0 N--CA 1.468 0.46 0 O-C-N 121.662 -0.905 . . . . 0.0 112.13 177.151 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.89 -35.66 78.99 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 118.609 0.641 . . . . 0.0 112.467 -175.182 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 5.6 pttp -84.9 -35.39 22.18 Favored 'General case' 0 N--CA 1.481 1.093 0 N-CA-C 113.86 1.059 . . . . 0.0 113.86 170.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 75.8 m -67.86 -31.61 71.54 Favored 'General case' 0 N--CA 1.486 1.346 0 CA-C-N 118.828 0.74 . . . . 0.0 112.141 -179.266 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 72.4 mt -96.47 -37.26 10.5 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.801 1.64 . . . . 0.0 112.69 175.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -98.48 4.3 59.93 Favored Glycine 0 N--CA 1.471 1.024 0 N-CA-C 116.572 1.389 . . . . 0.0 116.572 -169.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.18 143.14 56.09 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-N 120.97 2.385 . . . . 0.0 112.524 177.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 83.53 -20.07 12.6 Favored Glycine 0 CA--C 1.542 1.732 0 C-N-CA 124.868 1.223 . . . . 0.0 113.251 -169.322 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.428 ' O ' ' HA ' ' A' ' 1' ' ' MET . 78.4 mttt -101.25 -44.52 5.64 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 125.889 1.676 . . . . 0.0 112.253 169.868 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 38.5 pt -139.33 158.12 28.2 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 C-N-CA 124.162 0.985 . . . . 0.0 113.627 -175.507 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -106.81 145.51 32.02 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 127.252 2.221 . . . . 0.0 109.7 169.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 72.7 t -134.3 141.96 42.19 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 CA-C-N 118.69 0.677 . . . . 0.0 112.759 -175.349 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 38.9 m -134.72 153.01 52.19 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 125.513 1.525 . . . . 0.0 109.075 169.589 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 55.4 p -130.03 146.83 51.72 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.845 0.831 . . . . 0.0 111.288 168.176 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 53.7 p -147.89 -173.63 4.35 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 114.704 -1.135 . . . . 0.0 111.708 175.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -135.96 170.11 23.31 Favored Glycine 0 N--CA 1.468 0.782 0 O-C-N 120.909 -1.119 . . . . 0.0 112.038 177.419 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 10.8 mp -91.68 -9.01 45.44 Favored 'General case' 0 N--CA 1.479 1.021 0 N-CA-C 114.967 1.469 . . . . 0.0 114.967 -169.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -142.13 63.9 1.4 Allowed 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 124.71 1.204 . . . . 0.0 110.934 -176.746 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.402 ' H ' ' HB3' ' A' ' 64' ' ' PRO . 72.7 m 49.53 45.8 23.88 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 126.194 1.798 . . . . 0.0 112.392 -175.456 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 16.6 p -123.26 165.88 16.2 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 126.078 1.751 . . . . 0.0 115.65 -168.812 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 29.3 ptt-85 -138.0 -171.62 3.06 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 127.695 2.398 . . . . 0.0 107.631 171.465 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 26.9 m -60.44 151.72 5.79 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.189 0 CA-C-N 120.369 1.44 . . . . 0.0 110.941 169.418 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -62.99 143.29 97.54 Favored Pre-proline 0 CA--C 1.55 0.975 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 168.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_exo -48.53 -37.11 33.15 Favored 'Trans proline' 0 CA--C 1.542 0.876 0 C-N-CA 123.421 2.748 . . . . 0.0 117.717 -168.195 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 93.9 m -63.23 -24.62 67.96 Favored 'General case' 0 N--CA 1.485 1.304 0 CA-C-N 119.721 1.146 . . . . 0.0 112.777 -174.695 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -51.97 -43.76 63.71 Favored 'General case' 0 CA--C 1.546 0.802 0 CA-C-O 118.352 -0.832 . . . . 0.0 111.034 170.697 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.6 mp -55.79 -54.05 30.71 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.297 0 CA-C-N 120.239 1.382 . . . . 0.0 110.1 178.159 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -62.27 -30.65 71.27 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 123.447 0.699 . . . . 0.0 112.736 -178.18 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' MET . . . . . 0.442 ' HG2' ' CD1' ' A' ' 112' ' ' PHE . 0.0 OUTLIER -76.91 -33.5 57.76 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 113.119 0.785 . . . . 0.0 113.119 176.813 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 3.5 mmt -74.2 -32.5 63.07 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 118.877 0.762 . . . . 0.0 110.735 172.697 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -65.47 -14.05 60.14 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 124.534 1.134 . . . . 0.0 113.787 173.197 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 60.3 mt-10 -62.1 -27.18 68.74 Favored 'General case' 0 N--CA 1.482 1.161 0 CA-C-N 120.66 1.573 . . . . 0.0 110.896 168.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 56.5 t -96.5 -3.63 10.2 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.874 0 C-N-CA 127.54 2.336 . . . . 0.0 111.275 176.118 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 78.93 19.13 73.49 Favored Glycine 0 CA--C 1.541 1.677 0 C-N-CA 125.029 1.299 . . . . 0.0 114.374 -175.784 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 85.7 mt -77.88 135.3 26.53 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 C-N-CA 124.709 1.204 . . . . 0.0 111.638 -174.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 17.9 t0 -96.05 102.19 13.96 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 112.667 0.617 . . . . 0.0 112.667 178.133 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 8.6 pt -129.58 14.92 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.273 0 C-N-CA 125.214 1.406 . . . . 0.0 113.396 170.514 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 72.7 m -59.48 126.7 28.7 Favored 'General case' 0 N--CA 1.473 0.715 0 O-C-N 120.711 -1.243 . . . . 0.0 112.295 -172.592 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 80.15 -22.62 4.29 Favored Glycine 0 CA--C 1.538 1.48 0 C-N-CA 125.278 1.418 . . . . 0.0 115.938 179.653 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 70.8 mt-30 41.0 -96.12 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 127.482 2.313 . . . . 0.0 113.428 -175.535 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 9.1 t -145.63 163.95 33.24 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 126.655 1.982 . . . . 0.0 109.914 169.719 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 75.5 m -100.55 -2.52 32.75 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 125.904 1.682 . . . . 0.0 113.148 172.216 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 29.2 m-20 -111.05 146.79 35.22 Favored Pre-proline 0 CA--C 1.544 0.742 0 C-N-CA 124.053 0.941 . . . . 0.0 113.38 -174.523 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.402 ' HB3' ' H ' ' A' ' 39' ' ' SER . 57.6 Cg_endo -71.52 162.07 43.41 Favored 'Trans proline' 0 C--N 1.349 0.58 0 C-N-CA 122.541 2.16 . . . . 0.0 113.163 176.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 5.5 tt -48.74 -43.97 14.4 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 C-N-CA 124.465 1.106 . . . . 0.0 111.36 171.322 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -69.12 -5.64 23.53 Favored 'General case' 0 CA--C 1.546 0.813 0 N-CA-C 114.466 1.284 . . . . 0.0 114.466 -177.591 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 5.4 t-20 -84.27 -21.59 31.03 Favored 'General case' 0 CA--C 1.547 0.839 0 N-CA-C 113.312 0.856 . . . . 0.0 113.312 172.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 83.5 m-85 -91.3 -171.58 3.0 Favored 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 125.431 1.492 . . . . 0.0 111.838 -179.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 14.9 t30 -117.53 120.44 38.1 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.52 1.128 . . . . 0.0 109.351 175.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -64.97 -44.64 88.7 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 115.108 1.521 . . . . 0.0 115.108 -169.122 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -79.77 6.22 11.48 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 113.591 0.96 . . . . 0.0 113.591 -172.458 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -73.57 -26.66 60.93 Favored 'General case' 0 CA--C 1.545 0.783 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 167.617 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 76.4 m-85 -86.44 157.84 19.73 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 127.101 2.161 . . . . 0.0 110.244 169.635 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -116.07 -15.79 11.1 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 124.237 1.015 . . . . 0.0 112.355 174.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 91.6 t -129.33 135.27 62.13 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 C-N-CA 126.93 2.092 . . . . 0.0 107.648 174.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 66.7 t -131.8 123.42 51.65 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 169.471 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 45.7 mm -108.59 106.79 21.35 Favored 'Isoleucine or valine' 0 C--O 1.235 0.298 0 C-N-CA 124.645 1.178 . . . . 0.0 108.76 -175.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 4.1 m -85.42 92.26 8.44 Favored 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 123.983 0.913 . . . . 0.0 110.061 171.596 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 81.4 mt -67.34 172.52 4.77 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 126.259 1.823 . . . . 0.0 111.794 172.801 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 17.3 m 65.88 7.94 4.97 Favored 'General case' 0 CA--C 1.549 0.906 0 N-CA-C 114.868 1.433 . . . . 0.0 114.868 175.03 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 69.37 132.02 0.06 OUTLIER Glycine 0 CA--C 1.535 1.286 0 C-N-CA 126.793 2.14 . . . . 0.0 115.157 -179.801 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 38.2 m 60.18 43.48 13.98 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 125.84 1.656 . . . . 0.0 112.311 174.277 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -75.7 65.14 2.53 Favored Glycine 0 N--CA 1.472 1.058 0 C-N-CA 124.951 1.263 . . . . 0.0 111.281 174.44 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.9 p -112.81 -2.32 10.3 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 C-N-CA 125.263 1.425 . . . . 0.0 113.622 -169.647 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 62.0 t30 -77.26 -11.14 59.79 Favored 'General case' 0 CA--C 1.552 1.03 0 O-C-N 121.221 -0.924 . . . . 0.0 113.289 176.284 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -66.23 158.61 76.45 Favored Pre-proline 0 CA--C 1.556 1.19 0 C-N-CA 124.335 1.054 . . . . 0.0 112.494 170.282 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -60.1 151.27 73.91 Favored 'Trans proline' 0 CA--C 1.543 0.933 0 C-N-CA 122.776 2.317 . . . . 0.0 113.337 179.645 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -61.33 -26.54 81.8 Favored 'Trans proline' 0 C--N 1.35 0.656 0 C-N-CA 123.364 2.709 . . . . 0.0 113.863 -174.146 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -59.82 -22.2 61.9 Favored 'General case' 0 CA--C 1.541 0.596 0 CA-C-O 117.966 -1.016 . . . . 0.0 113.534 174.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 93.5 m95 -87.64 -12.97 43.97 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 125.025 1.33 . . . . 0.0 113.806 177.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 4.7 m -96.47 -7.75 9.48 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 CA-C-N 119.072 0.851 . . . . 0.0 112.946 171.736 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . 0.269 0.7 OUTLIER -96.47 -4.57 41.34 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 114.818 1.414 . . . . 0.0 114.818 -175.548 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 11.8 mp0 -61.05 156.89 16.86 Favored 'General case' 0 N--CA 1.487 1.384 0 CA-C-O 122.531 1.158 . . . . 0.0 111.183 168.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -61.83 -39.54 92.15 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 114.354 -1.294 . . . . 0.0 113.4 -168.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 16.6 mm -115.63 59.07 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 C-N-CA 125.321 1.448 . . . . 0.0 109.071 176.439 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 35.4 t80 -76.22 109.73 10.14 Favored 'General case' 0 CA--C 1.535 0.376 0 O-C-N 120.51 -1.369 . . . . 0.0 107.945 169.054 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 9.6 mt-10 -111.39 128.66 56.05 Favored 'General case' 0 N--CA 1.471 0.625 0 N-CA-C 113.214 0.82 . . . . 0.0 113.214 174.298 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -93.84 112.51 24.37 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 168.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 38.7 m0 -94.04 104.2 16.25 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 124.375 1.07 . . . . 0.0 108.983 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 73.7 mm-40 -74.73 54.82 0.64 Allowed 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 126.797 2.039 . . . . 0.0 110.342 173.32 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.1 tt -104.81 146.22 29.28 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 127.099 2.159 . . . . 0.0 110.624 -169.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -56.5 144.15 32.49 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 125.06 1.344 . . . . 0.0 113.848 174.289 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -97.34 119.77 62.31 Favored Pre-proline 0 CA--C 1.546 0.825 0 C-N-CA 124.661 1.184 . . . . 0.0 108.015 168.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -76.4 -11.22 19.03 Favored 'Trans proline' 0 CA--C 1.542 0.906 0 C-N-CA 122.067 1.845 . . . . 0.0 114.132 -173.671 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -74.72 155.87 37.23 Favored 'General case' 0 CA--C 1.546 0.795 0 CA-C-N 119.684 1.129 . . . . 0.0 113.689 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 76.47 8.41 85.83 Favored Glycine 0 CA--C 1.536 1.394 0 C-N-CA 124.712 1.149 . . . . 0.0 114.434 -177.667 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 15.0 pt20 -143.31 170.52 15.61 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 126.824 2.049 . . . . 0.0 111.196 179.239 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 15.9 m -56.77 154.32 9.34 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 125.031 1.332 . . . . 0.0 114.56 -169.568 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 60.2 tp -58.34 -30.05 66.42 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.902 0.881 . . . . 0.0 112.493 176.338 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -59.35 -31.93 69.64 Favored 'General case' 0 N--CA 1.475 0.793 0 O-C-N 121.351 -0.843 . . . . 0.0 113.268 170.559 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 14.0 t -74.12 -41.53 51.91 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 O-C-N 121.008 -1.058 . . . . 0.0 110.306 173.624 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.442 ' CD1' ' HG2' ' A' ' 49' ' ' MET . 0.3 OUTLIER -54.38 -47.26 72.87 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 119.097 0.862 . . . . 0.0 112.611 169.76 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -70.9 -34.21 71.33 Favored 'General case' 0 N--CA 1.477 0.902 0 O-C-N 121.395 -0.816 . . . . 0.0 112.726 179.191 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 53.3 m -64.98 -41.25 95.6 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.834 0.854 . . . . 0.0 111.13 170.686 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 54.7 t -68.34 -35.73 72.11 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 CA-C-O 117.371 -1.299 . . . . 0.0 111.029 175.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 28.6 mtm105 -56.23 -43.02 78.2 Favored 'General case' 0 N--CA 1.485 1.292 0 CA-C-N 121.275 1.852 . . . . 0.0 111.355 169.611 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -61.18 -49.98 72.12 Favored Glycine 0 CA--C 1.54 1.629 0 CA-C-N 119.132 0.878 . . . . 0.0 113.594 175.197 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 64.0 mm-40 -62.74 -46.73 86.7 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.537 0.735 . . . . 0.0 112.136 177.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 91.3 t -69.89 -34.71 61.4 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 C-N-CA 124.324 1.049 . . . . 0.0 111.262 -179.5 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 63.7 tttm -55.96 -51.85 66.23 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 120.44 1.473 . . . . 0.0 110.908 172.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -63.92 -42.07 97.48 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 123.303 0.641 . . . . 0.0 112.522 177.418 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -66.88 -34.8 78.58 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 125.446 1.498 . . . . 0.0 112.306 179.407 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 76.9 t -76.57 -40.89 34.18 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.089 0 C-N-CA 125.098 1.359 . . . . 0.0 111.511 173.716 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -62.6 -34.12 76.38 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 119.425 1.011 . . . . 0.0 111.604 173.156 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 9.6 m-80 -65.72 -44.4 86.17 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 119.056 0.844 . . . . 0.0 113.035 172.031 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -53.49 -55.48 25.0 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 123.884 0.874 . . . . 0.0 110.304 172.482 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 75.5 mt -61.39 -43.17 96.22 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 CA-C-O 119.164 -0.446 . . . . 0.0 110.666 -179.819 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -68.9 -13.58 62.51 Favored 'General case' 0 CA--C 1.544 0.744 0 N-CA-C 115.116 1.524 . . . . 0.0 115.116 179.704 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 21.4 ptmt -98.61 -28.17 13.68 Favored 'General case' 0 N--CA 1.477 0.887 0 CA-C-N 119.382 0.992 . . . . 0.0 113.541 172.767 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 18.5 pt -93.98 -22.57 5.55 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 N-CA-C 114.486 1.291 . . . . 0.0 114.486 177.581 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 75.6 m . . . . . 0 C--O 1.252 1.227 0 C-N-CA 125.418 1.487 . . . . 0.0 111.552 -173.77 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.3 ttt . . . . . 0 N--CA 1.504 2.234 0 N-CA-C 111.556 0.206 . . . . 0.0 111.556 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.14 166.0 25.9 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 125.018 1.327 . . . . 0.0 112.971 176.071 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 70.0 mttt -94.81 146.07 24.44 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 123.82 0.848 . . . . 0.0 112.629 174.466 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 16.7 t -124.28 138.13 54.85 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 125.645 1.578 . . . . 0.0 111.083 172.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -109.74 121.2 44.68 Favored 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 110.19 -0.3 . . . . 0.0 110.19 169.136 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 45.2 m-85 -96.52 125.19 40.83 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 170.608 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 28.8 m -140.49 151.57 21.0 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 N-CA-C 113.786 1.032 . . . . 0.0 113.786 -168.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 33.5 t -152.95 142.55 21.86 Favored 'General case' 0 CA--C 1.548 0.904 0 C-N-CA 124.711 1.204 . . . . 0.0 113.606 -172.717 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -80.79 140.52 35.44 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 124.779 1.232 . . . . 0.0 109.324 168.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 31.2 mtm180 52.54 47.34 24.91 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 125.48 1.512 . . . . 0.0 112.522 -169.12 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 23.4 t30 -57.32 -27.63 62.36 Favored 'General case' 0 CA--C 1.551 0.996 0 C-N-CA 125.581 1.552 . . . . 0.0 113.282 -179.786 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 72.8 m -73.32 -30.75 63.58 Favored 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 113.419 0.896 . . . . 0.0 113.419 172.041 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 48.8 m -80.66 -40.04 26.23 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 123.876 0.87 . . . . 0.0 112.082 179.458 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 11.7 mmt180 -101.88 163.34 12.3 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 124.645 1.178 . . . . 0.0 113.458 -173.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 3.7 m -106.92 134.96 49.3 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.148 0.979 . . . . 0.0 111.041 174.13 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 3.9 mp0 -105.11 -38.14 6.67 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 115.018 1.488 . . . . 0.0 115.018 -168.27 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' MET . . . . . 0.416 ' HG2' ' SD ' ' A' ' 50' ' ' MET . 0.0 OUTLIER 67.16 -55.55 0.45 Allowed 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 126.71 2.004 . . . . 0.0 115.66 170.372 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -57.82 -37.04 73.09 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.923 1.289 . . . . 0.0 114.205 -169.577 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 7.5 pm0 -58.76 -31.97 68.84 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 125.391 1.476 . . . . 0.0 113.709 179.523 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -66.83 -68.06 1.79 Allowed Glycine 0 C--N 1.337 0.622 0 N-CA-C 110.588 -1.005 . . . . 0.0 110.588 174.506 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -50.65 -34.12 25.15 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 124.135 0.974 . . . . 0.0 113.449 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -60.24 -32.58 71.27 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 -177.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . 0.273 0.0 OUTLIER -98.84 -24.91 14.81 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 114.081 1.141 . . . . 0.0 114.081 169.947 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 1.3 m -64.51 -36.54 84.52 Favored 'General case' 0 N--CA 1.488 1.436 0 CA-C-N 120.33 1.423 . . . . 0.0 111.974 173.796 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 68.6 mt -98.96 -28.26 13.51 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 125.454 1.502 . . . . 0.0 113.206 178.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -111.93 2.77 27.2 Favored Glycine 0 N--CA 1.474 1.204 0 N-CA-C 118.112 2.005 . . . . 0.0 118.112 -169.389 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -66.34 -20.37 66.07 Favored 'General case' 0 N--CA 1.477 0.878 0 CA-C-N 122.548 3.174 . . . . 0.0 116.648 -169.684 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -75.69 -6.68 82.1 Favored Glycine 0 CA--C 1.542 1.748 0 O-C-N 121.339 -0.85 . . . . 0.0 113.881 169.627 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 61.1 mttp -119.87 -40.06 2.78 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 127.162 2.185 . . . . 0.0 113.101 -174.375 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 43.6 pt -144.27 157.22 15.31 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 C-N-CA 125.911 1.684 . . . . 0.0 112.686 -171.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -101.02 139.78 36.23 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.415 1.086 . . . . 0.0 109.39 169.486 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 30.2 t -130.79 136.46 58.14 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.076 0 CA-C-N 119.831 1.196 . . . . 0.0 113.179 177.632 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 37.1 m -131.02 154.91 47.7 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 125.969 1.708 . . . . 0.0 109.73 175.034 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 3.2 m -124.64 147.86 48.28 Favored 'General case' 0 CA--C 1.513 -0.458 0 CA-C-O 121.617 0.722 . . . . 0.0 112.42 168.358 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 2.2 m -142.74 149.74 39.15 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 113.688 -1.596 . . . . 0.0 111.167 172.636 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -79.82 165.21 49.23 Favored Glycine 0 CA--C 1.528 0.852 0 N-CA-C 110.888 -0.885 . . . . 0.0 110.888 169.484 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 9.1 mp -80.17 -11.51 59.74 Favored 'General case' 0 N--CA 1.48 1.036 0 O-C-N 121.653 -0.91 . . . . 0.0 112.809 169.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -132.03 165.5 23.84 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 126.973 2.109 . . . . 0.0 108.811 169.662 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 68.4 m -57.78 114.31 2.24 Favored 'General case' 0 N--CA 1.479 1.012 0 O-C-N 121.232 -0.917 . . . . 0.0 110.574 178.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 88.9 p -158.24 178.17 10.47 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 114.748 1.388 . . . . 0.0 114.748 -168.717 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 13.2 tpt180 -132.35 147.32 52.39 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 128.178 2.591 . . . . 0.0 108.631 174.296 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 33.0 m -62.28 154.91 5.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 CA-C-N 120.668 1.576 . . . . 0.0 109.425 168.394 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 11.9 t-80 -53.53 135.09 53.51 Favored Pre-proline 0 C--N 1.327 -0.389 0 CA-C-N 114.87 -1.059 . . . . 0.0 112.564 -170.13 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_exo -60.75 -26.11 82.37 Favored 'Trans proline' 0 CA--C 1.548 1.175 0 CA-C-N 121.01 1.397 . . . . 0.0 112.677 175.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 51.1 m -70.02 -33.94 72.65 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 125.296 1.438 . . . . 0.0 112.058 171.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -57.99 -43.2 86.44 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 124.018 0.927 . . . . 0.0 111.636 -178.474 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.7 mp -52.85 -54.15 17.82 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 CA-C-N 119.182 0.901 . . . . 0.0 109.425 -178.652 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -65.76 -32.28 73.73 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 113.351 0.871 . . . . 0.0 113.351 -177.406 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -79.19 -29.95 43.14 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 113.433 0.901 . . . . 0.0 113.433 178.683 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' MET . . . . . 0.416 ' SD ' ' HG2' ' A' ' 17' ' ' MET . 1.0 OUTLIER -80.82 -29.57 35.95 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 123.521 0.728 . . . . 0.0 110.828 172.739 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -66.92 -12.27 58.93 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 124.719 1.208 . . . . 0.0 113.486 170.02 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -65.62 -26.23 67.73 Favored 'General case' 0 N--CA 1.481 1.076 0 CA-C-N 120.513 1.506 . . . . 0.0 110.892 169.06 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 56.7 t -93.72 -7.54 10.17 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.804 0 C-N-CA 126.996 2.119 . . . . 0.0 111.049 173.023 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 82.16 20.11 63.46 Favored Glycine 0 CA--C 1.538 1.501 0 C-N-CA 125.086 1.327 . . . . 0.0 114.22 -175.183 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 36.0 mt -85.68 126.13 40.51 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 CA-C-N 118.48 1.14 . . . . 0.0 110.805 -176.645 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 19.9 t0 -87.43 121.33 29.72 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.143 0.577 . . . . 0.0 111.537 170.692 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 29.2 pt -136.37 -1.72 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.24 0 N-CA-C 116.083 1.883 . . . . 0.0 116.083 -178.568 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 79.1 p -62.93 -25.61 68.42 Favored 'General case' 0 N--CA 1.482 1.17 0 N-CA-C 116.122 1.897 . . . . 0.0 116.122 -169.019 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -102.29 3.21 50.79 Favored Glycine 0 CA--C 1.537 1.431 0 N-CA-C 116.12 1.208 . . . . 0.0 116.12 -176.132 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 31.5 mt-30 -72.89 -44.3 61.46 Favored 'General case' 0 N--CA 1.48 1.05 0 CA-C-N 119.31 1.555 . . . . 0.0 113.639 -169.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 12.3 p -90.7 119.33 30.85 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 124.115 0.966 . . . . 0.0 112.382 -178.701 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 99.4 p -141.08 -12.17 0.95 Allowed 'General case' 0 N--CA 1.478 0.944 0 N-CA-C 114.884 1.439 . . . . 0.0 114.884 177.191 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -147.36 150.6 38.04 Favored Pre-proline 0 CA--C 1.546 0.821 0 C-N-CA 125.131 1.372 . . . . 0.0 111.58 179.522 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -63.15 155.71 59.66 Favored 'Trans proline' 0 C--N 1.35 0.624 0 C-N-CA 123.31 2.673 . . . . 0.0 112.168 169.543 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 10.3 tt -50.77 -33.84 12.47 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 C-N-CA 124.869 1.268 . . . . 0.0 112.291 171.261 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -62.41 -21.54 65.47 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.575 1.15 . . . . 0.0 112.87 -177.074 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 82.0 m-20 -91.7 4.7 52.14 Favored 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 124.452 1.101 . . . . 0.0 113.645 -176.264 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -116.48 -176.82 3.04 Favored 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 126.304 1.842 . . . . 0.0 112.377 179.283 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -119.76 125.0 47.56 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 125.874 1.67 . . . . 0.0 110.068 175.368 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -67.79 -34.91 77.7 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 113.921 1.082 . . . . 0.0 113.921 -171.201 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . 0.261 0.0 OUTLIER -71.6 -4.32 26.39 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 114.278 1.214 . . . . 0.0 114.278 -176.602 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -73.18 -15.96 61.44 Favored 'General case' 0 CA--C 1.548 0.871 0 O-C-N 121.711 -0.618 . . . . 0.0 111.136 168.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -112.45 138.5 49.11 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 127.074 2.15 . . . . 0.0 111.497 178.676 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -88.42 -23.68 23.25 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-O 122.112 0.958 . . . . 0.0 112.317 176.125 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 76.3 t -133.29 137.65 52.86 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 C-N-CA 126.679 1.992 . . . . 0.0 108.769 -175.487 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 78.8 t -133.56 131.92 57.3 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 173.184 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 43.3 mm -121.51 106.06 17.59 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 C-N-CA 124.243 1.017 . . . . 0.0 109.344 -171.378 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 4.1 m -88.75 109.79 20.45 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 123.631 0.772 . . . . 0.0 110.643 178.406 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 89.3 mt -90.76 -19.02 23.98 Favored 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 114.899 1.444 . . . . 0.0 114.899 -172.45 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 10.6 m -141.56 144.52 34.3 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.746 1.218 . . . . 0.0 110.703 -169.789 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 62.15 -125.37 35.97 Favored Glycine 0 CA--C 1.533 1.205 0 N-CA-C 110.632 -0.987 . . . . 0.0 110.632 -171.538 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 77.9 p -152.62 171.86 17.51 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.671 1.188 . . . . 0.0 111.527 169.719 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -66.41 65.0 0.16 Allowed Glycine 0 CA--C 1.538 1.512 0 C-N-CA 125.757 1.646 . . . . 0.0 114.691 176.043 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 7.7 p -143.79 -28.4 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.105 0 C-N-CA 125.633 1.573 . . . . 0.0 113.345 -178.324 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -91.19 22.95 3.51 Favored 'General case' 0 CA--C 1.554 1.121 0 C-N-CA 124.337 1.055 . . . . 0.0 112.447 178.115 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -133.54 159.28 73.15 Favored Pre-proline 0 CA--C 1.549 0.93 0 C-N-CA 126.338 1.855 . . . . 0.0 111.024 173.208 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -58.89 149.2 80.11 Favored 'Trans proline' 0 CA--C 1.543 0.937 0 C-N-CA 122.58 2.187 . . . . 0.0 112.695 178.229 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -61.77 -28.94 82.47 Favored 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 122.909 2.406 . . . . 0.0 113.626 -170.489 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -60.36 -20.95 61.4 Favored 'General case' 0 CA--C 1.544 0.723 0 N-CA-C 114.071 1.137 . . . . 0.0 114.071 177.704 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 88.6 m95 -80.34 -19.86 45.54 Favored 'General case' 0 N--CA 1.47 0.563 0 O-C-N 120.622 -1.299 . . . . 0.0 113.257 175.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 16.3 m -93.81 -8.21 9.98 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.125 0 N-CA-C 113.634 0.975 . . . . 0.0 113.634 172.213 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 67.5 p -96.98 -0.31 47.61 Favored 'General case' 0 N--CA 1.48 1.032 0 N-CA-C 114.796 1.406 . . . . 0.0 114.796 177.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 73.3 mm-40 -65.2 152.63 43.16 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 119.172 0.896 . . . . 0.0 111.213 169.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -54.01 -42.91 69.6 Favored 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 114.986 1.476 . . . . 0.0 114.986 -167.734 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 8.6 mm -118.26 65.16 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 C-N-CA 124.072 0.949 . . . . 0.0 109.224 173.41 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 23.3 t80 -75.31 109.46 8.85 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 106.909 -1.515 . . . . 0.0 106.909 168.645 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -104.58 130.45 52.55 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-O 121.797 0.808 . . . . 0.0 112.93 171.489 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -92.14 105.99 18.1 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 123.692 0.797 . . . . 0.0 109.399 169.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 19.0 m0 -94.47 99.26 11.46 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 124.571 1.148 . . . . 0.0 110.239 -176.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 99.9 mm-40 -79.13 53.7 1.5 Allowed 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 124.699 1.2 . . . . 0.0 110.514 170.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 5.0 tt -91.84 150.91 20.82 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 127.057 2.143 . . . . 0.0 111.9 -172.147 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -68.23 117.92 10.67 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 123.553 0.741 . . . . 0.0 112.868 179.029 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -74.43 133.25 77.62 Favored Pre-proline 0 CA--C 1.556 1.173 0 O-C-N 121.522 -0.736 . . . . 0.0 110.317 169.664 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -87.8 -6.96 6.57 Favored 'Trans proline' 0 CA--C 1.554 1.479 0 C-N-CA 122.295 1.997 . . . . 0.0 114.646 -178.597 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -64.38 146.91 53.69 Favored 'General case' 0 CA--C 1.547 0.864 0 CA-C-N 120.537 1.517 . . . . 0.0 113.188 176.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 75.77 8.62 84.65 Favored Glycine 0 CA--C 1.537 1.436 0 C-N-CA 123.869 0.747 . . . . 0.0 114.872 176.153 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 13.2 pt20 -140.75 165.46 27.44 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 125.893 1.677 . . . . 0.0 112.257 178.365 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 70.9 m -57.92 157.65 7.48 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 125.638 1.575 . . . . 0.0 114.843 -169.47 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 35.9 tp -59.25 -29.19 67.37 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 124.605 1.162 . . . . 0.0 113.001 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -61.9 -31.42 71.71 Favored 'General case' 0 N--CA 1.472 0.661 0 O-C-N 120.812 -1.18 . . . . 0.0 112.208 172.346 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 4.7 t -72.78 -40.49 60.97 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 O-C-N 121.146 -0.971 . . . . 0.0 111.114 171.73 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -55.16 -47.88 74.54 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 120.02 1.282 . . . . 0.0 112.056 169.857 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -69.13 -36.7 77.75 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.46 0.704 . . . . 0.0 112.506 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 79.0 m -63.86 -42.4 97.55 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 123.777 0.831 . . . . 0.0 110.832 171.593 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 44.1 t -65.96 -41.25 89.46 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 CA-C-O 117.567 -1.206 . . . . 0.0 110.803 176.429 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 30.8 mtm105 -55.73 -44.41 77.49 Favored 'General case' 0 N--CA 1.483 1.185 0 CA-C-N 120.841 1.655 . . . . 0.0 112.243 171.608 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -61.14 -50.85 62.75 Favored Glycine 0 CA--C 1.537 1.464 0 CA-C-N 118.979 0.809 . . . . 0.0 113.103 177.114 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 56.5 mm-40 -63.58 -45.0 92.42 Favored 'General case' 0 N--CA 1.473 0.689 0 O-C-N 121.996 -0.708 . . . . 0.0 112.217 178.387 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 70.4 t -64.78 -40.86 90.51 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 124.964 1.306 . . . . 0.0 111.301 177.679 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 84.3 tttt -54.44 -49.52 69.82 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 119.89 1.223 . . . . 0.0 110.474 176.215 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -63.64 -42.37 98.16 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 112.637 0.606 . . . . 0.0 112.637 176.268 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.24 -36.28 83.12 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 124.181 0.992 . . . . 0.0 112.897 177.803 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 92.5 t -78.44 -38.9 23.19 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 C-N-CA 125.521 1.529 . . . . 0.0 111.713 177.574 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -63.36 -35.43 80.38 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 119.546 1.066 . . . . 0.0 111.285 171.472 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 12.5 m-80 -64.89 -44.47 89.52 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 118.827 0.74 . . . . 0.0 112.52 172.328 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 9.8 tt -52.57 -57.18 10.81 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 124.237 1.015 . . . . 0.0 110.25 170.534 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 70.2 mt -60.58 -42.69 92.55 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 O-C-N 121.387 -0.821 . . . . 0.0 110.744 -177.805 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -68.45 -14.61 63.12 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 114.828 1.418 . . . . 0.0 114.828 178.263 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 19.0 ptmt -106.0 -32.75 8.16 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 113.596 0.961 . . . . 0.0 113.596 176.577 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 4.7 pt -88.98 -18.97 7.69 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 CA-C-O 118.038 -0.982 . . . . 0.0 113.619 -176.692 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 69.7 m . . . . . 0 C--O 1.253 1.274 0 N-CA-C 112.781 0.66 . . . . 0.0 112.781 -177.946 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.0 ttt . . . . . 0 N--CA 1.503 2.179 0 N-CA-C 111.774 0.287 . . . . 0.0 111.774 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.89 156.17 38.36 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 125.667 1.587 . . . . 0.0 113.207 179.422 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 44.1 mtmt -101.72 108.65 20.24 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 125.518 1.527 . . . . 0.0 107.342 167.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 16.3 t -95.18 131.92 40.64 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 125.981 1.713 . . . . 0.0 113.72 175.475 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 37.6 tpp -102.98 120.2 40.22 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 123.765 0.826 . . . . 0.0 109.162 168.804 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 65.0 m-85 -99.0 118.93 36.9 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 125.68 1.592 . . . . 0.0 108.307 174.588 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 1.5 m -137.91 151.44 25.56 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.143 0 N-CA-C 115.013 1.486 . . . . 0.0 115.013 -168.64 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 41.5 t -155.31 162.99 40.72 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 125.691 1.597 . . . . 0.0 111.028 169.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 40.2 ttmt -69.99 133.05 46.84 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 125.052 1.341 . . . . 0.0 110.855 169.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 98.2 mtt180 51.13 80.12 0.09 Allowed 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 126.88 2.072 . . . . 0.0 112.386 -176.541 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 21.9 t-20 -67.98 -32.99 73.78 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 113.828 1.047 . . . . 0.0 113.828 -174.174 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 60.4 p -76.29 157.45 32.51 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 125.008 1.323 . . . . 0.0 112.688 169.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 67.1 m 53.62 26.45 5.77 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 124.901 1.28 . . . . 0.0 114.242 -174.681 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 23.9 ttm180 -147.33 151.85 37.24 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 127.76 2.424 . . . . 0.0 110.048 -175.32 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 46.0 t -109.07 152.84 24.49 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.49 0.716 . . . . 0.0 111.248 170.157 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -139.98 -42.43 0.43 Allowed 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 125.887 1.675 . . . . 0.0 111.893 -169.52 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 65.91 -36.72 0.24 Allowed 'General case' 0 N--CA 1.478 0.975 0 N-CA-C 118.205 2.668 . . . . 0.0 118.205 169.238 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.27 -36.56 80.36 Favored 'General case' 0 C--O 1.224 -0.289 0 CA-C-N 119.278 0.944 . . . . 0.0 113.406 -171.26 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.5 pm0 -57.46 -34.37 68.94 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 124.361 1.064 . . . . 0.0 113.307 171.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -72.49 -57.03 5.73 Favored Glycine 0 C--N 1.332 0.332 0 C-N-CA 124.293 0.949 . . . . 0.0 111.425 177.437 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -59.34 -33.79 71.57 Favored 'General case' 0 N--CA 1.468 0.43 0 O-C-N 122.24 -0.565 . . . . 0.0 112.427 177.902 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -63.38 -40.16 96.47 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 119.198 0.908 . . . . 0.0 112.285 -178.825 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 33.7 mttm -58.3 -56.39 22.73 Favored 'General case' 0 N--CA 1.486 1.373 0 CA-C-O 121.544 0.688 . . . . 0.0 110.874 168.782 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 35.9 m -69.75 -24.15 63.48 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 125.186 1.394 . . . . 0.0 114.056 -169.392 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 76.7 mt -96.38 -19.15 19.41 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 125.066 1.347 . . . . 0.0 114.461 177.262 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -159.01 26.29 0.37 Allowed Glycine 0 C--N 1.344 0.979 0 N-CA-C 119.021 2.368 . . . . 0.0 119.021 -169.001 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -66.56 -21.28 66.15 Favored 'General case' 0 CA--C 1.546 0.812 0 CA-C-N 122.15 2.975 . . . . 0.0 115.37 -176.501 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -74.86 -5.47 75.03 Favored Glycine 0 CA--C 1.542 1.745 0 O-C-N 121.493 -0.755 . . . . 0.0 113.776 169.546 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 70.0 mttt -117.18 -37.24 3.58 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 127.536 2.335 . . . . 0.0 113.301 -178.565 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 40.1 pt -142.76 150.07 18.41 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 C-N-CA 124.386 1.074 . . . . 0.0 113.171 -174.619 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -99.53 139.23 35.5 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 125.813 1.645 . . . . 0.0 108.337 169.355 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 5.1 m -132.14 144.91 35.71 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.236 0 C-N-CA 124.033 0.933 . . . . 0.0 110.352 -173.578 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 72.3 m -138.42 138.91 38.65 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 123.522 0.729 . . . . 0.0 109.411 175.091 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 2.8 p -98.67 138.04 36.42 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 112.127 0.417 . . . . 0.0 112.127 168.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 24.4 p -149.18 162.29 40.28 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 113.274 0.842 . . . . 0.0 113.274 170.095 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -109.78 147.1 17.11 Favored Glycine 0 N--CA 1.473 1.165 0 C-N-CA 124.236 0.922 . . . . 0.0 113.89 -179.393 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 11.2 mp -68.32 -25.55 65.17 Favored 'General case' 0 N--CA 1.485 1.298 0 CA-C-N 119.395 1.597 . . . . 0.0 111.041 169.603 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -142.36 144.31 33.12 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 127.688 2.395 . . . . 0.0 106.955 169.06 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 25.5 p 58.05 171.42 0.05 Allowed 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 126.91 2.084 . . . . 0.0 116.172 -176.106 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 83.2 p -137.79 168.38 19.8 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 125.805 1.642 . . . . 0.0 114.34 178.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 24.5 ttt-85 61.74 124.24 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 129.494 3.117 . . . . 0.0 113.398 -169.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 32.0 m -57.89 144.8 9.97 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.32 0 C-N-CA 123.376 0.67 . . . . 0.0 109.557 169.696 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -65.13 147.68 98.39 Favored Pre-proline 0 CA--C 1.544 0.749 0 C-N-CA 119.369 -0.932 . . . . 0.0 112.332 -169.614 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo -48.27 -41.72 34.59 Favored 'Trans proline' 0 CA--C 1.538 0.707 0 C-N-CA 123.375 2.717 . . . . 0.0 117.51 -168.185 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 86.1 m -64.82 -24.0 67.41 Favored 'General case' 0 N--CA 1.485 1.32 0 O-C-N 121.211 -0.931 . . . . 0.0 112.267 -177.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -57.6 -34.25 69.06 Favored 'General case' 0 CA--C 1.536 0.406 0 O-C-N 121.315 -0.865 . . . . 0.0 112.153 173.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.7 mp -60.58 -57.88 9.94 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 CA-C-N 119.901 1.228 . . . . 0.0 109.312 175.564 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -61.31 -32.77 72.63 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 113.122 0.786 . . . . 0.0 113.122 -178.561 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 3.8 tpp -77.36 -24.14 50.7 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 113.209 0.818 . . . . 0.0 113.209 178.051 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -87.49 -27.35 22.71 Favored 'General case' 0 CA--C 1.541 0.615 0 O-C-N 121.136 -0.977 . . . . 0.0 110.876 172.464 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -65.62 -5.16 7.51 Favored 'General case' 0 CA--C 1.552 1.055 0 C-N-CA 125.166 1.386 . . . . 0.0 113.036 169.456 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 18.5 mt-10 -72.79 -29.26 63.13 Favored 'General case' 0 N--CA 1.484 1.263 0 CA-C-N 120.039 1.29 . . . . 0.0 111.082 171.284 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 8.5 p -113.21 12.94 8.34 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.798 0 C-N-CA 127.143 2.177 . . . . 0.0 111.26 -177.142 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 80.17 18.06 72.75 Favored Glycine 0 CA--C 1.533 1.202 0 C-N-CA 124.978 1.275 . . . . 0.0 115.861 170.668 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 2.4 mm -71.92 143.49 14.14 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 CA-C-N 119.549 1.674 . . . . 0.0 110.286 177.757 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -97.82 29.63 3.32 Favored 'General case' 0 CA--C 1.553 1.083 0 C-N-CA 125.986 1.714 . . . . 0.0 115.476 -176.825 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 11.6 pt -72.11 -2.75 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.384 0 N-CA-C 115.594 1.702 . . . . 0.0 115.594 -175.173 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 91.6 p -55.58 -32.35 62.98 Favored 'General case' 0 N--CA 1.479 1.016 0 CA-C-N 119.851 1.205 . . . . 0.0 113.828 179.453 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -82.44 3.61 81.27 Favored Glycine 0 CA--C 1.536 1.364 0 C-N-CA 125.237 1.399 . . . . 0.0 116.105 177.412 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 5.1 mt-30 -79.48 132.68 36.41 Favored 'General case' 0 C--N 1.343 0.319 0 CA-C-N 120.362 2.081 . . . . 0.0 112.33 -179.019 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 40.4 p -139.66 113.58 8.75 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 126.068 1.747 . . . . 0.0 107.051 168.747 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 59.7 p -114.61 -174.7 2.53 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 114.703 1.371 . . . . 0.0 114.703 -169.208 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -133.86 164.49 43.64 Favored Pre-proline 0 CA--C 1.546 0.812 0 C-N-CA 126.833 2.053 . . . . 0.0 109.628 176.798 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -60.78 155.95 46.03 Favored 'Trans proline' 0 CA--C 1.541 0.871 0 C-N-CA 122.193 1.928 . . . . 0.0 112.522 169.769 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 7.5 tt -53.55 -33.17 21.67 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 C-N-CA 125.428 1.491 . . . . 0.0 111.552 175.045 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 17.8 mt-10 -59.66 -20.58 57.08 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 125.315 1.446 . . . . 0.0 113.112 178.662 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -85.31 -9.96 57.01 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 125.294 1.438 . . . . 0.0 113.609 -179.015 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -108.27 178.77 4.4 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 126.334 1.854 . . . . 0.0 112.301 -176.312 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 20.3 t30 -114.58 126.08 54.5 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 125.208 1.403 . . . . 0.0 110.075 175.774 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -63.47 -43.34 97.6 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 114.515 1.302 . . . . 0.0 114.515 -169.756 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -75.26 -0.9 21.13 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 113.495 0.924 . . . . 0.0 113.495 -178.468 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -71.83 -12.96 61.54 Favored 'General case' 0 CA--C 1.544 0.724 0 O-C-N 121.572 -0.705 . . . . 0.0 110.784 168.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -116.21 141.81 47.65 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 126.175 1.79 . . . . 0.0 111.222 178.715 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -86.71 -31.73 20.85 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 125.464 1.505 . . . . 0.0 111.651 174.717 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 94.3 t -129.12 138.03 55.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 C-N-CA 125.446 1.498 . . . . 0.0 108.38 -171.366 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 37.3 t -130.56 125.15 58.49 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 173.488 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 44.3 mm -116.25 102.87 14.27 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 C-N-CA 125.052 1.341 . . . . 0.0 108.8 -173.403 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 15.8 m -86.31 106.77 17.61 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 124.041 0.936 . . . . 0.0 110.111 176.493 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 81.1 mt -82.04 -4.92 57.86 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 125.271 1.428 . . . . 0.0 114.647 -169.772 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 28.6 p -152.9 147.96 26.59 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 124.34 1.056 . . . . 0.0 112.121 -175.7 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 60.84 -160.39 25.61 Favored Glycine 0 CA--C 1.536 1.385 0 C-N-CA 124.585 1.088 . . . . 0.0 114.739 176.589 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 86.9 p -71.45 -22.69 61.8 Favored 'General case' 0 N--CA 1.475 0.782 0 O-C-N 121.305 -1.115 . . . . 0.0 113.575 175.454 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 72.58 10.0 75.02 Favored Glycine 0 CA--C 1.533 1.201 0 C-N-CA 124.968 1.27 . . . . 0.0 114.367 -176.39 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.0 p -77.07 -16.76 14.57 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 CA-C-N 119.36 1.58 . . . . 0.0 114.664 -169.702 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 36.4 m120 -80.44 -9.3 59.76 Favored 'General case' 0 CA--C 1.548 0.901 0 N-CA-C 114.984 1.475 . . . . 0.0 114.984 -170.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -75.59 159.64 81.1 Favored Pre-proline 0 CA--C 1.552 1.033 0 CA-C-N 119.323 0.965 . . . . 0.0 112.066 169.727 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_exo -58.43 142.97 98.26 Favored 'Trans proline' 0 CA--C 1.547 1.146 0 C-N-CA 122.607 2.205 . . . . 0.0 113.011 179.287 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_exo -54.85 -32.08 75.8 Favored 'Trans proline' 0 C--N 1.353 0.777 0 C-N-CA 123.358 2.706 . . . . 0.0 115.62 -171.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 2.9 pm0 -61.95 -16.82 54.04 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 114.239 1.2 . . . . 0.0 114.239 177.76 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 93.6 m95 -80.58 -24.01 39.49 Favored 'General case' 0 CA--C 1.542 0.669 0 O-C-N 120.45 -1.406 . . . . 0.0 112.908 171.728 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 11.8 m -85.98 -10.19 11.27 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.167 0 CA-C-N 119.909 1.231 . . . . 0.0 113.555 174.195 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 72.0 p -98.31 0.96 46.57 Favored 'General case' 0 N--CA 1.477 0.917 0 N-CA-C 115.225 1.565 . . . . 0.0 115.225 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 76.7 mm-40 -67.4 160.35 27.55 Favored 'General case' 0 N--CA 1.478 0.971 0 CA-C-N 119.482 1.037 . . . . 0.0 110.95 169.803 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -58.01 -36.04 72.12 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 116.09 1.885 . . . . 0.0 116.09 -168.34 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 12.1 mm -127.18 74.55 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 CA-C-N 119.605 1.093 . . . . 0.0 109.062 177.707 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 12.4 t80 -81.57 109.78 16.34 Favored 'General case' 0 CA--C 1.534 0.365 0 O-C-N 121.224 -0.922 . . . . 0.0 108.544 169.289 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -111.32 139.33 46.82 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 114.636 1.347 . . . . 0.0 114.636 174.403 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -104.94 121.15 43.12 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.242 1.017 . . . . 0.0 108.98 168.754 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 43.8 m0 -107.07 111.61 24.15 Favored 'General case' 0 C--N 1.33 -0.239 0 C-N-CA 124.756 1.222 . . . . 0.0 108.352 -179.686 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 84.0 mm-40 -83.95 53.96 2.76 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-O 122.318 1.056 . . . . 0.0 111.561 -173.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 87.7 mt -85.53 165.86 16.76 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 126.957 2.103 . . . . 0.0 112.22 -179.704 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -96.29 157.0 16.1 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 123.98 0.912 . . . . 0.0 113.147 172.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 51.5 t0 -86.34 124.26 70.21 Favored Pre-proline 0 CA--C 1.542 0.665 0 C-N-CA 124.445 1.098 . . . . 0.0 110.266 173.021 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_exo -58.67 -24.4 70.57 Favored 'Trans proline' 0 CA--C 1.543 0.952 0 C-N-CA 122.925 2.417 . . . . 0.0 115.343 172.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -65.94 143.52 57.35 Favored 'General case' 0 CA--C 1.546 0.792 0 CA-C-N 119.444 1.02 . . . . 0.0 112.995 -178.771 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 80.95 5.95 89.78 Favored Glycine 0 CA--C 1.536 1.399 0 N-CA-C 115.176 0.83 . . . . 0.0 115.176 178.617 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 8.6 pt20 -142.17 168.3 20.07 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 125.378 1.471 . . . . 0.0 112.833 179.275 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 66.8 m -59.67 155.21 16.17 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 125.503 1.521 . . . . 0.0 114.085 -170.181 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 7.9 tt -60.51 -30.98 70.07 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.746 1.218 . . . . 0.0 113.569 -175.107 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -65.17 -23.96 67.25 Favored 'General case' 0 CA--C 1.546 0.81 0 O-C-N 121.059 -1.026 . . . . 0.0 112.899 173.544 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 11.3 t -72.84 -38.15 56.47 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 O-C-N 120.789 -1.195 . . . . 0.0 110.734 170.651 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -53.76 -45.73 70.69 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 118.78 0.718 . . . . 0.0 110.686 169.045 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 38.9 mtt180 -66.77 -39.08 87.71 Favored 'General case' 0 N--CA 1.482 1.159 0 N-CA-C 113.012 0.745 . . . . 0.0 113.012 175.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 28.9 m -58.89 -42.88 90.58 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 124.345 1.058 . . . . 0.0 110.946 172.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 77.6 t -67.99 -38.57 80.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 CA-C-O 117.894 -1.051 . . . . 0.0 111.083 177.361 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 65.9 mtm-85 -57.25 -43.82 83.34 Favored 'General case' 0 N--CA 1.487 1.413 0 CA-C-N 120.696 1.589 . . . . 0.0 112.208 170.169 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -59.37 -49.6 76.74 Favored Glycine 0 CA--C 1.536 1.403 0 CA-C-N 119.104 0.865 . . . . 0.0 113.253 176.522 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 55.5 mm-40 -64.57 -44.11 91.73 Favored 'General case' 0 N--CA 1.473 0.709 0 O-C-N 122.078 -0.66 . . . . 0.0 112.131 177.788 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 75.6 t -65.95 -37.38 79.72 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 124.203 1.001 . . . . 0.0 111.344 177.201 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 58.2 tttm -55.93 -51.9 66.0 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-N 119.81 1.186 . . . . 0.0 110.743 176.212 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -63.78 -40.82 97.6 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.119 0.568 . . . . 0.0 112.199 178.347 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -62.87 -44.08 97.07 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 124.583 1.153 . . . . 0.0 113.272 176.486 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 66.8 t -74.31 -35.8 40.93 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 124.188 0.995 . . . . 0.0 111.518 178.56 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -63.1 -39.76 95.65 Favored 'General case' 0 N--CA 1.471 0.58 0 O-C-N 121.138 -0.976 . . . . 0.0 111.679 169.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 11.6 m-80 -63.36 -44.94 93.36 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 118.976 0.807 . . . . 0.0 112.225 172.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 8.4 tt -51.49 -56.79 11.41 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 124.48 1.112 . . . . 0.0 110.306 174.334 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 62.8 mt -66.82 -44.24 89.23 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 O-C-N 121.848 -0.533 . . . . 0.0 111.174 -175.731 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -69.4 -10.53 58.38 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 114.102 1.149 . . . . 0.0 114.102 177.559 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 72.7 tttt -95.77 -48.26 5.83 Favored 'General case' 0 C--O 1.234 0.239 0 C-N-CA 125.811 1.644 . . . . 0.0 111.428 176.037 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 7.5 pt -93.71 -15.17 7.99 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 N-CA-C 114.375 1.25 . . . . 0.0 114.375 -172.798 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 73.8 m . . . . . 0 C--O 1.256 1.408 0 C-N-CA 125.606 1.562 . . . . 0.0 111.722 -176.464 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.8 ttt . . . . . 0 N--CA 1.502 2.166 0 N-CA-C 111.861 0.319 . . . . 0.0 111.861 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.72 164.99 28.88 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 125.371 1.468 . . . . 0.0 112.937 178.737 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 71.1 mttt -94.49 146.42 24.11 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 124.085 0.954 . . . . 0.0 112.872 175.58 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 14.5 t -123.51 134.45 66.31 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 C-N-CA 125.543 1.537 . . . . 0.0 111.998 175.019 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 48.6 tpp -102.81 123.48 46.54 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 168.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 72.4 m-85 -101.35 131.19 47.54 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 169.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -140.65 143.18 29.35 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 N-CA-C 114.012 1.116 . . . . 0.0 114.012 -169.379 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 46.4 t -145.14 160.11 41.94 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 127.473 2.309 . . . . 0.0 109.081 169.36 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 64.9 pttt -66.23 -42.67 88.32 Favored 'General case' 0 N--CA 1.485 1.311 0 N-CA-C 115.117 1.525 . . . . 0.0 115.117 -171.341 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 12.7 mmm180 -113.29 63.12 0.64 Allowed 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 126.758 2.023 . . . . 0.0 112.148 -175.705 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 47.2 t30 -45.42 -46.6 13.48 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 125.139 1.376 . . . . 0.0 113.834 -172.52 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 86.0 p -78.36 -10.2 59.59 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 115.717 1.747 . . . . 0.0 115.717 -175.674 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 88.6 p -133.36 0.34 3.35 Favored 'General case' 0 N--CA 1.479 1.003 0 N-CA-C 116.3 1.963 . . . . 0.0 116.3 179.401 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 2.4 tpt180 -112.82 -27.38 8.15 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 114.889 1.44 . . . . 0.0 114.889 178.766 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 3.0 t 63.77 166.63 0.14 Allowed 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 115.639 1.718 . . . . 0.0 115.639 -176.221 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -141.58 -50.06 0.41 Allowed 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 114.396 1.258 . . . . 0.0 114.396 -170.006 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 70.52 -38.78 0.43 Allowed 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 126.185 1.794 . . . . 0.0 114.096 -178.374 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -63.02 -30.79 71.88 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 113.992 1.108 . . . . 0.0 113.992 -173.73 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.2 pm0 -67.2 -42.42 84.18 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 119.568 1.077 . . . . 0.0 111.837 175.759 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -66.77 -41.31 93.75 Favored Glycine 0 C--N 1.335 0.48 0 N-CA-C 111.351 -0.7 . . . . 0.0 111.351 -178.324 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -70.89 -39.25 72.92 Favored 'General case' 0 N--CA 1.469 0.497 0 O-C-N 121.842 -0.799 . . . . 0.0 111.815 174.91 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -63.76 -35.92 82.19 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 119.375 0.989 . . . . 0.0 112.909 -176.08 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 7.5 pttp -82.72 -28.35 30.54 Favored 'General case' 0 N--CA 1.479 0.996 0 N-CA-C 113.972 1.101 . . . . 0.0 113.972 171.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 96.6 m -70.22 -35.74 74.08 Favored 'General case' 0 N--CA 1.486 1.341 0 CA-C-N 118.76 0.709 . . . . 0.0 111.937 175.093 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 74.1 mt -91.0 -38.03 13.08 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 125.92 1.688 . . . . 0.0 113.324 179.175 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -105.11 5.98 42.57 Favored Glycine 0 N--CA 1.471 1.008 0 N-CA-C 117.5 1.76 . . . . 0.0 117.5 -169.303 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.61 141.23 57.91 Favored 'General case' 0 CA--C 1.546 0.821 0 CA-C-N 121.149 2.474 . . . . 0.0 112.294 178.122 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 82.88 -16.93 24.46 Favored Glycine 0 CA--C 1.539 1.564 0 C-N-CA 124.868 1.223 . . . . 0.0 113.959 -169.539 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 62.7 mttp -104.0 -44.29 5.06 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 125.897 1.679 . . . . 0.0 112.172 171.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 38.1 pt -139.53 159.63 27.99 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 C-N-CA 125.323 1.449 . . . . 0.0 112.64 -178.257 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -107.85 149.23 28.52 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.378 1.471 . . . . 0.0 110.397 170.017 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 98.1 t -133.46 141.64 43.86 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 O-C-N 121.497 -0.752 . . . . 0.0 112.796 -176.173 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 38.8 m -134.91 153.33 52.1 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 125.732 1.613 . . . . 0.0 108.926 169.703 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 92.8 p -133.33 145.73 50.67 Favored 'General case' 0 CA--C 1.512 -0.497 0 CA-C-O 122.372 1.082 . . . . 0.0 112.179 167.774 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 54.4 p -145.97 166.53 25.77 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 113.714 -1.584 . . . . 0.0 112.199 -177.68 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -106.63 162.82 13.57 Favored Glycine 0 N--CA 1.467 0.753 0 C-N-CA 123.587 0.613 . . . . 0.0 112.754 172.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 9.0 mp -76.0 -32.27 59.33 Favored 'General case' 0 N--CA 1.479 1.024 0 O-C-N 122.144 -0.621 . . . . 0.0 111.819 172.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -134.29 27.23 3.8 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 125.734 1.614 . . . . 0.0 111.916 177.12 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 37.5 t -154.66 145.45 22.46 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 124.319 1.048 . . . . 0.0 112.796 -170.353 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 98.8 p -107.96 -13.04 15.05 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 116.853 2.168 . . . . 0.0 116.853 -169.679 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 71.7 ttt180 -134.38 149.12 50.79 Favored 'General case' 0 N--CA 1.483 1.217 0 CA-C-N 120.009 1.277 . . . . 0.0 111.072 -176.382 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 22.3 m -68.11 166.27 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.15 0 CA-C-O 122.908 1.337 . . . . 0.0 110.98 169.536 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 6.1 t-80 -57.04 129.87 79.18 Favored Pre-proline 0 N--CA 1.447 -0.586 0 CA-C-N 114.049 -1.432 . . . . 0.0 111.716 179.163 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_exo -61.1 -29.2 86.88 Favored 'Trans proline' 0 CA--C 1.549 1.25 0 CA-C-N 121.145 1.445 . . . . 0.0 112.3 177.506 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 99.3 m -67.64 -28.24 67.56 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 126.069 1.748 . . . . 0.0 112.656 172.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -59.68 -41.06 89.84 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 119.119 0.872 . . . . 0.0 111.748 -176.717 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.9 mp -54.17 -55.16 15.83 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 C-N-CA 123.976 0.91 . . . . 0.0 109.298 -177.585 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -65.83 -34.63 78.61 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 113.94 1.089 . . . . 0.0 113.94 -176.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -78.26 -20.57 51.38 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 113.676 0.991 . . . . 0.0 113.676 179.785 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 43.0 mtt -98.16 -26.78 14.45 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 125.032 1.333 . . . . 0.0 110.493 177.391 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -66.53 -13.82 61.47 Favored 'General case' 0 CA--C 1.544 0.717 0 O-C-N 120.662 -1.274 . . . . 0.0 111.784 168.525 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -61.83 -24.65 67.02 Favored 'General case' 0 N--CA 1.482 1.136 0 O-C-N 121.001 -1.062 . . . . 0.0 110.652 168.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 40.0 t -99.62 -6.77 9.15 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.882 0 C-N-CA 127.896 2.478 . . . . 0.0 111.275 175.358 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 81.68 20.82 62.95 Favored Glycine 0 CA--C 1.54 1.647 0 C-N-CA 125.293 1.425 . . . . 0.0 114.378 -173.44 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 85.7 mt -79.65 127.14 39.37 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 CA-C-N 118.485 1.143 . . . . 0.0 111.874 -173.51 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 20.7 t0 -89.15 93.73 9.68 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 123.538 0.735 . . . . 0.0 112.006 177.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 7.2 pt -118.27 11.08 7.03 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.082 0 C-N-CA 124.703 1.201 . . . . 0.0 113.957 170.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 72.7 m -60.42 -27.33 67.4 Favored 'General case' 0 N--CA 1.479 0.988 0 O-C-N 120.793 -1.192 . . . . 0.0 112.541 176.57 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -82.55 6.8 67.43 Favored Glycine 0 CA--C 1.538 1.472 0 C-N-CA 125.63 1.586 . . . . 0.0 116.031 174.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 26.5 mm100 -78.16 43.4 0.44 Allowed 'General case' 0 N--CA 1.478 0.969 0 CA-C-N 120.069 1.934 . . . . 0.0 113.599 -179.812 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 36.6 p -87.96 111.97 22.06 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 107.102 -1.444 . . . . 0.0 107.102 168.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 70.4 m -130.81 -160.59 1.05 Allowed 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 124.831 1.252 . . . . 0.0 111.374 -168.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -124.14 166.98 16.71 Favored Pre-proline 0 CA--C 1.546 0.797 0 C-N-CA 126.354 1.862 . . . . 0.0 108.464 169.543 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_endo -58.21 156.92 27.7 Favored 'Trans proline' 0 CA--C 1.539 0.761 0 C-N-CA 121.917 1.744 . . . . 0.0 112.38 169.573 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 9.8 tp -49.94 -34.02 9.51 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 C-N-CA 125.537 1.535 . . . . 0.0 112.363 174.183 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 12.7 mt-10 -64.32 -18.42 64.6 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.864 1.266 . . . . 0.0 113.126 -177.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -87.06 -13.9 43.01 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 124.994 1.318 . . . . 0.0 113.583 -173.255 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -104.67 -174.24 2.49 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 126.164 1.786 . . . . 0.0 112.686 -174.594 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 6.1 t30 -121.94 121.99 38.35 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 125.679 1.591 . . . . 0.0 109.519 175.035 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -64.11 -37.79 88.71 Favored 'General case' 0 C--N 1.333 -0.139 0 N-CA-C 114.943 1.46 . . . . 0.0 114.943 -169.617 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -73.64 -1.4 18.76 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 114.141 1.163 . . . . 0.0 114.141 -174.071 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -73.37 -14.87 61.36 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 123.392 0.677 . . . . 0.0 110.743 168.712 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 81.2 m-85 -112.44 140.57 47.07 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 127.315 2.246 . . . . 0.0 111.203 178.195 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -91.21 -22.58 20.55 Favored 'General case' 0 N--CA 1.477 0.879 0 CA-C-O 121.992 0.901 . . . . 0.0 112.303 176.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 90.5 t -134.5 138.1 50.26 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 C-N-CA 126.849 2.06 . . . . 0.0 108.948 -173.611 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 47.3 t -134.52 130.4 53.52 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 172.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 39.3 mm -119.0 104.83 16.51 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 C-N-CA 124.292 1.037 . . . . 0.0 109.717 -172.363 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 7.3 m -81.88 118.92 23.31 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 123.807 0.843 . . . . 0.0 109.634 171.359 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 90.5 mt -100.11 -7.23 25.13 Favored 'General case' 0 N--CA 1.478 0.929 0 N-CA-C 114.491 1.293 . . . . 0.0 114.491 -171.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 76.5 m -131.06 59.92 1.67 Allowed 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 125.217 1.407 . . . . 0.0 109.177 -169.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 82.4 -155.44 34.16 Favored Glycine 0 CA--C 1.536 1.354 0 C-N-CA 124.846 1.212 . . . . 0.0 111.602 -169.577 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 83.6 p -66.3 -29.91 70.22 Favored 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 113.483 0.92 . . . . 0.0 113.483 177.855 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 66.4 20.5 69.66 Favored Glycine 0 CA--C 1.534 1.247 0 C-N-CA 124.402 1.001 . . . . 0.0 114.11 -177.312 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 7.3 p -55.99 -9.89 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.34 0 N-CA-C 116.118 1.896 . . . . 0.0 116.118 -169.691 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -66.82 -22.18 66.01 Favored 'General case' 0 CA--C 1.554 1.124 0 N-CA-C 114.362 1.245 . . . . 0.0 114.362 169.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -67.82 154.51 93.41 Favored Pre-proline 0 N--CA 1.483 1.202 0 CA-C-N 120.903 1.683 . . . . 0.0 112.009 169.693 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_exo -57.71 148.51 73.86 Favored 'Trans proline' 0 CA--C 1.545 1.045 0 C-N-CA 122.698 2.265 . . . . 0.0 113.825 -175.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_exo -56.04 -32.54 86.65 Favored 'Trans proline' 0 C--N 1.354 0.85 0 C-N-CA 123.12 2.547 . . . . 0.0 114.898 -171.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -60.51 -21.69 62.73 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 114.057 1.132 . . . . 0.0 114.057 179.411 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 93.7 m95 -79.48 -21.52 45.29 Favored 'General case' 0 N--CA 1.47 0.529 0 O-C-N 120.695 -1.253 . . . . 0.0 113.169 175.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 14.2 m -92.42 -5.94 10.69 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 N-CA-C 113.481 0.919 . . . . 0.0 113.481 173.431 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 59.9 p -100.32 0.39 39.99 Favored 'General case' 0 N--CA 1.479 1.006 0 N-CA-C 115.29 1.589 . . . . 0.0 115.29 177.32 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 74.0 mm-40 -66.89 155.42 38.46 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-N 119.459 1.027 . . . . 0.0 110.722 169.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -54.78 -43.12 72.55 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 115.093 1.516 . . . . 0.0 115.093 -167.78 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 10.0 mm -116.53 66.39 0.23 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 C-N-CA 123.875 0.87 . . . . 0.0 109.579 176.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 12.2 t80 -77.04 108.71 10.3 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 168.595 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 9.1 mt-10 -107.62 142.58 37.34 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 114.321 1.23 . . . . 0.0 114.321 173.511 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -107.66 120.24 41.66 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 124.634 1.174 . . . . 0.0 108.23 168.381 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 37.3 m0 -103.84 133.67 48.44 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.545 1.138 . . . . 0.0 108.814 177.504 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 63.8 mt-30 -113.88 29.36 8.06 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 123.993 0.917 . . . . 0.0 111.987 -169.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -70.37 164.62 24.15 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 125.732 1.613 . . . . 0.0 112.292 170.621 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -73.63 158.71 34.25 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-O 121.773 0.797 . . . . 0.0 111.49 169.824 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -97.02 150.77 37.2 Favored Pre-proline 0 CA--C 1.542 0.653 0 C-N-CA 123.418 0.687 . . . . 0.0 110.055 169.797 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -88.59 -12.44 3.71 Favored 'Trans proline' 0 CA--C 1.547 1.152 0 CA-C-N 120.845 1.338 . . . . 0.0 115.072 -173.415 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -62.53 -50.27 72.04 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 114.928 1.455 . . . . 0.0 114.928 -170.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -77.24 16.69 5.63 Favored Glycine 0 CA--C 1.537 1.425 0 N-CA-C 115.256 0.862 . . . . 0.0 115.256 -169.825 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 7.9 pt20 -155.92 179.28 9.36 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 126.006 1.722 . . . . 0.0 112.63 -169.221 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 27.8 p -68.8 167.46 15.43 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 116.27 1.952 . . . . 0.0 116.27 -169.314 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 36.0 tp -59.88 -31.81 70.14 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.412 1.085 . . . . 0.0 112.46 172.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -63.46 -32.51 73.98 Favored 'General case' 0 N--CA 1.47 0.537 0 O-C-N 121.073 -1.017 . . . . 0.0 111.499 172.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 4.4 t -74.1 -35.07 40.21 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 O-C-N 121.2 -0.937 . . . . 0.0 112.069 171.54 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -55.59 -46.95 77.18 Favored 'General case' 0 N--CA 1.477 0.889 0 CA-C-N 120.424 1.466 . . . . 0.0 111.255 169.413 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 96.9 mtt180 -69.87 -33.91 72.87 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.75 0.82 . . . . 0.0 112.585 178.275 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 53.2 m -63.34 -42.89 98.98 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 123.787 0.835 . . . . 0.0 110.96 170.212 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 50.8 t -65.11 -40.56 89.28 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.475 0 CA-C-O 117.316 -1.326 . . . . 0.0 110.55 176.413 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 24.7 mtm105 -53.63 -47.38 70.34 Favored 'General case' 0 N--CA 1.484 1.248 0 CA-C-N 120.804 1.638 . . . . 0.0 112.287 170.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -61.36 -50.65 64.54 Favored Glycine 0 CA--C 1.537 1.417 0 CA-C-N 119.027 0.831 . . . . 0.0 113.644 177.743 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 65.2 mm-40 -63.49 -44.48 94.24 Favored 'General case' 0 N--CA 1.474 0.736 0 O-C-N 121.991 -0.711 . . . . 0.0 112.332 179.221 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 56.0 t -63.79 -43.73 98.02 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 C-N-CA 124.507 1.123 . . . . 0.0 110.603 176.485 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 59.5 tttm -53.56 -50.69 65.01 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-N 119.804 1.184 . . . . 0.0 111.295 179.602 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -63.58 -41.32 98.38 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 179.064 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 8.5 mtp85 -64.25 -42.12 96.65 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 113.145 0.794 . . . . 0.0 113.145 175.766 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 94.2 t -71.0 -36.44 63.53 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 C-N-CA 123.674 0.79 . . . . 0.0 111.156 178.71 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -63.31 -38.09 89.81 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 119.386 0.994 . . . . 0.0 111.606 170.724 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 12.5 m-80 -62.67 -48.02 81.12 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 118.914 0.779 . . . . 0.0 112.052 171.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 10.3 tt -50.45 -57.24 8.49 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 124.483 1.113 . . . . 0.0 110.07 173.809 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 75.3 mt -64.02 -42.57 96.1 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 CA-C-N 119.25 0.932 . . . . 0.0 111.56 -176.601 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -68.22 -10.46 54.62 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 114.535 1.309 . . . . 0.0 114.535 175.781 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 74.6 tttt -103.5 -45.78 4.75 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 126.049 1.74 . . . . 0.0 111.664 -179.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 5.4 pt -92.06 -16.53 7.88 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 N-CA-C 114.48 1.289 . . . . 0.0 114.48 -170.293 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 72.5 m . . . . . 0 C--O 1.253 1.281 0 CA-C-N 118.913 0.778 . . . . 0.0 112.9 -175.603 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.1 ttt . . . . . 0 N--CA 1.502 2.151 0 N-CA-C 111.615 0.228 . . . . 0.0 111.615 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.75 166.5 25.06 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 124.768 1.227 . . . . 0.0 113.654 177.266 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 44.2 mtmt -94.76 138.71 32.23 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 126.154 1.782 . . . . 0.0 112.954 -179.191 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 21.2 t -123.6 133.51 68.99 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 C-N-CA 126.036 1.734 . . . . 0.0 112.479 -179.151 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 41.8 tpp -104.66 125.51 50.85 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.562 0.745 . . . . 0.0 109.492 168.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 58.6 m-85 -102.81 127.72 49.86 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.266 1.026 . . . . 0.0 109.667 170.351 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 1.3 m -140.51 144.98 26.46 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.182 0 N-CA-C 114.414 1.265 . . . . 0.0 114.414 -168.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 41.7 t -157.06 159.65 38.15 Favored 'General case' 0 CA--C 1.556 1.18 0 C-N-CA 127.369 2.268 . . . . 0.0 111.974 177.443 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 17.9 ptpt -90.57 157.67 17.39 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 124.997 1.319 . . . . 0.0 111.638 169.522 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 34.1 mtp180 60.15 25.47 14.81 Favored 'General case' 0 N--CA 1.494 1.746 0 C-N-CA 126.074 1.75 . . . . 0.0 113.804 -169.098 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 5.8 t30 -52.95 -38.61 62.18 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 124.839 1.256 . . . . 0.0 114.045 -169.449 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 50.2 m -80.31 -8.34 59.44 Favored 'General case' 0 N--CA 1.478 0.96 0 N-CA-C 114.692 1.367 . . . . 0.0 114.692 -178.621 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 83.6 p -119.76 16.54 12.72 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 125.394 1.478 . . . . 0.0 112.996 170.672 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 19.5 ttm180 -139.49 156.06 47.17 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 125.653 1.581 . . . . 0.0 112.115 -175.78 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 73.0 m -94.76 138.08 33.03 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 125.015 1.326 . . . . 0.0 111.046 169.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 3.9 mp0 -113.71 -39.1 4.1 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 124.291 1.037 . . . . 0.0 112.497 -177.1 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' MET . . . . . 0.415 ' HG2' ' SD ' ' A' ' 50' ' ' MET . 0.0 OUTLIER 68.96 -50.98 0.59 Allowed 'General case' 0 N--CA 1.478 0.954 0 N-CA-C 117.641 2.46 . . . . 0.0 117.641 169.212 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -56.73 -35.3 68.4 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 114.398 1.258 . . . . 0.0 114.398 -169.246 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 23.4 pm0 -61.13 -40.06 92.37 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.944 1.297 . . . . 0.0 112.711 177.137 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -69.91 -37.77 74.79 Favored Glycine 0 C--N 1.336 0.554 0 N-CA-C 111.377 -0.689 . . . . 0.0 111.377 178.46 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -70.43 -40.25 73.9 Favored 'General case' 0 N--CA 1.47 0.546 0 O-C-N 121.89 -0.771 . . . . 0.0 111.184 176.514 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.21 -41.79 97.46 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 119.024 0.829 . . . . 0.0 112.527 -175.567 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 10.5 pttp -79.49 -27.53 41.48 Favored 'General case' 0 N--CA 1.479 1.013 0 N-CA-C 113.662 0.986 . . . . 0.0 113.662 173.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 96.3 m -68.84 -36.59 78.34 Favored 'General case' 0 N--CA 1.486 1.342 0 O-C-N 121.185 -0.947 . . . . 0.0 111.636 172.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 72.1 mt -87.89 -29.67 20.7 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 125.656 1.582 . . . . 0.0 114.037 -178.489 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -146.03 28.95 1.69 Allowed Glycine 0 N--CA 1.473 1.129 0 N-CA-C 118.502 2.161 . . . . 0.0 118.502 -169.206 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -66.62 -20.2 65.94 Favored 'General case' 0 CA--C 1.546 0.813 0 CA-C-N 122.108 2.954 . . . . 0.0 115.197 -177.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -76.49 -7.73 85.5 Favored Glycine 0 CA--C 1.542 1.771 0 O-C-N 121.432 -0.793 . . . . 0.0 113.597 169.575 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 61.1 mttp -111.33 -40.73 4.32 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 127.088 2.155 . . . . 0.0 112.692 -178.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 28.3 pt -141.09 155.71 21.63 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 C-N-CA 125.366 1.466 . . . . 0.0 112.42 -172.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -103.06 136.6 42.56 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 124.678 1.191 . . . . 0.0 110.199 171.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 74.6 t -123.54 137.18 57.65 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 CA-C-N 118.814 0.734 . . . . 0.0 112.134 -175.327 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 41.4 m -129.59 153.71 47.8 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 125.566 1.547 . . . . 0.0 108.763 169.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 26.0 p -129.59 146.33 51.4 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.806 0.812 . . . . 0.0 111.991 168.671 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 59.4 p -145.78 148.17 32.66 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 114.247 -1.342 . . . . 0.0 112.117 177.45 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -82.32 152.66 31.16 Favored Glycine 0 CA--C 1.53 1.009 0 O-C-N 121.429 -0.794 . . . . 0.0 111.493 172.646 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.7 mp -69.4 -32.8 72.04 Favored 'General case' 0 N--CA 1.477 0.877 0 O-C-N 120.843 -1.387 . . . . 0.0 113.389 179.006 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -134.77 11.9 3.68 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 124.683 1.193 . . . . 0.0 113.027 178.641 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 23.6 p -152.73 173.89 14.71 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 125.227 1.411 . . . . 0.0 112.013 -174.71 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 62.6 m -99.0 -73.39 0.62 Allowed 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 113.738 1.014 . . . . 0.0 113.738 -169.838 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 30.3 ttt85 -86.18 165.89 16.18 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 125.906 1.682 . . . . 0.0 111.463 -169.397 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 21.3 m -82.57 166.38 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 C-N-CA 123.258 0.623 . . . . 0.0 111.316 170.356 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . 0.262 0.0 OUTLIER -67.67 137.76 93.12 Favored Pre-proline 0 CA--C 1.545 0.766 0 C-N-CA 118.971 -1.091 . . . . 0.0 109.879 169.752 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -61.38 -30.06 86.65 Favored 'Trans proline' 0 CA--C 1.537 0.67 0 C-N-CA 123.219 2.613 . . . . 0.0 116.148 -167.793 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 90.7 m -64.14 -23.96 67.51 Favored 'General case' 0 N--CA 1.481 1.075 0 O-C-N 120.969 -1.082 . . . . 0.0 111.86 -177.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -55.67 -38.62 69.85 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.117 0.967 . . . . 0.0 112.507 172.513 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 5.0 mp -60.22 -54.7 31.26 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 CA-C-N 119.588 1.085 . . . . 0.0 110.018 179.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.3 -32.09 73.41 Favored 'General case' 0 CA--C 1.542 0.656 0 N-CA-C 113.222 0.823 . . . . 0.0 113.222 -178.535 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 2.1 tpp -77.71 -25.6 49.48 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 113.679 0.992 . . . . 0.0 113.679 177.176 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' MET . . . . . 0.415 ' SD ' ' HG2' ' A' ' 17' ' ' MET . 0.0 OUTLIER -88.01 -26.84 22.4 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-N 119.723 1.147 . . . . 0.0 111.04 174.145 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -65.12 -11.83 44.22 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 124.998 1.319 . . . . 0.0 113.219 169.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 17.9 mt-10 -61.7 -27.05 68.42 Favored 'General case' 0 N--CA 1.485 1.29 0 CA-C-N 120.012 1.278 . . . . 0.0 110.26 168.551 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 21.6 t -98.27 -1.52 10.17 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.958 0 C-N-CA 128.232 2.613 . . . . 0.0 110.829 178.774 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 77.04 20.13 76.3 Favored Glycine 0 CA--C 1.538 1.512 0 C-N-CA 125.041 1.305 . . . . 0.0 114.474 -176.036 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 70.5 mt -80.25 128.12 38.86 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 124.279 1.032 . . . . 0.0 111.72 -172.122 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 10.4 p-10 -88.22 100.35 12.91 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 124.372 1.069 . . . . 0.0 112.582 -179.734 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 12.9 pt -133.25 15.4 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.141 0 N-CA-C 114.934 1.457 . . . . 0.0 114.934 178.473 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 66.5 m -63.56 -19.77 65.09 Favored 'General case' 0 N--CA 1.481 1.09 0 O-C-N 120.32 -1.487 . . . . 0.0 113.293 177.514 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -85.41 10.08 65.3 Favored Glycine 0 CA--C 1.538 1.506 0 C-N-CA 125.993 1.759 . . . . 0.0 116.59 179.636 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 64.3 mt-30 -71.96 40.45 0.08 Allowed 'General case' 0 N--CA 1.486 1.34 0 CA-C-N 120.334 2.067 . . . . 0.0 114.699 -178.753 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 88.8 m -80.98 -4.56 55.51 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 119.788 -1.82 . . . . 0.0 112.662 177.198 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 70.5 m -45.11 146.4 0.87 Allowed 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 127.416 2.287 . . . . 0.0 114.323 176.332 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -67.69 171.51 5.18 Favored Pre-proline 0 CA--C 1.553 1.087 0 C-N-CA 127.169 2.188 . . . . 0.0 114.1 -175.558 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -59.03 160.06 19.8 Favored 'Trans proline' 0 C--N 1.353 0.798 0 C-N-CA 122.987 2.458 . . . . 0.0 113.621 169.73 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 7.6 tt -51.21 -37.6 18.11 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 C-N-CA 124.864 1.266 . . . . 0.0 111.854 174.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 14.1 mt-10 -64.61 -17.4 63.96 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.715 1.206 . . . . 0.0 113.111 -177.269 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -83.71 -12.3 56.01 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 124.927 1.291 . . . . 0.0 113.233 -178.31 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -106.94 -175.31 2.76 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 126.449 1.9 . . . . 0.0 112.723 -175.603 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 5.6 t30 -124.35 124.35 42.18 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 126.008 1.723 . . . . 0.0 109.103 174.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.74 -34.29 77.52 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 114.012 1.115 . . . . 0.0 114.012 -169.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . 0.264 0.0 OUTLIER -71.24 -4.58 26.49 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 114.06 1.133 . . . . 0.0 114.06 -177.752 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -72.94 -12.75 61.07 Favored 'General case' 0 CA--C 1.549 0.942 0 C-N-CA 123.4 0.68 . . . . 0.0 111.012 168.52 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 88.6 m-85 -118.19 138.5 52.27 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 126.806 2.042 . . . . 0.0 111.562 -177.713 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -89.08 -22.15 23.06 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-O 122.104 0.954 . . . . 0.0 112.38 176.404 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 77.9 t -131.44 138.59 52.74 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 C-N-CA 127.136 2.174 . . . . 0.0 108.908 -175.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 48.5 t -131.49 123.93 53.57 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 169.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 45.2 mm -109.42 103.72 15.95 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 C-N-CA 124.6 1.16 . . . . 0.0 109.536 -176.377 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 13.2 m -83.35 102.07 11.75 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 124.333 1.053 . . . . 0.0 109.439 169.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 92.4 mt -72.37 -36.25 68.69 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 112.755 0.65 . . . . 0.0 112.755 -177.371 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 36.4 m -112.05 122.27 47.3 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 125.61 1.564 . . . . 0.0 110.492 -169.221 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 62.9 -157.28 39.23 Favored Glycine 0 CA--C 1.537 1.455 0 C-N-CA 123.626 0.631 . . . . 0.0 114.055 -175.737 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 50.3 m -90.08 0.08 57.32 Favored 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 114.8 1.407 . . . . 0.0 114.8 -172.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 71.34 29.16 68.67 Favored Glycine 0 CA--C 1.535 1.315 0 O-C-N 121.478 -0.764 . . . . 0.0 114.609 179.249 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 60.0 t -90.46 -17.6 7.86 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.384 0 CA-C-N 118.216 1.008 . . . . 0.0 112.144 -179.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -84.23 12.63 6.26 Favored 'General case' 0 CA--C 1.555 1.144 0 C-N-CA 124.955 1.302 . . . . 0.0 113.641 -173.418 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -119.88 163.85 25.51 Favored Pre-proline 0 CA--C 1.552 1.047 0 C-N-CA 126.186 1.794 . . . . 0.0 112.464 177.671 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -63.53 150.1 89.35 Favored 'Trans proline' 0 CA--C 1.545 1.064 0 C-N-CA 122.437 2.091 . . . . 0.0 113.981 -178.16 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_exo -58.44 -27.96 83.63 Favored 'Trans proline' 0 C--N 1.353 0.789 0 C-N-CA 123.442 2.762 . . . . 0.0 115.559 -173.215 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -61.11 -24.14 66.03 Favored 'General case' 0 CA--C 1.544 0.725 0 O-C-N 120.976 -1.077 . . . . 0.0 113.214 177.059 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 89.6 m95 -82.96 -23.52 33.38 Favored 'General case' 0 N--CA 1.469 0.491 0 O-C-N 120.791 -1.193 . . . . 0.0 113.2 176.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 4.4 m -85.15 -18.98 8.91 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.228 0 CA-C-N 119.331 0.968 . . . . 0.0 113.142 173.084 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -88.53 -2.18 58.45 Favored 'General case' 0 N--CA 1.478 0.958 0 N-CA-C 114.847 1.425 . . . . 0.0 114.847 -177.517 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 73.0 mm-40 -66.33 157.07 32.65 Favored 'General case' 0 N--CA 1.481 1.08 0 O-C-N 120.963 -1.086 . . . . 0.0 111.575 171.126 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -59.28 -42.22 90.71 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 114.245 1.202 . . . . 0.0 114.245 -168.304 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 21.1 mm -117.88 61.75 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 C-N-CA 124.883 1.273 . . . . 0.0 108.949 179.273 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 19.9 t80 -78.18 110.42 13.15 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 168.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 24.9 mt-10 -114.54 137.3 52.04 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 114.047 1.129 . . . . 0.0 114.047 175.185 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -105.37 121.42 43.85 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 124.935 1.294 . . . . 0.0 108.852 169.176 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 42.9 m0 -100.52 -18.22 16.75 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 115.871 1.804 . . . . 0.0 115.871 -168.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 41.6 mm-40 55.11 30.61 14.69 Favored 'General case' 0 CA--C 1.555 1.158 0 N-CA-C 113.964 1.098 . . . . 0.0 113.964 174.19 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 30.0 mt -84.22 158.63 21.22 Favored 'General case' 0 N--CA 1.47 0.54 0 O-C-N 120.768 -1.208 . . . . 0.0 112.82 -170.3 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 9.7 tt0 -69.35 133.77 48.24 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.513 169.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 16.3 p-10 -90.46 137.66 27.3 Favored Pre-proline 0 CA--C 1.551 0.988 0 C-N-CA 126.011 1.724 . . . . 0.0 112.057 173.068 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_exo -67.79 -14.55 41.95 Favored 'Trans proline' 0 CA--C 1.551 1.333 0 C-N-CA 122.35 2.033 . . . . 0.0 115.358 178.225 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -59.25 136.73 58.05 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 124.773 1.229 . . . . 0.0 113.541 -175.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 76.46 8.99 86.11 Favored Glycine 0 CA--C 1.536 1.377 0 C-N-CA 124.449 1.023 . . . . 0.0 115.019 175.52 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 12.7 pt20 -141.17 168.92 18.62 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 125.53 1.532 . . . . 0.0 112.592 -179.131 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 28.1 p -66.54 166.08 13.36 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 115.453 1.649 . . . . 0.0 115.453 -169.407 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . 0.315 2.4 pp -68.72 -12.81 61.87 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 114.298 1.221 . . . . 0.0 114.298 173.887 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -70.81 -32.96 70.21 Favored 'General case' 0 CA--C 1.541 0.597 0 O-C-N 121.094 -1.004 . . . . 0.0 109.717 168.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 5.3 t -70.63 -40.18 76.8 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 CA-C-O 117.876 -1.059 . . . . 0.0 111.255 170.009 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 14.3 m-85 -54.05 -52.12 61.9 Favored 'General case' 0 N--CA 1.478 0.941 0 CA-C-N 120.287 1.403 . . . . 0.0 111.03 169.356 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 97.6 mtt180 -60.95 -38.69 86.77 Favored 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 124.03 0.932 . . . . 0.0 112.385 -179.138 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 75.2 m -64.84 -43.68 92.24 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.949 0.899 . . . . 0.0 111.341 172.776 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 54.5 t -66.72 -40.6 86.45 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 CA-C-O 117.739 -1.124 . . . . 0.0 111.213 177.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 47.8 mtm-85 -57.04 -41.06 77.95 Favored 'General case' 0 N--CA 1.482 1.153 0 CA-C-N 120.733 1.606 . . . . 0.0 111.295 174.13 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -60.92 -51.84 56.05 Favored Glycine 0 CA--C 1.537 1.462 0 CA-C-N 118.935 0.788 . . . . 0.0 113.597 173.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 60.6 mm-40 -63.89 -44.94 91.51 Favored 'General case' 0 N--CA 1.477 0.882 0 O-C-N 121.965 -0.727 . . . . 0.0 112.199 179.087 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 77.4 t -65.71 -40.61 88.35 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 C-N-CA 124.949 1.3 . . . . 0.0 110.711 178.201 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 36.2 ttmt -54.68 -50.3 68.58 Favored 'General case' 0 N--CA 1.478 0.948 0 CA-C-N 120.311 1.414 . . . . 0.0 110.41 175.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -61.8 -41.31 97.59 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 122.759 0.423 . . . . 0.0 112.119 178.821 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.63 -34.36 78.05 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 124.224 1.01 . . . . 0.0 113.561 176.824 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 97.3 t -80.19 -36.43 16.55 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 C-N-CA 125.353 1.461 . . . . 0.0 111.931 176.576 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -62.61 -39.56 94.19 Favored 'General case' 0 N--CA 1.47 0.536 0 O-C-N 120.885 -1.134 . . . . 0.0 110.97 170.09 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 14.2 m-80 -64.23 -44.72 90.98 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 118.747 0.703 . . . . 0.0 112.598 173.731 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 1.2 tt -48.22 -61.41 2.01 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 125.01 1.324 . . . . 0.0 109.702 172.233 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 82.9 mt -60.4 -44.98 97.28 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 C-N-CA 123.24 0.616 . . . . 0.0 110.648 -177.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -65.78 -12.76 56.66 Favored 'General case' 0 CA--C 1.547 0.853 0 N-CA-C 114.812 1.412 . . . . 0.0 114.812 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 21.1 ptmt -104.11 -27.13 12.27 Favored 'General case' 0 N--CA 1.477 0.904 0 N-CA-C 114.188 1.181 . . . . 0.0 114.188 172.494 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 16.3 pt -95.22 -12.88 8.42 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 N-CA-C 114.625 1.343 . . . . 0.0 114.625 178.618 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 70.1 m . . . . . 0 C--O 1.254 1.335 0 C-N-CA 125.146 1.379 . . . . 0.0 112.501 -179.742 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 36.4 ttm . . . . . 0 N--CA 1.501 2.083 0 N-CA-C 111.793 0.294 . . . . 0.0 111.793 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.0 163.17 30.47 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 125.151 1.38 . . . . 0.0 111.574 169.439 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 34.5 ttmt -101.63 144.17 30.69 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 124.639 1.175 . . . . 0.0 112.513 -179.044 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 21.7 t -124.15 135.09 64.79 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 125.33 1.452 . . . . 0.0 112.561 -176.358 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 49.8 tpp -103.74 125.91 50.53 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.396 0.678 . . . . 0.0 109.716 169.565 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 32.4 m-85 -108.73 121.96 46.13 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.917 1.287 . . . . 0.0 109.04 170.519 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.8 m -140.5 159.32 24.9 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 N-CA-C 115.267 1.58 . . . . 0.0 115.267 -168.619 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.6 m -150.98 160.85 43.66 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 128.529 2.731 . . . . 0.0 110.693 169.68 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 64.8 pttt -82.77 138.38 34.03 Favored 'General case' 0 N--CA 1.48 1.031 0 O-C-N 121.061 -1.024 . . . . 0.0 112.4 171.283 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 20.5 tpt180 44.31 55.06 5.82 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 126.388 1.875 . . . . 0.0 112.729 -169.879 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 63.3 t30 -50.54 -22.12 1.83 Allowed 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 127.725 2.41 . . . . 0.0 113.475 175.012 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 31.1 m -53.2 -22.64 6.95 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 125.885 1.674 . . . . 0.0 113.929 170.473 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 58.7 m -112.35 157.52 20.91 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 126.212 1.805 . . . . 0.0 111.136 171.021 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 61.9 mtt85 61.26 168.9 0.1 Allowed 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 126.468 1.907 . . . . 0.0 114.728 -178.166 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 62.2 m -113.98 122.48 47.07 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 125.493 1.517 . . . . 0.0 110.165 -177.333 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 3.2 mp0 -97.21 -33.89 11.31 Favored 'General case' 0 N--CA 1.48 1.06 0 N-CA-C 115.748 1.759 . . . . 0.0 115.748 -168.647 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 70.1 -46.67 0.61 Allowed 'General case' 0 N--CA 1.482 1.158 0 N-CA-C 118.313 2.709 . . . . 0.0 118.313 168.804 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.69 -30.13 70.54 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 115.169 1.544 . . . . 0.0 115.169 -169.449 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 5.7 pm0 -61.76 -39.1 90.45 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 118.813 0.733 . . . . 0.0 111.854 172.045 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -69.45 -44.77 63.08 Favored Glycine 0 C--N 1.334 0.457 0 C-N-CA 124.216 0.912 . . . . 0.0 111.783 -177.467 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -68.67 -36.01 77.98 Favored 'General case' 0 N--CA 1.467 0.412 0 O-C-N 121.569 -0.959 . . . . 0.0 112.152 173.965 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -65.02 -34.97 79.7 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 119.345 0.975 . . . . 0.0 112.363 178.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 22.2 mtpp -67.26 -48.86 66.49 Favored 'General case' 0 N--CA 1.481 1.094 0 O-C-N 121.884 -0.51 . . . . 0.0 111.217 169.572 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 24.7 m -73.71 -28.12 61.55 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 113.239 0.829 . . . . 0.0 113.239 -169.568 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 56.8 mt -97.2 -35.14 10.86 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 125.612 1.565 . . . . 0.0 112.96 176.043 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -103.47 -10.44 35.9 Favored Glycine 0 N--CA 1.469 0.884 0 N-CA-C 117.243 1.657 . . . . 0.0 117.243 -169.157 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -62.81 140.04 58.75 Favored 'General case' 0 CA--C 1.544 0.726 0 CA-C-N 120.936 2.368 . . . . 0.0 112.06 179.805 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 89.88 -21.24 31.34 Favored Glycine 0 CA--C 1.541 1.688 0 C-N-CA 125.048 1.309 . . . . 0.0 113.374 -169.342 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -101.44 -50.71 3.67 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 125.942 1.697 . . . . 0.0 111.026 169.853 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 2.6 pp -131.35 155.93 42.24 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 C-N-CA 125.813 1.645 . . . . 0.0 111.721 179.225 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -103.24 151.62 22.44 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 124.783 1.233 . . . . 0.0 109.718 175.402 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 44.4 t -138.07 142.77 34.85 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.051 0 O-C-N 121.282 -0.886 . . . . 0.0 113.061 -173.716 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 29.6 m -132.93 152.69 51.87 Favored 'General case' 0 CA--C 1.513 -0.465 0 C-N-CA 125.478 1.511 . . . . 0.0 108.029 168.792 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 2.8 p -132.57 141.36 48.67 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 122.283 1.04 . . . . 0.0 111.533 169.638 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 59.9 p -152.3 -174.46 4.89 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 113.599 -1.637 . . . . 0.0 110.209 178.857 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -135.16 170.89 22.72 Favored Glycine 0 C--N 1.335 0.495 0 O-C-N 121.142 -0.974 . . . . 0.0 112.351 174.195 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 6.2 mp -89.86 124.07 34.37 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 105.556 -2.016 . . . . 0.0 105.556 168.633 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 60.25 26.96 16.46 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 124.852 1.261 . . . . 0.0 113.439 -175.018 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 26.9 p -169.51 156.82 6.88 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 125.876 1.671 . . . . 0.0 112.773 -174.474 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 88.6 p -110.16 -51.63 2.85 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 115.546 1.684 . . . . 0.0 115.546 178.396 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 56.6 ttt180 -115.58 139.69 49.85 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 126.779 2.031 . . . . 0.0 113.988 -168.527 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 10.7 m -51.61 148.99 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 126.636 1.975 . . . . 0.0 111.924 169.365 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -62.26 144.65 94.68 Favored Pre-proline 0 CA--C 1.551 1.01 0 CA-C-O 118.893 -0.575 . . . . 0.0 110.448 176.263 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_exo -47.93 -36.04 26.29 Favored 'Trans proline' 0 CA--C 1.538 0.719 0 C-N-CA 124.087 3.191 . . . . 0.0 118.319 -168.12 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 58.7 m -59.64 -27.03 65.99 Favored 'General case' 0 N--CA 1.483 1.187 0 CA-C-N 119.622 1.101 . . . . 0.0 112.166 -178.228 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -55.85 -37.64 69.01 Favored 'General case' 0 CA--C 1.535 0.365 0 C-N-CA 124.113 0.965 . . . . 0.0 113.059 175.247 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.6 mp -63.86 -54.28 33.86 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 CA-C-N 119.183 0.901 . . . . 0.0 108.628 -178.428 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -62.98 -35.44 80.17 Favored 'General case' 0 CA--C 1.544 0.729 0 N-CA-C 113.361 0.874 . . . . 0.0 113.361 -177.552 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -77.75 -23.77 49.21 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 113.923 1.083 . . . . 0.0 113.923 178.188 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -87.93 -29.71 20.63 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 118.948 0.794 . . . . 0.0 109.732 174.612 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -67.19 -13.14 61.68 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.315 1.446 . . . . 0.0 113.791 172.338 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 -60.09 -26.24 66.04 Favored 'General case' 0 N--CA 1.482 1.171 0 CA-C-N 120.452 1.478 . . . . 0.0 110.641 168.836 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 40.8 t -98.26 -0.42 10.36 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.02 0 C-N-CA 127.668 2.387 . . . . 0.0 111.232 178.471 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 78.28 18.62 75.92 Favored Glycine 0 CA--C 1.541 1.675 0 C-N-CA 125.076 1.322 . . . . 0.0 114.878 -176.529 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 77.1 mt -81.68 133.66 28.77 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 C-N-CA 124.929 1.291 . . . . 0.0 111.736 -172.514 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 31.6 t0 -98.21 116.95 31.51 Favored 'General case' 0 N--CA 1.473 0.725 0 CA-C-O 121.41 0.624 . . . . 0.0 111.96 169.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 19.4 pt -127.97 19.43 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 C-N-CA 126.24 1.816 . . . . 0.0 112.379 171.059 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 98.1 p -70.68 -16.23 62.78 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 115.39 1.626 . . . . 0.0 115.39 -173.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -82.69 -0.96 90.48 Favored Glycine 0 CA--C 1.537 1.466 0 C-N-CA 124.762 1.172 . . . . 0.0 115.922 -177.139 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 4.4 tt0 -68.36 -6.15 22.78 Favored 'General case' 0 CA--C 1.547 0.836 0 N-CA-C 116.402 2.001 . . . . 0.0 116.402 -170.29 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.3 m -67.53 -7.83 29.06 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 125.86 1.664 . . . . 0.0 114.6 -170.809 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 78.2 p -64.73 -78.9 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 115.524 1.676 . . . . 0.0 115.524 -170.541 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -148.59 157.85 40.91 Favored Pre-proline 0 CA--C 1.554 1.133 0 N-CA-C 115.459 1.651 . . . . 0.0 115.459 -169.283 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -69.55 163.71 37.08 Favored 'Trans proline' 0 C--N 1.354 0.865 0 C-N-CA 124.967 3.778 . . . . 0.0 114.921 170.107 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 6.0 tt -52.82 -44.69 48.88 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 C-N-CA 124.905 1.282 . . . . 0.0 111.851 178.054 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -66.93 -9.56 39.56 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 114.092 1.145 . . . . 0.0 114.092 -177.681 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 -81.12 -22.67 38.9 Favored 'General case' 0 CA--C 1.548 0.899 0 N-CA-C 113.129 0.789 . . . . 0.0 113.129 174.145 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 82.1 m-85 -94.19 -169.98 2.19 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 125.805 1.642 . . . . 0.0 112.159 -177.251 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -124.6 124.76 42.91 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 125.657 1.583 . . . . 0.0 109.791 176.375 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -67.42 -34.9 78.18 Favored 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 114.241 1.2 . . . . 0.0 114.241 -170.125 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . 0.252 0.0 OUTLIER -72.19 -5.09 33.24 Favored 'General case' 0 CA--C 1.545 0.778 0 N-CA-C 114.163 1.172 . . . . 0.0 114.163 -176.457 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -73.93 -11.39 60.34 Favored 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 123.833 0.853 . . . . 0.0 111.244 168.711 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 74.5 m-85 -117.36 139.57 50.69 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 127.379 2.272 . . . . 0.0 111.251 -179.664 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -92.17 -23.51 19.37 Favored 'General case' 0 N--CA 1.479 1.004 0 CA-C-O 122.359 1.076 . . . . 0.0 112.342 177.055 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 80.3 t -129.56 138.12 55.06 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 C-N-CA 127.252 2.221 . . . . 0.0 108.886 -176.429 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 83.0 t -131.94 127.82 58.82 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 N-CA-C 107.562 -1.273 . . . . 0.0 107.562 170.694 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 27.5 mm -119.31 117.07 52.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 C-N-CA 124.356 1.063 . . . . 0.0 109.251 -178.162 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 22.6 t -98.54 130.93 45.11 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 122.596 0.359 . . . . 0.0 110.553 169.609 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 8.3 mt -101.32 0.51 37.32 Favored 'General case' 0 N--CA 1.478 0.95 0 N-CA-C 113.779 1.029 . . . . 0.0 113.779 178.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 84.6 m -135.95 146.67 47.52 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.213 1.005 . . . . 0.0 113.186 -169.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 63.15 -146.57 50.45 Favored Glycine 0 CA--C 1.532 1.147 0 C-N-CA 124.547 1.07 . . . . 0.0 114.356 170.149 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 93.9 p -86.1 -16.61 37.48 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 125.212 1.405 . . . . 0.0 114.593 -178.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 76.68 6.83 85.43 Favored Glycine 0 CA--C 1.54 1.6 0 C-N-CA 124.32 0.962 . . . . 0.0 114.598 -170.278 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 58.6 t -88.68 -22.27 6.69 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.162 0 CA-C-N 119.017 1.408 . . . . 0.0 113.118 -175.377 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 34.2 m120 -71.62 -19.47 62.11 Favored 'General case' 0 CA--C 1.547 0.86 0 N-CA-C 114.545 1.313 . . . . 0.0 114.545 -174.452 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -79.19 148.01 70.31 Favored Pre-proline 0 CA--C 1.549 0.915 0 CA-C-N 118.929 0.786 . . . . 0.0 111.768 176.557 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -59.42 155.11 43.05 Favored 'Trans proline' 0 CA--C 1.543 0.974 0 C-N-CA 122.769 2.313 . . . . 0.0 114.151 -178.164 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_exo -55.01 -32.46 79.09 Favored 'Trans proline' 0 C--N 1.35 0.649 0 C-N-CA 123.46 2.773 . . . . 0.0 114.412 -177.318 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -63.62 -31.78 73.05 Favored 'General case' 0 N--CA 1.471 0.617 0 O-C-N 121.277 -0.889 . . . . 0.0 113.025 177.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 94.8 m95 -80.4 -32.34 37.51 Favored 'General case' 0 N--CA 1.473 0.68 0 O-C-N 121.071 -1.018 . . . . 0.0 111.989 175.428 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 75.8 t -67.57 -31.97 54.94 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 C-N-CA 124.499 1.12 . . . . 0.0 112.159 172.527 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -91.98 3.33 55.45 Favored 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 115.799 1.777 . . . . 0.0 115.799 -171.513 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 80.2 mm-40 -65.6 155.17 36.65 Favored 'General case' 0 N--CA 1.478 0.941 0 O-C-N 120.741 -1.224 . . . . 0.0 111.547 170.651 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -56.18 -41.28 75.25 Favored 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 114.466 1.284 . . . . 0.0 114.466 -167.638 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 18.7 mm -119.31 64.57 0.23 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 C-N-CA 125.089 1.356 . . . . 0.0 108.407 177.308 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 15.9 t80 -79.54 108.29 12.96 Favored 'General case' 0 CA--C 1.534 0.356 0 O-C-N 120.989 -1.07 . . . . 0.0 108.77 169.326 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 11.1 mt-10 -110.32 146.47 35.69 Favored 'General case' 0 CA--C 1.545 0.756 0 N-CA-C 114.627 1.343 . . . . 0.0 114.627 174.591 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -114.36 117.21 30.41 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 125.566 1.546 . . . . 0.0 110.022 169.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 39.4 m0 -104.96 106.94 17.65 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 124.63 1.172 . . . . 0.0 109.884 -176.482 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 11.2 mm100 -86.9 47.95 1.57 Allowed 'General case' 0 CA--C 1.547 0.862 0 CA-C-O 122.118 0.961 . . . . 0.0 111.843 -172.309 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 89.7 mt -75.36 162.65 28.2 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 126.22 1.808 . . . . 0.0 112.297 178.434 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -79.01 149.57 32.17 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-O 121.351 0.596 . . . . 0.0 112.457 170.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -83.19 127.57 68.41 Favored Pre-proline 0 CA--C 1.544 0.728 0 C-N-CA 123.96 0.904 . . . . 0.0 110.854 174.31 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -82.04 -16.42 8.65 Favored 'Trans proline' 0 CA--C 1.542 0.92 0 C-N-CA 121.335 1.357 . . . . 0.0 115.242 -170.701 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -72.62 -39.81 66.95 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 116.77 2.137 . . . . 0.0 116.77 -168.788 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -75.3 16.79 3.48 Favored Glycine 0 CA--C 1.539 1.559 0 C-N-CA 123.938 0.78 . . . . 0.0 114.679 -175.164 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 8.8 pt20 -157.98 174.44 15.24 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 126.876 2.07 . . . . 0.0 111.818 -169.321 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 70.4 m -63.29 159.29 18.25 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 114.721 1.378 . . . . 0.0 114.721 -169.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 42.3 tp -59.75 -27.15 66.26 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 124.905 1.282 . . . . 0.0 113.295 179.771 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -62.88 -30.7 71.72 Favored 'General case' 0 N--CA 1.473 0.711 0 O-C-N 120.733 -1.229 . . . . 0.0 112.008 171.753 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 3.0 t -75.69 -36.19 33.16 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 O-C-N 120.955 -1.091 . . . . 0.0 111.152 172.725 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -55.48 -48.01 75.24 Favored 'General case' 0 N--CA 1.479 0.978 0 CA-C-N 119.688 1.131 . . . . 0.0 110.548 169.086 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -67.01 -35.94 81.05 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 124.141 0.976 . . . . 0.0 112.382 178.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 31.2 m -61.16 -45.53 94.27 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 124.329 1.052 . . . . 0.0 111.239 169.724 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 56.2 t -67.14 -39.19 82.61 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 CA-C-O 117.638 -1.173 . . . . 0.0 111.339 178.2 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 67.4 mtm-85 -56.43 -43.02 79.04 Favored 'General case' 0 N--CA 1.484 1.249 0 CA-C-N 120.694 1.588 . . . . 0.0 111.724 169.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -59.61 -49.47 78.22 Favored Glycine 0 CA--C 1.537 1.417 0 CA-C-N 118.982 0.81 . . . . 0.0 113.871 174.529 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 52.4 mm-40 -65.66 -44.38 86.48 Favored 'General case' 0 N--CA 1.475 0.784 0 O-C-N 121.585 -0.95 . . . . 0.0 112.193 178.274 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 60.5 t -65.13 -40.15 87.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 C-N-CA 124.622 1.169 . . . . 0.0 110.789 177.816 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 61.4 tttm -54.71 -49.9 69.6 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 119.515 1.052 . . . . 0.0 110.932 175.796 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -64.48 -42.05 96.12 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 112.486 0.55 . . . . 0.0 112.486 177.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 16.5 mmm180 -61.26 -45.97 92.32 Favored 'General case' 0 N--CA 1.479 0.982 0 O-C-N 121.597 -0.689 . . . . 0.0 112.529 175.409 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 92.7 t -68.38 -40.95 83.11 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 C-N-CA 124.006 0.923 . . . . 0.0 111.268 179.49 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -62.48 -39.95 95.11 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 119.258 0.935 . . . . 0.0 111.593 173.165 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 13.9 m-80 -63.25 -46.7 85.67 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 118.982 0.81 . . . . 0.0 112.189 173.751 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -54.7 -55.21 32.17 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 124.607 1.163 . . . . 0.0 110.585 176.467 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 73.1 mt -59.82 -45.88 94.32 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 CA-C-O 119.079 -0.486 . . . . 0.0 110.084 178.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -67.89 -11.47 58.75 Favored 'General case' 0 CA--C 1.545 0.776 0 N-CA-C 115.318 1.599 . . . . 0.0 115.318 -179.215 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 21.0 ptmt -100.54 -24.13 14.53 Favored 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 113.798 1.036 . . . . 0.0 113.798 171.286 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 16.4 pt -97.78 -13.95 7.92 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 N-CA-C 114.592 1.33 . . . . 0.0 114.592 177.692 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 54.5 m . . . . . 0 C--O 1.254 1.293 0 C-N-CA 125.373 1.469 . . . . 0.0 112.032 -179.815 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.412 ' HA ' ' O ' ' A' ' 29' ' ' LYS . 22.6 ttt . . . . . 0 N--CA 1.503 2.207 0 N-CA-C 111.74 0.274 . . . . 0.0 111.74 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.21 164.06 31.28 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 125.089 1.355 . . . . 0.0 112.527 176.575 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 58.9 mttt -99.14 151.07 21.39 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 124.185 0.994 . . . . 0.0 112.46 177.731 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 12.5 t -129.2 138.49 54.29 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 C-N-CA 125.103 1.361 . . . . 0.0 112.674 179.019 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 62.0 tpp -107.75 120.94 43.65 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 123.726 0.81 . . . . 0.0 109.429 168.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 68.5 m-85 -100.73 127.09 47.29 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 124.27 1.028 . . . . 0.0 108.99 170.58 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -144.43 156.12 14.96 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.084 0 N-CA-C 114.769 1.396 . . . . 0.0 114.769 -168.177 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -151.38 169.29 22.36 Favored 'General case' 0 CA--C 1.552 1.043 0 C-N-CA 127.159 2.183 . . . . 0.0 110.939 173.944 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 61.8 mtpt -49.26 -62.74 1.37 Allowed 'General case' 0 N--CA 1.495 1.788 0 C-N-CA 126.126 1.77 . . . . 0.0 113.789 -173.762 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 28.8 mmt85 -127.68 106.3 9.05 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 126.164 1.785 . . . . 0.0 107.588 172.506 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 36.1 p-10 -74.32 -11.1 60.17 Favored 'General case' 0 CA--C 1.556 1.195 0 CA-C-N 119.458 1.027 . . . . 0.0 112.357 -176.831 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 69.8 m -80.13 -6.71 58.19 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 125.08 1.352 . . . . 0.0 112.855 169.464 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 72.8 m -108.18 -69.61 0.84 Allowed 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 124.71 1.204 . . . . 0.0 110.03 172.02 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 66.7 mtt85 -74.35 122.61 23.2 Favored 'General case' 0 N--CA 1.479 1.015 0 O-C-N 121.444 -0.785 . . . . 0.0 109.092 173.679 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 52.4 p -69.45 -28.29 65.98 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 115.644 1.72 . . . . 0.0 115.644 -168.784 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 7.6 mt-30 61.26 -177.81 0.11 Allowed 'General case' 0 CA--C 1.552 1.027 0 C-N-CA 124.633 1.173 . . . . 0.0 112.482 -170.07 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -175.12 -47.48 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 126.366 1.867 . . . . 0.0 110.947 -169.447 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -56.73 -32.16 65.26 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 115.331 1.604 . . . . 0.0 115.331 -169.398 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.3 pm0 -57.16 -41.68 79.66 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 123.528 0.731 . . . . 0.0 112.757 177.545 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -67.25 -43.79 87.95 Favored Glycine 0 C--N 1.334 0.436 0 C-N-CA 124.821 1.2 . . . . 0.0 112.071 -177.465 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -71.53 -35.36 70.65 Favored 'General case' 0 N--CA 1.47 0.534 0 O-C-N 121.542 -0.975 . . . . 0.0 112.005 174.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -64.09 -33.66 76.27 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 118.986 0.812 . . . . 0.0 112.034 -175.652 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 2.7 pttp -85.08 -36.43 21.19 Favored 'General case' 0 N--CA 1.479 1.024 0 N-CA-C 113.644 0.979 . . . . 0.0 113.644 169.686 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 56.3 m -68.88 -31.29 70.11 Favored 'General case' 0 N--CA 1.486 1.338 0 CA-C-N 119.455 1.025 . . . . 0.0 112.3 -178.642 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 70.8 mt -91.22 -37.85 13.07 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 126.131 1.772 . . . . 0.0 112.645 173.022 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -100.62 2.08 55.81 Favored Glycine 0 N--CA 1.472 1.06 0 N-CA-C 117.262 1.665 . . . . 0.0 117.262 -169.539 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -60.55 141.63 56.34 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-N 121.133 2.466 . . . . 0.0 112.303 177.648 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 82.91 -15.15 33.67 Favored Glycine 0 CA--C 1.54 1.643 0 C-N-CA 124.74 1.162 . . . . 0.0 113.657 -169.408 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.412 ' O ' ' HA ' ' A' ' 1' ' ' MET . 69.7 mttt -108.22 -43.7 4.31 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 126.309 1.844 . . . . 0.0 112.484 171.841 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 42.7 pt -139.93 160.02 26.66 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 C-N-CA 124.92 1.288 . . . . 0.0 113.416 -177.203 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -107.64 149.31 28.24 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 125.487 1.515 . . . . 0.0 110.724 169.747 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 98.8 t -137.78 141.11 39.79 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 O-C-N 121.197 -0.94 . . . . 0.0 113.085 -175.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 79.3 m -135.51 152.85 51.73 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 125.805 1.642 . . . . 0.0 109.28 169.521 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 88.9 p -133.21 142.7 48.71 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 122.419 1.104 . . . . 0.0 113.208 167.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 35.7 p -145.43 170.5 16.23 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 114.002 -1.453 . . . . 0.0 112.251 -173.863 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -92.82 152.83 21.24 Favored Glycine 0 N--CA 1.467 0.763 0 O-C-N 121.56 -0.713 . . . . 0.0 111.392 174.863 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 2.2 mp -65.97 -32.8 74.5 Favored 'General case' 0 N--CA 1.483 1.207 0 CA-C-N 118.807 1.303 . . . . 0.0 111.744 171.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -120.47 165.49 14.88 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 126.685 1.994 . . . . 0.0 108.93 169.089 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 52.2 m -53.95 100.19 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 125.281 1.432 . . . . 0.0 113.6 -169.703 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 24.0 p -156.97 156.44 33.0 Favored 'General case' 0 CA--C 1.548 0.897 0 N-CA-C 114.159 1.17 . . . . 0.0 114.159 -175.666 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 49.7 ttt180 -107.77 140.66 40.51 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 128.815 2.846 . . . . 0.0 109.199 174.781 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 18.5 m -53.65 117.97 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.36 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 173.477 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . 0.276 0.0 OUTLIER -58.25 143.75 78.67 Favored Pre-proline 0 CA--C 1.536 0.439 0 N-CA-C 112.699 0.629 . . . . 0.0 112.699 -167.901 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 81.5 Cg_exo -47.34 -36.25 22.59 Favored 'Trans proline' 0 CA--C 1.538 0.681 0 C-N-CA 123.449 2.766 . . . . 0.0 116.792 -168.121 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 56.3 m -64.18 -26.27 68.45 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.915 0.886 . . . . 0.0 112.552 -179.091 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -55.08 -49.53 71.43 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 119.517 1.053 . . . . 0.0 110.601 173.25 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.6 mp -54.2 -57.16 6.6 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 C-N-CA 124.189 0.996 . . . . 0.0 110.176 -173.41 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.95 -28.09 69.59 Favored 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 113.22 0.822 . . . . 0.0 113.22 -175.243 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -79.91 -28.51 39.8 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 113.6 0.963 . . . . 0.0 113.6 177.79 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 4.9 mmt -77.39 -36.49 53.35 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-N 119.142 0.883 . . . . 0.0 110.645 169.743 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -61.9 -16.39 50.3 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 125.095 1.358 . . . . 0.0 114.17 174.421 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -61.08 -29.79 69.96 Favored 'General case' 0 N--CA 1.479 0.984 0 CA-C-N 120.714 1.597 . . . . 0.0 111.747 169.508 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 59.1 t -89.89 -6.38 10.79 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.889 0 C-N-CA 126.627 1.971 . . . . 0.0 111.294 175.673 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 81.63 13.93 79.04 Favored Glycine 0 CA--C 1.539 1.554 0 C-N-CA 125.245 1.402 . . . . 0.0 114.281 -170.589 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 83.5 mt -77.91 142.04 14.7 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 124.618 1.167 . . . . 0.0 111.144 -178.016 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -101.05 131.3 47.01 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 123.517 0.727 . . . . 0.0 111.044 169.172 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 13.4 pt -135.3 8.25 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 C-N-CA 124.234 1.014 . . . . 0.0 113.33 169.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 51.8 m -77.65 152.06 34.0 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 125.228 1.411 . . . . 0.0 113.228 -171.004 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 67.89 20.61 72.68 Favored Glycine 0 N--CA 1.473 1.119 0 N-CA-C 116.035 1.174 . . . . 0.0 116.035 169.758 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 48.1 mt-30 -67.0 -69.98 0.28 Allowed 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 118.701 1.25 . . . . 0.0 112.158 -179.387 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 7.4 t -166.37 169.82 13.65 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 125.238 1.415 . . . . 0.0 112.323 -177.087 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 96.8 p -129.05 5.05 5.33 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 128.419 2.687 . . . . 0.0 112.379 169.474 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 32.5 m-20 -89.94 153.94 47.4 Favored Pre-proline 0 CA--C 1.543 0.676 0 C-N-CA 124.721 1.208 . . . . 0.0 113.299 -177.866 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -70.43 157.28 59.57 Favored 'Trans proline' 0 N--CA 1.458 -0.579 0 C-N-CA 123.089 2.526 . . . . 0.0 112.12 175.771 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 5.9 tt -50.57 -34.34 12.17 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 C-N-CA 124.991 1.316 . . . . 0.0 111.349 169.556 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 18.8 mt-10 -63.71 -17.91 63.47 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 125.547 1.539 . . . . 0.0 113.558 -178.758 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -83.61 -12.34 56.16 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 124.669 1.188 . . . . 0.0 113.659 -178.627 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 74.7 m-85 -106.64 -172.21 2.04 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 125.946 1.699 . . . . 0.0 111.733 -176.417 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 10.5 t30 -120.77 122.44 40.37 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 125.182 1.393 . . . . 0.0 110.274 177.328 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -68.05 -35.83 78.88 Favored 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 113.726 1.01 . . . . 0.0 113.726 -171.42 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -71.28 -4.98 28.83 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 114.409 1.262 . . . . 0.0 114.409 -175.155 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -73.08 -14.0 61.31 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 123.573 0.749 . . . . 0.0 111.691 168.823 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 39.2 m-85 -119.54 134.2 55.33 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 126.939 2.096 . . . . 0.0 111.068 -178.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -88.44 -19.64 26.26 Favored 'General case' 0 N--CA 1.48 1.058 0 CA-C-O 122.36 1.076 . . . . 0.0 112.672 -179.806 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 95.9 t -130.88 136.77 57.43 Favored 'Isoleucine or valine' 0 C--O 1.235 0.336 0 C-N-CA 127.722 2.409 . . . . 0.0 107.853 -175.411 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 65.3 t -134.13 127.07 50.79 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 170.384 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 48.3 mm -116.17 106.7 20.87 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.249 0 C-N-CA 124.454 1.101 . . . . 0.0 109.395 -171.873 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 4.0 m -92.38 108.2 19.78 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 123.049 0.54 . . . . 0.0 110.321 177.202 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 78.3 mt -78.07 -9.48 59.16 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 125.872 1.669 . . . . 0.0 113.406 -179.371 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 23.9 m -108.34 103.99 13.26 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 125.664 1.586 . . . . 0.0 110.733 -179.04 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 57.65 -139.66 46.72 Favored Glycine 0 CA--C 1.535 1.331 0 C-N-CA 124.325 0.964 . . . . 0.0 114.236 172.831 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 85.0 p -69.91 -14.28 62.65 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 124.84 1.256 . . . . 0.0 114.108 175.793 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 72.09 7.79 67.84 Favored Glycine 0 CA--C 1.528 0.902 0 N-CA-C 115.6 1.0 . . . . 0.0 115.6 178.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.3 p -72.51 -9.58 13.08 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.988 0 CA-C-N 119.593 1.696 . . . . 0.0 114.675 -169.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 -80.64 -16.71 53.34 Favored 'General case' 0 CA--C 1.547 0.857 0 N-CA-C 114.701 1.371 . . . . 0.0 114.701 -174.162 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -71.07 159.14 86.51 Favored Pre-proline 0 CA--C 1.551 0.985 0 CA-C-N 119.214 0.916 . . . . 0.0 112.317 170.926 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_exo -60.53 151.86 72.33 Favored 'Trans proline' 0 CA--C 1.544 1.014 0 C-N-CA 122.133 1.888 . . . . 0.0 113.321 -176.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_exo -54.35 -36.59 87.59 Favored 'Trans proline' 0 C--N 1.352 0.751 0 C-N-CA 123.458 2.772 . . . . 0.0 115.164 -169.816 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -63.71 -22.28 66.83 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 114.131 1.16 . . . . 0.0 114.131 179.723 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 77.7 m95 -82.99 -23.1 33.47 Favored 'General case' 0 N--CA 1.47 0.531 0 O-C-N 120.888 -1.133 . . . . 0.0 112.486 172.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 10.5 t -73.67 -30.37 29.01 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 C-N-CA 124.996 1.318 . . . . 0.0 110.91 170.336 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 76.5 p -91.14 3.33 55.06 Favored 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 116.252 1.945 . . . . 0.0 116.252 -174.869 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 80.4 mm-40 -66.36 149.62 50.11 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 119.503 1.047 . . . . 0.0 108.984 169.294 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -59.73 -37.97 80.41 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 114.577 1.325 . . . . 0.0 114.577 -167.154 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 16.2 mm -113.01 56.64 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 C-N-CA 124.715 1.206 . . . . 0.0 109.385 177.488 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 40.7 t80 -75.57 106.52 7.17 Favored 'General case' 0 CA--C 1.535 0.395 0 O-C-N 120.633 -1.292 . . . . 0.0 107.522 168.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.7 mt-10 -106.41 133.28 51.34 Favored 'General case' 0 CA--C 1.543 0.678 0 N-CA-C 113.556 0.947 . . . . 0.0 113.556 175.877 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -88.95 111.51 22.21 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.41 1.084 . . . . 0.0 109.339 169.432 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 15.2 m0 -97.99 101.22 12.65 Favored 'General case' 0 N--CA 1.462 0.158 0 C-N-CA 123.813 0.845 . . . . 0.0 109.48 -176.859 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 54.9 mm-40 -78.64 41.14 0.4 Allowed 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 125.995 1.718 . . . . 0.0 111.676 -177.291 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 33.1 mt -91.59 163.68 14.04 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 126.277 1.831 . . . . 0.0 113.19 -172.155 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -73.92 150.42 40.85 Favored 'General case' 0 CA--C 1.545 0.784 0 CA-C-N 114.857 -1.065 . . . . 0.0 111.715 169.728 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -112.71 138.85 22.23 Favored Pre-proline 0 CA--C 1.549 0.923 0 C-N-CA 124.339 1.056 . . . . 0.0 111.108 169.564 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_exo -66.81 -19.84 52.57 Favored 'Trans proline' 0 CA--C 1.54 0.822 0 C-N-CA 122.511 2.141 . . . . 0.0 116.61 -178.139 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -68.03 144.83 54.95 Favored 'General case' 0 CA--C 1.545 0.757 0 CA-C-N 120.375 1.443 . . . . 0.0 114.102 -170.424 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 77.69 6.52 86.98 Favored Glycine 0 CA--C 1.535 1.338 0 C-N-CA 124.815 1.198 . . . . 0.0 114.586 -177.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 13.3 pt20 -140.85 174.37 10.58 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 126.015 1.726 . . . . 0.0 112.165 179.832 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 25.0 p -67.71 164.73 18.72 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 117.395 2.369 . . . . 0.0 117.395 -168.659 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -53.5 -41.35 66.19 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 126.272 1.829 . . . . 0.0 111.961 169.767 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -60.01 -36.11 76.52 Favored 'General case' 0 CA--C 1.543 0.697 0 O-C-N 121.47 -0.769 . . . . 0.0 111.922 174.653 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 16.3 t -68.86 -40.8 81.68 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 O-C-N 121.177 -0.952 . . . . 0.0 111.463 171.141 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -52.31 -50.55 61.99 Favored 'General case' 0 N--CA 1.476 0.839 0 CA-C-N 119.56 1.073 . . . . 0.0 112.104 170.629 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 96.0 mtt180 -67.87 -35.17 78.06 Favored 'General case' 0 N--CA 1.477 0.883 0 O-C-N 121.399 -0.813 . . . . 0.0 112.751 179.428 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 79.4 m -63.67 -42.17 98.09 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.682 0.793 . . . . 0.0 110.957 172.229 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 71.5 t -67.9 -39.86 82.47 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 CA-C-O 117.914 -1.041 . . . . 0.0 111.215 176.603 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 27.1 mtm105 -54.56 -42.71 71.31 Favored 'General case' 0 N--CA 1.484 1.252 0 CA-C-N 120.52 1.509 . . . . 0.0 112.109 173.026 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -62.39 -51.34 57.08 Favored Glycine 0 CA--C 1.539 1.549 0 CA-C-N 119.052 0.842 . . . . 0.0 113.311 176.383 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 68.8 mm-40 -63.3 -44.42 95.08 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.234 0.614 . . . . 0.0 112.017 179.845 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 69.3 t -67.18 -41.16 86.51 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 C-N-CA 124.592 1.157 . . . . 0.0 111.028 177.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 34.6 ttmt -54.56 -49.9 69.21 Favored 'General case' 0 N--CA 1.478 0.971 0 CA-C-N 120.491 1.496 . . . . 0.0 110.773 177.645 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -61.1 -40.14 92.61 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 112.242 0.46 . . . . 0.0 112.242 177.492 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.11 -35.26 80.02 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 124.226 1.011 . . . . 0.0 113.228 176.947 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 99.6 t -77.34 -38.46 26.84 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 C-N-CA 125.195 1.398 . . . . 0.0 111.621 176.508 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -60.25 -40.2 89.45 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 119.198 0.908 . . . . 0.0 111.178 170.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 17.1 m-80 -64.35 -43.55 94.21 Favored 'General case' 0 CA--C 1.542 0.635 0 N-CA-C 112.56 0.578 . . . . 0.0 112.56 174.093 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 9.1 tt -53.69 -55.01 29.86 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 124.401 1.08 . . . . 0.0 110.477 173.148 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 76.4 mt -63.49 -41.81 93.98 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.625 0 C-N-CA 122.658 0.383 . . . . 0.0 110.589 -178.433 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -69.72 -12.68 61.82 Favored 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 114.578 1.325 . . . . 0.0 114.578 178.346 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 20.7 ptmt -101.27 -30.93 11.24 Favored 'General case' 0 N--CA 1.477 0.906 0 N-CA-C 113.915 1.08 . . . . 0.0 113.915 173.297 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 13.5 pt -94.09 -18.84 6.77 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 N-CA-C 114.528 1.307 . . . . 0.0 114.528 179.255 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 74.5 m . . . . . 0 C--O 1.253 1.26 0 C-N-CA 125.539 1.536 . . . . 0.0 111.708 -175.354 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 34.8 ttm . . . . . 0 N--CA 1.501 2.086 0 N-CA-C 112.087 0.403 . . . . 0.0 112.087 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.47 162.92 26.05 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 125.146 1.379 . . . . 0.0 111.247 169.234 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 69.0 mttt -96.99 147.44 23.99 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.648 0.779 . . . . 0.0 111.527 172.728 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 17.2 t -124.42 135.53 63.49 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 C-N-CA 125.297 1.439 . . . . 0.0 111.927 176.046 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 54.3 tpp -106.07 125.75 51.37 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 123.229 0.611 . . . . 0.0 109.501 168.724 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 67.1 m-85 -103.89 125.18 50.11 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.43 1.092 . . . . 0.0 108.918 172.846 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.1 m -143.46 156.99 16.82 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.167 0 C-N-CA 124.661 1.184 . . . . 0.0 113.151 -169.175 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 18.2 t -153.65 141.7 20.33 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 126.304 1.842 . . . . 0.0 108.437 168.625 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . 0.263 60.7 pttt -73.79 -15.98 61.17 Favored 'General case' 0 N--CA 1.486 1.335 0 N-CA-C 116.385 1.994 . . . . 0.0 116.385 -169.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 16.2 ptm180 -121.08 49.68 1.46 Allowed 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 125.46 1.504 . . . . 0.0 112.645 169.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 5.8 t30 -46.79 -31.87 3.3 Favored 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 126.058 1.743 . . . . 0.0 114.582 -177.683 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 67.7 m -69.61 -23.78 63.56 Favored 'General case' 0 N--CA 1.479 1.0 0 N-CA-C 114.017 1.117 . . . . 0.0 114.017 178.131 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 36.9 m -89.9 -15.63 31.72 Favored 'General case' 0 N--CA 1.478 0.954 0 N-CA-C 114.247 1.203 . . . . 0.0 114.247 -176.244 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 55.7 mtp85 -135.5 159.03 42.88 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 125.607 1.563 . . . . 0.0 112.632 -169.847 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 26.1 t -100.25 145.59 27.9 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.234 1.414 . . . . 0.0 107.742 168.478 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 3.9 mp0 -108.76 -37.67 5.83 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 115.331 1.604 . . . . 0.0 115.331 -168.361 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 66.07 -47.48 0.41 Allowed 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 126.996 2.118 . . . . 0.0 116.281 170.46 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.16 -35.81 76.15 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.649 1.18 . . . . 0.0 113.945 -169.824 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 3.9 pm0 -58.94 -38.31 78.72 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 125.049 1.339 . . . . 0.0 113.215 176.057 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -69.92 -45.03 59.4 Favored Glycine 0 N--CA 1.464 0.552 0 C-N-CA 123.688 0.661 . . . . 0.0 111.831 -177.737 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -69.29 -32.7 72.03 Favored 'General case' 0 N--CA 1.466 0.347 0 O-C-N 121.793 -0.828 . . . . 0.0 112.51 173.73 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -64.61 -36.71 85.12 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 119.347 0.976 . . . . 0.0 112.302 -174.804 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.23 -38.96 30.01 Favored 'General case' 0 N--CA 1.482 1.163 0 N-CA-C 112.904 0.705 . . . . 0.0 112.904 169.464 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 70.7 m -67.09 -32.46 73.63 Favored 'General case' 0 N--CA 1.485 1.286 0 CA-C-N 118.96 0.8 . . . . 0.0 112.24 -176.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 66.9 mt -91.85 -39.86 11.51 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 125.733 1.613 . . . . 0.0 112.926 173.858 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -99.02 3.43 58.5 Favored Glycine 0 N--CA 1.472 1.036 0 N-CA-C 117.444 1.738 . . . . 0.0 117.444 -169.431 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.24 142.02 57.11 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 121.034 2.417 . . . . 0.0 112.11 178.369 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 84.16 -21.65 9.74 Favored Glycine 0 CA--C 1.539 1.572 0 C-N-CA 125.092 1.33 . . . . 0.0 113.268 -169.442 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -98.88 -46.39 5.65 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 125.603 1.561 . . . . 0.0 111.985 171.609 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 43.0 pt -137.58 154.58 29.86 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 C-N-CA 124.96 1.304 . . . . 0.0 113.37 -175.375 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -102.59 142.37 33.87 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 124.757 1.223 . . . . 0.0 109.938 169.809 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 85.9 t -131.16 139.57 50.66 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 CA-C-N 118.928 0.785 . . . . 0.0 113.058 -176.455 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 27.5 m -139.69 154.24 47.44 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 125.815 1.646 . . . . 0.0 109.586 173.346 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 52.2 m -128.64 147.74 50.75 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.718 0.771 . . . . 0.0 110.841 168.448 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 3.8 m -142.69 151.76 41.68 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 113.926 -1.488 . . . . 0.0 110.981 177.119 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -89.59 174.08 40.97 Favored Glycine 0 CA--C 1.527 0.825 0 N-CA-C 110.383 -1.087 . . . . 0.0 110.383 169.166 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -84.47 -36.99 21.9 Favored 'General case' 0 N--CA 1.477 0.924 0 O-C-N 121.414 -1.05 . . . . 0.0 112.816 175.138 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -128.77 18.83 6.17 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 126.192 1.797 . . . . 0.0 111.628 175.02 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 34.7 p -142.86 153.13 42.87 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 126.069 1.747 . . . . 0.0 111.975 -173.768 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 98.5 p -95.8 -18.56 20.31 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 117.528 2.418 . . . . 0.0 117.528 -168.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 19.0 ttm105 -152.29 151.77 31.32 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 124.916 1.286 . . . . 0.0 111.789 -169.757 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 34.1 m -64.94 136.84 26.02 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 C-N-CA 123.328 0.651 . . . . 0.0 109.364 170.032 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -60.84 143.23 91.59 Favored Pre-proline 0 CA--C 1.551 1.005 0 N-CA-C 112.678 0.622 . . . . 0.0 112.678 -169.046 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_exo -46.59 -40.4 23.66 Favored 'Trans proline' 0 CA--C 1.538 0.718 0 C-N-CA 124.192 3.261 . . . . 0.0 118.731 -168.154 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 33.5 m -63.74 -27.25 69.07 Favored 'General case' 0 N--CA 1.484 1.249 0 CA-C-N 119.759 1.163 . . . . 0.0 111.936 -177.354 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -57.49 -50.15 73.99 Favored 'General case' 0 CA--C 1.537 0.448 0 O-C-N 121.373 -0.83 . . . . 0.0 111.548 173.705 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 4.6 mp -56.94 -50.94 74.22 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 CA-C-N 119.438 1.017 . . . . 0.0 111.126 -175.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -61.22 -27.9 68.77 Favored 'General case' 0 CA--C 1.546 0.804 0 N-CA-C 113.176 0.806 . . . . 0.0 113.176 -179.255 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -83.5 -24.0 31.91 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 113.963 1.098 . . . . 0.0 113.963 175.133 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 4.4 mmt -80.44 -30.5 37.57 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 119.758 1.163 . . . . 0.0 110.188 169.602 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -64.9 -14.92 61.24 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 125.345 1.458 . . . . 0.0 113.604 173.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -61.58 -27.0 68.32 Favored 'General case' 0 N--CA 1.482 1.173 0 CA-C-N 120.639 1.563 . . . . 0.0 110.918 169.104 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 61.0 t -95.8 -2.96 10.48 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.902 0 C-N-CA 127.574 2.349 . . . . 0.0 111.148 177.837 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 77.98 16.87 79.29 Favored Glycine 0 CA--C 1.54 1.598 0 O-C-N 120.699 -1.25 . . . . 0.0 114.397 -174.737 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 77.5 mt -72.34 137.32 23.79 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 124.687 1.195 . . . . 0.0 111.247 -177.456 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 18.0 t0 -105.29 105.41 15.43 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 124.331 1.052 . . . . 0.0 112.098 179.347 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 15.8 pt -137.32 18.99 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.309 0 N-CA-C 114.867 1.432 . . . . 0.0 114.867 -178.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 89.1 p -70.95 -36.87 72.76 Favored 'General case' 0 N--CA 1.479 0.982 0 O-C-N 120.138 -1.601 . . . . 0.0 112.691 175.33 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -77.54 39.16 1.7 Allowed Glycine 0 CA--C 1.538 1.471 0 C-N-CA 126.502 2.001 . . . . 0.0 114.788 177.443 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 5.9 mm-40 -83.42 65.78 8.53 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 125.621 1.568 . . . . 0.0 112.57 -172.427 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER 63.59 -30.79 0.1 Allowed 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 119.741 3.237 . . . . 0.0 119.741 169.11 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 71.2 m 59.37 32.3 21.73 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 125.387 1.475 . . . . 0.0 114.382 -179.622 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -150.95 145.92 18.7 Favored Pre-proline 0 CA--C 1.551 1.013 0 O-C-N 120.974 -1.079 . . . . 0.0 113.798 179.221 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -66.24 162.9 33.95 Favored 'Trans proline' 0 CA--C 1.54 0.795 0 C-N-CA 124.543 3.496 . . . . 0.0 114.599 171.095 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 9.3 tp -57.33 -35.1 47.9 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 C-N-CA 124.536 1.134 . . . . 0.0 112.113 177.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -68.21 -10.22 52.85 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 113.79 1.033 . . . . 0.0 113.79 -179.569 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 66.2 m-20 -95.27 11.72 31.53 Favored 'General case' 0 CA--C 1.555 1.157 0 N-CA-C 113.791 1.034 . . . . 0.0 113.791 178.892 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 76.8 m-85 -130.86 177.72 7.2 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 125.526 1.531 . . . . 0.0 114.514 -174.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 8.1 t30 -107.69 131.81 54.02 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 126.921 2.088 . . . . 0.0 109.975 172.858 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -73.89 -35.34 64.69 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 114.673 1.361 . . . . 0.0 114.673 -176.436 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . 0.273 0.0 OUTLIER -71.69 -6.38 40.74 Favored 'General case' 0 CA--C 1.544 0.734 0 N-CA-C 114.401 1.26 . . . . 0.0 114.401 -172.213 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -62.55 -27.73 69.37 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 124.28 1.032 . . . . 0.0 110.494 168.327 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 19.4 m-85 -113.77 121.65 44.71 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 125.65 1.58 . . . . 0.0 111.132 -172.213 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -73.0 -23.57 60.65 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-O 121.77 0.795 . . . . 0.0 112.555 175.851 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 90.8 t -126.9 136.41 60.87 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 C-N-CA 127.486 2.314 . . . . 0.0 109.299 -174.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 54.2 t -135.51 120.23 27.5 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 169.621 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 25.9 mm -106.82 117.97 53.65 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 C-N-CA 123.314 0.646 . . . . 0.0 109.498 -176.63 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 14.2 t -89.07 124.09 33.97 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 169.607 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 87.6 mt -100.08 13.58 33.61 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 125.147 1.379 . . . . 0.0 114.188 -170.044 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 20.8 p -149.19 1.74 0.55 Allowed 'General case' 0 CA--C 1.547 0.845 0 N-CA-C 114.926 1.454 . . . . 0.0 114.926 177.597 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 68.53 170.34 5.99 Favored Glycine 0 CA--C 1.541 1.682 0 C-N-CA 124.261 0.934 . . . . 0.0 114.161 -176.288 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 71.7 m 54.89 29.5 12.2 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 125.192 1.397 . . . . 0.0 113.685 178.342 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -73.4 18.02 1.77 Allowed Glycine 0 N--CA 1.474 1.213 0 C-N-CA 126.327 1.917 . . . . 0.0 114.688 -177.799 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 4.2 p -65.24 -5.46 2.57 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.881 0 C-N-CA 126.227 1.811 . . . . 0.0 114.482 -169.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 26.7 m120 -76.27 -18.43 58.99 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 125.072 1.349 . . . . 0.0 114.338 176.106 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -74.27 156.48 87.39 Favored Pre-proline 0 N--CA 1.483 1.179 0 CA-C-N 120.277 1.399 . . . . 0.0 112.144 169.918 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_exo -57.27 150.57 57.37 Favored 'Trans proline' 0 CA--C 1.544 1.01 0 C-N-CA 122.999 2.466 . . . . 0.0 114.087 179.308 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -62.22 -24.17 75.95 Favored 'Trans proline' 0 CA--C 1.536 0.586 0 C-N-CA 123.531 2.821 . . . . 0.0 113.814 -174.358 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -60.98 -24.14 65.88 Favored 'General case' 0 CA--C 1.54 0.578 0 O-C-N 121.056 -1.028 . . . . 0.0 113.534 176.052 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 87.3 m95 -79.51 -35.88 39.38 Favored 'General case' 0 N--CA 1.473 0.719 0 O-C-N 120.818 -1.176 . . . . 0.0 112.668 175.364 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 3.9 m -79.34 -18.49 12.87 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.149 0 N-CA-C 113.164 0.802 . . . . 0.0 113.164 178.295 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -86.68 -1.38 57.66 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 114.406 1.262 . . . . 0.0 114.406 177.662 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 84.7 mm-40 -64.14 154.33 35.0 Favored 'General case' 0 N--CA 1.478 0.935 0 O-C-N 120.907 -1.12 . . . . 0.0 110.625 170.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -59.76 -38.25 81.29 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 114.007 1.114 . . . . 0.0 114.007 -168.281 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 17.0 mm -118.18 60.08 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 C-N-CA 125.078 1.351 . . . . 0.0 109.783 179.057 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 47.2 t80 -78.94 106.25 10.84 Favored 'General case' 0 CA--C 1.536 0.413 0 O-C-N 120.749 -1.219 . . . . 0.0 107.777 168.853 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -111.18 131.24 55.27 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 113.523 0.934 . . . . 0.0 113.523 -179.581 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 -92.08 113.01 25.17 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 124.977 1.311 . . . . 0.0 110.825 169.503 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 39.6 m0 -103.97 113.12 26.43 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 124.863 1.265 . . . . 0.0 109.459 174.341 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 34.6 mm-40 -78.98 59.69 2.72 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 124.58 1.152 . . . . 0.0 109.115 169.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 17.4 tp -79.32 145.58 33.39 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 126.068 1.747 . . . . 0.0 111.255 -169.76 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -69.2 125.3 26.27 Favored 'General case' 0 CA--C 1.542 0.645 0 O-C-N 122.146 -0.346 . . . . 0.0 111.068 169.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -75.45 134.78 72.86 Favored Pre-proline 0 CA--C 1.544 0.72 0 O-C-N 121.54 -0.725 . . . . 0.0 109.678 169.657 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -87.63 -17.12 2.83 Favored 'Trans proline' 0 CA--C 1.544 1.003 0 C-N-CA 121.441 1.427 . . . . 0.0 114.836 174.523 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -69.86 -40.45 75.74 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 115.032 1.493 . . . . 0.0 115.032 -169.852 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -68.33 -3.25 30.86 Favored Glycine 0 CA--C 1.54 1.631 0 N-CA-C 115.677 1.031 . . . . 0.0 115.677 -175.892 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -141.86 176.18 9.13 Favored 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 127.017 2.127 . . . . 0.0 112.148 -170.057 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 57.1 m -64.29 161.06 17.43 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 114.866 1.432 . . . . 0.0 114.866 -169.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 39.0 tp -59.02 -28.85 66.8 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 124.791 1.236 . . . . 0.0 113.409 -178.552 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -63.18 -32.42 73.81 Favored 'General case' 0 N--CA 1.473 0.717 0 O-C-N 120.641 -1.287 . . . . 0.0 112.004 172.448 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 4.9 t -72.76 -36.38 52.49 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 O-C-N 121.093 -1.005 . . . . 0.0 110.819 172.308 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -55.95 -49.15 74.31 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-N 119.944 1.247 . . . . 0.0 111.391 169.83 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -66.76 -38.27 86.26 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.586 0.755 . . . . 0.0 112.122 -179.63 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 84.4 m -63.52 -43.92 95.77 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.761 0.824 . . . . 0.0 111.394 172.139 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 52.8 t -69.23 -35.66 69.0 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 CA-C-O 117.704 -1.141 . . . . 0.0 111.186 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 72.3 mtm-85 -57.12 -41.41 78.94 Favored 'General case' 0 N--CA 1.484 1.229 0 CA-C-N 120.903 1.683 . . . . 0.0 111.322 169.76 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -58.66 -50.58 65.77 Favored Glycine 0 CA--C 1.541 1.695 0 CA-C-N 118.898 0.772 . . . . 0.0 113.531 173.401 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 41.3 mt-30 -65.12 -43.64 91.31 Favored 'General case' 0 N--CA 1.477 0.906 0 O-C-N 121.645 -0.915 . . . . 0.0 112.63 178.471 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 69.8 t -66.93 -40.58 86.0 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 C-N-CA 124.012 0.925 . . . . 0.0 110.726 179.325 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 63.7 tttm -54.39 -48.54 71.44 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 119.31 0.959 . . . . 0.0 110.802 175.176 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -61.87 -46.89 87.46 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 123.537 0.735 . . . . 0.0 112.242 177.004 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 12.7 mtp85 -61.74 -40.19 94.22 Favored 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 113.414 0.894 . . . . 0.0 113.414 176.831 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 69.2 t -76.26 -30.76 20.29 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 O-C-N 121.627 -0.671 . . . . 0.0 111.176 -179.44 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -64.63 -38.1 89.84 Favored 'General case' 0 CA--C 1.54 0.585 0 O-C-N 121.184 -0.948 . . . . 0.0 110.166 169.118 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 97.7 m-20 -63.74 -45.48 89.7 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 123.572 0.749 . . . . 0.0 112.493 174.099 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 8.1 tt -50.53 -58.92 4.65 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 125.464 1.505 . . . . 0.0 110.724 170.725 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 80.4 mt -62.62 -44.07 99.07 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 CA-C-O 118.692 -0.67 . . . . 0.0 110.457 -176.449 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -68.14 -14.0 62.65 Favored 'General case' 0 CA--C 1.546 0.816 0 N-CA-C 114.372 1.249 . . . . 0.0 114.372 179.058 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 18.2 ptmt -99.12 -32.31 11.31 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 113.793 1.034 . . . . 0.0 113.793 174.385 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 17.8 pt -90.1 -18.1 7.77 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 N-CA-C 114.109 1.151 . . . . 0.0 114.109 179.815 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 72.9 m . . . . . 0 C--O 1.254 1.319 0 CA-C-O 118.294 -0.86 . . . . 0.0 112.507 -179.783 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.4 ttt . . . . . 0 N--CA 1.501 2.12 0 N-CA-C 111.924 0.342 . . . . 0.0 111.924 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.2 164.25 31.27 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 124.868 1.267 . . . . 0.0 113.363 178.16 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 60.1 mtpt -90.44 142.71 27.46 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 125.059 1.344 . . . . 0.0 113.221 175.681 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 21.6 t -125.49 131.63 71.94 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 C-N-CA 125.791 1.637 . . . . 0.0 112.301 179.186 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 55.0 tpp -101.47 116.5 32.91 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.967 0.907 . . . . 0.0 109.828 169.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 51.2 m-85 -100.74 120.76 40.56 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 124.536 1.134 . . . . 0.0 108.908 171.452 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 3.0 m -140.74 156.66 23.16 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 N-CA-C 115.062 1.504 . . . . 0.0 115.062 -168.774 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 39.4 t -151.82 164.67 36.55 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 128.324 2.65 . . . . 0.0 108.054 169.826 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 39.1 ttpt -56.07 -51.37 68.11 Favored 'General case' 0 N--CA 1.482 1.132 0 CA-C-N 119.532 1.06 . . . . 0.0 112.995 -172.079 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 10.0 tpt180 -103.23 133.38 48.41 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 124.734 1.214 . . . . 0.0 109.64 175.763 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 -90.89 -42.64 10.5 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-N 118.627 0.648 . . . . 0.0 110.661 171.787 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 94.0 p -66.25 158.35 29.17 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 124.426 1.09 . . . . 0.0 110.938 168.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 24.4 p 50.53 -19.48 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.467 0 C-N-CA 129.254 3.021 . . . . 0.0 119.015 -170.048 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 13.9 tpt180 -107.06 112.97 26.16 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 125.806 1.642 . . . . 0.0 112.062 -173.184 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 3.4 p -69.26 136.99 52.71 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 123.914 0.885 . . . . 0.0 110.914 169.756 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 16.0 mt-30 -122.14 -39.68 2.57 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 124.894 1.278 . . . . 0.0 112.263 -169.783 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 68.13 -43.55 0.48 Allowed 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 127.29 2.236 . . . . 0.0 116.357 169.511 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -65.2 -34.29 78.02 Favored 'General case' 0 CA--C 1.533 0.306 0 O-C-N 120.831 -1.168 . . . . 0.0 113.738 -172.206 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 3.1 pm0 -59.88 -40.67 89.48 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 118.919 0.781 . . . . 0.0 111.929 170.378 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -66.24 -52.3 37.21 Favored Glycine 0 C--N 1.335 0.525 0 C-N-CA 123.839 0.733 . . . . 0.0 111.813 178.138 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -64.73 -34.45 78.34 Favored 'General case' 0 N--CA 1.467 0.405 0 O-C-N 121.659 -0.907 . . . . 0.0 112.008 177.902 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -66.16 -32.1 73.35 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 119.568 1.076 . . . . 0.0 112.72 178.637 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 22.6 mtpp -68.42 -52.95 27.08 Favored 'General case' 0 N--CA 1.478 0.943 0 CA-C-N 118.496 0.589 . . . . 0.0 110.129 169.794 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 98.5 m -72.4 -22.76 61.07 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 113.841 1.052 . . . . 0.0 113.841 -170.81 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 49.9 mt -95.38 -37.25 11.03 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 125.472 1.509 . . . . 0.0 113.253 171.631 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -104.92 -4.5 41.97 Favored Glycine 0 N--CA 1.47 0.915 0 N-CA-C 117.848 1.899 . . . . 0.0 117.848 -168.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -62.66 137.66 58.31 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-N 121.526 2.663 . . . . 0.0 111.971 179.794 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 86.88 -14.0 57.74 Favored Glycine 0 CA--C 1.542 1.732 0 C-N-CA 124.92 1.248 . . . . 0.0 113.857 -169.365 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -108.35 -42.88 4.47 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 126.512 1.925 . . . . 0.0 111.768 170.776 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 34.3 pt -136.83 160.65 36.83 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 C-N-CA 126.18 1.792 . . . . 0.0 112.246 179.48 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -108.66 149.34 29.08 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 125.504 1.522 . . . . 0.0 109.893 169.822 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 84.7 t -138.25 141.18 38.63 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 O-C-N 121.471 -0.768 . . . . 0.0 111.916 -170.111 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 18.6 m -140.08 153.49 46.76 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 125.249 1.42 . . . . 0.0 109.936 174.796 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 38.8 p -137.74 138.99 39.86 Favored 'General case' 0 CA--C 1.516 -0.342 0 C-N-CA 124.505 1.122 . . . . 0.0 110.237 168.59 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 96.4 p -127.44 -62.45 1.09 Allowed 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 115.532 1.679 . . . . 0.0 115.532 -168.528 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 111.28 162.11 17.36 Favored Glycine 0 N--CA 1.469 0.841 0 C-N-CA 126.149 1.833 . . . . 0.0 110.6 -174.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -97.66 -20.01 17.9 Favored 'General case' 0 N--CA 1.482 1.16 0 CA-C-N 119.384 1.592 . . . . 0.0 113.66 171.801 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 61.0 mt-10 -132.37 -31.94 1.38 Allowed 'General case' 0 N--CA 1.48 1.039 0 N-CA-C 113.901 1.074 . . . . 0.0 113.901 -171.33 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 94.2 p -137.14 160.38 39.16 Favored 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 125.901 1.681 . . . . 0.0 110.875 -177.17 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 96.6 p -116.59 165.64 13.02 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 125.678 1.591 . . . . 0.0 112.995 -175.588 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 72.2 ttt180 62.87 133.39 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 128.161 2.585 . . . . 0.0 113.728 -171.647 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 26.5 m -61.98 135.13 26.92 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 170.675 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -59.88 144.98 85.22 Favored Pre-proline 0 CA--C 1.548 0.88 0 C-N-CA 120.274 -0.57 . . . . 0.0 112.536 -169.603 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -49.12 -40.93 41.92 Favored 'Trans proline' 0 CA--C 1.539 0.761 0 C-N-CA 123.23 2.62 . . . . 0.0 117.763 -167.762 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 59.8 m -65.75 -26.54 67.77 Favored 'General case' 0 N--CA 1.484 1.252 0 CA-C-N 119.475 1.034 . . . . 0.0 111.661 -176.471 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -57.12 -36.94 71.26 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 123.905 0.882 . . . . 0.0 112.199 177.279 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.8 mp -59.5 -60.15 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 CA-C-N 119.05 0.841 . . . . 0.0 109.269 -179.404 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -62.49 -31.25 71.97 Favored 'General case' 0 CA--C 1.544 0.734 0 N-CA-C 113.434 0.901 . . . . 0.0 113.434 -176.677 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -81.29 -6.15 58.57 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 124.815 1.246 . . . . 0.0 114.184 177.672 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 40.6 mtt -114.94 -22.9 9.36 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 125.383 1.473 . . . . 0.0 110.704 175.026 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -65.15 -19.2 65.87 Favored 'General case' 0 CA--C 1.541 0.628 0 O-C-N 120.594 -1.316 . . . . 0.0 111.729 168.751 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 11.7 mt-10 -60.73 -28.27 68.55 Favored 'General case' 0 N--CA 1.481 1.107 0 CA-C-N 119.558 1.072 . . . . 0.0 111.48 169.377 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 67.8 t -93.14 -5.43 10.69 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.946 0 C-N-CA 127.472 2.309 . . . . 0.0 111.021 177.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 82.22 16.87 70.67 Favored Glycine 0 CA--C 1.538 1.494 0 C-N-CA 125.16 1.362 . . . . 0.0 114.307 -175.224 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 78.5 mt -77.14 139.6 18.47 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 C-N-CA 124.645 1.178 . . . . 0.0 111.53 -173.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 20.0 t0 -103.7 106.68 17.26 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 124.614 1.166 . . . . 0.0 111.873 170.709 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 3.8 pt -131.54 13.71 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.212 0 C-N-CA 125.515 1.526 . . . . 0.0 113.811 178.048 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 72.7 m -73.37 119.56 17.78 Favored 'General case' 0 N--CA 1.472 0.628 0 O-C-N 120.834 -1.167 . . . . 0.0 112.119 -176.31 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 63.78 35.43 92.01 Favored Glycine 0 CA--C 1.537 1.416 0 N-CA-C 115.797 1.079 . . . . 0.0 115.797 169.831 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 41.0 mt-30 -59.99 -50.32 74.22 Favored 'General case' 0 N--CA 1.477 0.906 0 N-CA-C 113.887 1.069 . . . . 0.0 113.887 -172.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 76.1 p -139.13 154.18 48.08 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 125.267 1.427 . . . . 0.0 113.348 -169.065 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 69.5 m -122.99 5.86 9.3 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 125.664 1.586 . . . . 0.0 113.982 -176.829 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 -143.14 153.07 59.55 Favored Pre-proline 0 CA--C 1.55 0.976 0 C-N-CA 124.44 1.096 . . . . 0.0 113.562 -173.411 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_exo -66.07 167.11 18.81 Favored 'Trans proline' 0 C--N 1.353 0.808 0 C-N-CA 123.349 2.7 . . . . 0.0 113.84 170.085 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 8.3 tt -50.79 -30.36 8.52 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 C-N-CA 126.699 2.0 . . . . 0.0 111.498 169.073 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -53.44 -27.49 25.04 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 126.514 1.925 . . . . 0.0 113.347 177.123 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -88.34 -6.82 57.5 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 125.119 1.368 . . . . 0.0 113.72 -174.875 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 71.6 m-85 -109.04 179.95 4.02 Favored 'General case' 0 CA--C 1.55 0.981 0 C-N-CA 126.51 1.924 . . . . 0.0 111.485 -174.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 5.8 t30 -122.52 126.24 47.4 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 125.495 1.518 . . . . 0.0 109.757 175.023 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.59 -35.66 80.73 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 113.895 1.072 . . . . 0.0 113.895 -169.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . 0.254 0.0 OUTLIER -71.46 -5.34 32.17 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 114.085 1.142 . . . . 0.0 114.085 -177.02 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -76.08 -12.96 60.21 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 124.013 0.925 . . . . 0.0 111.463 169.245 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 86.5 m-85 -115.51 139.54 49.97 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 127.098 2.159 . . . . 0.0 111.167 178.676 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -91.14 -21.97 20.91 Favored 'General case' 0 N--CA 1.478 0.959 0 CA-C-O 122.078 0.942 . . . . 0.0 112.556 178.303 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 80.7 t -133.78 139.29 48.98 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 C-N-CA 126.957 2.103 . . . . 0.0 109.014 -174.547 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 45.1 t -131.71 124.07 53.19 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 169.789 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 44.8 mm -111.86 108.01 24.42 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 C-N-CA 124.578 1.151 . . . . 0.0 108.653 -179.486 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 46.8 m -93.64 114.97 27.42 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 123.201 0.6 . . . . 0.0 109.738 174.859 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 82.7 mt -86.77 -13.7 44.45 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.971 1.308 . . . . 0.0 114.059 -172.118 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 14.5 p -147.85 157.78 43.71 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 124.835 1.254 . . . . 0.0 111.29 -176.603 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 62.1 -143.08 48.49 Favored Glycine 0 CA--C 1.538 1.472 0 C-N-CA 123.431 0.538 . . . . 0.0 113.494 179.572 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 56.9 m -131.43 164.12 26.43 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 125.584 1.554 . . . . 0.0 111.209 179.067 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -72.67 63.97 1.49 Allowed Glycine 0 CA--C 1.538 1.517 0 C-N-CA 124.953 1.264 . . . . 0.0 113.525 177.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 10.0 p -141.6 -30.65 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 N-CA-C 114.492 1.293 . . . . 0.0 114.492 -171.597 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 10.9 t-20 -75.0 -29.25 60.83 Favored 'General case' 0 N--CA 1.477 0.882 0 CA-C-N 119.417 1.008 . . . . 0.0 112.193 176.525 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -83.18 150.93 62.12 Favored Pre-proline 0 CA--C 1.548 0.888 0 C-N-CA 125.024 1.329 . . . . 0.0 111.279 169.628 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -65.35 155.44 68.62 Favored 'Trans proline' 0 CA--C 1.541 0.828 0 C-N-CA 122.574 2.182 . . . . 0.0 111.655 178.141 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -59.41 -26.34 81.6 Favored 'Trans proline' 0 C--N 1.35 0.61 0 C-N-CA 123.474 2.782 . . . . 0.0 114.913 -169.157 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -59.59 -22.7 62.15 Favored 'General case' 0 N--CA 1.472 0.629 0 O-C-N 120.841 -1.162 . . . . 0.0 114.119 178.285 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 84.9 m95 -82.44 -16.99 46.93 Favored 'General case' 0 N--CA 1.471 0.616 0 O-C-N 120.79 -1.194 . . . . 0.0 113.593 174.904 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 10.3 m -93.33 -10.41 9.45 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 CA-C-N 119.299 0.954 . . . . 0.0 113.498 170.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 60.3 p -93.48 -1.35 55.75 Favored 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 114.771 1.397 . . . . 0.0 114.771 177.016 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 72.8 mm-40 -67.64 154.21 41.96 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 119.3 0.954 . . . . 0.0 110.909 169.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -56.62 -40.01 74.62 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 114.601 1.334 . . . . 0.0 114.601 -167.82 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 15.7 mm -120.89 61.64 0.23 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 C-N-CA 124.972 1.309 . . . . 0.0 109.357 178.822 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 13.3 t80 -77.29 110.83 12.34 Favored 'General case' 0 CA--C 1.536 0.404 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 168.849 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 16.3 mt-10 -114.66 138.56 50.54 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 113.988 1.107 . . . . 0.0 113.988 173.197 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -101.65 120.25 40.04 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 124.143 0.977 . . . . 0.0 108.518 168.603 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 35.8 m0 -103.56 134.81 46.29 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 123.722 0.809 . . . . 0.0 108.867 176.629 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 64.2 mt-30 -114.8 30.56 7.26 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 123.865 0.866 . . . . 0.0 112.554 -169.563 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -76.16 159.71 30.44 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 125.709 1.604 . . . . 0.0 112.579 174.783 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -73.44 156.18 38.52 Favored 'General case' 0 CA--C 1.539 0.53 0 O-C-N 121.88 -0.512 . . . . 0.0 111.906 170.029 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 64.2 m-20 -106.44 155.06 39.39 Favored Pre-proline 0 CA--C 1.549 0.918 0 C-N-CA 123.292 0.637 . . . . 0.0 111.111 173.096 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_exo -70.87 -21.59 28.12 Favored 'Trans proline' 0 CA--C 1.544 1.007 0 C-N-CA 122.464 2.109 . . . . 0.0 115.115 179.795 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -42.19 125.26 3.02 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 114.329 1.233 . . . . 0.0 114.329 172.756 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 81.54 3.24 90.67 Favored Glycine 0 CA--C 1.535 1.335 0 C-N-CA 124.39 0.995 . . . . 0.0 115.167 177.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 9.8 pt20 -137.81 172.8 12.41 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 124.938 1.295 . . . . 0.0 113.59 -178.595 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 51.9 p -71.67 169.75 14.95 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 117.666 2.469 . . . . 0.0 117.666 -168.442 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -54.84 -41.68 71.03 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 126.436 1.894 . . . . 0.0 112.17 170.129 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -57.25 -32.85 66.99 Favored 'General case' 0 N--CA 1.473 0.716 0 O-C-N 121.225 -0.922 . . . . 0.0 112.23 172.382 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 7.7 t -75.14 -36.2 36.77 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 O-C-N 121.051 -1.031 . . . . 0.0 112.05 171.101 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 12.1 m-85 -56.58 -42.77 79.23 Favored 'General case' 0 N--CA 1.478 0.949 0 CA-C-N 120.792 1.633 . . . . 0.0 111.132 169.229 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 83.2 mtp180 -64.82 -42.9 94.61 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 124.1 0.96 . . . . 0.0 112.11 175.063 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 53.1 m -60.45 -45.31 94.15 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 124.1 0.96 . . . . 0.0 111.283 175.398 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 74.3 t -68.16 -42.1 84.62 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 CA-C-O 117.929 -1.034 . . . . 0.0 110.643 177.66 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 18.0 mtp180 -52.91 -44.9 67.3 Favored 'General case' 0 N--CA 1.482 1.158 0 CA-C-N 120.283 1.401 . . . . 0.0 112.215 171.761 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -60.09 -51.49 58.57 Favored Glycine 0 CA--C 1.539 1.577 0 CA-C-N 119.243 0.928 . . . . 0.0 113.694 175.303 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 56.4 mm-40 -65.45 -44.48 87.12 Favored 'General case' 0 N--CA 1.477 0.883 0 O-C-N 121.797 -0.825 . . . . 0.0 112.221 179.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 52.9 t -63.21 -42.06 95.09 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 124.673 1.189 . . . . 0.0 110.496 177.022 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 60.0 tttm -54.81 -50.93 67.35 Favored 'General case' 0 N--CA 1.477 0.888 0 CA-C-N 119.689 1.132 . . . . 0.0 110.91 177.664 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -63.99 -41.77 97.4 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 112.458 0.54 . . . . 0.0 112.458 178.756 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 4.8 mtp85 -63.3 -43.97 96.35 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 113.254 0.835 . . . . 0.0 113.254 175.772 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 94.1 t -71.34 -37.76 66.68 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 C-N-CA 124.044 0.937 . . . . 0.0 111.105 179.407 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -61.24 -40.97 96.02 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 119.417 1.008 . . . . 0.0 111.682 170.409 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 11.6 m-80 -61.8 -48.59 79.93 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 118.727 0.694 . . . . 0.0 112.165 173.394 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -51.83 -56.61 12.96 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 125.33 1.452 . . . . 0.0 110.465 175.725 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 75.2 mt -61.25 -46.3 96.89 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 CA-C-O 119.124 -0.465 . . . . 0.0 110.138 -179.574 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -66.62 -12.04 56.27 Favored 'General case' 0 CA--C 1.546 0.795 0 N-CA-C 114.983 1.475 . . . . 0.0 114.983 -178.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -102.14 -26.45 13.35 Favored 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 113.824 1.046 . . . . 0.0 113.824 172.355 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 13.6 pt -97.45 -12.85 8.26 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 N-CA-C 114.866 1.432 . . . . 0.0 114.866 178.655 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 57.8 m . . . . . 0 C--O 1.252 1.199 0 C-N-CA 125.333 1.453 . . . . 0.0 112.255 -179.792 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.3 ttt . . . . . 0 N--CA 1.501 2.088 0 N-CA-C 111.937 0.347 . . . . 0.0 111.937 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.15 164.34 30.41 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 124.966 1.306 . . . . 0.0 112.886 175.922 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 41.5 mtpt -94.73 143.4 26.47 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 124.449 1.1 . . . . 0.0 112.136 178.141 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 18.9 t -124.71 133.86 68.33 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 C-N-CA 125.289 1.435 . . . . 0.0 112.749 -178.877 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 36.8 tpp -104.2 122.45 45.39 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 123.412 0.685 . . . . 0.0 109.257 168.717 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 68.6 m-85 -98.94 128.66 45.15 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.337 1.055 . . . . 0.0 108.993 170.22 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -138.27 144.17 31.11 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 N-CA-C 114.363 1.245 . . . . 0.0 114.363 -168.778 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -141.18 166.81 23.76 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 127.131 2.173 . . . . 0.0 110.68 170.122 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -57.19 -49.15 76.87 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.263 -0.898 . . . . 0.0 112.928 -173.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 96.8 mtt180 -125.05 130.55 52.52 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 124.679 1.191 . . . . 0.0 110.088 169.559 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 35.5 t30 -81.54 -43.0 19.35 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-N 117.819 0.281 . . . . 0.0 111.498 -179.735 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 45.0 m -68.25 -32.23 72.28 Favored 'General case' 0 N--CA 1.478 0.954 0 N-CA-C 113.52 0.933 . . . . 0.0 113.52 -170.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 97.8 p -90.92 -5.7 55.12 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 114.855 1.428 . . . . 0.0 114.855 -175.138 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 60.2 mtt85 -134.93 156.64 48.64 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 124.583 1.153 . . . . 0.0 112.341 -175.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 37.2 m -105.47 103.83 13.44 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 124.565 1.146 . . . . 0.0 110.077 -179.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 3.1 mp0 -78.4 -34.51 48.03 Favored 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 114.162 1.171 . . . . 0.0 114.162 -169.206 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 68.74 -49.2 0.57 Allowed 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 126.474 1.91 . . . . 0.0 115.99 169.653 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.97 -33.57 73.41 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.185 0.994 . . . . 0.0 113.574 -171.131 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 3.4 pm0 -62.5 -46.3 89.05 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 123.978 0.911 . . . . 0.0 112.277 174.295 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -65.57 -39.87 95.74 Favored Glycine 0 C--N 1.335 0.49 0 C-N-CA 123.64 0.638 . . . . 0.0 111.66 178.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -69.92 -41.78 74.19 Favored 'General case' 0 N--CA 1.468 0.431 0 O-C-N 121.838 -0.801 . . . . 0.0 111.271 176.156 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -60.4 -43.36 96.75 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 119.626 1.103 . . . . 0.0 112.735 -176.446 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 8.8 pttp -77.91 -24.31 48.37 Favored 'General case' 0 N--CA 1.479 1.011 0 N-CA-C 113.65 0.981 . . . . 0.0 113.65 175.097 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 85.5 m -71.63 -36.01 70.6 Favored 'General case' 0 N--CA 1.48 1.071 0 O-C-N 121.401 -0.812 . . . . 0.0 111.623 171.682 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 61.4 mt -88.09 -31.73 19.09 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 125.711 1.604 . . . . 0.0 114.172 -177.698 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -145.8 30.97 1.65 Allowed Glycine 0 N--CA 1.474 1.219 0 N-CA-C 118.297 2.079 . . . . 0.0 118.297 -169.035 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -66.71 -19.75 65.82 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-N 121.794 2.797 . . . . 0.0 115.202 -178.238 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -75.36 -10.37 84.45 Favored Glycine 0 CA--C 1.541 1.711 0 O-C-N 121.293 -0.88 . . . . 0.0 113.18 169.586 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 76.0 mttt -108.64 -39.66 5.31 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 127.185 2.194 . . . . 0.0 113.375 179.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 22.6 pt -142.12 155.72 19.33 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 C-N-CA 124.966 1.306 . . . . 0.0 112.562 -173.235 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -104.27 142.68 34.11 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 124.156 0.982 . . . . 0.0 110.48 171.199 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 74.3 t -130.11 140.11 49.76 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 CA-C-N 119.186 0.903 . . . . 0.0 112.88 -171.776 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 36.4 m -137.59 154.18 49.82 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 126.302 1.841 . . . . 0.0 109.02 170.885 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 61.3 p -128.95 147.31 50.84 Favored 'General case' 0 CA--C 1.515 -0.366 0 CA-C-O 121.931 0.872 . . . . 0.0 112.506 167.464 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 25.8 p -144.79 157.44 44.17 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 114.353 -1.294 . . . . 0.0 112.378 -178.59 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -97.92 150.74 19.52 Favored Glycine 0 N--CA 1.468 0.814 0 CA-C-O 119.318 -0.712 . . . . 0.0 111.846 174.663 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 10.8 mp -66.44 -30.9 71.35 Favored 'General case' 0 N--CA 1.483 1.207 0 CA-C-N 119.299 1.55 . . . . 0.0 108.992 168.864 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 52.6 mt-10 -133.1 154.8 50.24 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 128.359 2.664 . . . . 0.0 107.201 168.214 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 27.0 p 64.46 161.38 0.12 Allowed 'General case' 0 N--CA 1.486 1.331 0 N-CA-C 117.504 2.409 . . . . 0.0 117.504 178.678 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 75.1 m -118.76 143.55 46.83 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 126.621 1.968 . . . . 0.0 113.18 -170.248 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 59.1 ttt-85 62.3 148.13 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.897 0 C-N-CA 127.612 2.365 . . . . 0.0 114.091 -176.381 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 24.9 m -61.38 166.18 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.255 0 CA-C-O 122.662 1.22 . . . . 0.0 111.824 169.782 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 2.7 t-80 -41.22 136.45 1.71 Allowed Pre-proline 0 C--N 1.327 -0.386 0 CA-C-N 113.761 -1.563 . . . . 0.0 113.243 169.426 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -60.36 -27.5 84.99 Favored 'Trans proline' 0 CA--C 1.546 1.12 0 CA-C-N 120.753 1.305 . . . . 0.0 112.252 170.647 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 99.0 m -67.89 -31.89 71.99 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 124.966 1.306 . . . . 0.0 112.077 174.566 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -57.39 -39.48 76.2 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 124.289 1.036 . . . . 0.0 111.636 -175.055 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.7 mp -57.45 -60.61 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 C-N-CA 124.226 1.01 . . . . 0.0 109.361 -178.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -61.82 -31.62 71.88 Favored 'General case' 0 CA--C 1.545 0.761 0 N-CA-C 113.384 0.883 . . . . 0.0 113.384 -177.17 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -82.25 -6.61 59.35 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 114.248 1.203 . . . . 0.0 114.248 177.953 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 39.1 mtt -112.52 -24.35 9.75 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 125.418 1.487 . . . . 0.0 110.464 174.604 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 27.0 mt-10 -65.46 -16.43 63.64 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 125.128 1.371 . . . . 0.0 111.519 168.559 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 11.5 mt-10 -60.21 -30.52 69.43 Favored 'General case' 0 N--CA 1.481 1.095 0 CA-C-N 119.726 1.148 . . . . 0.0 110.74 169.103 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 60.2 t -92.45 -4.99 10.79 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.955 0 C-N-CA 127.59 2.356 . . . . 0.0 111.017 178.721 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 80.1 18.3 72.37 Favored Glycine 0 CA--C 1.538 1.497 0 C-N-CA 125.073 1.32 . . . . 0.0 114.55 -173.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 73.8 mt -76.89 136.69 23.99 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 124.368 1.067 . . . . 0.0 111.661 -173.082 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 19.7 t0 -97.33 88.45 4.43 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.588 1.155 . . . . 0.0 112.061 -179.112 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 7.6 pt -125.8 8.66 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.33 0 N-CA-C 114.265 1.209 . . . . 0.0 114.265 174.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 97.7 p -59.28 -42.12 90.48 Favored 'General case' 0 N--CA 1.477 0.92 0 O-C-N 120.824 -1.173 . . . . 0.0 114.044 -171.59 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -93.35 15.39 63.07 Favored Glycine 0 CA--C 1.534 1.237 0 C-N-CA 125.18 1.371 . . . . 0.0 116.092 -176.533 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . 0.268 0.0 OUTLIER -77.51 62.07 2.4 Favored 'General case' 0 N--CA 1.478 0.93 0 CA-C-N 119.912 1.856 . . . . 0.0 114.481 -172.18 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 40.2 p -69.38 107.86 3.49 Favored 'General case' 0 N--CA 1.471 0.585 0 O-C-N 120.431 -1.418 . . . . 0.0 108.93 169.186 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 70.2 m -142.18 129.32 20.92 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.204 1.002 . . . . 0.0 111.456 -169.567 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -67.02 170.39 6.37 Favored Pre-proline 0 CA--C 1.549 0.922 0 C-N-CA 127.575 2.35 . . . . 0.0 114.496 -176.249 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -64.3 156.51 59.38 Favored 'Trans proline' 0 C--N 1.352 0.728 0 C-N-CA 122.665 2.243 . . . . 0.0 111.819 169.129 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 6.0 tt -51.59 -33.71 15.17 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 C-N-CA 125.874 1.669 . . . . 0.0 111.571 174.632 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 12.3 mt-10 -61.97 -24.18 66.85 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.748 1.219 . . . . 0.0 113.295 -178.044 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 71.1 m-20 -91.89 6.17 47.22 Favored 'General case' 0 CA--C 1.55 0.981 0 C-N-CA 124.378 1.071 . . . . 0.0 112.898 -175.408 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 -119.15 -175.55 2.94 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 126.833 2.053 . . . . 0.0 112.683 -179.76 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 9.6 p-10 -123.73 129.26 50.81 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 125.737 1.615 . . . . 0.0 109.728 172.474 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -64.72 -37.19 86.76 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 112.81 0.671 . . . . 0.0 112.81 -172.607 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -68.4 -4.39 14.52 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 114.291 1.219 . . . . 0.0 114.291 179.364 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -68.51 -21.39 64.58 Favored 'General case' 0 CA--C 1.549 0.916 0 CA-C-N 119.317 0.962 . . . . 0.0 109.932 168.449 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 76.6 m-85 -115.35 146.13 41.85 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 127.726 2.41 . . . . 0.0 111.842 -175.179 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -101.91 -18.12 15.84 Favored 'General case' 0 N--CA 1.481 1.088 0 CA-C-O 122.153 0.978 . . . . 0.0 112.614 178.584 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 76.0 t -128.62 138.64 54.05 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 C-N-CA 127.605 2.362 . . . . 0.0 108.022 177.731 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 48.7 t -132.82 124.98 51.68 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 169.836 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 46.2 mm -112.3 104.82 17.66 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.344 0 C-N-CA 124.275 1.03 . . . . 0.0 109.602 -175.054 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 3.6 m -80.28 106.69 12.49 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 123.494 0.718 . . . . 0.0 109.868 170.463 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 91.2 mt -83.58 -19.95 34.63 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 126.237 1.815 . . . . 0.0 113.852 -176.293 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 80.6 m -97.01 121.59 39.06 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 106.931 -1.507 . . . . 0.0 106.931 171.328 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -59.73 141.47 47.55 Favored Glycine 0 CA--C 1.535 1.337 0 CA-C-N 118.484 0.583 . . . . 0.0 113.199 -172.571 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 75.7 m 56.85 43.65 24.57 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.744 1.218 . . . . 0.0 111.114 -169.526 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -74.29 62.61 2.2 Favored Glycine 0 N--CA 1.471 1.002 0 C-N-CA 125.91 1.719 . . . . 0.0 111.802 176.331 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.3 p -113.17 -0.41 9.3 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 C-N-CA 126.119 1.768 . . . . 0.0 112.913 -170.074 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 29.0 m120 -74.46 -11.34 60.2 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 124.338 1.055 . . . . 0.0 113.252 174.844 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -65.77 158.96 72.46 Favored Pre-proline 0 CA--C 1.553 1.07 0 C-N-CA 124.274 1.03 . . . . 0.0 112.389 170.501 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -59.94 149.93 81.15 Favored 'Trans proline' 0 CA--C 1.543 0.975 0 C-N-CA 122.437 2.091 . . . . 0.0 113.11 178.721 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_exo -56.25 -33.4 90.88 Favored 'Trans proline' 0 C--N 1.351 0.694 0 C-N-CA 123.102 2.535 . . . . 0.0 114.948 -171.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -59.61 -22.49 61.89 Favored 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 114.019 1.118 . . . . 0.0 114.019 178.879 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 88.7 m95 -79.75 -15.82 56.76 Favored 'General case' 0 N--CA 1.469 0.511 0 O-C-N 120.685 -1.259 . . . . 0.0 113.487 176.439 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 8.2 m -96.35 -8.13 9.43 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 N-CA-C 113.711 1.004 . . . . 0.0 113.711 170.731 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 68.5 p -95.77 -2.85 46.86 Favored 'General case' 0 N--CA 1.48 1.044 0 N-CA-C 114.866 1.432 . . . . 0.0 114.866 178.206 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 68.6 mm-40 -65.93 155.09 37.51 Favored 'General case' 0 N--CA 1.477 0.916 0 CA-C-N 119.368 0.985 . . . . 0.0 110.236 169.553 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -56.78 -40.05 75.16 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 114.773 1.397 . . . . 0.0 114.773 -168.154 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 19.7 mm -120.26 65.92 0.26 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 C-N-CA 124.652 1.181 . . . . 0.0 109.147 -178.795 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 32.7 t80 -80.04 109.76 14.79 Favored 'General case' 0 C--O 1.236 0.375 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 168.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -110.2 135.19 51.36 Favored 'General case' 0 CA--C 1.545 0.76 0 N-CA-C 113.441 0.904 . . . . 0.0 113.441 174.478 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -102.06 103.71 14.32 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.435 1.094 . . . . 0.0 109.584 169.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 38.1 m0 -91.84 114.1 26.55 Favored 'General case' 0 N--CA 1.463 0.181 0 C-N-CA 124.275 1.03 . . . . 0.0 109.294 179.523 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 41.7 mt-30 -91.8 48.54 1.46 Allowed 'General case' 0 CA--C 1.544 0.749 0 CA-C-O 122.289 1.043 . . . . 0.0 111.26 -172.678 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 86.5 mt -78.39 166.25 22.87 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 127.115 2.166 . . . . 0.0 111.953 176.485 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -88.9 152.49 21.7 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-O 121.555 0.693 . . . . 0.0 112.415 169.573 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 13.4 p-10 -89.6 136.77 29.23 Favored Pre-proline 0 CA--C 1.55 0.968 0 C-N-CA 125.47 1.508 . . . . 0.0 112.008 176.214 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -70.25 -20.01 33.05 Favored 'Trans proline' 0 CA--C 1.547 1.126 0 C-N-CA 121.955 1.77 . . . . 0.0 115.491 -178.42 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -66.52 145.0 56.12 Favored 'General case' 0 N--CA 1.476 0.834 0 O-C-N 121.103 -0.998 . . . . 0.0 113.179 -175.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 78.36 4.81 87.37 Favored Glycine 0 CA--C 1.535 1.296 0 C-N-CA 123.943 0.782 . . . . 0.0 114.661 -179.156 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -141.61 166.83 23.67 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 125.465 1.506 . . . . 0.0 112.878 -179.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 66.9 m -63.86 163.23 12.23 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 115.698 1.74 . . . . 0.0 115.698 -169.239 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -51.82 -39.64 59.11 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 126.673 1.989 . . . . 0.0 112.837 171.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -55.27 -31.81 61.86 Favored 'General case' 0 N--CA 1.474 0.737 0 O-C-N 121.265 -0.897 . . . . 0.0 112.515 172.598 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 4.3 t -76.94 -37.27 26.7 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 O-C-N 121.163 -0.961 . . . . 0.0 111.75 173.575 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 21.4 m-85 -57.16 -42.66 81.49 Favored 'General case' 0 N--CA 1.477 0.88 0 CA-C-N 119.943 1.247 . . . . 0.0 111.221 169.302 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 97.7 mtt180 -68.45 -38.35 81.06 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.612 0.765 . . . . 0.0 112.474 176.158 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 45.8 m -61.71 -45.65 93.06 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 124.187 0.995 . . . . 0.0 111.37 172.638 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 72.1 t -67.77 -40.97 84.74 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 CA-C-O 118.266 -0.873 . . . . 0.0 110.463 178.324 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 20.4 mtp180 -54.45 -43.74 71.92 Favored 'General case' 0 N--CA 1.484 1.273 0 CA-C-N 120.239 1.381 . . . . 0.0 112.915 170.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -61.59 -50.02 70.69 Favored Glycine 0 CA--C 1.537 1.417 0 CA-C-N 119.45 1.023 . . . . 0.0 113.255 175.784 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 53.6 mm-40 -64.59 -44.13 91.65 Favored 'General case' 0 N--CA 1.476 0.837 0 O-C-N 122.043 -0.68 . . . . 0.0 112.012 178.478 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 58.8 t -63.92 -41.46 92.58 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 C-N-CA 124.91 1.284 . . . . 0.0 111.125 176.752 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 60.7 tttm -54.27 -49.75 68.84 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-N 120.13 1.332 . . . . 0.0 110.628 176.832 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -63.49 -44.79 93.33 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 112.557 0.577 . . . . 0.0 112.557 176.306 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.23 -35.38 80.86 Favored 'General case' 0 N--CA 1.481 1.105 0 N-CA-C 113.6 0.963 . . . . 0.0 113.6 -179.921 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 92.3 t -78.01 -40.55 26.61 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 C-N-CA 125.411 1.484 . . . . 0.0 110.992 177.008 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -61.43 -38.57 87.61 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 119.185 0.902 . . . . 0.0 111.542 172.257 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 11.1 m-80 -63.91 -44.96 91.37 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 118.846 0.748 . . . . 0.0 112.701 173.561 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -54.47 -56.32 20.0 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 124.223 1.009 . . . . 0.0 110.667 174.392 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 95.3 mt -61.76 -42.01 92.77 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 CA-C-O 119.199 -0.429 . . . . 0.0 110.51 -179.26 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -68.72 -14.38 62.99 Favored 'General case' 0 CA--C 1.545 0.763 0 N-CA-C 114.933 1.457 . . . . 0.0 114.933 179.072 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 21.1 ptmt -99.96 -27.96 13.32 Favored 'General case' 0 N--CA 1.479 0.986 0 N-CA-C 113.855 1.057 . . . . 0.0 113.855 173.523 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 16.6 pt -94.86 -20.54 6.03 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 N-CA-C 114.295 1.22 . . . . 0.0 114.295 177.338 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 74.7 m . . . . . 0 C--O 1.253 1.28 0 C-N-CA 125.074 1.349 . . . . 0.0 111.889 -173.788 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.401 ' HA ' ' O ' ' A' ' 29' ' ' LYS . 32.9 ttm . . . . . 0 N--CA 1.502 2.133 0 N-CA-C 112.044 0.387 . . . . 0.0 112.044 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 3.5 mptp? -103.92 155.51 18.58 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 125.181 1.392 . . . . 0.0 112.688 169.812 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 44.7 mtpt -105.4 113.78 27.56 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 106.089 -1.819 . . . . 0.0 106.089 167.088 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 14.4 t -105.95 130.49 57.41 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 C-N-CA 125.247 1.419 . . . . 0.0 113.15 -178.788 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 61.3 tpp -101.65 117.74 35.51 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.501 0.72 . . . . 0.0 109.137 169.193 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 54.8 m-85 -98.79 128.09 44.91 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 169.744 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 1.3 m -144.22 153.1 15.4 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.127 0 N-CA-C 113.527 0.936 . . . . 0.0 113.527 -169.195 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 44.0 t -146.2 137.66 24.71 Favored 'General case' 0 CA--C 1.552 1.024 0 C-N-CA 125.315 1.446 . . . . 0.0 113.052 -178.457 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -67.36 135.44 53.24 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 125.029 1.331 . . . . 0.0 111.718 172.439 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . 0.263 19.1 ttm180 47.24 56.36 6.99 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 126.693 1.997 . . . . 0.0 113.31 -174.53 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 -48.76 -29.93 5.07 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 126.746 2.018 . . . . 0.0 114.654 175.461 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 81.4 p -62.69 -19.17 63.61 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 114.558 1.318 . . . . 0.0 114.558 179.72 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 84.7 p -127.32 24.07 6.32 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.458 1.503 . . . . 0.0 113.872 175.019 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 72.2 mtt85 -139.32 150.44 45.4 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 124.846 1.259 . . . . 0.0 113.26 177.196 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 22.3 m -106.81 153.87 21.84 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 125.552 1.541 . . . . 0.0 111.147 172.499 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 30.7 mt-30 -110.15 -55.91 2.4 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 113.248 0.833 . . . . 0.0 113.248 -171.846 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 73.28 -48.21 0.68 Allowed 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 126.608 1.963 . . . . 0.0 113.523 176.984 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.92 -33.31 74.02 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 113.552 0.945 . . . . 0.0 113.552 -175.1 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 5.4 pm0 -68.58 -42.3 78.45 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 123.846 0.859 . . . . 0.0 111.306 177.419 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -65.0 -40.59 97.23 Favored Glycine 0 C--N 1.336 0.581 0 N-CA-C 111.504 -0.638 . . . . 0.0 111.504 178.7 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -72.64 -38.93 67.54 Favored 'General case' 0 N--CA 1.466 0.366 0 O-C-N 121.809 -0.818 . . . . 0.0 112.054 177.403 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.9 -37.48 84.78 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 113.552 0.945 . . . . 0.0 113.552 -173.749 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 6.9 pttp -79.47 -31.16 42.37 Favored 'General case' 0 N--CA 1.481 1.102 0 N-CA-C 113.689 0.996 . . . . 0.0 113.689 172.115 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 59.0 m -70.74 -33.34 70.71 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.197 0.599 . . . . 0.0 111.498 178.583 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 68.3 mt -92.78 -37.5 12.3 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 125.864 1.666 . . . . 0.0 113.277 177.587 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -106.82 8.91 39.96 Favored Glycine 0 N--CA 1.472 1.055 0 N-CA-C 117.892 1.917 . . . . 0.0 117.892 -169.021 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.12 141.88 57.11 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-N 121.318 2.559 . . . . 0.0 112.203 177.407 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 83.91 -21.34 9.79 Favored Glycine 0 CA--C 1.538 1.495 0 C-N-CA 124.984 1.278 . . . . 0.0 113.749 -169.485 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.401 ' O ' ' HA ' ' A' ' 1' ' ' MET . 65.1 mttm -97.45 -48.22 5.37 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 125.786 1.635 . . . . 0.0 111.796 169.863 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 40.6 pt -135.39 150.13 29.03 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 C-N-CA 124.364 1.066 . . . . 0.0 113.085 -175.087 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -102.48 137.76 40.29 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 125.407 1.483 . . . . 0.0 108.921 169.769 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 99.4 t -126.49 140.67 48.16 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 C-N-CA 123.265 0.626 . . . . 0.0 111.976 -173.785 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 27.3 m -140.04 151.59 45.54 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 125.191 1.396 . . . . 0.0 109.626 174.745 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 53.0 p -138.37 145.75 41.46 Favored 'General case' 0 CA--C 1.516 -0.339 0 CA-C-O 122.486 1.136 . . . . 0.0 111.784 167.454 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 88.5 p -139.59 153.56 47.4 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 113.227 -1.806 . . . . 0.0 110.657 -171.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -75.98 162.82 53.0 Favored Glycine 0 CA--C 1.535 1.329 0 O-C-N 121.162 -0.961 . . . . 0.0 112.57 176.741 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.6 mp -95.5 -6.58 40.24 Favored 'General case' 0 N--CA 1.479 1.016 0 O-C-N 120.218 -1.754 . . . . 0.0 111.305 168.565 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -129.21 165.59 21.06 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 128.64 2.776 . . . . 0.0 107.386 169.799 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 70.1 m -77.24 59.7 1.82 Allowed 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 124.23 1.012 . . . . 0.0 113.159 -170.072 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 89.3 p -152.56 -179.63 7.76 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 125.748 1.619 . . . . 0.0 114.124 -169.685 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 58.8 ttt85 -94.8 163.17 13.46 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 128.798 2.839 . . . . 0.0 110.553 -174.571 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 21.2 m -78.51 178.49 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.235 0 C-N-CA 123.974 0.91 . . . . 0.0 110.056 169.238 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 2.1 t-80 -61.01 129.62 90.58 Favored Pre-proline 0 CA--C 1.534 0.344 0 CA-C-O 118.445 -0.788 . . . . 0.0 113.041 -177.06 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo -58.18 -28.01 82.42 Favored 'Trans proline' 0 CA--C 1.544 0.982 0 C-N-CA 121.728 1.618 . . . . 0.0 112.083 169.722 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 96.9 m -61.18 -32.32 72.06 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 125.5 1.52 . . . . 0.0 112.282 173.872 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -57.99 -47.24 83.59 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 118.98 0.809 . . . . 0.0 110.786 179.895 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.5 mp -53.42 -54.5 17.97 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 C-N-CA 124.222 1.009 . . . . 0.0 110.299 -174.596 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.24 -31.05 72.09 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 113.223 0.823 . . . . 0.0 113.223 -178.534 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -81.61 -21.72 38.13 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 113.761 1.022 . . . . 0.0 113.761 177.653 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 4.8 mmt -84.87 -31.27 23.83 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 119.491 1.042 . . . . 0.0 110.484 169.549 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -66.97 -15.05 63.46 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.752 1.221 . . . . 0.0 113.774 175.571 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 14.3 mt-10 -61.97 -25.7 67.77 Favored 'General case' 0 N--CA 1.482 1.137 0 CA-C-N 120.313 1.415 . . . . 0.0 110.797 168.864 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 48.6 t -98.44 -2.76 9.86 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.006 0 C-N-CA 127.69 2.396 . . . . 0.0 111.163 176.749 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 79.42 17.86 75.06 Favored Glycine 0 CA--C 1.539 1.591 0 C-N-CA 125.096 1.331 . . . . 0.0 114.498 -176.805 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 84.4 mt -79.49 136.16 24.17 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 C-N-CA 125.06 1.344 . . . . 0.0 111.523 -174.449 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 15.0 t0 -95.35 111.0 22.94 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 112.896 0.702 . . . . 0.0 112.896 175.29 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 6.7 pt -135.89 24.35 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.363 0 C-N-CA 124.77 1.228 . . . . 0.0 114.05 172.52 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 70.4 m -69.85 -20.47 63.42 Favored 'General case' 0 N--CA 1.48 1.048 0 O-C-N 120.153 -1.592 . . . . 0.0 114.608 -172.242 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -90.06 10.85 72.65 Favored Glycine 0 CA--C 1.537 1.416 0 N-CA-C 116.521 1.369 . . . . 0.0 116.521 -175.871 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 25.2 mt-30 -81.83 50.49 1.54 Allowed 'General case' 0 N--CA 1.482 1.154 0 CA-C-N 120.08 1.94 . . . . 0.0 114.97 -169.573 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 37.8 m -104.65 -7.15 19.82 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 125.501 1.52 . . . . 0.0 111.249 169.655 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 68.7 m -69.59 79.36 0.42 Allowed 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 115.921 1.823 . . . . 0.0 115.921 -169.299 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 34.8 m-20 65.35 158.91 0.13 Allowed Pre-proline 0 CA--C 1.552 1.039 0 C-N-CA 128.57 2.748 . . . . 0.0 117.48 169.116 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -73.04 158.47 49.49 Favored 'Trans proline' 0 CA--C 1.539 0.74 0 C-N-CA 122.656 2.237 . . . . 0.0 113.052 169.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 6.3 tt -51.22 -40.92 23.4 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 125.705 1.602 . . . . 0.0 112.065 174.336 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -69.54 -7.32 37.32 Favored 'General case' 0 CA--C 1.543 0.707 0 N-CA-C 113.999 1.111 . . . . 0.0 113.999 -179.331 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 -81.14 -19.92 42.45 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 123.682 0.793 . . . . 0.0 113.128 171.349 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -99.27 -173.04 2.38 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 126.104 1.762 . . . . 0.0 112.581 -176.201 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 14.7 t30 -117.75 124.87 49.52 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 125.363 1.465 . . . . 0.0 110.14 175.488 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.99 -38.29 88.13 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 113.694 0.998 . . . . 0.0 113.694 -172.237 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -72.72 -5.09 35.39 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 113.951 1.093 . . . . 0.0 113.951 -176.694 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -72.69 -16.05 61.68 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 123.485 0.714 . . . . 0.0 111.385 168.866 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 60.3 m-85 -115.11 132.11 56.71 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 126.348 1.859 . . . . 0.0 111.166 179.313 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -89.03 -20.6 24.18 Favored 'General case' 0 N--CA 1.476 0.875 0 CA-C-O 121.966 0.889 . . . . 0.0 112.73 -177.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 82.0 t -128.57 137.74 56.5 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 C-N-CA 127.488 2.315 . . . . 0.0 107.965 178.75 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 65.9 t -131.37 123.68 53.41 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 169.569 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 36.1 mm -109.77 104.46 17.11 Favored 'Isoleucine or valine' 0 C--O 1.234 0.287 0 C-N-CA 124.397 1.079 . . . . 0.0 108.462 -179.053 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 5.4 m -82.71 125.42 31.22 Favored 'General case' 0 N--CA 1.466 0.375 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 170.264 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 89.5 mt -102.33 -11.96 18.29 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 114.497 1.295 . . . . 0.0 114.497 -173.189 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 35.1 m -141.65 143.41 33.61 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 125.015 1.326 . . . . 0.0 110.426 -169.595 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 65.39 -133.4 35.85 Favored Glycine 0 CA--C 1.537 1.464 0 CA-C-N 118.083 0.402 . . . . 0.0 112.515 -176.762 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 88.4 p -131.02 13.84 5.21 Favored 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 115.143 1.534 . . . . 0.0 115.143 -175.212 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 67.57 69.17 1.43 Allowed Glycine 0 N--CA 1.475 1.276 0 CA-C-O 122.832 1.24 . . . . 0.0 111.968 -171.046 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 10.2 p -136.44 176.05 8.94 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 C-N-CA 127.876 2.47 . . . . 0.0 107.036 175.018 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 20.8 t-20 66.28 -36.93 0.26 Allowed 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 126.339 1.856 . . . . 0.0 114.844 -172.358 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -71.04 155.72 92.94 Favored Pre-proline 0 CA--C 1.554 1.106 0 CA-C-N 119.742 1.155 . . . . 0.0 111.592 169.18 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_exo -63.17 146.25 94.03 Favored 'Trans proline' 0 CA--C 1.548 1.183 0 C-N-CA 122.094 1.863 . . . . 0.0 113.169 179.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_exo -55.58 -28.8 66.98 Favored 'Trans proline' 0 C--N 1.352 0.738 0 C-N-CA 123.703 2.935 . . . . 0.0 115.804 -175.682 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 4.4 pm0 -62.61 -18.93 63.17 Favored 'General case' 0 CA--C 1.544 0.745 0 O-C-N 120.664 -1.273 . . . . 0.0 114.168 176.373 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 86.6 m95 -83.39 -24.11 32.1 Favored 'General case' 0 N--CA 1.471 0.578 0 O-C-N 120.552 -1.343 . . . . 0.0 112.934 175.708 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 9.7 m -86.21 -3.41 8.66 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.31 0 N-CA-C 113.608 0.966 . . . . 0.0 113.608 173.443 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -111.2 4.69 19.43 Favored 'General case' 0 N--CA 1.48 1.026 0 N-CA-C 114.581 1.326 . . . . 0.0 114.581 -177.957 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 85.9 mm-40 -64.56 158.35 24.47 Favored 'General case' 0 N--CA 1.478 0.956 0 O-C-N 120.863 -1.148 . . . . 0.0 111.976 170.882 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -57.52 -41.83 81.65 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 114.002 1.112 . . . . 0.0 114.002 -168.249 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 15.5 mm -116.03 58.97 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 C-N-CA 124.892 1.277 . . . . 0.0 109.049 174.401 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 27.0 t80 -74.17 110.12 8.2 Favored 'General case' 0 CA--C 1.534 0.356 0 O-C-N 120.441 -1.412 . . . . 0.0 107.666 168.8 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 9.1 mt-10 -107.67 129.43 55.01 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-O 121.586 0.708 . . . . 0.0 112.687 172.404 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -98.35 88.81 4.25 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 124.163 0.985 . . . . 0.0 110.215 174.287 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 29.2 m0 -81.09 102.09 10.03 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-O 122.031 0.919 . . . . 0.0 109.618 176.63 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 27.6 mt-30 -82.29 60.13 4.86 Favored 'General case' 0 CA--C 1.545 0.787 0 CA-C-O 122.527 1.156 . . . . 0.0 109.049 175.83 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 5.9 tt -95.13 156.31 16.37 Favored 'General case' 0 CA--C 1.539 0.519 0 C-N-CA 128.226 2.61 . . . . 0.0 112.87 -169.148 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -67.67 109.88 3.49 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 125.185 1.394 . . . . 0.0 112.398 177.473 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -71.63 123.9 90.12 Favored Pre-proline 0 CA--C 1.548 0.883 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 169.313 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -79.0 -8.57 15.5 Favored 'Trans proline' 0 CA--C 1.551 1.339 0 C-N-CA 122.092 1.861 . . . . 0.0 114.134 -172.456 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -72.82 155.0 40.37 Favored 'General case' 0 CA--C 1.549 0.934 0 CA-C-N 120.668 1.576 . . . . 0.0 113.338 176.416 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 76.57 5.94 83.65 Favored Glycine 0 CA--C 1.538 1.474 0 C-N-CA 124.428 1.013 . . . . 0.0 114.089 -178.12 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 -142.92 167.51 21.9 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 126.998 2.119 . . . . 0.0 111.226 179.284 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 70.6 m -59.83 157.16 12.78 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 115.081 1.511 . . . . 0.0 115.081 -169.42 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -51.1 -38.32 51.11 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 126.202 1.801 . . . . 0.0 112.689 172.304 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -55.11 -38.93 68.79 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 123.787 0.835 . . . . 0.0 112.107 172.7 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 14.6 t -67.96 -40.76 83.88 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 CA-C-O 118.674 -0.679 . . . . 0.0 111.071 173.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -53.7 -47.39 70.53 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 119.346 0.975 . . . . 0.0 112.339 169.821 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 96.9 mtt180 -69.01 -39.0 79.55 Favored 'General case' 0 N--CA 1.479 0.999 0 CA-C-N 118.842 0.746 . . . . 0.0 112.652 -179.603 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 30.7 m -62.18 -40.92 97.65 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 123.718 0.807 . . . . 0.0 111.306 170.432 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 41.8 t -65.69 -41.07 89.68 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 CA-C-O 117.407 -1.282 . . . . 0.0 111.19 176.57 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 75.5 mtm-85 -55.28 -43.52 74.82 Favored 'General case' 0 N--CA 1.485 1.315 0 CA-C-N 121.038 1.745 . . . . 0.0 112.26 172.576 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -60.85 -51.67 57.15 Favored Glycine 0 CA--C 1.537 1.429 0 CA-C-N 119.036 0.835 . . . . 0.0 113.514 176.269 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 57.6 mm-40 -64.81 -42.97 94.58 Favored 'General case' 0 N--CA 1.474 0.765 0 O-C-N 121.758 -0.848 . . . . 0.0 112.124 179.107 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 55.0 t -65.39 -42.54 93.78 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 C-N-CA 124.799 1.24 . . . . 0.0 110.957 177.378 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 62.9 tttm -53.57 -49.36 67.88 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-N 119.721 1.146 . . . . 0.0 111.147 176.629 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -63.68 -41.7 98.12 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 178.444 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 13.3 mtp85 -63.82 -43.5 96.04 Favored 'General case' 0 N--CA 1.478 0.952 0 N-CA-C 113.22 0.822 . . . . 0.0 113.22 175.435 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 86.2 t -69.06 -38.9 78.92 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 C-N-CA 123.453 0.701 . . . . 0.0 110.729 179.534 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -62.75 -37.63 87.36 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 118.897 0.771 . . . . 0.0 111.773 170.791 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 9.4 m-80 -63.29 -46.85 84.81 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 119.185 0.902 . . . . 0.0 112.549 173.495 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -52.98 -56.81 13.26 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 125.035 1.334 . . . . 0.0 110.253 173.696 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 75.4 mt -61.63 -40.53 87.0 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 O-C-N 122.004 -0.435 . . . . 0.0 110.603 -179.121 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -70.69 -12.11 61.36 Favored 'General case' 0 CA--C 1.545 0.779 0 N-CA-C 114.95 1.463 . . . . 0.0 114.95 178.695 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 20.9 ptmt -102.67 -25.9 13.38 Favored 'General case' 0 N--CA 1.478 0.952 0 N-CA-C 114.038 1.125 . . . . 0.0 114.038 172.882 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 16.7 pt -99.18 -19.16 6.01 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 N-CA-C 114.432 1.271 . . . . 0.0 114.432 177.733 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 68.8 m . . . . . 0 C--O 1.255 1.39 0 C-N-CA 125.132 1.373 . . . . 0.0 112.292 -174.777 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.8 ttt . . . . . 0 N--CA 1.503 2.22 0 N-CA-C 111.745 0.276 . . . . 0.0 111.745 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 3.3 mptp? -125.92 156.43 39.73 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 125.685 1.594 . . . . 0.0 112.681 175.759 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 30.5 ttmt -107.64 117.89 35.3 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 106.651 -1.611 . . . . 0.0 106.651 167.115 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 14.3 t -103.01 135.23 41.45 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 N-CA-C 114.239 1.2 . . . . 0.0 114.239 -179.376 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 42.4 tpp -104.48 124.37 49.14 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 123.886 0.874 . . . . 0.0 108.908 168.503 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 67.2 m-85 -105.03 126.09 51.69 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 123.839 0.856 . . . . 0.0 108.972 169.798 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 1.5 m -141.95 150.6 19.03 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.194 0 N-CA-C 114.902 1.445 . . . . 0.0 114.902 -168.784 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 48.7 t -148.16 162.28 39.76 Favored 'General case' 0 CA--C 1.556 1.193 0 C-N-CA 127.501 2.32 . . . . 0.0 112.303 -179.432 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 21.9 ptmt -63.3 132.51 51.84 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 125.316 1.446 . . . . 0.0 112.298 172.597 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 6.9 mmm180 42.31 -135.84 0.32 Allowed 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 126.04 1.736 . . . . 0.0 112.255 -172.868 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 34.1 p-10 -154.39 -45.95 0.09 Allowed 'General case' 0 CA--C 1.549 0.942 0 N-CA-C 114.78 1.4 . . . . 0.0 114.78 172.715 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 67.5 m -56.73 -15.16 4.09 Favored 'General case' 0 N--CA 1.481 1.118 0 N-CA-C 117.685 2.476 . . . . 0.0 117.685 -169.067 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 97.7 p -102.17 -9.9 20.08 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 115.577 1.695 . . . . 0.0 115.577 -179.791 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 77.6 mtt85 -144.68 150.2 36.92 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 125.017 1.327 . . . . 0.0 113.468 -169.634 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 86.9 p -119.16 -5.07 10.49 Favored 'General case' 0 N--CA 1.478 0.944 0 N-CA-C 116.196 1.924 . . . . 0.0 116.196 -170.071 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 27.7 mt-30 64.25 -59.59 0.21 Allowed 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 128.013 2.525 . . . . 0.0 117.318 169.853 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 65.02 -43.88 0.33 Allowed 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 127.851 2.46 . . . . 0.0 116.597 -179.748 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.93 -28.34 68.87 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 115.137 1.532 . . . . 0.0 115.137 -169.212 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.0 pm0 -59.69 -37.1 77.87 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 119.132 0.878 . . . . 0.0 112.406 171.588 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -70.3 -50.45 27.17 Favored Glycine 0 C--O 1.224 -0.515 0 C-N-CA 124.408 1.004 . . . . 0.0 112.151 -169.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -66.4 -30.13 70.44 Favored 'General case' 0 N--CA 1.467 0.394 0 O-C-N 121.554 -0.968 . . . . 0.0 112.744 173.499 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -66.32 -35.86 81.46 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 118.499 0.59 . . . . 0.0 111.691 -176.001 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 13.4 ptmm? -82.1 -39.95 22.64 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 123.41 0.684 . . . . 0.0 112.319 169.227 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 16.9 m -76.02 -23.73 55.21 Favored 'General case' 0 N--CA 1.486 1.351 0 N-CA-C 112.905 0.706 . . . . 0.0 112.905 -169.255 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 85.3 mt -103.38 -30.61 10.48 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 125.378 1.471 . . . . 0.0 112.577 169.397 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -99.95 0.72 56.35 Favored Glycine 0 N--CA 1.471 1.026 0 N-CA-C 117.379 1.711 . . . . 0.0 117.379 -169.534 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -60.45 142.93 54.48 Favored 'General case' 0 CA--C 1.546 0.81 0 CA-C-N 121.09 2.445 . . . . 0.0 112.566 178.371 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 84.15 -23.51 7.0 Favored Glycine 0 CA--C 1.54 1.606 0 C-N-CA 124.822 1.201 . . . . 0.0 113.337 -169.48 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 62.1 mttp -96.93 -43.87 7.27 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 125.884 1.674 . . . . 0.0 111.883 169.834 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 43.7 pt -141.74 160.41 21.25 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 C-N-CA 125.178 1.391 . . . . 0.0 113.173 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -108.4 148.16 30.53 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 127.157 2.183 . . . . 0.0 109.17 169.831 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 58.7 t -136.02 143.85 34.95 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 CA-C-N 119.294 0.952 . . . . 0.0 113.165 -177.457 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 59.7 m -135.98 152.2 50.7 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 125.722 1.609 . . . . 0.0 109.539 169.821 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 96.7 p -136.06 142.32 44.36 Favored 'General case' 0 CA--C 1.514 -0.423 0 CA-C-O 121.942 0.877 . . . . 0.0 111.998 167.248 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 29.3 p -141.74 169.14 18.15 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 113.485 -1.689 . . . . 0.0 111.075 -176.707 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -106.02 164.23 13.76 Favored Glycine 0 CA--C 1.525 0.677 0 C-N-CA 123.731 0.681 . . . . 0.0 111.741 178.795 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -90.41 117.54 29.19 Favored 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 106.66 -1.608 . . . . 0.0 106.66 168.859 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 68.5 -41.57 0.46 Allowed 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 127.701 2.4 . . . . 0.0 113.955 -171.904 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 74.2 m -78.8 155.25 29.33 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 124.537 1.135 . . . . 0.0 111.142 169.547 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 67.9 p -90.74 -83.07 0.27 Allowed 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 114.394 1.257 . . . . 0.0 114.394 -179.273 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 52.1 ttt-85 -79.47 148.4 31.9 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 127.764 2.426 . . . . 0.0 110.457 -172.17 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 6.4 m -66.16 141.05 18.55 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 N-CA-C 109.214 -0.662 . . . . 0.0 109.214 171.739 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . 0.256 0.0 OUTLIER -65.36 144.35 98.96 Favored Pre-proline 0 CA--C 1.549 0.917 0 C-N-CA 119.636 -0.826 . . . . 0.0 111.103 -169.294 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_exo -46.32 -37.8 19.49 Favored 'Trans proline' 0 CA--C 1.54 0.792 0 C-N-CA 123.848 3.032 . . . . 0.0 118.331 -167.858 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 27.7 m -62.0 -26.59 68.31 Favored 'General case' 0 N--CA 1.485 1.299 0 O-C-N 120.702 -1.249 . . . . 0.0 112.206 -177.822 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.81 -21.96 66.69 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 113.538 0.94 . . . . 0.0 113.538 174.579 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.5 mp -74.91 -58.46 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 CA-C-N 119.527 1.058 . . . . 0.0 109.113 178.243 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.59 -33.89 76.97 Favored 'General case' 0 CA--C 1.545 0.752 0 N-CA-C 114.166 1.173 . . . . 0.0 114.166 -171.149 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.46 -25.54 57.48 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 124.268 1.027 . . . . 0.0 113.244 179.746 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -92.03 -32.63 15.13 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.578 1.151 . . . . 0.0 109.893 177.812 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -63.92 -12.18 34.83 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.092 1.357 . . . . 0.0 113.985 169.738 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -59.59 -19.68 50.51 Favored 'General case' 0 CA--C 1.553 1.087 0 CA-C-N 119.537 1.062 . . . . 0.0 110.458 168.041 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 16.5 t -108.75 -3.53 10.35 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.035 0 C-N-CA 128.548 2.739 . . . . 0.0 111.987 -179.585 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 73.99 34.41 55.72 Favored Glycine 0 CA--C 1.542 1.747 0 O-C-N 120.429 -1.419 . . . . 0.0 114.578 -177.137 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 9.4 mt -75.86 -19.17 15.53 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 N-CA-C 116.759 2.133 . . . . 0.0 116.759 -169.813 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 24.1 t0 43.7 72.28 0.2 Allowed 'General case' 0 CA--C 1.556 1.186 0 C-N-CA 126.747 2.019 . . . . 0.0 114.885 -179.185 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 35.3 pt -114.62 34.23 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 C-N-CA 125.569 1.548 . . . . 0.0 112.408 173.706 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 75.0 m -70.58 -34.0 71.7 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 114.594 1.331 . . . . 0.0 114.594 -170.104 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -84.41 -68.42 1.4 Allowed Glycine 0 CA--C 1.529 0.947 0 C-N-CA 123.477 0.561 . . . . 0.0 113.506 -179.62 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 8.0 mm100 54.46 -166.87 0.08 Allowed 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 126.527 1.931 . . . . 0.0 111.447 -169.091 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 64.2 p -73.21 138.19 45.48 Favored 'General case' 0 N--CA 1.473 0.701 0 O-C-N 121.141 -0.974 . . . . 0.0 112.56 -179.254 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 68.5 m -80.26 3.0 22.28 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.631 1.172 . . . . 0.0 113.012 169.782 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -144.72 157.35 55.26 Favored Pre-proline 0 CA--C 1.548 0.901 0 C-N-CA 125.87 1.668 . . . . 0.0 112.011 -176.365 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -64.89 165.99 19.63 Favored 'Trans proline' 0 CA--C 1.538 0.695 0 C-N-CA 124.183 3.255 . . . . 0.0 114.721 174.905 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 5.4 tt -49.83 -42.99 18.95 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.2 0 C-N-CA 124.59 1.156 . . . . 0.0 112.154 174.474 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -69.25 -10.69 58.99 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 113.524 0.935 . . . . 0.0 113.524 -174.83 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -77.39 -15.53 59.32 Favored 'General case' 0 CA--C 1.548 0.886 0 N-CA-C 112.807 0.669 . . . . 0.0 112.807 176.117 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 76.1 m-85 -107.28 -168.27 1.37 Allowed 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 126.53 1.932 . . . . 0.0 112.475 -174.868 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 8.9 p-10 -124.05 129.16 50.42 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 125.314 1.445 . . . . 0.0 109.921 176.629 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -64.55 -36.34 83.89 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 113.209 0.818 . . . . 0.0 113.209 -171.224 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -68.8 -4.55 16.55 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 114.067 1.136 . . . . 0.0 114.067 178.075 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -68.44 -16.68 63.99 Favored 'General case' 0 CA--C 1.549 0.913 0 CA-C-N 118.775 0.716 . . . . 0.0 110.296 168.286 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 79.6 m-85 -119.78 146.26 45.83 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 128.006 2.523 . . . . 0.0 111.709 -177.791 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -94.99 -29.06 14.82 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 124.838 1.255 . . . . 0.0 111.903 178.055 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 71.1 t -125.74 135.39 64.05 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 C-N-CA 126.067 1.747 . . . . 0.0 107.063 -177.212 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 69.0 t -127.04 121.39 57.83 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 169.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 45.1 mm -107.81 106.52 20.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 C-N-CA 124.703 1.201 . . . . 0.0 108.557 -177.597 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 8.1 m -90.68 111.85 23.36 Favored 'General case' 0 N--CA 1.463 0.222 0 C-N-CA 123.699 0.8 . . . . 0.0 109.829 176.611 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 89.9 mt -91.71 -11.32 37.18 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 124.855 1.262 . . . . 0.0 114.405 -170.539 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 57.3 m -139.94 156.27 46.75 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.565 1.146 . . . . 0.0 112.548 -168.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 60.62 -133.24 49.94 Favored Glycine 0 CA--C 1.536 1.377 0 N-CA-C 111.409 -0.677 . . . . 0.0 111.409 -175.326 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 75.3 m -125.19 26.87 6.79 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 124.305 1.042 . . . . 0.0 112.169 172.199 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 69.49 25.31 75.63 Favored Glycine 0 CA--C 1.533 1.172 0 O-C-N 121.344 -0.847 . . . . 0.0 114.905 -174.477 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 33.4 m -82.63 -178.54 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 C-N-CA 124.933 1.293 . . . . 0.0 110.254 169.713 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 12.5 t-20 66.18 -34.04 0.2 Allowed 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 127.182 2.193 . . . . 0.0 115.781 -179.35 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -71.85 142.36 85.55 Favored Pre-proline 0 CA--C 1.551 0.986 0 CA-C-N 120.271 1.396 . . . . 0.0 110.73 169.008 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -60.21 154.9 48.9 Favored 'Trans proline' 0 CA--C 1.543 0.946 0 C-N-CA 122.831 2.354 . . . . 0.0 114.492 -179.429 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_exo -56.03 -28.73 70.75 Favored 'Trans proline' 0 C--N 1.353 0.775 0 C-N-CA 123.733 2.955 . . . . 0.0 115.121 -177.483 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -62.11 -30.26 70.9 Favored 'General case' 0 CA--C 1.54 0.582 0 O-C-N 120.888 -1.132 . . . . 0.0 113.103 176.004 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 85.5 m95 -79.59 -29.83 41.33 Favored 'General case' 0 N--CA 1.476 0.846 0 O-C-N 120.942 -1.099 . . . . 0.0 111.998 174.303 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 48.8 t -68.91 -26.93 33.73 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.925 0 C-N-CA 125.216 1.406 . . . . 0.0 112.068 172.55 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -102.33 6.98 40.67 Favored 'General case' 0 N--CA 1.48 1.053 0 N-CA-C 116.051 1.871 . . . . 0.0 116.051 -170.894 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 89.7 mm-40 -65.49 160.33 22.45 Favored 'General case' 0 N--CA 1.481 1.112 0 O-C-N 120.633 -1.292 . . . . 0.0 112.255 172.537 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -51.35 -44.33 62.01 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 124.63 1.172 . . . . 0.0 113.849 -168.703 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 16.8 mm -123.19 69.1 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 C-N-CA 125.015 1.326 . . . . 0.0 108.343 177.781 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 57.1 t80 -78.58 107.55 11.33 Favored 'General case' 0 CA--C 1.534 0.356 0 O-C-N 120.796 -1.19 . . . . 0.0 108.58 169.399 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 9.1 mt-10 -105.92 132.7 51.7 Favored 'General case' 0 CA--C 1.545 0.778 0 N-CA-C 113.773 1.027 . . . . 0.0 113.773 174.551 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -93.75 104.39 16.48 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.648 1.179 . . . . 0.0 109.868 169.816 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 17.4 m0 -92.74 98.68 11.56 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.345 1.058 . . . . 0.0 110.002 -177.246 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 87.8 mm-40 -79.41 61.29 3.43 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 125.087 1.355 . . . . 0.0 109.985 172.833 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 6.2 tt -109.5 149.3 29.8 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 127.092 2.157 . . . . 0.0 113.054 -169.432 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -67.2 111.58 4.02 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 125.962 1.705 . . . . 0.0 111.912 176.444 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -84.0 129.88 57.06 Favored Pre-proline 0 CA--C 1.545 0.776 0 O-C-N 120.887 -1.133 . . . . 0.0 110.849 171.556 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -86.74 -9.63 6.52 Favored 'Trans proline' 0 CA--C 1.541 0.845 0 C-N-CA 121.955 1.77 . . . . 0.0 114.515 -169.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -60.39 -41.68 94.32 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 115.307 1.595 . . . . 0.0 115.307 -169.503 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -76.52 10.17 18.5 Favored Glycine 0 CA--C 1.537 1.444 0 C-N-CA 124.212 0.911 . . . . 0.0 114.755 -178.046 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 8.0 pt20 -146.69 -177.65 5.76 Favored 'General case' 0 CA--C 1.551 1.012 0 C-N-CA 126.848 2.059 . . . . 0.0 111.499 -169.877 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 10.5 p -66.76 164.68 16.6 Favored 'General case' 0 N--CA 1.478 0.947 0 N-CA-C 116.172 1.916 . . . . 0.0 116.172 -168.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 36.4 tp -63.02 -26.49 68.87 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 123.832 0.853 . . . . 0.0 112.338 170.591 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -69.39 -34.87 75.16 Favored 'General case' 0 CA--C 1.539 0.539 0 O-C-N 120.922 -1.111 . . . . 0.0 111.243 171.278 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 20.7 t -68.15 -38.94 80.48 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 CA-C-O 117.93 -1.034 . . . . 0.0 111.155 169.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 5.0 m-85 -54.72 -52.21 63.19 Favored 'General case' 0 N--CA 1.478 0.968 0 CA-C-N 120.664 1.574 . . . . 0.0 111.956 169.796 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -67.91 -34.33 76.41 Favored 'General case' 0 N--CA 1.479 0.992 0 CA-C-N 118.954 0.797 . . . . 0.0 112.221 -177.165 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 76.4 m -64.83 -46.42 82.04 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 123.871 0.868 . . . . 0.0 111.042 170.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 53.7 t -67.95 -35.21 71.17 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 CA-C-O 117.602 -1.19 . . . . 0.0 111.022 179.526 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 22.2 mtm105 -55.4 -46.71 76.59 Favored 'General case' 0 N--CA 1.481 1.112 0 CA-C-N 120.66 1.573 . . . . 0.0 111.031 170.629 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -58.47 -48.8 82.12 Favored Glycine 0 CA--C 1.542 1.765 0 CA-C-N 119.432 1.015 . . . . 0.0 113.848 175.188 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 15.5 mm100 -65.25 -44.9 86.63 Favored 'General case' 0 N--CA 1.474 0.742 0 O-C-N 121.778 -0.836 . . . . 0.0 112.02 179.846 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 78.6 t -66.97 -36.22 76.61 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 125.052 1.341 . . . . 0.0 111.308 177.255 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 78.1 tttt -54.64 -49.68 69.97 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-N 119.842 1.201 . . . . 0.0 110.207 174.472 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -64.23 -43.66 94.28 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 112.705 0.631 . . . . 0.0 112.705 175.873 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.57 -36.51 84.04 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 124.16 0.984 . . . . 0.0 112.894 179.47 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 94.4 t -77.48 -40.64 28.83 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 C-N-CA 125.515 1.526 . . . . 0.0 111.475 176.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -62.59 -31.84 72.73 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 119.567 1.076 . . . . 0.0 111.541 172.167 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 12.5 m-80 -67.28 -46.12 74.57 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-N 119.121 0.873 . . . . 0.0 112.867 171.294 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -50.83 -54.98 19.16 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 124.296 1.038 . . . . 0.0 110.138 171.259 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 74.3 mt -58.79 -49.53 82.51 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 CA-C-O 119.163 -0.446 . . . . 0.0 110.179 178.693 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -65.24 -11.26 39.26 Favored 'General case' 0 CA--C 1.544 0.743 0 N-CA-C 115.567 1.691 . . . . 0.0 115.567 -178.827 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 20.9 ptmt -103.23 -17.54 15.29 Favored 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 114.165 1.172 . . . . 0.0 114.165 171.823 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 14.3 pt -106.79 -12.22 10.16 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 N-CA-C 114.436 1.273 . . . . 0.0 114.436 177.153 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 73.8 m . . . . . 0 C--O 1.253 1.27 0 C-N-CA 125.185 1.394 . . . . 0.0 112.436 -176.763 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.9 ttt . . . . . 0 N--CA 1.503 2.185 0 N-CA-C 111.602 0.223 . . . . 0.0 111.602 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.28 163.71 32.9 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 124.828 1.251 . . . . 0.0 113.775 177.667 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 58.6 mtpt -89.72 141.82 28.26 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 125.226 1.41 . . . . 0.0 113.007 175.898 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 21.6 t -122.94 130.54 74.4 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 C-N-CA 125.971 1.708 . . . . 0.0 112.397 177.45 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 35.6 tpp -102.05 127.55 48.89 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 168.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 66.1 m-85 -104.68 132.32 51.06 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 123.728 0.811 . . . . 0.0 109.428 170.032 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -141.13 146.76 23.23 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 N-CA-C 114.584 1.327 . . . . 0.0 114.584 -169.441 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 41.8 t -151.19 176.32 11.31 Favored 'General case' 0 CA--C 1.552 1.056 0 C-N-CA 127.31 2.244 . . . . 0.0 110.853 171.472 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 54.1 mtpt -85.24 135.04 34.1 Favored 'General case' 0 N--CA 1.482 1.166 0 O-C-N 120.672 -1.267 . . . . 0.0 112.16 170.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 23.2 tpt180 47.58 56.45 7.05 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 127.507 2.323 . . . . 0.0 113.226 179.276 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -52.08 -28.56 17.94 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 113.857 1.058 . . . . 0.0 113.857 -179.422 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 67.2 m -63.69 -16.97 62.44 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-N 120.13 1.332 . . . . 0.0 112.661 -176.168 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 98.6 p -121.91 21.43 10.64 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 126.476 1.91 . . . . 0.0 113.767 171.11 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 73.6 mtt85 -137.73 151.32 48.08 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 125.762 1.625 . . . . 0.0 112.216 175.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 33.0 m -93.02 -31.93 14.69 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 114.977 1.473 . . . . 0.0 114.977 -169.729 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 59.89 -44.29 0.09 Allowed 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 127.887 2.475 . . . . 0.0 117.331 -179.043 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' MET . . . . . 0.411 ' HG2' ' SD ' ' A' ' 50' ' ' MET . 0.0 OUTLIER 68.73 -46.55 0.55 Allowed 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 127.605 2.362 . . . . 0.0 115.907 172.389 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.08 -35.21 74.69 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 115.908 1.818 . . . . 0.0 115.908 -169.112 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.3 pm0 -64.36 -43.69 93.73 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 119.151 0.887 . . . . 0.0 112.426 -179.044 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -61.41 -38.04 95.09 Favored Glycine 0 C--N 1.336 0.57 0 C-N-CA 123.903 0.763 . . . . 0.0 112.123 175.12 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -73.58 -42.47 61.56 Favored 'General case' 0 N--CA 1.47 0.527 0 O-C-N 121.782 -0.834 . . . . 0.0 111.518 177.541 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -60.33 -40.97 92.57 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 119.243 0.929 . . . . 0.0 112.705 -175.613 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 11.7 pttp -78.77 -24.92 44.43 Favored 'General case' 0 N--CA 1.479 1.016 0 N-CA-C 113.787 1.032 . . . . 0.0 113.787 174.036 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 90.4 m -72.52 -34.98 67.98 Favored 'General case' 0 N--CA 1.486 1.329 0 O-C-N 121.432 -0.792 . . . . 0.0 111.779 171.896 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 82.4 mt -88.66 -28.58 20.52 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 125.625 1.57 . . . . 0.0 113.824 -177.026 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -148.23 29.24 1.36 Allowed Glycine 0 N--CA 1.473 1.102 0 N-CA-C 118.256 2.062 . . . . 0.0 118.256 -169.411 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -66.53 -20.39 66.01 Favored 'General case' 0 N--CA 1.477 0.919 0 CA-C-N 121.867 2.834 . . . . 0.0 115.301 -177.752 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -77.56 -4.59 85.0 Favored Glycine 0 CA--C 1.541 1.696 0 O-C-N 121.305 -0.872 . . . . 0.0 113.923 169.593 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 60.7 mttp -115.93 -40.58 3.3 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 126.981 2.112 . . . . 0.0 112.315 -177.286 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 19.8 pt -140.69 159.04 24.32 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 125.961 1.704 . . . . 0.0 112.558 -174.308 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -106.23 140.32 39.37 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.682 1.193 . . . . 0.0 110.209 171.099 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 69.5 t -125.15 140.92 46.75 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 CA-C-N 118.911 0.778 . . . . 0.0 111.819 -175.104 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 22.4 m -134.56 143.39 47.36 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 125.058 1.343 . . . . 0.0 109.95 173.815 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 78.6 p -97.39 144.38 27.2 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.846 0.831 . . . . 0.0 111.24 169.198 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 32.7 t -149.05 165.04 32.87 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 123.593 0.757 . . . . 0.0 110.311 169.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -134.67 161.61 24.53 Favored Glycine 0 C--O 1.229 -0.167 0 CA-C-O 121.808 0.671 . . . . 0.0 112.604 -178.547 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -95.0 111.28 23.1 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 106.351 -1.722 . . . . 0.0 106.351 169.58 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 19.0 mt-10 66.68 30.77 8.03 Favored 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 125.122 1.369 . . . . 0.0 114.392 -173.587 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 7.6 m -151.31 151.34 31.66 Favored 'General case' 0 N--CA 1.482 1.152 0 N-CA-C 114.681 1.364 . . . . 0.0 114.681 175.56 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 88.0 p -109.43 -15.34 14.25 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 126.985 2.114 . . . . 0.0 116.327 173.632 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 7.6 tpt180 -123.4 170.32 10.46 Favored 'General case' 0 N--CA 1.488 1.462 0 CA-C-N 120.497 1.499 . . . . 0.0 110.781 -178.512 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 27.0 m -111.93 163.84 8.45 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.266 0 C-N-CA 126.435 1.894 . . . . 0.0 109.57 169.481 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 3.1 t-80 -48.59 129.91 13.81 Favored Pre-proline 0 CA--C 1.536 0.408 0 N-CA-C 113.945 1.091 . . . . 0.0 113.945 -173.866 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 81.5 Cg_exo -59.93 -26.76 83.26 Favored 'Trans proline' 0 CA--C 1.549 1.23 0 CA-C-N 120.273 1.133 . . . . 0.0 112.5 173.231 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 55.0 m -70.91 -29.15 65.12 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 125.17 1.388 . . . . 0.0 112.363 174.033 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -55.45 -44.55 76.48 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 119.245 0.93 . . . . 0.0 111.226 -178.078 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.7 mp -47.2 -55.11 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 125.178 1.391 . . . . 0.0 110.483 -177.41 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.99 -30.89 71.91 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 113.486 0.921 . . . . 0.0 113.486 -176.748 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -82.73 -26.35 32.02 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 113.421 0.897 . . . . 0.0 113.421 179.064 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' MET . . . . . 0.411 ' SD ' ' HG2' ' A' ' 17' ' ' MET . 3.9 mmt -80.3 -32.92 38.01 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.223 0.609 . . . . 0.0 110.8 170.266 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -66.01 -14.78 62.25 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 124.61 1.164 . . . . 0.0 113.348 172.845 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -60.56 -27.65 67.83 Favored 'General case' 0 N--CA 1.482 1.138 0 CA-C-N 120.106 1.321 . . . . 0.0 110.731 168.844 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 57.7 t -98.22 -6.5 9.35 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.939 0 C-N-CA 127.229 2.212 . . . . 0.0 111.282 176.894 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 81.14 19.36 67.22 Favored Glycine 0 CA--C 1.539 1.582 0 C-N-CA 124.951 1.263 . . . . 0.0 114.425 -174.506 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 83.0 mt -77.77 135.14 26.9 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 124.925 1.29 . . . . 0.0 111.266 -175.654 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 21.6 t0 -94.58 104.46 16.41 Favored 'General case' 0 CA--C 1.544 0.729 0 N-CA-C 113.236 0.828 . . . . 0.0 113.236 177.629 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 15.0 pt -130.56 23.25 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 C-N-CA 125.273 1.429 . . . . 0.0 112.338 169.688 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 72.2 m -87.69 153.53 21.29 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 124.729 1.212 . . . . 0.0 112.435 -178.379 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 65.68 18.5 66.1 Favored Glycine 0 CA--C 1.537 1.454 0 N-CA-C 115.28 0.872 . . . . 0.0 115.28 171.86 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -115.12 143.93 44.45 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 124.969 1.307 . . . . 0.0 111.957 -177.357 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 33.4 m -135.24 148.63 49.66 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 107.818 -1.179 . . . . 0.0 107.818 169.32 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 68.1 m -123.26 -161.45 0.97 Allowed 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 126.329 1.852 . . . . 0.0 109.916 -171.786 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -134.91 159.03 73.65 Favored Pre-proline 0 CA--C 1.54 0.567 0 C-N-CA 123.854 0.862 . . . . 0.0 110.923 179.332 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -62.17 157.27 45.63 Favored 'Trans proline' 0 N--CA 1.46 -0.476 0 C-N-CA 122.294 1.996 . . . . 0.0 112.311 171.77 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 6.7 tp -60.99 -30.21 47.16 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 O-C-N 121.667 -0.645 . . . . 0.0 112.423 -173.876 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -67.52 -12.5 60.49 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 114.341 1.237 . . . . 0.0 114.341 176.794 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 -79.95 -21.53 43.67 Favored 'General case' 0 CA--C 1.547 0.855 0 N-CA-C 113.22 0.822 . . . . 0.0 113.22 179.839 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 99.3 m-85 -102.39 -174.52 2.59 Favored 'General case' 0 CA--C 1.552 1.045 0 C-N-CA 126.216 1.806 . . . . 0.0 112.922 -173.319 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 5.9 t30 -123.6 126.7 47.1 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 126.21 1.804 . . . . 0.0 109.572 171.799 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.91 -35.9 81.05 Favored 'General case' 0 CA--C 1.53 0.184 0 N-CA-C 114.361 1.245 . . . . 0.0 114.361 -170.048 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . 0.256 0.0 OUTLIER -72.67 -3.63 26.18 Favored 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 114.221 1.193 . . . . 0.0 114.221 -175.672 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -75.21 -13.25 60.43 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 124.076 0.95 . . . . 0.0 111.543 168.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 87.8 m-85 -118.08 135.73 54.02 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 126.774 2.029 . . . . 0.0 111.574 -179.287 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -87.15 -24.23 24.56 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-O 122.297 1.046 . . . . 0.0 112.655 178.47 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 80.1 t -129.73 138.99 52.76 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 C-N-CA 127.28 2.232 . . . . 0.0 108.772 -176.569 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 59.2 t -135.15 122.66 37.29 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 171.509 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 45.1 mm -110.21 101.1 12.08 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 C-N-CA 124.255 1.022 . . . . 0.0 109.919 -174.693 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 8.8 m -86.15 94.43 9.28 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 124.224 1.01 . . . . 0.0 109.208 171.139 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -97.78 19.68 13.29 Favored 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 116.065 1.876 . . . . 0.0 116.065 -169.427 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 14.7 p -152.14 155.08 37.14 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 123.812 0.845 . . . . 0.0 110.941 170.695 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 62.06 -137.34 45.86 Favored Glycine 0 CA--C 1.535 1.334 0 C-N-CA 123.685 0.659 . . . . 0.0 113.948 177.571 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 83.4 p -93.21 -23.59 18.5 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.996 1.318 . . . . 0.0 114.552 179.544 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 77.07 4.44 83.4 Favored Glycine 0 CA--C 1.535 1.292 0 C-N-CA 124.555 1.074 . . . . 0.0 115.343 -169.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 48.9 t -88.73 -10.92 10.58 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 CA-C-N 119.564 1.682 . . . . 0.0 112.91 -172.373 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -72.65 -9.56 58.75 Favored 'General case' 0 CA--C 1.549 0.917 0 O-C-N 120.426 -1.421 . . . . 0.0 114.153 -176.168 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -95.06 158.43 34.9 Favored Pre-proline 0 CA--C 1.549 0.927 0 C-N-CA 124.791 1.236 . . . . 0.0 113.644 176.479 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_exo -61.18 152.92 68.56 Favored 'Trans proline' 0 CA--C 1.544 0.991 0 C-N-CA 122.96 2.44 . . . . 0.0 114.24 -179.198 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_exo -55.76 -29.66 72.59 Favored 'Trans proline' 0 C--N 1.354 0.824 0 C-N-CA 123.692 2.928 . . . . 0.0 115.082 -177.599 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -61.81 -29.31 70.07 Favored 'General case' 0 CA--C 1.539 0.551 0 O-C-N 121.077 -1.015 . . . . 0.0 112.888 177.02 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 92.8 m95 -80.94 -33.79 33.75 Favored 'General case' 0 N--CA 1.473 0.698 0 O-C-N 121.202 -0.936 . . . . 0.0 112.119 174.269 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 25.0 t -63.25 -31.72 53.78 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 C-N-CA 124.679 1.192 . . . . 0.0 111.606 172.239 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -96.93 6.18 49.12 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 115.675 1.732 . . . . 0.0 115.675 -171.299 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 87.0 mm-40 -64.74 157.25 27.98 Favored 'General case' 0 N--CA 1.481 1.077 0 O-C-N 120.615 -1.303 . . . . 0.0 111.248 169.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -58.74 -39.53 81.2 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 113.967 1.099 . . . . 0.0 113.967 -168.092 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 19.1 mm -118.82 59.61 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 C-N-CA 124.958 1.303 . . . . 0.0 109.017 177.235 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 52.0 t80 -76.89 106.97 8.89 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 107.333 -1.358 . . . . 0.0 107.333 168.724 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 13.2 mt-10 -109.11 134.82 51.2 Favored 'General case' 0 N--CA 1.467 0.375 0 N-CA-C 113.11 0.781 . . . . 0.0 113.11 174.561 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -103.51 118.05 35.86 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.062 0.945 . . . . 0.0 109.453 169.089 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 28.4 m0 -109.96 114.34 27.8 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 107.672 -1.233 . . . . 0.0 107.672 176.415 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 19.3 mt-30 -85.22 49.07 1.67 Allowed 'General case' 0 CA--C 1.545 0.763 0 O-C-N 121.3 -0.875 . . . . 0.0 111.701 -175.003 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 82.7 mt -73.94 160.16 31.75 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 125.848 1.659 . . . . 0.0 111.918 175.54 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -88.34 155.22 19.83 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.846 169.286 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -94.14 143.86 27.1 Favored Pre-proline 0 CA--C 1.547 0.834 0 O-C-N 121.422 -0.799 . . . . 0.0 111.606 171.023 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -64.1 -18.5 63.75 Favored 'Trans proline' 0 CA--C 1.546 1.08 0 C-N-CA 122.661 2.241 . . . . 0.0 116.07 176.01 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -57.12 138.15 54.9 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 120.255 1.389 . . . . 0.0 113.583 -178.801 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 78.41 6.59 87.99 Favored Glycine 0 CA--C 1.535 1.311 0 C-N-CA 124.384 0.993 . . . . 0.0 115.058 177.19 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 11.7 pt20 -141.8 165.13 28.31 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 125.17 1.388 . . . . 0.0 113.499 -178.376 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 68.4 m -63.68 162.89 12.36 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 125.774 1.63 . . . . 0.0 115.393 -169.52 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 21.4 tp -59.75 -29.25 68.04 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 125.181 1.392 . . . . 0.0 113.445 178.518 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -62.1 -28.94 69.97 Favored 'General case' 0 N--CA 1.476 0.844 0 O-C-N 120.544 -1.348 . . . . 0.0 111.92 171.617 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 3.5 t -76.56 -37.39 29.64 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 O-C-N 120.86 -1.15 . . . . 0.0 111.427 172.628 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -56.34 -46.55 79.88 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-N 120.028 1.286 . . . . 0.0 110.531 168.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -66.85 -36.15 81.67 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.702 0.801 . . . . 0.0 112.002 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 25.5 m -60.85 -52.16 66.25 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 124.414 1.085 . . . . 0.0 111.162 170.43 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 69.3 t -64.54 -45.97 94.02 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 O-C-N 121.712 -0.617 . . . . 0.0 110.528 179.831 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 42.6 ttp85 -59.53 -38.59 81.41 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 125.359 1.463 . . . . 0.0 112.394 178.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -64.73 -50.5 58.33 Favored Glycine 0 CA--C 1.538 1.505 0 CA-C-N 119.156 0.889 . . . . 0.0 113.481 171.632 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 15.2 mm100 -63.7 -42.17 98.02 Favored 'General case' 0 N--CA 1.477 0.891 0 O-C-N 121.819 -0.812 . . . . 0.0 111.836 178.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 52.9 t -64.01 -42.07 94.5 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 C-N-CA 125.397 1.479 . . . . 0.0 110.887 175.437 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 82.4 tttt -53.24 -49.45 66.8 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 120.153 1.342 . . . . 0.0 110.478 176.854 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -64.96 -42.67 94.38 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 123.454 0.702 . . . . 0.0 112.788 178.689 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 16.1 mmm180 -60.29 -45.34 93.69 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 123.438 0.695 . . . . 0.0 112.649 175.278 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 87.2 t -71.4 -39.45 71.57 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 C-N-CA 124.147 0.979 . . . . 0.0 111.267 -178.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -61.15 -41.66 97.14 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 119.386 0.994 . . . . 0.0 111.638 171.151 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 14.4 m-80 -63.4 -46.26 87.26 Favored 'General case' 0 CA--C 1.539 0.519 0 CA-C-N 118.692 0.678 . . . . 0.0 112.275 174.911 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -54.1 -54.95 32.4 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 124.694 1.198 . . . . 0.0 110.766 175.492 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 97.1 mt -61.09 -44.48 98.37 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 CA-C-O 118.857 -0.592 . . . . 0.0 110.541 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -67.48 -14.47 62.96 Favored 'General case' 0 CA--C 1.543 0.681 0 N-CA-C 115.084 1.512 . . . . 0.0 115.084 -179.738 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 21.1 ptmt -100.17 -28.02 13.23 Favored 'General case' 0 N--CA 1.478 0.931 0 CA-C-N 119.298 0.953 . . . . 0.0 113.552 173.646 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 17.5 pt -92.27 -14.72 8.39 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 N-CA-C 114.491 1.293 . . . . 0.0 114.491 178.091 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 67.4 m . . . . . 0 C--O 1.254 1.291 0 C-N-CA 123.893 0.877 . . . . 0.0 112.892 179.573 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.1 ttt . . . . . 0 N--CA 1.501 2.123 0 N-CA-C 111.599 0.222 . . . . 0.0 111.599 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -123.74 160.39 27.38 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 125.844 1.658 . . . . 0.0 112.662 176.557 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 32.4 ttmt -110.91 113.68 26.43 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 167.588 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 16.2 t -103.7 133.65 47.07 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 N-CA-C 113.839 1.051 . . . . 0.0 113.839 -177.852 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 46.4 tpp -101.59 119.61 39.03 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.456 1.102 . . . . 0.0 109.58 169.093 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 56.3 m-85 -103.34 121.75 43.4 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 124.899 1.28 . . . . 0.0 109.134 173.433 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 4.2 m -144.57 162.32 14.27 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 C-N-CA 124.163 0.985 . . . . 0.0 113.002 -168.894 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 12.7 t -146.86 157.03 43.55 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 126.095 1.758 . . . . 0.0 110.749 169.807 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -30.59 -46.78 0.08 Allowed 'General case' 0 N--CA 1.489 1.476 0 C-N-CA 129.119 2.968 . . . . 0.0 117.126 -176.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 32.1 ttm180 -137.35 -26.01 1.01 Allowed 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 117.309 2.337 . . . . 0.0 117.309 -174.882 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 6.9 t30 60.34 -33.38 0.07 Allowed 'General case' 0 N--CA 1.485 1.319 0 N-CA-C 117.577 2.436 . . . . 0.0 117.577 -178.534 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 84.1 p -62.69 139.98 58.69 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 121.192 1.815 . . . . 0.0 111.946 175.049 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 69.7 m 49.85 31.39 4.54 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 125.943 1.697 . . . . 0.0 114.486 -175.115 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 77.0 mtt85 -141.61 162.75 34.71 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 126.631 1.972 . . . . 0.0 111.53 -175.576 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 4.0 m -124.16 149.32 46.42 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 125.766 1.626 . . . . 0.0 111.774 174.089 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 -112.71 -35.59 5.45 Favored 'General case' 0 N--CA 1.478 0.933 0 N-CA-C 114.347 1.24 . . . . 0.0 114.347 -178.185 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' MET . . . . . 0.429 ' HG2' ' SD ' ' A' ' 50' ' ' MET . 0.0 OUTLIER 68.56 -47.78 0.55 Allowed 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 126.783 2.033 . . . . 0.0 115.681 173.887 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.17 -30.01 70.75 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 115.613 1.709 . . . . 0.0 115.613 -169.614 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 3.5 pm0 -62.7 -44.55 95.96 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 119.385 0.993 . . . . 0.0 112.096 178.062 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -64.77 -42.98 96.86 Favored Glycine 0 C--O 1.226 -0.402 0 C-N-CA 124.135 0.874 . . . . 0.0 111.736 179.405 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -68.6 -39.85 80.69 Favored 'General case' 0 N--CA 1.466 0.336 0 O-C-N 121.856 -0.791 . . . . 0.0 111.504 176.839 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -62.32 -41.41 98.52 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 119.226 0.921 . . . . 0.0 112.63 -177.837 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 10.5 pttp -81.17 -20.38 41.36 Favored 'General case' 0 N--CA 1.48 1.067 0 N-CA-C 114.037 1.125 . . . . 0.0 114.037 174.288 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 93.3 m -74.52 -36.13 63.18 Favored 'General case' 0 N--CA 1.483 1.224 0 O-C-N 121.561 -0.712 . . . . 0.0 111.645 170.806 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 74.4 mt -92.75 -30.83 15.31 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 125.374 1.47 . . . . 0.0 114.672 -174.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -137.21 25.71 3.01 Favored Glycine 0 N--CA 1.475 1.238 0 N-CA-C 118.224 2.049 . . . . 0.0 118.224 -169.002 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -66.69 -22.04 66.08 Favored 'General case' 0 N--CA 1.476 0.856 0 CA-C-N 121.895 2.848 . . . . 0.0 115.391 -174.459 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -72.74 -12.54 78.25 Favored Glycine 0 CA--C 1.542 1.748 0 O-C-N 121.18 -0.95 . . . . 0.0 113.632 169.576 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 53.2 mttm -107.34 -39.54 5.64 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 127.318 2.247 . . . . 0.0 113.161 -179.75 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 45.2 pt -144.41 154.46 15.0 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 C-N-CA 124.667 1.187 . . . . 0.0 114.094 -171.624 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -98.14 140.33 32.61 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 126.021 1.728 . . . . 0.0 109.247 169.548 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 92.3 t -127.27 139.02 53.08 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 CA-C-N 118.553 0.615 . . . . 0.0 111.735 -175.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 33.5 m -136.35 148.16 47.75 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 125.269 1.428 . . . . 0.0 109.432 172.182 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 86.1 p -136.02 143.19 44.62 Favored 'General case' 0 CA--C 1.514 -0.406 0 CA-C-O 122.249 1.023 . . . . 0.0 111.16 167.801 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 8.0 m -139.36 152.23 46.97 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 113.393 -1.731 . . . . 0.0 111.25 -169.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -81.33 163.76 45.1 Favored Glycine 0 CA--C 1.527 0.819 0 N-CA-C 110.382 -1.087 . . . . 0.0 110.382 169.222 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 8.2 mp -91.07 -23.09 20.43 Favored 'General case' 0 N--CA 1.477 0.911 0 O-C-N 120.885 -1.362 . . . . 0.0 112.895 174.173 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -148.8 29.68 0.82 Allowed 'General case' 0 CA--C 1.551 0.985 0 C-N-CA 125.734 1.614 . . . . 0.0 111.076 176.815 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 32.6 p -152.29 153.0 32.83 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 126.54 1.936 . . . . 0.0 112.16 -174.186 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 47.6 m -116.25 19.04 15.08 Favored 'General case' 0 N--CA 1.483 1.216 0 N-CA-C 116.198 1.925 . . . . 0.0 116.198 -169.003 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 7.8 tpt180 -159.3 144.76 15.98 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 124.702 1.201 . . . . 0.0 111.759 171.511 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 22.0 m -70.87 129.37 34.83 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.321 0 N-CA-C 105.92 -1.881 . . . . 0.0 105.92 167.847 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . 0.271 0.0 OUTLIER -60.46 141.49 91.56 Favored Pre-proline 0 CA--C 1.552 1.05 0 N-CA-C 112.681 0.622 . . . . 0.0 112.681 -168.413 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_exo -46.49 -39.26 22.26 Favored 'Trans proline' 0 CA--C 1.54 0.778 0 C-N-CA 124.257 3.305 . . . . 0.0 118.567 -168.001 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 26.0 m -65.04 -24.3 67.44 Favored 'General case' 0 N--CA 1.484 1.242 0 CA-C-N 119.418 1.008 . . . . 0.0 112.802 -174.703 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -52.83 -48.77 66.74 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 123.673 0.789 . . . . 0.0 111.573 172.873 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.6 mp -54.01 -56.02 11.38 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 C-N-CA 124.373 1.069 . . . . 0.0 110.37 -171.764 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -62.4 -28.28 69.67 Favored 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 113.392 0.886 . . . . 0.0 113.392 -177.14 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -81.85 -20.64 38.53 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 113.69 0.996 . . . . 0.0 113.69 176.758 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' MET . . . . . 0.429 ' SD ' ' HG2' ' A' ' 17' ' ' MET . 5.7 mmt -87.52 -32.55 19.35 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 119.465 1.03 . . . . 0.0 110.729 169.887 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -64.5 -15.29 60.58 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.752 1.221 . . . . 0.0 113.559 176.229 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 -61.15 -28.44 69.12 Favored 'General case' 0 N--CA 1.48 1.032 0 CA-C-N 120.225 1.375 . . . . 0.0 111.077 169.345 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 59.3 t -94.91 -3.65 10.58 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.047 0 C-N-CA 127.356 2.262 . . . . 0.0 111.253 178.03 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 79.4 17.54 75.83 Favored Glycine 0 CA--C 1.54 1.609 0 O-C-N 120.525 -1.359 . . . . 0.0 114.588 -174.572 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 67.2 mt -76.57 145.48 10.28 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 C-N-CA 125.09 1.356 . . . . 0.0 111.941 -174.445 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -106.3 53.16 0.71 Allowed 'General case' 0 CA--C 1.548 0.897 0 N-CA-C 115.11 1.522 . . . . 0.0 115.11 -170.092 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 12.0 pt -85.42 -0.12 6.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 120.017 -1.677 . . . . 0.0 114.252 173.334 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 84.5 p -67.09 -28.13 67.92 Favored 'General case' 0 N--CA 1.476 0.841 0 O-C-N 120.838 -1.163 . . . . 0.0 113.502 174.694 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -82.0 -6.95 88.47 Favored Glycine 0 CA--C 1.537 1.415 0 C-N-CA 125.075 1.321 . . . . 0.0 116.381 -177.112 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 14.8 pt20 -100.19 138.34 37.39 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 119.309 1.555 . . . . 0.0 112.077 179.364 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 58.8 p -106.38 -64.24 1.19 Allowed 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 125.701 1.6 . . . . 0.0 110.82 173.28 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 59.1 m 63.7 127.12 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 129.152 2.981 . . . . 0.0 116.639 173.621 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 24.6 m-20 -67.35 162.11 58.53 Favored Pre-proline 0 CA--C 1.548 0.87 0 C-N-CA 124.402 1.081 . . . . 0.0 111.012 169.555 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -58.1 157.95 23.44 Favored 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 122.627 2.218 . . . . 0.0 112.977 171.075 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 2.9 tt -57.1 -37.7 56.8 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 C-N-CA 123.778 0.831 . . . . 0.0 110.939 -178.506 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.98 -1.55 26.2 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 114.302 1.223 . . . . 0.0 114.302 -177.247 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -88.22 -6.85 57.59 Favored 'General case' 0 CA--C 1.555 1.167 0 C-N-CA 124.573 1.149 . . . . 0.0 111.9 169.242 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 77.2 m-85 -113.86 -174.93 2.56 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 126.796 2.038 . . . . 0.0 112.739 -178.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 13.3 p-10 -116.83 132.73 56.62 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 127.04 2.136 . . . . 0.0 109.915 174.607 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -67.45 -35.75 79.84 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 113.636 0.976 . . . . 0.0 113.636 -174.315 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -70.02 -3.45 16.37 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 114.429 1.27 . . . . 0.0 114.429 -179.334 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -69.96 -16.72 63.24 Favored 'General case' 0 CA--C 1.543 0.699 0 O-C-N 121.652 -0.655 . . . . 0.0 110.976 168.946 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 45.2 m-85 -120.42 131.14 54.66 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 126.661 1.985 . . . . 0.0 111.378 -172.724 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -80.69 -22.85 40.01 Favored 'General case' 0 N--CA 1.477 0.911 0 CA-C-O 122.234 1.016 . . . . 0.0 112.498 178.065 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 82.2 t -132.4 136.37 56.34 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 C-N-CA 127.501 2.32 . . . . 0.0 108.125 -175.113 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 59.7 t -131.92 127.3 58.19 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 169.561 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 41.8 mm -114.61 115.91 50.98 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 C-N-CA 123.777 0.831 . . . . 0.0 109.645 -174.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 10.5 t -89.18 122.46 32.49 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 169.208 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 92.7 mt -97.19 5.32 50.33 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 116.141 1.904 . . . . 0.0 116.141 -168.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 25.4 p -144.94 39.04 1.21 Allowed 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 123.273 0.629 . . . . 0.0 112.077 -174.435 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 110.53 -148.25 17.58 Favored Glycine 0 CA--C 1.531 1.08 0 C-N-CA 125.024 1.297 . . . . 0.0 112.992 -174.224 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 87.2 p -76.29 174.51 10.09 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 124.963 1.305 . . . . 0.0 113.502 -178.629 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -76.07 119.81 5.74 Favored Glycine 0 N--CA 1.469 0.889 0 CA-C-O 122.244 0.914 . . . . 0.0 111.317 169.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 7.6 p -148.0 151.73 13.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 C-N-CA 127.86 2.464 . . . . 0.0 106.471 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 51.7 t30 65.73 2.66 2.2 Favored 'General case' 0 CA--C 1.556 1.185 0 N-CA-C 115.996 1.85 . . . . 0.0 115.996 179.647 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -117.54 152.18 49.24 Favored Pre-proline 0 N--CA 1.479 0.996 0 C-N-CA 126.14 1.776 . . . . 0.0 111.681 169.679 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -71.89 160.36 47.97 Favored 'Trans proline' 0 CA--C 1.548 1.219 0 C-N-CA 122.407 2.071 . . . . 0.0 113.061 -179.082 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_exo -57.81 -25.77 70.59 Favored 'Trans proline' 0 C--N 1.354 0.834 0 C-N-CA 123.931 3.087 . . . . 0.0 116.363 -169.696 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -62.46 -25.78 68.17 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 114.024 1.12 . . . . 0.0 114.024 -178.711 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 93.8 m95 -81.13 -33.05 33.48 Favored 'General case' 0 N--CA 1.472 0.662 0 O-C-N 120.676 -1.265 . . . . 0.0 112.682 178.436 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 9.4 m -80.73 -6.2 9.36 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 N-CA-C 113.145 0.795 . . . . 0.0 113.145 176.046 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -106.82 6.01 29.06 Favored 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 114.741 1.386 . . . . 0.0 114.741 179.678 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 91.1 mm-40 -65.75 158.61 27.14 Favored 'General case' 0 N--CA 1.479 0.999 0 O-C-N 120.785 -1.197 . . . . 0.0 111.621 170.512 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -57.44 -43.47 83.91 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 114.224 1.194 . . . . 0.0 114.224 -168.15 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 22.0 mm -114.96 60.52 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 C-N-CA 124.93 1.292 . . . . 0.0 108.77 175.794 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 42.6 t80 -76.57 110.83 11.45 Favored 'General case' 0 CA--C 1.536 0.41 0 O-C-N 120.746 -1.221 . . . . 0.0 108.229 169.084 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 17.0 mt-10 -110.73 137.76 47.98 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 114.573 1.323 . . . . 0.0 114.573 175.7 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -97.71 114.74 26.79 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.99 1.316 . . . . 0.0 109.726 169.373 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 34.0 m0 -104.79 118.61 36.99 Favored 'General case' 0 N--CA 1.462 0.156 0 C-N-CA 124.438 1.095 . . . . 0.0 108.189 176.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 61.7 mt-30 -91.18 44.21 1.18 Allowed 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 124.508 1.123 . . . . 0.0 111.162 -169.627 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 90.1 mt -82.99 168.13 17.28 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 126.926 2.09 . . . . 0.0 112.222 -179.165 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -96.97 152.95 18.21 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 123.856 0.863 . . . . 0.0 113.108 172.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -77.7 121.62 84.52 Favored Pre-proline 0 CA--C 1.543 0.703 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 169.458 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -79.9 -9.06 14.42 Favored 'Trans proline' 0 CA--C 1.542 0.923 0 C-N-CA 121.403 1.402 . . . . 0.0 114.317 -178.798 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -72.89 -41.9 64.15 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 115.905 1.817 . . . . 0.0 115.905 -169.416 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -72.89 20.37 1.09 Allowed Glycine 0 CA--C 1.541 1.707 0 C-N-CA 124.387 0.994 . . . . 0.0 114.872 -177.471 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 7.3 pt20 -158.74 176.94 11.73 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 127.78 2.432 . . . . 0.0 110.876 -169.662 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 52.8 p -66.65 161.94 22.2 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 114.122 1.156 . . . . 0.0 114.122 -172.82 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . 0.32 2.9 pp -67.99 -11.97 59.88 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 114.194 1.183 . . . . 0.0 114.194 176.803 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -67.82 -30.07 69.39 Favored 'General case' 0 CA--C 1.543 0.682 0 O-C-N 120.968 -1.082 . . . . 0.0 109.953 168.845 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 3.4 t -74.35 -36.92 44.02 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 O-C-N 121.031 -1.043 . . . . 0.0 111.147 170.806 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 16.5 m-85 -58.05 -42.26 85.03 Favored 'General case' 0 N--CA 1.482 1.141 0 CA-C-N 120.229 1.377 . . . . 0.0 111.313 168.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -66.5 -37.51 85.22 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 124.19 0.996 . . . . 0.0 112.439 175.864 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 18.9 m -61.36 -50.53 72.53 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 124.491 1.116 . . . . 0.0 111.252 171.203 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 78.4 t -67.44 -37.73 79.44 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 C-N-CA 124.131 0.972 . . . . 0.0 111.098 -178.887 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 19.9 mtp180 -54.55 -43.38 71.93 Favored 'General case' 0 N--CA 1.48 1.052 0 CA-C-N 120.109 1.322 . . . . 0.0 112.467 170.255 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -61.74 -50.9 61.34 Favored Glycine 0 CA--C 1.535 1.332 0 CA-C-N 119.297 0.953 . . . . 0.0 112.954 175.239 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 52.4 mt-30 -61.03 -46.77 89.36 Favored 'General case' 0 N--CA 1.474 0.729 0 O-C-N 122.138 -0.625 . . . . 0.0 111.737 177.686 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 55.3 t -66.02 -41.02 88.88 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 C-N-CA 125.028 1.331 . . . . 0.0 111.144 -179.41 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -55.98 -48.15 76.36 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 120.117 1.326 . . . . 0.0 110.437 177.129 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -63.47 -44.66 93.8 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 112.682 0.623 . . . . 0.0 112.682 175.376 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.17 -33.72 76.67 Favored 'General case' 0 N--CA 1.478 0.967 0 N-CA-C 113.52 0.933 . . . . 0.0 113.52 179.188 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 82.4 t -78.99 -39.29 21.46 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 C-N-CA 125.698 1.599 . . . . 0.0 111.291 177.027 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -60.89 -40.11 91.79 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 119.58 1.082 . . . . 0.0 111.16 171.171 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 16.6 m-80 -63.96 -45.86 87.22 Favored 'General case' 0 CA--C 1.538 0.51 0 O-C-N 121.865 -0.522 . . . . 0.0 112.341 174.19 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -51.67 -57.9 7.9 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 124.729 1.212 . . . . 0.0 110.6 173.522 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 74.1 mt -62.59 -42.99 98.03 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 C-N-CA 122.827 0.451 . . . . 0.0 110.548 -177.11 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -72.92 -10.62 60.0 Favored 'General case' 0 CA--C 1.544 0.721 0 N-CA-C 114.86 1.43 . . . . 0.0 114.86 -178.854 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 20.7 ptmt -99.53 -29.93 12.44 Favored 'General case' 0 N--CA 1.479 0.976 0 N-CA-C 113.636 0.976 . . . . 0.0 113.636 170.198 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 12.7 pt -93.24 -8.91 9.93 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 N-CA-C 114.527 1.306 . . . . 0.0 114.527 178.313 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 27.1 p . . . . . 0 C--O 1.255 1.387 0 N-CA-C 114.663 1.357 . . . . 0.0 114.663 174.501 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.3 ttt . . . . . 0 N--CA 1.502 2.139 0 N-CA-C 111.501 0.186 . . . . 0.0 111.501 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.79 155.97 36.97 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 125.059 1.344 . . . . 0.0 112.774 173.951 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 30.8 ttmt -106.73 112.6 25.66 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 106.812 -1.551 . . . . 0.0 106.812 167.651 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 23.4 t -97.3 131.7 43.57 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 C-N-CA 125.38 1.472 . . . . 0.0 113.826 178.751 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 23.3 tpp -98.73 128.2 44.9 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 168.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 48.6 m-85 -109.46 121.35 44.99 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 125.784 1.633 . . . . 0.0 108.2 174.079 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.1 m -137.69 143.02 34.85 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 N-CA-C 113.926 1.084 . . . . 0.0 113.926 -168.823 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 5.3 t -131.03 147.45 52.63 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 126.41 1.884 . . . . 0.0 112.086 174.786 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 63.2 tttm -52.86 -39.71 62.82 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 126.477 1.911 . . . . 0.0 114.297 -177.641 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 53.4 ttt180 -101.95 -49.73 3.87 Favored 'General case' 0 N--CA 1.483 1.217 0 N-CA-C 113.719 1.007 . . . . 0.0 113.719 169.872 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 1.8 t30 63.63 -47.5 0.25 Allowed 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 127.232 2.213 . . . . 0.0 116.15 -173.515 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 59.6 p -64.85 145.97 55.54 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 119.044 0.838 . . . . 0.0 110.243 169.687 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 66.6 m 51.39 24.62 2.23 Favored 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 114.564 1.32 . . . . 0.0 114.564 -174.548 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 85.2 mtt180 -137.47 152.4 49.5 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 126.975 2.11 . . . . 0.0 110.399 176.403 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 61.1 m -97.01 -29.28 13.74 Favored 'General case' 0 N--CA 1.48 1.058 0 N-CA-C 115.771 1.767 . . . . 0.0 115.771 -169.295 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 3.9 mp0 59.96 -44.24 0.09 Allowed 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 128.596 2.758 . . . . 0.0 117.09 -178.517 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 68.73 -46.38 0.55 Allowed 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 127.54 2.336 . . . . 0.0 115.753 171.931 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.86 -38.78 86.73 Favored 'General case' 0 C--O 1.222 -0.39 0 N-CA-C 115.494 1.665 . . . . 0.0 115.494 -169.605 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -69.15 -36.5 77.5 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-N 119.788 1.176 . . . . 0.0 112.134 -177.122 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -64.14 -40.16 97.81 Favored Glycine 0 N--CA 1.469 0.866 0 C-N-CA 124.135 0.874 . . . . 0.0 112.107 173.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -69.74 -38.32 76.77 Favored 'General case' 0 N--CA 1.47 0.533 0 O-C-N 121.75 -0.853 . . . . 0.0 111.686 172.404 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -64.59 -43.1 94.88 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 119.424 1.011 . . . . 0.0 112.402 -174.75 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 15.2 ptpt -64.75 -38.33 90.63 Favored 'General case' 0 N--CA 1.486 1.351 0 O-C-N 121.514 -0.741 . . . . 0.0 112.025 169.753 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 92.3 m -71.55 -34.07 69.67 Favored 'General case' 0 N--CA 1.479 1.001 0 O-C-N 121.632 -0.668 . . . . 0.0 112.475 -176.709 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 71.9 mt -88.66 -26.07 22.05 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 125.498 1.519 . . . . 0.0 113.84 -178.717 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -145.78 27.08 1.77 Allowed Glycine 0 N--CA 1.47 0.94 0 N-CA-C 118.487 2.155 . . . . 0.0 118.487 -169.083 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -65.82 -21.92 66.52 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-N 122.31 3.055 . . . . 0.0 115.329 -177.323 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -74.36 -5.17 71.47 Favored Glycine 0 CA--C 1.541 1.671 0 O-C-N 121.546 -0.721 . . . . 0.0 113.799 169.479 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 76.8 mttt -118.81 -39.81 2.93 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 127.339 2.256 . . . . 0.0 113.255 -177.506 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 43.7 pt -145.11 159.3 13.62 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 124.805 1.242 . . . . 0.0 113.399 -172.355 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -108.87 139.96 42.99 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 126.343 1.857 . . . . 0.0 108.65 169.752 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 4.2 m -129.55 148.83 33.23 Favored 'Isoleucine or valine' 0 C--O 1.234 0.273 0 CA-C-N 119.53 1.059 . . . . 0.0 111.067 -177.196 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 85.1 m -136.39 136.8 39.9 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 123.151 0.581 . . . . 0.0 110.781 179.0 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 11.5 t -88.51 133.67 34.08 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 124.329 1.052 . . . . 0.0 109.435 169.174 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 23.2 p -146.6 149.41 33.48 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 114.982 1.475 . . . . 0.0 114.982 169.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -98.22 152.11 19.75 Favored Glycine 0 C--N 1.338 0.643 0 C-N-CA 124.272 0.939 . . . . 0.0 113.725 -172.615 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 10.5 mp -96.12 99.51 11.24 Favored 'General case' 0 CA--C 1.536 0.41 0 O-C-N 120.604 -1.527 . . . . 0.0 108.956 176.616 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 25.9 mt-10 63.96 26.47 14.15 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 125.243 1.417 . . . . 0.0 113.324 -171.619 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 94.6 p -151.13 167.16 28.6 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 125.248 1.419 . . . . 0.0 113.705 -169.654 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 77.6 p -129.41 169.3 15.09 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 125.398 1.479 . . . . 0.0 113.911 173.05 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.473 ' HG3' ' H ' ' A' ' 42' ' ' VAL . 5.7 tpt180 60.94 -178.86 0.11 Allowed 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 128.636 2.775 . . . . 0.0 113.589 -179.143 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.473 ' H ' ' HG3' ' A' ' 41' ' ' ARG . 20.9 m -133.37 179.51 4.34 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 C-N-CA 129.808 3.243 . . . . 0.0 107.716 172.179 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 2.6 t-80 -58.77 130.75 85.89 Favored Pre-proline 0 C--N 1.325 -0.499 0 CA-C-O 118.052 -0.975 . . . . 0.0 112.127 178.482 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_exo -58.99 -27.2 84.33 Favored 'Trans proline' 0 CA--C 1.548 1.197 0 C-N-CA 121.337 1.358 . . . . 0.0 112.154 169.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 89.9 m -64.94 -29.66 70.61 Favored 'General case' 0 N--CA 1.482 1.175 0 C-N-CA 125.698 1.599 . . . . 0.0 112.452 173.209 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -56.65 -43.47 80.35 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 124.027 0.931 . . . . 0.0 111.114 -177.878 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.7 mp -51.74 -55.01 10.47 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 C-N-CA 124.233 1.013 . . . . 0.0 110.226 -176.564 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -62.95 -32.96 74.38 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 113.111 0.782 . . . . 0.0 113.111 -179.578 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -80.72 -20.68 42.29 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 113.719 1.007 . . . . 0.0 113.719 178.326 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 4.5 mmt -85.87 -32.51 21.64 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 119.54 1.064 . . . . 0.0 110.344 169.74 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -66.72 -15.75 63.75 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.953 1.301 . . . . 0.0 113.97 175.131 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 -62.29 -26.54 68.46 Favored 'General case' 0 N--CA 1.481 1.1 0 CA-C-N 120.367 1.439 . . . . 0.0 110.895 168.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 59.4 t -95.02 -5.77 10.24 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.82 0 C-N-CA 127.318 2.247 . . . . 0.0 111.348 175.613 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 80.22 18.4 71.83 Favored Glycine 0 CA--C 1.539 1.551 0 C-N-CA 125.165 1.364 . . . . 0.0 114.575 -174.65 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 94.6 mt -75.96 134.38 29.21 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 C-N-CA 124.843 1.257 . . . . 0.0 111.22 -176.727 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 21.8 t0 -94.68 108.71 20.69 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 123.231 0.612 . . . . 0.0 112.337 172.241 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 15.7 pt -129.82 12.68 2.39 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 C-N-CA 125.142 1.377 . . . . 0.0 113.284 169.641 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 72.5 m -69.67 138.24 52.82 Favored 'General case' 0 N--CA 1.47 0.57 0 O-C-N 120.603 -1.311 . . . . 0.0 111.93 -175.815 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 73.97 3.37 64.15 Favored Glycine 0 CA--C 1.537 1.429 0 N-CA-C 116.047 1.179 . . . . 0.0 116.047 176.468 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 9.2 pt20 -77.77 135.23 37.96 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 119.536 1.668 . . . . 0.0 110.903 177.414 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 24.1 p -77.36 -33.17 55.35 Favored 'General case' 0 N--CA 1.48 1.051 0 N-CA-C 114.853 1.427 . . . . 0.0 114.853 -173.196 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 31.8 m 47.85 54.27 10.21 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.804 1.242 . . . . 0.0 112.189 -170.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -54.04 159.02 3.12 Favored Pre-proline 0 CA--C 1.542 0.656 0 C-N-CA 124.306 1.042 . . . . 0.0 112.357 177.792 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -62.91 149.6 90.99 Favored 'Trans proline' 0 N--CA 1.457 -0.674 0 CA-C-N 120.312 1.147 . . . . 0.0 112.927 -176.489 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 7.7 tt -51.35 -32.22 12.72 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 125.246 1.418 . . . . 0.0 111.42 173.603 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 -65.73 -17.44 64.61 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 125.545 1.538 . . . . 0.0 113.35 -179.247 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -79.75 -9.29 59.63 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 125.103 1.361 . . . . 0.0 112.9 177.93 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 77.5 m-85 -117.35 -179.07 3.61 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 126.408 1.883 . . . . 0.0 112.254 -173.498 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 5.2 t30 -123.07 128.31 49.95 Favored 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 125.56 1.544 . . . . 0.0 109.711 175.015 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.33 -35.87 81.47 Favored 'General case' 0 CA--C 1.531 0.25 0 N-CA-C 114.205 1.187 . . . . 0.0 114.205 -169.861 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . 0.263 0.0 OUTLIER -72.18 -5.71 37.57 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 114.009 1.115 . . . . 0.0 114.009 -178.226 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -75.49 -10.39 59.4 Favored 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 124.082 0.953 . . . . 0.0 111.331 168.648 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 68.1 m-85 -116.55 145.09 43.6 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 127.167 2.187 . . . . 0.0 111.882 179.635 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -93.57 -26.25 17.2 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.892 1.277 . . . . 0.0 112.202 179.489 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 68.9 t -137.09 139.69 43.86 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 C-N-CA 126.99 2.116 . . . . 0.0 107.953 -169.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 61.0 t -130.9 126.39 59.78 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 170.268 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 45.5 mm -112.55 105.63 19.17 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 C-N-CA 125.331 1.452 . . . . 0.0 109.407 -177.137 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 9.5 m -84.44 117.93 23.96 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 123.976 0.91 . . . . 0.0 110.305 170.275 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 1.4 pp -130.91 168.93 16.5 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 125.79 1.636 . . . . 0.0 110.182 176.428 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER 65.84 -27.42 0.11 Allowed 'General case' 0 CA--C 1.553 1.075 0 C-N-CA 126.753 2.021 . . . . 0.0 114.982 -169.45 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -170.78 -173.09 37.68 Favored Glycine 0 CA--C 1.536 1.359 0 C-N-CA 126.395 1.95 . . . . 0.0 112.328 174.521 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 74.9 m -76.84 149.83 36.14 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.96 0.904 . . . . 0.0 112.51 -178.739 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -76.67 63.29 3.09 Favored Glycine 0 CA--C 1.535 1.336 0 C-N-CA 125.01 1.291 . . . . 0.0 113.625 176.461 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 58.2 t -105.09 -38.33 4.62 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.129 0 C-N-CA 124.284 1.034 . . . . 0.0 112.659 -176.284 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 62.7 t30 -91.31 33.16 0.99 Allowed 'General case' 0 CA--C 1.55 0.951 0 N-CA-C 113.344 0.868 . . . . 0.0 113.344 -178.772 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.1 pp -126.83 156.82 73.23 Favored Pre-proline 0 CA--C 1.55 0.976 0 C-N-CA 126.32 1.848 . . . . 0.0 111.853 172.41 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -61.65 149.0 91.74 Favored 'Trans proline' 0 CA--C 1.545 1.031 0 C-N-CA 122.315 2.01 . . . . 0.0 113.906 -179.581 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_exo -57.63 -26.03 70.55 Favored 'Trans proline' 0 C--N 1.354 0.827 0 C-N-CA 123.596 2.864 . . . . 0.0 115.244 -176.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -62.12 -22.8 66.13 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 113.695 0.998 . . . . 0.0 113.695 176.086 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 89.5 m95 -82.52 -28.65 30.95 Favored 'General case' 0 N--CA 1.473 0.681 0 O-C-N 120.821 -1.175 . . . . 0.0 113.193 176.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 6.4 m -80.25 -14.11 13.01 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.256 0 CA-C-N 119.232 0.924 . . . . 0.0 113.24 174.167 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -96.52 0.09 49.66 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 114.95 1.463 . . . . 0.0 114.95 -178.467 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 80.6 mm-40 -65.63 157.13 30.75 Favored 'General case' 0 N--CA 1.479 1.011 0 O-C-N 120.87 -1.144 . . . . 0.0 111.865 171.239 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -55.19 -42.54 73.37 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 114.392 1.256 . . . . 0.0 114.392 -167.872 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 14.0 mm -119.82 64.43 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 C-N-CA 124.63 1.172 . . . . 0.0 109.412 176.753 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 14.9 t80 -77.2 108.29 10.2 Favored 'General case' 0 CA--C 1.536 0.413 0 O-C-N 120.492 -1.38 . . . . 0.0 108.063 169.246 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -109.32 144.29 37.69 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 113.217 0.821 . . . . 0.0 113.217 172.788 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -121.42 115.54 23.09 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 124.13 0.972 . . . . 0.0 109.732 169.413 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 45.5 m0 -93.16 -19.78 21.13 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 113.903 1.075 . . . . 0.0 113.903 -169.859 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 66.5 mm-40 53.25 29.92 9.22 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 125.218 1.407 . . . . 0.0 113.177 -175.721 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.3 tt -80.83 132.73 35.5 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 125.428 1.491 . . . . 0.0 109.676 -174.599 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -65.74 151.98 45.34 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 113.131 0.789 . . . . 0.0 113.131 -179.43 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -92.9 148.82 36.61 Favored Pre-proline 0 CA--C 1.548 0.886 0 O-C-N 121.772 -0.58 . . . . 0.0 111.106 171.345 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -62.42 -19.19 66.63 Favored 'Trans proline' 0 CA--C 1.548 1.204 0 C-N-CA 122.779 2.32 . . . . 0.0 115.3 173.001 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -49.32 130.83 20.03 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 125.281 1.432 . . . . 0.0 114.582 175.761 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 79.29 7.95 88.13 Favored Glycine 0 CA--C 1.535 1.312 0 C-N-CA 124.736 1.16 . . . . 0.0 114.914 175.625 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 10.5 pt20 -143.36 173.2 11.82 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 125.098 1.359 . . . . 0.0 113.117 -177.122 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 26.5 p -68.3 167.46 14.41 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 116.61 2.078 . . . . 0.0 116.61 -168.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 41.7 tp -59.42 -30.8 68.73 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.516 1.126 . . . . 0.0 112.288 170.073 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -66.88 -31.76 72.57 Favored 'General case' 0 N--CA 1.47 0.536 0 O-C-N 120.818 -1.176 . . . . 0.0 111.487 173.849 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 7.6 t -71.49 -33.81 50.92 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 O-C-N 121.172 -0.955 . . . . 0.0 111.687 169.867 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -57.52 -48.34 79.55 Favored 'General case' 0 N--CA 1.477 0.893 0 CA-C-N 120.041 1.291 . . . . 0.0 111.261 169.34 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 2.8 mpt_? -63.35 -40.58 97.68 Favored 'General case' 0 N--CA 1.484 1.261 0 O-C-N 121.473 -0.767 . . . . 0.0 112.066 175.873 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 28.0 m -58.81 -46.5 87.45 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 124.095 0.958 . . . . 0.0 111.175 173.659 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 54.4 t -64.57 -43.19 96.77 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 CA-C-O 117.522 -1.228 . . . . 0.0 110.514 177.621 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 67.5 mtm-85 -57.3 -43.62 83.4 Favored 'General case' 0 N--CA 1.484 1.264 0 CA-C-N 121.076 1.762 . . . . 0.0 112.528 173.738 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -61.83 -51.21 58.79 Favored Glycine 0 CA--C 1.538 1.479 0 CA-C-N 119.046 0.839 . . . . 0.0 112.914 177.113 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 58.9 mm-40 -62.29 -45.36 93.6 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 123.742 0.817 . . . . 0.0 111.754 177.751 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 58.7 t -65.41 -40.59 88.84 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 C-N-CA 124.62 1.168 . . . . 0.0 111.375 178.342 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 82.3 tttt -56.02 -50.07 71.91 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 120.337 1.426 . . . . 0.0 110.131 177.594 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -62.81 -41.19 99.19 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 112.68 0.622 . . . . 0.0 112.68 176.64 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.77 -34.49 73.85 Favored 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 113.858 1.058 . . . . 0.0 113.858 -179.864 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 98.6 t -78.3 -38.53 23.3 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 C-N-CA 125.17 1.388 . . . . 0.0 110.926 175.744 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -62.3 -41.21 98.32 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 119.041 0.837 . . . . 0.0 111.506 171.661 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 15.2 m-80 -64.43 -42.13 96.18 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 119.249 0.931 . . . . 0.0 112.462 173.722 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -54.77 -57.23 12.38 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.234 0.614 . . . . 0.0 110.26 174.149 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 77.5 mt -63.32 -45.38 98.34 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 CA-C-O 118.995 -0.526 . . . . 0.0 111.251 -177.237 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -68.91 -10.84 59.31 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 114.222 1.193 . . . . 0.0 114.222 177.632 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 70.2 tttt -92.61 -45.63 7.99 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 125.425 1.49 . . . . 0.0 111.29 174.422 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 18.7 pt -91.89 -18.86 7.15 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 N-CA-C 114.41 1.263 . . . . 0.0 114.41 -174.257 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 73.7 m . . . . . 0 C--O 1.254 1.31 0 C-N-CA 125.783 1.633 . . . . 0.0 111.188 -175.878 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.8 ttt . . . . . 0 N--CA 1.503 2.183 0 N-CA-C 111.563 0.209 . . . . 0.0 111.563 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.9 164.35 30.33 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 125.061 1.344 . . . . 0.0 112.907 174.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 75.3 mttt -93.75 145.61 24.46 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 124.206 1.002 . . . . 0.0 112.193 177.269 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 21.5 t -129.06 131.57 67.91 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 125.569 1.548 . . . . 0.0 112.318 178.43 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 47.0 tpp -98.35 132.37 43.88 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 168.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 42.6 m-85 -115.61 127.32 55.13 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 124.441 1.096 . . . . 0.0 109.645 173.142 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 5.7 m -149.16 163.94 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 C-N-CA 124.398 1.079 . . . . 0.0 112.891 -169.779 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 47.1 t -132.25 165.52 23.96 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 127.312 2.245 . . . . 0.0 109.384 169.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -52.96 -37.6 61.26 Favored 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 124.547 1.139 . . . . 0.0 112.741 -178.529 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 82.3 mtt180 -141.18 150.73 43.11 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 127.203 2.201 . . . . 0.0 109.822 169.028 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 24.0 t30 -110.15 -27.11 9.31 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 124.341 1.056 . . . . 0.0 113.746 -173.222 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 60.5 m -56.29 126.54 26.69 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 118.769 0.713 . . . . 0.0 110.461 177.662 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 68.3 m 50.36 36.81 13.85 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 124.798 1.239 . . . . 0.0 113.945 -176.459 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -121.98 143.25 49.59 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 125.778 1.631 . . . . 0.0 109.478 171.082 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 15.8 m -97.02 -33.17 11.65 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 114.742 1.386 . . . . 0.0 114.742 -170.334 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 5.2 mt-30 60.75 -55.88 0.09 Allowed 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 128.578 2.751 . . . . 0.0 116.648 171.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 69.86 -42.67 0.52 Allowed 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 127.929 2.492 . . . . 0.0 117.498 169.599 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -59.9 -33.21 71.55 Favored 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 113.858 1.059 . . . . 0.0 113.858 -170.406 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.9 pm0 -61.56 -42.47 98.89 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.658 1.183 . . . . 0.0 112.275 173.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -68.75 -38.95 86.19 Favored Glycine 0 C--N 1.336 0.563 0 O-C-N 121.557 -0.715 . . . . 0.0 111.59 178.607 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -70.05 -41.65 73.91 Favored 'General case' 0 C--O 1.221 -0.414 0 O-C-N 121.834 -0.804 . . . . 0.0 111.258 175.865 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -60.16 -41.9 93.79 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 119.467 1.031 . . . . 0.0 113.008 -175.736 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 10.3 pttp -76.78 -29.28 55.99 Favored 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 113.502 0.927 . . . . 0.0 113.502 173.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 83.7 m -71.66 -31.29 66.65 Favored 'General case' 0 N--CA 1.485 1.281 0 O-C-N 121.585 -0.697 . . . . 0.0 111.842 175.241 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 78.2 mt -91.57 -30.82 16.17 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 125.923 1.689 . . . . 0.0 114.123 179.827 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -142.89 26.36 2.22 Favored Glycine 0 N--CA 1.475 1.292 0 N-CA-C 118.233 2.053 . . . . 0.0 118.233 -169.086 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -66.27 -20.3 66.07 Favored 'General case' 0 CA--C 1.547 0.833 0 CA-C-N 122.016 2.908 . . . . 0.0 114.952 -178.578 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -76.4 -4.18 79.21 Favored Glycine 0 CA--C 1.541 1.675 0 O-C-N 121.235 -0.916 . . . . 0.0 113.757 169.368 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -118.11 -40.94 2.91 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 127.178 2.191 . . . . 0.0 112.513 -175.536 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 29.4 pt -141.38 154.93 20.56 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 C-N-CA 125.919 1.687 . . . . 0.0 112.168 -175.103 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -97.3 137.53 36.17 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 123.872 0.869 . . . . 0.0 109.702 169.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 84.0 t -122.14 140.22 46.71 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 CA-C-N 118.996 0.817 . . . . 0.0 111.542 -178.769 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 20.4 m -135.68 151.2 49.95 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 124.923 1.289 . . . . 0.0 109.31 173.331 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 77.9 p -133.06 147.73 52.2 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 122.308 1.051 . . . . 0.0 110.913 168.32 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 88.7 p -144.2 157.9 44.03 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 114.066 -1.425 . . . . 0.0 112.461 -174.478 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -79.07 167.67 52.72 Favored Glycine 0 CA--C 1.527 0.818 0 N-CA-C 111.166 -0.774 . . . . 0.0 111.166 169.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 9.2 mp -100.91 -16.91 17.05 Favored 'General case' 0 N--CA 1.484 1.237 0 CA-C-N 120.27 2.035 . . . . 0.0 112.164 169.559 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -138.36 170.02 16.75 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 129.587 3.155 . . . . 0.0 107.095 172.331 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 69.0 m -57.46 110.17 0.82 Allowed 'General case' 0 N--CA 1.48 1.061 0 CA-C-N 119.759 1.163 . . . . 0.0 111.112 -178.461 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 91.2 p -158.51 175.02 14.21 Favored 'General case' 0 N--CA 1.478 0.966 0 N-CA-C 115.673 1.731 . . . . 0.0 115.673 -169.145 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 15.3 tpt180 -139.79 145.01 37.67 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 128.398 2.679 . . . . 0.0 108.852 171.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 35.5 m -56.21 163.98 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 CA-C-O 122.761 1.267 . . . . 0.0 111.155 169.598 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 1.6 t-80 -48.86 127.05 14.09 Favored Pre-proline 0 C--N 1.323 -0.543 0 CA-C-N 114.05 -1.432 . . . . 0.0 112.965 172.354 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_exo -60.64 -28.68 86.99 Favored 'Trans proline' 0 CA--C 1.542 0.907 0 CA-C-N 120.54 1.229 . . . . 0.0 111.904 171.497 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 88.6 m -65.6 -29.72 70.35 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 125.213 1.405 . . . . 0.0 112.238 173.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.32 -39.69 87.96 Favored 'General case' 0 N--CA 1.471 0.582 0 O-C-N 121.108 -0.995 . . . . 0.0 112.089 -175.714 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.9 mp -57.83 -56.03 18.09 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 -177.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.53 -33.62 76.33 Favored 'General case' 0 CA--C 1.542 0.656 0 N-CA-C 113.378 0.881 . . . . 0.0 113.378 -178.004 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -79.95 -21.19 44.07 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 114.13 1.159 . . . . 0.0 114.13 178.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -90.74 -28.01 18.57 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 118.96 0.8 . . . . 0.0 110.306 172.092 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -66.07 -13.12 59.47 Favored 'General case' 0 CA--C 1.543 0.692 0 O-C-N 120.641 -1.287 . . . . 0.0 113.247 171.248 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 13.3 mt-10 -61.41 -27.49 68.58 Favored 'General case' 0 N--CA 1.48 1.059 0 CA-C-N 120.233 1.378 . . . . 0.0 110.464 168.665 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 35.7 t -96.45 -2.29 10.4 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.032 0 C-N-CA 127.581 2.353 . . . . 0.0 111.135 176.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 78.93 21.26 68.66 Favored Glycine 0 CA--C 1.538 1.53 0 C-N-CA 125.35 1.452 . . . . 0.0 114.742 -176.606 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 77.8 mt -83.6 131.07 34.71 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 C-N-CA 124.798 1.239 . . . . 0.0 112.006 -171.436 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 19.4 t0 -96.06 107.14 19.41 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 112.895 0.702 . . . . 0.0 112.895 -178.616 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 15.6 pt -142.68 23.06 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.208 0 C-N-CA 125.302 1.441 . . . . 0.0 114.369 -177.286 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 95.2 p -48.15 -37.34 15.34 Favored 'General case' 0 N--CA 1.483 1.201 0 N-CA-C 116.567 2.062 . . . . 0.0 116.567 -169.341 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -142.97 40.04 1.28 Allowed Glycine 0 N--CA 1.474 1.179 0 C-N-CA 125.358 1.456 . . . . 0.0 113.01 -179.371 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 24.3 pt20 -66.5 -34.68 78.45 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 115.637 1.717 . . . . 0.0 115.637 -169.529 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 68.0 p -93.65 104.17 16.29 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 121.211 0.529 . . . . 0.0 111.352 173.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 95.9 p -108.94 -23.55 11.66 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 125.473 1.509 . . . . 0.0 114.278 178.316 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -145.46 155.34 53.53 Favored Pre-proline 0 CA--C 1.544 0.722 0 C-N-CA 124.722 1.209 . . . . 0.0 111.046 -171.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -74.37 155.13 46.07 Favored 'Trans proline' 0 CA--C 1.538 0.714 0 C-N-CA 122.561 2.174 . . . . 0.0 112.657 173.257 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 5.6 tt -54.44 -38.65 41.77 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 126.171 1.788 . . . . 0.0 111.615 179.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -68.34 -8.6 41.37 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 124.56 1.144 . . . . 0.0 113.763 178.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 -79.92 -21.73 43.54 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 124.085 0.954 . . . . 0.0 112.824 170.71 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 84.6 m-85 -93.62 -176.73 4.17 Favored 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 126.444 1.897 . . . . 0.0 111.879 -179.354 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 7.0 t30 -113.84 129.19 56.62 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 125.783 1.633 . . . . 0.0 109.695 171.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -69.38 -36.9 77.26 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 113.918 1.081 . . . . 0.0 113.918 -175.517 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . 0.272 0.0 OUTLIER -72.07 -7.82 51.11 Favored 'General case' 0 CA--C 1.544 0.744 0 N-CA-C 114.562 1.319 . . . . 0.0 114.562 -173.077 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -65.1 -26.35 68.18 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 123.664 0.786 . . . . 0.0 110.449 168.295 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 55.5 m-85 -108.4 120.75 43.31 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 125.834 1.654 . . . . 0.0 111.44 -173.307 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -74.0 -20.87 60.19 Favored 'General case' 0 CA--C 1.545 0.776 0 CA-C-O 122.195 0.998 . . . . 0.0 112.473 177.55 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 92.3 t -133.95 137.84 51.5 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 C-N-CA 127.381 2.272 . . . . 0.0 108.891 -173.407 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 63.0 t -133.91 118.61 29.65 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 169.685 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 44.8 mm -103.09 113.16 39.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 C-N-CA 123.818 0.847 . . . . 0.0 109.299 -177.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 15.5 m -92.78 114.12 26.59 Favored 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 169.531 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 90.7 mt -86.79 -3.16 59.02 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 125.644 1.577 . . . . 0.0 115.217 -169.548 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 77.5 m -130.34 40.32 3.54 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 125.359 1.463 . . . . 0.0 110.553 -169.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 80.51 -131.72 10.7 Favored Glycine 0 CA--C 1.532 1.109 0 C-N-CA 124.371 0.986 . . . . 0.0 111.174 -169.49 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 93.3 p -63.71 154.49 32.98 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 124.015 0.926 . . . . 0.0 113.479 176.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -75.35 -51.42 7.43 Favored Glycine 0 CA--C 1.534 1.269 0 O-C-N 121.739 -0.601 . . . . 0.0 112.339 176.009 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . 0.273 7.7 p 48.97 -47.54 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.677 1 C-N-CA 132.148 4.179 . . . . 0.0 119.021 169.883 . . . . . . . . 3 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 63.1 t30 -85.9 15.95 4.51 Favored 'General case' 0 CA--C 1.556 1.202 0 C-N-CA 126.734 2.014 . . . . 0.0 112.761 -179.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -122.87 160.45 49.13 Favored Pre-proline 0 CA--C 1.55 0.98 0 C-N-CA 127.589 2.356 . . . . 0.0 112.598 179.605 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -63.34 151.61 84.04 Favored 'Trans proline' 0 CA--C 1.546 1.084 0 C-N-CA 122.774 2.316 . . . . 0.0 113.948 178.721 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_exo -58.82 -27.05 82.8 Favored 'Trans proline' 0 C--N 1.352 0.728 0 C-N-CA 123.609 2.873 . . . . 0.0 115.309 -177.108 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -61.72 -21.24 64.32 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 113.74 1.015 . . . . 0.0 113.74 177.763 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 92.7 m95 -83.73 -28.95 27.88 Favored 'General case' 0 N--CA 1.474 0.733 0 O-C-N 120.83 -1.168 . . . . 0.0 113.318 177.32 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 6.4 m -82.88 -13.37 12.08 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.315 0 N-CA-C 113.36 0.874 . . . . 0.0 113.36 174.41 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -95.31 1.46 54.42 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 114.603 1.334 . . . . 0.0 114.603 -179.33 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 85.6 mm-40 -66.39 156.31 34.94 Favored 'General case' 0 N--CA 1.481 1.081 0 O-C-N 120.83 -1.169 . . . . 0.0 111.596 172.005 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -59.49 -42.54 92.37 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 114.196 1.184 . . . . 0.0 114.196 -168.183 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 16.3 mm -113.21 55.44 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 C-N-CA 125.083 1.353 . . . . 0.0 109.276 177.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 25.1 t80 -74.66 109.19 7.93 Favored 'General case' 0 CA--C 1.536 0.414 0 O-C-N 120.565 -1.334 . . . . 0.0 107.675 169.009 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 13.8 mt-10 -110.95 131.36 55.12 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 114.432 1.271 . . . . 0.0 114.432 176.657 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 12.5 p-10 -94.74 104.69 16.61 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 126.128 1.771 . . . . 0.0 110.053 169.214 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 34.2 m0 -93.35 124.56 37.42 Favored 'General case' 0 N--CA 1.464 0.236 0 C-N-CA 124.183 0.993 . . . . 0.0 109.089 174.703 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 32.5 mt-30 -91.95 42.3 1.1 Allowed 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 124.012 0.925 . . . . 0.0 111.574 -173.324 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 76.1 mt -81.28 164.07 22.5 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 125.271 1.428 . . . . 0.0 112.695 -178.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -87.2 163.74 16.75 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 124.901 1.28 . . . . 0.0 111.221 169.106 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -108.3 139.6 20.91 Favored Pre-proline 0 N--CA 1.474 0.755 0 O-C-N 121.33 -0.856 . . . . 0.0 110.526 169.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_exo -59.9 -17.13 42.27 Favored 'Trans proline' 0 CA--C 1.545 1.028 0 C-N-CA 123.006 2.471 . . . . 0.0 116.392 176.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -54.41 135.44 45.28 Favored 'General case' 0 CA--C 1.546 0.816 0 CA-C-N 120.13 1.332 . . . . 0.0 113.924 178.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 76.54 6.74 84.86 Favored Glycine 0 CA--C 1.538 1.48 0 C-N-CA 124.461 1.029 . . . . 0.0 115.007 178.453 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 -138.05 170.47 15.98 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 125.473 1.509 . . . . 0.0 113.033 -179.459 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 26.4 p -68.07 168.56 11.77 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 117.461 2.393 . . . . 0.0 117.461 -168.524 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 25.0 tp -60.18 -30.09 69.13 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 125.097 1.359 . . . . 0.0 112.483 169.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -65.58 -31.54 72.64 Favored 'General case' 0 CA--C 1.539 0.523 0 O-C-N 121.038 -1.039 . . . . 0.0 111.259 171.684 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 11.4 t -74.16 -38.52 48.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 CA-C-O 118.154 -0.927 . . . . 0.0 112.14 171.104 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 17.1 m-85 -56.25 -44.08 79.33 Favored 'General case' 0 N--CA 1.482 1.134 0 CA-C-N 120.698 1.59 . . . . 0.0 111.74 169.588 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -69.49 -37.5 77.26 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 124.351 1.06 . . . . 0.0 112.408 178.182 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 21.6 m -60.46 -48.04 83.48 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 124.507 1.123 . . . . 0.0 111.201 170.362 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 75.1 t -65.52 -43.52 94.28 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 CA-C-O 118.181 -0.914 . . . . 0.0 110.236 179.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 16.8 mtp180 -53.5 -45.48 69.69 Favored 'General case' 0 N--CA 1.481 1.118 0 CA-C-N 119.914 1.234 . . . . 0.0 112.716 172.091 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -60.57 -51.34 59.34 Favored Glycine 0 CA--C 1.538 1.482 0 CA-C-N 119.431 1.014 . . . . 0.0 113.218 176.432 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 58.9 mm-40 -63.37 -45.09 92.76 Favored 'General case' 0 N--CA 1.472 0.653 0 O-C-N 121.978 -0.719 . . . . 0.0 111.912 178.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 50.5 t -63.83 -41.72 93.48 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 C-N-CA 124.881 1.272 . . . . 0.0 111.237 177.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 78.1 tttt -56.77 -48.02 78.83 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 119.832 1.196 . . . . 0.0 110.425 178.407 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -64.35 -42.31 96.29 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 112.641 0.608 . . . . 0.0 112.641 177.523 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 16.6 mmm180 -61.14 -45.59 94.03 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.393 0.677 . . . . 0.0 112.696 175.144 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 79.3 t -69.45 -41.05 80.55 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 C-N-CA 124.5 1.12 . . . . 0.0 111.157 -179.392 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -62.51 -40.0 95.32 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 118.875 0.761 . . . . 0.0 111.647 172.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 13.0 m-80 -64.02 -46.11 85.95 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-N 118.782 0.719 . . . . 0.0 112.236 174.123 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -54.05 -54.78 34.53 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 124.734 1.213 . . . . 0.0 110.499 175.272 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 91.4 mt -59.88 -45.11 95.41 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 CA-C-O 119.024 -0.512 . . . . 0.0 110.393 179.255 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -68.83 -10.77 58.67 Favored 'General case' 0 CA--C 1.548 0.871 0 N-CA-C 115.245 1.572 . . . . 0.0 115.245 -179.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 21.4 ptmt -102.49 -24.18 13.84 Favored 'General case' 0 N--CA 1.479 1.01 0 N-CA-C 113.91 1.078 . . . . 0.0 113.91 171.271 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 14.7 pt -96.65 -7.97 9.4 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 N-CA-C 114.435 1.272 . . . . 0.0 114.435 176.179 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 83.4 p . . . . . 0 C--O 1.255 1.35 0 C-N-CA 125.075 1.35 . . . . 0.0 114.269 173.526 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.1 ttp . . . . . 0 N--CA 1.502 2.172 0 N-CA-C 112.087 0.403 . . . . 0.0 112.087 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 3.3 mptp? -86.03 159.91 19.46 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 124.602 1.161 . . . . 0.0 113.113 171.003 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 79.3 mttt -112.14 113.21 25.34 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 125.816 1.646 . . . . 0.0 106.577 167.671 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 18.9 t -102.91 132.5 48.95 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 C-N-CA 125.793 1.637 . . . . 0.0 113.579 -178.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 36.6 tpp -107.05 119.86 40.53 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.567 0.747 . . . . 0.0 109.266 168.552 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 60.1 m-85 -97.16 125.08 41.42 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.232 1.013 . . . . 0.0 109.533 171.476 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -140.99 147.78 22.25 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 N-CA-C 114.179 1.177 . . . . 0.0 114.179 -168.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 52.7 t -157.55 164.72 37.03 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 126.189 1.795 . . . . 0.0 112.417 172.298 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 53.4 mtmt -75.08 154.92 37.67 Favored 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 125.753 1.621 . . . . 0.0 112.628 171.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 6.4 tmm_? 49.3 84.45 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 127.377 2.271 . . . . 0.0 112.661 175.618 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 30.2 t-20 -79.69 -25.27 41.26 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 124.62 1.168 . . . . 0.0 113.132 -171.738 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 78.2 p -58.3 141.68 50.29 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.208 1.003 . . . . 0.0 111.567 170.092 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 66.9 m 56.23 -4.26 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.325 0 N-CA-C 116.647 2.091 . . . . 0.0 116.647 -170.598 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 58.8 ttm-85 -92.37 138.57 31.41 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 124.886 1.274 . . . . 0.0 113.372 -170.131 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 45.5 m -96.17 -38.16 10.26 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 114.578 1.325 . . . . 0.0 114.578 -176.64 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 60.82 -46.75 0.11 Allowed 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 127.622 2.369 . . . . 0.0 116.271 -177.132 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' MET . . . . . 0.402 ' HG2' ' SD ' ' A' ' 50' ' ' MET . 0.0 OUTLIER 66.67 -50.54 0.45 Allowed 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 127.771 2.429 . . . . 0.0 116.579 169.619 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -56.17 -37.13 69.13 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 115.584 1.698 . . . . 0.0 115.584 -169.132 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.89 -34.94 77.62 Favored 'General case' 0 N--CA 1.476 0.864 0 O-C-N 121.412 -0.805 . . . . 0.0 112.774 -177.162 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -69.87 -42.83 68.53 Favored Glycine 0 N--CA 1.468 0.813 0 C-N-CA 123.692 0.663 . . . . 0.0 111.764 176.371 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -64.39 -36.94 85.79 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 117.884 0.842 . . . . 0.0 111.313 170.79 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -65.32 -39.12 92.03 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 119.449 1.022 . . . . 0.0 112.663 179.586 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 23.7 mtpp -62.05 -46.62 88.33 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 123.314 0.645 . . . . 0.0 110.978 169.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 69.6 m -68.15 -38.09 81.75 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 123.12 0.568 . . . . 0.0 112.245 -174.448 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 47.7 mt -85.49 -35.46 21.16 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 125.416 1.487 . . . . 0.0 113.362 -179.445 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -117.29 5.15 17.68 Favored Glycine 0 CA--C 1.528 0.867 0 N-CA-C 118.214 2.046 . . . . 0.0 118.214 -168.737 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -60.81 139.48 57.92 Favored 'General case' 0 CA--C 1.545 0.784 0 CA-C-N 122.064 2.932 . . . . 0.0 111.959 177.316 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 88.68 -21.38 26.56 Favored Glycine 0 CA--C 1.54 1.649 0 C-N-CA 124.797 1.189 . . . . 0.0 113.233 -169.206 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 72.4 mttt -101.77 -42.22 6.25 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 126.302 1.841 . . . . 0.0 112.015 169.531 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 36.0 pt -135.12 146.11 30.92 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 C-N-CA 124.676 1.19 . . . . 0.0 113.126 -178.566 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -98.58 145.77 26.49 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 126.685 1.994 . . . . 0.0 108.337 169.197 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 71.3 t -141.38 139.01 32.9 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 O-C-N 121.781 -0.575 . . . . 0.0 112.435 -169.696 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 31.7 m -136.9 159.2 42.57 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 126.198 1.799 . . . . 0.0 108.745 169.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 26.5 p -133.98 148.55 51.15 Favored 'General case' 0 CA--C 1.515 -0.368 0 CA-C-O 121.742 0.782 . . . . 0.0 111.896 168.086 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 59.9 p -147.58 153.81 39.89 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 114.806 -1.088 . . . . 0.0 113.312 176.212 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -83.22 152.97 30.1 Favored Glycine 0 N--CA 1.473 1.138 0 O-C-N 121.735 -0.603 . . . . 0.0 111.987 173.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.4 mp -76.23 -20.43 57.45 Favored 'General case' 0 N--CA 1.481 1.088 0 CA-C-N 119.126 1.463 . . . . 0.0 113.973 176.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -138.31 -52.42 0.6 Allowed 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.934 0.893 . . . . 0.0 113.31 177.226 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 50.2 p -98.93 150.57 21.8 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 115.106 1.521 . . . . 0.0 115.106 -172.403 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 80.5 p -84.81 149.21 25.87 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 125.818 1.647 . . . . 0.0 114.23 -174.497 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 13.2 tpt180 57.61 137.58 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 129.483 3.113 . . . . 0.0 116.045 -178.662 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 15.6 m -67.49 156.48 6.79 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.354 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 168.695 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . 0.437 ' CE1' ' HB ' ' A' ' 45' ' ' THR 0.255 0.0 OUTLIER -68.19 140.18 92.98 Favored Pre-proline 0 CA--C 1.546 0.793 0 C-N-CA 118.188 -1.405 . . . . 0.0 110.943 178.08 . . . . . . . . 4 4 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -63.81 -31.01 68.69 Favored 'Trans proline' 0 CA--C 1.539 0.732 0 C-N-CA 123.254 2.636 . . . . 0.0 114.84 -168.291 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.437 ' HB ' ' CE1' ' A' ' 43' ' ' HIS . 51.7 m -65.46 -24.64 67.22 Favored 'General case' 0 N--CA 1.48 1.062 0 O-C-N 121.404 -0.81 . . . . 0.0 111.787 -176.334 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -50.51 -48.44 57.05 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.11 0.964 . . . . 0.0 111.67 169.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 4.7 mp -55.39 -53.26 37.61 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 CA-C-N 119.433 1.015 . . . . 0.0 111.015 -176.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -62.81 -25.55 68.3 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 113.648 0.981 . . . . 0.0 113.648 -177.709 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -81.08 -35.19 32.05 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 123.644 0.778 . . . . 0.0 112.808 174.859 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' MET . . . . . 0.402 ' SD ' ' HG2' ' A' ' 17' ' ' MET . 4.5 mmt -72.49 -29.76 63.93 Favored 'General case' 0 N--CA 1.473 0.707 0 O-C-N 121.129 -0.982 . . . . 0.0 111.13 172.219 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -67.41 -9.08 38.2 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 125.339 1.456 . . . . 0.0 113.816 172.189 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -69.02 -29.74 67.96 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-N 120.325 1.421 . . . . 0.0 110.857 169.526 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . 0.295 2.2 p -109.66 8.25 8.95 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.815 0 C-N-CA 127.189 2.196 . . . . 0.0 111.955 -172.475 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 85.84 14.08 68.2 Favored Glycine 0 CA--C 1.538 1.497 0 C-N-CA 124.855 1.217 . . . . 0.0 115.369 171.673 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -76.19 138.39 20.83 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 C-N-CA 124.625 1.17 . . . . 0.0 109.698 -178.335 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 19.6 t0 -110.55 104.37 13.08 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 124.272 1.029 . . . . 0.0 111.767 175.088 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 21.4 pt -133.75 6.33 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.248 0 N-CA-C 116.289 1.959 . . . . 0.0 116.289 -175.727 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 72.3 m -60.21 -31.43 70.16 Favored 'General case' 0 N--CA 1.483 1.214 0 CA-C-N 120.438 1.472 . . . . 0.0 111.662 175.207 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -79.35 14.78 14.65 Favored Glycine 0 CA--C 1.539 1.559 0 C-N-CA 126.193 1.854 . . . . 0.0 115.934 175.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 70.6 mt-30 -62.38 157.21 20.46 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 119.434 1.617 . . . . 0.0 110.429 169.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 7.6 t -74.86 172.89 11.4 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 121.538 0.685 . . . . 0.0 112.061 169.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 73.4 m -118.09 -18.53 9.36 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 125.098 1.359 . . . . 0.0 114.211 -174.185 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 27.3 m-20 -86.11 158.68 55.29 Favored Pre-proline 0 CA--C 1.55 0.949 0 N-CA-C 114.691 1.367 . . . . 0.0 114.691 -169.703 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -63.98 160.91 35.38 Favored 'Trans proline' 0 C--N 1.353 0.787 0 C-N-CA 124.001 3.134 . . . . 0.0 114.371 172.268 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 8.4 tt -51.5 -36.47 17.93 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 C-N-CA 125.622 1.569 . . . . 0.0 112.103 173.092 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 17.8 mt-10 -65.0 -16.77 63.81 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.598 1.159 . . . . 0.0 112.825 -177.511 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -83.26 -8.18 59.49 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 124.815 1.246 . . . . 0.0 113.565 -178.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 69.7 m-85 -116.77 -175.44 2.77 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 126.221 1.808 . . . . 0.0 112.614 -172.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 11.2 t30 -120.69 125.81 48.61 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 125.603 1.561 . . . . 0.0 110.026 177.613 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -69.13 -35.4 76.34 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 114.021 1.119 . . . . 0.0 114.021 -173.363 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . 0.275 0.0 OUTLIER -71.92 -5.21 33.01 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 114.329 1.233 . . . . 0.0 114.329 -174.15 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -70.42 -25.73 63.34 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 122.968 0.507 . . . . 0.0 109.949 168.446 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 80.1 m-85 -99.23 148.67 23.88 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 126.473 1.909 . . . . 0.0 111.644 -179.205 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -107.04 -17.92 14.05 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 124.342 1.057 . . . . 0.0 112.176 176.011 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 71.7 t -129.94 137.81 55.64 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 C-N-CA 126.89 2.076 . . . . 0.0 107.959 177.454 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 60.2 t -132.93 123.46 48.48 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 169.591 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 41.5 mm -108.35 104.13 16.6 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 C-N-CA 124.496 1.119 . . . . 0.0 108.883 -176.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 3.6 m -81.78 107.48 14.54 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 169.646 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 75.4 mt -75.71 -18.72 59.51 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 114.945 1.461 . . . . 0.0 114.945 -170.062 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 28.7 p -136.66 30.81 2.83 Favored 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 114.935 1.457 . . . . 0.0 114.935 -168.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 152.03 -172.67 31.32 Favored Glycine 0 CA--C 1.532 1.096 0 N-CA-C 115.246 0.858 . . . . 0.0 115.246 177.685 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 97.0 p -79.01 160.64 27.08 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 125.295 1.438 . . . . 0.0 112.681 176.63 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -81.12 49.96 4.09 Favored Glycine 0 CA--C 1.534 1.267 0 C-N-CA 124.861 1.22 . . . . 0.0 114.951 -171.047 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 24.8 t -104.06 -33.17 3.01 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 CA-C-N 117.864 0.832 . . . . 0.0 112.88 -172.455 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 17.9 t-20 -84.84 -21.91 29.66 Favored 'General case' 0 CA--C 1.55 0.945 0 N-CA-C 113.865 1.061 . . . . 0.0 113.865 -179.239 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -82.42 160.49 62.02 Favored Pre-proline 0 CA--C 1.553 1.085 0 C-N-CA 124.0 0.92 . . . . 0.0 112.55 170.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_exo -61.47 149.75 88.23 Favored 'Trans proline' 0 CA--C 1.543 0.97 0 C-N-CA 122.79 2.327 . . . . 0.0 112.786 176.428 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -62.56 -29.04 77.87 Favored 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 122.95 2.433 . . . . 0.0 114.008 -170.356 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -60.64 -19.59 58.53 Favored 'General case' 0 CA--C 1.544 0.748 0 O-C-N 120.849 -1.157 . . . . 0.0 113.989 177.425 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 84.1 m95 -82.98 -14.71 53.53 Favored 'General case' 0 CA--C 1.542 0.662 0 O-C-N 120.659 -1.276 . . . . 0.0 113.324 175.667 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 14.5 m -93.49 -13.21 8.59 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.209 0 N-CA-C 113.729 1.011 . . . . 0.0 113.729 169.756 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 59.1 p -88.27 -5.46 58.35 Favored 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 114.48 1.289 . . . . 0.0 114.48 179.382 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 55.1 mm-40 -67.87 149.58 49.66 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-O 121.982 0.896 . . . . 0.0 110.275 169.63 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -53.88 -42.48 68.7 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 115.127 1.528 . . . . 0.0 115.127 -167.516 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 19.8 mm -117.44 63.83 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 C-N-CA 124.982 1.313 . . . . 0.0 109.232 179.21 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 33.0 t80 -76.11 111.86 11.96 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 168.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 9.0 mt-10 -108.97 130.92 55.47 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 114.15 1.167 . . . . 0.0 114.15 175.011 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 11.7 p-10 -93.89 109.7 21.4 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 125.016 1.326 . . . . 0.0 109.31 168.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 27.5 m0 -101.7 158.33 16.18 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.568 1.147 . . . . 0.0 108.943 169.627 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 8.3 mm-40 -128.41 65.84 1.39 Allowed 'General case' 0 CA--C 1.537 0.477 0 CA-C-O 122.875 1.321 . . . . 0.0 108.265 173.36 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 14.1 tp -77.11 150.63 35.61 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 126.608 1.963 . . . . 0.0 110.992 -174.344 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 29.4 tp10 -64.32 -43.01 96.01 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 113.681 0.993 . . . . 0.0 113.681 178.572 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 8.4 t0 62.88 126.39 0.02 OUTLIER Pre-proline 0 CA--C 1.558 1.257 0 C-N-CA 127.283 2.233 . . . . 0.0 113.596 -169.659 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_exo -62.61 -12.18 27.03 Favored 'Trans proline' 0 CA--C 1.55 1.301 0 C-N-CA 121.997 1.798 . . . . 0.0 114.499 172.189 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 8.6 t0 -23.99 107.47 0.03 OUTLIER 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 128.31 2.644 . . . . 0.0 116.068 169.629 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 72.16 10.59 74.08 Favored Glycine 0 CA--C 1.537 1.448 0 N-CA-C 116.379 1.312 . . . . 0.0 116.379 169.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 13.2 pt20 -128.73 166.5 18.84 Favored 'General case' 0 CA--C 1.545 0.753 0 CA-C-N 119.159 1.48 . . . . 0.0 113.999 -175.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 49.6 m -58.14 160.1 5.27 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 126.447 1.899 . . . . 0.0 115.63 -169.24 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 20.3 tp -59.41 -32.6 70.33 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.917 1.287 . . . . 0.0 113.069 178.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -61.76 -32.19 72.43 Favored 'General case' 0 N--CA 1.473 0.716 0 O-C-N 120.808 -1.183 . . . . 0.0 112.091 172.481 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 6.4 t -74.02 -37.62 47.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 CA-C-O 118.461 -0.78 . . . . 0.0 110.891 172.748 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 17.5 m-85 -57.08 -48.08 79.47 Favored 'General case' 0 N--CA 1.478 0.972 0 CA-C-N 120.273 1.397 . . . . 0.0 112.119 169.68 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 48.4 mtt-85 -60.12 -48.64 80.88 Favored 'General case' 0 N--CA 1.484 1.253 0 CA-C-N 119.185 0.902 . . . . 0.0 111.326 178.117 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 83.4 m -62.5 -46.13 89.85 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.884 0.873 . . . . 0.0 111.179 179.739 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 96.6 t -74.45 -41.19 49.58 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 CA-C-O 117.586 -1.197 . . . . 0.0 110.83 -175.307 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . 0.304 24.6 ptt85 -64.04 -28.65 69.94 Favored 'General case' 0 N--CA 1.483 1.225 0 CA-C-N 121.638 2.017 . . . . 0.0 113.12 177.487 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -65.15 -46.68 87.11 Favored Glycine 0 CA--C 1.542 1.772 0 CA-C-N 119.356 0.98 . . . . 0.0 112.938 169.279 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 15.0 mm100 -65.75 -41.32 92.25 Favored 'General case' 0 N--CA 1.475 0.824 0 O-C-N 121.387 -1.067 . . . . 0.0 112.151 177.014 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 77.7 t -60.82 -43.8 96.25 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 C-N-CA 125.416 1.487 . . . . 0.0 110.714 173.095 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 82.0 tttt -53.98 -49.68 68.24 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 119.205 0.911 . . . . 0.0 110.231 179.039 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -62.43 -41.65 98.88 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 112.742 0.645 . . . . 0.0 112.742 178.5 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 14.8 mtp85 -64.03 -43.6 95.08 Favored 'General case' 0 N--CA 1.479 1.01 0 N-CA-C 113.135 0.791 . . . . 0.0 113.135 176.024 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 94.2 t -70.91 -38.06 70.78 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 C-N-CA 123.181 0.592 . . . . 0.0 110.762 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -60.2 -38.52 83.56 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 118.613 0.642 . . . . 0.0 111.214 169.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 7.9 m-80 -62.48 -48.69 78.5 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 119.283 0.947 . . . . 0.0 112.153 174.112 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -52.89 -56.55 15.05 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.576 1.151 . . . . 0.0 110.699 174.076 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 85.4 mt -61.37 -42.15 92.59 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 O-C-N 122.017 -0.427 . . . . 0.0 111.08 -179.196 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -70.13 -13.18 62.08 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 114.755 1.391 . . . . 0.0 114.755 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -99.69 -28.5 13.15 Favored 'General case' 0 N--CA 1.479 0.998 0 N-CA-C 113.723 1.009 . . . . 0.0 113.723 172.24 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 19.1 pt -94.37 -21.43 5.84 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 N-CA-C 114.423 1.268 . . . . 0.0 114.423 177.755 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 66.6 m . . . . . 0 C--O 1.254 1.326 0 C-N-CA 125.074 1.35 . . . . 0.0 111.886 -174.085 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.8 ttt . . . . . 0 N--CA 1.503 2.196 0 N-CA-C 111.787 0.291 . . . . 0.0 111.787 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.67 161.3 30.92 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 126.336 1.855 . . . . 0.0 112.358 177.819 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 32.6 ttmt -114.5 116.49 28.91 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 107.136 -1.431 . . . . 0.0 107.136 167.73 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 16.0 t -106.17 134.6 47.27 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 C-N-CA 124.604 1.162 . . . . 0.0 114.085 -178.251 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 40.6 tpp -103.1 128.1 50.12 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 168.355 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 70.3 m-85 -108.97 131.8 54.71 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.984 0.914 . . . . 0.0 109.381 170.007 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.6 m -148.11 158.8 7.8 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.239 0 C-N-CA 124.179 0.992 . . . . 0.0 113.616 -171.666 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 35.1 t -152.31 156.48 39.72 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 126.941 2.096 . . . . 0.0 110.657 179.315 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 61.3 mtpt -72.62 138.83 47.0 Favored 'General case' 0 N--CA 1.484 1.275 0 C-N-CA 123.911 0.884 . . . . 0.0 110.42 169.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 69.9 mtp180 52.73 49.62 19.9 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 125.427 1.491 . . . . 0.0 113.571 -170.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -57.61 -26.51 61.64 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 115.134 1.531 . . . . 0.0 115.134 -176.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 77.1 p -80.2 -31.11 38.73 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 124.169 0.988 . . . . 0.0 112.857 176.725 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 16.4 m -77.79 -9.04 58.82 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.681 1.192 . . . . 0.0 112.79 173.743 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 74.6 mtt180 -131.5 157.96 42.16 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 125.491 1.516 . . . . 0.0 113.381 -169.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 71.0 m -105.22 129.74 53.53 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.979 0.912 . . . . 0.0 109.701 169.76 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 4.1 mp0 -98.67 -29.7 12.88 Favored 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 113.436 0.902 . . . . 0.0 113.436 -169.653 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' MET . . . . . 0.422 ' HG2' ' SD ' ' A' ' 50' ' ' MET . 0.0 OUTLIER 67.1 -43.63 0.44 Allowed 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 127.104 2.162 . . . . 0.0 115.35 172.904 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -66.16 -32.64 74.2 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 114.073 1.138 . . . . 0.0 114.073 -169.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.2 pm0 -62.76 -37.14 85.45 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 119.032 0.833 . . . . 0.0 111.565 172.266 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -62.77 -61.82 6.11 Favored Glycine 0 C--N 1.336 0.548 0 N-CA-C 110.688 -0.965 . . . . 0.0 110.688 177.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -59.55 -33.09 70.97 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 117.584 0.692 . . . . 0.0 112.768 -179.449 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -67.56 -25.87 66.02 Favored 'General case' 0 CA--C 1.539 0.554 0 O-C-N 121.289 -0.882 . . . . 0.0 112.612 177.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 23.4 mtpp -77.57 -44.09 29.62 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.719 0.808 . . . . 0.0 110.665 169.464 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -67.31 -38.58 85.19 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 123.424 0.69 . . . . 0.0 112.738 -175.875 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 55.6 mt -93.21 -27.65 16.74 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 125.388 1.475 . . . . 0.0 112.774 -178.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -111.72 -4.93 26.16 Favored Glycine 0 N--CA 1.471 1.006 0 N-CA-C 117.556 1.782 . . . . 0.0 117.556 -169.058 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -62.84 139.54 58.72 Favored 'General case' 0 CA--C 1.545 0.78 0 CA-C-N 121.42 2.61 . . . . 0.0 112.327 178.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 86.41 -22.1 14.59 Favored Glycine 0 CA--C 1.541 1.671 0 C-N-CA 125.114 1.34 . . . . 0.0 113.437 -169.327 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 63.5 mttp -96.67 -44.28 7.18 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 125.981 1.712 . . . . 0.0 111.686 169.813 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 46.0 pt -141.18 157.01 22.17 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 C-N-CA 125.182 1.393 . . . . 0.0 113.009 -174.354 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -101.25 144.91 29.53 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 127.12 2.168 . . . . 0.0 108.796 169.405 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 73.7 t -140.3 137.6 37.11 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 C-N-CA 123.675 0.79 . . . . 0.0 111.578 -171.578 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 54.1 m -145.28 150.68 37.09 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 124.11 0.964 . . . . 0.0 110.852 177.738 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 93.5 p -133.21 137.98 46.35 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 124.52 1.128 . . . . 0.0 109.012 166.684 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 88.2 p -119.35 -70.05 0.81 Allowed 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 114.259 1.207 . . . . 0.0 114.259 -168.337 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 130.07 154.49 8.08 Favored Glycine 0 N--CA 1.465 0.597 0 C-N-CA 125.716 1.626 . . . . 0.0 113.346 173.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 10.3 mp -89.36 -13.21 38.35 Favored 'General case' 0 N--CA 1.474 0.754 0 O-C-N 121.797 -0.825 . . . . 0.0 113.173 -178.118 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -140.96 -57.06 0.5 Allowed 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 124.282 1.033 . . . . 0.0 112.444 179.322 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 39.7 m -108.44 155.91 20.05 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 124.714 1.206 . . . . 0.0 111.405 178.094 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 95.9 p -90.86 14.58 13.29 Favored 'General case' 0 N--CA 1.478 0.957 0 N-CA-C 116.694 2.109 . . . . 0.0 116.694 -170.042 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 64.3 ttt180 -130.87 157.12 43.77 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 125.541 1.536 . . . . 0.0 111.871 -177.075 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 24.1 m -111.77 165.27 6.95 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 C-N-CA 126.6 1.96 . . . . 0.0 109.55 170.765 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 5.1 t-80 -50.98 131.65 30.06 Favored Pre-proline 0 CA--C 1.532 0.275 0 CA-C-O 118.19 -0.91 . . . . 0.0 113.231 -170.698 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_exo -57.57 -27.94 78.99 Favored 'Trans proline' 0 CA--C 1.548 1.218 0 CA-C-N 120.612 1.254 . . . . 0.0 112.361 173.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 46.1 m -63.93 -32.5 74.05 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 126.08 1.752 . . . . 0.0 112.986 172.192 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -55.12 -45.23 75.55 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 123.977 0.911 . . . . 0.0 110.97 178.753 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.4 mp -53.95 -51.7 43.15 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 C-N-CA 124.09 0.956 . . . . 0.0 109.483 -176.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.4 -32.3 73.7 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 113.147 0.795 . . . . 0.0 113.147 -179.587 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -80.1 -30.15 39.11 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 113.452 0.908 . . . . 0.0 113.452 178.545 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' MET . . . . . 0.422 ' SD ' ' HG2' ' A' ' 17' ' ' MET . 3.2 mmt -76.91 -30.77 56.29 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.42 0.688 . . . . 0.0 110.851 170.712 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -68.58 -13.25 62.21 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 124.41 1.084 . . . . 0.0 113.323 172.508 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -63.94 -29.71 70.85 Favored 'General case' 0 N--CA 1.481 1.124 0 CA-C-N 120.706 1.594 . . . . 0.0 110.695 168.705 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 61.5 t -91.62 -7.68 10.56 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.903 0 C-N-CA 126.896 2.078 . . . . 0.0 111.058 173.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 83.54 21.75 57.58 Favored Glycine 0 CA--C 1.539 1.56 0 C-N-CA 125.434 1.492 . . . . 0.0 114.447 -177.71 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 31.9 mt -88.82 135.73 25.08 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 C-N-CA 124.595 1.158 . . . . 0.0 111.505 -172.188 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 18.6 t0 -94.39 120.19 34.26 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 123.582 0.753 . . . . 0.0 112.332 171.492 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 9.2 pt -134.67 -1.94 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.358 0 N-CA-C 116.094 1.887 . . . . 0.0 116.094 179.257 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 83.5 p -73.28 -21.9 60.49 Favored 'General case' 0 N--CA 1.481 1.092 0 N-CA-C 115.175 1.546 . . . . 0.0 115.175 -169.638 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -78.44 0.86 73.87 Favored Glycine 0 CA--C 1.54 1.604 0 N-CA-C 116.39 1.316 . . . . 0.0 116.39 -173.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 33.4 mt-30 -78.65 -11.98 60.0 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 115.304 1.594 . . . . 0.0 115.304 -171.345 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 42.8 p -63.94 115.42 4.86 Favored 'General case' 0 N--CA 1.477 0.883 0 CA-C-N 119.537 1.062 . . . . 0.0 113.56 -169.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 89.2 p -152.35 -77.86 0.12 Allowed 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.765 1.226 . . . . 0.0 112.708 177.762 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -146.43 159.26 45.43 Favored Pre-proline 0 CA--C 1.554 1.112 0 C-N-CA 124.41 1.084 . . . . 0.0 113.522 -171.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_endo -61.71 161.04 26.24 Favored 'Trans proline' 0 C--N 1.352 0.742 0 C-N-CA 124.174 3.249 . . . . 0.0 114.133 169.745 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 11.6 tt -51.32 -35.68 16.28 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.128 0 C-N-CA 125.824 1.65 . . . . 0.0 112.444 172.484 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 17.5 mt-10 -64.42 -17.77 64.1 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 123.779 0.832 . . . . 0.0 112.961 -177.718 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -84.69 -10.67 57.07 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 124.792 1.237 . . . . 0.0 113.604 -175.898 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 76.6 m-85 -111.5 -168.32 1.29 Allowed 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 125.979 1.711 . . . . 0.0 112.348 -173.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 6.4 t30 -124.39 123.47 40.25 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 126.064 1.745 . . . . 0.0 109.864 178.673 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.81 -33.61 75.98 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 114.187 1.18 . . . . 0.0 114.187 -170.601 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . 0.269 0.0 OUTLIER -71.41 -4.62 27.4 Favored 'General case' 0 CA--C 1.544 0.721 0 N-CA-C 114.212 1.19 . . . . 0.0 114.212 -178.11 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -73.94 -12.33 60.62 Favored 'General case' 0 CA--C 1.549 0.904 0 C-N-CA 123.965 0.906 . . . . 0.0 111.348 168.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 58.3 m-85 -117.22 138.88 51.42 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 127.001 2.12 . . . . 0.0 111.268 179.128 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -90.5 -23.23 21.0 Favored 'General case' 0 N--CA 1.478 0.956 0 CA-C-O 122.207 1.003 . . . . 0.0 112.926 178.349 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 96.5 t -132.28 136.11 56.93 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 C-N-CA 126.988 2.115 . . . . 0.0 108.249 -174.12 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 91.0 t -131.8 125.76 56.04 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 170.104 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 45.1 mm -112.39 105.15 18.23 Favored 'Isoleucine or valine' 0 C--O 1.233 0.237 0 C-N-CA 124.257 1.023 . . . . 0.0 109.354 -176.239 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 24.4 m -86.66 98.79 11.31 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 123.667 0.787 . . . . 0.0 109.117 171.807 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 52.7 mt -69.69 178.62 2.49 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 125.499 1.52 . . . . 0.0 110.966 170.474 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 16.2 m 63.1 19.7 11.82 Favored 'General case' 0 CA--C 1.547 0.841 0 N-CA-C 114.784 1.401 . . . . 0.0 114.784 169.78 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 131.79 -120.43 2.81 Favored Glycine 0 CA--C 1.531 1.048 0 C-N-CA 124.512 1.053 . . . . 0.0 111.971 -172.152 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 9.2 t -135.96 157.99 45.48 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 124.908 1.283 . . . . 0.0 112.82 178.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -74.66 113.93 4.22 Favored Glycine 0 CA--C 1.531 1.087 0 C-N-CA 124.414 1.006 . . . . 0.0 112.261 -179.326 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 11.3 p -139.53 -39.06 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.26 0 N-CA-C 114.594 1.331 . . . . 0.0 114.594 -178.147 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 65.0 t30 -92.43 -15.63 26.92 Favored 'General case' 0 CA--C 1.549 0.911 0 N-CA-C 114.12 1.155 . . . . 0.0 114.12 -177.228 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -71.44 157.13 90.58 Favored Pre-proline 0 CA--C 1.552 1.024 0 O-C-N 121.309 -0.869 . . . . 0.0 111.843 169.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_exo -62.2 149.03 92.1 Favored 'Trans proline' 0 CA--C 1.545 1.047 0 C-N-CA 122.215 1.944 . . . . 0.0 113.352 -177.52 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_exo -57.33 -33.63 96.5 Favored 'Trans proline' 0 C--N 1.351 0.707 0 C-N-CA 122.935 2.423 . . . . 0.0 115.144 -169.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -60.98 -21.4 63.5 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 114.284 1.216 . . . . 0.0 114.284 179.763 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 87.5 m95 -81.51 -22.2 38.1 Favored 'General case' 0 CA--C 1.535 0.388 0 O-C-N 120.637 -1.289 . . . . 0.0 112.663 176.302 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 10.6 m -89.77 -3.16 10.06 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 N-CA-C 113.463 0.912 . . . . 0.0 113.463 172.568 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 59.3 p -103.24 3.8 35.96 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 125.373 1.469 . . . . 0.0 114.888 176.251 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 80.6 mm-40 -66.86 156.66 35.07 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 119.351 0.978 . . . . 0.0 111.973 171.668 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -58.19 -42.01 85.2 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 114.278 1.214 . . . . 0.0 114.278 -167.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 20.1 mm -115.0 59.52 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 C-N-CA 124.822 1.249 . . . . 0.0 108.708 175.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 21.7 t80 -75.6 109.7 9.39 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 169.069 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 13.1 mt-10 -109.18 140.61 42.56 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 114.665 1.357 . . . . 0.0 114.665 174.252 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -98.23 121.05 39.67 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.985 1.314 . . . . 0.0 109.706 169.249 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 24.4 m0 -112.79 105.59 13.75 Favored 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 124.917 1.287 . . . . 0.0 109.063 -177.349 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -85.11 37.21 0.66 Allowed 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 124.933 1.293 . . . . 0.0 112.02 -171.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 73.9 mt -76.17 158.68 31.44 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 126.114 1.766 . . . . 0.0 111.934 178.561 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -81.41 152.08 27.6 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-O 121.559 0.695 . . . . 0.0 112.564 170.639 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 12.5 p-10 -88.02 136.87 31.73 Favored Pre-proline 0 CA--C 1.546 0.808 0 C-N-CA 125.0 1.32 . . . . 0.0 110.987 170.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -82.42 -9.22 11.43 Favored 'Trans proline' 0 CA--C 1.55 1.301 0 C-N-CA 121.57 1.513 . . . . 0.0 114.461 -174.785 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -65.29 146.14 55.32 Favored 'General case' 0 CA--C 1.547 0.837 0 CA-C-N 119.438 1.017 . . . . 0.0 112.47 175.675 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 77.78 5.58 86.54 Favored Glycine 0 CA--C 1.538 1.501 0 C-N-CA 123.829 0.728 . . . . 0.0 114.751 179.449 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -141.9 173.62 11.34 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 126.208 1.803 . . . . 0.0 112.015 178.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 24.4 p -65.78 164.97 13.62 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 116.161 1.911 . . . . 0.0 116.161 -169.274 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 43.7 tp -60.91 -27.91 68.53 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.171 0.988 . . . . 0.0 112.25 171.533 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -66.62 -32.14 73.28 Favored 'General case' 0 CA--C 1.54 0.575 0 O-C-N 120.681 -1.262 . . . . 0.0 111.508 172.597 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 4.4 t -72.49 -36.92 55.72 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 O-C-N 121.108 -0.995 . . . . 0.0 111.841 170.656 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -55.1 -47.57 74.79 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 119.724 1.147 . . . . 0.0 111.471 169.501 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -69.66 -32.59 71.32 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.658 0.783 . . . . 0.0 112.498 178.573 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 42.9 m -62.94 -43.89 97.55 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 123.883 0.873 . . . . 0.0 110.627 169.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 68.8 t -65.7 -41.01 89.53 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 CA-C-O 117.576 -1.202 . . . . 0.0 110.576 175.727 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 24.9 mtm105 -53.98 -49.48 68.71 Favored 'General case' 0 N--CA 1.484 1.24 0 CA-C-N 120.607 1.548 . . . . 0.0 111.592 169.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -59.22 -49.65 76.19 Favored Glycine 0 CA--C 1.538 1.505 0 CA-C-N 119.438 1.017 . . . . 0.0 113.641 179.326 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 56.7 mm-40 -63.58 -44.08 95.12 Favored 'General case' 0 N--CA 1.473 0.708 0 O-C-N 121.996 -0.708 . . . . 0.0 111.988 178.178 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 53.4 t -64.81 -39.71 86.58 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 C-N-CA 124.048 0.939 . . . . 0.0 111.186 176.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 12.3 tmtt? -56.07 -48.83 75.33 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 119.654 1.115 . . . . 0.0 110.312 179.041 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -65.15 -42.62 93.6 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 112.929 0.714 . . . . 0.0 112.929 176.792 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 15.5 mmm180 -62.03 -43.87 97.91 Favored 'General case' 0 N--CA 1.48 1.055 0 O-C-N 121.467 -0.771 . . . . 0.0 112.737 176.536 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 85.6 t -70.38 -37.75 71.75 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 123.776 0.83 . . . . 0.0 111.273 179.082 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 70.6 mt-10 -60.23 -41.91 94.12 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 119.537 1.062 . . . . 0.0 111.6 170.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 15.2 m-80 -63.33 -45.36 91.62 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 118.347 0.521 . . . . 0.0 112.151 175.432 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 8.6 tt -53.19 -55.9 20.63 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 124.604 1.162 . . . . 0.0 110.892 173.642 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 84.2 mt -63.27 -43.0 98.47 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 O-C-N 121.593 -0.692 . . . . 0.0 110.376 -177.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -68.07 -14.02 62.65 Favored 'General case' 0 CA--C 1.546 0.789 0 N-CA-C 114.822 1.415 . . . . 0.0 114.822 178.807 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 20.0 ptmt -102.04 -32.76 10.0 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 113.573 0.953 . . . . 0.0 113.573 174.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 13.5 pt -89.54 -17.3 8.18 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 N-CA-C 114.185 1.18 . . . . 0.0 114.185 -179.529 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 68.8 m . . . . . 0 C--O 1.255 1.365 0 N-CA-C 112.888 0.699 . . . . 0.0 112.888 -179.92 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.8 ttt . . . . . 0 N--CA 1.504 2.259 0 N-CA-C 111.493 0.183 . . . . 0.0 111.493 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 3.0 mptp? -121.91 160.31 25.05 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 125.683 1.593 . . . . 0.0 112.3 175.139 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 33.9 ttmt -111.03 116.92 32.0 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 106.647 -1.612 . . . . 0.0 106.647 167.146 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 16.8 t -104.41 132.05 51.91 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 C-N-CA 124.752 1.221 . . . . 0.0 113.831 -177.719 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 48.5 tpp -100.43 123.4 44.6 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 123.882 0.873 . . . . 0.0 109.137 169.177 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 48.6 m-85 -108.18 121.07 44.09 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 124.574 1.15 . . . . 0.0 109.241 172.178 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 5.1 m -144.14 165.64 13.51 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 C-N-CA 125.009 1.323 . . . . 0.0 112.369 -169.308 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -154.39 148.7 26.04 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 125.999 1.72 . . . . 0.0 110.301 175.165 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 39.5 ttpt -46.3 122.31 3.93 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 125.272 1.429 . . . . 0.0 111.968 175.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . 0.261 91.6 mtt180 52.67 -30.86 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 129.034 2.934 . . . . 0.0 118.896 -174.444 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 5.1 t30 61.81 -19.65 0.04 OUTLIER 'General case' 0 CA--C 1.558 1.261 0 N-CA-C 117.813 2.523 . . . . 0.0 117.813 169.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 75.7 m -50.41 121.27 5.44 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 126.525 1.93 . . . . 0.0 113.157 -177.3 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 66.5 m 51.41 41.07 27.95 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 125.006 1.323 . . . . 0.0 113.096 174.619 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 14.9 ttt180 -126.83 153.18 45.98 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 125.911 1.684 . . . . 0.0 110.023 177.171 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 33.1 m -102.94 126.87 50.28 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 124.062 0.945 . . . . 0.0 110.836 -179.455 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 3.9 mp0 -106.09 -36.16 7.01 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.793 0.837 . . . . 0.0 112.606 -172.523 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 68.78 -48.59 0.57 Allowed 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 126.823 2.049 . . . . 0.0 115.867 169.348 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -59.01 -36.23 74.58 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.59 1.156 . . . . 0.0 113.58 -171.13 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 6.3 pm0 -61.97 -41.63 98.23 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 124.739 1.216 . . . . 0.0 112.499 175.593 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -69.03 -40.23 83.94 Favored Glycine 0 C--N 1.335 0.483 0 N-CA-C 111.54 -0.624 . . . . 0.0 111.54 178.331 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -70.01 -40.41 75.27 Favored 'General case' 0 N--CA 1.468 0.434 0 O-C-N 121.947 -0.737 . . . . 0.0 111.493 177.489 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -60.19 -43.7 95.69 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 119.255 0.934 . . . . 0.0 112.941 -174.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 8.0 pttp -77.19 -26.61 53.05 Favored 'General case' 0 N--CA 1.481 1.115 0 N-CA-C 113.586 0.958 . . . . 0.0 113.586 174.253 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 94.2 m -72.47 -32.85 66.58 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.06 0.544 . . . . 0.0 111.754 174.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 72.3 mt -91.33 -34.36 14.94 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 125.847 1.659 . . . . 0.0 114.598 -179.221 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -135.41 28.04 3.05 Favored Glycine 0 N--CA 1.474 1.175 0 N-CA-C 118.789 2.275 . . . . 0.0 118.789 -168.711 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -65.05 -22.73 67.02 Favored 'General case' 0 CA--C 1.546 0.8 0 CA-C-N 122.108 2.954 . . . . 0.0 115.701 -176.315 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -72.62 -10.92 76.81 Favored Glycine 0 CA--C 1.542 1.77 0 O-C-N 121.209 -0.932 . . . . 0.0 113.868 169.639 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 54.8 mttm -109.56 -39.54 5.13 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 127.251 2.22 . . . . 0.0 112.98 -179.472 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 41.2 pt -145.49 155.43 13.32 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 C-N-CA 124.555 1.142 . . . . 0.0 113.942 -171.174 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -99.43 142.49 30.85 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 126.065 1.746 . . . . 0.0 108.916 169.295 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 97.6 t -130.4 140.11 49.66 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 O-C-N 121.439 -0.788 . . . . 0.0 111.704 -176.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 13.9 m -139.38 153.72 47.71 Favored 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 124.981 1.312 . . . . 0.0 109.698 175.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 91.4 p -128.59 155.58 44.71 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 123.803 0.841 . . . . 0.0 109.742 167.751 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 60.5 p -140.33 161.68 37.11 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 114.824 -1.08 . . . . 0.0 112.149 173.702 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -119.79 101.78 0.86 Allowed Glycine 0 C--N 1.339 0.696 0 N-CA-C 110.343 -1.103 . . . . 0.0 110.343 -169.731 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 10.6 mp -59.63 125.58 24.2 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.734 0.814 . . . . 0.0 109.512 -169.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 68.15 42.05 1.84 Allowed 'General case' 0 CA--C 1.553 1.074 0 C-N-CA 124.716 1.206 . . . . 0.0 113.02 -173.251 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 69.6 m 61.85 54.63 2.82 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 127.724 2.409 . . . . 0.0 113.776 169.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 79.2 p -114.39 164.77 13.5 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 115.587 1.699 . . . . 0.0 115.587 -171.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 22.2 tpt180 -113.38 144.85 42.08 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 126.363 1.865 . . . . 0.0 110.453 177.014 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 16.7 m -68.51 171.56 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.206 0 CA-C-O 122.002 0.906 . . . . 0.0 110.282 169.089 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 1.7 t-80 -59.37 131.02 87.73 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-O 118.431 -0.795 . . . . 0.0 112.659 179.617 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo -60.43 -27.69 85.33 Favored 'Trans proline' 0 CA--C 1.547 1.171 0 C-N-CA 121.35 1.367 . . . . 0.0 111.569 169.607 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 90.0 m -65.83 -30.83 71.51 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 125.278 1.431 . . . . 0.0 112.321 174.341 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -57.52 -39.42 76.5 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.365 1.066 . . . . 0.0 111.532 -175.163 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 2.3 mp -57.12 -60.38 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 C-N-CA 123.665 0.786 . . . . 0.0 109.311 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.19 -31.11 72.18 Favored 'General case' 0 CA--C 1.546 0.808 0 N-CA-C 113.616 0.969 . . . . 0.0 113.616 -177.04 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -81.55 -8.05 59.67 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 114.305 1.224 . . . . 0.0 114.305 177.373 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 41.3 mtt -109.88 -24.02 11.06 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 125.057 1.343 . . . . 0.0 110.211 173.606 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 24.3 mt-10 -64.98 -16.01 62.9 Favored 'General case' 0 CA--C 1.546 0.818 0 O-C-N 120.609 -1.307 . . . . 0.0 111.749 168.694 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 12.3 mt-10 -61.16 -29.33 69.73 Favored 'General case' 0 N--CA 1.482 1.173 0 CA-C-N 119.877 1.217 . . . . 0.0 110.92 169.108 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 48.1 t -92.27 -4.99 10.8 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.981 0 C-N-CA 127.437 2.295 . . . . 0.0 111.118 177.032 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 80.91 17.39 72.63 Favored Glycine 0 CA--C 1.538 1.494 0 C-N-CA 125.223 1.392 . . . . 0.0 114.566 -173.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 78.9 mt -77.64 139.92 17.87 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 C-N-CA 124.309 1.044 . . . . 0.0 111.893 -173.275 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -104.98 104.97 14.81 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.58 1.152 . . . . 0.0 111.761 175.598 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 3.5 pt -131.7 0.84 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 N-CA-C 115.696 1.739 . . . . 0.0 115.696 -178.283 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 93.6 p -70.74 -30.98 67.65 Favored 'General case' 0 N--CA 1.48 1.051 0 CA-C-N 120.012 1.278 . . . . 0.0 113.635 -177.541 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -79.74 13.16 25.26 Favored Glycine 0 CA--C 1.539 1.567 0 C-N-CA 125.743 1.64 . . . . 0.0 115.75 -179.201 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 32.0 mt-30 -80.9 167.98 19.26 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 118.886 1.343 . . . . 0.0 111.868 178.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 3.6 t -71.77 171.64 11.25 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 114.963 1.468 . . . . 0.0 114.963 -178.33 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 48.8 m -125.21 6.07 7.81 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 128.436 2.694 . . . . 0.0 111.66 169.475 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 23.7 m-20 -88.17 155.34 52.08 Favored Pre-proline 0 CA--C 1.546 0.818 0 C-N-CA 124.729 1.212 . . . . 0.0 113.746 179.22 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -78.43 158.78 29.23 Favored 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 123.49 2.793 . . . . 0.0 114.406 -177.685 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 8.5 tt -53.12 -38.98 31.62 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 C-N-CA 124.308 1.043 . . . . 0.0 112.486 174.781 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -70.16 -6.77 36.55 Favored 'General case' 0 CA--C 1.545 0.778 0 N-CA-C 114.116 1.154 . . . . 0.0 114.116 179.11 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -76.42 -15.13 60.0 Favored 'General case' 0 CA--C 1.547 0.83 0 O-C-N 121.429 -0.794 . . . . 0.0 112.569 170.691 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 61.5 m-85 -109.04 -171.61 1.88 Allowed 'General case' 0 CA--C 1.552 1.041 0 C-N-CA 126.921 2.088 . . . . 0.0 111.57 -179.175 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -125.79 126.57 44.76 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 125.337 1.455 . . . . 0.0 110.232 177.397 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.65 -35.88 82.06 Favored 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 113.641 0.978 . . . . 0.0 113.641 -170.1 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . 0.258 0.0 OUTLIER -72.67 -4.88 33.83 Favored 'General case' 0 CA--C 1.547 0.853 0 N-CA-C 113.718 1.007 . . . . 0.0 113.718 -177.559 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -74.47 -12.21 60.43 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 123.982 0.913 . . . . 0.0 111.142 168.588 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 65.7 m-85 -115.28 146.55 41.38 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 127.483 2.313 . . . . 0.0 110.989 178.345 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -105.25 -16.16 14.85 Favored 'General case' 0 N--CA 1.479 1.022 0 CA-C-O 121.97 0.891 . . . . 0.0 112.641 178.148 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 80.3 t -133.17 136.69 54.79 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 C-N-CA 127.306 2.242 . . . . 0.0 107.671 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 60.0 t -132.35 126.9 56.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 N-CA-C 107.999 -1.111 . . . . 0.0 107.999 169.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 43.5 mm -114.31 118.37 58.3 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 C-N-CA 124.635 1.174 . . . . 0.0 108.815 -175.669 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 8.6 t -100.47 116.61 32.81 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 122.934 0.493 . . . . 0.0 111.462 173.672 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 49.9 mt -94.52 -13.38 26.13 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 125.724 1.61 . . . . 0.0 113.71 -172.291 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 1.5 p -156.63 147.45 21.82 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 124.075 0.95 . . . . 0.0 111.412 176.041 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 80.19 179.99 52.94 Favored Glycine 0 CA--C 1.539 1.567 0 C-N-CA 124.53 1.062 . . . . 0.0 114.528 -178.224 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 67.2 m -92.04 3.65 54.79 Favored 'General case' 0 N--CA 1.479 0.993 0 N-CA-C 114.719 1.377 . . . . 0.0 114.719 -170.01 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 79.67 23.59 62.02 Favored Glycine 0 CA--C 1.537 1.414 0 N-CA-C 115.164 0.826 . . . . 0.0 115.164 178.673 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 14.3 t -106.46 -12.0 10.09 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.374 0 C-N-CA 124.323 1.049 . . . . 0.0 112.855 -179.318 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 12.9 t-20 -81.35 6.62 13.79 Favored 'General case' 0 CA--C 1.552 1.023 0 C-N-CA 125.202 1.401 . . . . 0.0 113.397 -179.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -127.97 161.07 58.08 Favored Pre-proline 0 CA--C 1.552 1.032 0 C-N-CA 126.912 2.085 . . . . 0.0 112.058 178.165 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_exo -63.36 148.06 93.08 Favored 'Trans proline' 0 CA--C 1.546 1.11 0 C-N-CA 122.355 2.036 . . . . 0.0 112.773 177.344 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_exo -56.83 -30.61 85.84 Favored 'Trans proline' 0 C--N 1.352 0.733 0 C-N-CA 123.051 2.5 . . . . 0.0 115.286 -174.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -59.77 -20.44 56.65 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 114.237 1.199 . . . . 0.0 114.237 178.458 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 89.1 m95 -81.88 -17.04 48.69 Favored 'General case' 0 CA--C 1.539 0.522 0 O-C-N 120.594 -1.316 . . . . 0.0 113.364 175.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 5.4 m -92.83 -8.38 10.16 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.105 0 CA-C-N 119.404 1.002 . . . . 0.0 113.398 170.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 72.5 p -98.24 -0.46 44.01 Favored 'General case' 0 N--CA 1.479 0.995 0 N-CA-C 114.873 1.434 . . . . 0.0 114.873 179.216 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 73.9 mm-40 -66.01 152.71 44.01 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 119.442 1.019 . . . . 0.0 111.202 169.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -55.38 -43.15 74.88 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 114.634 1.346 . . . . 0.0 114.634 -167.661 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 19.9 mm -114.49 61.15 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 C-N-CA 124.84 1.256 . . . . 0.0 109.003 176.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 41.7 t80 -77.23 108.16 10.14 Favored 'General case' 0 CA--C 1.535 0.393 0 O-C-N 120.639 -1.288 . . . . 0.0 108.22 169.119 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 9.4 mt-10 -108.23 136.86 47.18 Favored 'General case' 0 CA--C 1.545 0.758 0 N-CA-C 114.947 1.462 . . . . 0.0 114.947 177.071 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -91.54 114.1 26.54 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.916 1.287 . . . . 0.0 110.202 169.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 23.1 m0 -111.88 81.97 1.55 Allowed 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 125.047 1.339 . . . . 0.0 109.538 179.579 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 7.5 pt20 -75.88 55.77 0.91 Allowed 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 125.576 1.55 . . . . 0.0 112.279 176.709 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 73.4 mt -86.99 167.19 14.47 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 127.493 2.317 . . . . 0.0 112.481 -178.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -68.68 149.65 48.84 Favored 'General case' 0 CA--C 1.546 0.812 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.99 169.255 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -117.75 142.76 31.2 Favored Pre-proline 0 CA--C 1.553 1.085 0 C-N-CA 125.073 1.349 . . . . 0.0 112.148 175.544 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_exo -75.26 -15.96 19.9 Favored 'Trans proline' 0 CA--C 1.547 1.126 0 N-CA-C 116.929 1.857 . . . . 0.0 116.929 -172.104 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -67.2 141.79 57.2 Favored 'General case' 0 N--CA 1.476 0.837 0 CA-C-N 120.313 1.415 . . . . 0.0 113.334 -170.296 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 77.33 8.59 87.04 Favored Glycine 0 CA--C 1.538 1.527 0 C-N-CA 124.635 1.112 . . . . 0.0 114.901 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 -141.58 164.64 29.68 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 125.033 1.333 . . . . 0.0 113.553 -178.127 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 66.4 m -63.49 164.07 9.96 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 116.161 1.911 . . . . 0.0 116.161 -169.129 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 25.8 tp -57.12 -31.38 65.26 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 125.686 1.594 . . . . 0.0 113.274 176.202 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -62.04 -30.52 71.03 Favored 'General case' 0 CA--C 1.541 0.628 0 O-C-N 121.002 -1.061 . . . . 0.0 111.988 172.662 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 4.2 t -75.89 -38.86 37.08 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 O-C-N 121.122 -0.986 . . . . 0.0 111.388 173.159 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 20.0 m-85 -56.85 -45.31 82.51 Favored 'General case' 0 N--CA 1.481 1.082 0 CA-C-N 120.169 1.349 . . . . 0.0 111.609 169.521 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -67.79 -37.29 81.82 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 124.179 0.991 . . . . 0.0 112.135 178.566 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 70.6 m -67.91 -42.62 80.83 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 123.793 0.837 . . . . 0.0 111.567 174.042 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 53.3 t -66.19 -41.41 89.23 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 CA-C-O 118.387 -0.816 . . . . 0.0 110.142 177.252 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 15.7 mtp180 -52.78 -46.89 67.78 Favored 'General case' 0 N--CA 1.479 1.022 0 CA-C-N 119.755 1.161 . . . . 0.0 112.507 170.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -59.69 -50.56 66.39 Favored Glycine 0 CA--C 1.54 1.6 0 CA-C-N 119.375 0.988 . . . . 0.0 113.427 176.352 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 60.3 mm-40 -65.89 -44.39 85.43 Favored 'General case' 0 N--CA 1.472 0.672 0 O-C-N 121.775 -0.838 . . . . 0.0 112.304 -179.682 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 65.6 t -64.25 -41.43 92.36 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 C-N-CA 124.782 1.233 . . . . 0.0 110.685 176.21 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 80.0 tttt -54.98 -50.06 69.89 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 120.18 1.355 . . . . 0.0 111.068 178.133 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -61.72 -40.67 95.87 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 112.205 0.446 . . . . 0.0 112.205 176.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.89 -35.91 81.96 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 124.354 1.062 . . . . 0.0 113.722 177.133 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 95.2 t -76.24 -40.92 36.64 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 C-N-CA 125.421 1.489 . . . . 0.0 111.284 176.228 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -61.47 -39.6 91.46 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 119.039 0.836 . . . . 0.0 111.39 172.373 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 13.6 m-80 -64.42 -43.57 93.95 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 118.69 0.677 . . . . 0.0 112.611 174.3 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -54.52 -56.58 17.39 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 124.256 1.023 . . . . 0.0 110.442 173.132 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 85.0 mt -61.04 -42.45 93.14 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 CA-C-O 119.166 -0.445 . . . . 0.0 110.532 -178.576 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -73.67 -10.77 60.04 Favored 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 115.073 1.508 . . . . 0.0 115.073 -179.449 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 20.7 ptmt -98.66 -27.16 14.11 Favored 'General case' 0 N--CA 1.479 0.997 0 CA-C-N 119.501 1.046 . . . . 0.0 113.388 169.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 14.3 pt -95.45 -7.6 9.75 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 N-CA-C 114.599 1.333 . . . . 0.0 114.599 176.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 27.3 p . . . . . 0 C--O 1.255 1.391 0 N-CA-C 114.774 1.398 . . . . 0.0 114.774 176.06 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.5 ttt . . . . . 0 N--CA 1.501 2.114 0 N-CA-C 111.725 0.269 . . . . 0.0 111.725 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.5 165.08 28.39 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 125.135 1.374 . . . . 0.0 112.684 175.573 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 67.9 mttt -95.75 145.02 25.64 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.996 0.918 . . . . 0.0 112.333 177.184 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 15.0 t -124.46 134.28 67.13 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 C-N-CA 125.301 1.44 . . . . 0.0 111.884 177.285 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 14.4 tpp -101.02 123.78 45.73 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.087 0.555 . . . . 0.0 109.894 169.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 48.4 m-85 -110.8 99.02 8.02 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 124.533 1.133 . . . . 0.0 110.509 175.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 1.4 m -111.7 165.21 6.94 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 C-N-CA 125.035 1.334 . . . . 0.0 112.042 -173.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 7.8 t -142.44 140.29 31.9 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 125.279 1.432 . . . . 0.0 111.041 179.444 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 37.5 ttmt -66.13 118.56 10.04 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.42 0.688 . . . . 0.0 110.499 175.231 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 28.6 mmt85 45.51 91.48 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 127.441 2.296 . . . . 0.0 113.14 -175.575 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 15.9 m120 -61.36 -17.46 54.04 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 115.839 1.792 . . . . 0.0 115.839 -171.692 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 70.8 m -50.48 138.65 17.04 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.489 1.116 . . . . 0.0 112.212 178.049 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 24.6 p 55.03 -10.62 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.246 0 N-CA-C 118.12 2.637 . . . . 0.0 118.12 -173.707 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 52.3 mtm-85 -93.6 157.22 16.29 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 125.985 1.714 . . . . 0.0 113.789 -174.678 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 5.5 m -113.94 -22.18 10.23 Favored 'General case' 0 N--CA 1.477 0.924 0 N-CA-C 116.457 2.021 . . . . 0.0 116.457 -169.463 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 26.0 mt-30 62.12 -64.0 0.09 Allowed 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 127.078 2.151 . . . . 0.0 116.674 -178.174 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' MET . . . . . 0.4 ' HG2' ' SD ' ' A' ' 50' ' ' MET . 0.0 OUTLIER 74.13 -49.24 0.67 Allowed 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 127.209 2.203 . . . . 0.0 114.344 177.026 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.68 -34.57 74.54 Favored 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 114.602 1.334 . . . . 0.0 114.602 -170.337 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 20.3 pm0 -63.47 -38.18 90.16 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 124.783 1.233 . . . . 0.0 112.138 178.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -72.22 -37.67 59.37 Favored Glycine 0 C--N 1.337 0.593 0 C-N-CA 123.681 0.657 . . . . 0.0 111.794 178.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -73.36 -37.98 65.87 Favored 'General case' 0 N--CA 1.469 0.49 0 O-C-N 121.685 -0.891 . . . . 0.0 111.772 176.819 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -62.74 -35.86 81.15 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 113.403 0.89 . . . . 0.0 113.403 -173.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 6.2 pttp -79.48 -36.36 38.82 Favored 'General case' 0 N--CA 1.479 1.023 0 N-CA-C 113.269 0.84 . . . . 0.0 113.269 170.135 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 39.0 m -69.46 -31.06 69.13 Favored 'General case' 0 N--CA 1.484 1.253 0 O-C-N 121.8 -0.563 . . . . 0.0 111.977 -178.57 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 83.8 mt -91.74 -36.35 13.62 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 125.868 1.667 . . . . 0.0 112.889 174.529 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -104.11 3.03 44.11 Favored Glycine 0 N--CA 1.473 1.13 0 N-CA-C 117.574 1.789 . . . . 0.0 117.574 -169.529 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.49 140.76 58.03 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 121.356 2.578 . . . . 0.0 112.413 178.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 81.31 -11.48 43.89 Favored Glycine 0 CA--C 1.541 1.671 0 C-N-CA 124.783 1.182 . . . . 0.0 114.081 -169.673 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 63.5 mttp -110.01 -44.61 3.75 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 126.089 1.756 . . . . 0.0 111.69 172.771 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 44.5 pt -138.99 159.95 29.67 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 125.903 1.681 . . . . 0.0 112.408 179.497 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -106.52 148.21 28.49 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.092 1.357 . . . . 0.0 110.378 169.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 57.2 t -133.44 139.54 48.81 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 CA-C-N 119.002 0.819 . . . . 0.0 112.483 -177.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 85.9 m -133.14 150.85 52.01 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 125.696 1.598 . . . . 0.0 108.168 169.592 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 10.1 p -90.49 -73.97 0.51 Allowed 'General case' 0 N--CA 1.47 0.534 0 O-C-N 121.589 -0.695 . . . . 0.0 112.759 174.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 9.6 p 66.06 156.57 0.1 Allowed 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 127.925 2.49 . . . . 0.0 113.602 -169.645 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -106.61 156.33 16.2 Favored Glycine 0 N--CA 1.465 0.586 0 O-C-N 121.432 -0.793 . . . . 0.0 112.18 -175.052 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 9.7 mp -99.52 108.97 21.54 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 169.234 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 69.14 64.71 0.28 Allowed 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 126.44 1.896 . . . . 0.0 113.173 -176.661 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 67.5 m 48.51 48.39 19.47 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 126.968 2.107 . . . . 0.0 115.058 169.575 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 58.1 m -129.59 156.63 43.89 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 124.455 1.102 . . . . 0.0 113.172 -172.584 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 59.5 ttt-85 -115.78 153.55 31.23 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 128.232 2.613 . . . . 0.0 109.139 178.619 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 16.2 m -62.98 157.99 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.132 0 O-C-N 122.04 -0.412 . . . . 0.0 111.318 171.33 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . 0.486 ' CE1' ' HB ' ' A' ' 45' ' ' THR . 0.1 OUTLIER -63.74 142.91 98.08 Favored Pre-proline 0 CA--C 1.544 0.712 0 C-N-CA 119.755 -0.778 . . . . 0.0 110.318 174.871 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -60.97 -29.49 88.08 Favored 'Trans proline' 0 CA--C 1.539 0.768 0 C-N-CA 123.266 2.644 . . . . 0.0 114.758 -168.443 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.486 ' HB ' ' CE1' ' A' ' 43' ' ' HIS . 88.7 m -66.17 -22.67 66.37 Favored 'General case' 0 N--CA 1.475 0.813 0 O-C-N 121.273 -0.892 . . . . 0.0 111.924 -178.675 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -52.48 -50.28 63.02 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 118.948 0.795 . . . . 0.0 110.405 169.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 4.5 mp -57.56 -48.64 82.65 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 C-N-CA 123.377 0.671 . . . . 0.0 110.728 -179.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -60.17 -32.42 71.04 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 113.102 0.779 . . . . 0.0 113.102 178.822 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -80.63 -30.43 36.69 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 113.87 1.063 . . . . 0.0 113.87 177.087 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' MET . . . . . 0.4 ' SD ' ' HG2' ' A' ' 17' ' ' MET . 3.6 mmt -73.41 -32.63 64.54 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 118.789 0.722 . . . . 0.0 110.352 170.251 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -67.01 -13.25 61.73 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 124.806 1.242 . . . . 0.0 113.548 174.267 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 58.4 mt-10 -63.11 -27.57 69.47 Favored 'General case' 0 N--CA 1.48 1.073 0 CA-C-N 120.355 1.434 . . . . 0.0 110.666 168.517 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 60.8 t -95.02 -4.51 10.45 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.91 0 C-N-CA 127.041 2.136 . . . . 0.0 111.15 175.465 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 80.29 18.9 70.46 Favored Glycine 0 CA--C 1.539 1.547 0 C-N-CA 125.005 1.288 . . . . 0.0 114.272 -175.649 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 93.2 mt -77.31 132.86 31.92 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 C-N-CA 124.731 1.212 . . . . 0.0 111.28 -174.577 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 19.0 t0 -96.19 104.8 16.78 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.502 0.721 . . . . 0.0 112.627 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 14.1 pt -138.22 17.25 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.365 0 N-CA-C 114.727 1.38 . . . . 0.0 114.727 176.046 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 94.1 p -49.35 -41.73 39.81 Favored 'General case' 0 N--CA 1.484 1.259 0 N-CA-C 116.151 1.908 . . . . 0.0 116.151 -169.798 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -126.98 35.68 2.8 Favored Glycine 0 CA--C 1.534 1.248 0 C-N-CA 125.59 1.567 . . . . 0.0 113.179 -179.293 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 24.0 pt20 -64.88 -33.91 77.13 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 115.56 1.689 . . . . 0.0 115.56 -169.738 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 28.2 p -92.83 106.23 18.23 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 121.559 0.695 . . . . 0.0 111.68 179.633 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 67.4 m -104.57 -28.93 10.98 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 124.521 1.128 . . . . 0.0 113.311 176.469 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -147.75 158.2 43.06 Favored Pre-proline 0 CA--C 1.544 0.737 0 C-N-CA 124.514 1.125 . . . . 0.0 111.997 -176.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -64.49 156.41 60.75 Favored 'Trans proline' 0 CA--C 1.537 0.671 0 C-N-CA 122.42 2.08 . . . . 0.0 112.414 169.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 12.2 tt -50.12 -36.03 12.11 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.181 0 C-N-CA 124.016 0.926 . . . . 0.0 112.098 171.54 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 19.3 mt-10 -63.91 -18.08 63.86 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.153 0.981 . . . . 0.0 113.225 -176.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -85.1 -14.92 45.63 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 124.553 1.141 . . . . 0.0 113.785 -177.059 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -97.06 176.03 6.1 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 126.016 1.727 . . . . 0.0 112.304 -177.081 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 23.6 t30 -99.81 126.95 45.99 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 169.77 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.84 -46.52 74.82 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 112.433 0.531 . . . . 0.0 112.433 -175.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -72.57 -1.0 14.38 Favored 'General case' 0 CA--C 1.546 0.823 0 N-CA-C 114.796 1.406 . . . . 0.0 114.796 -173.169 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -70.24 -17.68 63.13 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 123.668 0.787 . . . . 0.0 110.245 168.255 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 58.6 m-85 -105.53 158.32 16.76 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 128.355 2.662 . . . . 0.0 111.14 174.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -116.94 -12.94 10.66 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 124.781 1.232 . . . . 0.0 112.874 179.465 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 87.3 t -142.54 136.49 27.82 Favored 'Isoleucine or valine' 0 C--O 1.236 0.384 0 C-N-CA 127.86 2.464 . . . . 0.0 107.699 -174.291 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 59.0 t -131.75 133.46 61.31 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 N-CA-C 108.431 -0.952 . . . . 0.0 108.431 169.799 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 43.6 mm -116.41 111.16 34.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 C-N-CA 124.832 1.253 . . . . 0.0 107.916 -177.069 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 4.3 m -95.61 101.36 13.06 Favored 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 123.521 0.728 . . . . 0.0 110.097 176.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 34.1 mt -79.15 176.73 9.4 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 126.495 1.918 . . . . 0.0 110.955 173.445 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 14.8 m 63.2 57.0 1.64 Allowed 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 124.408 1.083 . . . . 0.0 113.422 169.787 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 83.06 -137.14 16.07 Favored Glycine 0 CA--C 1.534 1.268 0 C-N-CA 123.863 0.744 . . . . 0.0 111.706 -171.437 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 98.9 p -83.82 163.29 20.22 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 113.26 0.837 . . . . 0.0 113.26 176.561 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -69.03 -88.85 0.08 OUTLIER Glycine 0 CA--C 1.528 0.892 0 N-CA-C 110.658 -0.977 . . . . 0.0 110.658 169.409 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 98.7 t 63.13 -48.17 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.239 0 C-N-CA 128.054 2.542 . . . . 0.0 116.571 170.139 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 29.3 t-20 -74.98 -30.84 61.3 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 124.883 1.273 . . . . 0.0 113.031 -179.545 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -68.25 146.77 98.15 Favored Pre-proline 0 CA--C 1.555 1.145 0 CA-C-O 118.709 -0.662 . . . . 0.0 112.373 174.412 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_exo -62.05 156.87 47.16 Favored 'Trans proline' 0 CA--C 1.549 1.243 0 C-N-CA 122.775 2.317 . . . . 0.0 115.234 -176.773 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 80.6 Cg_exo -54.3 -36.44 86.7 Favored 'Trans proline' 0 C--N 1.355 0.869 0 C-N-CA 123.984 3.123 . . . . 0.0 115.119 -174.798 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -61.47 -15.86 41.66 Favored 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 115.052 1.501 . . . . 0.0 115.052 178.725 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 82.6 m95 -91.43 -34.51 14.81 Favored 'General case' 0 CA--C 1.539 0.552 0 O-C-N 121.029 -1.044 . . . . 0.0 112.314 172.702 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 6.7 m -84.73 -16.32 10.53 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.186 0 N-CA-C 113.588 0.958 . . . . 0.0 113.588 177.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 1.3 t -78.59 -5.8 53.81 Favored 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 114.627 1.343 . . . . 0.0 114.627 177.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 58.4 mt-30 -71.24 166.23 21.98 Favored 'General case' 0 N--CA 1.478 0.934 0 O-C-N 121.05 -1.031 . . . . 0.0 112.95 -172.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -60.0 -43.52 95.14 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 113.761 1.022 . . . . 0.0 113.761 -168.661 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 10.8 mm -121.23 62.0 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 C-N-CA 124.65 1.18 . . . . 0.0 109.186 176.052 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 17.2 t80 -75.02 113.16 12.02 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 107.394 -1.336 . . . . 0.0 107.394 168.727 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 14.0 mt-10 -108.19 126.72 53.12 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-O 122.26 1.029 . . . . 0.0 113.246 174.224 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -91.4 89.21 7.15 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 125.146 1.378 . . . . 0.0 109.197 176.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 20.4 m0 -81.8 90.97 6.43 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 124.621 1.168 . . . . 0.0 111.405 -173.021 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 70.2 mm-40 -71.55 41.64 0.07 Allowed 'General case' 0 CA--C 1.553 1.062 0 C-N-CA 127.212 2.205 . . . . 0.0 112.345 173.379 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 40.3 mt -84.06 161.94 20.52 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 125.917 1.687 . . . . 0.0 112.156 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -70.94 150.02 46.12 Favored 'General case' 0 CA--C 1.545 0.769 0 CA-C-N 114.757 -1.111 . . . . 0.0 112.222 169.729 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -116.28 142.63 29.67 Favored Pre-proline 0 CA--C 1.552 1.043 0 C-N-CA 124.66 1.184 . . . . 0.0 110.061 169.303 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -63.23 -4.83 7.01 Favored 'Trans proline' 0 CA--C 1.55 1.29 0 C-N-CA 123.107 2.538 . . . . 0.0 116.148 178.701 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -54.18 131.11 40.66 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 115.234 1.568 . . . . 0.0 115.234 -174.814 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 69.52 10.09 62.8 Favored Glycine 0 CA--C 1.538 1.496 0 N-CA-C 115.923 1.129 . . . . 0.0 115.923 175.379 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 16.1 pt20 -134.87 171.24 14.68 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 125.141 1.377 . . . . 0.0 113.909 -175.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 42.7 p -67.26 166.04 15.03 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 116.663 2.097 . . . . 0.0 116.663 -168.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 40.5 tp -57.66 -32.16 67.03 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 124.476 1.11 . . . . 0.0 112.375 172.431 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -62.71 -36.47 83.06 Favored 'General case' 0 CA--C 1.54 0.586 0 O-C-N 121.192 -0.942 . . . . 0.0 111.366 175.531 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 6.2 t -69.29 -40.26 80.01 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 O-C-N 121.482 -0.761 . . . . 0.0 111.477 172.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -53.8 -47.88 70.38 Favored 'General case' 0 N--CA 1.477 0.911 0 CA-C-N 119.298 0.954 . . . . 0.0 112.29 170.089 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 28.6 mmt85 -63.79 -44.41 93.44 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 124.221 1.008 . . . . 0.0 111.884 178.738 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 19.2 m -62.7 -40.99 98.89 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.776 0.831 . . . . 0.0 111.607 174.087 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 52.9 t -66.4 -42.35 90.32 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 CA-C-O 117.546 -1.216 . . . . 0.0 110.712 177.347 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 20.3 mtm105 -54.83 -44.18 73.67 Favored 'General case' 0 N--CA 1.483 1.224 0 CA-C-N 120.539 1.518 . . . . 0.0 111.708 171.647 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -60.4 -51.55 58.11 Favored Glycine 0 CA--C 1.538 1.499 0 CA-C-N 119.115 0.871 . . . . 0.0 113.797 176.411 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 60.2 mm-40 -65.48 -43.63 89.66 Favored 'General case' 0 N--CA 1.476 0.83 0 O-C-N 121.913 -0.757 . . . . 0.0 112.207 -179.426 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 69.3 t -66.58 -40.09 85.47 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 C-N-CA 124.737 1.215 . . . . 0.0 110.883 177.21 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -56.22 -49.48 73.97 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-N 120.163 1.347 . . . . 0.0 110.965 177.241 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -61.48 -41.99 98.11 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 122.92 0.488 . . . . 0.0 112.231 178.037 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -61.45 -42.98 99.6 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 124.824 1.25 . . . . 0.0 113.204 174.619 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 94.8 t -71.84 -39.46 67.81 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 C-N-CA 124.466 1.107 . . . . 0.0 111.663 177.72 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -62.54 -39.04 92.33 Favored 'General case' 0 N--CA 1.469 0.514 0 O-C-N 121.274 -0.891 . . . . 0.0 111.384 172.443 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 12.6 m-80 -63.78 -45.84 87.89 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 118.703 0.683 . . . . 0.0 112.487 173.155 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 9.8 tt -52.19 -54.39 31.5 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.935 1.294 . . . . 0.0 110.775 173.412 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 68.3 mt -63.87 -42.95 97.52 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 O-C-N 121.749 -0.594 . . . . 0.0 110.518 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -67.53 -10.97 56.66 Favored 'General case' 0 CA--C 1.548 0.866 0 N-CA-C 114.921 1.452 . . . . 0.0 114.921 177.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 20.2 ptmt -107.31 -30.93 8.43 Favored 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 113.942 1.089 . . . . 0.0 113.942 174.373 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . 0.263 7.1 pt -95.63 -11.57 8.73 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 N-CA-C 114.576 1.324 . . . . 0.0 114.576 -178.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 65.4 m . . . . . 0 C--O 1.253 1.246 0 C-N-CA 124.805 1.242 . . . . 0.0 112.78 177.846 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.428 ' HA ' ' O ' ' A' ' 29' ' ' LYS . 25.1 ttt . . . . . 0 N--CA 1.504 2.249 0 N-CA-C 112.133 0.42 . . . . 0.0 112.133 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 2.9 mptp? -126.12 158.0 36.61 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 125.729 1.612 . . . . 0.0 113.264 179.301 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 73.8 mttt -105.35 115.2 29.85 Favored 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 125.929 1.692 . . . . 0.0 106.629 167.39 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 10.7 t -105.81 130.89 56.56 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 C-N-CA 125.079 1.351 . . . . 0.0 113.9 178.62 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 48.8 tpp -102.02 125.66 48.76 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 168.677 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 49.8 m-85 -108.62 119.29 39.1 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 124.362 1.065 . . . . 0.0 109.82 171.486 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 3.4 m -140.3 149.74 21.62 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 C-N-CA 124.675 1.19 . . . . 0.0 111.788 -169.386 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 14.9 t -137.15 148.53 46.68 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 125.821 1.648 . . . . 0.0 111.283 -178.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 47.0 pttt -59.51 123.22 16.14 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 123.88 0.872 . . . . 0.0 111.922 177.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 74.5 mtp85 58.27 -33.9 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.784 0 C-N-CA 129.411 3.084 . . . . 0.0 116.718 -169.319 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . 0.412 HD22 ' NE2' ' A' ' 16' ' ' GLN . 17.9 t-20 59.35 -48.82 0.07 Allowed 'General case' 0 CA--C 1.553 1.065 0 C-N-CA 129.382 3.073 . . . . 0.0 117.116 174.61 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 26.2 m -68.76 -8.6 44.64 Favored 'General case' 0 N--CA 1.482 1.167 0 CA-C-N 120.89 1.677 . . . . 0.0 114.023 -176.348 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 84.1 p -100.22 2.54 42.92 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 126.531 1.932 . . . . 0.0 114.506 170.028 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 83.7 mtt85 -140.86 173.83 11.1 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 126.682 1.993 . . . . 0.0 112.928 -169.645 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 35.1 t -114.92 174.9 5.74 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 125.176 1.391 . . . . 0.0 110.252 169.245 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 0.412 ' NE2' HD22 ' A' ' 11' ' ' ASN . 29.3 mt-30 -141.94 -49.28 0.38 Allowed 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 113.956 1.095 . . . . 0.0 113.956 -170.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 71.67 -46.37 0.64 Allowed 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 126.231 1.812 . . . . 0.0 114.236 173.683 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.19 -32.53 73.18 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 114.258 1.207 . . . . 0.0 114.258 -169.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 7.3 pm0 -63.77 -38.39 90.92 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 123.289 0.635 . . . . 0.0 111.919 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -70.24 -42.84 65.24 Favored Glycine 0 C--N 1.335 0.492 0 C-N-CA 123.715 0.674 . . . . 0.0 111.726 -178.765 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -71.76 -36.25 70.33 Favored 'General case' 0 N--CA 1.468 0.46 0 O-C-N 121.662 -0.905 . . . . 0.0 112.13 177.151 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.89 -35.66 78.99 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 118.609 0.641 . . . . 0.0 112.467 -175.182 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 5.6 pttp -84.9 -35.39 22.18 Favored 'General case' 0 N--CA 1.481 1.093 0 N-CA-C 113.86 1.059 . . . . 0.0 113.86 170.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 75.8 m -67.86 -31.61 71.54 Favored 'General case' 0 N--CA 1.486 1.346 0 CA-C-N 118.828 0.74 . . . . 0.0 112.141 -179.266 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 72.4 mt -96.47 -37.26 10.5 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.801 1.64 . . . . 0.0 112.69 175.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -98.48 4.3 59.93 Favored Glycine 0 N--CA 1.471 1.024 0 N-CA-C 116.572 1.389 . . . . 0.0 116.572 -169.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.18 143.14 56.09 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-N 120.97 2.385 . . . . 0.0 112.524 177.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 83.53 -20.07 12.6 Favored Glycine 0 CA--C 1.542 1.732 0 C-N-CA 124.868 1.223 . . . . 0.0 113.251 -169.322 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.428 ' O ' ' HA ' ' A' ' 1' ' ' MET . 78.4 mttt -101.25 -44.52 5.64 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 125.889 1.676 . . . . 0.0 112.253 169.868 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 38.5 pt -139.33 158.12 28.2 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 C-N-CA 124.162 0.985 . . . . 0.0 113.627 -175.507 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -106.81 145.51 32.02 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 127.252 2.221 . . . . 0.0 109.7 169.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 72.7 t -134.3 141.96 42.19 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 CA-C-N 118.69 0.677 . . . . 0.0 112.759 -175.349 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 38.9 m -134.72 153.01 52.19 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 125.513 1.525 . . . . 0.0 109.075 169.589 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 55.4 p -130.03 146.83 51.72 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.845 0.831 . . . . 0.0 111.288 168.176 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 53.7 p -147.89 -173.63 4.35 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 114.704 -1.135 . . . . 0.0 111.708 175.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -135.96 170.11 23.31 Favored Glycine 0 N--CA 1.468 0.782 0 O-C-N 120.909 -1.119 . . . . 0.0 112.038 177.419 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 10.8 mp -91.68 -9.01 45.44 Favored 'General case' 0 N--CA 1.479 1.021 0 N-CA-C 114.967 1.469 . . . . 0.0 114.967 -169.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -142.13 63.9 1.4 Allowed 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 124.71 1.204 . . . . 0.0 110.934 -176.746 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.402 ' H ' ' HB3' ' A' ' 64' ' ' PRO . 72.7 m 49.53 45.8 23.88 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 126.194 1.798 . . . . 0.0 112.392 -175.456 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 16.6 p -123.26 165.88 16.2 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 126.078 1.751 . . . . 0.0 115.65 -168.812 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 29.3 ptt-85 -138.0 -171.62 3.06 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 127.695 2.398 . . . . 0.0 107.631 171.465 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 26.9 m -60.44 151.72 5.79 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.189 0 CA-C-N 120.369 1.44 . . . . 0.0 110.941 169.418 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -62.99 143.29 97.54 Favored Pre-proline 0 CA--C 1.55 0.975 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 168.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_exo -48.53 -37.11 33.15 Favored 'Trans proline' 0 CA--C 1.542 0.876 0 C-N-CA 123.421 2.748 . . . . 0.0 117.717 -168.195 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 93.9 m -63.23 -24.62 67.96 Favored 'General case' 0 N--CA 1.485 1.304 0 CA-C-N 119.721 1.146 . . . . 0.0 112.777 -174.695 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -51.97 -43.76 63.71 Favored 'General case' 0 CA--C 1.546 0.802 0 CA-C-O 118.352 -0.832 . . . . 0.0 111.034 170.697 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.6 mp -55.79 -54.05 30.71 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.297 0 CA-C-N 120.239 1.382 . . . . 0.0 110.1 178.159 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -62.27 -30.65 71.27 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 123.447 0.699 . . . . 0.0 112.736 -178.18 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' MET . . . . . 0.442 ' HG2' ' CD1' ' A' ' 112' ' ' PHE . 0.0 OUTLIER -76.91 -33.5 57.76 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 113.119 0.785 . . . . 0.0 113.119 176.813 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 3.5 mmt -74.2 -32.5 63.07 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 118.877 0.762 . . . . 0.0 110.735 172.697 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -65.47 -14.05 60.14 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 124.534 1.134 . . . . 0.0 113.787 173.197 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 60.3 mt-10 -62.1 -27.18 68.74 Favored 'General case' 0 N--CA 1.482 1.161 0 CA-C-N 120.66 1.573 . . . . 0.0 110.896 168.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 56.5 t -96.5 -3.63 10.2 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.874 0 C-N-CA 127.54 2.336 . . . . 0.0 111.275 176.118 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 78.93 19.13 73.49 Favored Glycine 0 CA--C 1.541 1.677 0 C-N-CA 125.029 1.299 . . . . 0.0 114.374 -175.784 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 85.7 mt -77.88 135.3 26.53 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 C-N-CA 124.709 1.204 . . . . 0.0 111.638 -174.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 17.9 t0 -96.05 102.19 13.96 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 112.667 0.617 . . . . 0.0 112.667 178.133 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 8.6 pt -129.58 14.92 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.273 0 C-N-CA 125.214 1.406 . . . . 0.0 113.396 170.514 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 72.7 m -59.48 126.7 28.7 Favored 'General case' 0 N--CA 1.473 0.715 0 O-C-N 120.711 -1.243 . . . . 0.0 112.295 -172.592 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 80.15 -22.62 4.29 Favored Glycine 0 CA--C 1.538 1.48 0 C-N-CA 125.278 1.418 . . . . 0.0 115.938 179.653 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 70.8 mt-30 41.0 -96.12 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 127.482 2.313 . . . . 0.0 113.428 -175.535 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 9.1 t -145.63 163.95 33.24 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 126.655 1.982 . . . . 0.0 109.914 169.719 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 75.5 m -100.55 -2.52 32.75 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 125.904 1.682 . . . . 0.0 113.148 172.216 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 29.2 m-20 -111.05 146.79 35.22 Favored Pre-proline 0 CA--C 1.544 0.742 0 C-N-CA 124.053 0.941 . . . . 0.0 113.38 -174.523 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.402 ' HB3' ' H ' ' A' ' 39' ' ' SER . 57.6 Cg_endo -71.52 162.07 43.41 Favored 'Trans proline' 0 C--N 1.349 0.58 0 C-N-CA 122.541 2.16 . . . . 0.0 113.163 176.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 5.5 tt -48.74 -43.97 14.4 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 C-N-CA 124.465 1.106 . . . . 0.0 111.36 171.322 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -69.12 -5.64 23.53 Favored 'General case' 0 CA--C 1.546 0.813 0 N-CA-C 114.466 1.284 . . . . 0.0 114.466 -177.591 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 5.4 t-20 -84.27 -21.59 31.03 Favored 'General case' 0 CA--C 1.547 0.839 0 N-CA-C 113.312 0.856 . . . . 0.0 113.312 172.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 83.5 m-85 -91.3 -171.58 3.0 Favored 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 125.431 1.492 . . . . 0.0 111.838 -179.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 14.9 t30 -117.53 120.44 38.1 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.52 1.128 . . . . 0.0 109.351 175.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -64.97 -44.64 88.7 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 115.108 1.521 . . . . 0.0 115.108 -169.122 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -79.77 6.22 11.48 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 113.591 0.96 . . . . 0.0 113.591 -172.458 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -73.57 -26.66 60.93 Favored 'General case' 0 CA--C 1.545 0.783 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 167.617 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 76.4 m-85 -86.44 157.84 19.73 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 127.101 2.161 . . . . 0.0 110.244 169.635 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -116.07 -15.79 11.1 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 124.237 1.015 . . . . 0.0 112.355 174.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 91.6 t -129.33 135.27 62.13 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 C-N-CA 126.93 2.092 . . . . 0.0 107.648 174.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 66.7 t -131.8 123.42 51.65 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 169.471 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 45.7 mm -108.59 106.79 21.35 Favored 'Isoleucine or valine' 0 C--O 1.235 0.298 0 C-N-CA 124.645 1.178 . . . . 0.0 108.76 -175.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 4.1 m -85.42 92.26 8.44 Favored 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 123.983 0.913 . . . . 0.0 110.061 171.596 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 81.4 mt -67.34 172.52 4.77 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 126.259 1.823 . . . . 0.0 111.794 172.801 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 17.3 m 65.88 7.94 4.97 Favored 'General case' 0 CA--C 1.549 0.906 0 N-CA-C 114.868 1.433 . . . . 0.0 114.868 175.03 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 69.37 132.02 0.06 OUTLIER Glycine 0 CA--C 1.535 1.286 0 C-N-CA 126.793 2.14 . . . . 0.0 115.157 -179.801 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 38.2 m 60.18 43.48 13.98 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 125.84 1.656 . . . . 0.0 112.311 174.277 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -75.7 65.14 2.53 Favored Glycine 0 N--CA 1.472 1.058 0 C-N-CA 124.951 1.263 . . . . 0.0 111.281 174.44 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.9 p -112.81 -2.32 10.3 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 C-N-CA 125.263 1.425 . . . . 0.0 113.622 -169.647 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 62.0 t30 -77.26 -11.14 59.79 Favored 'General case' 0 CA--C 1.552 1.03 0 O-C-N 121.221 -0.924 . . . . 0.0 113.289 176.284 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -66.23 158.61 76.45 Favored Pre-proline 0 CA--C 1.556 1.19 0 C-N-CA 124.335 1.054 . . . . 0.0 112.494 170.282 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -60.1 151.27 73.91 Favored 'Trans proline' 0 CA--C 1.543 0.933 0 C-N-CA 122.776 2.317 . . . . 0.0 113.337 179.645 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -61.33 -26.54 81.8 Favored 'Trans proline' 0 C--N 1.35 0.656 0 C-N-CA 123.364 2.709 . . . . 0.0 113.863 -174.146 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -59.82 -22.2 61.9 Favored 'General case' 0 CA--C 1.541 0.596 0 CA-C-O 117.966 -1.016 . . . . 0.0 113.534 174.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 93.5 m95 -87.64 -12.97 43.97 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 125.025 1.33 . . . . 0.0 113.806 177.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 4.7 m -96.47 -7.75 9.48 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 CA-C-N 119.072 0.851 . . . . 0.0 112.946 171.736 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . 0.269 0.7 OUTLIER -96.47 -4.57 41.34 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 114.818 1.414 . . . . 0.0 114.818 -175.548 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 11.8 mp0 -61.05 156.89 16.86 Favored 'General case' 0 N--CA 1.487 1.384 0 CA-C-O 122.531 1.158 . . . . 0.0 111.183 168.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -61.83 -39.54 92.15 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 114.354 -1.294 . . . . 0.0 113.4 -168.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 16.6 mm -115.63 59.07 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 C-N-CA 125.321 1.448 . . . . 0.0 109.071 176.439 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 35.4 t80 -76.22 109.73 10.14 Favored 'General case' 0 CA--C 1.535 0.376 0 O-C-N 120.51 -1.369 . . . . 0.0 107.945 169.054 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 9.6 mt-10 -111.39 128.66 56.05 Favored 'General case' 0 N--CA 1.471 0.625 0 N-CA-C 113.214 0.82 . . . . 0.0 113.214 174.298 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -93.84 112.51 24.37 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 168.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 38.7 m0 -94.04 104.2 16.25 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 124.375 1.07 . . . . 0.0 108.983 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 73.7 mm-40 -74.73 54.82 0.64 Allowed 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 126.797 2.039 . . . . 0.0 110.342 173.32 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.1 tt -104.81 146.22 29.28 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 127.099 2.159 . . . . 0.0 110.624 -169.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -56.5 144.15 32.49 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 125.06 1.344 . . . . 0.0 113.848 174.289 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -97.34 119.77 62.31 Favored Pre-proline 0 CA--C 1.546 0.825 0 C-N-CA 124.661 1.184 . . . . 0.0 108.015 168.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -76.4 -11.22 19.03 Favored 'Trans proline' 0 CA--C 1.542 0.906 0 C-N-CA 122.067 1.845 . . . . 0.0 114.132 -173.671 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -74.72 155.87 37.23 Favored 'General case' 0 CA--C 1.546 0.795 0 CA-C-N 119.684 1.129 . . . . 0.0 113.689 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 76.47 8.41 85.83 Favored Glycine 0 CA--C 1.536 1.394 0 C-N-CA 124.712 1.149 . . . . 0.0 114.434 -177.667 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 15.0 pt20 -143.31 170.52 15.61 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 126.824 2.049 . . . . 0.0 111.196 179.239 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 15.9 m -56.77 154.32 9.34 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 125.031 1.332 . . . . 0.0 114.56 -169.568 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 60.2 tp -58.34 -30.05 66.42 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.902 0.881 . . . . 0.0 112.493 176.338 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -59.35 -31.93 69.64 Favored 'General case' 0 N--CA 1.475 0.793 0 O-C-N 121.351 -0.843 . . . . 0.0 113.268 170.559 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 14.0 t -74.12 -41.53 51.91 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 O-C-N 121.008 -1.058 . . . . 0.0 110.306 173.624 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.442 ' CD1' ' HG2' ' A' ' 49' ' ' MET . 0.3 OUTLIER -54.38 -47.26 72.87 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 119.097 0.862 . . . . 0.0 112.611 169.76 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -70.9 -34.21 71.33 Favored 'General case' 0 N--CA 1.477 0.902 0 O-C-N 121.395 -0.816 . . . . 0.0 112.726 179.191 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 53.3 m -64.98 -41.25 95.6 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.834 0.854 . . . . 0.0 111.13 170.686 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 54.7 t -68.34 -35.73 72.11 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 CA-C-O 117.371 -1.299 . . . . 0.0 111.029 175.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 28.6 mtm105 -56.23 -43.02 78.2 Favored 'General case' 0 N--CA 1.485 1.292 0 CA-C-N 121.275 1.852 . . . . 0.0 111.355 169.611 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -61.18 -49.98 72.12 Favored Glycine 0 CA--C 1.54 1.629 0 CA-C-N 119.132 0.878 . . . . 0.0 113.594 175.197 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 64.0 mm-40 -62.74 -46.73 86.7 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.537 0.735 . . . . 0.0 112.136 177.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 91.3 t -69.89 -34.71 61.4 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 C-N-CA 124.324 1.049 . . . . 0.0 111.262 -179.5 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 63.7 tttm -55.96 -51.85 66.23 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 120.44 1.473 . . . . 0.0 110.908 172.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -63.92 -42.07 97.48 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 123.303 0.641 . . . . 0.0 112.522 177.418 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -66.88 -34.8 78.58 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 125.446 1.498 . . . . 0.0 112.306 179.407 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 76.9 t -76.57 -40.89 34.18 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.089 0 C-N-CA 125.098 1.359 . . . . 0.0 111.511 173.716 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -62.6 -34.12 76.38 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 119.425 1.011 . . . . 0.0 111.604 173.156 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 9.6 m-80 -65.72 -44.4 86.17 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 119.056 0.844 . . . . 0.0 113.035 172.031 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -53.49 -55.48 25.0 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 123.884 0.874 . . . . 0.0 110.304 172.482 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 75.5 mt -61.39 -43.17 96.22 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 CA-C-O 119.164 -0.446 . . . . 0.0 110.666 -179.819 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -68.9 -13.58 62.51 Favored 'General case' 0 CA--C 1.544 0.744 0 N-CA-C 115.116 1.524 . . . . 0.0 115.116 179.704 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 21.4 ptmt -98.61 -28.17 13.68 Favored 'General case' 0 N--CA 1.477 0.887 0 CA-C-N 119.382 0.992 . . . . 0.0 113.541 172.767 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 18.5 pt -93.98 -22.57 5.55 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 N-CA-C 114.486 1.291 . . . . 0.0 114.486 177.581 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 75.6 m . . . . . 0 C--O 1.252 1.227 0 C-N-CA 125.418 1.487 . . . . 0.0 111.552 -173.77 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.3 ttt . . . . . 0 N--CA 1.504 2.234 0 N-CA-C 111.556 0.206 . . . . 0.0 111.556 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.14 166.0 25.9 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 125.018 1.327 . . . . 0.0 112.971 176.071 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 70.0 mttt -94.81 146.07 24.44 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 123.82 0.848 . . . . 0.0 112.629 174.466 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 16.7 t -124.28 138.13 54.85 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 125.645 1.578 . . . . 0.0 111.083 172.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -109.74 121.2 44.68 Favored 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 110.19 -0.3 . . . . 0.0 110.19 169.136 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 45.2 m-85 -96.52 125.19 40.83 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 170.608 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 28.8 m -140.49 151.57 21.0 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 N-CA-C 113.786 1.032 . . . . 0.0 113.786 -168.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 33.5 t -152.95 142.55 21.86 Favored 'General case' 0 CA--C 1.548 0.904 0 C-N-CA 124.711 1.204 . . . . 0.0 113.606 -172.717 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -80.79 140.52 35.44 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 124.779 1.232 . . . . 0.0 109.324 168.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 31.2 mtm180 52.54 47.34 24.91 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 125.48 1.512 . . . . 0.0 112.522 -169.12 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 23.4 t30 -57.32 -27.63 62.36 Favored 'General case' 0 CA--C 1.551 0.996 0 C-N-CA 125.581 1.552 . . . . 0.0 113.282 -179.786 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 72.8 m -73.32 -30.75 63.58 Favored 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 113.419 0.896 . . . . 0.0 113.419 172.041 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 48.8 m -80.66 -40.04 26.23 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 123.876 0.87 . . . . 0.0 112.082 179.458 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 11.7 mmt180 -101.88 163.34 12.3 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 124.645 1.178 . . . . 0.0 113.458 -173.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 3.7 m -106.92 134.96 49.3 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.148 0.979 . . . . 0.0 111.041 174.13 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 3.9 mp0 -105.11 -38.14 6.67 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 115.018 1.488 . . . . 0.0 115.018 -168.27 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' MET . . . . . 0.416 ' HG2' ' SD ' ' A' ' 50' ' ' MET . 0.0 OUTLIER 67.16 -55.55 0.45 Allowed 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 126.71 2.004 . . . . 0.0 115.66 170.372 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -57.82 -37.04 73.09 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.923 1.289 . . . . 0.0 114.205 -169.577 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 7.5 pm0 -58.76 -31.97 68.84 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 125.391 1.476 . . . . 0.0 113.709 179.523 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -66.83 -68.06 1.79 Allowed Glycine 0 C--N 1.337 0.622 0 N-CA-C 110.588 -1.005 . . . . 0.0 110.588 174.506 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -50.65 -34.12 25.15 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 124.135 0.974 . . . . 0.0 113.449 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -60.24 -32.58 71.27 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 -177.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . 0.273 0.0 OUTLIER -98.84 -24.91 14.81 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 114.081 1.141 . . . . 0.0 114.081 169.947 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 1.3 m -64.51 -36.54 84.52 Favored 'General case' 0 N--CA 1.488 1.436 0 CA-C-N 120.33 1.423 . . . . 0.0 111.974 173.796 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 68.6 mt -98.96 -28.26 13.51 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 125.454 1.502 . . . . 0.0 113.206 178.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -111.93 2.77 27.2 Favored Glycine 0 N--CA 1.474 1.204 0 N-CA-C 118.112 2.005 . . . . 0.0 118.112 -169.389 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -66.34 -20.37 66.07 Favored 'General case' 0 N--CA 1.477 0.878 0 CA-C-N 122.548 3.174 . . . . 0.0 116.648 -169.684 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -75.69 -6.68 82.1 Favored Glycine 0 CA--C 1.542 1.748 0 O-C-N 121.339 -0.85 . . . . 0.0 113.881 169.627 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 61.1 mttp -119.87 -40.06 2.78 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 127.162 2.185 . . . . 0.0 113.101 -174.375 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 43.6 pt -144.27 157.22 15.31 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 C-N-CA 125.911 1.684 . . . . 0.0 112.686 -171.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -101.02 139.78 36.23 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.415 1.086 . . . . 0.0 109.39 169.486 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 30.2 t -130.79 136.46 58.14 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.076 0 CA-C-N 119.831 1.196 . . . . 0.0 113.179 177.632 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 37.1 m -131.02 154.91 47.7 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 125.969 1.708 . . . . 0.0 109.73 175.034 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 3.2 m -124.64 147.86 48.28 Favored 'General case' 0 CA--C 1.513 -0.458 0 CA-C-O 121.617 0.722 . . . . 0.0 112.42 168.358 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 2.2 m -142.74 149.74 39.15 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 113.688 -1.596 . . . . 0.0 111.167 172.636 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -79.82 165.21 49.23 Favored Glycine 0 CA--C 1.528 0.852 0 N-CA-C 110.888 -0.885 . . . . 0.0 110.888 169.484 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 9.1 mp -80.17 -11.51 59.74 Favored 'General case' 0 N--CA 1.48 1.036 0 O-C-N 121.653 -0.91 . . . . 0.0 112.809 169.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -132.03 165.5 23.84 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 126.973 2.109 . . . . 0.0 108.811 169.662 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 68.4 m -57.78 114.31 2.24 Favored 'General case' 0 N--CA 1.479 1.012 0 O-C-N 121.232 -0.917 . . . . 0.0 110.574 178.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 88.9 p -158.24 178.17 10.47 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 114.748 1.388 . . . . 0.0 114.748 -168.717 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 13.2 tpt180 -132.35 147.32 52.39 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 128.178 2.591 . . . . 0.0 108.631 174.296 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 33.0 m -62.28 154.91 5.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 CA-C-N 120.668 1.576 . . . . 0.0 109.425 168.394 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 11.9 t-80 -53.53 135.09 53.51 Favored Pre-proline 0 C--N 1.327 -0.389 0 CA-C-N 114.87 -1.059 . . . . 0.0 112.564 -170.13 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_exo -60.75 -26.11 82.37 Favored 'Trans proline' 0 CA--C 1.548 1.175 0 CA-C-N 121.01 1.397 . . . . 0.0 112.677 175.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 51.1 m -70.02 -33.94 72.65 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 125.296 1.438 . . . . 0.0 112.058 171.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -57.99 -43.2 86.44 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 124.018 0.927 . . . . 0.0 111.636 -178.474 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.7 mp -52.85 -54.15 17.82 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 CA-C-N 119.182 0.901 . . . . 0.0 109.425 -178.652 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -65.76 -32.28 73.73 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 113.351 0.871 . . . . 0.0 113.351 -177.406 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -79.19 -29.95 43.14 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 113.433 0.901 . . . . 0.0 113.433 178.683 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' MET . . . . . 0.416 ' SD ' ' HG2' ' A' ' 17' ' ' MET . 1.0 OUTLIER -80.82 -29.57 35.95 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 123.521 0.728 . . . . 0.0 110.828 172.739 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -66.92 -12.27 58.93 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 124.719 1.208 . . . . 0.0 113.486 170.02 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -65.62 -26.23 67.73 Favored 'General case' 0 N--CA 1.481 1.076 0 CA-C-N 120.513 1.506 . . . . 0.0 110.892 169.06 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 56.7 t -93.72 -7.54 10.17 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.804 0 C-N-CA 126.996 2.119 . . . . 0.0 111.049 173.023 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 82.16 20.11 63.46 Favored Glycine 0 CA--C 1.538 1.501 0 C-N-CA 125.086 1.327 . . . . 0.0 114.22 -175.183 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 36.0 mt -85.68 126.13 40.51 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 CA-C-N 118.48 1.14 . . . . 0.0 110.805 -176.645 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 19.9 t0 -87.43 121.33 29.72 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.143 0.577 . . . . 0.0 111.537 170.692 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 29.2 pt -136.37 -1.72 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.24 0 N-CA-C 116.083 1.883 . . . . 0.0 116.083 -178.568 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 79.1 p -62.93 -25.61 68.42 Favored 'General case' 0 N--CA 1.482 1.17 0 N-CA-C 116.122 1.897 . . . . 0.0 116.122 -169.019 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -102.29 3.21 50.79 Favored Glycine 0 CA--C 1.537 1.431 0 N-CA-C 116.12 1.208 . . . . 0.0 116.12 -176.132 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 31.5 mt-30 -72.89 -44.3 61.46 Favored 'General case' 0 N--CA 1.48 1.05 0 CA-C-N 119.31 1.555 . . . . 0.0 113.639 -169.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 12.3 p -90.7 119.33 30.85 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 124.115 0.966 . . . . 0.0 112.382 -178.701 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 99.4 p -141.08 -12.17 0.95 Allowed 'General case' 0 N--CA 1.478 0.944 0 N-CA-C 114.884 1.439 . . . . 0.0 114.884 177.191 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -147.36 150.6 38.04 Favored Pre-proline 0 CA--C 1.546 0.821 0 C-N-CA 125.131 1.372 . . . . 0.0 111.58 179.522 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -63.15 155.71 59.66 Favored 'Trans proline' 0 C--N 1.35 0.624 0 C-N-CA 123.31 2.673 . . . . 0.0 112.168 169.543 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 10.3 tt -50.77 -33.84 12.47 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 C-N-CA 124.869 1.268 . . . . 0.0 112.291 171.261 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -62.41 -21.54 65.47 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.575 1.15 . . . . 0.0 112.87 -177.074 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 82.0 m-20 -91.7 4.7 52.14 Favored 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 124.452 1.101 . . . . 0.0 113.645 -176.264 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -116.48 -176.82 3.04 Favored 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 126.304 1.842 . . . . 0.0 112.377 179.283 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -119.76 125.0 47.56 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 125.874 1.67 . . . . 0.0 110.068 175.368 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -67.79 -34.91 77.7 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 113.921 1.082 . . . . 0.0 113.921 -171.201 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . 0.261 0.0 OUTLIER -71.6 -4.32 26.39 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 114.278 1.214 . . . . 0.0 114.278 -176.602 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -73.18 -15.96 61.44 Favored 'General case' 0 CA--C 1.548 0.871 0 O-C-N 121.711 -0.618 . . . . 0.0 111.136 168.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -112.45 138.5 49.11 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 127.074 2.15 . . . . 0.0 111.497 178.676 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -88.42 -23.68 23.25 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-O 122.112 0.958 . . . . 0.0 112.317 176.125 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 76.3 t -133.29 137.65 52.86 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 C-N-CA 126.679 1.992 . . . . 0.0 108.769 -175.487 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 78.8 t -133.56 131.92 57.3 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 173.184 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 43.3 mm -121.51 106.06 17.59 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 C-N-CA 124.243 1.017 . . . . 0.0 109.344 -171.378 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 4.1 m -88.75 109.79 20.45 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 123.631 0.772 . . . . 0.0 110.643 178.406 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 89.3 mt -90.76 -19.02 23.98 Favored 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 114.899 1.444 . . . . 0.0 114.899 -172.45 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 10.6 m -141.56 144.52 34.3 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.746 1.218 . . . . 0.0 110.703 -169.789 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 62.15 -125.37 35.97 Favored Glycine 0 CA--C 1.533 1.205 0 N-CA-C 110.632 -0.987 . . . . 0.0 110.632 -171.538 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 77.9 p -152.62 171.86 17.51 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.671 1.188 . . . . 0.0 111.527 169.719 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -66.41 65.0 0.16 Allowed Glycine 0 CA--C 1.538 1.512 0 C-N-CA 125.757 1.646 . . . . 0.0 114.691 176.043 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 7.7 p -143.79 -28.4 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.105 0 C-N-CA 125.633 1.573 . . . . 0.0 113.345 -178.324 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -91.19 22.95 3.51 Favored 'General case' 0 CA--C 1.554 1.121 0 C-N-CA 124.337 1.055 . . . . 0.0 112.447 178.115 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -133.54 159.28 73.15 Favored Pre-proline 0 CA--C 1.549 0.93 0 C-N-CA 126.338 1.855 . . . . 0.0 111.024 173.208 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -58.89 149.2 80.11 Favored 'Trans proline' 0 CA--C 1.543 0.937 0 C-N-CA 122.58 2.187 . . . . 0.0 112.695 178.229 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -61.77 -28.94 82.47 Favored 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 122.909 2.406 . . . . 0.0 113.626 -170.489 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -60.36 -20.95 61.4 Favored 'General case' 0 CA--C 1.544 0.723 0 N-CA-C 114.071 1.137 . . . . 0.0 114.071 177.704 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 88.6 m95 -80.34 -19.86 45.54 Favored 'General case' 0 N--CA 1.47 0.563 0 O-C-N 120.622 -1.299 . . . . 0.0 113.257 175.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 16.3 m -93.81 -8.21 9.98 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.125 0 N-CA-C 113.634 0.975 . . . . 0.0 113.634 172.213 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 67.5 p -96.98 -0.31 47.61 Favored 'General case' 0 N--CA 1.48 1.032 0 N-CA-C 114.796 1.406 . . . . 0.0 114.796 177.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 73.3 mm-40 -65.2 152.63 43.16 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 119.172 0.896 . . . . 0.0 111.213 169.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -54.01 -42.91 69.6 Favored 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 114.986 1.476 . . . . 0.0 114.986 -167.734 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 8.6 mm -118.26 65.16 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 C-N-CA 124.072 0.949 . . . . 0.0 109.224 173.41 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 23.3 t80 -75.31 109.46 8.85 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 106.909 -1.515 . . . . 0.0 106.909 168.645 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -104.58 130.45 52.55 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-O 121.797 0.808 . . . . 0.0 112.93 171.489 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -92.14 105.99 18.1 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 123.692 0.797 . . . . 0.0 109.399 169.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 19.0 m0 -94.47 99.26 11.46 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 124.571 1.148 . . . . 0.0 110.239 -176.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 99.9 mm-40 -79.13 53.7 1.5 Allowed 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 124.699 1.2 . . . . 0.0 110.514 170.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 5.0 tt -91.84 150.91 20.82 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 127.057 2.143 . . . . 0.0 111.9 -172.147 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -68.23 117.92 10.67 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 123.553 0.741 . . . . 0.0 112.868 179.029 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -74.43 133.25 77.62 Favored Pre-proline 0 CA--C 1.556 1.173 0 O-C-N 121.522 -0.736 . . . . 0.0 110.317 169.664 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -87.8 -6.96 6.57 Favored 'Trans proline' 0 CA--C 1.554 1.479 0 C-N-CA 122.295 1.997 . . . . 0.0 114.646 -178.597 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -64.38 146.91 53.69 Favored 'General case' 0 CA--C 1.547 0.864 0 CA-C-N 120.537 1.517 . . . . 0.0 113.188 176.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 75.77 8.62 84.65 Favored Glycine 0 CA--C 1.537 1.436 0 C-N-CA 123.869 0.747 . . . . 0.0 114.872 176.153 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 13.2 pt20 -140.75 165.46 27.44 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 125.893 1.677 . . . . 0.0 112.257 178.365 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 70.9 m -57.92 157.65 7.48 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 125.638 1.575 . . . . 0.0 114.843 -169.47 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 35.9 tp -59.25 -29.19 67.37 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 124.605 1.162 . . . . 0.0 113.001 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -61.9 -31.42 71.71 Favored 'General case' 0 N--CA 1.472 0.661 0 O-C-N 120.812 -1.18 . . . . 0.0 112.208 172.346 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 4.7 t -72.78 -40.49 60.97 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 O-C-N 121.146 -0.971 . . . . 0.0 111.114 171.73 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -55.16 -47.88 74.54 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 120.02 1.282 . . . . 0.0 112.056 169.857 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -69.13 -36.7 77.75 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.46 0.704 . . . . 0.0 112.506 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 79.0 m -63.86 -42.4 97.55 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 123.777 0.831 . . . . 0.0 110.832 171.593 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 44.1 t -65.96 -41.25 89.46 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 CA-C-O 117.567 -1.206 . . . . 0.0 110.803 176.429 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 30.8 mtm105 -55.73 -44.41 77.49 Favored 'General case' 0 N--CA 1.483 1.185 0 CA-C-N 120.841 1.655 . . . . 0.0 112.243 171.608 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -61.14 -50.85 62.75 Favored Glycine 0 CA--C 1.537 1.464 0 CA-C-N 118.979 0.809 . . . . 0.0 113.103 177.114 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 56.5 mm-40 -63.58 -45.0 92.42 Favored 'General case' 0 N--CA 1.473 0.689 0 O-C-N 121.996 -0.708 . . . . 0.0 112.217 178.387 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 70.4 t -64.78 -40.86 90.51 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 124.964 1.306 . . . . 0.0 111.301 177.679 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 84.3 tttt -54.44 -49.52 69.82 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 119.89 1.223 . . . . 0.0 110.474 176.215 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -63.64 -42.37 98.16 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 112.637 0.606 . . . . 0.0 112.637 176.268 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.24 -36.28 83.12 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 124.181 0.992 . . . . 0.0 112.897 177.803 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 92.5 t -78.44 -38.9 23.19 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 C-N-CA 125.521 1.529 . . . . 0.0 111.713 177.574 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -63.36 -35.43 80.38 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 119.546 1.066 . . . . 0.0 111.285 171.472 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 12.5 m-80 -64.89 -44.47 89.52 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 118.827 0.74 . . . . 0.0 112.52 172.328 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 9.8 tt -52.57 -57.18 10.81 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 124.237 1.015 . . . . 0.0 110.25 170.534 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 70.2 mt -60.58 -42.69 92.55 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 O-C-N 121.387 -0.821 . . . . 0.0 110.744 -177.805 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -68.45 -14.61 63.12 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 114.828 1.418 . . . . 0.0 114.828 178.263 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 19.0 ptmt -106.0 -32.75 8.16 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 113.596 0.961 . . . . 0.0 113.596 176.577 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 4.7 pt -88.98 -18.97 7.69 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 CA-C-O 118.038 -0.982 . . . . 0.0 113.619 -176.692 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 69.7 m . . . . . 0 C--O 1.253 1.274 0 N-CA-C 112.781 0.66 . . . . 0.0 112.781 -177.946 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.0 ttt . . . . . 0 N--CA 1.503 2.179 0 N-CA-C 111.774 0.287 . . . . 0.0 111.774 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.89 156.17 38.36 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 125.667 1.587 . . . . 0.0 113.207 179.422 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 44.1 mtmt -101.72 108.65 20.24 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 125.518 1.527 . . . . 0.0 107.342 167.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 16.3 t -95.18 131.92 40.64 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 125.981 1.713 . . . . 0.0 113.72 175.475 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 37.6 tpp -102.98 120.2 40.22 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 123.765 0.826 . . . . 0.0 109.162 168.804 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 65.0 m-85 -99.0 118.93 36.9 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 125.68 1.592 . . . . 0.0 108.307 174.588 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 1.5 m -137.91 151.44 25.56 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.143 0 N-CA-C 115.013 1.486 . . . . 0.0 115.013 -168.64 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 41.5 t -155.31 162.99 40.72 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 125.691 1.597 . . . . 0.0 111.028 169.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 40.2 ttmt -69.99 133.05 46.84 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 125.052 1.341 . . . . 0.0 110.855 169.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 98.2 mtt180 51.13 80.12 0.09 Allowed 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 126.88 2.072 . . . . 0.0 112.386 -176.541 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 21.9 t-20 -67.98 -32.99 73.78 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 113.828 1.047 . . . . 0.0 113.828 -174.174 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 60.4 p -76.29 157.45 32.51 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 125.008 1.323 . . . . 0.0 112.688 169.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 67.1 m 53.62 26.45 5.77 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 124.901 1.28 . . . . 0.0 114.242 -174.681 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 23.9 ttm180 -147.33 151.85 37.24 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 127.76 2.424 . . . . 0.0 110.048 -175.32 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 46.0 t -109.07 152.84 24.49 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.49 0.716 . . . . 0.0 111.248 170.157 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -139.98 -42.43 0.43 Allowed 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 125.887 1.675 . . . . 0.0 111.893 -169.52 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 65.91 -36.72 0.24 Allowed 'General case' 0 N--CA 1.478 0.975 0 N-CA-C 118.205 2.668 . . . . 0.0 118.205 169.238 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.27 -36.56 80.36 Favored 'General case' 0 C--O 1.224 -0.289 0 CA-C-N 119.278 0.944 . . . . 0.0 113.406 -171.26 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.5 pm0 -57.46 -34.37 68.94 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 124.361 1.064 . . . . 0.0 113.307 171.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -72.49 -57.03 5.73 Favored Glycine 0 C--N 1.332 0.332 0 C-N-CA 124.293 0.949 . . . . 0.0 111.425 177.437 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -59.34 -33.79 71.57 Favored 'General case' 0 N--CA 1.468 0.43 0 O-C-N 122.24 -0.565 . . . . 0.0 112.427 177.902 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -63.38 -40.16 96.47 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 119.198 0.908 . . . . 0.0 112.285 -178.825 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 33.7 mttm -58.3 -56.39 22.73 Favored 'General case' 0 N--CA 1.486 1.373 0 CA-C-O 121.544 0.688 . . . . 0.0 110.874 168.782 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 35.9 m -69.75 -24.15 63.48 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 125.186 1.394 . . . . 0.0 114.056 -169.392 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 76.7 mt -96.38 -19.15 19.41 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 125.066 1.347 . . . . 0.0 114.461 177.262 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -159.01 26.29 0.37 Allowed Glycine 0 C--N 1.344 0.979 0 N-CA-C 119.021 2.368 . . . . 0.0 119.021 -169.001 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -66.56 -21.28 66.15 Favored 'General case' 0 CA--C 1.546 0.812 0 CA-C-N 122.15 2.975 . . . . 0.0 115.37 -176.501 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -74.86 -5.47 75.03 Favored Glycine 0 CA--C 1.542 1.745 0 O-C-N 121.493 -0.755 . . . . 0.0 113.776 169.546 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 70.0 mttt -117.18 -37.24 3.58 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 127.536 2.335 . . . . 0.0 113.301 -178.565 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 40.1 pt -142.76 150.07 18.41 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 C-N-CA 124.386 1.074 . . . . 0.0 113.171 -174.619 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -99.53 139.23 35.5 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 125.813 1.645 . . . . 0.0 108.337 169.355 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 5.1 m -132.14 144.91 35.71 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.236 0 C-N-CA 124.033 0.933 . . . . 0.0 110.352 -173.578 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 72.3 m -138.42 138.91 38.65 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 123.522 0.729 . . . . 0.0 109.411 175.091 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 2.8 p -98.67 138.04 36.42 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 112.127 0.417 . . . . 0.0 112.127 168.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 24.4 p -149.18 162.29 40.28 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 113.274 0.842 . . . . 0.0 113.274 170.095 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -109.78 147.1 17.11 Favored Glycine 0 N--CA 1.473 1.165 0 C-N-CA 124.236 0.922 . . . . 0.0 113.89 -179.393 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 11.2 mp -68.32 -25.55 65.17 Favored 'General case' 0 N--CA 1.485 1.298 0 CA-C-N 119.395 1.597 . . . . 0.0 111.041 169.603 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -142.36 144.31 33.12 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 127.688 2.395 . . . . 0.0 106.955 169.06 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 25.5 p 58.05 171.42 0.05 Allowed 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 126.91 2.084 . . . . 0.0 116.172 -176.106 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 83.2 p -137.79 168.38 19.8 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 125.805 1.642 . . . . 0.0 114.34 178.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 24.5 ttt-85 61.74 124.24 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 129.494 3.117 . . . . 0.0 113.398 -169.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 32.0 m -57.89 144.8 9.97 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.32 0 C-N-CA 123.376 0.67 . . . . 0.0 109.557 169.696 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -65.13 147.68 98.39 Favored Pre-proline 0 CA--C 1.544 0.749 0 C-N-CA 119.369 -0.932 . . . . 0.0 112.332 -169.614 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo -48.27 -41.72 34.59 Favored 'Trans proline' 0 CA--C 1.538 0.707 0 C-N-CA 123.375 2.717 . . . . 0.0 117.51 -168.185 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 86.1 m -64.82 -24.0 67.41 Favored 'General case' 0 N--CA 1.485 1.32 0 O-C-N 121.211 -0.931 . . . . 0.0 112.267 -177.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -57.6 -34.25 69.06 Favored 'General case' 0 CA--C 1.536 0.406 0 O-C-N 121.315 -0.865 . . . . 0.0 112.153 173.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.7 mp -60.58 -57.88 9.94 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 CA-C-N 119.901 1.228 . . . . 0.0 109.312 175.564 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -61.31 -32.77 72.63 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 113.122 0.786 . . . . 0.0 113.122 -178.561 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 3.8 tpp -77.36 -24.14 50.7 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 113.209 0.818 . . . . 0.0 113.209 178.051 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -87.49 -27.35 22.71 Favored 'General case' 0 CA--C 1.541 0.615 0 O-C-N 121.136 -0.977 . . . . 0.0 110.876 172.464 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -65.62 -5.16 7.51 Favored 'General case' 0 CA--C 1.552 1.055 0 C-N-CA 125.166 1.386 . . . . 0.0 113.036 169.456 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 18.5 mt-10 -72.79 -29.26 63.13 Favored 'General case' 0 N--CA 1.484 1.263 0 CA-C-N 120.039 1.29 . . . . 0.0 111.082 171.284 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 8.5 p -113.21 12.94 8.34 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.798 0 C-N-CA 127.143 2.177 . . . . 0.0 111.26 -177.142 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 80.17 18.06 72.75 Favored Glycine 0 CA--C 1.533 1.202 0 C-N-CA 124.978 1.275 . . . . 0.0 115.861 170.668 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 2.4 mm -71.92 143.49 14.14 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 CA-C-N 119.549 1.674 . . . . 0.0 110.286 177.757 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -97.82 29.63 3.32 Favored 'General case' 0 CA--C 1.553 1.083 0 C-N-CA 125.986 1.714 . . . . 0.0 115.476 -176.825 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 11.6 pt -72.11 -2.75 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.384 0 N-CA-C 115.594 1.702 . . . . 0.0 115.594 -175.173 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 91.6 p -55.58 -32.35 62.98 Favored 'General case' 0 N--CA 1.479 1.016 0 CA-C-N 119.851 1.205 . . . . 0.0 113.828 179.453 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -82.44 3.61 81.27 Favored Glycine 0 CA--C 1.536 1.364 0 C-N-CA 125.237 1.399 . . . . 0.0 116.105 177.412 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 5.1 mt-30 -79.48 132.68 36.41 Favored 'General case' 0 C--N 1.343 0.319 0 CA-C-N 120.362 2.081 . . . . 0.0 112.33 -179.019 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 40.4 p -139.66 113.58 8.75 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 126.068 1.747 . . . . 0.0 107.051 168.747 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 59.7 p -114.61 -174.7 2.53 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 114.703 1.371 . . . . 0.0 114.703 -169.208 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -133.86 164.49 43.64 Favored Pre-proline 0 CA--C 1.546 0.812 0 C-N-CA 126.833 2.053 . . . . 0.0 109.628 176.798 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -60.78 155.95 46.03 Favored 'Trans proline' 0 CA--C 1.541 0.871 0 C-N-CA 122.193 1.928 . . . . 0.0 112.522 169.769 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 7.5 tt -53.55 -33.17 21.67 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 C-N-CA 125.428 1.491 . . . . 0.0 111.552 175.045 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 17.8 mt-10 -59.66 -20.58 57.08 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 125.315 1.446 . . . . 0.0 113.112 178.662 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -85.31 -9.96 57.01 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 125.294 1.438 . . . . 0.0 113.609 -179.015 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -108.27 178.77 4.4 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 126.334 1.854 . . . . 0.0 112.301 -176.312 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 20.3 t30 -114.58 126.08 54.5 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 125.208 1.403 . . . . 0.0 110.075 175.774 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -63.47 -43.34 97.6 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 114.515 1.302 . . . . 0.0 114.515 -169.756 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -75.26 -0.9 21.13 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 113.495 0.924 . . . . 0.0 113.495 -178.468 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -71.83 -12.96 61.54 Favored 'General case' 0 CA--C 1.544 0.724 0 O-C-N 121.572 -0.705 . . . . 0.0 110.784 168.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -116.21 141.81 47.65 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 126.175 1.79 . . . . 0.0 111.222 178.715 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -86.71 -31.73 20.85 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 125.464 1.505 . . . . 0.0 111.651 174.717 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 94.3 t -129.12 138.03 55.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 C-N-CA 125.446 1.498 . . . . 0.0 108.38 -171.366 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 37.3 t -130.56 125.15 58.49 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 173.488 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 44.3 mm -116.25 102.87 14.27 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 C-N-CA 125.052 1.341 . . . . 0.0 108.8 -173.403 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 15.8 m -86.31 106.77 17.61 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 124.041 0.936 . . . . 0.0 110.111 176.493 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 81.1 mt -82.04 -4.92 57.86 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 125.271 1.428 . . . . 0.0 114.647 -169.772 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 28.6 p -152.9 147.96 26.59 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 124.34 1.056 . . . . 0.0 112.121 -175.7 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 60.84 -160.39 25.61 Favored Glycine 0 CA--C 1.536 1.385 0 C-N-CA 124.585 1.088 . . . . 0.0 114.739 176.589 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 86.9 p -71.45 -22.69 61.8 Favored 'General case' 0 N--CA 1.475 0.782 0 O-C-N 121.305 -1.115 . . . . 0.0 113.575 175.454 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 72.58 10.0 75.02 Favored Glycine 0 CA--C 1.533 1.201 0 C-N-CA 124.968 1.27 . . . . 0.0 114.367 -176.39 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.0 p -77.07 -16.76 14.57 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 CA-C-N 119.36 1.58 . . . . 0.0 114.664 -169.702 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 36.4 m120 -80.44 -9.3 59.76 Favored 'General case' 0 CA--C 1.548 0.901 0 N-CA-C 114.984 1.475 . . . . 0.0 114.984 -170.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -75.59 159.64 81.1 Favored Pre-proline 0 CA--C 1.552 1.033 0 CA-C-N 119.323 0.965 . . . . 0.0 112.066 169.727 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_exo -58.43 142.97 98.26 Favored 'Trans proline' 0 CA--C 1.547 1.146 0 C-N-CA 122.607 2.205 . . . . 0.0 113.011 179.287 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_exo -54.85 -32.08 75.8 Favored 'Trans proline' 0 C--N 1.353 0.777 0 C-N-CA 123.358 2.706 . . . . 0.0 115.62 -171.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 2.9 pm0 -61.95 -16.82 54.04 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 114.239 1.2 . . . . 0.0 114.239 177.76 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 93.6 m95 -80.58 -24.01 39.49 Favored 'General case' 0 CA--C 1.542 0.669 0 O-C-N 120.45 -1.406 . . . . 0.0 112.908 171.728 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 11.8 m -85.98 -10.19 11.27 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.167 0 CA-C-N 119.909 1.231 . . . . 0.0 113.555 174.195 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 72.0 p -98.31 0.96 46.57 Favored 'General case' 0 N--CA 1.477 0.917 0 N-CA-C 115.225 1.565 . . . . 0.0 115.225 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 76.7 mm-40 -67.4 160.35 27.55 Favored 'General case' 0 N--CA 1.478 0.971 0 CA-C-N 119.482 1.037 . . . . 0.0 110.95 169.803 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -58.01 -36.04 72.12 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 116.09 1.885 . . . . 0.0 116.09 -168.34 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 12.1 mm -127.18 74.55 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 CA-C-N 119.605 1.093 . . . . 0.0 109.062 177.707 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 12.4 t80 -81.57 109.78 16.34 Favored 'General case' 0 CA--C 1.534 0.365 0 O-C-N 121.224 -0.922 . . . . 0.0 108.544 169.289 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -111.32 139.33 46.82 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 114.636 1.347 . . . . 0.0 114.636 174.403 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -104.94 121.15 43.12 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.242 1.017 . . . . 0.0 108.98 168.754 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 43.8 m0 -107.07 111.61 24.15 Favored 'General case' 0 C--N 1.33 -0.239 0 C-N-CA 124.756 1.222 . . . . 0.0 108.352 -179.686 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 84.0 mm-40 -83.95 53.96 2.76 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-O 122.318 1.056 . . . . 0.0 111.561 -173.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 87.7 mt -85.53 165.86 16.76 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 126.957 2.103 . . . . 0.0 112.22 -179.704 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -96.29 157.0 16.1 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 123.98 0.912 . . . . 0.0 113.147 172.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 51.5 t0 -86.34 124.26 70.21 Favored Pre-proline 0 CA--C 1.542 0.665 0 C-N-CA 124.445 1.098 . . . . 0.0 110.266 173.021 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_exo -58.67 -24.4 70.57 Favored 'Trans proline' 0 CA--C 1.543 0.952 0 C-N-CA 122.925 2.417 . . . . 0.0 115.343 172.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -65.94 143.52 57.35 Favored 'General case' 0 CA--C 1.546 0.792 0 CA-C-N 119.444 1.02 . . . . 0.0 112.995 -178.771 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 80.95 5.95 89.78 Favored Glycine 0 CA--C 1.536 1.399 0 N-CA-C 115.176 0.83 . . . . 0.0 115.176 178.617 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 8.6 pt20 -142.17 168.3 20.07 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 125.378 1.471 . . . . 0.0 112.833 179.275 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 66.8 m -59.67 155.21 16.17 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 125.503 1.521 . . . . 0.0 114.085 -170.181 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 7.9 tt -60.51 -30.98 70.07 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.746 1.218 . . . . 0.0 113.569 -175.107 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -65.17 -23.96 67.25 Favored 'General case' 0 CA--C 1.546 0.81 0 O-C-N 121.059 -1.026 . . . . 0.0 112.899 173.544 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 11.3 t -72.84 -38.15 56.47 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 O-C-N 120.789 -1.195 . . . . 0.0 110.734 170.651 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -53.76 -45.73 70.69 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 118.78 0.718 . . . . 0.0 110.686 169.045 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 38.9 mtt180 -66.77 -39.08 87.71 Favored 'General case' 0 N--CA 1.482 1.159 0 N-CA-C 113.012 0.745 . . . . 0.0 113.012 175.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 28.9 m -58.89 -42.88 90.58 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 124.345 1.058 . . . . 0.0 110.946 172.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 77.6 t -67.99 -38.57 80.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 CA-C-O 117.894 -1.051 . . . . 0.0 111.083 177.361 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 65.9 mtm-85 -57.25 -43.82 83.34 Favored 'General case' 0 N--CA 1.487 1.413 0 CA-C-N 120.696 1.589 . . . . 0.0 112.208 170.169 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -59.37 -49.6 76.74 Favored Glycine 0 CA--C 1.536 1.403 0 CA-C-N 119.104 0.865 . . . . 0.0 113.253 176.522 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 55.5 mm-40 -64.57 -44.11 91.73 Favored 'General case' 0 N--CA 1.473 0.709 0 O-C-N 122.078 -0.66 . . . . 0.0 112.131 177.788 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 75.6 t -65.95 -37.38 79.72 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 124.203 1.001 . . . . 0.0 111.344 177.201 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 58.2 tttm -55.93 -51.9 66.0 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-N 119.81 1.186 . . . . 0.0 110.743 176.212 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -63.78 -40.82 97.6 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.119 0.568 . . . . 0.0 112.199 178.347 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -62.87 -44.08 97.07 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 124.583 1.153 . . . . 0.0 113.272 176.486 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 66.8 t -74.31 -35.8 40.93 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 124.188 0.995 . . . . 0.0 111.518 178.56 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -63.1 -39.76 95.65 Favored 'General case' 0 N--CA 1.471 0.58 0 O-C-N 121.138 -0.976 . . . . 0.0 111.679 169.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 11.6 m-80 -63.36 -44.94 93.36 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 118.976 0.807 . . . . 0.0 112.225 172.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 8.4 tt -51.49 -56.79 11.41 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 124.48 1.112 . . . . 0.0 110.306 174.334 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 62.8 mt -66.82 -44.24 89.23 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 O-C-N 121.848 -0.533 . . . . 0.0 111.174 -175.731 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -69.4 -10.53 58.38 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 114.102 1.149 . . . . 0.0 114.102 177.559 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 72.7 tttt -95.77 -48.26 5.83 Favored 'General case' 0 C--O 1.234 0.239 0 C-N-CA 125.811 1.644 . . . . 0.0 111.428 176.037 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 7.5 pt -93.71 -15.17 7.99 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 N-CA-C 114.375 1.25 . . . . 0.0 114.375 -172.798 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 73.8 m . . . . . 0 C--O 1.256 1.408 0 C-N-CA 125.606 1.562 . . . . 0.0 111.722 -176.464 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.8 ttt . . . . . 0 N--CA 1.502 2.166 0 N-CA-C 111.861 0.319 . . . . 0.0 111.861 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.72 164.99 28.88 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 125.371 1.468 . . . . 0.0 112.937 178.737 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 71.1 mttt -94.49 146.42 24.11 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 124.085 0.954 . . . . 0.0 112.872 175.58 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 14.5 t -123.51 134.45 66.31 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 C-N-CA 125.543 1.537 . . . . 0.0 111.998 175.019 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 48.6 tpp -102.81 123.48 46.54 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 168.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 72.4 m-85 -101.35 131.19 47.54 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 169.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -140.65 143.18 29.35 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 N-CA-C 114.012 1.116 . . . . 0.0 114.012 -169.379 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 46.4 t -145.14 160.11 41.94 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 127.473 2.309 . . . . 0.0 109.081 169.36 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 64.9 pttt -66.23 -42.67 88.32 Favored 'General case' 0 N--CA 1.485 1.311 0 N-CA-C 115.117 1.525 . . . . 0.0 115.117 -171.341 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 12.7 mmm180 -113.29 63.12 0.64 Allowed 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 126.758 2.023 . . . . 0.0 112.148 -175.705 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 47.2 t30 -45.42 -46.6 13.48 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 125.139 1.376 . . . . 0.0 113.834 -172.52 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 86.0 p -78.36 -10.2 59.59 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 115.717 1.747 . . . . 0.0 115.717 -175.674 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 88.6 p -133.36 0.34 3.35 Favored 'General case' 0 N--CA 1.479 1.003 0 N-CA-C 116.3 1.963 . . . . 0.0 116.3 179.401 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 2.4 tpt180 -112.82 -27.38 8.15 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 114.889 1.44 . . . . 0.0 114.889 178.766 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 3.0 t 63.77 166.63 0.14 Allowed 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 115.639 1.718 . . . . 0.0 115.639 -176.221 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -141.58 -50.06 0.41 Allowed 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 114.396 1.258 . . . . 0.0 114.396 -170.006 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 70.52 -38.78 0.43 Allowed 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 126.185 1.794 . . . . 0.0 114.096 -178.374 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -63.02 -30.79 71.88 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 113.992 1.108 . . . . 0.0 113.992 -173.73 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.2 pm0 -67.2 -42.42 84.18 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 119.568 1.077 . . . . 0.0 111.837 175.759 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -66.77 -41.31 93.75 Favored Glycine 0 C--N 1.335 0.48 0 N-CA-C 111.351 -0.7 . . . . 0.0 111.351 -178.324 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -70.89 -39.25 72.92 Favored 'General case' 0 N--CA 1.469 0.497 0 O-C-N 121.842 -0.799 . . . . 0.0 111.815 174.91 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -63.76 -35.92 82.19 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 119.375 0.989 . . . . 0.0 112.909 -176.08 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 7.5 pttp -82.72 -28.35 30.54 Favored 'General case' 0 N--CA 1.479 0.996 0 N-CA-C 113.972 1.101 . . . . 0.0 113.972 171.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 96.6 m -70.22 -35.74 74.08 Favored 'General case' 0 N--CA 1.486 1.341 0 CA-C-N 118.76 0.709 . . . . 0.0 111.937 175.093 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 74.1 mt -91.0 -38.03 13.08 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 125.92 1.688 . . . . 0.0 113.324 179.175 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -105.11 5.98 42.57 Favored Glycine 0 N--CA 1.471 1.008 0 N-CA-C 117.5 1.76 . . . . 0.0 117.5 -169.303 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.61 141.23 57.91 Favored 'General case' 0 CA--C 1.546 0.821 0 CA-C-N 121.149 2.474 . . . . 0.0 112.294 178.122 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 82.88 -16.93 24.46 Favored Glycine 0 CA--C 1.539 1.564 0 C-N-CA 124.868 1.223 . . . . 0.0 113.959 -169.539 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 62.7 mttp -104.0 -44.29 5.06 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 125.897 1.679 . . . . 0.0 112.172 171.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 38.1 pt -139.53 159.63 27.99 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 C-N-CA 125.323 1.449 . . . . 0.0 112.64 -178.257 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -107.85 149.23 28.52 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.378 1.471 . . . . 0.0 110.397 170.017 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 98.1 t -133.46 141.64 43.86 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 O-C-N 121.497 -0.752 . . . . 0.0 112.796 -176.173 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 38.8 m -134.91 153.33 52.1 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 125.732 1.613 . . . . 0.0 108.926 169.703 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 92.8 p -133.33 145.73 50.67 Favored 'General case' 0 CA--C 1.512 -0.497 0 CA-C-O 122.372 1.082 . . . . 0.0 112.179 167.774 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 54.4 p -145.97 166.53 25.77 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 113.714 -1.584 . . . . 0.0 112.199 -177.68 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -106.63 162.82 13.57 Favored Glycine 0 N--CA 1.467 0.753 0 C-N-CA 123.587 0.613 . . . . 0.0 112.754 172.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 9.0 mp -76.0 -32.27 59.33 Favored 'General case' 0 N--CA 1.479 1.024 0 O-C-N 122.144 -0.621 . . . . 0.0 111.819 172.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -134.29 27.23 3.8 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 125.734 1.614 . . . . 0.0 111.916 177.12 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 37.5 t -154.66 145.45 22.46 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 124.319 1.048 . . . . 0.0 112.796 -170.353 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 98.8 p -107.96 -13.04 15.05 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 116.853 2.168 . . . . 0.0 116.853 -169.679 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 71.7 ttt180 -134.38 149.12 50.79 Favored 'General case' 0 N--CA 1.483 1.217 0 CA-C-N 120.009 1.277 . . . . 0.0 111.072 -176.382 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 22.3 m -68.11 166.27 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.15 0 CA-C-O 122.908 1.337 . . . . 0.0 110.98 169.536 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 6.1 t-80 -57.04 129.87 79.18 Favored Pre-proline 0 N--CA 1.447 -0.586 0 CA-C-N 114.049 -1.432 . . . . 0.0 111.716 179.163 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_exo -61.1 -29.2 86.88 Favored 'Trans proline' 0 CA--C 1.549 1.25 0 CA-C-N 121.145 1.445 . . . . 0.0 112.3 177.506 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 99.3 m -67.64 -28.24 67.56 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 126.069 1.748 . . . . 0.0 112.656 172.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -59.68 -41.06 89.84 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 119.119 0.872 . . . . 0.0 111.748 -176.717 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.9 mp -54.17 -55.16 15.83 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 C-N-CA 123.976 0.91 . . . . 0.0 109.298 -177.585 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -65.83 -34.63 78.61 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 113.94 1.089 . . . . 0.0 113.94 -176.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -78.26 -20.57 51.38 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 113.676 0.991 . . . . 0.0 113.676 179.785 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 43.0 mtt -98.16 -26.78 14.45 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 125.032 1.333 . . . . 0.0 110.493 177.391 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -66.53 -13.82 61.47 Favored 'General case' 0 CA--C 1.544 0.717 0 O-C-N 120.662 -1.274 . . . . 0.0 111.784 168.525 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -61.83 -24.65 67.02 Favored 'General case' 0 N--CA 1.482 1.136 0 O-C-N 121.001 -1.062 . . . . 0.0 110.652 168.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 40.0 t -99.62 -6.77 9.15 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.882 0 C-N-CA 127.896 2.478 . . . . 0.0 111.275 175.358 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 81.68 20.82 62.95 Favored Glycine 0 CA--C 1.54 1.647 0 C-N-CA 125.293 1.425 . . . . 0.0 114.378 -173.44 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 85.7 mt -79.65 127.14 39.37 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 CA-C-N 118.485 1.143 . . . . 0.0 111.874 -173.51 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 20.7 t0 -89.15 93.73 9.68 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 123.538 0.735 . . . . 0.0 112.006 177.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 7.2 pt -118.27 11.08 7.03 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.082 0 C-N-CA 124.703 1.201 . . . . 0.0 113.957 170.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 72.7 m -60.42 -27.33 67.4 Favored 'General case' 0 N--CA 1.479 0.988 0 O-C-N 120.793 -1.192 . . . . 0.0 112.541 176.57 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -82.55 6.8 67.43 Favored Glycine 0 CA--C 1.538 1.472 0 C-N-CA 125.63 1.586 . . . . 0.0 116.031 174.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 26.5 mm100 -78.16 43.4 0.44 Allowed 'General case' 0 N--CA 1.478 0.969 0 CA-C-N 120.069 1.934 . . . . 0.0 113.599 -179.812 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 36.6 p -87.96 111.97 22.06 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 107.102 -1.444 . . . . 0.0 107.102 168.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 70.4 m -130.81 -160.59 1.05 Allowed 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 124.831 1.252 . . . . 0.0 111.374 -168.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -124.14 166.98 16.71 Favored Pre-proline 0 CA--C 1.546 0.797 0 C-N-CA 126.354 1.862 . . . . 0.0 108.464 169.543 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_endo -58.21 156.92 27.7 Favored 'Trans proline' 0 CA--C 1.539 0.761 0 C-N-CA 121.917 1.744 . . . . 0.0 112.38 169.573 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 9.8 tp -49.94 -34.02 9.51 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 C-N-CA 125.537 1.535 . . . . 0.0 112.363 174.183 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 12.7 mt-10 -64.32 -18.42 64.6 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.864 1.266 . . . . 0.0 113.126 -177.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -87.06 -13.9 43.01 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 124.994 1.318 . . . . 0.0 113.583 -173.255 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -104.67 -174.24 2.49 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 126.164 1.786 . . . . 0.0 112.686 -174.594 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 6.1 t30 -121.94 121.99 38.35 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 125.679 1.591 . . . . 0.0 109.519 175.035 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -64.11 -37.79 88.71 Favored 'General case' 0 C--N 1.333 -0.139 0 N-CA-C 114.943 1.46 . . . . 0.0 114.943 -169.617 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -73.64 -1.4 18.76 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 114.141 1.163 . . . . 0.0 114.141 -174.071 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -73.37 -14.87 61.36 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 123.392 0.677 . . . . 0.0 110.743 168.712 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 81.2 m-85 -112.44 140.57 47.07 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 127.315 2.246 . . . . 0.0 111.203 178.195 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -91.21 -22.58 20.55 Favored 'General case' 0 N--CA 1.477 0.879 0 CA-C-O 121.992 0.901 . . . . 0.0 112.303 176.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 90.5 t -134.5 138.1 50.26 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 C-N-CA 126.849 2.06 . . . . 0.0 108.948 -173.611 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 47.3 t -134.52 130.4 53.52 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 172.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 39.3 mm -119.0 104.83 16.51 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 C-N-CA 124.292 1.037 . . . . 0.0 109.717 -172.363 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 7.3 m -81.88 118.92 23.31 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 123.807 0.843 . . . . 0.0 109.634 171.359 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 90.5 mt -100.11 -7.23 25.13 Favored 'General case' 0 N--CA 1.478 0.929 0 N-CA-C 114.491 1.293 . . . . 0.0 114.491 -171.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 76.5 m -131.06 59.92 1.67 Allowed 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 125.217 1.407 . . . . 0.0 109.177 -169.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 82.4 -155.44 34.16 Favored Glycine 0 CA--C 1.536 1.354 0 C-N-CA 124.846 1.212 . . . . 0.0 111.602 -169.577 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 83.6 p -66.3 -29.91 70.22 Favored 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 113.483 0.92 . . . . 0.0 113.483 177.855 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 66.4 20.5 69.66 Favored Glycine 0 CA--C 1.534 1.247 0 C-N-CA 124.402 1.001 . . . . 0.0 114.11 -177.312 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 7.3 p -55.99 -9.89 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.34 0 N-CA-C 116.118 1.896 . . . . 0.0 116.118 -169.691 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -66.82 -22.18 66.01 Favored 'General case' 0 CA--C 1.554 1.124 0 N-CA-C 114.362 1.245 . . . . 0.0 114.362 169.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -67.82 154.51 93.41 Favored Pre-proline 0 N--CA 1.483 1.202 0 CA-C-N 120.903 1.683 . . . . 0.0 112.009 169.693 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_exo -57.71 148.51 73.86 Favored 'Trans proline' 0 CA--C 1.545 1.045 0 C-N-CA 122.698 2.265 . . . . 0.0 113.825 -175.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_exo -56.04 -32.54 86.65 Favored 'Trans proline' 0 C--N 1.354 0.85 0 C-N-CA 123.12 2.547 . . . . 0.0 114.898 -171.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -60.51 -21.69 62.73 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 114.057 1.132 . . . . 0.0 114.057 179.411 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 93.7 m95 -79.48 -21.52 45.29 Favored 'General case' 0 N--CA 1.47 0.529 0 O-C-N 120.695 -1.253 . . . . 0.0 113.169 175.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 14.2 m -92.42 -5.94 10.69 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 N-CA-C 113.481 0.919 . . . . 0.0 113.481 173.431 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 59.9 p -100.32 0.39 39.99 Favored 'General case' 0 N--CA 1.479 1.006 0 N-CA-C 115.29 1.589 . . . . 0.0 115.29 177.32 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 74.0 mm-40 -66.89 155.42 38.46 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-N 119.459 1.027 . . . . 0.0 110.722 169.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -54.78 -43.12 72.55 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 115.093 1.516 . . . . 0.0 115.093 -167.78 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 10.0 mm -116.53 66.39 0.23 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 C-N-CA 123.875 0.87 . . . . 0.0 109.579 176.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 12.2 t80 -77.04 108.71 10.3 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 168.595 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 9.1 mt-10 -107.62 142.58 37.34 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 114.321 1.23 . . . . 0.0 114.321 173.511 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -107.66 120.24 41.66 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 124.634 1.174 . . . . 0.0 108.23 168.381 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 37.3 m0 -103.84 133.67 48.44 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.545 1.138 . . . . 0.0 108.814 177.504 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 63.8 mt-30 -113.88 29.36 8.06 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 123.993 0.917 . . . . 0.0 111.987 -169.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -70.37 164.62 24.15 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 125.732 1.613 . . . . 0.0 112.292 170.621 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -73.63 158.71 34.25 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-O 121.773 0.797 . . . . 0.0 111.49 169.824 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -97.02 150.77 37.2 Favored Pre-proline 0 CA--C 1.542 0.653 0 C-N-CA 123.418 0.687 . . . . 0.0 110.055 169.797 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -88.59 -12.44 3.71 Favored 'Trans proline' 0 CA--C 1.547 1.152 0 CA-C-N 120.845 1.338 . . . . 0.0 115.072 -173.415 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -62.53 -50.27 72.04 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 114.928 1.455 . . . . 0.0 114.928 -170.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -77.24 16.69 5.63 Favored Glycine 0 CA--C 1.537 1.425 0 N-CA-C 115.256 0.862 . . . . 0.0 115.256 -169.825 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 7.9 pt20 -155.92 179.28 9.36 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 126.006 1.722 . . . . 0.0 112.63 -169.221 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 27.8 p -68.8 167.46 15.43 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 116.27 1.952 . . . . 0.0 116.27 -169.314 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 36.0 tp -59.88 -31.81 70.14 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.412 1.085 . . . . 0.0 112.46 172.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -63.46 -32.51 73.98 Favored 'General case' 0 N--CA 1.47 0.537 0 O-C-N 121.073 -1.017 . . . . 0.0 111.499 172.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 4.4 t -74.1 -35.07 40.21 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 O-C-N 121.2 -0.937 . . . . 0.0 112.069 171.54 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -55.59 -46.95 77.18 Favored 'General case' 0 N--CA 1.477 0.889 0 CA-C-N 120.424 1.466 . . . . 0.0 111.255 169.413 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 96.9 mtt180 -69.87 -33.91 72.87 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.75 0.82 . . . . 0.0 112.585 178.275 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 53.2 m -63.34 -42.89 98.98 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 123.787 0.835 . . . . 0.0 110.96 170.212 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 50.8 t -65.11 -40.56 89.28 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.475 0 CA-C-O 117.316 -1.326 . . . . 0.0 110.55 176.413 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 24.7 mtm105 -53.63 -47.38 70.34 Favored 'General case' 0 N--CA 1.484 1.248 0 CA-C-N 120.804 1.638 . . . . 0.0 112.287 170.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -61.36 -50.65 64.54 Favored Glycine 0 CA--C 1.537 1.417 0 CA-C-N 119.027 0.831 . . . . 0.0 113.644 177.743 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 65.2 mm-40 -63.49 -44.48 94.24 Favored 'General case' 0 N--CA 1.474 0.736 0 O-C-N 121.991 -0.711 . . . . 0.0 112.332 179.221 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 56.0 t -63.79 -43.73 98.02 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 C-N-CA 124.507 1.123 . . . . 0.0 110.603 176.485 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 59.5 tttm -53.56 -50.69 65.01 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-N 119.804 1.184 . . . . 0.0 111.295 179.602 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -63.58 -41.32 98.38 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 179.064 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 8.5 mtp85 -64.25 -42.12 96.65 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 113.145 0.794 . . . . 0.0 113.145 175.766 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 94.2 t -71.0 -36.44 63.53 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 C-N-CA 123.674 0.79 . . . . 0.0 111.156 178.71 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -63.31 -38.09 89.81 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 119.386 0.994 . . . . 0.0 111.606 170.724 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 12.5 m-80 -62.67 -48.02 81.12 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 118.914 0.779 . . . . 0.0 112.052 171.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 10.3 tt -50.45 -57.24 8.49 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 124.483 1.113 . . . . 0.0 110.07 173.809 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 75.3 mt -64.02 -42.57 96.1 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 CA-C-N 119.25 0.932 . . . . 0.0 111.56 -176.601 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -68.22 -10.46 54.62 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 114.535 1.309 . . . . 0.0 114.535 175.781 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 74.6 tttt -103.5 -45.78 4.75 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 126.049 1.74 . . . . 0.0 111.664 -179.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 5.4 pt -92.06 -16.53 7.88 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 N-CA-C 114.48 1.289 . . . . 0.0 114.48 -170.293 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 72.5 m . . . . . 0 C--O 1.253 1.281 0 CA-C-N 118.913 0.778 . . . . 0.0 112.9 -175.603 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.1 ttt . . . . . 0 N--CA 1.502 2.151 0 N-CA-C 111.615 0.228 . . . . 0.0 111.615 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.75 166.5 25.06 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 124.768 1.227 . . . . 0.0 113.654 177.266 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 44.2 mtmt -94.76 138.71 32.23 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 126.154 1.782 . . . . 0.0 112.954 -179.191 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 21.2 t -123.6 133.51 68.99 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 C-N-CA 126.036 1.734 . . . . 0.0 112.479 -179.151 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 41.8 tpp -104.66 125.51 50.85 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.562 0.745 . . . . 0.0 109.492 168.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 58.6 m-85 -102.81 127.72 49.86 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.266 1.026 . . . . 0.0 109.667 170.351 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 1.3 m -140.51 144.98 26.46 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.182 0 N-CA-C 114.414 1.265 . . . . 0.0 114.414 -168.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 41.7 t -157.06 159.65 38.15 Favored 'General case' 0 CA--C 1.556 1.18 0 C-N-CA 127.369 2.268 . . . . 0.0 111.974 177.443 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 17.9 ptpt -90.57 157.67 17.39 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 124.997 1.319 . . . . 0.0 111.638 169.522 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 34.1 mtp180 60.15 25.47 14.81 Favored 'General case' 0 N--CA 1.494 1.746 0 C-N-CA 126.074 1.75 . . . . 0.0 113.804 -169.098 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 5.8 t30 -52.95 -38.61 62.18 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 124.839 1.256 . . . . 0.0 114.045 -169.449 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 50.2 m -80.31 -8.34 59.44 Favored 'General case' 0 N--CA 1.478 0.96 0 N-CA-C 114.692 1.367 . . . . 0.0 114.692 -178.621 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 83.6 p -119.76 16.54 12.72 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 125.394 1.478 . . . . 0.0 112.996 170.672 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 19.5 ttm180 -139.49 156.06 47.17 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 125.653 1.581 . . . . 0.0 112.115 -175.78 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 73.0 m -94.76 138.08 33.03 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 125.015 1.326 . . . . 0.0 111.046 169.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 3.9 mp0 -113.71 -39.1 4.1 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 124.291 1.037 . . . . 0.0 112.497 -177.1 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' MET . . . . . 0.415 ' HG2' ' SD ' ' A' ' 50' ' ' MET . 0.0 OUTLIER 68.96 -50.98 0.59 Allowed 'General case' 0 N--CA 1.478 0.954 0 N-CA-C 117.641 2.46 . . . . 0.0 117.641 169.212 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -56.73 -35.3 68.4 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 114.398 1.258 . . . . 0.0 114.398 -169.246 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 23.4 pm0 -61.13 -40.06 92.37 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.944 1.297 . . . . 0.0 112.711 177.137 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -69.91 -37.77 74.79 Favored Glycine 0 C--N 1.336 0.554 0 N-CA-C 111.377 -0.689 . . . . 0.0 111.377 178.46 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -70.43 -40.25 73.9 Favored 'General case' 0 N--CA 1.47 0.546 0 O-C-N 121.89 -0.771 . . . . 0.0 111.184 176.514 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.21 -41.79 97.46 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 119.024 0.829 . . . . 0.0 112.527 -175.567 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 10.5 pttp -79.49 -27.53 41.48 Favored 'General case' 0 N--CA 1.479 1.013 0 N-CA-C 113.662 0.986 . . . . 0.0 113.662 173.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 96.3 m -68.84 -36.59 78.34 Favored 'General case' 0 N--CA 1.486 1.342 0 O-C-N 121.185 -0.947 . . . . 0.0 111.636 172.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 72.1 mt -87.89 -29.67 20.7 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 125.656 1.582 . . . . 0.0 114.037 -178.489 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -146.03 28.95 1.69 Allowed Glycine 0 N--CA 1.473 1.129 0 N-CA-C 118.502 2.161 . . . . 0.0 118.502 -169.206 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -66.62 -20.2 65.94 Favored 'General case' 0 CA--C 1.546 0.813 0 CA-C-N 122.108 2.954 . . . . 0.0 115.197 -177.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -76.49 -7.73 85.5 Favored Glycine 0 CA--C 1.542 1.771 0 O-C-N 121.432 -0.793 . . . . 0.0 113.597 169.575 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 61.1 mttp -111.33 -40.73 4.32 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 127.088 2.155 . . . . 0.0 112.692 -178.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 28.3 pt -141.09 155.71 21.63 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 C-N-CA 125.366 1.466 . . . . 0.0 112.42 -172.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -103.06 136.6 42.56 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 124.678 1.191 . . . . 0.0 110.199 171.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 74.6 t -123.54 137.18 57.65 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 CA-C-N 118.814 0.734 . . . . 0.0 112.134 -175.327 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 41.4 m -129.59 153.71 47.8 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 125.566 1.547 . . . . 0.0 108.763 169.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 26.0 p -129.59 146.33 51.4 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.806 0.812 . . . . 0.0 111.991 168.671 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 59.4 p -145.78 148.17 32.66 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 114.247 -1.342 . . . . 0.0 112.117 177.45 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -82.32 152.66 31.16 Favored Glycine 0 CA--C 1.53 1.009 0 O-C-N 121.429 -0.794 . . . . 0.0 111.493 172.646 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.7 mp -69.4 -32.8 72.04 Favored 'General case' 0 N--CA 1.477 0.877 0 O-C-N 120.843 -1.387 . . . . 0.0 113.389 179.006 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -134.77 11.9 3.68 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 124.683 1.193 . . . . 0.0 113.027 178.641 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 23.6 p -152.73 173.89 14.71 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 125.227 1.411 . . . . 0.0 112.013 -174.71 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 62.6 m -99.0 -73.39 0.62 Allowed 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 113.738 1.014 . . . . 0.0 113.738 -169.838 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 30.3 ttt85 -86.18 165.89 16.18 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 125.906 1.682 . . . . 0.0 111.463 -169.397 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 21.3 m -82.57 166.38 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 C-N-CA 123.258 0.623 . . . . 0.0 111.316 170.356 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . 0.262 0.0 OUTLIER -67.67 137.76 93.12 Favored Pre-proline 0 CA--C 1.545 0.766 0 C-N-CA 118.971 -1.091 . . . . 0.0 109.879 169.752 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -61.38 -30.06 86.65 Favored 'Trans proline' 0 CA--C 1.537 0.67 0 C-N-CA 123.219 2.613 . . . . 0.0 116.148 -167.793 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 90.7 m -64.14 -23.96 67.51 Favored 'General case' 0 N--CA 1.481 1.075 0 O-C-N 120.969 -1.082 . . . . 0.0 111.86 -177.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -55.67 -38.62 69.85 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.117 0.967 . . . . 0.0 112.507 172.513 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 5.0 mp -60.22 -54.7 31.26 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 CA-C-N 119.588 1.085 . . . . 0.0 110.018 179.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.3 -32.09 73.41 Favored 'General case' 0 CA--C 1.542 0.656 0 N-CA-C 113.222 0.823 . . . . 0.0 113.222 -178.535 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 2.1 tpp -77.71 -25.6 49.48 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 113.679 0.992 . . . . 0.0 113.679 177.176 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' MET . . . . . 0.415 ' SD ' ' HG2' ' A' ' 17' ' ' MET . 0.0 OUTLIER -88.01 -26.84 22.4 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-N 119.723 1.147 . . . . 0.0 111.04 174.145 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -65.12 -11.83 44.22 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 124.998 1.319 . . . . 0.0 113.219 169.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 17.9 mt-10 -61.7 -27.05 68.42 Favored 'General case' 0 N--CA 1.485 1.29 0 CA-C-N 120.012 1.278 . . . . 0.0 110.26 168.551 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 21.6 t -98.27 -1.52 10.17 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.958 0 C-N-CA 128.232 2.613 . . . . 0.0 110.829 178.774 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 77.04 20.13 76.3 Favored Glycine 0 CA--C 1.538 1.512 0 C-N-CA 125.041 1.305 . . . . 0.0 114.474 -176.036 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 70.5 mt -80.25 128.12 38.86 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 124.279 1.032 . . . . 0.0 111.72 -172.122 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 10.4 p-10 -88.22 100.35 12.91 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 124.372 1.069 . . . . 0.0 112.582 -179.734 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 12.9 pt -133.25 15.4 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.141 0 N-CA-C 114.934 1.457 . . . . 0.0 114.934 178.473 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 66.5 m -63.56 -19.77 65.09 Favored 'General case' 0 N--CA 1.481 1.09 0 O-C-N 120.32 -1.487 . . . . 0.0 113.293 177.514 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -85.41 10.08 65.3 Favored Glycine 0 CA--C 1.538 1.506 0 C-N-CA 125.993 1.759 . . . . 0.0 116.59 179.636 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 64.3 mt-30 -71.96 40.45 0.08 Allowed 'General case' 0 N--CA 1.486 1.34 0 CA-C-N 120.334 2.067 . . . . 0.0 114.699 -178.753 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 88.8 m -80.98 -4.56 55.51 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 119.788 -1.82 . . . . 0.0 112.662 177.198 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 70.5 m -45.11 146.4 0.87 Allowed 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 127.416 2.287 . . . . 0.0 114.323 176.332 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -67.69 171.51 5.18 Favored Pre-proline 0 CA--C 1.553 1.087 0 C-N-CA 127.169 2.188 . . . . 0.0 114.1 -175.558 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -59.03 160.06 19.8 Favored 'Trans proline' 0 C--N 1.353 0.798 0 C-N-CA 122.987 2.458 . . . . 0.0 113.621 169.73 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 7.6 tt -51.21 -37.6 18.11 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 C-N-CA 124.864 1.266 . . . . 0.0 111.854 174.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 14.1 mt-10 -64.61 -17.4 63.96 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.715 1.206 . . . . 0.0 113.111 -177.269 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -83.71 -12.3 56.01 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 124.927 1.291 . . . . 0.0 113.233 -178.31 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -106.94 -175.31 2.76 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 126.449 1.9 . . . . 0.0 112.723 -175.603 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 5.6 t30 -124.35 124.35 42.18 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 126.008 1.723 . . . . 0.0 109.103 174.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.74 -34.29 77.52 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 114.012 1.115 . . . . 0.0 114.012 -169.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . 0.264 0.0 OUTLIER -71.24 -4.58 26.49 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 114.06 1.133 . . . . 0.0 114.06 -177.752 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -72.94 -12.75 61.07 Favored 'General case' 0 CA--C 1.549 0.942 0 C-N-CA 123.4 0.68 . . . . 0.0 111.012 168.52 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 88.6 m-85 -118.19 138.5 52.27 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 126.806 2.042 . . . . 0.0 111.562 -177.713 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -89.08 -22.15 23.06 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-O 122.104 0.954 . . . . 0.0 112.38 176.404 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 77.9 t -131.44 138.59 52.74 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 C-N-CA 127.136 2.174 . . . . 0.0 108.908 -175.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 48.5 t -131.49 123.93 53.57 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 169.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 45.2 mm -109.42 103.72 15.95 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 C-N-CA 124.6 1.16 . . . . 0.0 109.536 -176.377 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 13.2 m -83.35 102.07 11.75 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 124.333 1.053 . . . . 0.0 109.439 169.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 92.4 mt -72.37 -36.25 68.69 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 112.755 0.65 . . . . 0.0 112.755 -177.371 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 36.4 m -112.05 122.27 47.3 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 125.61 1.564 . . . . 0.0 110.492 -169.221 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 62.9 -157.28 39.23 Favored Glycine 0 CA--C 1.537 1.455 0 C-N-CA 123.626 0.631 . . . . 0.0 114.055 -175.737 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 50.3 m -90.08 0.08 57.32 Favored 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 114.8 1.407 . . . . 0.0 114.8 -172.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 71.34 29.16 68.67 Favored Glycine 0 CA--C 1.535 1.315 0 O-C-N 121.478 -0.764 . . . . 0.0 114.609 179.249 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 60.0 t -90.46 -17.6 7.86 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.384 0 CA-C-N 118.216 1.008 . . . . 0.0 112.144 -179.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -84.23 12.63 6.26 Favored 'General case' 0 CA--C 1.555 1.144 0 C-N-CA 124.955 1.302 . . . . 0.0 113.641 -173.418 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -119.88 163.85 25.51 Favored Pre-proline 0 CA--C 1.552 1.047 0 C-N-CA 126.186 1.794 . . . . 0.0 112.464 177.671 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -63.53 150.1 89.35 Favored 'Trans proline' 0 CA--C 1.545 1.064 0 C-N-CA 122.437 2.091 . . . . 0.0 113.981 -178.16 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_exo -58.44 -27.96 83.63 Favored 'Trans proline' 0 C--N 1.353 0.789 0 C-N-CA 123.442 2.762 . . . . 0.0 115.559 -173.215 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -61.11 -24.14 66.03 Favored 'General case' 0 CA--C 1.544 0.725 0 O-C-N 120.976 -1.077 . . . . 0.0 113.214 177.059 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 89.6 m95 -82.96 -23.52 33.38 Favored 'General case' 0 N--CA 1.469 0.491 0 O-C-N 120.791 -1.193 . . . . 0.0 113.2 176.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 4.4 m -85.15 -18.98 8.91 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.228 0 CA-C-N 119.331 0.968 . . . . 0.0 113.142 173.084 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -88.53 -2.18 58.45 Favored 'General case' 0 N--CA 1.478 0.958 0 N-CA-C 114.847 1.425 . . . . 0.0 114.847 -177.517 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 73.0 mm-40 -66.33 157.07 32.65 Favored 'General case' 0 N--CA 1.481 1.08 0 O-C-N 120.963 -1.086 . . . . 0.0 111.575 171.126 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -59.28 -42.22 90.71 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 114.245 1.202 . . . . 0.0 114.245 -168.304 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 21.1 mm -117.88 61.75 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 C-N-CA 124.883 1.273 . . . . 0.0 108.949 179.273 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 19.9 t80 -78.18 110.42 13.15 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 168.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 24.9 mt-10 -114.54 137.3 52.04 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 114.047 1.129 . . . . 0.0 114.047 175.185 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -105.37 121.42 43.85 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 124.935 1.294 . . . . 0.0 108.852 169.176 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 42.9 m0 -100.52 -18.22 16.75 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 115.871 1.804 . . . . 0.0 115.871 -168.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 41.6 mm-40 55.11 30.61 14.69 Favored 'General case' 0 CA--C 1.555 1.158 0 N-CA-C 113.964 1.098 . . . . 0.0 113.964 174.19 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 30.0 mt -84.22 158.63 21.22 Favored 'General case' 0 N--CA 1.47 0.54 0 O-C-N 120.768 -1.208 . . . . 0.0 112.82 -170.3 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 9.7 tt0 -69.35 133.77 48.24 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.513 169.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 16.3 p-10 -90.46 137.66 27.3 Favored Pre-proline 0 CA--C 1.551 0.988 0 C-N-CA 126.011 1.724 . . . . 0.0 112.057 173.068 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_exo -67.79 -14.55 41.95 Favored 'Trans proline' 0 CA--C 1.551 1.333 0 C-N-CA 122.35 2.033 . . . . 0.0 115.358 178.225 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -59.25 136.73 58.05 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 124.773 1.229 . . . . 0.0 113.541 -175.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 76.46 8.99 86.11 Favored Glycine 0 CA--C 1.536 1.377 0 C-N-CA 124.449 1.023 . . . . 0.0 115.019 175.52 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 12.7 pt20 -141.17 168.92 18.62 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 125.53 1.532 . . . . 0.0 112.592 -179.131 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 28.1 p -66.54 166.08 13.36 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 115.453 1.649 . . . . 0.0 115.453 -169.407 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . 0.315 2.4 pp -68.72 -12.81 61.87 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 114.298 1.221 . . . . 0.0 114.298 173.887 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -70.81 -32.96 70.21 Favored 'General case' 0 CA--C 1.541 0.597 0 O-C-N 121.094 -1.004 . . . . 0.0 109.717 168.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 5.3 t -70.63 -40.18 76.8 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 CA-C-O 117.876 -1.059 . . . . 0.0 111.255 170.009 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 14.3 m-85 -54.05 -52.12 61.9 Favored 'General case' 0 N--CA 1.478 0.941 0 CA-C-N 120.287 1.403 . . . . 0.0 111.03 169.356 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 97.6 mtt180 -60.95 -38.69 86.77 Favored 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 124.03 0.932 . . . . 0.0 112.385 -179.138 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 75.2 m -64.84 -43.68 92.24 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.949 0.899 . . . . 0.0 111.341 172.776 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 54.5 t -66.72 -40.6 86.45 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 CA-C-O 117.739 -1.124 . . . . 0.0 111.213 177.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 47.8 mtm-85 -57.04 -41.06 77.95 Favored 'General case' 0 N--CA 1.482 1.153 0 CA-C-N 120.733 1.606 . . . . 0.0 111.295 174.13 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -60.92 -51.84 56.05 Favored Glycine 0 CA--C 1.537 1.462 0 CA-C-N 118.935 0.788 . . . . 0.0 113.597 173.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 60.6 mm-40 -63.89 -44.94 91.51 Favored 'General case' 0 N--CA 1.477 0.882 0 O-C-N 121.965 -0.727 . . . . 0.0 112.199 179.087 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 77.4 t -65.71 -40.61 88.35 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 C-N-CA 124.949 1.3 . . . . 0.0 110.711 178.201 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 36.2 ttmt -54.68 -50.3 68.58 Favored 'General case' 0 N--CA 1.478 0.948 0 CA-C-N 120.311 1.414 . . . . 0.0 110.41 175.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -61.8 -41.31 97.59 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 122.759 0.423 . . . . 0.0 112.119 178.821 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.63 -34.36 78.05 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 124.224 1.01 . . . . 0.0 113.561 176.824 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 97.3 t -80.19 -36.43 16.55 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 C-N-CA 125.353 1.461 . . . . 0.0 111.931 176.576 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -62.61 -39.56 94.19 Favored 'General case' 0 N--CA 1.47 0.536 0 O-C-N 120.885 -1.134 . . . . 0.0 110.97 170.09 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 14.2 m-80 -64.23 -44.72 90.98 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 118.747 0.703 . . . . 0.0 112.598 173.731 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 1.2 tt -48.22 -61.41 2.01 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 125.01 1.324 . . . . 0.0 109.702 172.233 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 82.9 mt -60.4 -44.98 97.28 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 C-N-CA 123.24 0.616 . . . . 0.0 110.648 -177.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -65.78 -12.76 56.66 Favored 'General case' 0 CA--C 1.547 0.853 0 N-CA-C 114.812 1.412 . . . . 0.0 114.812 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 21.1 ptmt -104.11 -27.13 12.27 Favored 'General case' 0 N--CA 1.477 0.904 0 N-CA-C 114.188 1.181 . . . . 0.0 114.188 172.494 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 16.3 pt -95.22 -12.88 8.42 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 N-CA-C 114.625 1.343 . . . . 0.0 114.625 178.618 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 70.1 m . . . . . 0 C--O 1.254 1.335 0 C-N-CA 125.146 1.379 . . . . 0.0 112.501 -179.742 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 36.4 ttm . . . . . 0 N--CA 1.501 2.083 0 N-CA-C 111.793 0.294 . . . . 0.0 111.793 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.0 163.17 30.47 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 125.151 1.38 . . . . 0.0 111.574 169.439 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 34.5 ttmt -101.63 144.17 30.69 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 124.639 1.175 . . . . 0.0 112.513 -179.044 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 21.7 t -124.15 135.09 64.79 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 125.33 1.452 . . . . 0.0 112.561 -176.358 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 49.8 tpp -103.74 125.91 50.53 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.396 0.678 . . . . 0.0 109.716 169.565 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 32.4 m-85 -108.73 121.96 46.13 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.917 1.287 . . . . 0.0 109.04 170.519 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.8 m -140.5 159.32 24.9 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 N-CA-C 115.267 1.58 . . . . 0.0 115.267 -168.619 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.6 m -150.98 160.85 43.66 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 128.529 2.731 . . . . 0.0 110.693 169.68 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 64.8 pttt -82.77 138.38 34.03 Favored 'General case' 0 N--CA 1.48 1.031 0 O-C-N 121.061 -1.024 . . . . 0.0 112.4 171.283 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 20.5 tpt180 44.31 55.06 5.82 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 126.388 1.875 . . . . 0.0 112.729 -169.879 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 63.3 t30 -50.54 -22.12 1.83 Allowed 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 127.725 2.41 . . . . 0.0 113.475 175.012 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 31.1 m -53.2 -22.64 6.95 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 125.885 1.674 . . . . 0.0 113.929 170.473 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 58.7 m -112.35 157.52 20.91 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 126.212 1.805 . . . . 0.0 111.136 171.021 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 61.9 mtt85 61.26 168.9 0.1 Allowed 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 126.468 1.907 . . . . 0.0 114.728 -178.166 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 62.2 m -113.98 122.48 47.07 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 125.493 1.517 . . . . 0.0 110.165 -177.333 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 3.2 mp0 -97.21 -33.89 11.31 Favored 'General case' 0 N--CA 1.48 1.06 0 N-CA-C 115.748 1.759 . . . . 0.0 115.748 -168.647 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 70.1 -46.67 0.61 Allowed 'General case' 0 N--CA 1.482 1.158 0 N-CA-C 118.313 2.709 . . . . 0.0 118.313 168.804 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.69 -30.13 70.54 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 115.169 1.544 . . . . 0.0 115.169 -169.449 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 5.7 pm0 -61.76 -39.1 90.45 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 118.813 0.733 . . . . 0.0 111.854 172.045 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -69.45 -44.77 63.08 Favored Glycine 0 C--N 1.334 0.457 0 C-N-CA 124.216 0.912 . . . . 0.0 111.783 -177.467 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -68.67 -36.01 77.98 Favored 'General case' 0 N--CA 1.467 0.412 0 O-C-N 121.569 -0.959 . . . . 0.0 112.152 173.965 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -65.02 -34.97 79.7 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 119.345 0.975 . . . . 0.0 112.363 178.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 22.2 mtpp -67.26 -48.86 66.49 Favored 'General case' 0 N--CA 1.481 1.094 0 O-C-N 121.884 -0.51 . . . . 0.0 111.217 169.572 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 24.7 m -73.71 -28.12 61.55 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 113.239 0.829 . . . . 0.0 113.239 -169.568 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 56.8 mt -97.2 -35.14 10.86 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 125.612 1.565 . . . . 0.0 112.96 176.043 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -103.47 -10.44 35.9 Favored Glycine 0 N--CA 1.469 0.884 0 N-CA-C 117.243 1.657 . . . . 0.0 117.243 -169.157 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -62.81 140.04 58.75 Favored 'General case' 0 CA--C 1.544 0.726 0 CA-C-N 120.936 2.368 . . . . 0.0 112.06 179.805 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 89.88 -21.24 31.34 Favored Glycine 0 CA--C 1.541 1.688 0 C-N-CA 125.048 1.309 . . . . 0.0 113.374 -169.342 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -101.44 -50.71 3.67 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 125.942 1.697 . . . . 0.0 111.026 169.853 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 2.6 pp -131.35 155.93 42.24 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 C-N-CA 125.813 1.645 . . . . 0.0 111.721 179.225 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -103.24 151.62 22.44 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 124.783 1.233 . . . . 0.0 109.718 175.402 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 44.4 t -138.07 142.77 34.85 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.051 0 O-C-N 121.282 -0.886 . . . . 0.0 113.061 -173.716 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 29.6 m -132.93 152.69 51.87 Favored 'General case' 0 CA--C 1.513 -0.465 0 C-N-CA 125.478 1.511 . . . . 0.0 108.029 168.792 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 2.8 p -132.57 141.36 48.67 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 122.283 1.04 . . . . 0.0 111.533 169.638 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 59.9 p -152.3 -174.46 4.89 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 113.599 -1.637 . . . . 0.0 110.209 178.857 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -135.16 170.89 22.72 Favored Glycine 0 C--N 1.335 0.495 0 O-C-N 121.142 -0.974 . . . . 0.0 112.351 174.195 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 6.2 mp -89.86 124.07 34.37 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 105.556 -2.016 . . . . 0.0 105.556 168.633 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 60.25 26.96 16.46 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 124.852 1.261 . . . . 0.0 113.439 -175.018 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 26.9 p -169.51 156.82 6.88 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 125.876 1.671 . . . . 0.0 112.773 -174.474 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 88.6 p -110.16 -51.63 2.85 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 115.546 1.684 . . . . 0.0 115.546 178.396 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 56.6 ttt180 -115.58 139.69 49.85 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 126.779 2.031 . . . . 0.0 113.988 -168.527 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 10.7 m -51.61 148.99 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 126.636 1.975 . . . . 0.0 111.924 169.365 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -62.26 144.65 94.68 Favored Pre-proline 0 CA--C 1.551 1.01 0 CA-C-O 118.893 -0.575 . . . . 0.0 110.448 176.263 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_exo -47.93 -36.04 26.29 Favored 'Trans proline' 0 CA--C 1.538 0.719 0 C-N-CA 124.087 3.191 . . . . 0.0 118.319 -168.12 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 58.7 m -59.64 -27.03 65.99 Favored 'General case' 0 N--CA 1.483 1.187 0 CA-C-N 119.622 1.101 . . . . 0.0 112.166 -178.228 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -55.85 -37.64 69.01 Favored 'General case' 0 CA--C 1.535 0.365 0 C-N-CA 124.113 0.965 . . . . 0.0 113.059 175.247 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.6 mp -63.86 -54.28 33.86 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 CA-C-N 119.183 0.901 . . . . 0.0 108.628 -178.428 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -62.98 -35.44 80.17 Favored 'General case' 0 CA--C 1.544 0.729 0 N-CA-C 113.361 0.874 . . . . 0.0 113.361 -177.552 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -77.75 -23.77 49.21 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 113.923 1.083 . . . . 0.0 113.923 178.188 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -87.93 -29.71 20.63 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 118.948 0.794 . . . . 0.0 109.732 174.612 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -67.19 -13.14 61.68 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.315 1.446 . . . . 0.0 113.791 172.338 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 -60.09 -26.24 66.04 Favored 'General case' 0 N--CA 1.482 1.171 0 CA-C-N 120.452 1.478 . . . . 0.0 110.641 168.836 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 40.8 t -98.26 -0.42 10.36 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.02 0 C-N-CA 127.668 2.387 . . . . 0.0 111.232 178.471 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 78.28 18.62 75.92 Favored Glycine 0 CA--C 1.541 1.675 0 C-N-CA 125.076 1.322 . . . . 0.0 114.878 -176.529 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 77.1 mt -81.68 133.66 28.77 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 C-N-CA 124.929 1.291 . . . . 0.0 111.736 -172.514 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 31.6 t0 -98.21 116.95 31.51 Favored 'General case' 0 N--CA 1.473 0.725 0 CA-C-O 121.41 0.624 . . . . 0.0 111.96 169.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 19.4 pt -127.97 19.43 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 C-N-CA 126.24 1.816 . . . . 0.0 112.379 171.059 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 98.1 p -70.68 -16.23 62.78 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 115.39 1.626 . . . . 0.0 115.39 -173.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -82.69 -0.96 90.48 Favored Glycine 0 CA--C 1.537 1.466 0 C-N-CA 124.762 1.172 . . . . 0.0 115.922 -177.139 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 4.4 tt0 -68.36 -6.15 22.78 Favored 'General case' 0 CA--C 1.547 0.836 0 N-CA-C 116.402 2.001 . . . . 0.0 116.402 -170.29 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.3 m -67.53 -7.83 29.06 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 125.86 1.664 . . . . 0.0 114.6 -170.809 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 78.2 p -64.73 -78.9 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 115.524 1.676 . . . . 0.0 115.524 -170.541 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -148.59 157.85 40.91 Favored Pre-proline 0 CA--C 1.554 1.133 0 N-CA-C 115.459 1.651 . . . . 0.0 115.459 -169.283 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -69.55 163.71 37.08 Favored 'Trans proline' 0 C--N 1.354 0.865 0 C-N-CA 124.967 3.778 . . . . 0.0 114.921 170.107 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 6.0 tt -52.82 -44.69 48.88 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 C-N-CA 124.905 1.282 . . . . 0.0 111.851 178.054 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -66.93 -9.56 39.56 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 114.092 1.145 . . . . 0.0 114.092 -177.681 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 -81.12 -22.67 38.9 Favored 'General case' 0 CA--C 1.548 0.899 0 N-CA-C 113.129 0.789 . . . . 0.0 113.129 174.145 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 82.1 m-85 -94.19 -169.98 2.19 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 125.805 1.642 . . . . 0.0 112.159 -177.251 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -124.6 124.76 42.91 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 125.657 1.583 . . . . 0.0 109.791 176.375 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -67.42 -34.9 78.18 Favored 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 114.241 1.2 . . . . 0.0 114.241 -170.125 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . 0.252 0.0 OUTLIER -72.19 -5.09 33.24 Favored 'General case' 0 CA--C 1.545 0.778 0 N-CA-C 114.163 1.172 . . . . 0.0 114.163 -176.457 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -73.93 -11.39 60.34 Favored 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 123.833 0.853 . . . . 0.0 111.244 168.711 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 74.5 m-85 -117.36 139.57 50.69 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 127.379 2.272 . . . . 0.0 111.251 -179.664 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -92.17 -23.51 19.37 Favored 'General case' 0 N--CA 1.479 1.004 0 CA-C-O 122.359 1.076 . . . . 0.0 112.342 177.055 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 80.3 t -129.56 138.12 55.06 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 C-N-CA 127.252 2.221 . . . . 0.0 108.886 -176.429 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 83.0 t -131.94 127.82 58.82 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 N-CA-C 107.562 -1.273 . . . . 0.0 107.562 170.694 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 27.5 mm -119.31 117.07 52.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 C-N-CA 124.356 1.063 . . . . 0.0 109.251 -178.162 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 22.6 t -98.54 130.93 45.11 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 122.596 0.359 . . . . 0.0 110.553 169.609 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 8.3 mt -101.32 0.51 37.32 Favored 'General case' 0 N--CA 1.478 0.95 0 N-CA-C 113.779 1.029 . . . . 0.0 113.779 178.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 84.6 m -135.95 146.67 47.52 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.213 1.005 . . . . 0.0 113.186 -169.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 63.15 -146.57 50.45 Favored Glycine 0 CA--C 1.532 1.147 0 C-N-CA 124.547 1.07 . . . . 0.0 114.356 170.149 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 93.9 p -86.1 -16.61 37.48 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 125.212 1.405 . . . . 0.0 114.593 -178.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 76.68 6.83 85.43 Favored Glycine 0 CA--C 1.54 1.6 0 C-N-CA 124.32 0.962 . . . . 0.0 114.598 -170.278 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 58.6 t -88.68 -22.27 6.69 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.162 0 CA-C-N 119.017 1.408 . . . . 0.0 113.118 -175.377 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 34.2 m120 -71.62 -19.47 62.11 Favored 'General case' 0 CA--C 1.547 0.86 0 N-CA-C 114.545 1.313 . . . . 0.0 114.545 -174.452 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -79.19 148.01 70.31 Favored Pre-proline 0 CA--C 1.549 0.915 0 CA-C-N 118.929 0.786 . . . . 0.0 111.768 176.557 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -59.42 155.11 43.05 Favored 'Trans proline' 0 CA--C 1.543 0.974 0 C-N-CA 122.769 2.313 . . . . 0.0 114.151 -178.164 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_exo -55.01 -32.46 79.09 Favored 'Trans proline' 0 C--N 1.35 0.649 0 C-N-CA 123.46 2.773 . . . . 0.0 114.412 -177.318 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -63.62 -31.78 73.05 Favored 'General case' 0 N--CA 1.471 0.617 0 O-C-N 121.277 -0.889 . . . . 0.0 113.025 177.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 94.8 m95 -80.4 -32.34 37.51 Favored 'General case' 0 N--CA 1.473 0.68 0 O-C-N 121.071 -1.018 . . . . 0.0 111.989 175.428 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 75.8 t -67.57 -31.97 54.94 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 C-N-CA 124.499 1.12 . . . . 0.0 112.159 172.527 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -91.98 3.33 55.45 Favored 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 115.799 1.777 . . . . 0.0 115.799 -171.513 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 80.2 mm-40 -65.6 155.17 36.65 Favored 'General case' 0 N--CA 1.478 0.941 0 O-C-N 120.741 -1.224 . . . . 0.0 111.547 170.651 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -56.18 -41.28 75.25 Favored 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 114.466 1.284 . . . . 0.0 114.466 -167.638 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 18.7 mm -119.31 64.57 0.23 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 C-N-CA 125.089 1.356 . . . . 0.0 108.407 177.308 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 15.9 t80 -79.54 108.29 12.96 Favored 'General case' 0 CA--C 1.534 0.356 0 O-C-N 120.989 -1.07 . . . . 0.0 108.77 169.326 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 11.1 mt-10 -110.32 146.47 35.69 Favored 'General case' 0 CA--C 1.545 0.756 0 N-CA-C 114.627 1.343 . . . . 0.0 114.627 174.591 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -114.36 117.21 30.41 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 125.566 1.546 . . . . 0.0 110.022 169.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 39.4 m0 -104.96 106.94 17.65 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 124.63 1.172 . . . . 0.0 109.884 -176.482 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 11.2 mm100 -86.9 47.95 1.57 Allowed 'General case' 0 CA--C 1.547 0.862 0 CA-C-O 122.118 0.961 . . . . 0.0 111.843 -172.309 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 89.7 mt -75.36 162.65 28.2 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 126.22 1.808 . . . . 0.0 112.297 178.434 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -79.01 149.57 32.17 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-O 121.351 0.596 . . . . 0.0 112.457 170.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -83.19 127.57 68.41 Favored Pre-proline 0 CA--C 1.544 0.728 0 C-N-CA 123.96 0.904 . . . . 0.0 110.854 174.31 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -82.04 -16.42 8.65 Favored 'Trans proline' 0 CA--C 1.542 0.92 0 C-N-CA 121.335 1.357 . . . . 0.0 115.242 -170.701 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -72.62 -39.81 66.95 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 116.77 2.137 . . . . 0.0 116.77 -168.788 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -75.3 16.79 3.48 Favored Glycine 0 CA--C 1.539 1.559 0 C-N-CA 123.938 0.78 . . . . 0.0 114.679 -175.164 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 8.8 pt20 -157.98 174.44 15.24 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 126.876 2.07 . . . . 0.0 111.818 -169.321 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 70.4 m -63.29 159.29 18.25 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 114.721 1.378 . . . . 0.0 114.721 -169.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 42.3 tp -59.75 -27.15 66.26 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 124.905 1.282 . . . . 0.0 113.295 179.771 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -62.88 -30.7 71.72 Favored 'General case' 0 N--CA 1.473 0.711 0 O-C-N 120.733 -1.229 . . . . 0.0 112.008 171.753 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 3.0 t -75.69 -36.19 33.16 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 O-C-N 120.955 -1.091 . . . . 0.0 111.152 172.725 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -55.48 -48.01 75.24 Favored 'General case' 0 N--CA 1.479 0.978 0 CA-C-N 119.688 1.131 . . . . 0.0 110.548 169.086 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -67.01 -35.94 81.05 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 124.141 0.976 . . . . 0.0 112.382 178.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 31.2 m -61.16 -45.53 94.27 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 124.329 1.052 . . . . 0.0 111.239 169.724 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 56.2 t -67.14 -39.19 82.61 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 CA-C-O 117.638 -1.173 . . . . 0.0 111.339 178.2 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 67.4 mtm-85 -56.43 -43.02 79.04 Favored 'General case' 0 N--CA 1.484 1.249 0 CA-C-N 120.694 1.588 . . . . 0.0 111.724 169.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -59.61 -49.47 78.22 Favored Glycine 0 CA--C 1.537 1.417 0 CA-C-N 118.982 0.81 . . . . 0.0 113.871 174.529 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 52.4 mm-40 -65.66 -44.38 86.48 Favored 'General case' 0 N--CA 1.475 0.784 0 O-C-N 121.585 -0.95 . . . . 0.0 112.193 178.274 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 60.5 t -65.13 -40.15 87.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 C-N-CA 124.622 1.169 . . . . 0.0 110.789 177.816 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 61.4 tttm -54.71 -49.9 69.6 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 119.515 1.052 . . . . 0.0 110.932 175.796 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -64.48 -42.05 96.12 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 112.486 0.55 . . . . 0.0 112.486 177.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 16.5 mmm180 -61.26 -45.97 92.32 Favored 'General case' 0 N--CA 1.479 0.982 0 O-C-N 121.597 -0.689 . . . . 0.0 112.529 175.409 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 92.7 t -68.38 -40.95 83.11 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 C-N-CA 124.006 0.923 . . . . 0.0 111.268 179.49 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -62.48 -39.95 95.11 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 119.258 0.935 . . . . 0.0 111.593 173.165 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 13.9 m-80 -63.25 -46.7 85.67 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 118.982 0.81 . . . . 0.0 112.189 173.751 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -54.7 -55.21 32.17 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 124.607 1.163 . . . . 0.0 110.585 176.467 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 73.1 mt -59.82 -45.88 94.32 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 CA-C-O 119.079 -0.486 . . . . 0.0 110.084 178.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -67.89 -11.47 58.75 Favored 'General case' 0 CA--C 1.545 0.776 0 N-CA-C 115.318 1.599 . . . . 0.0 115.318 -179.215 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 21.0 ptmt -100.54 -24.13 14.53 Favored 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 113.798 1.036 . . . . 0.0 113.798 171.286 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 16.4 pt -97.78 -13.95 7.92 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 N-CA-C 114.592 1.33 . . . . 0.0 114.592 177.692 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 54.5 m . . . . . 0 C--O 1.254 1.293 0 C-N-CA 125.373 1.469 . . . . 0.0 112.032 -179.815 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.412 ' HA ' ' O ' ' A' ' 29' ' ' LYS . 22.6 ttt . . . . . 0 N--CA 1.503 2.207 0 N-CA-C 111.74 0.274 . . . . 0.0 111.74 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.21 164.06 31.28 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 125.089 1.355 . . . . 0.0 112.527 176.575 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 58.9 mttt -99.14 151.07 21.39 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 124.185 0.994 . . . . 0.0 112.46 177.731 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 12.5 t -129.2 138.49 54.29 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 C-N-CA 125.103 1.361 . . . . 0.0 112.674 179.019 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 62.0 tpp -107.75 120.94 43.65 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 123.726 0.81 . . . . 0.0 109.429 168.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 68.5 m-85 -100.73 127.09 47.29 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 124.27 1.028 . . . . 0.0 108.99 170.58 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -144.43 156.12 14.96 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.084 0 N-CA-C 114.769 1.396 . . . . 0.0 114.769 -168.177 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -151.38 169.29 22.36 Favored 'General case' 0 CA--C 1.552 1.043 0 C-N-CA 127.159 2.183 . . . . 0.0 110.939 173.944 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 61.8 mtpt -49.26 -62.74 1.37 Allowed 'General case' 0 N--CA 1.495 1.788 0 C-N-CA 126.126 1.77 . . . . 0.0 113.789 -173.762 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 28.8 mmt85 -127.68 106.3 9.05 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 126.164 1.785 . . . . 0.0 107.588 172.506 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 36.1 p-10 -74.32 -11.1 60.17 Favored 'General case' 0 CA--C 1.556 1.195 0 CA-C-N 119.458 1.027 . . . . 0.0 112.357 -176.831 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 69.8 m -80.13 -6.71 58.19 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 125.08 1.352 . . . . 0.0 112.855 169.464 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 72.8 m -108.18 -69.61 0.84 Allowed 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 124.71 1.204 . . . . 0.0 110.03 172.02 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 66.7 mtt85 -74.35 122.61 23.2 Favored 'General case' 0 N--CA 1.479 1.015 0 O-C-N 121.444 -0.785 . . . . 0.0 109.092 173.679 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 52.4 p -69.45 -28.29 65.98 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 115.644 1.72 . . . . 0.0 115.644 -168.784 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 7.6 mt-30 61.26 -177.81 0.11 Allowed 'General case' 0 CA--C 1.552 1.027 0 C-N-CA 124.633 1.173 . . . . 0.0 112.482 -170.07 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -175.12 -47.48 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 126.366 1.867 . . . . 0.0 110.947 -169.447 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -56.73 -32.16 65.26 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 115.331 1.604 . . . . 0.0 115.331 -169.398 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.3 pm0 -57.16 -41.68 79.66 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 123.528 0.731 . . . . 0.0 112.757 177.545 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -67.25 -43.79 87.95 Favored Glycine 0 C--N 1.334 0.436 0 C-N-CA 124.821 1.2 . . . . 0.0 112.071 -177.465 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -71.53 -35.36 70.65 Favored 'General case' 0 N--CA 1.47 0.534 0 O-C-N 121.542 -0.975 . . . . 0.0 112.005 174.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -64.09 -33.66 76.27 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 118.986 0.812 . . . . 0.0 112.034 -175.652 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 2.7 pttp -85.08 -36.43 21.19 Favored 'General case' 0 N--CA 1.479 1.024 0 N-CA-C 113.644 0.979 . . . . 0.0 113.644 169.686 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 56.3 m -68.88 -31.29 70.11 Favored 'General case' 0 N--CA 1.486 1.338 0 CA-C-N 119.455 1.025 . . . . 0.0 112.3 -178.642 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 70.8 mt -91.22 -37.85 13.07 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 126.131 1.772 . . . . 0.0 112.645 173.022 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -100.62 2.08 55.81 Favored Glycine 0 N--CA 1.472 1.06 0 N-CA-C 117.262 1.665 . . . . 0.0 117.262 -169.539 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -60.55 141.63 56.34 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-N 121.133 2.466 . . . . 0.0 112.303 177.648 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 82.91 -15.15 33.67 Favored Glycine 0 CA--C 1.54 1.643 0 C-N-CA 124.74 1.162 . . . . 0.0 113.657 -169.408 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.412 ' O ' ' HA ' ' A' ' 1' ' ' MET . 69.7 mttt -108.22 -43.7 4.31 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 126.309 1.844 . . . . 0.0 112.484 171.841 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 42.7 pt -139.93 160.02 26.66 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 C-N-CA 124.92 1.288 . . . . 0.0 113.416 -177.203 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -107.64 149.31 28.24 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 125.487 1.515 . . . . 0.0 110.724 169.747 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 98.8 t -137.78 141.11 39.79 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 O-C-N 121.197 -0.94 . . . . 0.0 113.085 -175.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 79.3 m -135.51 152.85 51.73 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 125.805 1.642 . . . . 0.0 109.28 169.521 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 88.9 p -133.21 142.7 48.71 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 122.419 1.104 . . . . 0.0 113.208 167.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 35.7 p -145.43 170.5 16.23 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 114.002 -1.453 . . . . 0.0 112.251 -173.863 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -92.82 152.83 21.24 Favored Glycine 0 N--CA 1.467 0.763 0 O-C-N 121.56 -0.713 . . . . 0.0 111.392 174.863 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 2.2 mp -65.97 -32.8 74.5 Favored 'General case' 0 N--CA 1.483 1.207 0 CA-C-N 118.807 1.303 . . . . 0.0 111.744 171.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -120.47 165.49 14.88 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 126.685 1.994 . . . . 0.0 108.93 169.089 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 52.2 m -53.95 100.19 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 125.281 1.432 . . . . 0.0 113.6 -169.703 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 24.0 p -156.97 156.44 33.0 Favored 'General case' 0 CA--C 1.548 0.897 0 N-CA-C 114.159 1.17 . . . . 0.0 114.159 -175.666 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 49.7 ttt180 -107.77 140.66 40.51 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 128.815 2.846 . . . . 0.0 109.199 174.781 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 18.5 m -53.65 117.97 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.36 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 173.477 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . 0.276 0.0 OUTLIER -58.25 143.75 78.67 Favored Pre-proline 0 CA--C 1.536 0.439 0 N-CA-C 112.699 0.629 . . . . 0.0 112.699 -167.901 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 81.5 Cg_exo -47.34 -36.25 22.59 Favored 'Trans proline' 0 CA--C 1.538 0.681 0 C-N-CA 123.449 2.766 . . . . 0.0 116.792 -168.121 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 56.3 m -64.18 -26.27 68.45 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.915 0.886 . . . . 0.0 112.552 -179.091 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -55.08 -49.53 71.43 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 119.517 1.053 . . . . 0.0 110.601 173.25 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.6 mp -54.2 -57.16 6.6 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 C-N-CA 124.189 0.996 . . . . 0.0 110.176 -173.41 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.95 -28.09 69.59 Favored 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 113.22 0.822 . . . . 0.0 113.22 -175.243 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -79.91 -28.51 39.8 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 113.6 0.963 . . . . 0.0 113.6 177.79 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 4.9 mmt -77.39 -36.49 53.35 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-N 119.142 0.883 . . . . 0.0 110.645 169.743 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -61.9 -16.39 50.3 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 125.095 1.358 . . . . 0.0 114.17 174.421 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -61.08 -29.79 69.96 Favored 'General case' 0 N--CA 1.479 0.984 0 CA-C-N 120.714 1.597 . . . . 0.0 111.747 169.508 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 59.1 t -89.89 -6.38 10.79 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.889 0 C-N-CA 126.627 1.971 . . . . 0.0 111.294 175.673 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 81.63 13.93 79.04 Favored Glycine 0 CA--C 1.539 1.554 0 C-N-CA 125.245 1.402 . . . . 0.0 114.281 -170.589 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 83.5 mt -77.91 142.04 14.7 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 124.618 1.167 . . . . 0.0 111.144 -178.016 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -101.05 131.3 47.01 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 123.517 0.727 . . . . 0.0 111.044 169.172 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 13.4 pt -135.3 8.25 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 C-N-CA 124.234 1.014 . . . . 0.0 113.33 169.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 51.8 m -77.65 152.06 34.0 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 125.228 1.411 . . . . 0.0 113.228 -171.004 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 67.89 20.61 72.68 Favored Glycine 0 N--CA 1.473 1.119 0 N-CA-C 116.035 1.174 . . . . 0.0 116.035 169.758 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 48.1 mt-30 -67.0 -69.98 0.28 Allowed 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 118.701 1.25 . . . . 0.0 112.158 -179.387 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 7.4 t -166.37 169.82 13.65 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 125.238 1.415 . . . . 0.0 112.323 -177.087 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 96.8 p -129.05 5.05 5.33 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 128.419 2.687 . . . . 0.0 112.379 169.474 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 32.5 m-20 -89.94 153.94 47.4 Favored Pre-proline 0 CA--C 1.543 0.676 0 C-N-CA 124.721 1.208 . . . . 0.0 113.299 -177.866 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -70.43 157.28 59.57 Favored 'Trans proline' 0 N--CA 1.458 -0.579 0 C-N-CA 123.089 2.526 . . . . 0.0 112.12 175.771 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 5.9 tt -50.57 -34.34 12.17 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 C-N-CA 124.991 1.316 . . . . 0.0 111.349 169.556 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 18.8 mt-10 -63.71 -17.91 63.47 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 125.547 1.539 . . . . 0.0 113.558 -178.758 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -83.61 -12.34 56.16 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 124.669 1.188 . . . . 0.0 113.659 -178.627 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 74.7 m-85 -106.64 -172.21 2.04 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 125.946 1.699 . . . . 0.0 111.733 -176.417 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 10.5 t30 -120.77 122.44 40.37 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 125.182 1.393 . . . . 0.0 110.274 177.328 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -68.05 -35.83 78.88 Favored 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 113.726 1.01 . . . . 0.0 113.726 -171.42 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -71.28 -4.98 28.83 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 114.409 1.262 . . . . 0.0 114.409 -175.155 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -73.08 -14.0 61.31 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 123.573 0.749 . . . . 0.0 111.691 168.823 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 39.2 m-85 -119.54 134.2 55.33 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 126.939 2.096 . . . . 0.0 111.068 -178.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -88.44 -19.64 26.26 Favored 'General case' 0 N--CA 1.48 1.058 0 CA-C-O 122.36 1.076 . . . . 0.0 112.672 -179.806 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 95.9 t -130.88 136.77 57.43 Favored 'Isoleucine or valine' 0 C--O 1.235 0.336 0 C-N-CA 127.722 2.409 . . . . 0.0 107.853 -175.411 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 65.3 t -134.13 127.07 50.79 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 170.384 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 48.3 mm -116.17 106.7 20.87 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.249 0 C-N-CA 124.454 1.101 . . . . 0.0 109.395 -171.873 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 4.0 m -92.38 108.2 19.78 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 123.049 0.54 . . . . 0.0 110.321 177.202 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 78.3 mt -78.07 -9.48 59.16 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 125.872 1.669 . . . . 0.0 113.406 -179.371 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 23.9 m -108.34 103.99 13.26 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 125.664 1.586 . . . . 0.0 110.733 -179.04 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 57.65 -139.66 46.72 Favored Glycine 0 CA--C 1.535 1.331 0 C-N-CA 124.325 0.964 . . . . 0.0 114.236 172.831 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 85.0 p -69.91 -14.28 62.65 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 124.84 1.256 . . . . 0.0 114.108 175.793 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 72.09 7.79 67.84 Favored Glycine 0 CA--C 1.528 0.902 0 N-CA-C 115.6 1.0 . . . . 0.0 115.6 178.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.3 p -72.51 -9.58 13.08 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.988 0 CA-C-N 119.593 1.696 . . . . 0.0 114.675 -169.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 -80.64 -16.71 53.34 Favored 'General case' 0 CA--C 1.547 0.857 0 N-CA-C 114.701 1.371 . . . . 0.0 114.701 -174.162 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -71.07 159.14 86.51 Favored Pre-proline 0 CA--C 1.551 0.985 0 CA-C-N 119.214 0.916 . . . . 0.0 112.317 170.926 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_exo -60.53 151.86 72.33 Favored 'Trans proline' 0 CA--C 1.544 1.014 0 C-N-CA 122.133 1.888 . . . . 0.0 113.321 -176.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_exo -54.35 -36.59 87.59 Favored 'Trans proline' 0 C--N 1.352 0.751 0 C-N-CA 123.458 2.772 . . . . 0.0 115.164 -169.816 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -63.71 -22.28 66.83 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 114.131 1.16 . . . . 0.0 114.131 179.723 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 77.7 m95 -82.99 -23.1 33.47 Favored 'General case' 0 N--CA 1.47 0.531 0 O-C-N 120.888 -1.133 . . . . 0.0 112.486 172.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 10.5 t -73.67 -30.37 29.01 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 C-N-CA 124.996 1.318 . . . . 0.0 110.91 170.336 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 76.5 p -91.14 3.33 55.06 Favored 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 116.252 1.945 . . . . 0.0 116.252 -174.869 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 80.4 mm-40 -66.36 149.62 50.11 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 119.503 1.047 . . . . 0.0 108.984 169.294 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -59.73 -37.97 80.41 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 114.577 1.325 . . . . 0.0 114.577 -167.154 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 16.2 mm -113.01 56.64 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 C-N-CA 124.715 1.206 . . . . 0.0 109.385 177.488 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 40.7 t80 -75.57 106.52 7.17 Favored 'General case' 0 CA--C 1.535 0.395 0 O-C-N 120.633 -1.292 . . . . 0.0 107.522 168.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.7 mt-10 -106.41 133.28 51.34 Favored 'General case' 0 CA--C 1.543 0.678 0 N-CA-C 113.556 0.947 . . . . 0.0 113.556 175.877 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -88.95 111.51 22.21 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.41 1.084 . . . . 0.0 109.339 169.432 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 15.2 m0 -97.99 101.22 12.65 Favored 'General case' 0 N--CA 1.462 0.158 0 C-N-CA 123.813 0.845 . . . . 0.0 109.48 -176.859 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 54.9 mm-40 -78.64 41.14 0.4 Allowed 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 125.995 1.718 . . . . 0.0 111.676 -177.291 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 33.1 mt -91.59 163.68 14.04 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 126.277 1.831 . . . . 0.0 113.19 -172.155 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -73.92 150.42 40.85 Favored 'General case' 0 CA--C 1.545 0.784 0 CA-C-N 114.857 -1.065 . . . . 0.0 111.715 169.728 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -112.71 138.85 22.23 Favored Pre-proline 0 CA--C 1.549 0.923 0 C-N-CA 124.339 1.056 . . . . 0.0 111.108 169.564 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_exo -66.81 -19.84 52.57 Favored 'Trans proline' 0 CA--C 1.54 0.822 0 C-N-CA 122.511 2.141 . . . . 0.0 116.61 -178.139 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -68.03 144.83 54.95 Favored 'General case' 0 CA--C 1.545 0.757 0 CA-C-N 120.375 1.443 . . . . 0.0 114.102 -170.424 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 77.69 6.52 86.98 Favored Glycine 0 CA--C 1.535 1.338 0 C-N-CA 124.815 1.198 . . . . 0.0 114.586 -177.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 13.3 pt20 -140.85 174.37 10.58 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 126.015 1.726 . . . . 0.0 112.165 179.832 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 25.0 p -67.71 164.73 18.72 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 117.395 2.369 . . . . 0.0 117.395 -168.659 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -53.5 -41.35 66.19 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 126.272 1.829 . . . . 0.0 111.961 169.767 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -60.01 -36.11 76.52 Favored 'General case' 0 CA--C 1.543 0.697 0 O-C-N 121.47 -0.769 . . . . 0.0 111.922 174.653 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 16.3 t -68.86 -40.8 81.68 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 O-C-N 121.177 -0.952 . . . . 0.0 111.463 171.141 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -52.31 -50.55 61.99 Favored 'General case' 0 N--CA 1.476 0.839 0 CA-C-N 119.56 1.073 . . . . 0.0 112.104 170.629 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 96.0 mtt180 -67.87 -35.17 78.06 Favored 'General case' 0 N--CA 1.477 0.883 0 O-C-N 121.399 -0.813 . . . . 0.0 112.751 179.428 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 79.4 m -63.67 -42.17 98.09 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.682 0.793 . . . . 0.0 110.957 172.229 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 71.5 t -67.9 -39.86 82.47 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 CA-C-O 117.914 -1.041 . . . . 0.0 111.215 176.603 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 27.1 mtm105 -54.56 -42.71 71.31 Favored 'General case' 0 N--CA 1.484 1.252 0 CA-C-N 120.52 1.509 . . . . 0.0 112.109 173.026 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -62.39 -51.34 57.08 Favored Glycine 0 CA--C 1.539 1.549 0 CA-C-N 119.052 0.842 . . . . 0.0 113.311 176.383 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 68.8 mm-40 -63.3 -44.42 95.08 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.234 0.614 . . . . 0.0 112.017 179.845 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 69.3 t -67.18 -41.16 86.51 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 C-N-CA 124.592 1.157 . . . . 0.0 111.028 177.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 34.6 ttmt -54.56 -49.9 69.21 Favored 'General case' 0 N--CA 1.478 0.971 0 CA-C-N 120.491 1.496 . . . . 0.0 110.773 177.645 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -61.1 -40.14 92.61 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 112.242 0.46 . . . . 0.0 112.242 177.492 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.11 -35.26 80.02 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 124.226 1.011 . . . . 0.0 113.228 176.947 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 99.6 t -77.34 -38.46 26.84 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 C-N-CA 125.195 1.398 . . . . 0.0 111.621 176.508 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -60.25 -40.2 89.45 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 119.198 0.908 . . . . 0.0 111.178 170.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 17.1 m-80 -64.35 -43.55 94.21 Favored 'General case' 0 CA--C 1.542 0.635 0 N-CA-C 112.56 0.578 . . . . 0.0 112.56 174.093 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 9.1 tt -53.69 -55.01 29.86 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 124.401 1.08 . . . . 0.0 110.477 173.148 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 76.4 mt -63.49 -41.81 93.98 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.625 0 C-N-CA 122.658 0.383 . . . . 0.0 110.589 -178.433 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -69.72 -12.68 61.82 Favored 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 114.578 1.325 . . . . 0.0 114.578 178.346 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 20.7 ptmt -101.27 -30.93 11.24 Favored 'General case' 0 N--CA 1.477 0.906 0 N-CA-C 113.915 1.08 . . . . 0.0 113.915 173.297 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 13.5 pt -94.09 -18.84 6.77 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 N-CA-C 114.528 1.307 . . . . 0.0 114.528 179.255 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 74.5 m . . . . . 0 C--O 1.253 1.26 0 C-N-CA 125.539 1.536 . . . . 0.0 111.708 -175.354 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 34.8 ttm . . . . . 0 N--CA 1.501 2.086 0 N-CA-C 112.087 0.403 . . . . 0.0 112.087 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.47 162.92 26.05 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 125.146 1.379 . . . . 0.0 111.247 169.234 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 69.0 mttt -96.99 147.44 23.99 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.648 0.779 . . . . 0.0 111.527 172.728 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 17.2 t -124.42 135.53 63.49 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 C-N-CA 125.297 1.439 . . . . 0.0 111.927 176.046 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 54.3 tpp -106.07 125.75 51.37 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 123.229 0.611 . . . . 0.0 109.501 168.724 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 67.1 m-85 -103.89 125.18 50.11 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.43 1.092 . . . . 0.0 108.918 172.846 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.1 m -143.46 156.99 16.82 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.167 0 C-N-CA 124.661 1.184 . . . . 0.0 113.151 -169.175 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 18.2 t -153.65 141.7 20.33 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 126.304 1.842 . . . . 0.0 108.437 168.625 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . 0.263 60.7 pttt -73.79 -15.98 61.17 Favored 'General case' 0 N--CA 1.486 1.335 0 N-CA-C 116.385 1.994 . . . . 0.0 116.385 -169.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 16.2 ptm180 -121.08 49.68 1.46 Allowed 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 125.46 1.504 . . . . 0.0 112.645 169.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 5.8 t30 -46.79 -31.87 3.3 Favored 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 126.058 1.743 . . . . 0.0 114.582 -177.683 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 67.7 m -69.61 -23.78 63.56 Favored 'General case' 0 N--CA 1.479 1.0 0 N-CA-C 114.017 1.117 . . . . 0.0 114.017 178.131 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 36.9 m -89.9 -15.63 31.72 Favored 'General case' 0 N--CA 1.478 0.954 0 N-CA-C 114.247 1.203 . . . . 0.0 114.247 -176.244 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 55.7 mtp85 -135.5 159.03 42.88 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 125.607 1.563 . . . . 0.0 112.632 -169.847 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 26.1 t -100.25 145.59 27.9 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.234 1.414 . . . . 0.0 107.742 168.478 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 3.9 mp0 -108.76 -37.67 5.83 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 115.331 1.604 . . . . 0.0 115.331 -168.361 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 66.07 -47.48 0.41 Allowed 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 126.996 2.118 . . . . 0.0 116.281 170.46 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.16 -35.81 76.15 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.649 1.18 . . . . 0.0 113.945 -169.824 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 3.9 pm0 -58.94 -38.31 78.72 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 125.049 1.339 . . . . 0.0 113.215 176.057 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -69.92 -45.03 59.4 Favored Glycine 0 N--CA 1.464 0.552 0 C-N-CA 123.688 0.661 . . . . 0.0 111.831 -177.737 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -69.29 -32.7 72.03 Favored 'General case' 0 N--CA 1.466 0.347 0 O-C-N 121.793 -0.828 . . . . 0.0 112.51 173.73 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -64.61 -36.71 85.12 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 119.347 0.976 . . . . 0.0 112.302 -174.804 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.23 -38.96 30.01 Favored 'General case' 0 N--CA 1.482 1.163 0 N-CA-C 112.904 0.705 . . . . 0.0 112.904 169.464 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 70.7 m -67.09 -32.46 73.63 Favored 'General case' 0 N--CA 1.485 1.286 0 CA-C-N 118.96 0.8 . . . . 0.0 112.24 -176.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 66.9 mt -91.85 -39.86 11.51 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 125.733 1.613 . . . . 0.0 112.926 173.858 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -99.02 3.43 58.5 Favored Glycine 0 N--CA 1.472 1.036 0 N-CA-C 117.444 1.738 . . . . 0.0 117.444 -169.431 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.24 142.02 57.11 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 121.034 2.417 . . . . 0.0 112.11 178.369 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 84.16 -21.65 9.74 Favored Glycine 0 CA--C 1.539 1.572 0 C-N-CA 125.092 1.33 . . . . 0.0 113.268 -169.442 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -98.88 -46.39 5.65 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 125.603 1.561 . . . . 0.0 111.985 171.609 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 43.0 pt -137.58 154.58 29.86 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 C-N-CA 124.96 1.304 . . . . 0.0 113.37 -175.375 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -102.59 142.37 33.87 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 124.757 1.223 . . . . 0.0 109.938 169.809 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 85.9 t -131.16 139.57 50.66 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 CA-C-N 118.928 0.785 . . . . 0.0 113.058 -176.455 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 27.5 m -139.69 154.24 47.44 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 125.815 1.646 . . . . 0.0 109.586 173.346 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 52.2 m -128.64 147.74 50.75 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.718 0.771 . . . . 0.0 110.841 168.448 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 3.8 m -142.69 151.76 41.68 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 113.926 -1.488 . . . . 0.0 110.981 177.119 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -89.59 174.08 40.97 Favored Glycine 0 CA--C 1.527 0.825 0 N-CA-C 110.383 -1.087 . . . . 0.0 110.383 169.166 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -84.47 -36.99 21.9 Favored 'General case' 0 N--CA 1.477 0.924 0 O-C-N 121.414 -1.05 . . . . 0.0 112.816 175.138 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -128.77 18.83 6.17 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 126.192 1.797 . . . . 0.0 111.628 175.02 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 34.7 p -142.86 153.13 42.87 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 126.069 1.747 . . . . 0.0 111.975 -173.768 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 98.5 p -95.8 -18.56 20.31 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 117.528 2.418 . . . . 0.0 117.528 -168.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 19.0 ttm105 -152.29 151.77 31.32 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 124.916 1.286 . . . . 0.0 111.789 -169.757 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 34.1 m -64.94 136.84 26.02 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 C-N-CA 123.328 0.651 . . . . 0.0 109.364 170.032 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -60.84 143.23 91.59 Favored Pre-proline 0 CA--C 1.551 1.005 0 N-CA-C 112.678 0.622 . . . . 0.0 112.678 -169.046 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_exo -46.59 -40.4 23.66 Favored 'Trans proline' 0 CA--C 1.538 0.718 0 C-N-CA 124.192 3.261 . . . . 0.0 118.731 -168.154 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 33.5 m -63.74 -27.25 69.07 Favored 'General case' 0 N--CA 1.484 1.249 0 CA-C-N 119.759 1.163 . . . . 0.0 111.936 -177.354 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -57.49 -50.15 73.99 Favored 'General case' 0 CA--C 1.537 0.448 0 O-C-N 121.373 -0.83 . . . . 0.0 111.548 173.705 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 4.6 mp -56.94 -50.94 74.22 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 CA-C-N 119.438 1.017 . . . . 0.0 111.126 -175.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -61.22 -27.9 68.77 Favored 'General case' 0 CA--C 1.546 0.804 0 N-CA-C 113.176 0.806 . . . . 0.0 113.176 -179.255 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -83.5 -24.0 31.91 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 113.963 1.098 . . . . 0.0 113.963 175.133 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 4.4 mmt -80.44 -30.5 37.57 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 119.758 1.163 . . . . 0.0 110.188 169.602 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -64.9 -14.92 61.24 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 125.345 1.458 . . . . 0.0 113.604 173.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -61.58 -27.0 68.32 Favored 'General case' 0 N--CA 1.482 1.173 0 CA-C-N 120.639 1.563 . . . . 0.0 110.918 169.104 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 61.0 t -95.8 -2.96 10.48 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.902 0 C-N-CA 127.574 2.349 . . . . 0.0 111.148 177.837 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 77.98 16.87 79.29 Favored Glycine 0 CA--C 1.54 1.598 0 O-C-N 120.699 -1.25 . . . . 0.0 114.397 -174.737 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 77.5 mt -72.34 137.32 23.79 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 124.687 1.195 . . . . 0.0 111.247 -177.456 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 18.0 t0 -105.29 105.41 15.43 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 124.331 1.052 . . . . 0.0 112.098 179.347 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 15.8 pt -137.32 18.99 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.309 0 N-CA-C 114.867 1.432 . . . . 0.0 114.867 -178.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 89.1 p -70.95 -36.87 72.76 Favored 'General case' 0 N--CA 1.479 0.982 0 O-C-N 120.138 -1.601 . . . . 0.0 112.691 175.33 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -77.54 39.16 1.7 Allowed Glycine 0 CA--C 1.538 1.471 0 C-N-CA 126.502 2.001 . . . . 0.0 114.788 177.443 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 5.9 mm-40 -83.42 65.78 8.53 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 125.621 1.568 . . . . 0.0 112.57 -172.427 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER 63.59 -30.79 0.1 Allowed 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 119.741 3.237 . . . . 0.0 119.741 169.11 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 71.2 m 59.37 32.3 21.73 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 125.387 1.475 . . . . 0.0 114.382 -179.622 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -150.95 145.92 18.7 Favored Pre-proline 0 CA--C 1.551 1.013 0 O-C-N 120.974 -1.079 . . . . 0.0 113.798 179.221 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -66.24 162.9 33.95 Favored 'Trans proline' 0 CA--C 1.54 0.795 0 C-N-CA 124.543 3.496 . . . . 0.0 114.599 171.095 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 9.3 tp -57.33 -35.1 47.9 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 C-N-CA 124.536 1.134 . . . . 0.0 112.113 177.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -68.21 -10.22 52.85 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 113.79 1.033 . . . . 0.0 113.79 -179.569 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 66.2 m-20 -95.27 11.72 31.53 Favored 'General case' 0 CA--C 1.555 1.157 0 N-CA-C 113.791 1.034 . . . . 0.0 113.791 178.892 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 76.8 m-85 -130.86 177.72 7.2 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 125.526 1.531 . . . . 0.0 114.514 -174.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 8.1 t30 -107.69 131.81 54.02 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 126.921 2.088 . . . . 0.0 109.975 172.858 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -73.89 -35.34 64.69 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 114.673 1.361 . . . . 0.0 114.673 -176.436 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . 0.273 0.0 OUTLIER -71.69 -6.38 40.74 Favored 'General case' 0 CA--C 1.544 0.734 0 N-CA-C 114.401 1.26 . . . . 0.0 114.401 -172.213 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -62.55 -27.73 69.37 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 124.28 1.032 . . . . 0.0 110.494 168.327 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 19.4 m-85 -113.77 121.65 44.71 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 125.65 1.58 . . . . 0.0 111.132 -172.213 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -73.0 -23.57 60.65 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-O 121.77 0.795 . . . . 0.0 112.555 175.851 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 90.8 t -126.9 136.41 60.87 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 C-N-CA 127.486 2.314 . . . . 0.0 109.299 -174.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 54.2 t -135.51 120.23 27.5 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 169.621 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 25.9 mm -106.82 117.97 53.65 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 C-N-CA 123.314 0.646 . . . . 0.0 109.498 -176.63 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 14.2 t -89.07 124.09 33.97 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 169.607 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 87.6 mt -100.08 13.58 33.61 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 125.147 1.379 . . . . 0.0 114.188 -170.044 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 20.8 p -149.19 1.74 0.55 Allowed 'General case' 0 CA--C 1.547 0.845 0 N-CA-C 114.926 1.454 . . . . 0.0 114.926 177.597 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 68.53 170.34 5.99 Favored Glycine 0 CA--C 1.541 1.682 0 C-N-CA 124.261 0.934 . . . . 0.0 114.161 -176.288 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 71.7 m 54.89 29.5 12.2 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 125.192 1.397 . . . . 0.0 113.685 178.342 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -73.4 18.02 1.77 Allowed Glycine 0 N--CA 1.474 1.213 0 C-N-CA 126.327 1.917 . . . . 0.0 114.688 -177.799 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 4.2 p -65.24 -5.46 2.57 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.881 0 C-N-CA 126.227 1.811 . . . . 0.0 114.482 -169.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 26.7 m120 -76.27 -18.43 58.99 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 125.072 1.349 . . . . 0.0 114.338 176.106 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -74.27 156.48 87.39 Favored Pre-proline 0 N--CA 1.483 1.179 0 CA-C-N 120.277 1.399 . . . . 0.0 112.144 169.918 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_exo -57.27 150.57 57.37 Favored 'Trans proline' 0 CA--C 1.544 1.01 0 C-N-CA 122.999 2.466 . . . . 0.0 114.087 179.308 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -62.22 -24.17 75.95 Favored 'Trans proline' 0 CA--C 1.536 0.586 0 C-N-CA 123.531 2.821 . . . . 0.0 113.814 -174.358 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -60.98 -24.14 65.88 Favored 'General case' 0 CA--C 1.54 0.578 0 O-C-N 121.056 -1.028 . . . . 0.0 113.534 176.052 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 87.3 m95 -79.51 -35.88 39.38 Favored 'General case' 0 N--CA 1.473 0.719 0 O-C-N 120.818 -1.176 . . . . 0.0 112.668 175.364 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 3.9 m -79.34 -18.49 12.87 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.149 0 N-CA-C 113.164 0.802 . . . . 0.0 113.164 178.295 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -86.68 -1.38 57.66 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 114.406 1.262 . . . . 0.0 114.406 177.662 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 84.7 mm-40 -64.14 154.33 35.0 Favored 'General case' 0 N--CA 1.478 0.935 0 O-C-N 120.907 -1.12 . . . . 0.0 110.625 170.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -59.76 -38.25 81.29 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 114.007 1.114 . . . . 0.0 114.007 -168.281 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 17.0 mm -118.18 60.08 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 C-N-CA 125.078 1.351 . . . . 0.0 109.783 179.057 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 47.2 t80 -78.94 106.25 10.84 Favored 'General case' 0 CA--C 1.536 0.413 0 O-C-N 120.749 -1.219 . . . . 0.0 107.777 168.853 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -111.18 131.24 55.27 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 113.523 0.934 . . . . 0.0 113.523 -179.581 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 -92.08 113.01 25.17 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 124.977 1.311 . . . . 0.0 110.825 169.503 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 39.6 m0 -103.97 113.12 26.43 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 124.863 1.265 . . . . 0.0 109.459 174.341 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 34.6 mm-40 -78.98 59.69 2.72 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 124.58 1.152 . . . . 0.0 109.115 169.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 17.4 tp -79.32 145.58 33.39 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 126.068 1.747 . . . . 0.0 111.255 -169.76 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -69.2 125.3 26.27 Favored 'General case' 0 CA--C 1.542 0.645 0 O-C-N 122.146 -0.346 . . . . 0.0 111.068 169.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -75.45 134.78 72.86 Favored Pre-proline 0 CA--C 1.544 0.72 0 O-C-N 121.54 -0.725 . . . . 0.0 109.678 169.657 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -87.63 -17.12 2.83 Favored 'Trans proline' 0 CA--C 1.544 1.003 0 C-N-CA 121.441 1.427 . . . . 0.0 114.836 174.523 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -69.86 -40.45 75.74 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 115.032 1.493 . . . . 0.0 115.032 -169.852 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -68.33 -3.25 30.86 Favored Glycine 0 CA--C 1.54 1.631 0 N-CA-C 115.677 1.031 . . . . 0.0 115.677 -175.892 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -141.86 176.18 9.13 Favored 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 127.017 2.127 . . . . 0.0 112.148 -170.057 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 57.1 m -64.29 161.06 17.43 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 114.866 1.432 . . . . 0.0 114.866 -169.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 39.0 tp -59.02 -28.85 66.8 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 124.791 1.236 . . . . 0.0 113.409 -178.552 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -63.18 -32.42 73.81 Favored 'General case' 0 N--CA 1.473 0.717 0 O-C-N 120.641 -1.287 . . . . 0.0 112.004 172.448 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 4.9 t -72.76 -36.38 52.49 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 O-C-N 121.093 -1.005 . . . . 0.0 110.819 172.308 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -55.95 -49.15 74.31 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-N 119.944 1.247 . . . . 0.0 111.391 169.83 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -66.76 -38.27 86.26 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.586 0.755 . . . . 0.0 112.122 -179.63 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 84.4 m -63.52 -43.92 95.77 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.761 0.824 . . . . 0.0 111.394 172.139 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 52.8 t -69.23 -35.66 69.0 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 CA-C-O 117.704 -1.141 . . . . 0.0 111.186 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 72.3 mtm-85 -57.12 -41.41 78.94 Favored 'General case' 0 N--CA 1.484 1.229 0 CA-C-N 120.903 1.683 . . . . 0.0 111.322 169.76 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -58.66 -50.58 65.77 Favored Glycine 0 CA--C 1.541 1.695 0 CA-C-N 118.898 0.772 . . . . 0.0 113.531 173.401 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 41.3 mt-30 -65.12 -43.64 91.31 Favored 'General case' 0 N--CA 1.477 0.906 0 O-C-N 121.645 -0.915 . . . . 0.0 112.63 178.471 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 69.8 t -66.93 -40.58 86.0 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 C-N-CA 124.012 0.925 . . . . 0.0 110.726 179.325 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 63.7 tttm -54.39 -48.54 71.44 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 119.31 0.959 . . . . 0.0 110.802 175.176 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -61.87 -46.89 87.46 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 123.537 0.735 . . . . 0.0 112.242 177.004 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 12.7 mtp85 -61.74 -40.19 94.22 Favored 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 113.414 0.894 . . . . 0.0 113.414 176.831 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 69.2 t -76.26 -30.76 20.29 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 O-C-N 121.627 -0.671 . . . . 0.0 111.176 -179.44 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -64.63 -38.1 89.84 Favored 'General case' 0 CA--C 1.54 0.585 0 O-C-N 121.184 -0.948 . . . . 0.0 110.166 169.118 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 97.7 m-20 -63.74 -45.48 89.7 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 123.572 0.749 . . . . 0.0 112.493 174.099 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 8.1 tt -50.53 -58.92 4.65 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 125.464 1.505 . . . . 0.0 110.724 170.725 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 80.4 mt -62.62 -44.07 99.07 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 CA-C-O 118.692 -0.67 . . . . 0.0 110.457 -176.449 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -68.14 -14.0 62.65 Favored 'General case' 0 CA--C 1.546 0.816 0 N-CA-C 114.372 1.249 . . . . 0.0 114.372 179.058 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 18.2 ptmt -99.12 -32.31 11.31 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 113.793 1.034 . . . . 0.0 113.793 174.385 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 17.8 pt -90.1 -18.1 7.77 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 N-CA-C 114.109 1.151 . . . . 0.0 114.109 179.815 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 72.9 m . . . . . 0 C--O 1.254 1.319 0 CA-C-O 118.294 -0.86 . . . . 0.0 112.507 -179.783 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.4 ttt . . . . . 0 N--CA 1.501 2.12 0 N-CA-C 111.924 0.342 . . . . 0.0 111.924 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.2 164.25 31.27 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 124.868 1.267 . . . . 0.0 113.363 178.16 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 60.1 mtpt -90.44 142.71 27.46 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 125.059 1.344 . . . . 0.0 113.221 175.681 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 21.6 t -125.49 131.63 71.94 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 C-N-CA 125.791 1.637 . . . . 0.0 112.301 179.186 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 55.0 tpp -101.47 116.5 32.91 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.967 0.907 . . . . 0.0 109.828 169.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 51.2 m-85 -100.74 120.76 40.56 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 124.536 1.134 . . . . 0.0 108.908 171.452 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 3.0 m -140.74 156.66 23.16 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 N-CA-C 115.062 1.504 . . . . 0.0 115.062 -168.774 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 39.4 t -151.82 164.67 36.55 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 128.324 2.65 . . . . 0.0 108.054 169.826 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 39.1 ttpt -56.07 -51.37 68.11 Favored 'General case' 0 N--CA 1.482 1.132 0 CA-C-N 119.532 1.06 . . . . 0.0 112.995 -172.079 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 10.0 tpt180 -103.23 133.38 48.41 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 124.734 1.214 . . . . 0.0 109.64 175.763 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 -90.89 -42.64 10.5 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-N 118.627 0.648 . . . . 0.0 110.661 171.787 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 94.0 p -66.25 158.35 29.17 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 124.426 1.09 . . . . 0.0 110.938 168.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 24.4 p 50.53 -19.48 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.467 0 C-N-CA 129.254 3.021 . . . . 0.0 119.015 -170.048 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 13.9 tpt180 -107.06 112.97 26.16 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 125.806 1.642 . . . . 0.0 112.062 -173.184 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 3.4 p -69.26 136.99 52.71 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 123.914 0.885 . . . . 0.0 110.914 169.756 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 16.0 mt-30 -122.14 -39.68 2.57 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 124.894 1.278 . . . . 0.0 112.263 -169.783 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 68.13 -43.55 0.48 Allowed 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 127.29 2.236 . . . . 0.0 116.357 169.511 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -65.2 -34.29 78.02 Favored 'General case' 0 CA--C 1.533 0.306 0 O-C-N 120.831 -1.168 . . . . 0.0 113.738 -172.206 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 3.1 pm0 -59.88 -40.67 89.48 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 118.919 0.781 . . . . 0.0 111.929 170.378 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -66.24 -52.3 37.21 Favored Glycine 0 C--N 1.335 0.525 0 C-N-CA 123.839 0.733 . . . . 0.0 111.813 178.138 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -64.73 -34.45 78.34 Favored 'General case' 0 N--CA 1.467 0.405 0 O-C-N 121.659 -0.907 . . . . 0.0 112.008 177.902 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -66.16 -32.1 73.35 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 119.568 1.076 . . . . 0.0 112.72 178.637 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 22.6 mtpp -68.42 -52.95 27.08 Favored 'General case' 0 N--CA 1.478 0.943 0 CA-C-N 118.496 0.589 . . . . 0.0 110.129 169.794 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 98.5 m -72.4 -22.76 61.07 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 113.841 1.052 . . . . 0.0 113.841 -170.81 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 49.9 mt -95.38 -37.25 11.03 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 125.472 1.509 . . . . 0.0 113.253 171.631 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -104.92 -4.5 41.97 Favored Glycine 0 N--CA 1.47 0.915 0 N-CA-C 117.848 1.899 . . . . 0.0 117.848 -168.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -62.66 137.66 58.31 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-N 121.526 2.663 . . . . 0.0 111.971 179.794 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 86.88 -14.0 57.74 Favored Glycine 0 CA--C 1.542 1.732 0 C-N-CA 124.92 1.248 . . . . 0.0 113.857 -169.365 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -108.35 -42.88 4.47 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 126.512 1.925 . . . . 0.0 111.768 170.776 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 34.3 pt -136.83 160.65 36.83 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 C-N-CA 126.18 1.792 . . . . 0.0 112.246 179.48 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -108.66 149.34 29.08 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 125.504 1.522 . . . . 0.0 109.893 169.822 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 84.7 t -138.25 141.18 38.63 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 O-C-N 121.471 -0.768 . . . . 0.0 111.916 -170.111 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 18.6 m -140.08 153.49 46.76 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 125.249 1.42 . . . . 0.0 109.936 174.796 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 38.8 p -137.74 138.99 39.86 Favored 'General case' 0 CA--C 1.516 -0.342 0 C-N-CA 124.505 1.122 . . . . 0.0 110.237 168.59 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 96.4 p -127.44 -62.45 1.09 Allowed 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 115.532 1.679 . . . . 0.0 115.532 -168.528 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 111.28 162.11 17.36 Favored Glycine 0 N--CA 1.469 0.841 0 C-N-CA 126.149 1.833 . . . . 0.0 110.6 -174.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -97.66 -20.01 17.9 Favored 'General case' 0 N--CA 1.482 1.16 0 CA-C-N 119.384 1.592 . . . . 0.0 113.66 171.801 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 61.0 mt-10 -132.37 -31.94 1.38 Allowed 'General case' 0 N--CA 1.48 1.039 0 N-CA-C 113.901 1.074 . . . . 0.0 113.901 -171.33 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 94.2 p -137.14 160.38 39.16 Favored 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 125.901 1.681 . . . . 0.0 110.875 -177.17 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 96.6 p -116.59 165.64 13.02 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 125.678 1.591 . . . . 0.0 112.995 -175.588 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 72.2 ttt180 62.87 133.39 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 128.161 2.585 . . . . 0.0 113.728 -171.647 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 26.5 m -61.98 135.13 26.92 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 170.675 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -59.88 144.98 85.22 Favored Pre-proline 0 CA--C 1.548 0.88 0 C-N-CA 120.274 -0.57 . . . . 0.0 112.536 -169.603 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -49.12 -40.93 41.92 Favored 'Trans proline' 0 CA--C 1.539 0.761 0 C-N-CA 123.23 2.62 . . . . 0.0 117.763 -167.762 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 59.8 m -65.75 -26.54 67.77 Favored 'General case' 0 N--CA 1.484 1.252 0 CA-C-N 119.475 1.034 . . . . 0.0 111.661 -176.471 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -57.12 -36.94 71.26 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 123.905 0.882 . . . . 0.0 112.199 177.279 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.8 mp -59.5 -60.15 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 CA-C-N 119.05 0.841 . . . . 0.0 109.269 -179.404 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -62.49 -31.25 71.97 Favored 'General case' 0 CA--C 1.544 0.734 0 N-CA-C 113.434 0.901 . . . . 0.0 113.434 -176.677 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -81.29 -6.15 58.57 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 124.815 1.246 . . . . 0.0 114.184 177.672 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 40.6 mtt -114.94 -22.9 9.36 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 125.383 1.473 . . . . 0.0 110.704 175.026 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -65.15 -19.2 65.87 Favored 'General case' 0 CA--C 1.541 0.628 0 O-C-N 120.594 -1.316 . . . . 0.0 111.729 168.751 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 11.7 mt-10 -60.73 -28.27 68.55 Favored 'General case' 0 N--CA 1.481 1.107 0 CA-C-N 119.558 1.072 . . . . 0.0 111.48 169.377 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 67.8 t -93.14 -5.43 10.69 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.946 0 C-N-CA 127.472 2.309 . . . . 0.0 111.021 177.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 82.22 16.87 70.67 Favored Glycine 0 CA--C 1.538 1.494 0 C-N-CA 125.16 1.362 . . . . 0.0 114.307 -175.224 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 78.5 mt -77.14 139.6 18.47 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 C-N-CA 124.645 1.178 . . . . 0.0 111.53 -173.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 20.0 t0 -103.7 106.68 17.26 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 124.614 1.166 . . . . 0.0 111.873 170.709 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 3.8 pt -131.54 13.71 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.212 0 C-N-CA 125.515 1.526 . . . . 0.0 113.811 178.048 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 72.7 m -73.37 119.56 17.78 Favored 'General case' 0 N--CA 1.472 0.628 0 O-C-N 120.834 -1.167 . . . . 0.0 112.119 -176.31 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 63.78 35.43 92.01 Favored Glycine 0 CA--C 1.537 1.416 0 N-CA-C 115.797 1.079 . . . . 0.0 115.797 169.831 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 41.0 mt-30 -59.99 -50.32 74.22 Favored 'General case' 0 N--CA 1.477 0.906 0 N-CA-C 113.887 1.069 . . . . 0.0 113.887 -172.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 76.1 p -139.13 154.18 48.08 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 125.267 1.427 . . . . 0.0 113.348 -169.065 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 69.5 m -122.99 5.86 9.3 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 125.664 1.586 . . . . 0.0 113.982 -176.829 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 -143.14 153.07 59.55 Favored Pre-proline 0 CA--C 1.55 0.976 0 C-N-CA 124.44 1.096 . . . . 0.0 113.562 -173.411 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_exo -66.07 167.11 18.81 Favored 'Trans proline' 0 C--N 1.353 0.808 0 C-N-CA 123.349 2.7 . . . . 0.0 113.84 170.085 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 8.3 tt -50.79 -30.36 8.52 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 C-N-CA 126.699 2.0 . . . . 0.0 111.498 169.073 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -53.44 -27.49 25.04 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 126.514 1.925 . . . . 0.0 113.347 177.123 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -88.34 -6.82 57.5 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 125.119 1.368 . . . . 0.0 113.72 -174.875 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 71.6 m-85 -109.04 179.95 4.02 Favored 'General case' 0 CA--C 1.55 0.981 0 C-N-CA 126.51 1.924 . . . . 0.0 111.485 -174.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 5.8 t30 -122.52 126.24 47.4 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 125.495 1.518 . . . . 0.0 109.757 175.023 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.59 -35.66 80.73 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 113.895 1.072 . . . . 0.0 113.895 -169.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . 0.254 0.0 OUTLIER -71.46 -5.34 32.17 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 114.085 1.142 . . . . 0.0 114.085 -177.02 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -76.08 -12.96 60.21 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 124.013 0.925 . . . . 0.0 111.463 169.245 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 86.5 m-85 -115.51 139.54 49.97 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 127.098 2.159 . . . . 0.0 111.167 178.676 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -91.14 -21.97 20.91 Favored 'General case' 0 N--CA 1.478 0.959 0 CA-C-O 122.078 0.942 . . . . 0.0 112.556 178.303 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 80.7 t -133.78 139.29 48.98 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 C-N-CA 126.957 2.103 . . . . 0.0 109.014 -174.547 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 45.1 t -131.71 124.07 53.19 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 169.789 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 44.8 mm -111.86 108.01 24.42 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 C-N-CA 124.578 1.151 . . . . 0.0 108.653 -179.486 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 46.8 m -93.64 114.97 27.42 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 123.201 0.6 . . . . 0.0 109.738 174.859 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 82.7 mt -86.77 -13.7 44.45 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.971 1.308 . . . . 0.0 114.059 -172.118 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 14.5 p -147.85 157.78 43.71 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 124.835 1.254 . . . . 0.0 111.29 -176.603 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 62.1 -143.08 48.49 Favored Glycine 0 CA--C 1.538 1.472 0 C-N-CA 123.431 0.538 . . . . 0.0 113.494 179.572 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 56.9 m -131.43 164.12 26.43 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 125.584 1.554 . . . . 0.0 111.209 179.067 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -72.67 63.97 1.49 Allowed Glycine 0 CA--C 1.538 1.517 0 C-N-CA 124.953 1.264 . . . . 0.0 113.525 177.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 10.0 p -141.6 -30.65 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 N-CA-C 114.492 1.293 . . . . 0.0 114.492 -171.597 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 10.9 t-20 -75.0 -29.25 60.83 Favored 'General case' 0 N--CA 1.477 0.882 0 CA-C-N 119.417 1.008 . . . . 0.0 112.193 176.525 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -83.18 150.93 62.12 Favored Pre-proline 0 CA--C 1.548 0.888 0 C-N-CA 125.024 1.329 . . . . 0.0 111.279 169.628 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -65.35 155.44 68.62 Favored 'Trans proline' 0 CA--C 1.541 0.828 0 C-N-CA 122.574 2.182 . . . . 0.0 111.655 178.141 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -59.41 -26.34 81.6 Favored 'Trans proline' 0 C--N 1.35 0.61 0 C-N-CA 123.474 2.782 . . . . 0.0 114.913 -169.157 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -59.59 -22.7 62.15 Favored 'General case' 0 N--CA 1.472 0.629 0 O-C-N 120.841 -1.162 . . . . 0.0 114.119 178.285 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 84.9 m95 -82.44 -16.99 46.93 Favored 'General case' 0 N--CA 1.471 0.616 0 O-C-N 120.79 -1.194 . . . . 0.0 113.593 174.904 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 10.3 m -93.33 -10.41 9.45 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 CA-C-N 119.299 0.954 . . . . 0.0 113.498 170.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 60.3 p -93.48 -1.35 55.75 Favored 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 114.771 1.397 . . . . 0.0 114.771 177.016 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 72.8 mm-40 -67.64 154.21 41.96 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 119.3 0.954 . . . . 0.0 110.909 169.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -56.62 -40.01 74.62 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 114.601 1.334 . . . . 0.0 114.601 -167.82 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 15.7 mm -120.89 61.64 0.23 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 C-N-CA 124.972 1.309 . . . . 0.0 109.357 178.822 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 13.3 t80 -77.29 110.83 12.34 Favored 'General case' 0 CA--C 1.536 0.404 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 168.849 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 16.3 mt-10 -114.66 138.56 50.54 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 113.988 1.107 . . . . 0.0 113.988 173.197 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -101.65 120.25 40.04 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 124.143 0.977 . . . . 0.0 108.518 168.603 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 35.8 m0 -103.56 134.81 46.29 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 123.722 0.809 . . . . 0.0 108.867 176.629 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 64.2 mt-30 -114.8 30.56 7.26 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 123.865 0.866 . . . . 0.0 112.554 -169.563 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -76.16 159.71 30.44 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 125.709 1.604 . . . . 0.0 112.579 174.783 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -73.44 156.18 38.52 Favored 'General case' 0 CA--C 1.539 0.53 0 O-C-N 121.88 -0.512 . . . . 0.0 111.906 170.029 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 64.2 m-20 -106.44 155.06 39.39 Favored Pre-proline 0 CA--C 1.549 0.918 0 C-N-CA 123.292 0.637 . . . . 0.0 111.111 173.096 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_exo -70.87 -21.59 28.12 Favored 'Trans proline' 0 CA--C 1.544 1.007 0 C-N-CA 122.464 2.109 . . . . 0.0 115.115 179.795 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -42.19 125.26 3.02 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 114.329 1.233 . . . . 0.0 114.329 172.756 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 81.54 3.24 90.67 Favored Glycine 0 CA--C 1.535 1.335 0 C-N-CA 124.39 0.995 . . . . 0.0 115.167 177.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 9.8 pt20 -137.81 172.8 12.41 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 124.938 1.295 . . . . 0.0 113.59 -178.595 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 51.9 p -71.67 169.75 14.95 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 117.666 2.469 . . . . 0.0 117.666 -168.442 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -54.84 -41.68 71.03 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 126.436 1.894 . . . . 0.0 112.17 170.129 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -57.25 -32.85 66.99 Favored 'General case' 0 N--CA 1.473 0.716 0 O-C-N 121.225 -0.922 . . . . 0.0 112.23 172.382 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 7.7 t -75.14 -36.2 36.77 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 O-C-N 121.051 -1.031 . . . . 0.0 112.05 171.101 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 12.1 m-85 -56.58 -42.77 79.23 Favored 'General case' 0 N--CA 1.478 0.949 0 CA-C-N 120.792 1.633 . . . . 0.0 111.132 169.229 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 83.2 mtp180 -64.82 -42.9 94.61 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 124.1 0.96 . . . . 0.0 112.11 175.063 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 53.1 m -60.45 -45.31 94.15 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 124.1 0.96 . . . . 0.0 111.283 175.398 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 74.3 t -68.16 -42.1 84.62 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 CA-C-O 117.929 -1.034 . . . . 0.0 110.643 177.66 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 18.0 mtp180 -52.91 -44.9 67.3 Favored 'General case' 0 N--CA 1.482 1.158 0 CA-C-N 120.283 1.401 . . . . 0.0 112.215 171.761 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -60.09 -51.49 58.57 Favored Glycine 0 CA--C 1.539 1.577 0 CA-C-N 119.243 0.928 . . . . 0.0 113.694 175.303 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 56.4 mm-40 -65.45 -44.48 87.12 Favored 'General case' 0 N--CA 1.477 0.883 0 O-C-N 121.797 -0.825 . . . . 0.0 112.221 179.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 52.9 t -63.21 -42.06 95.09 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 124.673 1.189 . . . . 0.0 110.496 177.022 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 60.0 tttm -54.81 -50.93 67.35 Favored 'General case' 0 N--CA 1.477 0.888 0 CA-C-N 119.689 1.132 . . . . 0.0 110.91 177.664 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -63.99 -41.77 97.4 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 112.458 0.54 . . . . 0.0 112.458 178.756 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 4.8 mtp85 -63.3 -43.97 96.35 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 113.254 0.835 . . . . 0.0 113.254 175.772 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 94.1 t -71.34 -37.76 66.68 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 C-N-CA 124.044 0.937 . . . . 0.0 111.105 179.407 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -61.24 -40.97 96.02 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 119.417 1.008 . . . . 0.0 111.682 170.409 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 11.6 m-80 -61.8 -48.59 79.93 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 118.727 0.694 . . . . 0.0 112.165 173.394 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -51.83 -56.61 12.96 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 125.33 1.452 . . . . 0.0 110.465 175.725 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 75.2 mt -61.25 -46.3 96.89 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 CA-C-O 119.124 -0.465 . . . . 0.0 110.138 -179.574 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -66.62 -12.04 56.27 Favored 'General case' 0 CA--C 1.546 0.795 0 N-CA-C 114.983 1.475 . . . . 0.0 114.983 -178.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -102.14 -26.45 13.35 Favored 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 113.824 1.046 . . . . 0.0 113.824 172.355 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 13.6 pt -97.45 -12.85 8.26 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 N-CA-C 114.866 1.432 . . . . 0.0 114.866 178.655 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 57.8 m . . . . . 0 C--O 1.252 1.199 0 C-N-CA 125.333 1.453 . . . . 0.0 112.255 -179.792 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.3 ttt . . . . . 0 N--CA 1.501 2.088 0 N-CA-C 111.937 0.347 . . . . 0.0 111.937 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.15 164.34 30.41 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 124.966 1.306 . . . . 0.0 112.886 175.922 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 41.5 mtpt -94.73 143.4 26.47 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 124.449 1.1 . . . . 0.0 112.136 178.141 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 18.9 t -124.71 133.86 68.33 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 C-N-CA 125.289 1.435 . . . . 0.0 112.749 -178.877 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 36.8 tpp -104.2 122.45 45.39 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 123.412 0.685 . . . . 0.0 109.257 168.717 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 68.6 m-85 -98.94 128.66 45.15 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.337 1.055 . . . . 0.0 108.993 170.22 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -138.27 144.17 31.11 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 N-CA-C 114.363 1.245 . . . . 0.0 114.363 -168.778 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -141.18 166.81 23.76 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 127.131 2.173 . . . . 0.0 110.68 170.122 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -57.19 -49.15 76.87 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.263 -0.898 . . . . 0.0 112.928 -173.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 96.8 mtt180 -125.05 130.55 52.52 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 124.679 1.191 . . . . 0.0 110.088 169.559 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 35.5 t30 -81.54 -43.0 19.35 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-N 117.819 0.281 . . . . 0.0 111.498 -179.735 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 45.0 m -68.25 -32.23 72.28 Favored 'General case' 0 N--CA 1.478 0.954 0 N-CA-C 113.52 0.933 . . . . 0.0 113.52 -170.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 97.8 p -90.92 -5.7 55.12 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 114.855 1.428 . . . . 0.0 114.855 -175.138 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 60.2 mtt85 -134.93 156.64 48.64 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 124.583 1.153 . . . . 0.0 112.341 -175.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 37.2 m -105.47 103.83 13.44 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 124.565 1.146 . . . . 0.0 110.077 -179.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 3.1 mp0 -78.4 -34.51 48.03 Favored 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 114.162 1.171 . . . . 0.0 114.162 -169.206 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 68.74 -49.2 0.57 Allowed 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 126.474 1.91 . . . . 0.0 115.99 169.653 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.97 -33.57 73.41 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.185 0.994 . . . . 0.0 113.574 -171.131 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 3.4 pm0 -62.5 -46.3 89.05 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 123.978 0.911 . . . . 0.0 112.277 174.295 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -65.57 -39.87 95.74 Favored Glycine 0 C--N 1.335 0.49 0 C-N-CA 123.64 0.638 . . . . 0.0 111.66 178.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -69.92 -41.78 74.19 Favored 'General case' 0 N--CA 1.468 0.431 0 O-C-N 121.838 -0.801 . . . . 0.0 111.271 176.156 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -60.4 -43.36 96.75 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 119.626 1.103 . . . . 0.0 112.735 -176.446 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 8.8 pttp -77.91 -24.31 48.37 Favored 'General case' 0 N--CA 1.479 1.011 0 N-CA-C 113.65 0.981 . . . . 0.0 113.65 175.097 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 85.5 m -71.63 -36.01 70.6 Favored 'General case' 0 N--CA 1.48 1.071 0 O-C-N 121.401 -0.812 . . . . 0.0 111.623 171.682 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 61.4 mt -88.09 -31.73 19.09 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 125.711 1.604 . . . . 0.0 114.172 -177.698 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -145.8 30.97 1.65 Allowed Glycine 0 N--CA 1.474 1.219 0 N-CA-C 118.297 2.079 . . . . 0.0 118.297 -169.035 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -66.71 -19.75 65.82 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-N 121.794 2.797 . . . . 0.0 115.202 -178.238 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -75.36 -10.37 84.45 Favored Glycine 0 CA--C 1.541 1.711 0 O-C-N 121.293 -0.88 . . . . 0.0 113.18 169.586 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 76.0 mttt -108.64 -39.66 5.31 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 127.185 2.194 . . . . 0.0 113.375 179.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 22.6 pt -142.12 155.72 19.33 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 C-N-CA 124.966 1.306 . . . . 0.0 112.562 -173.235 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -104.27 142.68 34.11 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 124.156 0.982 . . . . 0.0 110.48 171.199 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 74.3 t -130.11 140.11 49.76 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 CA-C-N 119.186 0.903 . . . . 0.0 112.88 -171.776 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 36.4 m -137.59 154.18 49.82 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 126.302 1.841 . . . . 0.0 109.02 170.885 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 61.3 p -128.95 147.31 50.84 Favored 'General case' 0 CA--C 1.515 -0.366 0 CA-C-O 121.931 0.872 . . . . 0.0 112.506 167.464 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 25.8 p -144.79 157.44 44.17 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 114.353 -1.294 . . . . 0.0 112.378 -178.59 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -97.92 150.74 19.52 Favored Glycine 0 N--CA 1.468 0.814 0 CA-C-O 119.318 -0.712 . . . . 0.0 111.846 174.663 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 10.8 mp -66.44 -30.9 71.35 Favored 'General case' 0 N--CA 1.483 1.207 0 CA-C-N 119.299 1.55 . . . . 0.0 108.992 168.864 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 52.6 mt-10 -133.1 154.8 50.24 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 128.359 2.664 . . . . 0.0 107.201 168.214 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 27.0 p 64.46 161.38 0.12 Allowed 'General case' 0 N--CA 1.486 1.331 0 N-CA-C 117.504 2.409 . . . . 0.0 117.504 178.678 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 75.1 m -118.76 143.55 46.83 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 126.621 1.968 . . . . 0.0 113.18 -170.248 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 59.1 ttt-85 62.3 148.13 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.897 0 C-N-CA 127.612 2.365 . . . . 0.0 114.091 -176.381 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 24.9 m -61.38 166.18 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.255 0 CA-C-O 122.662 1.22 . . . . 0.0 111.824 169.782 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 2.7 t-80 -41.22 136.45 1.71 Allowed Pre-proline 0 C--N 1.327 -0.386 0 CA-C-N 113.761 -1.563 . . . . 0.0 113.243 169.426 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -60.36 -27.5 84.99 Favored 'Trans proline' 0 CA--C 1.546 1.12 0 CA-C-N 120.753 1.305 . . . . 0.0 112.252 170.647 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 99.0 m -67.89 -31.89 71.99 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 124.966 1.306 . . . . 0.0 112.077 174.566 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -57.39 -39.48 76.2 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 124.289 1.036 . . . . 0.0 111.636 -175.055 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.7 mp -57.45 -60.61 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 C-N-CA 124.226 1.01 . . . . 0.0 109.361 -178.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -61.82 -31.62 71.88 Favored 'General case' 0 CA--C 1.545 0.761 0 N-CA-C 113.384 0.883 . . . . 0.0 113.384 -177.17 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -82.25 -6.61 59.35 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 114.248 1.203 . . . . 0.0 114.248 177.953 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 39.1 mtt -112.52 -24.35 9.75 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 125.418 1.487 . . . . 0.0 110.464 174.604 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 27.0 mt-10 -65.46 -16.43 63.64 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 125.128 1.371 . . . . 0.0 111.519 168.559 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 11.5 mt-10 -60.21 -30.52 69.43 Favored 'General case' 0 N--CA 1.481 1.095 0 CA-C-N 119.726 1.148 . . . . 0.0 110.74 169.103 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 60.2 t -92.45 -4.99 10.79 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.955 0 C-N-CA 127.59 2.356 . . . . 0.0 111.017 178.721 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 80.1 18.3 72.37 Favored Glycine 0 CA--C 1.538 1.497 0 C-N-CA 125.073 1.32 . . . . 0.0 114.55 -173.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 73.8 mt -76.89 136.69 23.99 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 124.368 1.067 . . . . 0.0 111.661 -173.082 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 19.7 t0 -97.33 88.45 4.43 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.588 1.155 . . . . 0.0 112.061 -179.112 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 7.6 pt -125.8 8.66 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.33 0 N-CA-C 114.265 1.209 . . . . 0.0 114.265 174.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 97.7 p -59.28 -42.12 90.48 Favored 'General case' 0 N--CA 1.477 0.92 0 O-C-N 120.824 -1.173 . . . . 0.0 114.044 -171.59 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -93.35 15.39 63.07 Favored Glycine 0 CA--C 1.534 1.237 0 C-N-CA 125.18 1.371 . . . . 0.0 116.092 -176.533 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . 0.268 0.0 OUTLIER -77.51 62.07 2.4 Favored 'General case' 0 N--CA 1.478 0.93 0 CA-C-N 119.912 1.856 . . . . 0.0 114.481 -172.18 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 40.2 p -69.38 107.86 3.49 Favored 'General case' 0 N--CA 1.471 0.585 0 O-C-N 120.431 -1.418 . . . . 0.0 108.93 169.186 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 70.2 m -142.18 129.32 20.92 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.204 1.002 . . . . 0.0 111.456 -169.567 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -67.02 170.39 6.37 Favored Pre-proline 0 CA--C 1.549 0.922 0 C-N-CA 127.575 2.35 . . . . 0.0 114.496 -176.249 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -64.3 156.51 59.38 Favored 'Trans proline' 0 C--N 1.352 0.728 0 C-N-CA 122.665 2.243 . . . . 0.0 111.819 169.129 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 6.0 tt -51.59 -33.71 15.17 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 C-N-CA 125.874 1.669 . . . . 0.0 111.571 174.632 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 12.3 mt-10 -61.97 -24.18 66.85 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.748 1.219 . . . . 0.0 113.295 -178.044 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 71.1 m-20 -91.89 6.17 47.22 Favored 'General case' 0 CA--C 1.55 0.981 0 C-N-CA 124.378 1.071 . . . . 0.0 112.898 -175.408 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 -119.15 -175.55 2.94 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 126.833 2.053 . . . . 0.0 112.683 -179.76 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 9.6 p-10 -123.73 129.26 50.81 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 125.737 1.615 . . . . 0.0 109.728 172.474 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -64.72 -37.19 86.76 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 112.81 0.671 . . . . 0.0 112.81 -172.607 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -68.4 -4.39 14.52 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 114.291 1.219 . . . . 0.0 114.291 179.364 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -68.51 -21.39 64.58 Favored 'General case' 0 CA--C 1.549 0.916 0 CA-C-N 119.317 0.962 . . . . 0.0 109.932 168.449 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 76.6 m-85 -115.35 146.13 41.85 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 127.726 2.41 . . . . 0.0 111.842 -175.179 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -101.91 -18.12 15.84 Favored 'General case' 0 N--CA 1.481 1.088 0 CA-C-O 122.153 0.978 . . . . 0.0 112.614 178.584 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 76.0 t -128.62 138.64 54.05 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 C-N-CA 127.605 2.362 . . . . 0.0 108.022 177.731 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 48.7 t -132.82 124.98 51.68 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 169.836 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 46.2 mm -112.3 104.82 17.66 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.344 0 C-N-CA 124.275 1.03 . . . . 0.0 109.602 -175.054 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 3.6 m -80.28 106.69 12.49 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 123.494 0.718 . . . . 0.0 109.868 170.463 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 91.2 mt -83.58 -19.95 34.63 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 126.237 1.815 . . . . 0.0 113.852 -176.293 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 80.6 m -97.01 121.59 39.06 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 106.931 -1.507 . . . . 0.0 106.931 171.328 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -59.73 141.47 47.55 Favored Glycine 0 CA--C 1.535 1.337 0 CA-C-N 118.484 0.583 . . . . 0.0 113.199 -172.571 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 75.7 m 56.85 43.65 24.57 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.744 1.218 . . . . 0.0 111.114 -169.526 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -74.29 62.61 2.2 Favored Glycine 0 N--CA 1.471 1.002 0 C-N-CA 125.91 1.719 . . . . 0.0 111.802 176.331 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.3 p -113.17 -0.41 9.3 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 C-N-CA 126.119 1.768 . . . . 0.0 112.913 -170.074 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 29.0 m120 -74.46 -11.34 60.2 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 124.338 1.055 . . . . 0.0 113.252 174.844 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -65.77 158.96 72.46 Favored Pre-proline 0 CA--C 1.553 1.07 0 C-N-CA 124.274 1.03 . . . . 0.0 112.389 170.501 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -59.94 149.93 81.15 Favored 'Trans proline' 0 CA--C 1.543 0.975 0 C-N-CA 122.437 2.091 . . . . 0.0 113.11 178.721 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_exo -56.25 -33.4 90.88 Favored 'Trans proline' 0 C--N 1.351 0.694 0 C-N-CA 123.102 2.535 . . . . 0.0 114.948 -171.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -59.61 -22.49 61.89 Favored 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 114.019 1.118 . . . . 0.0 114.019 178.879 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 88.7 m95 -79.75 -15.82 56.76 Favored 'General case' 0 N--CA 1.469 0.511 0 O-C-N 120.685 -1.259 . . . . 0.0 113.487 176.439 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 8.2 m -96.35 -8.13 9.43 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 N-CA-C 113.711 1.004 . . . . 0.0 113.711 170.731 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 68.5 p -95.77 -2.85 46.86 Favored 'General case' 0 N--CA 1.48 1.044 0 N-CA-C 114.866 1.432 . . . . 0.0 114.866 178.206 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 68.6 mm-40 -65.93 155.09 37.51 Favored 'General case' 0 N--CA 1.477 0.916 0 CA-C-N 119.368 0.985 . . . . 0.0 110.236 169.553 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -56.78 -40.05 75.16 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 114.773 1.397 . . . . 0.0 114.773 -168.154 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 19.7 mm -120.26 65.92 0.26 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 C-N-CA 124.652 1.181 . . . . 0.0 109.147 -178.795 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 32.7 t80 -80.04 109.76 14.79 Favored 'General case' 0 C--O 1.236 0.375 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 168.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -110.2 135.19 51.36 Favored 'General case' 0 CA--C 1.545 0.76 0 N-CA-C 113.441 0.904 . . . . 0.0 113.441 174.478 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -102.06 103.71 14.32 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.435 1.094 . . . . 0.0 109.584 169.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 38.1 m0 -91.84 114.1 26.55 Favored 'General case' 0 N--CA 1.463 0.181 0 C-N-CA 124.275 1.03 . . . . 0.0 109.294 179.523 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 41.7 mt-30 -91.8 48.54 1.46 Allowed 'General case' 0 CA--C 1.544 0.749 0 CA-C-O 122.289 1.043 . . . . 0.0 111.26 -172.678 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 86.5 mt -78.39 166.25 22.87 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 127.115 2.166 . . . . 0.0 111.953 176.485 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -88.9 152.49 21.7 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-O 121.555 0.693 . . . . 0.0 112.415 169.573 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 13.4 p-10 -89.6 136.77 29.23 Favored Pre-proline 0 CA--C 1.55 0.968 0 C-N-CA 125.47 1.508 . . . . 0.0 112.008 176.214 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -70.25 -20.01 33.05 Favored 'Trans proline' 0 CA--C 1.547 1.126 0 C-N-CA 121.955 1.77 . . . . 0.0 115.491 -178.42 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -66.52 145.0 56.12 Favored 'General case' 0 N--CA 1.476 0.834 0 O-C-N 121.103 -0.998 . . . . 0.0 113.179 -175.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 78.36 4.81 87.37 Favored Glycine 0 CA--C 1.535 1.296 0 C-N-CA 123.943 0.782 . . . . 0.0 114.661 -179.156 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -141.61 166.83 23.67 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 125.465 1.506 . . . . 0.0 112.878 -179.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 66.9 m -63.86 163.23 12.23 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 115.698 1.74 . . . . 0.0 115.698 -169.239 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -51.82 -39.64 59.11 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 126.673 1.989 . . . . 0.0 112.837 171.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -55.27 -31.81 61.86 Favored 'General case' 0 N--CA 1.474 0.737 0 O-C-N 121.265 -0.897 . . . . 0.0 112.515 172.598 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 4.3 t -76.94 -37.27 26.7 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 O-C-N 121.163 -0.961 . . . . 0.0 111.75 173.575 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 21.4 m-85 -57.16 -42.66 81.49 Favored 'General case' 0 N--CA 1.477 0.88 0 CA-C-N 119.943 1.247 . . . . 0.0 111.221 169.302 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 97.7 mtt180 -68.45 -38.35 81.06 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.612 0.765 . . . . 0.0 112.474 176.158 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 45.8 m -61.71 -45.65 93.06 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 124.187 0.995 . . . . 0.0 111.37 172.638 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 72.1 t -67.77 -40.97 84.74 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 CA-C-O 118.266 -0.873 . . . . 0.0 110.463 178.324 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 20.4 mtp180 -54.45 -43.74 71.92 Favored 'General case' 0 N--CA 1.484 1.273 0 CA-C-N 120.239 1.381 . . . . 0.0 112.915 170.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -61.59 -50.02 70.69 Favored Glycine 0 CA--C 1.537 1.417 0 CA-C-N 119.45 1.023 . . . . 0.0 113.255 175.784 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 53.6 mm-40 -64.59 -44.13 91.65 Favored 'General case' 0 N--CA 1.476 0.837 0 O-C-N 122.043 -0.68 . . . . 0.0 112.012 178.478 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 58.8 t -63.92 -41.46 92.58 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 C-N-CA 124.91 1.284 . . . . 0.0 111.125 176.752 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 60.7 tttm -54.27 -49.75 68.84 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-N 120.13 1.332 . . . . 0.0 110.628 176.832 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -63.49 -44.79 93.33 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 112.557 0.577 . . . . 0.0 112.557 176.306 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.23 -35.38 80.86 Favored 'General case' 0 N--CA 1.481 1.105 0 N-CA-C 113.6 0.963 . . . . 0.0 113.6 -179.921 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 92.3 t -78.01 -40.55 26.61 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 C-N-CA 125.411 1.484 . . . . 0.0 110.992 177.008 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -61.43 -38.57 87.61 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 119.185 0.902 . . . . 0.0 111.542 172.257 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 11.1 m-80 -63.91 -44.96 91.37 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 118.846 0.748 . . . . 0.0 112.701 173.561 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -54.47 -56.32 20.0 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 124.223 1.009 . . . . 0.0 110.667 174.392 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 95.3 mt -61.76 -42.01 92.77 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 CA-C-O 119.199 -0.429 . . . . 0.0 110.51 -179.26 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -68.72 -14.38 62.99 Favored 'General case' 0 CA--C 1.545 0.763 0 N-CA-C 114.933 1.457 . . . . 0.0 114.933 179.072 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 21.1 ptmt -99.96 -27.96 13.32 Favored 'General case' 0 N--CA 1.479 0.986 0 N-CA-C 113.855 1.057 . . . . 0.0 113.855 173.523 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 16.6 pt -94.86 -20.54 6.03 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 N-CA-C 114.295 1.22 . . . . 0.0 114.295 177.338 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 74.7 m . . . . . 0 C--O 1.253 1.28 0 C-N-CA 125.074 1.349 . . . . 0.0 111.889 -173.788 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.401 ' HA ' ' O ' ' A' ' 29' ' ' LYS . 32.9 ttm . . . . . 0 N--CA 1.502 2.133 0 N-CA-C 112.044 0.387 . . . . 0.0 112.044 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 3.5 mptp? -103.92 155.51 18.58 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 125.181 1.392 . . . . 0.0 112.688 169.812 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 44.7 mtpt -105.4 113.78 27.56 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 106.089 -1.819 . . . . 0.0 106.089 167.088 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 14.4 t -105.95 130.49 57.41 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 C-N-CA 125.247 1.419 . . . . 0.0 113.15 -178.788 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 61.3 tpp -101.65 117.74 35.51 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.501 0.72 . . . . 0.0 109.137 169.193 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 54.8 m-85 -98.79 128.09 44.91 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 169.744 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 1.3 m -144.22 153.1 15.4 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.127 0 N-CA-C 113.527 0.936 . . . . 0.0 113.527 -169.195 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 44.0 t -146.2 137.66 24.71 Favored 'General case' 0 CA--C 1.552 1.024 0 C-N-CA 125.315 1.446 . . . . 0.0 113.052 -178.457 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -67.36 135.44 53.24 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 125.029 1.331 . . . . 0.0 111.718 172.439 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . 0.263 19.1 ttm180 47.24 56.36 6.99 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 126.693 1.997 . . . . 0.0 113.31 -174.53 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 -48.76 -29.93 5.07 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 126.746 2.018 . . . . 0.0 114.654 175.461 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 81.4 p -62.69 -19.17 63.61 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 114.558 1.318 . . . . 0.0 114.558 179.72 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 84.7 p -127.32 24.07 6.32 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.458 1.503 . . . . 0.0 113.872 175.019 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 72.2 mtt85 -139.32 150.44 45.4 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 124.846 1.259 . . . . 0.0 113.26 177.196 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 22.3 m -106.81 153.87 21.84 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 125.552 1.541 . . . . 0.0 111.147 172.499 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 30.7 mt-30 -110.15 -55.91 2.4 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 113.248 0.833 . . . . 0.0 113.248 -171.846 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 73.28 -48.21 0.68 Allowed 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 126.608 1.963 . . . . 0.0 113.523 176.984 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.92 -33.31 74.02 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 113.552 0.945 . . . . 0.0 113.552 -175.1 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 5.4 pm0 -68.58 -42.3 78.45 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 123.846 0.859 . . . . 0.0 111.306 177.419 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -65.0 -40.59 97.23 Favored Glycine 0 C--N 1.336 0.581 0 N-CA-C 111.504 -0.638 . . . . 0.0 111.504 178.7 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -72.64 -38.93 67.54 Favored 'General case' 0 N--CA 1.466 0.366 0 O-C-N 121.809 -0.818 . . . . 0.0 112.054 177.403 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.9 -37.48 84.78 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 113.552 0.945 . . . . 0.0 113.552 -173.749 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 6.9 pttp -79.47 -31.16 42.37 Favored 'General case' 0 N--CA 1.481 1.102 0 N-CA-C 113.689 0.996 . . . . 0.0 113.689 172.115 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 59.0 m -70.74 -33.34 70.71 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.197 0.599 . . . . 0.0 111.498 178.583 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 68.3 mt -92.78 -37.5 12.3 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 125.864 1.666 . . . . 0.0 113.277 177.587 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -106.82 8.91 39.96 Favored Glycine 0 N--CA 1.472 1.055 0 N-CA-C 117.892 1.917 . . . . 0.0 117.892 -169.021 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.12 141.88 57.11 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-N 121.318 2.559 . . . . 0.0 112.203 177.407 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 83.91 -21.34 9.79 Favored Glycine 0 CA--C 1.538 1.495 0 C-N-CA 124.984 1.278 . . . . 0.0 113.749 -169.485 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.401 ' O ' ' HA ' ' A' ' 1' ' ' MET . 65.1 mttm -97.45 -48.22 5.37 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 125.786 1.635 . . . . 0.0 111.796 169.863 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 40.6 pt -135.39 150.13 29.03 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 C-N-CA 124.364 1.066 . . . . 0.0 113.085 -175.087 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -102.48 137.76 40.29 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 125.407 1.483 . . . . 0.0 108.921 169.769 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 99.4 t -126.49 140.67 48.16 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 C-N-CA 123.265 0.626 . . . . 0.0 111.976 -173.785 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 27.3 m -140.04 151.59 45.54 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 125.191 1.396 . . . . 0.0 109.626 174.745 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 53.0 p -138.37 145.75 41.46 Favored 'General case' 0 CA--C 1.516 -0.339 0 CA-C-O 122.486 1.136 . . . . 0.0 111.784 167.454 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 88.5 p -139.59 153.56 47.4 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 113.227 -1.806 . . . . 0.0 110.657 -171.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -75.98 162.82 53.0 Favored Glycine 0 CA--C 1.535 1.329 0 O-C-N 121.162 -0.961 . . . . 0.0 112.57 176.741 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.6 mp -95.5 -6.58 40.24 Favored 'General case' 0 N--CA 1.479 1.016 0 O-C-N 120.218 -1.754 . . . . 0.0 111.305 168.565 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -129.21 165.59 21.06 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 128.64 2.776 . . . . 0.0 107.386 169.799 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 70.1 m -77.24 59.7 1.82 Allowed 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 124.23 1.012 . . . . 0.0 113.159 -170.072 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 89.3 p -152.56 -179.63 7.76 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 125.748 1.619 . . . . 0.0 114.124 -169.685 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 58.8 ttt85 -94.8 163.17 13.46 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 128.798 2.839 . . . . 0.0 110.553 -174.571 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 21.2 m -78.51 178.49 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.235 0 C-N-CA 123.974 0.91 . . . . 0.0 110.056 169.238 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 2.1 t-80 -61.01 129.62 90.58 Favored Pre-proline 0 CA--C 1.534 0.344 0 CA-C-O 118.445 -0.788 . . . . 0.0 113.041 -177.06 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo -58.18 -28.01 82.42 Favored 'Trans proline' 0 CA--C 1.544 0.982 0 C-N-CA 121.728 1.618 . . . . 0.0 112.083 169.722 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 96.9 m -61.18 -32.32 72.06 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 125.5 1.52 . . . . 0.0 112.282 173.872 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -57.99 -47.24 83.59 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 118.98 0.809 . . . . 0.0 110.786 179.895 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.5 mp -53.42 -54.5 17.97 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 C-N-CA 124.222 1.009 . . . . 0.0 110.299 -174.596 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.24 -31.05 72.09 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 113.223 0.823 . . . . 0.0 113.223 -178.534 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -81.61 -21.72 38.13 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 113.761 1.022 . . . . 0.0 113.761 177.653 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 4.8 mmt -84.87 -31.27 23.83 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 119.491 1.042 . . . . 0.0 110.484 169.549 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -66.97 -15.05 63.46 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.752 1.221 . . . . 0.0 113.774 175.571 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 14.3 mt-10 -61.97 -25.7 67.77 Favored 'General case' 0 N--CA 1.482 1.137 0 CA-C-N 120.313 1.415 . . . . 0.0 110.797 168.864 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 48.6 t -98.44 -2.76 9.86 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.006 0 C-N-CA 127.69 2.396 . . . . 0.0 111.163 176.749 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 79.42 17.86 75.06 Favored Glycine 0 CA--C 1.539 1.591 0 C-N-CA 125.096 1.331 . . . . 0.0 114.498 -176.805 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 84.4 mt -79.49 136.16 24.17 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 C-N-CA 125.06 1.344 . . . . 0.0 111.523 -174.449 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 15.0 t0 -95.35 111.0 22.94 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 112.896 0.702 . . . . 0.0 112.896 175.29 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 6.7 pt -135.89 24.35 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.363 0 C-N-CA 124.77 1.228 . . . . 0.0 114.05 172.52 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 70.4 m -69.85 -20.47 63.42 Favored 'General case' 0 N--CA 1.48 1.048 0 O-C-N 120.153 -1.592 . . . . 0.0 114.608 -172.242 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -90.06 10.85 72.65 Favored Glycine 0 CA--C 1.537 1.416 0 N-CA-C 116.521 1.369 . . . . 0.0 116.521 -175.871 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 25.2 mt-30 -81.83 50.49 1.54 Allowed 'General case' 0 N--CA 1.482 1.154 0 CA-C-N 120.08 1.94 . . . . 0.0 114.97 -169.573 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 37.8 m -104.65 -7.15 19.82 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 125.501 1.52 . . . . 0.0 111.249 169.655 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 68.7 m -69.59 79.36 0.42 Allowed 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 115.921 1.823 . . . . 0.0 115.921 -169.299 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 34.8 m-20 65.35 158.91 0.13 Allowed Pre-proline 0 CA--C 1.552 1.039 0 C-N-CA 128.57 2.748 . . . . 0.0 117.48 169.116 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -73.04 158.47 49.49 Favored 'Trans proline' 0 CA--C 1.539 0.74 0 C-N-CA 122.656 2.237 . . . . 0.0 113.052 169.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 6.3 tt -51.22 -40.92 23.4 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 125.705 1.602 . . . . 0.0 112.065 174.336 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -69.54 -7.32 37.32 Favored 'General case' 0 CA--C 1.543 0.707 0 N-CA-C 113.999 1.111 . . . . 0.0 113.999 -179.331 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 -81.14 -19.92 42.45 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 123.682 0.793 . . . . 0.0 113.128 171.349 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -99.27 -173.04 2.38 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 126.104 1.762 . . . . 0.0 112.581 -176.201 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 14.7 t30 -117.75 124.87 49.52 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 125.363 1.465 . . . . 0.0 110.14 175.488 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.99 -38.29 88.13 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 113.694 0.998 . . . . 0.0 113.694 -172.237 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -72.72 -5.09 35.39 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 113.951 1.093 . . . . 0.0 113.951 -176.694 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -72.69 -16.05 61.68 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 123.485 0.714 . . . . 0.0 111.385 168.866 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 60.3 m-85 -115.11 132.11 56.71 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 126.348 1.859 . . . . 0.0 111.166 179.313 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -89.03 -20.6 24.18 Favored 'General case' 0 N--CA 1.476 0.875 0 CA-C-O 121.966 0.889 . . . . 0.0 112.73 -177.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 82.0 t -128.57 137.74 56.5 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 C-N-CA 127.488 2.315 . . . . 0.0 107.965 178.75 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 65.9 t -131.37 123.68 53.41 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 169.569 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 36.1 mm -109.77 104.46 17.11 Favored 'Isoleucine or valine' 0 C--O 1.234 0.287 0 C-N-CA 124.397 1.079 . . . . 0.0 108.462 -179.053 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 5.4 m -82.71 125.42 31.22 Favored 'General case' 0 N--CA 1.466 0.375 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 170.264 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 89.5 mt -102.33 -11.96 18.29 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 114.497 1.295 . . . . 0.0 114.497 -173.189 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 35.1 m -141.65 143.41 33.61 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 125.015 1.326 . . . . 0.0 110.426 -169.595 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 65.39 -133.4 35.85 Favored Glycine 0 CA--C 1.537 1.464 0 CA-C-N 118.083 0.402 . . . . 0.0 112.515 -176.762 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 88.4 p -131.02 13.84 5.21 Favored 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 115.143 1.534 . . . . 0.0 115.143 -175.212 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 67.57 69.17 1.43 Allowed Glycine 0 N--CA 1.475 1.276 0 CA-C-O 122.832 1.24 . . . . 0.0 111.968 -171.046 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 10.2 p -136.44 176.05 8.94 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 C-N-CA 127.876 2.47 . . . . 0.0 107.036 175.018 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 20.8 t-20 66.28 -36.93 0.26 Allowed 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 126.339 1.856 . . . . 0.0 114.844 -172.358 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -71.04 155.72 92.94 Favored Pre-proline 0 CA--C 1.554 1.106 0 CA-C-N 119.742 1.155 . . . . 0.0 111.592 169.18 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_exo -63.17 146.25 94.03 Favored 'Trans proline' 0 CA--C 1.548 1.183 0 C-N-CA 122.094 1.863 . . . . 0.0 113.169 179.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_exo -55.58 -28.8 66.98 Favored 'Trans proline' 0 C--N 1.352 0.738 0 C-N-CA 123.703 2.935 . . . . 0.0 115.804 -175.682 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 4.4 pm0 -62.61 -18.93 63.17 Favored 'General case' 0 CA--C 1.544 0.745 0 O-C-N 120.664 -1.273 . . . . 0.0 114.168 176.373 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 86.6 m95 -83.39 -24.11 32.1 Favored 'General case' 0 N--CA 1.471 0.578 0 O-C-N 120.552 -1.343 . . . . 0.0 112.934 175.708 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 9.7 m -86.21 -3.41 8.66 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.31 0 N-CA-C 113.608 0.966 . . . . 0.0 113.608 173.443 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -111.2 4.69 19.43 Favored 'General case' 0 N--CA 1.48 1.026 0 N-CA-C 114.581 1.326 . . . . 0.0 114.581 -177.957 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 85.9 mm-40 -64.56 158.35 24.47 Favored 'General case' 0 N--CA 1.478 0.956 0 O-C-N 120.863 -1.148 . . . . 0.0 111.976 170.882 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -57.52 -41.83 81.65 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 114.002 1.112 . . . . 0.0 114.002 -168.249 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 15.5 mm -116.03 58.97 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 C-N-CA 124.892 1.277 . . . . 0.0 109.049 174.401 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 27.0 t80 -74.17 110.12 8.2 Favored 'General case' 0 CA--C 1.534 0.356 0 O-C-N 120.441 -1.412 . . . . 0.0 107.666 168.8 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 9.1 mt-10 -107.67 129.43 55.01 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-O 121.586 0.708 . . . . 0.0 112.687 172.404 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -98.35 88.81 4.25 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 124.163 0.985 . . . . 0.0 110.215 174.287 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 29.2 m0 -81.09 102.09 10.03 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-O 122.031 0.919 . . . . 0.0 109.618 176.63 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 27.6 mt-30 -82.29 60.13 4.86 Favored 'General case' 0 CA--C 1.545 0.787 0 CA-C-O 122.527 1.156 . . . . 0.0 109.049 175.83 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 5.9 tt -95.13 156.31 16.37 Favored 'General case' 0 CA--C 1.539 0.519 0 C-N-CA 128.226 2.61 . . . . 0.0 112.87 -169.148 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -67.67 109.88 3.49 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 125.185 1.394 . . . . 0.0 112.398 177.473 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -71.63 123.9 90.12 Favored Pre-proline 0 CA--C 1.548 0.883 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 169.313 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -79.0 -8.57 15.5 Favored 'Trans proline' 0 CA--C 1.551 1.339 0 C-N-CA 122.092 1.861 . . . . 0.0 114.134 -172.456 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -72.82 155.0 40.37 Favored 'General case' 0 CA--C 1.549 0.934 0 CA-C-N 120.668 1.576 . . . . 0.0 113.338 176.416 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 76.57 5.94 83.65 Favored Glycine 0 CA--C 1.538 1.474 0 C-N-CA 124.428 1.013 . . . . 0.0 114.089 -178.12 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 -142.92 167.51 21.9 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 126.998 2.119 . . . . 0.0 111.226 179.284 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 70.6 m -59.83 157.16 12.78 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 115.081 1.511 . . . . 0.0 115.081 -169.42 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -51.1 -38.32 51.11 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 126.202 1.801 . . . . 0.0 112.689 172.304 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -55.11 -38.93 68.79 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 123.787 0.835 . . . . 0.0 112.107 172.7 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 14.6 t -67.96 -40.76 83.88 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 CA-C-O 118.674 -0.679 . . . . 0.0 111.071 173.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -53.7 -47.39 70.53 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 119.346 0.975 . . . . 0.0 112.339 169.821 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 96.9 mtt180 -69.01 -39.0 79.55 Favored 'General case' 0 N--CA 1.479 0.999 0 CA-C-N 118.842 0.746 . . . . 0.0 112.652 -179.603 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 30.7 m -62.18 -40.92 97.65 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 123.718 0.807 . . . . 0.0 111.306 170.432 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 41.8 t -65.69 -41.07 89.68 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 CA-C-O 117.407 -1.282 . . . . 0.0 111.19 176.57 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 75.5 mtm-85 -55.28 -43.52 74.82 Favored 'General case' 0 N--CA 1.485 1.315 0 CA-C-N 121.038 1.745 . . . . 0.0 112.26 172.576 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -60.85 -51.67 57.15 Favored Glycine 0 CA--C 1.537 1.429 0 CA-C-N 119.036 0.835 . . . . 0.0 113.514 176.269 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 57.6 mm-40 -64.81 -42.97 94.58 Favored 'General case' 0 N--CA 1.474 0.765 0 O-C-N 121.758 -0.848 . . . . 0.0 112.124 179.107 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 55.0 t -65.39 -42.54 93.78 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 C-N-CA 124.799 1.24 . . . . 0.0 110.957 177.378 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 62.9 tttm -53.57 -49.36 67.88 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-N 119.721 1.146 . . . . 0.0 111.147 176.629 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -63.68 -41.7 98.12 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 178.444 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 13.3 mtp85 -63.82 -43.5 96.04 Favored 'General case' 0 N--CA 1.478 0.952 0 N-CA-C 113.22 0.822 . . . . 0.0 113.22 175.435 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 86.2 t -69.06 -38.9 78.92 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 C-N-CA 123.453 0.701 . . . . 0.0 110.729 179.534 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -62.75 -37.63 87.36 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 118.897 0.771 . . . . 0.0 111.773 170.791 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 9.4 m-80 -63.29 -46.85 84.81 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 119.185 0.902 . . . . 0.0 112.549 173.495 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -52.98 -56.81 13.26 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 125.035 1.334 . . . . 0.0 110.253 173.696 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 75.4 mt -61.63 -40.53 87.0 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 O-C-N 122.004 -0.435 . . . . 0.0 110.603 -179.121 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -70.69 -12.11 61.36 Favored 'General case' 0 CA--C 1.545 0.779 0 N-CA-C 114.95 1.463 . . . . 0.0 114.95 178.695 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 20.9 ptmt -102.67 -25.9 13.38 Favored 'General case' 0 N--CA 1.478 0.952 0 N-CA-C 114.038 1.125 . . . . 0.0 114.038 172.882 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 16.7 pt -99.18 -19.16 6.01 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 N-CA-C 114.432 1.271 . . . . 0.0 114.432 177.733 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 68.8 m . . . . . 0 C--O 1.255 1.39 0 C-N-CA 125.132 1.373 . . . . 0.0 112.292 -174.777 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.8 ttt . . . . . 0 N--CA 1.503 2.22 0 N-CA-C 111.745 0.276 . . . . 0.0 111.745 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 3.3 mptp? -125.92 156.43 39.73 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 125.685 1.594 . . . . 0.0 112.681 175.759 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 30.5 ttmt -107.64 117.89 35.3 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 106.651 -1.611 . . . . 0.0 106.651 167.115 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 14.3 t -103.01 135.23 41.45 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 N-CA-C 114.239 1.2 . . . . 0.0 114.239 -179.376 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 42.4 tpp -104.48 124.37 49.14 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 123.886 0.874 . . . . 0.0 108.908 168.503 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 67.2 m-85 -105.03 126.09 51.69 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 123.839 0.856 . . . . 0.0 108.972 169.798 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 1.5 m -141.95 150.6 19.03 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.194 0 N-CA-C 114.902 1.445 . . . . 0.0 114.902 -168.784 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 48.7 t -148.16 162.28 39.76 Favored 'General case' 0 CA--C 1.556 1.193 0 C-N-CA 127.501 2.32 . . . . 0.0 112.303 -179.432 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 21.9 ptmt -63.3 132.51 51.84 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 125.316 1.446 . . . . 0.0 112.298 172.597 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 6.9 mmm180 42.31 -135.84 0.32 Allowed 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 126.04 1.736 . . . . 0.0 112.255 -172.868 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 34.1 p-10 -154.39 -45.95 0.09 Allowed 'General case' 0 CA--C 1.549 0.942 0 N-CA-C 114.78 1.4 . . . . 0.0 114.78 172.715 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 67.5 m -56.73 -15.16 4.09 Favored 'General case' 0 N--CA 1.481 1.118 0 N-CA-C 117.685 2.476 . . . . 0.0 117.685 -169.067 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 97.7 p -102.17 -9.9 20.08 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 115.577 1.695 . . . . 0.0 115.577 -179.791 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 77.6 mtt85 -144.68 150.2 36.92 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 125.017 1.327 . . . . 0.0 113.468 -169.634 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 86.9 p -119.16 -5.07 10.49 Favored 'General case' 0 N--CA 1.478 0.944 0 N-CA-C 116.196 1.924 . . . . 0.0 116.196 -170.071 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 27.7 mt-30 64.25 -59.59 0.21 Allowed 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 128.013 2.525 . . . . 0.0 117.318 169.853 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 65.02 -43.88 0.33 Allowed 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 127.851 2.46 . . . . 0.0 116.597 -179.748 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.93 -28.34 68.87 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 115.137 1.532 . . . . 0.0 115.137 -169.212 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.0 pm0 -59.69 -37.1 77.87 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 119.132 0.878 . . . . 0.0 112.406 171.588 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -70.3 -50.45 27.17 Favored Glycine 0 C--O 1.224 -0.515 0 C-N-CA 124.408 1.004 . . . . 0.0 112.151 -169.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -66.4 -30.13 70.44 Favored 'General case' 0 N--CA 1.467 0.394 0 O-C-N 121.554 -0.968 . . . . 0.0 112.744 173.499 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -66.32 -35.86 81.46 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 118.499 0.59 . . . . 0.0 111.691 -176.001 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 13.4 ptmm? -82.1 -39.95 22.64 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 123.41 0.684 . . . . 0.0 112.319 169.227 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 16.9 m -76.02 -23.73 55.21 Favored 'General case' 0 N--CA 1.486 1.351 0 N-CA-C 112.905 0.706 . . . . 0.0 112.905 -169.255 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 85.3 mt -103.38 -30.61 10.48 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 125.378 1.471 . . . . 0.0 112.577 169.397 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -99.95 0.72 56.35 Favored Glycine 0 N--CA 1.471 1.026 0 N-CA-C 117.379 1.711 . . . . 0.0 117.379 -169.534 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -60.45 142.93 54.48 Favored 'General case' 0 CA--C 1.546 0.81 0 CA-C-N 121.09 2.445 . . . . 0.0 112.566 178.371 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 84.15 -23.51 7.0 Favored Glycine 0 CA--C 1.54 1.606 0 C-N-CA 124.822 1.201 . . . . 0.0 113.337 -169.48 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 62.1 mttp -96.93 -43.87 7.27 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 125.884 1.674 . . . . 0.0 111.883 169.834 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 43.7 pt -141.74 160.41 21.25 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 C-N-CA 125.178 1.391 . . . . 0.0 113.173 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -108.4 148.16 30.53 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 127.157 2.183 . . . . 0.0 109.17 169.831 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 58.7 t -136.02 143.85 34.95 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 CA-C-N 119.294 0.952 . . . . 0.0 113.165 -177.457 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 59.7 m -135.98 152.2 50.7 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 125.722 1.609 . . . . 0.0 109.539 169.821 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 96.7 p -136.06 142.32 44.36 Favored 'General case' 0 CA--C 1.514 -0.423 0 CA-C-O 121.942 0.877 . . . . 0.0 111.998 167.248 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 29.3 p -141.74 169.14 18.15 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 113.485 -1.689 . . . . 0.0 111.075 -176.707 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -106.02 164.23 13.76 Favored Glycine 0 CA--C 1.525 0.677 0 C-N-CA 123.731 0.681 . . . . 0.0 111.741 178.795 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -90.41 117.54 29.19 Favored 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 106.66 -1.608 . . . . 0.0 106.66 168.859 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 68.5 -41.57 0.46 Allowed 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 127.701 2.4 . . . . 0.0 113.955 -171.904 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 74.2 m -78.8 155.25 29.33 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 124.537 1.135 . . . . 0.0 111.142 169.547 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 67.9 p -90.74 -83.07 0.27 Allowed 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 114.394 1.257 . . . . 0.0 114.394 -179.273 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 52.1 ttt-85 -79.47 148.4 31.9 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 127.764 2.426 . . . . 0.0 110.457 -172.17 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 6.4 m -66.16 141.05 18.55 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 N-CA-C 109.214 -0.662 . . . . 0.0 109.214 171.739 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . 0.256 0.0 OUTLIER -65.36 144.35 98.96 Favored Pre-proline 0 CA--C 1.549 0.917 0 C-N-CA 119.636 -0.826 . . . . 0.0 111.103 -169.294 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_exo -46.32 -37.8 19.49 Favored 'Trans proline' 0 CA--C 1.54 0.792 0 C-N-CA 123.848 3.032 . . . . 0.0 118.331 -167.858 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 27.7 m -62.0 -26.59 68.31 Favored 'General case' 0 N--CA 1.485 1.299 0 O-C-N 120.702 -1.249 . . . . 0.0 112.206 -177.822 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.81 -21.96 66.69 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 113.538 0.94 . . . . 0.0 113.538 174.579 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.5 mp -74.91 -58.46 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 CA-C-N 119.527 1.058 . . . . 0.0 109.113 178.243 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.59 -33.89 76.97 Favored 'General case' 0 CA--C 1.545 0.752 0 N-CA-C 114.166 1.173 . . . . 0.0 114.166 -171.149 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.46 -25.54 57.48 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 124.268 1.027 . . . . 0.0 113.244 179.746 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -92.03 -32.63 15.13 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.578 1.151 . . . . 0.0 109.893 177.812 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -63.92 -12.18 34.83 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.092 1.357 . . . . 0.0 113.985 169.738 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -59.59 -19.68 50.51 Favored 'General case' 0 CA--C 1.553 1.087 0 CA-C-N 119.537 1.062 . . . . 0.0 110.458 168.041 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 16.5 t -108.75 -3.53 10.35 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.035 0 C-N-CA 128.548 2.739 . . . . 0.0 111.987 -179.585 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 73.99 34.41 55.72 Favored Glycine 0 CA--C 1.542 1.747 0 O-C-N 120.429 -1.419 . . . . 0.0 114.578 -177.137 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 9.4 mt -75.86 -19.17 15.53 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 N-CA-C 116.759 2.133 . . . . 0.0 116.759 -169.813 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 24.1 t0 43.7 72.28 0.2 Allowed 'General case' 0 CA--C 1.556 1.186 0 C-N-CA 126.747 2.019 . . . . 0.0 114.885 -179.185 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 35.3 pt -114.62 34.23 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 C-N-CA 125.569 1.548 . . . . 0.0 112.408 173.706 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 75.0 m -70.58 -34.0 71.7 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 114.594 1.331 . . . . 0.0 114.594 -170.104 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -84.41 -68.42 1.4 Allowed Glycine 0 CA--C 1.529 0.947 0 C-N-CA 123.477 0.561 . . . . 0.0 113.506 -179.62 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 8.0 mm100 54.46 -166.87 0.08 Allowed 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 126.527 1.931 . . . . 0.0 111.447 -169.091 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 64.2 p -73.21 138.19 45.48 Favored 'General case' 0 N--CA 1.473 0.701 0 O-C-N 121.141 -0.974 . . . . 0.0 112.56 -179.254 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 68.5 m -80.26 3.0 22.28 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.631 1.172 . . . . 0.0 113.012 169.782 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -144.72 157.35 55.26 Favored Pre-proline 0 CA--C 1.548 0.901 0 C-N-CA 125.87 1.668 . . . . 0.0 112.011 -176.365 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -64.89 165.99 19.63 Favored 'Trans proline' 0 CA--C 1.538 0.695 0 C-N-CA 124.183 3.255 . . . . 0.0 114.721 174.905 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 5.4 tt -49.83 -42.99 18.95 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.2 0 C-N-CA 124.59 1.156 . . . . 0.0 112.154 174.474 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -69.25 -10.69 58.99 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 113.524 0.935 . . . . 0.0 113.524 -174.83 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -77.39 -15.53 59.32 Favored 'General case' 0 CA--C 1.548 0.886 0 N-CA-C 112.807 0.669 . . . . 0.0 112.807 176.117 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 76.1 m-85 -107.28 -168.27 1.37 Allowed 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 126.53 1.932 . . . . 0.0 112.475 -174.868 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 8.9 p-10 -124.05 129.16 50.42 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 125.314 1.445 . . . . 0.0 109.921 176.629 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -64.55 -36.34 83.89 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 113.209 0.818 . . . . 0.0 113.209 -171.224 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -68.8 -4.55 16.55 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 114.067 1.136 . . . . 0.0 114.067 178.075 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -68.44 -16.68 63.99 Favored 'General case' 0 CA--C 1.549 0.913 0 CA-C-N 118.775 0.716 . . . . 0.0 110.296 168.286 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 79.6 m-85 -119.78 146.26 45.83 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 128.006 2.523 . . . . 0.0 111.709 -177.791 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -94.99 -29.06 14.82 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 124.838 1.255 . . . . 0.0 111.903 178.055 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 71.1 t -125.74 135.39 64.05 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 C-N-CA 126.067 1.747 . . . . 0.0 107.063 -177.212 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 69.0 t -127.04 121.39 57.83 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 169.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 45.1 mm -107.81 106.52 20.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 C-N-CA 124.703 1.201 . . . . 0.0 108.557 -177.597 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 8.1 m -90.68 111.85 23.36 Favored 'General case' 0 N--CA 1.463 0.222 0 C-N-CA 123.699 0.8 . . . . 0.0 109.829 176.611 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 89.9 mt -91.71 -11.32 37.18 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 124.855 1.262 . . . . 0.0 114.405 -170.539 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 57.3 m -139.94 156.27 46.75 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.565 1.146 . . . . 0.0 112.548 -168.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 60.62 -133.24 49.94 Favored Glycine 0 CA--C 1.536 1.377 0 N-CA-C 111.409 -0.677 . . . . 0.0 111.409 -175.326 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 75.3 m -125.19 26.87 6.79 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 124.305 1.042 . . . . 0.0 112.169 172.199 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 69.49 25.31 75.63 Favored Glycine 0 CA--C 1.533 1.172 0 O-C-N 121.344 -0.847 . . . . 0.0 114.905 -174.477 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 33.4 m -82.63 -178.54 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 C-N-CA 124.933 1.293 . . . . 0.0 110.254 169.713 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 12.5 t-20 66.18 -34.04 0.2 Allowed 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 127.182 2.193 . . . . 0.0 115.781 -179.35 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -71.85 142.36 85.55 Favored Pre-proline 0 CA--C 1.551 0.986 0 CA-C-N 120.271 1.396 . . . . 0.0 110.73 169.008 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -60.21 154.9 48.9 Favored 'Trans proline' 0 CA--C 1.543 0.946 0 C-N-CA 122.831 2.354 . . . . 0.0 114.492 -179.429 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_exo -56.03 -28.73 70.75 Favored 'Trans proline' 0 C--N 1.353 0.775 0 C-N-CA 123.733 2.955 . . . . 0.0 115.121 -177.483 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -62.11 -30.26 70.9 Favored 'General case' 0 CA--C 1.54 0.582 0 O-C-N 120.888 -1.132 . . . . 0.0 113.103 176.004 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 85.5 m95 -79.59 -29.83 41.33 Favored 'General case' 0 N--CA 1.476 0.846 0 O-C-N 120.942 -1.099 . . . . 0.0 111.998 174.303 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 48.8 t -68.91 -26.93 33.73 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.925 0 C-N-CA 125.216 1.406 . . . . 0.0 112.068 172.55 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -102.33 6.98 40.67 Favored 'General case' 0 N--CA 1.48 1.053 0 N-CA-C 116.051 1.871 . . . . 0.0 116.051 -170.894 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 89.7 mm-40 -65.49 160.33 22.45 Favored 'General case' 0 N--CA 1.481 1.112 0 O-C-N 120.633 -1.292 . . . . 0.0 112.255 172.537 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -51.35 -44.33 62.01 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 124.63 1.172 . . . . 0.0 113.849 -168.703 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 16.8 mm -123.19 69.1 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 C-N-CA 125.015 1.326 . . . . 0.0 108.343 177.781 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 57.1 t80 -78.58 107.55 11.33 Favored 'General case' 0 CA--C 1.534 0.356 0 O-C-N 120.796 -1.19 . . . . 0.0 108.58 169.399 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 9.1 mt-10 -105.92 132.7 51.7 Favored 'General case' 0 CA--C 1.545 0.778 0 N-CA-C 113.773 1.027 . . . . 0.0 113.773 174.551 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -93.75 104.39 16.48 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.648 1.179 . . . . 0.0 109.868 169.816 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 17.4 m0 -92.74 98.68 11.56 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.345 1.058 . . . . 0.0 110.002 -177.246 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 87.8 mm-40 -79.41 61.29 3.43 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 125.087 1.355 . . . . 0.0 109.985 172.833 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 6.2 tt -109.5 149.3 29.8 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 127.092 2.157 . . . . 0.0 113.054 -169.432 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -67.2 111.58 4.02 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 125.962 1.705 . . . . 0.0 111.912 176.444 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -84.0 129.88 57.06 Favored Pre-proline 0 CA--C 1.545 0.776 0 O-C-N 120.887 -1.133 . . . . 0.0 110.849 171.556 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -86.74 -9.63 6.52 Favored 'Trans proline' 0 CA--C 1.541 0.845 0 C-N-CA 121.955 1.77 . . . . 0.0 114.515 -169.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -60.39 -41.68 94.32 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 115.307 1.595 . . . . 0.0 115.307 -169.503 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -76.52 10.17 18.5 Favored Glycine 0 CA--C 1.537 1.444 0 C-N-CA 124.212 0.911 . . . . 0.0 114.755 -178.046 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 8.0 pt20 -146.69 -177.65 5.76 Favored 'General case' 0 CA--C 1.551 1.012 0 C-N-CA 126.848 2.059 . . . . 0.0 111.499 -169.877 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 10.5 p -66.76 164.68 16.6 Favored 'General case' 0 N--CA 1.478 0.947 0 N-CA-C 116.172 1.916 . . . . 0.0 116.172 -168.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 36.4 tp -63.02 -26.49 68.87 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 123.832 0.853 . . . . 0.0 112.338 170.591 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -69.39 -34.87 75.16 Favored 'General case' 0 CA--C 1.539 0.539 0 O-C-N 120.922 -1.111 . . . . 0.0 111.243 171.278 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 20.7 t -68.15 -38.94 80.48 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 CA-C-O 117.93 -1.034 . . . . 0.0 111.155 169.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 5.0 m-85 -54.72 -52.21 63.19 Favored 'General case' 0 N--CA 1.478 0.968 0 CA-C-N 120.664 1.574 . . . . 0.0 111.956 169.796 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -67.91 -34.33 76.41 Favored 'General case' 0 N--CA 1.479 0.992 0 CA-C-N 118.954 0.797 . . . . 0.0 112.221 -177.165 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 76.4 m -64.83 -46.42 82.04 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 123.871 0.868 . . . . 0.0 111.042 170.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 53.7 t -67.95 -35.21 71.17 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 CA-C-O 117.602 -1.19 . . . . 0.0 111.022 179.526 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 22.2 mtm105 -55.4 -46.71 76.59 Favored 'General case' 0 N--CA 1.481 1.112 0 CA-C-N 120.66 1.573 . . . . 0.0 111.031 170.629 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -58.47 -48.8 82.12 Favored Glycine 0 CA--C 1.542 1.765 0 CA-C-N 119.432 1.015 . . . . 0.0 113.848 175.188 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 15.5 mm100 -65.25 -44.9 86.63 Favored 'General case' 0 N--CA 1.474 0.742 0 O-C-N 121.778 -0.836 . . . . 0.0 112.02 179.846 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 78.6 t -66.97 -36.22 76.61 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 125.052 1.341 . . . . 0.0 111.308 177.255 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 78.1 tttt -54.64 -49.68 69.97 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-N 119.842 1.201 . . . . 0.0 110.207 174.472 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -64.23 -43.66 94.28 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 112.705 0.631 . . . . 0.0 112.705 175.873 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.57 -36.51 84.04 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 124.16 0.984 . . . . 0.0 112.894 179.47 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 94.4 t -77.48 -40.64 28.83 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 C-N-CA 125.515 1.526 . . . . 0.0 111.475 176.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -62.59 -31.84 72.73 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 119.567 1.076 . . . . 0.0 111.541 172.167 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 12.5 m-80 -67.28 -46.12 74.57 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-N 119.121 0.873 . . . . 0.0 112.867 171.294 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -50.83 -54.98 19.16 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 124.296 1.038 . . . . 0.0 110.138 171.259 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 74.3 mt -58.79 -49.53 82.51 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 CA-C-O 119.163 -0.446 . . . . 0.0 110.179 178.693 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -65.24 -11.26 39.26 Favored 'General case' 0 CA--C 1.544 0.743 0 N-CA-C 115.567 1.691 . . . . 0.0 115.567 -178.827 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 20.9 ptmt -103.23 -17.54 15.29 Favored 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 114.165 1.172 . . . . 0.0 114.165 171.823 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 14.3 pt -106.79 -12.22 10.16 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 N-CA-C 114.436 1.273 . . . . 0.0 114.436 177.153 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 73.8 m . . . . . 0 C--O 1.253 1.27 0 C-N-CA 125.185 1.394 . . . . 0.0 112.436 -176.763 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.9 ttt . . . . . 0 N--CA 1.503 2.185 0 N-CA-C 111.602 0.223 . . . . 0.0 111.602 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.28 163.71 32.9 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 124.828 1.251 . . . . 0.0 113.775 177.667 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 58.6 mtpt -89.72 141.82 28.26 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 125.226 1.41 . . . . 0.0 113.007 175.898 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 21.6 t -122.94 130.54 74.4 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 C-N-CA 125.971 1.708 . . . . 0.0 112.397 177.45 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 35.6 tpp -102.05 127.55 48.89 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 168.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 66.1 m-85 -104.68 132.32 51.06 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 123.728 0.811 . . . . 0.0 109.428 170.032 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -141.13 146.76 23.23 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 N-CA-C 114.584 1.327 . . . . 0.0 114.584 -169.441 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 41.8 t -151.19 176.32 11.31 Favored 'General case' 0 CA--C 1.552 1.056 0 C-N-CA 127.31 2.244 . . . . 0.0 110.853 171.472 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 54.1 mtpt -85.24 135.04 34.1 Favored 'General case' 0 N--CA 1.482 1.166 0 O-C-N 120.672 -1.267 . . . . 0.0 112.16 170.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 23.2 tpt180 47.58 56.45 7.05 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 127.507 2.323 . . . . 0.0 113.226 179.276 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -52.08 -28.56 17.94 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 113.857 1.058 . . . . 0.0 113.857 -179.422 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 67.2 m -63.69 -16.97 62.44 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-N 120.13 1.332 . . . . 0.0 112.661 -176.168 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 98.6 p -121.91 21.43 10.64 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 126.476 1.91 . . . . 0.0 113.767 171.11 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 73.6 mtt85 -137.73 151.32 48.08 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 125.762 1.625 . . . . 0.0 112.216 175.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 33.0 m -93.02 -31.93 14.69 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 114.977 1.473 . . . . 0.0 114.977 -169.729 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 59.89 -44.29 0.09 Allowed 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 127.887 2.475 . . . . 0.0 117.331 -179.043 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' MET . . . . . 0.411 ' HG2' ' SD ' ' A' ' 50' ' ' MET . 0.0 OUTLIER 68.73 -46.55 0.55 Allowed 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 127.605 2.362 . . . . 0.0 115.907 172.389 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.08 -35.21 74.69 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 115.908 1.818 . . . . 0.0 115.908 -169.112 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.3 pm0 -64.36 -43.69 93.73 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 119.151 0.887 . . . . 0.0 112.426 -179.044 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -61.41 -38.04 95.09 Favored Glycine 0 C--N 1.336 0.57 0 C-N-CA 123.903 0.763 . . . . 0.0 112.123 175.12 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -73.58 -42.47 61.56 Favored 'General case' 0 N--CA 1.47 0.527 0 O-C-N 121.782 -0.834 . . . . 0.0 111.518 177.541 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -60.33 -40.97 92.57 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 119.243 0.929 . . . . 0.0 112.705 -175.613 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 11.7 pttp -78.77 -24.92 44.43 Favored 'General case' 0 N--CA 1.479 1.016 0 N-CA-C 113.787 1.032 . . . . 0.0 113.787 174.036 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 90.4 m -72.52 -34.98 67.98 Favored 'General case' 0 N--CA 1.486 1.329 0 O-C-N 121.432 -0.792 . . . . 0.0 111.779 171.896 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 82.4 mt -88.66 -28.58 20.52 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 125.625 1.57 . . . . 0.0 113.824 -177.026 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -148.23 29.24 1.36 Allowed Glycine 0 N--CA 1.473 1.102 0 N-CA-C 118.256 2.062 . . . . 0.0 118.256 -169.411 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -66.53 -20.39 66.01 Favored 'General case' 0 N--CA 1.477 0.919 0 CA-C-N 121.867 2.834 . . . . 0.0 115.301 -177.752 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -77.56 -4.59 85.0 Favored Glycine 0 CA--C 1.541 1.696 0 O-C-N 121.305 -0.872 . . . . 0.0 113.923 169.593 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 60.7 mttp -115.93 -40.58 3.3 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 126.981 2.112 . . . . 0.0 112.315 -177.286 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 19.8 pt -140.69 159.04 24.32 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 125.961 1.704 . . . . 0.0 112.558 -174.308 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -106.23 140.32 39.37 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.682 1.193 . . . . 0.0 110.209 171.099 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 69.5 t -125.15 140.92 46.75 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 CA-C-N 118.911 0.778 . . . . 0.0 111.819 -175.104 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 22.4 m -134.56 143.39 47.36 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 125.058 1.343 . . . . 0.0 109.95 173.815 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 78.6 p -97.39 144.38 27.2 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.846 0.831 . . . . 0.0 111.24 169.198 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 32.7 t -149.05 165.04 32.87 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 123.593 0.757 . . . . 0.0 110.311 169.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -134.67 161.61 24.53 Favored Glycine 0 C--O 1.229 -0.167 0 CA-C-O 121.808 0.671 . . . . 0.0 112.604 -178.547 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -95.0 111.28 23.1 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 106.351 -1.722 . . . . 0.0 106.351 169.58 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 19.0 mt-10 66.68 30.77 8.03 Favored 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 125.122 1.369 . . . . 0.0 114.392 -173.587 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 7.6 m -151.31 151.34 31.66 Favored 'General case' 0 N--CA 1.482 1.152 0 N-CA-C 114.681 1.364 . . . . 0.0 114.681 175.56 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 88.0 p -109.43 -15.34 14.25 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 126.985 2.114 . . . . 0.0 116.327 173.632 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 7.6 tpt180 -123.4 170.32 10.46 Favored 'General case' 0 N--CA 1.488 1.462 0 CA-C-N 120.497 1.499 . . . . 0.0 110.781 -178.512 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 27.0 m -111.93 163.84 8.45 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.266 0 C-N-CA 126.435 1.894 . . . . 0.0 109.57 169.481 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 3.1 t-80 -48.59 129.91 13.81 Favored Pre-proline 0 CA--C 1.536 0.408 0 N-CA-C 113.945 1.091 . . . . 0.0 113.945 -173.866 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 81.5 Cg_exo -59.93 -26.76 83.26 Favored 'Trans proline' 0 CA--C 1.549 1.23 0 CA-C-N 120.273 1.133 . . . . 0.0 112.5 173.231 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 55.0 m -70.91 -29.15 65.12 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 125.17 1.388 . . . . 0.0 112.363 174.033 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -55.45 -44.55 76.48 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 119.245 0.93 . . . . 0.0 111.226 -178.078 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.7 mp -47.2 -55.11 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 125.178 1.391 . . . . 0.0 110.483 -177.41 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.99 -30.89 71.91 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 113.486 0.921 . . . . 0.0 113.486 -176.748 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -82.73 -26.35 32.02 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 113.421 0.897 . . . . 0.0 113.421 179.064 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' MET . . . . . 0.411 ' SD ' ' HG2' ' A' ' 17' ' ' MET . 3.9 mmt -80.3 -32.92 38.01 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.223 0.609 . . . . 0.0 110.8 170.266 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -66.01 -14.78 62.25 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 124.61 1.164 . . . . 0.0 113.348 172.845 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -60.56 -27.65 67.83 Favored 'General case' 0 N--CA 1.482 1.138 0 CA-C-N 120.106 1.321 . . . . 0.0 110.731 168.844 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 57.7 t -98.22 -6.5 9.35 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.939 0 C-N-CA 127.229 2.212 . . . . 0.0 111.282 176.894 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 81.14 19.36 67.22 Favored Glycine 0 CA--C 1.539 1.582 0 C-N-CA 124.951 1.263 . . . . 0.0 114.425 -174.506 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 83.0 mt -77.77 135.14 26.9 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 124.925 1.29 . . . . 0.0 111.266 -175.654 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 21.6 t0 -94.58 104.46 16.41 Favored 'General case' 0 CA--C 1.544 0.729 0 N-CA-C 113.236 0.828 . . . . 0.0 113.236 177.629 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 15.0 pt -130.56 23.25 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 C-N-CA 125.273 1.429 . . . . 0.0 112.338 169.688 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 72.2 m -87.69 153.53 21.29 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 124.729 1.212 . . . . 0.0 112.435 -178.379 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 65.68 18.5 66.1 Favored Glycine 0 CA--C 1.537 1.454 0 N-CA-C 115.28 0.872 . . . . 0.0 115.28 171.86 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -115.12 143.93 44.45 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 124.969 1.307 . . . . 0.0 111.957 -177.357 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 33.4 m -135.24 148.63 49.66 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 107.818 -1.179 . . . . 0.0 107.818 169.32 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 68.1 m -123.26 -161.45 0.97 Allowed 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 126.329 1.852 . . . . 0.0 109.916 -171.786 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -134.91 159.03 73.65 Favored Pre-proline 0 CA--C 1.54 0.567 0 C-N-CA 123.854 0.862 . . . . 0.0 110.923 179.332 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -62.17 157.27 45.63 Favored 'Trans proline' 0 N--CA 1.46 -0.476 0 C-N-CA 122.294 1.996 . . . . 0.0 112.311 171.77 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 6.7 tp -60.99 -30.21 47.16 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 O-C-N 121.667 -0.645 . . . . 0.0 112.423 -173.876 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -67.52 -12.5 60.49 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 114.341 1.237 . . . . 0.0 114.341 176.794 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 -79.95 -21.53 43.67 Favored 'General case' 0 CA--C 1.547 0.855 0 N-CA-C 113.22 0.822 . . . . 0.0 113.22 179.839 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 99.3 m-85 -102.39 -174.52 2.59 Favored 'General case' 0 CA--C 1.552 1.045 0 C-N-CA 126.216 1.806 . . . . 0.0 112.922 -173.319 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 5.9 t30 -123.6 126.7 47.1 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 126.21 1.804 . . . . 0.0 109.572 171.799 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.91 -35.9 81.05 Favored 'General case' 0 CA--C 1.53 0.184 0 N-CA-C 114.361 1.245 . . . . 0.0 114.361 -170.048 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . 0.256 0.0 OUTLIER -72.67 -3.63 26.18 Favored 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 114.221 1.193 . . . . 0.0 114.221 -175.672 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -75.21 -13.25 60.43 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 124.076 0.95 . . . . 0.0 111.543 168.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 87.8 m-85 -118.08 135.73 54.02 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 126.774 2.029 . . . . 0.0 111.574 -179.287 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -87.15 -24.23 24.56 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-O 122.297 1.046 . . . . 0.0 112.655 178.47 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 80.1 t -129.73 138.99 52.76 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 C-N-CA 127.28 2.232 . . . . 0.0 108.772 -176.569 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 59.2 t -135.15 122.66 37.29 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 171.509 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 45.1 mm -110.21 101.1 12.08 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 C-N-CA 124.255 1.022 . . . . 0.0 109.919 -174.693 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 8.8 m -86.15 94.43 9.28 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 124.224 1.01 . . . . 0.0 109.208 171.139 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -97.78 19.68 13.29 Favored 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 116.065 1.876 . . . . 0.0 116.065 -169.427 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 14.7 p -152.14 155.08 37.14 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 123.812 0.845 . . . . 0.0 110.941 170.695 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 62.06 -137.34 45.86 Favored Glycine 0 CA--C 1.535 1.334 0 C-N-CA 123.685 0.659 . . . . 0.0 113.948 177.571 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 83.4 p -93.21 -23.59 18.5 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.996 1.318 . . . . 0.0 114.552 179.544 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 77.07 4.44 83.4 Favored Glycine 0 CA--C 1.535 1.292 0 C-N-CA 124.555 1.074 . . . . 0.0 115.343 -169.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 48.9 t -88.73 -10.92 10.58 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 CA-C-N 119.564 1.682 . . . . 0.0 112.91 -172.373 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -72.65 -9.56 58.75 Favored 'General case' 0 CA--C 1.549 0.917 0 O-C-N 120.426 -1.421 . . . . 0.0 114.153 -176.168 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -95.06 158.43 34.9 Favored Pre-proline 0 CA--C 1.549 0.927 0 C-N-CA 124.791 1.236 . . . . 0.0 113.644 176.479 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_exo -61.18 152.92 68.56 Favored 'Trans proline' 0 CA--C 1.544 0.991 0 C-N-CA 122.96 2.44 . . . . 0.0 114.24 -179.198 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_exo -55.76 -29.66 72.59 Favored 'Trans proline' 0 C--N 1.354 0.824 0 C-N-CA 123.692 2.928 . . . . 0.0 115.082 -177.599 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -61.81 -29.31 70.07 Favored 'General case' 0 CA--C 1.539 0.551 0 O-C-N 121.077 -1.015 . . . . 0.0 112.888 177.02 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 92.8 m95 -80.94 -33.79 33.75 Favored 'General case' 0 N--CA 1.473 0.698 0 O-C-N 121.202 -0.936 . . . . 0.0 112.119 174.269 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 25.0 t -63.25 -31.72 53.78 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 C-N-CA 124.679 1.192 . . . . 0.0 111.606 172.239 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -96.93 6.18 49.12 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 115.675 1.732 . . . . 0.0 115.675 -171.299 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 87.0 mm-40 -64.74 157.25 27.98 Favored 'General case' 0 N--CA 1.481 1.077 0 O-C-N 120.615 -1.303 . . . . 0.0 111.248 169.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -58.74 -39.53 81.2 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 113.967 1.099 . . . . 0.0 113.967 -168.092 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 19.1 mm -118.82 59.61 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 C-N-CA 124.958 1.303 . . . . 0.0 109.017 177.235 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 52.0 t80 -76.89 106.97 8.89 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 107.333 -1.358 . . . . 0.0 107.333 168.724 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 13.2 mt-10 -109.11 134.82 51.2 Favored 'General case' 0 N--CA 1.467 0.375 0 N-CA-C 113.11 0.781 . . . . 0.0 113.11 174.561 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -103.51 118.05 35.86 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.062 0.945 . . . . 0.0 109.453 169.089 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 28.4 m0 -109.96 114.34 27.8 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 107.672 -1.233 . . . . 0.0 107.672 176.415 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 19.3 mt-30 -85.22 49.07 1.67 Allowed 'General case' 0 CA--C 1.545 0.763 0 O-C-N 121.3 -0.875 . . . . 0.0 111.701 -175.003 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 82.7 mt -73.94 160.16 31.75 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 125.848 1.659 . . . . 0.0 111.918 175.54 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -88.34 155.22 19.83 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.846 169.286 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -94.14 143.86 27.1 Favored Pre-proline 0 CA--C 1.547 0.834 0 O-C-N 121.422 -0.799 . . . . 0.0 111.606 171.023 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -64.1 -18.5 63.75 Favored 'Trans proline' 0 CA--C 1.546 1.08 0 C-N-CA 122.661 2.241 . . . . 0.0 116.07 176.01 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -57.12 138.15 54.9 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 120.255 1.389 . . . . 0.0 113.583 -178.801 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 78.41 6.59 87.99 Favored Glycine 0 CA--C 1.535 1.311 0 C-N-CA 124.384 0.993 . . . . 0.0 115.058 177.19 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 11.7 pt20 -141.8 165.13 28.31 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 125.17 1.388 . . . . 0.0 113.499 -178.376 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 68.4 m -63.68 162.89 12.36 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 125.774 1.63 . . . . 0.0 115.393 -169.52 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 21.4 tp -59.75 -29.25 68.04 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 125.181 1.392 . . . . 0.0 113.445 178.518 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -62.1 -28.94 69.97 Favored 'General case' 0 N--CA 1.476 0.844 0 O-C-N 120.544 -1.348 . . . . 0.0 111.92 171.617 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 3.5 t -76.56 -37.39 29.64 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 O-C-N 120.86 -1.15 . . . . 0.0 111.427 172.628 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -56.34 -46.55 79.88 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-N 120.028 1.286 . . . . 0.0 110.531 168.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -66.85 -36.15 81.67 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.702 0.801 . . . . 0.0 112.002 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 25.5 m -60.85 -52.16 66.25 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 124.414 1.085 . . . . 0.0 111.162 170.43 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 69.3 t -64.54 -45.97 94.02 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 O-C-N 121.712 -0.617 . . . . 0.0 110.528 179.831 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 42.6 ttp85 -59.53 -38.59 81.41 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 125.359 1.463 . . . . 0.0 112.394 178.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -64.73 -50.5 58.33 Favored Glycine 0 CA--C 1.538 1.505 0 CA-C-N 119.156 0.889 . . . . 0.0 113.481 171.632 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 15.2 mm100 -63.7 -42.17 98.02 Favored 'General case' 0 N--CA 1.477 0.891 0 O-C-N 121.819 -0.812 . . . . 0.0 111.836 178.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 52.9 t -64.01 -42.07 94.5 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 C-N-CA 125.397 1.479 . . . . 0.0 110.887 175.437 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 82.4 tttt -53.24 -49.45 66.8 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 120.153 1.342 . . . . 0.0 110.478 176.854 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -64.96 -42.67 94.38 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 123.454 0.702 . . . . 0.0 112.788 178.689 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 16.1 mmm180 -60.29 -45.34 93.69 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 123.438 0.695 . . . . 0.0 112.649 175.278 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 87.2 t -71.4 -39.45 71.57 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 C-N-CA 124.147 0.979 . . . . 0.0 111.267 -178.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -61.15 -41.66 97.14 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 119.386 0.994 . . . . 0.0 111.638 171.151 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 14.4 m-80 -63.4 -46.26 87.26 Favored 'General case' 0 CA--C 1.539 0.519 0 CA-C-N 118.692 0.678 . . . . 0.0 112.275 174.911 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -54.1 -54.95 32.4 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 124.694 1.198 . . . . 0.0 110.766 175.492 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 97.1 mt -61.09 -44.48 98.37 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 CA-C-O 118.857 -0.592 . . . . 0.0 110.541 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -67.48 -14.47 62.96 Favored 'General case' 0 CA--C 1.543 0.681 0 N-CA-C 115.084 1.512 . . . . 0.0 115.084 -179.738 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 21.1 ptmt -100.17 -28.02 13.23 Favored 'General case' 0 N--CA 1.478 0.931 0 CA-C-N 119.298 0.953 . . . . 0.0 113.552 173.646 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 17.5 pt -92.27 -14.72 8.39 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 N-CA-C 114.491 1.293 . . . . 0.0 114.491 178.091 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 67.4 m . . . . . 0 C--O 1.254 1.291 0 C-N-CA 123.893 0.877 . . . . 0.0 112.892 179.573 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.1 ttt . . . . . 0 N--CA 1.501 2.123 0 N-CA-C 111.599 0.222 . . . . 0.0 111.599 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -123.74 160.39 27.38 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 125.844 1.658 . . . . 0.0 112.662 176.557 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 32.4 ttmt -110.91 113.68 26.43 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 167.588 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 16.2 t -103.7 133.65 47.07 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 N-CA-C 113.839 1.051 . . . . 0.0 113.839 -177.852 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 46.4 tpp -101.59 119.61 39.03 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.456 1.102 . . . . 0.0 109.58 169.093 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 56.3 m-85 -103.34 121.75 43.4 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 124.899 1.28 . . . . 0.0 109.134 173.433 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 4.2 m -144.57 162.32 14.27 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 C-N-CA 124.163 0.985 . . . . 0.0 113.002 -168.894 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 12.7 t -146.86 157.03 43.55 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 126.095 1.758 . . . . 0.0 110.749 169.807 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -30.59 -46.78 0.08 Allowed 'General case' 0 N--CA 1.489 1.476 0 C-N-CA 129.119 2.968 . . . . 0.0 117.126 -176.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 32.1 ttm180 -137.35 -26.01 1.01 Allowed 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 117.309 2.337 . . . . 0.0 117.309 -174.882 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 6.9 t30 60.34 -33.38 0.07 Allowed 'General case' 0 N--CA 1.485 1.319 0 N-CA-C 117.577 2.436 . . . . 0.0 117.577 -178.534 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 84.1 p -62.69 139.98 58.69 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 121.192 1.815 . . . . 0.0 111.946 175.049 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 69.7 m 49.85 31.39 4.54 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 125.943 1.697 . . . . 0.0 114.486 -175.115 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 77.0 mtt85 -141.61 162.75 34.71 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 126.631 1.972 . . . . 0.0 111.53 -175.576 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 4.0 m -124.16 149.32 46.42 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 125.766 1.626 . . . . 0.0 111.774 174.089 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 -112.71 -35.59 5.45 Favored 'General case' 0 N--CA 1.478 0.933 0 N-CA-C 114.347 1.24 . . . . 0.0 114.347 -178.185 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' MET . . . . . 0.429 ' HG2' ' SD ' ' A' ' 50' ' ' MET . 0.0 OUTLIER 68.56 -47.78 0.55 Allowed 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 126.783 2.033 . . . . 0.0 115.681 173.887 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.17 -30.01 70.75 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 115.613 1.709 . . . . 0.0 115.613 -169.614 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 3.5 pm0 -62.7 -44.55 95.96 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 119.385 0.993 . . . . 0.0 112.096 178.062 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -64.77 -42.98 96.86 Favored Glycine 0 C--O 1.226 -0.402 0 C-N-CA 124.135 0.874 . . . . 0.0 111.736 179.405 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -68.6 -39.85 80.69 Favored 'General case' 0 N--CA 1.466 0.336 0 O-C-N 121.856 -0.791 . . . . 0.0 111.504 176.839 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -62.32 -41.41 98.52 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 119.226 0.921 . . . . 0.0 112.63 -177.837 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 10.5 pttp -81.17 -20.38 41.36 Favored 'General case' 0 N--CA 1.48 1.067 0 N-CA-C 114.037 1.125 . . . . 0.0 114.037 174.288 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 93.3 m -74.52 -36.13 63.18 Favored 'General case' 0 N--CA 1.483 1.224 0 O-C-N 121.561 -0.712 . . . . 0.0 111.645 170.806 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 74.4 mt -92.75 -30.83 15.31 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 125.374 1.47 . . . . 0.0 114.672 -174.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -137.21 25.71 3.01 Favored Glycine 0 N--CA 1.475 1.238 0 N-CA-C 118.224 2.049 . . . . 0.0 118.224 -169.002 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -66.69 -22.04 66.08 Favored 'General case' 0 N--CA 1.476 0.856 0 CA-C-N 121.895 2.848 . . . . 0.0 115.391 -174.459 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -72.74 -12.54 78.25 Favored Glycine 0 CA--C 1.542 1.748 0 O-C-N 121.18 -0.95 . . . . 0.0 113.632 169.576 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 53.2 mttm -107.34 -39.54 5.64 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 127.318 2.247 . . . . 0.0 113.161 -179.75 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 45.2 pt -144.41 154.46 15.0 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 C-N-CA 124.667 1.187 . . . . 0.0 114.094 -171.624 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -98.14 140.33 32.61 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 126.021 1.728 . . . . 0.0 109.247 169.548 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 92.3 t -127.27 139.02 53.08 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 CA-C-N 118.553 0.615 . . . . 0.0 111.735 -175.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 33.5 m -136.35 148.16 47.75 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 125.269 1.428 . . . . 0.0 109.432 172.182 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 86.1 p -136.02 143.19 44.62 Favored 'General case' 0 CA--C 1.514 -0.406 0 CA-C-O 122.249 1.023 . . . . 0.0 111.16 167.801 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 8.0 m -139.36 152.23 46.97 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 113.393 -1.731 . . . . 0.0 111.25 -169.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -81.33 163.76 45.1 Favored Glycine 0 CA--C 1.527 0.819 0 N-CA-C 110.382 -1.087 . . . . 0.0 110.382 169.222 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 8.2 mp -91.07 -23.09 20.43 Favored 'General case' 0 N--CA 1.477 0.911 0 O-C-N 120.885 -1.362 . . . . 0.0 112.895 174.173 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -148.8 29.68 0.82 Allowed 'General case' 0 CA--C 1.551 0.985 0 C-N-CA 125.734 1.614 . . . . 0.0 111.076 176.815 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 32.6 p -152.29 153.0 32.83 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 126.54 1.936 . . . . 0.0 112.16 -174.186 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 47.6 m -116.25 19.04 15.08 Favored 'General case' 0 N--CA 1.483 1.216 0 N-CA-C 116.198 1.925 . . . . 0.0 116.198 -169.003 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 7.8 tpt180 -159.3 144.76 15.98 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 124.702 1.201 . . . . 0.0 111.759 171.511 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 22.0 m -70.87 129.37 34.83 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.321 0 N-CA-C 105.92 -1.881 . . . . 0.0 105.92 167.847 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . 0.271 0.0 OUTLIER -60.46 141.49 91.56 Favored Pre-proline 0 CA--C 1.552 1.05 0 N-CA-C 112.681 0.622 . . . . 0.0 112.681 -168.413 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_exo -46.49 -39.26 22.26 Favored 'Trans proline' 0 CA--C 1.54 0.778 0 C-N-CA 124.257 3.305 . . . . 0.0 118.567 -168.001 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 26.0 m -65.04 -24.3 67.44 Favored 'General case' 0 N--CA 1.484 1.242 0 CA-C-N 119.418 1.008 . . . . 0.0 112.802 -174.703 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -52.83 -48.77 66.74 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 123.673 0.789 . . . . 0.0 111.573 172.873 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.6 mp -54.01 -56.02 11.38 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 C-N-CA 124.373 1.069 . . . . 0.0 110.37 -171.764 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -62.4 -28.28 69.67 Favored 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 113.392 0.886 . . . . 0.0 113.392 -177.14 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -81.85 -20.64 38.53 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 113.69 0.996 . . . . 0.0 113.69 176.758 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' MET . . . . . 0.429 ' SD ' ' HG2' ' A' ' 17' ' ' MET . 5.7 mmt -87.52 -32.55 19.35 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 119.465 1.03 . . . . 0.0 110.729 169.887 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -64.5 -15.29 60.58 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.752 1.221 . . . . 0.0 113.559 176.229 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 -61.15 -28.44 69.12 Favored 'General case' 0 N--CA 1.48 1.032 0 CA-C-N 120.225 1.375 . . . . 0.0 111.077 169.345 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 59.3 t -94.91 -3.65 10.58 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.047 0 C-N-CA 127.356 2.262 . . . . 0.0 111.253 178.03 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 79.4 17.54 75.83 Favored Glycine 0 CA--C 1.54 1.609 0 O-C-N 120.525 -1.359 . . . . 0.0 114.588 -174.572 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 67.2 mt -76.57 145.48 10.28 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 C-N-CA 125.09 1.356 . . . . 0.0 111.941 -174.445 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -106.3 53.16 0.71 Allowed 'General case' 0 CA--C 1.548 0.897 0 N-CA-C 115.11 1.522 . . . . 0.0 115.11 -170.092 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 12.0 pt -85.42 -0.12 6.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 120.017 -1.677 . . . . 0.0 114.252 173.334 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 84.5 p -67.09 -28.13 67.92 Favored 'General case' 0 N--CA 1.476 0.841 0 O-C-N 120.838 -1.163 . . . . 0.0 113.502 174.694 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -82.0 -6.95 88.47 Favored Glycine 0 CA--C 1.537 1.415 0 C-N-CA 125.075 1.321 . . . . 0.0 116.381 -177.112 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 14.8 pt20 -100.19 138.34 37.39 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 119.309 1.555 . . . . 0.0 112.077 179.364 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 58.8 p -106.38 -64.24 1.19 Allowed 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 125.701 1.6 . . . . 0.0 110.82 173.28 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 59.1 m 63.7 127.12 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 129.152 2.981 . . . . 0.0 116.639 173.621 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 24.6 m-20 -67.35 162.11 58.53 Favored Pre-proline 0 CA--C 1.548 0.87 0 C-N-CA 124.402 1.081 . . . . 0.0 111.012 169.555 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -58.1 157.95 23.44 Favored 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 122.627 2.218 . . . . 0.0 112.977 171.075 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 2.9 tt -57.1 -37.7 56.8 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 C-N-CA 123.778 0.831 . . . . 0.0 110.939 -178.506 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.98 -1.55 26.2 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 114.302 1.223 . . . . 0.0 114.302 -177.247 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -88.22 -6.85 57.59 Favored 'General case' 0 CA--C 1.555 1.167 0 C-N-CA 124.573 1.149 . . . . 0.0 111.9 169.242 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 77.2 m-85 -113.86 -174.93 2.56 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 126.796 2.038 . . . . 0.0 112.739 -178.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 13.3 p-10 -116.83 132.73 56.62 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 127.04 2.136 . . . . 0.0 109.915 174.607 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -67.45 -35.75 79.84 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 113.636 0.976 . . . . 0.0 113.636 -174.315 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -70.02 -3.45 16.37 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 114.429 1.27 . . . . 0.0 114.429 -179.334 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -69.96 -16.72 63.24 Favored 'General case' 0 CA--C 1.543 0.699 0 O-C-N 121.652 -0.655 . . . . 0.0 110.976 168.946 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 45.2 m-85 -120.42 131.14 54.66 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 126.661 1.985 . . . . 0.0 111.378 -172.724 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -80.69 -22.85 40.01 Favored 'General case' 0 N--CA 1.477 0.911 0 CA-C-O 122.234 1.016 . . . . 0.0 112.498 178.065 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 82.2 t -132.4 136.37 56.34 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 C-N-CA 127.501 2.32 . . . . 0.0 108.125 -175.113 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 59.7 t -131.92 127.3 58.19 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 169.561 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 41.8 mm -114.61 115.91 50.98 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 C-N-CA 123.777 0.831 . . . . 0.0 109.645 -174.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 10.5 t -89.18 122.46 32.49 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 169.208 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 92.7 mt -97.19 5.32 50.33 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 116.141 1.904 . . . . 0.0 116.141 -168.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 25.4 p -144.94 39.04 1.21 Allowed 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 123.273 0.629 . . . . 0.0 112.077 -174.435 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 110.53 -148.25 17.58 Favored Glycine 0 CA--C 1.531 1.08 0 C-N-CA 125.024 1.297 . . . . 0.0 112.992 -174.224 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 87.2 p -76.29 174.51 10.09 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 124.963 1.305 . . . . 0.0 113.502 -178.629 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -76.07 119.81 5.74 Favored Glycine 0 N--CA 1.469 0.889 0 CA-C-O 122.244 0.914 . . . . 0.0 111.317 169.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 7.6 p -148.0 151.73 13.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 C-N-CA 127.86 2.464 . . . . 0.0 106.471 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 51.7 t30 65.73 2.66 2.2 Favored 'General case' 0 CA--C 1.556 1.185 0 N-CA-C 115.996 1.85 . . . . 0.0 115.996 179.647 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -117.54 152.18 49.24 Favored Pre-proline 0 N--CA 1.479 0.996 0 C-N-CA 126.14 1.776 . . . . 0.0 111.681 169.679 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -71.89 160.36 47.97 Favored 'Trans proline' 0 CA--C 1.548 1.219 0 C-N-CA 122.407 2.071 . . . . 0.0 113.061 -179.082 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_exo -57.81 -25.77 70.59 Favored 'Trans proline' 0 C--N 1.354 0.834 0 C-N-CA 123.931 3.087 . . . . 0.0 116.363 -169.696 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -62.46 -25.78 68.17 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 114.024 1.12 . . . . 0.0 114.024 -178.711 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 93.8 m95 -81.13 -33.05 33.48 Favored 'General case' 0 N--CA 1.472 0.662 0 O-C-N 120.676 -1.265 . . . . 0.0 112.682 178.436 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 9.4 m -80.73 -6.2 9.36 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 N-CA-C 113.145 0.795 . . . . 0.0 113.145 176.046 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -106.82 6.01 29.06 Favored 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 114.741 1.386 . . . . 0.0 114.741 179.678 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 91.1 mm-40 -65.75 158.61 27.14 Favored 'General case' 0 N--CA 1.479 0.999 0 O-C-N 120.785 -1.197 . . . . 0.0 111.621 170.512 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -57.44 -43.47 83.91 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 114.224 1.194 . . . . 0.0 114.224 -168.15 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 22.0 mm -114.96 60.52 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 C-N-CA 124.93 1.292 . . . . 0.0 108.77 175.794 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 42.6 t80 -76.57 110.83 11.45 Favored 'General case' 0 CA--C 1.536 0.41 0 O-C-N 120.746 -1.221 . . . . 0.0 108.229 169.084 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 17.0 mt-10 -110.73 137.76 47.98 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 114.573 1.323 . . . . 0.0 114.573 175.7 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -97.71 114.74 26.79 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.99 1.316 . . . . 0.0 109.726 169.373 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 34.0 m0 -104.79 118.61 36.99 Favored 'General case' 0 N--CA 1.462 0.156 0 C-N-CA 124.438 1.095 . . . . 0.0 108.189 176.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 61.7 mt-30 -91.18 44.21 1.18 Allowed 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 124.508 1.123 . . . . 0.0 111.162 -169.627 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 90.1 mt -82.99 168.13 17.28 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 126.926 2.09 . . . . 0.0 112.222 -179.165 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -96.97 152.95 18.21 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 123.856 0.863 . . . . 0.0 113.108 172.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -77.7 121.62 84.52 Favored Pre-proline 0 CA--C 1.543 0.703 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 169.458 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -79.9 -9.06 14.42 Favored 'Trans proline' 0 CA--C 1.542 0.923 0 C-N-CA 121.403 1.402 . . . . 0.0 114.317 -178.798 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -72.89 -41.9 64.15 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 115.905 1.817 . . . . 0.0 115.905 -169.416 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -72.89 20.37 1.09 Allowed Glycine 0 CA--C 1.541 1.707 0 C-N-CA 124.387 0.994 . . . . 0.0 114.872 -177.471 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 7.3 pt20 -158.74 176.94 11.73 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 127.78 2.432 . . . . 0.0 110.876 -169.662 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 52.8 p -66.65 161.94 22.2 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 114.122 1.156 . . . . 0.0 114.122 -172.82 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . 0.32 2.9 pp -67.99 -11.97 59.88 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 114.194 1.183 . . . . 0.0 114.194 176.803 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -67.82 -30.07 69.39 Favored 'General case' 0 CA--C 1.543 0.682 0 O-C-N 120.968 -1.082 . . . . 0.0 109.953 168.845 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 3.4 t -74.35 -36.92 44.02 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 O-C-N 121.031 -1.043 . . . . 0.0 111.147 170.806 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 16.5 m-85 -58.05 -42.26 85.03 Favored 'General case' 0 N--CA 1.482 1.141 0 CA-C-N 120.229 1.377 . . . . 0.0 111.313 168.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -66.5 -37.51 85.22 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 124.19 0.996 . . . . 0.0 112.439 175.864 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 18.9 m -61.36 -50.53 72.53 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 124.491 1.116 . . . . 0.0 111.252 171.203 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 78.4 t -67.44 -37.73 79.44 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 C-N-CA 124.131 0.972 . . . . 0.0 111.098 -178.887 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 19.9 mtp180 -54.55 -43.38 71.93 Favored 'General case' 0 N--CA 1.48 1.052 0 CA-C-N 120.109 1.322 . . . . 0.0 112.467 170.255 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -61.74 -50.9 61.34 Favored Glycine 0 CA--C 1.535 1.332 0 CA-C-N 119.297 0.953 . . . . 0.0 112.954 175.239 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 52.4 mt-30 -61.03 -46.77 89.36 Favored 'General case' 0 N--CA 1.474 0.729 0 O-C-N 122.138 -0.625 . . . . 0.0 111.737 177.686 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 55.3 t -66.02 -41.02 88.88 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 C-N-CA 125.028 1.331 . . . . 0.0 111.144 -179.41 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -55.98 -48.15 76.36 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 120.117 1.326 . . . . 0.0 110.437 177.129 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -63.47 -44.66 93.8 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 112.682 0.623 . . . . 0.0 112.682 175.376 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.17 -33.72 76.67 Favored 'General case' 0 N--CA 1.478 0.967 0 N-CA-C 113.52 0.933 . . . . 0.0 113.52 179.188 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 82.4 t -78.99 -39.29 21.46 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 C-N-CA 125.698 1.599 . . . . 0.0 111.291 177.027 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -60.89 -40.11 91.79 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 119.58 1.082 . . . . 0.0 111.16 171.171 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 16.6 m-80 -63.96 -45.86 87.22 Favored 'General case' 0 CA--C 1.538 0.51 0 O-C-N 121.865 -0.522 . . . . 0.0 112.341 174.19 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -51.67 -57.9 7.9 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 124.729 1.212 . . . . 0.0 110.6 173.522 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 74.1 mt -62.59 -42.99 98.03 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 C-N-CA 122.827 0.451 . . . . 0.0 110.548 -177.11 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -72.92 -10.62 60.0 Favored 'General case' 0 CA--C 1.544 0.721 0 N-CA-C 114.86 1.43 . . . . 0.0 114.86 -178.854 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 20.7 ptmt -99.53 -29.93 12.44 Favored 'General case' 0 N--CA 1.479 0.976 0 N-CA-C 113.636 0.976 . . . . 0.0 113.636 170.198 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 12.7 pt -93.24 -8.91 9.93 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 N-CA-C 114.527 1.306 . . . . 0.0 114.527 178.313 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 27.1 p . . . . . 0 C--O 1.255 1.387 0 N-CA-C 114.663 1.357 . . . . 0.0 114.663 174.501 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.3 ttt . . . . . 0 N--CA 1.502 2.139 0 N-CA-C 111.501 0.186 . . . . 0.0 111.501 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.79 155.97 36.97 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 125.059 1.344 . . . . 0.0 112.774 173.951 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 30.8 ttmt -106.73 112.6 25.66 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 106.812 -1.551 . . . . 0.0 106.812 167.651 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 23.4 t -97.3 131.7 43.57 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 C-N-CA 125.38 1.472 . . . . 0.0 113.826 178.751 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 23.3 tpp -98.73 128.2 44.9 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 168.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 48.6 m-85 -109.46 121.35 44.99 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 125.784 1.633 . . . . 0.0 108.2 174.079 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.1 m -137.69 143.02 34.85 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 N-CA-C 113.926 1.084 . . . . 0.0 113.926 -168.823 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 5.3 t -131.03 147.45 52.63 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 126.41 1.884 . . . . 0.0 112.086 174.786 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 63.2 tttm -52.86 -39.71 62.82 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 126.477 1.911 . . . . 0.0 114.297 -177.641 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 53.4 ttt180 -101.95 -49.73 3.87 Favored 'General case' 0 N--CA 1.483 1.217 0 N-CA-C 113.719 1.007 . . . . 0.0 113.719 169.872 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 1.8 t30 63.63 -47.5 0.25 Allowed 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 127.232 2.213 . . . . 0.0 116.15 -173.515 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 59.6 p -64.85 145.97 55.54 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 119.044 0.838 . . . . 0.0 110.243 169.687 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 66.6 m 51.39 24.62 2.23 Favored 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 114.564 1.32 . . . . 0.0 114.564 -174.548 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 85.2 mtt180 -137.47 152.4 49.5 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 126.975 2.11 . . . . 0.0 110.399 176.403 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 61.1 m -97.01 -29.28 13.74 Favored 'General case' 0 N--CA 1.48 1.058 0 N-CA-C 115.771 1.767 . . . . 0.0 115.771 -169.295 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 3.9 mp0 59.96 -44.24 0.09 Allowed 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 128.596 2.758 . . . . 0.0 117.09 -178.517 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 68.73 -46.38 0.55 Allowed 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 127.54 2.336 . . . . 0.0 115.753 171.931 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.86 -38.78 86.73 Favored 'General case' 0 C--O 1.222 -0.39 0 N-CA-C 115.494 1.665 . . . . 0.0 115.494 -169.605 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -69.15 -36.5 77.5 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-N 119.788 1.176 . . . . 0.0 112.134 -177.122 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -64.14 -40.16 97.81 Favored Glycine 0 N--CA 1.469 0.866 0 C-N-CA 124.135 0.874 . . . . 0.0 112.107 173.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -69.74 -38.32 76.77 Favored 'General case' 0 N--CA 1.47 0.533 0 O-C-N 121.75 -0.853 . . . . 0.0 111.686 172.404 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -64.59 -43.1 94.88 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 119.424 1.011 . . . . 0.0 112.402 -174.75 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 15.2 ptpt -64.75 -38.33 90.63 Favored 'General case' 0 N--CA 1.486 1.351 0 O-C-N 121.514 -0.741 . . . . 0.0 112.025 169.753 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 92.3 m -71.55 -34.07 69.67 Favored 'General case' 0 N--CA 1.479 1.001 0 O-C-N 121.632 -0.668 . . . . 0.0 112.475 -176.709 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 71.9 mt -88.66 -26.07 22.05 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 125.498 1.519 . . . . 0.0 113.84 -178.717 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -145.78 27.08 1.77 Allowed Glycine 0 N--CA 1.47 0.94 0 N-CA-C 118.487 2.155 . . . . 0.0 118.487 -169.083 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -65.82 -21.92 66.52 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-N 122.31 3.055 . . . . 0.0 115.329 -177.323 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -74.36 -5.17 71.47 Favored Glycine 0 CA--C 1.541 1.671 0 O-C-N 121.546 -0.721 . . . . 0.0 113.799 169.479 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 76.8 mttt -118.81 -39.81 2.93 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 127.339 2.256 . . . . 0.0 113.255 -177.506 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 43.7 pt -145.11 159.3 13.62 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 124.805 1.242 . . . . 0.0 113.399 -172.355 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -108.87 139.96 42.99 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 126.343 1.857 . . . . 0.0 108.65 169.752 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 4.2 m -129.55 148.83 33.23 Favored 'Isoleucine or valine' 0 C--O 1.234 0.273 0 CA-C-N 119.53 1.059 . . . . 0.0 111.067 -177.196 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 85.1 m -136.39 136.8 39.9 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 123.151 0.581 . . . . 0.0 110.781 179.0 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 11.5 t -88.51 133.67 34.08 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 124.329 1.052 . . . . 0.0 109.435 169.174 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 23.2 p -146.6 149.41 33.48 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 114.982 1.475 . . . . 0.0 114.982 169.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -98.22 152.11 19.75 Favored Glycine 0 C--N 1.338 0.643 0 C-N-CA 124.272 0.939 . . . . 0.0 113.725 -172.615 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 10.5 mp -96.12 99.51 11.24 Favored 'General case' 0 CA--C 1.536 0.41 0 O-C-N 120.604 -1.527 . . . . 0.0 108.956 176.616 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 25.9 mt-10 63.96 26.47 14.15 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 125.243 1.417 . . . . 0.0 113.324 -171.619 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 94.6 p -151.13 167.16 28.6 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 125.248 1.419 . . . . 0.0 113.705 -169.654 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 77.6 p -129.41 169.3 15.09 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 125.398 1.479 . . . . 0.0 113.911 173.05 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.473 ' HG3' ' H ' ' A' ' 42' ' ' VAL . 5.7 tpt180 60.94 -178.86 0.11 Allowed 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 128.636 2.775 . . . . 0.0 113.589 -179.143 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.473 ' H ' ' HG3' ' A' ' 41' ' ' ARG . 20.9 m -133.37 179.51 4.34 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 C-N-CA 129.808 3.243 . . . . 0.0 107.716 172.179 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 2.6 t-80 -58.77 130.75 85.89 Favored Pre-proline 0 C--N 1.325 -0.499 0 CA-C-O 118.052 -0.975 . . . . 0.0 112.127 178.482 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_exo -58.99 -27.2 84.33 Favored 'Trans proline' 0 CA--C 1.548 1.197 0 C-N-CA 121.337 1.358 . . . . 0.0 112.154 169.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 89.9 m -64.94 -29.66 70.61 Favored 'General case' 0 N--CA 1.482 1.175 0 C-N-CA 125.698 1.599 . . . . 0.0 112.452 173.209 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -56.65 -43.47 80.35 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 124.027 0.931 . . . . 0.0 111.114 -177.878 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.7 mp -51.74 -55.01 10.47 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 C-N-CA 124.233 1.013 . . . . 0.0 110.226 -176.564 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -62.95 -32.96 74.38 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 113.111 0.782 . . . . 0.0 113.111 -179.578 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -80.72 -20.68 42.29 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 113.719 1.007 . . . . 0.0 113.719 178.326 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 4.5 mmt -85.87 -32.51 21.64 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 119.54 1.064 . . . . 0.0 110.344 169.74 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -66.72 -15.75 63.75 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.953 1.301 . . . . 0.0 113.97 175.131 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 -62.29 -26.54 68.46 Favored 'General case' 0 N--CA 1.481 1.1 0 CA-C-N 120.367 1.439 . . . . 0.0 110.895 168.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 59.4 t -95.02 -5.77 10.24 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.82 0 C-N-CA 127.318 2.247 . . . . 0.0 111.348 175.613 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 80.22 18.4 71.83 Favored Glycine 0 CA--C 1.539 1.551 0 C-N-CA 125.165 1.364 . . . . 0.0 114.575 -174.65 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 94.6 mt -75.96 134.38 29.21 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 C-N-CA 124.843 1.257 . . . . 0.0 111.22 -176.727 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 21.8 t0 -94.68 108.71 20.69 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 123.231 0.612 . . . . 0.0 112.337 172.241 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 15.7 pt -129.82 12.68 2.39 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 C-N-CA 125.142 1.377 . . . . 0.0 113.284 169.641 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 72.5 m -69.67 138.24 52.82 Favored 'General case' 0 N--CA 1.47 0.57 0 O-C-N 120.603 -1.311 . . . . 0.0 111.93 -175.815 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 73.97 3.37 64.15 Favored Glycine 0 CA--C 1.537 1.429 0 N-CA-C 116.047 1.179 . . . . 0.0 116.047 176.468 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 9.2 pt20 -77.77 135.23 37.96 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 119.536 1.668 . . . . 0.0 110.903 177.414 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 24.1 p -77.36 -33.17 55.35 Favored 'General case' 0 N--CA 1.48 1.051 0 N-CA-C 114.853 1.427 . . . . 0.0 114.853 -173.196 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 31.8 m 47.85 54.27 10.21 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.804 1.242 . . . . 0.0 112.189 -170.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -54.04 159.02 3.12 Favored Pre-proline 0 CA--C 1.542 0.656 0 C-N-CA 124.306 1.042 . . . . 0.0 112.357 177.792 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -62.91 149.6 90.99 Favored 'Trans proline' 0 N--CA 1.457 -0.674 0 CA-C-N 120.312 1.147 . . . . 0.0 112.927 -176.489 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 7.7 tt -51.35 -32.22 12.72 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 125.246 1.418 . . . . 0.0 111.42 173.603 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 -65.73 -17.44 64.61 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 125.545 1.538 . . . . 0.0 113.35 -179.247 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -79.75 -9.29 59.63 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 125.103 1.361 . . . . 0.0 112.9 177.93 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 77.5 m-85 -117.35 -179.07 3.61 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 126.408 1.883 . . . . 0.0 112.254 -173.498 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 5.2 t30 -123.07 128.31 49.95 Favored 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 125.56 1.544 . . . . 0.0 109.711 175.015 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.33 -35.87 81.47 Favored 'General case' 0 CA--C 1.531 0.25 0 N-CA-C 114.205 1.187 . . . . 0.0 114.205 -169.861 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . 0.263 0.0 OUTLIER -72.18 -5.71 37.57 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 114.009 1.115 . . . . 0.0 114.009 -178.226 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -75.49 -10.39 59.4 Favored 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 124.082 0.953 . . . . 0.0 111.331 168.648 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 68.1 m-85 -116.55 145.09 43.6 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 127.167 2.187 . . . . 0.0 111.882 179.635 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -93.57 -26.25 17.2 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.892 1.277 . . . . 0.0 112.202 179.489 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 68.9 t -137.09 139.69 43.86 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 C-N-CA 126.99 2.116 . . . . 0.0 107.953 -169.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 61.0 t -130.9 126.39 59.78 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 170.268 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 45.5 mm -112.55 105.63 19.17 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 C-N-CA 125.331 1.452 . . . . 0.0 109.407 -177.137 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 9.5 m -84.44 117.93 23.96 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 123.976 0.91 . . . . 0.0 110.305 170.275 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 1.4 pp -130.91 168.93 16.5 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 125.79 1.636 . . . . 0.0 110.182 176.428 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER 65.84 -27.42 0.11 Allowed 'General case' 0 CA--C 1.553 1.075 0 C-N-CA 126.753 2.021 . . . . 0.0 114.982 -169.45 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -170.78 -173.09 37.68 Favored Glycine 0 CA--C 1.536 1.359 0 C-N-CA 126.395 1.95 . . . . 0.0 112.328 174.521 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 74.9 m -76.84 149.83 36.14 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.96 0.904 . . . . 0.0 112.51 -178.739 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -76.67 63.29 3.09 Favored Glycine 0 CA--C 1.535 1.336 0 C-N-CA 125.01 1.291 . . . . 0.0 113.625 176.461 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 58.2 t -105.09 -38.33 4.62 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.129 0 C-N-CA 124.284 1.034 . . . . 0.0 112.659 -176.284 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 62.7 t30 -91.31 33.16 0.99 Allowed 'General case' 0 CA--C 1.55 0.951 0 N-CA-C 113.344 0.868 . . . . 0.0 113.344 -178.772 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.1 pp -126.83 156.82 73.23 Favored Pre-proline 0 CA--C 1.55 0.976 0 C-N-CA 126.32 1.848 . . . . 0.0 111.853 172.41 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -61.65 149.0 91.74 Favored 'Trans proline' 0 CA--C 1.545 1.031 0 C-N-CA 122.315 2.01 . . . . 0.0 113.906 -179.581 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_exo -57.63 -26.03 70.55 Favored 'Trans proline' 0 C--N 1.354 0.827 0 C-N-CA 123.596 2.864 . . . . 0.0 115.244 -176.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -62.12 -22.8 66.13 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 113.695 0.998 . . . . 0.0 113.695 176.086 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 89.5 m95 -82.52 -28.65 30.95 Favored 'General case' 0 N--CA 1.473 0.681 0 O-C-N 120.821 -1.175 . . . . 0.0 113.193 176.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 6.4 m -80.25 -14.11 13.01 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.256 0 CA-C-N 119.232 0.924 . . . . 0.0 113.24 174.167 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -96.52 0.09 49.66 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 114.95 1.463 . . . . 0.0 114.95 -178.467 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 80.6 mm-40 -65.63 157.13 30.75 Favored 'General case' 0 N--CA 1.479 1.011 0 O-C-N 120.87 -1.144 . . . . 0.0 111.865 171.239 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -55.19 -42.54 73.37 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 114.392 1.256 . . . . 0.0 114.392 -167.872 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 14.0 mm -119.82 64.43 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 C-N-CA 124.63 1.172 . . . . 0.0 109.412 176.753 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 14.9 t80 -77.2 108.29 10.2 Favored 'General case' 0 CA--C 1.536 0.413 0 O-C-N 120.492 -1.38 . . . . 0.0 108.063 169.246 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -109.32 144.29 37.69 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 113.217 0.821 . . . . 0.0 113.217 172.788 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -121.42 115.54 23.09 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 124.13 0.972 . . . . 0.0 109.732 169.413 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 45.5 m0 -93.16 -19.78 21.13 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 113.903 1.075 . . . . 0.0 113.903 -169.859 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 66.5 mm-40 53.25 29.92 9.22 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 125.218 1.407 . . . . 0.0 113.177 -175.721 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.3 tt -80.83 132.73 35.5 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 125.428 1.491 . . . . 0.0 109.676 -174.599 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -65.74 151.98 45.34 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 113.131 0.789 . . . . 0.0 113.131 -179.43 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -92.9 148.82 36.61 Favored Pre-proline 0 CA--C 1.548 0.886 0 O-C-N 121.772 -0.58 . . . . 0.0 111.106 171.345 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -62.42 -19.19 66.63 Favored 'Trans proline' 0 CA--C 1.548 1.204 0 C-N-CA 122.779 2.32 . . . . 0.0 115.3 173.001 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -49.32 130.83 20.03 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 125.281 1.432 . . . . 0.0 114.582 175.761 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 79.29 7.95 88.13 Favored Glycine 0 CA--C 1.535 1.312 0 C-N-CA 124.736 1.16 . . . . 0.0 114.914 175.625 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 10.5 pt20 -143.36 173.2 11.82 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 125.098 1.359 . . . . 0.0 113.117 -177.122 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 26.5 p -68.3 167.46 14.41 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 116.61 2.078 . . . . 0.0 116.61 -168.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 41.7 tp -59.42 -30.8 68.73 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.516 1.126 . . . . 0.0 112.288 170.073 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -66.88 -31.76 72.57 Favored 'General case' 0 N--CA 1.47 0.536 0 O-C-N 120.818 -1.176 . . . . 0.0 111.487 173.849 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 7.6 t -71.49 -33.81 50.92 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 O-C-N 121.172 -0.955 . . . . 0.0 111.687 169.867 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -57.52 -48.34 79.55 Favored 'General case' 0 N--CA 1.477 0.893 0 CA-C-N 120.041 1.291 . . . . 0.0 111.261 169.34 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 2.8 mpt_? -63.35 -40.58 97.68 Favored 'General case' 0 N--CA 1.484 1.261 0 O-C-N 121.473 -0.767 . . . . 0.0 112.066 175.873 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 28.0 m -58.81 -46.5 87.45 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 124.095 0.958 . . . . 0.0 111.175 173.659 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 54.4 t -64.57 -43.19 96.77 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 CA-C-O 117.522 -1.228 . . . . 0.0 110.514 177.621 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 67.5 mtm-85 -57.3 -43.62 83.4 Favored 'General case' 0 N--CA 1.484 1.264 0 CA-C-N 121.076 1.762 . . . . 0.0 112.528 173.738 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -61.83 -51.21 58.79 Favored Glycine 0 CA--C 1.538 1.479 0 CA-C-N 119.046 0.839 . . . . 0.0 112.914 177.113 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 58.9 mm-40 -62.29 -45.36 93.6 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 123.742 0.817 . . . . 0.0 111.754 177.751 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 58.7 t -65.41 -40.59 88.84 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 C-N-CA 124.62 1.168 . . . . 0.0 111.375 178.342 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 82.3 tttt -56.02 -50.07 71.91 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 120.337 1.426 . . . . 0.0 110.131 177.594 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -62.81 -41.19 99.19 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 112.68 0.622 . . . . 0.0 112.68 176.64 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.77 -34.49 73.85 Favored 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 113.858 1.058 . . . . 0.0 113.858 -179.864 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 98.6 t -78.3 -38.53 23.3 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 C-N-CA 125.17 1.388 . . . . 0.0 110.926 175.744 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -62.3 -41.21 98.32 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 119.041 0.837 . . . . 0.0 111.506 171.661 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 15.2 m-80 -64.43 -42.13 96.18 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 119.249 0.931 . . . . 0.0 112.462 173.722 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -54.77 -57.23 12.38 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.234 0.614 . . . . 0.0 110.26 174.149 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 77.5 mt -63.32 -45.38 98.34 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 CA-C-O 118.995 -0.526 . . . . 0.0 111.251 -177.237 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -68.91 -10.84 59.31 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 114.222 1.193 . . . . 0.0 114.222 177.632 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 70.2 tttt -92.61 -45.63 7.99 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 125.425 1.49 . . . . 0.0 111.29 174.422 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 18.7 pt -91.89 -18.86 7.15 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 N-CA-C 114.41 1.263 . . . . 0.0 114.41 -174.257 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 73.7 m . . . . . 0 C--O 1.254 1.31 0 C-N-CA 125.783 1.633 . . . . 0.0 111.188 -175.878 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.8 ttt . . . . . 0 N--CA 1.503 2.183 0 N-CA-C 111.563 0.209 . . . . 0.0 111.563 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.9 164.35 30.33 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 125.061 1.344 . . . . 0.0 112.907 174.986 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 75.3 mttt -93.75 145.61 24.46 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 124.206 1.002 . . . . 0.0 112.193 177.269 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.408 HG13 ' CG1' ' A' ' 75' ' ' VAL . 21.5 t -129.06 131.57 67.91 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 125.569 1.548 . . . . 0.0 112.318 178.43 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 47.0 tpp -98.35 132.37 43.88 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 168.944 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 42.6 m-85 -115.61 127.32 55.13 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 124.441 1.096 . . . . 0.0 109.645 173.142 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 5.7 m -149.16 163.94 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 C-N-CA 124.398 1.079 . . . . 0.0 112.891 -169.779 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 47.1 t -132.25 165.52 23.96 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 127.312 2.245 . . . . 0.0 109.384 169.807 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -52.96 -37.6 61.26 Favored 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 124.547 1.139 . . . . 0.0 112.741 -178.529 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 82.3 mtt180 -141.18 150.73 43.11 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 127.203 2.201 . . . . 0.0 109.822 169.028 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 24.0 t30 -110.15 -27.11 9.31 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 124.341 1.056 . . . . 0.0 113.746 -173.222 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 60.5 m -56.29 126.54 26.69 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 118.769 0.713 . . . . 0.0 110.461 177.662 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 68.3 m 50.36 36.81 13.85 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 124.798 1.239 . . . . 0.0 113.945 -176.459 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -121.98 143.25 49.59 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 125.778 1.631 . . . . 0.0 109.478 171.082 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 15.8 m -97.02 -33.17 11.65 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 114.742 1.386 . . . . 0.0 114.742 -170.334 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 5.2 mt-30 60.75 -55.88 0.09 Allowed 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 128.578 2.751 . . . . 0.0 116.648 171.886 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 69.86 -42.67 0.52 Allowed 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 127.929 2.492 . . . . 0.0 117.498 169.599 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -59.9 -33.21 71.55 Favored 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 113.858 1.059 . . . . 0.0 113.858 -170.406 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.9 pm0 -61.56 -42.47 98.89 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.658 1.183 . . . . 0.0 112.275 173.767 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -68.75 -38.95 86.19 Favored Glycine 0 C--N 1.336 0.563 0 O-C-N 121.557 -0.715 . . . . 0.0 111.59 178.607 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -70.05 -41.65 73.91 Favored 'General case' 0 C--O 1.221 -0.414 0 O-C-N 121.834 -0.804 . . . . 0.0 111.258 175.865 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -60.16 -41.9 93.79 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 119.467 1.031 . . . . 0.0 113.008 -175.736 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 10.3 pttp -76.78 -29.28 55.99 Favored 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 113.502 0.927 . . . . 0.0 113.502 173.891 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 83.7 m -71.66 -31.29 66.65 Favored 'General case' 0 N--CA 1.485 1.281 0 O-C-N 121.585 -0.697 . . . . 0.0 111.842 175.241 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 78.2 mt -91.57 -30.82 16.17 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 125.923 1.689 . . . . 0.0 114.123 179.827 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -142.89 26.36 2.22 Favored Glycine 0 N--CA 1.475 1.292 0 N-CA-C 118.233 2.053 . . . . 0.0 118.233 -169.086 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -66.27 -20.3 66.07 Favored 'General case' 0 CA--C 1.547 0.833 0 CA-C-N 122.016 2.908 . . . . 0.0 114.952 -178.578 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -76.4 -4.18 79.21 Favored Glycine 0 CA--C 1.541 1.675 0 O-C-N 121.235 -0.916 . . . . 0.0 113.757 169.368 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -118.11 -40.94 2.91 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 127.178 2.191 . . . . 0.0 112.513 -175.536 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 29.4 pt -141.38 154.93 20.56 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 C-N-CA 125.919 1.687 . . . . 0.0 112.168 -175.103 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -97.3 137.53 36.17 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 123.872 0.869 . . . . 0.0 109.702 169.875 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 84.0 t -122.14 140.22 46.71 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 CA-C-N 118.996 0.817 . . . . 0.0 111.542 -178.769 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 20.4 m -135.68 151.2 49.95 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 124.923 1.289 . . . . 0.0 109.31 173.331 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 77.9 p -133.06 147.73 52.2 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 122.308 1.051 . . . . 0.0 110.913 168.32 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 88.7 p -144.2 157.9 44.03 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 114.066 -1.425 . . . . 0.0 112.461 -174.478 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -79.07 167.67 52.72 Favored Glycine 0 CA--C 1.527 0.818 0 N-CA-C 111.166 -0.774 . . . . 0.0 111.166 169.748 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 9.2 mp -100.91 -16.91 17.05 Favored 'General case' 0 N--CA 1.484 1.237 0 CA-C-N 120.27 2.035 . . . . 0.0 112.164 169.559 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -138.36 170.02 16.75 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 129.587 3.155 . . . . 0.0 107.095 172.331 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 69.0 m -57.46 110.17 0.82 Allowed 'General case' 0 N--CA 1.48 1.061 0 CA-C-N 119.759 1.163 . . . . 0.0 111.112 -178.461 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 91.2 p -158.51 175.02 14.21 Favored 'General case' 0 N--CA 1.478 0.966 0 N-CA-C 115.673 1.731 . . . . 0.0 115.673 -169.145 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 15.3 tpt180 -139.79 145.01 37.67 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 128.398 2.679 . . . . 0.0 108.852 171.76 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 35.5 m -56.21 163.98 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 CA-C-O 122.761 1.267 . . . . 0.0 111.155 169.598 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 1.6 t-80 -48.86 127.05 14.09 Favored Pre-proline 0 C--N 1.323 -0.543 0 CA-C-N 114.05 -1.432 . . . . 0.0 112.965 172.354 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_exo -60.64 -28.68 86.99 Favored 'Trans proline' 0 CA--C 1.542 0.907 0 CA-C-N 120.54 1.229 . . . . 0.0 111.904 171.497 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 88.6 m -65.6 -29.72 70.35 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 125.213 1.405 . . . . 0.0 112.238 173.845 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.32 -39.69 87.96 Favored 'General case' 0 N--CA 1.471 0.582 0 O-C-N 121.108 -0.995 . . . . 0.0 112.089 -175.714 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.9 mp -57.83 -56.03 18.09 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 -177.922 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.53 -33.62 76.33 Favored 'General case' 0 CA--C 1.542 0.656 0 N-CA-C 113.378 0.881 . . . . 0.0 113.378 -178.004 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -79.95 -21.19 44.07 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 114.13 1.159 . . . . 0.0 114.13 178.953 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -90.74 -28.01 18.57 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 118.96 0.8 . . . . 0.0 110.306 172.092 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -66.07 -13.12 59.47 Favored 'General case' 0 CA--C 1.543 0.692 0 O-C-N 120.641 -1.287 . . . . 0.0 113.247 171.248 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 13.3 mt-10 -61.41 -27.49 68.58 Favored 'General case' 0 N--CA 1.48 1.059 0 CA-C-N 120.233 1.378 . . . . 0.0 110.464 168.665 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 35.7 t -96.45 -2.29 10.4 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.032 0 C-N-CA 127.581 2.353 . . . . 0.0 111.135 176.874 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 78.93 21.26 68.66 Favored Glycine 0 CA--C 1.538 1.53 0 C-N-CA 125.35 1.452 . . . . 0.0 114.742 -176.606 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 77.8 mt -83.6 131.07 34.71 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 C-N-CA 124.798 1.239 . . . . 0.0 112.006 -171.436 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 19.4 t0 -96.06 107.14 19.41 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 112.895 0.702 . . . . 0.0 112.895 -178.616 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 15.6 pt -142.68 23.06 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.208 0 C-N-CA 125.302 1.441 . . . . 0.0 114.369 -177.286 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 95.2 p -48.15 -37.34 15.34 Favored 'General case' 0 N--CA 1.483 1.201 0 N-CA-C 116.567 2.062 . . . . 0.0 116.567 -169.341 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -142.97 40.04 1.28 Allowed Glycine 0 N--CA 1.474 1.179 0 C-N-CA 125.358 1.456 . . . . 0.0 113.01 -179.371 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 24.3 pt20 -66.5 -34.68 78.45 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 115.637 1.717 . . . . 0.0 115.637 -169.529 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 68.0 p -93.65 104.17 16.29 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 121.211 0.529 . . . . 0.0 111.352 173.856 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 95.9 p -108.94 -23.55 11.66 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 125.473 1.509 . . . . 0.0 114.278 178.316 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -145.46 155.34 53.53 Favored Pre-proline 0 CA--C 1.544 0.722 0 C-N-CA 124.722 1.209 . . . . 0.0 111.046 -171.795 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -74.37 155.13 46.07 Favored 'Trans proline' 0 CA--C 1.538 0.714 0 C-N-CA 122.561 2.174 . . . . 0.0 112.657 173.257 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 5.6 tt -54.44 -38.65 41.77 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 126.171 1.788 . . . . 0.0 111.615 179.74 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -68.34 -8.6 41.37 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 124.56 1.144 . . . . 0.0 113.763 178.785 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 -79.92 -21.73 43.54 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 124.085 0.954 . . . . 0.0 112.824 170.71 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 84.6 m-85 -93.62 -176.73 4.17 Favored 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 126.444 1.897 . . . . 0.0 111.879 -179.354 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 7.0 t30 -113.84 129.19 56.62 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 125.783 1.633 . . . . 0.0 109.695 171.889 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -69.38 -36.9 77.26 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 113.918 1.081 . . . . 0.0 113.918 -175.517 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . 0.272 0.0 OUTLIER -72.07 -7.82 51.11 Favored 'General case' 0 CA--C 1.544 0.744 0 N-CA-C 114.562 1.319 . . . . 0.0 114.562 -173.077 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -65.1 -26.35 68.18 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 123.664 0.786 . . . . 0.0 110.449 168.295 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 55.5 m-85 -108.4 120.75 43.31 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 125.834 1.654 . . . . 0.0 111.44 -173.307 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -74.0 -20.87 60.19 Favored 'General case' 0 CA--C 1.545 0.776 0 CA-C-O 122.195 0.998 . . . . 0.0 112.473 177.55 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.609 HG22 ' HB ' ' A' ' 95' ' ' ILE . 92.3 t -133.95 137.84 51.5 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 C-N-CA 127.381 2.272 . . . . 0.0 108.891 -173.407 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 63.0 t -133.91 118.61 29.65 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 169.685 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 44.8 mm -103.09 113.16 39.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 C-N-CA 123.818 0.847 . . . . 0.0 109.299 -177.918 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 15.5 m -92.78 114.12 26.59 Favored 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 169.531 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 90.7 mt -86.79 -3.16 59.02 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 125.644 1.577 . . . . 0.0 115.217 -169.548 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 77.5 m -130.34 40.32 3.54 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 125.359 1.463 . . . . 0.0 110.553 -169.82 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 80.51 -131.72 10.7 Favored Glycine 0 CA--C 1.532 1.109 0 C-N-CA 124.371 0.986 . . . . 0.0 111.174 -169.49 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 93.3 p -63.71 154.49 32.98 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 124.015 0.926 . . . . 0.0 113.479 176.994 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -75.35 -51.42 7.43 Favored Glycine 0 CA--C 1.534 1.269 0 O-C-N 121.739 -0.601 . . . . 0.0 112.339 176.009 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . 0.273 7.7 p 48.97 -47.54 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.677 1 C-N-CA 132.148 4.179 . . . . 0.0 119.021 169.883 . . . . . . . . 3 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 63.1 t30 -85.9 15.95 4.51 Favored 'General case' 0 CA--C 1.556 1.202 0 C-N-CA 126.734 2.014 . . . . 0.0 112.761 -179.834 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -122.87 160.45 49.13 Favored Pre-proline 0 CA--C 1.55 0.98 0 C-N-CA 127.589 2.356 . . . . 0.0 112.598 179.605 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -63.34 151.61 84.04 Favored 'Trans proline' 0 CA--C 1.546 1.084 0 C-N-CA 122.774 2.316 . . . . 0.0 113.948 178.721 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_exo -58.82 -27.05 82.8 Favored 'Trans proline' 0 C--N 1.352 0.728 0 C-N-CA 123.609 2.873 . . . . 0.0 115.309 -177.108 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -61.72 -21.24 64.32 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 113.74 1.015 . . . . 0.0 113.74 177.763 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 92.7 m95 -83.73 -28.95 27.88 Favored 'General case' 0 N--CA 1.474 0.733 0 O-C-N 120.83 -1.168 . . . . 0.0 113.318 177.32 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 6.4 m -82.88 -13.37 12.08 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.315 0 N-CA-C 113.36 0.874 . . . . 0.0 113.36 174.41 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -95.31 1.46 54.42 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 114.603 1.334 . . . . 0.0 114.603 -179.33 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 85.6 mm-40 -66.39 156.31 34.94 Favored 'General case' 0 N--CA 1.481 1.081 0 O-C-N 120.83 -1.169 . . . . 0.0 111.596 172.005 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -59.49 -42.54 92.37 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 114.196 1.184 . . . . 0.0 114.196 -168.183 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.609 ' HB ' HG22 ' A' ' 75' ' ' VAL . 16.3 mm -113.21 55.44 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 C-N-CA 125.083 1.353 . . . . 0.0 109.276 177.788 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 25.1 t80 -74.66 109.19 7.93 Favored 'General case' 0 CA--C 1.536 0.414 0 O-C-N 120.565 -1.334 . . . . 0.0 107.675 169.009 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 13.8 mt-10 -110.95 131.36 55.12 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 114.432 1.271 . . . . 0.0 114.432 176.657 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 12.5 p-10 -94.74 104.69 16.61 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 126.128 1.771 . . . . 0.0 110.053 169.214 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 34.2 m0 -93.35 124.56 37.42 Favored 'General case' 0 N--CA 1.464 0.236 0 C-N-CA 124.183 0.993 . . . . 0.0 109.089 174.703 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 32.5 mt-30 -91.95 42.3 1.1 Allowed 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 124.012 0.925 . . . . 0.0 111.574 -173.324 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 76.1 mt -81.28 164.07 22.5 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 125.271 1.428 . . . . 0.0 112.695 -178.863 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -87.2 163.74 16.75 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 124.901 1.28 . . . . 0.0 111.221 169.106 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -108.3 139.6 20.91 Favored Pre-proline 0 N--CA 1.474 0.755 0 O-C-N 121.33 -0.856 . . . . 0.0 110.526 169.748 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_exo -59.9 -17.13 42.27 Favored 'Trans proline' 0 CA--C 1.545 1.028 0 C-N-CA 123.006 2.471 . . . . 0.0 116.392 176.955 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -54.41 135.44 45.28 Favored 'General case' 0 CA--C 1.546 0.816 0 CA-C-N 120.13 1.332 . . . . 0.0 113.924 178.858 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 76.54 6.74 84.86 Favored Glycine 0 CA--C 1.538 1.48 0 C-N-CA 124.461 1.029 . . . . 0.0 115.007 178.453 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 -138.05 170.47 15.98 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 125.473 1.509 . . . . 0.0 113.033 -179.459 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 26.4 p -68.07 168.56 11.77 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 117.461 2.393 . . . . 0.0 117.461 -168.524 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 25.0 tp -60.18 -30.09 69.13 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 125.097 1.359 . . . . 0.0 112.483 169.801 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -65.58 -31.54 72.64 Favored 'General case' 0 CA--C 1.539 0.523 0 O-C-N 121.038 -1.039 . . . . 0.0 111.259 171.684 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 11.4 t -74.16 -38.52 48.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 CA-C-O 118.154 -0.927 . . . . 0.0 112.14 171.104 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 17.1 m-85 -56.25 -44.08 79.33 Favored 'General case' 0 N--CA 1.482 1.134 0 CA-C-N 120.698 1.59 . . . . 0.0 111.74 169.588 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -69.49 -37.5 77.26 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 124.351 1.06 . . . . 0.0 112.408 178.182 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 21.6 m -60.46 -48.04 83.48 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 124.507 1.123 . . . . 0.0 111.201 170.362 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 75.1 t -65.52 -43.52 94.28 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 CA-C-O 118.181 -0.914 . . . . 0.0 110.236 179.853 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 16.8 mtp180 -53.5 -45.48 69.69 Favored 'General case' 0 N--CA 1.481 1.118 0 CA-C-N 119.914 1.234 . . . . 0.0 112.716 172.091 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -60.57 -51.34 59.34 Favored Glycine 0 CA--C 1.538 1.482 0 CA-C-N 119.431 1.014 . . . . 0.0 113.218 176.432 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 58.9 mm-40 -63.37 -45.09 92.76 Favored 'General case' 0 N--CA 1.472 0.653 0 O-C-N 121.978 -0.719 . . . . 0.0 111.912 178.822 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 50.5 t -63.83 -41.72 93.48 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 C-N-CA 124.881 1.272 . . . . 0.0 111.237 177.818 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 78.1 tttt -56.77 -48.02 78.83 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 119.832 1.196 . . . . 0.0 110.425 178.407 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -64.35 -42.31 96.29 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 112.641 0.608 . . . . 0.0 112.641 177.523 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 16.6 mmm180 -61.14 -45.59 94.03 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.393 0.677 . . . . 0.0 112.696 175.144 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 79.3 t -69.45 -41.05 80.55 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 C-N-CA 124.5 1.12 . . . . 0.0 111.157 -179.392 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -62.51 -40.0 95.32 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 118.875 0.761 . . . . 0.0 111.647 172.879 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 13.0 m-80 -64.02 -46.11 85.95 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-N 118.782 0.719 . . . . 0.0 112.236 174.123 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -54.05 -54.78 34.53 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 124.734 1.213 . . . . 0.0 110.499 175.272 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 91.4 mt -59.88 -45.11 95.41 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 CA-C-O 119.024 -0.512 . . . . 0.0 110.393 179.255 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -68.83 -10.77 58.67 Favored 'General case' 0 CA--C 1.548 0.871 0 N-CA-C 115.245 1.572 . . . . 0.0 115.245 -179.807 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 21.4 ptmt -102.49 -24.18 13.84 Favored 'General case' 0 N--CA 1.479 1.01 0 N-CA-C 113.91 1.078 . . . . 0.0 113.91 171.271 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 14.7 pt -96.65 -7.97 9.4 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 N-CA-C 114.435 1.272 . . . . 0.0 114.435 176.179 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 83.4 p . . . . . 0 C--O 1.255 1.35 0 C-N-CA 125.075 1.35 . . . . 0.0 114.269 173.526 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.403 ' HG3' ' HA ' ' A' ' 30' ' ' ILE . 4.1 ttp . . . . . 0 N--CA 1.502 2.172 0 N-CA-C 112.087 0.403 . . . . 0.0 112.087 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 3.3 mptp? -86.03 159.91 19.46 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 124.602 1.161 . . . . 0.0 113.113 171.003 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 79.3 mttt -112.14 113.21 25.34 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 125.816 1.646 . . . . 0.0 106.577 167.671 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 18.9 t -102.91 132.5 48.95 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 C-N-CA 125.793 1.637 . . . . 0.0 113.579 -178.864 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' MET . . . . . 0.538 ' HG3' HG13 ' A' ' 7' ' ' VAL . 36.6 tpp -107.05 119.86 40.53 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.567 0.747 . . . . 0.0 109.266 168.552 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 60.1 m-85 -97.16 125.08 41.42 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.232 1.013 . . . . 0.0 109.533 171.476 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.54 HG11 HD12 ' A' ' 65' ' ' ILE . 1.0 OUTLIER -140.99 147.78 22.25 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 N-CA-C 114.179 1.177 . . . . 0.0 114.179 -168.95 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 52.7 t -157.55 164.72 37.03 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 126.189 1.795 . . . . 0.0 112.417 172.298 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 53.4 mtmt -75.08 154.92 37.67 Favored 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 125.753 1.621 . . . . 0.0 112.628 171.943 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 6.4 tmm_? 49.3 84.45 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 127.377 2.271 . . . . 0.0 112.661 175.618 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 30.2 t-20 -79.69 -25.27 41.26 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 124.62 1.168 . . . . 0.0 113.132 -171.738 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 78.2 p -58.3 141.68 50.29 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.208 1.003 . . . . 0.0 111.567 170.092 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 66.9 m 56.23 -4.26 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.325 0 N-CA-C 116.647 2.091 . . . . 0.0 116.647 -170.598 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 58.8 ttm-85 -92.37 138.57 31.41 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 124.886 1.274 . . . . 0.0 113.372 -170.131 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 45.5 m -96.17 -38.16 10.26 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 114.578 1.325 . . . . 0.0 114.578 -176.64 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 60.82 -46.75 0.11 Allowed 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 127.622 2.369 . . . . 0.0 116.271 -177.132 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' MET . . . . . 0.41 ' HG2' ' SD ' ' A' ' 50' ' ' MET . 0.0 OUTLIER 66.67 -50.54 0.45 Allowed 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 127.771 2.429 . . . . 0.0 116.579 169.619 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -56.17 -37.13 69.13 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 115.584 1.698 . . . . 0.0 115.584 -169.132 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.89 -34.94 77.62 Favored 'General case' 0 N--CA 1.476 0.864 0 O-C-N 121.412 -0.805 . . . . 0.0 112.774 -177.162 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -69.87 -42.83 68.53 Favored Glycine 0 N--CA 1.468 0.813 0 C-N-CA 123.692 0.663 . . . . 0.0 111.764 176.371 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -64.39 -36.94 85.79 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 117.884 0.842 . . . . 0.0 111.313 170.79 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -65.32 -39.12 92.03 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 119.449 1.022 . . . . 0.0 112.663 179.586 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 23.7 mtpp -62.05 -46.62 88.33 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 123.314 0.645 . . . . 0.0 110.978 169.918 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 69.6 m -68.15 -38.09 81.75 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 123.12 0.568 . . . . 0.0 112.245 -174.448 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 47.7 mt -85.49 -35.46 21.16 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 125.416 1.487 . . . . 0.0 113.362 -179.445 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -117.29 5.15 17.68 Favored Glycine 0 CA--C 1.528 0.867 0 N-CA-C 118.214 2.046 . . . . 0.0 118.214 -168.737 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -60.81 139.48 57.92 Favored 'General case' 0 CA--C 1.545 0.784 0 CA-C-N 122.064 2.932 . . . . 0.0 111.959 177.316 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 88.68 -21.38 26.56 Favored Glycine 0 CA--C 1.54 1.649 0 C-N-CA 124.797 1.189 . . . . 0.0 113.233 -169.206 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 72.4 mttt -101.77 -42.22 6.25 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 126.302 1.841 . . . . 0.0 112.015 169.531 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.403 ' HA ' ' HG3' ' A' ' 1' ' ' MET . 36.0 pt -135.12 146.11 30.92 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 C-N-CA 124.676 1.19 . . . . 0.0 113.126 -178.566 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -98.58 145.77 26.49 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 126.685 1.994 . . . . 0.0 108.337 169.197 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 71.3 t -141.38 139.01 32.9 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 O-C-N 121.781 -0.575 . . . . 0.0 112.435 -169.696 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 31.7 m -136.9 159.2 42.57 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 126.198 1.799 . . . . 0.0 108.745 169.909 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 26.5 p -133.98 148.55 51.15 Favored 'General case' 0 CA--C 1.515 -0.368 0 CA-C-O 121.742 0.782 . . . . 0.0 111.896 168.086 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 59.9 p -147.58 153.81 39.89 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 114.806 -1.088 . . . . 0.0 113.312 176.212 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -83.22 152.97 30.1 Favored Glycine 0 N--CA 1.473 1.138 0 O-C-N 121.735 -0.603 . . . . 0.0 111.987 173.913 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.4 mp -76.23 -20.43 57.45 Favored 'General case' 0 N--CA 1.481 1.088 0 CA-C-N 119.126 1.463 . . . . 0.0 113.973 176.904 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -138.31 -52.42 0.6 Allowed 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.934 0.893 . . . . 0.0 113.31 177.226 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 50.2 p -98.93 150.57 21.8 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 115.106 1.521 . . . . 0.0 115.106 -172.403 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 80.5 p -84.81 149.21 25.87 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 125.818 1.647 . . . . 0.0 114.23 -174.497 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 13.2 tpt180 57.61 137.58 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 129.483 3.113 . . . . 0.0 116.045 -178.662 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 15.6 m -67.49 156.48 6.79 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.354 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 168.695 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' HIS . . . . . 0.441 ' CE1' ' HB ' ' A' ' 45' ' ' THR 0.255 0.0 OUTLIER -68.19 140.18 92.98 Favored Pre-proline 0 CA--C 1.546 0.793 0 C-N-CA 118.188 -1.405 . . . . 0.0 110.943 178.08 . . . . . . . . 4 4 . 1 . 002 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -63.81 -31.01 68.69 Favored 'Trans proline' 0 CA--C 1.539 0.732 0 C-N-CA 123.254 2.636 . . . . 0.0 114.84 -168.291 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.441 ' HB ' ' CE1' ' A' ' 43' ' ' HIS . 51.7 m -65.46 -24.64 67.22 Favored 'General case' 0 N--CA 1.48 1.062 0 O-C-N 121.404 -0.81 . . . . 0.0 111.787 -176.334 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -50.51 -48.44 57.05 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.11 0.964 . . . . 0.0 111.67 169.796 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 4.7 mp -55.39 -53.26 37.61 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 CA-C-N 119.433 1.015 . . . . 0.0 111.015 -176.866 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -62.81 -25.55 68.3 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 113.648 0.981 . . . . 0.0 113.648 -177.709 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -81.08 -35.19 32.05 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 123.644 0.778 . . . . 0.0 112.808 174.859 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' MET . . . . . 0.41 ' SD ' ' HG2' ' A' ' 17' ' ' MET . 4.5 mmt -72.49 -29.76 63.93 Favored 'General case' 0 N--CA 1.473 0.707 0 O-C-N 121.129 -0.982 . . . . 0.0 111.13 172.219 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -67.41 -9.08 38.2 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 125.339 1.456 . . . . 0.0 113.816 172.189 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -69.02 -29.74 67.96 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-N 120.325 1.421 . . . . 0.0 110.857 169.526 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . 0.295 2.2 p -109.66 8.25 8.95 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.815 0 C-N-CA 127.189 2.196 . . . . 0.0 111.955 -172.475 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 85.84 14.08 68.2 Favored Glycine 0 CA--C 1.538 1.497 0 C-N-CA 124.855 1.217 . . . . 0.0 115.369 171.673 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -76.19 138.39 20.83 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 C-N-CA 124.625 1.17 . . . . 0.0 109.698 -178.335 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 19.6 t0 -110.55 104.37 13.08 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 124.272 1.029 . . . . 0.0 111.767 175.088 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 21.4 pt -133.75 6.33 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.248 0 N-CA-C 116.289 1.959 . . . . 0.0 116.289 -175.727 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 72.3 m -60.21 -31.43 70.16 Favored 'General case' 0 N--CA 1.483 1.214 0 CA-C-N 120.438 1.472 . . . . 0.0 111.662 175.207 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -79.35 14.78 14.65 Favored Glycine 0 CA--C 1.539 1.559 0 C-N-CA 126.193 1.854 . . . . 0.0 115.934 175.863 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 70.6 mt-30 -62.38 157.21 20.46 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 119.434 1.617 . . . . 0.0 110.429 169.838 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 7.6 t -74.86 172.89 11.4 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 121.538 0.685 . . . . 0.0 112.061 169.928 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 73.4 m -118.09 -18.53 9.36 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 125.098 1.359 . . . . 0.0 114.211 -174.185 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 27.3 m-20 -86.11 158.68 55.29 Favored Pre-proline 0 CA--C 1.55 0.949 0 N-CA-C 114.691 1.367 . . . . 0.0 114.691 -169.703 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -63.98 160.91 35.38 Favored 'Trans proline' 0 C--N 1.353 0.787 0 C-N-CA 124.001 3.134 . . . . 0.0 114.371 172.268 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.54 HD12 HG11 ' A' ' 7' ' ' VAL . 8.4 tt -51.5 -36.47 17.93 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 C-N-CA 125.622 1.569 . . . . 0.0 112.103 173.092 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 17.8 mt-10 -65.0 -16.77 63.81 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.598 1.159 . . . . 0.0 112.825 -177.511 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -83.26 -8.18 59.49 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 124.815 1.246 . . . . 0.0 113.565 -178.953 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 69.7 m-85 -116.77 -175.44 2.77 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 126.221 1.808 . . . . 0.0 112.614 -172.914 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 11.2 t30 -120.69 125.81 48.61 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 125.603 1.561 . . . . 0.0 110.026 177.613 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -69.13 -35.4 76.34 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 114.021 1.119 . . . . 0.0 114.021 -173.363 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . 0.275 0.0 OUTLIER -71.92 -5.21 33.01 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 114.329 1.233 . . . . 0.0 114.329 -174.15 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -70.42 -25.73 63.34 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 122.968 0.507 . . . . 0.0 109.949 168.446 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 80.1 m-85 -99.23 148.67 23.88 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 126.473 1.909 . . . . 0.0 111.644 -179.205 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -107.04 -17.92 14.05 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 124.342 1.057 . . . . 0.0 112.176 176.011 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.662 HG22 ' HB ' ' A' ' 95' ' ' ILE . 71.7 t -129.94 137.81 55.64 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 C-N-CA 126.89 2.076 . . . . 0.0 107.959 177.454 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 60.2 t -132.93 123.46 48.48 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 169.591 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 41.5 mm -108.35 104.13 16.6 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 C-N-CA 124.496 1.119 . . . . 0.0 108.883 -176.963 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 3.6 m -81.78 107.48 14.54 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 169.646 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 75.4 mt -75.71 -18.72 59.51 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 114.945 1.461 . . . . 0.0 114.945 -170.062 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 28.7 p -136.66 30.81 2.83 Favored 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 114.935 1.457 . . . . 0.0 114.935 -168.904 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 152.03 -172.67 31.32 Favored Glycine 0 CA--C 1.532 1.096 0 N-CA-C 115.246 0.858 . . . . 0.0 115.246 177.685 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 97.0 p -79.01 160.64 27.08 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 125.295 1.438 . . . . 0.0 112.681 176.63 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -81.12 49.96 4.09 Favored Glycine 0 CA--C 1.534 1.267 0 C-N-CA 124.861 1.22 . . . . 0.0 114.951 -171.047 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 24.8 t -104.06 -33.17 3.01 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 CA-C-N 117.864 0.832 . . . . 0.0 112.88 -172.455 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 17.9 t-20 -84.84 -21.91 29.66 Favored 'General case' 0 CA--C 1.55 0.945 0 N-CA-C 113.865 1.061 . . . . 0.0 113.865 -179.239 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -82.42 160.49 62.02 Favored Pre-proline 0 CA--C 1.553 1.085 0 C-N-CA 124.0 0.92 . . . . 0.0 112.55 170.999 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_exo -61.47 149.75 88.23 Favored 'Trans proline' 0 CA--C 1.543 0.97 0 C-N-CA 122.79 2.327 . . . . 0.0 112.786 176.428 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -62.56 -29.04 77.87 Favored 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 122.95 2.433 . . . . 0.0 114.008 -170.356 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -60.64 -19.59 58.53 Favored 'General case' 0 CA--C 1.544 0.748 0 O-C-N 120.849 -1.157 . . . . 0.0 113.989 177.425 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 84.1 m95 -82.98 -14.71 53.53 Favored 'General case' 0 CA--C 1.542 0.662 0 O-C-N 120.659 -1.276 . . . . 0.0 113.324 175.667 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 14.5 m -93.49 -13.21 8.59 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.209 0 N-CA-C 113.729 1.011 . . . . 0.0 113.729 169.756 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 59.1 p -88.27 -5.46 58.35 Favored 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 114.48 1.289 . . . . 0.0 114.48 179.382 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 55.1 mm-40 -67.87 149.58 49.66 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-O 121.982 0.896 . . . . 0.0 110.275 169.63 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -53.88 -42.48 68.7 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 115.127 1.528 . . . . 0.0 115.127 -167.516 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.662 ' HB ' HG22 ' A' ' 75' ' ' VAL . 19.8 mm -117.44 63.83 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 C-N-CA 124.982 1.313 . . . . 0.0 109.232 179.21 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 33.0 t80 -76.11 111.86 11.96 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 168.799 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 9.0 mt-10 -108.97 130.92 55.47 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 114.15 1.167 . . . . 0.0 114.15 175.011 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 11.7 p-10 -93.89 109.7 21.4 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 125.016 1.326 . . . . 0.0 109.31 168.791 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 27.5 m0 -101.7 158.33 16.18 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.568 1.147 . . . . 0.0 108.943 169.627 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 8.3 mm-40 -128.41 65.84 1.39 Allowed 'General case' 0 CA--C 1.537 0.477 0 CA-C-O 122.875 1.321 . . . . 0.0 108.265 173.36 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.478 HD11 HG22 ' A' ' 119' ' ' VAL . 14.1 tp -77.11 150.63 35.61 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 126.608 1.963 . . . . 0.0 110.992 -174.344 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 29.4 tp10 -64.32 -43.01 96.01 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 113.681 0.993 . . . . 0.0 113.681 178.572 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 8.4 t0 62.88 126.39 0.02 OUTLIER Pre-proline 0 CA--C 1.558 1.257 0 C-N-CA 127.283 2.233 . . . . 0.0 113.596 -169.659 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_exo -62.61 -12.18 27.03 Favored 'Trans proline' 0 CA--C 1.55 1.301 0 C-N-CA 121.997 1.798 . . . . 0.0 114.499 172.189 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 8.6 t0 -23.99 107.47 0.03 OUTLIER 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 128.31 2.644 . . . . 0.0 116.068 169.629 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 72.16 10.59 74.08 Favored Glycine 0 CA--C 1.537 1.448 0 N-CA-C 116.379 1.312 . . . . 0.0 116.379 169.904 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 13.2 pt20 -128.73 166.5 18.84 Favored 'General case' 0 CA--C 1.545 0.753 0 CA-C-N 119.159 1.48 . . . . 0.0 113.999 -175.904 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 49.6 m -58.14 160.1 5.27 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 126.447 1.899 . . . . 0.0 115.63 -169.24 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 20.3 tp -59.41 -32.6 70.33 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.917 1.287 . . . . 0.0 113.069 178.986 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -61.76 -32.19 72.43 Favored 'General case' 0 N--CA 1.473 0.716 0 O-C-N 120.808 -1.183 . . . . 0.0 112.091 172.481 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 6.4 t -74.02 -37.62 47.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 CA-C-O 118.461 -0.78 . . . . 0.0 110.891 172.748 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 17.5 m-85 -57.08 -48.08 79.47 Favored 'General case' 0 N--CA 1.478 0.972 0 CA-C-N 120.273 1.397 . . . . 0.0 112.119 169.68 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 48.4 mtt-85 -60.12 -48.64 80.88 Favored 'General case' 0 N--CA 1.484 1.253 0 CA-C-N 119.185 0.902 . . . . 0.0 111.326 178.117 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 83.4 m -62.5 -46.13 89.85 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.884 0.873 . . . . 0.0 111.179 179.739 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 96.6 t -74.45 -41.19 49.58 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 CA-C-O 117.586 -1.197 . . . . 0.0 110.83 -175.307 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . 0.304 24.6 ptt85 -64.04 -28.65 69.94 Favored 'General case' 0 N--CA 1.483 1.225 0 CA-C-N 121.638 2.017 . . . . 0.0 113.12 177.487 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -65.15 -46.68 87.11 Favored Glycine 0 CA--C 1.542 1.772 0 CA-C-N 119.356 0.98 . . . . 0.0 112.938 169.279 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 15.0 mm100 -65.75 -41.32 92.25 Favored 'General case' 0 N--CA 1.475 0.824 0 O-C-N 121.387 -1.067 . . . . 0.0 112.151 177.014 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.478 HG22 HD11 ' A' ' 101' ' ' LEU . 77.7 t -60.82 -43.8 96.25 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 C-N-CA 125.416 1.487 . . . . 0.0 110.714 173.095 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 82.0 tttt -53.98 -49.68 68.24 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 119.205 0.911 . . . . 0.0 110.231 179.039 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -62.43 -41.65 98.88 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 112.742 0.645 . . . . 0.0 112.742 178.5 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 14.8 mtp85 -64.03 -43.6 95.08 Favored 'General case' 0 N--CA 1.479 1.01 0 N-CA-C 113.135 0.791 . . . . 0.0 113.135 176.024 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 94.2 t -70.91 -38.06 70.78 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 C-N-CA 123.181 0.592 . . . . 0.0 110.762 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -60.2 -38.52 83.56 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 118.613 0.642 . . . . 0.0 111.214 169.803 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 7.9 m-80 -62.48 -48.69 78.5 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 119.283 0.947 . . . . 0.0 112.153 174.112 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -52.89 -56.55 15.05 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.576 1.151 . . . . 0.0 110.699 174.076 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 85.4 mt -61.37 -42.15 92.59 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 O-C-N 122.017 -0.427 . . . . 0.0 111.08 -179.196 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -70.13 -13.18 62.08 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 114.755 1.391 . . . . 0.0 114.755 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -99.69 -28.5 13.15 Favored 'General case' 0 N--CA 1.479 0.998 0 N-CA-C 113.723 1.009 . . . . 0.0 113.723 172.24 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 19.1 pt -94.37 -21.43 5.84 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 N-CA-C 114.423 1.268 . . . . 0.0 114.423 177.755 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 66.6 m . . . . . 0 C--O 1.254 1.326 0 C-N-CA 125.074 1.35 . . . . 0.0 111.886 -174.085 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.8 ttt . . . . . 0 N--CA 1.503 2.196 0 N-CA-C 111.787 0.291 . . . . 0.0 111.787 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.67 161.3 30.92 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 126.336 1.855 . . . . 0.0 112.358 177.819 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 32.6 ttmt -114.5 116.49 28.91 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 107.136 -1.431 . . . . 0.0 107.136 167.73 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 16.0 t -106.17 134.6 47.27 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 C-N-CA 124.604 1.162 . . . . 0.0 114.085 -178.251 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 40.6 tpp -103.1 128.1 50.12 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 168.355 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 70.3 m-85 -108.97 131.8 54.71 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.984 0.914 . . . . 0.0 109.381 170.007 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.509 HG11 HD12 ' A' ' 65' ' ' ILE . 2.6 m -148.11 158.8 7.8 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.239 0 C-N-CA 124.179 0.992 . . . . 0.0 113.616 -171.666 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 35.1 t -152.31 156.48 39.72 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 126.941 2.096 . . . . 0.0 110.657 179.315 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 61.3 mtpt -72.62 138.83 47.0 Favored 'General case' 0 N--CA 1.484 1.275 0 C-N-CA 123.911 0.884 . . . . 0.0 110.42 169.848 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 69.9 mtp180 52.73 49.62 19.9 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 125.427 1.491 . . . . 0.0 113.571 -170.812 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -57.61 -26.51 61.64 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 115.134 1.531 . . . . 0.0 115.134 -176.812 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 77.1 p -80.2 -31.11 38.73 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 124.169 0.988 . . . . 0.0 112.857 176.725 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 16.4 m -77.79 -9.04 58.82 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.681 1.192 . . . . 0.0 112.79 173.743 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 74.6 mtt180 -131.5 157.96 42.16 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 125.491 1.516 . . . . 0.0 113.381 -169.999 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 71.0 m -105.22 129.74 53.53 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.979 0.912 . . . . 0.0 109.701 169.76 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 4.1 mp0 -98.67 -29.7 12.88 Favored 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 113.436 0.902 . . . . 0.0 113.436 -169.653 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' MET . . . . . 0.467 ' HG2' ' SD ' ' A' ' 50' ' ' MET . 0.0 OUTLIER 67.1 -43.63 0.44 Allowed 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 127.104 2.162 . . . . 0.0 115.35 172.904 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -66.16 -32.64 74.2 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 114.073 1.138 . . . . 0.0 114.073 -169.968 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.2 pm0 -62.76 -37.14 85.45 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 119.032 0.833 . . . . 0.0 111.565 172.266 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -62.77 -61.82 6.11 Favored Glycine 0 C--N 1.336 0.548 0 N-CA-C 110.688 -0.965 . . . . 0.0 110.688 177.877 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -59.55 -33.09 70.97 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 117.584 0.692 . . . . 0.0 112.768 -179.449 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -67.56 -25.87 66.02 Favored 'General case' 0 CA--C 1.539 0.554 0 O-C-N 121.289 -0.882 . . . . 0.0 112.612 177.812 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 23.4 mtpp -77.57 -44.09 29.62 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.719 0.808 . . . . 0.0 110.665 169.464 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -67.31 -38.58 85.19 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 123.424 0.69 . . . . 0.0 112.738 -175.875 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 55.6 mt -93.21 -27.65 16.74 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 125.388 1.475 . . . . 0.0 112.774 -178.975 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -111.72 -4.93 26.16 Favored Glycine 0 N--CA 1.471 1.006 0 N-CA-C 117.556 1.782 . . . . 0.0 117.556 -169.058 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -62.84 139.54 58.72 Favored 'General case' 0 CA--C 1.545 0.78 0 CA-C-N 121.42 2.61 . . . . 0.0 112.327 178.992 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 86.41 -22.1 14.59 Favored Glycine 0 CA--C 1.541 1.671 0 C-N-CA 125.114 1.34 . . . . 0.0 113.437 -169.327 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 63.5 mttp -96.67 -44.28 7.18 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 125.981 1.712 . . . . 0.0 111.686 169.813 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 46.0 pt -141.18 157.01 22.17 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 C-N-CA 125.182 1.393 . . . . 0.0 113.009 -174.354 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -101.25 144.91 29.53 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 127.12 2.168 . . . . 0.0 108.796 169.405 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 73.7 t -140.3 137.6 37.11 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 C-N-CA 123.675 0.79 . . . . 0.0 111.578 -171.578 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 54.1 m -145.28 150.68 37.09 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 124.11 0.964 . . . . 0.0 110.852 177.738 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 93.5 p -133.21 137.98 46.35 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 124.52 1.128 . . . . 0.0 109.012 166.684 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 88.2 p -119.35 -70.05 0.81 Allowed 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 114.259 1.207 . . . . 0.0 114.259 -168.337 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 130.07 154.49 8.08 Favored Glycine 0 N--CA 1.465 0.597 0 C-N-CA 125.716 1.626 . . . . 0.0 113.346 173.823 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 10.3 mp -89.36 -13.21 38.35 Favored 'General case' 0 N--CA 1.474 0.754 0 O-C-N 121.797 -0.825 . . . . 0.0 113.173 -178.118 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -140.96 -57.06 0.5 Allowed 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 124.282 1.033 . . . . 0.0 112.444 179.322 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 39.7 m -108.44 155.91 20.05 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 124.714 1.206 . . . . 0.0 111.405 178.094 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 95.9 p -90.86 14.58 13.29 Favored 'General case' 0 N--CA 1.478 0.957 0 N-CA-C 116.694 2.109 . . . . 0.0 116.694 -170.042 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 64.3 ttt180 -130.87 157.12 43.77 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 125.541 1.536 . . . . 0.0 111.871 -177.075 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 24.1 m -111.77 165.27 6.95 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 C-N-CA 126.6 1.96 . . . . 0.0 109.55 170.765 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 5.1 t-80 -50.98 131.65 30.06 Favored Pre-proline 0 CA--C 1.532 0.275 0 CA-C-O 118.19 -0.91 . . . . 0.0 113.231 -170.698 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_exo -57.57 -27.94 78.99 Favored 'Trans proline' 0 CA--C 1.548 1.218 0 CA-C-N 120.612 1.254 . . . . 0.0 112.361 173.878 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 46.1 m -63.93 -32.5 74.05 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 126.08 1.752 . . . . 0.0 112.986 172.192 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -55.12 -45.23 75.55 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 123.977 0.911 . . . . 0.0 110.97 178.753 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.4 mp -53.95 -51.7 43.15 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 C-N-CA 124.09 0.956 . . . . 0.0 109.483 -176.854 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.4 -32.3 73.7 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 113.147 0.795 . . . . 0.0 113.147 -179.587 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -80.1 -30.15 39.11 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 113.452 0.908 . . . . 0.0 113.452 178.545 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' MET . . . . . 0.467 ' SD ' ' HG2' ' A' ' 17' ' ' MET . 3.2 mmt -76.91 -30.77 56.29 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.42 0.688 . . . . 0.0 110.851 170.712 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -68.58 -13.25 62.21 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 124.41 1.084 . . . . 0.0 113.323 172.508 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -63.94 -29.71 70.85 Favored 'General case' 0 N--CA 1.481 1.124 0 CA-C-N 120.706 1.594 . . . . 0.0 110.695 168.705 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 61.5 t -91.62 -7.68 10.56 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.903 0 C-N-CA 126.896 2.078 . . . . 0.0 111.058 173.882 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 83.54 21.75 57.58 Favored Glycine 0 CA--C 1.539 1.56 0 C-N-CA 125.434 1.492 . . . . 0.0 114.447 -177.71 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 31.9 mt -88.82 135.73 25.08 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 C-N-CA 124.595 1.158 . . . . 0.0 111.505 -172.188 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 18.6 t0 -94.39 120.19 34.26 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 123.582 0.753 . . . . 0.0 112.332 171.492 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 9.2 pt -134.67 -1.94 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.358 0 N-CA-C 116.094 1.887 . . . . 0.0 116.094 179.257 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 83.5 p -73.28 -21.9 60.49 Favored 'General case' 0 N--CA 1.481 1.092 0 N-CA-C 115.175 1.546 . . . . 0.0 115.175 -169.638 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -78.44 0.86 73.87 Favored Glycine 0 CA--C 1.54 1.604 0 N-CA-C 116.39 1.316 . . . . 0.0 116.39 -173.81 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 33.4 mt-30 -78.65 -11.98 60.0 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 115.304 1.594 . . . . 0.0 115.304 -171.345 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 42.8 p -63.94 115.42 4.86 Favored 'General case' 0 N--CA 1.477 0.883 0 CA-C-N 119.537 1.062 . . . . 0.0 113.56 -169.933 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 89.2 p -152.35 -77.86 0.12 Allowed 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.765 1.226 . . . . 0.0 112.708 177.762 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -146.43 159.26 45.43 Favored Pre-proline 0 CA--C 1.554 1.112 0 C-N-CA 124.41 1.084 . . . . 0.0 113.522 -171.837 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_endo -61.71 161.04 26.24 Favored 'Trans proline' 0 C--N 1.352 0.742 0 C-N-CA 124.174 3.249 . . . . 0.0 114.133 169.745 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.509 HD12 HG11 ' A' ' 7' ' ' VAL . 11.6 tt -51.32 -35.68 16.28 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.128 0 C-N-CA 125.824 1.65 . . . . 0.0 112.444 172.484 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 17.5 mt-10 -64.42 -17.77 64.1 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 123.779 0.832 . . . . 0.0 112.961 -177.718 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -84.69 -10.67 57.07 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 124.792 1.237 . . . . 0.0 113.604 -175.898 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 76.6 m-85 -111.5 -168.32 1.29 Allowed 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 125.979 1.711 . . . . 0.0 112.348 -173.97 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 6.4 t30 -124.39 123.47 40.25 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 126.064 1.745 . . . . 0.0 109.864 178.673 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.81 -33.61 75.98 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 114.187 1.18 . . . . 0.0 114.187 -170.601 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . 0.269 0.0 OUTLIER -71.41 -4.62 27.4 Favored 'General case' 0 CA--C 1.544 0.721 0 N-CA-C 114.212 1.19 . . . . 0.0 114.212 -178.11 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -73.94 -12.33 60.62 Favored 'General case' 0 CA--C 1.549 0.904 0 C-N-CA 123.965 0.906 . . . . 0.0 111.348 168.752 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 58.3 m-85 -117.22 138.88 51.42 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 127.001 2.12 . . . . 0.0 111.268 179.128 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -90.5 -23.23 21.0 Favored 'General case' 0 N--CA 1.478 0.956 0 CA-C-O 122.207 1.003 . . . . 0.0 112.926 178.349 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.629 HG22 ' HB ' ' A' ' 95' ' ' ILE . 96.5 t -132.28 136.11 56.93 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 C-N-CA 126.988 2.115 . . . . 0.0 108.249 -174.12 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 91.0 t -131.8 125.76 56.04 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 170.104 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 45.1 mm -112.39 105.15 18.23 Favored 'Isoleucine or valine' 0 C--O 1.233 0.237 0 C-N-CA 124.257 1.023 . . . . 0.0 109.354 -176.239 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 24.4 m -86.66 98.79 11.31 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 123.667 0.787 . . . . 0.0 109.117 171.807 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 52.7 mt -69.69 178.62 2.49 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 125.499 1.52 . . . . 0.0 110.966 170.474 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 16.2 m 63.1 19.7 11.82 Favored 'General case' 0 CA--C 1.547 0.841 0 N-CA-C 114.784 1.401 . . . . 0.0 114.784 169.78 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 131.79 -120.43 2.81 Favored Glycine 0 CA--C 1.531 1.048 0 C-N-CA 124.512 1.053 . . . . 0.0 111.971 -172.152 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 9.2 t -135.96 157.99 45.48 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 124.908 1.283 . . . . 0.0 112.82 178.848 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -74.66 113.93 4.22 Favored Glycine 0 CA--C 1.531 1.087 0 C-N-CA 124.414 1.006 . . . . 0.0 112.261 -179.326 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 11.3 p -139.53 -39.06 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.26 0 N-CA-C 114.594 1.331 . . . . 0.0 114.594 -178.147 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 65.0 t30 -92.43 -15.63 26.92 Favored 'General case' 0 CA--C 1.549 0.911 0 N-CA-C 114.12 1.155 . . . . 0.0 114.12 -177.228 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -71.44 157.13 90.58 Favored Pre-proline 0 CA--C 1.552 1.024 0 O-C-N 121.309 -0.869 . . . . 0.0 111.843 169.856 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.41 ' HA ' ' HD3' ' A' ' 88' ' ' PRO . 43.3 Cg_exo -62.2 149.03 92.1 Favored 'Trans proline' 0 CA--C 1.545 1.047 0 C-N-CA 122.215 1.944 . . . . 0.0 113.352 -177.52 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 87' ' ' PRO . 88.8 Cg_exo -57.33 -33.63 96.5 Favored 'Trans proline' 0 C--N 1.351 0.707 0 C-N-CA 122.935 2.423 . . . . 0.0 115.144 -169.875 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -60.98 -21.4 63.5 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 114.284 1.216 . . . . 0.0 114.284 179.763 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 87.5 m95 -81.51 -22.2 38.1 Favored 'General case' 0 CA--C 1.535 0.388 0 O-C-N 120.637 -1.289 . . . . 0.0 112.663 176.302 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 10.6 m -89.77 -3.16 10.06 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 N-CA-C 113.463 0.912 . . . . 0.0 113.463 172.568 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 59.3 p -103.24 3.8 35.96 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 125.373 1.469 . . . . 0.0 114.888 176.251 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 80.6 mm-40 -66.86 156.66 35.07 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 119.351 0.978 . . . . 0.0 111.973 171.668 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -58.19 -42.01 85.2 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 114.278 1.214 . . . . 0.0 114.278 -167.973 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.629 ' HB ' HG22 ' A' ' 75' ' ' VAL . 20.1 mm -115.0 59.52 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 C-N-CA 124.822 1.249 . . . . 0.0 108.708 175.866 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 21.7 t80 -75.6 109.7 9.39 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 169.069 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 13.1 mt-10 -109.18 140.61 42.56 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 114.665 1.357 . . . . 0.0 114.665 174.252 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -98.23 121.05 39.67 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.985 1.314 . . . . 0.0 109.706 169.249 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 24.4 m0 -112.79 105.59 13.75 Favored 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 124.917 1.287 . . . . 0.0 109.063 -177.349 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -85.11 37.21 0.66 Allowed 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 124.933 1.293 . . . . 0.0 112.02 -171.882 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 73.9 mt -76.17 158.68 31.44 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 126.114 1.766 . . . . 0.0 111.934 178.561 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -81.41 152.08 27.6 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-O 121.559 0.695 . . . . 0.0 112.564 170.639 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 12.5 p-10 -88.02 136.87 31.73 Favored Pre-proline 0 CA--C 1.546 0.808 0 C-N-CA 125.0 1.32 . . . . 0.0 110.987 170.853 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -82.42 -9.22 11.43 Favored 'Trans proline' 0 CA--C 1.55 1.301 0 C-N-CA 121.57 1.513 . . . . 0.0 114.461 -174.785 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -65.29 146.14 55.32 Favored 'General case' 0 CA--C 1.547 0.837 0 CA-C-N 119.438 1.017 . . . . 0.0 112.47 175.675 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 77.78 5.58 86.54 Favored Glycine 0 CA--C 1.538 1.501 0 C-N-CA 123.829 0.728 . . . . 0.0 114.751 179.449 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -141.9 173.62 11.34 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 126.208 1.803 . . . . 0.0 112.015 178.808 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 24.4 p -65.78 164.97 13.62 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 116.161 1.911 . . . . 0.0 116.161 -169.274 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 43.7 tp -60.91 -27.91 68.53 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.171 0.988 . . . . 0.0 112.25 171.533 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -66.62 -32.14 73.28 Favored 'General case' 0 CA--C 1.54 0.575 0 O-C-N 120.681 -1.262 . . . . 0.0 111.508 172.597 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 4.4 t -72.49 -36.92 55.72 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 O-C-N 121.108 -0.995 . . . . 0.0 111.841 170.656 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -55.1 -47.57 74.79 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 119.724 1.147 . . . . 0.0 111.471 169.501 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -69.66 -32.59 71.32 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.658 0.783 . . . . 0.0 112.498 178.573 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 42.9 m -62.94 -43.89 97.55 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 123.883 0.873 . . . . 0.0 110.627 169.808 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 68.8 t -65.7 -41.01 89.53 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 CA-C-O 117.576 -1.202 . . . . 0.0 110.576 175.727 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 24.9 mtm105 -53.98 -49.48 68.71 Favored 'General case' 0 N--CA 1.484 1.24 0 CA-C-N 120.607 1.548 . . . . 0.0 111.592 169.989 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -59.22 -49.65 76.19 Favored Glycine 0 CA--C 1.538 1.505 0 CA-C-N 119.438 1.017 . . . . 0.0 113.641 179.326 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 56.7 mm-40 -63.58 -44.08 95.12 Favored 'General case' 0 N--CA 1.473 0.708 0 O-C-N 121.996 -0.708 . . . . 0.0 111.988 178.178 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 53.4 t -64.81 -39.71 86.58 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 C-N-CA 124.048 0.939 . . . . 0.0 111.186 176.791 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 12.3 tmtt? -56.07 -48.83 75.33 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 119.654 1.115 . . . . 0.0 110.312 179.041 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -65.15 -42.62 93.6 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 112.929 0.714 . . . . 0.0 112.929 176.792 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 15.5 mmm180 -62.03 -43.87 97.91 Favored 'General case' 0 N--CA 1.48 1.055 0 O-C-N 121.467 -0.771 . . . . 0.0 112.737 176.536 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 85.6 t -70.38 -37.75 71.75 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 123.776 0.83 . . . . 0.0 111.273 179.082 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 70.6 mt-10 -60.23 -41.91 94.12 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 119.537 1.062 . . . . 0.0 111.6 170.93 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 15.2 m-80 -63.33 -45.36 91.62 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 118.347 0.521 . . . . 0.0 112.151 175.432 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 8.6 tt -53.19 -55.9 20.63 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 124.604 1.162 . . . . 0.0 110.892 173.642 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 84.2 mt -63.27 -43.0 98.47 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 O-C-N 121.593 -0.692 . . . . 0.0 110.376 -177.882 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -68.07 -14.02 62.65 Favored 'General case' 0 CA--C 1.546 0.789 0 N-CA-C 114.822 1.415 . . . . 0.0 114.822 178.807 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 20.0 ptmt -102.04 -32.76 10.0 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 113.573 0.953 . . . . 0.0 113.573 174.928 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 13.5 pt -89.54 -17.3 8.18 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 N-CA-C 114.185 1.18 . . . . 0.0 114.185 -179.529 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 68.8 m . . . . . 0 C--O 1.255 1.365 0 N-CA-C 112.888 0.699 . . . . 0.0 112.888 -179.92 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.8 ttt . . . . . 0 N--CA 1.504 2.259 0 N-CA-C 111.493 0.183 . . . . 0.0 111.493 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 3.0 mptp? -121.91 160.31 25.05 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 125.683 1.593 . . . . 0.0 112.3 175.139 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 33.9 ttmt -111.03 116.92 32.0 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 106.647 -1.612 . . . . 0.0 106.647 167.146 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 16.8 t -104.41 132.05 51.91 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 C-N-CA 124.752 1.221 . . . . 0.0 113.831 -177.719 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' MET . . . . . 0.406 ' HG3' HG13 ' A' ' 7' ' ' VAL . 48.5 tpp -100.43 123.4 44.6 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 123.882 0.873 . . . . 0.0 109.137 169.177 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 48.6 m-85 -108.18 121.07 44.09 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 124.574 1.15 . . . . 0.0 109.241 172.178 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.406 HG13 ' HG3' ' A' ' 5' ' ' MET . 5.1 m -144.14 165.64 13.51 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 C-N-CA 125.009 1.323 . . . . 0.0 112.369 -169.308 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -154.39 148.7 26.04 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 125.999 1.72 . . . . 0.0 110.301 175.165 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 39.5 ttpt -46.3 122.31 3.93 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 125.272 1.429 . . . . 0.0 111.968 175.866 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . 0.261 91.6 mtt180 52.67 -30.86 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 129.034 2.934 . . . . 0.0 118.896 -174.444 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 5.1 t30 61.81 -19.65 0.04 OUTLIER 'General case' 0 CA--C 1.558 1.261 0 N-CA-C 117.813 2.523 . . . . 0.0 117.813 169.789 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 75.7 m -50.41 121.27 5.44 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 126.525 1.93 . . . . 0.0 113.157 -177.3 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 66.5 m 51.41 41.07 27.95 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 125.006 1.323 . . . . 0.0 113.096 174.619 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 14.9 ttt180 -126.83 153.18 45.98 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 125.911 1.684 . . . . 0.0 110.023 177.171 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 33.1 m -102.94 126.87 50.28 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 124.062 0.945 . . . . 0.0 110.836 -179.455 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 3.9 mp0 -106.09 -36.16 7.01 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.793 0.837 . . . . 0.0 112.606 -172.523 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 68.78 -48.59 0.57 Allowed 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 126.823 2.049 . . . . 0.0 115.867 169.348 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -59.01 -36.23 74.58 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.59 1.156 . . . . 0.0 113.58 -171.13 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 6.3 pm0 -61.97 -41.63 98.23 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 124.739 1.216 . . . . 0.0 112.499 175.593 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -69.03 -40.23 83.94 Favored Glycine 0 C--N 1.335 0.483 0 N-CA-C 111.54 -0.624 . . . . 0.0 111.54 178.331 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -70.01 -40.41 75.27 Favored 'General case' 0 N--CA 1.468 0.434 0 O-C-N 121.947 -0.737 . . . . 0.0 111.493 177.489 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -60.19 -43.7 95.69 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 119.255 0.934 . . . . 0.0 112.941 -174.931 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 8.0 pttp -77.19 -26.61 53.05 Favored 'General case' 0 N--CA 1.481 1.115 0 N-CA-C 113.586 0.958 . . . . 0.0 113.586 174.253 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 94.2 m -72.47 -32.85 66.58 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.06 0.544 . . . . 0.0 111.754 174.877 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 72.3 mt -91.33 -34.36 14.94 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 125.847 1.659 . . . . 0.0 114.598 -179.221 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -135.41 28.04 3.05 Favored Glycine 0 N--CA 1.474 1.175 0 N-CA-C 118.789 2.275 . . . . 0.0 118.789 -168.711 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -65.05 -22.73 67.02 Favored 'General case' 0 CA--C 1.546 0.8 0 CA-C-N 122.108 2.954 . . . . 0.0 115.701 -176.315 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -72.62 -10.92 76.81 Favored Glycine 0 CA--C 1.542 1.77 0 O-C-N 121.209 -0.932 . . . . 0.0 113.868 169.639 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 54.8 mttm -109.56 -39.54 5.13 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 127.251 2.22 . . . . 0.0 112.98 -179.472 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 41.2 pt -145.49 155.43 13.32 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 C-N-CA 124.555 1.142 . . . . 0.0 113.942 -171.174 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -99.43 142.49 30.85 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 126.065 1.746 . . . . 0.0 108.916 169.295 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 97.6 t -130.4 140.11 49.66 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 O-C-N 121.439 -0.788 . . . . 0.0 111.704 -176.859 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 13.9 m -139.38 153.72 47.71 Favored 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 124.981 1.312 . . . . 0.0 109.698 175.931 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 91.4 p -128.59 155.58 44.71 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 123.803 0.841 . . . . 0.0 109.742 167.751 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 60.5 p -140.33 161.68 37.11 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 114.824 -1.08 . . . . 0.0 112.149 173.702 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -119.79 101.78 0.86 Allowed Glycine 0 C--N 1.339 0.696 0 N-CA-C 110.343 -1.103 . . . . 0.0 110.343 -169.731 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 10.6 mp -59.63 125.58 24.2 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.734 0.814 . . . . 0.0 109.512 -169.89 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 68.15 42.05 1.84 Allowed 'General case' 0 CA--C 1.553 1.074 0 C-N-CA 124.716 1.206 . . . . 0.0 113.02 -173.251 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 69.6 m 61.85 54.63 2.82 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 127.724 2.409 . . . . 0.0 113.776 169.95 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 79.2 p -114.39 164.77 13.5 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 115.587 1.699 . . . . 0.0 115.587 -171.967 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 22.2 tpt180 -113.38 144.85 42.08 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 126.363 1.865 . . . . 0.0 110.453 177.014 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 16.7 m -68.51 171.56 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.206 0 CA-C-O 122.002 0.906 . . . . 0.0 110.282 169.089 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 1.7 t-80 -59.37 131.02 87.73 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-O 118.431 -0.795 . . . . 0.0 112.659 179.617 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo -60.43 -27.69 85.33 Favored 'Trans proline' 0 CA--C 1.547 1.171 0 C-N-CA 121.35 1.367 . . . . 0.0 111.569 169.607 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 90.0 m -65.83 -30.83 71.51 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 125.278 1.431 . . . . 0.0 112.321 174.341 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -57.52 -39.42 76.5 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.365 1.066 . . . . 0.0 111.532 -175.163 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 2.3 mp -57.12 -60.38 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 C-N-CA 123.665 0.786 . . . . 0.0 109.311 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.19 -31.11 72.18 Favored 'General case' 0 CA--C 1.546 0.808 0 N-CA-C 113.616 0.969 . . . . 0.0 113.616 -177.04 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -81.55 -8.05 59.67 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 114.305 1.224 . . . . 0.0 114.305 177.373 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 41.3 mtt -109.88 -24.02 11.06 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 125.057 1.343 . . . . 0.0 110.211 173.606 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 24.3 mt-10 -64.98 -16.01 62.9 Favored 'General case' 0 CA--C 1.546 0.818 0 O-C-N 120.609 -1.307 . . . . 0.0 111.749 168.694 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 12.3 mt-10 -61.16 -29.33 69.73 Favored 'General case' 0 N--CA 1.482 1.173 0 CA-C-N 119.877 1.217 . . . . 0.0 110.92 169.108 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 48.1 t -92.27 -4.99 10.8 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.981 0 C-N-CA 127.437 2.295 . . . . 0.0 111.118 177.032 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 80.91 17.39 72.63 Favored Glycine 0 CA--C 1.538 1.494 0 C-N-CA 125.223 1.392 . . . . 0.0 114.566 -173.873 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 78.9 mt -77.64 139.92 17.87 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 C-N-CA 124.309 1.044 . . . . 0.0 111.893 -173.275 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -104.98 104.97 14.81 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.58 1.152 . . . . 0.0 111.761 175.598 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 3.5 pt -131.7 0.84 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 N-CA-C 115.696 1.739 . . . . 0.0 115.696 -178.283 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 93.6 p -70.74 -30.98 67.65 Favored 'General case' 0 N--CA 1.48 1.051 0 CA-C-N 120.012 1.278 . . . . 0.0 113.635 -177.541 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -79.74 13.16 25.26 Favored Glycine 0 CA--C 1.539 1.567 0 C-N-CA 125.743 1.64 . . . . 0.0 115.75 -179.201 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 32.0 mt-30 -80.9 167.98 19.26 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 118.886 1.343 . . . . 0.0 111.868 178.859 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 3.6 t -71.77 171.64 11.25 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 114.963 1.468 . . . . 0.0 114.963 -178.33 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 48.8 m -125.21 6.07 7.81 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 128.436 2.694 . . . . 0.0 111.66 169.475 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 23.7 m-20 -88.17 155.34 52.08 Favored Pre-proline 0 CA--C 1.546 0.818 0 C-N-CA 124.729 1.212 . . . . 0.0 113.746 179.22 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -78.43 158.78 29.23 Favored 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 123.49 2.793 . . . . 0.0 114.406 -177.685 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 8.5 tt -53.12 -38.98 31.62 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 C-N-CA 124.308 1.043 . . . . 0.0 112.486 174.781 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -70.16 -6.77 36.55 Favored 'General case' 0 CA--C 1.545 0.778 0 N-CA-C 114.116 1.154 . . . . 0.0 114.116 179.11 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -76.42 -15.13 60.0 Favored 'General case' 0 CA--C 1.547 0.83 0 O-C-N 121.429 -0.794 . . . . 0.0 112.569 170.691 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 61.5 m-85 -109.04 -171.61 1.88 Allowed 'General case' 0 CA--C 1.552 1.041 0 C-N-CA 126.921 2.088 . . . . 0.0 111.57 -179.175 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -125.79 126.57 44.76 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 125.337 1.455 . . . . 0.0 110.232 177.397 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.65 -35.88 82.06 Favored 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 113.641 0.978 . . . . 0.0 113.641 -170.1 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . 0.258 0.0 OUTLIER -72.67 -4.88 33.83 Favored 'General case' 0 CA--C 1.547 0.853 0 N-CA-C 113.718 1.007 . . . . 0.0 113.718 -177.559 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -74.47 -12.21 60.43 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 123.982 0.913 . . . . 0.0 111.142 168.588 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 65.7 m-85 -115.28 146.55 41.38 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 127.483 2.313 . . . . 0.0 110.989 178.345 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -105.25 -16.16 14.85 Favored 'General case' 0 N--CA 1.479 1.022 0 CA-C-O 121.97 0.891 . . . . 0.0 112.641 178.148 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.65 HG22 ' HB ' ' A' ' 95' ' ' ILE . 80.3 t -133.17 136.69 54.79 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 C-N-CA 127.306 2.242 . . . . 0.0 107.671 -179.881 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 60.0 t -132.35 126.9 56.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 N-CA-C 107.999 -1.111 . . . . 0.0 107.999 169.81 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 43.5 mm -114.31 118.37 58.3 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 C-N-CA 124.635 1.174 . . . . 0.0 108.815 -175.669 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 8.6 t -100.47 116.61 32.81 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 122.934 0.493 . . . . 0.0 111.462 173.672 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 49.9 mt -94.52 -13.38 26.13 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 125.724 1.61 . . . . 0.0 113.71 -172.291 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 1.5 p -156.63 147.45 21.82 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 124.075 0.95 . . . . 0.0 111.412 176.041 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 80.19 179.99 52.94 Favored Glycine 0 CA--C 1.539 1.567 0 C-N-CA 124.53 1.062 . . . . 0.0 114.528 -178.224 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 67.2 m -92.04 3.65 54.79 Favored 'General case' 0 N--CA 1.479 0.993 0 N-CA-C 114.719 1.377 . . . . 0.0 114.719 -170.01 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 79.67 23.59 62.02 Favored Glycine 0 CA--C 1.537 1.414 0 N-CA-C 115.164 0.826 . . . . 0.0 115.164 178.673 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 14.3 t -106.46 -12.0 10.09 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.374 0 C-N-CA 124.323 1.049 . . . . 0.0 112.855 -179.318 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 12.9 t-20 -81.35 6.62 13.79 Favored 'General case' 0 CA--C 1.552 1.023 0 C-N-CA 125.202 1.401 . . . . 0.0 113.397 -179.823 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -127.97 161.07 58.08 Favored Pre-proline 0 CA--C 1.552 1.032 0 C-N-CA 126.912 2.085 . . . . 0.0 112.058 178.165 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.404 ' HA ' ' HD3' ' A' ' 88' ' ' PRO . 38.4 Cg_exo -63.36 148.06 93.08 Favored 'Trans proline' 0 CA--C 1.546 1.11 0 C-N-CA 122.355 2.036 . . . . 0.0 112.773 177.344 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 87' ' ' PRO . 87.1 Cg_exo -56.83 -30.61 85.84 Favored 'Trans proline' 0 C--N 1.352 0.733 0 C-N-CA 123.051 2.5 . . . . 0.0 115.286 -174.99 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -59.77 -20.44 56.65 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 114.237 1.199 . . . . 0.0 114.237 178.458 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 89.1 m95 -81.88 -17.04 48.69 Favored 'General case' 0 CA--C 1.539 0.522 0 O-C-N 120.594 -1.316 . . . . 0.0 113.364 175.847 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 5.4 m -92.83 -8.38 10.16 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.105 0 CA-C-N 119.404 1.002 . . . . 0.0 113.398 170.863 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 72.5 p -98.24 -0.46 44.01 Favored 'General case' 0 N--CA 1.479 0.995 0 N-CA-C 114.873 1.434 . . . . 0.0 114.873 179.216 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 73.9 mm-40 -66.01 152.71 44.01 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 119.442 1.019 . . . . 0.0 111.202 169.917 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -55.38 -43.15 74.88 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 114.634 1.346 . . . . 0.0 114.634 -167.661 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.65 ' HB ' HG22 ' A' ' 75' ' ' VAL . 19.9 mm -114.49 61.15 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 C-N-CA 124.84 1.256 . . . . 0.0 109.003 176.832 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 41.7 t80 -77.23 108.16 10.14 Favored 'General case' 0 CA--C 1.535 0.393 0 O-C-N 120.639 -1.288 . . . . 0.0 108.22 169.119 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 9.4 mt-10 -108.23 136.86 47.18 Favored 'General case' 0 CA--C 1.545 0.758 0 N-CA-C 114.947 1.462 . . . . 0.0 114.947 177.071 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -91.54 114.1 26.54 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.916 1.287 . . . . 0.0 110.202 169.786 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 23.1 m0 -111.88 81.97 1.55 Allowed 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 125.047 1.339 . . . . 0.0 109.538 179.579 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 7.5 pt20 -75.88 55.77 0.91 Allowed 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 125.576 1.55 . . . . 0.0 112.279 176.709 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 73.4 mt -86.99 167.19 14.47 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 127.493 2.317 . . . . 0.0 112.481 -178.953 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -68.68 149.65 48.84 Favored 'General case' 0 CA--C 1.546 0.812 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.99 169.255 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' ASP . . . . . 0.454 ' HA ' ' HD3' ' A' ' 104' ' ' PRO . 0.8 OUTLIER -117.75 142.76 31.2 Favored Pre-proline 0 CA--C 1.553 1.085 0 C-N-CA 125.073 1.349 . . . . 0.0 112.148 175.544 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 104' ' ' PRO . . . . . 0.454 ' HD3' ' HA ' ' A' ' 103' ' ' ASP . 34.8 Cg_exo -75.26 -15.96 19.9 Favored 'Trans proline' 0 CA--C 1.547 1.126 0 N-CA-C 116.929 1.857 . . . . 0.0 116.929 -172.104 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -67.2 141.79 57.2 Favored 'General case' 0 N--CA 1.476 0.837 0 CA-C-N 120.313 1.415 . . . . 0.0 113.334 -170.296 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 77.33 8.59 87.04 Favored Glycine 0 CA--C 1.538 1.527 0 C-N-CA 124.635 1.112 . . . . 0.0 114.901 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 -141.58 164.64 29.68 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 125.033 1.333 . . . . 0.0 113.553 -178.127 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 66.4 m -63.49 164.07 9.96 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 116.161 1.911 . . . . 0.0 116.161 -169.129 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 25.8 tp -57.12 -31.38 65.26 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 125.686 1.594 . . . . 0.0 113.274 176.202 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -62.04 -30.52 71.03 Favored 'General case' 0 CA--C 1.541 0.628 0 O-C-N 121.002 -1.061 . . . . 0.0 111.988 172.662 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 4.2 t -75.89 -38.86 37.08 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 O-C-N 121.122 -0.986 . . . . 0.0 111.388 173.159 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 20.0 m-85 -56.85 -45.31 82.51 Favored 'General case' 0 N--CA 1.481 1.082 0 CA-C-N 120.169 1.349 . . . . 0.0 111.609 169.521 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -67.79 -37.29 81.82 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 124.179 0.991 . . . . 0.0 112.135 178.566 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 70.6 m -67.91 -42.62 80.83 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 123.793 0.837 . . . . 0.0 111.567 174.042 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 53.3 t -66.19 -41.41 89.23 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 CA-C-O 118.387 -0.816 . . . . 0.0 110.142 177.252 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 15.7 mtp180 -52.78 -46.89 67.78 Favored 'General case' 0 N--CA 1.479 1.022 0 CA-C-N 119.755 1.161 . . . . 0.0 112.507 170.95 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -59.69 -50.56 66.39 Favored Glycine 0 CA--C 1.54 1.6 0 CA-C-N 119.375 0.988 . . . . 0.0 113.427 176.352 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 60.3 mm-40 -65.89 -44.39 85.43 Favored 'General case' 0 N--CA 1.472 0.672 0 O-C-N 121.775 -0.838 . . . . 0.0 112.304 -179.682 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 65.6 t -64.25 -41.43 92.36 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 C-N-CA 124.782 1.233 . . . . 0.0 110.685 176.21 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 80.0 tttt -54.98 -50.06 69.89 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 120.18 1.355 . . . . 0.0 111.068 178.133 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -61.72 -40.67 95.87 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 112.205 0.446 . . . . 0.0 112.205 176.902 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.89 -35.91 81.96 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 124.354 1.062 . . . . 0.0 113.722 177.133 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 95.2 t -76.24 -40.92 36.64 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 C-N-CA 125.421 1.489 . . . . 0.0 111.284 176.228 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -61.47 -39.6 91.46 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 119.039 0.836 . . . . 0.0 111.39 172.373 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 13.6 m-80 -64.42 -43.57 93.95 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 118.69 0.677 . . . . 0.0 112.611 174.3 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -54.52 -56.58 17.39 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 124.256 1.023 . . . . 0.0 110.442 173.132 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 85.0 mt -61.04 -42.45 93.14 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 CA-C-O 119.166 -0.445 . . . . 0.0 110.532 -178.576 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -73.67 -10.77 60.04 Favored 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 115.073 1.508 . . . . 0.0 115.073 -179.449 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 20.7 ptmt -98.66 -27.16 14.11 Favored 'General case' 0 N--CA 1.479 0.997 0 CA-C-N 119.501 1.046 . . . . 0.0 113.388 169.97 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 14.3 pt -95.45 -7.6 9.75 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 N-CA-C 114.599 1.333 . . . . 0.0 114.599 176.915 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 27.3 p . . . . . 0 C--O 1.255 1.391 0 N-CA-C 114.774 1.398 . . . . 0.0 114.774 176.06 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.5 ttt . . . . . 0 N--CA 1.501 2.114 0 N-CA-C 111.725 0.269 . . . . 0.0 111.725 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.5 165.08 28.39 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 125.135 1.374 . . . . 0.0 112.684 175.573 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 67.9 mttt -95.75 145.02 25.64 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.996 0.918 . . . . 0.0 112.333 177.184 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 15.0 t -124.46 134.28 67.13 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 C-N-CA 125.301 1.44 . . . . 0.0 111.884 177.285 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 14.4 tpp -101.02 123.78 45.73 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.087 0.555 . . . . 0.0 109.894 169.894 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 48.4 m-85 -110.8 99.02 8.02 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 124.533 1.133 . . . . 0.0 110.509 175.934 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.603 HG11 HD12 ' A' ' 65' ' ' ILE . 1.4 m -111.7 165.21 6.94 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 C-N-CA 125.035 1.334 . . . . 0.0 112.042 -173.893 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 7.8 t -142.44 140.29 31.9 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 125.279 1.432 . . . . 0.0 111.041 179.444 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 37.5 ttmt -66.13 118.56 10.04 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.42 0.688 . . . . 0.0 110.499 175.231 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 28.6 mmt85 45.51 91.48 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 127.441 2.296 . . . . 0.0 113.14 -175.575 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 15.9 m120 -61.36 -17.46 54.04 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 115.839 1.792 . . . . 0.0 115.839 -171.692 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 70.8 m -50.48 138.65 17.04 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.489 1.116 . . . . 0.0 112.212 178.049 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 24.6 p 55.03 -10.62 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.246 0 N-CA-C 118.12 2.637 . . . . 0.0 118.12 -173.707 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 52.3 mtm-85 -93.6 157.22 16.29 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 125.985 1.714 . . . . 0.0 113.789 -174.678 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 5.5 m -113.94 -22.18 10.23 Favored 'General case' 0 N--CA 1.477 0.924 0 N-CA-C 116.457 2.021 . . . . 0.0 116.457 -169.463 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 26.0 mt-30 62.12 -64.0 0.09 Allowed 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 127.078 2.151 . . . . 0.0 116.674 -178.174 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' MET . . . . . 0.434 ' HG2' ' SD ' ' A' ' 50' ' ' MET . 0.0 OUTLIER 74.13 -49.24 0.67 Allowed 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 127.209 2.203 . . . . 0.0 114.344 177.026 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.68 -34.57 74.54 Favored 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 114.602 1.334 . . . . 0.0 114.602 -170.337 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 20.3 pm0 -63.47 -38.18 90.16 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 124.783 1.233 . . . . 0.0 112.138 178.9 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -72.22 -37.67 59.37 Favored Glycine 0 C--N 1.337 0.593 0 C-N-CA 123.681 0.657 . . . . 0.0 111.794 178.834 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -73.36 -37.98 65.87 Favored 'General case' 0 N--CA 1.469 0.49 0 O-C-N 121.685 -0.891 . . . . 0.0 111.772 176.819 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -62.74 -35.86 81.15 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 113.403 0.89 . . . . 0.0 113.403 -173.866 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 6.2 pttp -79.48 -36.36 38.82 Favored 'General case' 0 N--CA 1.479 1.023 0 N-CA-C 113.269 0.84 . . . . 0.0 113.269 170.135 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 39.0 m -69.46 -31.06 69.13 Favored 'General case' 0 N--CA 1.484 1.253 0 O-C-N 121.8 -0.563 . . . . 0.0 111.977 -178.57 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 83.8 mt -91.74 -36.35 13.62 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 125.868 1.667 . . . . 0.0 112.889 174.529 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -104.11 3.03 44.11 Favored Glycine 0 N--CA 1.473 1.13 0 N-CA-C 117.574 1.789 . . . . 0.0 117.574 -169.529 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.49 140.76 58.03 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 121.356 2.578 . . . . 0.0 112.413 178.917 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 81.31 -11.48 43.89 Favored Glycine 0 CA--C 1.541 1.671 0 C-N-CA 124.783 1.182 . . . . 0.0 114.081 -169.673 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 63.5 mttp -110.01 -44.61 3.75 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 126.089 1.756 . . . . 0.0 111.69 172.771 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 44.5 pt -138.99 159.95 29.67 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 125.903 1.681 . . . . 0.0 112.408 179.497 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -106.52 148.21 28.49 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.092 1.357 . . . . 0.0 110.378 169.911 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 57.2 t -133.44 139.54 48.81 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 CA-C-N 119.002 0.819 . . . . 0.0 112.483 -177.965 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 85.9 m -133.14 150.85 52.01 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 125.696 1.598 . . . . 0.0 108.168 169.592 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 10.1 p -90.49 -73.97 0.51 Allowed 'General case' 0 N--CA 1.47 0.534 0 O-C-N 121.589 -0.695 . . . . 0.0 112.759 174.694 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 9.6 p 66.06 156.57 0.1 Allowed 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 127.925 2.49 . . . . 0.0 113.602 -169.645 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -106.61 156.33 16.2 Favored Glycine 0 N--CA 1.465 0.586 0 O-C-N 121.432 -0.793 . . . . 0.0 112.18 -175.052 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 9.7 mp -99.52 108.97 21.54 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 169.234 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 69.14 64.71 0.28 Allowed 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 126.44 1.896 . . . . 0.0 113.173 -176.661 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 67.5 m 48.51 48.39 19.47 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 126.968 2.107 . . . . 0.0 115.058 169.575 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 58.1 m -129.59 156.63 43.89 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 124.455 1.102 . . . . 0.0 113.172 -172.584 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 59.5 ttt-85 -115.78 153.55 31.23 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 128.232 2.613 . . . . 0.0 109.139 178.619 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 16.2 m -62.98 157.99 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.132 0 O-C-N 122.04 -0.412 . . . . 0.0 111.318 171.33 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' HIS . . . . . 0.477 ' CE1' ' HB ' ' A' ' 45' ' ' THR . 0.1 OUTLIER -63.74 142.91 98.08 Favored Pre-proline 0 CA--C 1.544 0.712 0 C-N-CA 119.755 -0.778 . . . . 0.0 110.318 174.871 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -60.97 -29.49 88.08 Favored 'Trans proline' 0 CA--C 1.539 0.768 0 C-N-CA 123.266 2.644 . . . . 0.0 114.758 -168.443 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.477 ' HB ' ' CE1' ' A' ' 43' ' ' HIS . 88.7 m -66.17 -22.67 66.37 Favored 'General case' 0 N--CA 1.475 0.813 0 O-C-N 121.273 -0.892 . . . . 0.0 111.924 -178.675 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -52.48 -50.28 63.02 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 118.948 0.795 . . . . 0.0 110.405 169.766 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.414 ' H ' HD12 ' A' ' 47' ' ' ILE . 4.5 mp -57.56 -48.64 82.65 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 C-N-CA 123.377 0.671 . . . . 0.0 110.728 -179.842 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -60.17 -32.42 71.04 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 113.102 0.779 . . . . 0.0 113.102 178.822 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -80.63 -30.43 36.69 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 113.87 1.063 . . . . 0.0 113.87 177.087 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' MET . . . . . 0.434 ' SD ' ' HG2' ' A' ' 17' ' ' MET . 3.6 mmt -73.41 -32.63 64.54 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 118.789 0.722 . . . . 0.0 110.352 170.251 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -67.01 -13.25 61.73 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 124.806 1.242 . . . . 0.0 113.548 174.267 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 58.4 mt-10 -63.11 -27.57 69.47 Favored 'General case' 0 N--CA 1.48 1.073 0 CA-C-N 120.355 1.434 . . . . 0.0 110.666 168.517 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 60.8 t -95.02 -4.51 10.45 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.91 0 C-N-CA 127.041 2.136 . . . . 0.0 111.15 175.465 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 80.29 18.9 70.46 Favored Glycine 0 CA--C 1.539 1.547 0 C-N-CA 125.005 1.288 . . . . 0.0 114.272 -175.649 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 93.2 mt -77.31 132.86 31.92 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 C-N-CA 124.731 1.212 . . . . 0.0 111.28 -174.577 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 19.0 t0 -96.19 104.8 16.78 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.502 0.721 . . . . 0.0 112.627 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 14.1 pt -138.22 17.25 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.365 0 N-CA-C 114.727 1.38 . . . . 0.0 114.727 176.046 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 94.1 p -49.35 -41.73 39.81 Favored 'General case' 0 N--CA 1.484 1.259 0 N-CA-C 116.151 1.908 . . . . 0.0 116.151 -169.798 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -126.98 35.68 2.8 Favored Glycine 0 CA--C 1.534 1.248 0 C-N-CA 125.59 1.567 . . . . 0.0 113.179 -179.293 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 24.0 pt20 -64.88 -33.91 77.13 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 115.56 1.689 . . . . 0.0 115.56 -169.738 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 28.2 p -92.83 106.23 18.23 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 121.559 0.695 . . . . 0.0 111.68 179.633 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 67.4 m -104.57 -28.93 10.98 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 124.521 1.128 . . . . 0.0 113.311 176.469 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -147.75 158.2 43.06 Favored Pre-proline 0 CA--C 1.544 0.737 0 C-N-CA 124.514 1.125 . . . . 0.0 111.997 -176.978 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -64.49 156.41 60.75 Favored 'Trans proline' 0 CA--C 1.537 0.671 0 C-N-CA 122.42 2.08 . . . . 0.0 112.414 169.935 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.603 HD12 HG11 ' A' ' 7' ' ' VAL . 12.2 tt -50.12 -36.03 12.11 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.181 0 C-N-CA 124.016 0.926 . . . . 0.0 112.098 171.54 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 19.3 mt-10 -63.91 -18.08 63.86 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.153 0.981 . . . . 0.0 113.225 -176.931 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -85.1 -14.92 45.63 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 124.553 1.141 . . . . 0.0 113.785 -177.059 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -97.06 176.03 6.1 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 126.016 1.727 . . . . 0.0 112.304 -177.081 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 23.6 t30 -99.81 126.95 45.99 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 169.77 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.84 -46.52 74.82 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 112.433 0.531 . . . . 0.0 112.433 -175.853 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -72.57 -1.0 14.38 Favored 'General case' 0 CA--C 1.546 0.823 0 N-CA-C 114.796 1.406 . . . . 0.0 114.796 -173.169 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -70.24 -17.68 63.13 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 123.668 0.787 . . . . 0.0 110.245 168.255 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 58.6 m-85 -105.53 158.32 16.76 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 128.355 2.662 . . . . 0.0 111.14 174.97 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -116.94 -12.94 10.66 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 124.781 1.232 . . . . 0.0 112.874 179.465 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.631 HG22 ' HB ' ' A' ' 95' ' ' ILE . 87.3 t -142.54 136.49 27.82 Favored 'Isoleucine or valine' 0 C--O 1.236 0.384 0 C-N-CA 127.86 2.464 . . . . 0.0 107.699 -174.291 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 59.0 t -131.75 133.46 61.31 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 N-CA-C 108.431 -0.952 . . . . 0.0 108.431 169.799 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 43.6 mm -116.41 111.16 34.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 C-N-CA 124.832 1.253 . . . . 0.0 107.916 -177.069 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 4.3 m -95.61 101.36 13.06 Favored 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 123.521 0.728 . . . . 0.0 110.097 176.81 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 34.1 mt -79.15 176.73 9.4 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 126.495 1.918 . . . . 0.0 110.955 173.445 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 14.8 m 63.2 57.0 1.64 Allowed 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 124.408 1.083 . . . . 0.0 113.422 169.787 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 83.06 -137.14 16.07 Favored Glycine 0 CA--C 1.534 1.268 0 C-N-CA 123.863 0.744 . . . . 0.0 111.706 -171.437 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 98.9 p -83.82 163.29 20.22 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 113.26 0.837 . . . . 0.0 113.26 176.561 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -69.03 -88.85 0.08 OUTLIER Glycine 0 CA--C 1.528 0.892 0 N-CA-C 110.658 -0.977 . . . . 0.0 110.658 169.409 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 98.7 t 63.13 -48.17 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.239 0 C-N-CA 128.054 2.542 . . . . 0.0 116.571 170.139 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 29.3 t-20 -74.98 -30.84 61.3 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 124.883 1.273 . . . . 0.0 113.031 -179.545 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.4 ' HA ' ' HD3' ' A' ' 87' ' ' PRO . 2.5 pt? -68.25 146.77 98.15 Favored Pre-proline 0 CA--C 1.555 1.145 0 CA-C-O 118.709 -0.662 . . . . 0.0 112.373 174.412 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 86' ' ' LEU . 64.3 Cg_exo -62.05 156.87 47.16 Favored 'Trans proline' 0 CA--C 1.549 1.243 0 C-N-CA 122.775 2.317 . . . . 0.0 115.234 -176.773 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 80.6 Cg_exo -54.3 -36.44 86.7 Favored 'Trans proline' 0 C--N 1.355 0.869 0 C-N-CA 123.984 3.123 . . . . 0.0 115.119 -174.798 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -61.47 -15.86 41.66 Favored 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 115.052 1.501 . . . . 0.0 115.052 178.725 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 82.6 m95 -91.43 -34.51 14.81 Favored 'General case' 0 CA--C 1.539 0.552 0 O-C-N 121.029 -1.044 . . . . 0.0 112.314 172.702 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 6.7 m -84.73 -16.32 10.53 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.186 0 N-CA-C 113.588 0.958 . . . . 0.0 113.588 177.821 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 1.3 t -78.59 -5.8 53.81 Favored 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 114.627 1.343 . . . . 0.0 114.627 177.961 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 58.4 mt-30 -71.24 166.23 21.98 Favored 'General case' 0 N--CA 1.478 0.934 0 O-C-N 121.05 -1.031 . . . . 0.0 112.95 -172.903 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -60.0 -43.52 95.14 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 113.761 1.022 . . . . 0.0 113.761 -168.661 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.631 ' HB ' HG22 ' A' ' 75' ' ' VAL . 10.8 mm -121.23 62.0 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 C-N-CA 124.65 1.18 . . . . 0.0 109.186 176.052 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 17.2 t80 -75.02 113.16 12.02 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 107.394 -1.336 . . . . 0.0 107.394 168.727 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 14.0 mt-10 -108.19 126.72 53.12 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-O 122.26 1.029 . . . . 0.0 113.246 174.224 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -91.4 89.21 7.15 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 125.146 1.378 . . . . 0.0 109.197 176.831 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 20.4 m0 -81.8 90.97 6.43 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 124.621 1.168 . . . . 0.0 111.405 -173.021 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 70.2 mm-40 -71.55 41.64 0.07 Allowed 'General case' 0 CA--C 1.553 1.062 0 C-N-CA 127.212 2.205 . . . . 0.0 112.345 173.379 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 40.3 mt -84.06 161.94 20.52 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 125.917 1.687 . . . . 0.0 112.156 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -70.94 150.02 46.12 Favored 'General case' 0 CA--C 1.545 0.769 0 CA-C-N 114.757 -1.111 . . . . 0.0 112.222 169.729 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -116.28 142.63 29.67 Favored Pre-proline 0 CA--C 1.552 1.043 0 C-N-CA 124.66 1.184 . . . . 0.0 110.061 169.303 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -63.23 -4.83 7.01 Favored 'Trans proline' 0 CA--C 1.55 1.29 0 C-N-CA 123.107 2.538 . . . . 0.0 116.148 178.701 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -54.18 131.11 40.66 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 115.234 1.568 . . . . 0.0 115.234 -174.814 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 69.52 10.09 62.8 Favored Glycine 0 CA--C 1.538 1.496 0 N-CA-C 115.923 1.129 . . . . 0.0 115.923 175.379 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 16.1 pt20 -134.87 171.24 14.68 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 125.141 1.377 . . . . 0.0 113.909 -175.876 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 42.7 p -67.26 166.04 15.03 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 116.663 2.097 . . . . 0.0 116.663 -168.966 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 40.5 tp -57.66 -32.16 67.03 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 124.476 1.11 . . . . 0.0 112.375 172.431 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -62.71 -36.47 83.06 Favored 'General case' 0 CA--C 1.54 0.586 0 O-C-N 121.192 -0.942 . . . . 0.0 111.366 175.531 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 6.2 t -69.29 -40.26 80.01 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 O-C-N 121.482 -0.761 . . . . 0.0 111.477 172.955 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -53.8 -47.88 70.38 Favored 'General case' 0 N--CA 1.477 0.911 0 CA-C-N 119.298 0.954 . . . . 0.0 112.29 170.089 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 28.6 mmt85 -63.79 -44.41 93.44 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 124.221 1.008 . . . . 0.0 111.884 178.738 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 19.2 m -62.7 -40.99 98.89 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.776 0.831 . . . . 0.0 111.607 174.087 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 52.9 t -66.4 -42.35 90.32 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 CA-C-O 117.546 -1.216 . . . . 0.0 110.712 177.347 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 20.3 mtm105 -54.83 -44.18 73.67 Favored 'General case' 0 N--CA 1.483 1.224 0 CA-C-N 120.539 1.518 . . . . 0.0 111.708 171.647 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -60.4 -51.55 58.11 Favored Glycine 0 CA--C 1.538 1.499 0 CA-C-N 119.115 0.871 . . . . 0.0 113.797 176.411 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 60.2 mm-40 -65.48 -43.63 89.66 Favored 'General case' 0 N--CA 1.476 0.83 0 O-C-N 121.913 -0.757 . . . . 0.0 112.207 -179.426 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 69.3 t -66.58 -40.09 85.47 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 C-N-CA 124.737 1.215 . . . . 0.0 110.883 177.21 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -56.22 -49.48 73.97 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-N 120.163 1.347 . . . . 0.0 110.965 177.241 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -61.48 -41.99 98.11 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 122.92 0.488 . . . . 0.0 112.231 178.037 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -61.45 -42.98 99.6 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 124.824 1.25 . . . . 0.0 113.204 174.619 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 94.8 t -71.84 -39.46 67.81 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 C-N-CA 124.466 1.107 . . . . 0.0 111.663 177.72 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -62.54 -39.04 92.33 Favored 'General case' 0 N--CA 1.469 0.514 0 O-C-N 121.274 -0.891 . . . . 0.0 111.384 172.443 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 12.6 m-80 -63.78 -45.84 87.89 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 118.703 0.683 . . . . 0.0 112.487 173.155 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 9.8 tt -52.19 -54.39 31.5 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.935 1.294 . . . . 0.0 110.775 173.412 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 68.3 mt -63.87 -42.95 97.52 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 O-C-N 121.749 -0.594 . . . . 0.0 110.518 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -67.53 -10.97 56.66 Favored 'General case' 0 CA--C 1.548 0.866 0 N-CA-C 114.921 1.452 . . . . 0.0 114.921 177.857 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 20.2 ptmt -107.31 -30.93 8.43 Favored 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 113.942 1.089 . . . . 0.0 113.942 174.373 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . 0.263 7.1 pt -95.63 -11.57 8.73 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 N-CA-C 114.576 1.324 . . . . 0.0 114.576 -178.932 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 65.4 m . . . . . 0 C--O 1.253 1.246 0 C-N-CA 124.805 1.242 . . . . 0.0 112.78 177.846 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.421 ' HA ' ' O ' ' A' ' 29' ' ' LYS . 25.1 ttt . . . . . 0 N--CA 1.504 2.249 0 N-CA-C 112.133 0.42 . . . . 0.0 112.133 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 2.9 mptp? -126.12 158.0 36.61 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 125.729 1.612 . . . . 0.0 113.264 179.301 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 73.8 mttt -105.35 115.2 29.85 Favored 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 125.929 1.692 . . . . 0.0 106.629 167.39 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 10.7 t -105.81 130.89 56.56 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 C-N-CA 125.079 1.351 . . . . 0.0 113.9 178.62 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' MET . . . . . 0.472 ' HG3' HG13 ' A' ' 7' ' ' VAL . 48.8 tpp -102.02 125.66 48.76 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 168.677 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 49.8 m-85 -108.62 119.29 39.1 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 124.362 1.065 . . . . 0.0 109.82 171.486 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.472 HG13 ' HG3' ' A' ' 5' ' ' MET . 3.4 m -140.3 149.74 21.62 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 C-N-CA 124.675 1.19 . . . . 0.0 111.788 -169.386 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 14.9 t -137.15 148.53 46.68 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 125.821 1.648 . . . . 0.0 111.283 -178.93 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 47.0 pttt -59.51 123.22 16.14 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 123.88 0.872 . . . . 0.0 111.922 177.915 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 74.5 mtp85 58.27 -33.9 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.784 0 C-N-CA 129.411 3.084 . . . . 0.0 116.718 -169.319 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 17.9 t-20 59.35 -48.82 0.07 Allowed 'General case' 0 CA--C 1.553 1.065 0 C-N-CA 129.382 3.073 . . . . 0.0 117.116 174.61 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 26.2 m -68.76 -8.6 44.64 Favored 'General case' 0 N--CA 1.482 1.167 0 CA-C-N 120.89 1.677 . . . . 0.0 114.023 -176.348 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 84.1 p -100.22 2.54 42.92 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 126.531 1.932 . . . . 0.0 114.506 170.028 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 83.7 mtt85 -140.86 173.83 11.1 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 126.682 1.993 . . . . 0.0 112.928 -169.645 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 35.1 t -114.92 174.9 5.74 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 125.176 1.391 . . . . 0.0 110.252 169.245 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 83.7 mt-30 -141.94 -49.28 0.38 Allowed 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 113.956 1.095 . . . . 0.0 113.956 -170.956 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' MET . . . . . 0.434 ' HG2' ' SD ' ' A' ' 50' ' ' MET . 0.0 OUTLIER 71.67 -46.37 0.64 Allowed 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 126.231 1.812 . . . . 0.0 114.236 173.683 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.19 -32.53 73.18 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 114.258 1.207 . . . . 0.0 114.258 -169.998 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 7.3 pm0 -63.77 -38.39 90.92 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 123.289 0.635 . . . . 0.0 111.919 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -70.24 -42.84 65.24 Favored Glycine 0 C--N 1.335 0.492 0 C-N-CA 123.715 0.674 . . . . 0.0 111.726 -178.765 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -71.76 -36.25 70.33 Favored 'General case' 0 N--CA 1.468 0.46 0 O-C-N 121.662 -0.905 . . . . 0.0 112.13 177.151 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.89 -35.66 78.99 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 118.609 0.641 . . . . 0.0 112.467 -175.182 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 5.6 pttp -84.9 -35.39 22.18 Favored 'General case' 0 N--CA 1.481 1.093 0 N-CA-C 113.86 1.059 . . . . 0.0 113.86 170.836 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 75.8 m -67.86 -31.61 71.54 Favored 'General case' 0 N--CA 1.486 1.346 0 CA-C-N 118.828 0.74 . . . . 0.0 112.141 -179.266 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 72.4 mt -96.47 -37.26 10.5 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.801 1.64 . . . . 0.0 112.69 175.896 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -98.48 4.3 59.93 Favored Glycine 0 N--CA 1.471 1.024 0 N-CA-C 116.572 1.389 . . . . 0.0 116.572 -169.811 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.18 143.14 56.09 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-N 120.97 2.385 . . . . 0.0 112.524 177.865 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 83.53 -20.07 12.6 Favored Glycine 0 CA--C 1.542 1.732 0 C-N-CA 124.868 1.223 . . . . 0.0 113.251 -169.322 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.421 ' O ' ' HA ' ' A' ' 1' ' ' MET . 78.4 mttt -101.25 -44.52 5.64 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 125.889 1.676 . . . . 0.0 112.253 169.868 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 38.5 pt -139.33 158.12 28.2 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 C-N-CA 124.162 0.985 . . . . 0.0 113.627 -175.507 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -106.81 145.51 32.02 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 127.252 2.221 . . . . 0.0 109.7 169.846 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 72.7 t -134.3 141.96 42.19 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 CA-C-N 118.69 0.677 . . . . 0.0 112.759 -175.349 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 38.9 m -134.72 153.01 52.19 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 125.513 1.525 . . . . 0.0 109.075 169.589 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 55.4 p -130.03 146.83 51.72 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.845 0.831 . . . . 0.0 111.288 168.176 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 53.7 p -147.89 -173.63 4.35 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 114.704 -1.135 . . . . 0.0 111.708 175.833 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -135.96 170.11 23.31 Favored Glycine 0 N--CA 1.468 0.782 0 O-C-N 120.909 -1.119 . . . . 0.0 112.038 177.419 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 10.8 mp -91.68 -9.01 45.44 Favored 'General case' 0 N--CA 1.479 1.021 0 N-CA-C 114.967 1.469 . . . . 0.0 114.967 -169.965 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -142.13 63.9 1.4 Allowed 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 124.71 1.204 . . . . 0.0 110.934 -176.746 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.451 ' H ' ' HB3' ' A' ' 64' ' ' PRO . 72.7 m 49.53 45.8 23.88 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 126.194 1.798 . . . . 0.0 112.392 -175.456 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 16.6 p -123.26 165.88 16.2 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 126.078 1.751 . . . . 0.0 115.65 -168.812 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 29.3 ptt-85 -138.0 -171.62 3.06 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 127.695 2.398 . . . . 0.0 107.631 171.465 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 26.9 m -60.44 151.72 5.79 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.189 0 CA-C-N 120.369 1.44 . . . . 0.0 110.941 169.418 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -62.99 143.29 97.54 Favored Pre-proline 0 CA--C 1.55 0.975 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 168.963 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_exo -48.53 -37.11 33.15 Favored 'Trans proline' 0 CA--C 1.542 0.876 0 C-N-CA 123.421 2.748 . . . . 0.0 117.717 -168.195 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 93.9 m -63.23 -24.62 67.96 Favored 'General case' 0 N--CA 1.485 1.304 0 CA-C-N 119.721 1.146 . . . . 0.0 112.777 -174.695 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -51.97 -43.76 63.71 Favored 'General case' 0 CA--C 1.546 0.802 0 CA-C-O 118.352 -0.832 . . . . 0.0 111.034 170.697 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.6 mp -55.79 -54.05 30.71 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.297 0 CA-C-N 120.239 1.382 . . . . 0.0 110.1 178.159 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -62.27 -30.65 71.27 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 123.447 0.699 . . . . 0.0 112.736 -178.18 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' MET . . . . . 0.41 ' HG2' ' CD1' ' A' ' 112' ' ' PHE . 0.0 OUTLIER -76.91 -33.5 57.76 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 113.119 0.785 . . . . 0.0 113.119 176.813 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 50' ' ' MET . . . . . 0.434 ' SD ' ' HG2' ' A' ' 17' ' ' MET . 3.5 mmt -74.2 -32.5 63.07 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 118.877 0.762 . . . . 0.0 110.735 172.697 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -65.47 -14.05 60.14 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 124.534 1.134 . . . . 0.0 113.787 173.197 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 60.3 mt-10 -62.1 -27.18 68.74 Favored 'General case' 0 N--CA 1.482 1.161 0 CA-C-N 120.66 1.573 . . . . 0.0 110.896 168.899 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 56.5 t -96.5 -3.63 10.2 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.874 0 C-N-CA 127.54 2.336 . . . . 0.0 111.275 176.118 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 78.93 19.13 73.49 Favored Glycine 0 CA--C 1.541 1.677 0 C-N-CA 125.029 1.299 . . . . 0.0 114.374 -175.784 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 85.7 mt -77.88 135.3 26.53 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 C-N-CA 124.709 1.204 . . . . 0.0 111.638 -174.722 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 17.9 t0 -96.05 102.19 13.96 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 112.667 0.617 . . . . 0.0 112.667 178.133 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 8.6 pt -129.58 14.92 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.273 0 C-N-CA 125.214 1.406 . . . . 0.0 113.396 170.514 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 72.7 m -59.48 126.7 28.7 Favored 'General case' 0 N--CA 1.473 0.715 0 O-C-N 120.711 -1.243 . . . . 0.0 112.295 -172.592 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 80.15 -22.62 4.29 Favored Glycine 0 CA--C 1.538 1.48 0 C-N-CA 125.278 1.418 . . . . 0.0 115.938 179.653 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 70.8 mt-30 41.0 -96.12 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 127.482 2.313 . . . . 0.0 113.428 -175.535 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 9.1 t -145.63 163.95 33.24 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 126.655 1.982 . . . . 0.0 109.914 169.719 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 75.5 m -100.55 -2.52 32.75 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 125.904 1.682 . . . . 0.0 113.148 172.216 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 29.2 m-20 -111.05 146.79 35.22 Favored Pre-proline 0 CA--C 1.544 0.742 0 C-N-CA 124.053 0.941 . . . . 0.0 113.38 -174.523 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.451 ' HB3' ' H ' ' A' ' 39' ' ' SER . 57.6 Cg_endo -71.52 162.07 43.41 Favored 'Trans proline' 0 C--N 1.349 0.58 0 C-N-CA 122.541 2.16 . . . . 0.0 113.163 176.984 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 5.5 tt -48.74 -43.97 14.4 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 C-N-CA 124.465 1.106 . . . . 0.0 111.36 171.322 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -69.12 -5.64 23.53 Favored 'General case' 0 CA--C 1.546 0.813 0 N-CA-C 114.466 1.284 . . . . 0.0 114.466 -177.591 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 5.4 t-20 -84.27 -21.59 31.03 Favored 'General case' 0 CA--C 1.547 0.839 0 N-CA-C 113.312 0.856 . . . . 0.0 113.312 172.791 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 83.5 m-85 -91.3 -171.58 3.0 Favored 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 125.431 1.492 . . . . 0.0 111.838 -179.864 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 14.9 t30 -117.53 120.44 38.1 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.52 1.128 . . . . 0.0 109.351 175.804 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -64.97 -44.64 88.7 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 115.108 1.521 . . . . 0.0 115.108 -169.122 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -79.77 6.22 11.48 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 113.591 0.96 . . . . 0.0 113.591 -172.458 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -73.57 -26.66 60.93 Favored 'General case' 0 CA--C 1.545 0.783 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 167.617 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 76.4 m-85 -86.44 157.84 19.73 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 127.101 2.161 . . . . 0.0 110.244 169.635 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -116.07 -15.79 11.1 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 124.237 1.015 . . . . 0.0 112.355 174.955 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.632 HG22 ' HB ' ' A' ' 95' ' ' ILE . 91.6 t -129.33 135.27 62.13 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 C-N-CA 126.93 2.092 . . . . 0.0 107.648 174.919 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 66.7 t -131.8 123.42 51.65 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 169.471 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 45.7 mm -108.59 106.79 21.35 Favored 'Isoleucine or valine' 0 C--O 1.235 0.298 0 C-N-CA 124.645 1.178 . . . . 0.0 108.76 -175.981 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 4.1 m -85.42 92.26 8.44 Favored 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 123.983 0.913 . . . . 0.0 110.061 171.596 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 81.4 mt -67.34 172.52 4.77 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 126.259 1.823 . . . . 0.0 111.794 172.801 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 17.3 m 65.88 7.94 4.97 Favored 'General case' 0 CA--C 1.549 0.906 0 N-CA-C 114.868 1.433 . . . . 0.0 114.868 175.03 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 69.37 132.02 0.06 OUTLIER Glycine 0 CA--C 1.535 1.286 0 C-N-CA 126.793 2.14 . . . . 0.0 115.157 -179.801 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 38.2 m 60.18 43.48 13.98 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 125.84 1.656 . . . . 0.0 112.311 174.277 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -75.7 65.14 2.53 Favored Glycine 0 N--CA 1.472 1.058 0 C-N-CA 124.951 1.263 . . . . 0.0 111.281 174.44 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.9 p -112.81 -2.32 10.3 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 C-N-CA 125.263 1.425 . . . . 0.0 113.622 -169.647 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 62.0 t30 -77.26 -11.14 59.79 Favored 'General case' 0 CA--C 1.552 1.03 0 O-C-N 121.221 -0.924 . . . . 0.0 113.289 176.284 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -66.23 158.61 76.45 Favored Pre-proline 0 CA--C 1.556 1.19 0 C-N-CA 124.335 1.054 . . . . 0.0 112.494 170.282 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -60.1 151.27 73.91 Favored 'Trans proline' 0 CA--C 1.543 0.933 0 C-N-CA 122.776 2.317 . . . . 0.0 113.337 179.645 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -61.33 -26.54 81.8 Favored 'Trans proline' 0 C--N 1.35 0.656 0 C-N-CA 123.364 2.709 . . . . 0.0 113.863 -174.146 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -59.82 -22.2 61.9 Favored 'General case' 0 CA--C 1.541 0.596 0 CA-C-O 117.966 -1.016 . . . . 0.0 113.534 174.909 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 93.5 m95 -87.64 -12.97 43.97 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 125.025 1.33 . . . . 0.0 113.806 177.789 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 4.7 m -96.47 -7.75 9.48 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 CA-C-N 119.072 0.851 . . . . 0.0 112.946 171.736 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . 0.269 0.7 OUTLIER -96.47 -4.57 41.34 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 114.818 1.414 . . . . 0.0 114.818 -175.548 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 11.8 mp0 -61.05 156.89 16.86 Favored 'General case' 0 N--CA 1.487 1.384 0 CA-C-O 122.531 1.158 . . . . 0.0 111.183 168.928 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -61.83 -39.54 92.15 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 114.354 -1.294 . . . . 0.0 113.4 -168.831 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.632 ' HB ' HG22 ' A' ' 75' ' ' VAL . 16.6 mm -115.63 59.07 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 C-N-CA 125.321 1.448 . . . . 0.0 109.071 176.439 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 35.4 t80 -76.22 109.73 10.14 Favored 'General case' 0 CA--C 1.535 0.376 0 O-C-N 120.51 -1.369 . . . . 0.0 107.945 169.054 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 9.6 mt-10 -111.39 128.66 56.05 Favored 'General case' 0 N--CA 1.471 0.625 0 N-CA-C 113.214 0.82 . . . . 0.0 113.214 174.298 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -93.84 112.51 24.37 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 168.979 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 38.7 m0 -94.04 104.2 16.25 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 124.375 1.07 . . . . 0.0 108.983 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 73.7 mm-40 -74.73 54.82 0.64 Allowed 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 126.797 2.039 . . . . 0.0 110.342 173.32 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.1 tt -104.81 146.22 29.28 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 127.099 2.159 . . . . 0.0 110.624 -169.858 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -56.5 144.15 32.49 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 125.06 1.344 . . . . 0.0 113.848 174.289 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -97.34 119.77 62.31 Favored Pre-proline 0 CA--C 1.546 0.825 0 C-N-CA 124.661 1.184 . . . . 0.0 108.015 168.823 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -76.4 -11.22 19.03 Favored 'Trans proline' 0 CA--C 1.542 0.906 0 C-N-CA 122.067 1.845 . . . . 0.0 114.132 -173.671 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -74.72 155.87 37.23 Favored 'General case' 0 CA--C 1.546 0.795 0 CA-C-N 119.684 1.129 . . . . 0.0 113.689 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 76.47 8.41 85.83 Favored Glycine 0 CA--C 1.536 1.394 0 C-N-CA 124.712 1.149 . . . . 0.0 114.434 -177.667 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 15.0 pt20 -143.31 170.52 15.61 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 126.824 2.049 . . . . 0.0 111.196 179.239 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 15.9 m -56.77 154.32 9.34 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 125.031 1.332 . . . . 0.0 114.56 -169.568 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 60.2 tp -58.34 -30.05 66.42 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.902 0.881 . . . . 0.0 112.493 176.338 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -59.35 -31.93 69.64 Favored 'General case' 0 N--CA 1.475 0.793 0 O-C-N 121.351 -0.843 . . . . 0.0 113.268 170.559 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 14.0 t -74.12 -41.53 51.91 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 O-C-N 121.008 -1.058 . . . . 0.0 110.306 173.624 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.41 ' CD1' ' HG2' ' A' ' 49' ' ' MET . 0.3 OUTLIER -54.38 -47.26 72.87 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 119.097 0.862 . . . . 0.0 112.611 169.76 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -70.9 -34.21 71.33 Favored 'General case' 0 N--CA 1.477 0.902 0 O-C-N 121.395 -0.816 . . . . 0.0 112.726 179.191 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 53.3 m -64.98 -41.25 95.6 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.834 0.854 . . . . 0.0 111.13 170.686 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 54.7 t -68.34 -35.73 72.11 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 CA-C-O 117.371 -1.299 . . . . 0.0 111.029 175.806 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 28.6 mtm105 -56.23 -43.02 78.2 Favored 'General case' 0 N--CA 1.485 1.292 0 CA-C-N 121.275 1.852 . . . . 0.0 111.355 169.611 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -61.18 -49.98 72.12 Favored Glycine 0 CA--C 1.54 1.629 0 CA-C-N 119.132 0.878 . . . . 0.0 113.594 175.197 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 64.0 mm-40 -62.74 -46.73 86.7 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.537 0.735 . . . . 0.0 112.136 177.885 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 91.3 t -69.89 -34.71 61.4 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 C-N-CA 124.324 1.049 . . . . 0.0 111.262 -179.5 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 63.7 tttm -55.96 -51.85 66.23 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 120.44 1.473 . . . . 0.0 110.908 172.938 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -63.92 -42.07 97.48 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 123.303 0.641 . . . . 0.0 112.522 177.418 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -66.88 -34.8 78.58 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 125.446 1.498 . . . . 0.0 112.306 179.407 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 76.9 t -76.57 -40.89 34.18 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.089 0 C-N-CA 125.098 1.359 . . . . 0.0 111.511 173.716 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -62.6 -34.12 76.38 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 119.425 1.011 . . . . 0.0 111.604 173.156 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 9.6 m-80 -65.72 -44.4 86.17 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 119.056 0.844 . . . . 0.0 113.035 172.031 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -53.49 -55.48 25.0 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 123.884 0.874 . . . . 0.0 110.304 172.482 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 75.5 mt -61.39 -43.17 96.22 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 CA-C-O 119.164 -0.446 . . . . 0.0 110.666 -179.819 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -68.9 -13.58 62.51 Favored 'General case' 0 CA--C 1.544 0.744 0 N-CA-C 115.116 1.524 . . . . 0.0 115.116 179.704 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 21.4 ptmt -98.61 -28.17 13.68 Favored 'General case' 0 N--CA 1.477 0.887 0 CA-C-N 119.382 0.992 . . . . 0.0 113.541 172.767 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 18.5 pt -93.98 -22.57 5.55 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 N-CA-C 114.486 1.291 . . . . 0.0 114.486 177.581 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 75.6 m . . . . . 0 C--O 1.252 1.227 0 C-N-CA 125.418 1.487 . . . . 0.0 111.552 -173.77 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.3 ttt . . . . . 0 N--CA 1.504 2.234 0 N-CA-C 111.556 0.206 . . . . 0.0 111.556 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.14 166.0 25.9 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 125.018 1.327 . . . . 0.0 112.971 176.071 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 70.0 mttt -94.81 146.07 24.44 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 123.82 0.848 . . . . 0.0 112.629 174.466 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 16.7 t -124.28 138.13 54.85 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 125.645 1.578 . . . . 0.0 111.083 172.888 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -109.74 121.2 44.68 Favored 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 110.19 -0.3 . . . . 0.0 110.19 169.136 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 45.2 m-85 -96.52 125.19 40.83 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 170.608 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 28.8 m -140.49 151.57 21.0 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 N-CA-C 113.786 1.032 . . . . 0.0 113.786 -168.766 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 33.5 t -152.95 142.55 21.86 Favored 'General case' 0 CA--C 1.548 0.904 0 C-N-CA 124.711 1.204 . . . . 0.0 113.606 -172.717 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -80.79 140.52 35.44 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 124.779 1.232 . . . . 0.0 109.324 168.927 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 31.2 mtm180 52.54 47.34 24.91 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 125.48 1.512 . . . . 0.0 112.522 -169.12 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 23.4 t30 -57.32 -27.63 62.36 Favored 'General case' 0 CA--C 1.551 0.996 0 C-N-CA 125.581 1.552 . . . . 0.0 113.282 -179.786 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 72.8 m -73.32 -30.75 63.58 Favored 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 113.419 0.896 . . . . 0.0 113.419 172.041 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 48.8 m -80.66 -40.04 26.23 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 123.876 0.87 . . . . 0.0 112.082 179.458 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 11.7 mmt180 -101.88 163.34 12.3 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 124.645 1.178 . . . . 0.0 113.458 -173.844 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 3.7 m -106.92 134.96 49.3 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.148 0.979 . . . . 0.0 111.041 174.13 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 3.9 mp0 -105.11 -38.14 6.67 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 115.018 1.488 . . . . 0.0 115.018 -168.27 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' MET . . . . . 0.438 ' HG2' ' SD ' ' A' ' 50' ' ' MET . 0.0 OUTLIER 67.16 -55.55 0.45 Allowed 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 126.71 2.004 . . . . 0.0 115.66 170.372 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -57.82 -37.04 73.09 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.923 1.289 . . . . 0.0 114.205 -169.577 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 7.5 pm0 -58.76 -31.97 68.84 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 125.391 1.476 . . . . 0.0 113.709 179.523 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -66.83 -68.06 1.79 Allowed Glycine 0 C--N 1.337 0.622 0 N-CA-C 110.588 -1.005 . . . . 0.0 110.588 174.506 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -50.65 -34.12 25.15 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 124.135 0.974 . . . . 0.0 113.449 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.47 ' HB1' HG21 ' A' ' 32' ' ' VAL . . . -60.24 -32.58 71.27 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 -177.998 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . 0.273 0.0 OUTLIER -98.84 -24.91 14.81 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 114.081 1.141 . . . . 0.0 114.081 169.947 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 1.3 m -64.51 -36.54 84.52 Favored 'General case' 0 N--CA 1.488 1.436 0 CA-C-N 120.33 1.423 . . . . 0.0 111.974 173.796 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 68.6 mt -98.96 -28.26 13.51 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 125.454 1.502 . . . . 0.0 113.206 178.778 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -111.93 2.77 27.2 Favored Glycine 0 N--CA 1.474 1.204 0 N-CA-C 118.112 2.005 . . . . 0.0 118.112 -169.389 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -66.34 -20.37 66.07 Favored 'General case' 0 N--CA 1.477 0.878 0 CA-C-N 122.548 3.174 . . . . 0.0 116.648 -169.684 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -75.69 -6.68 82.1 Favored Glycine 0 CA--C 1.542 1.748 0 O-C-N 121.339 -0.85 . . . . 0.0 113.881 169.627 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 61.1 mttp -119.87 -40.06 2.78 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 127.162 2.185 . . . . 0.0 113.101 -174.375 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 43.6 pt -144.27 157.22 15.31 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 C-N-CA 125.911 1.684 . . . . 0.0 112.686 -171.896 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -101.02 139.78 36.23 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.415 1.086 . . . . 0.0 109.39 169.486 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.47 HG21 ' HB1' ' A' ' 22' ' ' ALA . 30.2 t -130.79 136.46 58.14 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.076 0 CA-C-N 119.831 1.196 . . . . 0.0 113.179 177.632 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 37.1 m -131.02 154.91 47.7 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 125.969 1.708 . . . . 0.0 109.73 175.034 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 3.2 m -124.64 147.86 48.28 Favored 'General case' 0 CA--C 1.513 -0.458 0 CA-C-O 121.617 0.722 . . . . 0.0 112.42 168.358 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 2.2 m -142.74 149.74 39.15 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 113.688 -1.596 . . . . 0.0 111.167 172.636 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -79.82 165.21 49.23 Favored Glycine 0 CA--C 1.528 0.852 0 N-CA-C 110.888 -0.885 . . . . 0.0 110.888 169.484 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 9.1 mp -80.17 -11.51 59.74 Favored 'General case' 0 N--CA 1.48 1.036 0 O-C-N 121.653 -0.91 . . . . 0.0 112.809 169.993 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -132.03 165.5 23.84 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 126.973 2.109 . . . . 0.0 108.811 169.662 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 68.4 m -57.78 114.31 2.24 Favored 'General case' 0 N--CA 1.479 1.012 0 O-C-N 121.232 -0.917 . . . . 0.0 110.574 178.984 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 88.9 p -158.24 178.17 10.47 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 114.748 1.388 . . . . 0.0 114.748 -168.717 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 13.2 tpt180 -132.35 147.32 52.39 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 128.178 2.591 . . . . 0.0 108.631 174.296 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 33.0 m -62.28 154.91 5.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 CA-C-N 120.668 1.576 . . . . 0.0 109.425 168.394 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 11.9 t-80 -53.53 135.09 53.51 Favored Pre-proline 0 C--N 1.327 -0.389 0 CA-C-N 114.87 -1.059 . . . . 0.0 112.564 -170.13 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_exo -60.75 -26.11 82.37 Favored 'Trans proline' 0 CA--C 1.548 1.175 0 CA-C-N 121.01 1.397 . . . . 0.0 112.677 175.885 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 51.1 m -70.02 -33.94 72.65 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 125.296 1.438 . . . . 0.0 112.058 171.968 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -57.99 -43.2 86.44 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 124.018 0.927 . . . . 0.0 111.636 -178.474 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.7 mp -52.85 -54.15 17.82 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 CA-C-N 119.182 0.901 . . . . 0.0 109.425 -178.652 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -65.76 -32.28 73.73 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 113.351 0.871 . . . . 0.0 113.351 -177.406 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -79.19 -29.95 43.14 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 113.433 0.901 . . . . 0.0 113.433 178.683 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' MET . . . . . 0.438 ' SD ' ' HG2' ' A' ' 17' ' ' MET . 1.0 OUTLIER -80.82 -29.57 35.95 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 123.521 0.728 . . . . 0.0 110.828 172.739 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -66.92 -12.27 58.93 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 124.719 1.208 . . . . 0.0 113.486 170.02 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -65.62 -26.23 67.73 Favored 'General case' 0 N--CA 1.481 1.076 0 CA-C-N 120.513 1.506 . . . . 0.0 110.892 169.06 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 56.7 t -93.72 -7.54 10.17 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.804 0 C-N-CA 126.996 2.119 . . . . 0.0 111.049 173.023 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 82.16 20.11 63.46 Favored Glycine 0 CA--C 1.538 1.501 0 C-N-CA 125.086 1.327 . . . . 0.0 114.22 -175.183 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.427 HG22 HG23 ' A' ' 57' ' ' ILE . 36.0 mt -85.68 126.13 40.51 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 CA-C-N 118.48 1.14 . . . . 0.0 110.805 -176.645 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 19.9 t0 -87.43 121.33 29.72 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.143 0.577 . . . . 0.0 111.537 170.692 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.427 HG23 HG22 ' A' ' 55' ' ' ILE . 29.2 pt -136.37 -1.72 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.24 0 N-CA-C 116.083 1.883 . . . . 0.0 116.083 -178.568 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 79.1 p -62.93 -25.61 68.42 Favored 'General case' 0 N--CA 1.482 1.17 0 N-CA-C 116.122 1.897 . . . . 0.0 116.122 -169.019 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -102.29 3.21 50.79 Favored Glycine 0 CA--C 1.537 1.431 0 N-CA-C 116.12 1.208 . . . . 0.0 116.12 -176.132 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 31.5 mt-30 -72.89 -44.3 61.46 Favored 'General case' 0 N--CA 1.48 1.05 0 CA-C-N 119.31 1.555 . . . . 0.0 113.639 -169.949 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 12.3 p -90.7 119.33 30.85 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 124.115 0.966 . . . . 0.0 112.382 -178.701 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 99.4 p -141.08 -12.17 0.95 Allowed 'General case' 0 N--CA 1.478 0.944 0 N-CA-C 114.884 1.439 . . . . 0.0 114.884 177.191 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -147.36 150.6 38.04 Favored Pre-proline 0 CA--C 1.546 0.821 0 C-N-CA 125.131 1.372 . . . . 0.0 111.58 179.522 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -63.15 155.71 59.66 Favored 'Trans proline' 0 C--N 1.35 0.624 0 C-N-CA 123.31 2.673 . . . . 0.0 112.168 169.543 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 10.3 tt -50.77 -33.84 12.47 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 C-N-CA 124.869 1.268 . . . . 0.0 112.291 171.261 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -62.41 -21.54 65.47 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.575 1.15 . . . . 0.0 112.87 -177.074 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 82.0 m-20 -91.7 4.7 52.14 Favored 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 124.452 1.101 . . . . 0.0 113.645 -176.264 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -116.48 -176.82 3.04 Favored 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 126.304 1.842 . . . . 0.0 112.377 179.283 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -119.76 125.0 47.56 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 125.874 1.67 . . . . 0.0 110.068 175.368 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -67.79 -34.91 77.7 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 113.921 1.082 . . . . 0.0 113.921 -171.201 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . 0.261 0.0 OUTLIER -71.6 -4.32 26.39 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 114.278 1.214 . . . . 0.0 114.278 -176.602 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -73.18 -15.96 61.44 Favored 'General case' 0 CA--C 1.548 0.871 0 O-C-N 121.711 -0.618 . . . . 0.0 111.136 168.898 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -112.45 138.5 49.11 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 127.074 2.15 . . . . 0.0 111.497 178.676 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -88.42 -23.68 23.25 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-O 122.112 0.958 . . . . 0.0 112.317 176.125 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.682 HG22 ' HB ' ' A' ' 95' ' ' ILE . 76.3 t -133.29 137.65 52.86 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 C-N-CA 126.679 1.992 . . . . 0.0 108.769 -175.487 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 78.8 t -133.56 131.92 57.3 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 173.184 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 43.3 mm -121.51 106.06 17.59 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 C-N-CA 124.243 1.017 . . . . 0.0 109.344 -171.378 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 4.1 m -88.75 109.79 20.45 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 123.631 0.772 . . . . 0.0 110.643 178.406 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 89.3 mt -90.76 -19.02 23.98 Favored 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 114.899 1.444 . . . . 0.0 114.899 -172.45 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 10.6 m -141.56 144.52 34.3 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.746 1.218 . . . . 0.0 110.703 -169.789 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 62.15 -125.37 35.97 Favored Glycine 0 CA--C 1.533 1.205 0 N-CA-C 110.632 -0.987 . . . . 0.0 110.632 -171.538 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 77.9 p -152.62 171.86 17.51 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.671 1.188 . . . . 0.0 111.527 169.719 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -66.41 65.0 0.16 Allowed Glycine 0 CA--C 1.538 1.512 0 C-N-CA 125.757 1.646 . . . . 0.0 114.691 176.043 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 7.7 p -143.79 -28.4 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.105 0 C-N-CA 125.633 1.573 . . . . 0.0 113.345 -178.324 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -91.19 22.95 3.51 Favored 'General case' 0 CA--C 1.554 1.121 0 C-N-CA 124.337 1.055 . . . . 0.0 112.447 178.115 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -133.54 159.28 73.15 Favored Pre-proline 0 CA--C 1.549 0.93 0 C-N-CA 126.338 1.855 . . . . 0.0 111.024 173.208 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -58.89 149.2 80.11 Favored 'Trans proline' 0 CA--C 1.543 0.937 0 C-N-CA 122.58 2.187 . . . . 0.0 112.695 178.229 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -61.77 -28.94 82.47 Favored 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 122.909 2.406 . . . . 0.0 113.626 -170.489 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -60.36 -20.95 61.4 Favored 'General case' 0 CA--C 1.544 0.723 0 N-CA-C 114.071 1.137 . . . . 0.0 114.071 177.704 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 88.6 m95 -80.34 -19.86 45.54 Favored 'General case' 0 N--CA 1.47 0.563 0 O-C-N 120.622 -1.299 . . . . 0.0 113.257 175.856 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 16.3 m -93.81 -8.21 9.98 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.125 0 N-CA-C 113.634 0.975 . . . . 0.0 113.634 172.213 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 67.5 p -96.98 -0.31 47.61 Favored 'General case' 0 N--CA 1.48 1.032 0 N-CA-C 114.796 1.406 . . . . 0.0 114.796 177.96 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 73.3 mm-40 -65.2 152.63 43.16 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 119.172 0.896 . . . . 0.0 111.213 169.84 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -54.01 -42.91 69.6 Favored 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 114.986 1.476 . . . . 0.0 114.986 -167.734 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.682 ' HB ' HG22 ' A' ' 75' ' ' VAL . 8.6 mm -118.26 65.16 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 C-N-CA 124.072 0.949 . . . . 0.0 109.224 173.41 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 23.3 t80 -75.31 109.46 8.85 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 106.909 -1.515 . . . . 0.0 106.909 168.645 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -104.58 130.45 52.55 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-O 121.797 0.808 . . . . 0.0 112.93 171.489 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -92.14 105.99 18.1 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 123.692 0.797 . . . . 0.0 109.399 169.95 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 19.0 m0 -94.47 99.26 11.46 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 124.571 1.148 . . . . 0.0 110.239 -176.945 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 99.9 mm-40 -79.13 53.7 1.5 Allowed 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 124.699 1.2 . . . . 0.0 110.514 170.957 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 5.0 tt -91.84 150.91 20.82 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 127.057 2.143 . . . . 0.0 111.9 -172.147 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -68.23 117.92 10.67 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 123.553 0.741 . . . . 0.0 112.868 179.029 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -74.43 133.25 77.62 Favored Pre-proline 0 CA--C 1.556 1.173 0 O-C-N 121.522 -0.736 . . . . 0.0 110.317 169.664 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -87.8 -6.96 6.57 Favored 'Trans proline' 0 CA--C 1.554 1.479 0 C-N-CA 122.295 1.997 . . . . 0.0 114.646 -178.597 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -64.38 146.91 53.69 Favored 'General case' 0 CA--C 1.547 0.864 0 CA-C-N 120.537 1.517 . . . . 0.0 113.188 176.91 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 75.77 8.62 84.65 Favored Glycine 0 CA--C 1.537 1.436 0 C-N-CA 123.869 0.747 . . . . 0.0 114.872 176.153 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 13.2 pt20 -140.75 165.46 27.44 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 125.893 1.677 . . . . 0.0 112.257 178.365 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 70.9 m -57.92 157.65 7.48 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 125.638 1.575 . . . . 0.0 114.843 -169.47 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 35.9 tp -59.25 -29.19 67.37 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 124.605 1.162 . . . . 0.0 113.001 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -61.9 -31.42 71.71 Favored 'General case' 0 N--CA 1.472 0.661 0 O-C-N 120.812 -1.18 . . . . 0.0 112.208 172.346 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 4.7 t -72.78 -40.49 60.97 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 O-C-N 121.146 -0.971 . . . . 0.0 111.114 171.73 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -55.16 -47.88 74.54 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 120.02 1.282 . . . . 0.0 112.056 169.857 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -69.13 -36.7 77.75 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.46 0.704 . . . . 0.0 112.506 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 79.0 m -63.86 -42.4 97.55 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 123.777 0.831 . . . . 0.0 110.832 171.593 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 44.1 t -65.96 -41.25 89.46 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 CA-C-O 117.567 -1.206 . . . . 0.0 110.803 176.429 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 30.8 mtm105 -55.73 -44.41 77.49 Favored 'General case' 0 N--CA 1.483 1.185 0 CA-C-N 120.841 1.655 . . . . 0.0 112.243 171.608 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -61.14 -50.85 62.75 Favored Glycine 0 CA--C 1.537 1.464 0 CA-C-N 118.979 0.809 . . . . 0.0 113.103 177.114 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 56.5 mm-40 -63.58 -45.0 92.42 Favored 'General case' 0 N--CA 1.473 0.689 0 O-C-N 121.996 -0.708 . . . . 0.0 112.217 178.387 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 70.4 t -64.78 -40.86 90.51 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 124.964 1.306 . . . . 0.0 111.301 177.679 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 84.3 tttt -54.44 -49.52 69.82 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 119.89 1.223 . . . . 0.0 110.474 176.215 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -63.64 -42.37 98.16 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 112.637 0.606 . . . . 0.0 112.637 176.268 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.24 -36.28 83.12 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 124.181 0.992 . . . . 0.0 112.897 177.803 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 92.5 t -78.44 -38.9 23.19 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 C-N-CA 125.521 1.529 . . . . 0.0 111.713 177.574 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -63.36 -35.43 80.38 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 119.546 1.066 . . . . 0.0 111.285 171.472 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 12.5 m-80 -64.89 -44.47 89.52 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 118.827 0.74 . . . . 0.0 112.52 172.328 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 9.8 tt -52.57 -57.18 10.81 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 124.237 1.015 . . . . 0.0 110.25 170.534 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 70.2 mt -60.58 -42.69 92.55 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 O-C-N 121.387 -0.821 . . . . 0.0 110.744 -177.805 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -68.45 -14.61 63.12 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 114.828 1.418 . . . . 0.0 114.828 178.263 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 19.0 ptmt -106.0 -32.75 8.16 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 113.596 0.961 . . . . 0.0 113.596 176.577 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.427 HD13 HG21 ' A' ' 75' ' ' VAL . 4.7 pt -88.98 -18.97 7.69 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 CA-C-O 118.038 -0.982 . . . . 0.0 113.619 -176.692 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 69.7 m . . . . . 0 C--O 1.253 1.274 0 N-CA-C 112.781 0.66 . . . . 0.0 112.781 -177.946 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.0 ttt . . . . . 0 N--CA 1.503 2.179 0 N-CA-C 111.774 0.287 . . . . 0.0 111.774 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.89 156.17 38.36 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 125.667 1.587 . . . . 0.0 113.207 179.422 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 44.1 mtmt -101.72 108.65 20.24 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 125.518 1.527 . . . . 0.0 107.342 167.851 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 16.3 t -95.18 131.92 40.64 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 125.981 1.713 . . . . 0.0 113.72 175.475 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' MET . . . . . 0.558 ' HG3' HG13 ' A' ' 7' ' ' VAL . 37.6 tpp -102.98 120.2 40.22 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 123.765 0.826 . . . . 0.0 109.162 168.804 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 65.0 m-85 -99.0 118.93 36.9 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 125.68 1.592 . . . . 0.0 108.307 174.588 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.558 HG13 ' HG3' ' A' ' 5' ' ' MET . 1.5 m -137.91 151.44 25.56 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.143 0 N-CA-C 115.013 1.486 . . . . 0.0 115.013 -168.64 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 41.5 t -155.31 162.99 40.72 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 125.691 1.597 . . . . 0.0 111.028 169.918 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 40.2 ttmt -69.99 133.05 46.84 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 125.052 1.341 . . . . 0.0 110.855 169.827 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 98.2 mtt180 51.13 80.12 0.09 Allowed 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 126.88 2.072 . . . . 0.0 112.386 -176.541 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 21.9 t-20 -67.98 -32.99 73.78 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 113.828 1.047 . . . . 0.0 113.828 -174.174 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 60.4 p -76.29 157.45 32.51 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 125.008 1.323 . . . . 0.0 112.688 169.922 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 67.1 m 53.62 26.45 5.77 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 124.901 1.28 . . . . 0.0 114.242 -174.681 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 23.9 ttm180 -147.33 151.85 37.24 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 127.76 2.424 . . . . 0.0 110.048 -175.32 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 46.0 t -109.07 152.84 24.49 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.49 0.716 . . . . 0.0 111.248 170.157 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -139.98 -42.43 0.43 Allowed 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 125.887 1.675 . . . . 0.0 111.893 -169.52 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 65.91 -36.72 0.24 Allowed 'General case' 0 N--CA 1.478 0.975 0 N-CA-C 118.205 2.668 . . . . 0.0 118.205 169.238 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.27 -36.56 80.36 Favored 'General case' 0 C--O 1.224 -0.289 0 CA-C-N 119.278 0.944 . . . . 0.0 113.406 -171.26 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.5 pm0 -57.46 -34.37 68.94 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 124.361 1.064 . . . . 0.0 113.307 171.93 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -72.49 -57.03 5.73 Favored Glycine 0 C--N 1.332 0.332 0 C-N-CA 124.293 0.949 . . . . 0.0 111.425 177.437 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -59.34 -33.79 71.57 Favored 'General case' 0 N--CA 1.468 0.43 0 O-C-N 122.24 -0.565 . . . . 0.0 112.427 177.902 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -63.38 -40.16 96.47 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 119.198 0.908 . . . . 0.0 112.285 -178.825 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 33.7 mttm -58.3 -56.39 22.73 Favored 'General case' 0 N--CA 1.486 1.373 0 CA-C-O 121.544 0.688 . . . . 0.0 110.874 168.782 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 35.9 m -69.75 -24.15 63.48 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 125.186 1.394 . . . . 0.0 114.056 -169.392 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 76.7 mt -96.38 -19.15 19.41 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 125.066 1.347 . . . . 0.0 114.461 177.262 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -159.01 26.29 0.37 Allowed Glycine 0 C--N 1.344 0.979 0 N-CA-C 119.021 2.368 . . . . 0.0 119.021 -169.001 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -66.56 -21.28 66.15 Favored 'General case' 0 CA--C 1.546 0.812 0 CA-C-N 122.15 2.975 . . . . 0.0 115.37 -176.501 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -74.86 -5.47 75.03 Favored Glycine 0 CA--C 1.542 1.745 0 O-C-N 121.493 -0.755 . . . . 0.0 113.776 169.546 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 70.0 mttt -117.18 -37.24 3.58 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 127.536 2.335 . . . . 0.0 113.301 -178.565 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 40.1 pt -142.76 150.07 18.41 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 C-N-CA 124.386 1.074 . . . . 0.0 113.171 -174.619 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -99.53 139.23 35.5 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 125.813 1.645 . . . . 0.0 108.337 169.355 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 5.1 m -132.14 144.91 35.71 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.236 0 C-N-CA 124.033 0.933 . . . . 0.0 110.352 -173.578 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 72.3 m -138.42 138.91 38.65 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 123.522 0.729 . . . . 0.0 109.411 175.091 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 2.8 p -98.67 138.04 36.42 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 112.127 0.417 . . . . 0.0 112.127 168.755 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 24.4 p -149.18 162.29 40.28 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 113.274 0.842 . . . . 0.0 113.274 170.095 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -109.78 147.1 17.11 Favored Glycine 0 N--CA 1.473 1.165 0 C-N-CA 124.236 0.922 . . . . 0.0 113.89 -179.393 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 11.2 mp -68.32 -25.55 65.17 Favored 'General case' 0 N--CA 1.485 1.298 0 CA-C-N 119.395 1.597 . . . . 0.0 111.041 169.603 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -142.36 144.31 33.12 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 127.688 2.395 . . . . 0.0 106.955 169.06 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 25.5 p 58.05 171.42 0.05 Allowed 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 126.91 2.084 . . . . 0.0 116.172 -176.106 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 83.2 p -137.79 168.38 19.8 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 125.805 1.642 . . . . 0.0 114.34 178.958 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 24.5 ttt-85 61.74 124.24 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 129.494 3.117 . . . . 0.0 113.398 -169.925 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 32.0 m -57.89 144.8 9.97 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.32 0 C-N-CA 123.376 0.67 . . . . 0.0 109.557 169.696 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -65.13 147.68 98.39 Favored Pre-proline 0 CA--C 1.544 0.749 0 C-N-CA 119.369 -0.932 . . . . 0.0 112.332 -169.614 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo -48.27 -41.72 34.59 Favored 'Trans proline' 0 CA--C 1.538 0.707 0 C-N-CA 123.375 2.717 . . . . 0.0 117.51 -168.185 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 86.1 m -64.82 -24.0 67.41 Favored 'General case' 0 N--CA 1.485 1.32 0 O-C-N 121.211 -0.931 . . . . 0.0 112.267 -177.879 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -57.6 -34.25 69.06 Favored 'General case' 0 CA--C 1.536 0.406 0 O-C-N 121.315 -0.865 . . . . 0.0 112.153 173.86 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.7 mp -60.58 -57.88 9.94 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 CA-C-N 119.901 1.228 . . . . 0.0 109.312 175.564 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -61.31 -32.77 72.63 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 113.122 0.786 . . . . 0.0 113.122 -178.561 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 3.8 tpp -77.36 -24.14 50.7 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 113.209 0.818 . . . . 0.0 113.209 178.051 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -87.49 -27.35 22.71 Favored 'General case' 0 CA--C 1.541 0.615 0 O-C-N 121.136 -0.977 . . . . 0.0 110.876 172.464 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -65.62 -5.16 7.51 Favored 'General case' 0 CA--C 1.552 1.055 0 C-N-CA 125.166 1.386 . . . . 0.0 113.036 169.456 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 18.5 mt-10 -72.79 -29.26 63.13 Favored 'General case' 0 N--CA 1.484 1.263 0 CA-C-N 120.039 1.29 . . . . 0.0 111.082 171.284 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 8.5 p -113.21 12.94 8.34 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.798 0 C-N-CA 127.143 2.177 . . . . 0.0 111.26 -177.142 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 80.17 18.06 72.75 Favored Glycine 0 CA--C 1.533 1.202 0 C-N-CA 124.978 1.275 . . . . 0.0 115.861 170.668 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 2.4 mm -71.92 143.49 14.14 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 CA-C-N 119.549 1.674 . . . . 0.0 110.286 177.757 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -97.82 29.63 3.32 Favored 'General case' 0 CA--C 1.553 1.083 0 C-N-CA 125.986 1.714 . . . . 0.0 115.476 -176.825 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 11.6 pt -72.11 -2.75 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.384 0 N-CA-C 115.594 1.702 . . . . 0.0 115.594 -175.173 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 91.6 p -55.58 -32.35 62.98 Favored 'General case' 0 N--CA 1.479 1.016 0 CA-C-N 119.851 1.205 . . . . 0.0 113.828 179.453 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -82.44 3.61 81.27 Favored Glycine 0 CA--C 1.536 1.364 0 C-N-CA 125.237 1.399 . . . . 0.0 116.105 177.412 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 5.1 mt-30 -79.48 132.68 36.41 Favored 'General case' 0 C--N 1.343 0.319 0 CA-C-N 120.362 2.081 . . . . 0.0 112.33 -179.019 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 40.4 p -139.66 113.58 8.75 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 126.068 1.747 . . . . 0.0 107.051 168.747 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 59.7 p -114.61 -174.7 2.53 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 114.703 1.371 . . . . 0.0 114.703 -169.208 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -133.86 164.49 43.64 Favored Pre-proline 0 CA--C 1.546 0.812 0 C-N-CA 126.833 2.053 . . . . 0.0 109.628 176.798 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -60.78 155.95 46.03 Favored 'Trans proline' 0 CA--C 1.541 0.871 0 C-N-CA 122.193 1.928 . . . . 0.0 112.522 169.769 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.531 HD12 HG11 ' A' ' 7' ' ' VAL . 7.5 tt -53.55 -33.17 21.67 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 C-N-CA 125.428 1.491 . . . . 0.0 111.552 175.045 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 17.8 mt-10 -59.66 -20.58 57.08 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 125.315 1.446 . . . . 0.0 113.112 178.662 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -85.31 -9.96 57.01 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 125.294 1.438 . . . . 0.0 113.609 -179.015 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -108.27 178.77 4.4 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 126.334 1.854 . . . . 0.0 112.301 -176.312 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 20.3 t30 -114.58 126.08 54.5 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 125.208 1.403 . . . . 0.0 110.075 175.774 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -63.47 -43.34 97.6 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 114.515 1.302 . . . . 0.0 114.515 -169.756 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -75.26 -0.9 21.13 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 113.495 0.924 . . . . 0.0 113.495 -178.468 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -71.83 -12.96 61.54 Favored 'General case' 0 CA--C 1.544 0.724 0 O-C-N 121.572 -0.705 . . . . 0.0 110.784 168.917 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -116.21 141.81 47.65 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 126.175 1.79 . . . . 0.0 111.222 178.715 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -86.71 -31.73 20.85 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 125.464 1.505 . . . . 0.0 111.651 174.717 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.76 HG22 ' HB ' ' A' ' 95' ' ' ILE . 94.3 t -129.12 138.03 55.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 C-N-CA 125.446 1.498 . . . . 0.0 108.38 -171.366 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 37.3 t -130.56 125.15 58.49 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 173.488 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 44.3 mm -116.25 102.87 14.27 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 C-N-CA 125.052 1.341 . . . . 0.0 108.8 -173.403 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 15.8 m -86.31 106.77 17.61 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 124.041 0.936 . . . . 0.0 110.111 176.493 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 81.1 mt -82.04 -4.92 57.86 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 125.271 1.428 . . . . 0.0 114.647 -169.772 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 28.6 p -152.9 147.96 26.59 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 124.34 1.056 . . . . 0.0 112.121 -175.7 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 60.84 -160.39 25.61 Favored Glycine 0 CA--C 1.536 1.385 0 C-N-CA 124.585 1.088 . . . . 0.0 114.739 176.589 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 86.9 p -71.45 -22.69 61.8 Favored 'General case' 0 N--CA 1.475 0.782 0 O-C-N 121.305 -1.115 . . . . 0.0 113.575 175.454 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 72.58 10.0 75.02 Favored Glycine 0 CA--C 1.533 1.201 0 C-N-CA 124.968 1.27 . . . . 0.0 114.367 -176.39 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.0 p -77.07 -16.76 14.57 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 CA-C-N 119.36 1.58 . . . . 0.0 114.664 -169.702 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 36.4 m120 -80.44 -9.3 59.76 Favored 'General case' 0 CA--C 1.548 0.901 0 N-CA-C 114.984 1.475 . . . . 0.0 114.984 -170.966 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -75.59 159.64 81.1 Favored Pre-proline 0 CA--C 1.552 1.033 0 CA-C-N 119.323 0.965 . . . . 0.0 112.066 169.727 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_exo -58.43 142.97 98.26 Favored 'Trans proline' 0 CA--C 1.547 1.146 0 C-N-CA 122.607 2.205 . . . . 0.0 113.011 179.287 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_exo -54.85 -32.08 75.8 Favored 'Trans proline' 0 C--N 1.353 0.777 0 C-N-CA 123.358 2.706 . . . . 0.0 115.62 -171.902 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 2.9 pm0 -61.95 -16.82 54.04 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 114.239 1.2 . . . . 0.0 114.239 177.76 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 93.6 m95 -80.58 -24.01 39.49 Favored 'General case' 0 CA--C 1.542 0.669 0 O-C-N 120.45 -1.406 . . . . 0.0 112.908 171.728 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 11.8 m -85.98 -10.19 11.27 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.167 0 CA-C-N 119.909 1.231 . . . . 0.0 113.555 174.195 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 72.0 p -98.31 0.96 46.57 Favored 'General case' 0 N--CA 1.477 0.917 0 N-CA-C 115.225 1.565 . . . . 0.0 115.225 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 76.7 mm-40 -67.4 160.35 27.55 Favored 'General case' 0 N--CA 1.478 0.971 0 CA-C-N 119.482 1.037 . . . . 0.0 110.95 169.803 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -58.01 -36.04 72.12 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 116.09 1.885 . . . . 0.0 116.09 -168.34 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.76 ' HB ' HG22 ' A' ' 75' ' ' VAL . 12.1 mm -127.18 74.55 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 CA-C-N 119.605 1.093 . . . . 0.0 109.062 177.707 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 12.4 t80 -81.57 109.78 16.34 Favored 'General case' 0 CA--C 1.534 0.365 0 O-C-N 121.224 -0.922 . . . . 0.0 108.544 169.289 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -111.32 139.33 46.82 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 114.636 1.347 . . . . 0.0 114.636 174.403 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -104.94 121.15 43.12 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.242 1.017 . . . . 0.0 108.98 168.754 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 43.8 m0 -107.07 111.61 24.15 Favored 'General case' 0 C--N 1.33 -0.239 0 C-N-CA 124.756 1.222 . . . . 0.0 108.352 -179.686 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 84.0 mm-40 -83.95 53.96 2.76 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-O 122.318 1.056 . . . . 0.0 111.561 -173.832 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 87.7 mt -85.53 165.86 16.76 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 126.957 2.103 . . . . 0.0 112.22 -179.704 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -96.29 157.0 16.1 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 123.98 0.912 . . . . 0.0 113.147 172.972 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 51.5 t0 -86.34 124.26 70.21 Favored Pre-proline 0 CA--C 1.542 0.665 0 C-N-CA 124.445 1.098 . . . . 0.0 110.266 173.021 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_exo -58.67 -24.4 70.57 Favored 'Trans proline' 0 CA--C 1.543 0.952 0 C-N-CA 122.925 2.417 . . . . 0.0 115.343 172.868 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -65.94 143.52 57.35 Favored 'General case' 0 CA--C 1.546 0.792 0 CA-C-N 119.444 1.02 . . . . 0.0 112.995 -178.771 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 80.95 5.95 89.78 Favored Glycine 0 CA--C 1.536 1.399 0 N-CA-C 115.176 0.83 . . . . 0.0 115.176 178.617 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 8.6 pt20 -142.17 168.3 20.07 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 125.378 1.471 . . . . 0.0 112.833 179.275 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 66.8 m -59.67 155.21 16.17 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 125.503 1.521 . . . . 0.0 114.085 -170.181 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 7.9 tt -60.51 -30.98 70.07 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.746 1.218 . . . . 0.0 113.569 -175.107 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -65.17 -23.96 67.25 Favored 'General case' 0 CA--C 1.546 0.81 0 O-C-N 121.059 -1.026 . . . . 0.0 112.899 173.544 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 11.3 t -72.84 -38.15 56.47 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 O-C-N 120.789 -1.195 . . . . 0.0 110.734 170.651 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -53.76 -45.73 70.69 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 118.78 0.718 . . . . 0.0 110.686 169.045 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 38.9 mtt180 -66.77 -39.08 87.71 Favored 'General case' 0 N--CA 1.482 1.159 0 N-CA-C 113.012 0.745 . . . . 0.0 113.012 175.979 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 28.9 m -58.89 -42.88 90.58 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 124.345 1.058 . . . . 0.0 110.946 172.833 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 77.6 t -67.99 -38.57 80.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 CA-C-O 117.894 -1.051 . . . . 0.0 111.083 177.361 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 65.9 mtm-85 -57.25 -43.82 83.34 Favored 'General case' 0 N--CA 1.487 1.413 0 CA-C-N 120.696 1.589 . . . . 0.0 112.208 170.169 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -59.37 -49.6 76.74 Favored Glycine 0 CA--C 1.536 1.403 0 CA-C-N 119.104 0.865 . . . . 0.0 113.253 176.522 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 55.5 mm-40 -64.57 -44.11 91.73 Favored 'General case' 0 N--CA 1.473 0.709 0 O-C-N 122.078 -0.66 . . . . 0.0 112.131 177.788 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 75.6 t -65.95 -37.38 79.72 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 124.203 1.001 . . . . 0.0 111.344 177.201 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 58.2 tttm -55.93 -51.9 66.0 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-N 119.81 1.186 . . . . 0.0 110.743 176.212 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -63.78 -40.82 97.6 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.119 0.568 . . . . 0.0 112.199 178.347 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -62.87 -44.08 97.07 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 124.583 1.153 . . . . 0.0 113.272 176.486 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 66.8 t -74.31 -35.8 40.93 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 124.188 0.995 . . . . 0.0 111.518 178.56 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -63.1 -39.76 95.65 Favored 'General case' 0 N--CA 1.471 0.58 0 O-C-N 121.138 -0.976 . . . . 0.0 111.679 169.809 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 11.6 m-80 -63.36 -44.94 93.36 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 118.976 0.807 . . . . 0.0 112.225 172.932 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 8.4 tt -51.49 -56.79 11.41 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 124.48 1.112 . . . . 0.0 110.306 174.334 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 62.8 mt -66.82 -44.24 89.23 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 O-C-N 121.848 -0.533 . . . . 0.0 111.174 -175.731 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -69.4 -10.53 58.38 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 114.102 1.149 . . . . 0.0 114.102 177.559 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 72.7 tttt -95.77 -48.26 5.83 Favored 'General case' 0 C--O 1.234 0.239 0 C-N-CA 125.811 1.644 . . . . 0.0 111.428 176.037 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 7.5 pt -93.71 -15.17 7.99 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 N-CA-C 114.375 1.25 . . . . 0.0 114.375 -172.798 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 73.8 m . . . . . 0 C--O 1.256 1.408 0 C-N-CA 125.606 1.562 . . . . 0.0 111.722 -176.464 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.8 ttt . . . . . 0 N--CA 1.502 2.166 0 N-CA-C 111.861 0.319 . . . . 0.0 111.861 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.72 164.99 28.88 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 125.371 1.468 . . . . 0.0 112.937 178.737 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 71.1 mttt -94.49 146.42 24.11 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 124.085 0.954 . . . . 0.0 112.872 175.58 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 14.5 t -123.51 134.45 66.31 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 C-N-CA 125.543 1.537 . . . . 0.0 111.998 175.019 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 48.6 tpp -102.81 123.48 46.54 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 168.806 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 72.4 m-85 -101.35 131.19 47.54 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 169.858 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -140.65 143.18 29.35 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 N-CA-C 114.012 1.116 . . . . 0.0 114.012 -169.379 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 46.4 t -145.14 160.11 41.94 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 127.473 2.309 . . . . 0.0 109.081 169.36 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 64.9 pttt -66.23 -42.67 88.32 Favored 'General case' 0 N--CA 1.485 1.311 0 N-CA-C 115.117 1.525 . . . . 0.0 115.117 -171.341 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 12.7 mmm180 -113.29 63.12 0.64 Allowed 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 126.758 2.023 . . . . 0.0 112.148 -175.705 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 47.2 t30 -45.42 -46.6 13.48 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 125.139 1.376 . . . . 0.0 113.834 -172.52 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 86.0 p -78.36 -10.2 59.59 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 115.717 1.747 . . . . 0.0 115.717 -175.674 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 88.6 p -133.36 0.34 3.35 Favored 'General case' 0 N--CA 1.479 1.003 0 N-CA-C 116.3 1.963 . . . . 0.0 116.3 179.401 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 2.4 tpt180 -112.82 -27.38 8.15 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 114.889 1.44 . . . . 0.0 114.889 178.766 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 3.0 t 63.77 166.63 0.14 Allowed 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 115.639 1.718 . . . . 0.0 115.639 -176.221 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -141.58 -50.06 0.41 Allowed 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 114.396 1.258 . . . . 0.0 114.396 -170.006 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 70.52 -38.78 0.43 Allowed 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 126.185 1.794 . . . . 0.0 114.096 -178.374 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -63.02 -30.79 71.88 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 113.992 1.108 . . . . 0.0 113.992 -173.73 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.2 pm0 -67.2 -42.42 84.18 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 119.568 1.077 . . . . 0.0 111.837 175.759 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -66.77 -41.31 93.75 Favored Glycine 0 C--N 1.335 0.48 0 N-CA-C 111.351 -0.7 . . . . 0.0 111.351 -178.324 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -70.89 -39.25 72.92 Favored 'General case' 0 N--CA 1.469 0.497 0 O-C-N 121.842 -0.799 . . . . 0.0 111.815 174.91 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -63.76 -35.92 82.19 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 119.375 0.989 . . . . 0.0 112.909 -176.08 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 7.5 pttp -82.72 -28.35 30.54 Favored 'General case' 0 N--CA 1.479 0.996 0 N-CA-C 113.972 1.101 . . . . 0.0 113.972 171.964 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 96.6 m -70.22 -35.74 74.08 Favored 'General case' 0 N--CA 1.486 1.341 0 CA-C-N 118.76 0.709 . . . . 0.0 111.937 175.093 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 74.1 mt -91.0 -38.03 13.08 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 125.92 1.688 . . . . 0.0 113.324 179.175 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -105.11 5.98 42.57 Favored Glycine 0 N--CA 1.471 1.008 0 N-CA-C 117.5 1.76 . . . . 0.0 117.5 -169.303 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.61 141.23 57.91 Favored 'General case' 0 CA--C 1.546 0.821 0 CA-C-N 121.149 2.474 . . . . 0.0 112.294 178.122 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 82.88 -16.93 24.46 Favored Glycine 0 CA--C 1.539 1.564 0 C-N-CA 124.868 1.223 . . . . 0.0 113.959 -169.539 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 62.7 mttp -104.0 -44.29 5.06 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 125.897 1.679 . . . . 0.0 112.172 171.808 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 38.1 pt -139.53 159.63 27.99 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 C-N-CA 125.323 1.449 . . . . 0.0 112.64 -178.257 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -107.85 149.23 28.52 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.378 1.471 . . . . 0.0 110.397 170.017 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 98.1 t -133.46 141.64 43.86 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 O-C-N 121.497 -0.752 . . . . 0.0 112.796 -176.173 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 38.8 m -134.91 153.33 52.1 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 125.732 1.613 . . . . 0.0 108.926 169.703 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 92.8 p -133.33 145.73 50.67 Favored 'General case' 0 CA--C 1.512 -0.497 0 CA-C-O 122.372 1.082 . . . . 0.0 112.179 167.774 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 54.4 p -145.97 166.53 25.77 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 113.714 -1.584 . . . . 0.0 112.199 -177.68 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -106.63 162.82 13.57 Favored Glycine 0 N--CA 1.467 0.753 0 C-N-CA 123.587 0.613 . . . . 0.0 112.754 172.986 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 9.0 mp -76.0 -32.27 59.33 Favored 'General case' 0 N--CA 1.479 1.024 0 O-C-N 122.144 -0.621 . . . . 0.0 111.819 172.988 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -134.29 27.23 3.8 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 125.734 1.614 . . . . 0.0 111.916 177.12 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 37.5 t -154.66 145.45 22.46 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 124.319 1.048 . . . . 0.0 112.796 -170.353 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 98.8 p -107.96 -13.04 15.05 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 116.853 2.168 . . . . 0.0 116.853 -169.679 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 71.7 ttt180 -134.38 149.12 50.79 Favored 'General case' 0 N--CA 1.483 1.217 0 CA-C-N 120.009 1.277 . . . . 0.0 111.072 -176.382 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 22.3 m -68.11 166.27 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.15 0 CA-C-O 122.908 1.337 . . . . 0.0 110.98 169.536 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 6.1 t-80 -57.04 129.87 79.18 Favored Pre-proline 0 N--CA 1.447 -0.586 0 CA-C-N 114.049 -1.432 . . . . 0.0 111.716 179.163 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_exo -61.1 -29.2 86.88 Favored 'Trans proline' 0 CA--C 1.549 1.25 0 CA-C-N 121.145 1.445 . . . . 0.0 112.3 177.506 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 99.3 m -67.64 -28.24 67.56 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 126.069 1.748 . . . . 0.0 112.656 172.918 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -59.68 -41.06 89.84 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 119.119 0.872 . . . . 0.0 111.748 -176.717 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.9 mp -54.17 -55.16 15.83 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 C-N-CA 123.976 0.91 . . . . 0.0 109.298 -177.585 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -65.83 -34.63 78.61 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 113.94 1.089 . . . . 0.0 113.94 -176.859 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -78.26 -20.57 51.38 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 113.676 0.991 . . . . 0.0 113.676 179.785 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 43.0 mtt -98.16 -26.78 14.45 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 125.032 1.333 . . . . 0.0 110.493 177.391 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -66.53 -13.82 61.47 Favored 'General case' 0 CA--C 1.544 0.717 0 O-C-N 120.662 -1.274 . . . . 0.0 111.784 168.525 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -61.83 -24.65 67.02 Favored 'General case' 0 N--CA 1.482 1.136 0 O-C-N 121.001 -1.062 . . . . 0.0 110.652 168.806 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 40.0 t -99.62 -6.77 9.15 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.882 0 C-N-CA 127.896 2.478 . . . . 0.0 111.275 175.358 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 81.68 20.82 62.95 Favored Glycine 0 CA--C 1.54 1.647 0 C-N-CA 125.293 1.425 . . . . 0.0 114.378 -173.44 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 85.7 mt -79.65 127.14 39.37 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 CA-C-N 118.485 1.143 . . . . 0.0 111.874 -173.51 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 20.7 t0 -89.15 93.73 9.68 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 123.538 0.735 . . . . 0.0 112.006 177.983 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 7.2 pt -118.27 11.08 7.03 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.082 0 C-N-CA 124.703 1.201 . . . . 0.0 113.957 170.761 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 72.7 m -60.42 -27.33 67.4 Favored 'General case' 0 N--CA 1.479 0.988 0 O-C-N 120.793 -1.192 . . . . 0.0 112.541 176.57 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -82.55 6.8 67.43 Favored Glycine 0 CA--C 1.538 1.472 0 C-N-CA 125.63 1.586 . . . . 0.0 116.031 174.976 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 26.5 mm100 -78.16 43.4 0.44 Allowed 'General case' 0 N--CA 1.478 0.969 0 CA-C-N 120.069 1.934 . . . . 0.0 113.599 -179.812 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 36.6 p -87.96 111.97 22.06 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 107.102 -1.444 . . . . 0.0 107.102 168.769 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 70.4 m -130.81 -160.59 1.05 Allowed 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 124.831 1.252 . . . . 0.0 111.374 -168.897 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -124.14 166.98 16.71 Favored Pre-proline 0 CA--C 1.546 0.797 0 C-N-CA 126.354 1.862 . . . . 0.0 108.464 169.543 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_endo -58.21 156.92 27.7 Favored 'Trans proline' 0 CA--C 1.539 0.761 0 C-N-CA 121.917 1.744 . . . . 0.0 112.38 169.573 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.492 HD11 ' CE3' ' A' ' 90' ' ' TRP . 9.8 tp -49.94 -34.02 9.51 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 C-N-CA 125.537 1.535 . . . . 0.0 112.363 174.183 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 12.7 mt-10 -64.32 -18.42 64.6 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.864 1.266 . . . . 0.0 113.126 -177.912 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -87.06 -13.9 43.01 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 124.994 1.318 . . . . 0.0 113.583 -173.255 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -104.67 -174.24 2.49 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 126.164 1.786 . . . . 0.0 112.686 -174.594 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 6.1 t30 -121.94 121.99 38.35 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 125.679 1.591 . . . . 0.0 109.519 175.035 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -64.11 -37.79 88.71 Favored 'General case' 0 C--N 1.333 -0.139 0 N-CA-C 114.943 1.46 . . . . 0.0 114.943 -169.617 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -73.64 -1.4 18.76 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 114.141 1.163 . . . . 0.0 114.141 -174.071 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -73.37 -14.87 61.36 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 123.392 0.677 . . . . 0.0 110.743 168.712 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 81.2 m-85 -112.44 140.57 47.07 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 127.315 2.246 . . . . 0.0 111.203 178.195 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -91.21 -22.58 20.55 Favored 'General case' 0 N--CA 1.477 0.879 0 CA-C-O 121.992 0.901 . . . . 0.0 112.303 176.939 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.714 HG22 ' HB ' ' A' ' 95' ' ' ILE . 90.5 t -134.5 138.1 50.26 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 C-N-CA 126.849 2.06 . . . . 0.0 108.948 -173.611 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 47.3 t -134.52 130.4 53.52 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 172.761 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 39.3 mm -119.0 104.83 16.51 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 C-N-CA 124.292 1.037 . . . . 0.0 109.717 -172.363 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 7.3 m -81.88 118.92 23.31 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 123.807 0.843 . . . . 0.0 109.634 171.359 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 90.5 mt -100.11 -7.23 25.13 Favored 'General case' 0 N--CA 1.478 0.929 0 N-CA-C 114.491 1.293 . . . . 0.0 114.491 -171.643 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 76.5 m -131.06 59.92 1.67 Allowed 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 125.217 1.407 . . . . 0.0 109.177 -169.745 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 82.4 -155.44 34.16 Favored Glycine 0 CA--C 1.536 1.354 0 C-N-CA 124.846 1.212 . . . . 0.0 111.602 -169.577 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 83.6 p -66.3 -29.91 70.22 Favored 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 113.483 0.92 . . . . 0.0 113.483 177.855 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 66.4 20.5 69.66 Favored Glycine 0 CA--C 1.534 1.247 0 C-N-CA 124.402 1.001 . . . . 0.0 114.11 -177.312 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 7.3 p -55.99 -9.89 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.34 0 N-CA-C 116.118 1.896 . . . . 0.0 116.118 -169.691 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -66.82 -22.18 66.01 Favored 'General case' 0 CA--C 1.554 1.124 0 N-CA-C 114.362 1.245 . . . . 0.0 114.362 169.953 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -67.82 154.51 93.41 Favored Pre-proline 0 N--CA 1.483 1.202 0 CA-C-N 120.903 1.683 . . . . 0.0 112.009 169.693 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.407 ' HA ' ' HD3' ' A' ' 88' ' ' PRO . 74.4 Cg_exo -57.71 148.51 73.86 Favored 'Trans proline' 0 CA--C 1.545 1.045 0 C-N-CA 122.698 2.265 . . . . 0.0 113.825 -175.975 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 87' ' ' PRO . 82.2 Cg_exo -56.04 -32.54 86.65 Favored 'Trans proline' 0 C--N 1.354 0.85 0 C-N-CA 123.12 2.547 . . . . 0.0 114.898 -171.755 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -60.51 -21.69 62.73 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 114.057 1.132 . . . . 0.0 114.057 179.411 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' TRP . . . . . 0.492 ' CE3' HD11 ' A' ' 65' ' ' ILE . 93.7 m95 -79.48 -21.52 45.29 Favored 'General case' 0 N--CA 1.47 0.529 0 O-C-N 120.695 -1.253 . . . . 0.0 113.169 175.0 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 14.2 m -92.42 -5.94 10.69 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 N-CA-C 113.481 0.919 . . . . 0.0 113.481 173.431 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 59.9 p -100.32 0.39 39.99 Favored 'General case' 0 N--CA 1.479 1.006 0 N-CA-C 115.29 1.589 . . . . 0.0 115.29 177.32 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 74.0 mm-40 -66.89 155.42 38.46 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-N 119.459 1.027 . . . . 0.0 110.722 169.789 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -54.78 -43.12 72.55 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 115.093 1.516 . . . . 0.0 115.093 -167.78 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.714 ' HB ' HG22 ' A' ' 75' ' ' VAL . 10.0 mm -116.53 66.39 0.23 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 C-N-CA 123.875 0.87 . . . . 0.0 109.579 176.932 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 12.2 t80 -77.04 108.71 10.3 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 168.595 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 9.1 mt-10 -107.62 142.58 37.34 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 114.321 1.23 . . . . 0.0 114.321 173.511 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -107.66 120.24 41.66 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 124.634 1.174 . . . . 0.0 108.23 168.381 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 37.3 m0 -103.84 133.67 48.44 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.545 1.138 . . . . 0.0 108.814 177.504 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 63.8 mt-30 -113.88 29.36 8.06 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 123.993 0.917 . . . . 0.0 111.987 -169.907 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -70.37 164.62 24.15 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 125.732 1.613 . . . . 0.0 112.292 170.621 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -73.63 158.71 34.25 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-O 121.773 0.797 . . . . 0.0 111.49 169.824 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -97.02 150.77 37.2 Favored Pre-proline 0 CA--C 1.542 0.653 0 C-N-CA 123.418 0.687 . . . . 0.0 110.055 169.797 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -88.59 -12.44 3.71 Favored 'Trans proline' 0 CA--C 1.547 1.152 0 CA-C-N 120.845 1.338 . . . . 0.0 115.072 -173.415 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -62.53 -50.27 72.04 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 114.928 1.455 . . . . 0.0 114.928 -170.82 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -77.24 16.69 5.63 Favored Glycine 0 CA--C 1.537 1.425 0 N-CA-C 115.256 0.862 . . . . 0.0 115.256 -169.825 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 7.9 pt20 -155.92 179.28 9.36 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 126.006 1.722 . . . . 0.0 112.63 -169.221 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 27.8 p -68.8 167.46 15.43 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 116.27 1.952 . . . . 0.0 116.27 -169.314 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 36.0 tp -59.88 -31.81 70.14 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.412 1.085 . . . . 0.0 112.46 172.945 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -63.46 -32.51 73.98 Favored 'General case' 0 N--CA 1.47 0.537 0 O-C-N 121.073 -1.017 . . . . 0.0 111.499 172.896 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 4.4 t -74.1 -35.07 40.21 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 O-C-N 121.2 -0.937 . . . . 0.0 112.069 171.54 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -55.59 -46.95 77.18 Favored 'General case' 0 N--CA 1.477 0.889 0 CA-C-N 120.424 1.466 . . . . 0.0 111.255 169.413 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 96.9 mtt180 -69.87 -33.91 72.87 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.75 0.82 . . . . 0.0 112.585 178.275 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 53.2 m -63.34 -42.89 98.98 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 123.787 0.835 . . . . 0.0 110.96 170.212 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 50.8 t -65.11 -40.56 89.28 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.475 0 CA-C-O 117.316 -1.326 . . . . 0.0 110.55 176.413 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 24.7 mtm105 -53.63 -47.38 70.34 Favored 'General case' 0 N--CA 1.484 1.248 0 CA-C-N 120.804 1.638 . . . . 0.0 112.287 170.879 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -61.36 -50.65 64.54 Favored Glycine 0 CA--C 1.537 1.417 0 CA-C-N 119.027 0.831 . . . . 0.0 113.644 177.743 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 65.2 mm-40 -63.49 -44.48 94.24 Favored 'General case' 0 N--CA 1.474 0.736 0 O-C-N 121.991 -0.711 . . . . 0.0 112.332 179.221 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 56.0 t -63.79 -43.73 98.02 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 C-N-CA 124.507 1.123 . . . . 0.0 110.603 176.485 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 59.5 tttm -53.56 -50.69 65.01 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-N 119.804 1.184 . . . . 0.0 111.295 179.602 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -63.58 -41.32 98.38 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 179.064 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 8.5 mtp85 -64.25 -42.12 96.65 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 113.145 0.794 . . . . 0.0 113.145 175.766 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 94.2 t -71.0 -36.44 63.53 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 C-N-CA 123.674 0.79 . . . . 0.0 111.156 178.71 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -63.31 -38.09 89.81 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 119.386 0.994 . . . . 0.0 111.606 170.724 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 12.5 m-80 -62.67 -48.02 81.12 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 118.914 0.779 . . . . 0.0 112.052 171.807 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 10.3 tt -50.45 -57.24 8.49 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 124.483 1.113 . . . . 0.0 110.07 173.809 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 75.3 mt -64.02 -42.57 96.1 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 CA-C-N 119.25 0.932 . . . . 0.0 111.56 -176.601 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -68.22 -10.46 54.62 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 114.535 1.309 . . . . 0.0 114.535 175.781 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 74.6 tttt -103.5 -45.78 4.75 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 126.049 1.74 . . . . 0.0 111.664 -179.813 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.573 HD13 HG21 ' A' ' 75' ' ' VAL . 5.4 pt -92.06 -16.53 7.88 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 N-CA-C 114.48 1.289 . . . . 0.0 114.48 -170.293 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 72.5 m . . . . . 0 C--O 1.253 1.281 0 CA-C-N 118.913 0.778 . . . . 0.0 112.9 -175.603 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.1 ttt . . . . . 0 N--CA 1.502 2.151 0 N-CA-C 111.615 0.228 . . . . 0.0 111.615 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.75 166.5 25.06 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 124.768 1.227 . . . . 0.0 113.654 177.266 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 44.2 mtmt -94.76 138.71 32.23 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 126.154 1.782 . . . . 0.0 112.954 -179.191 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 21.2 t -123.6 133.51 68.99 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 C-N-CA 126.036 1.734 . . . . 0.0 112.479 -179.151 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' MET . . . . . 0.494 ' HG3' HG13 ' A' ' 7' ' ' VAL . 41.8 tpp -104.66 125.51 50.85 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.562 0.745 . . . . 0.0 109.492 168.888 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 58.6 m-85 -102.81 127.72 49.86 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.266 1.026 . . . . 0.0 109.667 170.351 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.531 HG11 HD12 ' A' ' 65' ' ' ILE . 1.3 m -140.51 144.98 26.46 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.182 0 N-CA-C 114.414 1.265 . . . . 0.0 114.414 -168.862 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 41.7 t -157.06 159.65 38.15 Favored 'General case' 0 CA--C 1.556 1.18 0 C-N-CA 127.369 2.268 . . . . 0.0 111.974 177.443 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 17.9 ptpt -90.57 157.67 17.39 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 124.997 1.319 . . . . 0.0 111.638 169.522 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 34.1 mtp180 60.15 25.47 14.81 Favored 'General case' 0 N--CA 1.494 1.746 0 C-N-CA 126.074 1.75 . . . . 0.0 113.804 -169.098 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 5.8 t30 -52.95 -38.61 62.18 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 124.839 1.256 . . . . 0.0 114.045 -169.449 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 50.2 m -80.31 -8.34 59.44 Favored 'General case' 0 N--CA 1.478 0.96 0 N-CA-C 114.692 1.367 . . . . 0.0 114.692 -178.621 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 83.6 p -119.76 16.54 12.72 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 125.394 1.478 . . . . 0.0 112.996 170.672 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 19.5 ttm180 -139.49 156.06 47.17 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 125.653 1.581 . . . . 0.0 112.115 -175.78 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 73.0 m -94.76 138.08 33.03 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 125.015 1.326 . . . . 0.0 111.046 169.785 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 3.9 mp0 -113.71 -39.1 4.1 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 124.291 1.037 . . . . 0.0 112.497 -177.1 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' MET . . . . . 0.43 ' HG2' ' SD ' ' A' ' 50' ' ' MET . 0.0 OUTLIER 68.96 -50.98 0.59 Allowed 'General case' 0 N--CA 1.478 0.954 0 N-CA-C 117.641 2.46 . . . . 0.0 117.641 169.212 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -56.73 -35.3 68.4 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 114.398 1.258 . . . . 0.0 114.398 -169.246 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 23.4 pm0 -61.13 -40.06 92.37 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.944 1.297 . . . . 0.0 112.711 177.137 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -69.91 -37.77 74.79 Favored Glycine 0 C--N 1.336 0.554 0 N-CA-C 111.377 -0.689 . . . . 0.0 111.377 178.46 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -70.43 -40.25 73.9 Favored 'General case' 0 N--CA 1.47 0.546 0 O-C-N 121.89 -0.771 . . . . 0.0 111.184 176.514 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.21 -41.79 97.46 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 119.024 0.829 . . . . 0.0 112.527 -175.567 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 10.5 pttp -79.49 -27.53 41.48 Favored 'General case' 0 N--CA 1.479 1.013 0 N-CA-C 113.662 0.986 . . . . 0.0 113.662 173.891 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 96.3 m -68.84 -36.59 78.34 Favored 'General case' 0 N--CA 1.486 1.342 0 O-C-N 121.185 -0.947 . . . . 0.0 111.636 172.81 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 72.1 mt -87.89 -29.67 20.7 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 125.656 1.582 . . . . 0.0 114.037 -178.489 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -146.03 28.95 1.69 Allowed Glycine 0 N--CA 1.473 1.129 0 N-CA-C 118.502 2.161 . . . . 0.0 118.502 -169.206 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -66.62 -20.2 65.94 Favored 'General case' 0 CA--C 1.546 0.813 0 CA-C-N 122.108 2.954 . . . . 0.0 115.197 -177.995 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -76.49 -7.73 85.5 Favored Glycine 0 CA--C 1.542 1.771 0 O-C-N 121.432 -0.793 . . . . 0.0 113.597 169.575 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 61.1 mttp -111.33 -40.73 4.32 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 127.088 2.155 . . . . 0.0 112.692 -178.872 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 28.3 pt -141.09 155.71 21.63 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 C-N-CA 125.366 1.466 . . . . 0.0 112.42 -172.806 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -103.06 136.6 42.56 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 124.678 1.191 . . . . 0.0 110.199 171.909 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 74.6 t -123.54 137.18 57.65 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 CA-C-N 118.814 0.734 . . . . 0.0 112.134 -175.327 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 41.4 m -129.59 153.71 47.8 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 125.566 1.547 . . . . 0.0 108.763 169.844 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 26.0 p -129.59 146.33 51.4 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.806 0.812 . . . . 0.0 111.991 168.671 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 59.4 p -145.78 148.17 32.66 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 114.247 -1.342 . . . . 0.0 112.117 177.45 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -82.32 152.66 31.16 Favored Glycine 0 CA--C 1.53 1.009 0 O-C-N 121.429 -0.794 . . . . 0.0 111.493 172.646 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.7 mp -69.4 -32.8 72.04 Favored 'General case' 0 N--CA 1.477 0.877 0 O-C-N 120.843 -1.387 . . . . 0.0 113.389 179.006 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -134.77 11.9 3.68 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 124.683 1.193 . . . . 0.0 113.027 178.641 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 23.6 p -152.73 173.89 14.71 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 125.227 1.411 . . . . 0.0 112.013 -174.71 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 62.6 m -99.0 -73.39 0.62 Allowed 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 113.738 1.014 . . . . 0.0 113.738 -169.838 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 30.3 ttt85 -86.18 165.89 16.18 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 125.906 1.682 . . . . 0.0 111.463 -169.397 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 21.3 m -82.57 166.38 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 C-N-CA 123.258 0.623 . . . . 0.0 111.316 170.356 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . 0.262 0.0 OUTLIER -67.67 137.76 93.12 Favored Pre-proline 0 CA--C 1.545 0.766 0 C-N-CA 118.971 -1.091 . . . . 0.0 109.879 169.752 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -61.38 -30.06 86.65 Favored 'Trans proline' 0 CA--C 1.537 0.67 0 C-N-CA 123.219 2.613 . . . . 0.0 116.148 -167.793 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 90.7 m -64.14 -23.96 67.51 Favored 'General case' 0 N--CA 1.481 1.075 0 O-C-N 120.969 -1.082 . . . . 0.0 111.86 -177.939 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -55.67 -38.62 69.85 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.117 0.967 . . . . 0.0 112.507 172.513 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 5.0 mp -60.22 -54.7 31.26 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 CA-C-N 119.588 1.085 . . . . 0.0 110.018 179.863 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.3 -32.09 73.41 Favored 'General case' 0 CA--C 1.542 0.656 0 N-CA-C 113.222 0.823 . . . . 0.0 113.222 -178.535 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 2.1 tpp -77.71 -25.6 49.48 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 113.679 0.992 . . . . 0.0 113.679 177.176 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' MET . . . . . 0.43 ' SD ' ' HG2' ' A' ' 17' ' ' MET . 0.0 OUTLIER -88.01 -26.84 22.4 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-N 119.723 1.147 . . . . 0.0 111.04 174.145 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -65.12 -11.83 44.22 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 124.998 1.319 . . . . 0.0 113.219 169.917 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 17.9 mt-10 -61.7 -27.05 68.42 Favored 'General case' 0 N--CA 1.485 1.29 0 CA-C-N 120.012 1.278 . . . . 0.0 110.26 168.551 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 21.6 t -98.27 -1.52 10.17 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.958 0 C-N-CA 128.232 2.613 . . . . 0.0 110.829 178.774 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 77.04 20.13 76.3 Favored Glycine 0 CA--C 1.538 1.512 0 C-N-CA 125.041 1.305 . . . . 0.0 114.474 -176.036 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 70.5 mt -80.25 128.12 38.86 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 124.279 1.032 . . . . 0.0 111.72 -172.122 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 10.4 p-10 -88.22 100.35 12.91 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 124.372 1.069 . . . . 0.0 112.582 -179.734 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 12.9 pt -133.25 15.4 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.141 0 N-CA-C 114.934 1.457 . . . . 0.0 114.934 178.473 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 66.5 m -63.56 -19.77 65.09 Favored 'General case' 0 N--CA 1.481 1.09 0 O-C-N 120.32 -1.487 . . . . 0.0 113.293 177.514 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -85.41 10.08 65.3 Favored Glycine 0 CA--C 1.538 1.506 0 C-N-CA 125.993 1.759 . . . . 0.0 116.59 179.636 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 64.3 mt-30 -71.96 40.45 0.08 Allowed 'General case' 0 N--CA 1.486 1.34 0 CA-C-N 120.334 2.067 . . . . 0.0 114.699 -178.753 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 88.8 m -80.98 -4.56 55.51 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 119.788 -1.82 . . . . 0.0 112.662 177.198 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 70.5 m -45.11 146.4 0.87 Allowed 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 127.416 2.287 . . . . 0.0 114.323 176.332 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -67.69 171.51 5.18 Favored Pre-proline 0 CA--C 1.553 1.087 0 C-N-CA 127.169 2.188 . . . . 0.0 114.1 -175.558 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -59.03 160.06 19.8 Favored 'Trans proline' 0 C--N 1.353 0.798 0 C-N-CA 122.987 2.458 . . . . 0.0 113.621 169.73 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.531 HD12 HG11 ' A' ' 7' ' ' VAL . 7.6 tt -51.21 -37.6 18.11 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 C-N-CA 124.864 1.266 . . . . 0.0 111.854 174.988 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 14.1 mt-10 -64.61 -17.4 63.96 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.715 1.206 . . . . 0.0 113.111 -177.269 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -83.71 -12.3 56.01 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 124.927 1.291 . . . . 0.0 113.233 -178.31 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -106.94 -175.31 2.76 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 126.449 1.9 . . . . 0.0 112.723 -175.603 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 5.6 t30 -124.35 124.35 42.18 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 126.008 1.723 . . . . 0.0 109.103 174.942 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.74 -34.29 77.52 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 114.012 1.115 . . . . 0.0 114.012 -169.937 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . 0.264 0.0 OUTLIER -71.24 -4.58 26.49 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 114.06 1.133 . . . . 0.0 114.06 -177.752 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -72.94 -12.75 61.07 Favored 'General case' 0 CA--C 1.549 0.942 0 C-N-CA 123.4 0.68 . . . . 0.0 111.012 168.52 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 88.6 m-85 -118.19 138.5 52.27 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 126.806 2.042 . . . . 0.0 111.562 -177.713 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -89.08 -22.15 23.06 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-O 122.104 0.954 . . . . 0.0 112.38 176.404 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.712 HG22 ' HB ' ' A' ' 95' ' ' ILE . 77.9 t -131.44 138.59 52.74 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 C-N-CA 127.136 2.174 . . . . 0.0 108.908 -175.895 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 48.5 t -131.49 123.93 53.57 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 169.899 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 45.2 mm -109.42 103.72 15.95 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 C-N-CA 124.6 1.16 . . . . 0.0 109.536 -176.377 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 13.2 m -83.35 102.07 11.75 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 124.333 1.053 . . . . 0.0 109.439 169.989 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 92.4 mt -72.37 -36.25 68.69 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 112.755 0.65 . . . . 0.0 112.755 -177.371 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 36.4 m -112.05 122.27 47.3 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 125.61 1.564 . . . . 0.0 110.492 -169.221 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 62.9 -157.28 39.23 Favored Glycine 0 CA--C 1.537 1.455 0 C-N-CA 123.626 0.631 . . . . 0.0 114.055 -175.737 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 50.3 m -90.08 0.08 57.32 Favored 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 114.8 1.407 . . . . 0.0 114.8 -172.806 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 71.34 29.16 68.67 Favored Glycine 0 CA--C 1.535 1.315 0 O-C-N 121.478 -0.764 . . . . 0.0 114.609 179.249 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 60.0 t -90.46 -17.6 7.86 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.384 0 CA-C-N 118.216 1.008 . . . . 0.0 112.144 -179.69 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -84.23 12.63 6.26 Favored 'General case' 0 CA--C 1.555 1.144 0 C-N-CA 124.955 1.302 . . . . 0.0 113.641 -173.418 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -119.88 163.85 25.51 Favored Pre-proline 0 CA--C 1.552 1.047 0 C-N-CA 126.186 1.794 . . . . 0.0 112.464 177.671 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.415 ' HA ' ' HD3' ' A' ' 88' ' ' PRO . 52.0 Cg_exo -63.53 150.1 89.35 Favored 'Trans proline' 0 CA--C 1.545 1.064 0 C-N-CA 122.437 2.091 . . . . 0.0 113.981 -178.16 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 87' ' ' PRO . 74.7 Cg_exo -58.44 -27.96 83.63 Favored 'Trans proline' 0 C--N 1.353 0.789 0 C-N-CA 123.442 2.762 . . . . 0.0 115.559 -173.215 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -61.11 -24.14 66.03 Favored 'General case' 0 CA--C 1.544 0.725 0 O-C-N 120.976 -1.077 . . . . 0.0 113.214 177.059 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 89.6 m95 -82.96 -23.52 33.38 Favored 'General case' 0 N--CA 1.469 0.491 0 O-C-N 120.791 -1.193 . . . . 0.0 113.2 176.901 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 4.4 m -85.15 -18.98 8.91 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.228 0 CA-C-N 119.331 0.968 . . . . 0.0 113.142 173.084 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -88.53 -2.18 58.45 Favored 'General case' 0 N--CA 1.478 0.958 0 N-CA-C 114.847 1.425 . . . . 0.0 114.847 -177.517 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 73.0 mm-40 -66.33 157.07 32.65 Favored 'General case' 0 N--CA 1.481 1.08 0 O-C-N 120.963 -1.086 . . . . 0.0 111.575 171.126 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -59.28 -42.22 90.71 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 114.245 1.202 . . . . 0.0 114.245 -168.304 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.712 ' HB ' HG22 ' A' ' 75' ' ' VAL . 21.1 mm -117.88 61.75 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 C-N-CA 124.883 1.273 . . . . 0.0 108.949 179.273 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 19.9 t80 -78.18 110.42 13.15 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 168.967 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 24.9 mt-10 -114.54 137.3 52.04 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 114.047 1.129 . . . . 0.0 114.047 175.185 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -105.37 121.42 43.85 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 124.935 1.294 . . . . 0.0 108.852 169.176 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 42.9 m0 -100.52 -18.22 16.75 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 115.871 1.804 . . . . 0.0 115.871 -168.921 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 41.6 mm-40 55.11 30.61 14.69 Favored 'General case' 0 CA--C 1.555 1.158 0 N-CA-C 113.964 1.098 . . . . 0.0 113.964 174.19 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 30.0 mt -84.22 158.63 21.22 Favored 'General case' 0 N--CA 1.47 0.54 0 O-C-N 120.768 -1.208 . . . . 0.0 112.82 -170.3 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 9.7 tt0 -69.35 133.77 48.24 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.513 169.9 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 16.3 p-10 -90.46 137.66 27.3 Favored Pre-proline 0 CA--C 1.551 0.988 0 C-N-CA 126.011 1.724 . . . . 0.0 112.057 173.068 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_exo -67.79 -14.55 41.95 Favored 'Trans proline' 0 CA--C 1.551 1.333 0 C-N-CA 122.35 2.033 . . . . 0.0 115.358 178.225 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -59.25 136.73 58.05 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 124.773 1.229 . . . . 0.0 113.541 -175.902 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 76.46 8.99 86.11 Favored Glycine 0 CA--C 1.536 1.377 0 C-N-CA 124.449 1.023 . . . . 0.0 115.019 175.52 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 12.7 pt20 -141.17 168.92 18.62 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 125.53 1.532 . . . . 0.0 112.592 -179.131 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 28.1 p -66.54 166.08 13.36 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 115.453 1.649 . . . . 0.0 115.453 -169.407 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . 0.315 2.4 pp -68.72 -12.81 61.87 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 114.298 1.221 . . . . 0.0 114.298 173.887 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -70.81 -32.96 70.21 Favored 'General case' 0 CA--C 1.541 0.597 0 O-C-N 121.094 -1.004 . . . . 0.0 109.717 168.785 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 5.3 t -70.63 -40.18 76.8 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 CA-C-O 117.876 -1.059 . . . . 0.0 111.255 170.009 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 14.3 m-85 -54.05 -52.12 61.9 Favored 'General case' 0 N--CA 1.478 0.941 0 CA-C-N 120.287 1.403 . . . . 0.0 111.03 169.356 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 97.6 mtt180 -60.95 -38.69 86.77 Favored 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 124.03 0.932 . . . . 0.0 112.385 -179.138 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 75.2 m -64.84 -43.68 92.24 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.949 0.899 . . . . 0.0 111.341 172.776 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 54.5 t -66.72 -40.6 86.45 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 CA-C-O 117.739 -1.124 . . . . 0.0 111.213 177.973 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 47.8 mtm-85 -57.04 -41.06 77.95 Favored 'General case' 0 N--CA 1.482 1.153 0 CA-C-N 120.733 1.606 . . . . 0.0 111.295 174.13 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -60.92 -51.84 56.05 Favored Glycine 0 CA--C 1.537 1.462 0 CA-C-N 118.935 0.788 . . . . 0.0 113.597 173.995 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 60.6 mm-40 -63.89 -44.94 91.51 Favored 'General case' 0 N--CA 1.477 0.882 0 O-C-N 121.965 -0.727 . . . . 0.0 112.199 179.087 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 77.4 t -65.71 -40.61 88.35 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 C-N-CA 124.949 1.3 . . . . 0.0 110.711 178.201 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 36.2 ttmt -54.68 -50.3 68.58 Favored 'General case' 0 N--CA 1.478 0.948 0 CA-C-N 120.311 1.414 . . . . 0.0 110.41 175.989 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -61.8 -41.31 97.59 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 122.759 0.423 . . . . 0.0 112.119 178.821 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.63 -34.36 78.05 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 124.224 1.01 . . . . 0.0 113.561 176.824 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 97.3 t -80.19 -36.43 16.55 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 C-N-CA 125.353 1.461 . . . . 0.0 111.931 176.576 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -62.61 -39.56 94.19 Favored 'General case' 0 N--CA 1.47 0.536 0 O-C-N 120.885 -1.134 . . . . 0.0 110.97 170.09 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 14.2 m-80 -64.23 -44.72 90.98 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 118.747 0.703 . . . . 0.0 112.598 173.731 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 1.2 tt -48.22 -61.41 2.01 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 125.01 1.324 . . . . 0.0 109.702 172.233 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 82.9 mt -60.4 -44.98 97.28 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 C-N-CA 123.24 0.616 . . . . 0.0 110.648 -177.916 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -65.78 -12.76 56.66 Favored 'General case' 0 CA--C 1.547 0.853 0 N-CA-C 114.812 1.412 . . . . 0.0 114.812 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 21.1 ptmt -104.11 -27.13 12.27 Favored 'General case' 0 N--CA 1.477 0.904 0 N-CA-C 114.188 1.181 . . . . 0.0 114.188 172.494 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 16.3 pt -95.22 -12.88 8.42 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 N-CA-C 114.625 1.343 . . . . 0.0 114.625 178.618 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 70.1 m . . . . . 0 C--O 1.254 1.335 0 C-N-CA 125.146 1.379 . . . . 0.0 112.501 -179.742 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 36.4 ttm . . . . . 0 N--CA 1.501 2.083 0 N-CA-C 111.793 0.294 . . . . 0.0 111.793 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.0 163.17 30.47 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 125.151 1.38 . . . . 0.0 111.574 169.439 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 34.5 ttmt -101.63 144.17 30.69 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 124.639 1.175 . . . . 0.0 112.513 -179.044 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 21.7 t -124.15 135.09 64.79 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 125.33 1.452 . . . . 0.0 112.561 -176.358 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' MET . . . . . 0.53 ' HG3' HG13 ' A' ' 7' ' ' VAL . 49.8 tpp -103.74 125.91 50.53 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.396 0.678 . . . . 0.0 109.716 169.565 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 32.4 m-85 -108.73 121.96 46.13 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.917 1.287 . . . . 0.0 109.04 170.519 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.53 HG13 ' HG3' ' A' ' 5' ' ' MET . 2.8 m -140.5 159.32 24.9 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 N-CA-C 115.267 1.58 . . . . 0.0 115.267 -168.619 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.6 m -150.98 160.85 43.66 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 128.529 2.731 . . . . 0.0 110.693 169.68 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 64.8 pttt -82.77 138.38 34.03 Favored 'General case' 0 N--CA 1.48 1.031 0 O-C-N 121.061 -1.024 . . . . 0.0 112.4 171.283 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 20.5 tpt180 44.31 55.06 5.82 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 126.388 1.875 . . . . 0.0 112.729 -169.879 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 63.3 t30 -50.54 -22.12 1.83 Allowed 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 127.725 2.41 . . . . 0.0 113.475 175.012 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 31.1 m -53.2 -22.64 6.95 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 125.885 1.674 . . . . 0.0 113.929 170.473 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 58.7 m -112.35 157.52 20.91 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 126.212 1.805 . . . . 0.0 111.136 171.021 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 61.9 mtt85 61.26 168.9 0.1 Allowed 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 126.468 1.907 . . . . 0.0 114.728 -178.166 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 62.2 m -113.98 122.48 47.07 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 125.493 1.517 . . . . 0.0 110.165 -177.333 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 3.2 mp0 -97.21 -33.89 11.31 Favored 'General case' 0 N--CA 1.48 1.06 0 N-CA-C 115.748 1.759 . . . . 0.0 115.748 -168.647 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 70.1 -46.67 0.61 Allowed 'General case' 0 N--CA 1.482 1.158 0 N-CA-C 118.313 2.709 . . . . 0.0 118.313 168.804 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.69 -30.13 70.54 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 115.169 1.544 . . . . 0.0 115.169 -169.449 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 5.7 pm0 -61.76 -39.1 90.45 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 118.813 0.733 . . . . 0.0 111.854 172.045 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -69.45 -44.77 63.08 Favored Glycine 0 C--N 1.334 0.457 0 C-N-CA 124.216 0.912 . . . . 0.0 111.783 -177.467 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -68.67 -36.01 77.98 Favored 'General case' 0 N--CA 1.467 0.412 0 O-C-N 121.569 -0.959 . . . . 0.0 112.152 173.965 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -65.02 -34.97 79.7 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 119.345 0.975 . . . . 0.0 112.363 178.952 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 22.2 mtpp -67.26 -48.86 66.49 Favored 'General case' 0 N--CA 1.481 1.094 0 O-C-N 121.884 -0.51 . . . . 0.0 111.217 169.572 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 24.7 m -73.71 -28.12 61.55 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 113.239 0.829 . . . . 0.0 113.239 -169.568 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 56.8 mt -97.2 -35.14 10.86 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 125.612 1.565 . . . . 0.0 112.96 176.043 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -103.47 -10.44 35.9 Favored Glycine 0 N--CA 1.469 0.884 0 N-CA-C 117.243 1.657 . . . . 0.0 117.243 -169.157 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -62.81 140.04 58.75 Favored 'General case' 0 CA--C 1.544 0.726 0 CA-C-N 120.936 2.368 . . . . 0.0 112.06 179.805 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 89.88 -21.24 31.34 Favored Glycine 0 CA--C 1.541 1.688 0 C-N-CA 125.048 1.309 . . . . 0.0 113.374 -169.342 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -101.44 -50.71 3.67 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 125.942 1.697 . . . . 0.0 111.026 169.853 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 2.6 pp -131.35 155.93 42.24 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 C-N-CA 125.813 1.645 . . . . 0.0 111.721 179.225 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -103.24 151.62 22.44 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 124.783 1.233 . . . . 0.0 109.718 175.402 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 44.4 t -138.07 142.77 34.85 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.051 0 O-C-N 121.282 -0.886 . . . . 0.0 113.061 -173.716 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 29.6 m -132.93 152.69 51.87 Favored 'General case' 0 CA--C 1.513 -0.465 0 C-N-CA 125.478 1.511 . . . . 0.0 108.029 168.792 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 2.8 p -132.57 141.36 48.67 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 122.283 1.04 . . . . 0.0 111.533 169.638 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 59.9 p -152.3 -174.46 4.89 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 113.599 -1.637 . . . . 0.0 110.209 178.857 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -135.16 170.89 22.72 Favored Glycine 0 C--N 1.335 0.495 0 O-C-N 121.142 -0.974 . . . . 0.0 112.351 174.195 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 6.2 mp -89.86 124.07 34.37 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 105.556 -2.016 . . . . 0.0 105.556 168.633 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 60.25 26.96 16.46 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 124.852 1.261 . . . . 0.0 113.439 -175.018 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 26.9 p -169.51 156.82 6.88 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 125.876 1.671 . . . . 0.0 112.773 -174.474 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 88.6 p -110.16 -51.63 2.85 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 115.546 1.684 . . . . 0.0 115.546 178.396 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 56.6 ttt180 -115.58 139.69 49.85 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 126.779 2.031 . . . . 0.0 113.988 -168.527 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 10.7 m -51.61 148.99 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 126.636 1.975 . . . . 0.0 111.924 169.365 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -62.26 144.65 94.68 Favored Pre-proline 0 CA--C 1.551 1.01 0 CA-C-O 118.893 -0.575 . . . . 0.0 110.448 176.263 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_exo -47.93 -36.04 26.29 Favored 'Trans proline' 0 CA--C 1.538 0.719 0 C-N-CA 124.087 3.191 . . . . 0.0 118.319 -168.12 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 58.7 m -59.64 -27.03 65.99 Favored 'General case' 0 N--CA 1.483 1.187 0 CA-C-N 119.622 1.101 . . . . 0.0 112.166 -178.228 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -55.85 -37.64 69.01 Favored 'General case' 0 CA--C 1.535 0.365 0 C-N-CA 124.113 0.965 . . . . 0.0 113.059 175.247 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.6 mp -63.86 -54.28 33.86 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 CA-C-N 119.183 0.901 . . . . 0.0 108.628 -178.428 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -62.98 -35.44 80.17 Favored 'General case' 0 CA--C 1.544 0.729 0 N-CA-C 113.361 0.874 . . . . 0.0 113.361 -177.552 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -77.75 -23.77 49.21 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 113.923 1.083 . . . . 0.0 113.923 178.188 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -87.93 -29.71 20.63 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 118.948 0.794 . . . . 0.0 109.732 174.612 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -67.19 -13.14 61.68 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.315 1.446 . . . . 0.0 113.791 172.338 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 -60.09 -26.24 66.04 Favored 'General case' 0 N--CA 1.482 1.171 0 CA-C-N 120.452 1.478 . . . . 0.0 110.641 168.836 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 40.8 t -98.26 -0.42 10.36 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.02 0 C-N-CA 127.668 2.387 . . . . 0.0 111.232 178.471 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 78.28 18.62 75.92 Favored Glycine 0 CA--C 1.541 1.675 0 C-N-CA 125.076 1.322 . . . . 0.0 114.878 -176.529 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 77.1 mt -81.68 133.66 28.77 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 C-N-CA 124.929 1.291 . . . . 0.0 111.736 -172.514 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 31.6 t0 -98.21 116.95 31.51 Favored 'General case' 0 N--CA 1.473 0.725 0 CA-C-O 121.41 0.624 . . . . 0.0 111.96 169.942 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 19.4 pt -127.97 19.43 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 C-N-CA 126.24 1.816 . . . . 0.0 112.379 171.059 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 98.1 p -70.68 -16.23 62.78 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 115.39 1.626 . . . . 0.0 115.39 -173.874 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -82.69 -0.96 90.48 Favored Glycine 0 CA--C 1.537 1.466 0 C-N-CA 124.762 1.172 . . . . 0.0 115.922 -177.139 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 4.4 tt0 -68.36 -6.15 22.78 Favored 'General case' 0 CA--C 1.547 0.836 0 N-CA-C 116.402 2.001 . . . . 0.0 116.402 -170.29 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.3 m -67.53 -7.83 29.06 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 125.86 1.664 . . . . 0.0 114.6 -170.809 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 78.2 p -64.73 -78.9 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 115.524 1.676 . . . . 0.0 115.524 -170.541 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -148.59 157.85 40.91 Favored Pre-proline 0 CA--C 1.554 1.133 0 N-CA-C 115.459 1.651 . . . . 0.0 115.459 -169.283 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -69.55 163.71 37.08 Favored 'Trans proline' 0 C--N 1.354 0.865 0 C-N-CA 124.967 3.778 . . . . 0.0 114.921 170.107 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 6.0 tt -52.82 -44.69 48.88 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 C-N-CA 124.905 1.282 . . . . 0.0 111.851 178.054 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -66.93 -9.56 39.56 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 114.092 1.145 . . . . 0.0 114.092 -177.681 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 -81.12 -22.67 38.9 Favored 'General case' 0 CA--C 1.548 0.899 0 N-CA-C 113.129 0.789 . . . . 0.0 113.129 174.145 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 82.1 m-85 -94.19 -169.98 2.19 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 125.805 1.642 . . . . 0.0 112.159 -177.251 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -124.6 124.76 42.91 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 125.657 1.583 . . . . 0.0 109.791 176.375 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -67.42 -34.9 78.18 Favored 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 114.241 1.2 . . . . 0.0 114.241 -170.125 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . 0.252 0.0 OUTLIER -72.19 -5.09 33.24 Favored 'General case' 0 CA--C 1.545 0.778 0 N-CA-C 114.163 1.172 . . . . 0.0 114.163 -176.457 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -73.93 -11.39 60.34 Favored 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 123.833 0.853 . . . . 0.0 111.244 168.711 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 74.5 m-85 -117.36 139.57 50.69 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 127.379 2.272 . . . . 0.0 111.251 -179.664 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -92.17 -23.51 19.37 Favored 'General case' 0 N--CA 1.479 1.004 0 CA-C-O 122.359 1.076 . . . . 0.0 112.342 177.055 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.69 HG22 ' HB ' ' A' ' 95' ' ' ILE . 80.3 t -129.56 138.12 55.06 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 C-N-CA 127.252 2.221 . . . . 0.0 108.886 -176.429 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 83.0 t -131.94 127.82 58.82 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 N-CA-C 107.562 -1.273 . . . . 0.0 107.562 170.694 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 27.5 mm -119.31 117.07 52.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 C-N-CA 124.356 1.063 . . . . 0.0 109.251 -178.162 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 22.6 t -98.54 130.93 45.11 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 122.596 0.359 . . . . 0.0 110.553 169.609 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 8.3 mt -101.32 0.51 37.32 Favored 'General case' 0 N--CA 1.478 0.95 0 N-CA-C 113.779 1.029 . . . . 0.0 113.779 178.838 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 84.6 m -135.95 146.67 47.52 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.213 1.005 . . . . 0.0 113.186 -169.977 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 63.15 -146.57 50.45 Favored Glycine 0 CA--C 1.532 1.147 0 C-N-CA 124.547 1.07 . . . . 0.0 114.356 170.149 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 93.9 p -86.1 -16.61 37.48 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 125.212 1.405 . . . . 0.0 114.593 -178.907 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 76.68 6.83 85.43 Favored Glycine 0 CA--C 1.54 1.6 0 C-N-CA 124.32 0.962 . . . . 0.0 114.598 -170.278 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 58.6 t -88.68 -22.27 6.69 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.162 0 CA-C-N 119.017 1.408 . . . . 0.0 113.118 -175.377 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 34.2 m120 -71.62 -19.47 62.11 Favored 'General case' 0 CA--C 1.547 0.86 0 N-CA-C 114.545 1.313 . . . . 0.0 114.545 -174.452 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -79.19 148.01 70.31 Favored Pre-proline 0 CA--C 1.549 0.915 0 CA-C-N 118.929 0.786 . . . . 0.0 111.768 176.557 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -59.42 155.11 43.05 Favored 'Trans proline' 0 CA--C 1.543 0.974 0 C-N-CA 122.769 2.313 . . . . 0.0 114.151 -178.164 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_exo -55.01 -32.46 79.09 Favored 'Trans proline' 0 C--N 1.35 0.649 0 C-N-CA 123.46 2.773 . . . . 0.0 114.412 -177.318 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -63.62 -31.78 73.05 Favored 'General case' 0 N--CA 1.471 0.617 0 O-C-N 121.277 -0.889 . . . . 0.0 113.025 177.911 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 94.8 m95 -80.4 -32.34 37.51 Favored 'General case' 0 N--CA 1.473 0.68 0 O-C-N 121.071 -1.018 . . . . 0.0 111.989 175.428 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 75.8 t -67.57 -31.97 54.94 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 C-N-CA 124.499 1.12 . . . . 0.0 112.159 172.527 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -91.98 3.33 55.45 Favored 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 115.799 1.777 . . . . 0.0 115.799 -171.513 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 80.2 mm-40 -65.6 155.17 36.65 Favored 'General case' 0 N--CA 1.478 0.941 0 O-C-N 120.741 -1.224 . . . . 0.0 111.547 170.651 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -56.18 -41.28 75.25 Favored 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 114.466 1.284 . . . . 0.0 114.466 -167.638 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.69 ' HB ' HG22 ' A' ' 75' ' ' VAL . 18.7 mm -119.31 64.57 0.23 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 C-N-CA 125.089 1.356 . . . . 0.0 108.407 177.308 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 15.9 t80 -79.54 108.29 12.96 Favored 'General case' 0 CA--C 1.534 0.356 0 O-C-N 120.989 -1.07 . . . . 0.0 108.77 169.326 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 11.1 mt-10 -110.32 146.47 35.69 Favored 'General case' 0 CA--C 1.545 0.756 0 N-CA-C 114.627 1.343 . . . . 0.0 114.627 174.591 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -114.36 117.21 30.41 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 125.566 1.546 . . . . 0.0 110.022 169.914 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 39.4 m0 -104.96 106.94 17.65 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 124.63 1.172 . . . . 0.0 109.884 -176.482 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 11.2 mm100 -86.9 47.95 1.57 Allowed 'General case' 0 CA--C 1.547 0.862 0 CA-C-O 122.118 0.961 . . . . 0.0 111.843 -172.309 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 89.7 mt -75.36 162.65 28.2 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 126.22 1.808 . . . . 0.0 112.297 178.434 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -79.01 149.57 32.17 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-O 121.351 0.596 . . . . 0.0 112.457 170.902 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -83.19 127.57 68.41 Favored Pre-proline 0 CA--C 1.544 0.728 0 C-N-CA 123.96 0.904 . . . . 0.0 110.854 174.31 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -82.04 -16.42 8.65 Favored 'Trans proline' 0 CA--C 1.542 0.92 0 C-N-CA 121.335 1.357 . . . . 0.0 115.242 -170.701 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -72.62 -39.81 66.95 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 116.77 2.137 . . . . 0.0 116.77 -168.788 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -75.3 16.79 3.48 Favored Glycine 0 CA--C 1.539 1.559 0 C-N-CA 123.938 0.78 . . . . 0.0 114.679 -175.164 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 8.8 pt20 -157.98 174.44 15.24 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 126.876 2.07 . . . . 0.0 111.818 -169.321 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 70.4 m -63.29 159.29 18.25 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 114.721 1.378 . . . . 0.0 114.721 -169.96 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 42.3 tp -59.75 -27.15 66.26 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 124.905 1.282 . . . . 0.0 113.295 179.771 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -62.88 -30.7 71.72 Favored 'General case' 0 N--CA 1.473 0.711 0 O-C-N 120.733 -1.229 . . . . 0.0 112.008 171.753 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 3.0 t -75.69 -36.19 33.16 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 O-C-N 120.955 -1.091 . . . . 0.0 111.152 172.725 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -55.48 -48.01 75.24 Favored 'General case' 0 N--CA 1.479 0.978 0 CA-C-N 119.688 1.131 . . . . 0.0 110.548 169.086 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -67.01 -35.94 81.05 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 124.141 0.976 . . . . 0.0 112.382 178.907 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 31.2 m -61.16 -45.53 94.27 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 124.329 1.052 . . . . 0.0 111.239 169.724 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 56.2 t -67.14 -39.19 82.61 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 CA-C-O 117.638 -1.173 . . . . 0.0 111.339 178.2 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 67.4 mtm-85 -56.43 -43.02 79.04 Favored 'General case' 0 N--CA 1.484 1.249 0 CA-C-N 120.694 1.588 . . . . 0.0 111.724 169.93 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -59.61 -49.47 78.22 Favored Glycine 0 CA--C 1.537 1.417 0 CA-C-N 118.982 0.81 . . . . 0.0 113.871 174.529 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 52.4 mm-40 -65.66 -44.38 86.48 Favored 'General case' 0 N--CA 1.475 0.784 0 O-C-N 121.585 -0.95 . . . . 0.0 112.193 178.274 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 60.5 t -65.13 -40.15 87.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 C-N-CA 124.622 1.169 . . . . 0.0 110.789 177.816 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 61.4 tttm -54.71 -49.9 69.6 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 119.515 1.052 . . . . 0.0 110.932 175.796 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -64.48 -42.05 96.12 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 112.486 0.55 . . . . 0.0 112.486 177.999 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 16.5 mmm180 -61.26 -45.97 92.32 Favored 'General case' 0 N--CA 1.479 0.982 0 O-C-N 121.597 -0.689 . . . . 0.0 112.529 175.409 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 92.7 t -68.38 -40.95 83.11 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 C-N-CA 124.006 0.923 . . . . 0.0 111.268 179.49 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -62.48 -39.95 95.11 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 119.258 0.935 . . . . 0.0 111.593 173.165 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 13.9 m-80 -63.25 -46.7 85.67 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 118.982 0.81 . . . . 0.0 112.189 173.751 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -54.7 -55.21 32.17 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 124.607 1.163 . . . . 0.0 110.585 176.467 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 73.1 mt -59.82 -45.88 94.32 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 CA-C-O 119.079 -0.486 . . . . 0.0 110.084 178.922 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -67.89 -11.47 58.75 Favored 'General case' 0 CA--C 1.545 0.776 0 N-CA-C 115.318 1.599 . . . . 0.0 115.318 -179.215 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 21.0 ptmt -100.54 -24.13 14.53 Favored 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 113.798 1.036 . . . . 0.0 113.798 171.286 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 16.4 pt -97.78 -13.95 7.92 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 N-CA-C 114.592 1.33 . . . . 0.0 114.592 177.692 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 54.5 m . . . . . 0 C--O 1.254 1.293 0 C-N-CA 125.373 1.469 . . . . 0.0 112.032 -179.815 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.407 ' HA ' ' O ' ' A' ' 29' ' ' LYS . 22.6 ttt . . . . . 0 N--CA 1.503 2.207 0 N-CA-C 111.74 0.274 . . . . 0.0 111.74 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.21 164.06 31.28 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 125.089 1.355 . . . . 0.0 112.527 176.575 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 58.9 mttt -99.14 151.07 21.39 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 124.185 0.994 . . . . 0.0 112.46 177.731 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 12.5 t -129.2 138.49 54.29 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 C-N-CA 125.103 1.361 . . . . 0.0 112.674 179.019 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' MET . . . . . 0.503 ' HG3' HG13 ' A' ' 7' ' ' VAL . 62.0 tpp -107.75 120.94 43.65 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 123.726 0.81 . . . . 0.0 109.429 168.997 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 68.5 m-85 -100.73 127.09 47.29 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 124.27 1.028 . . . . 0.0 108.99 170.58 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.503 HG13 ' HG3' ' A' ' 5' ' ' MET . 1.0 OUTLIER -144.43 156.12 14.96 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.084 0 N-CA-C 114.769 1.396 . . . . 0.0 114.769 -168.177 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -151.38 169.29 22.36 Favored 'General case' 0 CA--C 1.552 1.043 0 C-N-CA 127.159 2.183 . . . . 0.0 110.939 173.944 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 61.8 mtpt -49.26 -62.74 1.37 Allowed 'General case' 0 N--CA 1.495 1.788 0 C-N-CA 126.126 1.77 . . . . 0.0 113.789 -173.762 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 28.8 mmt85 -127.68 106.3 9.05 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 126.164 1.785 . . . . 0.0 107.588 172.506 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 36.1 p-10 -74.32 -11.1 60.17 Favored 'General case' 0 CA--C 1.556 1.195 0 CA-C-N 119.458 1.027 . . . . 0.0 112.357 -176.831 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 69.8 m -80.13 -6.71 58.19 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 125.08 1.352 . . . . 0.0 112.855 169.464 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 72.8 m -108.18 -69.61 0.84 Allowed 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 124.71 1.204 . . . . 0.0 110.03 172.02 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 66.7 mtt85 -74.35 122.61 23.2 Favored 'General case' 0 N--CA 1.479 1.015 0 O-C-N 121.444 -0.785 . . . . 0.0 109.092 173.679 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 52.4 p -69.45 -28.29 65.98 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 115.644 1.72 . . . . 0.0 115.644 -168.784 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 7.6 mt-30 61.26 -177.81 0.11 Allowed 'General case' 0 CA--C 1.552 1.027 0 C-N-CA 124.633 1.173 . . . . 0.0 112.482 -170.07 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -175.12 -47.48 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 126.366 1.867 . . . . 0.0 110.947 -169.447 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -56.73 -32.16 65.26 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 115.331 1.604 . . . . 0.0 115.331 -169.398 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.3 pm0 -57.16 -41.68 79.66 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 123.528 0.731 . . . . 0.0 112.757 177.545 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -67.25 -43.79 87.95 Favored Glycine 0 C--N 1.334 0.436 0 C-N-CA 124.821 1.2 . . . . 0.0 112.071 -177.465 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -71.53 -35.36 70.65 Favored 'General case' 0 N--CA 1.47 0.534 0 O-C-N 121.542 -0.975 . . . . 0.0 112.005 174.972 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -64.09 -33.66 76.27 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 118.986 0.812 . . . . 0.0 112.034 -175.652 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 2.7 pttp -85.08 -36.43 21.19 Favored 'General case' 0 N--CA 1.479 1.024 0 N-CA-C 113.644 0.979 . . . . 0.0 113.644 169.686 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 56.3 m -68.88 -31.29 70.11 Favored 'General case' 0 N--CA 1.486 1.338 0 CA-C-N 119.455 1.025 . . . . 0.0 112.3 -178.642 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 70.8 mt -91.22 -37.85 13.07 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 126.131 1.772 . . . . 0.0 112.645 173.022 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -100.62 2.08 55.81 Favored Glycine 0 N--CA 1.472 1.06 0 N-CA-C 117.262 1.665 . . . . 0.0 117.262 -169.539 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -60.55 141.63 56.34 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-N 121.133 2.466 . . . . 0.0 112.303 177.648 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 82.91 -15.15 33.67 Favored Glycine 0 CA--C 1.54 1.643 0 C-N-CA 124.74 1.162 . . . . 0.0 113.657 -169.408 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.407 ' O ' ' HA ' ' A' ' 1' ' ' MET . 69.7 mttt -108.22 -43.7 4.31 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 126.309 1.844 . . . . 0.0 112.484 171.841 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 42.7 pt -139.93 160.02 26.66 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 C-N-CA 124.92 1.288 . . . . 0.0 113.416 -177.203 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -107.64 149.31 28.24 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 125.487 1.515 . . . . 0.0 110.724 169.747 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 98.8 t -137.78 141.11 39.79 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 O-C-N 121.197 -0.94 . . . . 0.0 113.085 -175.987 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 79.3 m -135.51 152.85 51.73 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 125.805 1.642 . . . . 0.0 109.28 169.521 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 88.9 p -133.21 142.7 48.71 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 122.419 1.104 . . . . 0.0 113.208 167.931 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 35.7 p -145.43 170.5 16.23 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 114.002 -1.453 . . . . 0.0 112.251 -173.863 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -92.82 152.83 21.24 Favored Glycine 0 N--CA 1.467 0.763 0 O-C-N 121.56 -0.713 . . . . 0.0 111.392 174.863 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 2.2 mp -65.97 -32.8 74.5 Favored 'General case' 0 N--CA 1.483 1.207 0 CA-C-N 118.807 1.303 . . . . 0.0 111.744 171.967 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -120.47 165.49 14.88 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 126.685 1.994 . . . . 0.0 108.93 169.089 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 52.2 m -53.95 100.19 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 125.281 1.432 . . . . 0.0 113.6 -169.703 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 24.0 p -156.97 156.44 33.0 Favored 'General case' 0 CA--C 1.548 0.897 0 N-CA-C 114.159 1.17 . . . . 0.0 114.159 -175.666 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 49.7 ttt180 -107.77 140.66 40.51 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 128.815 2.846 . . . . 0.0 109.199 174.781 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 18.5 m -53.65 117.97 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.36 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 173.477 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . 0.276 0.0 OUTLIER -58.25 143.75 78.67 Favored Pre-proline 0 CA--C 1.536 0.439 0 N-CA-C 112.699 0.629 . . . . 0.0 112.699 -167.901 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 81.5 Cg_exo -47.34 -36.25 22.59 Favored 'Trans proline' 0 CA--C 1.538 0.681 0 C-N-CA 123.449 2.766 . . . . 0.0 116.792 -168.121 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 56.3 m -64.18 -26.27 68.45 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.915 0.886 . . . . 0.0 112.552 -179.091 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -55.08 -49.53 71.43 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 119.517 1.053 . . . . 0.0 110.601 173.25 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.6 mp -54.2 -57.16 6.6 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 C-N-CA 124.189 0.996 . . . . 0.0 110.176 -173.41 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.95 -28.09 69.59 Favored 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 113.22 0.822 . . . . 0.0 113.22 -175.243 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -79.91 -28.51 39.8 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 113.6 0.963 . . . . 0.0 113.6 177.79 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 4.9 mmt -77.39 -36.49 53.35 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-N 119.142 0.883 . . . . 0.0 110.645 169.743 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -61.9 -16.39 50.3 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 125.095 1.358 . . . . 0.0 114.17 174.421 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -61.08 -29.79 69.96 Favored 'General case' 0 N--CA 1.479 0.984 0 CA-C-N 120.714 1.597 . . . . 0.0 111.747 169.508 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 59.1 t -89.89 -6.38 10.79 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.889 0 C-N-CA 126.627 1.971 . . . . 0.0 111.294 175.673 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 81.63 13.93 79.04 Favored Glycine 0 CA--C 1.539 1.554 0 C-N-CA 125.245 1.402 . . . . 0.0 114.281 -170.589 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 83.5 mt -77.91 142.04 14.7 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 124.618 1.167 . . . . 0.0 111.144 -178.016 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -101.05 131.3 47.01 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 123.517 0.727 . . . . 0.0 111.044 169.172 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 13.4 pt -135.3 8.25 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 C-N-CA 124.234 1.014 . . . . 0.0 113.33 169.928 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 51.8 m -77.65 152.06 34.0 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 125.228 1.411 . . . . 0.0 113.228 -171.004 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 67.89 20.61 72.68 Favored Glycine 0 N--CA 1.473 1.119 0 N-CA-C 116.035 1.174 . . . . 0.0 116.035 169.758 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 48.1 mt-30 -67.0 -69.98 0.28 Allowed 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 118.701 1.25 . . . . 0.0 112.158 -179.387 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 7.4 t -166.37 169.82 13.65 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 125.238 1.415 . . . . 0.0 112.323 -177.087 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 96.8 p -129.05 5.05 5.33 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 128.419 2.687 . . . . 0.0 112.379 169.474 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 32.5 m-20 -89.94 153.94 47.4 Favored Pre-proline 0 CA--C 1.543 0.676 0 C-N-CA 124.721 1.208 . . . . 0.0 113.299 -177.866 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -70.43 157.28 59.57 Favored 'Trans proline' 0 N--CA 1.458 -0.579 0 C-N-CA 123.089 2.526 . . . . 0.0 112.12 175.771 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 5.9 tt -50.57 -34.34 12.17 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 C-N-CA 124.991 1.316 . . . . 0.0 111.349 169.556 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 18.8 mt-10 -63.71 -17.91 63.47 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 125.547 1.539 . . . . 0.0 113.558 -178.758 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -83.61 -12.34 56.16 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 124.669 1.188 . . . . 0.0 113.659 -178.627 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 74.7 m-85 -106.64 -172.21 2.04 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 125.946 1.699 . . . . 0.0 111.733 -176.417 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 10.5 t30 -120.77 122.44 40.37 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 125.182 1.393 . . . . 0.0 110.274 177.328 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -68.05 -35.83 78.88 Favored 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 113.726 1.01 . . . . 0.0 113.726 -171.42 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -71.28 -4.98 28.83 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 114.409 1.262 . . . . 0.0 114.409 -175.155 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -73.08 -14.0 61.31 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 123.573 0.749 . . . . 0.0 111.691 168.823 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 39.2 m-85 -119.54 134.2 55.33 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 126.939 2.096 . . . . 0.0 111.068 -178.984 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -88.44 -19.64 26.26 Favored 'General case' 0 N--CA 1.48 1.058 0 CA-C-O 122.36 1.076 . . . . 0.0 112.672 -179.806 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.647 HG22 ' HB ' ' A' ' 95' ' ' ILE . 95.9 t -130.88 136.77 57.43 Favored 'Isoleucine or valine' 0 C--O 1.235 0.336 0 C-N-CA 127.722 2.409 . . . . 0.0 107.853 -175.411 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 65.3 t -134.13 127.07 50.79 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 170.384 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 48.3 mm -116.17 106.7 20.87 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.249 0 C-N-CA 124.454 1.101 . . . . 0.0 109.395 -171.873 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 4.0 m -92.38 108.2 19.78 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 123.049 0.54 . . . . 0.0 110.321 177.202 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 78.3 mt -78.07 -9.48 59.16 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 125.872 1.669 . . . . 0.0 113.406 -179.371 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 23.9 m -108.34 103.99 13.26 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 125.664 1.586 . . . . 0.0 110.733 -179.04 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 57.65 -139.66 46.72 Favored Glycine 0 CA--C 1.535 1.331 0 C-N-CA 124.325 0.964 . . . . 0.0 114.236 172.831 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 85.0 p -69.91 -14.28 62.65 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 124.84 1.256 . . . . 0.0 114.108 175.793 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 72.09 7.79 67.84 Favored Glycine 0 CA--C 1.528 0.902 0 N-CA-C 115.6 1.0 . . . . 0.0 115.6 178.872 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.3 p -72.51 -9.58 13.08 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.988 0 CA-C-N 119.593 1.696 . . . . 0.0 114.675 -169.89 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 -80.64 -16.71 53.34 Favored 'General case' 0 CA--C 1.547 0.857 0 N-CA-C 114.701 1.371 . . . . 0.0 114.701 -174.162 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -71.07 159.14 86.51 Favored Pre-proline 0 CA--C 1.551 0.985 0 CA-C-N 119.214 0.916 . . . . 0.0 112.317 170.926 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_exo -60.53 151.86 72.33 Favored 'Trans proline' 0 CA--C 1.544 1.014 0 C-N-CA 122.133 1.888 . . . . 0.0 113.321 -176.951 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_exo -54.35 -36.59 87.59 Favored 'Trans proline' 0 C--N 1.352 0.751 0 C-N-CA 123.458 2.772 . . . . 0.0 115.164 -169.816 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -63.71 -22.28 66.83 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 114.131 1.16 . . . . 0.0 114.131 179.723 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 77.7 m95 -82.99 -23.1 33.47 Favored 'General case' 0 N--CA 1.47 0.531 0 O-C-N 120.888 -1.133 . . . . 0.0 112.486 172.951 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 10.5 t -73.67 -30.37 29.01 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 C-N-CA 124.996 1.318 . . . . 0.0 110.91 170.336 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 76.5 p -91.14 3.33 55.06 Favored 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 116.252 1.945 . . . . 0.0 116.252 -174.869 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 80.4 mm-40 -66.36 149.62 50.11 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 119.503 1.047 . . . . 0.0 108.984 169.294 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -59.73 -37.97 80.41 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 114.577 1.325 . . . . 0.0 114.577 -167.154 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.647 ' HB ' HG22 ' A' ' 75' ' ' VAL . 16.2 mm -113.01 56.64 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 C-N-CA 124.715 1.206 . . . . 0.0 109.385 177.488 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 40.7 t80 -75.57 106.52 7.17 Favored 'General case' 0 CA--C 1.535 0.395 0 O-C-N 120.633 -1.292 . . . . 0.0 107.522 168.958 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.7 mt-10 -106.41 133.28 51.34 Favored 'General case' 0 CA--C 1.543 0.678 0 N-CA-C 113.556 0.947 . . . . 0.0 113.556 175.877 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -88.95 111.51 22.21 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.41 1.084 . . . . 0.0 109.339 169.432 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 15.2 m0 -97.99 101.22 12.65 Favored 'General case' 0 N--CA 1.462 0.158 0 C-N-CA 123.813 0.845 . . . . 0.0 109.48 -176.859 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 54.9 mm-40 -78.64 41.14 0.4 Allowed 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 125.995 1.718 . . . . 0.0 111.676 -177.291 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 33.1 mt -91.59 163.68 14.04 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 126.277 1.831 . . . . 0.0 113.19 -172.155 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -73.92 150.42 40.85 Favored 'General case' 0 CA--C 1.545 0.784 0 CA-C-N 114.857 -1.065 . . . . 0.0 111.715 169.728 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' ASP . . . . . 0.415 ' HA ' ' HD3' ' A' ' 104' ' ' PRO . 18.9 t70 -112.71 138.85 22.23 Favored Pre-proline 0 CA--C 1.549 0.923 0 C-N-CA 124.339 1.056 . . . . 0.0 111.108 169.564 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 104' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 103' ' ' ASP . 45.0 Cg_exo -66.81 -19.84 52.57 Favored 'Trans proline' 0 CA--C 1.54 0.822 0 C-N-CA 122.511 2.141 . . . . 0.0 116.61 -178.139 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -68.03 144.83 54.95 Favored 'General case' 0 CA--C 1.545 0.757 0 CA-C-N 120.375 1.443 . . . . 0.0 114.102 -170.424 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 77.69 6.52 86.98 Favored Glycine 0 CA--C 1.535 1.338 0 C-N-CA 124.815 1.198 . . . . 0.0 114.586 -177.936 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 13.3 pt20 -140.85 174.37 10.58 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 126.015 1.726 . . . . 0.0 112.165 179.832 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 25.0 p -67.71 164.73 18.72 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 117.395 2.369 . . . . 0.0 117.395 -168.659 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -53.5 -41.35 66.19 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 126.272 1.829 . . . . 0.0 111.961 169.767 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -60.01 -36.11 76.52 Favored 'General case' 0 CA--C 1.543 0.697 0 O-C-N 121.47 -0.769 . . . . 0.0 111.922 174.653 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 16.3 t -68.86 -40.8 81.68 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 O-C-N 121.177 -0.952 . . . . 0.0 111.463 171.141 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -52.31 -50.55 61.99 Favored 'General case' 0 N--CA 1.476 0.839 0 CA-C-N 119.56 1.073 . . . . 0.0 112.104 170.629 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 96.0 mtt180 -67.87 -35.17 78.06 Favored 'General case' 0 N--CA 1.477 0.883 0 O-C-N 121.399 -0.813 . . . . 0.0 112.751 179.428 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 79.4 m -63.67 -42.17 98.09 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.682 0.793 . . . . 0.0 110.957 172.229 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 71.5 t -67.9 -39.86 82.47 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 CA-C-O 117.914 -1.041 . . . . 0.0 111.215 176.603 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 27.1 mtm105 -54.56 -42.71 71.31 Favored 'General case' 0 N--CA 1.484 1.252 0 CA-C-N 120.52 1.509 . . . . 0.0 112.109 173.026 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -62.39 -51.34 57.08 Favored Glycine 0 CA--C 1.539 1.549 0 CA-C-N 119.052 0.842 . . . . 0.0 113.311 176.383 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 68.8 mm-40 -63.3 -44.42 95.08 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.234 0.614 . . . . 0.0 112.017 179.845 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 69.3 t -67.18 -41.16 86.51 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 C-N-CA 124.592 1.157 . . . . 0.0 111.028 177.984 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 34.6 ttmt -54.56 -49.9 69.21 Favored 'General case' 0 N--CA 1.478 0.971 0 CA-C-N 120.491 1.496 . . . . 0.0 110.773 177.645 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -61.1 -40.14 92.61 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 112.242 0.46 . . . . 0.0 112.242 177.492 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.11 -35.26 80.02 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 124.226 1.011 . . . . 0.0 113.228 176.947 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 99.6 t -77.34 -38.46 26.84 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 C-N-CA 125.195 1.398 . . . . 0.0 111.621 176.508 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -60.25 -40.2 89.45 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 119.198 0.908 . . . . 0.0 111.178 170.892 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 17.1 m-80 -64.35 -43.55 94.21 Favored 'General case' 0 CA--C 1.542 0.635 0 N-CA-C 112.56 0.578 . . . . 0.0 112.56 174.093 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 9.1 tt -53.69 -55.01 29.86 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 124.401 1.08 . . . . 0.0 110.477 173.148 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 76.4 mt -63.49 -41.81 93.98 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.625 0 C-N-CA 122.658 0.383 . . . . 0.0 110.589 -178.433 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -69.72 -12.68 61.82 Favored 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 114.578 1.325 . . . . 0.0 114.578 178.346 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 20.7 ptmt -101.27 -30.93 11.24 Favored 'General case' 0 N--CA 1.477 0.906 0 N-CA-C 113.915 1.08 . . . . 0.0 113.915 173.297 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 13.5 pt -94.09 -18.84 6.77 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 N-CA-C 114.528 1.307 . . . . 0.0 114.528 179.255 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 74.5 m . . . . . 0 C--O 1.253 1.26 0 C-N-CA 125.539 1.536 . . . . 0.0 111.708 -175.354 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 34.8 ttm . . . . . 0 N--CA 1.501 2.086 0 N-CA-C 112.087 0.403 . . . . 0.0 112.087 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.47 162.92 26.05 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 125.146 1.379 . . . . 0.0 111.247 169.234 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 69.0 mttt -96.99 147.44 23.99 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.648 0.779 . . . . 0.0 111.527 172.728 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 17.2 t -124.42 135.53 63.49 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 C-N-CA 125.297 1.439 . . . . 0.0 111.927 176.046 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' MET . . . . . 0.478 ' HG3' HG13 ' A' ' 7' ' ' VAL . 54.3 tpp -106.07 125.75 51.37 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 123.229 0.611 . . . . 0.0 109.501 168.724 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 67.1 m-85 -103.89 125.18 50.11 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.43 1.092 . . . . 0.0 108.918 172.846 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.478 HG13 ' HG3' ' A' ' 5' ' ' MET . 2.1 m -143.46 156.99 16.82 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.167 0 C-N-CA 124.661 1.184 . . . . 0.0 113.151 -169.175 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 18.2 t -153.65 141.7 20.33 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 126.304 1.842 . . . . 0.0 108.437 168.625 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . 0.263 60.7 pttt -73.79 -15.98 61.17 Favored 'General case' 0 N--CA 1.486 1.335 0 N-CA-C 116.385 1.994 . . . . 0.0 116.385 -169.993 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 16.2 ptm180 -121.08 49.68 1.46 Allowed 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 125.46 1.504 . . . . 0.0 112.645 169.899 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 5.8 t30 -46.79 -31.87 3.3 Favored 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 126.058 1.743 . . . . 0.0 114.582 -177.683 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 67.7 m -69.61 -23.78 63.56 Favored 'General case' 0 N--CA 1.479 1.0 0 N-CA-C 114.017 1.117 . . . . 0.0 114.017 178.131 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 36.9 m -89.9 -15.63 31.72 Favored 'General case' 0 N--CA 1.478 0.954 0 N-CA-C 114.247 1.203 . . . . 0.0 114.247 -176.244 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 55.7 mtp85 -135.5 159.03 42.88 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 125.607 1.563 . . . . 0.0 112.632 -169.847 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 26.1 t -100.25 145.59 27.9 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.234 1.414 . . . . 0.0 107.742 168.478 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 3.9 mp0 -108.76 -37.67 5.83 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 115.331 1.604 . . . . 0.0 115.331 -168.361 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' MET . . . . . 0.4 ' HG2' ' SD ' ' A' ' 50' ' ' MET . 0.0 OUTLIER 66.07 -47.48 0.41 Allowed 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 126.996 2.118 . . . . 0.0 116.281 170.46 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.16 -35.81 76.15 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.649 1.18 . . . . 0.0 113.945 -169.824 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 3.9 pm0 -58.94 -38.31 78.72 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 125.049 1.339 . . . . 0.0 113.215 176.057 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -69.92 -45.03 59.4 Favored Glycine 0 N--CA 1.464 0.552 0 C-N-CA 123.688 0.661 . . . . 0.0 111.831 -177.737 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -69.29 -32.7 72.03 Favored 'General case' 0 N--CA 1.466 0.347 0 O-C-N 121.793 -0.828 . . . . 0.0 112.51 173.73 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -64.61 -36.71 85.12 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 119.347 0.976 . . . . 0.0 112.302 -174.804 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.23 -38.96 30.01 Favored 'General case' 0 N--CA 1.482 1.163 0 N-CA-C 112.904 0.705 . . . . 0.0 112.904 169.464 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 70.7 m -67.09 -32.46 73.63 Favored 'General case' 0 N--CA 1.485 1.286 0 CA-C-N 118.96 0.8 . . . . 0.0 112.24 -176.935 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 66.9 mt -91.85 -39.86 11.51 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 125.733 1.613 . . . . 0.0 112.926 173.858 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -99.02 3.43 58.5 Favored Glycine 0 N--CA 1.472 1.036 0 N-CA-C 117.444 1.738 . . . . 0.0 117.444 -169.431 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.24 142.02 57.11 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 121.034 2.417 . . . . 0.0 112.11 178.369 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 84.16 -21.65 9.74 Favored Glycine 0 CA--C 1.539 1.572 0 C-N-CA 125.092 1.33 . . . . 0.0 113.268 -169.442 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -98.88 -46.39 5.65 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 125.603 1.561 . . . . 0.0 111.985 171.609 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 43.0 pt -137.58 154.58 29.86 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 C-N-CA 124.96 1.304 . . . . 0.0 113.37 -175.375 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -102.59 142.37 33.87 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 124.757 1.223 . . . . 0.0 109.938 169.809 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 85.9 t -131.16 139.57 50.66 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 CA-C-N 118.928 0.785 . . . . 0.0 113.058 -176.455 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 27.5 m -139.69 154.24 47.44 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 125.815 1.646 . . . . 0.0 109.586 173.346 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 52.2 m -128.64 147.74 50.75 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.718 0.771 . . . . 0.0 110.841 168.448 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 3.8 m -142.69 151.76 41.68 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 113.926 -1.488 . . . . 0.0 110.981 177.119 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -89.59 174.08 40.97 Favored Glycine 0 CA--C 1.527 0.825 0 N-CA-C 110.383 -1.087 . . . . 0.0 110.383 169.166 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -84.47 -36.99 21.9 Favored 'General case' 0 N--CA 1.477 0.924 0 O-C-N 121.414 -1.05 . . . . 0.0 112.816 175.138 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -128.77 18.83 6.17 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 126.192 1.797 . . . . 0.0 111.628 175.02 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 34.7 p -142.86 153.13 42.87 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 126.069 1.747 . . . . 0.0 111.975 -173.768 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 98.5 p -95.8 -18.56 20.31 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 117.528 2.418 . . . . 0.0 117.528 -168.931 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 19.0 ttm105 -152.29 151.77 31.32 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 124.916 1.286 . . . . 0.0 111.789 -169.757 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 34.1 m -64.94 136.84 26.02 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 C-N-CA 123.328 0.651 . . . . 0.0 109.364 170.032 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -60.84 143.23 91.59 Favored Pre-proline 0 CA--C 1.551 1.005 0 N-CA-C 112.678 0.622 . . . . 0.0 112.678 -169.046 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_exo -46.59 -40.4 23.66 Favored 'Trans proline' 0 CA--C 1.538 0.718 0 C-N-CA 124.192 3.261 . . . . 0.0 118.731 -168.154 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 33.5 m -63.74 -27.25 69.07 Favored 'General case' 0 N--CA 1.484 1.249 0 CA-C-N 119.759 1.163 . . . . 0.0 111.936 -177.354 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -57.49 -50.15 73.99 Favored 'General case' 0 CA--C 1.537 0.448 0 O-C-N 121.373 -0.83 . . . . 0.0 111.548 173.705 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 4.6 mp -56.94 -50.94 74.22 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 CA-C-N 119.438 1.017 . . . . 0.0 111.126 -175.999 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -61.22 -27.9 68.77 Favored 'General case' 0 CA--C 1.546 0.804 0 N-CA-C 113.176 0.806 . . . . 0.0 113.176 -179.255 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -83.5 -24.0 31.91 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 113.963 1.098 . . . . 0.0 113.963 175.133 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' MET . . . . . 0.4 ' SD ' ' HG2' ' A' ' 17' ' ' MET . 4.4 mmt -80.44 -30.5 37.57 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 119.758 1.163 . . . . 0.0 110.188 169.602 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -64.9 -14.92 61.24 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 125.345 1.458 . . . . 0.0 113.604 173.991 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -61.58 -27.0 68.32 Favored 'General case' 0 N--CA 1.482 1.173 0 CA-C-N 120.639 1.563 . . . . 0.0 110.918 169.104 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 61.0 t -95.8 -2.96 10.48 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.902 0 C-N-CA 127.574 2.349 . . . . 0.0 111.148 177.837 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 77.98 16.87 79.29 Favored Glycine 0 CA--C 1.54 1.598 0 O-C-N 120.699 -1.25 . . . . 0.0 114.397 -174.737 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 77.5 mt -72.34 137.32 23.79 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 124.687 1.195 . . . . 0.0 111.247 -177.456 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 18.0 t0 -105.29 105.41 15.43 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 124.331 1.052 . . . . 0.0 112.098 179.347 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 15.8 pt -137.32 18.99 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.309 0 N-CA-C 114.867 1.432 . . . . 0.0 114.867 -178.933 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 89.1 p -70.95 -36.87 72.76 Favored 'General case' 0 N--CA 1.479 0.982 0 O-C-N 120.138 -1.601 . . . . 0.0 112.691 175.33 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -77.54 39.16 1.7 Allowed Glycine 0 CA--C 1.538 1.471 0 C-N-CA 126.502 2.001 . . . . 0.0 114.788 177.443 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 5.9 mm-40 -83.42 65.78 8.53 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 125.621 1.568 . . . . 0.0 112.57 -172.427 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER 63.59 -30.79 0.1 Allowed 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 119.741 3.237 . . . . 0.0 119.741 169.11 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 71.2 m 59.37 32.3 21.73 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 125.387 1.475 . . . . 0.0 114.382 -179.622 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -150.95 145.92 18.7 Favored Pre-proline 0 CA--C 1.551 1.013 0 O-C-N 120.974 -1.079 . . . . 0.0 113.798 179.221 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -66.24 162.9 33.95 Favored 'Trans proline' 0 CA--C 1.54 0.795 0 C-N-CA 124.543 3.496 . . . . 0.0 114.599 171.095 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.432 HD11 ' CE3' ' A' ' 90' ' ' TRP . 9.3 tp -57.33 -35.1 47.9 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 C-N-CA 124.536 1.134 . . . . 0.0 112.113 177.924 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -68.21 -10.22 52.85 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 113.79 1.033 . . . . 0.0 113.79 -179.569 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 66.2 m-20 -95.27 11.72 31.53 Favored 'General case' 0 CA--C 1.555 1.157 0 N-CA-C 113.791 1.034 . . . . 0.0 113.791 178.892 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 76.8 m-85 -130.86 177.72 7.2 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 125.526 1.531 . . . . 0.0 114.514 -174.899 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 8.1 t30 -107.69 131.81 54.02 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 126.921 2.088 . . . . 0.0 109.975 172.858 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -73.89 -35.34 64.69 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 114.673 1.361 . . . . 0.0 114.673 -176.436 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . 0.273 0.0 OUTLIER -71.69 -6.38 40.74 Favored 'General case' 0 CA--C 1.544 0.734 0 N-CA-C 114.401 1.26 . . . . 0.0 114.401 -172.213 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -62.55 -27.73 69.37 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 124.28 1.032 . . . . 0.0 110.494 168.327 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 19.4 m-85 -113.77 121.65 44.71 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 125.65 1.58 . . . . 0.0 111.132 -172.213 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -73.0 -23.57 60.65 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-O 121.77 0.795 . . . . 0.0 112.555 175.851 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.51 HG22 ' HB ' ' A' ' 95' ' ' ILE . 90.8 t -126.9 136.41 60.87 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 C-N-CA 127.486 2.314 . . . . 0.0 109.299 -174.917 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 54.2 t -135.51 120.23 27.5 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 169.621 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 25.9 mm -106.82 117.97 53.65 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 C-N-CA 123.314 0.646 . . . . 0.0 109.498 -176.63 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 14.2 t -89.07 124.09 33.97 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 169.607 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 87.6 mt -100.08 13.58 33.61 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 125.147 1.379 . . . . 0.0 114.188 -170.044 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 20.8 p -149.19 1.74 0.55 Allowed 'General case' 0 CA--C 1.547 0.845 0 N-CA-C 114.926 1.454 . . . . 0.0 114.926 177.597 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 68.53 170.34 5.99 Favored Glycine 0 CA--C 1.541 1.682 0 C-N-CA 124.261 0.934 . . . . 0.0 114.161 -176.288 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 71.7 m 54.89 29.5 12.2 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 125.192 1.397 . . . . 0.0 113.685 178.342 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -73.4 18.02 1.77 Allowed Glycine 0 N--CA 1.474 1.213 0 C-N-CA 126.327 1.917 . . . . 0.0 114.688 -177.799 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 4.2 p -65.24 -5.46 2.57 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.881 0 C-N-CA 126.227 1.811 . . . . 0.0 114.482 -169.886 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 26.7 m120 -76.27 -18.43 58.99 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 125.072 1.349 . . . . 0.0 114.338 176.106 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -74.27 156.48 87.39 Favored Pre-proline 0 N--CA 1.483 1.179 0 CA-C-N 120.277 1.399 . . . . 0.0 112.144 169.918 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_exo -57.27 150.57 57.37 Favored 'Trans proline' 0 CA--C 1.544 1.01 0 C-N-CA 122.999 2.466 . . . . 0.0 114.087 179.308 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -62.22 -24.17 75.95 Favored 'Trans proline' 0 CA--C 1.536 0.586 0 C-N-CA 123.531 2.821 . . . . 0.0 113.814 -174.358 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -60.98 -24.14 65.88 Favored 'General case' 0 CA--C 1.54 0.578 0 O-C-N 121.056 -1.028 . . . . 0.0 113.534 176.052 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' TRP . . . . . 0.432 ' CE3' HD11 ' A' ' 65' ' ' ILE . 87.3 m95 -79.51 -35.88 39.38 Favored 'General case' 0 N--CA 1.473 0.719 0 O-C-N 120.818 -1.176 . . . . 0.0 112.668 175.364 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 3.9 m -79.34 -18.49 12.87 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.149 0 N-CA-C 113.164 0.802 . . . . 0.0 113.164 178.295 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -86.68 -1.38 57.66 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 114.406 1.262 . . . . 0.0 114.406 177.662 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 84.7 mm-40 -64.14 154.33 35.0 Favored 'General case' 0 N--CA 1.478 0.935 0 O-C-N 120.907 -1.12 . . . . 0.0 110.625 170.911 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -59.76 -38.25 81.29 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 114.007 1.114 . . . . 0.0 114.007 -168.281 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.51 ' HB ' HG22 ' A' ' 75' ' ' VAL . 17.0 mm -118.18 60.08 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 C-N-CA 125.078 1.351 . . . . 0.0 109.783 179.057 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 47.2 t80 -78.94 106.25 10.84 Favored 'General case' 0 CA--C 1.536 0.413 0 O-C-N 120.749 -1.219 . . . . 0.0 107.777 168.853 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -111.18 131.24 55.27 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 113.523 0.934 . . . . 0.0 113.523 -179.581 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 -92.08 113.01 25.17 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 124.977 1.311 . . . . 0.0 110.825 169.503 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 39.6 m0 -103.97 113.12 26.43 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 124.863 1.265 . . . . 0.0 109.459 174.341 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 34.6 mm-40 -78.98 59.69 2.72 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 124.58 1.152 . . . . 0.0 109.115 169.933 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 17.4 tp -79.32 145.58 33.39 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 126.068 1.747 . . . . 0.0 111.255 -169.76 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -69.2 125.3 26.27 Favored 'General case' 0 CA--C 1.542 0.645 0 O-C-N 122.146 -0.346 . . . . 0.0 111.068 169.941 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -75.45 134.78 72.86 Favored Pre-proline 0 CA--C 1.544 0.72 0 O-C-N 121.54 -0.725 . . . . 0.0 109.678 169.657 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -87.63 -17.12 2.83 Favored 'Trans proline' 0 CA--C 1.544 1.003 0 C-N-CA 121.441 1.427 . . . . 0.0 114.836 174.523 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -69.86 -40.45 75.74 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 115.032 1.493 . . . . 0.0 115.032 -169.852 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -68.33 -3.25 30.86 Favored Glycine 0 CA--C 1.54 1.631 0 N-CA-C 115.677 1.031 . . . . 0.0 115.677 -175.892 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -141.86 176.18 9.13 Favored 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 127.017 2.127 . . . . 0.0 112.148 -170.057 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 57.1 m -64.29 161.06 17.43 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 114.866 1.432 . . . . 0.0 114.866 -169.939 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 39.0 tp -59.02 -28.85 66.8 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 124.791 1.236 . . . . 0.0 113.409 -178.552 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -63.18 -32.42 73.81 Favored 'General case' 0 N--CA 1.473 0.717 0 O-C-N 120.641 -1.287 . . . . 0.0 112.004 172.448 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 4.9 t -72.76 -36.38 52.49 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 O-C-N 121.093 -1.005 . . . . 0.0 110.819 172.308 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -55.95 -49.15 74.31 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-N 119.944 1.247 . . . . 0.0 111.391 169.83 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -66.76 -38.27 86.26 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.586 0.755 . . . . 0.0 112.122 -179.63 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 84.4 m -63.52 -43.92 95.77 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.761 0.824 . . . . 0.0 111.394 172.139 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 52.8 t -69.23 -35.66 69.0 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 CA-C-O 117.704 -1.141 . . . . 0.0 111.186 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 72.3 mtm-85 -57.12 -41.41 78.94 Favored 'General case' 0 N--CA 1.484 1.229 0 CA-C-N 120.903 1.683 . . . . 0.0 111.322 169.76 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -58.66 -50.58 65.77 Favored Glycine 0 CA--C 1.541 1.695 0 CA-C-N 118.898 0.772 . . . . 0.0 113.531 173.401 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 41.3 mt-30 -65.12 -43.64 91.31 Favored 'General case' 0 N--CA 1.477 0.906 0 O-C-N 121.645 -0.915 . . . . 0.0 112.63 178.471 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 69.8 t -66.93 -40.58 86.0 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 C-N-CA 124.012 0.925 . . . . 0.0 110.726 179.325 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 63.7 tttm -54.39 -48.54 71.44 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 119.31 0.959 . . . . 0.0 110.802 175.176 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -61.87 -46.89 87.46 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 123.537 0.735 . . . . 0.0 112.242 177.004 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 12.7 mtp85 -61.74 -40.19 94.22 Favored 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 113.414 0.894 . . . . 0.0 113.414 176.831 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 69.2 t -76.26 -30.76 20.29 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 O-C-N 121.627 -0.671 . . . . 0.0 111.176 -179.44 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -64.63 -38.1 89.84 Favored 'General case' 0 CA--C 1.54 0.585 0 O-C-N 121.184 -0.948 . . . . 0.0 110.166 169.118 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 97.7 m-20 -63.74 -45.48 89.7 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 123.572 0.749 . . . . 0.0 112.493 174.099 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 8.1 tt -50.53 -58.92 4.65 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 125.464 1.505 . . . . 0.0 110.724 170.725 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 80.4 mt -62.62 -44.07 99.07 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 CA-C-O 118.692 -0.67 . . . . 0.0 110.457 -176.449 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -68.14 -14.0 62.65 Favored 'General case' 0 CA--C 1.546 0.816 0 N-CA-C 114.372 1.249 . . . . 0.0 114.372 179.058 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 18.2 ptmt -99.12 -32.31 11.31 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 113.793 1.034 . . . . 0.0 113.793 174.385 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 17.8 pt -90.1 -18.1 7.77 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 N-CA-C 114.109 1.151 . . . . 0.0 114.109 179.815 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 72.9 m . . . . . 0 C--O 1.254 1.319 0 CA-C-O 118.294 -0.86 . . . . 0.0 112.507 -179.783 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.4 ttt . . . . . 0 N--CA 1.501 2.12 0 N-CA-C 111.924 0.342 . . . . 0.0 111.924 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.2 164.25 31.27 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 124.868 1.267 . . . . 0.0 113.363 178.16 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 60.1 mtpt -90.44 142.71 27.46 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 125.059 1.344 . . . . 0.0 113.221 175.681 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 21.6 t -125.49 131.63 71.94 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 C-N-CA 125.791 1.637 . . . . 0.0 112.301 179.186 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' MET . . . . . 0.421 ' HG3' HG13 ' A' ' 7' ' ' VAL . 55.0 tpp -101.47 116.5 32.91 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.967 0.907 . . . . 0.0 109.828 169.912 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 51.2 m-85 -100.74 120.76 40.56 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 124.536 1.134 . . . . 0.0 108.908 171.452 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.421 HG13 ' HG3' ' A' ' 5' ' ' MET . 3.0 m -140.74 156.66 23.16 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 N-CA-C 115.062 1.504 . . . . 0.0 115.062 -168.774 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 39.4 t -151.82 164.67 36.55 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 128.324 2.65 . . . . 0.0 108.054 169.826 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 39.1 ttpt -56.07 -51.37 68.11 Favored 'General case' 0 N--CA 1.482 1.132 0 CA-C-N 119.532 1.06 . . . . 0.0 112.995 -172.079 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 10.0 tpt180 -103.23 133.38 48.41 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 124.734 1.214 . . . . 0.0 109.64 175.763 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 -90.89 -42.64 10.5 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-N 118.627 0.648 . . . . 0.0 110.661 171.787 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 94.0 p -66.25 158.35 29.17 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 124.426 1.09 . . . . 0.0 110.938 168.896 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 24.4 p 50.53 -19.48 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.467 0 C-N-CA 129.254 3.021 . . . . 0.0 119.015 -170.048 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 13.9 tpt180 -107.06 112.97 26.16 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 125.806 1.642 . . . . 0.0 112.062 -173.184 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 3.4 p -69.26 136.99 52.71 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 123.914 0.885 . . . . 0.0 110.914 169.756 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 16.0 mt-30 -122.14 -39.68 2.57 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 124.894 1.278 . . . . 0.0 112.263 -169.783 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 68.13 -43.55 0.48 Allowed 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 127.29 2.236 . . . . 0.0 116.357 169.511 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -65.2 -34.29 78.02 Favored 'General case' 0 CA--C 1.533 0.306 0 O-C-N 120.831 -1.168 . . . . 0.0 113.738 -172.206 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 3.1 pm0 -59.88 -40.67 89.48 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 118.919 0.781 . . . . 0.0 111.929 170.378 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -66.24 -52.3 37.21 Favored Glycine 0 C--N 1.335 0.525 0 C-N-CA 123.839 0.733 . . . . 0.0 111.813 178.138 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -64.73 -34.45 78.34 Favored 'General case' 0 N--CA 1.467 0.405 0 O-C-N 121.659 -0.907 . . . . 0.0 112.008 177.902 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -66.16 -32.1 73.35 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 119.568 1.076 . . . . 0.0 112.72 178.637 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 22.6 mtpp -68.42 -52.95 27.08 Favored 'General case' 0 N--CA 1.478 0.943 0 CA-C-N 118.496 0.589 . . . . 0.0 110.129 169.794 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 98.5 m -72.4 -22.76 61.07 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 113.841 1.052 . . . . 0.0 113.841 -170.81 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 49.9 mt -95.38 -37.25 11.03 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 125.472 1.509 . . . . 0.0 113.253 171.631 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -104.92 -4.5 41.97 Favored Glycine 0 N--CA 1.47 0.915 0 N-CA-C 117.848 1.899 . . . . 0.0 117.848 -168.94 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -62.66 137.66 58.31 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-N 121.526 2.663 . . . . 0.0 111.971 179.794 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 86.88 -14.0 57.74 Favored Glycine 0 CA--C 1.542 1.732 0 C-N-CA 124.92 1.248 . . . . 0.0 113.857 -169.365 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -108.35 -42.88 4.47 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 126.512 1.925 . . . . 0.0 111.768 170.776 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 34.3 pt -136.83 160.65 36.83 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 C-N-CA 126.18 1.792 . . . . 0.0 112.246 179.48 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -108.66 149.34 29.08 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 125.504 1.522 . . . . 0.0 109.893 169.822 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 84.7 t -138.25 141.18 38.63 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 O-C-N 121.471 -0.768 . . . . 0.0 111.916 -170.111 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 18.6 m -140.08 153.49 46.76 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 125.249 1.42 . . . . 0.0 109.936 174.796 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 38.8 p -137.74 138.99 39.86 Favored 'General case' 0 CA--C 1.516 -0.342 0 C-N-CA 124.505 1.122 . . . . 0.0 110.237 168.59 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 96.4 p -127.44 -62.45 1.09 Allowed 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 115.532 1.679 . . . . 0.0 115.532 -168.528 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 111.28 162.11 17.36 Favored Glycine 0 N--CA 1.469 0.841 0 C-N-CA 126.149 1.833 . . . . 0.0 110.6 -174.939 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -97.66 -20.01 17.9 Favored 'General case' 0 N--CA 1.482 1.16 0 CA-C-N 119.384 1.592 . . . . 0.0 113.66 171.801 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 61.0 mt-10 -132.37 -31.94 1.38 Allowed 'General case' 0 N--CA 1.48 1.039 0 N-CA-C 113.901 1.074 . . . . 0.0 113.901 -171.33 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 94.2 p -137.14 160.38 39.16 Favored 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 125.901 1.681 . . . . 0.0 110.875 -177.17 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 96.6 p -116.59 165.64 13.02 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 125.678 1.591 . . . . 0.0 112.995 -175.588 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 72.2 ttt180 62.87 133.39 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 128.161 2.585 . . . . 0.0 113.728 -171.647 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 26.5 m -61.98 135.13 26.92 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 170.675 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -59.88 144.98 85.22 Favored Pre-proline 0 CA--C 1.548 0.88 0 C-N-CA 120.274 -0.57 . . . . 0.0 112.536 -169.603 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -49.12 -40.93 41.92 Favored 'Trans proline' 0 CA--C 1.539 0.761 0 C-N-CA 123.23 2.62 . . . . 0.0 117.763 -167.762 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 59.8 m -65.75 -26.54 67.77 Favored 'General case' 0 N--CA 1.484 1.252 0 CA-C-N 119.475 1.034 . . . . 0.0 111.661 -176.471 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -57.12 -36.94 71.26 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 123.905 0.882 . . . . 0.0 112.199 177.279 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.8 mp -59.5 -60.15 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 CA-C-N 119.05 0.841 . . . . 0.0 109.269 -179.404 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -62.49 -31.25 71.97 Favored 'General case' 0 CA--C 1.544 0.734 0 N-CA-C 113.434 0.901 . . . . 0.0 113.434 -176.677 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -81.29 -6.15 58.57 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 124.815 1.246 . . . . 0.0 114.184 177.672 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 40.6 mtt -114.94 -22.9 9.36 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 125.383 1.473 . . . . 0.0 110.704 175.026 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -65.15 -19.2 65.87 Favored 'General case' 0 CA--C 1.541 0.628 0 O-C-N 120.594 -1.316 . . . . 0.0 111.729 168.751 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 11.7 mt-10 -60.73 -28.27 68.55 Favored 'General case' 0 N--CA 1.481 1.107 0 CA-C-N 119.558 1.072 . . . . 0.0 111.48 169.377 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 67.8 t -93.14 -5.43 10.69 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.946 0 C-N-CA 127.472 2.309 . . . . 0.0 111.021 177.893 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 82.22 16.87 70.67 Favored Glycine 0 CA--C 1.538 1.494 0 C-N-CA 125.16 1.362 . . . . 0.0 114.307 -175.224 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 78.5 mt -77.14 139.6 18.47 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 C-N-CA 124.645 1.178 . . . . 0.0 111.53 -173.912 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 20.0 t0 -103.7 106.68 17.26 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 124.614 1.166 . . . . 0.0 111.873 170.709 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 3.8 pt -131.54 13.71 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.212 0 C-N-CA 125.515 1.526 . . . . 0.0 113.811 178.048 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 72.7 m -73.37 119.56 17.78 Favored 'General case' 0 N--CA 1.472 0.628 0 O-C-N 120.834 -1.167 . . . . 0.0 112.119 -176.31 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 63.78 35.43 92.01 Favored Glycine 0 CA--C 1.537 1.416 0 N-CA-C 115.797 1.079 . . . . 0.0 115.797 169.831 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 41.0 mt-30 -59.99 -50.32 74.22 Favored 'General case' 0 N--CA 1.477 0.906 0 N-CA-C 113.887 1.069 . . . . 0.0 113.887 -172.949 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 76.1 p -139.13 154.18 48.08 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 125.267 1.427 . . . . 0.0 113.348 -169.065 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 69.5 m -122.99 5.86 9.3 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 125.664 1.586 . . . . 0.0 113.982 -176.829 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 -143.14 153.07 59.55 Favored Pre-proline 0 CA--C 1.55 0.976 0 C-N-CA 124.44 1.096 . . . . 0.0 113.562 -173.411 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_exo -66.07 167.11 18.81 Favored 'Trans proline' 0 C--N 1.353 0.808 0 C-N-CA 123.349 2.7 . . . . 0.0 113.84 170.085 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 8.3 tt -50.79 -30.36 8.52 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 C-N-CA 126.699 2.0 . . . . 0.0 111.498 169.073 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -53.44 -27.49 25.04 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 126.514 1.925 . . . . 0.0 113.347 177.123 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -88.34 -6.82 57.5 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 125.119 1.368 . . . . 0.0 113.72 -174.875 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 71.6 m-85 -109.04 179.95 4.02 Favored 'General case' 0 CA--C 1.55 0.981 0 C-N-CA 126.51 1.924 . . . . 0.0 111.485 -174.917 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 5.8 t30 -122.52 126.24 47.4 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 125.495 1.518 . . . . 0.0 109.757 175.023 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.59 -35.66 80.73 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 113.895 1.072 . . . . 0.0 113.895 -169.947 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . 0.254 0.0 OUTLIER -71.46 -5.34 32.17 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 114.085 1.142 . . . . 0.0 114.085 -177.02 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -76.08 -12.96 60.21 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 124.013 0.925 . . . . 0.0 111.463 169.245 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 86.5 m-85 -115.51 139.54 49.97 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 127.098 2.159 . . . . 0.0 111.167 178.676 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -91.14 -21.97 20.91 Favored 'General case' 0 N--CA 1.478 0.959 0 CA-C-O 122.078 0.942 . . . . 0.0 112.556 178.303 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.721 HG22 ' HB ' ' A' ' 95' ' ' ILE . 80.7 t -133.78 139.29 48.98 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 C-N-CA 126.957 2.103 . . . . 0.0 109.014 -174.547 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 45.1 t -131.71 124.07 53.19 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 169.789 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 44.8 mm -111.86 108.01 24.42 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 C-N-CA 124.578 1.151 . . . . 0.0 108.653 -179.486 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 46.8 m -93.64 114.97 27.42 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 123.201 0.6 . . . . 0.0 109.738 174.859 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 82.7 mt -86.77 -13.7 44.45 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.971 1.308 . . . . 0.0 114.059 -172.118 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 14.5 p -147.85 157.78 43.71 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 124.835 1.254 . . . . 0.0 111.29 -176.603 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 62.1 -143.08 48.49 Favored Glycine 0 CA--C 1.538 1.472 0 C-N-CA 123.431 0.538 . . . . 0.0 113.494 179.572 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 56.9 m -131.43 164.12 26.43 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 125.584 1.554 . . . . 0.0 111.209 179.067 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -72.67 63.97 1.49 Allowed Glycine 0 CA--C 1.538 1.517 0 C-N-CA 124.953 1.264 . . . . 0.0 113.525 177.946 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 10.0 p -141.6 -30.65 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 N-CA-C 114.492 1.293 . . . . 0.0 114.492 -171.597 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 10.9 t-20 -75.0 -29.25 60.83 Favored 'General case' 0 N--CA 1.477 0.882 0 CA-C-N 119.417 1.008 . . . . 0.0 112.193 176.525 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -83.18 150.93 62.12 Favored Pre-proline 0 CA--C 1.548 0.888 0 C-N-CA 125.024 1.329 . . . . 0.0 111.279 169.628 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -65.35 155.44 68.62 Favored 'Trans proline' 0 CA--C 1.541 0.828 0 C-N-CA 122.574 2.182 . . . . 0.0 111.655 178.141 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -59.41 -26.34 81.6 Favored 'Trans proline' 0 C--N 1.35 0.61 0 C-N-CA 123.474 2.782 . . . . 0.0 114.913 -169.157 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -59.59 -22.7 62.15 Favored 'General case' 0 N--CA 1.472 0.629 0 O-C-N 120.841 -1.162 . . . . 0.0 114.119 178.285 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 84.9 m95 -82.44 -16.99 46.93 Favored 'General case' 0 N--CA 1.471 0.616 0 O-C-N 120.79 -1.194 . . . . 0.0 113.593 174.904 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 10.3 m -93.33 -10.41 9.45 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 CA-C-N 119.299 0.954 . . . . 0.0 113.498 170.967 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 60.3 p -93.48 -1.35 55.75 Favored 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 114.771 1.397 . . . . 0.0 114.771 177.016 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 72.8 mm-40 -67.64 154.21 41.96 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 119.3 0.954 . . . . 0.0 110.909 169.92 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -56.62 -40.01 74.62 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 114.601 1.334 . . . . 0.0 114.601 -167.82 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.721 ' HB ' HG22 ' A' ' 75' ' ' VAL . 15.7 mm -120.89 61.64 0.23 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 C-N-CA 124.972 1.309 . . . . 0.0 109.357 178.822 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 13.3 t80 -77.29 110.83 12.34 Favored 'General case' 0 CA--C 1.536 0.404 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 168.849 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 16.3 mt-10 -114.66 138.56 50.54 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 113.988 1.107 . . . . 0.0 113.988 173.197 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -101.65 120.25 40.04 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 124.143 0.977 . . . . 0.0 108.518 168.603 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 35.8 m0 -103.56 134.81 46.29 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 123.722 0.809 . . . . 0.0 108.867 176.629 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 64.2 mt-30 -114.8 30.56 7.26 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 123.865 0.866 . . . . 0.0 112.554 -169.563 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -76.16 159.71 30.44 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 125.709 1.604 . . . . 0.0 112.579 174.783 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -73.44 156.18 38.52 Favored 'General case' 0 CA--C 1.539 0.53 0 O-C-N 121.88 -0.512 . . . . 0.0 111.906 170.029 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 64.2 m-20 -106.44 155.06 39.39 Favored Pre-proline 0 CA--C 1.549 0.918 0 C-N-CA 123.292 0.637 . . . . 0.0 111.111 173.096 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_exo -70.87 -21.59 28.12 Favored 'Trans proline' 0 CA--C 1.544 1.007 0 C-N-CA 122.464 2.109 . . . . 0.0 115.115 179.795 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -42.19 125.26 3.02 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 114.329 1.233 . . . . 0.0 114.329 172.756 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 81.54 3.24 90.67 Favored Glycine 0 CA--C 1.535 1.335 0 C-N-CA 124.39 0.995 . . . . 0.0 115.167 177.931 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 9.8 pt20 -137.81 172.8 12.41 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 124.938 1.295 . . . . 0.0 113.59 -178.595 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 51.9 p -71.67 169.75 14.95 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 117.666 2.469 . . . . 0.0 117.666 -168.442 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -54.84 -41.68 71.03 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 126.436 1.894 . . . . 0.0 112.17 170.129 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -57.25 -32.85 66.99 Favored 'General case' 0 N--CA 1.473 0.716 0 O-C-N 121.225 -0.922 . . . . 0.0 112.23 172.382 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 7.7 t -75.14 -36.2 36.77 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 O-C-N 121.051 -1.031 . . . . 0.0 112.05 171.101 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 12.1 m-85 -56.58 -42.77 79.23 Favored 'General case' 0 N--CA 1.478 0.949 0 CA-C-N 120.792 1.633 . . . . 0.0 111.132 169.229 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 83.2 mtp180 -64.82 -42.9 94.61 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 124.1 0.96 . . . . 0.0 112.11 175.063 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 53.1 m -60.45 -45.31 94.15 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 124.1 0.96 . . . . 0.0 111.283 175.398 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 74.3 t -68.16 -42.1 84.62 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 CA-C-O 117.929 -1.034 . . . . 0.0 110.643 177.66 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 18.0 mtp180 -52.91 -44.9 67.3 Favored 'General case' 0 N--CA 1.482 1.158 0 CA-C-N 120.283 1.401 . . . . 0.0 112.215 171.761 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -60.09 -51.49 58.57 Favored Glycine 0 CA--C 1.539 1.577 0 CA-C-N 119.243 0.928 . . . . 0.0 113.694 175.303 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 56.4 mm-40 -65.45 -44.48 87.12 Favored 'General case' 0 N--CA 1.477 0.883 0 O-C-N 121.797 -0.825 . . . . 0.0 112.221 179.873 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 52.9 t -63.21 -42.06 95.09 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 124.673 1.189 . . . . 0.0 110.496 177.022 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 60.0 tttm -54.81 -50.93 67.35 Favored 'General case' 0 N--CA 1.477 0.888 0 CA-C-N 119.689 1.132 . . . . 0.0 110.91 177.664 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -63.99 -41.77 97.4 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 112.458 0.54 . . . . 0.0 112.458 178.756 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 4.8 mtp85 -63.3 -43.97 96.35 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 113.254 0.835 . . . . 0.0 113.254 175.772 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 94.1 t -71.34 -37.76 66.68 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 C-N-CA 124.044 0.937 . . . . 0.0 111.105 179.407 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -61.24 -40.97 96.02 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 119.417 1.008 . . . . 0.0 111.682 170.409 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 11.6 m-80 -61.8 -48.59 79.93 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 118.727 0.694 . . . . 0.0 112.165 173.394 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -51.83 -56.61 12.96 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 125.33 1.452 . . . . 0.0 110.465 175.725 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 75.2 mt -61.25 -46.3 96.89 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 CA-C-O 119.124 -0.465 . . . . 0.0 110.138 -179.574 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -66.62 -12.04 56.27 Favored 'General case' 0 CA--C 1.546 0.795 0 N-CA-C 114.983 1.475 . . . . 0.0 114.983 -178.998 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -102.14 -26.45 13.35 Favored 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 113.824 1.046 . . . . 0.0 113.824 172.355 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 13.6 pt -97.45 -12.85 8.26 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 N-CA-C 114.866 1.432 . . . . 0.0 114.866 178.655 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 57.8 m . . . . . 0 C--O 1.252 1.199 0 C-N-CA 125.333 1.453 . . . . 0.0 112.255 -179.792 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.3 ttt . . . . . 0 N--CA 1.501 2.088 0 N-CA-C 111.937 0.347 . . . . 0.0 111.937 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.15 164.34 30.41 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 124.966 1.306 . . . . 0.0 112.886 175.922 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 41.5 mtpt -94.73 143.4 26.47 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 124.449 1.1 . . . . 0.0 112.136 178.141 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 18.9 t -124.71 133.86 68.33 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 C-N-CA 125.289 1.435 . . . . 0.0 112.749 -178.877 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' MET . . . . . 0.51 ' HG3' HG13 ' A' ' 7' ' ' VAL . 36.8 tpp -104.2 122.45 45.39 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 123.412 0.685 . . . . 0.0 109.257 168.717 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 68.6 m-85 -98.94 128.66 45.15 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.337 1.055 . . . . 0.0 108.993 170.22 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.58 HG11 HD12 ' A' ' 65' ' ' ILE . 0.4 OUTLIER -138.27 144.17 31.11 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 N-CA-C 114.363 1.245 . . . . 0.0 114.363 -168.778 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -141.18 166.81 23.76 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 127.131 2.173 . . . . 0.0 110.68 170.122 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -57.19 -49.15 76.87 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.263 -0.898 . . . . 0.0 112.928 -173.881 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 96.8 mtt180 -125.05 130.55 52.52 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 124.679 1.191 . . . . 0.0 110.088 169.559 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 35.5 t30 -81.54 -43.0 19.35 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-N 117.819 0.281 . . . . 0.0 111.498 -179.735 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 45.0 m -68.25 -32.23 72.28 Favored 'General case' 0 N--CA 1.478 0.954 0 N-CA-C 113.52 0.933 . . . . 0.0 113.52 -170.959 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 97.8 p -90.92 -5.7 55.12 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 114.855 1.428 . . . . 0.0 114.855 -175.138 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 60.2 mtt85 -134.93 156.64 48.64 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 124.583 1.153 . . . . 0.0 112.341 -175.917 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 37.2 m -105.47 103.83 13.44 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 124.565 1.146 . . . . 0.0 110.077 -179.893 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 3.1 mp0 -78.4 -34.51 48.03 Favored 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 114.162 1.171 . . . . 0.0 114.162 -169.206 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 68.74 -49.2 0.57 Allowed 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 126.474 1.91 . . . . 0.0 115.99 169.653 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.97 -33.57 73.41 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.185 0.994 . . . . 0.0 113.574 -171.131 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 3.4 pm0 -62.5 -46.3 89.05 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 123.978 0.911 . . . . 0.0 112.277 174.295 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -65.57 -39.87 95.74 Favored Glycine 0 C--N 1.335 0.49 0 C-N-CA 123.64 0.638 . . . . 0.0 111.66 178.849 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -69.92 -41.78 74.19 Favored 'General case' 0 N--CA 1.468 0.431 0 O-C-N 121.838 -0.801 . . . . 0.0 111.271 176.156 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -60.4 -43.36 96.75 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 119.626 1.103 . . . . 0.0 112.735 -176.446 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 8.8 pttp -77.91 -24.31 48.37 Favored 'General case' 0 N--CA 1.479 1.011 0 N-CA-C 113.65 0.981 . . . . 0.0 113.65 175.097 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 85.5 m -71.63 -36.01 70.6 Favored 'General case' 0 N--CA 1.48 1.071 0 O-C-N 121.401 -0.812 . . . . 0.0 111.623 171.682 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 61.4 mt -88.09 -31.73 19.09 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 125.711 1.604 . . . . 0.0 114.172 -177.698 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -145.8 30.97 1.65 Allowed Glycine 0 N--CA 1.474 1.219 0 N-CA-C 118.297 2.079 . . . . 0.0 118.297 -169.035 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -66.71 -19.75 65.82 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-N 121.794 2.797 . . . . 0.0 115.202 -178.238 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -75.36 -10.37 84.45 Favored Glycine 0 CA--C 1.541 1.711 0 O-C-N 121.293 -0.88 . . . . 0.0 113.18 169.586 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 76.0 mttt -108.64 -39.66 5.31 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 127.185 2.194 . . . . 0.0 113.375 179.873 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 22.6 pt -142.12 155.72 19.33 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 C-N-CA 124.966 1.306 . . . . 0.0 112.562 -173.235 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -104.27 142.68 34.11 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 124.156 0.982 . . . . 0.0 110.48 171.199 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 74.3 t -130.11 140.11 49.76 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 CA-C-N 119.186 0.903 . . . . 0.0 112.88 -171.776 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 36.4 m -137.59 154.18 49.82 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 126.302 1.841 . . . . 0.0 109.02 170.885 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 61.3 p -128.95 147.31 50.84 Favored 'General case' 0 CA--C 1.515 -0.366 0 CA-C-O 121.931 0.872 . . . . 0.0 112.506 167.464 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 25.8 p -144.79 157.44 44.17 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 114.353 -1.294 . . . . 0.0 112.378 -178.59 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -97.92 150.74 19.52 Favored Glycine 0 N--CA 1.468 0.814 0 CA-C-O 119.318 -0.712 . . . . 0.0 111.846 174.663 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 10.8 mp -66.44 -30.9 71.35 Favored 'General case' 0 N--CA 1.483 1.207 0 CA-C-N 119.299 1.55 . . . . 0.0 108.992 168.864 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 52.6 mt-10 -133.1 154.8 50.24 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 128.359 2.664 . . . . 0.0 107.201 168.214 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 27.0 p 64.46 161.38 0.12 Allowed 'General case' 0 N--CA 1.486 1.331 0 N-CA-C 117.504 2.409 . . . . 0.0 117.504 178.678 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 75.1 m -118.76 143.55 46.83 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 126.621 1.968 . . . . 0.0 113.18 -170.248 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 59.1 ttt-85 62.3 148.13 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.897 0 C-N-CA 127.612 2.365 . . . . 0.0 114.091 -176.381 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 24.9 m -61.38 166.18 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.255 0 CA-C-O 122.662 1.22 . . . . 0.0 111.824 169.782 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 2.7 t-80 -41.22 136.45 1.71 Allowed Pre-proline 0 C--N 1.327 -0.386 0 CA-C-N 113.761 -1.563 . . . . 0.0 113.243 169.426 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -60.36 -27.5 84.99 Favored 'Trans proline' 0 CA--C 1.546 1.12 0 CA-C-N 120.753 1.305 . . . . 0.0 112.252 170.647 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 99.0 m -67.89 -31.89 71.99 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 124.966 1.306 . . . . 0.0 112.077 174.566 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -57.39 -39.48 76.2 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 124.289 1.036 . . . . 0.0 111.636 -175.055 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.7 mp -57.45 -60.61 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 C-N-CA 124.226 1.01 . . . . 0.0 109.361 -178.908 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -61.82 -31.62 71.88 Favored 'General case' 0 CA--C 1.545 0.761 0 N-CA-C 113.384 0.883 . . . . 0.0 113.384 -177.17 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -82.25 -6.61 59.35 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 114.248 1.203 . . . . 0.0 114.248 177.953 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 39.1 mtt -112.52 -24.35 9.75 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 125.418 1.487 . . . . 0.0 110.464 174.604 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 27.0 mt-10 -65.46 -16.43 63.64 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 125.128 1.371 . . . . 0.0 111.519 168.559 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 11.5 mt-10 -60.21 -30.52 69.43 Favored 'General case' 0 N--CA 1.481 1.095 0 CA-C-N 119.726 1.148 . . . . 0.0 110.74 169.103 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 60.2 t -92.45 -4.99 10.79 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.955 0 C-N-CA 127.59 2.356 . . . . 0.0 111.017 178.721 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 80.1 18.3 72.37 Favored Glycine 0 CA--C 1.538 1.497 0 C-N-CA 125.073 1.32 . . . . 0.0 114.55 -173.933 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 73.8 mt -76.89 136.69 23.99 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 124.368 1.067 . . . . 0.0 111.661 -173.082 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 19.7 t0 -97.33 88.45 4.43 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.588 1.155 . . . . 0.0 112.061 -179.112 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 7.6 pt -125.8 8.66 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.33 0 N-CA-C 114.265 1.209 . . . . 0.0 114.265 174.957 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 97.7 p -59.28 -42.12 90.48 Favored 'General case' 0 N--CA 1.477 0.92 0 O-C-N 120.824 -1.173 . . . . 0.0 114.044 -171.59 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -93.35 15.39 63.07 Favored Glycine 0 CA--C 1.534 1.237 0 C-N-CA 125.18 1.371 . . . . 0.0 116.092 -176.533 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . 0.268 0.0 OUTLIER -77.51 62.07 2.4 Favored 'General case' 0 N--CA 1.478 0.93 0 CA-C-N 119.912 1.856 . . . . 0.0 114.481 -172.18 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 40.2 p -69.38 107.86 3.49 Favored 'General case' 0 N--CA 1.471 0.585 0 O-C-N 120.431 -1.418 . . . . 0.0 108.93 169.186 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 70.2 m -142.18 129.32 20.92 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.204 1.002 . . . . 0.0 111.456 -169.567 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -67.02 170.39 6.37 Favored Pre-proline 0 CA--C 1.549 0.922 0 C-N-CA 127.575 2.35 . . . . 0.0 114.496 -176.249 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -64.3 156.51 59.38 Favored 'Trans proline' 0 C--N 1.352 0.728 0 C-N-CA 122.665 2.243 . . . . 0.0 111.819 169.129 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.58 HD12 HG11 ' A' ' 7' ' ' VAL . 6.0 tt -51.59 -33.71 15.17 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 C-N-CA 125.874 1.669 . . . . 0.0 111.571 174.632 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 12.3 mt-10 -61.97 -24.18 66.85 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.748 1.219 . . . . 0.0 113.295 -178.044 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 71.1 m-20 -91.89 6.17 47.22 Favored 'General case' 0 CA--C 1.55 0.981 0 C-N-CA 124.378 1.071 . . . . 0.0 112.898 -175.408 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 -119.15 -175.55 2.94 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 126.833 2.053 . . . . 0.0 112.683 -179.76 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 9.6 p-10 -123.73 129.26 50.81 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 125.737 1.615 . . . . 0.0 109.728 172.474 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -64.72 -37.19 86.76 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 112.81 0.671 . . . . 0.0 112.81 -172.607 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -68.4 -4.39 14.52 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 114.291 1.219 . . . . 0.0 114.291 179.364 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -68.51 -21.39 64.58 Favored 'General case' 0 CA--C 1.549 0.916 0 CA-C-N 119.317 0.962 . . . . 0.0 109.932 168.449 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 76.6 m-85 -115.35 146.13 41.85 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 127.726 2.41 . . . . 0.0 111.842 -175.179 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -101.91 -18.12 15.84 Favored 'General case' 0 N--CA 1.481 1.088 0 CA-C-O 122.153 0.978 . . . . 0.0 112.614 178.584 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.657 HG22 ' HB ' ' A' ' 95' ' ' ILE . 76.0 t -128.62 138.64 54.05 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 C-N-CA 127.605 2.362 . . . . 0.0 108.022 177.731 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 48.7 t -132.82 124.98 51.68 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 169.836 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 46.2 mm -112.3 104.82 17.66 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.344 0 C-N-CA 124.275 1.03 . . . . 0.0 109.602 -175.054 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 3.6 m -80.28 106.69 12.49 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 123.494 0.718 . . . . 0.0 109.868 170.463 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 91.2 mt -83.58 -19.95 34.63 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 126.237 1.815 . . . . 0.0 113.852 -176.293 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 80.6 m -97.01 121.59 39.06 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 106.931 -1.507 . . . . 0.0 106.931 171.328 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -59.73 141.47 47.55 Favored Glycine 0 CA--C 1.535 1.337 0 CA-C-N 118.484 0.583 . . . . 0.0 113.199 -172.571 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 75.7 m 56.85 43.65 24.57 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.744 1.218 . . . . 0.0 111.114 -169.526 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -74.29 62.61 2.2 Favored Glycine 0 N--CA 1.471 1.002 0 C-N-CA 125.91 1.719 . . . . 0.0 111.802 176.331 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.3 p -113.17 -0.41 9.3 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 C-N-CA 126.119 1.768 . . . . 0.0 112.913 -170.074 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 29.0 m120 -74.46 -11.34 60.2 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 124.338 1.055 . . . . 0.0 113.252 174.844 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -65.77 158.96 72.46 Favored Pre-proline 0 CA--C 1.553 1.07 0 C-N-CA 124.274 1.03 . . . . 0.0 112.389 170.501 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -59.94 149.93 81.15 Favored 'Trans proline' 0 CA--C 1.543 0.975 0 C-N-CA 122.437 2.091 . . . . 0.0 113.11 178.721 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_exo -56.25 -33.4 90.88 Favored 'Trans proline' 0 C--N 1.351 0.694 0 C-N-CA 123.102 2.535 . . . . 0.0 114.948 -171.873 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -59.61 -22.49 61.89 Favored 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 114.019 1.118 . . . . 0.0 114.019 178.879 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 88.7 m95 -79.75 -15.82 56.76 Favored 'General case' 0 N--CA 1.469 0.511 0 O-C-N 120.685 -1.259 . . . . 0.0 113.487 176.439 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 8.2 m -96.35 -8.13 9.43 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 N-CA-C 113.711 1.004 . . . . 0.0 113.711 170.731 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 68.5 p -95.77 -2.85 46.86 Favored 'General case' 0 N--CA 1.48 1.044 0 N-CA-C 114.866 1.432 . . . . 0.0 114.866 178.206 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 68.6 mm-40 -65.93 155.09 37.51 Favored 'General case' 0 N--CA 1.477 0.916 0 CA-C-N 119.368 0.985 . . . . 0.0 110.236 169.553 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -56.78 -40.05 75.16 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 114.773 1.397 . . . . 0.0 114.773 -168.154 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.657 ' HB ' HG22 ' A' ' 75' ' ' VAL . 19.7 mm -120.26 65.92 0.26 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 C-N-CA 124.652 1.181 . . . . 0.0 109.147 -178.795 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 32.7 t80 -80.04 109.76 14.79 Favored 'General case' 0 C--O 1.236 0.375 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 168.961 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -110.2 135.19 51.36 Favored 'General case' 0 CA--C 1.545 0.76 0 N-CA-C 113.441 0.904 . . . . 0.0 113.441 174.478 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -102.06 103.71 14.32 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.435 1.094 . . . . 0.0 109.584 169.895 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 38.1 m0 -91.84 114.1 26.55 Favored 'General case' 0 N--CA 1.463 0.181 0 C-N-CA 124.275 1.03 . . . . 0.0 109.294 179.523 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 41.7 mt-30 -91.8 48.54 1.46 Allowed 'General case' 0 CA--C 1.544 0.749 0 CA-C-O 122.289 1.043 . . . . 0.0 111.26 -172.678 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 86.5 mt -78.39 166.25 22.87 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 127.115 2.166 . . . . 0.0 111.953 176.485 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -88.9 152.49 21.7 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-O 121.555 0.693 . . . . 0.0 112.415 169.573 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 13.4 p-10 -89.6 136.77 29.23 Favored Pre-proline 0 CA--C 1.55 0.968 0 C-N-CA 125.47 1.508 . . . . 0.0 112.008 176.214 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -70.25 -20.01 33.05 Favored 'Trans proline' 0 CA--C 1.547 1.126 0 C-N-CA 121.955 1.77 . . . . 0.0 115.491 -178.42 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -66.52 145.0 56.12 Favored 'General case' 0 N--CA 1.476 0.834 0 O-C-N 121.103 -0.998 . . . . 0.0 113.179 -175.965 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 78.36 4.81 87.37 Favored Glycine 0 CA--C 1.535 1.296 0 C-N-CA 123.943 0.782 . . . . 0.0 114.661 -179.156 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -141.61 166.83 23.67 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 125.465 1.506 . . . . 0.0 112.878 -179.921 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 66.9 m -63.86 163.23 12.23 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 115.698 1.74 . . . . 0.0 115.698 -169.239 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -51.82 -39.64 59.11 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 126.673 1.989 . . . . 0.0 112.837 171.911 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -55.27 -31.81 61.86 Favored 'General case' 0 N--CA 1.474 0.737 0 O-C-N 121.265 -0.897 . . . . 0.0 112.515 172.598 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 4.3 t -76.94 -37.27 26.7 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 O-C-N 121.163 -0.961 . . . . 0.0 111.75 173.575 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 21.4 m-85 -57.16 -42.66 81.49 Favored 'General case' 0 N--CA 1.477 0.88 0 CA-C-N 119.943 1.247 . . . . 0.0 111.221 169.302 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 97.7 mtt180 -68.45 -38.35 81.06 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.612 0.765 . . . . 0.0 112.474 176.158 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 45.8 m -61.71 -45.65 93.06 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 124.187 0.995 . . . . 0.0 111.37 172.638 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 72.1 t -67.77 -40.97 84.74 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 CA-C-O 118.266 -0.873 . . . . 0.0 110.463 178.324 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 20.4 mtp180 -54.45 -43.74 71.92 Favored 'General case' 0 N--CA 1.484 1.273 0 CA-C-N 120.239 1.381 . . . . 0.0 112.915 170.912 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -61.59 -50.02 70.69 Favored Glycine 0 CA--C 1.537 1.417 0 CA-C-N 119.45 1.023 . . . . 0.0 113.255 175.784 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 53.6 mm-40 -64.59 -44.13 91.65 Favored 'General case' 0 N--CA 1.476 0.837 0 O-C-N 122.043 -0.68 . . . . 0.0 112.012 178.478 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 58.8 t -63.92 -41.46 92.58 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 C-N-CA 124.91 1.284 . . . . 0.0 111.125 176.752 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 60.7 tttm -54.27 -49.75 68.84 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-N 120.13 1.332 . . . . 0.0 110.628 176.832 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -63.49 -44.79 93.33 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 112.557 0.577 . . . . 0.0 112.557 176.306 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.23 -35.38 80.86 Favored 'General case' 0 N--CA 1.481 1.105 0 N-CA-C 113.6 0.963 . . . . 0.0 113.6 -179.921 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 92.3 t -78.01 -40.55 26.61 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 C-N-CA 125.411 1.484 . . . . 0.0 110.992 177.008 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -61.43 -38.57 87.61 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 119.185 0.902 . . . . 0.0 111.542 172.257 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 11.1 m-80 -63.91 -44.96 91.37 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 118.846 0.748 . . . . 0.0 112.701 173.561 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -54.47 -56.32 20.0 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 124.223 1.009 . . . . 0.0 110.667 174.392 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 95.3 mt -61.76 -42.01 92.77 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 CA-C-O 119.199 -0.429 . . . . 0.0 110.51 -179.26 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -68.72 -14.38 62.99 Favored 'General case' 0 CA--C 1.545 0.763 0 N-CA-C 114.933 1.457 . . . . 0.0 114.933 179.072 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 21.1 ptmt -99.96 -27.96 13.32 Favored 'General case' 0 N--CA 1.479 0.986 0 N-CA-C 113.855 1.057 . . . . 0.0 113.855 173.523 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 16.6 pt -94.86 -20.54 6.03 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 N-CA-C 114.295 1.22 . . . . 0.0 114.295 177.338 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 74.7 m . . . . . 0 C--O 1.253 1.28 0 C-N-CA 125.074 1.349 . . . . 0.0 111.889 -173.788 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 32.9 ttm . . . . . 0 N--CA 1.502 2.133 0 N-CA-C 112.044 0.387 . . . . 0.0 112.044 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 3.5 mptp? -103.92 155.51 18.58 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 125.181 1.392 . . . . 0.0 112.688 169.812 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 44.7 mtpt -105.4 113.78 27.56 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 106.089 -1.819 . . . . 0.0 106.089 167.088 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 14.4 t -105.95 130.49 57.41 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 C-N-CA 125.247 1.419 . . . . 0.0 113.15 -178.788 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' MET . . . . . 0.52 ' HG3' HG13 ' A' ' 7' ' ' VAL . 61.3 tpp -101.65 117.74 35.51 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.501 0.72 . . . . 0.0 109.137 169.193 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 54.8 m-85 -98.79 128.09 44.91 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 169.744 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.52 HG13 ' HG3' ' A' ' 5' ' ' MET . 1.3 m -144.22 153.1 15.4 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.127 0 N-CA-C 113.527 0.936 . . . . 0.0 113.527 -169.195 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 44.0 t -146.2 137.66 24.71 Favored 'General case' 0 CA--C 1.552 1.024 0 C-N-CA 125.315 1.446 . . . . 0.0 113.052 -178.457 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -67.36 135.44 53.24 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 125.029 1.331 . . . . 0.0 111.718 172.439 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . 0.263 19.1 ttm180 47.24 56.36 6.99 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 126.693 1.997 . . . . 0.0 113.31 -174.53 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 -48.76 -29.93 5.07 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 126.746 2.018 . . . . 0.0 114.654 175.461 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 81.4 p -62.69 -19.17 63.61 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 114.558 1.318 . . . . 0.0 114.558 179.72 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 84.7 p -127.32 24.07 6.32 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.458 1.503 . . . . 0.0 113.872 175.019 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 72.2 mtt85 -139.32 150.44 45.4 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 124.846 1.259 . . . . 0.0 113.26 177.196 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 22.3 m -106.81 153.87 21.84 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 125.552 1.541 . . . . 0.0 111.147 172.499 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 30.7 mt-30 -110.15 -55.91 2.4 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 113.248 0.833 . . . . 0.0 113.248 -171.846 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' MET . . . . . 0.433 ' HG2' ' SD ' ' A' ' 50' ' ' MET . 0.0 OUTLIER 73.28 -48.21 0.68 Allowed 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 126.608 1.963 . . . . 0.0 113.523 176.984 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.92 -33.31 74.02 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 113.552 0.945 . . . . 0.0 113.552 -175.1 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 5.4 pm0 -68.58 -42.3 78.45 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 123.846 0.859 . . . . 0.0 111.306 177.419 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -65.0 -40.59 97.23 Favored Glycine 0 C--N 1.336 0.581 0 N-CA-C 111.504 -0.638 . . . . 0.0 111.504 178.7 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -72.64 -38.93 67.54 Favored 'General case' 0 N--CA 1.466 0.366 0 O-C-N 121.809 -0.818 . . . . 0.0 112.054 177.403 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.9 -37.48 84.78 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 113.552 0.945 . . . . 0.0 113.552 -173.749 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 6.9 pttp -79.47 -31.16 42.37 Favored 'General case' 0 N--CA 1.481 1.102 0 N-CA-C 113.689 0.996 . . . . 0.0 113.689 172.115 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 59.0 m -70.74 -33.34 70.71 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.197 0.599 . . . . 0.0 111.498 178.583 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 68.3 mt -92.78 -37.5 12.3 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 125.864 1.666 . . . . 0.0 113.277 177.587 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -106.82 8.91 39.96 Favored Glycine 0 N--CA 1.472 1.055 0 N-CA-C 117.892 1.917 . . . . 0.0 117.892 -169.021 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.12 141.88 57.11 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-N 121.318 2.559 . . . . 0.0 112.203 177.407 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 83.91 -21.34 9.79 Favored Glycine 0 CA--C 1.538 1.495 0 C-N-CA 124.984 1.278 . . . . 0.0 113.749 -169.485 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 65.1 mttm -97.45 -48.22 5.37 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 125.786 1.635 . . . . 0.0 111.796 169.863 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 40.6 pt -135.39 150.13 29.03 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 C-N-CA 124.364 1.066 . . . . 0.0 113.085 -175.087 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -102.48 137.76 40.29 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 125.407 1.483 . . . . 0.0 108.921 169.769 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 99.4 t -126.49 140.67 48.16 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 C-N-CA 123.265 0.626 . . . . 0.0 111.976 -173.785 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 27.3 m -140.04 151.59 45.54 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 125.191 1.396 . . . . 0.0 109.626 174.745 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 53.0 p -138.37 145.75 41.46 Favored 'General case' 0 CA--C 1.516 -0.339 0 CA-C-O 122.486 1.136 . . . . 0.0 111.784 167.454 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 88.5 p -139.59 153.56 47.4 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 113.227 -1.806 . . . . 0.0 110.657 -171.951 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -75.98 162.82 53.0 Favored Glycine 0 CA--C 1.535 1.329 0 O-C-N 121.162 -0.961 . . . . 0.0 112.57 176.741 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.6 mp -95.5 -6.58 40.24 Favored 'General case' 0 N--CA 1.479 1.016 0 O-C-N 120.218 -1.754 . . . . 0.0 111.305 168.565 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -129.21 165.59 21.06 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 128.64 2.776 . . . . 0.0 107.386 169.799 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 70.1 m -77.24 59.7 1.82 Allowed 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 124.23 1.012 . . . . 0.0 113.159 -170.072 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 89.3 p -152.56 -179.63 7.76 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 125.748 1.619 . . . . 0.0 114.124 -169.685 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 58.8 ttt85 -94.8 163.17 13.46 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 128.798 2.839 . . . . 0.0 110.553 -174.571 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 21.2 m -78.51 178.49 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.235 0 C-N-CA 123.974 0.91 . . . . 0.0 110.056 169.238 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 2.1 t-80 -61.01 129.62 90.58 Favored Pre-proline 0 CA--C 1.534 0.344 0 CA-C-O 118.445 -0.788 . . . . 0.0 113.041 -177.06 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo -58.18 -28.01 82.42 Favored 'Trans proline' 0 CA--C 1.544 0.982 0 C-N-CA 121.728 1.618 . . . . 0.0 112.083 169.722 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 96.9 m -61.18 -32.32 72.06 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 125.5 1.52 . . . . 0.0 112.282 173.872 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -57.99 -47.24 83.59 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 118.98 0.809 . . . . 0.0 110.786 179.895 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.5 mp -53.42 -54.5 17.97 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 C-N-CA 124.222 1.009 . . . . 0.0 110.299 -174.596 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.24 -31.05 72.09 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 113.223 0.823 . . . . 0.0 113.223 -178.534 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -81.61 -21.72 38.13 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 113.761 1.022 . . . . 0.0 113.761 177.653 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' MET . . . . . 0.433 ' SD ' ' HG2' ' A' ' 17' ' ' MET . 4.8 mmt -84.87 -31.27 23.83 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 119.491 1.042 . . . . 0.0 110.484 169.549 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -66.97 -15.05 63.46 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.752 1.221 . . . . 0.0 113.774 175.571 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 14.3 mt-10 -61.97 -25.7 67.77 Favored 'General case' 0 N--CA 1.482 1.137 0 CA-C-N 120.313 1.415 . . . . 0.0 110.797 168.864 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 48.6 t -98.44 -2.76 9.86 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.006 0 C-N-CA 127.69 2.396 . . . . 0.0 111.163 176.749 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 79.42 17.86 75.06 Favored Glycine 0 CA--C 1.539 1.591 0 C-N-CA 125.096 1.331 . . . . 0.0 114.498 -176.805 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 84.4 mt -79.49 136.16 24.17 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 C-N-CA 125.06 1.344 . . . . 0.0 111.523 -174.449 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 15.0 t0 -95.35 111.0 22.94 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 112.896 0.702 . . . . 0.0 112.896 175.29 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 6.7 pt -135.89 24.35 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.363 0 C-N-CA 124.77 1.228 . . . . 0.0 114.05 172.52 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 70.4 m -69.85 -20.47 63.42 Favored 'General case' 0 N--CA 1.48 1.048 0 O-C-N 120.153 -1.592 . . . . 0.0 114.608 -172.242 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -90.06 10.85 72.65 Favored Glycine 0 CA--C 1.537 1.416 0 N-CA-C 116.521 1.369 . . . . 0.0 116.521 -175.871 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 25.2 mt-30 -81.83 50.49 1.54 Allowed 'General case' 0 N--CA 1.482 1.154 0 CA-C-N 120.08 1.94 . . . . 0.0 114.97 -169.573 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 37.8 m -104.65 -7.15 19.82 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 125.501 1.52 . . . . 0.0 111.249 169.655 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 68.7 m -69.59 79.36 0.42 Allowed 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 115.921 1.823 . . . . 0.0 115.921 -169.299 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 34.8 m-20 65.35 158.91 0.13 Allowed Pre-proline 0 CA--C 1.552 1.039 0 C-N-CA 128.57 2.748 . . . . 0.0 117.48 169.116 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -73.04 158.47 49.49 Favored 'Trans proline' 0 CA--C 1.539 0.74 0 C-N-CA 122.656 2.237 . . . . 0.0 113.052 169.934 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.47 HD12 HG11 ' A' ' 7' ' ' VAL . 6.3 tt -51.22 -40.92 23.4 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 125.705 1.602 . . . . 0.0 112.065 174.336 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -69.54 -7.32 37.32 Favored 'General case' 0 CA--C 1.543 0.707 0 N-CA-C 113.999 1.111 . . . . 0.0 113.999 -179.331 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 -81.14 -19.92 42.45 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 123.682 0.793 . . . . 0.0 113.128 171.349 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -99.27 -173.04 2.38 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 126.104 1.762 . . . . 0.0 112.581 -176.201 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 14.7 t30 -117.75 124.87 49.52 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 125.363 1.465 . . . . 0.0 110.14 175.488 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.99 -38.29 88.13 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 113.694 0.998 . . . . 0.0 113.694 -172.237 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -72.72 -5.09 35.39 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 113.951 1.093 . . . . 0.0 113.951 -176.694 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -72.69 -16.05 61.68 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 123.485 0.714 . . . . 0.0 111.385 168.866 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 60.3 m-85 -115.11 132.11 56.71 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 126.348 1.859 . . . . 0.0 111.166 179.313 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -89.03 -20.6 24.18 Favored 'General case' 0 N--CA 1.476 0.875 0 CA-C-O 121.966 0.889 . . . . 0.0 112.73 -177.972 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.686 HG22 ' HB ' ' A' ' 95' ' ' ILE . 82.0 t -128.57 137.74 56.5 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 C-N-CA 127.488 2.315 . . . . 0.0 107.965 178.75 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 65.9 t -131.37 123.68 53.41 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 169.569 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 36.1 mm -109.77 104.46 17.11 Favored 'Isoleucine or valine' 0 C--O 1.234 0.287 0 C-N-CA 124.397 1.079 . . . . 0.0 108.462 -179.053 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 5.4 m -82.71 125.42 31.22 Favored 'General case' 0 N--CA 1.466 0.375 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 170.264 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 89.5 mt -102.33 -11.96 18.29 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 114.497 1.295 . . . . 0.0 114.497 -173.189 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 35.1 m -141.65 143.41 33.61 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 125.015 1.326 . . . . 0.0 110.426 -169.595 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 65.39 -133.4 35.85 Favored Glycine 0 CA--C 1.537 1.464 0 CA-C-N 118.083 0.402 . . . . 0.0 112.515 -176.762 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 88.4 p -131.02 13.84 5.21 Favored 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 115.143 1.534 . . . . 0.0 115.143 -175.212 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 67.57 69.17 1.43 Allowed Glycine 0 N--CA 1.475 1.276 0 CA-C-O 122.832 1.24 . . . . 0.0 111.968 -171.046 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 10.2 p -136.44 176.05 8.94 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 C-N-CA 127.876 2.47 . . . . 0.0 107.036 175.018 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 20.8 t-20 66.28 -36.93 0.26 Allowed 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 126.339 1.856 . . . . 0.0 114.844 -172.358 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -71.04 155.72 92.94 Favored Pre-proline 0 CA--C 1.554 1.106 0 CA-C-N 119.742 1.155 . . . . 0.0 111.592 169.18 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_exo -63.17 146.25 94.03 Favored 'Trans proline' 0 CA--C 1.548 1.183 0 C-N-CA 122.094 1.863 . . . . 0.0 113.169 179.917 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_exo -55.58 -28.8 66.98 Favored 'Trans proline' 0 C--N 1.352 0.738 0 C-N-CA 123.703 2.935 . . . . 0.0 115.804 -175.682 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 4.4 pm0 -62.61 -18.93 63.17 Favored 'General case' 0 CA--C 1.544 0.745 0 O-C-N 120.664 -1.273 . . . . 0.0 114.168 176.373 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 86.6 m95 -83.39 -24.11 32.1 Favored 'General case' 0 N--CA 1.471 0.578 0 O-C-N 120.552 -1.343 . . . . 0.0 112.934 175.708 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 9.7 m -86.21 -3.41 8.66 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.31 0 N-CA-C 113.608 0.966 . . . . 0.0 113.608 173.443 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -111.2 4.69 19.43 Favored 'General case' 0 N--CA 1.48 1.026 0 N-CA-C 114.581 1.326 . . . . 0.0 114.581 -177.957 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 85.9 mm-40 -64.56 158.35 24.47 Favored 'General case' 0 N--CA 1.478 0.956 0 O-C-N 120.863 -1.148 . . . . 0.0 111.976 170.882 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -57.52 -41.83 81.65 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 114.002 1.112 . . . . 0.0 114.002 -168.249 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.686 ' HB ' HG22 ' A' ' 75' ' ' VAL . 15.5 mm -116.03 58.97 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 C-N-CA 124.892 1.277 . . . . 0.0 109.049 174.401 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 27.0 t80 -74.17 110.12 8.2 Favored 'General case' 0 CA--C 1.534 0.356 0 O-C-N 120.441 -1.412 . . . . 0.0 107.666 168.8 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 9.1 mt-10 -107.67 129.43 55.01 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-O 121.586 0.708 . . . . 0.0 112.687 172.404 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -98.35 88.81 4.25 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 124.163 0.985 . . . . 0.0 110.215 174.287 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 29.2 m0 -81.09 102.09 10.03 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-O 122.031 0.919 . . . . 0.0 109.618 176.63 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 27.6 mt-30 -82.29 60.13 4.86 Favored 'General case' 0 CA--C 1.545 0.787 0 CA-C-O 122.527 1.156 . . . . 0.0 109.049 175.83 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 5.9 tt -95.13 156.31 16.37 Favored 'General case' 0 CA--C 1.539 0.519 0 C-N-CA 128.226 2.61 . . . . 0.0 112.87 -169.148 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -67.67 109.88 3.49 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 125.185 1.394 . . . . 0.0 112.398 177.473 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -71.63 123.9 90.12 Favored Pre-proline 0 CA--C 1.548 0.883 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 169.313 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -79.0 -8.57 15.5 Favored 'Trans proline' 0 CA--C 1.551 1.339 0 C-N-CA 122.092 1.861 . . . . 0.0 114.134 -172.456 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -72.82 155.0 40.37 Favored 'General case' 0 CA--C 1.549 0.934 0 CA-C-N 120.668 1.576 . . . . 0.0 113.338 176.416 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 76.57 5.94 83.65 Favored Glycine 0 CA--C 1.538 1.474 0 C-N-CA 124.428 1.013 . . . . 0.0 114.089 -178.12 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 -142.92 167.51 21.9 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 126.998 2.119 . . . . 0.0 111.226 179.284 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 70.6 m -59.83 157.16 12.78 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 115.081 1.511 . . . . 0.0 115.081 -169.42 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -51.1 -38.32 51.11 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 126.202 1.801 . . . . 0.0 112.689 172.304 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -55.11 -38.93 68.79 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 123.787 0.835 . . . . 0.0 112.107 172.7 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 14.6 t -67.96 -40.76 83.88 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 CA-C-O 118.674 -0.679 . . . . 0.0 111.071 173.968 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -53.7 -47.39 70.53 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 119.346 0.975 . . . . 0.0 112.339 169.821 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 96.9 mtt180 -69.01 -39.0 79.55 Favored 'General case' 0 N--CA 1.479 0.999 0 CA-C-N 118.842 0.746 . . . . 0.0 112.652 -179.603 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 30.7 m -62.18 -40.92 97.65 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 123.718 0.807 . . . . 0.0 111.306 170.432 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 41.8 t -65.69 -41.07 89.68 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 CA-C-O 117.407 -1.282 . . . . 0.0 111.19 176.57 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 75.5 mtm-85 -55.28 -43.52 74.82 Favored 'General case' 0 N--CA 1.485 1.315 0 CA-C-N 121.038 1.745 . . . . 0.0 112.26 172.576 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -60.85 -51.67 57.15 Favored Glycine 0 CA--C 1.537 1.429 0 CA-C-N 119.036 0.835 . . . . 0.0 113.514 176.269 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 57.6 mm-40 -64.81 -42.97 94.58 Favored 'General case' 0 N--CA 1.474 0.765 0 O-C-N 121.758 -0.848 . . . . 0.0 112.124 179.107 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 55.0 t -65.39 -42.54 93.78 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 C-N-CA 124.799 1.24 . . . . 0.0 110.957 177.378 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 62.9 tttm -53.57 -49.36 67.88 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-N 119.721 1.146 . . . . 0.0 111.147 176.629 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -63.68 -41.7 98.12 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 178.444 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 13.3 mtp85 -63.82 -43.5 96.04 Favored 'General case' 0 N--CA 1.478 0.952 0 N-CA-C 113.22 0.822 . . . . 0.0 113.22 175.435 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 86.2 t -69.06 -38.9 78.92 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 C-N-CA 123.453 0.701 . . . . 0.0 110.729 179.534 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -62.75 -37.63 87.36 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 118.897 0.771 . . . . 0.0 111.773 170.791 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 9.4 m-80 -63.29 -46.85 84.81 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 119.185 0.902 . . . . 0.0 112.549 173.495 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -52.98 -56.81 13.26 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 125.035 1.334 . . . . 0.0 110.253 173.696 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 75.4 mt -61.63 -40.53 87.0 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 O-C-N 122.004 -0.435 . . . . 0.0 110.603 -179.121 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -70.69 -12.11 61.36 Favored 'General case' 0 CA--C 1.545 0.779 0 N-CA-C 114.95 1.463 . . . . 0.0 114.95 178.695 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 20.9 ptmt -102.67 -25.9 13.38 Favored 'General case' 0 N--CA 1.478 0.952 0 N-CA-C 114.038 1.125 . . . . 0.0 114.038 172.882 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 16.7 pt -99.18 -19.16 6.01 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 N-CA-C 114.432 1.271 . . . . 0.0 114.432 177.733 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 68.8 m . . . . . 0 C--O 1.255 1.39 0 C-N-CA 125.132 1.373 . . . . 0.0 112.292 -174.777 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.8 ttt . . . . . 0 N--CA 1.503 2.22 0 N-CA-C 111.745 0.276 . . . . 0.0 111.745 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 3.3 mptp? -125.92 156.43 39.73 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 125.685 1.594 . . . . 0.0 112.681 175.759 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 30.5 ttmt -107.64 117.89 35.3 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 106.651 -1.611 . . . . 0.0 106.651 167.115 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 14.3 t -103.01 135.23 41.45 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 N-CA-C 114.239 1.2 . . . . 0.0 114.239 -179.376 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' MET . . . . . 0.511 ' HG3' HG13 ' A' ' 7' ' ' VAL . 42.4 tpp -104.48 124.37 49.14 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 123.886 0.874 . . . . 0.0 108.908 168.503 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 67.2 m-85 -105.03 126.09 51.69 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 123.839 0.856 . . . . 0.0 108.972 169.798 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.511 HG13 ' HG3' ' A' ' 5' ' ' MET . 1.5 m -141.95 150.6 19.03 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.194 0 N-CA-C 114.902 1.445 . . . . 0.0 114.902 -168.784 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 48.7 t -148.16 162.28 39.76 Favored 'General case' 0 CA--C 1.556 1.193 0 C-N-CA 127.501 2.32 . . . . 0.0 112.303 -179.432 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 21.9 ptmt -63.3 132.51 51.84 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 125.316 1.446 . . . . 0.0 112.298 172.597 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 6.9 mmm180 42.31 -135.84 0.32 Allowed 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 126.04 1.736 . . . . 0.0 112.255 -172.868 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 34.1 p-10 -154.39 -45.95 0.09 Allowed 'General case' 0 CA--C 1.549 0.942 0 N-CA-C 114.78 1.4 . . . . 0.0 114.78 172.715 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 67.5 m -56.73 -15.16 4.09 Favored 'General case' 0 N--CA 1.481 1.118 0 N-CA-C 117.685 2.476 . . . . 0.0 117.685 -169.067 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 97.7 p -102.17 -9.9 20.08 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 115.577 1.695 . . . . 0.0 115.577 -179.791 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 77.6 mtt85 -144.68 150.2 36.92 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 125.017 1.327 . . . . 0.0 113.468 -169.634 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 86.9 p -119.16 -5.07 10.49 Favored 'General case' 0 N--CA 1.478 0.944 0 N-CA-C 116.196 1.924 . . . . 0.0 116.196 -170.071 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 27.7 mt-30 64.25 -59.59 0.21 Allowed 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 128.013 2.525 . . . . 0.0 117.318 169.853 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 65.02 -43.88 0.33 Allowed 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 127.851 2.46 . . . . 0.0 116.597 -179.748 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.93 -28.34 68.87 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 115.137 1.532 . . . . 0.0 115.137 -169.212 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.0 pm0 -59.69 -37.1 77.87 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 119.132 0.878 . . . . 0.0 112.406 171.588 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -70.3 -50.45 27.17 Favored Glycine 0 C--O 1.224 -0.515 0 C-N-CA 124.408 1.004 . . . . 0.0 112.151 -169.993 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -66.4 -30.13 70.44 Favored 'General case' 0 N--CA 1.467 0.394 0 O-C-N 121.554 -0.968 . . . . 0.0 112.744 173.499 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -66.32 -35.86 81.46 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 118.499 0.59 . . . . 0.0 111.691 -176.001 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 13.4 ptmm? -82.1 -39.95 22.64 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 123.41 0.684 . . . . 0.0 112.319 169.227 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 16.9 m -76.02 -23.73 55.21 Favored 'General case' 0 N--CA 1.486 1.351 0 N-CA-C 112.905 0.706 . . . . 0.0 112.905 -169.255 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 85.3 mt -103.38 -30.61 10.48 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 125.378 1.471 . . . . 0.0 112.577 169.397 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -99.95 0.72 56.35 Favored Glycine 0 N--CA 1.471 1.026 0 N-CA-C 117.379 1.711 . . . . 0.0 117.379 -169.534 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -60.45 142.93 54.48 Favored 'General case' 0 CA--C 1.546 0.81 0 CA-C-N 121.09 2.445 . . . . 0.0 112.566 178.371 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 84.15 -23.51 7.0 Favored Glycine 0 CA--C 1.54 1.606 0 C-N-CA 124.822 1.201 . . . . 0.0 113.337 -169.48 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 62.1 mttp -96.93 -43.87 7.27 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 125.884 1.674 . . . . 0.0 111.883 169.834 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 43.7 pt -141.74 160.41 21.25 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 C-N-CA 125.178 1.391 . . . . 0.0 113.173 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -108.4 148.16 30.53 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 127.157 2.183 . . . . 0.0 109.17 169.831 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 58.7 t -136.02 143.85 34.95 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 CA-C-N 119.294 0.952 . . . . 0.0 113.165 -177.457 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 59.7 m -135.98 152.2 50.7 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 125.722 1.609 . . . . 0.0 109.539 169.821 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 96.7 p -136.06 142.32 44.36 Favored 'General case' 0 CA--C 1.514 -0.423 0 CA-C-O 121.942 0.877 . . . . 0.0 111.998 167.248 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 29.3 p -141.74 169.14 18.15 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 113.485 -1.689 . . . . 0.0 111.075 -176.707 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -106.02 164.23 13.76 Favored Glycine 0 CA--C 1.525 0.677 0 C-N-CA 123.731 0.681 . . . . 0.0 111.741 178.795 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -90.41 117.54 29.19 Favored 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 106.66 -1.608 . . . . 0.0 106.66 168.859 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 68.5 -41.57 0.46 Allowed 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 127.701 2.4 . . . . 0.0 113.955 -171.904 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 74.2 m -78.8 155.25 29.33 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 124.537 1.135 . . . . 0.0 111.142 169.547 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 67.9 p -90.74 -83.07 0.27 Allowed 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 114.394 1.257 . . . . 0.0 114.394 -179.273 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 52.1 ttt-85 -79.47 148.4 31.9 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 127.764 2.426 . . . . 0.0 110.457 -172.17 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 6.4 m -66.16 141.05 18.55 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 N-CA-C 109.214 -0.662 . . . . 0.0 109.214 171.739 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . 0.256 0.0 OUTLIER -65.36 144.35 98.96 Favored Pre-proline 0 CA--C 1.549 0.917 0 C-N-CA 119.636 -0.826 . . . . 0.0 111.103 -169.294 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_exo -46.32 -37.8 19.49 Favored 'Trans proline' 0 CA--C 1.54 0.792 0 C-N-CA 123.848 3.032 . . . . 0.0 118.331 -167.858 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 27.7 m -62.0 -26.59 68.31 Favored 'General case' 0 N--CA 1.485 1.299 0 O-C-N 120.702 -1.249 . . . . 0.0 112.206 -177.822 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.81 -21.96 66.69 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 113.538 0.94 . . . . 0.0 113.538 174.579 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.5 mp -74.91 -58.46 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 CA-C-N 119.527 1.058 . . . . 0.0 109.113 178.243 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.59 -33.89 76.97 Favored 'General case' 0 CA--C 1.545 0.752 0 N-CA-C 114.166 1.173 . . . . 0.0 114.166 -171.149 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.46 -25.54 57.48 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 124.268 1.027 . . . . 0.0 113.244 179.746 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -92.03 -32.63 15.13 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.578 1.151 . . . . 0.0 109.893 177.812 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -63.92 -12.18 34.83 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.092 1.357 . . . . 0.0 113.985 169.738 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -59.59 -19.68 50.51 Favored 'General case' 0 CA--C 1.553 1.087 0 CA-C-N 119.537 1.062 . . . . 0.0 110.458 168.041 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 16.5 t -108.75 -3.53 10.35 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.035 0 C-N-CA 128.548 2.739 . . . . 0.0 111.987 -179.585 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 73.99 34.41 55.72 Favored Glycine 0 CA--C 1.542 1.747 0 O-C-N 120.429 -1.419 . . . . 0.0 114.578 -177.137 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 9.4 mt -75.86 -19.17 15.53 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 N-CA-C 116.759 2.133 . . . . 0.0 116.759 -169.813 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 24.1 t0 43.7 72.28 0.2 Allowed 'General case' 0 CA--C 1.556 1.186 0 C-N-CA 126.747 2.019 . . . . 0.0 114.885 -179.185 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 35.3 pt -114.62 34.23 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 C-N-CA 125.569 1.548 . . . . 0.0 112.408 173.706 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 75.0 m -70.58 -34.0 71.7 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 114.594 1.331 . . . . 0.0 114.594 -170.104 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -84.41 -68.42 1.4 Allowed Glycine 0 CA--C 1.529 0.947 0 C-N-CA 123.477 0.561 . . . . 0.0 113.506 -179.62 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 8.0 mm100 54.46 -166.87 0.08 Allowed 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 126.527 1.931 . . . . 0.0 111.447 -169.091 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 64.2 p -73.21 138.19 45.48 Favored 'General case' 0 N--CA 1.473 0.701 0 O-C-N 121.141 -0.974 . . . . 0.0 112.56 -179.254 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 68.5 m -80.26 3.0 22.28 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.631 1.172 . . . . 0.0 113.012 169.782 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -144.72 157.35 55.26 Favored Pre-proline 0 CA--C 1.548 0.901 0 C-N-CA 125.87 1.668 . . . . 0.0 112.011 -176.365 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -64.89 165.99 19.63 Favored 'Trans proline' 0 CA--C 1.538 0.695 0 C-N-CA 124.183 3.255 . . . . 0.0 114.721 174.905 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.477 HD12 HG11 ' A' ' 7' ' ' VAL . 5.4 tt -49.83 -42.99 18.95 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.2 0 C-N-CA 124.59 1.156 . . . . 0.0 112.154 174.474 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -69.25 -10.69 58.99 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 113.524 0.935 . . . . 0.0 113.524 -174.83 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -77.39 -15.53 59.32 Favored 'General case' 0 CA--C 1.548 0.886 0 N-CA-C 112.807 0.669 . . . . 0.0 112.807 176.117 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 76.1 m-85 -107.28 -168.27 1.37 Allowed 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 126.53 1.932 . . . . 0.0 112.475 -174.868 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 8.9 p-10 -124.05 129.16 50.42 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 125.314 1.445 . . . . 0.0 109.921 176.629 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -64.55 -36.34 83.89 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 113.209 0.818 . . . . 0.0 113.209 -171.224 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -68.8 -4.55 16.55 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 114.067 1.136 . . . . 0.0 114.067 178.075 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -68.44 -16.68 63.99 Favored 'General case' 0 CA--C 1.549 0.913 0 CA-C-N 118.775 0.716 . . . . 0.0 110.296 168.286 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 79.6 m-85 -119.78 146.26 45.83 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 128.006 2.523 . . . . 0.0 111.709 -177.791 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -94.99 -29.06 14.82 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 124.838 1.255 . . . . 0.0 111.903 178.055 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.736 HG22 ' HB ' ' A' ' 95' ' ' ILE . 71.1 t -125.74 135.39 64.05 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 C-N-CA 126.067 1.747 . . . . 0.0 107.063 -177.212 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 69.0 t -127.04 121.39 57.83 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 169.963 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 45.1 mm -107.81 106.52 20.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 C-N-CA 124.703 1.201 . . . . 0.0 108.557 -177.597 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 8.1 m -90.68 111.85 23.36 Favored 'General case' 0 N--CA 1.463 0.222 0 C-N-CA 123.699 0.8 . . . . 0.0 109.829 176.611 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 89.9 mt -91.71 -11.32 37.18 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 124.855 1.262 . . . . 0.0 114.405 -170.539 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 57.3 m -139.94 156.27 46.75 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.565 1.146 . . . . 0.0 112.548 -168.927 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 60.62 -133.24 49.94 Favored Glycine 0 CA--C 1.536 1.377 0 N-CA-C 111.409 -0.677 . . . . 0.0 111.409 -175.326 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 75.3 m -125.19 26.87 6.79 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 124.305 1.042 . . . . 0.0 112.169 172.199 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 69.49 25.31 75.63 Favored Glycine 0 CA--C 1.533 1.172 0 O-C-N 121.344 -0.847 . . . . 0.0 114.905 -174.477 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 33.4 m -82.63 -178.54 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 C-N-CA 124.933 1.293 . . . . 0.0 110.254 169.713 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 12.5 t-20 66.18 -34.04 0.2 Allowed 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 127.182 2.193 . . . . 0.0 115.781 -179.35 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -71.85 142.36 85.55 Favored Pre-proline 0 CA--C 1.551 0.986 0 CA-C-N 120.271 1.396 . . . . 0.0 110.73 169.008 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -60.21 154.9 48.9 Favored 'Trans proline' 0 CA--C 1.543 0.946 0 C-N-CA 122.831 2.354 . . . . 0.0 114.492 -179.429 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_exo -56.03 -28.73 70.75 Favored 'Trans proline' 0 C--N 1.353 0.775 0 C-N-CA 123.733 2.955 . . . . 0.0 115.121 -177.483 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -62.11 -30.26 70.9 Favored 'General case' 0 CA--C 1.54 0.582 0 O-C-N 120.888 -1.132 . . . . 0.0 113.103 176.004 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 85.5 m95 -79.59 -29.83 41.33 Favored 'General case' 0 N--CA 1.476 0.846 0 O-C-N 120.942 -1.099 . . . . 0.0 111.998 174.303 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 48.8 t -68.91 -26.93 33.73 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.925 0 C-N-CA 125.216 1.406 . . . . 0.0 112.068 172.55 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -102.33 6.98 40.67 Favored 'General case' 0 N--CA 1.48 1.053 0 N-CA-C 116.051 1.871 . . . . 0.0 116.051 -170.894 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 89.7 mm-40 -65.49 160.33 22.45 Favored 'General case' 0 N--CA 1.481 1.112 0 O-C-N 120.633 -1.292 . . . . 0.0 112.255 172.537 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -51.35 -44.33 62.01 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 124.63 1.172 . . . . 0.0 113.849 -168.703 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.736 ' HB ' HG22 ' A' ' 75' ' ' VAL . 16.8 mm -123.19 69.1 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 C-N-CA 125.015 1.326 . . . . 0.0 108.343 177.781 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 57.1 t80 -78.58 107.55 11.33 Favored 'General case' 0 CA--C 1.534 0.356 0 O-C-N 120.796 -1.19 . . . . 0.0 108.58 169.399 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 9.1 mt-10 -105.92 132.7 51.7 Favored 'General case' 0 CA--C 1.545 0.778 0 N-CA-C 113.773 1.027 . . . . 0.0 113.773 174.551 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -93.75 104.39 16.48 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.648 1.179 . . . . 0.0 109.868 169.816 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 17.4 m0 -92.74 98.68 11.56 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.345 1.058 . . . . 0.0 110.002 -177.246 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 87.8 mm-40 -79.41 61.29 3.43 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 125.087 1.355 . . . . 0.0 109.985 172.833 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 6.2 tt -109.5 149.3 29.8 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 127.092 2.157 . . . . 0.0 113.054 -169.432 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -67.2 111.58 4.02 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 125.962 1.705 . . . . 0.0 111.912 176.444 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -84.0 129.88 57.06 Favored Pre-proline 0 CA--C 1.545 0.776 0 O-C-N 120.887 -1.133 . . . . 0.0 110.849 171.556 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -86.74 -9.63 6.52 Favored 'Trans proline' 0 CA--C 1.541 0.845 0 C-N-CA 121.955 1.77 . . . . 0.0 114.515 -169.957 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -60.39 -41.68 94.32 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 115.307 1.595 . . . . 0.0 115.307 -169.503 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -76.52 10.17 18.5 Favored Glycine 0 CA--C 1.537 1.444 0 C-N-CA 124.212 0.911 . . . . 0.0 114.755 -178.046 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 8.0 pt20 -146.69 -177.65 5.76 Favored 'General case' 0 CA--C 1.551 1.012 0 C-N-CA 126.848 2.059 . . . . 0.0 111.499 -169.877 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 10.5 p -66.76 164.68 16.6 Favored 'General case' 0 N--CA 1.478 0.947 0 N-CA-C 116.172 1.916 . . . . 0.0 116.172 -168.948 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 36.4 tp -63.02 -26.49 68.87 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 123.832 0.853 . . . . 0.0 112.338 170.591 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -69.39 -34.87 75.16 Favored 'General case' 0 CA--C 1.539 0.539 0 O-C-N 120.922 -1.111 . . . . 0.0 111.243 171.278 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 20.7 t -68.15 -38.94 80.48 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 CA-C-O 117.93 -1.034 . . . . 0.0 111.155 169.949 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 5.0 m-85 -54.72 -52.21 63.19 Favored 'General case' 0 N--CA 1.478 0.968 0 CA-C-N 120.664 1.574 . . . . 0.0 111.956 169.796 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -67.91 -34.33 76.41 Favored 'General case' 0 N--CA 1.479 0.992 0 CA-C-N 118.954 0.797 . . . . 0.0 112.221 -177.165 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 76.4 m -64.83 -46.42 82.04 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 123.871 0.868 . . . . 0.0 111.042 170.947 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 53.7 t -67.95 -35.21 71.17 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 CA-C-O 117.602 -1.19 . . . . 0.0 111.022 179.526 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 22.2 mtm105 -55.4 -46.71 76.59 Favored 'General case' 0 N--CA 1.481 1.112 0 CA-C-N 120.66 1.573 . . . . 0.0 111.031 170.629 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -58.47 -48.8 82.12 Favored Glycine 0 CA--C 1.542 1.765 0 CA-C-N 119.432 1.015 . . . . 0.0 113.848 175.188 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 15.5 mm100 -65.25 -44.9 86.63 Favored 'General case' 0 N--CA 1.474 0.742 0 O-C-N 121.778 -0.836 . . . . 0.0 112.02 179.846 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 78.6 t -66.97 -36.22 76.61 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 125.052 1.341 . . . . 0.0 111.308 177.255 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 78.1 tttt -54.64 -49.68 69.97 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-N 119.842 1.201 . . . . 0.0 110.207 174.472 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -64.23 -43.66 94.28 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 112.705 0.631 . . . . 0.0 112.705 175.873 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.57 -36.51 84.04 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 124.16 0.984 . . . . 0.0 112.894 179.47 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 94.4 t -77.48 -40.64 28.83 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 C-N-CA 125.515 1.526 . . . . 0.0 111.475 176.983 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -62.59 -31.84 72.73 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 119.567 1.076 . . . . 0.0 111.541 172.167 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 12.5 m-80 -67.28 -46.12 74.57 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-N 119.121 0.873 . . . . 0.0 112.867 171.294 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -50.83 -54.98 19.16 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 124.296 1.038 . . . . 0.0 110.138 171.259 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 74.3 mt -58.79 -49.53 82.51 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 CA-C-O 119.163 -0.446 . . . . 0.0 110.179 178.693 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -65.24 -11.26 39.26 Favored 'General case' 0 CA--C 1.544 0.743 0 N-CA-C 115.567 1.691 . . . . 0.0 115.567 -178.827 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 20.9 ptmt -103.23 -17.54 15.29 Favored 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 114.165 1.172 . . . . 0.0 114.165 171.823 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 14.3 pt -106.79 -12.22 10.16 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 N-CA-C 114.436 1.273 . . . . 0.0 114.436 177.153 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 73.8 m . . . . . 0 C--O 1.253 1.27 0 C-N-CA 125.185 1.394 . . . . 0.0 112.436 -176.763 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.9 ttt . . . . . 0 N--CA 1.503 2.185 0 N-CA-C 111.602 0.223 . . . . 0.0 111.602 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.28 163.71 32.9 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 124.828 1.251 . . . . 0.0 113.775 177.667 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 58.6 mtpt -89.72 141.82 28.26 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 125.226 1.41 . . . . 0.0 113.007 175.898 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 21.6 t -122.94 130.54 74.4 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 C-N-CA 125.971 1.708 . . . . 0.0 112.397 177.45 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 35.6 tpp -102.05 127.55 48.89 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 168.955 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 66.1 m-85 -104.68 132.32 51.06 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 123.728 0.811 . . . . 0.0 109.428 170.032 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -141.13 146.76 23.23 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 N-CA-C 114.584 1.327 . . . . 0.0 114.584 -169.441 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 41.8 t -151.19 176.32 11.31 Favored 'General case' 0 CA--C 1.552 1.056 0 C-N-CA 127.31 2.244 . . . . 0.0 110.853 171.472 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 54.1 mtpt -85.24 135.04 34.1 Favored 'General case' 0 N--CA 1.482 1.166 0 O-C-N 120.672 -1.267 . . . . 0.0 112.16 170.968 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 23.2 tpt180 47.58 56.45 7.05 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 127.507 2.323 . . . . 0.0 113.226 179.276 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -52.08 -28.56 17.94 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 113.857 1.058 . . . . 0.0 113.857 -179.422 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 67.2 m -63.69 -16.97 62.44 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-N 120.13 1.332 . . . . 0.0 112.661 -176.168 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 98.6 p -121.91 21.43 10.64 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 126.476 1.91 . . . . 0.0 113.767 171.11 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 73.6 mtt85 -137.73 151.32 48.08 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 125.762 1.625 . . . . 0.0 112.216 175.948 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 33.0 m -93.02 -31.93 14.69 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 114.977 1.473 . . . . 0.0 114.977 -169.729 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 59.89 -44.29 0.09 Allowed 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 127.887 2.475 . . . . 0.0 117.331 -179.043 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' MET . . . . . 0.438 ' HG2' ' SD ' ' A' ' 50' ' ' MET . 0.0 OUTLIER 68.73 -46.55 0.55 Allowed 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 127.605 2.362 . . . . 0.0 115.907 172.389 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.08 -35.21 74.69 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 115.908 1.818 . . . . 0.0 115.908 -169.112 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.3 pm0 -64.36 -43.69 93.73 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 119.151 0.887 . . . . 0.0 112.426 -179.044 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -61.41 -38.04 95.09 Favored Glycine 0 C--N 1.336 0.57 0 C-N-CA 123.903 0.763 . . . . 0.0 112.123 175.12 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -73.58 -42.47 61.56 Favored 'General case' 0 N--CA 1.47 0.527 0 O-C-N 121.782 -0.834 . . . . 0.0 111.518 177.541 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -60.33 -40.97 92.57 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 119.243 0.929 . . . . 0.0 112.705 -175.613 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 11.7 pttp -78.77 -24.92 44.43 Favored 'General case' 0 N--CA 1.479 1.016 0 N-CA-C 113.787 1.032 . . . . 0.0 113.787 174.036 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 90.4 m -72.52 -34.98 67.98 Favored 'General case' 0 N--CA 1.486 1.329 0 O-C-N 121.432 -0.792 . . . . 0.0 111.779 171.896 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 82.4 mt -88.66 -28.58 20.52 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 125.625 1.57 . . . . 0.0 113.824 -177.026 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -148.23 29.24 1.36 Allowed Glycine 0 N--CA 1.473 1.102 0 N-CA-C 118.256 2.062 . . . . 0.0 118.256 -169.411 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -66.53 -20.39 66.01 Favored 'General case' 0 N--CA 1.477 0.919 0 CA-C-N 121.867 2.834 . . . . 0.0 115.301 -177.752 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -77.56 -4.59 85.0 Favored Glycine 0 CA--C 1.541 1.696 0 O-C-N 121.305 -0.872 . . . . 0.0 113.923 169.593 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 60.7 mttp -115.93 -40.58 3.3 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 126.981 2.112 . . . . 0.0 112.315 -177.286 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 19.8 pt -140.69 159.04 24.32 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 125.961 1.704 . . . . 0.0 112.558 -174.308 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -106.23 140.32 39.37 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.682 1.193 . . . . 0.0 110.209 171.099 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 69.5 t -125.15 140.92 46.75 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 CA-C-N 118.911 0.778 . . . . 0.0 111.819 -175.104 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 22.4 m -134.56 143.39 47.36 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 125.058 1.343 . . . . 0.0 109.95 173.815 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 78.6 p -97.39 144.38 27.2 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.846 0.831 . . . . 0.0 111.24 169.198 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 32.7 t -149.05 165.04 32.87 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 123.593 0.757 . . . . 0.0 110.311 169.948 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -134.67 161.61 24.53 Favored Glycine 0 C--O 1.229 -0.167 0 CA-C-O 121.808 0.671 . . . . 0.0 112.604 -178.547 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -95.0 111.28 23.1 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 106.351 -1.722 . . . . 0.0 106.351 169.58 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 19.0 mt-10 66.68 30.77 8.03 Favored 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 125.122 1.369 . . . . 0.0 114.392 -173.587 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 7.6 m -151.31 151.34 31.66 Favored 'General case' 0 N--CA 1.482 1.152 0 N-CA-C 114.681 1.364 . . . . 0.0 114.681 175.56 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 88.0 p -109.43 -15.34 14.25 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 126.985 2.114 . . . . 0.0 116.327 173.632 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 7.6 tpt180 -123.4 170.32 10.46 Favored 'General case' 0 N--CA 1.488 1.462 0 CA-C-N 120.497 1.499 . . . . 0.0 110.781 -178.512 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 27.0 m -111.93 163.84 8.45 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.266 0 C-N-CA 126.435 1.894 . . . . 0.0 109.57 169.481 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 3.1 t-80 -48.59 129.91 13.81 Favored Pre-proline 0 CA--C 1.536 0.408 0 N-CA-C 113.945 1.091 . . . . 0.0 113.945 -173.866 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 81.5 Cg_exo -59.93 -26.76 83.26 Favored 'Trans proline' 0 CA--C 1.549 1.23 0 CA-C-N 120.273 1.133 . . . . 0.0 112.5 173.231 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 55.0 m -70.91 -29.15 65.12 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 125.17 1.388 . . . . 0.0 112.363 174.033 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -55.45 -44.55 76.48 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 119.245 0.93 . . . . 0.0 111.226 -178.078 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.7 mp -47.2 -55.11 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 125.178 1.391 . . . . 0.0 110.483 -177.41 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.99 -30.89 71.91 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 113.486 0.921 . . . . 0.0 113.486 -176.748 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -82.73 -26.35 32.02 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 113.421 0.897 . . . . 0.0 113.421 179.064 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' MET . . . . . 0.438 ' SD ' ' HG2' ' A' ' 17' ' ' MET . 3.9 mmt -80.3 -32.92 38.01 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.223 0.609 . . . . 0.0 110.8 170.266 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -66.01 -14.78 62.25 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 124.61 1.164 . . . . 0.0 113.348 172.845 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -60.56 -27.65 67.83 Favored 'General case' 0 N--CA 1.482 1.138 0 CA-C-N 120.106 1.321 . . . . 0.0 110.731 168.844 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 57.7 t -98.22 -6.5 9.35 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.939 0 C-N-CA 127.229 2.212 . . . . 0.0 111.282 176.894 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 81.14 19.36 67.22 Favored Glycine 0 CA--C 1.539 1.582 0 C-N-CA 124.951 1.263 . . . . 0.0 114.425 -174.506 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 83.0 mt -77.77 135.14 26.9 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 124.925 1.29 . . . . 0.0 111.266 -175.654 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 21.6 t0 -94.58 104.46 16.41 Favored 'General case' 0 CA--C 1.544 0.729 0 N-CA-C 113.236 0.828 . . . . 0.0 113.236 177.629 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 15.0 pt -130.56 23.25 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 C-N-CA 125.273 1.429 . . . . 0.0 112.338 169.688 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 72.2 m -87.69 153.53 21.29 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 124.729 1.212 . . . . 0.0 112.435 -178.379 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 65.68 18.5 66.1 Favored Glycine 0 CA--C 1.537 1.454 0 N-CA-C 115.28 0.872 . . . . 0.0 115.28 171.86 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -115.12 143.93 44.45 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 124.969 1.307 . . . . 0.0 111.957 -177.357 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 33.4 m -135.24 148.63 49.66 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 107.818 -1.179 . . . . 0.0 107.818 169.32 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 68.1 m -123.26 -161.45 0.97 Allowed 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 126.329 1.852 . . . . 0.0 109.916 -171.786 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -134.91 159.03 73.65 Favored Pre-proline 0 CA--C 1.54 0.567 0 C-N-CA 123.854 0.862 . . . . 0.0 110.923 179.332 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -62.17 157.27 45.63 Favored 'Trans proline' 0 N--CA 1.46 -0.476 0 C-N-CA 122.294 1.996 . . . . 0.0 112.311 171.77 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.426 HD11 ' CE3' ' A' ' 90' ' ' TRP . 6.7 tp -60.99 -30.21 47.16 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 O-C-N 121.667 -0.645 . . . . 0.0 112.423 -173.876 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -67.52 -12.5 60.49 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 114.341 1.237 . . . . 0.0 114.341 176.794 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 -79.95 -21.53 43.67 Favored 'General case' 0 CA--C 1.547 0.855 0 N-CA-C 113.22 0.822 . . . . 0.0 113.22 179.839 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 99.3 m-85 -102.39 -174.52 2.59 Favored 'General case' 0 CA--C 1.552 1.045 0 C-N-CA 126.216 1.806 . . . . 0.0 112.922 -173.319 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 5.9 t30 -123.6 126.7 47.1 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 126.21 1.804 . . . . 0.0 109.572 171.799 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.91 -35.9 81.05 Favored 'General case' 0 CA--C 1.53 0.184 0 N-CA-C 114.361 1.245 . . . . 0.0 114.361 -170.048 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . 0.256 0.0 OUTLIER -72.67 -3.63 26.18 Favored 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 114.221 1.193 . . . . 0.0 114.221 -175.672 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -75.21 -13.25 60.43 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 124.076 0.95 . . . . 0.0 111.543 168.935 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 87.8 m-85 -118.08 135.73 54.02 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 126.774 2.029 . . . . 0.0 111.574 -179.287 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -87.15 -24.23 24.56 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-O 122.297 1.046 . . . . 0.0 112.655 178.47 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.623 HG22 ' HB ' ' A' ' 95' ' ' ILE . 80.1 t -129.73 138.99 52.76 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 C-N-CA 127.28 2.232 . . . . 0.0 108.772 -176.569 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 59.2 t -135.15 122.66 37.29 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 171.509 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 45.1 mm -110.21 101.1 12.08 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 C-N-CA 124.255 1.022 . . . . 0.0 109.919 -174.693 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 8.8 m -86.15 94.43 9.28 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 124.224 1.01 . . . . 0.0 109.208 171.139 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -97.78 19.68 13.29 Favored 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 116.065 1.876 . . . . 0.0 116.065 -169.427 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 14.7 p -152.14 155.08 37.14 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 123.812 0.845 . . . . 0.0 110.941 170.695 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 62.06 -137.34 45.86 Favored Glycine 0 CA--C 1.535 1.334 0 C-N-CA 123.685 0.659 . . . . 0.0 113.948 177.571 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 83.4 p -93.21 -23.59 18.5 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.996 1.318 . . . . 0.0 114.552 179.544 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 77.07 4.44 83.4 Favored Glycine 0 CA--C 1.535 1.292 0 C-N-CA 124.555 1.074 . . . . 0.0 115.343 -169.946 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 48.9 t -88.73 -10.92 10.58 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 CA-C-N 119.564 1.682 . . . . 0.0 112.91 -172.373 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -72.65 -9.56 58.75 Favored 'General case' 0 CA--C 1.549 0.917 0 O-C-N 120.426 -1.421 . . . . 0.0 114.153 -176.168 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -95.06 158.43 34.9 Favored Pre-proline 0 CA--C 1.549 0.927 0 C-N-CA 124.791 1.236 . . . . 0.0 113.644 176.479 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_exo -61.18 152.92 68.56 Favored 'Trans proline' 0 CA--C 1.544 0.991 0 C-N-CA 122.96 2.44 . . . . 0.0 114.24 -179.198 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_exo -55.76 -29.66 72.59 Favored 'Trans proline' 0 C--N 1.354 0.824 0 C-N-CA 123.692 2.928 . . . . 0.0 115.082 -177.599 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -61.81 -29.31 70.07 Favored 'General case' 0 CA--C 1.539 0.551 0 O-C-N 121.077 -1.015 . . . . 0.0 112.888 177.02 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' TRP . . . . . 0.426 ' CE3' HD11 ' A' ' 65' ' ' ILE . 92.8 m95 -80.94 -33.79 33.75 Favored 'General case' 0 N--CA 1.473 0.698 0 O-C-N 121.202 -0.936 . . . . 0.0 112.119 174.269 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 25.0 t -63.25 -31.72 53.78 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 C-N-CA 124.679 1.192 . . . . 0.0 111.606 172.239 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -96.93 6.18 49.12 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 115.675 1.732 . . . . 0.0 115.675 -171.299 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 87.0 mm-40 -64.74 157.25 27.98 Favored 'General case' 0 N--CA 1.481 1.077 0 O-C-N 120.615 -1.303 . . . . 0.0 111.248 169.897 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -58.74 -39.53 81.2 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 113.967 1.099 . . . . 0.0 113.967 -168.092 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.623 ' HB ' HG22 ' A' ' 75' ' ' VAL . 19.1 mm -118.82 59.61 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 C-N-CA 124.958 1.303 . . . . 0.0 109.017 177.235 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 52.0 t80 -76.89 106.97 8.89 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 107.333 -1.358 . . . . 0.0 107.333 168.724 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 13.2 mt-10 -109.11 134.82 51.2 Favored 'General case' 0 N--CA 1.467 0.375 0 N-CA-C 113.11 0.781 . . . . 0.0 113.11 174.561 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -103.51 118.05 35.86 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.062 0.945 . . . . 0.0 109.453 169.089 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 28.4 m0 -109.96 114.34 27.8 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 107.672 -1.233 . . . . 0.0 107.672 176.415 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 19.3 mt-30 -85.22 49.07 1.67 Allowed 'General case' 0 CA--C 1.545 0.763 0 O-C-N 121.3 -0.875 . . . . 0.0 111.701 -175.003 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 82.7 mt -73.94 160.16 31.75 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 125.848 1.659 . . . . 0.0 111.918 175.54 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -88.34 155.22 19.83 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.846 169.286 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -94.14 143.86 27.1 Favored Pre-proline 0 CA--C 1.547 0.834 0 O-C-N 121.422 -0.799 . . . . 0.0 111.606 171.023 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -64.1 -18.5 63.75 Favored 'Trans proline' 0 CA--C 1.546 1.08 0 C-N-CA 122.661 2.241 . . . . 0.0 116.07 176.01 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -57.12 138.15 54.9 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 120.255 1.389 . . . . 0.0 113.583 -178.801 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 78.41 6.59 87.99 Favored Glycine 0 CA--C 1.535 1.311 0 C-N-CA 124.384 0.993 . . . . 0.0 115.058 177.19 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 11.7 pt20 -141.8 165.13 28.31 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 125.17 1.388 . . . . 0.0 113.499 -178.376 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 68.4 m -63.68 162.89 12.36 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 125.774 1.63 . . . . 0.0 115.393 -169.52 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 21.4 tp -59.75 -29.25 68.04 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 125.181 1.392 . . . . 0.0 113.445 178.518 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -62.1 -28.94 69.97 Favored 'General case' 0 N--CA 1.476 0.844 0 O-C-N 120.544 -1.348 . . . . 0.0 111.92 171.617 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 3.5 t -76.56 -37.39 29.64 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 O-C-N 120.86 -1.15 . . . . 0.0 111.427 172.628 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -56.34 -46.55 79.88 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-N 120.028 1.286 . . . . 0.0 110.531 168.961 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -66.85 -36.15 81.67 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.702 0.801 . . . . 0.0 112.002 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 25.5 m -60.85 -52.16 66.25 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 124.414 1.085 . . . . 0.0 111.162 170.43 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 69.3 t -64.54 -45.97 94.02 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 O-C-N 121.712 -0.617 . . . . 0.0 110.528 179.831 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 42.6 ttp85 -59.53 -38.59 81.41 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 125.359 1.463 . . . . 0.0 112.394 178.985 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -64.73 -50.5 58.33 Favored Glycine 0 CA--C 1.538 1.505 0 CA-C-N 119.156 0.889 . . . . 0.0 113.481 171.632 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 15.2 mm100 -63.7 -42.17 98.02 Favored 'General case' 0 N--CA 1.477 0.891 0 O-C-N 121.819 -0.812 . . . . 0.0 111.836 178.905 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 52.9 t -64.01 -42.07 94.5 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 C-N-CA 125.397 1.479 . . . . 0.0 110.887 175.437 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 82.4 tttt -53.24 -49.45 66.8 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 120.153 1.342 . . . . 0.0 110.478 176.854 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -64.96 -42.67 94.38 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 123.454 0.702 . . . . 0.0 112.788 178.689 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 16.1 mmm180 -60.29 -45.34 93.69 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 123.438 0.695 . . . . 0.0 112.649 175.278 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 87.2 t -71.4 -39.45 71.57 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 C-N-CA 124.147 0.979 . . . . 0.0 111.267 -178.936 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -61.15 -41.66 97.14 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 119.386 0.994 . . . . 0.0 111.638 171.151 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 14.4 m-80 -63.4 -46.26 87.26 Favored 'General case' 0 CA--C 1.539 0.519 0 CA-C-N 118.692 0.678 . . . . 0.0 112.275 174.911 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -54.1 -54.95 32.4 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 124.694 1.198 . . . . 0.0 110.766 175.492 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 97.1 mt -61.09 -44.48 98.37 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 CA-C-O 118.857 -0.592 . . . . 0.0 110.541 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -67.48 -14.47 62.96 Favored 'General case' 0 CA--C 1.543 0.681 0 N-CA-C 115.084 1.512 . . . . 0.0 115.084 -179.738 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 21.1 ptmt -100.17 -28.02 13.23 Favored 'General case' 0 N--CA 1.478 0.931 0 CA-C-N 119.298 0.953 . . . . 0.0 113.552 173.646 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 17.5 pt -92.27 -14.72 8.39 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 N-CA-C 114.491 1.293 . . . . 0.0 114.491 178.091 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 67.4 m . . . . . 0 C--O 1.254 1.291 0 C-N-CA 123.893 0.877 . . . . 0.0 112.892 179.573 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.1 ttt . . . . . 0 N--CA 1.501 2.123 0 N-CA-C 111.599 0.222 . . . . 0.0 111.599 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -123.74 160.39 27.38 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 125.844 1.658 . . . . 0.0 112.662 176.557 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 32.4 ttmt -110.91 113.68 26.43 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 167.588 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 16.2 t -103.7 133.65 47.07 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 N-CA-C 113.839 1.051 . . . . 0.0 113.839 -177.852 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 46.4 tpp -101.59 119.61 39.03 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.456 1.102 . . . . 0.0 109.58 169.093 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 56.3 m-85 -103.34 121.75 43.4 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 124.899 1.28 . . . . 0.0 109.134 173.433 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.419 HG11 HD12 ' A' ' 65' ' ' ILE . 4.2 m -144.57 162.32 14.27 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 C-N-CA 124.163 0.985 . . . . 0.0 113.002 -168.894 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 12.7 t -146.86 157.03 43.55 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 126.095 1.758 . . . . 0.0 110.749 169.807 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -30.59 -46.78 0.08 Allowed 'General case' 0 N--CA 1.489 1.476 0 C-N-CA 129.119 2.968 . . . . 0.0 117.126 -176.992 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 32.1 ttm180 -137.35 -26.01 1.01 Allowed 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 117.309 2.337 . . . . 0.0 117.309 -174.882 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 6.9 t30 60.34 -33.38 0.07 Allowed 'General case' 0 N--CA 1.485 1.319 0 N-CA-C 117.577 2.436 . . . . 0.0 117.577 -178.534 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 84.1 p -62.69 139.98 58.69 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 121.192 1.815 . . . . 0.0 111.946 175.049 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 69.7 m 49.85 31.39 4.54 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 125.943 1.697 . . . . 0.0 114.486 -175.115 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 77.0 mtt85 -141.61 162.75 34.71 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 126.631 1.972 . . . . 0.0 111.53 -175.576 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 4.0 m -124.16 149.32 46.42 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 125.766 1.626 . . . . 0.0 111.774 174.089 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 -112.71 -35.59 5.45 Favored 'General case' 0 N--CA 1.478 0.933 0 N-CA-C 114.347 1.24 . . . . 0.0 114.347 -178.185 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' MET . . . . . 0.461 ' HG2' ' SD ' ' A' ' 50' ' ' MET . 0.0 OUTLIER 68.56 -47.78 0.55 Allowed 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 126.783 2.033 . . . . 0.0 115.681 173.887 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.17 -30.01 70.75 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 115.613 1.709 . . . . 0.0 115.613 -169.614 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 3.5 pm0 -62.7 -44.55 95.96 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 119.385 0.993 . . . . 0.0 112.096 178.062 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -64.77 -42.98 96.86 Favored Glycine 0 C--O 1.226 -0.402 0 C-N-CA 124.135 0.874 . . . . 0.0 111.736 179.405 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -68.6 -39.85 80.69 Favored 'General case' 0 N--CA 1.466 0.336 0 O-C-N 121.856 -0.791 . . . . 0.0 111.504 176.839 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -62.32 -41.41 98.52 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 119.226 0.921 . . . . 0.0 112.63 -177.837 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 10.5 pttp -81.17 -20.38 41.36 Favored 'General case' 0 N--CA 1.48 1.067 0 N-CA-C 114.037 1.125 . . . . 0.0 114.037 174.288 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 93.3 m -74.52 -36.13 63.18 Favored 'General case' 0 N--CA 1.483 1.224 0 O-C-N 121.561 -0.712 . . . . 0.0 111.645 170.806 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 74.4 mt -92.75 -30.83 15.31 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 125.374 1.47 . . . . 0.0 114.672 -174.974 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -137.21 25.71 3.01 Favored Glycine 0 N--CA 1.475 1.238 0 N-CA-C 118.224 2.049 . . . . 0.0 118.224 -169.002 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -66.69 -22.04 66.08 Favored 'General case' 0 N--CA 1.476 0.856 0 CA-C-N 121.895 2.848 . . . . 0.0 115.391 -174.459 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -72.74 -12.54 78.25 Favored Glycine 0 CA--C 1.542 1.748 0 O-C-N 121.18 -0.95 . . . . 0.0 113.632 169.576 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 53.2 mttm -107.34 -39.54 5.64 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 127.318 2.247 . . . . 0.0 113.161 -179.75 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 45.2 pt -144.41 154.46 15.0 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 C-N-CA 124.667 1.187 . . . . 0.0 114.094 -171.624 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -98.14 140.33 32.61 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 126.021 1.728 . . . . 0.0 109.247 169.548 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 92.3 t -127.27 139.02 53.08 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 CA-C-N 118.553 0.615 . . . . 0.0 111.735 -175.915 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 33.5 m -136.35 148.16 47.75 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 125.269 1.428 . . . . 0.0 109.432 172.182 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 86.1 p -136.02 143.19 44.62 Favored 'General case' 0 CA--C 1.514 -0.406 0 CA-C-O 122.249 1.023 . . . . 0.0 111.16 167.801 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 8.0 m -139.36 152.23 46.97 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 113.393 -1.731 . . . . 0.0 111.25 -169.949 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -81.33 163.76 45.1 Favored Glycine 0 CA--C 1.527 0.819 0 N-CA-C 110.382 -1.087 . . . . 0.0 110.382 169.222 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 8.2 mp -91.07 -23.09 20.43 Favored 'General case' 0 N--CA 1.477 0.911 0 O-C-N 120.885 -1.362 . . . . 0.0 112.895 174.173 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -148.8 29.68 0.82 Allowed 'General case' 0 CA--C 1.551 0.985 0 C-N-CA 125.734 1.614 . . . . 0.0 111.076 176.815 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 32.6 p -152.29 153.0 32.83 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 126.54 1.936 . . . . 0.0 112.16 -174.186 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 47.6 m -116.25 19.04 15.08 Favored 'General case' 0 N--CA 1.483 1.216 0 N-CA-C 116.198 1.925 . . . . 0.0 116.198 -169.003 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 7.8 tpt180 -159.3 144.76 15.98 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 124.702 1.201 . . . . 0.0 111.759 171.511 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 22.0 m -70.87 129.37 34.83 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.321 0 N-CA-C 105.92 -1.881 . . . . 0.0 105.92 167.847 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' HIS . . . . . 0.425 ' HA ' ' HD3' ' A' ' 44' ' ' PRO 0.271 0.0 OUTLIER -60.46 141.49 91.56 Favored Pre-proline 0 CA--C 1.552 1.05 0 N-CA-C 112.681 0.622 . . . . 0.0 112.681 -168.413 . . . . . . . . 4 4 . 1 . 019 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 43' ' ' HIS . 63.5 Cg_exo -46.49 -39.26 22.26 Favored 'Trans proline' 0 CA--C 1.54 0.778 0 C-N-CA 124.257 3.305 . . . . 0.0 118.567 -168.001 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 26.0 m -65.04 -24.3 67.44 Favored 'General case' 0 N--CA 1.484 1.242 0 CA-C-N 119.418 1.008 . . . . 0.0 112.802 -174.703 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -52.83 -48.77 66.74 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 123.673 0.789 . . . . 0.0 111.573 172.873 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.6 mp -54.01 -56.02 11.38 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 C-N-CA 124.373 1.069 . . . . 0.0 110.37 -171.764 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -62.4 -28.28 69.67 Favored 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 113.392 0.886 . . . . 0.0 113.392 -177.14 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -81.85 -20.64 38.53 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 113.69 0.996 . . . . 0.0 113.69 176.758 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' MET . . . . . 0.461 ' SD ' ' HG2' ' A' ' 17' ' ' MET . 5.7 mmt -87.52 -32.55 19.35 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 119.465 1.03 . . . . 0.0 110.729 169.887 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -64.5 -15.29 60.58 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.752 1.221 . . . . 0.0 113.559 176.229 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 -61.15 -28.44 69.12 Favored 'General case' 0 N--CA 1.48 1.032 0 CA-C-N 120.225 1.375 . . . . 0.0 111.077 169.345 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 59.3 t -94.91 -3.65 10.58 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.047 0 C-N-CA 127.356 2.262 . . . . 0.0 111.253 178.03 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 79.4 17.54 75.83 Favored Glycine 0 CA--C 1.54 1.609 0 O-C-N 120.525 -1.359 . . . . 0.0 114.588 -174.572 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 67.2 mt -76.57 145.48 10.28 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 C-N-CA 125.09 1.356 . . . . 0.0 111.941 -174.445 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -106.3 53.16 0.71 Allowed 'General case' 0 CA--C 1.548 0.897 0 N-CA-C 115.11 1.522 . . . . 0.0 115.11 -170.092 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 12.0 pt -85.42 -0.12 6.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 120.017 -1.677 . . . . 0.0 114.252 173.334 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 84.5 p -67.09 -28.13 67.92 Favored 'General case' 0 N--CA 1.476 0.841 0 O-C-N 120.838 -1.163 . . . . 0.0 113.502 174.694 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -82.0 -6.95 88.47 Favored Glycine 0 CA--C 1.537 1.415 0 C-N-CA 125.075 1.321 . . . . 0.0 116.381 -177.112 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 14.8 pt20 -100.19 138.34 37.39 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 119.309 1.555 . . . . 0.0 112.077 179.364 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 58.8 p -106.38 -64.24 1.19 Allowed 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 125.701 1.6 . . . . 0.0 110.82 173.28 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 59.1 m 63.7 127.12 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 129.152 2.981 . . . . 0.0 116.639 173.621 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 24.6 m-20 -67.35 162.11 58.53 Favored Pre-proline 0 CA--C 1.548 0.87 0 C-N-CA 124.402 1.081 . . . . 0.0 111.012 169.555 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -58.1 157.95 23.44 Favored 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 122.627 2.218 . . . . 0.0 112.977 171.075 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.419 HD12 HG11 ' A' ' 7' ' ' VAL . 2.9 tt -57.1 -37.7 56.8 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 C-N-CA 123.778 0.831 . . . . 0.0 110.939 -178.506 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.98 -1.55 26.2 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 114.302 1.223 . . . . 0.0 114.302 -177.247 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -88.22 -6.85 57.59 Favored 'General case' 0 CA--C 1.555 1.167 0 C-N-CA 124.573 1.149 . . . . 0.0 111.9 169.242 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 77.2 m-85 -113.86 -174.93 2.56 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 126.796 2.038 . . . . 0.0 112.739 -178.978 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 13.3 p-10 -116.83 132.73 56.62 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 127.04 2.136 . . . . 0.0 109.915 174.607 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -67.45 -35.75 79.84 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 113.636 0.976 . . . . 0.0 113.636 -174.315 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -70.02 -3.45 16.37 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 114.429 1.27 . . . . 0.0 114.429 -179.334 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -69.96 -16.72 63.24 Favored 'General case' 0 CA--C 1.543 0.699 0 O-C-N 121.652 -0.655 . . . . 0.0 110.976 168.946 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 45.2 m-85 -120.42 131.14 54.66 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 126.661 1.985 . . . . 0.0 111.378 -172.724 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -80.69 -22.85 40.01 Favored 'General case' 0 N--CA 1.477 0.911 0 CA-C-O 122.234 1.016 . . . . 0.0 112.498 178.065 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.632 HG22 ' HB ' ' A' ' 95' ' ' ILE . 82.2 t -132.4 136.37 56.34 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 C-N-CA 127.501 2.32 . . . . 0.0 108.125 -175.113 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 59.7 t -131.92 127.3 58.19 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 169.561 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 41.8 mm -114.61 115.91 50.98 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 C-N-CA 123.777 0.831 . . . . 0.0 109.645 -174.93 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 10.5 t -89.18 122.46 32.49 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 169.208 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 92.7 mt -97.19 5.32 50.33 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 116.141 1.904 . . . . 0.0 116.141 -168.979 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 25.4 p -144.94 39.04 1.21 Allowed 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 123.273 0.629 . . . . 0.0 112.077 -174.435 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 110.53 -148.25 17.58 Favored Glycine 0 CA--C 1.531 1.08 0 C-N-CA 125.024 1.297 . . . . 0.0 112.992 -174.224 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 87.2 p -76.29 174.51 10.09 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 124.963 1.305 . . . . 0.0 113.502 -178.629 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -76.07 119.81 5.74 Favored Glycine 0 N--CA 1.469 0.889 0 CA-C-O 122.244 0.914 . . . . 0.0 111.317 169.978 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 7.6 p -148.0 151.73 13.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 C-N-CA 127.86 2.464 . . . . 0.0 106.471 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 51.7 t30 65.73 2.66 2.2 Favored 'General case' 0 CA--C 1.556 1.185 0 N-CA-C 115.996 1.85 . . . . 0.0 115.996 179.647 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -117.54 152.18 49.24 Favored Pre-proline 0 N--CA 1.479 0.996 0 C-N-CA 126.14 1.776 . . . . 0.0 111.681 169.679 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -71.89 160.36 47.97 Favored 'Trans proline' 0 CA--C 1.548 1.219 0 C-N-CA 122.407 2.071 . . . . 0.0 113.061 -179.082 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_exo -57.81 -25.77 70.59 Favored 'Trans proline' 0 C--N 1.354 0.834 0 C-N-CA 123.931 3.087 . . . . 0.0 116.363 -169.696 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -62.46 -25.78 68.17 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 114.024 1.12 . . . . 0.0 114.024 -178.711 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 93.8 m95 -81.13 -33.05 33.48 Favored 'General case' 0 N--CA 1.472 0.662 0 O-C-N 120.676 -1.265 . . . . 0.0 112.682 178.436 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 9.4 m -80.73 -6.2 9.36 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 N-CA-C 113.145 0.795 . . . . 0.0 113.145 176.046 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -106.82 6.01 29.06 Favored 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 114.741 1.386 . . . . 0.0 114.741 179.678 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 91.1 mm-40 -65.75 158.61 27.14 Favored 'General case' 0 N--CA 1.479 0.999 0 O-C-N 120.785 -1.197 . . . . 0.0 111.621 170.512 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -57.44 -43.47 83.91 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 114.224 1.194 . . . . 0.0 114.224 -168.15 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.632 ' HB ' HG22 ' A' ' 75' ' ' VAL . 22.0 mm -114.96 60.52 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 C-N-CA 124.93 1.292 . . . . 0.0 108.77 175.794 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 42.6 t80 -76.57 110.83 11.45 Favored 'General case' 0 CA--C 1.536 0.41 0 O-C-N 120.746 -1.221 . . . . 0.0 108.229 169.084 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 17.0 mt-10 -110.73 137.76 47.98 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 114.573 1.323 . . . . 0.0 114.573 175.7 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -97.71 114.74 26.79 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.99 1.316 . . . . 0.0 109.726 169.373 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 34.0 m0 -104.79 118.61 36.99 Favored 'General case' 0 N--CA 1.462 0.156 0 C-N-CA 124.438 1.095 . . . . 0.0 108.189 176.985 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 61.7 mt-30 -91.18 44.21 1.18 Allowed 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 124.508 1.123 . . . . 0.0 111.162 -169.627 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 90.1 mt -82.99 168.13 17.28 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 126.926 2.09 . . . . 0.0 112.222 -179.165 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -96.97 152.95 18.21 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 123.856 0.863 . . . . 0.0 113.108 172.974 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -77.7 121.62 84.52 Favored Pre-proline 0 CA--C 1.543 0.703 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 169.458 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -79.9 -9.06 14.42 Favored 'Trans proline' 0 CA--C 1.542 0.923 0 C-N-CA 121.403 1.402 . . . . 0.0 114.317 -178.798 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -72.89 -41.9 64.15 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 115.905 1.817 . . . . 0.0 115.905 -169.416 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -72.89 20.37 1.09 Allowed Glycine 0 CA--C 1.541 1.707 0 C-N-CA 124.387 0.994 . . . . 0.0 114.872 -177.471 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 7.3 pt20 -158.74 176.94 11.73 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 127.78 2.432 . . . . 0.0 110.876 -169.662 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 52.8 p -66.65 161.94 22.2 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 114.122 1.156 . . . . 0.0 114.122 -172.82 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . 0.32 2.9 pp -67.99 -11.97 59.88 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 114.194 1.183 . . . . 0.0 114.194 176.803 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -67.82 -30.07 69.39 Favored 'General case' 0 CA--C 1.543 0.682 0 O-C-N 120.968 -1.082 . . . . 0.0 109.953 168.845 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 3.4 t -74.35 -36.92 44.02 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 O-C-N 121.031 -1.043 . . . . 0.0 111.147 170.806 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 16.5 m-85 -58.05 -42.26 85.03 Favored 'General case' 0 N--CA 1.482 1.141 0 CA-C-N 120.229 1.377 . . . . 0.0 111.313 168.941 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -66.5 -37.51 85.22 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 124.19 0.996 . . . . 0.0 112.439 175.864 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 18.9 m -61.36 -50.53 72.53 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 124.491 1.116 . . . . 0.0 111.252 171.203 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 78.4 t -67.44 -37.73 79.44 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 C-N-CA 124.131 0.972 . . . . 0.0 111.098 -178.887 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 19.9 mtp180 -54.55 -43.38 71.93 Favored 'General case' 0 N--CA 1.48 1.052 0 CA-C-N 120.109 1.322 . . . . 0.0 112.467 170.255 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -61.74 -50.9 61.34 Favored Glycine 0 CA--C 1.535 1.332 0 CA-C-N 119.297 0.953 . . . . 0.0 112.954 175.239 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 52.4 mt-30 -61.03 -46.77 89.36 Favored 'General case' 0 N--CA 1.474 0.729 0 O-C-N 122.138 -0.625 . . . . 0.0 111.737 177.686 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 55.3 t -66.02 -41.02 88.88 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 C-N-CA 125.028 1.331 . . . . 0.0 111.144 -179.41 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -55.98 -48.15 76.36 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 120.117 1.326 . . . . 0.0 110.437 177.129 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -63.47 -44.66 93.8 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 112.682 0.623 . . . . 0.0 112.682 175.376 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.17 -33.72 76.67 Favored 'General case' 0 N--CA 1.478 0.967 0 N-CA-C 113.52 0.933 . . . . 0.0 113.52 179.188 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 82.4 t -78.99 -39.29 21.46 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 C-N-CA 125.698 1.599 . . . . 0.0 111.291 177.027 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -60.89 -40.11 91.79 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 119.58 1.082 . . . . 0.0 111.16 171.171 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 16.6 m-80 -63.96 -45.86 87.22 Favored 'General case' 0 CA--C 1.538 0.51 0 O-C-N 121.865 -0.522 . . . . 0.0 112.341 174.19 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -51.67 -57.9 7.9 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 124.729 1.212 . . . . 0.0 110.6 173.522 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 74.1 mt -62.59 -42.99 98.03 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 C-N-CA 122.827 0.451 . . . . 0.0 110.548 -177.11 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -72.92 -10.62 60.0 Favored 'General case' 0 CA--C 1.544 0.721 0 N-CA-C 114.86 1.43 . . . . 0.0 114.86 -178.854 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 20.7 ptmt -99.53 -29.93 12.44 Favored 'General case' 0 N--CA 1.479 0.976 0 N-CA-C 113.636 0.976 . . . . 0.0 113.636 170.198 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 12.7 pt -93.24 -8.91 9.93 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 N-CA-C 114.527 1.306 . . . . 0.0 114.527 178.313 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 27.1 p . . . . . 0 C--O 1.255 1.387 0 N-CA-C 114.663 1.357 . . . . 0.0 114.663 174.501 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.3 ttt . . . . . 0 N--CA 1.502 2.139 0 N-CA-C 111.501 0.186 . . . . 0.0 111.501 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.79 155.97 36.97 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 125.059 1.344 . . . . 0.0 112.774 173.951 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 30.8 ttmt -106.73 112.6 25.66 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 106.812 -1.551 . . . . 0.0 106.812 167.651 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 23.4 t -97.3 131.7 43.57 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 C-N-CA 125.38 1.472 . . . . 0.0 113.826 178.751 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' MET . . . . . 0.49 ' HG3' HG13 ' A' ' 7' ' ' VAL . 23.3 tpp -98.73 128.2 44.9 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 168.986 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 48.6 m-85 -109.46 121.35 44.99 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 125.784 1.633 . . . . 0.0 108.2 174.079 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.58 HG11 HD12 ' A' ' 65' ' ' ILE . 2.1 m -137.69 143.02 34.85 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 N-CA-C 113.926 1.084 . . . . 0.0 113.926 -168.823 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 5.3 t -131.03 147.45 52.63 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 126.41 1.884 . . . . 0.0 112.086 174.786 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 63.2 tttm -52.86 -39.71 62.82 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 126.477 1.911 . . . . 0.0 114.297 -177.641 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 53.4 ttt180 -101.95 -49.73 3.87 Favored 'General case' 0 N--CA 1.483 1.217 0 N-CA-C 113.719 1.007 . . . . 0.0 113.719 169.872 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 1.8 t30 63.63 -47.5 0.25 Allowed 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 127.232 2.213 . . . . 0.0 116.15 -173.515 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 59.6 p -64.85 145.97 55.54 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 119.044 0.838 . . . . 0.0 110.243 169.687 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 66.6 m 51.39 24.62 2.23 Favored 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 114.564 1.32 . . . . 0.0 114.564 -174.548 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 85.2 mtt180 -137.47 152.4 49.5 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 126.975 2.11 . . . . 0.0 110.399 176.403 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 61.1 m -97.01 -29.28 13.74 Favored 'General case' 0 N--CA 1.48 1.058 0 N-CA-C 115.771 1.767 . . . . 0.0 115.771 -169.295 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 3.9 mp0 59.96 -44.24 0.09 Allowed 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 128.596 2.758 . . . . 0.0 117.09 -178.517 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' MET . . . . . 0.408 ' HG2' ' SD ' ' A' ' 50' ' ' MET . 0.0 OUTLIER 68.73 -46.38 0.55 Allowed 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 127.54 2.336 . . . . 0.0 115.753 171.931 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.86 -38.78 86.73 Favored 'General case' 0 C--O 1.222 -0.39 0 N-CA-C 115.494 1.665 . . . . 0.0 115.494 -169.605 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -69.15 -36.5 77.5 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-N 119.788 1.176 . . . . 0.0 112.134 -177.122 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -64.14 -40.16 97.81 Favored Glycine 0 N--CA 1.469 0.866 0 C-N-CA 124.135 0.874 . . . . 0.0 112.107 173.955 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -69.74 -38.32 76.77 Favored 'General case' 0 N--CA 1.47 0.533 0 O-C-N 121.75 -0.853 . . . . 0.0 111.686 172.404 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -64.59 -43.1 94.88 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 119.424 1.011 . . . . 0.0 112.402 -174.75 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 15.2 ptpt -64.75 -38.33 90.63 Favored 'General case' 0 N--CA 1.486 1.351 0 O-C-N 121.514 -0.741 . . . . 0.0 112.025 169.753 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 92.3 m -71.55 -34.07 69.67 Favored 'General case' 0 N--CA 1.479 1.001 0 O-C-N 121.632 -0.668 . . . . 0.0 112.475 -176.709 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 71.9 mt -88.66 -26.07 22.05 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 125.498 1.519 . . . . 0.0 113.84 -178.717 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -145.78 27.08 1.77 Allowed Glycine 0 N--CA 1.47 0.94 0 N-CA-C 118.487 2.155 . . . . 0.0 118.487 -169.083 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -65.82 -21.92 66.52 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-N 122.31 3.055 . . . . 0.0 115.329 -177.323 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -74.36 -5.17 71.47 Favored Glycine 0 CA--C 1.541 1.671 0 O-C-N 121.546 -0.721 . . . . 0.0 113.799 169.479 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 76.8 mttt -118.81 -39.81 2.93 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 127.339 2.256 . . . . 0.0 113.255 -177.506 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 43.7 pt -145.11 159.3 13.62 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 124.805 1.242 . . . . 0.0 113.399 -172.355 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -108.87 139.96 42.99 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 126.343 1.857 . . . . 0.0 108.65 169.752 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 4.2 m -129.55 148.83 33.23 Favored 'Isoleucine or valine' 0 C--O 1.234 0.273 0 CA-C-N 119.53 1.059 . . . . 0.0 111.067 -177.196 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 85.1 m -136.39 136.8 39.9 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 123.151 0.581 . . . . 0.0 110.781 179.0 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 11.5 t -88.51 133.67 34.08 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 124.329 1.052 . . . . 0.0 109.435 169.174 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 23.2 p -146.6 149.41 33.48 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 114.982 1.475 . . . . 0.0 114.982 169.935 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -98.22 152.11 19.75 Favored Glycine 0 C--N 1.338 0.643 0 C-N-CA 124.272 0.939 . . . . 0.0 113.725 -172.615 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 10.5 mp -96.12 99.51 11.24 Favored 'General case' 0 CA--C 1.536 0.41 0 O-C-N 120.604 -1.527 . . . . 0.0 108.956 176.616 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 25.9 mt-10 63.96 26.47 14.15 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 125.243 1.417 . . . . 0.0 113.324 -171.619 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 94.6 p -151.13 167.16 28.6 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 125.248 1.419 . . . . 0.0 113.705 -169.654 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 77.6 p -129.41 169.3 15.09 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 125.398 1.479 . . . . 0.0 113.911 173.05 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.454 ' HG3' ' H ' ' A' ' 42' ' ' VAL . 5.7 tpt180 60.94 -178.86 0.11 Allowed 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 128.636 2.775 . . . . 0.0 113.589 -179.143 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.454 ' H ' ' HG3' ' A' ' 41' ' ' ARG . 20.9 m -133.37 179.51 4.34 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 C-N-CA 129.808 3.243 . . . . 0.0 107.716 172.179 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 2.6 t-80 -58.77 130.75 85.89 Favored Pre-proline 0 C--N 1.325 -0.499 0 CA-C-O 118.052 -0.975 . . . . 0.0 112.127 178.482 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_exo -58.99 -27.2 84.33 Favored 'Trans proline' 0 CA--C 1.548 1.197 0 C-N-CA 121.337 1.358 . . . . 0.0 112.154 169.961 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 89.9 m -64.94 -29.66 70.61 Favored 'General case' 0 N--CA 1.482 1.175 0 C-N-CA 125.698 1.599 . . . . 0.0 112.452 173.209 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -56.65 -43.47 80.35 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 124.027 0.931 . . . . 0.0 111.114 -177.878 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.7 mp -51.74 -55.01 10.47 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 C-N-CA 124.233 1.013 . . . . 0.0 110.226 -176.564 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -62.95 -32.96 74.38 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 113.111 0.782 . . . . 0.0 113.111 -179.578 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -80.72 -20.68 42.29 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 113.719 1.007 . . . . 0.0 113.719 178.326 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' MET . . . . . 0.408 ' SD ' ' HG2' ' A' ' 17' ' ' MET . 4.5 mmt -85.87 -32.51 21.64 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 119.54 1.064 . . . . 0.0 110.344 169.74 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -66.72 -15.75 63.75 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.953 1.301 . . . . 0.0 113.97 175.131 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 -62.29 -26.54 68.46 Favored 'General case' 0 N--CA 1.481 1.1 0 CA-C-N 120.367 1.439 . . . . 0.0 110.895 168.959 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 59.4 t -95.02 -5.77 10.24 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.82 0 C-N-CA 127.318 2.247 . . . . 0.0 111.348 175.613 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 80.22 18.4 71.83 Favored Glycine 0 CA--C 1.539 1.551 0 C-N-CA 125.165 1.364 . . . . 0.0 114.575 -174.65 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 94.6 mt -75.96 134.38 29.21 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 C-N-CA 124.843 1.257 . . . . 0.0 111.22 -176.727 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 21.8 t0 -94.68 108.71 20.69 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 123.231 0.612 . . . . 0.0 112.337 172.241 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 15.7 pt -129.82 12.68 2.39 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 C-N-CA 125.142 1.377 . . . . 0.0 113.284 169.641 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 72.5 m -69.67 138.24 52.82 Favored 'General case' 0 N--CA 1.47 0.57 0 O-C-N 120.603 -1.311 . . . . 0.0 111.93 -175.815 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 73.97 3.37 64.15 Favored Glycine 0 CA--C 1.537 1.429 0 N-CA-C 116.047 1.179 . . . . 0.0 116.047 176.468 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 9.2 pt20 -77.77 135.23 37.96 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 119.536 1.668 . . . . 0.0 110.903 177.414 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 24.1 p -77.36 -33.17 55.35 Favored 'General case' 0 N--CA 1.48 1.051 0 N-CA-C 114.853 1.427 . . . . 0.0 114.853 -173.196 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 31.8 m 47.85 54.27 10.21 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.804 1.242 . . . . 0.0 112.189 -170.937 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -54.04 159.02 3.12 Favored Pre-proline 0 CA--C 1.542 0.656 0 C-N-CA 124.306 1.042 . . . . 0.0 112.357 177.792 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -62.91 149.6 90.99 Favored 'Trans proline' 0 N--CA 1.457 -0.674 0 CA-C-N 120.312 1.147 . . . . 0.0 112.927 -176.489 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.58 HD12 HG11 ' A' ' 7' ' ' VAL . 7.7 tt -51.35 -32.22 12.72 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 125.246 1.418 . . . . 0.0 111.42 173.603 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 -65.73 -17.44 64.61 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 125.545 1.538 . . . . 0.0 113.35 -179.247 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -79.75 -9.29 59.63 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 125.103 1.361 . . . . 0.0 112.9 177.93 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 77.5 m-85 -117.35 -179.07 3.61 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 126.408 1.883 . . . . 0.0 112.254 -173.498 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 5.2 t30 -123.07 128.31 49.95 Favored 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 125.56 1.544 . . . . 0.0 109.711 175.015 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.33 -35.87 81.47 Favored 'General case' 0 CA--C 1.531 0.25 0 N-CA-C 114.205 1.187 . . . . 0.0 114.205 -169.861 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . 0.263 0.0 OUTLIER -72.18 -5.71 37.57 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 114.009 1.115 . . . . 0.0 114.009 -178.226 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -75.49 -10.39 59.4 Favored 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 124.082 0.953 . . . . 0.0 111.331 168.648 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 68.1 m-85 -116.55 145.09 43.6 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 127.167 2.187 . . . . 0.0 111.882 179.635 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -93.57 -26.25 17.2 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.892 1.277 . . . . 0.0 112.202 179.489 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.703 HG22 ' HB ' ' A' ' 95' ' ' ILE . 68.9 t -137.09 139.69 43.86 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 C-N-CA 126.99 2.116 . . . . 0.0 107.953 -169.923 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 61.0 t -130.9 126.39 59.78 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 170.268 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 45.5 mm -112.55 105.63 19.17 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 C-N-CA 125.331 1.452 . . . . 0.0 109.407 -177.137 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 9.5 m -84.44 117.93 23.96 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 123.976 0.91 . . . . 0.0 110.305 170.275 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 1.4 pp -130.91 168.93 16.5 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 125.79 1.636 . . . . 0.0 110.182 176.428 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER 65.84 -27.42 0.11 Allowed 'General case' 0 CA--C 1.553 1.075 0 C-N-CA 126.753 2.021 . . . . 0.0 114.982 -169.45 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -170.78 -173.09 37.68 Favored Glycine 0 CA--C 1.536 1.359 0 C-N-CA 126.395 1.95 . . . . 0.0 112.328 174.521 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 74.9 m -76.84 149.83 36.14 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.96 0.904 . . . . 0.0 112.51 -178.739 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -76.67 63.29 3.09 Favored Glycine 0 CA--C 1.535 1.336 0 C-N-CA 125.01 1.291 . . . . 0.0 113.625 176.461 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 58.2 t -105.09 -38.33 4.62 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.129 0 C-N-CA 124.284 1.034 . . . . 0.0 112.659 -176.284 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 62.7 t30 -91.31 33.16 0.99 Allowed 'General case' 0 CA--C 1.55 0.951 0 N-CA-C 113.344 0.868 . . . . 0.0 113.344 -178.772 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.1 pp -126.83 156.82 73.23 Favored Pre-proline 0 CA--C 1.55 0.976 0 C-N-CA 126.32 1.848 . . . . 0.0 111.853 172.41 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -61.65 149.0 91.74 Favored 'Trans proline' 0 CA--C 1.545 1.031 0 C-N-CA 122.315 2.01 . . . . 0.0 113.906 -179.581 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_exo -57.63 -26.03 70.55 Favored 'Trans proline' 0 C--N 1.354 0.827 0 C-N-CA 123.596 2.864 . . . . 0.0 115.244 -176.962 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -62.12 -22.8 66.13 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 113.695 0.998 . . . . 0.0 113.695 176.086 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 89.5 m95 -82.52 -28.65 30.95 Favored 'General case' 0 N--CA 1.473 0.681 0 O-C-N 120.821 -1.175 . . . . 0.0 113.193 176.932 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 6.4 m -80.25 -14.11 13.01 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.256 0 CA-C-N 119.232 0.924 . . . . 0.0 113.24 174.167 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -96.52 0.09 49.66 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 114.95 1.463 . . . . 0.0 114.95 -178.467 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 80.6 mm-40 -65.63 157.13 30.75 Favored 'General case' 0 N--CA 1.479 1.011 0 O-C-N 120.87 -1.144 . . . . 0.0 111.865 171.239 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -55.19 -42.54 73.37 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 114.392 1.256 . . . . 0.0 114.392 -167.872 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.703 ' HB ' HG22 ' A' ' 75' ' ' VAL . 14.0 mm -119.82 64.43 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 C-N-CA 124.63 1.172 . . . . 0.0 109.412 176.753 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 14.9 t80 -77.2 108.29 10.2 Favored 'General case' 0 CA--C 1.536 0.413 0 O-C-N 120.492 -1.38 . . . . 0.0 108.063 169.246 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -109.32 144.29 37.69 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 113.217 0.821 . . . . 0.0 113.217 172.788 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -121.42 115.54 23.09 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 124.13 0.972 . . . . 0.0 109.732 169.413 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 45.5 m0 -93.16 -19.78 21.13 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 113.903 1.075 . . . . 0.0 113.903 -169.859 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 66.5 mm-40 53.25 29.92 9.22 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 125.218 1.407 . . . . 0.0 113.177 -175.721 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.3 tt -80.83 132.73 35.5 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 125.428 1.491 . . . . 0.0 109.676 -174.599 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -65.74 151.98 45.34 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 113.131 0.789 . . . . 0.0 113.131 -179.43 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -92.9 148.82 36.61 Favored Pre-proline 0 CA--C 1.548 0.886 0 O-C-N 121.772 -0.58 . . . . 0.0 111.106 171.345 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -62.42 -19.19 66.63 Favored 'Trans proline' 0 CA--C 1.548 1.204 0 C-N-CA 122.779 2.32 . . . . 0.0 115.3 173.001 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -49.32 130.83 20.03 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 125.281 1.432 . . . . 0.0 114.582 175.761 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 79.29 7.95 88.13 Favored Glycine 0 CA--C 1.535 1.312 0 C-N-CA 124.736 1.16 . . . . 0.0 114.914 175.625 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 10.5 pt20 -143.36 173.2 11.82 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 125.098 1.359 . . . . 0.0 113.117 -177.122 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 26.5 p -68.3 167.46 14.41 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 116.61 2.078 . . . . 0.0 116.61 -168.947 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 41.7 tp -59.42 -30.8 68.73 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.516 1.126 . . . . 0.0 112.288 170.073 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -66.88 -31.76 72.57 Favored 'General case' 0 N--CA 1.47 0.536 0 O-C-N 120.818 -1.176 . . . . 0.0 111.487 173.849 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 7.6 t -71.49 -33.81 50.92 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 O-C-N 121.172 -0.955 . . . . 0.0 111.687 169.867 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -57.52 -48.34 79.55 Favored 'General case' 0 N--CA 1.477 0.893 0 CA-C-N 120.041 1.291 . . . . 0.0 111.261 169.34 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 2.8 mpt_? -63.35 -40.58 97.68 Favored 'General case' 0 N--CA 1.484 1.261 0 O-C-N 121.473 -0.767 . . . . 0.0 112.066 175.873 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 28.0 m -58.81 -46.5 87.45 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 124.095 0.958 . . . . 0.0 111.175 173.659 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 54.4 t -64.57 -43.19 96.77 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 CA-C-O 117.522 -1.228 . . . . 0.0 110.514 177.621 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 67.5 mtm-85 -57.3 -43.62 83.4 Favored 'General case' 0 N--CA 1.484 1.264 0 CA-C-N 121.076 1.762 . . . . 0.0 112.528 173.738 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -61.83 -51.21 58.79 Favored Glycine 0 CA--C 1.538 1.479 0 CA-C-N 119.046 0.839 . . . . 0.0 112.914 177.113 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 58.9 mm-40 -62.29 -45.36 93.6 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 123.742 0.817 . . . . 0.0 111.754 177.751 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 58.7 t -65.41 -40.59 88.84 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 C-N-CA 124.62 1.168 . . . . 0.0 111.375 178.342 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 82.3 tttt -56.02 -50.07 71.91 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 120.337 1.426 . . . . 0.0 110.131 177.594 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -62.81 -41.19 99.19 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 112.68 0.622 . . . . 0.0 112.68 176.64 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.77 -34.49 73.85 Favored 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 113.858 1.058 . . . . 0.0 113.858 -179.864 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 98.6 t -78.3 -38.53 23.3 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 C-N-CA 125.17 1.388 . . . . 0.0 110.926 175.744 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -62.3 -41.21 98.32 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 119.041 0.837 . . . . 0.0 111.506 171.661 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 15.2 m-80 -64.43 -42.13 96.18 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 119.249 0.931 . . . . 0.0 112.462 173.722 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -54.77 -57.23 12.38 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.234 0.614 . . . . 0.0 110.26 174.149 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 77.5 mt -63.32 -45.38 98.34 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 CA-C-O 118.995 -0.526 . . . . 0.0 111.251 -177.237 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -68.91 -10.84 59.31 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 114.222 1.193 . . . . 0.0 114.222 177.632 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 70.2 tttt -92.61 -45.63 7.99 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 125.425 1.49 . . . . 0.0 111.29 174.422 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 18.7 pt -91.89 -18.86 7.15 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 N-CA-C 114.41 1.263 . . . . 0.0 114.41 -174.257 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 73.7 m . . . . . 0 C--O 1.254 1.31 0 C-N-CA 125.783 1.633 . . . . 0.0 111.188 -175.878 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.8 ttt . . . . . 0 N--CA 1.503 2.183 0 N-CA-C 111.563 0.209 . . . . 0.0 111.563 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.9 164.35 30.33 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 125.061 1.344 . . . . 0.0 112.907 174.986 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 75.3 mttt -93.75 145.61 24.46 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 124.206 1.002 . . . . 0.0 112.193 177.269 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.408 HG13 ' CG1' ' A' ' 75' ' ' VAL . 21.5 t -129.06 131.57 67.91 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 125.569 1.548 . . . . 0.0 112.318 178.43 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 47.0 tpp -98.35 132.37 43.88 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 168.944 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 42.6 m-85 -115.61 127.32 55.13 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 124.441 1.096 . . . . 0.0 109.645 173.142 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 5.7 m -149.16 163.94 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 C-N-CA 124.398 1.079 . . . . 0.0 112.891 -169.779 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 47.1 t -132.25 165.52 23.96 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 127.312 2.245 . . . . 0.0 109.384 169.807 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -52.96 -37.6 61.26 Favored 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 124.547 1.139 . . . . 0.0 112.741 -178.529 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 82.3 mtt180 -141.18 150.73 43.11 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 127.203 2.201 . . . . 0.0 109.822 169.028 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 24.0 t30 -110.15 -27.11 9.31 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 124.341 1.056 . . . . 0.0 113.746 -173.222 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 60.5 m -56.29 126.54 26.69 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 118.769 0.713 . . . . 0.0 110.461 177.662 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 68.3 m 50.36 36.81 13.85 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 124.798 1.239 . . . . 0.0 113.945 -176.459 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -121.98 143.25 49.59 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 125.778 1.631 . . . . 0.0 109.478 171.082 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 15.8 m -97.02 -33.17 11.65 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 114.742 1.386 . . . . 0.0 114.742 -170.334 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 5.2 mt-30 60.75 -55.88 0.09 Allowed 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 128.578 2.751 . . . . 0.0 116.648 171.886 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 69.86 -42.67 0.52 Allowed 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 127.929 2.492 . . . . 0.0 117.498 169.599 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -59.9 -33.21 71.55 Favored 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 113.858 1.059 . . . . 0.0 113.858 -170.406 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.9 pm0 -61.56 -42.47 98.89 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.658 1.183 . . . . 0.0 112.275 173.767 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -68.75 -38.95 86.19 Favored Glycine 0 C--N 1.336 0.563 0 O-C-N 121.557 -0.715 . . . . 0.0 111.59 178.607 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -70.05 -41.65 73.91 Favored 'General case' 0 C--O 1.221 -0.414 0 O-C-N 121.834 -0.804 . . . . 0.0 111.258 175.865 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -60.16 -41.9 93.79 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 119.467 1.031 . . . . 0.0 113.008 -175.736 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 10.3 pttp -76.78 -29.28 55.99 Favored 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 113.502 0.927 . . . . 0.0 113.502 173.891 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 83.7 m -71.66 -31.29 66.65 Favored 'General case' 0 N--CA 1.485 1.281 0 O-C-N 121.585 -0.697 . . . . 0.0 111.842 175.241 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 78.2 mt -91.57 -30.82 16.17 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 125.923 1.689 . . . . 0.0 114.123 179.827 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -142.89 26.36 2.22 Favored Glycine 0 N--CA 1.475 1.292 0 N-CA-C 118.233 2.053 . . . . 0.0 118.233 -169.086 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -66.27 -20.3 66.07 Favored 'General case' 0 CA--C 1.547 0.833 0 CA-C-N 122.016 2.908 . . . . 0.0 114.952 -178.578 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -76.4 -4.18 79.21 Favored Glycine 0 CA--C 1.541 1.675 0 O-C-N 121.235 -0.916 . . . . 0.0 113.757 169.368 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -118.11 -40.94 2.91 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 127.178 2.191 . . . . 0.0 112.513 -175.536 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 29.4 pt -141.38 154.93 20.56 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 C-N-CA 125.919 1.687 . . . . 0.0 112.168 -175.103 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -97.3 137.53 36.17 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 123.872 0.869 . . . . 0.0 109.702 169.875 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 84.0 t -122.14 140.22 46.71 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 CA-C-N 118.996 0.817 . . . . 0.0 111.542 -178.769 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 20.4 m -135.68 151.2 49.95 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 124.923 1.289 . . . . 0.0 109.31 173.331 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 77.9 p -133.06 147.73 52.2 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 122.308 1.051 . . . . 0.0 110.913 168.32 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 88.7 p -144.2 157.9 44.03 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 114.066 -1.425 . . . . 0.0 112.461 -174.478 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -79.07 167.67 52.72 Favored Glycine 0 CA--C 1.527 0.818 0 N-CA-C 111.166 -0.774 . . . . 0.0 111.166 169.748 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 9.2 mp -100.91 -16.91 17.05 Favored 'General case' 0 N--CA 1.484 1.237 0 CA-C-N 120.27 2.035 . . . . 0.0 112.164 169.559 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -138.36 170.02 16.75 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 129.587 3.155 . . . . 0.0 107.095 172.331 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 69.0 m -57.46 110.17 0.82 Allowed 'General case' 0 N--CA 1.48 1.061 0 CA-C-N 119.759 1.163 . . . . 0.0 111.112 -178.461 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 91.2 p -158.51 175.02 14.21 Favored 'General case' 0 N--CA 1.478 0.966 0 N-CA-C 115.673 1.731 . . . . 0.0 115.673 -169.145 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 15.3 tpt180 -139.79 145.01 37.67 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 128.398 2.679 . . . . 0.0 108.852 171.76 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 35.5 m -56.21 163.98 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 CA-C-O 122.761 1.267 . . . . 0.0 111.155 169.598 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 1.6 t-80 -48.86 127.05 14.09 Favored Pre-proline 0 C--N 1.323 -0.543 0 CA-C-N 114.05 -1.432 . . . . 0.0 112.965 172.354 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_exo -60.64 -28.68 86.99 Favored 'Trans proline' 0 CA--C 1.542 0.907 0 CA-C-N 120.54 1.229 . . . . 0.0 111.904 171.497 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 88.6 m -65.6 -29.72 70.35 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 125.213 1.405 . . . . 0.0 112.238 173.845 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.32 -39.69 87.96 Favored 'General case' 0 N--CA 1.471 0.582 0 O-C-N 121.108 -0.995 . . . . 0.0 112.089 -175.714 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.9 mp -57.83 -56.03 18.09 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 -177.922 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.53 -33.62 76.33 Favored 'General case' 0 CA--C 1.542 0.656 0 N-CA-C 113.378 0.881 . . . . 0.0 113.378 -178.004 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -79.95 -21.19 44.07 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 114.13 1.159 . . . . 0.0 114.13 178.953 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -90.74 -28.01 18.57 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 118.96 0.8 . . . . 0.0 110.306 172.092 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -66.07 -13.12 59.47 Favored 'General case' 0 CA--C 1.543 0.692 0 O-C-N 120.641 -1.287 . . . . 0.0 113.247 171.248 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 13.3 mt-10 -61.41 -27.49 68.58 Favored 'General case' 0 N--CA 1.48 1.059 0 CA-C-N 120.233 1.378 . . . . 0.0 110.464 168.665 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 35.7 t -96.45 -2.29 10.4 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.032 0 C-N-CA 127.581 2.353 . . . . 0.0 111.135 176.874 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 78.93 21.26 68.66 Favored Glycine 0 CA--C 1.538 1.53 0 C-N-CA 125.35 1.452 . . . . 0.0 114.742 -176.606 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 77.8 mt -83.6 131.07 34.71 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 C-N-CA 124.798 1.239 . . . . 0.0 112.006 -171.436 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 19.4 t0 -96.06 107.14 19.41 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 112.895 0.702 . . . . 0.0 112.895 -178.616 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 15.6 pt -142.68 23.06 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.208 0 C-N-CA 125.302 1.441 . . . . 0.0 114.369 -177.286 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 95.2 p -48.15 -37.34 15.34 Favored 'General case' 0 N--CA 1.483 1.201 0 N-CA-C 116.567 2.062 . . . . 0.0 116.567 -169.341 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -142.97 40.04 1.28 Allowed Glycine 0 N--CA 1.474 1.179 0 C-N-CA 125.358 1.456 . . . . 0.0 113.01 -179.371 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 24.3 pt20 -66.5 -34.68 78.45 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 115.637 1.717 . . . . 0.0 115.637 -169.529 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 68.0 p -93.65 104.17 16.29 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 121.211 0.529 . . . . 0.0 111.352 173.856 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 95.9 p -108.94 -23.55 11.66 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 125.473 1.509 . . . . 0.0 114.278 178.316 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -145.46 155.34 53.53 Favored Pre-proline 0 CA--C 1.544 0.722 0 C-N-CA 124.722 1.209 . . . . 0.0 111.046 -171.795 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -74.37 155.13 46.07 Favored 'Trans proline' 0 CA--C 1.538 0.714 0 C-N-CA 122.561 2.174 . . . . 0.0 112.657 173.257 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 5.6 tt -54.44 -38.65 41.77 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 126.171 1.788 . . . . 0.0 111.615 179.74 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -68.34 -8.6 41.37 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 124.56 1.144 . . . . 0.0 113.763 178.785 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 -79.92 -21.73 43.54 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 124.085 0.954 . . . . 0.0 112.824 170.71 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 84.6 m-85 -93.62 -176.73 4.17 Favored 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 126.444 1.897 . . . . 0.0 111.879 -179.354 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 7.0 t30 -113.84 129.19 56.62 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 125.783 1.633 . . . . 0.0 109.695 171.889 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -69.38 -36.9 77.26 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 113.918 1.081 . . . . 0.0 113.918 -175.517 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . 0.272 0.0 OUTLIER -72.07 -7.82 51.11 Favored 'General case' 0 CA--C 1.544 0.744 0 N-CA-C 114.562 1.319 . . . . 0.0 114.562 -173.077 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -65.1 -26.35 68.18 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 123.664 0.786 . . . . 0.0 110.449 168.295 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 55.5 m-85 -108.4 120.75 43.31 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 125.834 1.654 . . . . 0.0 111.44 -173.307 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -74.0 -20.87 60.19 Favored 'General case' 0 CA--C 1.545 0.776 0 CA-C-O 122.195 0.998 . . . . 0.0 112.473 177.55 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.609 HG22 ' HB ' ' A' ' 95' ' ' ILE . 92.3 t -133.95 137.84 51.5 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 C-N-CA 127.381 2.272 . . . . 0.0 108.891 -173.407 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 63.0 t -133.91 118.61 29.65 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 169.685 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 44.8 mm -103.09 113.16 39.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 C-N-CA 123.818 0.847 . . . . 0.0 109.299 -177.918 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 15.5 m -92.78 114.12 26.59 Favored 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 169.531 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 90.7 mt -86.79 -3.16 59.02 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 125.644 1.577 . . . . 0.0 115.217 -169.548 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 77.5 m -130.34 40.32 3.54 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 125.359 1.463 . . . . 0.0 110.553 -169.82 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 80.51 -131.72 10.7 Favored Glycine 0 CA--C 1.532 1.109 0 C-N-CA 124.371 0.986 . . . . 0.0 111.174 -169.49 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 93.3 p -63.71 154.49 32.98 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 124.015 0.926 . . . . 0.0 113.479 176.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -75.35 -51.42 7.43 Favored Glycine 0 CA--C 1.534 1.269 0 O-C-N 121.739 -0.601 . . . . 0.0 112.339 176.009 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . 0.273 7.7 p 48.97 -47.54 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.677 1 C-N-CA 132.148 4.179 . . . . 0.0 119.021 169.883 . . . . . . . . 3 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 63.1 t30 -85.9 15.95 4.51 Favored 'General case' 0 CA--C 1.556 1.202 0 C-N-CA 126.734 2.014 . . . . 0.0 112.761 -179.834 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -122.87 160.45 49.13 Favored Pre-proline 0 CA--C 1.55 0.98 0 C-N-CA 127.589 2.356 . . . . 0.0 112.598 179.605 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -63.34 151.61 84.04 Favored 'Trans proline' 0 CA--C 1.546 1.084 0 C-N-CA 122.774 2.316 . . . . 0.0 113.948 178.721 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_exo -58.82 -27.05 82.8 Favored 'Trans proline' 0 C--N 1.352 0.728 0 C-N-CA 123.609 2.873 . . . . 0.0 115.309 -177.108 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -61.72 -21.24 64.32 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 113.74 1.015 . . . . 0.0 113.74 177.763 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 92.7 m95 -83.73 -28.95 27.88 Favored 'General case' 0 N--CA 1.474 0.733 0 O-C-N 120.83 -1.168 . . . . 0.0 113.318 177.32 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 6.4 m -82.88 -13.37 12.08 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.315 0 N-CA-C 113.36 0.874 . . . . 0.0 113.36 174.41 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -95.31 1.46 54.42 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 114.603 1.334 . . . . 0.0 114.603 -179.33 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 85.6 mm-40 -66.39 156.31 34.94 Favored 'General case' 0 N--CA 1.481 1.081 0 O-C-N 120.83 -1.169 . . . . 0.0 111.596 172.005 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -59.49 -42.54 92.37 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 114.196 1.184 . . . . 0.0 114.196 -168.183 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.609 ' HB ' HG22 ' A' ' 75' ' ' VAL . 16.3 mm -113.21 55.44 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 C-N-CA 125.083 1.353 . . . . 0.0 109.276 177.788 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 25.1 t80 -74.66 109.19 7.93 Favored 'General case' 0 CA--C 1.536 0.414 0 O-C-N 120.565 -1.334 . . . . 0.0 107.675 169.009 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 13.8 mt-10 -110.95 131.36 55.12 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 114.432 1.271 . . . . 0.0 114.432 176.657 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 12.5 p-10 -94.74 104.69 16.61 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 126.128 1.771 . . . . 0.0 110.053 169.214 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 34.2 m0 -93.35 124.56 37.42 Favored 'General case' 0 N--CA 1.464 0.236 0 C-N-CA 124.183 0.993 . . . . 0.0 109.089 174.703 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 32.5 mt-30 -91.95 42.3 1.1 Allowed 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 124.012 0.925 . . . . 0.0 111.574 -173.324 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 76.1 mt -81.28 164.07 22.5 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 125.271 1.428 . . . . 0.0 112.695 -178.863 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -87.2 163.74 16.75 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 124.901 1.28 . . . . 0.0 111.221 169.106 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -108.3 139.6 20.91 Favored Pre-proline 0 N--CA 1.474 0.755 0 O-C-N 121.33 -0.856 . . . . 0.0 110.526 169.748 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_exo -59.9 -17.13 42.27 Favored 'Trans proline' 0 CA--C 1.545 1.028 0 C-N-CA 123.006 2.471 . . . . 0.0 116.392 176.955 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -54.41 135.44 45.28 Favored 'General case' 0 CA--C 1.546 0.816 0 CA-C-N 120.13 1.332 . . . . 0.0 113.924 178.858 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 76.54 6.74 84.86 Favored Glycine 0 CA--C 1.538 1.48 0 C-N-CA 124.461 1.029 . . . . 0.0 115.007 178.453 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 -138.05 170.47 15.98 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 125.473 1.509 . . . . 0.0 113.033 -179.459 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 26.4 p -68.07 168.56 11.77 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 117.461 2.393 . . . . 0.0 117.461 -168.524 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 25.0 tp -60.18 -30.09 69.13 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 125.097 1.359 . . . . 0.0 112.483 169.801 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -65.58 -31.54 72.64 Favored 'General case' 0 CA--C 1.539 0.523 0 O-C-N 121.038 -1.039 . . . . 0.0 111.259 171.684 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 11.4 t -74.16 -38.52 48.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 CA-C-O 118.154 -0.927 . . . . 0.0 112.14 171.104 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 17.1 m-85 -56.25 -44.08 79.33 Favored 'General case' 0 N--CA 1.482 1.134 0 CA-C-N 120.698 1.59 . . . . 0.0 111.74 169.588 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -69.49 -37.5 77.26 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 124.351 1.06 . . . . 0.0 112.408 178.182 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 21.6 m -60.46 -48.04 83.48 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 124.507 1.123 . . . . 0.0 111.201 170.362 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 75.1 t -65.52 -43.52 94.28 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 CA-C-O 118.181 -0.914 . . . . 0.0 110.236 179.853 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 16.8 mtp180 -53.5 -45.48 69.69 Favored 'General case' 0 N--CA 1.481 1.118 0 CA-C-N 119.914 1.234 . . . . 0.0 112.716 172.091 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -60.57 -51.34 59.34 Favored Glycine 0 CA--C 1.538 1.482 0 CA-C-N 119.431 1.014 . . . . 0.0 113.218 176.432 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 58.9 mm-40 -63.37 -45.09 92.76 Favored 'General case' 0 N--CA 1.472 0.653 0 O-C-N 121.978 -0.719 . . . . 0.0 111.912 178.822 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 50.5 t -63.83 -41.72 93.48 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 C-N-CA 124.881 1.272 . . . . 0.0 111.237 177.818 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 78.1 tttt -56.77 -48.02 78.83 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 119.832 1.196 . . . . 0.0 110.425 178.407 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -64.35 -42.31 96.29 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 112.641 0.608 . . . . 0.0 112.641 177.523 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 16.6 mmm180 -61.14 -45.59 94.03 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.393 0.677 . . . . 0.0 112.696 175.144 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 79.3 t -69.45 -41.05 80.55 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 C-N-CA 124.5 1.12 . . . . 0.0 111.157 -179.392 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -62.51 -40.0 95.32 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 118.875 0.761 . . . . 0.0 111.647 172.879 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 13.0 m-80 -64.02 -46.11 85.95 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-N 118.782 0.719 . . . . 0.0 112.236 174.123 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -54.05 -54.78 34.53 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 124.734 1.213 . . . . 0.0 110.499 175.272 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 91.4 mt -59.88 -45.11 95.41 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 CA-C-O 119.024 -0.512 . . . . 0.0 110.393 179.255 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -68.83 -10.77 58.67 Favored 'General case' 0 CA--C 1.548 0.871 0 N-CA-C 115.245 1.572 . . . . 0.0 115.245 -179.807 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 21.4 ptmt -102.49 -24.18 13.84 Favored 'General case' 0 N--CA 1.479 1.01 0 N-CA-C 113.91 1.078 . . . . 0.0 113.91 171.271 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 14.7 pt -96.65 -7.97 9.4 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 N-CA-C 114.435 1.272 . . . . 0.0 114.435 176.179 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 83.4 p . . . . . 0 C--O 1.255 1.35 0 C-N-CA 125.075 1.35 . . . . 0.0 114.269 173.526 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.403 ' HG3' ' HA ' ' A' ' 30' ' ' ILE . 4.1 ttp . . . . . 0 N--CA 1.502 2.172 0 N-CA-C 112.087 0.403 . . . . 0.0 112.087 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 3.3 mptp? -86.03 159.91 19.46 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 124.602 1.161 . . . . 0.0 113.113 171.003 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 79.3 mttt -112.14 113.21 25.34 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 125.816 1.646 . . . . 0.0 106.577 167.671 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 18.9 t -102.91 132.5 48.95 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 C-N-CA 125.793 1.637 . . . . 0.0 113.579 -178.864 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' MET . . . . . 0.538 ' HG3' HG13 ' A' ' 7' ' ' VAL . 36.6 tpp -107.05 119.86 40.53 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.567 0.747 . . . . 0.0 109.266 168.552 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 60.1 m-85 -97.16 125.08 41.42 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.232 1.013 . . . . 0.0 109.533 171.476 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.54 HG11 HD12 ' A' ' 65' ' ' ILE . 1.0 OUTLIER -140.99 147.78 22.25 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 N-CA-C 114.179 1.177 . . . . 0.0 114.179 -168.95 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 52.7 t -157.55 164.72 37.03 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 126.189 1.795 . . . . 0.0 112.417 172.298 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 53.4 mtmt -75.08 154.92 37.67 Favored 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 125.753 1.621 . . . . 0.0 112.628 171.943 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 6.4 tmm_? 49.3 84.45 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 127.377 2.271 . . . . 0.0 112.661 175.618 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 30.2 t-20 -79.69 -25.27 41.26 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 124.62 1.168 . . . . 0.0 113.132 -171.738 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 78.2 p -58.3 141.68 50.29 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.208 1.003 . . . . 0.0 111.567 170.092 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 66.9 m 56.23 -4.26 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.325 0 N-CA-C 116.647 2.091 . . . . 0.0 116.647 -170.598 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 58.8 ttm-85 -92.37 138.57 31.41 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 124.886 1.274 . . . . 0.0 113.372 -170.131 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 45.5 m -96.17 -38.16 10.26 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 114.578 1.325 . . . . 0.0 114.578 -176.64 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 60.82 -46.75 0.11 Allowed 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 127.622 2.369 . . . . 0.0 116.271 -177.132 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' MET . . . . . 0.41 ' HG2' ' SD ' ' A' ' 50' ' ' MET . 0.0 OUTLIER 66.67 -50.54 0.45 Allowed 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 127.771 2.429 . . . . 0.0 116.579 169.619 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -56.17 -37.13 69.13 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 115.584 1.698 . . . . 0.0 115.584 -169.132 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.89 -34.94 77.62 Favored 'General case' 0 N--CA 1.476 0.864 0 O-C-N 121.412 -0.805 . . . . 0.0 112.774 -177.162 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -69.87 -42.83 68.53 Favored Glycine 0 N--CA 1.468 0.813 0 C-N-CA 123.692 0.663 . . . . 0.0 111.764 176.371 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -64.39 -36.94 85.79 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 117.884 0.842 . . . . 0.0 111.313 170.79 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -65.32 -39.12 92.03 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 119.449 1.022 . . . . 0.0 112.663 179.586 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 23.7 mtpp -62.05 -46.62 88.33 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 123.314 0.645 . . . . 0.0 110.978 169.918 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 69.6 m -68.15 -38.09 81.75 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 123.12 0.568 . . . . 0.0 112.245 -174.448 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 47.7 mt -85.49 -35.46 21.16 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 125.416 1.487 . . . . 0.0 113.362 -179.445 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -117.29 5.15 17.68 Favored Glycine 0 CA--C 1.528 0.867 0 N-CA-C 118.214 2.046 . . . . 0.0 118.214 -168.737 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -60.81 139.48 57.92 Favored 'General case' 0 CA--C 1.545 0.784 0 CA-C-N 122.064 2.932 . . . . 0.0 111.959 177.316 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 88.68 -21.38 26.56 Favored Glycine 0 CA--C 1.54 1.649 0 C-N-CA 124.797 1.189 . . . . 0.0 113.233 -169.206 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 72.4 mttt -101.77 -42.22 6.25 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 126.302 1.841 . . . . 0.0 112.015 169.531 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.403 ' HA ' ' HG3' ' A' ' 1' ' ' MET . 36.0 pt -135.12 146.11 30.92 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 C-N-CA 124.676 1.19 . . . . 0.0 113.126 -178.566 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -98.58 145.77 26.49 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 126.685 1.994 . . . . 0.0 108.337 169.197 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 71.3 t -141.38 139.01 32.9 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 O-C-N 121.781 -0.575 . . . . 0.0 112.435 -169.696 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 31.7 m -136.9 159.2 42.57 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 126.198 1.799 . . . . 0.0 108.745 169.909 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 26.5 p -133.98 148.55 51.15 Favored 'General case' 0 CA--C 1.515 -0.368 0 CA-C-O 121.742 0.782 . . . . 0.0 111.896 168.086 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 59.9 p -147.58 153.81 39.89 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 114.806 -1.088 . . . . 0.0 113.312 176.212 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -83.22 152.97 30.1 Favored Glycine 0 N--CA 1.473 1.138 0 O-C-N 121.735 -0.603 . . . . 0.0 111.987 173.913 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.4 mp -76.23 -20.43 57.45 Favored 'General case' 0 N--CA 1.481 1.088 0 CA-C-N 119.126 1.463 . . . . 0.0 113.973 176.904 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -138.31 -52.42 0.6 Allowed 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.934 0.893 . . . . 0.0 113.31 177.226 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 50.2 p -98.93 150.57 21.8 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 115.106 1.521 . . . . 0.0 115.106 -172.403 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 80.5 p -84.81 149.21 25.87 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 125.818 1.647 . . . . 0.0 114.23 -174.497 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 13.2 tpt180 57.61 137.58 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 129.483 3.113 . . . . 0.0 116.045 -178.662 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 15.6 m -67.49 156.48 6.79 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.354 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 168.695 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' HIS . . . . . 0.441 ' CE1' ' HB ' ' A' ' 45' ' ' THR 0.255 0.0 OUTLIER -68.19 140.18 92.98 Favored Pre-proline 0 CA--C 1.546 0.793 0 C-N-CA 118.188 -1.405 . . . . 0.0 110.943 178.08 . . . . . . . . 4 4 . 1 . 002 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -63.81 -31.01 68.69 Favored 'Trans proline' 0 CA--C 1.539 0.732 0 C-N-CA 123.254 2.636 . . . . 0.0 114.84 -168.291 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.441 ' HB ' ' CE1' ' A' ' 43' ' ' HIS . 51.7 m -65.46 -24.64 67.22 Favored 'General case' 0 N--CA 1.48 1.062 0 O-C-N 121.404 -0.81 . . . . 0.0 111.787 -176.334 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -50.51 -48.44 57.05 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.11 0.964 . . . . 0.0 111.67 169.796 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 4.7 mp -55.39 -53.26 37.61 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 CA-C-N 119.433 1.015 . . . . 0.0 111.015 -176.866 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -62.81 -25.55 68.3 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 113.648 0.981 . . . . 0.0 113.648 -177.709 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -81.08 -35.19 32.05 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 123.644 0.778 . . . . 0.0 112.808 174.859 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' MET . . . . . 0.41 ' SD ' ' HG2' ' A' ' 17' ' ' MET . 4.5 mmt -72.49 -29.76 63.93 Favored 'General case' 0 N--CA 1.473 0.707 0 O-C-N 121.129 -0.982 . . . . 0.0 111.13 172.219 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -67.41 -9.08 38.2 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 125.339 1.456 . . . . 0.0 113.816 172.189 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -69.02 -29.74 67.96 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-N 120.325 1.421 . . . . 0.0 110.857 169.526 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . 0.295 2.2 p -109.66 8.25 8.95 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.815 0 C-N-CA 127.189 2.196 . . . . 0.0 111.955 -172.475 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 85.84 14.08 68.2 Favored Glycine 0 CA--C 1.538 1.497 0 C-N-CA 124.855 1.217 . . . . 0.0 115.369 171.673 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -76.19 138.39 20.83 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 C-N-CA 124.625 1.17 . . . . 0.0 109.698 -178.335 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 19.6 t0 -110.55 104.37 13.08 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 124.272 1.029 . . . . 0.0 111.767 175.088 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 21.4 pt -133.75 6.33 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.248 0 N-CA-C 116.289 1.959 . . . . 0.0 116.289 -175.727 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 72.3 m -60.21 -31.43 70.16 Favored 'General case' 0 N--CA 1.483 1.214 0 CA-C-N 120.438 1.472 . . . . 0.0 111.662 175.207 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -79.35 14.78 14.65 Favored Glycine 0 CA--C 1.539 1.559 0 C-N-CA 126.193 1.854 . . . . 0.0 115.934 175.863 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 70.6 mt-30 -62.38 157.21 20.46 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 119.434 1.617 . . . . 0.0 110.429 169.838 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 7.6 t -74.86 172.89 11.4 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 121.538 0.685 . . . . 0.0 112.061 169.928 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 73.4 m -118.09 -18.53 9.36 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 125.098 1.359 . . . . 0.0 114.211 -174.185 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 27.3 m-20 -86.11 158.68 55.29 Favored Pre-proline 0 CA--C 1.55 0.949 0 N-CA-C 114.691 1.367 . . . . 0.0 114.691 -169.703 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -63.98 160.91 35.38 Favored 'Trans proline' 0 C--N 1.353 0.787 0 C-N-CA 124.001 3.134 . . . . 0.0 114.371 172.268 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.54 HD12 HG11 ' A' ' 7' ' ' VAL . 8.4 tt -51.5 -36.47 17.93 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 C-N-CA 125.622 1.569 . . . . 0.0 112.103 173.092 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 17.8 mt-10 -65.0 -16.77 63.81 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.598 1.159 . . . . 0.0 112.825 -177.511 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -83.26 -8.18 59.49 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 124.815 1.246 . . . . 0.0 113.565 -178.953 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 69.7 m-85 -116.77 -175.44 2.77 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 126.221 1.808 . . . . 0.0 112.614 -172.914 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 11.2 t30 -120.69 125.81 48.61 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 125.603 1.561 . . . . 0.0 110.026 177.613 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -69.13 -35.4 76.34 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 114.021 1.119 . . . . 0.0 114.021 -173.363 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . 0.275 0.0 OUTLIER -71.92 -5.21 33.01 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 114.329 1.233 . . . . 0.0 114.329 -174.15 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -70.42 -25.73 63.34 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 122.968 0.507 . . . . 0.0 109.949 168.446 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 80.1 m-85 -99.23 148.67 23.88 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 126.473 1.909 . . . . 0.0 111.644 -179.205 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -107.04 -17.92 14.05 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 124.342 1.057 . . . . 0.0 112.176 176.011 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.662 HG22 ' HB ' ' A' ' 95' ' ' ILE . 71.7 t -129.94 137.81 55.64 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 C-N-CA 126.89 2.076 . . . . 0.0 107.959 177.454 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 60.2 t -132.93 123.46 48.48 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 169.591 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 41.5 mm -108.35 104.13 16.6 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 C-N-CA 124.496 1.119 . . . . 0.0 108.883 -176.963 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 3.6 m -81.78 107.48 14.54 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 169.646 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 75.4 mt -75.71 -18.72 59.51 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 114.945 1.461 . . . . 0.0 114.945 -170.062 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 28.7 p -136.66 30.81 2.83 Favored 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 114.935 1.457 . . . . 0.0 114.935 -168.904 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 152.03 -172.67 31.32 Favored Glycine 0 CA--C 1.532 1.096 0 N-CA-C 115.246 0.858 . . . . 0.0 115.246 177.685 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 97.0 p -79.01 160.64 27.08 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 125.295 1.438 . . . . 0.0 112.681 176.63 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -81.12 49.96 4.09 Favored Glycine 0 CA--C 1.534 1.267 0 C-N-CA 124.861 1.22 . . . . 0.0 114.951 -171.047 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 24.8 t -104.06 -33.17 3.01 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 CA-C-N 117.864 0.832 . . . . 0.0 112.88 -172.455 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 17.9 t-20 -84.84 -21.91 29.66 Favored 'General case' 0 CA--C 1.55 0.945 0 N-CA-C 113.865 1.061 . . . . 0.0 113.865 -179.239 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -82.42 160.49 62.02 Favored Pre-proline 0 CA--C 1.553 1.085 0 C-N-CA 124.0 0.92 . . . . 0.0 112.55 170.999 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_exo -61.47 149.75 88.23 Favored 'Trans proline' 0 CA--C 1.543 0.97 0 C-N-CA 122.79 2.327 . . . . 0.0 112.786 176.428 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -62.56 -29.04 77.87 Favored 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 122.95 2.433 . . . . 0.0 114.008 -170.356 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -60.64 -19.59 58.53 Favored 'General case' 0 CA--C 1.544 0.748 0 O-C-N 120.849 -1.157 . . . . 0.0 113.989 177.425 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 84.1 m95 -82.98 -14.71 53.53 Favored 'General case' 0 CA--C 1.542 0.662 0 O-C-N 120.659 -1.276 . . . . 0.0 113.324 175.667 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 14.5 m -93.49 -13.21 8.59 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.209 0 N-CA-C 113.729 1.011 . . . . 0.0 113.729 169.756 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 59.1 p -88.27 -5.46 58.35 Favored 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 114.48 1.289 . . . . 0.0 114.48 179.382 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 55.1 mm-40 -67.87 149.58 49.66 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-O 121.982 0.896 . . . . 0.0 110.275 169.63 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -53.88 -42.48 68.7 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 115.127 1.528 . . . . 0.0 115.127 -167.516 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.662 ' HB ' HG22 ' A' ' 75' ' ' VAL . 19.8 mm -117.44 63.83 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 C-N-CA 124.982 1.313 . . . . 0.0 109.232 179.21 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 33.0 t80 -76.11 111.86 11.96 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 168.799 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 9.0 mt-10 -108.97 130.92 55.47 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 114.15 1.167 . . . . 0.0 114.15 175.011 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 11.7 p-10 -93.89 109.7 21.4 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 125.016 1.326 . . . . 0.0 109.31 168.791 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 27.5 m0 -101.7 158.33 16.18 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.568 1.147 . . . . 0.0 108.943 169.627 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 8.3 mm-40 -128.41 65.84 1.39 Allowed 'General case' 0 CA--C 1.537 0.477 0 CA-C-O 122.875 1.321 . . . . 0.0 108.265 173.36 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.478 HD11 HG22 ' A' ' 119' ' ' VAL . 14.1 tp -77.11 150.63 35.61 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 126.608 1.963 . . . . 0.0 110.992 -174.344 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 29.4 tp10 -64.32 -43.01 96.01 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 113.681 0.993 . . . . 0.0 113.681 178.572 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 8.4 t0 62.88 126.39 0.02 OUTLIER Pre-proline 0 CA--C 1.558 1.257 0 C-N-CA 127.283 2.233 . . . . 0.0 113.596 -169.659 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_exo -62.61 -12.18 27.03 Favored 'Trans proline' 0 CA--C 1.55 1.301 0 C-N-CA 121.997 1.798 . . . . 0.0 114.499 172.189 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 8.6 t0 -23.99 107.47 0.03 OUTLIER 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 128.31 2.644 . . . . 0.0 116.068 169.629 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 72.16 10.59 74.08 Favored Glycine 0 CA--C 1.537 1.448 0 N-CA-C 116.379 1.312 . . . . 0.0 116.379 169.904 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 13.2 pt20 -128.73 166.5 18.84 Favored 'General case' 0 CA--C 1.545 0.753 0 CA-C-N 119.159 1.48 . . . . 0.0 113.999 -175.904 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 49.6 m -58.14 160.1 5.27 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 126.447 1.899 . . . . 0.0 115.63 -169.24 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 20.3 tp -59.41 -32.6 70.33 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.917 1.287 . . . . 0.0 113.069 178.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -61.76 -32.19 72.43 Favored 'General case' 0 N--CA 1.473 0.716 0 O-C-N 120.808 -1.183 . . . . 0.0 112.091 172.481 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 6.4 t -74.02 -37.62 47.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 CA-C-O 118.461 -0.78 . . . . 0.0 110.891 172.748 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 17.5 m-85 -57.08 -48.08 79.47 Favored 'General case' 0 N--CA 1.478 0.972 0 CA-C-N 120.273 1.397 . . . . 0.0 112.119 169.68 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 48.4 mtt-85 -60.12 -48.64 80.88 Favored 'General case' 0 N--CA 1.484 1.253 0 CA-C-N 119.185 0.902 . . . . 0.0 111.326 178.117 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 83.4 m -62.5 -46.13 89.85 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.884 0.873 . . . . 0.0 111.179 179.739 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 96.6 t -74.45 -41.19 49.58 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 CA-C-O 117.586 -1.197 . . . . 0.0 110.83 -175.307 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . 0.304 24.6 ptt85 -64.04 -28.65 69.94 Favored 'General case' 0 N--CA 1.483 1.225 0 CA-C-N 121.638 2.017 . . . . 0.0 113.12 177.487 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -65.15 -46.68 87.11 Favored Glycine 0 CA--C 1.542 1.772 0 CA-C-N 119.356 0.98 . . . . 0.0 112.938 169.279 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 15.0 mm100 -65.75 -41.32 92.25 Favored 'General case' 0 N--CA 1.475 0.824 0 O-C-N 121.387 -1.067 . . . . 0.0 112.151 177.014 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.478 HG22 HD11 ' A' ' 101' ' ' LEU . 77.7 t -60.82 -43.8 96.25 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 C-N-CA 125.416 1.487 . . . . 0.0 110.714 173.095 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 82.0 tttt -53.98 -49.68 68.24 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 119.205 0.911 . . . . 0.0 110.231 179.039 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -62.43 -41.65 98.88 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 112.742 0.645 . . . . 0.0 112.742 178.5 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 14.8 mtp85 -64.03 -43.6 95.08 Favored 'General case' 0 N--CA 1.479 1.01 0 N-CA-C 113.135 0.791 . . . . 0.0 113.135 176.024 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 94.2 t -70.91 -38.06 70.78 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 C-N-CA 123.181 0.592 . . . . 0.0 110.762 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -60.2 -38.52 83.56 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 118.613 0.642 . . . . 0.0 111.214 169.803 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 7.9 m-80 -62.48 -48.69 78.5 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 119.283 0.947 . . . . 0.0 112.153 174.112 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -52.89 -56.55 15.05 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.576 1.151 . . . . 0.0 110.699 174.076 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 85.4 mt -61.37 -42.15 92.59 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 O-C-N 122.017 -0.427 . . . . 0.0 111.08 -179.196 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -70.13 -13.18 62.08 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 114.755 1.391 . . . . 0.0 114.755 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -99.69 -28.5 13.15 Favored 'General case' 0 N--CA 1.479 0.998 0 N-CA-C 113.723 1.009 . . . . 0.0 113.723 172.24 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 19.1 pt -94.37 -21.43 5.84 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 N-CA-C 114.423 1.268 . . . . 0.0 114.423 177.755 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 66.6 m . . . . . 0 C--O 1.254 1.326 0 C-N-CA 125.074 1.35 . . . . 0.0 111.886 -174.085 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.8 ttt . . . . . 0 N--CA 1.503 2.196 0 N-CA-C 111.787 0.291 . . . . 0.0 111.787 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.67 161.3 30.92 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 126.336 1.855 . . . . 0.0 112.358 177.819 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 32.6 ttmt -114.5 116.49 28.91 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 107.136 -1.431 . . . . 0.0 107.136 167.73 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 16.0 t -106.17 134.6 47.27 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 C-N-CA 124.604 1.162 . . . . 0.0 114.085 -178.251 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 40.6 tpp -103.1 128.1 50.12 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 168.355 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 70.3 m-85 -108.97 131.8 54.71 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.984 0.914 . . . . 0.0 109.381 170.007 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.509 HG11 HD12 ' A' ' 65' ' ' ILE . 2.6 m -148.11 158.8 7.8 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.239 0 C-N-CA 124.179 0.992 . . . . 0.0 113.616 -171.666 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 35.1 t -152.31 156.48 39.72 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 126.941 2.096 . . . . 0.0 110.657 179.315 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 61.3 mtpt -72.62 138.83 47.0 Favored 'General case' 0 N--CA 1.484 1.275 0 C-N-CA 123.911 0.884 . . . . 0.0 110.42 169.848 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 69.9 mtp180 52.73 49.62 19.9 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 125.427 1.491 . . . . 0.0 113.571 -170.812 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -57.61 -26.51 61.64 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 115.134 1.531 . . . . 0.0 115.134 -176.812 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 77.1 p -80.2 -31.11 38.73 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 124.169 0.988 . . . . 0.0 112.857 176.725 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 16.4 m -77.79 -9.04 58.82 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.681 1.192 . . . . 0.0 112.79 173.743 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 74.6 mtt180 -131.5 157.96 42.16 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 125.491 1.516 . . . . 0.0 113.381 -169.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 71.0 m -105.22 129.74 53.53 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.979 0.912 . . . . 0.0 109.701 169.76 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 4.1 mp0 -98.67 -29.7 12.88 Favored 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 113.436 0.902 . . . . 0.0 113.436 -169.653 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' MET . . . . . 0.467 ' HG2' ' SD ' ' A' ' 50' ' ' MET . 0.0 OUTLIER 67.1 -43.63 0.44 Allowed 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 127.104 2.162 . . . . 0.0 115.35 172.904 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -66.16 -32.64 74.2 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 114.073 1.138 . . . . 0.0 114.073 -169.968 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.2 pm0 -62.76 -37.14 85.45 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 119.032 0.833 . . . . 0.0 111.565 172.266 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -62.77 -61.82 6.11 Favored Glycine 0 C--N 1.336 0.548 0 N-CA-C 110.688 -0.965 . . . . 0.0 110.688 177.877 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -59.55 -33.09 70.97 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 117.584 0.692 . . . . 0.0 112.768 -179.449 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -67.56 -25.87 66.02 Favored 'General case' 0 CA--C 1.539 0.554 0 O-C-N 121.289 -0.882 . . . . 0.0 112.612 177.812 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 23.4 mtpp -77.57 -44.09 29.62 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.719 0.808 . . . . 0.0 110.665 169.464 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -67.31 -38.58 85.19 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 123.424 0.69 . . . . 0.0 112.738 -175.875 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 55.6 mt -93.21 -27.65 16.74 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 125.388 1.475 . . . . 0.0 112.774 -178.975 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -111.72 -4.93 26.16 Favored Glycine 0 N--CA 1.471 1.006 0 N-CA-C 117.556 1.782 . . . . 0.0 117.556 -169.058 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -62.84 139.54 58.72 Favored 'General case' 0 CA--C 1.545 0.78 0 CA-C-N 121.42 2.61 . . . . 0.0 112.327 178.992 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 86.41 -22.1 14.59 Favored Glycine 0 CA--C 1.541 1.671 0 C-N-CA 125.114 1.34 . . . . 0.0 113.437 -169.327 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 63.5 mttp -96.67 -44.28 7.18 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 125.981 1.712 . . . . 0.0 111.686 169.813 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 46.0 pt -141.18 157.01 22.17 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 C-N-CA 125.182 1.393 . . . . 0.0 113.009 -174.354 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -101.25 144.91 29.53 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 127.12 2.168 . . . . 0.0 108.796 169.405 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 73.7 t -140.3 137.6 37.11 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 C-N-CA 123.675 0.79 . . . . 0.0 111.578 -171.578 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 54.1 m -145.28 150.68 37.09 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 124.11 0.964 . . . . 0.0 110.852 177.738 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 93.5 p -133.21 137.98 46.35 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 124.52 1.128 . . . . 0.0 109.012 166.684 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 88.2 p -119.35 -70.05 0.81 Allowed 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 114.259 1.207 . . . . 0.0 114.259 -168.337 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 130.07 154.49 8.08 Favored Glycine 0 N--CA 1.465 0.597 0 C-N-CA 125.716 1.626 . . . . 0.0 113.346 173.823 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 10.3 mp -89.36 -13.21 38.35 Favored 'General case' 0 N--CA 1.474 0.754 0 O-C-N 121.797 -0.825 . . . . 0.0 113.173 -178.118 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -140.96 -57.06 0.5 Allowed 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 124.282 1.033 . . . . 0.0 112.444 179.322 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 39.7 m -108.44 155.91 20.05 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 124.714 1.206 . . . . 0.0 111.405 178.094 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 95.9 p -90.86 14.58 13.29 Favored 'General case' 0 N--CA 1.478 0.957 0 N-CA-C 116.694 2.109 . . . . 0.0 116.694 -170.042 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 64.3 ttt180 -130.87 157.12 43.77 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 125.541 1.536 . . . . 0.0 111.871 -177.075 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 24.1 m -111.77 165.27 6.95 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 C-N-CA 126.6 1.96 . . . . 0.0 109.55 170.765 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 5.1 t-80 -50.98 131.65 30.06 Favored Pre-proline 0 CA--C 1.532 0.275 0 CA-C-O 118.19 -0.91 . . . . 0.0 113.231 -170.698 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_exo -57.57 -27.94 78.99 Favored 'Trans proline' 0 CA--C 1.548 1.218 0 CA-C-N 120.612 1.254 . . . . 0.0 112.361 173.878 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 46.1 m -63.93 -32.5 74.05 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 126.08 1.752 . . . . 0.0 112.986 172.192 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -55.12 -45.23 75.55 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 123.977 0.911 . . . . 0.0 110.97 178.753 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.4 mp -53.95 -51.7 43.15 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 C-N-CA 124.09 0.956 . . . . 0.0 109.483 -176.854 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.4 -32.3 73.7 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 113.147 0.795 . . . . 0.0 113.147 -179.587 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -80.1 -30.15 39.11 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 113.452 0.908 . . . . 0.0 113.452 178.545 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' MET . . . . . 0.467 ' SD ' ' HG2' ' A' ' 17' ' ' MET . 3.2 mmt -76.91 -30.77 56.29 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.42 0.688 . . . . 0.0 110.851 170.712 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -68.58 -13.25 62.21 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 124.41 1.084 . . . . 0.0 113.323 172.508 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -63.94 -29.71 70.85 Favored 'General case' 0 N--CA 1.481 1.124 0 CA-C-N 120.706 1.594 . . . . 0.0 110.695 168.705 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 61.5 t -91.62 -7.68 10.56 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.903 0 C-N-CA 126.896 2.078 . . . . 0.0 111.058 173.882 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 83.54 21.75 57.58 Favored Glycine 0 CA--C 1.539 1.56 0 C-N-CA 125.434 1.492 . . . . 0.0 114.447 -177.71 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 31.9 mt -88.82 135.73 25.08 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 C-N-CA 124.595 1.158 . . . . 0.0 111.505 -172.188 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 18.6 t0 -94.39 120.19 34.26 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 123.582 0.753 . . . . 0.0 112.332 171.492 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 9.2 pt -134.67 -1.94 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.358 0 N-CA-C 116.094 1.887 . . . . 0.0 116.094 179.257 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 83.5 p -73.28 -21.9 60.49 Favored 'General case' 0 N--CA 1.481 1.092 0 N-CA-C 115.175 1.546 . . . . 0.0 115.175 -169.638 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -78.44 0.86 73.87 Favored Glycine 0 CA--C 1.54 1.604 0 N-CA-C 116.39 1.316 . . . . 0.0 116.39 -173.81 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 33.4 mt-30 -78.65 -11.98 60.0 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 115.304 1.594 . . . . 0.0 115.304 -171.345 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 42.8 p -63.94 115.42 4.86 Favored 'General case' 0 N--CA 1.477 0.883 0 CA-C-N 119.537 1.062 . . . . 0.0 113.56 -169.933 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 89.2 p -152.35 -77.86 0.12 Allowed 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.765 1.226 . . . . 0.0 112.708 177.762 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -146.43 159.26 45.43 Favored Pre-proline 0 CA--C 1.554 1.112 0 C-N-CA 124.41 1.084 . . . . 0.0 113.522 -171.837 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_endo -61.71 161.04 26.24 Favored 'Trans proline' 0 C--N 1.352 0.742 0 C-N-CA 124.174 3.249 . . . . 0.0 114.133 169.745 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.509 HD12 HG11 ' A' ' 7' ' ' VAL . 11.6 tt -51.32 -35.68 16.28 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.128 0 C-N-CA 125.824 1.65 . . . . 0.0 112.444 172.484 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 17.5 mt-10 -64.42 -17.77 64.1 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 123.779 0.832 . . . . 0.0 112.961 -177.718 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -84.69 -10.67 57.07 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 124.792 1.237 . . . . 0.0 113.604 -175.898 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 76.6 m-85 -111.5 -168.32 1.29 Allowed 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 125.979 1.711 . . . . 0.0 112.348 -173.97 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 6.4 t30 -124.39 123.47 40.25 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 126.064 1.745 . . . . 0.0 109.864 178.673 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.81 -33.61 75.98 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 114.187 1.18 . . . . 0.0 114.187 -170.601 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . 0.269 0.0 OUTLIER -71.41 -4.62 27.4 Favored 'General case' 0 CA--C 1.544 0.721 0 N-CA-C 114.212 1.19 . . . . 0.0 114.212 -178.11 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -73.94 -12.33 60.62 Favored 'General case' 0 CA--C 1.549 0.904 0 C-N-CA 123.965 0.906 . . . . 0.0 111.348 168.752 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 58.3 m-85 -117.22 138.88 51.42 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 127.001 2.12 . . . . 0.0 111.268 179.128 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -90.5 -23.23 21.0 Favored 'General case' 0 N--CA 1.478 0.956 0 CA-C-O 122.207 1.003 . . . . 0.0 112.926 178.349 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.629 HG22 ' HB ' ' A' ' 95' ' ' ILE . 96.5 t -132.28 136.11 56.93 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 C-N-CA 126.988 2.115 . . . . 0.0 108.249 -174.12 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 91.0 t -131.8 125.76 56.04 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 170.104 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 45.1 mm -112.39 105.15 18.23 Favored 'Isoleucine or valine' 0 C--O 1.233 0.237 0 C-N-CA 124.257 1.023 . . . . 0.0 109.354 -176.239 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 24.4 m -86.66 98.79 11.31 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 123.667 0.787 . . . . 0.0 109.117 171.807 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 52.7 mt -69.69 178.62 2.49 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 125.499 1.52 . . . . 0.0 110.966 170.474 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 16.2 m 63.1 19.7 11.82 Favored 'General case' 0 CA--C 1.547 0.841 0 N-CA-C 114.784 1.401 . . . . 0.0 114.784 169.78 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 131.79 -120.43 2.81 Favored Glycine 0 CA--C 1.531 1.048 0 C-N-CA 124.512 1.053 . . . . 0.0 111.971 -172.152 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 9.2 t -135.96 157.99 45.48 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 124.908 1.283 . . . . 0.0 112.82 178.848 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -74.66 113.93 4.22 Favored Glycine 0 CA--C 1.531 1.087 0 C-N-CA 124.414 1.006 . . . . 0.0 112.261 -179.326 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 11.3 p -139.53 -39.06 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.26 0 N-CA-C 114.594 1.331 . . . . 0.0 114.594 -178.147 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 65.0 t30 -92.43 -15.63 26.92 Favored 'General case' 0 CA--C 1.549 0.911 0 N-CA-C 114.12 1.155 . . . . 0.0 114.12 -177.228 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -71.44 157.13 90.58 Favored Pre-proline 0 CA--C 1.552 1.024 0 O-C-N 121.309 -0.869 . . . . 0.0 111.843 169.856 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.41 ' HA ' ' HD3' ' A' ' 88' ' ' PRO . 43.3 Cg_exo -62.2 149.03 92.1 Favored 'Trans proline' 0 CA--C 1.545 1.047 0 C-N-CA 122.215 1.944 . . . . 0.0 113.352 -177.52 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 87' ' ' PRO . 88.8 Cg_exo -57.33 -33.63 96.5 Favored 'Trans proline' 0 C--N 1.351 0.707 0 C-N-CA 122.935 2.423 . . . . 0.0 115.144 -169.875 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -60.98 -21.4 63.5 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 114.284 1.216 . . . . 0.0 114.284 179.763 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 87.5 m95 -81.51 -22.2 38.1 Favored 'General case' 0 CA--C 1.535 0.388 0 O-C-N 120.637 -1.289 . . . . 0.0 112.663 176.302 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 10.6 m -89.77 -3.16 10.06 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 N-CA-C 113.463 0.912 . . . . 0.0 113.463 172.568 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 59.3 p -103.24 3.8 35.96 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 125.373 1.469 . . . . 0.0 114.888 176.251 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 80.6 mm-40 -66.86 156.66 35.07 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 119.351 0.978 . . . . 0.0 111.973 171.668 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -58.19 -42.01 85.2 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 114.278 1.214 . . . . 0.0 114.278 -167.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.629 ' HB ' HG22 ' A' ' 75' ' ' VAL . 20.1 mm -115.0 59.52 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 C-N-CA 124.822 1.249 . . . . 0.0 108.708 175.866 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 21.7 t80 -75.6 109.7 9.39 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 169.069 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 13.1 mt-10 -109.18 140.61 42.56 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 114.665 1.357 . . . . 0.0 114.665 174.252 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -98.23 121.05 39.67 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.985 1.314 . . . . 0.0 109.706 169.249 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 24.4 m0 -112.79 105.59 13.75 Favored 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 124.917 1.287 . . . . 0.0 109.063 -177.349 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -85.11 37.21 0.66 Allowed 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 124.933 1.293 . . . . 0.0 112.02 -171.882 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 73.9 mt -76.17 158.68 31.44 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 126.114 1.766 . . . . 0.0 111.934 178.561 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -81.41 152.08 27.6 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-O 121.559 0.695 . . . . 0.0 112.564 170.639 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 12.5 p-10 -88.02 136.87 31.73 Favored Pre-proline 0 CA--C 1.546 0.808 0 C-N-CA 125.0 1.32 . . . . 0.0 110.987 170.853 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -82.42 -9.22 11.43 Favored 'Trans proline' 0 CA--C 1.55 1.301 0 C-N-CA 121.57 1.513 . . . . 0.0 114.461 -174.785 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -65.29 146.14 55.32 Favored 'General case' 0 CA--C 1.547 0.837 0 CA-C-N 119.438 1.017 . . . . 0.0 112.47 175.675 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 77.78 5.58 86.54 Favored Glycine 0 CA--C 1.538 1.501 0 C-N-CA 123.829 0.728 . . . . 0.0 114.751 179.449 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -141.9 173.62 11.34 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 126.208 1.803 . . . . 0.0 112.015 178.808 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 24.4 p -65.78 164.97 13.62 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 116.161 1.911 . . . . 0.0 116.161 -169.274 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 43.7 tp -60.91 -27.91 68.53 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.171 0.988 . . . . 0.0 112.25 171.533 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -66.62 -32.14 73.28 Favored 'General case' 0 CA--C 1.54 0.575 0 O-C-N 120.681 -1.262 . . . . 0.0 111.508 172.597 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 4.4 t -72.49 -36.92 55.72 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 O-C-N 121.108 -0.995 . . . . 0.0 111.841 170.656 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -55.1 -47.57 74.79 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 119.724 1.147 . . . . 0.0 111.471 169.501 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -69.66 -32.59 71.32 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.658 0.783 . . . . 0.0 112.498 178.573 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 42.9 m -62.94 -43.89 97.55 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 123.883 0.873 . . . . 0.0 110.627 169.808 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 68.8 t -65.7 -41.01 89.53 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 CA-C-O 117.576 -1.202 . . . . 0.0 110.576 175.727 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 24.9 mtm105 -53.98 -49.48 68.71 Favored 'General case' 0 N--CA 1.484 1.24 0 CA-C-N 120.607 1.548 . . . . 0.0 111.592 169.989 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -59.22 -49.65 76.19 Favored Glycine 0 CA--C 1.538 1.505 0 CA-C-N 119.438 1.017 . . . . 0.0 113.641 179.326 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 56.7 mm-40 -63.58 -44.08 95.12 Favored 'General case' 0 N--CA 1.473 0.708 0 O-C-N 121.996 -0.708 . . . . 0.0 111.988 178.178 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 53.4 t -64.81 -39.71 86.58 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 C-N-CA 124.048 0.939 . . . . 0.0 111.186 176.791 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 12.3 tmtt? -56.07 -48.83 75.33 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 119.654 1.115 . . . . 0.0 110.312 179.041 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -65.15 -42.62 93.6 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 112.929 0.714 . . . . 0.0 112.929 176.792 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 15.5 mmm180 -62.03 -43.87 97.91 Favored 'General case' 0 N--CA 1.48 1.055 0 O-C-N 121.467 -0.771 . . . . 0.0 112.737 176.536 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 85.6 t -70.38 -37.75 71.75 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 123.776 0.83 . . . . 0.0 111.273 179.082 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 70.6 mt-10 -60.23 -41.91 94.12 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 119.537 1.062 . . . . 0.0 111.6 170.93 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 15.2 m-80 -63.33 -45.36 91.62 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 118.347 0.521 . . . . 0.0 112.151 175.432 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 8.6 tt -53.19 -55.9 20.63 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 124.604 1.162 . . . . 0.0 110.892 173.642 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 84.2 mt -63.27 -43.0 98.47 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 O-C-N 121.593 -0.692 . . . . 0.0 110.376 -177.882 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -68.07 -14.02 62.65 Favored 'General case' 0 CA--C 1.546 0.789 0 N-CA-C 114.822 1.415 . . . . 0.0 114.822 178.807 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 20.0 ptmt -102.04 -32.76 10.0 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 113.573 0.953 . . . . 0.0 113.573 174.928 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 13.5 pt -89.54 -17.3 8.18 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 N-CA-C 114.185 1.18 . . . . 0.0 114.185 -179.529 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 68.8 m . . . . . 0 C--O 1.255 1.365 0 N-CA-C 112.888 0.699 . . . . 0.0 112.888 -179.92 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.8 ttt . . . . . 0 N--CA 1.504 2.259 0 N-CA-C 111.493 0.183 . . . . 0.0 111.493 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 3.0 mptp? -121.91 160.31 25.05 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 125.683 1.593 . . . . 0.0 112.3 175.139 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 33.9 ttmt -111.03 116.92 32.0 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 106.647 -1.612 . . . . 0.0 106.647 167.146 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 16.8 t -104.41 132.05 51.91 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 C-N-CA 124.752 1.221 . . . . 0.0 113.831 -177.719 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' MET . . . . . 0.406 ' HG3' HG13 ' A' ' 7' ' ' VAL . 48.5 tpp -100.43 123.4 44.6 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 123.882 0.873 . . . . 0.0 109.137 169.177 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 48.6 m-85 -108.18 121.07 44.09 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 124.574 1.15 . . . . 0.0 109.241 172.178 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.406 HG13 ' HG3' ' A' ' 5' ' ' MET . 5.1 m -144.14 165.64 13.51 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 C-N-CA 125.009 1.323 . . . . 0.0 112.369 -169.308 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -154.39 148.7 26.04 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 125.999 1.72 . . . . 0.0 110.301 175.165 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 39.5 ttpt -46.3 122.31 3.93 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 125.272 1.429 . . . . 0.0 111.968 175.866 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . 0.261 91.6 mtt180 52.67 -30.86 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 129.034 2.934 . . . . 0.0 118.896 -174.444 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 5.1 t30 61.81 -19.65 0.04 OUTLIER 'General case' 0 CA--C 1.558 1.261 0 N-CA-C 117.813 2.523 . . . . 0.0 117.813 169.789 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 75.7 m -50.41 121.27 5.44 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 126.525 1.93 . . . . 0.0 113.157 -177.3 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 66.5 m 51.41 41.07 27.95 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 125.006 1.323 . . . . 0.0 113.096 174.619 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 14.9 ttt180 -126.83 153.18 45.98 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 125.911 1.684 . . . . 0.0 110.023 177.171 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 33.1 m -102.94 126.87 50.28 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 124.062 0.945 . . . . 0.0 110.836 -179.455 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 3.9 mp0 -106.09 -36.16 7.01 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.793 0.837 . . . . 0.0 112.606 -172.523 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 68.78 -48.59 0.57 Allowed 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 126.823 2.049 . . . . 0.0 115.867 169.348 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -59.01 -36.23 74.58 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.59 1.156 . . . . 0.0 113.58 -171.13 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 6.3 pm0 -61.97 -41.63 98.23 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 124.739 1.216 . . . . 0.0 112.499 175.593 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -69.03 -40.23 83.94 Favored Glycine 0 C--N 1.335 0.483 0 N-CA-C 111.54 -0.624 . . . . 0.0 111.54 178.331 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -70.01 -40.41 75.27 Favored 'General case' 0 N--CA 1.468 0.434 0 O-C-N 121.947 -0.737 . . . . 0.0 111.493 177.489 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -60.19 -43.7 95.69 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 119.255 0.934 . . . . 0.0 112.941 -174.931 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 8.0 pttp -77.19 -26.61 53.05 Favored 'General case' 0 N--CA 1.481 1.115 0 N-CA-C 113.586 0.958 . . . . 0.0 113.586 174.253 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 94.2 m -72.47 -32.85 66.58 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.06 0.544 . . . . 0.0 111.754 174.877 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 72.3 mt -91.33 -34.36 14.94 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 125.847 1.659 . . . . 0.0 114.598 -179.221 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -135.41 28.04 3.05 Favored Glycine 0 N--CA 1.474 1.175 0 N-CA-C 118.789 2.275 . . . . 0.0 118.789 -168.711 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -65.05 -22.73 67.02 Favored 'General case' 0 CA--C 1.546 0.8 0 CA-C-N 122.108 2.954 . . . . 0.0 115.701 -176.315 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -72.62 -10.92 76.81 Favored Glycine 0 CA--C 1.542 1.77 0 O-C-N 121.209 -0.932 . . . . 0.0 113.868 169.639 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 54.8 mttm -109.56 -39.54 5.13 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 127.251 2.22 . . . . 0.0 112.98 -179.472 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 41.2 pt -145.49 155.43 13.32 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 C-N-CA 124.555 1.142 . . . . 0.0 113.942 -171.174 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -99.43 142.49 30.85 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 126.065 1.746 . . . . 0.0 108.916 169.295 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 97.6 t -130.4 140.11 49.66 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 O-C-N 121.439 -0.788 . . . . 0.0 111.704 -176.859 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 13.9 m -139.38 153.72 47.71 Favored 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 124.981 1.312 . . . . 0.0 109.698 175.931 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 91.4 p -128.59 155.58 44.71 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 123.803 0.841 . . . . 0.0 109.742 167.751 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 60.5 p -140.33 161.68 37.11 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 114.824 -1.08 . . . . 0.0 112.149 173.702 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -119.79 101.78 0.86 Allowed Glycine 0 C--N 1.339 0.696 0 N-CA-C 110.343 -1.103 . . . . 0.0 110.343 -169.731 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 10.6 mp -59.63 125.58 24.2 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.734 0.814 . . . . 0.0 109.512 -169.89 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 68.15 42.05 1.84 Allowed 'General case' 0 CA--C 1.553 1.074 0 C-N-CA 124.716 1.206 . . . . 0.0 113.02 -173.251 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 69.6 m 61.85 54.63 2.82 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 127.724 2.409 . . . . 0.0 113.776 169.95 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 79.2 p -114.39 164.77 13.5 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 115.587 1.699 . . . . 0.0 115.587 -171.967 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 22.2 tpt180 -113.38 144.85 42.08 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 126.363 1.865 . . . . 0.0 110.453 177.014 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 16.7 m -68.51 171.56 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.206 0 CA-C-O 122.002 0.906 . . . . 0.0 110.282 169.089 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 1.7 t-80 -59.37 131.02 87.73 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-O 118.431 -0.795 . . . . 0.0 112.659 179.617 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo -60.43 -27.69 85.33 Favored 'Trans proline' 0 CA--C 1.547 1.171 0 C-N-CA 121.35 1.367 . . . . 0.0 111.569 169.607 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 90.0 m -65.83 -30.83 71.51 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 125.278 1.431 . . . . 0.0 112.321 174.341 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -57.52 -39.42 76.5 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.365 1.066 . . . . 0.0 111.532 -175.163 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 2.3 mp -57.12 -60.38 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 C-N-CA 123.665 0.786 . . . . 0.0 109.311 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.19 -31.11 72.18 Favored 'General case' 0 CA--C 1.546 0.808 0 N-CA-C 113.616 0.969 . . . . 0.0 113.616 -177.04 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -81.55 -8.05 59.67 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 114.305 1.224 . . . . 0.0 114.305 177.373 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 41.3 mtt -109.88 -24.02 11.06 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 125.057 1.343 . . . . 0.0 110.211 173.606 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 24.3 mt-10 -64.98 -16.01 62.9 Favored 'General case' 0 CA--C 1.546 0.818 0 O-C-N 120.609 -1.307 . . . . 0.0 111.749 168.694 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 12.3 mt-10 -61.16 -29.33 69.73 Favored 'General case' 0 N--CA 1.482 1.173 0 CA-C-N 119.877 1.217 . . . . 0.0 110.92 169.108 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 48.1 t -92.27 -4.99 10.8 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.981 0 C-N-CA 127.437 2.295 . . . . 0.0 111.118 177.032 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 80.91 17.39 72.63 Favored Glycine 0 CA--C 1.538 1.494 0 C-N-CA 125.223 1.392 . . . . 0.0 114.566 -173.873 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 78.9 mt -77.64 139.92 17.87 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 C-N-CA 124.309 1.044 . . . . 0.0 111.893 -173.275 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -104.98 104.97 14.81 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.58 1.152 . . . . 0.0 111.761 175.598 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 3.5 pt -131.7 0.84 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 N-CA-C 115.696 1.739 . . . . 0.0 115.696 -178.283 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 93.6 p -70.74 -30.98 67.65 Favored 'General case' 0 N--CA 1.48 1.051 0 CA-C-N 120.012 1.278 . . . . 0.0 113.635 -177.541 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -79.74 13.16 25.26 Favored Glycine 0 CA--C 1.539 1.567 0 C-N-CA 125.743 1.64 . . . . 0.0 115.75 -179.201 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 32.0 mt-30 -80.9 167.98 19.26 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 118.886 1.343 . . . . 0.0 111.868 178.859 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 3.6 t -71.77 171.64 11.25 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 114.963 1.468 . . . . 0.0 114.963 -178.33 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 48.8 m -125.21 6.07 7.81 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 128.436 2.694 . . . . 0.0 111.66 169.475 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 23.7 m-20 -88.17 155.34 52.08 Favored Pre-proline 0 CA--C 1.546 0.818 0 C-N-CA 124.729 1.212 . . . . 0.0 113.746 179.22 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -78.43 158.78 29.23 Favored 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 123.49 2.793 . . . . 0.0 114.406 -177.685 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 8.5 tt -53.12 -38.98 31.62 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 C-N-CA 124.308 1.043 . . . . 0.0 112.486 174.781 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -70.16 -6.77 36.55 Favored 'General case' 0 CA--C 1.545 0.778 0 N-CA-C 114.116 1.154 . . . . 0.0 114.116 179.11 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -76.42 -15.13 60.0 Favored 'General case' 0 CA--C 1.547 0.83 0 O-C-N 121.429 -0.794 . . . . 0.0 112.569 170.691 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 61.5 m-85 -109.04 -171.61 1.88 Allowed 'General case' 0 CA--C 1.552 1.041 0 C-N-CA 126.921 2.088 . . . . 0.0 111.57 -179.175 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -125.79 126.57 44.76 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 125.337 1.455 . . . . 0.0 110.232 177.397 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.65 -35.88 82.06 Favored 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 113.641 0.978 . . . . 0.0 113.641 -170.1 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . 0.258 0.0 OUTLIER -72.67 -4.88 33.83 Favored 'General case' 0 CA--C 1.547 0.853 0 N-CA-C 113.718 1.007 . . . . 0.0 113.718 -177.559 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -74.47 -12.21 60.43 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 123.982 0.913 . . . . 0.0 111.142 168.588 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 65.7 m-85 -115.28 146.55 41.38 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 127.483 2.313 . . . . 0.0 110.989 178.345 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -105.25 -16.16 14.85 Favored 'General case' 0 N--CA 1.479 1.022 0 CA-C-O 121.97 0.891 . . . . 0.0 112.641 178.148 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.65 HG22 ' HB ' ' A' ' 95' ' ' ILE . 80.3 t -133.17 136.69 54.79 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 C-N-CA 127.306 2.242 . . . . 0.0 107.671 -179.881 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 60.0 t -132.35 126.9 56.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 N-CA-C 107.999 -1.111 . . . . 0.0 107.999 169.81 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 43.5 mm -114.31 118.37 58.3 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 C-N-CA 124.635 1.174 . . . . 0.0 108.815 -175.669 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 8.6 t -100.47 116.61 32.81 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 122.934 0.493 . . . . 0.0 111.462 173.672 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 49.9 mt -94.52 -13.38 26.13 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 125.724 1.61 . . . . 0.0 113.71 -172.291 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 1.5 p -156.63 147.45 21.82 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 124.075 0.95 . . . . 0.0 111.412 176.041 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 80.19 179.99 52.94 Favored Glycine 0 CA--C 1.539 1.567 0 C-N-CA 124.53 1.062 . . . . 0.0 114.528 -178.224 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 67.2 m -92.04 3.65 54.79 Favored 'General case' 0 N--CA 1.479 0.993 0 N-CA-C 114.719 1.377 . . . . 0.0 114.719 -170.01 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 79.67 23.59 62.02 Favored Glycine 0 CA--C 1.537 1.414 0 N-CA-C 115.164 0.826 . . . . 0.0 115.164 178.673 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 14.3 t -106.46 -12.0 10.09 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.374 0 C-N-CA 124.323 1.049 . . . . 0.0 112.855 -179.318 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 12.9 t-20 -81.35 6.62 13.79 Favored 'General case' 0 CA--C 1.552 1.023 0 C-N-CA 125.202 1.401 . . . . 0.0 113.397 -179.823 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -127.97 161.07 58.08 Favored Pre-proline 0 CA--C 1.552 1.032 0 C-N-CA 126.912 2.085 . . . . 0.0 112.058 178.165 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.404 ' HA ' ' HD3' ' A' ' 88' ' ' PRO . 38.4 Cg_exo -63.36 148.06 93.08 Favored 'Trans proline' 0 CA--C 1.546 1.11 0 C-N-CA 122.355 2.036 . . . . 0.0 112.773 177.344 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 87' ' ' PRO . 87.1 Cg_exo -56.83 -30.61 85.84 Favored 'Trans proline' 0 C--N 1.352 0.733 0 C-N-CA 123.051 2.5 . . . . 0.0 115.286 -174.99 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -59.77 -20.44 56.65 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 114.237 1.199 . . . . 0.0 114.237 178.458 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 89.1 m95 -81.88 -17.04 48.69 Favored 'General case' 0 CA--C 1.539 0.522 0 O-C-N 120.594 -1.316 . . . . 0.0 113.364 175.847 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 5.4 m -92.83 -8.38 10.16 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.105 0 CA-C-N 119.404 1.002 . . . . 0.0 113.398 170.863 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 72.5 p -98.24 -0.46 44.01 Favored 'General case' 0 N--CA 1.479 0.995 0 N-CA-C 114.873 1.434 . . . . 0.0 114.873 179.216 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 73.9 mm-40 -66.01 152.71 44.01 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 119.442 1.019 . . . . 0.0 111.202 169.917 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -55.38 -43.15 74.88 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 114.634 1.346 . . . . 0.0 114.634 -167.661 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.65 ' HB ' HG22 ' A' ' 75' ' ' VAL . 19.9 mm -114.49 61.15 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 C-N-CA 124.84 1.256 . . . . 0.0 109.003 176.832 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 41.7 t80 -77.23 108.16 10.14 Favored 'General case' 0 CA--C 1.535 0.393 0 O-C-N 120.639 -1.288 . . . . 0.0 108.22 169.119 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 9.4 mt-10 -108.23 136.86 47.18 Favored 'General case' 0 CA--C 1.545 0.758 0 N-CA-C 114.947 1.462 . . . . 0.0 114.947 177.071 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -91.54 114.1 26.54 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.916 1.287 . . . . 0.0 110.202 169.786 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 23.1 m0 -111.88 81.97 1.55 Allowed 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 125.047 1.339 . . . . 0.0 109.538 179.579 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 7.5 pt20 -75.88 55.77 0.91 Allowed 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 125.576 1.55 . . . . 0.0 112.279 176.709 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 73.4 mt -86.99 167.19 14.47 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 127.493 2.317 . . . . 0.0 112.481 -178.953 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -68.68 149.65 48.84 Favored 'General case' 0 CA--C 1.546 0.812 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.99 169.255 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' ASP . . . . . 0.454 ' HA ' ' HD3' ' A' ' 104' ' ' PRO . 0.8 OUTLIER -117.75 142.76 31.2 Favored Pre-proline 0 CA--C 1.553 1.085 0 C-N-CA 125.073 1.349 . . . . 0.0 112.148 175.544 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 104' ' ' PRO . . . . . 0.454 ' HD3' ' HA ' ' A' ' 103' ' ' ASP . 34.8 Cg_exo -75.26 -15.96 19.9 Favored 'Trans proline' 0 CA--C 1.547 1.126 0 N-CA-C 116.929 1.857 . . . . 0.0 116.929 -172.104 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -67.2 141.79 57.2 Favored 'General case' 0 N--CA 1.476 0.837 0 CA-C-N 120.313 1.415 . . . . 0.0 113.334 -170.296 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 77.33 8.59 87.04 Favored Glycine 0 CA--C 1.538 1.527 0 C-N-CA 124.635 1.112 . . . . 0.0 114.901 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 -141.58 164.64 29.68 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 125.033 1.333 . . . . 0.0 113.553 -178.127 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 66.4 m -63.49 164.07 9.96 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 116.161 1.911 . . . . 0.0 116.161 -169.129 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 25.8 tp -57.12 -31.38 65.26 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 125.686 1.594 . . . . 0.0 113.274 176.202 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -62.04 -30.52 71.03 Favored 'General case' 0 CA--C 1.541 0.628 0 O-C-N 121.002 -1.061 . . . . 0.0 111.988 172.662 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 4.2 t -75.89 -38.86 37.08 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 O-C-N 121.122 -0.986 . . . . 0.0 111.388 173.159 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 20.0 m-85 -56.85 -45.31 82.51 Favored 'General case' 0 N--CA 1.481 1.082 0 CA-C-N 120.169 1.349 . . . . 0.0 111.609 169.521 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -67.79 -37.29 81.82 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 124.179 0.991 . . . . 0.0 112.135 178.566 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 70.6 m -67.91 -42.62 80.83 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 123.793 0.837 . . . . 0.0 111.567 174.042 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 53.3 t -66.19 -41.41 89.23 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 CA-C-O 118.387 -0.816 . . . . 0.0 110.142 177.252 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 15.7 mtp180 -52.78 -46.89 67.78 Favored 'General case' 0 N--CA 1.479 1.022 0 CA-C-N 119.755 1.161 . . . . 0.0 112.507 170.95 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -59.69 -50.56 66.39 Favored Glycine 0 CA--C 1.54 1.6 0 CA-C-N 119.375 0.988 . . . . 0.0 113.427 176.352 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 60.3 mm-40 -65.89 -44.39 85.43 Favored 'General case' 0 N--CA 1.472 0.672 0 O-C-N 121.775 -0.838 . . . . 0.0 112.304 -179.682 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 65.6 t -64.25 -41.43 92.36 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 C-N-CA 124.782 1.233 . . . . 0.0 110.685 176.21 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 80.0 tttt -54.98 -50.06 69.89 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 120.18 1.355 . . . . 0.0 111.068 178.133 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -61.72 -40.67 95.87 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 112.205 0.446 . . . . 0.0 112.205 176.902 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.89 -35.91 81.96 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 124.354 1.062 . . . . 0.0 113.722 177.133 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 95.2 t -76.24 -40.92 36.64 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 C-N-CA 125.421 1.489 . . . . 0.0 111.284 176.228 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -61.47 -39.6 91.46 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 119.039 0.836 . . . . 0.0 111.39 172.373 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 13.6 m-80 -64.42 -43.57 93.95 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 118.69 0.677 . . . . 0.0 112.611 174.3 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -54.52 -56.58 17.39 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 124.256 1.023 . . . . 0.0 110.442 173.132 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 85.0 mt -61.04 -42.45 93.14 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 CA-C-O 119.166 -0.445 . . . . 0.0 110.532 -178.576 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -73.67 -10.77 60.04 Favored 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 115.073 1.508 . . . . 0.0 115.073 -179.449 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 20.7 ptmt -98.66 -27.16 14.11 Favored 'General case' 0 N--CA 1.479 0.997 0 CA-C-N 119.501 1.046 . . . . 0.0 113.388 169.97 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 14.3 pt -95.45 -7.6 9.75 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 N-CA-C 114.599 1.333 . . . . 0.0 114.599 176.915 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 27.3 p . . . . . 0 C--O 1.255 1.391 0 N-CA-C 114.774 1.398 . . . . 0.0 114.774 176.06 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.5 ttt . . . . . 0 N--CA 1.501 2.114 0 N-CA-C 111.725 0.269 . . . . 0.0 111.725 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.5 165.08 28.39 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 125.135 1.374 . . . . 0.0 112.684 175.573 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 67.9 mttt -95.75 145.02 25.64 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.996 0.918 . . . . 0.0 112.333 177.184 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 15.0 t -124.46 134.28 67.13 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 C-N-CA 125.301 1.44 . . . . 0.0 111.884 177.285 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 14.4 tpp -101.02 123.78 45.73 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.087 0.555 . . . . 0.0 109.894 169.894 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 48.4 m-85 -110.8 99.02 8.02 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 124.533 1.133 . . . . 0.0 110.509 175.934 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.603 HG11 HD12 ' A' ' 65' ' ' ILE . 1.4 m -111.7 165.21 6.94 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 C-N-CA 125.035 1.334 . . . . 0.0 112.042 -173.893 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 7.8 t -142.44 140.29 31.9 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 125.279 1.432 . . . . 0.0 111.041 179.444 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 37.5 ttmt -66.13 118.56 10.04 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.42 0.688 . . . . 0.0 110.499 175.231 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 28.6 mmt85 45.51 91.48 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 127.441 2.296 . . . . 0.0 113.14 -175.575 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 15.9 m120 -61.36 -17.46 54.04 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 115.839 1.792 . . . . 0.0 115.839 -171.692 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 70.8 m -50.48 138.65 17.04 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.489 1.116 . . . . 0.0 112.212 178.049 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 24.6 p 55.03 -10.62 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.246 0 N-CA-C 118.12 2.637 . . . . 0.0 118.12 -173.707 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 52.3 mtm-85 -93.6 157.22 16.29 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 125.985 1.714 . . . . 0.0 113.789 -174.678 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 5.5 m -113.94 -22.18 10.23 Favored 'General case' 0 N--CA 1.477 0.924 0 N-CA-C 116.457 2.021 . . . . 0.0 116.457 -169.463 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 26.0 mt-30 62.12 -64.0 0.09 Allowed 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 127.078 2.151 . . . . 0.0 116.674 -178.174 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' MET . . . . . 0.434 ' HG2' ' SD ' ' A' ' 50' ' ' MET . 0.0 OUTLIER 74.13 -49.24 0.67 Allowed 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 127.209 2.203 . . . . 0.0 114.344 177.026 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.68 -34.57 74.54 Favored 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 114.602 1.334 . . . . 0.0 114.602 -170.337 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 20.3 pm0 -63.47 -38.18 90.16 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 124.783 1.233 . . . . 0.0 112.138 178.9 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -72.22 -37.67 59.37 Favored Glycine 0 C--N 1.337 0.593 0 C-N-CA 123.681 0.657 . . . . 0.0 111.794 178.834 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -73.36 -37.98 65.87 Favored 'General case' 0 N--CA 1.469 0.49 0 O-C-N 121.685 -0.891 . . . . 0.0 111.772 176.819 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -62.74 -35.86 81.15 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 113.403 0.89 . . . . 0.0 113.403 -173.866 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 6.2 pttp -79.48 -36.36 38.82 Favored 'General case' 0 N--CA 1.479 1.023 0 N-CA-C 113.269 0.84 . . . . 0.0 113.269 170.135 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 39.0 m -69.46 -31.06 69.13 Favored 'General case' 0 N--CA 1.484 1.253 0 O-C-N 121.8 -0.563 . . . . 0.0 111.977 -178.57 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 83.8 mt -91.74 -36.35 13.62 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 125.868 1.667 . . . . 0.0 112.889 174.529 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -104.11 3.03 44.11 Favored Glycine 0 N--CA 1.473 1.13 0 N-CA-C 117.574 1.789 . . . . 0.0 117.574 -169.529 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.49 140.76 58.03 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 121.356 2.578 . . . . 0.0 112.413 178.917 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 81.31 -11.48 43.89 Favored Glycine 0 CA--C 1.541 1.671 0 C-N-CA 124.783 1.182 . . . . 0.0 114.081 -169.673 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 63.5 mttp -110.01 -44.61 3.75 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 126.089 1.756 . . . . 0.0 111.69 172.771 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 44.5 pt -138.99 159.95 29.67 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 125.903 1.681 . . . . 0.0 112.408 179.497 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -106.52 148.21 28.49 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.092 1.357 . . . . 0.0 110.378 169.911 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 57.2 t -133.44 139.54 48.81 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 CA-C-N 119.002 0.819 . . . . 0.0 112.483 -177.965 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 85.9 m -133.14 150.85 52.01 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 125.696 1.598 . . . . 0.0 108.168 169.592 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 10.1 p -90.49 -73.97 0.51 Allowed 'General case' 0 N--CA 1.47 0.534 0 O-C-N 121.589 -0.695 . . . . 0.0 112.759 174.694 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 9.6 p 66.06 156.57 0.1 Allowed 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 127.925 2.49 . . . . 0.0 113.602 -169.645 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -106.61 156.33 16.2 Favored Glycine 0 N--CA 1.465 0.586 0 O-C-N 121.432 -0.793 . . . . 0.0 112.18 -175.052 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 9.7 mp -99.52 108.97 21.54 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 169.234 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 69.14 64.71 0.28 Allowed 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 126.44 1.896 . . . . 0.0 113.173 -176.661 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 67.5 m 48.51 48.39 19.47 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 126.968 2.107 . . . . 0.0 115.058 169.575 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 58.1 m -129.59 156.63 43.89 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 124.455 1.102 . . . . 0.0 113.172 -172.584 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 59.5 ttt-85 -115.78 153.55 31.23 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 128.232 2.613 . . . . 0.0 109.139 178.619 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 16.2 m -62.98 157.99 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.132 0 O-C-N 122.04 -0.412 . . . . 0.0 111.318 171.33 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' HIS . . . . . 0.477 ' CE1' ' HB ' ' A' ' 45' ' ' THR . 0.1 OUTLIER -63.74 142.91 98.08 Favored Pre-proline 0 CA--C 1.544 0.712 0 C-N-CA 119.755 -0.778 . . . . 0.0 110.318 174.871 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -60.97 -29.49 88.08 Favored 'Trans proline' 0 CA--C 1.539 0.768 0 C-N-CA 123.266 2.644 . . . . 0.0 114.758 -168.443 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.477 ' HB ' ' CE1' ' A' ' 43' ' ' HIS . 88.7 m -66.17 -22.67 66.37 Favored 'General case' 0 N--CA 1.475 0.813 0 O-C-N 121.273 -0.892 . . . . 0.0 111.924 -178.675 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -52.48 -50.28 63.02 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 118.948 0.795 . . . . 0.0 110.405 169.766 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.414 ' H ' HD12 ' A' ' 47' ' ' ILE . 4.5 mp -57.56 -48.64 82.65 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 C-N-CA 123.377 0.671 . . . . 0.0 110.728 -179.842 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -60.17 -32.42 71.04 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 113.102 0.779 . . . . 0.0 113.102 178.822 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -80.63 -30.43 36.69 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 113.87 1.063 . . . . 0.0 113.87 177.087 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' MET . . . . . 0.434 ' SD ' ' HG2' ' A' ' 17' ' ' MET . 3.6 mmt -73.41 -32.63 64.54 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 118.789 0.722 . . . . 0.0 110.352 170.251 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -67.01 -13.25 61.73 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 124.806 1.242 . . . . 0.0 113.548 174.267 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 58.4 mt-10 -63.11 -27.57 69.47 Favored 'General case' 0 N--CA 1.48 1.073 0 CA-C-N 120.355 1.434 . . . . 0.0 110.666 168.517 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 60.8 t -95.02 -4.51 10.45 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.91 0 C-N-CA 127.041 2.136 . . . . 0.0 111.15 175.465 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 80.29 18.9 70.46 Favored Glycine 0 CA--C 1.539 1.547 0 C-N-CA 125.005 1.288 . . . . 0.0 114.272 -175.649 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 93.2 mt -77.31 132.86 31.92 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 C-N-CA 124.731 1.212 . . . . 0.0 111.28 -174.577 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 19.0 t0 -96.19 104.8 16.78 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.502 0.721 . . . . 0.0 112.627 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 14.1 pt -138.22 17.25 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.365 0 N-CA-C 114.727 1.38 . . . . 0.0 114.727 176.046 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 94.1 p -49.35 -41.73 39.81 Favored 'General case' 0 N--CA 1.484 1.259 0 N-CA-C 116.151 1.908 . . . . 0.0 116.151 -169.798 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -126.98 35.68 2.8 Favored Glycine 0 CA--C 1.534 1.248 0 C-N-CA 125.59 1.567 . . . . 0.0 113.179 -179.293 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 24.0 pt20 -64.88 -33.91 77.13 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 115.56 1.689 . . . . 0.0 115.56 -169.738 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 28.2 p -92.83 106.23 18.23 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 121.559 0.695 . . . . 0.0 111.68 179.633 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 67.4 m -104.57 -28.93 10.98 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 124.521 1.128 . . . . 0.0 113.311 176.469 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -147.75 158.2 43.06 Favored Pre-proline 0 CA--C 1.544 0.737 0 C-N-CA 124.514 1.125 . . . . 0.0 111.997 -176.978 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -64.49 156.41 60.75 Favored 'Trans proline' 0 CA--C 1.537 0.671 0 C-N-CA 122.42 2.08 . . . . 0.0 112.414 169.935 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.603 HD12 HG11 ' A' ' 7' ' ' VAL . 12.2 tt -50.12 -36.03 12.11 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.181 0 C-N-CA 124.016 0.926 . . . . 0.0 112.098 171.54 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 19.3 mt-10 -63.91 -18.08 63.86 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.153 0.981 . . . . 0.0 113.225 -176.931 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -85.1 -14.92 45.63 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 124.553 1.141 . . . . 0.0 113.785 -177.059 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -97.06 176.03 6.1 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 126.016 1.727 . . . . 0.0 112.304 -177.081 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 23.6 t30 -99.81 126.95 45.99 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 169.77 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.84 -46.52 74.82 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 112.433 0.531 . . . . 0.0 112.433 -175.853 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -72.57 -1.0 14.38 Favored 'General case' 0 CA--C 1.546 0.823 0 N-CA-C 114.796 1.406 . . . . 0.0 114.796 -173.169 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -70.24 -17.68 63.13 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 123.668 0.787 . . . . 0.0 110.245 168.255 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 58.6 m-85 -105.53 158.32 16.76 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 128.355 2.662 . . . . 0.0 111.14 174.97 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -116.94 -12.94 10.66 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 124.781 1.232 . . . . 0.0 112.874 179.465 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.631 HG22 ' HB ' ' A' ' 95' ' ' ILE . 87.3 t -142.54 136.49 27.82 Favored 'Isoleucine or valine' 0 C--O 1.236 0.384 0 C-N-CA 127.86 2.464 . . . . 0.0 107.699 -174.291 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 59.0 t -131.75 133.46 61.31 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 N-CA-C 108.431 -0.952 . . . . 0.0 108.431 169.799 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 43.6 mm -116.41 111.16 34.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 C-N-CA 124.832 1.253 . . . . 0.0 107.916 -177.069 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 4.3 m -95.61 101.36 13.06 Favored 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 123.521 0.728 . . . . 0.0 110.097 176.81 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 34.1 mt -79.15 176.73 9.4 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 126.495 1.918 . . . . 0.0 110.955 173.445 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 14.8 m 63.2 57.0 1.64 Allowed 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 124.408 1.083 . . . . 0.0 113.422 169.787 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 83.06 -137.14 16.07 Favored Glycine 0 CA--C 1.534 1.268 0 C-N-CA 123.863 0.744 . . . . 0.0 111.706 -171.437 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 98.9 p -83.82 163.29 20.22 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 113.26 0.837 . . . . 0.0 113.26 176.561 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -69.03 -88.85 0.08 OUTLIER Glycine 0 CA--C 1.528 0.892 0 N-CA-C 110.658 -0.977 . . . . 0.0 110.658 169.409 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 98.7 t 63.13 -48.17 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.239 0 C-N-CA 128.054 2.542 . . . . 0.0 116.571 170.139 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 29.3 t-20 -74.98 -30.84 61.3 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 124.883 1.273 . . . . 0.0 113.031 -179.545 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.4 ' HA ' ' HD3' ' A' ' 87' ' ' PRO . 2.5 pt? -68.25 146.77 98.15 Favored Pre-proline 0 CA--C 1.555 1.145 0 CA-C-O 118.709 -0.662 . . . . 0.0 112.373 174.412 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 86' ' ' LEU . 64.3 Cg_exo -62.05 156.87 47.16 Favored 'Trans proline' 0 CA--C 1.549 1.243 0 C-N-CA 122.775 2.317 . . . . 0.0 115.234 -176.773 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 80.6 Cg_exo -54.3 -36.44 86.7 Favored 'Trans proline' 0 C--N 1.355 0.869 0 C-N-CA 123.984 3.123 . . . . 0.0 115.119 -174.798 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -61.47 -15.86 41.66 Favored 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 115.052 1.501 . . . . 0.0 115.052 178.725 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 82.6 m95 -91.43 -34.51 14.81 Favored 'General case' 0 CA--C 1.539 0.552 0 O-C-N 121.029 -1.044 . . . . 0.0 112.314 172.702 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 6.7 m -84.73 -16.32 10.53 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.186 0 N-CA-C 113.588 0.958 . . . . 0.0 113.588 177.821 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 1.3 t -78.59 -5.8 53.81 Favored 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 114.627 1.343 . . . . 0.0 114.627 177.961 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 58.4 mt-30 -71.24 166.23 21.98 Favored 'General case' 0 N--CA 1.478 0.934 0 O-C-N 121.05 -1.031 . . . . 0.0 112.95 -172.903 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -60.0 -43.52 95.14 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 113.761 1.022 . . . . 0.0 113.761 -168.661 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.631 ' HB ' HG22 ' A' ' 75' ' ' VAL . 10.8 mm -121.23 62.0 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 C-N-CA 124.65 1.18 . . . . 0.0 109.186 176.052 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 17.2 t80 -75.02 113.16 12.02 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 107.394 -1.336 . . . . 0.0 107.394 168.727 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 14.0 mt-10 -108.19 126.72 53.12 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-O 122.26 1.029 . . . . 0.0 113.246 174.224 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -91.4 89.21 7.15 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 125.146 1.378 . . . . 0.0 109.197 176.831 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 20.4 m0 -81.8 90.97 6.43 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 124.621 1.168 . . . . 0.0 111.405 -173.021 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 70.2 mm-40 -71.55 41.64 0.07 Allowed 'General case' 0 CA--C 1.553 1.062 0 C-N-CA 127.212 2.205 . . . . 0.0 112.345 173.379 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 40.3 mt -84.06 161.94 20.52 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 125.917 1.687 . . . . 0.0 112.156 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -70.94 150.02 46.12 Favored 'General case' 0 CA--C 1.545 0.769 0 CA-C-N 114.757 -1.111 . . . . 0.0 112.222 169.729 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -116.28 142.63 29.67 Favored Pre-proline 0 CA--C 1.552 1.043 0 C-N-CA 124.66 1.184 . . . . 0.0 110.061 169.303 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -63.23 -4.83 7.01 Favored 'Trans proline' 0 CA--C 1.55 1.29 0 C-N-CA 123.107 2.538 . . . . 0.0 116.148 178.701 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -54.18 131.11 40.66 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 115.234 1.568 . . . . 0.0 115.234 -174.814 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 69.52 10.09 62.8 Favored Glycine 0 CA--C 1.538 1.496 0 N-CA-C 115.923 1.129 . . . . 0.0 115.923 175.379 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 16.1 pt20 -134.87 171.24 14.68 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 125.141 1.377 . . . . 0.0 113.909 -175.876 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 42.7 p -67.26 166.04 15.03 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 116.663 2.097 . . . . 0.0 116.663 -168.966 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 40.5 tp -57.66 -32.16 67.03 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 124.476 1.11 . . . . 0.0 112.375 172.431 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -62.71 -36.47 83.06 Favored 'General case' 0 CA--C 1.54 0.586 0 O-C-N 121.192 -0.942 . . . . 0.0 111.366 175.531 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 6.2 t -69.29 -40.26 80.01 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 O-C-N 121.482 -0.761 . . . . 0.0 111.477 172.955 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -53.8 -47.88 70.38 Favored 'General case' 0 N--CA 1.477 0.911 0 CA-C-N 119.298 0.954 . . . . 0.0 112.29 170.089 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 28.6 mmt85 -63.79 -44.41 93.44 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 124.221 1.008 . . . . 0.0 111.884 178.738 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 19.2 m -62.7 -40.99 98.89 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.776 0.831 . . . . 0.0 111.607 174.087 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 52.9 t -66.4 -42.35 90.32 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 CA-C-O 117.546 -1.216 . . . . 0.0 110.712 177.347 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 20.3 mtm105 -54.83 -44.18 73.67 Favored 'General case' 0 N--CA 1.483 1.224 0 CA-C-N 120.539 1.518 . . . . 0.0 111.708 171.647 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -60.4 -51.55 58.11 Favored Glycine 0 CA--C 1.538 1.499 0 CA-C-N 119.115 0.871 . . . . 0.0 113.797 176.411 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 60.2 mm-40 -65.48 -43.63 89.66 Favored 'General case' 0 N--CA 1.476 0.83 0 O-C-N 121.913 -0.757 . . . . 0.0 112.207 -179.426 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 69.3 t -66.58 -40.09 85.47 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 C-N-CA 124.737 1.215 . . . . 0.0 110.883 177.21 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -56.22 -49.48 73.97 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-N 120.163 1.347 . . . . 0.0 110.965 177.241 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -61.48 -41.99 98.11 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 122.92 0.488 . . . . 0.0 112.231 178.037 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -61.45 -42.98 99.6 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 124.824 1.25 . . . . 0.0 113.204 174.619 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 94.8 t -71.84 -39.46 67.81 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 C-N-CA 124.466 1.107 . . . . 0.0 111.663 177.72 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -62.54 -39.04 92.33 Favored 'General case' 0 N--CA 1.469 0.514 0 O-C-N 121.274 -0.891 . . . . 0.0 111.384 172.443 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 12.6 m-80 -63.78 -45.84 87.89 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 118.703 0.683 . . . . 0.0 112.487 173.155 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 9.8 tt -52.19 -54.39 31.5 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.935 1.294 . . . . 0.0 110.775 173.412 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 68.3 mt -63.87 -42.95 97.52 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 O-C-N 121.749 -0.594 . . . . 0.0 110.518 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -67.53 -10.97 56.66 Favored 'General case' 0 CA--C 1.548 0.866 0 N-CA-C 114.921 1.452 . . . . 0.0 114.921 177.857 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 20.2 ptmt -107.31 -30.93 8.43 Favored 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 113.942 1.089 . . . . 0.0 113.942 174.373 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . 0.263 7.1 pt -95.63 -11.57 8.73 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 N-CA-C 114.576 1.324 . . . . 0.0 114.576 -178.932 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 65.4 m . . . . . 0 C--O 1.253 1.246 0 C-N-CA 124.805 1.242 . . . . 0.0 112.78 177.846 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.421 ' HA ' ' O ' ' A' ' 29' ' ' LYS . 25.1 ttt . . . . . 0 N--CA 1.504 2.249 0 N-CA-C 112.133 0.42 . . . . 0.0 112.133 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 2.9 mptp? -126.12 158.0 36.61 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 125.729 1.612 . . . . 0.0 113.264 179.301 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 73.8 mttt -105.35 115.2 29.85 Favored 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 125.929 1.692 . . . . 0.0 106.629 167.39 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 10.7 t -105.81 130.89 56.56 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 C-N-CA 125.079 1.351 . . . . 0.0 113.9 178.62 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' MET . . . . . 0.472 ' HG3' HG13 ' A' ' 7' ' ' VAL . 48.8 tpp -102.02 125.66 48.76 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 168.677 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 49.8 m-85 -108.62 119.29 39.1 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 124.362 1.065 . . . . 0.0 109.82 171.486 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.472 HG13 ' HG3' ' A' ' 5' ' ' MET . 3.4 m -140.3 149.74 21.62 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 C-N-CA 124.675 1.19 . . . . 0.0 111.788 -169.386 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 14.9 t -137.15 148.53 46.68 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 125.821 1.648 . . . . 0.0 111.283 -178.93 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 47.0 pttt -59.51 123.22 16.14 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 123.88 0.872 . . . . 0.0 111.922 177.915 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 74.5 mtp85 58.27 -33.9 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.784 0 C-N-CA 129.411 3.084 . . . . 0.0 116.718 -169.319 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 17.9 t-20 59.35 -48.82 0.07 Allowed 'General case' 0 CA--C 1.553 1.065 0 C-N-CA 129.382 3.073 . . . . 0.0 117.116 174.61 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 26.2 m -68.76 -8.6 44.64 Favored 'General case' 0 N--CA 1.482 1.167 0 CA-C-N 120.89 1.677 . . . . 0.0 114.023 -176.348 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 84.1 p -100.22 2.54 42.92 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 126.531 1.932 . . . . 0.0 114.506 170.028 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 83.7 mtt85 -140.86 173.83 11.1 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 126.682 1.993 . . . . 0.0 112.928 -169.645 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 35.1 t -114.92 174.9 5.74 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 125.176 1.391 . . . . 0.0 110.252 169.245 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 83.7 mt-30 -141.94 -49.28 0.38 Allowed 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 113.956 1.095 . . . . 0.0 113.956 -170.956 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' MET . . . . . 0.434 ' HG2' ' SD ' ' A' ' 50' ' ' MET . 0.0 OUTLIER 71.67 -46.37 0.64 Allowed 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 126.231 1.812 . . . . 0.0 114.236 173.683 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.19 -32.53 73.18 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 114.258 1.207 . . . . 0.0 114.258 -169.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 7.3 pm0 -63.77 -38.39 90.92 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 123.289 0.635 . . . . 0.0 111.919 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -70.24 -42.84 65.24 Favored Glycine 0 C--N 1.335 0.492 0 C-N-CA 123.715 0.674 . . . . 0.0 111.726 -178.765 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -71.76 -36.25 70.33 Favored 'General case' 0 N--CA 1.468 0.46 0 O-C-N 121.662 -0.905 . . . . 0.0 112.13 177.151 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.89 -35.66 78.99 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 118.609 0.641 . . . . 0.0 112.467 -175.182 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 5.6 pttp -84.9 -35.39 22.18 Favored 'General case' 0 N--CA 1.481 1.093 0 N-CA-C 113.86 1.059 . . . . 0.0 113.86 170.836 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 75.8 m -67.86 -31.61 71.54 Favored 'General case' 0 N--CA 1.486 1.346 0 CA-C-N 118.828 0.74 . . . . 0.0 112.141 -179.266 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 72.4 mt -96.47 -37.26 10.5 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.801 1.64 . . . . 0.0 112.69 175.896 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -98.48 4.3 59.93 Favored Glycine 0 N--CA 1.471 1.024 0 N-CA-C 116.572 1.389 . . . . 0.0 116.572 -169.811 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.18 143.14 56.09 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-N 120.97 2.385 . . . . 0.0 112.524 177.865 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 83.53 -20.07 12.6 Favored Glycine 0 CA--C 1.542 1.732 0 C-N-CA 124.868 1.223 . . . . 0.0 113.251 -169.322 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.421 ' O ' ' HA ' ' A' ' 1' ' ' MET . 78.4 mttt -101.25 -44.52 5.64 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 125.889 1.676 . . . . 0.0 112.253 169.868 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 38.5 pt -139.33 158.12 28.2 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 C-N-CA 124.162 0.985 . . . . 0.0 113.627 -175.507 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -106.81 145.51 32.02 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 127.252 2.221 . . . . 0.0 109.7 169.846 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 72.7 t -134.3 141.96 42.19 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 CA-C-N 118.69 0.677 . . . . 0.0 112.759 -175.349 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 38.9 m -134.72 153.01 52.19 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 125.513 1.525 . . . . 0.0 109.075 169.589 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 55.4 p -130.03 146.83 51.72 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.845 0.831 . . . . 0.0 111.288 168.176 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 53.7 p -147.89 -173.63 4.35 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 114.704 -1.135 . . . . 0.0 111.708 175.833 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -135.96 170.11 23.31 Favored Glycine 0 N--CA 1.468 0.782 0 O-C-N 120.909 -1.119 . . . . 0.0 112.038 177.419 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 10.8 mp -91.68 -9.01 45.44 Favored 'General case' 0 N--CA 1.479 1.021 0 N-CA-C 114.967 1.469 . . . . 0.0 114.967 -169.965 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -142.13 63.9 1.4 Allowed 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 124.71 1.204 . . . . 0.0 110.934 -176.746 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.451 ' H ' ' HB3' ' A' ' 64' ' ' PRO . 72.7 m 49.53 45.8 23.88 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 126.194 1.798 . . . . 0.0 112.392 -175.456 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 16.6 p -123.26 165.88 16.2 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 126.078 1.751 . . . . 0.0 115.65 -168.812 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 29.3 ptt-85 -138.0 -171.62 3.06 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 127.695 2.398 . . . . 0.0 107.631 171.465 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 26.9 m -60.44 151.72 5.79 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.189 0 CA-C-N 120.369 1.44 . . . . 0.0 110.941 169.418 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -62.99 143.29 97.54 Favored Pre-proline 0 CA--C 1.55 0.975 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 168.963 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_exo -48.53 -37.11 33.15 Favored 'Trans proline' 0 CA--C 1.542 0.876 0 C-N-CA 123.421 2.748 . . . . 0.0 117.717 -168.195 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 93.9 m -63.23 -24.62 67.96 Favored 'General case' 0 N--CA 1.485 1.304 0 CA-C-N 119.721 1.146 . . . . 0.0 112.777 -174.695 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -51.97 -43.76 63.71 Favored 'General case' 0 CA--C 1.546 0.802 0 CA-C-O 118.352 -0.832 . . . . 0.0 111.034 170.697 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.6 mp -55.79 -54.05 30.71 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.297 0 CA-C-N 120.239 1.382 . . . . 0.0 110.1 178.159 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -62.27 -30.65 71.27 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 123.447 0.699 . . . . 0.0 112.736 -178.18 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' MET . . . . . 0.41 ' HG2' ' CD1' ' A' ' 112' ' ' PHE . 0.0 OUTLIER -76.91 -33.5 57.76 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 113.119 0.785 . . . . 0.0 113.119 176.813 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 50' ' ' MET . . . . . 0.434 ' SD ' ' HG2' ' A' ' 17' ' ' MET . 3.5 mmt -74.2 -32.5 63.07 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 118.877 0.762 . . . . 0.0 110.735 172.697 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -65.47 -14.05 60.14 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 124.534 1.134 . . . . 0.0 113.787 173.197 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 60.3 mt-10 -62.1 -27.18 68.74 Favored 'General case' 0 N--CA 1.482 1.161 0 CA-C-N 120.66 1.573 . . . . 0.0 110.896 168.899 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 56.5 t -96.5 -3.63 10.2 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.874 0 C-N-CA 127.54 2.336 . . . . 0.0 111.275 176.118 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 78.93 19.13 73.49 Favored Glycine 0 CA--C 1.541 1.677 0 C-N-CA 125.029 1.299 . . . . 0.0 114.374 -175.784 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 85.7 mt -77.88 135.3 26.53 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 C-N-CA 124.709 1.204 . . . . 0.0 111.638 -174.722 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 17.9 t0 -96.05 102.19 13.96 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 112.667 0.617 . . . . 0.0 112.667 178.133 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 8.6 pt -129.58 14.92 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.273 0 C-N-CA 125.214 1.406 . . . . 0.0 113.396 170.514 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 72.7 m -59.48 126.7 28.7 Favored 'General case' 0 N--CA 1.473 0.715 0 O-C-N 120.711 -1.243 . . . . 0.0 112.295 -172.592 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 80.15 -22.62 4.29 Favored Glycine 0 CA--C 1.538 1.48 0 C-N-CA 125.278 1.418 . . . . 0.0 115.938 179.653 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 70.8 mt-30 41.0 -96.12 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 127.482 2.313 . . . . 0.0 113.428 -175.535 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 9.1 t -145.63 163.95 33.24 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 126.655 1.982 . . . . 0.0 109.914 169.719 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 75.5 m -100.55 -2.52 32.75 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 125.904 1.682 . . . . 0.0 113.148 172.216 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 29.2 m-20 -111.05 146.79 35.22 Favored Pre-proline 0 CA--C 1.544 0.742 0 C-N-CA 124.053 0.941 . . . . 0.0 113.38 -174.523 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.451 ' HB3' ' H ' ' A' ' 39' ' ' SER . 57.6 Cg_endo -71.52 162.07 43.41 Favored 'Trans proline' 0 C--N 1.349 0.58 0 C-N-CA 122.541 2.16 . . . . 0.0 113.163 176.984 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 5.5 tt -48.74 -43.97 14.4 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 C-N-CA 124.465 1.106 . . . . 0.0 111.36 171.322 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -69.12 -5.64 23.53 Favored 'General case' 0 CA--C 1.546 0.813 0 N-CA-C 114.466 1.284 . . . . 0.0 114.466 -177.591 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 5.4 t-20 -84.27 -21.59 31.03 Favored 'General case' 0 CA--C 1.547 0.839 0 N-CA-C 113.312 0.856 . . . . 0.0 113.312 172.791 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 83.5 m-85 -91.3 -171.58 3.0 Favored 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 125.431 1.492 . . . . 0.0 111.838 -179.864 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 14.9 t30 -117.53 120.44 38.1 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.52 1.128 . . . . 0.0 109.351 175.804 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -64.97 -44.64 88.7 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 115.108 1.521 . . . . 0.0 115.108 -169.122 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -79.77 6.22 11.48 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 113.591 0.96 . . . . 0.0 113.591 -172.458 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -73.57 -26.66 60.93 Favored 'General case' 0 CA--C 1.545 0.783 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 167.617 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 76.4 m-85 -86.44 157.84 19.73 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 127.101 2.161 . . . . 0.0 110.244 169.635 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -116.07 -15.79 11.1 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 124.237 1.015 . . . . 0.0 112.355 174.955 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.632 HG22 ' HB ' ' A' ' 95' ' ' ILE . 91.6 t -129.33 135.27 62.13 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 C-N-CA 126.93 2.092 . . . . 0.0 107.648 174.919 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 66.7 t -131.8 123.42 51.65 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 169.471 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 45.7 mm -108.59 106.79 21.35 Favored 'Isoleucine or valine' 0 C--O 1.235 0.298 0 C-N-CA 124.645 1.178 . . . . 0.0 108.76 -175.981 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 4.1 m -85.42 92.26 8.44 Favored 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 123.983 0.913 . . . . 0.0 110.061 171.596 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 81.4 mt -67.34 172.52 4.77 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 126.259 1.823 . . . . 0.0 111.794 172.801 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 17.3 m 65.88 7.94 4.97 Favored 'General case' 0 CA--C 1.549 0.906 0 N-CA-C 114.868 1.433 . . . . 0.0 114.868 175.03 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 69.37 132.02 0.06 OUTLIER Glycine 0 CA--C 1.535 1.286 0 C-N-CA 126.793 2.14 . . . . 0.0 115.157 -179.801 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 38.2 m 60.18 43.48 13.98 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 125.84 1.656 . . . . 0.0 112.311 174.277 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -75.7 65.14 2.53 Favored Glycine 0 N--CA 1.472 1.058 0 C-N-CA 124.951 1.263 . . . . 0.0 111.281 174.44 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.9 p -112.81 -2.32 10.3 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 C-N-CA 125.263 1.425 . . . . 0.0 113.622 -169.647 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 62.0 t30 -77.26 -11.14 59.79 Favored 'General case' 0 CA--C 1.552 1.03 0 O-C-N 121.221 -0.924 . . . . 0.0 113.289 176.284 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -66.23 158.61 76.45 Favored Pre-proline 0 CA--C 1.556 1.19 0 C-N-CA 124.335 1.054 . . . . 0.0 112.494 170.282 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -60.1 151.27 73.91 Favored 'Trans proline' 0 CA--C 1.543 0.933 0 C-N-CA 122.776 2.317 . . . . 0.0 113.337 179.645 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -61.33 -26.54 81.8 Favored 'Trans proline' 0 C--N 1.35 0.656 0 C-N-CA 123.364 2.709 . . . . 0.0 113.863 -174.146 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -59.82 -22.2 61.9 Favored 'General case' 0 CA--C 1.541 0.596 0 CA-C-O 117.966 -1.016 . . . . 0.0 113.534 174.909 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 93.5 m95 -87.64 -12.97 43.97 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 125.025 1.33 . . . . 0.0 113.806 177.789 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 4.7 m -96.47 -7.75 9.48 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 CA-C-N 119.072 0.851 . . . . 0.0 112.946 171.736 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . 0.269 0.7 OUTLIER -96.47 -4.57 41.34 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 114.818 1.414 . . . . 0.0 114.818 -175.548 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 11.8 mp0 -61.05 156.89 16.86 Favored 'General case' 0 N--CA 1.487 1.384 0 CA-C-O 122.531 1.158 . . . . 0.0 111.183 168.928 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -61.83 -39.54 92.15 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 114.354 -1.294 . . . . 0.0 113.4 -168.831 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.632 ' HB ' HG22 ' A' ' 75' ' ' VAL . 16.6 mm -115.63 59.07 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 C-N-CA 125.321 1.448 . . . . 0.0 109.071 176.439 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 35.4 t80 -76.22 109.73 10.14 Favored 'General case' 0 CA--C 1.535 0.376 0 O-C-N 120.51 -1.369 . . . . 0.0 107.945 169.054 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 9.6 mt-10 -111.39 128.66 56.05 Favored 'General case' 0 N--CA 1.471 0.625 0 N-CA-C 113.214 0.82 . . . . 0.0 113.214 174.298 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -93.84 112.51 24.37 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 168.979 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 38.7 m0 -94.04 104.2 16.25 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 124.375 1.07 . . . . 0.0 108.983 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 73.7 mm-40 -74.73 54.82 0.64 Allowed 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 126.797 2.039 . . . . 0.0 110.342 173.32 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.1 tt -104.81 146.22 29.28 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 127.099 2.159 . . . . 0.0 110.624 -169.858 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -56.5 144.15 32.49 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 125.06 1.344 . . . . 0.0 113.848 174.289 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -97.34 119.77 62.31 Favored Pre-proline 0 CA--C 1.546 0.825 0 C-N-CA 124.661 1.184 . . . . 0.0 108.015 168.823 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -76.4 -11.22 19.03 Favored 'Trans proline' 0 CA--C 1.542 0.906 0 C-N-CA 122.067 1.845 . . . . 0.0 114.132 -173.671 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -74.72 155.87 37.23 Favored 'General case' 0 CA--C 1.546 0.795 0 CA-C-N 119.684 1.129 . . . . 0.0 113.689 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 76.47 8.41 85.83 Favored Glycine 0 CA--C 1.536 1.394 0 C-N-CA 124.712 1.149 . . . . 0.0 114.434 -177.667 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 15.0 pt20 -143.31 170.52 15.61 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 126.824 2.049 . . . . 0.0 111.196 179.239 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 15.9 m -56.77 154.32 9.34 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 125.031 1.332 . . . . 0.0 114.56 -169.568 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 60.2 tp -58.34 -30.05 66.42 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.902 0.881 . . . . 0.0 112.493 176.338 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -59.35 -31.93 69.64 Favored 'General case' 0 N--CA 1.475 0.793 0 O-C-N 121.351 -0.843 . . . . 0.0 113.268 170.559 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 14.0 t -74.12 -41.53 51.91 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 O-C-N 121.008 -1.058 . . . . 0.0 110.306 173.624 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.41 ' CD1' ' HG2' ' A' ' 49' ' ' MET . 0.3 OUTLIER -54.38 -47.26 72.87 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 119.097 0.862 . . . . 0.0 112.611 169.76 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -70.9 -34.21 71.33 Favored 'General case' 0 N--CA 1.477 0.902 0 O-C-N 121.395 -0.816 . . . . 0.0 112.726 179.191 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 53.3 m -64.98 -41.25 95.6 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.834 0.854 . . . . 0.0 111.13 170.686 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 54.7 t -68.34 -35.73 72.11 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 CA-C-O 117.371 -1.299 . . . . 0.0 111.029 175.806 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 28.6 mtm105 -56.23 -43.02 78.2 Favored 'General case' 0 N--CA 1.485 1.292 0 CA-C-N 121.275 1.852 . . . . 0.0 111.355 169.611 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -61.18 -49.98 72.12 Favored Glycine 0 CA--C 1.54 1.629 0 CA-C-N 119.132 0.878 . . . . 0.0 113.594 175.197 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 64.0 mm-40 -62.74 -46.73 86.7 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.537 0.735 . . . . 0.0 112.136 177.885 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 91.3 t -69.89 -34.71 61.4 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 C-N-CA 124.324 1.049 . . . . 0.0 111.262 -179.5 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 63.7 tttm -55.96 -51.85 66.23 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 120.44 1.473 . . . . 0.0 110.908 172.938 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -63.92 -42.07 97.48 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 123.303 0.641 . . . . 0.0 112.522 177.418 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -66.88 -34.8 78.58 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 125.446 1.498 . . . . 0.0 112.306 179.407 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 76.9 t -76.57 -40.89 34.18 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.089 0 C-N-CA 125.098 1.359 . . . . 0.0 111.511 173.716 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -62.6 -34.12 76.38 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 119.425 1.011 . . . . 0.0 111.604 173.156 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 9.6 m-80 -65.72 -44.4 86.17 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 119.056 0.844 . . . . 0.0 113.035 172.031 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -53.49 -55.48 25.0 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 123.884 0.874 . . . . 0.0 110.304 172.482 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 75.5 mt -61.39 -43.17 96.22 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 CA-C-O 119.164 -0.446 . . . . 0.0 110.666 -179.819 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -68.9 -13.58 62.51 Favored 'General case' 0 CA--C 1.544 0.744 0 N-CA-C 115.116 1.524 . . . . 0.0 115.116 179.704 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 21.4 ptmt -98.61 -28.17 13.68 Favored 'General case' 0 N--CA 1.477 0.887 0 CA-C-N 119.382 0.992 . . . . 0.0 113.541 172.767 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 18.5 pt -93.98 -22.57 5.55 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 N-CA-C 114.486 1.291 . . . . 0.0 114.486 177.581 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 75.6 m . . . . . 0 C--O 1.252 1.227 0 C-N-CA 125.418 1.487 . . . . 0.0 111.552 -173.77 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.3 ttt . . . . . 0 N--CA 1.504 2.234 0 N-CA-C 111.556 0.206 . . . . 0.0 111.556 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.14 166.0 25.9 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 125.018 1.327 . . . . 0.0 112.971 176.071 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 70.0 mttt -94.81 146.07 24.44 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 123.82 0.848 . . . . 0.0 112.629 174.466 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 16.7 t -124.28 138.13 54.85 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 125.645 1.578 . . . . 0.0 111.083 172.888 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -109.74 121.2 44.68 Favored 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 110.19 -0.3 . . . . 0.0 110.19 169.136 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 45.2 m-85 -96.52 125.19 40.83 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 170.608 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 28.8 m -140.49 151.57 21.0 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 N-CA-C 113.786 1.032 . . . . 0.0 113.786 -168.766 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 33.5 t -152.95 142.55 21.86 Favored 'General case' 0 CA--C 1.548 0.904 0 C-N-CA 124.711 1.204 . . . . 0.0 113.606 -172.717 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -80.79 140.52 35.44 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 124.779 1.232 . . . . 0.0 109.324 168.927 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 31.2 mtm180 52.54 47.34 24.91 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 125.48 1.512 . . . . 0.0 112.522 -169.12 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 23.4 t30 -57.32 -27.63 62.36 Favored 'General case' 0 CA--C 1.551 0.996 0 C-N-CA 125.581 1.552 . . . . 0.0 113.282 -179.786 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 72.8 m -73.32 -30.75 63.58 Favored 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 113.419 0.896 . . . . 0.0 113.419 172.041 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 48.8 m -80.66 -40.04 26.23 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 123.876 0.87 . . . . 0.0 112.082 179.458 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 11.7 mmt180 -101.88 163.34 12.3 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 124.645 1.178 . . . . 0.0 113.458 -173.844 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 3.7 m -106.92 134.96 49.3 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.148 0.979 . . . . 0.0 111.041 174.13 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 3.9 mp0 -105.11 -38.14 6.67 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 115.018 1.488 . . . . 0.0 115.018 -168.27 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' MET . . . . . 0.438 ' HG2' ' SD ' ' A' ' 50' ' ' MET . 0.0 OUTLIER 67.16 -55.55 0.45 Allowed 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 126.71 2.004 . . . . 0.0 115.66 170.372 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -57.82 -37.04 73.09 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.923 1.289 . . . . 0.0 114.205 -169.577 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 7.5 pm0 -58.76 -31.97 68.84 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 125.391 1.476 . . . . 0.0 113.709 179.523 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -66.83 -68.06 1.79 Allowed Glycine 0 C--N 1.337 0.622 0 N-CA-C 110.588 -1.005 . . . . 0.0 110.588 174.506 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -50.65 -34.12 25.15 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 124.135 0.974 . . . . 0.0 113.449 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.47 ' HB1' HG21 ' A' ' 32' ' ' VAL . . . -60.24 -32.58 71.27 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 -177.998 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . 0.273 0.0 OUTLIER -98.84 -24.91 14.81 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 114.081 1.141 . . . . 0.0 114.081 169.947 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 1.3 m -64.51 -36.54 84.52 Favored 'General case' 0 N--CA 1.488 1.436 0 CA-C-N 120.33 1.423 . . . . 0.0 111.974 173.796 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 68.6 mt -98.96 -28.26 13.51 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 125.454 1.502 . . . . 0.0 113.206 178.778 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -111.93 2.77 27.2 Favored Glycine 0 N--CA 1.474 1.204 0 N-CA-C 118.112 2.005 . . . . 0.0 118.112 -169.389 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -66.34 -20.37 66.07 Favored 'General case' 0 N--CA 1.477 0.878 0 CA-C-N 122.548 3.174 . . . . 0.0 116.648 -169.684 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -75.69 -6.68 82.1 Favored Glycine 0 CA--C 1.542 1.748 0 O-C-N 121.339 -0.85 . . . . 0.0 113.881 169.627 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 61.1 mttp -119.87 -40.06 2.78 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 127.162 2.185 . . . . 0.0 113.101 -174.375 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 43.6 pt -144.27 157.22 15.31 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 C-N-CA 125.911 1.684 . . . . 0.0 112.686 -171.896 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -101.02 139.78 36.23 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.415 1.086 . . . . 0.0 109.39 169.486 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.47 HG21 ' HB1' ' A' ' 22' ' ' ALA . 30.2 t -130.79 136.46 58.14 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.076 0 CA-C-N 119.831 1.196 . . . . 0.0 113.179 177.632 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 37.1 m -131.02 154.91 47.7 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 125.969 1.708 . . . . 0.0 109.73 175.034 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 3.2 m -124.64 147.86 48.28 Favored 'General case' 0 CA--C 1.513 -0.458 0 CA-C-O 121.617 0.722 . . . . 0.0 112.42 168.358 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 2.2 m -142.74 149.74 39.15 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 113.688 -1.596 . . . . 0.0 111.167 172.636 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -79.82 165.21 49.23 Favored Glycine 0 CA--C 1.528 0.852 0 N-CA-C 110.888 -0.885 . . . . 0.0 110.888 169.484 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 9.1 mp -80.17 -11.51 59.74 Favored 'General case' 0 N--CA 1.48 1.036 0 O-C-N 121.653 -0.91 . . . . 0.0 112.809 169.993 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -132.03 165.5 23.84 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 126.973 2.109 . . . . 0.0 108.811 169.662 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 68.4 m -57.78 114.31 2.24 Favored 'General case' 0 N--CA 1.479 1.012 0 O-C-N 121.232 -0.917 . . . . 0.0 110.574 178.984 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 88.9 p -158.24 178.17 10.47 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 114.748 1.388 . . . . 0.0 114.748 -168.717 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 13.2 tpt180 -132.35 147.32 52.39 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 128.178 2.591 . . . . 0.0 108.631 174.296 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 33.0 m -62.28 154.91 5.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 CA-C-N 120.668 1.576 . . . . 0.0 109.425 168.394 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 11.9 t-80 -53.53 135.09 53.51 Favored Pre-proline 0 C--N 1.327 -0.389 0 CA-C-N 114.87 -1.059 . . . . 0.0 112.564 -170.13 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_exo -60.75 -26.11 82.37 Favored 'Trans proline' 0 CA--C 1.548 1.175 0 CA-C-N 121.01 1.397 . . . . 0.0 112.677 175.885 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 51.1 m -70.02 -33.94 72.65 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 125.296 1.438 . . . . 0.0 112.058 171.968 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -57.99 -43.2 86.44 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 124.018 0.927 . . . . 0.0 111.636 -178.474 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.7 mp -52.85 -54.15 17.82 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 CA-C-N 119.182 0.901 . . . . 0.0 109.425 -178.652 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -65.76 -32.28 73.73 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 113.351 0.871 . . . . 0.0 113.351 -177.406 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -79.19 -29.95 43.14 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 113.433 0.901 . . . . 0.0 113.433 178.683 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' MET . . . . . 0.438 ' SD ' ' HG2' ' A' ' 17' ' ' MET . 1.0 OUTLIER -80.82 -29.57 35.95 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 123.521 0.728 . . . . 0.0 110.828 172.739 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -66.92 -12.27 58.93 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 124.719 1.208 . . . . 0.0 113.486 170.02 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -65.62 -26.23 67.73 Favored 'General case' 0 N--CA 1.481 1.076 0 CA-C-N 120.513 1.506 . . . . 0.0 110.892 169.06 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 56.7 t -93.72 -7.54 10.17 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.804 0 C-N-CA 126.996 2.119 . . . . 0.0 111.049 173.023 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 82.16 20.11 63.46 Favored Glycine 0 CA--C 1.538 1.501 0 C-N-CA 125.086 1.327 . . . . 0.0 114.22 -175.183 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.427 HG22 HG23 ' A' ' 57' ' ' ILE . 36.0 mt -85.68 126.13 40.51 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 CA-C-N 118.48 1.14 . . . . 0.0 110.805 -176.645 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 19.9 t0 -87.43 121.33 29.72 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.143 0.577 . . . . 0.0 111.537 170.692 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.427 HG23 HG22 ' A' ' 55' ' ' ILE . 29.2 pt -136.37 -1.72 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.24 0 N-CA-C 116.083 1.883 . . . . 0.0 116.083 -178.568 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 79.1 p -62.93 -25.61 68.42 Favored 'General case' 0 N--CA 1.482 1.17 0 N-CA-C 116.122 1.897 . . . . 0.0 116.122 -169.019 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -102.29 3.21 50.79 Favored Glycine 0 CA--C 1.537 1.431 0 N-CA-C 116.12 1.208 . . . . 0.0 116.12 -176.132 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 31.5 mt-30 -72.89 -44.3 61.46 Favored 'General case' 0 N--CA 1.48 1.05 0 CA-C-N 119.31 1.555 . . . . 0.0 113.639 -169.949 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 12.3 p -90.7 119.33 30.85 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 124.115 0.966 . . . . 0.0 112.382 -178.701 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 99.4 p -141.08 -12.17 0.95 Allowed 'General case' 0 N--CA 1.478 0.944 0 N-CA-C 114.884 1.439 . . . . 0.0 114.884 177.191 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -147.36 150.6 38.04 Favored Pre-proline 0 CA--C 1.546 0.821 0 C-N-CA 125.131 1.372 . . . . 0.0 111.58 179.522 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -63.15 155.71 59.66 Favored 'Trans proline' 0 C--N 1.35 0.624 0 C-N-CA 123.31 2.673 . . . . 0.0 112.168 169.543 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 10.3 tt -50.77 -33.84 12.47 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 C-N-CA 124.869 1.268 . . . . 0.0 112.291 171.261 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -62.41 -21.54 65.47 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.575 1.15 . . . . 0.0 112.87 -177.074 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 82.0 m-20 -91.7 4.7 52.14 Favored 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 124.452 1.101 . . . . 0.0 113.645 -176.264 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -116.48 -176.82 3.04 Favored 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 126.304 1.842 . . . . 0.0 112.377 179.283 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -119.76 125.0 47.56 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 125.874 1.67 . . . . 0.0 110.068 175.368 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -67.79 -34.91 77.7 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 113.921 1.082 . . . . 0.0 113.921 -171.201 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . 0.261 0.0 OUTLIER -71.6 -4.32 26.39 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 114.278 1.214 . . . . 0.0 114.278 -176.602 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -73.18 -15.96 61.44 Favored 'General case' 0 CA--C 1.548 0.871 0 O-C-N 121.711 -0.618 . . . . 0.0 111.136 168.898 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -112.45 138.5 49.11 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 127.074 2.15 . . . . 0.0 111.497 178.676 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -88.42 -23.68 23.25 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-O 122.112 0.958 . . . . 0.0 112.317 176.125 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.682 HG22 ' HB ' ' A' ' 95' ' ' ILE . 76.3 t -133.29 137.65 52.86 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 C-N-CA 126.679 1.992 . . . . 0.0 108.769 -175.487 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 78.8 t -133.56 131.92 57.3 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 173.184 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 43.3 mm -121.51 106.06 17.59 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 C-N-CA 124.243 1.017 . . . . 0.0 109.344 -171.378 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 4.1 m -88.75 109.79 20.45 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 123.631 0.772 . . . . 0.0 110.643 178.406 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 89.3 mt -90.76 -19.02 23.98 Favored 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 114.899 1.444 . . . . 0.0 114.899 -172.45 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 10.6 m -141.56 144.52 34.3 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.746 1.218 . . . . 0.0 110.703 -169.789 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 62.15 -125.37 35.97 Favored Glycine 0 CA--C 1.533 1.205 0 N-CA-C 110.632 -0.987 . . . . 0.0 110.632 -171.538 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 77.9 p -152.62 171.86 17.51 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.671 1.188 . . . . 0.0 111.527 169.719 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -66.41 65.0 0.16 Allowed Glycine 0 CA--C 1.538 1.512 0 C-N-CA 125.757 1.646 . . . . 0.0 114.691 176.043 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 7.7 p -143.79 -28.4 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.105 0 C-N-CA 125.633 1.573 . . . . 0.0 113.345 -178.324 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -91.19 22.95 3.51 Favored 'General case' 0 CA--C 1.554 1.121 0 C-N-CA 124.337 1.055 . . . . 0.0 112.447 178.115 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -133.54 159.28 73.15 Favored Pre-proline 0 CA--C 1.549 0.93 0 C-N-CA 126.338 1.855 . . . . 0.0 111.024 173.208 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -58.89 149.2 80.11 Favored 'Trans proline' 0 CA--C 1.543 0.937 0 C-N-CA 122.58 2.187 . . . . 0.0 112.695 178.229 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -61.77 -28.94 82.47 Favored 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 122.909 2.406 . . . . 0.0 113.626 -170.489 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -60.36 -20.95 61.4 Favored 'General case' 0 CA--C 1.544 0.723 0 N-CA-C 114.071 1.137 . . . . 0.0 114.071 177.704 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 88.6 m95 -80.34 -19.86 45.54 Favored 'General case' 0 N--CA 1.47 0.563 0 O-C-N 120.622 -1.299 . . . . 0.0 113.257 175.856 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 16.3 m -93.81 -8.21 9.98 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.125 0 N-CA-C 113.634 0.975 . . . . 0.0 113.634 172.213 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 67.5 p -96.98 -0.31 47.61 Favored 'General case' 0 N--CA 1.48 1.032 0 N-CA-C 114.796 1.406 . . . . 0.0 114.796 177.96 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 73.3 mm-40 -65.2 152.63 43.16 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 119.172 0.896 . . . . 0.0 111.213 169.84 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -54.01 -42.91 69.6 Favored 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 114.986 1.476 . . . . 0.0 114.986 -167.734 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.682 ' HB ' HG22 ' A' ' 75' ' ' VAL . 8.6 mm -118.26 65.16 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 C-N-CA 124.072 0.949 . . . . 0.0 109.224 173.41 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 23.3 t80 -75.31 109.46 8.85 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 106.909 -1.515 . . . . 0.0 106.909 168.645 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -104.58 130.45 52.55 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-O 121.797 0.808 . . . . 0.0 112.93 171.489 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -92.14 105.99 18.1 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 123.692 0.797 . . . . 0.0 109.399 169.95 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 19.0 m0 -94.47 99.26 11.46 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 124.571 1.148 . . . . 0.0 110.239 -176.945 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 99.9 mm-40 -79.13 53.7 1.5 Allowed 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 124.699 1.2 . . . . 0.0 110.514 170.957 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 5.0 tt -91.84 150.91 20.82 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 127.057 2.143 . . . . 0.0 111.9 -172.147 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -68.23 117.92 10.67 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 123.553 0.741 . . . . 0.0 112.868 179.029 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -74.43 133.25 77.62 Favored Pre-proline 0 CA--C 1.556 1.173 0 O-C-N 121.522 -0.736 . . . . 0.0 110.317 169.664 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -87.8 -6.96 6.57 Favored 'Trans proline' 0 CA--C 1.554 1.479 0 C-N-CA 122.295 1.997 . . . . 0.0 114.646 -178.597 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -64.38 146.91 53.69 Favored 'General case' 0 CA--C 1.547 0.864 0 CA-C-N 120.537 1.517 . . . . 0.0 113.188 176.91 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 75.77 8.62 84.65 Favored Glycine 0 CA--C 1.537 1.436 0 C-N-CA 123.869 0.747 . . . . 0.0 114.872 176.153 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 13.2 pt20 -140.75 165.46 27.44 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 125.893 1.677 . . . . 0.0 112.257 178.365 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 70.9 m -57.92 157.65 7.48 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 125.638 1.575 . . . . 0.0 114.843 -169.47 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 35.9 tp -59.25 -29.19 67.37 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 124.605 1.162 . . . . 0.0 113.001 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -61.9 -31.42 71.71 Favored 'General case' 0 N--CA 1.472 0.661 0 O-C-N 120.812 -1.18 . . . . 0.0 112.208 172.346 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 4.7 t -72.78 -40.49 60.97 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 O-C-N 121.146 -0.971 . . . . 0.0 111.114 171.73 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -55.16 -47.88 74.54 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 120.02 1.282 . . . . 0.0 112.056 169.857 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -69.13 -36.7 77.75 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.46 0.704 . . . . 0.0 112.506 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 79.0 m -63.86 -42.4 97.55 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 123.777 0.831 . . . . 0.0 110.832 171.593 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 44.1 t -65.96 -41.25 89.46 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 CA-C-O 117.567 -1.206 . . . . 0.0 110.803 176.429 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 30.8 mtm105 -55.73 -44.41 77.49 Favored 'General case' 0 N--CA 1.483 1.185 0 CA-C-N 120.841 1.655 . . . . 0.0 112.243 171.608 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -61.14 -50.85 62.75 Favored Glycine 0 CA--C 1.537 1.464 0 CA-C-N 118.979 0.809 . . . . 0.0 113.103 177.114 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 56.5 mm-40 -63.58 -45.0 92.42 Favored 'General case' 0 N--CA 1.473 0.689 0 O-C-N 121.996 -0.708 . . . . 0.0 112.217 178.387 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 70.4 t -64.78 -40.86 90.51 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 124.964 1.306 . . . . 0.0 111.301 177.679 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 84.3 tttt -54.44 -49.52 69.82 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 119.89 1.223 . . . . 0.0 110.474 176.215 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -63.64 -42.37 98.16 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 112.637 0.606 . . . . 0.0 112.637 176.268 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.24 -36.28 83.12 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 124.181 0.992 . . . . 0.0 112.897 177.803 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 92.5 t -78.44 -38.9 23.19 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 C-N-CA 125.521 1.529 . . . . 0.0 111.713 177.574 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -63.36 -35.43 80.38 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 119.546 1.066 . . . . 0.0 111.285 171.472 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 12.5 m-80 -64.89 -44.47 89.52 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 118.827 0.74 . . . . 0.0 112.52 172.328 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 9.8 tt -52.57 -57.18 10.81 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 124.237 1.015 . . . . 0.0 110.25 170.534 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 70.2 mt -60.58 -42.69 92.55 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 O-C-N 121.387 -0.821 . . . . 0.0 110.744 -177.805 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -68.45 -14.61 63.12 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 114.828 1.418 . . . . 0.0 114.828 178.263 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 19.0 ptmt -106.0 -32.75 8.16 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 113.596 0.961 . . . . 0.0 113.596 176.577 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.427 HD13 HG21 ' A' ' 75' ' ' VAL . 4.7 pt -88.98 -18.97 7.69 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 CA-C-O 118.038 -0.982 . . . . 0.0 113.619 -176.692 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 69.7 m . . . . . 0 C--O 1.253 1.274 0 N-CA-C 112.781 0.66 . . . . 0.0 112.781 -177.946 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.0 ttt . . . . . 0 N--CA 1.503 2.179 0 N-CA-C 111.774 0.287 . . . . 0.0 111.774 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.89 156.17 38.36 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 125.667 1.587 . . . . 0.0 113.207 179.422 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 44.1 mtmt -101.72 108.65 20.24 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 125.518 1.527 . . . . 0.0 107.342 167.851 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 16.3 t -95.18 131.92 40.64 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 125.981 1.713 . . . . 0.0 113.72 175.475 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' MET . . . . . 0.558 ' HG3' HG13 ' A' ' 7' ' ' VAL . 37.6 tpp -102.98 120.2 40.22 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 123.765 0.826 . . . . 0.0 109.162 168.804 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 65.0 m-85 -99.0 118.93 36.9 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 125.68 1.592 . . . . 0.0 108.307 174.588 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.558 HG13 ' HG3' ' A' ' 5' ' ' MET . 1.5 m -137.91 151.44 25.56 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.143 0 N-CA-C 115.013 1.486 . . . . 0.0 115.013 -168.64 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 41.5 t -155.31 162.99 40.72 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 125.691 1.597 . . . . 0.0 111.028 169.918 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 40.2 ttmt -69.99 133.05 46.84 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 125.052 1.341 . . . . 0.0 110.855 169.827 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 98.2 mtt180 51.13 80.12 0.09 Allowed 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 126.88 2.072 . . . . 0.0 112.386 -176.541 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 21.9 t-20 -67.98 -32.99 73.78 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 113.828 1.047 . . . . 0.0 113.828 -174.174 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 60.4 p -76.29 157.45 32.51 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 125.008 1.323 . . . . 0.0 112.688 169.922 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 67.1 m 53.62 26.45 5.77 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 124.901 1.28 . . . . 0.0 114.242 -174.681 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 23.9 ttm180 -147.33 151.85 37.24 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 127.76 2.424 . . . . 0.0 110.048 -175.32 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 46.0 t -109.07 152.84 24.49 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.49 0.716 . . . . 0.0 111.248 170.157 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -139.98 -42.43 0.43 Allowed 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 125.887 1.675 . . . . 0.0 111.893 -169.52 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 65.91 -36.72 0.24 Allowed 'General case' 0 N--CA 1.478 0.975 0 N-CA-C 118.205 2.668 . . . . 0.0 118.205 169.238 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.27 -36.56 80.36 Favored 'General case' 0 C--O 1.224 -0.289 0 CA-C-N 119.278 0.944 . . . . 0.0 113.406 -171.26 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.5 pm0 -57.46 -34.37 68.94 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 124.361 1.064 . . . . 0.0 113.307 171.93 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -72.49 -57.03 5.73 Favored Glycine 0 C--N 1.332 0.332 0 C-N-CA 124.293 0.949 . . . . 0.0 111.425 177.437 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -59.34 -33.79 71.57 Favored 'General case' 0 N--CA 1.468 0.43 0 O-C-N 122.24 -0.565 . . . . 0.0 112.427 177.902 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -63.38 -40.16 96.47 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 119.198 0.908 . . . . 0.0 112.285 -178.825 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 33.7 mttm -58.3 -56.39 22.73 Favored 'General case' 0 N--CA 1.486 1.373 0 CA-C-O 121.544 0.688 . . . . 0.0 110.874 168.782 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 35.9 m -69.75 -24.15 63.48 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 125.186 1.394 . . . . 0.0 114.056 -169.392 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 76.7 mt -96.38 -19.15 19.41 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 125.066 1.347 . . . . 0.0 114.461 177.262 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -159.01 26.29 0.37 Allowed Glycine 0 C--N 1.344 0.979 0 N-CA-C 119.021 2.368 . . . . 0.0 119.021 -169.001 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -66.56 -21.28 66.15 Favored 'General case' 0 CA--C 1.546 0.812 0 CA-C-N 122.15 2.975 . . . . 0.0 115.37 -176.501 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -74.86 -5.47 75.03 Favored Glycine 0 CA--C 1.542 1.745 0 O-C-N 121.493 -0.755 . . . . 0.0 113.776 169.546 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 70.0 mttt -117.18 -37.24 3.58 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 127.536 2.335 . . . . 0.0 113.301 -178.565 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 40.1 pt -142.76 150.07 18.41 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 C-N-CA 124.386 1.074 . . . . 0.0 113.171 -174.619 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -99.53 139.23 35.5 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 125.813 1.645 . . . . 0.0 108.337 169.355 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 5.1 m -132.14 144.91 35.71 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.236 0 C-N-CA 124.033 0.933 . . . . 0.0 110.352 -173.578 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 72.3 m -138.42 138.91 38.65 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 123.522 0.729 . . . . 0.0 109.411 175.091 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 2.8 p -98.67 138.04 36.42 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 112.127 0.417 . . . . 0.0 112.127 168.755 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 24.4 p -149.18 162.29 40.28 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 113.274 0.842 . . . . 0.0 113.274 170.095 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -109.78 147.1 17.11 Favored Glycine 0 N--CA 1.473 1.165 0 C-N-CA 124.236 0.922 . . . . 0.0 113.89 -179.393 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 11.2 mp -68.32 -25.55 65.17 Favored 'General case' 0 N--CA 1.485 1.298 0 CA-C-N 119.395 1.597 . . . . 0.0 111.041 169.603 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -142.36 144.31 33.12 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 127.688 2.395 . . . . 0.0 106.955 169.06 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 25.5 p 58.05 171.42 0.05 Allowed 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 126.91 2.084 . . . . 0.0 116.172 -176.106 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 83.2 p -137.79 168.38 19.8 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 125.805 1.642 . . . . 0.0 114.34 178.958 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 24.5 ttt-85 61.74 124.24 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 129.494 3.117 . . . . 0.0 113.398 -169.925 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 32.0 m -57.89 144.8 9.97 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.32 0 C-N-CA 123.376 0.67 . . . . 0.0 109.557 169.696 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -65.13 147.68 98.39 Favored Pre-proline 0 CA--C 1.544 0.749 0 C-N-CA 119.369 -0.932 . . . . 0.0 112.332 -169.614 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo -48.27 -41.72 34.59 Favored 'Trans proline' 0 CA--C 1.538 0.707 0 C-N-CA 123.375 2.717 . . . . 0.0 117.51 -168.185 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 86.1 m -64.82 -24.0 67.41 Favored 'General case' 0 N--CA 1.485 1.32 0 O-C-N 121.211 -0.931 . . . . 0.0 112.267 -177.879 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -57.6 -34.25 69.06 Favored 'General case' 0 CA--C 1.536 0.406 0 O-C-N 121.315 -0.865 . . . . 0.0 112.153 173.86 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.7 mp -60.58 -57.88 9.94 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 CA-C-N 119.901 1.228 . . . . 0.0 109.312 175.564 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -61.31 -32.77 72.63 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 113.122 0.786 . . . . 0.0 113.122 -178.561 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 3.8 tpp -77.36 -24.14 50.7 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 113.209 0.818 . . . . 0.0 113.209 178.051 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -87.49 -27.35 22.71 Favored 'General case' 0 CA--C 1.541 0.615 0 O-C-N 121.136 -0.977 . . . . 0.0 110.876 172.464 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -65.62 -5.16 7.51 Favored 'General case' 0 CA--C 1.552 1.055 0 C-N-CA 125.166 1.386 . . . . 0.0 113.036 169.456 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 18.5 mt-10 -72.79 -29.26 63.13 Favored 'General case' 0 N--CA 1.484 1.263 0 CA-C-N 120.039 1.29 . . . . 0.0 111.082 171.284 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 8.5 p -113.21 12.94 8.34 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.798 0 C-N-CA 127.143 2.177 . . . . 0.0 111.26 -177.142 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 80.17 18.06 72.75 Favored Glycine 0 CA--C 1.533 1.202 0 C-N-CA 124.978 1.275 . . . . 0.0 115.861 170.668 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 2.4 mm -71.92 143.49 14.14 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 CA-C-N 119.549 1.674 . . . . 0.0 110.286 177.757 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -97.82 29.63 3.32 Favored 'General case' 0 CA--C 1.553 1.083 0 C-N-CA 125.986 1.714 . . . . 0.0 115.476 -176.825 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 11.6 pt -72.11 -2.75 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.384 0 N-CA-C 115.594 1.702 . . . . 0.0 115.594 -175.173 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 91.6 p -55.58 -32.35 62.98 Favored 'General case' 0 N--CA 1.479 1.016 0 CA-C-N 119.851 1.205 . . . . 0.0 113.828 179.453 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -82.44 3.61 81.27 Favored Glycine 0 CA--C 1.536 1.364 0 C-N-CA 125.237 1.399 . . . . 0.0 116.105 177.412 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 5.1 mt-30 -79.48 132.68 36.41 Favored 'General case' 0 C--N 1.343 0.319 0 CA-C-N 120.362 2.081 . . . . 0.0 112.33 -179.019 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 40.4 p -139.66 113.58 8.75 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 126.068 1.747 . . . . 0.0 107.051 168.747 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 59.7 p -114.61 -174.7 2.53 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 114.703 1.371 . . . . 0.0 114.703 -169.208 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -133.86 164.49 43.64 Favored Pre-proline 0 CA--C 1.546 0.812 0 C-N-CA 126.833 2.053 . . . . 0.0 109.628 176.798 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -60.78 155.95 46.03 Favored 'Trans proline' 0 CA--C 1.541 0.871 0 C-N-CA 122.193 1.928 . . . . 0.0 112.522 169.769 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.531 HD12 HG11 ' A' ' 7' ' ' VAL . 7.5 tt -53.55 -33.17 21.67 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 C-N-CA 125.428 1.491 . . . . 0.0 111.552 175.045 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 17.8 mt-10 -59.66 -20.58 57.08 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 125.315 1.446 . . . . 0.0 113.112 178.662 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -85.31 -9.96 57.01 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 125.294 1.438 . . . . 0.0 113.609 -179.015 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -108.27 178.77 4.4 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 126.334 1.854 . . . . 0.0 112.301 -176.312 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 20.3 t30 -114.58 126.08 54.5 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 125.208 1.403 . . . . 0.0 110.075 175.774 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -63.47 -43.34 97.6 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 114.515 1.302 . . . . 0.0 114.515 -169.756 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -75.26 -0.9 21.13 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 113.495 0.924 . . . . 0.0 113.495 -178.468 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -71.83 -12.96 61.54 Favored 'General case' 0 CA--C 1.544 0.724 0 O-C-N 121.572 -0.705 . . . . 0.0 110.784 168.917 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -116.21 141.81 47.65 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 126.175 1.79 . . . . 0.0 111.222 178.715 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -86.71 -31.73 20.85 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 125.464 1.505 . . . . 0.0 111.651 174.717 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.76 HG22 ' HB ' ' A' ' 95' ' ' ILE . 94.3 t -129.12 138.03 55.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 C-N-CA 125.446 1.498 . . . . 0.0 108.38 -171.366 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 37.3 t -130.56 125.15 58.49 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 173.488 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 44.3 mm -116.25 102.87 14.27 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 C-N-CA 125.052 1.341 . . . . 0.0 108.8 -173.403 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 15.8 m -86.31 106.77 17.61 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 124.041 0.936 . . . . 0.0 110.111 176.493 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 81.1 mt -82.04 -4.92 57.86 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 125.271 1.428 . . . . 0.0 114.647 -169.772 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 28.6 p -152.9 147.96 26.59 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 124.34 1.056 . . . . 0.0 112.121 -175.7 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 60.84 -160.39 25.61 Favored Glycine 0 CA--C 1.536 1.385 0 C-N-CA 124.585 1.088 . . . . 0.0 114.739 176.589 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 86.9 p -71.45 -22.69 61.8 Favored 'General case' 0 N--CA 1.475 0.782 0 O-C-N 121.305 -1.115 . . . . 0.0 113.575 175.454 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 72.58 10.0 75.02 Favored Glycine 0 CA--C 1.533 1.201 0 C-N-CA 124.968 1.27 . . . . 0.0 114.367 -176.39 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.0 p -77.07 -16.76 14.57 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 CA-C-N 119.36 1.58 . . . . 0.0 114.664 -169.702 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 36.4 m120 -80.44 -9.3 59.76 Favored 'General case' 0 CA--C 1.548 0.901 0 N-CA-C 114.984 1.475 . . . . 0.0 114.984 -170.966 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -75.59 159.64 81.1 Favored Pre-proline 0 CA--C 1.552 1.033 0 CA-C-N 119.323 0.965 . . . . 0.0 112.066 169.727 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_exo -58.43 142.97 98.26 Favored 'Trans proline' 0 CA--C 1.547 1.146 0 C-N-CA 122.607 2.205 . . . . 0.0 113.011 179.287 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_exo -54.85 -32.08 75.8 Favored 'Trans proline' 0 C--N 1.353 0.777 0 C-N-CA 123.358 2.706 . . . . 0.0 115.62 -171.902 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 2.9 pm0 -61.95 -16.82 54.04 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 114.239 1.2 . . . . 0.0 114.239 177.76 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 93.6 m95 -80.58 -24.01 39.49 Favored 'General case' 0 CA--C 1.542 0.669 0 O-C-N 120.45 -1.406 . . . . 0.0 112.908 171.728 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 11.8 m -85.98 -10.19 11.27 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.167 0 CA-C-N 119.909 1.231 . . . . 0.0 113.555 174.195 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 72.0 p -98.31 0.96 46.57 Favored 'General case' 0 N--CA 1.477 0.917 0 N-CA-C 115.225 1.565 . . . . 0.0 115.225 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 76.7 mm-40 -67.4 160.35 27.55 Favored 'General case' 0 N--CA 1.478 0.971 0 CA-C-N 119.482 1.037 . . . . 0.0 110.95 169.803 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -58.01 -36.04 72.12 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 116.09 1.885 . . . . 0.0 116.09 -168.34 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.76 ' HB ' HG22 ' A' ' 75' ' ' VAL . 12.1 mm -127.18 74.55 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 CA-C-N 119.605 1.093 . . . . 0.0 109.062 177.707 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 12.4 t80 -81.57 109.78 16.34 Favored 'General case' 0 CA--C 1.534 0.365 0 O-C-N 121.224 -0.922 . . . . 0.0 108.544 169.289 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -111.32 139.33 46.82 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 114.636 1.347 . . . . 0.0 114.636 174.403 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -104.94 121.15 43.12 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.242 1.017 . . . . 0.0 108.98 168.754 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 43.8 m0 -107.07 111.61 24.15 Favored 'General case' 0 C--N 1.33 -0.239 0 C-N-CA 124.756 1.222 . . . . 0.0 108.352 -179.686 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 84.0 mm-40 -83.95 53.96 2.76 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-O 122.318 1.056 . . . . 0.0 111.561 -173.832 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 87.7 mt -85.53 165.86 16.76 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 126.957 2.103 . . . . 0.0 112.22 -179.704 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -96.29 157.0 16.1 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 123.98 0.912 . . . . 0.0 113.147 172.972 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 51.5 t0 -86.34 124.26 70.21 Favored Pre-proline 0 CA--C 1.542 0.665 0 C-N-CA 124.445 1.098 . . . . 0.0 110.266 173.021 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_exo -58.67 -24.4 70.57 Favored 'Trans proline' 0 CA--C 1.543 0.952 0 C-N-CA 122.925 2.417 . . . . 0.0 115.343 172.868 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -65.94 143.52 57.35 Favored 'General case' 0 CA--C 1.546 0.792 0 CA-C-N 119.444 1.02 . . . . 0.0 112.995 -178.771 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 80.95 5.95 89.78 Favored Glycine 0 CA--C 1.536 1.399 0 N-CA-C 115.176 0.83 . . . . 0.0 115.176 178.617 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 8.6 pt20 -142.17 168.3 20.07 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 125.378 1.471 . . . . 0.0 112.833 179.275 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 66.8 m -59.67 155.21 16.17 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 125.503 1.521 . . . . 0.0 114.085 -170.181 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 7.9 tt -60.51 -30.98 70.07 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.746 1.218 . . . . 0.0 113.569 -175.107 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -65.17 -23.96 67.25 Favored 'General case' 0 CA--C 1.546 0.81 0 O-C-N 121.059 -1.026 . . . . 0.0 112.899 173.544 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 11.3 t -72.84 -38.15 56.47 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 O-C-N 120.789 -1.195 . . . . 0.0 110.734 170.651 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -53.76 -45.73 70.69 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 118.78 0.718 . . . . 0.0 110.686 169.045 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 38.9 mtt180 -66.77 -39.08 87.71 Favored 'General case' 0 N--CA 1.482 1.159 0 N-CA-C 113.012 0.745 . . . . 0.0 113.012 175.979 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 28.9 m -58.89 -42.88 90.58 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 124.345 1.058 . . . . 0.0 110.946 172.833 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 77.6 t -67.99 -38.57 80.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 CA-C-O 117.894 -1.051 . . . . 0.0 111.083 177.361 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 65.9 mtm-85 -57.25 -43.82 83.34 Favored 'General case' 0 N--CA 1.487 1.413 0 CA-C-N 120.696 1.589 . . . . 0.0 112.208 170.169 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -59.37 -49.6 76.74 Favored Glycine 0 CA--C 1.536 1.403 0 CA-C-N 119.104 0.865 . . . . 0.0 113.253 176.522 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 55.5 mm-40 -64.57 -44.11 91.73 Favored 'General case' 0 N--CA 1.473 0.709 0 O-C-N 122.078 -0.66 . . . . 0.0 112.131 177.788 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 75.6 t -65.95 -37.38 79.72 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 124.203 1.001 . . . . 0.0 111.344 177.201 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 58.2 tttm -55.93 -51.9 66.0 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-N 119.81 1.186 . . . . 0.0 110.743 176.212 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -63.78 -40.82 97.6 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.119 0.568 . . . . 0.0 112.199 178.347 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -62.87 -44.08 97.07 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 124.583 1.153 . . . . 0.0 113.272 176.486 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 66.8 t -74.31 -35.8 40.93 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 124.188 0.995 . . . . 0.0 111.518 178.56 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -63.1 -39.76 95.65 Favored 'General case' 0 N--CA 1.471 0.58 0 O-C-N 121.138 -0.976 . . . . 0.0 111.679 169.809 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 11.6 m-80 -63.36 -44.94 93.36 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 118.976 0.807 . . . . 0.0 112.225 172.932 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 8.4 tt -51.49 -56.79 11.41 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 124.48 1.112 . . . . 0.0 110.306 174.334 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 62.8 mt -66.82 -44.24 89.23 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 O-C-N 121.848 -0.533 . . . . 0.0 111.174 -175.731 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -69.4 -10.53 58.38 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 114.102 1.149 . . . . 0.0 114.102 177.559 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 72.7 tttt -95.77 -48.26 5.83 Favored 'General case' 0 C--O 1.234 0.239 0 C-N-CA 125.811 1.644 . . . . 0.0 111.428 176.037 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 7.5 pt -93.71 -15.17 7.99 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 N-CA-C 114.375 1.25 . . . . 0.0 114.375 -172.798 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 73.8 m . . . . . 0 C--O 1.256 1.408 0 C-N-CA 125.606 1.562 . . . . 0.0 111.722 -176.464 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.8 ttt . . . . . 0 N--CA 1.502 2.166 0 N-CA-C 111.861 0.319 . . . . 0.0 111.861 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.72 164.99 28.88 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 125.371 1.468 . . . . 0.0 112.937 178.737 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 71.1 mttt -94.49 146.42 24.11 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 124.085 0.954 . . . . 0.0 112.872 175.58 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 14.5 t -123.51 134.45 66.31 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 C-N-CA 125.543 1.537 . . . . 0.0 111.998 175.019 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 48.6 tpp -102.81 123.48 46.54 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 168.806 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 72.4 m-85 -101.35 131.19 47.54 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 169.858 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -140.65 143.18 29.35 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 N-CA-C 114.012 1.116 . . . . 0.0 114.012 -169.379 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 46.4 t -145.14 160.11 41.94 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 127.473 2.309 . . . . 0.0 109.081 169.36 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 64.9 pttt -66.23 -42.67 88.32 Favored 'General case' 0 N--CA 1.485 1.311 0 N-CA-C 115.117 1.525 . . . . 0.0 115.117 -171.341 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 12.7 mmm180 -113.29 63.12 0.64 Allowed 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 126.758 2.023 . . . . 0.0 112.148 -175.705 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 47.2 t30 -45.42 -46.6 13.48 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 125.139 1.376 . . . . 0.0 113.834 -172.52 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 86.0 p -78.36 -10.2 59.59 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 115.717 1.747 . . . . 0.0 115.717 -175.674 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 88.6 p -133.36 0.34 3.35 Favored 'General case' 0 N--CA 1.479 1.003 0 N-CA-C 116.3 1.963 . . . . 0.0 116.3 179.401 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 2.4 tpt180 -112.82 -27.38 8.15 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 114.889 1.44 . . . . 0.0 114.889 178.766 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 3.0 t 63.77 166.63 0.14 Allowed 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 115.639 1.718 . . . . 0.0 115.639 -176.221 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -141.58 -50.06 0.41 Allowed 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 114.396 1.258 . . . . 0.0 114.396 -170.006 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 70.52 -38.78 0.43 Allowed 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 126.185 1.794 . . . . 0.0 114.096 -178.374 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -63.02 -30.79 71.88 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 113.992 1.108 . . . . 0.0 113.992 -173.73 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.2 pm0 -67.2 -42.42 84.18 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 119.568 1.077 . . . . 0.0 111.837 175.759 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -66.77 -41.31 93.75 Favored Glycine 0 C--N 1.335 0.48 0 N-CA-C 111.351 -0.7 . . . . 0.0 111.351 -178.324 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -70.89 -39.25 72.92 Favored 'General case' 0 N--CA 1.469 0.497 0 O-C-N 121.842 -0.799 . . . . 0.0 111.815 174.91 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -63.76 -35.92 82.19 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 119.375 0.989 . . . . 0.0 112.909 -176.08 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 7.5 pttp -82.72 -28.35 30.54 Favored 'General case' 0 N--CA 1.479 0.996 0 N-CA-C 113.972 1.101 . . . . 0.0 113.972 171.964 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 96.6 m -70.22 -35.74 74.08 Favored 'General case' 0 N--CA 1.486 1.341 0 CA-C-N 118.76 0.709 . . . . 0.0 111.937 175.093 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 74.1 mt -91.0 -38.03 13.08 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 125.92 1.688 . . . . 0.0 113.324 179.175 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -105.11 5.98 42.57 Favored Glycine 0 N--CA 1.471 1.008 0 N-CA-C 117.5 1.76 . . . . 0.0 117.5 -169.303 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.61 141.23 57.91 Favored 'General case' 0 CA--C 1.546 0.821 0 CA-C-N 121.149 2.474 . . . . 0.0 112.294 178.122 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 82.88 -16.93 24.46 Favored Glycine 0 CA--C 1.539 1.564 0 C-N-CA 124.868 1.223 . . . . 0.0 113.959 -169.539 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 62.7 mttp -104.0 -44.29 5.06 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 125.897 1.679 . . . . 0.0 112.172 171.808 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 38.1 pt -139.53 159.63 27.99 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 C-N-CA 125.323 1.449 . . . . 0.0 112.64 -178.257 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -107.85 149.23 28.52 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.378 1.471 . . . . 0.0 110.397 170.017 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 98.1 t -133.46 141.64 43.86 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 O-C-N 121.497 -0.752 . . . . 0.0 112.796 -176.173 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 38.8 m -134.91 153.33 52.1 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 125.732 1.613 . . . . 0.0 108.926 169.703 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 92.8 p -133.33 145.73 50.67 Favored 'General case' 0 CA--C 1.512 -0.497 0 CA-C-O 122.372 1.082 . . . . 0.0 112.179 167.774 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 54.4 p -145.97 166.53 25.77 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 113.714 -1.584 . . . . 0.0 112.199 -177.68 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -106.63 162.82 13.57 Favored Glycine 0 N--CA 1.467 0.753 0 C-N-CA 123.587 0.613 . . . . 0.0 112.754 172.986 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 9.0 mp -76.0 -32.27 59.33 Favored 'General case' 0 N--CA 1.479 1.024 0 O-C-N 122.144 -0.621 . . . . 0.0 111.819 172.988 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -134.29 27.23 3.8 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 125.734 1.614 . . . . 0.0 111.916 177.12 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 37.5 t -154.66 145.45 22.46 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 124.319 1.048 . . . . 0.0 112.796 -170.353 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 98.8 p -107.96 -13.04 15.05 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 116.853 2.168 . . . . 0.0 116.853 -169.679 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 71.7 ttt180 -134.38 149.12 50.79 Favored 'General case' 0 N--CA 1.483 1.217 0 CA-C-N 120.009 1.277 . . . . 0.0 111.072 -176.382 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 22.3 m -68.11 166.27 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.15 0 CA-C-O 122.908 1.337 . . . . 0.0 110.98 169.536 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 6.1 t-80 -57.04 129.87 79.18 Favored Pre-proline 0 N--CA 1.447 -0.586 0 CA-C-N 114.049 -1.432 . . . . 0.0 111.716 179.163 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_exo -61.1 -29.2 86.88 Favored 'Trans proline' 0 CA--C 1.549 1.25 0 CA-C-N 121.145 1.445 . . . . 0.0 112.3 177.506 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 99.3 m -67.64 -28.24 67.56 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 126.069 1.748 . . . . 0.0 112.656 172.918 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -59.68 -41.06 89.84 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 119.119 0.872 . . . . 0.0 111.748 -176.717 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.9 mp -54.17 -55.16 15.83 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 C-N-CA 123.976 0.91 . . . . 0.0 109.298 -177.585 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -65.83 -34.63 78.61 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 113.94 1.089 . . . . 0.0 113.94 -176.859 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -78.26 -20.57 51.38 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 113.676 0.991 . . . . 0.0 113.676 179.785 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 43.0 mtt -98.16 -26.78 14.45 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 125.032 1.333 . . . . 0.0 110.493 177.391 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -66.53 -13.82 61.47 Favored 'General case' 0 CA--C 1.544 0.717 0 O-C-N 120.662 -1.274 . . . . 0.0 111.784 168.525 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -61.83 -24.65 67.02 Favored 'General case' 0 N--CA 1.482 1.136 0 O-C-N 121.001 -1.062 . . . . 0.0 110.652 168.806 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 40.0 t -99.62 -6.77 9.15 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.882 0 C-N-CA 127.896 2.478 . . . . 0.0 111.275 175.358 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 81.68 20.82 62.95 Favored Glycine 0 CA--C 1.54 1.647 0 C-N-CA 125.293 1.425 . . . . 0.0 114.378 -173.44 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 85.7 mt -79.65 127.14 39.37 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 CA-C-N 118.485 1.143 . . . . 0.0 111.874 -173.51 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 20.7 t0 -89.15 93.73 9.68 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 123.538 0.735 . . . . 0.0 112.006 177.983 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 7.2 pt -118.27 11.08 7.03 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.082 0 C-N-CA 124.703 1.201 . . . . 0.0 113.957 170.761 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 72.7 m -60.42 -27.33 67.4 Favored 'General case' 0 N--CA 1.479 0.988 0 O-C-N 120.793 -1.192 . . . . 0.0 112.541 176.57 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -82.55 6.8 67.43 Favored Glycine 0 CA--C 1.538 1.472 0 C-N-CA 125.63 1.586 . . . . 0.0 116.031 174.976 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 26.5 mm100 -78.16 43.4 0.44 Allowed 'General case' 0 N--CA 1.478 0.969 0 CA-C-N 120.069 1.934 . . . . 0.0 113.599 -179.812 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 36.6 p -87.96 111.97 22.06 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 107.102 -1.444 . . . . 0.0 107.102 168.769 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 70.4 m -130.81 -160.59 1.05 Allowed 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 124.831 1.252 . . . . 0.0 111.374 -168.897 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -124.14 166.98 16.71 Favored Pre-proline 0 CA--C 1.546 0.797 0 C-N-CA 126.354 1.862 . . . . 0.0 108.464 169.543 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_endo -58.21 156.92 27.7 Favored 'Trans proline' 0 CA--C 1.539 0.761 0 C-N-CA 121.917 1.744 . . . . 0.0 112.38 169.573 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.492 HD11 ' CE3' ' A' ' 90' ' ' TRP . 9.8 tp -49.94 -34.02 9.51 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 C-N-CA 125.537 1.535 . . . . 0.0 112.363 174.183 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 12.7 mt-10 -64.32 -18.42 64.6 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.864 1.266 . . . . 0.0 113.126 -177.912 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -87.06 -13.9 43.01 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 124.994 1.318 . . . . 0.0 113.583 -173.255 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -104.67 -174.24 2.49 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 126.164 1.786 . . . . 0.0 112.686 -174.594 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 6.1 t30 -121.94 121.99 38.35 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 125.679 1.591 . . . . 0.0 109.519 175.035 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -64.11 -37.79 88.71 Favored 'General case' 0 C--N 1.333 -0.139 0 N-CA-C 114.943 1.46 . . . . 0.0 114.943 -169.617 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -73.64 -1.4 18.76 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 114.141 1.163 . . . . 0.0 114.141 -174.071 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -73.37 -14.87 61.36 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 123.392 0.677 . . . . 0.0 110.743 168.712 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 81.2 m-85 -112.44 140.57 47.07 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 127.315 2.246 . . . . 0.0 111.203 178.195 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -91.21 -22.58 20.55 Favored 'General case' 0 N--CA 1.477 0.879 0 CA-C-O 121.992 0.901 . . . . 0.0 112.303 176.939 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.714 HG22 ' HB ' ' A' ' 95' ' ' ILE . 90.5 t -134.5 138.1 50.26 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 C-N-CA 126.849 2.06 . . . . 0.0 108.948 -173.611 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 47.3 t -134.52 130.4 53.52 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 172.761 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 39.3 mm -119.0 104.83 16.51 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 C-N-CA 124.292 1.037 . . . . 0.0 109.717 -172.363 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 7.3 m -81.88 118.92 23.31 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 123.807 0.843 . . . . 0.0 109.634 171.359 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 90.5 mt -100.11 -7.23 25.13 Favored 'General case' 0 N--CA 1.478 0.929 0 N-CA-C 114.491 1.293 . . . . 0.0 114.491 -171.643 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 76.5 m -131.06 59.92 1.67 Allowed 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 125.217 1.407 . . . . 0.0 109.177 -169.745 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 82.4 -155.44 34.16 Favored Glycine 0 CA--C 1.536 1.354 0 C-N-CA 124.846 1.212 . . . . 0.0 111.602 -169.577 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 83.6 p -66.3 -29.91 70.22 Favored 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 113.483 0.92 . . . . 0.0 113.483 177.855 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 66.4 20.5 69.66 Favored Glycine 0 CA--C 1.534 1.247 0 C-N-CA 124.402 1.001 . . . . 0.0 114.11 -177.312 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 7.3 p -55.99 -9.89 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.34 0 N-CA-C 116.118 1.896 . . . . 0.0 116.118 -169.691 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -66.82 -22.18 66.01 Favored 'General case' 0 CA--C 1.554 1.124 0 N-CA-C 114.362 1.245 . . . . 0.0 114.362 169.953 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -67.82 154.51 93.41 Favored Pre-proline 0 N--CA 1.483 1.202 0 CA-C-N 120.903 1.683 . . . . 0.0 112.009 169.693 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.407 ' HA ' ' HD3' ' A' ' 88' ' ' PRO . 74.4 Cg_exo -57.71 148.51 73.86 Favored 'Trans proline' 0 CA--C 1.545 1.045 0 C-N-CA 122.698 2.265 . . . . 0.0 113.825 -175.975 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 87' ' ' PRO . 82.2 Cg_exo -56.04 -32.54 86.65 Favored 'Trans proline' 0 C--N 1.354 0.85 0 C-N-CA 123.12 2.547 . . . . 0.0 114.898 -171.755 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -60.51 -21.69 62.73 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 114.057 1.132 . . . . 0.0 114.057 179.411 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' TRP . . . . . 0.492 ' CE3' HD11 ' A' ' 65' ' ' ILE . 93.7 m95 -79.48 -21.52 45.29 Favored 'General case' 0 N--CA 1.47 0.529 0 O-C-N 120.695 -1.253 . . . . 0.0 113.169 175.0 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 14.2 m -92.42 -5.94 10.69 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 N-CA-C 113.481 0.919 . . . . 0.0 113.481 173.431 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 59.9 p -100.32 0.39 39.99 Favored 'General case' 0 N--CA 1.479 1.006 0 N-CA-C 115.29 1.589 . . . . 0.0 115.29 177.32 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 74.0 mm-40 -66.89 155.42 38.46 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-N 119.459 1.027 . . . . 0.0 110.722 169.789 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -54.78 -43.12 72.55 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 115.093 1.516 . . . . 0.0 115.093 -167.78 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.714 ' HB ' HG22 ' A' ' 75' ' ' VAL . 10.0 mm -116.53 66.39 0.23 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 C-N-CA 123.875 0.87 . . . . 0.0 109.579 176.932 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 12.2 t80 -77.04 108.71 10.3 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 168.595 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 9.1 mt-10 -107.62 142.58 37.34 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 114.321 1.23 . . . . 0.0 114.321 173.511 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -107.66 120.24 41.66 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 124.634 1.174 . . . . 0.0 108.23 168.381 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 37.3 m0 -103.84 133.67 48.44 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.545 1.138 . . . . 0.0 108.814 177.504 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 63.8 mt-30 -113.88 29.36 8.06 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 123.993 0.917 . . . . 0.0 111.987 -169.907 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -70.37 164.62 24.15 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 125.732 1.613 . . . . 0.0 112.292 170.621 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -73.63 158.71 34.25 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-O 121.773 0.797 . . . . 0.0 111.49 169.824 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -97.02 150.77 37.2 Favored Pre-proline 0 CA--C 1.542 0.653 0 C-N-CA 123.418 0.687 . . . . 0.0 110.055 169.797 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -88.59 -12.44 3.71 Favored 'Trans proline' 0 CA--C 1.547 1.152 0 CA-C-N 120.845 1.338 . . . . 0.0 115.072 -173.415 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -62.53 -50.27 72.04 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 114.928 1.455 . . . . 0.0 114.928 -170.82 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -77.24 16.69 5.63 Favored Glycine 0 CA--C 1.537 1.425 0 N-CA-C 115.256 0.862 . . . . 0.0 115.256 -169.825 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 7.9 pt20 -155.92 179.28 9.36 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 126.006 1.722 . . . . 0.0 112.63 -169.221 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 27.8 p -68.8 167.46 15.43 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 116.27 1.952 . . . . 0.0 116.27 -169.314 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 36.0 tp -59.88 -31.81 70.14 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.412 1.085 . . . . 0.0 112.46 172.945 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -63.46 -32.51 73.98 Favored 'General case' 0 N--CA 1.47 0.537 0 O-C-N 121.073 -1.017 . . . . 0.0 111.499 172.896 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 4.4 t -74.1 -35.07 40.21 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 O-C-N 121.2 -0.937 . . . . 0.0 112.069 171.54 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -55.59 -46.95 77.18 Favored 'General case' 0 N--CA 1.477 0.889 0 CA-C-N 120.424 1.466 . . . . 0.0 111.255 169.413 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 96.9 mtt180 -69.87 -33.91 72.87 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.75 0.82 . . . . 0.0 112.585 178.275 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 53.2 m -63.34 -42.89 98.98 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 123.787 0.835 . . . . 0.0 110.96 170.212 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 50.8 t -65.11 -40.56 89.28 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.475 0 CA-C-O 117.316 -1.326 . . . . 0.0 110.55 176.413 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 24.7 mtm105 -53.63 -47.38 70.34 Favored 'General case' 0 N--CA 1.484 1.248 0 CA-C-N 120.804 1.638 . . . . 0.0 112.287 170.879 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -61.36 -50.65 64.54 Favored Glycine 0 CA--C 1.537 1.417 0 CA-C-N 119.027 0.831 . . . . 0.0 113.644 177.743 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 65.2 mm-40 -63.49 -44.48 94.24 Favored 'General case' 0 N--CA 1.474 0.736 0 O-C-N 121.991 -0.711 . . . . 0.0 112.332 179.221 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 56.0 t -63.79 -43.73 98.02 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 C-N-CA 124.507 1.123 . . . . 0.0 110.603 176.485 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 59.5 tttm -53.56 -50.69 65.01 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-N 119.804 1.184 . . . . 0.0 111.295 179.602 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -63.58 -41.32 98.38 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 179.064 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 8.5 mtp85 -64.25 -42.12 96.65 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 113.145 0.794 . . . . 0.0 113.145 175.766 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 94.2 t -71.0 -36.44 63.53 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 C-N-CA 123.674 0.79 . . . . 0.0 111.156 178.71 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -63.31 -38.09 89.81 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 119.386 0.994 . . . . 0.0 111.606 170.724 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 12.5 m-80 -62.67 -48.02 81.12 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 118.914 0.779 . . . . 0.0 112.052 171.807 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 10.3 tt -50.45 -57.24 8.49 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 124.483 1.113 . . . . 0.0 110.07 173.809 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 75.3 mt -64.02 -42.57 96.1 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 CA-C-N 119.25 0.932 . . . . 0.0 111.56 -176.601 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -68.22 -10.46 54.62 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 114.535 1.309 . . . . 0.0 114.535 175.781 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 74.6 tttt -103.5 -45.78 4.75 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 126.049 1.74 . . . . 0.0 111.664 -179.813 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.573 HD13 HG21 ' A' ' 75' ' ' VAL . 5.4 pt -92.06 -16.53 7.88 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 N-CA-C 114.48 1.289 . . . . 0.0 114.48 -170.293 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 72.5 m . . . . . 0 C--O 1.253 1.281 0 CA-C-N 118.913 0.778 . . . . 0.0 112.9 -175.603 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.1 ttt . . . . . 0 N--CA 1.502 2.151 0 N-CA-C 111.615 0.228 . . . . 0.0 111.615 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.75 166.5 25.06 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 124.768 1.227 . . . . 0.0 113.654 177.266 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 44.2 mtmt -94.76 138.71 32.23 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 126.154 1.782 . . . . 0.0 112.954 -179.191 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 21.2 t -123.6 133.51 68.99 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 C-N-CA 126.036 1.734 . . . . 0.0 112.479 -179.151 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' MET . . . . . 0.494 ' HG3' HG13 ' A' ' 7' ' ' VAL . 41.8 tpp -104.66 125.51 50.85 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.562 0.745 . . . . 0.0 109.492 168.888 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 58.6 m-85 -102.81 127.72 49.86 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.266 1.026 . . . . 0.0 109.667 170.351 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.531 HG11 HD12 ' A' ' 65' ' ' ILE . 1.3 m -140.51 144.98 26.46 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.182 0 N-CA-C 114.414 1.265 . . . . 0.0 114.414 -168.862 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 41.7 t -157.06 159.65 38.15 Favored 'General case' 0 CA--C 1.556 1.18 0 C-N-CA 127.369 2.268 . . . . 0.0 111.974 177.443 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 17.9 ptpt -90.57 157.67 17.39 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 124.997 1.319 . . . . 0.0 111.638 169.522 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 34.1 mtp180 60.15 25.47 14.81 Favored 'General case' 0 N--CA 1.494 1.746 0 C-N-CA 126.074 1.75 . . . . 0.0 113.804 -169.098 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 5.8 t30 -52.95 -38.61 62.18 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 124.839 1.256 . . . . 0.0 114.045 -169.449 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 50.2 m -80.31 -8.34 59.44 Favored 'General case' 0 N--CA 1.478 0.96 0 N-CA-C 114.692 1.367 . . . . 0.0 114.692 -178.621 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 83.6 p -119.76 16.54 12.72 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 125.394 1.478 . . . . 0.0 112.996 170.672 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 19.5 ttm180 -139.49 156.06 47.17 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 125.653 1.581 . . . . 0.0 112.115 -175.78 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 73.0 m -94.76 138.08 33.03 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 125.015 1.326 . . . . 0.0 111.046 169.785 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 3.9 mp0 -113.71 -39.1 4.1 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 124.291 1.037 . . . . 0.0 112.497 -177.1 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' MET . . . . . 0.43 ' HG2' ' SD ' ' A' ' 50' ' ' MET . 0.0 OUTLIER 68.96 -50.98 0.59 Allowed 'General case' 0 N--CA 1.478 0.954 0 N-CA-C 117.641 2.46 . . . . 0.0 117.641 169.212 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -56.73 -35.3 68.4 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 114.398 1.258 . . . . 0.0 114.398 -169.246 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 23.4 pm0 -61.13 -40.06 92.37 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.944 1.297 . . . . 0.0 112.711 177.137 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -69.91 -37.77 74.79 Favored Glycine 0 C--N 1.336 0.554 0 N-CA-C 111.377 -0.689 . . . . 0.0 111.377 178.46 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -70.43 -40.25 73.9 Favored 'General case' 0 N--CA 1.47 0.546 0 O-C-N 121.89 -0.771 . . . . 0.0 111.184 176.514 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.21 -41.79 97.46 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 119.024 0.829 . . . . 0.0 112.527 -175.567 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 10.5 pttp -79.49 -27.53 41.48 Favored 'General case' 0 N--CA 1.479 1.013 0 N-CA-C 113.662 0.986 . . . . 0.0 113.662 173.891 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 96.3 m -68.84 -36.59 78.34 Favored 'General case' 0 N--CA 1.486 1.342 0 O-C-N 121.185 -0.947 . . . . 0.0 111.636 172.81 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 72.1 mt -87.89 -29.67 20.7 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 125.656 1.582 . . . . 0.0 114.037 -178.489 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -146.03 28.95 1.69 Allowed Glycine 0 N--CA 1.473 1.129 0 N-CA-C 118.502 2.161 . . . . 0.0 118.502 -169.206 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -66.62 -20.2 65.94 Favored 'General case' 0 CA--C 1.546 0.813 0 CA-C-N 122.108 2.954 . . . . 0.0 115.197 -177.995 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -76.49 -7.73 85.5 Favored Glycine 0 CA--C 1.542 1.771 0 O-C-N 121.432 -0.793 . . . . 0.0 113.597 169.575 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 61.1 mttp -111.33 -40.73 4.32 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 127.088 2.155 . . . . 0.0 112.692 -178.872 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 28.3 pt -141.09 155.71 21.63 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 C-N-CA 125.366 1.466 . . . . 0.0 112.42 -172.806 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -103.06 136.6 42.56 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 124.678 1.191 . . . . 0.0 110.199 171.909 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 74.6 t -123.54 137.18 57.65 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 CA-C-N 118.814 0.734 . . . . 0.0 112.134 -175.327 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 41.4 m -129.59 153.71 47.8 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 125.566 1.547 . . . . 0.0 108.763 169.844 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 26.0 p -129.59 146.33 51.4 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.806 0.812 . . . . 0.0 111.991 168.671 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 59.4 p -145.78 148.17 32.66 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 114.247 -1.342 . . . . 0.0 112.117 177.45 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -82.32 152.66 31.16 Favored Glycine 0 CA--C 1.53 1.009 0 O-C-N 121.429 -0.794 . . . . 0.0 111.493 172.646 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.7 mp -69.4 -32.8 72.04 Favored 'General case' 0 N--CA 1.477 0.877 0 O-C-N 120.843 -1.387 . . . . 0.0 113.389 179.006 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -134.77 11.9 3.68 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 124.683 1.193 . . . . 0.0 113.027 178.641 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 23.6 p -152.73 173.89 14.71 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 125.227 1.411 . . . . 0.0 112.013 -174.71 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 62.6 m -99.0 -73.39 0.62 Allowed 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 113.738 1.014 . . . . 0.0 113.738 -169.838 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 30.3 ttt85 -86.18 165.89 16.18 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 125.906 1.682 . . . . 0.0 111.463 -169.397 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 21.3 m -82.57 166.38 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 C-N-CA 123.258 0.623 . . . . 0.0 111.316 170.356 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . 0.262 0.0 OUTLIER -67.67 137.76 93.12 Favored Pre-proline 0 CA--C 1.545 0.766 0 C-N-CA 118.971 -1.091 . . . . 0.0 109.879 169.752 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -61.38 -30.06 86.65 Favored 'Trans proline' 0 CA--C 1.537 0.67 0 C-N-CA 123.219 2.613 . . . . 0.0 116.148 -167.793 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 90.7 m -64.14 -23.96 67.51 Favored 'General case' 0 N--CA 1.481 1.075 0 O-C-N 120.969 -1.082 . . . . 0.0 111.86 -177.939 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -55.67 -38.62 69.85 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.117 0.967 . . . . 0.0 112.507 172.513 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 5.0 mp -60.22 -54.7 31.26 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 CA-C-N 119.588 1.085 . . . . 0.0 110.018 179.863 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.3 -32.09 73.41 Favored 'General case' 0 CA--C 1.542 0.656 0 N-CA-C 113.222 0.823 . . . . 0.0 113.222 -178.535 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 2.1 tpp -77.71 -25.6 49.48 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 113.679 0.992 . . . . 0.0 113.679 177.176 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' MET . . . . . 0.43 ' SD ' ' HG2' ' A' ' 17' ' ' MET . 0.0 OUTLIER -88.01 -26.84 22.4 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-N 119.723 1.147 . . . . 0.0 111.04 174.145 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -65.12 -11.83 44.22 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 124.998 1.319 . . . . 0.0 113.219 169.917 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 17.9 mt-10 -61.7 -27.05 68.42 Favored 'General case' 0 N--CA 1.485 1.29 0 CA-C-N 120.012 1.278 . . . . 0.0 110.26 168.551 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 21.6 t -98.27 -1.52 10.17 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.958 0 C-N-CA 128.232 2.613 . . . . 0.0 110.829 178.774 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 77.04 20.13 76.3 Favored Glycine 0 CA--C 1.538 1.512 0 C-N-CA 125.041 1.305 . . . . 0.0 114.474 -176.036 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 70.5 mt -80.25 128.12 38.86 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 124.279 1.032 . . . . 0.0 111.72 -172.122 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 10.4 p-10 -88.22 100.35 12.91 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 124.372 1.069 . . . . 0.0 112.582 -179.734 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 12.9 pt -133.25 15.4 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.141 0 N-CA-C 114.934 1.457 . . . . 0.0 114.934 178.473 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 66.5 m -63.56 -19.77 65.09 Favored 'General case' 0 N--CA 1.481 1.09 0 O-C-N 120.32 -1.487 . . . . 0.0 113.293 177.514 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -85.41 10.08 65.3 Favored Glycine 0 CA--C 1.538 1.506 0 C-N-CA 125.993 1.759 . . . . 0.0 116.59 179.636 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 64.3 mt-30 -71.96 40.45 0.08 Allowed 'General case' 0 N--CA 1.486 1.34 0 CA-C-N 120.334 2.067 . . . . 0.0 114.699 -178.753 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 88.8 m -80.98 -4.56 55.51 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 119.788 -1.82 . . . . 0.0 112.662 177.198 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 70.5 m -45.11 146.4 0.87 Allowed 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 127.416 2.287 . . . . 0.0 114.323 176.332 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -67.69 171.51 5.18 Favored Pre-proline 0 CA--C 1.553 1.087 0 C-N-CA 127.169 2.188 . . . . 0.0 114.1 -175.558 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -59.03 160.06 19.8 Favored 'Trans proline' 0 C--N 1.353 0.798 0 C-N-CA 122.987 2.458 . . . . 0.0 113.621 169.73 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.531 HD12 HG11 ' A' ' 7' ' ' VAL . 7.6 tt -51.21 -37.6 18.11 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 C-N-CA 124.864 1.266 . . . . 0.0 111.854 174.988 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 14.1 mt-10 -64.61 -17.4 63.96 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.715 1.206 . . . . 0.0 113.111 -177.269 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -83.71 -12.3 56.01 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 124.927 1.291 . . . . 0.0 113.233 -178.31 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -106.94 -175.31 2.76 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 126.449 1.9 . . . . 0.0 112.723 -175.603 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 5.6 t30 -124.35 124.35 42.18 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 126.008 1.723 . . . . 0.0 109.103 174.942 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.74 -34.29 77.52 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 114.012 1.115 . . . . 0.0 114.012 -169.937 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . 0.264 0.0 OUTLIER -71.24 -4.58 26.49 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 114.06 1.133 . . . . 0.0 114.06 -177.752 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -72.94 -12.75 61.07 Favored 'General case' 0 CA--C 1.549 0.942 0 C-N-CA 123.4 0.68 . . . . 0.0 111.012 168.52 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 88.6 m-85 -118.19 138.5 52.27 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 126.806 2.042 . . . . 0.0 111.562 -177.713 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -89.08 -22.15 23.06 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-O 122.104 0.954 . . . . 0.0 112.38 176.404 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.712 HG22 ' HB ' ' A' ' 95' ' ' ILE . 77.9 t -131.44 138.59 52.74 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 C-N-CA 127.136 2.174 . . . . 0.0 108.908 -175.895 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 48.5 t -131.49 123.93 53.57 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 169.899 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 45.2 mm -109.42 103.72 15.95 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 C-N-CA 124.6 1.16 . . . . 0.0 109.536 -176.377 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 13.2 m -83.35 102.07 11.75 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 124.333 1.053 . . . . 0.0 109.439 169.989 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 92.4 mt -72.37 -36.25 68.69 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 112.755 0.65 . . . . 0.0 112.755 -177.371 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 36.4 m -112.05 122.27 47.3 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 125.61 1.564 . . . . 0.0 110.492 -169.221 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 62.9 -157.28 39.23 Favored Glycine 0 CA--C 1.537 1.455 0 C-N-CA 123.626 0.631 . . . . 0.0 114.055 -175.737 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 50.3 m -90.08 0.08 57.32 Favored 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 114.8 1.407 . . . . 0.0 114.8 -172.806 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 71.34 29.16 68.67 Favored Glycine 0 CA--C 1.535 1.315 0 O-C-N 121.478 -0.764 . . . . 0.0 114.609 179.249 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 60.0 t -90.46 -17.6 7.86 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.384 0 CA-C-N 118.216 1.008 . . . . 0.0 112.144 -179.69 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -84.23 12.63 6.26 Favored 'General case' 0 CA--C 1.555 1.144 0 C-N-CA 124.955 1.302 . . . . 0.0 113.641 -173.418 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -119.88 163.85 25.51 Favored Pre-proline 0 CA--C 1.552 1.047 0 C-N-CA 126.186 1.794 . . . . 0.0 112.464 177.671 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.415 ' HA ' ' HD3' ' A' ' 88' ' ' PRO . 52.0 Cg_exo -63.53 150.1 89.35 Favored 'Trans proline' 0 CA--C 1.545 1.064 0 C-N-CA 122.437 2.091 . . . . 0.0 113.981 -178.16 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 87' ' ' PRO . 74.7 Cg_exo -58.44 -27.96 83.63 Favored 'Trans proline' 0 C--N 1.353 0.789 0 C-N-CA 123.442 2.762 . . . . 0.0 115.559 -173.215 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -61.11 -24.14 66.03 Favored 'General case' 0 CA--C 1.544 0.725 0 O-C-N 120.976 -1.077 . . . . 0.0 113.214 177.059 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 89.6 m95 -82.96 -23.52 33.38 Favored 'General case' 0 N--CA 1.469 0.491 0 O-C-N 120.791 -1.193 . . . . 0.0 113.2 176.901 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 4.4 m -85.15 -18.98 8.91 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.228 0 CA-C-N 119.331 0.968 . . . . 0.0 113.142 173.084 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -88.53 -2.18 58.45 Favored 'General case' 0 N--CA 1.478 0.958 0 N-CA-C 114.847 1.425 . . . . 0.0 114.847 -177.517 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 73.0 mm-40 -66.33 157.07 32.65 Favored 'General case' 0 N--CA 1.481 1.08 0 O-C-N 120.963 -1.086 . . . . 0.0 111.575 171.126 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -59.28 -42.22 90.71 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 114.245 1.202 . . . . 0.0 114.245 -168.304 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.712 ' HB ' HG22 ' A' ' 75' ' ' VAL . 21.1 mm -117.88 61.75 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 C-N-CA 124.883 1.273 . . . . 0.0 108.949 179.273 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 19.9 t80 -78.18 110.42 13.15 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 168.967 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 24.9 mt-10 -114.54 137.3 52.04 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 114.047 1.129 . . . . 0.0 114.047 175.185 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -105.37 121.42 43.85 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 124.935 1.294 . . . . 0.0 108.852 169.176 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 42.9 m0 -100.52 -18.22 16.75 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 115.871 1.804 . . . . 0.0 115.871 -168.921 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 41.6 mm-40 55.11 30.61 14.69 Favored 'General case' 0 CA--C 1.555 1.158 0 N-CA-C 113.964 1.098 . . . . 0.0 113.964 174.19 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 30.0 mt -84.22 158.63 21.22 Favored 'General case' 0 N--CA 1.47 0.54 0 O-C-N 120.768 -1.208 . . . . 0.0 112.82 -170.3 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 9.7 tt0 -69.35 133.77 48.24 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.513 169.9 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 16.3 p-10 -90.46 137.66 27.3 Favored Pre-proline 0 CA--C 1.551 0.988 0 C-N-CA 126.011 1.724 . . . . 0.0 112.057 173.068 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_exo -67.79 -14.55 41.95 Favored 'Trans proline' 0 CA--C 1.551 1.333 0 C-N-CA 122.35 2.033 . . . . 0.0 115.358 178.225 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -59.25 136.73 58.05 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 124.773 1.229 . . . . 0.0 113.541 -175.902 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 76.46 8.99 86.11 Favored Glycine 0 CA--C 1.536 1.377 0 C-N-CA 124.449 1.023 . . . . 0.0 115.019 175.52 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 12.7 pt20 -141.17 168.92 18.62 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 125.53 1.532 . . . . 0.0 112.592 -179.131 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 28.1 p -66.54 166.08 13.36 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 115.453 1.649 . . . . 0.0 115.453 -169.407 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . 0.315 2.4 pp -68.72 -12.81 61.87 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 114.298 1.221 . . . . 0.0 114.298 173.887 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -70.81 -32.96 70.21 Favored 'General case' 0 CA--C 1.541 0.597 0 O-C-N 121.094 -1.004 . . . . 0.0 109.717 168.785 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 5.3 t -70.63 -40.18 76.8 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 CA-C-O 117.876 -1.059 . . . . 0.0 111.255 170.009 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 14.3 m-85 -54.05 -52.12 61.9 Favored 'General case' 0 N--CA 1.478 0.941 0 CA-C-N 120.287 1.403 . . . . 0.0 111.03 169.356 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 97.6 mtt180 -60.95 -38.69 86.77 Favored 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 124.03 0.932 . . . . 0.0 112.385 -179.138 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 75.2 m -64.84 -43.68 92.24 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.949 0.899 . . . . 0.0 111.341 172.776 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 54.5 t -66.72 -40.6 86.45 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 CA-C-O 117.739 -1.124 . . . . 0.0 111.213 177.973 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 47.8 mtm-85 -57.04 -41.06 77.95 Favored 'General case' 0 N--CA 1.482 1.153 0 CA-C-N 120.733 1.606 . . . . 0.0 111.295 174.13 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -60.92 -51.84 56.05 Favored Glycine 0 CA--C 1.537 1.462 0 CA-C-N 118.935 0.788 . . . . 0.0 113.597 173.995 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 60.6 mm-40 -63.89 -44.94 91.51 Favored 'General case' 0 N--CA 1.477 0.882 0 O-C-N 121.965 -0.727 . . . . 0.0 112.199 179.087 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 77.4 t -65.71 -40.61 88.35 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 C-N-CA 124.949 1.3 . . . . 0.0 110.711 178.201 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 36.2 ttmt -54.68 -50.3 68.58 Favored 'General case' 0 N--CA 1.478 0.948 0 CA-C-N 120.311 1.414 . . . . 0.0 110.41 175.989 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -61.8 -41.31 97.59 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 122.759 0.423 . . . . 0.0 112.119 178.821 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.63 -34.36 78.05 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 124.224 1.01 . . . . 0.0 113.561 176.824 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 97.3 t -80.19 -36.43 16.55 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 C-N-CA 125.353 1.461 . . . . 0.0 111.931 176.576 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -62.61 -39.56 94.19 Favored 'General case' 0 N--CA 1.47 0.536 0 O-C-N 120.885 -1.134 . . . . 0.0 110.97 170.09 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 14.2 m-80 -64.23 -44.72 90.98 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 118.747 0.703 . . . . 0.0 112.598 173.731 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 1.2 tt -48.22 -61.41 2.01 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 125.01 1.324 . . . . 0.0 109.702 172.233 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 82.9 mt -60.4 -44.98 97.28 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 C-N-CA 123.24 0.616 . . . . 0.0 110.648 -177.916 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -65.78 -12.76 56.66 Favored 'General case' 0 CA--C 1.547 0.853 0 N-CA-C 114.812 1.412 . . . . 0.0 114.812 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 21.1 ptmt -104.11 -27.13 12.27 Favored 'General case' 0 N--CA 1.477 0.904 0 N-CA-C 114.188 1.181 . . . . 0.0 114.188 172.494 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 16.3 pt -95.22 -12.88 8.42 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 N-CA-C 114.625 1.343 . . . . 0.0 114.625 178.618 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 70.1 m . . . . . 0 C--O 1.254 1.335 0 C-N-CA 125.146 1.379 . . . . 0.0 112.501 -179.742 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 36.4 ttm . . . . . 0 N--CA 1.501 2.083 0 N-CA-C 111.793 0.294 . . . . 0.0 111.793 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.0 163.17 30.47 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 125.151 1.38 . . . . 0.0 111.574 169.439 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 34.5 ttmt -101.63 144.17 30.69 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 124.639 1.175 . . . . 0.0 112.513 -179.044 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 21.7 t -124.15 135.09 64.79 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 125.33 1.452 . . . . 0.0 112.561 -176.358 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' MET . . . . . 0.53 ' HG3' HG13 ' A' ' 7' ' ' VAL . 49.8 tpp -103.74 125.91 50.53 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.396 0.678 . . . . 0.0 109.716 169.565 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 32.4 m-85 -108.73 121.96 46.13 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.917 1.287 . . . . 0.0 109.04 170.519 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.53 HG13 ' HG3' ' A' ' 5' ' ' MET . 2.8 m -140.5 159.32 24.9 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 N-CA-C 115.267 1.58 . . . . 0.0 115.267 -168.619 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.6 m -150.98 160.85 43.66 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 128.529 2.731 . . . . 0.0 110.693 169.68 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 64.8 pttt -82.77 138.38 34.03 Favored 'General case' 0 N--CA 1.48 1.031 0 O-C-N 121.061 -1.024 . . . . 0.0 112.4 171.283 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 20.5 tpt180 44.31 55.06 5.82 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 126.388 1.875 . . . . 0.0 112.729 -169.879 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 63.3 t30 -50.54 -22.12 1.83 Allowed 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 127.725 2.41 . . . . 0.0 113.475 175.012 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 31.1 m -53.2 -22.64 6.95 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 125.885 1.674 . . . . 0.0 113.929 170.473 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 58.7 m -112.35 157.52 20.91 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 126.212 1.805 . . . . 0.0 111.136 171.021 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 61.9 mtt85 61.26 168.9 0.1 Allowed 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 126.468 1.907 . . . . 0.0 114.728 -178.166 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 62.2 m -113.98 122.48 47.07 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 125.493 1.517 . . . . 0.0 110.165 -177.333 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 3.2 mp0 -97.21 -33.89 11.31 Favored 'General case' 0 N--CA 1.48 1.06 0 N-CA-C 115.748 1.759 . . . . 0.0 115.748 -168.647 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 70.1 -46.67 0.61 Allowed 'General case' 0 N--CA 1.482 1.158 0 N-CA-C 118.313 2.709 . . . . 0.0 118.313 168.804 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.69 -30.13 70.54 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 115.169 1.544 . . . . 0.0 115.169 -169.449 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 5.7 pm0 -61.76 -39.1 90.45 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 118.813 0.733 . . . . 0.0 111.854 172.045 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -69.45 -44.77 63.08 Favored Glycine 0 C--N 1.334 0.457 0 C-N-CA 124.216 0.912 . . . . 0.0 111.783 -177.467 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -68.67 -36.01 77.98 Favored 'General case' 0 N--CA 1.467 0.412 0 O-C-N 121.569 -0.959 . . . . 0.0 112.152 173.965 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -65.02 -34.97 79.7 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 119.345 0.975 . . . . 0.0 112.363 178.952 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 22.2 mtpp -67.26 -48.86 66.49 Favored 'General case' 0 N--CA 1.481 1.094 0 O-C-N 121.884 -0.51 . . . . 0.0 111.217 169.572 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 24.7 m -73.71 -28.12 61.55 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 113.239 0.829 . . . . 0.0 113.239 -169.568 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 56.8 mt -97.2 -35.14 10.86 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 125.612 1.565 . . . . 0.0 112.96 176.043 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -103.47 -10.44 35.9 Favored Glycine 0 N--CA 1.469 0.884 0 N-CA-C 117.243 1.657 . . . . 0.0 117.243 -169.157 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -62.81 140.04 58.75 Favored 'General case' 0 CA--C 1.544 0.726 0 CA-C-N 120.936 2.368 . . . . 0.0 112.06 179.805 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 89.88 -21.24 31.34 Favored Glycine 0 CA--C 1.541 1.688 0 C-N-CA 125.048 1.309 . . . . 0.0 113.374 -169.342 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -101.44 -50.71 3.67 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 125.942 1.697 . . . . 0.0 111.026 169.853 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 2.6 pp -131.35 155.93 42.24 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 C-N-CA 125.813 1.645 . . . . 0.0 111.721 179.225 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -103.24 151.62 22.44 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 124.783 1.233 . . . . 0.0 109.718 175.402 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 44.4 t -138.07 142.77 34.85 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.051 0 O-C-N 121.282 -0.886 . . . . 0.0 113.061 -173.716 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 29.6 m -132.93 152.69 51.87 Favored 'General case' 0 CA--C 1.513 -0.465 0 C-N-CA 125.478 1.511 . . . . 0.0 108.029 168.792 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 2.8 p -132.57 141.36 48.67 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 122.283 1.04 . . . . 0.0 111.533 169.638 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 59.9 p -152.3 -174.46 4.89 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 113.599 -1.637 . . . . 0.0 110.209 178.857 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -135.16 170.89 22.72 Favored Glycine 0 C--N 1.335 0.495 0 O-C-N 121.142 -0.974 . . . . 0.0 112.351 174.195 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 6.2 mp -89.86 124.07 34.37 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 105.556 -2.016 . . . . 0.0 105.556 168.633 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 60.25 26.96 16.46 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 124.852 1.261 . . . . 0.0 113.439 -175.018 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 26.9 p -169.51 156.82 6.88 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 125.876 1.671 . . . . 0.0 112.773 -174.474 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 88.6 p -110.16 -51.63 2.85 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 115.546 1.684 . . . . 0.0 115.546 178.396 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 56.6 ttt180 -115.58 139.69 49.85 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 126.779 2.031 . . . . 0.0 113.988 -168.527 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 10.7 m -51.61 148.99 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 126.636 1.975 . . . . 0.0 111.924 169.365 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -62.26 144.65 94.68 Favored Pre-proline 0 CA--C 1.551 1.01 0 CA-C-O 118.893 -0.575 . . . . 0.0 110.448 176.263 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_exo -47.93 -36.04 26.29 Favored 'Trans proline' 0 CA--C 1.538 0.719 0 C-N-CA 124.087 3.191 . . . . 0.0 118.319 -168.12 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 58.7 m -59.64 -27.03 65.99 Favored 'General case' 0 N--CA 1.483 1.187 0 CA-C-N 119.622 1.101 . . . . 0.0 112.166 -178.228 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -55.85 -37.64 69.01 Favored 'General case' 0 CA--C 1.535 0.365 0 C-N-CA 124.113 0.965 . . . . 0.0 113.059 175.247 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.6 mp -63.86 -54.28 33.86 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 CA-C-N 119.183 0.901 . . . . 0.0 108.628 -178.428 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -62.98 -35.44 80.17 Favored 'General case' 0 CA--C 1.544 0.729 0 N-CA-C 113.361 0.874 . . . . 0.0 113.361 -177.552 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -77.75 -23.77 49.21 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 113.923 1.083 . . . . 0.0 113.923 178.188 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -87.93 -29.71 20.63 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 118.948 0.794 . . . . 0.0 109.732 174.612 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -67.19 -13.14 61.68 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.315 1.446 . . . . 0.0 113.791 172.338 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 -60.09 -26.24 66.04 Favored 'General case' 0 N--CA 1.482 1.171 0 CA-C-N 120.452 1.478 . . . . 0.0 110.641 168.836 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 40.8 t -98.26 -0.42 10.36 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.02 0 C-N-CA 127.668 2.387 . . . . 0.0 111.232 178.471 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 78.28 18.62 75.92 Favored Glycine 0 CA--C 1.541 1.675 0 C-N-CA 125.076 1.322 . . . . 0.0 114.878 -176.529 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 77.1 mt -81.68 133.66 28.77 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 C-N-CA 124.929 1.291 . . . . 0.0 111.736 -172.514 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 31.6 t0 -98.21 116.95 31.51 Favored 'General case' 0 N--CA 1.473 0.725 0 CA-C-O 121.41 0.624 . . . . 0.0 111.96 169.942 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 19.4 pt -127.97 19.43 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 C-N-CA 126.24 1.816 . . . . 0.0 112.379 171.059 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 98.1 p -70.68 -16.23 62.78 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 115.39 1.626 . . . . 0.0 115.39 -173.874 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -82.69 -0.96 90.48 Favored Glycine 0 CA--C 1.537 1.466 0 C-N-CA 124.762 1.172 . . . . 0.0 115.922 -177.139 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 4.4 tt0 -68.36 -6.15 22.78 Favored 'General case' 0 CA--C 1.547 0.836 0 N-CA-C 116.402 2.001 . . . . 0.0 116.402 -170.29 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.3 m -67.53 -7.83 29.06 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 125.86 1.664 . . . . 0.0 114.6 -170.809 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 78.2 p -64.73 -78.9 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 115.524 1.676 . . . . 0.0 115.524 -170.541 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -148.59 157.85 40.91 Favored Pre-proline 0 CA--C 1.554 1.133 0 N-CA-C 115.459 1.651 . . . . 0.0 115.459 -169.283 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -69.55 163.71 37.08 Favored 'Trans proline' 0 C--N 1.354 0.865 0 C-N-CA 124.967 3.778 . . . . 0.0 114.921 170.107 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 6.0 tt -52.82 -44.69 48.88 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 C-N-CA 124.905 1.282 . . . . 0.0 111.851 178.054 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -66.93 -9.56 39.56 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 114.092 1.145 . . . . 0.0 114.092 -177.681 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 -81.12 -22.67 38.9 Favored 'General case' 0 CA--C 1.548 0.899 0 N-CA-C 113.129 0.789 . . . . 0.0 113.129 174.145 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 82.1 m-85 -94.19 -169.98 2.19 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 125.805 1.642 . . . . 0.0 112.159 -177.251 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -124.6 124.76 42.91 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 125.657 1.583 . . . . 0.0 109.791 176.375 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -67.42 -34.9 78.18 Favored 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 114.241 1.2 . . . . 0.0 114.241 -170.125 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . 0.252 0.0 OUTLIER -72.19 -5.09 33.24 Favored 'General case' 0 CA--C 1.545 0.778 0 N-CA-C 114.163 1.172 . . . . 0.0 114.163 -176.457 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -73.93 -11.39 60.34 Favored 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 123.833 0.853 . . . . 0.0 111.244 168.711 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 74.5 m-85 -117.36 139.57 50.69 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 127.379 2.272 . . . . 0.0 111.251 -179.664 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -92.17 -23.51 19.37 Favored 'General case' 0 N--CA 1.479 1.004 0 CA-C-O 122.359 1.076 . . . . 0.0 112.342 177.055 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.69 HG22 ' HB ' ' A' ' 95' ' ' ILE . 80.3 t -129.56 138.12 55.06 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 C-N-CA 127.252 2.221 . . . . 0.0 108.886 -176.429 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 83.0 t -131.94 127.82 58.82 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 N-CA-C 107.562 -1.273 . . . . 0.0 107.562 170.694 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 27.5 mm -119.31 117.07 52.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 C-N-CA 124.356 1.063 . . . . 0.0 109.251 -178.162 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 22.6 t -98.54 130.93 45.11 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 122.596 0.359 . . . . 0.0 110.553 169.609 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 8.3 mt -101.32 0.51 37.32 Favored 'General case' 0 N--CA 1.478 0.95 0 N-CA-C 113.779 1.029 . . . . 0.0 113.779 178.838 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 84.6 m -135.95 146.67 47.52 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.213 1.005 . . . . 0.0 113.186 -169.977 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 63.15 -146.57 50.45 Favored Glycine 0 CA--C 1.532 1.147 0 C-N-CA 124.547 1.07 . . . . 0.0 114.356 170.149 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 93.9 p -86.1 -16.61 37.48 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 125.212 1.405 . . . . 0.0 114.593 -178.907 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 76.68 6.83 85.43 Favored Glycine 0 CA--C 1.54 1.6 0 C-N-CA 124.32 0.962 . . . . 0.0 114.598 -170.278 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 58.6 t -88.68 -22.27 6.69 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.162 0 CA-C-N 119.017 1.408 . . . . 0.0 113.118 -175.377 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 34.2 m120 -71.62 -19.47 62.11 Favored 'General case' 0 CA--C 1.547 0.86 0 N-CA-C 114.545 1.313 . . . . 0.0 114.545 -174.452 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -79.19 148.01 70.31 Favored Pre-proline 0 CA--C 1.549 0.915 0 CA-C-N 118.929 0.786 . . . . 0.0 111.768 176.557 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -59.42 155.11 43.05 Favored 'Trans proline' 0 CA--C 1.543 0.974 0 C-N-CA 122.769 2.313 . . . . 0.0 114.151 -178.164 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_exo -55.01 -32.46 79.09 Favored 'Trans proline' 0 C--N 1.35 0.649 0 C-N-CA 123.46 2.773 . . . . 0.0 114.412 -177.318 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -63.62 -31.78 73.05 Favored 'General case' 0 N--CA 1.471 0.617 0 O-C-N 121.277 -0.889 . . . . 0.0 113.025 177.911 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 94.8 m95 -80.4 -32.34 37.51 Favored 'General case' 0 N--CA 1.473 0.68 0 O-C-N 121.071 -1.018 . . . . 0.0 111.989 175.428 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 75.8 t -67.57 -31.97 54.94 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 C-N-CA 124.499 1.12 . . . . 0.0 112.159 172.527 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -91.98 3.33 55.45 Favored 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 115.799 1.777 . . . . 0.0 115.799 -171.513 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 80.2 mm-40 -65.6 155.17 36.65 Favored 'General case' 0 N--CA 1.478 0.941 0 O-C-N 120.741 -1.224 . . . . 0.0 111.547 170.651 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -56.18 -41.28 75.25 Favored 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 114.466 1.284 . . . . 0.0 114.466 -167.638 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.69 ' HB ' HG22 ' A' ' 75' ' ' VAL . 18.7 mm -119.31 64.57 0.23 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 C-N-CA 125.089 1.356 . . . . 0.0 108.407 177.308 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 15.9 t80 -79.54 108.29 12.96 Favored 'General case' 0 CA--C 1.534 0.356 0 O-C-N 120.989 -1.07 . . . . 0.0 108.77 169.326 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 11.1 mt-10 -110.32 146.47 35.69 Favored 'General case' 0 CA--C 1.545 0.756 0 N-CA-C 114.627 1.343 . . . . 0.0 114.627 174.591 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -114.36 117.21 30.41 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 125.566 1.546 . . . . 0.0 110.022 169.914 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 39.4 m0 -104.96 106.94 17.65 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 124.63 1.172 . . . . 0.0 109.884 -176.482 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 11.2 mm100 -86.9 47.95 1.57 Allowed 'General case' 0 CA--C 1.547 0.862 0 CA-C-O 122.118 0.961 . . . . 0.0 111.843 -172.309 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 89.7 mt -75.36 162.65 28.2 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 126.22 1.808 . . . . 0.0 112.297 178.434 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -79.01 149.57 32.17 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-O 121.351 0.596 . . . . 0.0 112.457 170.902 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -83.19 127.57 68.41 Favored Pre-proline 0 CA--C 1.544 0.728 0 C-N-CA 123.96 0.904 . . . . 0.0 110.854 174.31 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -82.04 -16.42 8.65 Favored 'Trans proline' 0 CA--C 1.542 0.92 0 C-N-CA 121.335 1.357 . . . . 0.0 115.242 -170.701 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -72.62 -39.81 66.95 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 116.77 2.137 . . . . 0.0 116.77 -168.788 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -75.3 16.79 3.48 Favored Glycine 0 CA--C 1.539 1.559 0 C-N-CA 123.938 0.78 . . . . 0.0 114.679 -175.164 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 8.8 pt20 -157.98 174.44 15.24 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 126.876 2.07 . . . . 0.0 111.818 -169.321 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 70.4 m -63.29 159.29 18.25 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 114.721 1.378 . . . . 0.0 114.721 -169.96 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 42.3 tp -59.75 -27.15 66.26 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 124.905 1.282 . . . . 0.0 113.295 179.771 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -62.88 -30.7 71.72 Favored 'General case' 0 N--CA 1.473 0.711 0 O-C-N 120.733 -1.229 . . . . 0.0 112.008 171.753 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 3.0 t -75.69 -36.19 33.16 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 O-C-N 120.955 -1.091 . . . . 0.0 111.152 172.725 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -55.48 -48.01 75.24 Favored 'General case' 0 N--CA 1.479 0.978 0 CA-C-N 119.688 1.131 . . . . 0.0 110.548 169.086 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -67.01 -35.94 81.05 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 124.141 0.976 . . . . 0.0 112.382 178.907 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 31.2 m -61.16 -45.53 94.27 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 124.329 1.052 . . . . 0.0 111.239 169.724 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 56.2 t -67.14 -39.19 82.61 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 CA-C-O 117.638 -1.173 . . . . 0.0 111.339 178.2 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 67.4 mtm-85 -56.43 -43.02 79.04 Favored 'General case' 0 N--CA 1.484 1.249 0 CA-C-N 120.694 1.588 . . . . 0.0 111.724 169.93 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -59.61 -49.47 78.22 Favored Glycine 0 CA--C 1.537 1.417 0 CA-C-N 118.982 0.81 . . . . 0.0 113.871 174.529 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 52.4 mm-40 -65.66 -44.38 86.48 Favored 'General case' 0 N--CA 1.475 0.784 0 O-C-N 121.585 -0.95 . . . . 0.0 112.193 178.274 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 60.5 t -65.13 -40.15 87.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 C-N-CA 124.622 1.169 . . . . 0.0 110.789 177.816 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 61.4 tttm -54.71 -49.9 69.6 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 119.515 1.052 . . . . 0.0 110.932 175.796 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -64.48 -42.05 96.12 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 112.486 0.55 . . . . 0.0 112.486 177.999 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 16.5 mmm180 -61.26 -45.97 92.32 Favored 'General case' 0 N--CA 1.479 0.982 0 O-C-N 121.597 -0.689 . . . . 0.0 112.529 175.409 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 92.7 t -68.38 -40.95 83.11 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 C-N-CA 124.006 0.923 . . . . 0.0 111.268 179.49 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -62.48 -39.95 95.11 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 119.258 0.935 . . . . 0.0 111.593 173.165 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 13.9 m-80 -63.25 -46.7 85.67 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 118.982 0.81 . . . . 0.0 112.189 173.751 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -54.7 -55.21 32.17 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 124.607 1.163 . . . . 0.0 110.585 176.467 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 73.1 mt -59.82 -45.88 94.32 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 CA-C-O 119.079 -0.486 . . . . 0.0 110.084 178.922 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -67.89 -11.47 58.75 Favored 'General case' 0 CA--C 1.545 0.776 0 N-CA-C 115.318 1.599 . . . . 0.0 115.318 -179.215 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 21.0 ptmt -100.54 -24.13 14.53 Favored 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 113.798 1.036 . . . . 0.0 113.798 171.286 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 16.4 pt -97.78 -13.95 7.92 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 N-CA-C 114.592 1.33 . . . . 0.0 114.592 177.692 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 54.5 m . . . . . 0 C--O 1.254 1.293 0 C-N-CA 125.373 1.469 . . . . 0.0 112.032 -179.815 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.407 ' HA ' ' O ' ' A' ' 29' ' ' LYS . 22.6 ttt . . . . . 0 N--CA 1.503 2.207 0 N-CA-C 111.74 0.274 . . . . 0.0 111.74 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.21 164.06 31.28 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 125.089 1.355 . . . . 0.0 112.527 176.575 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 58.9 mttt -99.14 151.07 21.39 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 124.185 0.994 . . . . 0.0 112.46 177.731 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 12.5 t -129.2 138.49 54.29 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 C-N-CA 125.103 1.361 . . . . 0.0 112.674 179.019 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' MET . . . . . 0.503 ' HG3' HG13 ' A' ' 7' ' ' VAL . 62.0 tpp -107.75 120.94 43.65 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 123.726 0.81 . . . . 0.0 109.429 168.997 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 68.5 m-85 -100.73 127.09 47.29 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 124.27 1.028 . . . . 0.0 108.99 170.58 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.503 HG13 ' HG3' ' A' ' 5' ' ' MET . 1.0 OUTLIER -144.43 156.12 14.96 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.084 0 N-CA-C 114.769 1.396 . . . . 0.0 114.769 -168.177 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -151.38 169.29 22.36 Favored 'General case' 0 CA--C 1.552 1.043 0 C-N-CA 127.159 2.183 . . . . 0.0 110.939 173.944 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 61.8 mtpt -49.26 -62.74 1.37 Allowed 'General case' 0 N--CA 1.495 1.788 0 C-N-CA 126.126 1.77 . . . . 0.0 113.789 -173.762 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 28.8 mmt85 -127.68 106.3 9.05 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 126.164 1.785 . . . . 0.0 107.588 172.506 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 36.1 p-10 -74.32 -11.1 60.17 Favored 'General case' 0 CA--C 1.556 1.195 0 CA-C-N 119.458 1.027 . . . . 0.0 112.357 -176.831 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 69.8 m -80.13 -6.71 58.19 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 125.08 1.352 . . . . 0.0 112.855 169.464 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 72.8 m -108.18 -69.61 0.84 Allowed 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 124.71 1.204 . . . . 0.0 110.03 172.02 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 66.7 mtt85 -74.35 122.61 23.2 Favored 'General case' 0 N--CA 1.479 1.015 0 O-C-N 121.444 -0.785 . . . . 0.0 109.092 173.679 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 52.4 p -69.45 -28.29 65.98 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 115.644 1.72 . . . . 0.0 115.644 -168.784 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 7.6 mt-30 61.26 -177.81 0.11 Allowed 'General case' 0 CA--C 1.552 1.027 0 C-N-CA 124.633 1.173 . . . . 0.0 112.482 -170.07 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -175.12 -47.48 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 126.366 1.867 . . . . 0.0 110.947 -169.447 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -56.73 -32.16 65.26 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 115.331 1.604 . . . . 0.0 115.331 -169.398 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.3 pm0 -57.16 -41.68 79.66 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 123.528 0.731 . . . . 0.0 112.757 177.545 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -67.25 -43.79 87.95 Favored Glycine 0 C--N 1.334 0.436 0 C-N-CA 124.821 1.2 . . . . 0.0 112.071 -177.465 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -71.53 -35.36 70.65 Favored 'General case' 0 N--CA 1.47 0.534 0 O-C-N 121.542 -0.975 . . . . 0.0 112.005 174.972 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -64.09 -33.66 76.27 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 118.986 0.812 . . . . 0.0 112.034 -175.652 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 2.7 pttp -85.08 -36.43 21.19 Favored 'General case' 0 N--CA 1.479 1.024 0 N-CA-C 113.644 0.979 . . . . 0.0 113.644 169.686 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 56.3 m -68.88 -31.29 70.11 Favored 'General case' 0 N--CA 1.486 1.338 0 CA-C-N 119.455 1.025 . . . . 0.0 112.3 -178.642 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 70.8 mt -91.22 -37.85 13.07 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 126.131 1.772 . . . . 0.0 112.645 173.022 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -100.62 2.08 55.81 Favored Glycine 0 N--CA 1.472 1.06 0 N-CA-C 117.262 1.665 . . . . 0.0 117.262 -169.539 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -60.55 141.63 56.34 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-N 121.133 2.466 . . . . 0.0 112.303 177.648 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 82.91 -15.15 33.67 Favored Glycine 0 CA--C 1.54 1.643 0 C-N-CA 124.74 1.162 . . . . 0.0 113.657 -169.408 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.407 ' O ' ' HA ' ' A' ' 1' ' ' MET . 69.7 mttt -108.22 -43.7 4.31 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 126.309 1.844 . . . . 0.0 112.484 171.841 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 42.7 pt -139.93 160.02 26.66 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 C-N-CA 124.92 1.288 . . . . 0.0 113.416 -177.203 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -107.64 149.31 28.24 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 125.487 1.515 . . . . 0.0 110.724 169.747 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 98.8 t -137.78 141.11 39.79 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 O-C-N 121.197 -0.94 . . . . 0.0 113.085 -175.987 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 79.3 m -135.51 152.85 51.73 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 125.805 1.642 . . . . 0.0 109.28 169.521 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 88.9 p -133.21 142.7 48.71 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 122.419 1.104 . . . . 0.0 113.208 167.931 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 35.7 p -145.43 170.5 16.23 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 114.002 -1.453 . . . . 0.0 112.251 -173.863 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -92.82 152.83 21.24 Favored Glycine 0 N--CA 1.467 0.763 0 O-C-N 121.56 -0.713 . . . . 0.0 111.392 174.863 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 2.2 mp -65.97 -32.8 74.5 Favored 'General case' 0 N--CA 1.483 1.207 0 CA-C-N 118.807 1.303 . . . . 0.0 111.744 171.967 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -120.47 165.49 14.88 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 126.685 1.994 . . . . 0.0 108.93 169.089 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 52.2 m -53.95 100.19 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 125.281 1.432 . . . . 0.0 113.6 -169.703 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 24.0 p -156.97 156.44 33.0 Favored 'General case' 0 CA--C 1.548 0.897 0 N-CA-C 114.159 1.17 . . . . 0.0 114.159 -175.666 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 49.7 ttt180 -107.77 140.66 40.51 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 128.815 2.846 . . . . 0.0 109.199 174.781 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 18.5 m -53.65 117.97 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.36 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 173.477 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . 0.276 0.0 OUTLIER -58.25 143.75 78.67 Favored Pre-proline 0 CA--C 1.536 0.439 0 N-CA-C 112.699 0.629 . . . . 0.0 112.699 -167.901 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 81.5 Cg_exo -47.34 -36.25 22.59 Favored 'Trans proline' 0 CA--C 1.538 0.681 0 C-N-CA 123.449 2.766 . . . . 0.0 116.792 -168.121 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 56.3 m -64.18 -26.27 68.45 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.915 0.886 . . . . 0.0 112.552 -179.091 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -55.08 -49.53 71.43 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 119.517 1.053 . . . . 0.0 110.601 173.25 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.6 mp -54.2 -57.16 6.6 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 C-N-CA 124.189 0.996 . . . . 0.0 110.176 -173.41 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.95 -28.09 69.59 Favored 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 113.22 0.822 . . . . 0.0 113.22 -175.243 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -79.91 -28.51 39.8 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 113.6 0.963 . . . . 0.0 113.6 177.79 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 4.9 mmt -77.39 -36.49 53.35 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-N 119.142 0.883 . . . . 0.0 110.645 169.743 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -61.9 -16.39 50.3 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 125.095 1.358 . . . . 0.0 114.17 174.421 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -61.08 -29.79 69.96 Favored 'General case' 0 N--CA 1.479 0.984 0 CA-C-N 120.714 1.597 . . . . 0.0 111.747 169.508 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 59.1 t -89.89 -6.38 10.79 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.889 0 C-N-CA 126.627 1.971 . . . . 0.0 111.294 175.673 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 81.63 13.93 79.04 Favored Glycine 0 CA--C 1.539 1.554 0 C-N-CA 125.245 1.402 . . . . 0.0 114.281 -170.589 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 83.5 mt -77.91 142.04 14.7 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 124.618 1.167 . . . . 0.0 111.144 -178.016 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -101.05 131.3 47.01 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 123.517 0.727 . . . . 0.0 111.044 169.172 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 13.4 pt -135.3 8.25 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 C-N-CA 124.234 1.014 . . . . 0.0 113.33 169.928 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 51.8 m -77.65 152.06 34.0 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 125.228 1.411 . . . . 0.0 113.228 -171.004 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 67.89 20.61 72.68 Favored Glycine 0 N--CA 1.473 1.119 0 N-CA-C 116.035 1.174 . . . . 0.0 116.035 169.758 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 48.1 mt-30 -67.0 -69.98 0.28 Allowed 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 118.701 1.25 . . . . 0.0 112.158 -179.387 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 7.4 t -166.37 169.82 13.65 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 125.238 1.415 . . . . 0.0 112.323 -177.087 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 96.8 p -129.05 5.05 5.33 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 128.419 2.687 . . . . 0.0 112.379 169.474 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 32.5 m-20 -89.94 153.94 47.4 Favored Pre-proline 0 CA--C 1.543 0.676 0 C-N-CA 124.721 1.208 . . . . 0.0 113.299 -177.866 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -70.43 157.28 59.57 Favored 'Trans proline' 0 N--CA 1.458 -0.579 0 C-N-CA 123.089 2.526 . . . . 0.0 112.12 175.771 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 5.9 tt -50.57 -34.34 12.17 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 C-N-CA 124.991 1.316 . . . . 0.0 111.349 169.556 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 18.8 mt-10 -63.71 -17.91 63.47 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 125.547 1.539 . . . . 0.0 113.558 -178.758 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -83.61 -12.34 56.16 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 124.669 1.188 . . . . 0.0 113.659 -178.627 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 74.7 m-85 -106.64 -172.21 2.04 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 125.946 1.699 . . . . 0.0 111.733 -176.417 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 10.5 t30 -120.77 122.44 40.37 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 125.182 1.393 . . . . 0.0 110.274 177.328 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -68.05 -35.83 78.88 Favored 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 113.726 1.01 . . . . 0.0 113.726 -171.42 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -71.28 -4.98 28.83 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 114.409 1.262 . . . . 0.0 114.409 -175.155 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -73.08 -14.0 61.31 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 123.573 0.749 . . . . 0.0 111.691 168.823 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 39.2 m-85 -119.54 134.2 55.33 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 126.939 2.096 . . . . 0.0 111.068 -178.984 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -88.44 -19.64 26.26 Favored 'General case' 0 N--CA 1.48 1.058 0 CA-C-O 122.36 1.076 . . . . 0.0 112.672 -179.806 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.647 HG22 ' HB ' ' A' ' 95' ' ' ILE . 95.9 t -130.88 136.77 57.43 Favored 'Isoleucine or valine' 0 C--O 1.235 0.336 0 C-N-CA 127.722 2.409 . . . . 0.0 107.853 -175.411 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 65.3 t -134.13 127.07 50.79 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 170.384 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 48.3 mm -116.17 106.7 20.87 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.249 0 C-N-CA 124.454 1.101 . . . . 0.0 109.395 -171.873 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 4.0 m -92.38 108.2 19.78 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 123.049 0.54 . . . . 0.0 110.321 177.202 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 78.3 mt -78.07 -9.48 59.16 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 125.872 1.669 . . . . 0.0 113.406 -179.371 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 23.9 m -108.34 103.99 13.26 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 125.664 1.586 . . . . 0.0 110.733 -179.04 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 57.65 -139.66 46.72 Favored Glycine 0 CA--C 1.535 1.331 0 C-N-CA 124.325 0.964 . . . . 0.0 114.236 172.831 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 85.0 p -69.91 -14.28 62.65 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 124.84 1.256 . . . . 0.0 114.108 175.793 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 72.09 7.79 67.84 Favored Glycine 0 CA--C 1.528 0.902 0 N-CA-C 115.6 1.0 . . . . 0.0 115.6 178.872 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.3 p -72.51 -9.58 13.08 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.988 0 CA-C-N 119.593 1.696 . . . . 0.0 114.675 -169.89 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 -80.64 -16.71 53.34 Favored 'General case' 0 CA--C 1.547 0.857 0 N-CA-C 114.701 1.371 . . . . 0.0 114.701 -174.162 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -71.07 159.14 86.51 Favored Pre-proline 0 CA--C 1.551 0.985 0 CA-C-N 119.214 0.916 . . . . 0.0 112.317 170.926 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_exo -60.53 151.86 72.33 Favored 'Trans proline' 0 CA--C 1.544 1.014 0 C-N-CA 122.133 1.888 . . . . 0.0 113.321 -176.951 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_exo -54.35 -36.59 87.59 Favored 'Trans proline' 0 C--N 1.352 0.751 0 C-N-CA 123.458 2.772 . . . . 0.0 115.164 -169.816 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -63.71 -22.28 66.83 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 114.131 1.16 . . . . 0.0 114.131 179.723 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 77.7 m95 -82.99 -23.1 33.47 Favored 'General case' 0 N--CA 1.47 0.531 0 O-C-N 120.888 -1.133 . . . . 0.0 112.486 172.951 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 10.5 t -73.67 -30.37 29.01 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 C-N-CA 124.996 1.318 . . . . 0.0 110.91 170.336 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 76.5 p -91.14 3.33 55.06 Favored 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 116.252 1.945 . . . . 0.0 116.252 -174.869 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 80.4 mm-40 -66.36 149.62 50.11 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 119.503 1.047 . . . . 0.0 108.984 169.294 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -59.73 -37.97 80.41 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 114.577 1.325 . . . . 0.0 114.577 -167.154 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.647 ' HB ' HG22 ' A' ' 75' ' ' VAL . 16.2 mm -113.01 56.64 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 C-N-CA 124.715 1.206 . . . . 0.0 109.385 177.488 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 40.7 t80 -75.57 106.52 7.17 Favored 'General case' 0 CA--C 1.535 0.395 0 O-C-N 120.633 -1.292 . . . . 0.0 107.522 168.958 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.7 mt-10 -106.41 133.28 51.34 Favored 'General case' 0 CA--C 1.543 0.678 0 N-CA-C 113.556 0.947 . . . . 0.0 113.556 175.877 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -88.95 111.51 22.21 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.41 1.084 . . . . 0.0 109.339 169.432 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 15.2 m0 -97.99 101.22 12.65 Favored 'General case' 0 N--CA 1.462 0.158 0 C-N-CA 123.813 0.845 . . . . 0.0 109.48 -176.859 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 54.9 mm-40 -78.64 41.14 0.4 Allowed 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 125.995 1.718 . . . . 0.0 111.676 -177.291 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 33.1 mt -91.59 163.68 14.04 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 126.277 1.831 . . . . 0.0 113.19 -172.155 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -73.92 150.42 40.85 Favored 'General case' 0 CA--C 1.545 0.784 0 CA-C-N 114.857 -1.065 . . . . 0.0 111.715 169.728 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' ASP . . . . . 0.415 ' HA ' ' HD3' ' A' ' 104' ' ' PRO . 18.9 t70 -112.71 138.85 22.23 Favored Pre-proline 0 CA--C 1.549 0.923 0 C-N-CA 124.339 1.056 . . . . 0.0 111.108 169.564 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 104' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 103' ' ' ASP . 45.0 Cg_exo -66.81 -19.84 52.57 Favored 'Trans proline' 0 CA--C 1.54 0.822 0 C-N-CA 122.511 2.141 . . . . 0.0 116.61 -178.139 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -68.03 144.83 54.95 Favored 'General case' 0 CA--C 1.545 0.757 0 CA-C-N 120.375 1.443 . . . . 0.0 114.102 -170.424 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 77.69 6.52 86.98 Favored Glycine 0 CA--C 1.535 1.338 0 C-N-CA 124.815 1.198 . . . . 0.0 114.586 -177.936 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 13.3 pt20 -140.85 174.37 10.58 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 126.015 1.726 . . . . 0.0 112.165 179.832 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 25.0 p -67.71 164.73 18.72 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 117.395 2.369 . . . . 0.0 117.395 -168.659 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -53.5 -41.35 66.19 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 126.272 1.829 . . . . 0.0 111.961 169.767 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -60.01 -36.11 76.52 Favored 'General case' 0 CA--C 1.543 0.697 0 O-C-N 121.47 -0.769 . . . . 0.0 111.922 174.653 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 16.3 t -68.86 -40.8 81.68 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 O-C-N 121.177 -0.952 . . . . 0.0 111.463 171.141 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -52.31 -50.55 61.99 Favored 'General case' 0 N--CA 1.476 0.839 0 CA-C-N 119.56 1.073 . . . . 0.0 112.104 170.629 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 96.0 mtt180 -67.87 -35.17 78.06 Favored 'General case' 0 N--CA 1.477 0.883 0 O-C-N 121.399 -0.813 . . . . 0.0 112.751 179.428 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 79.4 m -63.67 -42.17 98.09 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.682 0.793 . . . . 0.0 110.957 172.229 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 71.5 t -67.9 -39.86 82.47 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 CA-C-O 117.914 -1.041 . . . . 0.0 111.215 176.603 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 27.1 mtm105 -54.56 -42.71 71.31 Favored 'General case' 0 N--CA 1.484 1.252 0 CA-C-N 120.52 1.509 . . . . 0.0 112.109 173.026 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -62.39 -51.34 57.08 Favored Glycine 0 CA--C 1.539 1.549 0 CA-C-N 119.052 0.842 . . . . 0.0 113.311 176.383 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 68.8 mm-40 -63.3 -44.42 95.08 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.234 0.614 . . . . 0.0 112.017 179.845 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 69.3 t -67.18 -41.16 86.51 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 C-N-CA 124.592 1.157 . . . . 0.0 111.028 177.984 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 34.6 ttmt -54.56 -49.9 69.21 Favored 'General case' 0 N--CA 1.478 0.971 0 CA-C-N 120.491 1.496 . . . . 0.0 110.773 177.645 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -61.1 -40.14 92.61 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 112.242 0.46 . . . . 0.0 112.242 177.492 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.11 -35.26 80.02 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 124.226 1.011 . . . . 0.0 113.228 176.947 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 99.6 t -77.34 -38.46 26.84 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 C-N-CA 125.195 1.398 . . . . 0.0 111.621 176.508 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -60.25 -40.2 89.45 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 119.198 0.908 . . . . 0.0 111.178 170.892 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 17.1 m-80 -64.35 -43.55 94.21 Favored 'General case' 0 CA--C 1.542 0.635 0 N-CA-C 112.56 0.578 . . . . 0.0 112.56 174.093 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 9.1 tt -53.69 -55.01 29.86 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 124.401 1.08 . . . . 0.0 110.477 173.148 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 76.4 mt -63.49 -41.81 93.98 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.625 0 C-N-CA 122.658 0.383 . . . . 0.0 110.589 -178.433 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -69.72 -12.68 61.82 Favored 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 114.578 1.325 . . . . 0.0 114.578 178.346 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 20.7 ptmt -101.27 -30.93 11.24 Favored 'General case' 0 N--CA 1.477 0.906 0 N-CA-C 113.915 1.08 . . . . 0.0 113.915 173.297 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 13.5 pt -94.09 -18.84 6.77 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 N-CA-C 114.528 1.307 . . . . 0.0 114.528 179.255 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 74.5 m . . . . . 0 C--O 1.253 1.26 0 C-N-CA 125.539 1.536 . . . . 0.0 111.708 -175.354 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 34.8 ttm . . . . . 0 N--CA 1.501 2.086 0 N-CA-C 112.087 0.403 . . . . 0.0 112.087 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.47 162.92 26.05 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 125.146 1.379 . . . . 0.0 111.247 169.234 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 69.0 mttt -96.99 147.44 23.99 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.648 0.779 . . . . 0.0 111.527 172.728 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 17.2 t -124.42 135.53 63.49 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 C-N-CA 125.297 1.439 . . . . 0.0 111.927 176.046 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' MET . . . . . 0.478 ' HG3' HG13 ' A' ' 7' ' ' VAL . 54.3 tpp -106.07 125.75 51.37 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 123.229 0.611 . . . . 0.0 109.501 168.724 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 67.1 m-85 -103.89 125.18 50.11 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.43 1.092 . . . . 0.0 108.918 172.846 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.478 HG13 ' HG3' ' A' ' 5' ' ' MET . 2.1 m -143.46 156.99 16.82 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.167 0 C-N-CA 124.661 1.184 . . . . 0.0 113.151 -169.175 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 18.2 t -153.65 141.7 20.33 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 126.304 1.842 . . . . 0.0 108.437 168.625 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . 0.263 60.7 pttt -73.79 -15.98 61.17 Favored 'General case' 0 N--CA 1.486 1.335 0 N-CA-C 116.385 1.994 . . . . 0.0 116.385 -169.993 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 16.2 ptm180 -121.08 49.68 1.46 Allowed 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 125.46 1.504 . . . . 0.0 112.645 169.899 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 5.8 t30 -46.79 -31.87 3.3 Favored 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 126.058 1.743 . . . . 0.0 114.582 -177.683 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 67.7 m -69.61 -23.78 63.56 Favored 'General case' 0 N--CA 1.479 1.0 0 N-CA-C 114.017 1.117 . . . . 0.0 114.017 178.131 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 36.9 m -89.9 -15.63 31.72 Favored 'General case' 0 N--CA 1.478 0.954 0 N-CA-C 114.247 1.203 . . . . 0.0 114.247 -176.244 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 55.7 mtp85 -135.5 159.03 42.88 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 125.607 1.563 . . . . 0.0 112.632 -169.847 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 26.1 t -100.25 145.59 27.9 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.234 1.414 . . . . 0.0 107.742 168.478 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 3.9 mp0 -108.76 -37.67 5.83 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 115.331 1.604 . . . . 0.0 115.331 -168.361 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' MET . . . . . 0.4 ' HG2' ' SD ' ' A' ' 50' ' ' MET . 0.0 OUTLIER 66.07 -47.48 0.41 Allowed 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 126.996 2.118 . . . . 0.0 116.281 170.46 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.16 -35.81 76.15 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.649 1.18 . . . . 0.0 113.945 -169.824 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 3.9 pm0 -58.94 -38.31 78.72 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 125.049 1.339 . . . . 0.0 113.215 176.057 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -69.92 -45.03 59.4 Favored Glycine 0 N--CA 1.464 0.552 0 C-N-CA 123.688 0.661 . . . . 0.0 111.831 -177.737 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -69.29 -32.7 72.03 Favored 'General case' 0 N--CA 1.466 0.347 0 O-C-N 121.793 -0.828 . . . . 0.0 112.51 173.73 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -64.61 -36.71 85.12 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 119.347 0.976 . . . . 0.0 112.302 -174.804 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.23 -38.96 30.01 Favored 'General case' 0 N--CA 1.482 1.163 0 N-CA-C 112.904 0.705 . . . . 0.0 112.904 169.464 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 70.7 m -67.09 -32.46 73.63 Favored 'General case' 0 N--CA 1.485 1.286 0 CA-C-N 118.96 0.8 . . . . 0.0 112.24 -176.935 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 66.9 mt -91.85 -39.86 11.51 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 125.733 1.613 . . . . 0.0 112.926 173.858 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -99.02 3.43 58.5 Favored Glycine 0 N--CA 1.472 1.036 0 N-CA-C 117.444 1.738 . . . . 0.0 117.444 -169.431 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.24 142.02 57.11 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 121.034 2.417 . . . . 0.0 112.11 178.369 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 84.16 -21.65 9.74 Favored Glycine 0 CA--C 1.539 1.572 0 C-N-CA 125.092 1.33 . . . . 0.0 113.268 -169.442 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -98.88 -46.39 5.65 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 125.603 1.561 . . . . 0.0 111.985 171.609 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 43.0 pt -137.58 154.58 29.86 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 C-N-CA 124.96 1.304 . . . . 0.0 113.37 -175.375 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -102.59 142.37 33.87 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 124.757 1.223 . . . . 0.0 109.938 169.809 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 85.9 t -131.16 139.57 50.66 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 CA-C-N 118.928 0.785 . . . . 0.0 113.058 -176.455 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 27.5 m -139.69 154.24 47.44 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 125.815 1.646 . . . . 0.0 109.586 173.346 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 52.2 m -128.64 147.74 50.75 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.718 0.771 . . . . 0.0 110.841 168.448 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 3.8 m -142.69 151.76 41.68 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 113.926 -1.488 . . . . 0.0 110.981 177.119 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -89.59 174.08 40.97 Favored Glycine 0 CA--C 1.527 0.825 0 N-CA-C 110.383 -1.087 . . . . 0.0 110.383 169.166 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -84.47 -36.99 21.9 Favored 'General case' 0 N--CA 1.477 0.924 0 O-C-N 121.414 -1.05 . . . . 0.0 112.816 175.138 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -128.77 18.83 6.17 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 126.192 1.797 . . . . 0.0 111.628 175.02 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 34.7 p -142.86 153.13 42.87 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 126.069 1.747 . . . . 0.0 111.975 -173.768 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 98.5 p -95.8 -18.56 20.31 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 117.528 2.418 . . . . 0.0 117.528 -168.931 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 19.0 ttm105 -152.29 151.77 31.32 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 124.916 1.286 . . . . 0.0 111.789 -169.757 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 34.1 m -64.94 136.84 26.02 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 C-N-CA 123.328 0.651 . . . . 0.0 109.364 170.032 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -60.84 143.23 91.59 Favored Pre-proline 0 CA--C 1.551 1.005 0 N-CA-C 112.678 0.622 . . . . 0.0 112.678 -169.046 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_exo -46.59 -40.4 23.66 Favored 'Trans proline' 0 CA--C 1.538 0.718 0 C-N-CA 124.192 3.261 . . . . 0.0 118.731 -168.154 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 33.5 m -63.74 -27.25 69.07 Favored 'General case' 0 N--CA 1.484 1.249 0 CA-C-N 119.759 1.163 . . . . 0.0 111.936 -177.354 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -57.49 -50.15 73.99 Favored 'General case' 0 CA--C 1.537 0.448 0 O-C-N 121.373 -0.83 . . . . 0.0 111.548 173.705 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 4.6 mp -56.94 -50.94 74.22 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 CA-C-N 119.438 1.017 . . . . 0.0 111.126 -175.999 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -61.22 -27.9 68.77 Favored 'General case' 0 CA--C 1.546 0.804 0 N-CA-C 113.176 0.806 . . . . 0.0 113.176 -179.255 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -83.5 -24.0 31.91 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 113.963 1.098 . . . . 0.0 113.963 175.133 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' MET . . . . . 0.4 ' SD ' ' HG2' ' A' ' 17' ' ' MET . 4.4 mmt -80.44 -30.5 37.57 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 119.758 1.163 . . . . 0.0 110.188 169.602 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -64.9 -14.92 61.24 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 125.345 1.458 . . . . 0.0 113.604 173.991 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -61.58 -27.0 68.32 Favored 'General case' 0 N--CA 1.482 1.173 0 CA-C-N 120.639 1.563 . . . . 0.0 110.918 169.104 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 61.0 t -95.8 -2.96 10.48 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.902 0 C-N-CA 127.574 2.349 . . . . 0.0 111.148 177.837 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 77.98 16.87 79.29 Favored Glycine 0 CA--C 1.54 1.598 0 O-C-N 120.699 -1.25 . . . . 0.0 114.397 -174.737 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 77.5 mt -72.34 137.32 23.79 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 124.687 1.195 . . . . 0.0 111.247 -177.456 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 18.0 t0 -105.29 105.41 15.43 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 124.331 1.052 . . . . 0.0 112.098 179.347 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 15.8 pt -137.32 18.99 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.309 0 N-CA-C 114.867 1.432 . . . . 0.0 114.867 -178.933 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 89.1 p -70.95 -36.87 72.76 Favored 'General case' 0 N--CA 1.479 0.982 0 O-C-N 120.138 -1.601 . . . . 0.0 112.691 175.33 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -77.54 39.16 1.7 Allowed Glycine 0 CA--C 1.538 1.471 0 C-N-CA 126.502 2.001 . . . . 0.0 114.788 177.443 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 5.9 mm-40 -83.42 65.78 8.53 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 125.621 1.568 . . . . 0.0 112.57 -172.427 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER 63.59 -30.79 0.1 Allowed 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 119.741 3.237 . . . . 0.0 119.741 169.11 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 71.2 m 59.37 32.3 21.73 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 125.387 1.475 . . . . 0.0 114.382 -179.622 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -150.95 145.92 18.7 Favored Pre-proline 0 CA--C 1.551 1.013 0 O-C-N 120.974 -1.079 . . . . 0.0 113.798 179.221 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -66.24 162.9 33.95 Favored 'Trans proline' 0 CA--C 1.54 0.795 0 C-N-CA 124.543 3.496 . . . . 0.0 114.599 171.095 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.432 HD11 ' CE3' ' A' ' 90' ' ' TRP . 9.3 tp -57.33 -35.1 47.9 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 C-N-CA 124.536 1.134 . . . . 0.0 112.113 177.924 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -68.21 -10.22 52.85 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 113.79 1.033 . . . . 0.0 113.79 -179.569 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 66.2 m-20 -95.27 11.72 31.53 Favored 'General case' 0 CA--C 1.555 1.157 0 N-CA-C 113.791 1.034 . . . . 0.0 113.791 178.892 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 76.8 m-85 -130.86 177.72 7.2 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 125.526 1.531 . . . . 0.0 114.514 -174.899 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 8.1 t30 -107.69 131.81 54.02 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 126.921 2.088 . . . . 0.0 109.975 172.858 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -73.89 -35.34 64.69 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 114.673 1.361 . . . . 0.0 114.673 -176.436 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . 0.273 0.0 OUTLIER -71.69 -6.38 40.74 Favored 'General case' 0 CA--C 1.544 0.734 0 N-CA-C 114.401 1.26 . . . . 0.0 114.401 -172.213 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -62.55 -27.73 69.37 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 124.28 1.032 . . . . 0.0 110.494 168.327 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 19.4 m-85 -113.77 121.65 44.71 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 125.65 1.58 . . . . 0.0 111.132 -172.213 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -73.0 -23.57 60.65 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-O 121.77 0.795 . . . . 0.0 112.555 175.851 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.51 HG22 ' HB ' ' A' ' 95' ' ' ILE . 90.8 t -126.9 136.41 60.87 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 C-N-CA 127.486 2.314 . . . . 0.0 109.299 -174.917 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 54.2 t -135.51 120.23 27.5 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 169.621 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 25.9 mm -106.82 117.97 53.65 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 C-N-CA 123.314 0.646 . . . . 0.0 109.498 -176.63 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 14.2 t -89.07 124.09 33.97 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 169.607 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 87.6 mt -100.08 13.58 33.61 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 125.147 1.379 . . . . 0.0 114.188 -170.044 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 20.8 p -149.19 1.74 0.55 Allowed 'General case' 0 CA--C 1.547 0.845 0 N-CA-C 114.926 1.454 . . . . 0.0 114.926 177.597 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 68.53 170.34 5.99 Favored Glycine 0 CA--C 1.541 1.682 0 C-N-CA 124.261 0.934 . . . . 0.0 114.161 -176.288 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 71.7 m 54.89 29.5 12.2 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 125.192 1.397 . . . . 0.0 113.685 178.342 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -73.4 18.02 1.77 Allowed Glycine 0 N--CA 1.474 1.213 0 C-N-CA 126.327 1.917 . . . . 0.0 114.688 -177.799 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 4.2 p -65.24 -5.46 2.57 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.881 0 C-N-CA 126.227 1.811 . . . . 0.0 114.482 -169.886 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 26.7 m120 -76.27 -18.43 58.99 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 125.072 1.349 . . . . 0.0 114.338 176.106 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -74.27 156.48 87.39 Favored Pre-proline 0 N--CA 1.483 1.179 0 CA-C-N 120.277 1.399 . . . . 0.0 112.144 169.918 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_exo -57.27 150.57 57.37 Favored 'Trans proline' 0 CA--C 1.544 1.01 0 C-N-CA 122.999 2.466 . . . . 0.0 114.087 179.308 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -62.22 -24.17 75.95 Favored 'Trans proline' 0 CA--C 1.536 0.586 0 C-N-CA 123.531 2.821 . . . . 0.0 113.814 -174.358 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -60.98 -24.14 65.88 Favored 'General case' 0 CA--C 1.54 0.578 0 O-C-N 121.056 -1.028 . . . . 0.0 113.534 176.052 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' TRP . . . . . 0.432 ' CE3' HD11 ' A' ' 65' ' ' ILE . 87.3 m95 -79.51 -35.88 39.38 Favored 'General case' 0 N--CA 1.473 0.719 0 O-C-N 120.818 -1.176 . . . . 0.0 112.668 175.364 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 3.9 m -79.34 -18.49 12.87 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.149 0 N-CA-C 113.164 0.802 . . . . 0.0 113.164 178.295 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -86.68 -1.38 57.66 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 114.406 1.262 . . . . 0.0 114.406 177.662 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 84.7 mm-40 -64.14 154.33 35.0 Favored 'General case' 0 N--CA 1.478 0.935 0 O-C-N 120.907 -1.12 . . . . 0.0 110.625 170.911 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -59.76 -38.25 81.29 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 114.007 1.114 . . . . 0.0 114.007 -168.281 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.51 ' HB ' HG22 ' A' ' 75' ' ' VAL . 17.0 mm -118.18 60.08 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 C-N-CA 125.078 1.351 . . . . 0.0 109.783 179.057 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 47.2 t80 -78.94 106.25 10.84 Favored 'General case' 0 CA--C 1.536 0.413 0 O-C-N 120.749 -1.219 . . . . 0.0 107.777 168.853 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -111.18 131.24 55.27 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 113.523 0.934 . . . . 0.0 113.523 -179.581 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 -92.08 113.01 25.17 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 124.977 1.311 . . . . 0.0 110.825 169.503 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 39.6 m0 -103.97 113.12 26.43 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 124.863 1.265 . . . . 0.0 109.459 174.341 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 34.6 mm-40 -78.98 59.69 2.72 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 124.58 1.152 . . . . 0.0 109.115 169.933 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 17.4 tp -79.32 145.58 33.39 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 126.068 1.747 . . . . 0.0 111.255 -169.76 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -69.2 125.3 26.27 Favored 'General case' 0 CA--C 1.542 0.645 0 O-C-N 122.146 -0.346 . . . . 0.0 111.068 169.941 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -75.45 134.78 72.86 Favored Pre-proline 0 CA--C 1.544 0.72 0 O-C-N 121.54 -0.725 . . . . 0.0 109.678 169.657 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -87.63 -17.12 2.83 Favored 'Trans proline' 0 CA--C 1.544 1.003 0 C-N-CA 121.441 1.427 . . . . 0.0 114.836 174.523 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -69.86 -40.45 75.74 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 115.032 1.493 . . . . 0.0 115.032 -169.852 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -68.33 -3.25 30.86 Favored Glycine 0 CA--C 1.54 1.631 0 N-CA-C 115.677 1.031 . . . . 0.0 115.677 -175.892 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -141.86 176.18 9.13 Favored 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 127.017 2.127 . . . . 0.0 112.148 -170.057 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 57.1 m -64.29 161.06 17.43 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 114.866 1.432 . . . . 0.0 114.866 -169.939 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 39.0 tp -59.02 -28.85 66.8 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 124.791 1.236 . . . . 0.0 113.409 -178.552 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -63.18 -32.42 73.81 Favored 'General case' 0 N--CA 1.473 0.717 0 O-C-N 120.641 -1.287 . . . . 0.0 112.004 172.448 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 4.9 t -72.76 -36.38 52.49 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 O-C-N 121.093 -1.005 . . . . 0.0 110.819 172.308 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -55.95 -49.15 74.31 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-N 119.944 1.247 . . . . 0.0 111.391 169.83 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -66.76 -38.27 86.26 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.586 0.755 . . . . 0.0 112.122 -179.63 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 84.4 m -63.52 -43.92 95.77 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.761 0.824 . . . . 0.0 111.394 172.139 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 52.8 t -69.23 -35.66 69.0 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 CA-C-O 117.704 -1.141 . . . . 0.0 111.186 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 72.3 mtm-85 -57.12 -41.41 78.94 Favored 'General case' 0 N--CA 1.484 1.229 0 CA-C-N 120.903 1.683 . . . . 0.0 111.322 169.76 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -58.66 -50.58 65.77 Favored Glycine 0 CA--C 1.541 1.695 0 CA-C-N 118.898 0.772 . . . . 0.0 113.531 173.401 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 41.3 mt-30 -65.12 -43.64 91.31 Favored 'General case' 0 N--CA 1.477 0.906 0 O-C-N 121.645 -0.915 . . . . 0.0 112.63 178.471 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 69.8 t -66.93 -40.58 86.0 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 C-N-CA 124.012 0.925 . . . . 0.0 110.726 179.325 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 63.7 tttm -54.39 -48.54 71.44 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 119.31 0.959 . . . . 0.0 110.802 175.176 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -61.87 -46.89 87.46 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 123.537 0.735 . . . . 0.0 112.242 177.004 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 12.7 mtp85 -61.74 -40.19 94.22 Favored 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 113.414 0.894 . . . . 0.0 113.414 176.831 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 69.2 t -76.26 -30.76 20.29 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 O-C-N 121.627 -0.671 . . . . 0.0 111.176 -179.44 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -64.63 -38.1 89.84 Favored 'General case' 0 CA--C 1.54 0.585 0 O-C-N 121.184 -0.948 . . . . 0.0 110.166 169.118 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 97.7 m-20 -63.74 -45.48 89.7 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 123.572 0.749 . . . . 0.0 112.493 174.099 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 8.1 tt -50.53 -58.92 4.65 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 125.464 1.505 . . . . 0.0 110.724 170.725 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 80.4 mt -62.62 -44.07 99.07 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 CA-C-O 118.692 -0.67 . . . . 0.0 110.457 -176.449 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -68.14 -14.0 62.65 Favored 'General case' 0 CA--C 1.546 0.816 0 N-CA-C 114.372 1.249 . . . . 0.0 114.372 179.058 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 18.2 ptmt -99.12 -32.31 11.31 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 113.793 1.034 . . . . 0.0 113.793 174.385 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 17.8 pt -90.1 -18.1 7.77 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 N-CA-C 114.109 1.151 . . . . 0.0 114.109 179.815 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 72.9 m . . . . . 0 C--O 1.254 1.319 0 CA-C-O 118.294 -0.86 . . . . 0.0 112.507 -179.783 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.4 ttt . . . . . 0 N--CA 1.501 2.12 0 N-CA-C 111.924 0.342 . . . . 0.0 111.924 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.2 164.25 31.27 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 124.868 1.267 . . . . 0.0 113.363 178.16 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 60.1 mtpt -90.44 142.71 27.46 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 125.059 1.344 . . . . 0.0 113.221 175.681 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 21.6 t -125.49 131.63 71.94 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 C-N-CA 125.791 1.637 . . . . 0.0 112.301 179.186 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' MET . . . . . 0.421 ' HG3' HG13 ' A' ' 7' ' ' VAL . 55.0 tpp -101.47 116.5 32.91 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.967 0.907 . . . . 0.0 109.828 169.912 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 51.2 m-85 -100.74 120.76 40.56 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 124.536 1.134 . . . . 0.0 108.908 171.452 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.421 HG13 ' HG3' ' A' ' 5' ' ' MET . 3.0 m -140.74 156.66 23.16 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 N-CA-C 115.062 1.504 . . . . 0.0 115.062 -168.774 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 39.4 t -151.82 164.67 36.55 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 128.324 2.65 . . . . 0.0 108.054 169.826 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 39.1 ttpt -56.07 -51.37 68.11 Favored 'General case' 0 N--CA 1.482 1.132 0 CA-C-N 119.532 1.06 . . . . 0.0 112.995 -172.079 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 10.0 tpt180 -103.23 133.38 48.41 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 124.734 1.214 . . . . 0.0 109.64 175.763 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 -90.89 -42.64 10.5 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-N 118.627 0.648 . . . . 0.0 110.661 171.787 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 94.0 p -66.25 158.35 29.17 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 124.426 1.09 . . . . 0.0 110.938 168.896 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 24.4 p 50.53 -19.48 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.467 0 C-N-CA 129.254 3.021 . . . . 0.0 119.015 -170.048 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 13.9 tpt180 -107.06 112.97 26.16 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 125.806 1.642 . . . . 0.0 112.062 -173.184 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 3.4 p -69.26 136.99 52.71 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 123.914 0.885 . . . . 0.0 110.914 169.756 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 16.0 mt-30 -122.14 -39.68 2.57 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 124.894 1.278 . . . . 0.0 112.263 -169.783 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 68.13 -43.55 0.48 Allowed 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 127.29 2.236 . . . . 0.0 116.357 169.511 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -65.2 -34.29 78.02 Favored 'General case' 0 CA--C 1.533 0.306 0 O-C-N 120.831 -1.168 . . . . 0.0 113.738 -172.206 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 3.1 pm0 -59.88 -40.67 89.48 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 118.919 0.781 . . . . 0.0 111.929 170.378 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -66.24 -52.3 37.21 Favored Glycine 0 C--N 1.335 0.525 0 C-N-CA 123.839 0.733 . . . . 0.0 111.813 178.138 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -64.73 -34.45 78.34 Favored 'General case' 0 N--CA 1.467 0.405 0 O-C-N 121.659 -0.907 . . . . 0.0 112.008 177.902 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -66.16 -32.1 73.35 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 119.568 1.076 . . . . 0.0 112.72 178.637 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 22.6 mtpp -68.42 -52.95 27.08 Favored 'General case' 0 N--CA 1.478 0.943 0 CA-C-N 118.496 0.589 . . . . 0.0 110.129 169.794 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 98.5 m -72.4 -22.76 61.07 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 113.841 1.052 . . . . 0.0 113.841 -170.81 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 49.9 mt -95.38 -37.25 11.03 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 125.472 1.509 . . . . 0.0 113.253 171.631 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -104.92 -4.5 41.97 Favored Glycine 0 N--CA 1.47 0.915 0 N-CA-C 117.848 1.899 . . . . 0.0 117.848 -168.94 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -62.66 137.66 58.31 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-N 121.526 2.663 . . . . 0.0 111.971 179.794 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 86.88 -14.0 57.74 Favored Glycine 0 CA--C 1.542 1.732 0 C-N-CA 124.92 1.248 . . . . 0.0 113.857 -169.365 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -108.35 -42.88 4.47 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 126.512 1.925 . . . . 0.0 111.768 170.776 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 34.3 pt -136.83 160.65 36.83 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 C-N-CA 126.18 1.792 . . . . 0.0 112.246 179.48 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -108.66 149.34 29.08 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 125.504 1.522 . . . . 0.0 109.893 169.822 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 84.7 t -138.25 141.18 38.63 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 O-C-N 121.471 -0.768 . . . . 0.0 111.916 -170.111 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 18.6 m -140.08 153.49 46.76 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 125.249 1.42 . . . . 0.0 109.936 174.796 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 38.8 p -137.74 138.99 39.86 Favored 'General case' 0 CA--C 1.516 -0.342 0 C-N-CA 124.505 1.122 . . . . 0.0 110.237 168.59 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 96.4 p -127.44 -62.45 1.09 Allowed 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 115.532 1.679 . . . . 0.0 115.532 -168.528 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 111.28 162.11 17.36 Favored Glycine 0 N--CA 1.469 0.841 0 C-N-CA 126.149 1.833 . . . . 0.0 110.6 -174.939 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -97.66 -20.01 17.9 Favored 'General case' 0 N--CA 1.482 1.16 0 CA-C-N 119.384 1.592 . . . . 0.0 113.66 171.801 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 61.0 mt-10 -132.37 -31.94 1.38 Allowed 'General case' 0 N--CA 1.48 1.039 0 N-CA-C 113.901 1.074 . . . . 0.0 113.901 -171.33 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 94.2 p -137.14 160.38 39.16 Favored 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 125.901 1.681 . . . . 0.0 110.875 -177.17 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 96.6 p -116.59 165.64 13.02 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 125.678 1.591 . . . . 0.0 112.995 -175.588 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 72.2 ttt180 62.87 133.39 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 128.161 2.585 . . . . 0.0 113.728 -171.647 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 26.5 m -61.98 135.13 26.92 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 170.675 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -59.88 144.98 85.22 Favored Pre-proline 0 CA--C 1.548 0.88 0 C-N-CA 120.274 -0.57 . . . . 0.0 112.536 -169.603 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -49.12 -40.93 41.92 Favored 'Trans proline' 0 CA--C 1.539 0.761 0 C-N-CA 123.23 2.62 . . . . 0.0 117.763 -167.762 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 59.8 m -65.75 -26.54 67.77 Favored 'General case' 0 N--CA 1.484 1.252 0 CA-C-N 119.475 1.034 . . . . 0.0 111.661 -176.471 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -57.12 -36.94 71.26 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 123.905 0.882 . . . . 0.0 112.199 177.279 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.8 mp -59.5 -60.15 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 CA-C-N 119.05 0.841 . . . . 0.0 109.269 -179.404 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -62.49 -31.25 71.97 Favored 'General case' 0 CA--C 1.544 0.734 0 N-CA-C 113.434 0.901 . . . . 0.0 113.434 -176.677 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -81.29 -6.15 58.57 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 124.815 1.246 . . . . 0.0 114.184 177.672 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 40.6 mtt -114.94 -22.9 9.36 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 125.383 1.473 . . . . 0.0 110.704 175.026 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -65.15 -19.2 65.87 Favored 'General case' 0 CA--C 1.541 0.628 0 O-C-N 120.594 -1.316 . . . . 0.0 111.729 168.751 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 11.7 mt-10 -60.73 -28.27 68.55 Favored 'General case' 0 N--CA 1.481 1.107 0 CA-C-N 119.558 1.072 . . . . 0.0 111.48 169.377 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 67.8 t -93.14 -5.43 10.69 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.946 0 C-N-CA 127.472 2.309 . . . . 0.0 111.021 177.893 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 82.22 16.87 70.67 Favored Glycine 0 CA--C 1.538 1.494 0 C-N-CA 125.16 1.362 . . . . 0.0 114.307 -175.224 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 78.5 mt -77.14 139.6 18.47 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 C-N-CA 124.645 1.178 . . . . 0.0 111.53 -173.912 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 20.0 t0 -103.7 106.68 17.26 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 124.614 1.166 . . . . 0.0 111.873 170.709 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 3.8 pt -131.54 13.71 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.212 0 C-N-CA 125.515 1.526 . . . . 0.0 113.811 178.048 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 72.7 m -73.37 119.56 17.78 Favored 'General case' 0 N--CA 1.472 0.628 0 O-C-N 120.834 -1.167 . . . . 0.0 112.119 -176.31 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 63.78 35.43 92.01 Favored Glycine 0 CA--C 1.537 1.416 0 N-CA-C 115.797 1.079 . . . . 0.0 115.797 169.831 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 41.0 mt-30 -59.99 -50.32 74.22 Favored 'General case' 0 N--CA 1.477 0.906 0 N-CA-C 113.887 1.069 . . . . 0.0 113.887 -172.949 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 76.1 p -139.13 154.18 48.08 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 125.267 1.427 . . . . 0.0 113.348 -169.065 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 69.5 m -122.99 5.86 9.3 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 125.664 1.586 . . . . 0.0 113.982 -176.829 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 -143.14 153.07 59.55 Favored Pre-proline 0 CA--C 1.55 0.976 0 C-N-CA 124.44 1.096 . . . . 0.0 113.562 -173.411 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_exo -66.07 167.11 18.81 Favored 'Trans proline' 0 C--N 1.353 0.808 0 C-N-CA 123.349 2.7 . . . . 0.0 113.84 170.085 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 8.3 tt -50.79 -30.36 8.52 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 C-N-CA 126.699 2.0 . . . . 0.0 111.498 169.073 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -53.44 -27.49 25.04 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 126.514 1.925 . . . . 0.0 113.347 177.123 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -88.34 -6.82 57.5 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 125.119 1.368 . . . . 0.0 113.72 -174.875 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 71.6 m-85 -109.04 179.95 4.02 Favored 'General case' 0 CA--C 1.55 0.981 0 C-N-CA 126.51 1.924 . . . . 0.0 111.485 -174.917 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 5.8 t30 -122.52 126.24 47.4 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 125.495 1.518 . . . . 0.0 109.757 175.023 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.59 -35.66 80.73 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 113.895 1.072 . . . . 0.0 113.895 -169.947 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . 0.254 0.0 OUTLIER -71.46 -5.34 32.17 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 114.085 1.142 . . . . 0.0 114.085 -177.02 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -76.08 -12.96 60.21 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 124.013 0.925 . . . . 0.0 111.463 169.245 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 86.5 m-85 -115.51 139.54 49.97 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 127.098 2.159 . . . . 0.0 111.167 178.676 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -91.14 -21.97 20.91 Favored 'General case' 0 N--CA 1.478 0.959 0 CA-C-O 122.078 0.942 . . . . 0.0 112.556 178.303 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.721 HG22 ' HB ' ' A' ' 95' ' ' ILE . 80.7 t -133.78 139.29 48.98 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 C-N-CA 126.957 2.103 . . . . 0.0 109.014 -174.547 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 45.1 t -131.71 124.07 53.19 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 169.789 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 44.8 mm -111.86 108.01 24.42 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 C-N-CA 124.578 1.151 . . . . 0.0 108.653 -179.486 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 46.8 m -93.64 114.97 27.42 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 123.201 0.6 . . . . 0.0 109.738 174.859 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 82.7 mt -86.77 -13.7 44.45 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.971 1.308 . . . . 0.0 114.059 -172.118 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 14.5 p -147.85 157.78 43.71 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 124.835 1.254 . . . . 0.0 111.29 -176.603 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 62.1 -143.08 48.49 Favored Glycine 0 CA--C 1.538 1.472 0 C-N-CA 123.431 0.538 . . . . 0.0 113.494 179.572 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 56.9 m -131.43 164.12 26.43 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 125.584 1.554 . . . . 0.0 111.209 179.067 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -72.67 63.97 1.49 Allowed Glycine 0 CA--C 1.538 1.517 0 C-N-CA 124.953 1.264 . . . . 0.0 113.525 177.946 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 10.0 p -141.6 -30.65 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 N-CA-C 114.492 1.293 . . . . 0.0 114.492 -171.597 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 10.9 t-20 -75.0 -29.25 60.83 Favored 'General case' 0 N--CA 1.477 0.882 0 CA-C-N 119.417 1.008 . . . . 0.0 112.193 176.525 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -83.18 150.93 62.12 Favored Pre-proline 0 CA--C 1.548 0.888 0 C-N-CA 125.024 1.329 . . . . 0.0 111.279 169.628 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -65.35 155.44 68.62 Favored 'Trans proline' 0 CA--C 1.541 0.828 0 C-N-CA 122.574 2.182 . . . . 0.0 111.655 178.141 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -59.41 -26.34 81.6 Favored 'Trans proline' 0 C--N 1.35 0.61 0 C-N-CA 123.474 2.782 . . . . 0.0 114.913 -169.157 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -59.59 -22.7 62.15 Favored 'General case' 0 N--CA 1.472 0.629 0 O-C-N 120.841 -1.162 . . . . 0.0 114.119 178.285 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 84.9 m95 -82.44 -16.99 46.93 Favored 'General case' 0 N--CA 1.471 0.616 0 O-C-N 120.79 -1.194 . . . . 0.0 113.593 174.904 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 10.3 m -93.33 -10.41 9.45 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 CA-C-N 119.299 0.954 . . . . 0.0 113.498 170.967 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 60.3 p -93.48 -1.35 55.75 Favored 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 114.771 1.397 . . . . 0.0 114.771 177.016 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 72.8 mm-40 -67.64 154.21 41.96 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 119.3 0.954 . . . . 0.0 110.909 169.92 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -56.62 -40.01 74.62 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 114.601 1.334 . . . . 0.0 114.601 -167.82 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.721 ' HB ' HG22 ' A' ' 75' ' ' VAL . 15.7 mm -120.89 61.64 0.23 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 C-N-CA 124.972 1.309 . . . . 0.0 109.357 178.822 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 13.3 t80 -77.29 110.83 12.34 Favored 'General case' 0 CA--C 1.536 0.404 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 168.849 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 16.3 mt-10 -114.66 138.56 50.54 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 113.988 1.107 . . . . 0.0 113.988 173.197 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -101.65 120.25 40.04 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 124.143 0.977 . . . . 0.0 108.518 168.603 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 35.8 m0 -103.56 134.81 46.29 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 123.722 0.809 . . . . 0.0 108.867 176.629 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 64.2 mt-30 -114.8 30.56 7.26 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 123.865 0.866 . . . . 0.0 112.554 -169.563 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -76.16 159.71 30.44 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 125.709 1.604 . . . . 0.0 112.579 174.783 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -73.44 156.18 38.52 Favored 'General case' 0 CA--C 1.539 0.53 0 O-C-N 121.88 -0.512 . . . . 0.0 111.906 170.029 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 64.2 m-20 -106.44 155.06 39.39 Favored Pre-proline 0 CA--C 1.549 0.918 0 C-N-CA 123.292 0.637 . . . . 0.0 111.111 173.096 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_exo -70.87 -21.59 28.12 Favored 'Trans proline' 0 CA--C 1.544 1.007 0 C-N-CA 122.464 2.109 . . . . 0.0 115.115 179.795 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -42.19 125.26 3.02 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 114.329 1.233 . . . . 0.0 114.329 172.756 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 81.54 3.24 90.67 Favored Glycine 0 CA--C 1.535 1.335 0 C-N-CA 124.39 0.995 . . . . 0.0 115.167 177.931 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 9.8 pt20 -137.81 172.8 12.41 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 124.938 1.295 . . . . 0.0 113.59 -178.595 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 51.9 p -71.67 169.75 14.95 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 117.666 2.469 . . . . 0.0 117.666 -168.442 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -54.84 -41.68 71.03 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 126.436 1.894 . . . . 0.0 112.17 170.129 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -57.25 -32.85 66.99 Favored 'General case' 0 N--CA 1.473 0.716 0 O-C-N 121.225 -0.922 . . . . 0.0 112.23 172.382 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 7.7 t -75.14 -36.2 36.77 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 O-C-N 121.051 -1.031 . . . . 0.0 112.05 171.101 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 12.1 m-85 -56.58 -42.77 79.23 Favored 'General case' 0 N--CA 1.478 0.949 0 CA-C-N 120.792 1.633 . . . . 0.0 111.132 169.229 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 83.2 mtp180 -64.82 -42.9 94.61 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 124.1 0.96 . . . . 0.0 112.11 175.063 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 53.1 m -60.45 -45.31 94.15 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 124.1 0.96 . . . . 0.0 111.283 175.398 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 74.3 t -68.16 -42.1 84.62 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 CA-C-O 117.929 -1.034 . . . . 0.0 110.643 177.66 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 18.0 mtp180 -52.91 -44.9 67.3 Favored 'General case' 0 N--CA 1.482 1.158 0 CA-C-N 120.283 1.401 . . . . 0.0 112.215 171.761 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -60.09 -51.49 58.57 Favored Glycine 0 CA--C 1.539 1.577 0 CA-C-N 119.243 0.928 . . . . 0.0 113.694 175.303 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 56.4 mm-40 -65.45 -44.48 87.12 Favored 'General case' 0 N--CA 1.477 0.883 0 O-C-N 121.797 -0.825 . . . . 0.0 112.221 179.873 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 52.9 t -63.21 -42.06 95.09 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 124.673 1.189 . . . . 0.0 110.496 177.022 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 60.0 tttm -54.81 -50.93 67.35 Favored 'General case' 0 N--CA 1.477 0.888 0 CA-C-N 119.689 1.132 . . . . 0.0 110.91 177.664 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -63.99 -41.77 97.4 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 112.458 0.54 . . . . 0.0 112.458 178.756 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 4.8 mtp85 -63.3 -43.97 96.35 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 113.254 0.835 . . . . 0.0 113.254 175.772 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 94.1 t -71.34 -37.76 66.68 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 C-N-CA 124.044 0.937 . . . . 0.0 111.105 179.407 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -61.24 -40.97 96.02 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 119.417 1.008 . . . . 0.0 111.682 170.409 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 11.6 m-80 -61.8 -48.59 79.93 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 118.727 0.694 . . . . 0.0 112.165 173.394 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -51.83 -56.61 12.96 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 125.33 1.452 . . . . 0.0 110.465 175.725 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 75.2 mt -61.25 -46.3 96.89 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 CA-C-O 119.124 -0.465 . . . . 0.0 110.138 -179.574 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -66.62 -12.04 56.27 Favored 'General case' 0 CA--C 1.546 0.795 0 N-CA-C 114.983 1.475 . . . . 0.0 114.983 -178.998 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -102.14 -26.45 13.35 Favored 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 113.824 1.046 . . . . 0.0 113.824 172.355 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 13.6 pt -97.45 -12.85 8.26 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 N-CA-C 114.866 1.432 . . . . 0.0 114.866 178.655 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 57.8 m . . . . . 0 C--O 1.252 1.199 0 C-N-CA 125.333 1.453 . . . . 0.0 112.255 -179.792 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.3 ttt . . . . . 0 N--CA 1.501 2.088 0 N-CA-C 111.937 0.347 . . . . 0.0 111.937 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.15 164.34 30.41 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 124.966 1.306 . . . . 0.0 112.886 175.922 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 41.5 mtpt -94.73 143.4 26.47 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 124.449 1.1 . . . . 0.0 112.136 178.141 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 18.9 t -124.71 133.86 68.33 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 C-N-CA 125.289 1.435 . . . . 0.0 112.749 -178.877 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' MET . . . . . 0.51 ' HG3' HG13 ' A' ' 7' ' ' VAL . 36.8 tpp -104.2 122.45 45.39 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 123.412 0.685 . . . . 0.0 109.257 168.717 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 68.6 m-85 -98.94 128.66 45.15 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.337 1.055 . . . . 0.0 108.993 170.22 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.58 HG11 HD12 ' A' ' 65' ' ' ILE . 0.4 OUTLIER -138.27 144.17 31.11 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 N-CA-C 114.363 1.245 . . . . 0.0 114.363 -168.778 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -141.18 166.81 23.76 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 127.131 2.173 . . . . 0.0 110.68 170.122 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -57.19 -49.15 76.87 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.263 -0.898 . . . . 0.0 112.928 -173.881 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 96.8 mtt180 -125.05 130.55 52.52 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 124.679 1.191 . . . . 0.0 110.088 169.559 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 35.5 t30 -81.54 -43.0 19.35 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-N 117.819 0.281 . . . . 0.0 111.498 -179.735 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 45.0 m -68.25 -32.23 72.28 Favored 'General case' 0 N--CA 1.478 0.954 0 N-CA-C 113.52 0.933 . . . . 0.0 113.52 -170.959 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 97.8 p -90.92 -5.7 55.12 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 114.855 1.428 . . . . 0.0 114.855 -175.138 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 60.2 mtt85 -134.93 156.64 48.64 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 124.583 1.153 . . . . 0.0 112.341 -175.917 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 37.2 m -105.47 103.83 13.44 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 124.565 1.146 . . . . 0.0 110.077 -179.893 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 3.1 mp0 -78.4 -34.51 48.03 Favored 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 114.162 1.171 . . . . 0.0 114.162 -169.206 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 68.74 -49.2 0.57 Allowed 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 126.474 1.91 . . . . 0.0 115.99 169.653 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.97 -33.57 73.41 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.185 0.994 . . . . 0.0 113.574 -171.131 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 3.4 pm0 -62.5 -46.3 89.05 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 123.978 0.911 . . . . 0.0 112.277 174.295 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -65.57 -39.87 95.74 Favored Glycine 0 C--N 1.335 0.49 0 C-N-CA 123.64 0.638 . . . . 0.0 111.66 178.849 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -69.92 -41.78 74.19 Favored 'General case' 0 N--CA 1.468 0.431 0 O-C-N 121.838 -0.801 . . . . 0.0 111.271 176.156 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -60.4 -43.36 96.75 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 119.626 1.103 . . . . 0.0 112.735 -176.446 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 8.8 pttp -77.91 -24.31 48.37 Favored 'General case' 0 N--CA 1.479 1.011 0 N-CA-C 113.65 0.981 . . . . 0.0 113.65 175.097 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 85.5 m -71.63 -36.01 70.6 Favored 'General case' 0 N--CA 1.48 1.071 0 O-C-N 121.401 -0.812 . . . . 0.0 111.623 171.682 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 61.4 mt -88.09 -31.73 19.09 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 125.711 1.604 . . . . 0.0 114.172 -177.698 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -145.8 30.97 1.65 Allowed Glycine 0 N--CA 1.474 1.219 0 N-CA-C 118.297 2.079 . . . . 0.0 118.297 -169.035 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -66.71 -19.75 65.82 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-N 121.794 2.797 . . . . 0.0 115.202 -178.238 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -75.36 -10.37 84.45 Favored Glycine 0 CA--C 1.541 1.711 0 O-C-N 121.293 -0.88 . . . . 0.0 113.18 169.586 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 76.0 mttt -108.64 -39.66 5.31 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 127.185 2.194 . . . . 0.0 113.375 179.873 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 22.6 pt -142.12 155.72 19.33 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 C-N-CA 124.966 1.306 . . . . 0.0 112.562 -173.235 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -104.27 142.68 34.11 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 124.156 0.982 . . . . 0.0 110.48 171.199 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 74.3 t -130.11 140.11 49.76 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 CA-C-N 119.186 0.903 . . . . 0.0 112.88 -171.776 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 36.4 m -137.59 154.18 49.82 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 126.302 1.841 . . . . 0.0 109.02 170.885 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 61.3 p -128.95 147.31 50.84 Favored 'General case' 0 CA--C 1.515 -0.366 0 CA-C-O 121.931 0.872 . . . . 0.0 112.506 167.464 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 25.8 p -144.79 157.44 44.17 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 114.353 -1.294 . . . . 0.0 112.378 -178.59 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -97.92 150.74 19.52 Favored Glycine 0 N--CA 1.468 0.814 0 CA-C-O 119.318 -0.712 . . . . 0.0 111.846 174.663 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 10.8 mp -66.44 -30.9 71.35 Favored 'General case' 0 N--CA 1.483 1.207 0 CA-C-N 119.299 1.55 . . . . 0.0 108.992 168.864 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 52.6 mt-10 -133.1 154.8 50.24 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 128.359 2.664 . . . . 0.0 107.201 168.214 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 27.0 p 64.46 161.38 0.12 Allowed 'General case' 0 N--CA 1.486 1.331 0 N-CA-C 117.504 2.409 . . . . 0.0 117.504 178.678 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 75.1 m -118.76 143.55 46.83 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 126.621 1.968 . . . . 0.0 113.18 -170.248 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 59.1 ttt-85 62.3 148.13 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.897 0 C-N-CA 127.612 2.365 . . . . 0.0 114.091 -176.381 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 24.9 m -61.38 166.18 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.255 0 CA-C-O 122.662 1.22 . . . . 0.0 111.824 169.782 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 2.7 t-80 -41.22 136.45 1.71 Allowed Pre-proline 0 C--N 1.327 -0.386 0 CA-C-N 113.761 -1.563 . . . . 0.0 113.243 169.426 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -60.36 -27.5 84.99 Favored 'Trans proline' 0 CA--C 1.546 1.12 0 CA-C-N 120.753 1.305 . . . . 0.0 112.252 170.647 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 99.0 m -67.89 -31.89 71.99 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 124.966 1.306 . . . . 0.0 112.077 174.566 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -57.39 -39.48 76.2 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 124.289 1.036 . . . . 0.0 111.636 -175.055 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.7 mp -57.45 -60.61 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 C-N-CA 124.226 1.01 . . . . 0.0 109.361 -178.908 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -61.82 -31.62 71.88 Favored 'General case' 0 CA--C 1.545 0.761 0 N-CA-C 113.384 0.883 . . . . 0.0 113.384 -177.17 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -82.25 -6.61 59.35 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 114.248 1.203 . . . . 0.0 114.248 177.953 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 39.1 mtt -112.52 -24.35 9.75 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 125.418 1.487 . . . . 0.0 110.464 174.604 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 27.0 mt-10 -65.46 -16.43 63.64 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 125.128 1.371 . . . . 0.0 111.519 168.559 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 11.5 mt-10 -60.21 -30.52 69.43 Favored 'General case' 0 N--CA 1.481 1.095 0 CA-C-N 119.726 1.148 . . . . 0.0 110.74 169.103 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 60.2 t -92.45 -4.99 10.79 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.955 0 C-N-CA 127.59 2.356 . . . . 0.0 111.017 178.721 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 80.1 18.3 72.37 Favored Glycine 0 CA--C 1.538 1.497 0 C-N-CA 125.073 1.32 . . . . 0.0 114.55 -173.933 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 73.8 mt -76.89 136.69 23.99 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 124.368 1.067 . . . . 0.0 111.661 -173.082 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 19.7 t0 -97.33 88.45 4.43 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.588 1.155 . . . . 0.0 112.061 -179.112 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 7.6 pt -125.8 8.66 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.33 0 N-CA-C 114.265 1.209 . . . . 0.0 114.265 174.957 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 97.7 p -59.28 -42.12 90.48 Favored 'General case' 0 N--CA 1.477 0.92 0 O-C-N 120.824 -1.173 . . . . 0.0 114.044 -171.59 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -93.35 15.39 63.07 Favored Glycine 0 CA--C 1.534 1.237 0 C-N-CA 125.18 1.371 . . . . 0.0 116.092 -176.533 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . 0.268 0.0 OUTLIER -77.51 62.07 2.4 Favored 'General case' 0 N--CA 1.478 0.93 0 CA-C-N 119.912 1.856 . . . . 0.0 114.481 -172.18 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 40.2 p -69.38 107.86 3.49 Favored 'General case' 0 N--CA 1.471 0.585 0 O-C-N 120.431 -1.418 . . . . 0.0 108.93 169.186 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 70.2 m -142.18 129.32 20.92 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.204 1.002 . . . . 0.0 111.456 -169.567 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -67.02 170.39 6.37 Favored Pre-proline 0 CA--C 1.549 0.922 0 C-N-CA 127.575 2.35 . . . . 0.0 114.496 -176.249 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -64.3 156.51 59.38 Favored 'Trans proline' 0 C--N 1.352 0.728 0 C-N-CA 122.665 2.243 . . . . 0.0 111.819 169.129 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.58 HD12 HG11 ' A' ' 7' ' ' VAL . 6.0 tt -51.59 -33.71 15.17 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 C-N-CA 125.874 1.669 . . . . 0.0 111.571 174.632 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 12.3 mt-10 -61.97 -24.18 66.85 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.748 1.219 . . . . 0.0 113.295 -178.044 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 71.1 m-20 -91.89 6.17 47.22 Favored 'General case' 0 CA--C 1.55 0.981 0 C-N-CA 124.378 1.071 . . . . 0.0 112.898 -175.408 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 -119.15 -175.55 2.94 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 126.833 2.053 . . . . 0.0 112.683 -179.76 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 9.6 p-10 -123.73 129.26 50.81 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 125.737 1.615 . . . . 0.0 109.728 172.474 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -64.72 -37.19 86.76 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 112.81 0.671 . . . . 0.0 112.81 -172.607 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -68.4 -4.39 14.52 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 114.291 1.219 . . . . 0.0 114.291 179.364 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -68.51 -21.39 64.58 Favored 'General case' 0 CA--C 1.549 0.916 0 CA-C-N 119.317 0.962 . . . . 0.0 109.932 168.449 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 76.6 m-85 -115.35 146.13 41.85 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 127.726 2.41 . . . . 0.0 111.842 -175.179 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -101.91 -18.12 15.84 Favored 'General case' 0 N--CA 1.481 1.088 0 CA-C-O 122.153 0.978 . . . . 0.0 112.614 178.584 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.657 HG22 ' HB ' ' A' ' 95' ' ' ILE . 76.0 t -128.62 138.64 54.05 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 C-N-CA 127.605 2.362 . . . . 0.0 108.022 177.731 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 48.7 t -132.82 124.98 51.68 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 169.836 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 46.2 mm -112.3 104.82 17.66 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.344 0 C-N-CA 124.275 1.03 . . . . 0.0 109.602 -175.054 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 3.6 m -80.28 106.69 12.49 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 123.494 0.718 . . . . 0.0 109.868 170.463 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 91.2 mt -83.58 -19.95 34.63 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 126.237 1.815 . . . . 0.0 113.852 -176.293 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 80.6 m -97.01 121.59 39.06 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 106.931 -1.507 . . . . 0.0 106.931 171.328 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -59.73 141.47 47.55 Favored Glycine 0 CA--C 1.535 1.337 0 CA-C-N 118.484 0.583 . . . . 0.0 113.199 -172.571 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 75.7 m 56.85 43.65 24.57 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.744 1.218 . . . . 0.0 111.114 -169.526 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -74.29 62.61 2.2 Favored Glycine 0 N--CA 1.471 1.002 0 C-N-CA 125.91 1.719 . . . . 0.0 111.802 176.331 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.3 p -113.17 -0.41 9.3 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 C-N-CA 126.119 1.768 . . . . 0.0 112.913 -170.074 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 29.0 m120 -74.46 -11.34 60.2 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 124.338 1.055 . . . . 0.0 113.252 174.844 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -65.77 158.96 72.46 Favored Pre-proline 0 CA--C 1.553 1.07 0 C-N-CA 124.274 1.03 . . . . 0.0 112.389 170.501 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -59.94 149.93 81.15 Favored 'Trans proline' 0 CA--C 1.543 0.975 0 C-N-CA 122.437 2.091 . . . . 0.0 113.11 178.721 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_exo -56.25 -33.4 90.88 Favored 'Trans proline' 0 C--N 1.351 0.694 0 C-N-CA 123.102 2.535 . . . . 0.0 114.948 -171.873 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -59.61 -22.49 61.89 Favored 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 114.019 1.118 . . . . 0.0 114.019 178.879 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 88.7 m95 -79.75 -15.82 56.76 Favored 'General case' 0 N--CA 1.469 0.511 0 O-C-N 120.685 -1.259 . . . . 0.0 113.487 176.439 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 8.2 m -96.35 -8.13 9.43 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 N-CA-C 113.711 1.004 . . . . 0.0 113.711 170.731 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 68.5 p -95.77 -2.85 46.86 Favored 'General case' 0 N--CA 1.48 1.044 0 N-CA-C 114.866 1.432 . . . . 0.0 114.866 178.206 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 68.6 mm-40 -65.93 155.09 37.51 Favored 'General case' 0 N--CA 1.477 0.916 0 CA-C-N 119.368 0.985 . . . . 0.0 110.236 169.553 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -56.78 -40.05 75.16 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 114.773 1.397 . . . . 0.0 114.773 -168.154 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.657 ' HB ' HG22 ' A' ' 75' ' ' VAL . 19.7 mm -120.26 65.92 0.26 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 C-N-CA 124.652 1.181 . . . . 0.0 109.147 -178.795 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 32.7 t80 -80.04 109.76 14.79 Favored 'General case' 0 C--O 1.236 0.375 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 168.961 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -110.2 135.19 51.36 Favored 'General case' 0 CA--C 1.545 0.76 0 N-CA-C 113.441 0.904 . . . . 0.0 113.441 174.478 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -102.06 103.71 14.32 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.435 1.094 . . . . 0.0 109.584 169.895 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 38.1 m0 -91.84 114.1 26.55 Favored 'General case' 0 N--CA 1.463 0.181 0 C-N-CA 124.275 1.03 . . . . 0.0 109.294 179.523 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 41.7 mt-30 -91.8 48.54 1.46 Allowed 'General case' 0 CA--C 1.544 0.749 0 CA-C-O 122.289 1.043 . . . . 0.0 111.26 -172.678 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 86.5 mt -78.39 166.25 22.87 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 127.115 2.166 . . . . 0.0 111.953 176.485 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -88.9 152.49 21.7 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-O 121.555 0.693 . . . . 0.0 112.415 169.573 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 13.4 p-10 -89.6 136.77 29.23 Favored Pre-proline 0 CA--C 1.55 0.968 0 C-N-CA 125.47 1.508 . . . . 0.0 112.008 176.214 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -70.25 -20.01 33.05 Favored 'Trans proline' 0 CA--C 1.547 1.126 0 C-N-CA 121.955 1.77 . . . . 0.0 115.491 -178.42 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -66.52 145.0 56.12 Favored 'General case' 0 N--CA 1.476 0.834 0 O-C-N 121.103 -0.998 . . . . 0.0 113.179 -175.965 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 78.36 4.81 87.37 Favored Glycine 0 CA--C 1.535 1.296 0 C-N-CA 123.943 0.782 . . . . 0.0 114.661 -179.156 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -141.61 166.83 23.67 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 125.465 1.506 . . . . 0.0 112.878 -179.921 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 66.9 m -63.86 163.23 12.23 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 115.698 1.74 . . . . 0.0 115.698 -169.239 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -51.82 -39.64 59.11 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 126.673 1.989 . . . . 0.0 112.837 171.911 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -55.27 -31.81 61.86 Favored 'General case' 0 N--CA 1.474 0.737 0 O-C-N 121.265 -0.897 . . . . 0.0 112.515 172.598 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 4.3 t -76.94 -37.27 26.7 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 O-C-N 121.163 -0.961 . . . . 0.0 111.75 173.575 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 21.4 m-85 -57.16 -42.66 81.49 Favored 'General case' 0 N--CA 1.477 0.88 0 CA-C-N 119.943 1.247 . . . . 0.0 111.221 169.302 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 97.7 mtt180 -68.45 -38.35 81.06 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.612 0.765 . . . . 0.0 112.474 176.158 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 45.8 m -61.71 -45.65 93.06 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 124.187 0.995 . . . . 0.0 111.37 172.638 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 72.1 t -67.77 -40.97 84.74 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 CA-C-O 118.266 -0.873 . . . . 0.0 110.463 178.324 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 20.4 mtp180 -54.45 -43.74 71.92 Favored 'General case' 0 N--CA 1.484 1.273 0 CA-C-N 120.239 1.381 . . . . 0.0 112.915 170.912 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -61.59 -50.02 70.69 Favored Glycine 0 CA--C 1.537 1.417 0 CA-C-N 119.45 1.023 . . . . 0.0 113.255 175.784 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 53.6 mm-40 -64.59 -44.13 91.65 Favored 'General case' 0 N--CA 1.476 0.837 0 O-C-N 122.043 -0.68 . . . . 0.0 112.012 178.478 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 58.8 t -63.92 -41.46 92.58 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 C-N-CA 124.91 1.284 . . . . 0.0 111.125 176.752 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 60.7 tttm -54.27 -49.75 68.84 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-N 120.13 1.332 . . . . 0.0 110.628 176.832 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -63.49 -44.79 93.33 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 112.557 0.577 . . . . 0.0 112.557 176.306 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.23 -35.38 80.86 Favored 'General case' 0 N--CA 1.481 1.105 0 N-CA-C 113.6 0.963 . . . . 0.0 113.6 -179.921 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 92.3 t -78.01 -40.55 26.61 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 C-N-CA 125.411 1.484 . . . . 0.0 110.992 177.008 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -61.43 -38.57 87.61 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 119.185 0.902 . . . . 0.0 111.542 172.257 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 11.1 m-80 -63.91 -44.96 91.37 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 118.846 0.748 . . . . 0.0 112.701 173.561 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -54.47 -56.32 20.0 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 124.223 1.009 . . . . 0.0 110.667 174.392 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 95.3 mt -61.76 -42.01 92.77 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 CA-C-O 119.199 -0.429 . . . . 0.0 110.51 -179.26 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -68.72 -14.38 62.99 Favored 'General case' 0 CA--C 1.545 0.763 0 N-CA-C 114.933 1.457 . . . . 0.0 114.933 179.072 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 21.1 ptmt -99.96 -27.96 13.32 Favored 'General case' 0 N--CA 1.479 0.986 0 N-CA-C 113.855 1.057 . . . . 0.0 113.855 173.523 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 16.6 pt -94.86 -20.54 6.03 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 N-CA-C 114.295 1.22 . . . . 0.0 114.295 177.338 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 74.7 m . . . . . 0 C--O 1.253 1.28 0 C-N-CA 125.074 1.349 . . . . 0.0 111.889 -173.788 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 32.9 ttm . . . . . 0 N--CA 1.502 2.133 0 N-CA-C 112.044 0.387 . . . . 0.0 112.044 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 3.5 mptp? -103.92 155.51 18.58 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 125.181 1.392 . . . . 0.0 112.688 169.812 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 44.7 mtpt -105.4 113.78 27.56 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 106.089 -1.819 . . . . 0.0 106.089 167.088 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 14.4 t -105.95 130.49 57.41 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 C-N-CA 125.247 1.419 . . . . 0.0 113.15 -178.788 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' MET . . . . . 0.52 ' HG3' HG13 ' A' ' 7' ' ' VAL . 61.3 tpp -101.65 117.74 35.51 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.501 0.72 . . . . 0.0 109.137 169.193 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 54.8 m-85 -98.79 128.09 44.91 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 169.744 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.52 HG13 ' HG3' ' A' ' 5' ' ' MET . 1.3 m -144.22 153.1 15.4 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.127 0 N-CA-C 113.527 0.936 . . . . 0.0 113.527 -169.195 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 44.0 t -146.2 137.66 24.71 Favored 'General case' 0 CA--C 1.552 1.024 0 C-N-CA 125.315 1.446 . . . . 0.0 113.052 -178.457 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -67.36 135.44 53.24 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 125.029 1.331 . . . . 0.0 111.718 172.439 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . 0.263 19.1 ttm180 47.24 56.36 6.99 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 126.693 1.997 . . . . 0.0 113.31 -174.53 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 -48.76 -29.93 5.07 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 126.746 2.018 . . . . 0.0 114.654 175.461 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 81.4 p -62.69 -19.17 63.61 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 114.558 1.318 . . . . 0.0 114.558 179.72 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 84.7 p -127.32 24.07 6.32 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.458 1.503 . . . . 0.0 113.872 175.019 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 72.2 mtt85 -139.32 150.44 45.4 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 124.846 1.259 . . . . 0.0 113.26 177.196 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 22.3 m -106.81 153.87 21.84 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 125.552 1.541 . . . . 0.0 111.147 172.499 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 30.7 mt-30 -110.15 -55.91 2.4 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 113.248 0.833 . . . . 0.0 113.248 -171.846 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' MET . . . . . 0.433 ' HG2' ' SD ' ' A' ' 50' ' ' MET . 0.0 OUTLIER 73.28 -48.21 0.68 Allowed 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 126.608 1.963 . . . . 0.0 113.523 176.984 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.92 -33.31 74.02 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 113.552 0.945 . . . . 0.0 113.552 -175.1 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 5.4 pm0 -68.58 -42.3 78.45 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 123.846 0.859 . . . . 0.0 111.306 177.419 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -65.0 -40.59 97.23 Favored Glycine 0 C--N 1.336 0.581 0 N-CA-C 111.504 -0.638 . . . . 0.0 111.504 178.7 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -72.64 -38.93 67.54 Favored 'General case' 0 N--CA 1.466 0.366 0 O-C-N 121.809 -0.818 . . . . 0.0 112.054 177.403 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.9 -37.48 84.78 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 113.552 0.945 . . . . 0.0 113.552 -173.749 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 6.9 pttp -79.47 -31.16 42.37 Favored 'General case' 0 N--CA 1.481 1.102 0 N-CA-C 113.689 0.996 . . . . 0.0 113.689 172.115 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 59.0 m -70.74 -33.34 70.71 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.197 0.599 . . . . 0.0 111.498 178.583 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 68.3 mt -92.78 -37.5 12.3 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 125.864 1.666 . . . . 0.0 113.277 177.587 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -106.82 8.91 39.96 Favored Glycine 0 N--CA 1.472 1.055 0 N-CA-C 117.892 1.917 . . . . 0.0 117.892 -169.021 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.12 141.88 57.11 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-N 121.318 2.559 . . . . 0.0 112.203 177.407 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 83.91 -21.34 9.79 Favored Glycine 0 CA--C 1.538 1.495 0 C-N-CA 124.984 1.278 . . . . 0.0 113.749 -169.485 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 65.1 mttm -97.45 -48.22 5.37 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 125.786 1.635 . . . . 0.0 111.796 169.863 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 40.6 pt -135.39 150.13 29.03 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 C-N-CA 124.364 1.066 . . . . 0.0 113.085 -175.087 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -102.48 137.76 40.29 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 125.407 1.483 . . . . 0.0 108.921 169.769 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 99.4 t -126.49 140.67 48.16 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 C-N-CA 123.265 0.626 . . . . 0.0 111.976 -173.785 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 27.3 m -140.04 151.59 45.54 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 125.191 1.396 . . . . 0.0 109.626 174.745 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 53.0 p -138.37 145.75 41.46 Favored 'General case' 0 CA--C 1.516 -0.339 0 CA-C-O 122.486 1.136 . . . . 0.0 111.784 167.454 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 88.5 p -139.59 153.56 47.4 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 113.227 -1.806 . . . . 0.0 110.657 -171.951 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -75.98 162.82 53.0 Favored Glycine 0 CA--C 1.535 1.329 0 O-C-N 121.162 -0.961 . . . . 0.0 112.57 176.741 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.6 mp -95.5 -6.58 40.24 Favored 'General case' 0 N--CA 1.479 1.016 0 O-C-N 120.218 -1.754 . . . . 0.0 111.305 168.565 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -129.21 165.59 21.06 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 128.64 2.776 . . . . 0.0 107.386 169.799 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 70.1 m -77.24 59.7 1.82 Allowed 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 124.23 1.012 . . . . 0.0 113.159 -170.072 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 89.3 p -152.56 -179.63 7.76 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 125.748 1.619 . . . . 0.0 114.124 -169.685 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 58.8 ttt85 -94.8 163.17 13.46 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 128.798 2.839 . . . . 0.0 110.553 -174.571 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 21.2 m -78.51 178.49 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.235 0 C-N-CA 123.974 0.91 . . . . 0.0 110.056 169.238 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 2.1 t-80 -61.01 129.62 90.58 Favored Pre-proline 0 CA--C 1.534 0.344 0 CA-C-O 118.445 -0.788 . . . . 0.0 113.041 -177.06 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo -58.18 -28.01 82.42 Favored 'Trans proline' 0 CA--C 1.544 0.982 0 C-N-CA 121.728 1.618 . . . . 0.0 112.083 169.722 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 96.9 m -61.18 -32.32 72.06 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 125.5 1.52 . . . . 0.0 112.282 173.872 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -57.99 -47.24 83.59 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 118.98 0.809 . . . . 0.0 110.786 179.895 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.5 mp -53.42 -54.5 17.97 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 C-N-CA 124.222 1.009 . . . . 0.0 110.299 -174.596 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.24 -31.05 72.09 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 113.223 0.823 . . . . 0.0 113.223 -178.534 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -81.61 -21.72 38.13 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 113.761 1.022 . . . . 0.0 113.761 177.653 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' MET . . . . . 0.433 ' SD ' ' HG2' ' A' ' 17' ' ' MET . 4.8 mmt -84.87 -31.27 23.83 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 119.491 1.042 . . . . 0.0 110.484 169.549 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -66.97 -15.05 63.46 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.752 1.221 . . . . 0.0 113.774 175.571 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 14.3 mt-10 -61.97 -25.7 67.77 Favored 'General case' 0 N--CA 1.482 1.137 0 CA-C-N 120.313 1.415 . . . . 0.0 110.797 168.864 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 48.6 t -98.44 -2.76 9.86 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.006 0 C-N-CA 127.69 2.396 . . . . 0.0 111.163 176.749 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 79.42 17.86 75.06 Favored Glycine 0 CA--C 1.539 1.591 0 C-N-CA 125.096 1.331 . . . . 0.0 114.498 -176.805 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 84.4 mt -79.49 136.16 24.17 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 C-N-CA 125.06 1.344 . . . . 0.0 111.523 -174.449 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 15.0 t0 -95.35 111.0 22.94 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 112.896 0.702 . . . . 0.0 112.896 175.29 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 6.7 pt -135.89 24.35 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.363 0 C-N-CA 124.77 1.228 . . . . 0.0 114.05 172.52 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 70.4 m -69.85 -20.47 63.42 Favored 'General case' 0 N--CA 1.48 1.048 0 O-C-N 120.153 -1.592 . . . . 0.0 114.608 -172.242 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -90.06 10.85 72.65 Favored Glycine 0 CA--C 1.537 1.416 0 N-CA-C 116.521 1.369 . . . . 0.0 116.521 -175.871 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 25.2 mt-30 -81.83 50.49 1.54 Allowed 'General case' 0 N--CA 1.482 1.154 0 CA-C-N 120.08 1.94 . . . . 0.0 114.97 -169.573 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 37.8 m -104.65 -7.15 19.82 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 125.501 1.52 . . . . 0.0 111.249 169.655 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 68.7 m -69.59 79.36 0.42 Allowed 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 115.921 1.823 . . . . 0.0 115.921 -169.299 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 34.8 m-20 65.35 158.91 0.13 Allowed Pre-proline 0 CA--C 1.552 1.039 0 C-N-CA 128.57 2.748 . . . . 0.0 117.48 169.116 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -73.04 158.47 49.49 Favored 'Trans proline' 0 CA--C 1.539 0.74 0 C-N-CA 122.656 2.237 . . . . 0.0 113.052 169.934 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.47 HD12 HG11 ' A' ' 7' ' ' VAL . 6.3 tt -51.22 -40.92 23.4 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 125.705 1.602 . . . . 0.0 112.065 174.336 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -69.54 -7.32 37.32 Favored 'General case' 0 CA--C 1.543 0.707 0 N-CA-C 113.999 1.111 . . . . 0.0 113.999 -179.331 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 -81.14 -19.92 42.45 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 123.682 0.793 . . . . 0.0 113.128 171.349 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -99.27 -173.04 2.38 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 126.104 1.762 . . . . 0.0 112.581 -176.201 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 14.7 t30 -117.75 124.87 49.52 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 125.363 1.465 . . . . 0.0 110.14 175.488 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.99 -38.29 88.13 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 113.694 0.998 . . . . 0.0 113.694 -172.237 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -72.72 -5.09 35.39 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 113.951 1.093 . . . . 0.0 113.951 -176.694 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -72.69 -16.05 61.68 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 123.485 0.714 . . . . 0.0 111.385 168.866 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 60.3 m-85 -115.11 132.11 56.71 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 126.348 1.859 . . . . 0.0 111.166 179.313 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -89.03 -20.6 24.18 Favored 'General case' 0 N--CA 1.476 0.875 0 CA-C-O 121.966 0.889 . . . . 0.0 112.73 -177.972 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.686 HG22 ' HB ' ' A' ' 95' ' ' ILE . 82.0 t -128.57 137.74 56.5 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 C-N-CA 127.488 2.315 . . . . 0.0 107.965 178.75 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 65.9 t -131.37 123.68 53.41 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 169.569 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 36.1 mm -109.77 104.46 17.11 Favored 'Isoleucine or valine' 0 C--O 1.234 0.287 0 C-N-CA 124.397 1.079 . . . . 0.0 108.462 -179.053 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 5.4 m -82.71 125.42 31.22 Favored 'General case' 0 N--CA 1.466 0.375 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 170.264 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 89.5 mt -102.33 -11.96 18.29 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 114.497 1.295 . . . . 0.0 114.497 -173.189 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 35.1 m -141.65 143.41 33.61 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 125.015 1.326 . . . . 0.0 110.426 -169.595 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 65.39 -133.4 35.85 Favored Glycine 0 CA--C 1.537 1.464 0 CA-C-N 118.083 0.402 . . . . 0.0 112.515 -176.762 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 88.4 p -131.02 13.84 5.21 Favored 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 115.143 1.534 . . . . 0.0 115.143 -175.212 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 67.57 69.17 1.43 Allowed Glycine 0 N--CA 1.475 1.276 0 CA-C-O 122.832 1.24 . . . . 0.0 111.968 -171.046 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 10.2 p -136.44 176.05 8.94 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 C-N-CA 127.876 2.47 . . . . 0.0 107.036 175.018 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 20.8 t-20 66.28 -36.93 0.26 Allowed 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 126.339 1.856 . . . . 0.0 114.844 -172.358 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -71.04 155.72 92.94 Favored Pre-proline 0 CA--C 1.554 1.106 0 CA-C-N 119.742 1.155 . . . . 0.0 111.592 169.18 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_exo -63.17 146.25 94.03 Favored 'Trans proline' 0 CA--C 1.548 1.183 0 C-N-CA 122.094 1.863 . . . . 0.0 113.169 179.917 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_exo -55.58 -28.8 66.98 Favored 'Trans proline' 0 C--N 1.352 0.738 0 C-N-CA 123.703 2.935 . . . . 0.0 115.804 -175.682 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 4.4 pm0 -62.61 -18.93 63.17 Favored 'General case' 0 CA--C 1.544 0.745 0 O-C-N 120.664 -1.273 . . . . 0.0 114.168 176.373 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 86.6 m95 -83.39 -24.11 32.1 Favored 'General case' 0 N--CA 1.471 0.578 0 O-C-N 120.552 -1.343 . . . . 0.0 112.934 175.708 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 9.7 m -86.21 -3.41 8.66 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.31 0 N-CA-C 113.608 0.966 . . . . 0.0 113.608 173.443 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -111.2 4.69 19.43 Favored 'General case' 0 N--CA 1.48 1.026 0 N-CA-C 114.581 1.326 . . . . 0.0 114.581 -177.957 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 85.9 mm-40 -64.56 158.35 24.47 Favored 'General case' 0 N--CA 1.478 0.956 0 O-C-N 120.863 -1.148 . . . . 0.0 111.976 170.882 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -57.52 -41.83 81.65 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 114.002 1.112 . . . . 0.0 114.002 -168.249 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.686 ' HB ' HG22 ' A' ' 75' ' ' VAL . 15.5 mm -116.03 58.97 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 C-N-CA 124.892 1.277 . . . . 0.0 109.049 174.401 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 27.0 t80 -74.17 110.12 8.2 Favored 'General case' 0 CA--C 1.534 0.356 0 O-C-N 120.441 -1.412 . . . . 0.0 107.666 168.8 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 9.1 mt-10 -107.67 129.43 55.01 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-O 121.586 0.708 . . . . 0.0 112.687 172.404 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -98.35 88.81 4.25 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 124.163 0.985 . . . . 0.0 110.215 174.287 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 29.2 m0 -81.09 102.09 10.03 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-O 122.031 0.919 . . . . 0.0 109.618 176.63 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 27.6 mt-30 -82.29 60.13 4.86 Favored 'General case' 0 CA--C 1.545 0.787 0 CA-C-O 122.527 1.156 . . . . 0.0 109.049 175.83 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 5.9 tt -95.13 156.31 16.37 Favored 'General case' 0 CA--C 1.539 0.519 0 C-N-CA 128.226 2.61 . . . . 0.0 112.87 -169.148 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -67.67 109.88 3.49 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 125.185 1.394 . . . . 0.0 112.398 177.473 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -71.63 123.9 90.12 Favored Pre-proline 0 CA--C 1.548 0.883 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 169.313 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -79.0 -8.57 15.5 Favored 'Trans proline' 0 CA--C 1.551 1.339 0 C-N-CA 122.092 1.861 . . . . 0.0 114.134 -172.456 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -72.82 155.0 40.37 Favored 'General case' 0 CA--C 1.549 0.934 0 CA-C-N 120.668 1.576 . . . . 0.0 113.338 176.416 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 76.57 5.94 83.65 Favored Glycine 0 CA--C 1.538 1.474 0 C-N-CA 124.428 1.013 . . . . 0.0 114.089 -178.12 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 -142.92 167.51 21.9 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 126.998 2.119 . . . . 0.0 111.226 179.284 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 70.6 m -59.83 157.16 12.78 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 115.081 1.511 . . . . 0.0 115.081 -169.42 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -51.1 -38.32 51.11 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 126.202 1.801 . . . . 0.0 112.689 172.304 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -55.11 -38.93 68.79 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 123.787 0.835 . . . . 0.0 112.107 172.7 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 14.6 t -67.96 -40.76 83.88 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 CA-C-O 118.674 -0.679 . . . . 0.0 111.071 173.968 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -53.7 -47.39 70.53 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 119.346 0.975 . . . . 0.0 112.339 169.821 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 96.9 mtt180 -69.01 -39.0 79.55 Favored 'General case' 0 N--CA 1.479 0.999 0 CA-C-N 118.842 0.746 . . . . 0.0 112.652 -179.603 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 30.7 m -62.18 -40.92 97.65 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 123.718 0.807 . . . . 0.0 111.306 170.432 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 41.8 t -65.69 -41.07 89.68 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 CA-C-O 117.407 -1.282 . . . . 0.0 111.19 176.57 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 75.5 mtm-85 -55.28 -43.52 74.82 Favored 'General case' 0 N--CA 1.485 1.315 0 CA-C-N 121.038 1.745 . . . . 0.0 112.26 172.576 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -60.85 -51.67 57.15 Favored Glycine 0 CA--C 1.537 1.429 0 CA-C-N 119.036 0.835 . . . . 0.0 113.514 176.269 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 57.6 mm-40 -64.81 -42.97 94.58 Favored 'General case' 0 N--CA 1.474 0.765 0 O-C-N 121.758 -0.848 . . . . 0.0 112.124 179.107 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 55.0 t -65.39 -42.54 93.78 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 C-N-CA 124.799 1.24 . . . . 0.0 110.957 177.378 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 62.9 tttm -53.57 -49.36 67.88 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-N 119.721 1.146 . . . . 0.0 111.147 176.629 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -63.68 -41.7 98.12 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 178.444 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 13.3 mtp85 -63.82 -43.5 96.04 Favored 'General case' 0 N--CA 1.478 0.952 0 N-CA-C 113.22 0.822 . . . . 0.0 113.22 175.435 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 86.2 t -69.06 -38.9 78.92 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 C-N-CA 123.453 0.701 . . . . 0.0 110.729 179.534 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -62.75 -37.63 87.36 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 118.897 0.771 . . . . 0.0 111.773 170.791 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 9.4 m-80 -63.29 -46.85 84.81 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 119.185 0.902 . . . . 0.0 112.549 173.495 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -52.98 -56.81 13.26 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 125.035 1.334 . . . . 0.0 110.253 173.696 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 75.4 mt -61.63 -40.53 87.0 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 O-C-N 122.004 -0.435 . . . . 0.0 110.603 -179.121 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -70.69 -12.11 61.36 Favored 'General case' 0 CA--C 1.545 0.779 0 N-CA-C 114.95 1.463 . . . . 0.0 114.95 178.695 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 20.9 ptmt -102.67 -25.9 13.38 Favored 'General case' 0 N--CA 1.478 0.952 0 N-CA-C 114.038 1.125 . . . . 0.0 114.038 172.882 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 16.7 pt -99.18 -19.16 6.01 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 N-CA-C 114.432 1.271 . . . . 0.0 114.432 177.733 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 68.8 m . . . . . 0 C--O 1.255 1.39 0 C-N-CA 125.132 1.373 . . . . 0.0 112.292 -174.777 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.8 ttt . . . . . 0 N--CA 1.503 2.22 0 N-CA-C 111.745 0.276 . . . . 0.0 111.745 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 3.3 mptp? -125.92 156.43 39.73 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 125.685 1.594 . . . . 0.0 112.681 175.759 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 30.5 ttmt -107.64 117.89 35.3 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 106.651 -1.611 . . . . 0.0 106.651 167.115 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 14.3 t -103.01 135.23 41.45 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 N-CA-C 114.239 1.2 . . . . 0.0 114.239 -179.376 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' MET . . . . . 0.511 ' HG3' HG13 ' A' ' 7' ' ' VAL . 42.4 tpp -104.48 124.37 49.14 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 123.886 0.874 . . . . 0.0 108.908 168.503 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 67.2 m-85 -105.03 126.09 51.69 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 123.839 0.856 . . . . 0.0 108.972 169.798 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.511 HG13 ' HG3' ' A' ' 5' ' ' MET . 1.5 m -141.95 150.6 19.03 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.194 0 N-CA-C 114.902 1.445 . . . . 0.0 114.902 -168.784 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 48.7 t -148.16 162.28 39.76 Favored 'General case' 0 CA--C 1.556 1.193 0 C-N-CA 127.501 2.32 . . . . 0.0 112.303 -179.432 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 21.9 ptmt -63.3 132.51 51.84 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 125.316 1.446 . . . . 0.0 112.298 172.597 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 6.9 mmm180 42.31 -135.84 0.32 Allowed 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 126.04 1.736 . . . . 0.0 112.255 -172.868 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 34.1 p-10 -154.39 -45.95 0.09 Allowed 'General case' 0 CA--C 1.549 0.942 0 N-CA-C 114.78 1.4 . . . . 0.0 114.78 172.715 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 67.5 m -56.73 -15.16 4.09 Favored 'General case' 0 N--CA 1.481 1.118 0 N-CA-C 117.685 2.476 . . . . 0.0 117.685 -169.067 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 97.7 p -102.17 -9.9 20.08 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 115.577 1.695 . . . . 0.0 115.577 -179.791 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 77.6 mtt85 -144.68 150.2 36.92 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 125.017 1.327 . . . . 0.0 113.468 -169.634 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 86.9 p -119.16 -5.07 10.49 Favored 'General case' 0 N--CA 1.478 0.944 0 N-CA-C 116.196 1.924 . . . . 0.0 116.196 -170.071 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 27.7 mt-30 64.25 -59.59 0.21 Allowed 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 128.013 2.525 . . . . 0.0 117.318 169.853 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 65.02 -43.88 0.33 Allowed 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 127.851 2.46 . . . . 0.0 116.597 -179.748 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.93 -28.34 68.87 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 115.137 1.532 . . . . 0.0 115.137 -169.212 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.0 pm0 -59.69 -37.1 77.87 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 119.132 0.878 . . . . 0.0 112.406 171.588 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -70.3 -50.45 27.17 Favored Glycine 0 C--O 1.224 -0.515 0 C-N-CA 124.408 1.004 . . . . 0.0 112.151 -169.993 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -66.4 -30.13 70.44 Favored 'General case' 0 N--CA 1.467 0.394 0 O-C-N 121.554 -0.968 . . . . 0.0 112.744 173.499 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -66.32 -35.86 81.46 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 118.499 0.59 . . . . 0.0 111.691 -176.001 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 13.4 ptmm? -82.1 -39.95 22.64 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 123.41 0.684 . . . . 0.0 112.319 169.227 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 16.9 m -76.02 -23.73 55.21 Favored 'General case' 0 N--CA 1.486 1.351 0 N-CA-C 112.905 0.706 . . . . 0.0 112.905 -169.255 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 85.3 mt -103.38 -30.61 10.48 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 125.378 1.471 . . . . 0.0 112.577 169.397 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -99.95 0.72 56.35 Favored Glycine 0 N--CA 1.471 1.026 0 N-CA-C 117.379 1.711 . . . . 0.0 117.379 -169.534 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -60.45 142.93 54.48 Favored 'General case' 0 CA--C 1.546 0.81 0 CA-C-N 121.09 2.445 . . . . 0.0 112.566 178.371 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 84.15 -23.51 7.0 Favored Glycine 0 CA--C 1.54 1.606 0 C-N-CA 124.822 1.201 . . . . 0.0 113.337 -169.48 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 62.1 mttp -96.93 -43.87 7.27 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 125.884 1.674 . . . . 0.0 111.883 169.834 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 43.7 pt -141.74 160.41 21.25 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 C-N-CA 125.178 1.391 . . . . 0.0 113.173 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -108.4 148.16 30.53 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 127.157 2.183 . . . . 0.0 109.17 169.831 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 58.7 t -136.02 143.85 34.95 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 CA-C-N 119.294 0.952 . . . . 0.0 113.165 -177.457 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 59.7 m -135.98 152.2 50.7 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 125.722 1.609 . . . . 0.0 109.539 169.821 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 96.7 p -136.06 142.32 44.36 Favored 'General case' 0 CA--C 1.514 -0.423 0 CA-C-O 121.942 0.877 . . . . 0.0 111.998 167.248 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 29.3 p -141.74 169.14 18.15 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 113.485 -1.689 . . . . 0.0 111.075 -176.707 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -106.02 164.23 13.76 Favored Glycine 0 CA--C 1.525 0.677 0 C-N-CA 123.731 0.681 . . . . 0.0 111.741 178.795 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -90.41 117.54 29.19 Favored 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 106.66 -1.608 . . . . 0.0 106.66 168.859 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 68.5 -41.57 0.46 Allowed 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 127.701 2.4 . . . . 0.0 113.955 -171.904 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 74.2 m -78.8 155.25 29.33 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 124.537 1.135 . . . . 0.0 111.142 169.547 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 67.9 p -90.74 -83.07 0.27 Allowed 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 114.394 1.257 . . . . 0.0 114.394 -179.273 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 52.1 ttt-85 -79.47 148.4 31.9 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 127.764 2.426 . . . . 0.0 110.457 -172.17 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 6.4 m -66.16 141.05 18.55 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 N-CA-C 109.214 -0.662 . . . . 0.0 109.214 171.739 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . 0.256 0.0 OUTLIER -65.36 144.35 98.96 Favored Pre-proline 0 CA--C 1.549 0.917 0 C-N-CA 119.636 -0.826 . . . . 0.0 111.103 -169.294 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_exo -46.32 -37.8 19.49 Favored 'Trans proline' 0 CA--C 1.54 0.792 0 C-N-CA 123.848 3.032 . . . . 0.0 118.331 -167.858 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 27.7 m -62.0 -26.59 68.31 Favored 'General case' 0 N--CA 1.485 1.299 0 O-C-N 120.702 -1.249 . . . . 0.0 112.206 -177.822 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.81 -21.96 66.69 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 113.538 0.94 . . . . 0.0 113.538 174.579 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.5 mp -74.91 -58.46 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 CA-C-N 119.527 1.058 . . . . 0.0 109.113 178.243 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.59 -33.89 76.97 Favored 'General case' 0 CA--C 1.545 0.752 0 N-CA-C 114.166 1.173 . . . . 0.0 114.166 -171.149 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.46 -25.54 57.48 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 124.268 1.027 . . . . 0.0 113.244 179.746 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -92.03 -32.63 15.13 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.578 1.151 . . . . 0.0 109.893 177.812 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -63.92 -12.18 34.83 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.092 1.357 . . . . 0.0 113.985 169.738 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -59.59 -19.68 50.51 Favored 'General case' 0 CA--C 1.553 1.087 0 CA-C-N 119.537 1.062 . . . . 0.0 110.458 168.041 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 16.5 t -108.75 -3.53 10.35 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.035 0 C-N-CA 128.548 2.739 . . . . 0.0 111.987 -179.585 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 73.99 34.41 55.72 Favored Glycine 0 CA--C 1.542 1.747 0 O-C-N 120.429 -1.419 . . . . 0.0 114.578 -177.137 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 9.4 mt -75.86 -19.17 15.53 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 N-CA-C 116.759 2.133 . . . . 0.0 116.759 -169.813 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 24.1 t0 43.7 72.28 0.2 Allowed 'General case' 0 CA--C 1.556 1.186 0 C-N-CA 126.747 2.019 . . . . 0.0 114.885 -179.185 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 35.3 pt -114.62 34.23 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 C-N-CA 125.569 1.548 . . . . 0.0 112.408 173.706 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 75.0 m -70.58 -34.0 71.7 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 114.594 1.331 . . . . 0.0 114.594 -170.104 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -84.41 -68.42 1.4 Allowed Glycine 0 CA--C 1.529 0.947 0 C-N-CA 123.477 0.561 . . . . 0.0 113.506 -179.62 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 8.0 mm100 54.46 -166.87 0.08 Allowed 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 126.527 1.931 . . . . 0.0 111.447 -169.091 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 64.2 p -73.21 138.19 45.48 Favored 'General case' 0 N--CA 1.473 0.701 0 O-C-N 121.141 -0.974 . . . . 0.0 112.56 -179.254 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 68.5 m -80.26 3.0 22.28 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.631 1.172 . . . . 0.0 113.012 169.782 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -144.72 157.35 55.26 Favored Pre-proline 0 CA--C 1.548 0.901 0 C-N-CA 125.87 1.668 . . . . 0.0 112.011 -176.365 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -64.89 165.99 19.63 Favored 'Trans proline' 0 CA--C 1.538 0.695 0 C-N-CA 124.183 3.255 . . . . 0.0 114.721 174.905 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.477 HD12 HG11 ' A' ' 7' ' ' VAL . 5.4 tt -49.83 -42.99 18.95 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.2 0 C-N-CA 124.59 1.156 . . . . 0.0 112.154 174.474 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -69.25 -10.69 58.99 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 113.524 0.935 . . . . 0.0 113.524 -174.83 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -77.39 -15.53 59.32 Favored 'General case' 0 CA--C 1.548 0.886 0 N-CA-C 112.807 0.669 . . . . 0.0 112.807 176.117 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 76.1 m-85 -107.28 -168.27 1.37 Allowed 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 126.53 1.932 . . . . 0.0 112.475 -174.868 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 8.9 p-10 -124.05 129.16 50.42 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 125.314 1.445 . . . . 0.0 109.921 176.629 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -64.55 -36.34 83.89 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 113.209 0.818 . . . . 0.0 113.209 -171.224 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -68.8 -4.55 16.55 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 114.067 1.136 . . . . 0.0 114.067 178.075 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -68.44 -16.68 63.99 Favored 'General case' 0 CA--C 1.549 0.913 0 CA-C-N 118.775 0.716 . . . . 0.0 110.296 168.286 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 79.6 m-85 -119.78 146.26 45.83 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 128.006 2.523 . . . . 0.0 111.709 -177.791 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -94.99 -29.06 14.82 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 124.838 1.255 . . . . 0.0 111.903 178.055 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.736 HG22 ' HB ' ' A' ' 95' ' ' ILE . 71.1 t -125.74 135.39 64.05 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 C-N-CA 126.067 1.747 . . . . 0.0 107.063 -177.212 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 69.0 t -127.04 121.39 57.83 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 169.963 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 45.1 mm -107.81 106.52 20.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 C-N-CA 124.703 1.201 . . . . 0.0 108.557 -177.597 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 8.1 m -90.68 111.85 23.36 Favored 'General case' 0 N--CA 1.463 0.222 0 C-N-CA 123.699 0.8 . . . . 0.0 109.829 176.611 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 89.9 mt -91.71 -11.32 37.18 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 124.855 1.262 . . . . 0.0 114.405 -170.539 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 57.3 m -139.94 156.27 46.75 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.565 1.146 . . . . 0.0 112.548 -168.927 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 60.62 -133.24 49.94 Favored Glycine 0 CA--C 1.536 1.377 0 N-CA-C 111.409 -0.677 . . . . 0.0 111.409 -175.326 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 75.3 m -125.19 26.87 6.79 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 124.305 1.042 . . . . 0.0 112.169 172.199 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 69.49 25.31 75.63 Favored Glycine 0 CA--C 1.533 1.172 0 O-C-N 121.344 -0.847 . . . . 0.0 114.905 -174.477 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 33.4 m -82.63 -178.54 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 C-N-CA 124.933 1.293 . . . . 0.0 110.254 169.713 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 12.5 t-20 66.18 -34.04 0.2 Allowed 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 127.182 2.193 . . . . 0.0 115.781 -179.35 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -71.85 142.36 85.55 Favored Pre-proline 0 CA--C 1.551 0.986 0 CA-C-N 120.271 1.396 . . . . 0.0 110.73 169.008 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -60.21 154.9 48.9 Favored 'Trans proline' 0 CA--C 1.543 0.946 0 C-N-CA 122.831 2.354 . . . . 0.0 114.492 -179.429 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_exo -56.03 -28.73 70.75 Favored 'Trans proline' 0 C--N 1.353 0.775 0 C-N-CA 123.733 2.955 . . . . 0.0 115.121 -177.483 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -62.11 -30.26 70.9 Favored 'General case' 0 CA--C 1.54 0.582 0 O-C-N 120.888 -1.132 . . . . 0.0 113.103 176.004 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 85.5 m95 -79.59 -29.83 41.33 Favored 'General case' 0 N--CA 1.476 0.846 0 O-C-N 120.942 -1.099 . . . . 0.0 111.998 174.303 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 48.8 t -68.91 -26.93 33.73 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.925 0 C-N-CA 125.216 1.406 . . . . 0.0 112.068 172.55 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -102.33 6.98 40.67 Favored 'General case' 0 N--CA 1.48 1.053 0 N-CA-C 116.051 1.871 . . . . 0.0 116.051 -170.894 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 89.7 mm-40 -65.49 160.33 22.45 Favored 'General case' 0 N--CA 1.481 1.112 0 O-C-N 120.633 -1.292 . . . . 0.0 112.255 172.537 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -51.35 -44.33 62.01 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 124.63 1.172 . . . . 0.0 113.849 -168.703 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.736 ' HB ' HG22 ' A' ' 75' ' ' VAL . 16.8 mm -123.19 69.1 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 C-N-CA 125.015 1.326 . . . . 0.0 108.343 177.781 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 57.1 t80 -78.58 107.55 11.33 Favored 'General case' 0 CA--C 1.534 0.356 0 O-C-N 120.796 -1.19 . . . . 0.0 108.58 169.399 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 9.1 mt-10 -105.92 132.7 51.7 Favored 'General case' 0 CA--C 1.545 0.778 0 N-CA-C 113.773 1.027 . . . . 0.0 113.773 174.551 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -93.75 104.39 16.48 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.648 1.179 . . . . 0.0 109.868 169.816 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 17.4 m0 -92.74 98.68 11.56 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.345 1.058 . . . . 0.0 110.002 -177.246 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 87.8 mm-40 -79.41 61.29 3.43 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 125.087 1.355 . . . . 0.0 109.985 172.833 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 6.2 tt -109.5 149.3 29.8 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 127.092 2.157 . . . . 0.0 113.054 -169.432 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -67.2 111.58 4.02 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 125.962 1.705 . . . . 0.0 111.912 176.444 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -84.0 129.88 57.06 Favored Pre-proline 0 CA--C 1.545 0.776 0 O-C-N 120.887 -1.133 . . . . 0.0 110.849 171.556 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -86.74 -9.63 6.52 Favored 'Trans proline' 0 CA--C 1.541 0.845 0 C-N-CA 121.955 1.77 . . . . 0.0 114.515 -169.957 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -60.39 -41.68 94.32 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 115.307 1.595 . . . . 0.0 115.307 -169.503 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -76.52 10.17 18.5 Favored Glycine 0 CA--C 1.537 1.444 0 C-N-CA 124.212 0.911 . . . . 0.0 114.755 -178.046 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 8.0 pt20 -146.69 -177.65 5.76 Favored 'General case' 0 CA--C 1.551 1.012 0 C-N-CA 126.848 2.059 . . . . 0.0 111.499 -169.877 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 10.5 p -66.76 164.68 16.6 Favored 'General case' 0 N--CA 1.478 0.947 0 N-CA-C 116.172 1.916 . . . . 0.0 116.172 -168.948 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 36.4 tp -63.02 -26.49 68.87 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 123.832 0.853 . . . . 0.0 112.338 170.591 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -69.39 -34.87 75.16 Favored 'General case' 0 CA--C 1.539 0.539 0 O-C-N 120.922 -1.111 . . . . 0.0 111.243 171.278 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 20.7 t -68.15 -38.94 80.48 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 CA-C-O 117.93 -1.034 . . . . 0.0 111.155 169.949 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 5.0 m-85 -54.72 -52.21 63.19 Favored 'General case' 0 N--CA 1.478 0.968 0 CA-C-N 120.664 1.574 . . . . 0.0 111.956 169.796 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -67.91 -34.33 76.41 Favored 'General case' 0 N--CA 1.479 0.992 0 CA-C-N 118.954 0.797 . . . . 0.0 112.221 -177.165 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 76.4 m -64.83 -46.42 82.04 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 123.871 0.868 . . . . 0.0 111.042 170.947 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 53.7 t -67.95 -35.21 71.17 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 CA-C-O 117.602 -1.19 . . . . 0.0 111.022 179.526 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 22.2 mtm105 -55.4 -46.71 76.59 Favored 'General case' 0 N--CA 1.481 1.112 0 CA-C-N 120.66 1.573 . . . . 0.0 111.031 170.629 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -58.47 -48.8 82.12 Favored Glycine 0 CA--C 1.542 1.765 0 CA-C-N 119.432 1.015 . . . . 0.0 113.848 175.188 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 15.5 mm100 -65.25 -44.9 86.63 Favored 'General case' 0 N--CA 1.474 0.742 0 O-C-N 121.778 -0.836 . . . . 0.0 112.02 179.846 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 78.6 t -66.97 -36.22 76.61 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 125.052 1.341 . . . . 0.0 111.308 177.255 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 78.1 tttt -54.64 -49.68 69.97 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-N 119.842 1.201 . . . . 0.0 110.207 174.472 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -64.23 -43.66 94.28 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 112.705 0.631 . . . . 0.0 112.705 175.873 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.57 -36.51 84.04 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 124.16 0.984 . . . . 0.0 112.894 179.47 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 94.4 t -77.48 -40.64 28.83 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 C-N-CA 125.515 1.526 . . . . 0.0 111.475 176.983 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -62.59 -31.84 72.73 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 119.567 1.076 . . . . 0.0 111.541 172.167 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 12.5 m-80 -67.28 -46.12 74.57 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-N 119.121 0.873 . . . . 0.0 112.867 171.294 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -50.83 -54.98 19.16 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 124.296 1.038 . . . . 0.0 110.138 171.259 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 74.3 mt -58.79 -49.53 82.51 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 CA-C-O 119.163 -0.446 . . . . 0.0 110.179 178.693 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -65.24 -11.26 39.26 Favored 'General case' 0 CA--C 1.544 0.743 0 N-CA-C 115.567 1.691 . . . . 0.0 115.567 -178.827 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 20.9 ptmt -103.23 -17.54 15.29 Favored 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 114.165 1.172 . . . . 0.0 114.165 171.823 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 14.3 pt -106.79 -12.22 10.16 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 N-CA-C 114.436 1.273 . . . . 0.0 114.436 177.153 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 73.8 m . . . . . 0 C--O 1.253 1.27 0 C-N-CA 125.185 1.394 . . . . 0.0 112.436 -176.763 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.9 ttt . . . . . 0 N--CA 1.503 2.185 0 N-CA-C 111.602 0.223 . . . . 0.0 111.602 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.28 163.71 32.9 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 124.828 1.251 . . . . 0.0 113.775 177.667 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 58.6 mtpt -89.72 141.82 28.26 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 125.226 1.41 . . . . 0.0 113.007 175.898 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 21.6 t -122.94 130.54 74.4 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 C-N-CA 125.971 1.708 . . . . 0.0 112.397 177.45 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 35.6 tpp -102.05 127.55 48.89 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 168.955 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 66.1 m-85 -104.68 132.32 51.06 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 123.728 0.811 . . . . 0.0 109.428 170.032 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -141.13 146.76 23.23 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 N-CA-C 114.584 1.327 . . . . 0.0 114.584 -169.441 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 41.8 t -151.19 176.32 11.31 Favored 'General case' 0 CA--C 1.552 1.056 0 C-N-CA 127.31 2.244 . . . . 0.0 110.853 171.472 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 54.1 mtpt -85.24 135.04 34.1 Favored 'General case' 0 N--CA 1.482 1.166 0 O-C-N 120.672 -1.267 . . . . 0.0 112.16 170.968 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 23.2 tpt180 47.58 56.45 7.05 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 127.507 2.323 . . . . 0.0 113.226 179.276 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -52.08 -28.56 17.94 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 113.857 1.058 . . . . 0.0 113.857 -179.422 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 67.2 m -63.69 -16.97 62.44 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-N 120.13 1.332 . . . . 0.0 112.661 -176.168 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 98.6 p -121.91 21.43 10.64 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 126.476 1.91 . . . . 0.0 113.767 171.11 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 73.6 mtt85 -137.73 151.32 48.08 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 125.762 1.625 . . . . 0.0 112.216 175.948 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 33.0 m -93.02 -31.93 14.69 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 114.977 1.473 . . . . 0.0 114.977 -169.729 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 59.89 -44.29 0.09 Allowed 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 127.887 2.475 . . . . 0.0 117.331 -179.043 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' MET . . . . . 0.438 ' HG2' ' SD ' ' A' ' 50' ' ' MET . 0.0 OUTLIER 68.73 -46.55 0.55 Allowed 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 127.605 2.362 . . . . 0.0 115.907 172.389 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.08 -35.21 74.69 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 115.908 1.818 . . . . 0.0 115.908 -169.112 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.3 pm0 -64.36 -43.69 93.73 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 119.151 0.887 . . . . 0.0 112.426 -179.044 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -61.41 -38.04 95.09 Favored Glycine 0 C--N 1.336 0.57 0 C-N-CA 123.903 0.763 . . . . 0.0 112.123 175.12 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -73.58 -42.47 61.56 Favored 'General case' 0 N--CA 1.47 0.527 0 O-C-N 121.782 -0.834 . . . . 0.0 111.518 177.541 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -60.33 -40.97 92.57 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 119.243 0.929 . . . . 0.0 112.705 -175.613 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 11.7 pttp -78.77 -24.92 44.43 Favored 'General case' 0 N--CA 1.479 1.016 0 N-CA-C 113.787 1.032 . . . . 0.0 113.787 174.036 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 90.4 m -72.52 -34.98 67.98 Favored 'General case' 0 N--CA 1.486 1.329 0 O-C-N 121.432 -0.792 . . . . 0.0 111.779 171.896 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 82.4 mt -88.66 -28.58 20.52 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 125.625 1.57 . . . . 0.0 113.824 -177.026 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -148.23 29.24 1.36 Allowed Glycine 0 N--CA 1.473 1.102 0 N-CA-C 118.256 2.062 . . . . 0.0 118.256 -169.411 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -66.53 -20.39 66.01 Favored 'General case' 0 N--CA 1.477 0.919 0 CA-C-N 121.867 2.834 . . . . 0.0 115.301 -177.752 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -77.56 -4.59 85.0 Favored Glycine 0 CA--C 1.541 1.696 0 O-C-N 121.305 -0.872 . . . . 0.0 113.923 169.593 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 60.7 mttp -115.93 -40.58 3.3 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 126.981 2.112 . . . . 0.0 112.315 -177.286 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 19.8 pt -140.69 159.04 24.32 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 125.961 1.704 . . . . 0.0 112.558 -174.308 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -106.23 140.32 39.37 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.682 1.193 . . . . 0.0 110.209 171.099 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 69.5 t -125.15 140.92 46.75 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 CA-C-N 118.911 0.778 . . . . 0.0 111.819 -175.104 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 22.4 m -134.56 143.39 47.36 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 125.058 1.343 . . . . 0.0 109.95 173.815 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 78.6 p -97.39 144.38 27.2 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.846 0.831 . . . . 0.0 111.24 169.198 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 32.7 t -149.05 165.04 32.87 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 123.593 0.757 . . . . 0.0 110.311 169.948 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -134.67 161.61 24.53 Favored Glycine 0 C--O 1.229 -0.167 0 CA-C-O 121.808 0.671 . . . . 0.0 112.604 -178.547 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -95.0 111.28 23.1 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 106.351 -1.722 . . . . 0.0 106.351 169.58 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 19.0 mt-10 66.68 30.77 8.03 Favored 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 125.122 1.369 . . . . 0.0 114.392 -173.587 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 7.6 m -151.31 151.34 31.66 Favored 'General case' 0 N--CA 1.482 1.152 0 N-CA-C 114.681 1.364 . . . . 0.0 114.681 175.56 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 88.0 p -109.43 -15.34 14.25 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 126.985 2.114 . . . . 0.0 116.327 173.632 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 7.6 tpt180 -123.4 170.32 10.46 Favored 'General case' 0 N--CA 1.488 1.462 0 CA-C-N 120.497 1.499 . . . . 0.0 110.781 -178.512 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 27.0 m -111.93 163.84 8.45 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.266 0 C-N-CA 126.435 1.894 . . . . 0.0 109.57 169.481 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 3.1 t-80 -48.59 129.91 13.81 Favored Pre-proline 0 CA--C 1.536 0.408 0 N-CA-C 113.945 1.091 . . . . 0.0 113.945 -173.866 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 81.5 Cg_exo -59.93 -26.76 83.26 Favored 'Trans proline' 0 CA--C 1.549 1.23 0 CA-C-N 120.273 1.133 . . . . 0.0 112.5 173.231 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 55.0 m -70.91 -29.15 65.12 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 125.17 1.388 . . . . 0.0 112.363 174.033 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -55.45 -44.55 76.48 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 119.245 0.93 . . . . 0.0 111.226 -178.078 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.7 mp -47.2 -55.11 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 125.178 1.391 . . . . 0.0 110.483 -177.41 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.99 -30.89 71.91 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 113.486 0.921 . . . . 0.0 113.486 -176.748 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -82.73 -26.35 32.02 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 113.421 0.897 . . . . 0.0 113.421 179.064 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' MET . . . . . 0.438 ' SD ' ' HG2' ' A' ' 17' ' ' MET . 3.9 mmt -80.3 -32.92 38.01 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.223 0.609 . . . . 0.0 110.8 170.266 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -66.01 -14.78 62.25 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 124.61 1.164 . . . . 0.0 113.348 172.845 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -60.56 -27.65 67.83 Favored 'General case' 0 N--CA 1.482 1.138 0 CA-C-N 120.106 1.321 . . . . 0.0 110.731 168.844 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 57.7 t -98.22 -6.5 9.35 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.939 0 C-N-CA 127.229 2.212 . . . . 0.0 111.282 176.894 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 81.14 19.36 67.22 Favored Glycine 0 CA--C 1.539 1.582 0 C-N-CA 124.951 1.263 . . . . 0.0 114.425 -174.506 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 83.0 mt -77.77 135.14 26.9 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 124.925 1.29 . . . . 0.0 111.266 -175.654 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 21.6 t0 -94.58 104.46 16.41 Favored 'General case' 0 CA--C 1.544 0.729 0 N-CA-C 113.236 0.828 . . . . 0.0 113.236 177.629 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 15.0 pt -130.56 23.25 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 C-N-CA 125.273 1.429 . . . . 0.0 112.338 169.688 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 72.2 m -87.69 153.53 21.29 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 124.729 1.212 . . . . 0.0 112.435 -178.379 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 65.68 18.5 66.1 Favored Glycine 0 CA--C 1.537 1.454 0 N-CA-C 115.28 0.872 . . . . 0.0 115.28 171.86 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -115.12 143.93 44.45 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 124.969 1.307 . . . . 0.0 111.957 -177.357 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 33.4 m -135.24 148.63 49.66 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 107.818 -1.179 . . . . 0.0 107.818 169.32 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 68.1 m -123.26 -161.45 0.97 Allowed 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 126.329 1.852 . . . . 0.0 109.916 -171.786 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -134.91 159.03 73.65 Favored Pre-proline 0 CA--C 1.54 0.567 0 C-N-CA 123.854 0.862 . . . . 0.0 110.923 179.332 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -62.17 157.27 45.63 Favored 'Trans proline' 0 N--CA 1.46 -0.476 0 C-N-CA 122.294 1.996 . . . . 0.0 112.311 171.77 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.426 HD11 ' CE3' ' A' ' 90' ' ' TRP . 6.7 tp -60.99 -30.21 47.16 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 O-C-N 121.667 -0.645 . . . . 0.0 112.423 -173.876 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -67.52 -12.5 60.49 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 114.341 1.237 . . . . 0.0 114.341 176.794 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 -79.95 -21.53 43.67 Favored 'General case' 0 CA--C 1.547 0.855 0 N-CA-C 113.22 0.822 . . . . 0.0 113.22 179.839 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 99.3 m-85 -102.39 -174.52 2.59 Favored 'General case' 0 CA--C 1.552 1.045 0 C-N-CA 126.216 1.806 . . . . 0.0 112.922 -173.319 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 5.9 t30 -123.6 126.7 47.1 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 126.21 1.804 . . . . 0.0 109.572 171.799 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.91 -35.9 81.05 Favored 'General case' 0 CA--C 1.53 0.184 0 N-CA-C 114.361 1.245 . . . . 0.0 114.361 -170.048 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . 0.256 0.0 OUTLIER -72.67 -3.63 26.18 Favored 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 114.221 1.193 . . . . 0.0 114.221 -175.672 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -75.21 -13.25 60.43 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 124.076 0.95 . . . . 0.0 111.543 168.935 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 87.8 m-85 -118.08 135.73 54.02 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 126.774 2.029 . . . . 0.0 111.574 -179.287 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -87.15 -24.23 24.56 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-O 122.297 1.046 . . . . 0.0 112.655 178.47 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.623 HG22 ' HB ' ' A' ' 95' ' ' ILE . 80.1 t -129.73 138.99 52.76 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 C-N-CA 127.28 2.232 . . . . 0.0 108.772 -176.569 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 59.2 t -135.15 122.66 37.29 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 171.509 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 45.1 mm -110.21 101.1 12.08 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 C-N-CA 124.255 1.022 . . . . 0.0 109.919 -174.693 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 8.8 m -86.15 94.43 9.28 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 124.224 1.01 . . . . 0.0 109.208 171.139 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -97.78 19.68 13.29 Favored 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 116.065 1.876 . . . . 0.0 116.065 -169.427 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 14.7 p -152.14 155.08 37.14 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 123.812 0.845 . . . . 0.0 110.941 170.695 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 62.06 -137.34 45.86 Favored Glycine 0 CA--C 1.535 1.334 0 C-N-CA 123.685 0.659 . . . . 0.0 113.948 177.571 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 83.4 p -93.21 -23.59 18.5 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.996 1.318 . . . . 0.0 114.552 179.544 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 77.07 4.44 83.4 Favored Glycine 0 CA--C 1.535 1.292 0 C-N-CA 124.555 1.074 . . . . 0.0 115.343 -169.946 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 48.9 t -88.73 -10.92 10.58 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 CA-C-N 119.564 1.682 . . . . 0.0 112.91 -172.373 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -72.65 -9.56 58.75 Favored 'General case' 0 CA--C 1.549 0.917 0 O-C-N 120.426 -1.421 . . . . 0.0 114.153 -176.168 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -95.06 158.43 34.9 Favored Pre-proline 0 CA--C 1.549 0.927 0 C-N-CA 124.791 1.236 . . . . 0.0 113.644 176.479 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_exo -61.18 152.92 68.56 Favored 'Trans proline' 0 CA--C 1.544 0.991 0 C-N-CA 122.96 2.44 . . . . 0.0 114.24 -179.198 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_exo -55.76 -29.66 72.59 Favored 'Trans proline' 0 C--N 1.354 0.824 0 C-N-CA 123.692 2.928 . . . . 0.0 115.082 -177.599 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -61.81 -29.31 70.07 Favored 'General case' 0 CA--C 1.539 0.551 0 O-C-N 121.077 -1.015 . . . . 0.0 112.888 177.02 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' TRP . . . . . 0.426 ' CE3' HD11 ' A' ' 65' ' ' ILE . 92.8 m95 -80.94 -33.79 33.75 Favored 'General case' 0 N--CA 1.473 0.698 0 O-C-N 121.202 -0.936 . . . . 0.0 112.119 174.269 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 25.0 t -63.25 -31.72 53.78 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 C-N-CA 124.679 1.192 . . . . 0.0 111.606 172.239 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -96.93 6.18 49.12 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 115.675 1.732 . . . . 0.0 115.675 -171.299 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 87.0 mm-40 -64.74 157.25 27.98 Favored 'General case' 0 N--CA 1.481 1.077 0 O-C-N 120.615 -1.303 . . . . 0.0 111.248 169.897 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -58.74 -39.53 81.2 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 113.967 1.099 . . . . 0.0 113.967 -168.092 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.623 ' HB ' HG22 ' A' ' 75' ' ' VAL . 19.1 mm -118.82 59.61 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 C-N-CA 124.958 1.303 . . . . 0.0 109.017 177.235 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 52.0 t80 -76.89 106.97 8.89 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 107.333 -1.358 . . . . 0.0 107.333 168.724 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 13.2 mt-10 -109.11 134.82 51.2 Favored 'General case' 0 N--CA 1.467 0.375 0 N-CA-C 113.11 0.781 . . . . 0.0 113.11 174.561 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -103.51 118.05 35.86 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.062 0.945 . . . . 0.0 109.453 169.089 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 28.4 m0 -109.96 114.34 27.8 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 107.672 -1.233 . . . . 0.0 107.672 176.415 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 19.3 mt-30 -85.22 49.07 1.67 Allowed 'General case' 0 CA--C 1.545 0.763 0 O-C-N 121.3 -0.875 . . . . 0.0 111.701 -175.003 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 82.7 mt -73.94 160.16 31.75 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 125.848 1.659 . . . . 0.0 111.918 175.54 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -88.34 155.22 19.83 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.846 169.286 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -94.14 143.86 27.1 Favored Pre-proline 0 CA--C 1.547 0.834 0 O-C-N 121.422 -0.799 . . . . 0.0 111.606 171.023 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -64.1 -18.5 63.75 Favored 'Trans proline' 0 CA--C 1.546 1.08 0 C-N-CA 122.661 2.241 . . . . 0.0 116.07 176.01 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -57.12 138.15 54.9 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 120.255 1.389 . . . . 0.0 113.583 -178.801 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 78.41 6.59 87.99 Favored Glycine 0 CA--C 1.535 1.311 0 C-N-CA 124.384 0.993 . . . . 0.0 115.058 177.19 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 11.7 pt20 -141.8 165.13 28.31 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 125.17 1.388 . . . . 0.0 113.499 -178.376 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 68.4 m -63.68 162.89 12.36 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 125.774 1.63 . . . . 0.0 115.393 -169.52 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 21.4 tp -59.75 -29.25 68.04 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 125.181 1.392 . . . . 0.0 113.445 178.518 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -62.1 -28.94 69.97 Favored 'General case' 0 N--CA 1.476 0.844 0 O-C-N 120.544 -1.348 . . . . 0.0 111.92 171.617 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 3.5 t -76.56 -37.39 29.64 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 O-C-N 120.86 -1.15 . . . . 0.0 111.427 172.628 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -56.34 -46.55 79.88 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-N 120.028 1.286 . . . . 0.0 110.531 168.961 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -66.85 -36.15 81.67 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.702 0.801 . . . . 0.0 112.002 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 25.5 m -60.85 -52.16 66.25 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 124.414 1.085 . . . . 0.0 111.162 170.43 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 69.3 t -64.54 -45.97 94.02 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 O-C-N 121.712 -0.617 . . . . 0.0 110.528 179.831 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 42.6 ttp85 -59.53 -38.59 81.41 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 125.359 1.463 . . . . 0.0 112.394 178.985 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -64.73 -50.5 58.33 Favored Glycine 0 CA--C 1.538 1.505 0 CA-C-N 119.156 0.889 . . . . 0.0 113.481 171.632 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 15.2 mm100 -63.7 -42.17 98.02 Favored 'General case' 0 N--CA 1.477 0.891 0 O-C-N 121.819 -0.812 . . . . 0.0 111.836 178.905 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 52.9 t -64.01 -42.07 94.5 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 C-N-CA 125.397 1.479 . . . . 0.0 110.887 175.437 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 82.4 tttt -53.24 -49.45 66.8 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 120.153 1.342 . . . . 0.0 110.478 176.854 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -64.96 -42.67 94.38 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 123.454 0.702 . . . . 0.0 112.788 178.689 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 16.1 mmm180 -60.29 -45.34 93.69 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 123.438 0.695 . . . . 0.0 112.649 175.278 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 87.2 t -71.4 -39.45 71.57 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 C-N-CA 124.147 0.979 . . . . 0.0 111.267 -178.936 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -61.15 -41.66 97.14 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 119.386 0.994 . . . . 0.0 111.638 171.151 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 14.4 m-80 -63.4 -46.26 87.26 Favored 'General case' 0 CA--C 1.539 0.519 0 CA-C-N 118.692 0.678 . . . . 0.0 112.275 174.911 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -54.1 -54.95 32.4 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 124.694 1.198 . . . . 0.0 110.766 175.492 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 97.1 mt -61.09 -44.48 98.37 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 CA-C-O 118.857 -0.592 . . . . 0.0 110.541 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -67.48 -14.47 62.96 Favored 'General case' 0 CA--C 1.543 0.681 0 N-CA-C 115.084 1.512 . . . . 0.0 115.084 -179.738 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 21.1 ptmt -100.17 -28.02 13.23 Favored 'General case' 0 N--CA 1.478 0.931 0 CA-C-N 119.298 0.953 . . . . 0.0 113.552 173.646 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 17.5 pt -92.27 -14.72 8.39 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 N-CA-C 114.491 1.293 . . . . 0.0 114.491 178.091 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 67.4 m . . . . . 0 C--O 1.254 1.291 0 C-N-CA 123.893 0.877 . . . . 0.0 112.892 179.573 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.1 ttt . . . . . 0 N--CA 1.501 2.123 0 N-CA-C 111.599 0.222 . . . . 0.0 111.599 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -123.74 160.39 27.38 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 125.844 1.658 . . . . 0.0 112.662 176.557 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 32.4 ttmt -110.91 113.68 26.43 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 167.588 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 16.2 t -103.7 133.65 47.07 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 N-CA-C 113.839 1.051 . . . . 0.0 113.839 -177.852 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 46.4 tpp -101.59 119.61 39.03 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.456 1.102 . . . . 0.0 109.58 169.093 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 56.3 m-85 -103.34 121.75 43.4 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 124.899 1.28 . . . . 0.0 109.134 173.433 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.419 HG11 HD12 ' A' ' 65' ' ' ILE . 4.2 m -144.57 162.32 14.27 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 C-N-CA 124.163 0.985 . . . . 0.0 113.002 -168.894 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 12.7 t -146.86 157.03 43.55 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 126.095 1.758 . . . . 0.0 110.749 169.807 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -30.59 -46.78 0.08 Allowed 'General case' 0 N--CA 1.489 1.476 0 C-N-CA 129.119 2.968 . . . . 0.0 117.126 -176.992 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 32.1 ttm180 -137.35 -26.01 1.01 Allowed 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 117.309 2.337 . . . . 0.0 117.309 -174.882 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 6.9 t30 60.34 -33.38 0.07 Allowed 'General case' 0 N--CA 1.485 1.319 0 N-CA-C 117.577 2.436 . . . . 0.0 117.577 -178.534 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 84.1 p -62.69 139.98 58.69 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 121.192 1.815 . . . . 0.0 111.946 175.049 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 69.7 m 49.85 31.39 4.54 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 125.943 1.697 . . . . 0.0 114.486 -175.115 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 77.0 mtt85 -141.61 162.75 34.71 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 126.631 1.972 . . . . 0.0 111.53 -175.576 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 4.0 m -124.16 149.32 46.42 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 125.766 1.626 . . . . 0.0 111.774 174.089 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 -112.71 -35.59 5.45 Favored 'General case' 0 N--CA 1.478 0.933 0 N-CA-C 114.347 1.24 . . . . 0.0 114.347 -178.185 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' MET . . . . . 0.461 ' HG2' ' SD ' ' A' ' 50' ' ' MET . 0.0 OUTLIER 68.56 -47.78 0.55 Allowed 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 126.783 2.033 . . . . 0.0 115.681 173.887 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.17 -30.01 70.75 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 115.613 1.709 . . . . 0.0 115.613 -169.614 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 3.5 pm0 -62.7 -44.55 95.96 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 119.385 0.993 . . . . 0.0 112.096 178.062 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -64.77 -42.98 96.86 Favored Glycine 0 C--O 1.226 -0.402 0 C-N-CA 124.135 0.874 . . . . 0.0 111.736 179.405 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -68.6 -39.85 80.69 Favored 'General case' 0 N--CA 1.466 0.336 0 O-C-N 121.856 -0.791 . . . . 0.0 111.504 176.839 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -62.32 -41.41 98.52 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 119.226 0.921 . . . . 0.0 112.63 -177.837 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 10.5 pttp -81.17 -20.38 41.36 Favored 'General case' 0 N--CA 1.48 1.067 0 N-CA-C 114.037 1.125 . . . . 0.0 114.037 174.288 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 93.3 m -74.52 -36.13 63.18 Favored 'General case' 0 N--CA 1.483 1.224 0 O-C-N 121.561 -0.712 . . . . 0.0 111.645 170.806 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 74.4 mt -92.75 -30.83 15.31 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 125.374 1.47 . . . . 0.0 114.672 -174.974 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -137.21 25.71 3.01 Favored Glycine 0 N--CA 1.475 1.238 0 N-CA-C 118.224 2.049 . . . . 0.0 118.224 -169.002 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -66.69 -22.04 66.08 Favored 'General case' 0 N--CA 1.476 0.856 0 CA-C-N 121.895 2.848 . . . . 0.0 115.391 -174.459 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -72.74 -12.54 78.25 Favored Glycine 0 CA--C 1.542 1.748 0 O-C-N 121.18 -0.95 . . . . 0.0 113.632 169.576 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 53.2 mttm -107.34 -39.54 5.64 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 127.318 2.247 . . . . 0.0 113.161 -179.75 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 45.2 pt -144.41 154.46 15.0 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 C-N-CA 124.667 1.187 . . . . 0.0 114.094 -171.624 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -98.14 140.33 32.61 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 126.021 1.728 . . . . 0.0 109.247 169.548 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 92.3 t -127.27 139.02 53.08 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 CA-C-N 118.553 0.615 . . . . 0.0 111.735 -175.915 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 33.5 m -136.35 148.16 47.75 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 125.269 1.428 . . . . 0.0 109.432 172.182 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 86.1 p -136.02 143.19 44.62 Favored 'General case' 0 CA--C 1.514 -0.406 0 CA-C-O 122.249 1.023 . . . . 0.0 111.16 167.801 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 8.0 m -139.36 152.23 46.97 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 113.393 -1.731 . . . . 0.0 111.25 -169.949 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -81.33 163.76 45.1 Favored Glycine 0 CA--C 1.527 0.819 0 N-CA-C 110.382 -1.087 . . . . 0.0 110.382 169.222 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 8.2 mp -91.07 -23.09 20.43 Favored 'General case' 0 N--CA 1.477 0.911 0 O-C-N 120.885 -1.362 . . . . 0.0 112.895 174.173 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -148.8 29.68 0.82 Allowed 'General case' 0 CA--C 1.551 0.985 0 C-N-CA 125.734 1.614 . . . . 0.0 111.076 176.815 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 32.6 p -152.29 153.0 32.83 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 126.54 1.936 . . . . 0.0 112.16 -174.186 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 47.6 m -116.25 19.04 15.08 Favored 'General case' 0 N--CA 1.483 1.216 0 N-CA-C 116.198 1.925 . . . . 0.0 116.198 -169.003 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 7.8 tpt180 -159.3 144.76 15.98 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 124.702 1.201 . . . . 0.0 111.759 171.511 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 22.0 m -70.87 129.37 34.83 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.321 0 N-CA-C 105.92 -1.881 . . . . 0.0 105.92 167.847 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' HIS . . . . . 0.425 ' HA ' ' HD3' ' A' ' 44' ' ' PRO 0.271 0.0 OUTLIER -60.46 141.49 91.56 Favored Pre-proline 0 CA--C 1.552 1.05 0 N-CA-C 112.681 0.622 . . . . 0.0 112.681 -168.413 . . . . . . . . 4 4 . 1 . 019 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 43' ' ' HIS . 63.5 Cg_exo -46.49 -39.26 22.26 Favored 'Trans proline' 0 CA--C 1.54 0.778 0 C-N-CA 124.257 3.305 . . . . 0.0 118.567 -168.001 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 26.0 m -65.04 -24.3 67.44 Favored 'General case' 0 N--CA 1.484 1.242 0 CA-C-N 119.418 1.008 . . . . 0.0 112.802 -174.703 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -52.83 -48.77 66.74 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 123.673 0.789 . . . . 0.0 111.573 172.873 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.6 mp -54.01 -56.02 11.38 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 C-N-CA 124.373 1.069 . . . . 0.0 110.37 -171.764 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -62.4 -28.28 69.67 Favored 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 113.392 0.886 . . . . 0.0 113.392 -177.14 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -81.85 -20.64 38.53 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 113.69 0.996 . . . . 0.0 113.69 176.758 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' MET . . . . . 0.461 ' SD ' ' HG2' ' A' ' 17' ' ' MET . 5.7 mmt -87.52 -32.55 19.35 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 119.465 1.03 . . . . 0.0 110.729 169.887 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -64.5 -15.29 60.58 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.752 1.221 . . . . 0.0 113.559 176.229 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 -61.15 -28.44 69.12 Favored 'General case' 0 N--CA 1.48 1.032 0 CA-C-N 120.225 1.375 . . . . 0.0 111.077 169.345 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 59.3 t -94.91 -3.65 10.58 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.047 0 C-N-CA 127.356 2.262 . . . . 0.0 111.253 178.03 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 79.4 17.54 75.83 Favored Glycine 0 CA--C 1.54 1.609 0 O-C-N 120.525 -1.359 . . . . 0.0 114.588 -174.572 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 67.2 mt -76.57 145.48 10.28 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 C-N-CA 125.09 1.356 . . . . 0.0 111.941 -174.445 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -106.3 53.16 0.71 Allowed 'General case' 0 CA--C 1.548 0.897 0 N-CA-C 115.11 1.522 . . . . 0.0 115.11 -170.092 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 12.0 pt -85.42 -0.12 6.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 120.017 -1.677 . . . . 0.0 114.252 173.334 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 84.5 p -67.09 -28.13 67.92 Favored 'General case' 0 N--CA 1.476 0.841 0 O-C-N 120.838 -1.163 . . . . 0.0 113.502 174.694 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -82.0 -6.95 88.47 Favored Glycine 0 CA--C 1.537 1.415 0 C-N-CA 125.075 1.321 . . . . 0.0 116.381 -177.112 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 14.8 pt20 -100.19 138.34 37.39 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 119.309 1.555 . . . . 0.0 112.077 179.364 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 58.8 p -106.38 -64.24 1.19 Allowed 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 125.701 1.6 . . . . 0.0 110.82 173.28 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 59.1 m 63.7 127.12 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 129.152 2.981 . . . . 0.0 116.639 173.621 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 24.6 m-20 -67.35 162.11 58.53 Favored Pre-proline 0 CA--C 1.548 0.87 0 C-N-CA 124.402 1.081 . . . . 0.0 111.012 169.555 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -58.1 157.95 23.44 Favored 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 122.627 2.218 . . . . 0.0 112.977 171.075 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.419 HD12 HG11 ' A' ' 7' ' ' VAL . 2.9 tt -57.1 -37.7 56.8 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 C-N-CA 123.778 0.831 . . . . 0.0 110.939 -178.506 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.98 -1.55 26.2 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 114.302 1.223 . . . . 0.0 114.302 -177.247 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -88.22 -6.85 57.59 Favored 'General case' 0 CA--C 1.555 1.167 0 C-N-CA 124.573 1.149 . . . . 0.0 111.9 169.242 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 77.2 m-85 -113.86 -174.93 2.56 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 126.796 2.038 . . . . 0.0 112.739 -178.978 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 13.3 p-10 -116.83 132.73 56.62 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 127.04 2.136 . . . . 0.0 109.915 174.607 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -67.45 -35.75 79.84 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 113.636 0.976 . . . . 0.0 113.636 -174.315 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -70.02 -3.45 16.37 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 114.429 1.27 . . . . 0.0 114.429 -179.334 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -69.96 -16.72 63.24 Favored 'General case' 0 CA--C 1.543 0.699 0 O-C-N 121.652 -0.655 . . . . 0.0 110.976 168.946 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 45.2 m-85 -120.42 131.14 54.66 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 126.661 1.985 . . . . 0.0 111.378 -172.724 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -80.69 -22.85 40.01 Favored 'General case' 0 N--CA 1.477 0.911 0 CA-C-O 122.234 1.016 . . . . 0.0 112.498 178.065 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.632 HG22 ' HB ' ' A' ' 95' ' ' ILE . 82.2 t -132.4 136.37 56.34 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 C-N-CA 127.501 2.32 . . . . 0.0 108.125 -175.113 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 59.7 t -131.92 127.3 58.19 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 169.561 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 41.8 mm -114.61 115.91 50.98 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 C-N-CA 123.777 0.831 . . . . 0.0 109.645 -174.93 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 10.5 t -89.18 122.46 32.49 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 169.208 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 92.7 mt -97.19 5.32 50.33 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 116.141 1.904 . . . . 0.0 116.141 -168.979 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 25.4 p -144.94 39.04 1.21 Allowed 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 123.273 0.629 . . . . 0.0 112.077 -174.435 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 110.53 -148.25 17.58 Favored Glycine 0 CA--C 1.531 1.08 0 C-N-CA 125.024 1.297 . . . . 0.0 112.992 -174.224 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 87.2 p -76.29 174.51 10.09 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 124.963 1.305 . . . . 0.0 113.502 -178.629 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -76.07 119.81 5.74 Favored Glycine 0 N--CA 1.469 0.889 0 CA-C-O 122.244 0.914 . . . . 0.0 111.317 169.978 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 7.6 p -148.0 151.73 13.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 C-N-CA 127.86 2.464 . . . . 0.0 106.471 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 51.7 t30 65.73 2.66 2.2 Favored 'General case' 0 CA--C 1.556 1.185 0 N-CA-C 115.996 1.85 . . . . 0.0 115.996 179.647 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -117.54 152.18 49.24 Favored Pre-proline 0 N--CA 1.479 0.996 0 C-N-CA 126.14 1.776 . . . . 0.0 111.681 169.679 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -71.89 160.36 47.97 Favored 'Trans proline' 0 CA--C 1.548 1.219 0 C-N-CA 122.407 2.071 . . . . 0.0 113.061 -179.082 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_exo -57.81 -25.77 70.59 Favored 'Trans proline' 0 C--N 1.354 0.834 0 C-N-CA 123.931 3.087 . . . . 0.0 116.363 -169.696 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -62.46 -25.78 68.17 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 114.024 1.12 . . . . 0.0 114.024 -178.711 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 93.8 m95 -81.13 -33.05 33.48 Favored 'General case' 0 N--CA 1.472 0.662 0 O-C-N 120.676 -1.265 . . . . 0.0 112.682 178.436 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 9.4 m -80.73 -6.2 9.36 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 N-CA-C 113.145 0.795 . . . . 0.0 113.145 176.046 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -106.82 6.01 29.06 Favored 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 114.741 1.386 . . . . 0.0 114.741 179.678 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 91.1 mm-40 -65.75 158.61 27.14 Favored 'General case' 0 N--CA 1.479 0.999 0 O-C-N 120.785 -1.197 . . . . 0.0 111.621 170.512 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -57.44 -43.47 83.91 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 114.224 1.194 . . . . 0.0 114.224 -168.15 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.632 ' HB ' HG22 ' A' ' 75' ' ' VAL . 22.0 mm -114.96 60.52 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 C-N-CA 124.93 1.292 . . . . 0.0 108.77 175.794 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 42.6 t80 -76.57 110.83 11.45 Favored 'General case' 0 CA--C 1.536 0.41 0 O-C-N 120.746 -1.221 . . . . 0.0 108.229 169.084 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 17.0 mt-10 -110.73 137.76 47.98 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 114.573 1.323 . . . . 0.0 114.573 175.7 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -97.71 114.74 26.79 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.99 1.316 . . . . 0.0 109.726 169.373 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 34.0 m0 -104.79 118.61 36.99 Favored 'General case' 0 N--CA 1.462 0.156 0 C-N-CA 124.438 1.095 . . . . 0.0 108.189 176.985 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 61.7 mt-30 -91.18 44.21 1.18 Allowed 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 124.508 1.123 . . . . 0.0 111.162 -169.627 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 90.1 mt -82.99 168.13 17.28 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 126.926 2.09 . . . . 0.0 112.222 -179.165 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -96.97 152.95 18.21 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 123.856 0.863 . . . . 0.0 113.108 172.974 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -77.7 121.62 84.52 Favored Pre-proline 0 CA--C 1.543 0.703 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 169.458 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -79.9 -9.06 14.42 Favored 'Trans proline' 0 CA--C 1.542 0.923 0 C-N-CA 121.403 1.402 . . . . 0.0 114.317 -178.798 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -72.89 -41.9 64.15 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 115.905 1.817 . . . . 0.0 115.905 -169.416 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -72.89 20.37 1.09 Allowed Glycine 0 CA--C 1.541 1.707 0 C-N-CA 124.387 0.994 . . . . 0.0 114.872 -177.471 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 7.3 pt20 -158.74 176.94 11.73 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 127.78 2.432 . . . . 0.0 110.876 -169.662 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 52.8 p -66.65 161.94 22.2 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 114.122 1.156 . . . . 0.0 114.122 -172.82 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . 0.32 2.9 pp -67.99 -11.97 59.88 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 114.194 1.183 . . . . 0.0 114.194 176.803 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -67.82 -30.07 69.39 Favored 'General case' 0 CA--C 1.543 0.682 0 O-C-N 120.968 -1.082 . . . . 0.0 109.953 168.845 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 3.4 t -74.35 -36.92 44.02 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 O-C-N 121.031 -1.043 . . . . 0.0 111.147 170.806 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 16.5 m-85 -58.05 -42.26 85.03 Favored 'General case' 0 N--CA 1.482 1.141 0 CA-C-N 120.229 1.377 . . . . 0.0 111.313 168.941 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -66.5 -37.51 85.22 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 124.19 0.996 . . . . 0.0 112.439 175.864 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 18.9 m -61.36 -50.53 72.53 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 124.491 1.116 . . . . 0.0 111.252 171.203 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 78.4 t -67.44 -37.73 79.44 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 C-N-CA 124.131 0.972 . . . . 0.0 111.098 -178.887 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 19.9 mtp180 -54.55 -43.38 71.93 Favored 'General case' 0 N--CA 1.48 1.052 0 CA-C-N 120.109 1.322 . . . . 0.0 112.467 170.255 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -61.74 -50.9 61.34 Favored Glycine 0 CA--C 1.535 1.332 0 CA-C-N 119.297 0.953 . . . . 0.0 112.954 175.239 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 52.4 mt-30 -61.03 -46.77 89.36 Favored 'General case' 0 N--CA 1.474 0.729 0 O-C-N 122.138 -0.625 . . . . 0.0 111.737 177.686 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 55.3 t -66.02 -41.02 88.88 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 C-N-CA 125.028 1.331 . . . . 0.0 111.144 -179.41 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -55.98 -48.15 76.36 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 120.117 1.326 . . . . 0.0 110.437 177.129 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -63.47 -44.66 93.8 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 112.682 0.623 . . . . 0.0 112.682 175.376 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.17 -33.72 76.67 Favored 'General case' 0 N--CA 1.478 0.967 0 N-CA-C 113.52 0.933 . . . . 0.0 113.52 179.188 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 82.4 t -78.99 -39.29 21.46 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 C-N-CA 125.698 1.599 . . . . 0.0 111.291 177.027 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -60.89 -40.11 91.79 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 119.58 1.082 . . . . 0.0 111.16 171.171 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 16.6 m-80 -63.96 -45.86 87.22 Favored 'General case' 0 CA--C 1.538 0.51 0 O-C-N 121.865 -0.522 . . . . 0.0 112.341 174.19 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -51.67 -57.9 7.9 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 124.729 1.212 . . . . 0.0 110.6 173.522 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 74.1 mt -62.59 -42.99 98.03 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 C-N-CA 122.827 0.451 . . . . 0.0 110.548 -177.11 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -72.92 -10.62 60.0 Favored 'General case' 0 CA--C 1.544 0.721 0 N-CA-C 114.86 1.43 . . . . 0.0 114.86 -178.854 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 20.7 ptmt -99.53 -29.93 12.44 Favored 'General case' 0 N--CA 1.479 0.976 0 N-CA-C 113.636 0.976 . . . . 0.0 113.636 170.198 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 12.7 pt -93.24 -8.91 9.93 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 N-CA-C 114.527 1.306 . . . . 0.0 114.527 178.313 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 27.1 p . . . . . 0 C--O 1.255 1.387 0 N-CA-C 114.663 1.357 . . . . 0.0 114.663 174.501 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.3 ttt . . . . . 0 N--CA 1.502 2.139 0 N-CA-C 111.501 0.186 . . . . 0.0 111.501 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.79 155.97 36.97 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 125.059 1.344 . . . . 0.0 112.774 173.951 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 30.8 ttmt -106.73 112.6 25.66 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 106.812 -1.551 . . . . 0.0 106.812 167.651 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 23.4 t -97.3 131.7 43.57 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 C-N-CA 125.38 1.472 . . . . 0.0 113.826 178.751 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' MET . . . . . 0.49 ' HG3' HG13 ' A' ' 7' ' ' VAL . 23.3 tpp -98.73 128.2 44.9 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 168.986 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 48.6 m-85 -109.46 121.35 44.99 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 125.784 1.633 . . . . 0.0 108.2 174.079 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.58 HG11 HD12 ' A' ' 65' ' ' ILE . 2.1 m -137.69 143.02 34.85 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 N-CA-C 113.926 1.084 . . . . 0.0 113.926 -168.823 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 5.3 t -131.03 147.45 52.63 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 126.41 1.884 . . . . 0.0 112.086 174.786 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 63.2 tttm -52.86 -39.71 62.82 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 126.477 1.911 . . . . 0.0 114.297 -177.641 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 53.4 ttt180 -101.95 -49.73 3.87 Favored 'General case' 0 N--CA 1.483 1.217 0 N-CA-C 113.719 1.007 . . . . 0.0 113.719 169.872 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 1.8 t30 63.63 -47.5 0.25 Allowed 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 127.232 2.213 . . . . 0.0 116.15 -173.515 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 59.6 p -64.85 145.97 55.54 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 119.044 0.838 . . . . 0.0 110.243 169.687 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 66.6 m 51.39 24.62 2.23 Favored 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 114.564 1.32 . . . . 0.0 114.564 -174.548 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 85.2 mtt180 -137.47 152.4 49.5 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 126.975 2.11 . . . . 0.0 110.399 176.403 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 61.1 m -97.01 -29.28 13.74 Favored 'General case' 0 N--CA 1.48 1.058 0 N-CA-C 115.771 1.767 . . . . 0.0 115.771 -169.295 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 3.9 mp0 59.96 -44.24 0.09 Allowed 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 128.596 2.758 . . . . 0.0 117.09 -178.517 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' MET . . . . . 0.408 ' HG2' ' SD ' ' A' ' 50' ' ' MET . 0.0 OUTLIER 68.73 -46.38 0.55 Allowed 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 127.54 2.336 . . . . 0.0 115.753 171.931 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.86 -38.78 86.73 Favored 'General case' 0 C--O 1.222 -0.39 0 N-CA-C 115.494 1.665 . . . . 0.0 115.494 -169.605 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -69.15 -36.5 77.5 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-N 119.788 1.176 . . . . 0.0 112.134 -177.122 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -64.14 -40.16 97.81 Favored Glycine 0 N--CA 1.469 0.866 0 C-N-CA 124.135 0.874 . . . . 0.0 112.107 173.955 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -69.74 -38.32 76.77 Favored 'General case' 0 N--CA 1.47 0.533 0 O-C-N 121.75 -0.853 . . . . 0.0 111.686 172.404 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -64.59 -43.1 94.88 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 119.424 1.011 . . . . 0.0 112.402 -174.75 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 15.2 ptpt -64.75 -38.33 90.63 Favored 'General case' 0 N--CA 1.486 1.351 0 O-C-N 121.514 -0.741 . . . . 0.0 112.025 169.753 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 92.3 m -71.55 -34.07 69.67 Favored 'General case' 0 N--CA 1.479 1.001 0 O-C-N 121.632 -0.668 . . . . 0.0 112.475 -176.709 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 71.9 mt -88.66 -26.07 22.05 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 125.498 1.519 . . . . 0.0 113.84 -178.717 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -145.78 27.08 1.77 Allowed Glycine 0 N--CA 1.47 0.94 0 N-CA-C 118.487 2.155 . . . . 0.0 118.487 -169.083 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -65.82 -21.92 66.52 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-N 122.31 3.055 . . . . 0.0 115.329 -177.323 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -74.36 -5.17 71.47 Favored Glycine 0 CA--C 1.541 1.671 0 O-C-N 121.546 -0.721 . . . . 0.0 113.799 169.479 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 76.8 mttt -118.81 -39.81 2.93 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 127.339 2.256 . . . . 0.0 113.255 -177.506 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 43.7 pt -145.11 159.3 13.62 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 124.805 1.242 . . . . 0.0 113.399 -172.355 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -108.87 139.96 42.99 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 126.343 1.857 . . . . 0.0 108.65 169.752 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 4.2 m -129.55 148.83 33.23 Favored 'Isoleucine or valine' 0 C--O 1.234 0.273 0 CA-C-N 119.53 1.059 . . . . 0.0 111.067 -177.196 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 85.1 m -136.39 136.8 39.9 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 123.151 0.581 . . . . 0.0 110.781 179.0 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 11.5 t -88.51 133.67 34.08 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 124.329 1.052 . . . . 0.0 109.435 169.174 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 23.2 p -146.6 149.41 33.48 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 114.982 1.475 . . . . 0.0 114.982 169.935 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -98.22 152.11 19.75 Favored Glycine 0 C--N 1.338 0.643 0 C-N-CA 124.272 0.939 . . . . 0.0 113.725 -172.615 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 10.5 mp -96.12 99.51 11.24 Favored 'General case' 0 CA--C 1.536 0.41 0 O-C-N 120.604 -1.527 . . . . 0.0 108.956 176.616 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 25.9 mt-10 63.96 26.47 14.15 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 125.243 1.417 . . . . 0.0 113.324 -171.619 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 94.6 p -151.13 167.16 28.6 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 125.248 1.419 . . . . 0.0 113.705 -169.654 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 77.6 p -129.41 169.3 15.09 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 125.398 1.479 . . . . 0.0 113.911 173.05 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.454 ' HG3' ' H ' ' A' ' 42' ' ' VAL . 5.7 tpt180 60.94 -178.86 0.11 Allowed 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 128.636 2.775 . . . . 0.0 113.589 -179.143 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.454 ' H ' ' HG3' ' A' ' 41' ' ' ARG . 20.9 m -133.37 179.51 4.34 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 C-N-CA 129.808 3.243 . . . . 0.0 107.716 172.179 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 2.6 t-80 -58.77 130.75 85.89 Favored Pre-proline 0 C--N 1.325 -0.499 0 CA-C-O 118.052 -0.975 . . . . 0.0 112.127 178.482 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_exo -58.99 -27.2 84.33 Favored 'Trans proline' 0 CA--C 1.548 1.197 0 C-N-CA 121.337 1.358 . . . . 0.0 112.154 169.961 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 89.9 m -64.94 -29.66 70.61 Favored 'General case' 0 N--CA 1.482 1.175 0 C-N-CA 125.698 1.599 . . . . 0.0 112.452 173.209 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -56.65 -43.47 80.35 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 124.027 0.931 . . . . 0.0 111.114 -177.878 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.7 mp -51.74 -55.01 10.47 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 C-N-CA 124.233 1.013 . . . . 0.0 110.226 -176.564 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -62.95 -32.96 74.38 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 113.111 0.782 . . . . 0.0 113.111 -179.578 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -80.72 -20.68 42.29 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 113.719 1.007 . . . . 0.0 113.719 178.326 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' MET . . . . . 0.408 ' SD ' ' HG2' ' A' ' 17' ' ' MET . 4.5 mmt -85.87 -32.51 21.64 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 119.54 1.064 . . . . 0.0 110.344 169.74 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -66.72 -15.75 63.75 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.953 1.301 . . . . 0.0 113.97 175.131 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 -62.29 -26.54 68.46 Favored 'General case' 0 N--CA 1.481 1.1 0 CA-C-N 120.367 1.439 . . . . 0.0 110.895 168.959 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 59.4 t -95.02 -5.77 10.24 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.82 0 C-N-CA 127.318 2.247 . . . . 0.0 111.348 175.613 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 80.22 18.4 71.83 Favored Glycine 0 CA--C 1.539 1.551 0 C-N-CA 125.165 1.364 . . . . 0.0 114.575 -174.65 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 94.6 mt -75.96 134.38 29.21 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 C-N-CA 124.843 1.257 . . . . 0.0 111.22 -176.727 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 21.8 t0 -94.68 108.71 20.69 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 123.231 0.612 . . . . 0.0 112.337 172.241 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 15.7 pt -129.82 12.68 2.39 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 C-N-CA 125.142 1.377 . . . . 0.0 113.284 169.641 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 72.5 m -69.67 138.24 52.82 Favored 'General case' 0 N--CA 1.47 0.57 0 O-C-N 120.603 -1.311 . . . . 0.0 111.93 -175.815 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 73.97 3.37 64.15 Favored Glycine 0 CA--C 1.537 1.429 0 N-CA-C 116.047 1.179 . . . . 0.0 116.047 176.468 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 9.2 pt20 -77.77 135.23 37.96 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 119.536 1.668 . . . . 0.0 110.903 177.414 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 24.1 p -77.36 -33.17 55.35 Favored 'General case' 0 N--CA 1.48 1.051 0 N-CA-C 114.853 1.427 . . . . 0.0 114.853 -173.196 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 31.8 m 47.85 54.27 10.21 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.804 1.242 . . . . 0.0 112.189 -170.937 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -54.04 159.02 3.12 Favored Pre-proline 0 CA--C 1.542 0.656 0 C-N-CA 124.306 1.042 . . . . 0.0 112.357 177.792 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -62.91 149.6 90.99 Favored 'Trans proline' 0 N--CA 1.457 -0.674 0 CA-C-N 120.312 1.147 . . . . 0.0 112.927 -176.489 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.58 HD12 HG11 ' A' ' 7' ' ' VAL . 7.7 tt -51.35 -32.22 12.72 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 125.246 1.418 . . . . 0.0 111.42 173.603 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 -65.73 -17.44 64.61 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 125.545 1.538 . . . . 0.0 113.35 -179.247 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -79.75 -9.29 59.63 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 125.103 1.361 . . . . 0.0 112.9 177.93 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 77.5 m-85 -117.35 -179.07 3.61 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 126.408 1.883 . . . . 0.0 112.254 -173.498 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 5.2 t30 -123.07 128.31 49.95 Favored 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 125.56 1.544 . . . . 0.0 109.711 175.015 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.33 -35.87 81.47 Favored 'General case' 0 CA--C 1.531 0.25 0 N-CA-C 114.205 1.187 . . . . 0.0 114.205 -169.861 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . 0.263 0.0 OUTLIER -72.18 -5.71 37.57 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 114.009 1.115 . . . . 0.0 114.009 -178.226 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -75.49 -10.39 59.4 Favored 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 124.082 0.953 . . . . 0.0 111.331 168.648 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 68.1 m-85 -116.55 145.09 43.6 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 127.167 2.187 . . . . 0.0 111.882 179.635 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -93.57 -26.25 17.2 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.892 1.277 . . . . 0.0 112.202 179.489 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.703 HG22 ' HB ' ' A' ' 95' ' ' ILE . 68.9 t -137.09 139.69 43.86 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 C-N-CA 126.99 2.116 . . . . 0.0 107.953 -169.923 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 61.0 t -130.9 126.39 59.78 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 170.268 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 45.5 mm -112.55 105.63 19.17 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 C-N-CA 125.331 1.452 . . . . 0.0 109.407 -177.137 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 9.5 m -84.44 117.93 23.96 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 123.976 0.91 . . . . 0.0 110.305 170.275 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 1.4 pp -130.91 168.93 16.5 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 125.79 1.636 . . . . 0.0 110.182 176.428 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER 65.84 -27.42 0.11 Allowed 'General case' 0 CA--C 1.553 1.075 0 C-N-CA 126.753 2.021 . . . . 0.0 114.982 -169.45 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -170.78 -173.09 37.68 Favored Glycine 0 CA--C 1.536 1.359 0 C-N-CA 126.395 1.95 . . . . 0.0 112.328 174.521 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 74.9 m -76.84 149.83 36.14 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.96 0.904 . . . . 0.0 112.51 -178.739 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -76.67 63.29 3.09 Favored Glycine 0 CA--C 1.535 1.336 0 C-N-CA 125.01 1.291 . . . . 0.0 113.625 176.461 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 58.2 t -105.09 -38.33 4.62 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.129 0 C-N-CA 124.284 1.034 . . . . 0.0 112.659 -176.284 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 62.7 t30 -91.31 33.16 0.99 Allowed 'General case' 0 CA--C 1.55 0.951 0 N-CA-C 113.344 0.868 . . . . 0.0 113.344 -178.772 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.1 pp -126.83 156.82 73.23 Favored Pre-proline 0 CA--C 1.55 0.976 0 C-N-CA 126.32 1.848 . . . . 0.0 111.853 172.41 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -61.65 149.0 91.74 Favored 'Trans proline' 0 CA--C 1.545 1.031 0 C-N-CA 122.315 2.01 . . . . 0.0 113.906 -179.581 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_exo -57.63 -26.03 70.55 Favored 'Trans proline' 0 C--N 1.354 0.827 0 C-N-CA 123.596 2.864 . . . . 0.0 115.244 -176.962 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -62.12 -22.8 66.13 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 113.695 0.998 . . . . 0.0 113.695 176.086 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 89.5 m95 -82.52 -28.65 30.95 Favored 'General case' 0 N--CA 1.473 0.681 0 O-C-N 120.821 -1.175 . . . . 0.0 113.193 176.932 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 6.4 m -80.25 -14.11 13.01 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.256 0 CA-C-N 119.232 0.924 . . . . 0.0 113.24 174.167 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -96.52 0.09 49.66 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 114.95 1.463 . . . . 0.0 114.95 -178.467 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 80.6 mm-40 -65.63 157.13 30.75 Favored 'General case' 0 N--CA 1.479 1.011 0 O-C-N 120.87 -1.144 . . . . 0.0 111.865 171.239 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -55.19 -42.54 73.37 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 114.392 1.256 . . . . 0.0 114.392 -167.872 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.703 ' HB ' HG22 ' A' ' 75' ' ' VAL . 14.0 mm -119.82 64.43 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 C-N-CA 124.63 1.172 . . . . 0.0 109.412 176.753 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 14.9 t80 -77.2 108.29 10.2 Favored 'General case' 0 CA--C 1.536 0.413 0 O-C-N 120.492 -1.38 . . . . 0.0 108.063 169.246 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -109.32 144.29 37.69 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 113.217 0.821 . . . . 0.0 113.217 172.788 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -121.42 115.54 23.09 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 124.13 0.972 . . . . 0.0 109.732 169.413 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 45.5 m0 -93.16 -19.78 21.13 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 113.903 1.075 . . . . 0.0 113.903 -169.859 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 66.5 mm-40 53.25 29.92 9.22 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 125.218 1.407 . . . . 0.0 113.177 -175.721 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.3 tt -80.83 132.73 35.5 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 125.428 1.491 . . . . 0.0 109.676 -174.599 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -65.74 151.98 45.34 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 113.131 0.789 . . . . 0.0 113.131 -179.43 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -92.9 148.82 36.61 Favored Pre-proline 0 CA--C 1.548 0.886 0 O-C-N 121.772 -0.58 . . . . 0.0 111.106 171.345 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -62.42 -19.19 66.63 Favored 'Trans proline' 0 CA--C 1.548 1.204 0 C-N-CA 122.779 2.32 . . . . 0.0 115.3 173.001 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -49.32 130.83 20.03 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 125.281 1.432 . . . . 0.0 114.582 175.761 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 79.29 7.95 88.13 Favored Glycine 0 CA--C 1.535 1.312 0 C-N-CA 124.736 1.16 . . . . 0.0 114.914 175.625 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 10.5 pt20 -143.36 173.2 11.82 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 125.098 1.359 . . . . 0.0 113.117 -177.122 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 26.5 p -68.3 167.46 14.41 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 116.61 2.078 . . . . 0.0 116.61 -168.947 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 41.7 tp -59.42 -30.8 68.73 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.516 1.126 . . . . 0.0 112.288 170.073 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -66.88 -31.76 72.57 Favored 'General case' 0 N--CA 1.47 0.536 0 O-C-N 120.818 -1.176 . . . . 0.0 111.487 173.849 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 7.6 t -71.49 -33.81 50.92 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 O-C-N 121.172 -0.955 . . . . 0.0 111.687 169.867 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -57.52 -48.34 79.55 Favored 'General case' 0 N--CA 1.477 0.893 0 CA-C-N 120.041 1.291 . . . . 0.0 111.261 169.34 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 2.8 mpt_? -63.35 -40.58 97.68 Favored 'General case' 0 N--CA 1.484 1.261 0 O-C-N 121.473 -0.767 . . . . 0.0 112.066 175.873 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 28.0 m -58.81 -46.5 87.45 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 124.095 0.958 . . . . 0.0 111.175 173.659 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 54.4 t -64.57 -43.19 96.77 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 CA-C-O 117.522 -1.228 . . . . 0.0 110.514 177.621 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 67.5 mtm-85 -57.3 -43.62 83.4 Favored 'General case' 0 N--CA 1.484 1.264 0 CA-C-N 121.076 1.762 . . . . 0.0 112.528 173.738 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -61.83 -51.21 58.79 Favored Glycine 0 CA--C 1.538 1.479 0 CA-C-N 119.046 0.839 . . . . 0.0 112.914 177.113 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 58.9 mm-40 -62.29 -45.36 93.6 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 123.742 0.817 . . . . 0.0 111.754 177.751 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 58.7 t -65.41 -40.59 88.84 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 C-N-CA 124.62 1.168 . . . . 0.0 111.375 178.342 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 82.3 tttt -56.02 -50.07 71.91 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 120.337 1.426 . . . . 0.0 110.131 177.594 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -62.81 -41.19 99.19 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 112.68 0.622 . . . . 0.0 112.68 176.64 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.77 -34.49 73.85 Favored 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 113.858 1.058 . . . . 0.0 113.858 -179.864 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 98.6 t -78.3 -38.53 23.3 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 C-N-CA 125.17 1.388 . . . . 0.0 110.926 175.744 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -62.3 -41.21 98.32 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 119.041 0.837 . . . . 0.0 111.506 171.661 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 15.2 m-80 -64.43 -42.13 96.18 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 119.249 0.931 . . . . 0.0 112.462 173.722 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -54.77 -57.23 12.38 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.234 0.614 . . . . 0.0 110.26 174.149 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 77.5 mt -63.32 -45.38 98.34 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 CA-C-O 118.995 -0.526 . . . . 0.0 111.251 -177.237 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -68.91 -10.84 59.31 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 114.222 1.193 . . . . 0.0 114.222 177.632 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 70.2 tttt -92.61 -45.63 7.99 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 125.425 1.49 . . . . 0.0 111.29 174.422 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 18.7 pt -91.89 -18.86 7.15 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 N-CA-C 114.41 1.263 . . . . 0.0 114.41 -174.257 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 73.7 m . . . . . 0 C--O 1.254 1.31 0 C-N-CA 125.783 1.633 . . . . 0.0 111.188 -175.878 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.8 ttt . . . . . 0 N--CA 1.503 2.183 0 N-CA-C 111.563 0.209 . . . . 0.0 111.563 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.9 164.35 30.33 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 125.061 1.344 . . . . 0.0 112.907 174.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 75.3 mttt -93.75 145.61 24.46 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 124.206 1.002 . . . . 0.0 112.193 177.269 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.408 HG13 ' CG1' ' A' ' 75' ' ' VAL . 21.5 t -129.06 131.57 67.91 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 125.569 1.548 . . . . 0.0 112.318 178.43 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 47.0 tpp -98.35 132.37 43.88 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 168.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 42.6 m-85 -115.61 127.32 55.13 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 124.441 1.096 . . . . 0.0 109.645 173.142 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 5.7 m -149.16 163.94 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 C-N-CA 124.398 1.079 . . . . 0.0 112.891 -169.779 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 47.1 t -132.25 165.52 23.96 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 127.312 2.245 . . . . 0.0 109.384 169.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -52.96 -37.6 61.26 Favored 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 124.547 1.139 . . . . 0.0 112.741 -178.529 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 82.3 mtt180 -141.18 150.73 43.11 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 127.203 2.201 . . . . 0.0 109.822 169.028 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 24.0 t30 -110.15 -27.11 9.31 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 124.341 1.056 . . . . 0.0 113.746 -173.222 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 60.5 m -56.29 126.54 26.69 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 118.769 0.713 . . . . 0.0 110.461 177.662 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 68.3 m 50.36 36.81 13.85 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 124.798 1.239 . . . . 0.0 113.945 -176.459 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -121.98 143.25 49.59 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 125.778 1.631 . . . . 0.0 109.478 171.082 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 15.8 m -97.02 -33.17 11.65 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 114.742 1.386 . . . . 0.0 114.742 -170.334 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 5.2 mt-30 60.75 -55.88 0.09 Allowed 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 128.578 2.751 . . . . 0.0 116.648 171.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 69.86 -42.67 0.52 Allowed 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 127.929 2.492 . . . . 0.0 117.498 169.599 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -59.9 -33.21 71.55 Favored 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 113.858 1.059 . . . . 0.0 113.858 -170.406 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.9 pm0 -61.56 -42.47 98.89 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.658 1.183 . . . . 0.0 112.275 173.767 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -68.75 -38.95 86.19 Favored Glycine 0 C--N 1.336 0.563 0 O-C-N 121.557 -0.715 . . . . 0.0 111.59 178.607 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -70.05 -41.65 73.91 Favored 'General case' 0 C--O 1.221 -0.414 0 O-C-N 121.834 -0.804 . . . . 0.0 111.258 175.865 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -60.16 -41.9 93.79 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 119.467 1.031 . . . . 0.0 113.008 -175.736 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 10.3 pttp -76.78 -29.28 55.99 Favored 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 113.502 0.927 . . . . 0.0 113.502 173.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 83.7 m -71.66 -31.29 66.65 Favored 'General case' 0 N--CA 1.485 1.281 0 O-C-N 121.585 -0.697 . . . . 0.0 111.842 175.241 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 78.2 mt -91.57 -30.82 16.17 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 125.923 1.689 . . . . 0.0 114.123 179.827 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -142.89 26.36 2.22 Favored Glycine 0 N--CA 1.475 1.292 0 N-CA-C 118.233 2.053 . . . . 0.0 118.233 -169.086 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -66.27 -20.3 66.07 Favored 'General case' 0 CA--C 1.547 0.833 0 CA-C-N 122.016 2.908 . . . . 0.0 114.952 -178.578 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -76.4 -4.18 79.21 Favored Glycine 0 CA--C 1.541 1.675 0 O-C-N 121.235 -0.916 . . . . 0.0 113.757 169.368 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -118.11 -40.94 2.91 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 127.178 2.191 . . . . 0.0 112.513 -175.536 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 29.4 pt -141.38 154.93 20.56 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 C-N-CA 125.919 1.687 . . . . 0.0 112.168 -175.103 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -97.3 137.53 36.17 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 123.872 0.869 . . . . 0.0 109.702 169.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 84.0 t -122.14 140.22 46.71 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 CA-C-N 118.996 0.817 . . . . 0.0 111.542 -178.769 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 20.4 m -135.68 151.2 49.95 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 124.923 1.289 . . . . 0.0 109.31 173.331 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 77.9 p -133.06 147.73 52.2 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 122.308 1.051 . . . . 0.0 110.913 168.32 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 88.7 p -144.2 157.9 44.03 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 114.066 -1.425 . . . . 0.0 112.461 -174.478 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -79.07 167.67 52.72 Favored Glycine 0 CA--C 1.527 0.818 0 N-CA-C 111.166 -0.774 . . . . 0.0 111.166 169.748 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 9.2 mp -100.91 -16.91 17.05 Favored 'General case' 0 N--CA 1.484 1.237 0 CA-C-N 120.27 2.035 . . . . 0.0 112.164 169.559 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -138.36 170.02 16.75 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 129.587 3.155 . . . . 0.0 107.095 172.331 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 69.0 m -57.46 110.17 0.82 Allowed 'General case' 0 N--CA 1.48 1.061 0 CA-C-N 119.759 1.163 . . . . 0.0 111.112 -178.461 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 91.2 p -158.51 175.02 14.21 Favored 'General case' 0 N--CA 1.478 0.966 0 N-CA-C 115.673 1.731 . . . . 0.0 115.673 -169.145 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 15.3 tpt180 -139.79 145.01 37.67 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 128.398 2.679 . . . . 0.0 108.852 171.76 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 35.5 m -56.21 163.98 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 CA-C-O 122.761 1.267 . . . . 0.0 111.155 169.598 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 1.6 t-80 -48.86 127.05 14.09 Favored Pre-proline 0 C--N 1.323 -0.543 0 CA-C-N 114.05 -1.432 . . . . 0.0 112.965 172.354 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_exo -60.64 -28.68 86.99 Favored 'Trans proline' 0 CA--C 1.542 0.907 0 CA-C-N 120.54 1.229 . . . . 0.0 111.904 171.497 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 88.6 m -65.6 -29.72 70.35 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 125.213 1.405 . . . . 0.0 112.238 173.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.32 -39.69 87.96 Favored 'General case' 0 N--CA 1.471 0.582 0 O-C-N 121.108 -0.995 . . . . 0.0 112.089 -175.714 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.9 mp -57.83 -56.03 18.09 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 -177.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.53 -33.62 76.33 Favored 'General case' 0 CA--C 1.542 0.656 0 N-CA-C 113.378 0.881 . . . . 0.0 113.378 -178.004 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -79.95 -21.19 44.07 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 114.13 1.159 . . . . 0.0 114.13 178.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -90.74 -28.01 18.57 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 118.96 0.8 . . . . 0.0 110.306 172.092 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -66.07 -13.12 59.47 Favored 'General case' 0 CA--C 1.543 0.692 0 O-C-N 120.641 -1.287 . . . . 0.0 113.247 171.248 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 13.3 mt-10 -61.41 -27.49 68.58 Favored 'General case' 0 N--CA 1.48 1.059 0 CA-C-N 120.233 1.378 . . . . 0.0 110.464 168.665 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 35.7 t -96.45 -2.29 10.4 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.032 0 C-N-CA 127.581 2.353 . . . . 0.0 111.135 176.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 78.93 21.26 68.66 Favored Glycine 0 CA--C 1.538 1.53 0 C-N-CA 125.35 1.452 . . . . 0.0 114.742 -176.606 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 77.8 mt -83.6 131.07 34.71 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 C-N-CA 124.798 1.239 . . . . 0.0 112.006 -171.436 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 19.4 t0 -96.06 107.14 19.41 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 112.895 0.702 . . . . 0.0 112.895 -178.616 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 15.6 pt -142.68 23.06 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.208 0 C-N-CA 125.302 1.441 . . . . 0.0 114.369 -177.286 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 95.2 p -48.15 -37.34 15.34 Favored 'General case' 0 N--CA 1.483 1.201 0 N-CA-C 116.567 2.062 . . . . 0.0 116.567 -169.341 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -142.97 40.04 1.28 Allowed Glycine 0 N--CA 1.474 1.179 0 C-N-CA 125.358 1.456 . . . . 0.0 113.01 -179.371 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 24.3 pt20 -66.5 -34.68 78.45 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 115.637 1.717 . . . . 0.0 115.637 -169.529 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 68.0 p -93.65 104.17 16.29 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 121.211 0.529 . . . . 0.0 111.352 173.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 95.9 p -108.94 -23.55 11.66 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 125.473 1.509 . . . . 0.0 114.278 178.316 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -145.46 155.34 53.53 Favored Pre-proline 0 CA--C 1.544 0.722 0 C-N-CA 124.722 1.209 . . . . 0.0 111.046 -171.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -74.37 155.13 46.07 Favored 'Trans proline' 0 CA--C 1.538 0.714 0 C-N-CA 122.561 2.174 . . . . 0.0 112.657 173.257 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 5.6 tt -54.44 -38.65 41.77 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 126.171 1.788 . . . . 0.0 111.615 179.74 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -68.34 -8.6 41.37 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 124.56 1.144 . . . . 0.0 113.763 178.785 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 -79.92 -21.73 43.54 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 124.085 0.954 . . . . 0.0 112.824 170.71 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 84.6 m-85 -93.62 -176.73 4.17 Favored 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 126.444 1.897 . . . . 0.0 111.879 -179.354 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 7.0 t30 -113.84 129.19 56.62 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 125.783 1.633 . . . . 0.0 109.695 171.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -69.38 -36.9 77.26 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 113.918 1.081 . . . . 0.0 113.918 -175.517 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . 0.272 0.0 OUTLIER -72.07 -7.82 51.11 Favored 'General case' 0 CA--C 1.544 0.744 0 N-CA-C 114.562 1.319 . . . . 0.0 114.562 -173.077 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -65.1 -26.35 68.18 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 123.664 0.786 . . . . 0.0 110.449 168.295 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 55.5 m-85 -108.4 120.75 43.31 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 125.834 1.654 . . . . 0.0 111.44 -173.307 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -74.0 -20.87 60.19 Favored 'General case' 0 CA--C 1.545 0.776 0 CA-C-O 122.195 0.998 . . . . 0.0 112.473 177.55 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.609 HG22 ' HB ' ' A' ' 95' ' ' ILE . 92.3 t -133.95 137.84 51.5 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 C-N-CA 127.381 2.272 . . . . 0.0 108.891 -173.407 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 63.0 t -133.91 118.61 29.65 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 169.685 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 44.8 mm -103.09 113.16 39.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 C-N-CA 123.818 0.847 . . . . 0.0 109.299 -177.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 15.5 m -92.78 114.12 26.59 Favored 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 169.531 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 90.7 mt -86.79 -3.16 59.02 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 125.644 1.577 . . . . 0.0 115.217 -169.548 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 77.5 m -130.34 40.32 3.54 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 125.359 1.463 . . . . 0.0 110.553 -169.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 80.51 -131.72 10.7 Favored Glycine 0 CA--C 1.532 1.109 0 C-N-CA 124.371 0.986 . . . . 0.0 111.174 -169.49 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 93.3 p -63.71 154.49 32.98 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 124.015 0.926 . . . . 0.0 113.479 176.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -75.35 -51.42 7.43 Favored Glycine 0 CA--C 1.534 1.269 0 O-C-N 121.739 -0.601 . . . . 0.0 112.339 176.009 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . 0.273 7.7 p 48.97 -47.54 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.677 1 C-N-CA 132.148 4.179 . . . . 0.0 119.021 169.883 . . . . . . . . 3 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 63.1 t30 -85.9 15.95 4.51 Favored 'General case' 0 CA--C 1.556 1.202 0 C-N-CA 126.734 2.014 . . . . 0.0 112.761 -179.834 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -122.87 160.45 49.13 Favored Pre-proline 0 CA--C 1.55 0.98 0 C-N-CA 127.589 2.356 . . . . 0.0 112.598 179.605 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -63.34 151.61 84.04 Favored 'Trans proline' 0 CA--C 1.546 1.084 0 C-N-CA 122.774 2.316 . . . . 0.0 113.948 178.721 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_exo -58.82 -27.05 82.8 Favored 'Trans proline' 0 C--N 1.352 0.728 0 C-N-CA 123.609 2.873 . . . . 0.0 115.309 -177.108 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -61.72 -21.24 64.32 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 113.74 1.015 . . . . 0.0 113.74 177.763 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 92.7 m95 -83.73 -28.95 27.88 Favored 'General case' 0 N--CA 1.474 0.733 0 O-C-N 120.83 -1.168 . . . . 0.0 113.318 177.32 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 6.4 m -82.88 -13.37 12.08 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.315 0 N-CA-C 113.36 0.874 . . . . 0.0 113.36 174.41 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -95.31 1.46 54.42 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 114.603 1.334 . . . . 0.0 114.603 -179.33 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 85.6 mm-40 -66.39 156.31 34.94 Favored 'General case' 0 N--CA 1.481 1.081 0 O-C-N 120.83 -1.169 . . . . 0.0 111.596 172.005 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -59.49 -42.54 92.37 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 114.196 1.184 . . . . 0.0 114.196 -168.183 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.609 ' HB ' HG22 ' A' ' 75' ' ' VAL . 16.3 mm -113.21 55.44 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 C-N-CA 125.083 1.353 . . . . 0.0 109.276 177.788 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 25.1 t80 -74.66 109.19 7.93 Favored 'General case' 0 CA--C 1.536 0.414 0 O-C-N 120.565 -1.334 . . . . 0.0 107.675 169.009 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 13.8 mt-10 -110.95 131.36 55.12 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 114.432 1.271 . . . . 0.0 114.432 176.657 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 12.5 p-10 -94.74 104.69 16.61 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 126.128 1.771 . . . . 0.0 110.053 169.214 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 34.2 m0 -93.35 124.56 37.42 Favored 'General case' 0 N--CA 1.464 0.236 0 C-N-CA 124.183 0.993 . . . . 0.0 109.089 174.703 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 32.5 mt-30 -91.95 42.3 1.1 Allowed 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 124.012 0.925 . . . . 0.0 111.574 -173.324 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 76.1 mt -81.28 164.07 22.5 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 125.271 1.428 . . . . 0.0 112.695 -178.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -87.2 163.74 16.75 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 124.901 1.28 . . . . 0.0 111.221 169.106 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -108.3 139.6 20.91 Favored Pre-proline 0 N--CA 1.474 0.755 0 O-C-N 121.33 -0.856 . . . . 0.0 110.526 169.748 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_exo -59.9 -17.13 42.27 Favored 'Trans proline' 0 CA--C 1.545 1.028 0 C-N-CA 123.006 2.471 . . . . 0.0 116.392 176.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -54.41 135.44 45.28 Favored 'General case' 0 CA--C 1.546 0.816 0 CA-C-N 120.13 1.332 . . . . 0.0 113.924 178.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 76.54 6.74 84.86 Favored Glycine 0 CA--C 1.538 1.48 0 C-N-CA 124.461 1.029 . . . . 0.0 115.007 178.453 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 -138.05 170.47 15.98 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 125.473 1.509 . . . . 0.0 113.033 -179.459 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 26.4 p -68.07 168.56 11.77 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 117.461 2.393 . . . . 0.0 117.461 -168.524 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 25.0 tp -60.18 -30.09 69.13 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 125.097 1.359 . . . . 0.0 112.483 169.801 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -65.58 -31.54 72.64 Favored 'General case' 0 CA--C 1.539 0.523 0 O-C-N 121.038 -1.039 . . . . 0.0 111.259 171.684 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 11.4 t -74.16 -38.52 48.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 CA-C-O 118.154 -0.927 . . . . 0.0 112.14 171.104 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 17.1 m-85 -56.25 -44.08 79.33 Favored 'General case' 0 N--CA 1.482 1.134 0 CA-C-N 120.698 1.59 . . . . 0.0 111.74 169.588 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -69.49 -37.5 77.26 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 124.351 1.06 . . . . 0.0 112.408 178.182 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 21.6 m -60.46 -48.04 83.48 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 124.507 1.123 . . . . 0.0 111.201 170.362 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 75.1 t -65.52 -43.52 94.28 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 CA-C-O 118.181 -0.914 . . . . 0.0 110.236 179.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 16.8 mtp180 -53.5 -45.48 69.69 Favored 'General case' 0 N--CA 1.481 1.118 0 CA-C-N 119.914 1.234 . . . . 0.0 112.716 172.091 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -60.57 -51.34 59.34 Favored Glycine 0 CA--C 1.538 1.482 0 CA-C-N 119.431 1.014 . . . . 0.0 113.218 176.432 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 58.9 mm-40 -63.37 -45.09 92.76 Favored 'General case' 0 N--CA 1.472 0.653 0 O-C-N 121.978 -0.719 . . . . 0.0 111.912 178.822 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 50.5 t -63.83 -41.72 93.48 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 C-N-CA 124.881 1.272 . . . . 0.0 111.237 177.818 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 78.1 tttt -56.77 -48.02 78.83 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 119.832 1.196 . . . . 0.0 110.425 178.407 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -64.35 -42.31 96.29 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 112.641 0.608 . . . . 0.0 112.641 177.523 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 16.6 mmm180 -61.14 -45.59 94.03 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.393 0.677 . . . . 0.0 112.696 175.144 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 79.3 t -69.45 -41.05 80.55 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 C-N-CA 124.5 1.12 . . . . 0.0 111.157 -179.392 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -62.51 -40.0 95.32 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 118.875 0.761 . . . . 0.0 111.647 172.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 13.0 m-80 -64.02 -46.11 85.95 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-N 118.782 0.719 . . . . 0.0 112.236 174.123 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -54.05 -54.78 34.53 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 124.734 1.213 . . . . 0.0 110.499 175.272 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 91.4 mt -59.88 -45.11 95.41 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 CA-C-O 119.024 -0.512 . . . . 0.0 110.393 179.255 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -68.83 -10.77 58.67 Favored 'General case' 0 CA--C 1.548 0.871 0 N-CA-C 115.245 1.572 . . . . 0.0 115.245 -179.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 21.4 ptmt -102.49 -24.18 13.84 Favored 'General case' 0 N--CA 1.479 1.01 0 N-CA-C 113.91 1.078 . . . . 0.0 113.91 171.271 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 14.7 pt -96.65 -7.97 9.4 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 N-CA-C 114.435 1.272 . . . . 0.0 114.435 176.179 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 83.4 p . . . . . 0 C--O 1.255 1.35 0 C-N-CA 125.075 1.35 . . . . 0.0 114.269 173.526 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.403 ' HG3' ' HA ' ' A' ' 30' ' ' ILE . 4.1 ttp . . . . . 0 N--CA 1.502 2.172 0 N-CA-C 112.087 0.403 . . . . 0.0 112.087 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 3.3 mptp? -86.03 159.91 19.46 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 124.602 1.161 . . . . 0.0 113.113 171.003 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 79.3 mttt -112.14 113.21 25.34 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 125.816 1.646 . . . . 0.0 106.577 167.671 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 18.9 t -102.91 132.5 48.95 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 C-N-CA 125.793 1.637 . . . . 0.0 113.579 -178.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' MET . . . . . 0.538 ' HG3' HG13 ' A' ' 7' ' ' VAL . 36.6 tpp -107.05 119.86 40.53 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.567 0.747 . . . . 0.0 109.266 168.552 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 60.1 m-85 -97.16 125.08 41.42 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.232 1.013 . . . . 0.0 109.533 171.476 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.54 HG11 HD12 ' A' ' 65' ' ' ILE . 1.0 OUTLIER -140.99 147.78 22.25 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 N-CA-C 114.179 1.177 . . . . 0.0 114.179 -168.95 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 52.7 t -157.55 164.72 37.03 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 126.189 1.795 . . . . 0.0 112.417 172.298 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 53.4 mtmt -75.08 154.92 37.67 Favored 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 125.753 1.621 . . . . 0.0 112.628 171.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 6.4 tmm_? 49.3 84.45 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 127.377 2.271 . . . . 0.0 112.661 175.618 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 30.2 t-20 -79.69 -25.27 41.26 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 124.62 1.168 . . . . 0.0 113.132 -171.738 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 78.2 p -58.3 141.68 50.29 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.208 1.003 . . . . 0.0 111.567 170.092 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 66.9 m 56.23 -4.26 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.325 0 N-CA-C 116.647 2.091 . . . . 0.0 116.647 -170.598 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 58.8 ttm-85 -92.37 138.57 31.41 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 124.886 1.274 . . . . 0.0 113.372 -170.131 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 45.5 m -96.17 -38.16 10.26 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 114.578 1.325 . . . . 0.0 114.578 -176.64 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 60.82 -46.75 0.11 Allowed 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 127.622 2.369 . . . . 0.0 116.271 -177.132 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . 0.41 ' HG2' ' SD ' ' A' ' 50' ' ' MET . 0.0 OUTLIER 66.67 -50.54 0.45 Allowed 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 127.771 2.429 . . . . 0.0 116.579 169.619 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -56.17 -37.13 69.13 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 115.584 1.698 . . . . 0.0 115.584 -169.132 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.89 -34.94 77.62 Favored 'General case' 0 N--CA 1.476 0.864 0 O-C-N 121.412 -0.805 . . . . 0.0 112.774 -177.162 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -69.87 -42.83 68.53 Favored Glycine 0 N--CA 1.468 0.813 0 C-N-CA 123.692 0.663 . . . . 0.0 111.764 176.371 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -64.39 -36.94 85.79 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 117.884 0.842 . . . . 0.0 111.313 170.79 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -65.32 -39.12 92.03 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 119.449 1.022 . . . . 0.0 112.663 179.586 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 23.7 mtpp -62.05 -46.62 88.33 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 123.314 0.645 . . . . 0.0 110.978 169.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 69.6 m -68.15 -38.09 81.75 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 123.12 0.568 . . . . 0.0 112.245 -174.448 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 47.7 mt -85.49 -35.46 21.16 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 125.416 1.487 . . . . 0.0 113.362 -179.445 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -117.29 5.15 17.68 Favored Glycine 0 CA--C 1.528 0.867 0 N-CA-C 118.214 2.046 . . . . 0.0 118.214 -168.737 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -60.81 139.48 57.92 Favored 'General case' 0 CA--C 1.545 0.784 0 CA-C-N 122.064 2.932 . . . . 0.0 111.959 177.316 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 88.68 -21.38 26.56 Favored Glycine 0 CA--C 1.54 1.649 0 C-N-CA 124.797 1.189 . . . . 0.0 113.233 -169.206 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 72.4 mttt -101.77 -42.22 6.25 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 126.302 1.841 . . . . 0.0 112.015 169.531 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.403 ' HA ' ' HG3' ' A' ' 1' ' ' MET . 36.0 pt -135.12 146.11 30.92 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 C-N-CA 124.676 1.19 . . . . 0.0 113.126 -178.566 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -98.58 145.77 26.49 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 126.685 1.994 . . . . 0.0 108.337 169.197 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 71.3 t -141.38 139.01 32.9 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 O-C-N 121.781 -0.575 . . . . 0.0 112.435 -169.696 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 31.7 m -136.9 159.2 42.57 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 126.198 1.799 . . . . 0.0 108.745 169.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 26.5 p -133.98 148.55 51.15 Favored 'General case' 0 CA--C 1.515 -0.368 0 CA-C-O 121.742 0.782 . . . . 0.0 111.896 168.086 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 59.9 p -147.58 153.81 39.89 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 114.806 -1.088 . . . . 0.0 113.312 176.212 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -83.22 152.97 30.1 Favored Glycine 0 N--CA 1.473 1.138 0 O-C-N 121.735 -0.603 . . . . 0.0 111.987 173.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.4 mp -76.23 -20.43 57.45 Favored 'General case' 0 N--CA 1.481 1.088 0 CA-C-N 119.126 1.463 . . . . 0.0 113.973 176.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -138.31 -52.42 0.6 Allowed 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.934 0.893 . . . . 0.0 113.31 177.226 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 50.2 p -98.93 150.57 21.8 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 115.106 1.521 . . . . 0.0 115.106 -172.403 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 80.5 p -84.81 149.21 25.87 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 125.818 1.647 . . . . 0.0 114.23 -174.497 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 13.2 tpt180 57.61 137.58 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 129.483 3.113 . . . . 0.0 116.045 -178.662 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 15.6 m -67.49 156.48 6.79 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.354 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 168.695 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . 0.441 ' CE1' ' HB ' ' A' ' 45' ' ' THR 0.255 0.0 OUTLIER -68.19 140.18 92.98 Favored Pre-proline 0 CA--C 1.546 0.793 0 C-N-CA 118.188 -1.405 . . . . 0.0 110.943 178.08 . . . . . . . . 4 4 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -63.81 -31.01 68.69 Favored 'Trans proline' 0 CA--C 1.539 0.732 0 C-N-CA 123.254 2.636 . . . . 0.0 114.84 -168.291 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.441 ' HB ' ' CE1' ' A' ' 43' ' ' HIS . 51.7 m -65.46 -24.64 67.22 Favored 'General case' 0 N--CA 1.48 1.062 0 O-C-N 121.404 -0.81 . . . . 0.0 111.787 -176.334 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -50.51 -48.44 57.05 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.11 0.964 . . . . 0.0 111.67 169.796 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 4.7 mp -55.39 -53.26 37.61 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 CA-C-N 119.433 1.015 . . . . 0.0 111.015 -176.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -62.81 -25.55 68.3 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 113.648 0.981 . . . . 0.0 113.648 -177.709 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -81.08 -35.19 32.05 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 123.644 0.778 . . . . 0.0 112.808 174.859 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . 0.41 ' SD ' ' HG2' ' A' ' 17' ' ' MET . 4.5 mmt -72.49 -29.76 63.93 Favored 'General case' 0 N--CA 1.473 0.707 0 O-C-N 121.129 -0.982 . . . . 0.0 111.13 172.219 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -67.41 -9.08 38.2 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 125.339 1.456 . . . . 0.0 113.816 172.189 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -69.02 -29.74 67.96 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-N 120.325 1.421 . . . . 0.0 110.857 169.526 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . 0.295 2.2 p -109.66 8.25 8.95 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.815 0 C-N-CA 127.189 2.196 . . . . 0.0 111.955 -172.475 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 85.84 14.08 68.2 Favored Glycine 0 CA--C 1.538 1.497 0 C-N-CA 124.855 1.217 . . . . 0.0 115.369 171.673 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -76.19 138.39 20.83 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 C-N-CA 124.625 1.17 . . . . 0.0 109.698 -178.335 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 19.6 t0 -110.55 104.37 13.08 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 124.272 1.029 . . . . 0.0 111.767 175.088 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 21.4 pt -133.75 6.33 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.248 0 N-CA-C 116.289 1.959 . . . . 0.0 116.289 -175.727 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 72.3 m -60.21 -31.43 70.16 Favored 'General case' 0 N--CA 1.483 1.214 0 CA-C-N 120.438 1.472 . . . . 0.0 111.662 175.207 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -79.35 14.78 14.65 Favored Glycine 0 CA--C 1.539 1.559 0 C-N-CA 126.193 1.854 . . . . 0.0 115.934 175.863 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 70.6 mt-30 -62.38 157.21 20.46 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 119.434 1.617 . . . . 0.0 110.429 169.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 7.6 t -74.86 172.89 11.4 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 121.538 0.685 . . . . 0.0 112.061 169.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 73.4 m -118.09 -18.53 9.36 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 125.098 1.359 . . . . 0.0 114.211 -174.185 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 27.3 m-20 -86.11 158.68 55.29 Favored Pre-proline 0 CA--C 1.55 0.949 0 N-CA-C 114.691 1.367 . . . . 0.0 114.691 -169.703 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -63.98 160.91 35.38 Favored 'Trans proline' 0 C--N 1.353 0.787 0 C-N-CA 124.001 3.134 . . . . 0.0 114.371 172.268 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.54 HD12 HG11 ' A' ' 7' ' ' VAL . 8.4 tt -51.5 -36.47 17.93 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 C-N-CA 125.622 1.569 . . . . 0.0 112.103 173.092 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 17.8 mt-10 -65.0 -16.77 63.81 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.598 1.159 . . . . 0.0 112.825 -177.511 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -83.26 -8.18 59.49 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 124.815 1.246 . . . . 0.0 113.565 -178.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 69.7 m-85 -116.77 -175.44 2.77 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 126.221 1.808 . . . . 0.0 112.614 -172.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 11.2 t30 -120.69 125.81 48.61 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 125.603 1.561 . . . . 0.0 110.026 177.613 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -69.13 -35.4 76.34 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 114.021 1.119 . . . . 0.0 114.021 -173.363 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . 0.275 0.0 OUTLIER -71.92 -5.21 33.01 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 114.329 1.233 . . . . 0.0 114.329 -174.15 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -70.42 -25.73 63.34 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 122.968 0.507 . . . . 0.0 109.949 168.446 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 80.1 m-85 -99.23 148.67 23.88 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 126.473 1.909 . . . . 0.0 111.644 -179.205 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -107.04 -17.92 14.05 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 124.342 1.057 . . . . 0.0 112.176 176.011 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.662 HG22 ' HB ' ' A' ' 95' ' ' ILE . 71.7 t -129.94 137.81 55.64 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 C-N-CA 126.89 2.076 . . . . 0.0 107.959 177.454 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 60.2 t -132.93 123.46 48.48 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 169.591 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 41.5 mm -108.35 104.13 16.6 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 C-N-CA 124.496 1.119 . . . . 0.0 108.883 -176.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 3.6 m -81.78 107.48 14.54 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 169.646 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 75.4 mt -75.71 -18.72 59.51 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 114.945 1.461 . . . . 0.0 114.945 -170.062 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 28.7 p -136.66 30.81 2.83 Favored 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 114.935 1.457 . . . . 0.0 114.935 -168.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 152.03 -172.67 31.32 Favored Glycine 0 CA--C 1.532 1.096 0 N-CA-C 115.246 0.858 . . . . 0.0 115.246 177.685 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 97.0 p -79.01 160.64 27.08 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 125.295 1.438 . . . . 0.0 112.681 176.63 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -81.12 49.96 4.09 Favored Glycine 0 CA--C 1.534 1.267 0 C-N-CA 124.861 1.22 . . . . 0.0 114.951 -171.047 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 24.8 t -104.06 -33.17 3.01 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 CA-C-N 117.864 0.832 . . . . 0.0 112.88 -172.455 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 17.9 t-20 -84.84 -21.91 29.66 Favored 'General case' 0 CA--C 1.55 0.945 0 N-CA-C 113.865 1.061 . . . . 0.0 113.865 -179.239 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -82.42 160.49 62.02 Favored Pre-proline 0 CA--C 1.553 1.085 0 C-N-CA 124.0 0.92 . . . . 0.0 112.55 170.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_exo -61.47 149.75 88.23 Favored 'Trans proline' 0 CA--C 1.543 0.97 0 C-N-CA 122.79 2.327 . . . . 0.0 112.786 176.428 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -62.56 -29.04 77.87 Favored 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 122.95 2.433 . . . . 0.0 114.008 -170.356 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -60.64 -19.59 58.53 Favored 'General case' 0 CA--C 1.544 0.748 0 O-C-N 120.849 -1.157 . . . . 0.0 113.989 177.425 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 84.1 m95 -82.98 -14.71 53.53 Favored 'General case' 0 CA--C 1.542 0.662 0 O-C-N 120.659 -1.276 . . . . 0.0 113.324 175.667 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 14.5 m -93.49 -13.21 8.59 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.209 0 N-CA-C 113.729 1.011 . . . . 0.0 113.729 169.756 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 59.1 p -88.27 -5.46 58.35 Favored 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 114.48 1.289 . . . . 0.0 114.48 179.382 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 55.1 mm-40 -67.87 149.58 49.66 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-O 121.982 0.896 . . . . 0.0 110.275 169.63 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -53.88 -42.48 68.7 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 115.127 1.528 . . . . 0.0 115.127 -167.516 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.662 ' HB ' HG22 ' A' ' 75' ' ' VAL . 19.8 mm -117.44 63.83 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 C-N-CA 124.982 1.313 . . . . 0.0 109.232 179.21 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 33.0 t80 -76.11 111.86 11.96 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 168.799 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 9.0 mt-10 -108.97 130.92 55.47 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 114.15 1.167 . . . . 0.0 114.15 175.011 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 11.7 p-10 -93.89 109.7 21.4 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 125.016 1.326 . . . . 0.0 109.31 168.791 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 27.5 m0 -101.7 158.33 16.18 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.568 1.147 . . . . 0.0 108.943 169.627 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 8.3 mm-40 -128.41 65.84 1.39 Allowed 'General case' 0 CA--C 1.537 0.477 0 CA-C-O 122.875 1.321 . . . . 0.0 108.265 173.36 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.478 HD11 HG22 ' A' ' 119' ' ' VAL . 14.1 tp -77.11 150.63 35.61 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 126.608 1.963 . . . . 0.0 110.992 -174.344 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 29.4 tp10 -64.32 -43.01 96.01 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 113.681 0.993 . . . . 0.0 113.681 178.572 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 8.4 t0 62.88 126.39 0.02 OUTLIER Pre-proline 0 CA--C 1.558 1.257 0 C-N-CA 127.283 2.233 . . . . 0.0 113.596 -169.659 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_exo -62.61 -12.18 27.03 Favored 'Trans proline' 0 CA--C 1.55 1.301 0 C-N-CA 121.997 1.798 . . . . 0.0 114.499 172.189 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 8.6 t0 -23.99 107.47 0.03 OUTLIER 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 128.31 2.644 . . . . 0.0 116.068 169.629 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 72.16 10.59 74.08 Favored Glycine 0 CA--C 1.537 1.448 0 N-CA-C 116.379 1.312 . . . . 0.0 116.379 169.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 13.2 pt20 -128.73 166.5 18.84 Favored 'General case' 0 CA--C 1.545 0.753 0 CA-C-N 119.159 1.48 . . . . 0.0 113.999 -175.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 49.6 m -58.14 160.1 5.27 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 126.447 1.899 . . . . 0.0 115.63 -169.24 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 20.3 tp -59.41 -32.6 70.33 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.917 1.287 . . . . 0.0 113.069 178.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -61.76 -32.19 72.43 Favored 'General case' 0 N--CA 1.473 0.716 0 O-C-N 120.808 -1.183 . . . . 0.0 112.091 172.481 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 6.4 t -74.02 -37.62 47.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 CA-C-O 118.461 -0.78 . . . . 0.0 110.891 172.748 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 17.5 m-85 -57.08 -48.08 79.47 Favored 'General case' 0 N--CA 1.478 0.972 0 CA-C-N 120.273 1.397 . . . . 0.0 112.119 169.68 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 48.4 mtt-85 -60.12 -48.64 80.88 Favored 'General case' 0 N--CA 1.484 1.253 0 CA-C-N 119.185 0.902 . . . . 0.0 111.326 178.117 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 83.4 m -62.5 -46.13 89.85 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.884 0.873 . . . . 0.0 111.179 179.739 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 96.6 t -74.45 -41.19 49.58 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 CA-C-O 117.586 -1.197 . . . . 0.0 110.83 -175.307 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . 0.304 24.6 ptt85 -64.04 -28.65 69.94 Favored 'General case' 0 N--CA 1.483 1.225 0 CA-C-N 121.638 2.017 . . . . 0.0 113.12 177.487 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -65.15 -46.68 87.11 Favored Glycine 0 CA--C 1.542 1.772 0 CA-C-N 119.356 0.98 . . . . 0.0 112.938 169.279 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 15.0 mm100 -65.75 -41.32 92.25 Favored 'General case' 0 N--CA 1.475 0.824 0 O-C-N 121.387 -1.067 . . . . 0.0 112.151 177.014 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.478 HG22 HD11 ' A' ' 101' ' ' LEU . 77.7 t -60.82 -43.8 96.25 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 C-N-CA 125.416 1.487 . . . . 0.0 110.714 173.095 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 82.0 tttt -53.98 -49.68 68.24 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 119.205 0.911 . . . . 0.0 110.231 179.039 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -62.43 -41.65 98.88 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 112.742 0.645 . . . . 0.0 112.742 178.5 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 14.8 mtp85 -64.03 -43.6 95.08 Favored 'General case' 0 N--CA 1.479 1.01 0 N-CA-C 113.135 0.791 . . . . 0.0 113.135 176.024 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 94.2 t -70.91 -38.06 70.78 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 C-N-CA 123.181 0.592 . . . . 0.0 110.762 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -60.2 -38.52 83.56 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 118.613 0.642 . . . . 0.0 111.214 169.803 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 7.9 m-80 -62.48 -48.69 78.5 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 119.283 0.947 . . . . 0.0 112.153 174.112 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -52.89 -56.55 15.05 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.576 1.151 . . . . 0.0 110.699 174.076 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 85.4 mt -61.37 -42.15 92.59 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 O-C-N 122.017 -0.427 . . . . 0.0 111.08 -179.196 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -70.13 -13.18 62.08 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 114.755 1.391 . . . . 0.0 114.755 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -99.69 -28.5 13.15 Favored 'General case' 0 N--CA 1.479 0.998 0 N-CA-C 113.723 1.009 . . . . 0.0 113.723 172.24 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 19.1 pt -94.37 -21.43 5.84 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 N-CA-C 114.423 1.268 . . . . 0.0 114.423 177.755 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 66.6 m . . . . . 0 C--O 1.254 1.326 0 C-N-CA 125.074 1.35 . . . . 0.0 111.886 -174.085 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.8 ttt . . . . . 0 N--CA 1.503 2.196 0 N-CA-C 111.787 0.291 . . . . 0.0 111.787 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.67 161.3 30.92 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 126.336 1.855 . . . . 0.0 112.358 177.819 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 32.6 ttmt -114.5 116.49 28.91 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 107.136 -1.431 . . . . 0.0 107.136 167.73 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 16.0 t -106.17 134.6 47.27 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 C-N-CA 124.604 1.162 . . . . 0.0 114.085 -178.251 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 40.6 tpp -103.1 128.1 50.12 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 168.355 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 70.3 m-85 -108.97 131.8 54.71 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.984 0.914 . . . . 0.0 109.381 170.007 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.509 HG11 HD12 ' A' ' 65' ' ' ILE . 2.6 m -148.11 158.8 7.8 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.239 0 C-N-CA 124.179 0.992 . . . . 0.0 113.616 -171.666 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 35.1 t -152.31 156.48 39.72 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 126.941 2.096 . . . . 0.0 110.657 179.315 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 61.3 mtpt -72.62 138.83 47.0 Favored 'General case' 0 N--CA 1.484 1.275 0 C-N-CA 123.911 0.884 . . . . 0.0 110.42 169.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 69.9 mtp180 52.73 49.62 19.9 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 125.427 1.491 . . . . 0.0 113.571 -170.812 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -57.61 -26.51 61.64 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 115.134 1.531 . . . . 0.0 115.134 -176.812 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 77.1 p -80.2 -31.11 38.73 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 124.169 0.988 . . . . 0.0 112.857 176.725 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 16.4 m -77.79 -9.04 58.82 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.681 1.192 . . . . 0.0 112.79 173.743 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 74.6 mtt180 -131.5 157.96 42.16 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 125.491 1.516 . . . . 0.0 113.381 -169.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 71.0 m -105.22 129.74 53.53 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.979 0.912 . . . . 0.0 109.701 169.76 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 4.1 mp0 -98.67 -29.7 12.88 Favored 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 113.436 0.902 . . . . 0.0 113.436 -169.653 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . 0.467 ' HG2' ' SD ' ' A' ' 50' ' ' MET . 0.0 OUTLIER 67.1 -43.63 0.44 Allowed 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 127.104 2.162 . . . . 0.0 115.35 172.904 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -66.16 -32.64 74.2 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 114.073 1.138 . . . . 0.0 114.073 -169.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.2 pm0 -62.76 -37.14 85.45 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 119.032 0.833 . . . . 0.0 111.565 172.266 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -62.77 -61.82 6.11 Favored Glycine 0 C--N 1.336 0.548 0 N-CA-C 110.688 -0.965 . . . . 0.0 110.688 177.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -59.55 -33.09 70.97 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 117.584 0.692 . . . . 0.0 112.768 -179.449 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -67.56 -25.87 66.02 Favored 'General case' 0 CA--C 1.539 0.554 0 O-C-N 121.289 -0.882 . . . . 0.0 112.612 177.812 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 23.4 mtpp -77.57 -44.09 29.62 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.719 0.808 . . . . 0.0 110.665 169.464 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -67.31 -38.58 85.19 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 123.424 0.69 . . . . 0.0 112.738 -175.875 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 55.6 mt -93.21 -27.65 16.74 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 125.388 1.475 . . . . 0.0 112.774 -178.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -111.72 -4.93 26.16 Favored Glycine 0 N--CA 1.471 1.006 0 N-CA-C 117.556 1.782 . . . . 0.0 117.556 -169.058 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -62.84 139.54 58.72 Favored 'General case' 0 CA--C 1.545 0.78 0 CA-C-N 121.42 2.61 . . . . 0.0 112.327 178.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 86.41 -22.1 14.59 Favored Glycine 0 CA--C 1.541 1.671 0 C-N-CA 125.114 1.34 . . . . 0.0 113.437 -169.327 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 63.5 mttp -96.67 -44.28 7.18 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 125.981 1.712 . . . . 0.0 111.686 169.813 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 46.0 pt -141.18 157.01 22.17 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 C-N-CA 125.182 1.393 . . . . 0.0 113.009 -174.354 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -101.25 144.91 29.53 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 127.12 2.168 . . . . 0.0 108.796 169.405 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 73.7 t -140.3 137.6 37.11 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 C-N-CA 123.675 0.79 . . . . 0.0 111.578 -171.578 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 54.1 m -145.28 150.68 37.09 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 124.11 0.964 . . . . 0.0 110.852 177.738 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 93.5 p -133.21 137.98 46.35 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 124.52 1.128 . . . . 0.0 109.012 166.684 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 88.2 p -119.35 -70.05 0.81 Allowed 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 114.259 1.207 . . . . 0.0 114.259 -168.337 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 130.07 154.49 8.08 Favored Glycine 0 N--CA 1.465 0.597 0 C-N-CA 125.716 1.626 . . . . 0.0 113.346 173.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 10.3 mp -89.36 -13.21 38.35 Favored 'General case' 0 N--CA 1.474 0.754 0 O-C-N 121.797 -0.825 . . . . 0.0 113.173 -178.118 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -140.96 -57.06 0.5 Allowed 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 124.282 1.033 . . . . 0.0 112.444 179.322 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 39.7 m -108.44 155.91 20.05 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 124.714 1.206 . . . . 0.0 111.405 178.094 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 95.9 p -90.86 14.58 13.29 Favored 'General case' 0 N--CA 1.478 0.957 0 N-CA-C 116.694 2.109 . . . . 0.0 116.694 -170.042 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 64.3 ttt180 -130.87 157.12 43.77 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 125.541 1.536 . . . . 0.0 111.871 -177.075 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 24.1 m -111.77 165.27 6.95 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 C-N-CA 126.6 1.96 . . . . 0.0 109.55 170.765 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 5.1 t-80 -50.98 131.65 30.06 Favored Pre-proline 0 CA--C 1.532 0.275 0 CA-C-O 118.19 -0.91 . . . . 0.0 113.231 -170.698 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_exo -57.57 -27.94 78.99 Favored 'Trans proline' 0 CA--C 1.548 1.218 0 CA-C-N 120.612 1.254 . . . . 0.0 112.361 173.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 46.1 m -63.93 -32.5 74.05 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 126.08 1.752 . . . . 0.0 112.986 172.192 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -55.12 -45.23 75.55 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 123.977 0.911 . . . . 0.0 110.97 178.753 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.4 mp -53.95 -51.7 43.15 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 C-N-CA 124.09 0.956 . . . . 0.0 109.483 -176.854 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.4 -32.3 73.7 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 113.147 0.795 . . . . 0.0 113.147 -179.587 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -80.1 -30.15 39.11 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 113.452 0.908 . . . . 0.0 113.452 178.545 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . 0.467 ' SD ' ' HG2' ' A' ' 17' ' ' MET . 3.2 mmt -76.91 -30.77 56.29 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.42 0.688 . . . . 0.0 110.851 170.712 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -68.58 -13.25 62.21 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 124.41 1.084 . . . . 0.0 113.323 172.508 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -63.94 -29.71 70.85 Favored 'General case' 0 N--CA 1.481 1.124 0 CA-C-N 120.706 1.594 . . . . 0.0 110.695 168.705 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 61.5 t -91.62 -7.68 10.56 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.903 0 C-N-CA 126.896 2.078 . . . . 0.0 111.058 173.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 83.54 21.75 57.58 Favored Glycine 0 CA--C 1.539 1.56 0 C-N-CA 125.434 1.492 . . . . 0.0 114.447 -177.71 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 31.9 mt -88.82 135.73 25.08 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 C-N-CA 124.595 1.158 . . . . 0.0 111.505 -172.188 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 18.6 t0 -94.39 120.19 34.26 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 123.582 0.753 . . . . 0.0 112.332 171.492 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 9.2 pt -134.67 -1.94 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.358 0 N-CA-C 116.094 1.887 . . . . 0.0 116.094 179.257 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 83.5 p -73.28 -21.9 60.49 Favored 'General case' 0 N--CA 1.481 1.092 0 N-CA-C 115.175 1.546 . . . . 0.0 115.175 -169.638 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -78.44 0.86 73.87 Favored Glycine 0 CA--C 1.54 1.604 0 N-CA-C 116.39 1.316 . . . . 0.0 116.39 -173.81 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 33.4 mt-30 -78.65 -11.98 60.0 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 115.304 1.594 . . . . 0.0 115.304 -171.345 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 42.8 p -63.94 115.42 4.86 Favored 'General case' 0 N--CA 1.477 0.883 0 CA-C-N 119.537 1.062 . . . . 0.0 113.56 -169.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 89.2 p -152.35 -77.86 0.12 Allowed 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.765 1.226 . . . . 0.0 112.708 177.762 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -146.43 159.26 45.43 Favored Pre-proline 0 CA--C 1.554 1.112 0 C-N-CA 124.41 1.084 . . . . 0.0 113.522 -171.837 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_endo -61.71 161.04 26.24 Favored 'Trans proline' 0 C--N 1.352 0.742 0 C-N-CA 124.174 3.249 . . . . 0.0 114.133 169.745 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.509 HD12 HG11 ' A' ' 7' ' ' VAL . 11.6 tt -51.32 -35.68 16.28 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.128 0 C-N-CA 125.824 1.65 . . . . 0.0 112.444 172.484 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 17.5 mt-10 -64.42 -17.77 64.1 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 123.779 0.832 . . . . 0.0 112.961 -177.718 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -84.69 -10.67 57.07 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 124.792 1.237 . . . . 0.0 113.604 -175.898 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 76.6 m-85 -111.5 -168.32 1.29 Allowed 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 125.979 1.711 . . . . 0.0 112.348 -173.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 6.4 t30 -124.39 123.47 40.25 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 126.064 1.745 . . . . 0.0 109.864 178.673 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.81 -33.61 75.98 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 114.187 1.18 . . . . 0.0 114.187 -170.601 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . 0.269 0.0 OUTLIER -71.41 -4.62 27.4 Favored 'General case' 0 CA--C 1.544 0.721 0 N-CA-C 114.212 1.19 . . . . 0.0 114.212 -178.11 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -73.94 -12.33 60.62 Favored 'General case' 0 CA--C 1.549 0.904 0 C-N-CA 123.965 0.906 . . . . 0.0 111.348 168.752 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 58.3 m-85 -117.22 138.88 51.42 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 127.001 2.12 . . . . 0.0 111.268 179.128 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -90.5 -23.23 21.0 Favored 'General case' 0 N--CA 1.478 0.956 0 CA-C-O 122.207 1.003 . . . . 0.0 112.926 178.349 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.629 HG22 ' HB ' ' A' ' 95' ' ' ILE . 96.5 t -132.28 136.11 56.93 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 C-N-CA 126.988 2.115 . . . . 0.0 108.249 -174.12 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 91.0 t -131.8 125.76 56.04 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 170.104 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 45.1 mm -112.39 105.15 18.23 Favored 'Isoleucine or valine' 0 C--O 1.233 0.237 0 C-N-CA 124.257 1.023 . . . . 0.0 109.354 -176.239 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 24.4 m -86.66 98.79 11.31 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 123.667 0.787 . . . . 0.0 109.117 171.807 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 52.7 mt -69.69 178.62 2.49 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 125.499 1.52 . . . . 0.0 110.966 170.474 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 16.2 m 63.1 19.7 11.82 Favored 'General case' 0 CA--C 1.547 0.841 0 N-CA-C 114.784 1.401 . . . . 0.0 114.784 169.78 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 131.79 -120.43 2.81 Favored Glycine 0 CA--C 1.531 1.048 0 C-N-CA 124.512 1.053 . . . . 0.0 111.971 -172.152 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 9.2 t -135.96 157.99 45.48 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 124.908 1.283 . . . . 0.0 112.82 178.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -74.66 113.93 4.22 Favored Glycine 0 CA--C 1.531 1.087 0 C-N-CA 124.414 1.006 . . . . 0.0 112.261 -179.326 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 11.3 p -139.53 -39.06 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.26 0 N-CA-C 114.594 1.331 . . . . 0.0 114.594 -178.147 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 65.0 t30 -92.43 -15.63 26.92 Favored 'General case' 0 CA--C 1.549 0.911 0 N-CA-C 114.12 1.155 . . . . 0.0 114.12 -177.228 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -71.44 157.13 90.58 Favored Pre-proline 0 CA--C 1.552 1.024 0 O-C-N 121.309 -0.869 . . . . 0.0 111.843 169.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.41 ' HA ' ' HD3' ' A' ' 88' ' ' PRO . 43.3 Cg_exo -62.2 149.03 92.1 Favored 'Trans proline' 0 CA--C 1.545 1.047 0 C-N-CA 122.215 1.944 . . . . 0.0 113.352 -177.52 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 87' ' ' PRO . 88.8 Cg_exo -57.33 -33.63 96.5 Favored 'Trans proline' 0 C--N 1.351 0.707 0 C-N-CA 122.935 2.423 . . . . 0.0 115.144 -169.875 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -60.98 -21.4 63.5 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 114.284 1.216 . . . . 0.0 114.284 179.763 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 87.5 m95 -81.51 -22.2 38.1 Favored 'General case' 0 CA--C 1.535 0.388 0 O-C-N 120.637 -1.289 . . . . 0.0 112.663 176.302 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 10.6 m -89.77 -3.16 10.06 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 N-CA-C 113.463 0.912 . . . . 0.0 113.463 172.568 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 59.3 p -103.24 3.8 35.96 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 125.373 1.469 . . . . 0.0 114.888 176.251 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 80.6 mm-40 -66.86 156.66 35.07 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 119.351 0.978 . . . . 0.0 111.973 171.668 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -58.19 -42.01 85.2 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 114.278 1.214 . . . . 0.0 114.278 -167.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.629 ' HB ' HG22 ' A' ' 75' ' ' VAL . 20.1 mm -115.0 59.52 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 C-N-CA 124.822 1.249 . . . . 0.0 108.708 175.866 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 21.7 t80 -75.6 109.7 9.39 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 169.069 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 13.1 mt-10 -109.18 140.61 42.56 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 114.665 1.357 . . . . 0.0 114.665 174.252 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -98.23 121.05 39.67 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.985 1.314 . . . . 0.0 109.706 169.249 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 24.4 m0 -112.79 105.59 13.75 Favored 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 124.917 1.287 . . . . 0.0 109.063 -177.349 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -85.11 37.21 0.66 Allowed 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 124.933 1.293 . . . . 0.0 112.02 -171.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 73.9 mt -76.17 158.68 31.44 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 126.114 1.766 . . . . 0.0 111.934 178.561 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -81.41 152.08 27.6 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-O 121.559 0.695 . . . . 0.0 112.564 170.639 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 12.5 p-10 -88.02 136.87 31.73 Favored Pre-proline 0 CA--C 1.546 0.808 0 C-N-CA 125.0 1.32 . . . . 0.0 110.987 170.853 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -82.42 -9.22 11.43 Favored 'Trans proline' 0 CA--C 1.55 1.301 0 C-N-CA 121.57 1.513 . . . . 0.0 114.461 -174.785 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -65.29 146.14 55.32 Favored 'General case' 0 CA--C 1.547 0.837 0 CA-C-N 119.438 1.017 . . . . 0.0 112.47 175.675 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 77.78 5.58 86.54 Favored Glycine 0 CA--C 1.538 1.501 0 C-N-CA 123.829 0.728 . . . . 0.0 114.751 179.449 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -141.9 173.62 11.34 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 126.208 1.803 . . . . 0.0 112.015 178.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 24.4 p -65.78 164.97 13.62 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 116.161 1.911 . . . . 0.0 116.161 -169.274 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 43.7 tp -60.91 -27.91 68.53 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.171 0.988 . . . . 0.0 112.25 171.533 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -66.62 -32.14 73.28 Favored 'General case' 0 CA--C 1.54 0.575 0 O-C-N 120.681 -1.262 . . . . 0.0 111.508 172.597 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 4.4 t -72.49 -36.92 55.72 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 O-C-N 121.108 -0.995 . . . . 0.0 111.841 170.656 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -55.1 -47.57 74.79 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 119.724 1.147 . . . . 0.0 111.471 169.501 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -69.66 -32.59 71.32 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.658 0.783 . . . . 0.0 112.498 178.573 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 42.9 m -62.94 -43.89 97.55 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 123.883 0.873 . . . . 0.0 110.627 169.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 68.8 t -65.7 -41.01 89.53 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 CA-C-O 117.576 -1.202 . . . . 0.0 110.576 175.727 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 24.9 mtm105 -53.98 -49.48 68.71 Favored 'General case' 0 N--CA 1.484 1.24 0 CA-C-N 120.607 1.548 . . . . 0.0 111.592 169.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -59.22 -49.65 76.19 Favored Glycine 0 CA--C 1.538 1.505 0 CA-C-N 119.438 1.017 . . . . 0.0 113.641 179.326 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 56.7 mm-40 -63.58 -44.08 95.12 Favored 'General case' 0 N--CA 1.473 0.708 0 O-C-N 121.996 -0.708 . . . . 0.0 111.988 178.178 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 53.4 t -64.81 -39.71 86.58 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 C-N-CA 124.048 0.939 . . . . 0.0 111.186 176.791 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 12.3 tmtt? -56.07 -48.83 75.33 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 119.654 1.115 . . . . 0.0 110.312 179.041 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -65.15 -42.62 93.6 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 112.929 0.714 . . . . 0.0 112.929 176.792 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 15.5 mmm180 -62.03 -43.87 97.91 Favored 'General case' 0 N--CA 1.48 1.055 0 O-C-N 121.467 -0.771 . . . . 0.0 112.737 176.536 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 85.6 t -70.38 -37.75 71.75 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 123.776 0.83 . . . . 0.0 111.273 179.082 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 70.6 mt-10 -60.23 -41.91 94.12 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 119.537 1.062 . . . . 0.0 111.6 170.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 15.2 m-80 -63.33 -45.36 91.62 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 118.347 0.521 . . . . 0.0 112.151 175.432 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 8.6 tt -53.19 -55.9 20.63 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 124.604 1.162 . . . . 0.0 110.892 173.642 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 84.2 mt -63.27 -43.0 98.47 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 O-C-N 121.593 -0.692 . . . . 0.0 110.376 -177.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -68.07 -14.02 62.65 Favored 'General case' 0 CA--C 1.546 0.789 0 N-CA-C 114.822 1.415 . . . . 0.0 114.822 178.807 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 20.0 ptmt -102.04 -32.76 10.0 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 113.573 0.953 . . . . 0.0 113.573 174.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 13.5 pt -89.54 -17.3 8.18 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 N-CA-C 114.185 1.18 . . . . 0.0 114.185 -179.529 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 68.8 m . . . . . 0 C--O 1.255 1.365 0 N-CA-C 112.888 0.699 . . . . 0.0 112.888 -179.92 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.8 ttt . . . . . 0 N--CA 1.504 2.259 0 N-CA-C 111.493 0.183 . . . . 0.0 111.493 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 3.0 mptp? -121.91 160.31 25.05 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 125.683 1.593 . . . . 0.0 112.3 175.139 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 33.9 ttmt -111.03 116.92 32.0 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 106.647 -1.612 . . . . 0.0 106.647 167.146 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 16.8 t -104.41 132.05 51.91 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 C-N-CA 124.752 1.221 . . . . 0.0 113.831 -177.719 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' MET . . . . . 0.406 ' HG3' HG13 ' A' ' 7' ' ' VAL . 48.5 tpp -100.43 123.4 44.6 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 123.882 0.873 . . . . 0.0 109.137 169.177 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 48.6 m-85 -108.18 121.07 44.09 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 124.574 1.15 . . . . 0.0 109.241 172.178 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.406 HG13 ' HG3' ' A' ' 5' ' ' MET . 5.1 m -144.14 165.64 13.51 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 C-N-CA 125.009 1.323 . . . . 0.0 112.369 -169.308 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -154.39 148.7 26.04 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 125.999 1.72 . . . . 0.0 110.301 175.165 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 39.5 ttpt -46.3 122.31 3.93 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 125.272 1.429 . . . . 0.0 111.968 175.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . 0.261 91.6 mtt180 52.67 -30.86 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 129.034 2.934 . . . . 0.0 118.896 -174.444 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 5.1 t30 61.81 -19.65 0.04 OUTLIER 'General case' 0 CA--C 1.558 1.261 0 N-CA-C 117.813 2.523 . . . . 0.0 117.813 169.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 75.7 m -50.41 121.27 5.44 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 126.525 1.93 . . . . 0.0 113.157 -177.3 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 66.5 m 51.41 41.07 27.95 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 125.006 1.323 . . . . 0.0 113.096 174.619 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 14.9 ttt180 -126.83 153.18 45.98 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 125.911 1.684 . . . . 0.0 110.023 177.171 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 33.1 m -102.94 126.87 50.28 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 124.062 0.945 . . . . 0.0 110.836 -179.455 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 3.9 mp0 -106.09 -36.16 7.01 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.793 0.837 . . . . 0.0 112.606 -172.523 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 68.78 -48.59 0.57 Allowed 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 126.823 2.049 . . . . 0.0 115.867 169.348 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -59.01 -36.23 74.58 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.59 1.156 . . . . 0.0 113.58 -171.13 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 6.3 pm0 -61.97 -41.63 98.23 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 124.739 1.216 . . . . 0.0 112.499 175.593 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -69.03 -40.23 83.94 Favored Glycine 0 C--N 1.335 0.483 0 N-CA-C 111.54 -0.624 . . . . 0.0 111.54 178.331 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -70.01 -40.41 75.27 Favored 'General case' 0 N--CA 1.468 0.434 0 O-C-N 121.947 -0.737 . . . . 0.0 111.493 177.489 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -60.19 -43.7 95.69 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 119.255 0.934 . . . . 0.0 112.941 -174.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 8.0 pttp -77.19 -26.61 53.05 Favored 'General case' 0 N--CA 1.481 1.115 0 N-CA-C 113.586 0.958 . . . . 0.0 113.586 174.253 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 94.2 m -72.47 -32.85 66.58 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.06 0.544 . . . . 0.0 111.754 174.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 72.3 mt -91.33 -34.36 14.94 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 125.847 1.659 . . . . 0.0 114.598 -179.221 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -135.41 28.04 3.05 Favored Glycine 0 N--CA 1.474 1.175 0 N-CA-C 118.789 2.275 . . . . 0.0 118.789 -168.711 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -65.05 -22.73 67.02 Favored 'General case' 0 CA--C 1.546 0.8 0 CA-C-N 122.108 2.954 . . . . 0.0 115.701 -176.315 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -72.62 -10.92 76.81 Favored Glycine 0 CA--C 1.542 1.77 0 O-C-N 121.209 -0.932 . . . . 0.0 113.868 169.639 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 54.8 mttm -109.56 -39.54 5.13 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 127.251 2.22 . . . . 0.0 112.98 -179.472 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 41.2 pt -145.49 155.43 13.32 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 C-N-CA 124.555 1.142 . . . . 0.0 113.942 -171.174 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -99.43 142.49 30.85 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 126.065 1.746 . . . . 0.0 108.916 169.295 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 97.6 t -130.4 140.11 49.66 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 O-C-N 121.439 -0.788 . . . . 0.0 111.704 -176.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 13.9 m -139.38 153.72 47.71 Favored 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 124.981 1.312 . . . . 0.0 109.698 175.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 91.4 p -128.59 155.58 44.71 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 123.803 0.841 . . . . 0.0 109.742 167.751 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 60.5 p -140.33 161.68 37.11 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 114.824 -1.08 . . . . 0.0 112.149 173.702 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -119.79 101.78 0.86 Allowed Glycine 0 C--N 1.339 0.696 0 N-CA-C 110.343 -1.103 . . . . 0.0 110.343 -169.731 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 10.6 mp -59.63 125.58 24.2 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.734 0.814 . . . . 0.0 109.512 -169.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 68.15 42.05 1.84 Allowed 'General case' 0 CA--C 1.553 1.074 0 C-N-CA 124.716 1.206 . . . . 0.0 113.02 -173.251 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 69.6 m 61.85 54.63 2.82 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 127.724 2.409 . . . . 0.0 113.776 169.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 79.2 p -114.39 164.77 13.5 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 115.587 1.699 . . . . 0.0 115.587 -171.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 22.2 tpt180 -113.38 144.85 42.08 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 126.363 1.865 . . . . 0.0 110.453 177.014 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 16.7 m -68.51 171.56 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.206 0 CA-C-O 122.002 0.906 . . . . 0.0 110.282 169.089 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 1.7 t-80 -59.37 131.02 87.73 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-O 118.431 -0.795 . . . . 0.0 112.659 179.617 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo -60.43 -27.69 85.33 Favored 'Trans proline' 0 CA--C 1.547 1.171 0 C-N-CA 121.35 1.367 . . . . 0.0 111.569 169.607 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 90.0 m -65.83 -30.83 71.51 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 125.278 1.431 . . . . 0.0 112.321 174.341 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -57.52 -39.42 76.5 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.365 1.066 . . . . 0.0 111.532 -175.163 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 2.3 mp -57.12 -60.38 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 C-N-CA 123.665 0.786 . . . . 0.0 109.311 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.19 -31.11 72.18 Favored 'General case' 0 CA--C 1.546 0.808 0 N-CA-C 113.616 0.969 . . . . 0.0 113.616 -177.04 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -81.55 -8.05 59.67 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 114.305 1.224 . . . . 0.0 114.305 177.373 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 41.3 mtt -109.88 -24.02 11.06 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 125.057 1.343 . . . . 0.0 110.211 173.606 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 24.3 mt-10 -64.98 -16.01 62.9 Favored 'General case' 0 CA--C 1.546 0.818 0 O-C-N 120.609 -1.307 . . . . 0.0 111.749 168.694 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 12.3 mt-10 -61.16 -29.33 69.73 Favored 'General case' 0 N--CA 1.482 1.173 0 CA-C-N 119.877 1.217 . . . . 0.0 110.92 169.108 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 48.1 t -92.27 -4.99 10.8 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.981 0 C-N-CA 127.437 2.295 . . . . 0.0 111.118 177.032 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 80.91 17.39 72.63 Favored Glycine 0 CA--C 1.538 1.494 0 C-N-CA 125.223 1.392 . . . . 0.0 114.566 -173.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 78.9 mt -77.64 139.92 17.87 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 C-N-CA 124.309 1.044 . . . . 0.0 111.893 -173.275 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -104.98 104.97 14.81 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.58 1.152 . . . . 0.0 111.761 175.598 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 3.5 pt -131.7 0.84 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 N-CA-C 115.696 1.739 . . . . 0.0 115.696 -178.283 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 93.6 p -70.74 -30.98 67.65 Favored 'General case' 0 N--CA 1.48 1.051 0 CA-C-N 120.012 1.278 . . . . 0.0 113.635 -177.541 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -79.74 13.16 25.26 Favored Glycine 0 CA--C 1.539 1.567 0 C-N-CA 125.743 1.64 . . . . 0.0 115.75 -179.201 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 32.0 mt-30 -80.9 167.98 19.26 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 118.886 1.343 . . . . 0.0 111.868 178.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 3.6 t -71.77 171.64 11.25 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 114.963 1.468 . . . . 0.0 114.963 -178.33 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 48.8 m -125.21 6.07 7.81 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 128.436 2.694 . . . . 0.0 111.66 169.475 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 23.7 m-20 -88.17 155.34 52.08 Favored Pre-proline 0 CA--C 1.546 0.818 0 C-N-CA 124.729 1.212 . . . . 0.0 113.746 179.22 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -78.43 158.78 29.23 Favored 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 123.49 2.793 . . . . 0.0 114.406 -177.685 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 8.5 tt -53.12 -38.98 31.62 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 C-N-CA 124.308 1.043 . . . . 0.0 112.486 174.781 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -70.16 -6.77 36.55 Favored 'General case' 0 CA--C 1.545 0.778 0 N-CA-C 114.116 1.154 . . . . 0.0 114.116 179.11 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -76.42 -15.13 60.0 Favored 'General case' 0 CA--C 1.547 0.83 0 O-C-N 121.429 -0.794 . . . . 0.0 112.569 170.691 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 61.5 m-85 -109.04 -171.61 1.88 Allowed 'General case' 0 CA--C 1.552 1.041 0 C-N-CA 126.921 2.088 . . . . 0.0 111.57 -179.175 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -125.79 126.57 44.76 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 125.337 1.455 . . . . 0.0 110.232 177.397 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.65 -35.88 82.06 Favored 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 113.641 0.978 . . . . 0.0 113.641 -170.1 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . 0.258 0.0 OUTLIER -72.67 -4.88 33.83 Favored 'General case' 0 CA--C 1.547 0.853 0 N-CA-C 113.718 1.007 . . . . 0.0 113.718 -177.559 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -74.47 -12.21 60.43 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 123.982 0.913 . . . . 0.0 111.142 168.588 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 65.7 m-85 -115.28 146.55 41.38 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 127.483 2.313 . . . . 0.0 110.989 178.345 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -105.25 -16.16 14.85 Favored 'General case' 0 N--CA 1.479 1.022 0 CA-C-O 121.97 0.891 . . . . 0.0 112.641 178.148 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.65 HG22 ' HB ' ' A' ' 95' ' ' ILE . 80.3 t -133.17 136.69 54.79 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 C-N-CA 127.306 2.242 . . . . 0.0 107.671 -179.881 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 60.0 t -132.35 126.9 56.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 N-CA-C 107.999 -1.111 . . . . 0.0 107.999 169.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 43.5 mm -114.31 118.37 58.3 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 C-N-CA 124.635 1.174 . . . . 0.0 108.815 -175.669 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 8.6 t -100.47 116.61 32.81 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 122.934 0.493 . . . . 0.0 111.462 173.672 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 49.9 mt -94.52 -13.38 26.13 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 125.724 1.61 . . . . 0.0 113.71 -172.291 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 1.5 p -156.63 147.45 21.82 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 124.075 0.95 . . . . 0.0 111.412 176.041 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 80.19 179.99 52.94 Favored Glycine 0 CA--C 1.539 1.567 0 C-N-CA 124.53 1.062 . . . . 0.0 114.528 -178.224 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 67.2 m -92.04 3.65 54.79 Favored 'General case' 0 N--CA 1.479 0.993 0 N-CA-C 114.719 1.377 . . . . 0.0 114.719 -170.01 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 79.67 23.59 62.02 Favored Glycine 0 CA--C 1.537 1.414 0 N-CA-C 115.164 0.826 . . . . 0.0 115.164 178.673 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 14.3 t -106.46 -12.0 10.09 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.374 0 C-N-CA 124.323 1.049 . . . . 0.0 112.855 -179.318 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 12.9 t-20 -81.35 6.62 13.79 Favored 'General case' 0 CA--C 1.552 1.023 0 C-N-CA 125.202 1.401 . . . . 0.0 113.397 -179.823 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -127.97 161.07 58.08 Favored Pre-proline 0 CA--C 1.552 1.032 0 C-N-CA 126.912 2.085 . . . . 0.0 112.058 178.165 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.404 ' HA ' ' HD3' ' A' ' 88' ' ' PRO . 38.4 Cg_exo -63.36 148.06 93.08 Favored 'Trans proline' 0 CA--C 1.546 1.11 0 C-N-CA 122.355 2.036 . . . . 0.0 112.773 177.344 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 87' ' ' PRO . 87.1 Cg_exo -56.83 -30.61 85.84 Favored 'Trans proline' 0 C--N 1.352 0.733 0 C-N-CA 123.051 2.5 . . . . 0.0 115.286 -174.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -59.77 -20.44 56.65 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 114.237 1.199 . . . . 0.0 114.237 178.458 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 89.1 m95 -81.88 -17.04 48.69 Favored 'General case' 0 CA--C 1.539 0.522 0 O-C-N 120.594 -1.316 . . . . 0.0 113.364 175.847 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 5.4 m -92.83 -8.38 10.16 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.105 0 CA-C-N 119.404 1.002 . . . . 0.0 113.398 170.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 72.5 p -98.24 -0.46 44.01 Favored 'General case' 0 N--CA 1.479 0.995 0 N-CA-C 114.873 1.434 . . . . 0.0 114.873 179.216 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 73.9 mm-40 -66.01 152.71 44.01 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 119.442 1.019 . . . . 0.0 111.202 169.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -55.38 -43.15 74.88 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 114.634 1.346 . . . . 0.0 114.634 -167.661 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.65 ' HB ' HG22 ' A' ' 75' ' ' VAL . 19.9 mm -114.49 61.15 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 C-N-CA 124.84 1.256 . . . . 0.0 109.003 176.832 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 41.7 t80 -77.23 108.16 10.14 Favored 'General case' 0 CA--C 1.535 0.393 0 O-C-N 120.639 -1.288 . . . . 0.0 108.22 169.119 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 9.4 mt-10 -108.23 136.86 47.18 Favored 'General case' 0 CA--C 1.545 0.758 0 N-CA-C 114.947 1.462 . . . . 0.0 114.947 177.071 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -91.54 114.1 26.54 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.916 1.287 . . . . 0.0 110.202 169.786 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 23.1 m0 -111.88 81.97 1.55 Allowed 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 125.047 1.339 . . . . 0.0 109.538 179.579 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 7.5 pt20 -75.88 55.77 0.91 Allowed 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 125.576 1.55 . . . . 0.0 112.279 176.709 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 73.4 mt -86.99 167.19 14.47 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 127.493 2.317 . . . . 0.0 112.481 -178.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -68.68 149.65 48.84 Favored 'General case' 0 CA--C 1.546 0.812 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.99 169.255 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . 0.454 ' HA ' ' HD3' ' A' ' 104' ' ' PRO . 0.8 OUTLIER -117.75 142.76 31.2 Favored Pre-proline 0 CA--C 1.553 1.085 0 C-N-CA 125.073 1.349 . . . . 0.0 112.148 175.544 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . 0.454 ' HD3' ' HA ' ' A' ' 103' ' ' ASP . 34.8 Cg_exo -75.26 -15.96 19.9 Favored 'Trans proline' 0 CA--C 1.547 1.126 0 N-CA-C 116.929 1.857 . . . . 0.0 116.929 -172.104 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -67.2 141.79 57.2 Favored 'General case' 0 N--CA 1.476 0.837 0 CA-C-N 120.313 1.415 . . . . 0.0 113.334 -170.296 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 77.33 8.59 87.04 Favored Glycine 0 CA--C 1.538 1.527 0 C-N-CA 124.635 1.112 . . . . 0.0 114.901 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 -141.58 164.64 29.68 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 125.033 1.333 . . . . 0.0 113.553 -178.127 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 66.4 m -63.49 164.07 9.96 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 116.161 1.911 . . . . 0.0 116.161 -169.129 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 25.8 tp -57.12 -31.38 65.26 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 125.686 1.594 . . . . 0.0 113.274 176.202 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -62.04 -30.52 71.03 Favored 'General case' 0 CA--C 1.541 0.628 0 O-C-N 121.002 -1.061 . . . . 0.0 111.988 172.662 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 4.2 t -75.89 -38.86 37.08 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 O-C-N 121.122 -0.986 . . . . 0.0 111.388 173.159 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 20.0 m-85 -56.85 -45.31 82.51 Favored 'General case' 0 N--CA 1.481 1.082 0 CA-C-N 120.169 1.349 . . . . 0.0 111.609 169.521 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -67.79 -37.29 81.82 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 124.179 0.991 . . . . 0.0 112.135 178.566 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 70.6 m -67.91 -42.62 80.83 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 123.793 0.837 . . . . 0.0 111.567 174.042 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 53.3 t -66.19 -41.41 89.23 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 CA-C-O 118.387 -0.816 . . . . 0.0 110.142 177.252 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 15.7 mtp180 -52.78 -46.89 67.78 Favored 'General case' 0 N--CA 1.479 1.022 0 CA-C-N 119.755 1.161 . . . . 0.0 112.507 170.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -59.69 -50.56 66.39 Favored Glycine 0 CA--C 1.54 1.6 0 CA-C-N 119.375 0.988 . . . . 0.0 113.427 176.352 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 60.3 mm-40 -65.89 -44.39 85.43 Favored 'General case' 0 N--CA 1.472 0.672 0 O-C-N 121.775 -0.838 . . . . 0.0 112.304 -179.682 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 65.6 t -64.25 -41.43 92.36 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 C-N-CA 124.782 1.233 . . . . 0.0 110.685 176.21 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 80.0 tttt -54.98 -50.06 69.89 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 120.18 1.355 . . . . 0.0 111.068 178.133 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -61.72 -40.67 95.87 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 112.205 0.446 . . . . 0.0 112.205 176.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.89 -35.91 81.96 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 124.354 1.062 . . . . 0.0 113.722 177.133 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 95.2 t -76.24 -40.92 36.64 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 C-N-CA 125.421 1.489 . . . . 0.0 111.284 176.228 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -61.47 -39.6 91.46 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 119.039 0.836 . . . . 0.0 111.39 172.373 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 13.6 m-80 -64.42 -43.57 93.95 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 118.69 0.677 . . . . 0.0 112.611 174.3 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -54.52 -56.58 17.39 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 124.256 1.023 . . . . 0.0 110.442 173.132 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 85.0 mt -61.04 -42.45 93.14 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 CA-C-O 119.166 -0.445 . . . . 0.0 110.532 -178.576 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -73.67 -10.77 60.04 Favored 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 115.073 1.508 . . . . 0.0 115.073 -179.449 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 20.7 ptmt -98.66 -27.16 14.11 Favored 'General case' 0 N--CA 1.479 0.997 0 CA-C-N 119.501 1.046 . . . . 0.0 113.388 169.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 14.3 pt -95.45 -7.6 9.75 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 N-CA-C 114.599 1.333 . . . . 0.0 114.599 176.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 27.3 p . . . . . 0 C--O 1.255 1.391 0 N-CA-C 114.774 1.398 . . . . 0.0 114.774 176.06 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.5 ttt . . . . . 0 N--CA 1.501 2.114 0 N-CA-C 111.725 0.269 . . . . 0.0 111.725 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.5 165.08 28.39 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 125.135 1.374 . . . . 0.0 112.684 175.573 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 67.9 mttt -95.75 145.02 25.64 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.996 0.918 . . . . 0.0 112.333 177.184 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 15.0 t -124.46 134.28 67.13 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 C-N-CA 125.301 1.44 . . . . 0.0 111.884 177.285 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 14.4 tpp -101.02 123.78 45.73 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.087 0.555 . . . . 0.0 109.894 169.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 48.4 m-85 -110.8 99.02 8.02 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 124.533 1.133 . . . . 0.0 110.509 175.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.603 HG11 HD12 ' A' ' 65' ' ' ILE . 1.4 m -111.7 165.21 6.94 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 C-N-CA 125.035 1.334 . . . . 0.0 112.042 -173.893 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 7.8 t -142.44 140.29 31.9 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 125.279 1.432 . . . . 0.0 111.041 179.444 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 37.5 ttmt -66.13 118.56 10.04 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.42 0.688 . . . . 0.0 110.499 175.231 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 28.6 mmt85 45.51 91.48 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 127.441 2.296 . . . . 0.0 113.14 -175.575 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 15.9 m120 -61.36 -17.46 54.04 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 115.839 1.792 . . . . 0.0 115.839 -171.692 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 70.8 m -50.48 138.65 17.04 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.489 1.116 . . . . 0.0 112.212 178.049 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 24.6 p 55.03 -10.62 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.246 0 N-CA-C 118.12 2.637 . . . . 0.0 118.12 -173.707 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 52.3 mtm-85 -93.6 157.22 16.29 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 125.985 1.714 . . . . 0.0 113.789 -174.678 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 5.5 m -113.94 -22.18 10.23 Favored 'General case' 0 N--CA 1.477 0.924 0 N-CA-C 116.457 2.021 . . . . 0.0 116.457 -169.463 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 26.0 mt-30 62.12 -64.0 0.09 Allowed 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 127.078 2.151 . . . . 0.0 116.674 -178.174 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . 0.434 ' HG2' ' SD ' ' A' ' 50' ' ' MET . 0.0 OUTLIER 74.13 -49.24 0.67 Allowed 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 127.209 2.203 . . . . 0.0 114.344 177.026 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.68 -34.57 74.54 Favored 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 114.602 1.334 . . . . 0.0 114.602 -170.337 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 20.3 pm0 -63.47 -38.18 90.16 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 124.783 1.233 . . . . 0.0 112.138 178.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -72.22 -37.67 59.37 Favored Glycine 0 C--N 1.337 0.593 0 C-N-CA 123.681 0.657 . . . . 0.0 111.794 178.834 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -73.36 -37.98 65.87 Favored 'General case' 0 N--CA 1.469 0.49 0 O-C-N 121.685 -0.891 . . . . 0.0 111.772 176.819 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -62.74 -35.86 81.15 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 113.403 0.89 . . . . 0.0 113.403 -173.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 6.2 pttp -79.48 -36.36 38.82 Favored 'General case' 0 N--CA 1.479 1.023 0 N-CA-C 113.269 0.84 . . . . 0.0 113.269 170.135 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 39.0 m -69.46 -31.06 69.13 Favored 'General case' 0 N--CA 1.484 1.253 0 O-C-N 121.8 -0.563 . . . . 0.0 111.977 -178.57 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 83.8 mt -91.74 -36.35 13.62 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 125.868 1.667 . . . . 0.0 112.889 174.529 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -104.11 3.03 44.11 Favored Glycine 0 N--CA 1.473 1.13 0 N-CA-C 117.574 1.789 . . . . 0.0 117.574 -169.529 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.49 140.76 58.03 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 121.356 2.578 . . . . 0.0 112.413 178.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 81.31 -11.48 43.89 Favored Glycine 0 CA--C 1.541 1.671 0 C-N-CA 124.783 1.182 . . . . 0.0 114.081 -169.673 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 63.5 mttp -110.01 -44.61 3.75 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 126.089 1.756 . . . . 0.0 111.69 172.771 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 44.5 pt -138.99 159.95 29.67 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 125.903 1.681 . . . . 0.0 112.408 179.497 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -106.52 148.21 28.49 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.092 1.357 . . . . 0.0 110.378 169.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 57.2 t -133.44 139.54 48.81 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 CA-C-N 119.002 0.819 . . . . 0.0 112.483 -177.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 85.9 m -133.14 150.85 52.01 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 125.696 1.598 . . . . 0.0 108.168 169.592 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 10.1 p -90.49 -73.97 0.51 Allowed 'General case' 0 N--CA 1.47 0.534 0 O-C-N 121.589 -0.695 . . . . 0.0 112.759 174.694 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 9.6 p 66.06 156.57 0.1 Allowed 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 127.925 2.49 . . . . 0.0 113.602 -169.645 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -106.61 156.33 16.2 Favored Glycine 0 N--CA 1.465 0.586 0 O-C-N 121.432 -0.793 . . . . 0.0 112.18 -175.052 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 9.7 mp -99.52 108.97 21.54 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 169.234 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 69.14 64.71 0.28 Allowed 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 126.44 1.896 . . . . 0.0 113.173 -176.661 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 67.5 m 48.51 48.39 19.47 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 126.968 2.107 . . . . 0.0 115.058 169.575 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 58.1 m -129.59 156.63 43.89 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 124.455 1.102 . . . . 0.0 113.172 -172.584 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 59.5 ttt-85 -115.78 153.55 31.23 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 128.232 2.613 . . . . 0.0 109.139 178.619 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 16.2 m -62.98 157.99 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.132 0 O-C-N 122.04 -0.412 . . . . 0.0 111.318 171.33 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . 0.477 ' CE1' ' HB ' ' A' ' 45' ' ' THR . 0.1 OUTLIER -63.74 142.91 98.08 Favored Pre-proline 0 CA--C 1.544 0.712 0 C-N-CA 119.755 -0.778 . . . . 0.0 110.318 174.871 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -60.97 -29.49 88.08 Favored 'Trans proline' 0 CA--C 1.539 0.768 0 C-N-CA 123.266 2.644 . . . . 0.0 114.758 -168.443 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.477 ' HB ' ' CE1' ' A' ' 43' ' ' HIS . 88.7 m -66.17 -22.67 66.37 Favored 'General case' 0 N--CA 1.475 0.813 0 O-C-N 121.273 -0.892 . . . . 0.0 111.924 -178.675 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -52.48 -50.28 63.02 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 118.948 0.795 . . . . 0.0 110.405 169.766 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.414 ' H ' HD12 ' A' ' 47' ' ' ILE . 4.5 mp -57.56 -48.64 82.65 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 C-N-CA 123.377 0.671 . . . . 0.0 110.728 -179.842 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -60.17 -32.42 71.04 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 113.102 0.779 . . . . 0.0 113.102 178.822 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -80.63 -30.43 36.69 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 113.87 1.063 . . . . 0.0 113.87 177.087 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . 0.434 ' SD ' ' HG2' ' A' ' 17' ' ' MET . 3.6 mmt -73.41 -32.63 64.54 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 118.789 0.722 . . . . 0.0 110.352 170.251 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -67.01 -13.25 61.73 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 124.806 1.242 . . . . 0.0 113.548 174.267 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 58.4 mt-10 -63.11 -27.57 69.47 Favored 'General case' 0 N--CA 1.48 1.073 0 CA-C-N 120.355 1.434 . . . . 0.0 110.666 168.517 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 60.8 t -95.02 -4.51 10.45 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.91 0 C-N-CA 127.041 2.136 . . . . 0.0 111.15 175.465 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 80.29 18.9 70.46 Favored Glycine 0 CA--C 1.539 1.547 0 C-N-CA 125.005 1.288 . . . . 0.0 114.272 -175.649 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 93.2 mt -77.31 132.86 31.92 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 C-N-CA 124.731 1.212 . . . . 0.0 111.28 -174.577 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 19.0 t0 -96.19 104.8 16.78 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.502 0.721 . . . . 0.0 112.627 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 14.1 pt -138.22 17.25 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.365 0 N-CA-C 114.727 1.38 . . . . 0.0 114.727 176.046 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 94.1 p -49.35 -41.73 39.81 Favored 'General case' 0 N--CA 1.484 1.259 0 N-CA-C 116.151 1.908 . . . . 0.0 116.151 -169.798 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -126.98 35.68 2.8 Favored Glycine 0 CA--C 1.534 1.248 0 C-N-CA 125.59 1.567 . . . . 0.0 113.179 -179.293 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 24.0 pt20 -64.88 -33.91 77.13 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 115.56 1.689 . . . . 0.0 115.56 -169.738 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 28.2 p -92.83 106.23 18.23 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 121.559 0.695 . . . . 0.0 111.68 179.633 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 67.4 m -104.57 -28.93 10.98 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 124.521 1.128 . . . . 0.0 113.311 176.469 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -147.75 158.2 43.06 Favored Pre-proline 0 CA--C 1.544 0.737 0 C-N-CA 124.514 1.125 . . . . 0.0 111.997 -176.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -64.49 156.41 60.75 Favored 'Trans proline' 0 CA--C 1.537 0.671 0 C-N-CA 122.42 2.08 . . . . 0.0 112.414 169.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.603 HD12 HG11 ' A' ' 7' ' ' VAL . 12.2 tt -50.12 -36.03 12.11 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.181 0 C-N-CA 124.016 0.926 . . . . 0.0 112.098 171.54 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 19.3 mt-10 -63.91 -18.08 63.86 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.153 0.981 . . . . 0.0 113.225 -176.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -85.1 -14.92 45.63 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 124.553 1.141 . . . . 0.0 113.785 -177.059 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -97.06 176.03 6.1 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 126.016 1.727 . . . . 0.0 112.304 -177.081 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 23.6 t30 -99.81 126.95 45.99 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 169.77 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.84 -46.52 74.82 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 112.433 0.531 . . . . 0.0 112.433 -175.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -72.57 -1.0 14.38 Favored 'General case' 0 CA--C 1.546 0.823 0 N-CA-C 114.796 1.406 . . . . 0.0 114.796 -173.169 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -70.24 -17.68 63.13 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 123.668 0.787 . . . . 0.0 110.245 168.255 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 58.6 m-85 -105.53 158.32 16.76 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 128.355 2.662 . . . . 0.0 111.14 174.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -116.94 -12.94 10.66 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 124.781 1.232 . . . . 0.0 112.874 179.465 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.631 HG22 ' HB ' ' A' ' 95' ' ' ILE . 87.3 t -142.54 136.49 27.82 Favored 'Isoleucine or valine' 0 C--O 1.236 0.384 0 C-N-CA 127.86 2.464 . . . . 0.0 107.699 -174.291 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 59.0 t -131.75 133.46 61.31 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 N-CA-C 108.431 -0.952 . . . . 0.0 108.431 169.799 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 43.6 mm -116.41 111.16 34.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 C-N-CA 124.832 1.253 . . . . 0.0 107.916 -177.069 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 4.3 m -95.61 101.36 13.06 Favored 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 123.521 0.728 . . . . 0.0 110.097 176.81 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 34.1 mt -79.15 176.73 9.4 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 126.495 1.918 . . . . 0.0 110.955 173.445 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 14.8 m 63.2 57.0 1.64 Allowed 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 124.408 1.083 . . . . 0.0 113.422 169.787 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 83.06 -137.14 16.07 Favored Glycine 0 CA--C 1.534 1.268 0 C-N-CA 123.863 0.744 . . . . 0.0 111.706 -171.437 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 98.9 p -83.82 163.29 20.22 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 113.26 0.837 . . . . 0.0 113.26 176.561 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -69.03 -88.85 0.08 OUTLIER Glycine 0 CA--C 1.528 0.892 0 N-CA-C 110.658 -0.977 . . . . 0.0 110.658 169.409 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 98.7 t 63.13 -48.17 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.239 0 C-N-CA 128.054 2.542 . . . . 0.0 116.571 170.139 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 29.3 t-20 -74.98 -30.84 61.3 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 124.883 1.273 . . . . 0.0 113.031 -179.545 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.4 ' HA ' ' HD3' ' A' ' 87' ' ' PRO . 2.5 pt? -68.25 146.77 98.15 Favored Pre-proline 0 CA--C 1.555 1.145 0 CA-C-O 118.709 -0.662 . . . . 0.0 112.373 174.412 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 86' ' ' LEU . 64.3 Cg_exo -62.05 156.87 47.16 Favored 'Trans proline' 0 CA--C 1.549 1.243 0 C-N-CA 122.775 2.317 . . . . 0.0 115.234 -176.773 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 80.6 Cg_exo -54.3 -36.44 86.7 Favored 'Trans proline' 0 C--N 1.355 0.869 0 C-N-CA 123.984 3.123 . . . . 0.0 115.119 -174.798 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -61.47 -15.86 41.66 Favored 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 115.052 1.501 . . . . 0.0 115.052 178.725 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 82.6 m95 -91.43 -34.51 14.81 Favored 'General case' 0 CA--C 1.539 0.552 0 O-C-N 121.029 -1.044 . . . . 0.0 112.314 172.702 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 6.7 m -84.73 -16.32 10.53 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.186 0 N-CA-C 113.588 0.958 . . . . 0.0 113.588 177.821 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 1.3 t -78.59 -5.8 53.81 Favored 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 114.627 1.343 . . . . 0.0 114.627 177.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 58.4 mt-30 -71.24 166.23 21.98 Favored 'General case' 0 N--CA 1.478 0.934 0 O-C-N 121.05 -1.031 . . . . 0.0 112.95 -172.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -60.0 -43.52 95.14 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 113.761 1.022 . . . . 0.0 113.761 -168.661 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.631 ' HB ' HG22 ' A' ' 75' ' ' VAL . 10.8 mm -121.23 62.0 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 C-N-CA 124.65 1.18 . . . . 0.0 109.186 176.052 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 17.2 t80 -75.02 113.16 12.02 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 107.394 -1.336 . . . . 0.0 107.394 168.727 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 14.0 mt-10 -108.19 126.72 53.12 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-O 122.26 1.029 . . . . 0.0 113.246 174.224 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -91.4 89.21 7.15 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 125.146 1.378 . . . . 0.0 109.197 176.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 20.4 m0 -81.8 90.97 6.43 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 124.621 1.168 . . . . 0.0 111.405 -173.021 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 70.2 mm-40 -71.55 41.64 0.07 Allowed 'General case' 0 CA--C 1.553 1.062 0 C-N-CA 127.212 2.205 . . . . 0.0 112.345 173.379 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 40.3 mt -84.06 161.94 20.52 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 125.917 1.687 . . . . 0.0 112.156 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -70.94 150.02 46.12 Favored 'General case' 0 CA--C 1.545 0.769 0 CA-C-N 114.757 -1.111 . . . . 0.0 112.222 169.729 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -116.28 142.63 29.67 Favored Pre-proline 0 CA--C 1.552 1.043 0 C-N-CA 124.66 1.184 . . . . 0.0 110.061 169.303 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -63.23 -4.83 7.01 Favored 'Trans proline' 0 CA--C 1.55 1.29 0 C-N-CA 123.107 2.538 . . . . 0.0 116.148 178.701 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -54.18 131.11 40.66 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 115.234 1.568 . . . . 0.0 115.234 -174.814 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 69.52 10.09 62.8 Favored Glycine 0 CA--C 1.538 1.496 0 N-CA-C 115.923 1.129 . . . . 0.0 115.923 175.379 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 16.1 pt20 -134.87 171.24 14.68 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 125.141 1.377 . . . . 0.0 113.909 -175.876 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 42.7 p -67.26 166.04 15.03 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 116.663 2.097 . . . . 0.0 116.663 -168.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 40.5 tp -57.66 -32.16 67.03 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 124.476 1.11 . . . . 0.0 112.375 172.431 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -62.71 -36.47 83.06 Favored 'General case' 0 CA--C 1.54 0.586 0 O-C-N 121.192 -0.942 . . . . 0.0 111.366 175.531 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 6.2 t -69.29 -40.26 80.01 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 O-C-N 121.482 -0.761 . . . . 0.0 111.477 172.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -53.8 -47.88 70.38 Favored 'General case' 0 N--CA 1.477 0.911 0 CA-C-N 119.298 0.954 . . . . 0.0 112.29 170.089 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 28.6 mmt85 -63.79 -44.41 93.44 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 124.221 1.008 . . . . 0.0 111.884 178.738 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 19.2 m -62.7 -40.99 98.89 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.776 0.831 . . . . 0.0 111.607 174.087 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 52.9 t -66.4 -42.35 90.32 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 CA-C-O 117.546 -1.216 . . . . 0.0 110.712 177.347 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 20.3 mtm105 -54.83 -44.18 73.67 Favored 'General case' 0 N--CA 1.483 1.224 0 CA-C-N 120.539 1.518 . . . . 0.0 111.708 171.647 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -60.4 -51.55 58.11 Favored Glycine 0 CA--C 1.538 1.499 0 CA-C-N 119.115 0.871 . . . . 0.0 113.797 176.411 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 60.2 mm-40 -65.48 -43.63 89.66 Favored 'General case' 0 N--CA 1.476 0.83 0 O-C-N 121.913 -0.757 . . . . 0.0 112.207 -179.426 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 69.3 t -66.58 -40.09 85.47 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 C-N-CA 124.737 1.215 . . . . 0.0 110.883 177.21 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -56.22 -49.48 73.97 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-N 120.163 1.347 . . . . 0.0 110.965 177.241 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -61.48 -41.99 98.11 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 122.92 0.488 . . . . 0.0 112.231 178.037 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -61.45 -42.98 99.6 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 124.824 1.25 . . . . 0.0 113.204 174.619 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 94.8 t -71.84 -39.46 67.81 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 C-N-CA 124.466 1.107 . . . . 0.0 111.663 177.72 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -62.54 -39.04 92.33 Favored 'General case' 0 N--CA 1.469 0.514 0 O-C-N 121.274 -0.891 . . . . 0.0 111.384 172.443 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 12.6 m-80 -63.78 -45.84 87.89 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 118.703 0.683 . . . . 0.0 112.487 173.155 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 9.8 tt -52.19 -54.39 31.5 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.935 1.294 . . . . 0.0 110.775 173.412 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 68.3 mt -63.87 -42.95 97.52 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 O-C-N 121.749 -0.594 . . . . 0.0 110.518 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -67.53 -10.97 56.66 Favored 'General case' 0 CA--C 1.548 0.866 0 N-CA-C 114.921 1.452 . . . . 0.0 114.921 177.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 20.2 ptmt -107.31 -30.93 8.43 Favored 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 113.942 1.089 . . . . 0.0 113.942 174.373 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . 0.263 7.1 pt -95.63 -11.57 8.73 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 N-CA-C 114.576 1.324 . . . . 0.0 114.576 -178.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 65.4 m . . . . . 0 C--O 1.253 1.246 0 C-N-CA 124.805 1.242 . . . . 0.0 112.78 177.846 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.421 ' HA ' ' O ' ' A' ' 29' ' ' LYS . 25.1 ttt . . . . . 0 N--CA 1.504 2.249 0 N-CA-C 112.133 0.42 . . . . 0.0 112.133 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 2.9 mptp? -126.12 158.0 36.61 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 125.729 1.612 . . . . 0.0 113.264 179.301 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 73.8 mttt -105.35 115.2 29.85 Favored 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 125.929 1.692 . . . . 0.0 106.629 167.39 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 10.7 t -105.81 130.89 56.56 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 C-N-CA 125.079 1.351 . . . . 0.0 113.9 178.62 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' MET . . . . . 0.472 ' HG3' HG13 ' A' ' 7' ' ' VAL . 48.8 tpp -102.02 125.66 48.76 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 168.677 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 49.8 m-85 -108.62 119.29 39.1 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 124.362 1.065 . . . . 0.0 109.82 171.486 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.472 HG13 ' HG3' ' A' ' 5' ' ' MET . 3.4 m -140.3 149.74 21.62 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 C-N-CA 124.675 1.19 . . . . 0.0 111.788 -169.386 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 14.9 t -137.15 148.53 46.68 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 125.821 1.648 . . . . 0.0 111.283 -178.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 47.0 pttt -59.51 123.22 16.14 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 123.88 0.872 . . . . 0.0 111.922 177.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 74.5 mtp85 58.27 -33.9 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.784 0 C-N-CA 129.411 3.084 . . . . 0.0 116.718 -169.319 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 17.9 t-20 59.35 -48.82 0.07 Allowed 'General case' 0 CA--C 1.553 1.065 0 C-N-CA 129.382 3.073 . . . . 0.0 117.116 174.61 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 26.2 m -68.76 -8.6 44.64 Favored 'General case' 0 N--CA 1.482 1.167 0 CA-C-N 120.89 1.677 . . . . 0.0 114.023 -176.348 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 84.1 p -100.22 2.54 42.92 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 126.531 1.932 . . . . 0.0 114.506 170.028 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 83.7 mtt85 -140.86 173.83 11.1 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 126.682 1.993 . . . . 0.0 112.928 -169.645 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 35.1 t -114.92 174.9 5.74 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 125.176 1.391 . . . . 0.0 110.252 169.245 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 29.3 mt-30 -141.94 -49.28 0.38 Allowed 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 113.956 1.095 . . . . 0.0 113.956 -170.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . 0.434 ' HG2' ' SD ' ' A' ' 50' ' ' MET . 0.0 OUTLIER 71.67 -46.37 0.64 Allowed 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 126.231 1.812 . . . . 0.0 114.236 173.683 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.19 -32.53 73.18 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 114.258 1.207 . . . . 0.0 114.258 -169.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 7.3 pm0 -63.77 -38.39 90.92 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 123.289 0.635 . . . . 0.0 111.919 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -70.24 -42.84 65.24 Favored Glycine 0 C--N 1.335 0.492 0 C-N-CA 123.715 0.674 . . . . 0.0 111.726 -178.765 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -71.76 -36.25 70.33 Favored 'General case' 0 N--CA 1.468 0.46 0 O-C-N 121.662 -0.905 . . . . 0.0 112.13 177.151 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.89 -35.66 78.99 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 118.609 0.641 . . . . 0.0 112.467 -175.182 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 5.6 pttp -84.9 -35.39 22.18 Favored 'General case' 0 N--CA 1.481 1.093 0 N-CA-C 113.86 1.059 . . . . 0.0 113.86 170.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 75.8 m -67.86 -31.61 71.54 Favored 'General case' 0 N--CA 1.486 1.346 0 CA-C-N 118.828 0.74 . . . . 0.0 112.141 -179.266 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 72.4 mt -96.47 -37.26 10.5 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.801 1.64 . . . . 0.0 112.69 175.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -98.48 4.3 59.93 Favored Glycine 0 N--CA 1.471 1.024 0 N-CA-C 116.572 1.389 . . . . 0.0 116.572 -169.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.18 143.14 56.09 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-N 120.97 2.385 . . . . 0.0 112.524 177.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 83.53 -20.07 12.6 Favored Glycine 0 CA--C 1.542 1.732 0 C-N-CA 124.868 1.223 . . . . 0.0 113.251 -169.322 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.421 ' O ' ' HA ' ' A' ' 1' ' ' MET . 78.4 mttt -101.25 -44.52 5.64 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 125.889 1.676 . . . . 0.0 112.253 169.868 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 38.5 pt -139.33 158.12 28.2 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 C-N-CA 124.162 0.985 . . . . 0.0 113.627 -175.507 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -106.81 145.51 32.02 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 127.252 2.221 . . . . 0.0 109.7 169.846 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 72.7 t -134.3 141.96 42.19 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 CA-C-N 118.69 0.677 . . . . 0.0 112.759 -175.349 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 38.9 m -134.72 153.01 52.19 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 125.513 1.525 . . . . 0.0 109.075 169.589 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 55.4 p -130.03 146.83 51.72 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.845 0.831 . . . . 0.0 111.288 168.176 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 53.7 p -147.89 -173.63 4.35 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 114.704 -1.135 . . . . 0.0 111.708 175.833 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -135.96 170.11 23.31 Favored Glycine 0 N--CA 1.468 0.782 0 O-C-N 120.909 -1.119 . . . . 0.0 112.038 177.419 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 10.8 mp -91.68 -9.01 45.44 Favored 'General case' 0 N--CA 1.479 1.021 0 N-CA-C 114.967 1.469 . . . . 0.0 114.967 -169.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -142.13 63.9 1.4 Allowed 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 124.71 1.204 . . . . 0.0 110.934 -176.746 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.451 ' H ' ' HB3' ' A' ' 64' ' ' PRO . 72.7 m 49.53 45.8 23.88 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 126.194 1.798 . . . . 0.0 112.392 -175.456 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 16.6 p -123.26 165.88 16.2 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 126.078 1.751 . . . . 0.0 115.65 -168.812 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 29.3 ptt-85 -138.0 -171.62 3.06 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 127.695 2.398 . . . . 0.0 107.631 171.465 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 26.9 m -60.44 151.72 5.79 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.189 0 CA-C-N 120.369 1.44 . . . . 0.0 110.941 169.418 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -62.99 143.29 97.54 Favored Pre-proline 0 CA--C 1.55 0.975 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 168.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_exo -48.53 -37.11 33.15 Favored 'Trans proline' 0 CA--C 1.542 0.876 0 C-N-CA 123.421 2.748 . . . . 0.0 117.717 -168.195 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 93.9 m -63.23 -24.62 67.96 Favored 'General case' 0 N--CA 1.485 1.304 0 CA-C-N 119.721 1.146 . . . . 0.0 112.777 -174.695 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -51.97 -43.76 63.71 Favored 'General case' 0 CA--C 1.546 0.802 0 CA-C-O 118.352 -0.832 . . . . 0.0 111.034 170.697 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.6 mp -55.79 -54.05 30.71 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.297 0 CA-C-N 120.239 1.382 . . . . 0.0 110.1 178.159 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -62.27 -30.65 71.27 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 123.447 0.699 . . . . 0.0 112.736 -178.18 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . 0.41 ' HG2' ' CD1' ' A' ' 112' ' ' PHE . 0.0 OUTLIER -76.91 -33.5 57.76 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 113.119 0.785 . . . . 0.0 113.119 176.813 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . 0.434 ' SD ' ' HG2' ' A' ' 17' ' ' MET . 3.5 mmt -74.2 -32.5 63.07 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 118.877 0.762 . . . . 0.0 110.735 172.697 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -65.47 -14.05 60.14 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 124.534 1.134 . . . . 0.0 113.787 173.197 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 60.3 mt-10 -62.1 -27.18 68.74 Favored 'General case' 0 N--CA 1.482 1.161 0 CA-C-N 120.66 1.573 . . . . 0.0 110.896 168.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 56.5 t -96.5 -3.63 10.2 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.874 0 C-N-CA 127.54 2.336 . . . . 0.0 111.275 176.118 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 78.93 19.13 73.49 Favored Glycine 0 CA--C 1.541 1.677 0 C-N-CA 125.029 1.299 . . . . 0.0 114.374 -175.784 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 85.7 mt -77.88 135.3 26.53 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 C-N-CA 124.709 1.204 . . . . 0.0 111.638 -174.722 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 17.9 t0 -96.05 102.19 13.96 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 112.667 0.617 . . . . 0.0 112.667 178.133 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 8.6 pt -129.58 14.92 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.273 0 C-N-CA 125.214 1.406 . . . . 0.0 113.396 170.514 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 72.7 m -59.48 126.7 28.7 Favored 'General case' 0 N--CA 1.473 0.715 0 O-C-N 120.711 -1.243 . . . . 0.0 112.295 -172.592 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 80.15 -22.62 4.29 Favored Glycine 0 CA--C 1.538 1.48 0 C-N-CA 125.278 1.418 . . . . 0.0 115.938 179.653 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 70.8 mt-30 41.0 -96.12 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 127.482 2.313 . . . . 0.0 113.428 -175.535 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 9.1 t -145.63 163.95 33.24 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 126.655 1.982 . . . . 0.0 109.914 169.719 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 75.5 m -100.55 -2.52 32.75 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 125.904 1.682 . . . . 0.0 113.148 172.216 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 29.2 m-20 -111.05 146.79 35.22 Favored Pre-proline 0 CA--C 1.544 0.742 0 C-N-CA 124.053 0.941 . . . . 0.0 113.38 -174.523 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.451 ' HB3' ' H ' ' A' ' 39' ' ' SER . 57.6 Cg_endo -71.52 162.07 43.41 Favored 'Trans proline' 0 C--N 1.349 0.58 0 C-N-CA 122.541 2.16 . . . . 0.0 113.163 176.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 5.5 tt -48.74 -43.97 14.4 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 C-N-CA 124.465 1.106 . . . . 0.0 111.36 171.322 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -69.12 -5.64 23.53 Favored 'General case' 0 CA--C 1.546 0.813 0 N-CA-C 114.466 1.284 . . . . 0.0 114.466 -177.591 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 5.4 t-20 -84.27 -21.59 31.03 Favored 'General case' 0 CA--C 1.547 0.839 0 N-CA-C 113.312 0.856 . . . . 0.0 113.312 172.791 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 83.5 m-85 -91.3 -171.58 3.0 Favored 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 125.431 1.492 . . . . 0.0 111.838 -179.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 14.9 t30 -117.53 120.44 38.1 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.52 1.128 . . . . 0.0 109.351 175.804 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -64.97 -44.64 88.7 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 115.108 1.521 . . . . 0.0 115.108 -169.122 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -79.77 6.22 11.48 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 113.591 0.96 . . . . 0.0 113.591 -172.458 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -73.57 -26.66 60.93 Favored 'General case' 0 CA--C 1.545 0.783 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 167.617 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 76.4 m-85 -86.44 157.84 19.73 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 127.101 2.161 . . . . 0.0 110.244 169.635 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -116.07 -15.79 11.1 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 124.237 1.015 . . . . 0.0 112.355 174.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.632 HG22 ' HB ' ' A' ' 95' ' ' ILE . 91.6 t -129.33 135.27 62.13 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 C-N-CA 126.93 2.092 . . . . 0.0 107.648 174.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 66.7 t -131.8 123.42 51.65 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 169.471 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 45.7 mm -108.59 106.79 21.35 Favored 'Isoleucine or valine' 0 C--O 1.235 0.298 0 C-N-CA 124.645 1.178 . . . . 0.0 108.76 -175.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 4.1 m -85.42 92.26 8.44 Favored 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 123.983 0.913 . . . . 0.0 110.061 171.596 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 81.4 mt -67.34 172.52 4.77 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 126.259 1.823 . . . . 0.0 111.794 172.801 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 17.3 m 65.88 7.94 4.97 Favored 'General case' 0 CA--C 1.549 0.906 0 N-CA-C 114.868 1.433 . . . . 0.0 114.868 175.03 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 69.37 132.02 0.06 OUTLIER Glycine 0 CA--C 1.535 1.286 0 C-N-CA 126.793 2.14 . . . . 0.0 115.157 -179.801 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 38.2 m 60.18 43.48 13.98 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 125.84 1.656 . . . . 0.0 112.311 174.277 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -75.7 65.14 2.53 Favored Glycine 0 N--CA 1.472 1.058 0 C-N-CA 124.951 1.263 . . . . 0.0 111.281 174.44 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.9 p -112.81 -2.32 10.3 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 C-N-CA 125.263 1.425 . . . . 0.0 113.622 -169.647 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 62.0 t30 -77.26 -11.14 59.79 Favored 'General case' 0 CA--C 1.552 1.03 0 O-C-N 121.221 -0.924 . . . . 0.0 113.289 176.284 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -66.23 158.61 76.45 Favored Pre-proline 0 CA--C 1.556 1.19 0 C-N-CA 124.335 1.054 . . . . 0.0 112.494 170.282 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -60.1 151.27 73.91 Favored 'Trans proline' 0 CA--C 1.543 0.933 0 C-N-CA 122.776 2.317 . . . . 0.0 113.337 179.645 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -61.33 -26.54 81.8 Favored 'Trans proline' 0 C--N 1.35 0.656 0 C-N-CA 123.364 2.709 . . . . 0.0 113.863 -174.146 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -59.82 -22.2 61.9 Favored 'General case' 0 CA--C 1.541 0.596 0 CA-C-O 117.966 -1.016 . . . . 0.0 113.534 174.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 93.5 m95 -87.64 -12.97 43.97 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 125.025 1.33 . . . . 0.0 113.806 177.789 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 4.7 m -96.47 -7.75 9.48 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 CA-C-N 119.072 0.851 . . . . 0.0 112.946 171.736 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . 0.269 0.7 OUTLIER -96.47 -4.57 41.34 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 114.818 1.414 . . . . 0.0 114.818 -175.548 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 11.8 mp0 -61.05 156.89 16.86 Favored 'General case' 0 N--CA 1.487 1.384 0 CA-C-O 122.531 1.158 . . . . 0.0 111.183 168.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -61.83 -39.54 92.15 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 114.354 -1.294 . . . . 0.0 113.4 -168.831 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.632 ' HB ' HG22 ' A' ' 75' ' ' VAL . 16.6 mm -115.63 59.07 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 C-N-CA 125.321 1.448 . . . . 0.0 109.071 176.439 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 35.4 t80 -76.22 109.73 10.14 Favored 'General case' 0 CA--C 1.535 0.376 0 O-C-N 120.51 -1.369 . . . . 0.0 107.945 169.054 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 9.6 mt-10 -111.39 128.66 56.05 Favored 'General case' 0 N--CA 1.471 0.625 0 N-CA-C 113.214 0.82 . . . . 0.0 113.214 174.298 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -93.84 112.51 24.37 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 168.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 38.7 m0 -94.04 104.2 16.25 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 124.375 1.07 . . . . 0.0 108.983 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 73.7 mm-40 -74.73 54.82 0.64 Allowed 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 126.797 2.039 . . . . 0.0 110.342 173.32 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.1 tt -104.81 146.22 29.28 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 127.099 2.159 . . . . 0.0 110.624 -169.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -56.5 144.15 32.49 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 125.06 1.344 . . . . 0.0 113.848 174.289 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -97.34 119.77 62.31 Favored Pre-proline 0 CA--C 1.546 0.825 0 C-N-CA 124.661 1.184 . . . . 0.0 108.015 168.823 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -76.4 -11.22 19.03 Favored 'Trans proline' 0 CA--C 1.542 0.906 0 C-N-CA 122.067 1.845 . . . . 0.0 114.132 -173.671 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -74.72 155.87 37.23 Favored 'General case' 0 CA--C 1.546 0.795 0 CA-C-N 119.684 1.129 . . . . 0.0 113.689 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 76.47 8.41 85.83 Favored Glycine 0 CA--C 1.536 1.394 0 C-N-CA 124.712 1.149 . . . . 0.0 114.434 -177.667 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 15.0 pt20 -143.31 170.52 15.61 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 126.824 2.049 . . . . 0.0 111.196 179.239 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 15.9 m -56.77 154.32 9.34 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 125.031 1.332 . . . . 0.0 114.56 -169.568 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 60.2 tp -58.34 -30.05 66.42 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.902 0.881 . . . . 0.0 112.493 176.338 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -59.35 -31.93 69.64 Favored 'General case' 0 N--CA 1.475 0.793 0 O-C-N 121.351 -0.843 . . . . 0.0 113.268 170.559 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 14.0 t -74.12 -41.53 51.91 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 O-C-N 121.008 -1.058 . . . . 0.0 110.306 173.624 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.41 ' CD1' ' HG2' ' A' ' 49' ' ' MET . 0.3 OUTLIER -54.38 -47.26 72.87 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 119.097 0.862 . . . . 0.0 112.611 169.76 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -70.9 -34.21 71.33 Favored 'General case' 0 N--CA 1.477 0.902 0 O-C-N 121.395 -0.816 . . . . 0.0 112.726 179.191 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 53.3 m -64.98 -41.25 95.6 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.834 0.854 . . . . 0.0 111.13 170.686 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 54.7 t -68.34 -35.73 72.11 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 CA-C-O 117.371 -1.299 . . . . 0.0 111.029 175.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 28.6 mtm105 -56.23 -43.02 78.2 Favored 'General case' 0 N--CA 1.485 1.292 0 CA-C-N 121.275 1.852 . . . . 0.0 111.355 169.611 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -61.18 -49.98 72.12 Favored Glycine 0 CA--C 1.54 1.629 0 CA-C-N 119.132 0.878 . . . . 0.0 113.594 175.197 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 64.0 mm-40 -62.74 -46.73 86.7 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.537 0.735 . . . . 0.0 112.136 177.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 91.3 t -69.89 -34.71 61.4 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 C-N-CA 124.324 1.049 . . . . 0.0 111.262 -179.5 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 63.7 tttm -55.96 -51.85 66.23 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 120.44 1.473 . . . . 0.0 110.908 172.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -63.92 -42.07 97.48 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 123.303 0.641 . . . . 0.0 112.522 177.418 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -66.88 -34.8 78.58 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 125.446 1.498 . . . . 0.0 112.306 179.407 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 76.9 t -76.57 -40.89 34.18 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.089 0 C-N-CA 125.098 1.359 . . . . 0.0 111.511 173.716 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -62.6 -34.12 76.38 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 119.425 1.011 . . . . 0.0 111.604 173.156 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 9.6 m-80 -65.72 -44.4 86.17 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 119.056 0.844 . . . . 0.0 113.035 172.031 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -53.49 -55.48 25.0 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 123.884 0.874 . . . . 0.0 110.304 172.482 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 75.5 mt -61.39 -43.17 96.22 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 CA-C-O 119.164 -0.446 . . . . 0.0 110.666 -179.819 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -68.9 -13.58 62.51 Favored 'General case' 0 CA--C 1.544 0.744 0 N-CA-C 115.116 1.524 . . . . 0.0 115.116 179.704 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 21.4 ptmt -98.61 -28.17 13.68 Favored 'General case' 0 N--CA 1.477 0.887 0 CA-C-N 119.382 0.992 . . . . 0.0 113.541 172.767 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 18.5 pt -93.98 -22.57 5.55 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 N-CA-C 114.486 1.291 . . . . 0.0 114.486 177.581 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 75.6 m . . . . . 0 C--O 1.252 1.227 0 C-N-CA 125.418 1.487 . . . . 0.0 111.552 -173.77 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.3 ttt . . . . . 0 N--CA 1.504 2.234 0 N-CA-C 111.556 0.206 . . . . 0.0 111.556 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.14 166.0 25.9 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 125.018 1.327 . . . . 0.0 112.971 176.071 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 70.0 mttt -94.81 146.07 24.44 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 123.82 0.848 . . . . 0.0 112.629 174.466 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 16.7 t -124.28 138.13 54.85 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 125.645 1.578 . . . . 0.0 111.083 172.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -109.74 121.2 44.68 Favored 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 110.19 -0.3 . . . . 0.0 110.19 169.136 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 45.2 m-85 -96.52 125.19 40.83 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 170.608 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 28.8 m -140.49 151.57 21.0 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 N-CA-C 113.786 1.032 . . . . 0.0 113.786 -168.766 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 33.5 t -152.95 142.55 21.86 Favored 'General case' 0 CA--C 1.548 0.904 0 C-N-CA 124.711 1.204 . . . . 0.0 113.606 -172.717 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -80.79 140.52 35.44 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 124.779 1.232 . . . . 0.0 109.324 168.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 31.2 mtm180 52.54 47.34 24.91 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 125.48 1.512 . . . . 0.0 112.522 -169.12 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 23.4 t30 -57.32 -27.63 62.36 Favored 'General case' 0 CA--C 1.551 0.996 0 C-N-CA 125.581 1.552 . . . . 0.0 113.282 -179.786 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 72.8 m -73.32 -30.75 63.58 Favored 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 113.419 0.896 . . . . 0.0 113.419 172.041 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 48.8 m -80.66 -40.04 26.23 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 123.876 0.87 . . . . 0.0 112.082 179.458 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 11.7 mmt180 -101.88 163.34 12.3 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 124.645 1.178 . . . . 0.0 113.458 -173.844 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 3.7 m -106.92 134.96 49.3 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.148 0.979 . . . . 0.0 111.041 174.13 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 3.9 mp0 -105.11 -38.14 6.67 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 115.018 1.488 . . . . 0.0 115.018 -168.27 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . 0.438 ' HG2' ' SD ' ' A' ' 50' ' ' MET . 0.0 OUTLIER 67.16 -55.55 0.45 Allowed 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 126.71 2.004 . . . . 0.0 115.66 170.372 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -57.82 -37.04 73.09 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.923 1.289 . . . . 0.0 114.205 -169.577 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 7.5 pm0 -58.76 -31.97 68.84 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 125.391 1.476 . . . . 0.0 113.709 179.523 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -66.83 -68.06 1.79 Allowed Glycine 0 C--N 1.337 0.622 0 N-CA-C 110.588 -1.005 . . . . 0.0 110.588 174.506 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -50.65 -34.12 25.15 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 124.135 0.974 . . . . 0.0 113.449 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.47 ' HB1' HG21 ' A' ' 32' ' ' VAL . . . -60.24 -32.58 71.27 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 -177.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . 0.273 0.0 OUTLIER -98.84 -24.91 14.81 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 114.081 1.141 . . . . 0.0 114.081 169.947 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 1.3 m -64.51 -36.54 84.52 Favored 'General case' 0 N--CA 1.488 1.436 0 CA-C-N 120.33 1.423 . . . . 0.0 111.974 173.796 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 68.6 mt -98.96 -28.26 13.51 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 125.454 1.502 . . . . 0.0 113.206 178.778 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -111.93 2.77 27.2 Favored Glycine 0 N--CA 1.474 1.204 0 N-CA-C 118.112 2.005 . . . . 0.0 118.112 -169.389 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -66.34 -20.37 66.07 Favored 'General case' 0 N--CA 1.477 0.878 0 CA-C-N 122.548 3.174 . . . . 0.0 116.648 -169.684 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -75.69 -6.68 82.1 Favored Glycine 0 CA--C 1.542 1.748 0 O-C-N 121.339 -0.85 . . . . 0.0 113.881 169.627 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 61.1 mttp -119.87 -40.06 2.78 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 127.162 2.185 . . . . 0.0 113.101 -174.375 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 43.6 pt -144.27 157.22 15.31 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 C-N-CA 125.911 1.684 . . . . 0.0 112.686 -171.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -101.02 139.78 36.23 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.415 1.086 . . . . 0.0 109.39 169.486 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.47 HG21 ' HB1' ' A' ' 22' ' ' ALA . 30.2 t -130.79 136.46 58.14 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.076 0 CA-C-N 119.831 1.196 . . . . 0.0 113.179 177.632 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 37.1 m -131.02 154.91 47.7 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 125.969 1.708 . . . . 0.0 109.73 175.034 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 3.2 m -124.64 147.86 48.28 Favored 'General case' 0 CA--C 1.513 -0.458 0 CA-C-O 121.617 0.722 . . . . 0.0 112.42 168.358 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 2.2 m -142.74 149.74 39.15 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 113.688 -1.596 . . . . 0.0 111.167 172.636 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -79.82 165.21 49.23 Favored Glycine 0 CA--C 1.528 0.852 0 N-CA-C 110.888 -0.885 . . . . 0.0 110.888 169.484 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 9.1 mp -80.17 -11.51 59.74 Favored 'General case' 0 N--CA 1.48 1.036 0 O-C-N 121.653 -0.91 . . . . 0.0 112.809 169.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -132.03 165.5 23.84 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 126.973 2.109 . . . . 0.0 108.811 169.662 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 68.4 m -57.78 114.31 2.24 Favored 'General case' 0 N--CA 1.479 1.012 0 O-C-N 121.232 -0.917 . . . . 0.0 110.574 178.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 88.9 p -158.24 178.17 10.47 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 114.748 1.388 . . . . 0.0 114.748 -168.717 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 13.2 tpt180 -132.35 147.32 52.39 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 128.178 2.591 . . . . 0.0 108.631 174.296 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 33.0 m -62.28 154.91 5.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 CA-C-N 120.668 1.576 . . . . 0.0 109.425 168.394 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 11.9 t-80 -53.53 135.09 53.51 Favored Pre-proline 0 C--N 1.327 -0.389 0 CA-C-N 114.87 -1.059 . . . . 0.0 112.564 -170.13 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_exo -60.75 -26.11 82.37 Favored 'Trans proline' 0 CA--C 1.548 1.175 0 CA-C-N 121.01 1.397 . . . . 0.0 112.677 175.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 51.1 m -70.02 -33.94 72.65 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 125.296 1.438 . . . . 0.0 112.058 171.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -57.99 -43.2 86.44 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 124.018 0.927 . . . . 0.0 111.636 -178.474 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.7 mp -52.85 -54.15 17.82 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 CA-C-N 119.182 0.901 . . . . 0.0 109.425 -178.652 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -65.76 -32.28 73.73 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 113.351 0.871 . . . . 0.0 113.351 -177.406 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -79.19 -29.95 43.14 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 113.433 0.901 . . . . 0.0 113.433 178.683 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . 0.438 ' SD ' ' HG2' ' A' ' 17' ' ' MET . 1.0 OUTLIER -80.82 -29.57 35.95 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 123.521 0.728 . . . . 0.0 110.828 172.739 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -66.92 -12.27 58.93 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 124.719 1.208 . . . . 0.0 113.486 170.02 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -65.62 -26.23 67.73 Favored 'General case' 0 N--CA 1.481 1.076 0 CA-C-N 120.513 1.506 . . . . 0.0 110.892 169.06 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 56.7 t -93.72 -7.54 10.17 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.804 0 C-N-CA 126.996 2.119 . . . . 0.0 111.049 173.023 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 82.16 20.11 63.46 Favored Glycine 0 CA--C 1.538 1.501 0 C-N-CA 125.086 1.327 . . . . 0.0 114.22 -175.183 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.427 HG22 HG23 ' A' ' 57' ' ' ILE . 36.0 mt -85.68 126.13 40.51 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 CA-C-N 118.48 1.14 . . . . 0.0 110.805 -176.645 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 19.9 t0 -87.43 121.33 29.72 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.143 0.577 . . . . 0.0 111.537 170.692 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.427 HG23 HG22 ' A' ' 55' ' ' ILE . 29.2 pt -136.37 -1.72 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.24 0 N-CA-C 116.083 1.883 . . . . 0.0 116.083 -178.568 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 79.1 p -62.93 -25.61 68.42 Favored 'General case' 0 N--CA 1.482 1.17 0 N-CA-C 116.122 1.897 . . . . 0.0 116.122 -169.019 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -102.29 3.21 50.79 Favored Glycine 0 CA--C 1.537 1.431 0 N-CA-C 116.12 1.208 . . . . 0.0 116.12 -176.132 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 31.5 mt-30 -72.89 -44.3 61.46 Favored 'General case' 0 N--CA 1.48 1.05 0 CA-C-N 119.31 1.555 . . . . 0.0 113.639 -169.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 12.3 p -90.7 119.33 30.85 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 124.115 0.966 . . . . 0.0 112.382 -178.701 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 99.4 p -141.08 -12.17 0.95 Allowed 'General case' 0 N--CA 1.478 0.944 0 N-CA-C 114.884 1.439 . . . . 0.0 114.884 177.191 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -147.36 150.6 38.04 Favored Pre-proline 0 CA--C 1.546 0.821 0 C-N-CA 125.131 1.372 . . . . 0.0 111.58 179.522 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -63.15 155.71 59.66 Favored 'Trans proline' 0 C--N 1.35 0.624 0 C-N-CA 123.31 2.673 . . . . 0.0 112.168 169.543 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 10.3 tt -50.77 -33.84 12.47 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 C-N-CA 124.869 1.268 . . . . 0.0 112.291 171.261 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -62.41 -21.54 65.47 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.575 1.15 . . . . 0.0 112.87 -177.074 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 82.0 m-20 -91.7 4.7 52.14 Favored 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 124.452 1.101 . . . . 0.0 113.645 -176.264 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -116.48 -176.82 3.04 Favored 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 126.304 1.842 . . . . 0.0 112.377 179.283 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -119.76 125.0 47.56 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 125.874 1.67 . . . . 0.0 110.068 175.368 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -67.79 -34.91 77.7 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 113.921 1.082 . . . . 0.0 113.921 -171.201 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . 0.261 0.0 OUTLIER -71.6 -4.32 26.39 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 114.278 1.214 . . . . 0.0 114.278 -176.602 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -73.18 -15.96 61.44 Favored 'General case' 0 CA--C 1.548 0.871 0 O-C-N 121.711 -0.618 . . . . 0.0 111.136 168.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -112.45 138.5 49.11 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 127.074 2.15 . . . . 0.0 111.497 178.676 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -88.42 -23.68 23.25 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-O 122.112 0.958 . . . . 0.0 112.317 176.125 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.682 HG22 ' HB ' ' A' ' 95' ' ' ILE . 76.3 t -133.29 137.65 52.86 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 C-N-CA 126.679 1.992 . . . . 0.0 108.769 -175.487 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 78.8 t -133.56 131.92 57.3 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 173.184 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 43.3 mm -121.51 106.06 17.59 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 C-N-CA 124.243 1.017 . . . . 0.0 109.344 -171.378 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 4.1 m -88.75 109.79 20.45 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 123.631 0.772 . . . . 0.0 110.643 178.406 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 89.3 mt -90.76 -19.02 23.98 Favored 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 114.899 1.444 . . . . 0.0 114.899 -172.45 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 10.6 m -141.56 144.52 34.3 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.746 1.218 . . . . 0.0 110.703 -169.789 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 62.15 -125.37 35.97 Favored Glycine 0 CA--C 1.533 1.205 0 N-CA-C 110.632 -0.987 . . . . 0.0 110.632 -171.538 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 77.9 p -152.62 171.86 17.51 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.671 1.188 . . . . 0.0 111.527 169.719 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -66.41 65.0 0.16 Allowed Glycine 0 CA--C 1.538 1.512 0 C-N-CA 125.757 1.646 . . . . 0.0 114.691 176.043 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 7.7 p -143.79 -28.4 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.105 0 C-N-CA 125.633 1.573 . . . . 0.0 113.345 -178.324 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -91.19 22.95 3.51 Favored 'General case' 0 CA--C 1.554 1.121 0 C-N-CA 124.337 1.055 . . . . 0.0 112.447 178.115 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -133.54 159.28 73.15 Favored Pre-proline 0 CA--C 1.549 0.93 0 C-N-CA 126.338 1.855 . . . . 0.0 111.024 173.208 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -58.89 149.2 80.11 Favored 'Trans proline' 0 CA--C 1.543 0.937 0 C-N-CA 122.58 2.187 . . . . 0.0 112.695 178.229 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -61.77 -28.94 82.47 Favored 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 122.909 2.406 . . . . 0.0 113.626 -170.489 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -60.36 -20.95 61.4 Favored 'General case' 0 CA--C 1.544 0.723 0 N-CA-C 114.071 1.137 . . . . 0.0 114.071 177.704 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 88.6 m95 -80.34 -19.86 45.54 Favored 'General case' 0 N--CA 1.47 0.563 0 O-C-N 120.622 -1.299 . . . . 0.0 113.257 175.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 16.3 m -93.81 -8.21 9.98 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.125 0 N-CA-C 113.634 0.975 . . . . 0.0 113.634 172.213 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 67.5 p -96.98 -0.31 47.61 Favored 'General case' 0 N--CA 1.48 1.032 0 N-CA-C 114.796 1.406 . . . . 0.0 114.796 177.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 73.3 mm-40 -65.2 152.63 43.16 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 119.172 0.896 . . . . 0.0 111.213 169.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -54.01 -42.91 69.6 Favored 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 114.986 1.476 . . . . 0.0 114.986 -167.734 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.682 ' HB ' HG22 ' A' ' 75' ' ' VAL . 8.6 mm -118.26 65.16 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 C-N-CA 124.072 0.949 . . . . 0.0 109.224 173.41 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 23.3 t80 -75.31 109.46 8.85 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 106.909 -1.515 . . . . 0.0 106.909 168.645 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -104.58 130.45 52.55 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-O 121.797 0.808 . . . . 0.0 112.93 171.489 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -92.14 105.99 18.1 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 123.692 0.797 . . . . 0.0 109.399 169.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 19.0 m0 -94.47 99.26 11.46 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 124.571 1.148 . . . . 0.0 110.239 -176.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 99.9 mm-40 -79.13 53.7 1.5 Allowed 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 124.699 1.2 . . . . 0.0 110.514 170.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 5.0 tt -91.84 150.91 20.82 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 127.057 2.143 . . . . 0.0 111.9 -172.147 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -68.23 117.92 10.67 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 123.553 0.741 . . . . 0.0 112.868 179.029 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -74.43 133.25 77.62 Favored Pre-proline 0 CA--C 1.556 1.173 0 O-C-N 121.522 -0.736 . . . . 0.0 110.317 169.664 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -87.8 -6.96 6.57 Favored 'Trans proline' 0 CA--C 1.554 1.479 0 C-N-CA 122.295 1.997 . . . . 0.0 114.646 -178.597 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -64.38 146.91 53.69 Favored 'General case' 0 CA--C 1.547 0.864 0 CA-C-N 120.537 1.517 . . . . 0.0 113.188 176.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 75.77 8.62 84.65 Favored Glycine 0 CA--C 1.537 1.436 0 C-N-CA 123.869 0.747 . . . . 0.0 114.872 176.153 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 13.2 pt20 -140.75 165.46 27.44 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 125.893 1.677 . . . . 0.0 112.257 178.365 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 70.9 m -57.92 157.65 7.48 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 125.638 1.575 . . . . 0.0 114.843 -169.47 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 35.9 tp -59.25 -29.19 67.37 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 124.605 1.162 . . . . 0.0 113.001 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -61.9 -31.42 71.71 Favored 'General case' 0 N--CA 1.472 0.661 0 O-C-N 120.812 -1.18 . . . . 0.0 112.208 172.346 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 4.7 t -72.78 -40.49 60.97 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 O-C-N 121.146 -0.971 . . . . 0.0 111.114 171.73 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -55.16 -47.88 74.54 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 120.02 1.282 . . . . 0.0 112.056 169.857 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -69.13 -36.7 77.75 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.46 0.704 . . . . 0.0 112.506 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 79.0 m -63.86 -42.4 97.55 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 123.777 0.831 . . . . 0.0 110.832 171.593 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 44.1 t -65.96 -41.25 89.46 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 CA-C-O 117.567 -1.206 . . . . 0.0 110.803 176.429 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 30.8 mtm105 -55.73 -44.41 77.49 Favored 'General case' 0 N--CA 1.483 1.185 0 CA-C-N 120.841 1.655 . . . . 0.0 112.243 171.608 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -61.14 -50.85 62.75 Favored Glycine 0 CA--C 1.537 1.464 0 CA-C-N 118.979 0.809 . . . . 0.0 113.103 177.114 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 56.5 mm-40 -63.58 -45.0 92.42 Favored 'General case' 0 N--CA 1.473 0.689 0 O-C-N 121.996 -0.708 . . . . 0.0 112.217 178.387 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 70.4 t -64.78 -40.86 90.51 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 124.964 1.306 . . . . 0.0 111.301 177.679 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 84.3 tttt -54.44 -49.52 69.82 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 119.89 1.223 . . . . 0.0 110.474 176.215 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -63.64 -42.37 98.16 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 112.637 0.606 . . . . 0.0 112.637 176.268 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.24 -36.28 83.12 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 124.181 0.992 . . . . 0.0 112.897 177.803 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 92.5 t -78.44 -38.9 23.19 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 C-N-CA 125.521 1.529 . . . . 0.0 111.713 177.574 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -63.36 -35.43 80.38 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 119.546 1.066 . . . . 0.0 111.285 171.472 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 12.5 m-80 -64.89 -44.47 89.52 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 118.827 0.74 . . . . 0.0 112.52 172.328 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 9.8 tt -52.57 -57.18 10.81 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 124.237 1.015 . . . . 0.0 110.25 170.534 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 70.2 mt -60.58 -42.69 92.55 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 O-C-N 121.387 -0.821 . . . . 0.0 110.744 -177.805 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -68.45 -14.61 63.12 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 114.828 1.418 . . . . 0.0 114.828 178.263 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 19.0 ptmt -106.0 -32.75 8.16 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 113.596 0.961 . . . . 0.0 113.596 176.577 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.427 HD13 HG21 ' A' ' 75' ' ' VAL . 4.7 pt -88.98 -18.97 7.69 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 CA-C-O 118.038 -0.982 . . . . 0.0 113.619 -176.692 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 69.7 m . . . . . 0 C--O 1.253 1.274 0 N-CA-C 112.781 0.66 . . . . 0.0 112.781 -177.946 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.0 ttt . . . . . 0 N--CA 1.503 2.179 0 N-CA-C 111.774 0.287 . . . . 0.0 111.774 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.89 156.17 38.36 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 125.667 1.587 . . . . 0.0 113.207 179.422 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 44.1 mtmt -101.72 108.65 20.24 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 125.518 1.527 . . . . 0.0 107.342 167.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 16.3 t -95.18 131.92 40.64 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 125.981 1.713 . . . . 0.0 113.72 175.475 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' MET . . . . . 0.558 ' HG3' HG13 ' A' ' 7' ' ' VAL . 37.6 tpp -102.98 120.2 40.22 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 123.765 0.826 . . . . 0.0 109.162 168.804 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 65.0 m-85 -99.0 118.93 36.9 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 125.68 1.592 . . . . 0.0 108.307 174.588 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.558 HG13 ' HG3' ' A' ' 5' ' ' MET . 1.5 m -137.91 151.44 25.56 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.143 0 N-CA-C 115.013 1.486 . . . . 0.0 115.013 -168.64 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 41.5 t -155.31 162.99 40.72 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 125.691 1.597 . . . . 0.0 111.028 169.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 40.2 ttmt -69.99 133.05 46.84 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 125.052 1.341 . . . . 0.0 110.855 169.827 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 98.2 mtt180 51.13 80.12 0.09 Allowed 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 126.88 2.072 . . . . 0.0 112.386 -176.541 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 21.9 t-20 -67.98 -32.99 73.78 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 113.828 1.047 . . . . 0.0 113.828 -174.174 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 60.4 p -76.29 157.45 32.51 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 125.008 1.323 . . . . 0.0 112.688 169.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 67.1 m 53.62 26.45 5.77 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 124.901 1.28 . . . . 0.0 114.242 -174.681 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 23.9 ttm180 -147.33 151.85 37.24 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 127.76 2.424 . . . . 0.0 110.048 -175.32 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 46.0 t -109.07 152.84 24.49 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.49 0.716 . . . . 0.0 111.248 170.157 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -139.98 -42.43 0.43 Allowed 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 125.887 1.675 . . . . 0.0 111.893 -169.52 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 65.91 -36.72 0.24 Allowed 'General case' 0 N--CA 1.478 0.975 0 N-CA-C 118.205 2.668 . . . . 0.0 118.205 169.238 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.27 -36.56 80.36 Favored 'General case' 0 C--O 1.224 -0.289 0 CA-C-N 119.278 0.944 . . . . 0.0 113.406 -171.26 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.5 pm0 -57.46 -34.37 68.94 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 124.361 1.064 . . . . 0.0 113.307 171.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -72.49 -57.03 5.73 Favored Glycine 0 C--N 1.332 0.332 0 C-N-CA 124.293 0.949 . . . . 0.0 111.425 177.437 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -59.34 -33.79 71.57 Favored 'General case' 0 N--CA 1.468 0.43 0 O-C-N 122.24 -0.565 . . . . 0.0 112.427 177.902 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -63.38 -40.16 96.47 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 119.198 0.908 . . . . 0.0 112.285 -178.825 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 33.7 mttm -58.3 -56.39 22.73 Favored 'General case' 0 N--CA 1.486 1.373 0 CA-C-O 121.544 0.688 . . . . 0.0 110.874 168.782 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 35.9 m -69.75 -24.15 63.48 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 125.186 1.394 . . . . 0.0 114.056 -169.392 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 76.7 mt -96.38 -19.15 19.41 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 125.066 1.347 . . . . 0.0 114.461 177.262 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -159.01 26.29 0.37 Allowed Glycine 0 C--N 1.344 0.979 0 N-CA-C 119.021 2.368 . . . . 0.0 119.021 -169.001 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -66.56 -21.28 66.15 Favored 'General case' 0 CA--C 1.546 0.812 0 CA-C-N 122.15 2.975 . . . . 0.0 115.37 -176.501 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -74.86 -5.47 75.03 Favored Glycine 0 CA--C 1.542 1.745 0 O-C-N 121.493 -0.755 . . . . 0.0 113.776 169.546 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 70.0 mttt -117.18 -37.24 3.58 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 127.536 2.335 . . . . 0.0 113.301 -178.565 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 40.1 pt -142.76 150.07 18.41 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 C-N-CA 124.386 1.074 . . . . 0.0 113.171 -174.619 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -99.53 139.23 35.5 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 125.813 1.645 . . . . 0.0 108.337 169.355 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 5.1 m -132.14 144.91 35.71 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.236 0 C-N-CA 124.033 0.933 . . . . 0.0 110.352 -173.578 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 72.3 m -138.42 138.91 38.65 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 123.522 0.729 . . . . 0.0 109.411 175.091 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 2.8 p -98.67 138.04 36.42 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 112.127 0.417 . . . . 0.0 112.127 168.755 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 24.4 p -149.18 162.29 40.28 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 113.274 0.842 . . . . 0.0 113.274 170.095 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -109.78 147.1 17.11 Favored Glycine 0 N--CA 1.473 1.165 0 C-N-CA 124.236 0.922 . . . . 0.0 113.89 -179.393 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 11.2 mp -68.32 -25.55 65.17 Favored 'General case' 0 N--CA 1.485 1.298 0 CA-C-N 119.395 1.597 . . . . 0.0 111.041 169.603 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -142.36 144.31 33.12 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 127.688 2.395 . . . . 0.0 106.955 169.06 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 25.5 p 58.05 171.42 0.05 Allowed 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 126.91 2.084 . . . . 0.0 116.172 -176.106 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 83.2 p -137.79 168.38 19.8 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 125.805 1.642 . . . . 0.0 114.34 178.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 24.5 ttt-85 61.74 124.24 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 129.494 3.117 . . . . 0.0 113.398 -169.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 32.0 m -57.89 144.8 9.97 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.32 0 C-N-CA 123.376 0.67 . . . . 0.0 109.557 169.696 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -65.13 147.68 98.39 Favored Pre-proline 0 CA--C 1.544 0.749 0 C-N-CA 119.369 -0.932 . . . . 0.0 112.332 -169.614 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo -48.27 -41.72 34.59 Favored 'Trans proline' 0 CA--C 1.538 0.707 0 C-N-CA 123.375 2.717 . . . . 0.0 117.51 -168.185 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 86.1 m -64.82 -24.0 67.41 Favored 'General case' 0 N--CA 1.485 1.32 0 O-C-N 121.211 -0.931 . . . . 0.0 112.267 -177.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -57.6 -34.25 69.06 Favored 'General case' 0 CA--C 1.536 0.406 0 O-C-N 121.315 -0.865 . . . . 0.0 112.153 173.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.7 mp -60.58 -57.88 9.94 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 CA-C-N 119.901 1.228 . . . . 0.0 109.312 175.564 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -61.31 -32.77 72.63 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 113.122 0.786 . . . . 0.0 113.122 -178.561 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 3.8 tpp -77.36 -24.14 50.7 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 113.209 0.818 . . . . 0.0 113.209 178.051 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -87.49 -27.35 22.71 Favored 'General case' 0 CA--C 1.541 0.615 0 O-C-N 121.136 -0.977 . . . . 0.0 110.876 172.464 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -65.62 -5.16 7.51 Favored 'General case' 0 CA--C 1.552 1.055 0 C-N-CA 125.166 1.386 . . . . 0.0 113.036 169.456 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 18.5 mt-10 -72.79 -29.26 63.13 Favored 'General case' 0 N--CA 1.484 1.263 0 CA-C-N 120.039 1.29 . . . . 0.0 111.082 171.284 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 8.5 p -113.21 12.94 8.34 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.798 0 C-N-CA 127.143 2.177 . . . . 0.0 111.26 -177.142 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 80.17 18.06 72.75 Favored Glycine 0 CA--C 1.533 1.202 0 C-N-CA 124.978 1.275 . . . . 0.0 115.861 170.668 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 2.4 mm -71.92 143.49 14.14 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 CA-C-N 119.549 1.674 . . . . 0.0 110.286 177.757 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -97.82 29.63 3.32 Favored 'General case' 0 CA--C 1.553 1.083 0 C-N-CA 125.986 1.714 . . . . 0.0 115.476 -176.825 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 11.6 pt -72.11 -2.75 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.384 0 N-CA-C 115.594 1.702 . . . . 0.0 115.594 -175.173 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 91.6 p -55.58 -32.35 62.98 Favored 'General case' 0 N--CA 1.479 1.016 0 CA-C-N 119.851 1.205 . . . . 0.0 113.828 179.453 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -82.44 3.61 81.27 Favored Glycine 0 CA--C 1.536 1.364 0 C-N-CA 125.237 1.399 . . . . 0.0 116.105 177.412 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 5.1 mt-30 -79.48 132.68 36.41 Favored 'General case' 0 C--N 1.343 0.319 0 CA-C-N 120.362 2.081 . . . . 0.0 112.33 -179.019 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 40.4 p -139.66 113.58 8.75 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 126.068 1.747 . . . . 0.0 107.051 168.747 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 59.7 p -114.61 -174.7 2.53 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 114.703 1.371 . . . . 0.0 114.703 -169.208 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -133.86 164.49 43.64 Favored Pre-proline 0 CA--C 1.546 0.812 0 C-N-CA 126.833 2.053 . . . . 0.0 109.628 176.798 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -60.78 155.95 46.03 Favored 'Trans proline' 0 CA--C 1.541 0.871 0 C-N-CA 122.193 1.928 . . . . 0.0 112.522 169.769 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.531 HD12 HG11 ' A' ' 7' ' ' VAL . 7.5 tt -53.55 -33.17 21.67 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 C-N-CA 125.428 1.491 . . . . 0.0 111.552 175.045 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 17.8 mt-10 -59.66 -20.58 57.08 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 125.315 1.446 . . . . 0.0 113.112 178.662 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -85.31 -9.96 57.01 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 125.294 1.438 . . . . 0.0 113.609 -179.015 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -108.27 178.77 4.4 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 126.334 1.854 . . . . 0.0 112.301 -176.312 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 20.3 t30 -114.58 126.08 54.5 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 125.208 1.403 . . . . 0.0 110.075 175.774 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -63.47 -43.34 97.6 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 114.515 1.302 . . . . 0.0 114.515 -169.756 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -75.26 -0.9 21.13 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 113.495 0.924 . . . . 0.0 113.495 -178.468 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -71.83 -12.96 61.54 Favored 'General case' 0 CA--C 1.544 0.724 0 O-C-N 121.572 -0.705 . . . . 0.0 110.784 168.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -116.21 141.81 47.65 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 126.175 1.79 . . . . 0.0 111.222 178.715 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -86.71 -31.73 20.85 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 125.464 1.505 . . . . 0.0 111.651 174.717 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.76 HG22 ' HB ' ' A' ' 95' ' ' ILE . 94.3 t -129.12 138.03 55.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 C-N-CA 125.446 1.498 . . . . 0.0 108.38 -171.366 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 37.3 t -130.56 125.15 58.49 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 173.488 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 44.3 mm -116.25 102.87 14.27 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 C-N-CA 125.052 1.341 . . . . 0.0 108.8 -173.403 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 15.8 m -86.31 106.77 17.61 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 124.041 0.936 . . . . 0.0 110.111 176.493 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 81.1 mt -82.04 -4.92 57.86 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 125.271 1.428 . . . . 0.0 114.647 -169.772 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 28.6 p -152.9 147.96 26.59 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 124.34 1.056 . . . . 0.0 112.121 -175.7 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 60.84 -160.39 25.61 Favored Glycine 0 CA--C 1.536 1.385 0 C-N-CA 124.585 1.088 . . . . 0.0 114.739 176.589 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 86.9 p -71.45 -22.69 61.8 Favored 'General case' 0 N--CA 1.475 0.782 0 O-C-N 121.305 -1.115 . . . . 0.0 113.575 175.454 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 72.58 10.0 75.02 Favored Glycine 0 CA--C 1.533 1.201 0 C-N-CA 124.968 1.27 . . . . 0.0 114.367 -176.39 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.0 p -77.07 -16.76 14.57 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 CA-C-N 119.36 1.58 . . . . 0.0 114.664 -169.702 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 36.4 m120 -80.44 -9.3 59.76 Favored 'General case' 0 CA--C 1.548 0.901 0 N-CA-C 114.984 1.475 . . . . 0.0 114.984 -170.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -75.59 159.64 81.1 Favored Pre-proline 0 CA--C 1.552 1.033 0 CA-C-N 119.323 0.965 . . . . 0.0 112.066 169.727 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_exo -58.43 142.97 98.26 Favored 'Trans proline' 0 CA--C 1.547 1.146 0 C-N-CA 122.607 2.205 . . . . 0.0 113.011 179.287 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_exo -54.85 -32.08 75.8 Favored 'Trans proline' 0 C--N 1.353 0.777 0 C-N-CA 123.358 2.706 . . . . 0.0 115.62 -171.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 2.9 pm0 -61.95 -16.82 54.04 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 114.239 1.2 . . . . 0.0 114.239 177.76 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 93.6 m95 -80.58 -24.01 39.49 Favored 'General case' 0 CA--C 1.542 0.669 0 O-C-N 120.45 -1.406 . . . . 0.0 112.908 171.728 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 11.8 m -85.98 -10.19 11.27 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.167 0 CA-C-N 119.909 1.231 . . . . 0.0 113.555 174.195 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 72.0 p -98.31 0.96 46.57 Favored 'General case' 0 N--CA 1.477 0.917 0 N-CA-C 115.225 1.565 . . . . 0.0 115.225 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 76.7 mm-40 -67.4 160.35 27.55 Favored 'General case' 0 N--CA 1.478 0.971 0 CA-C-N 119.482 1.037 . . . . 0.0 110.95 169.803 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -58.01 -36.04 72.12 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 116.09 1.885 . . . . 0.0 116.09 -168.34 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.76 ' HB ' HG22 ' A' ' 75' ' ' VAL . 12.1 mm -127.18 74.55 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 CA-C-N 119.605 1.093 . . . . 0.0 109.062 177.707 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 12.4 t80 -81.57 109.78 16.34 Favored 'General case' 0 CA--C 1.534 0.365 0 O-C-N 121.224 -0.922 . . . . 0.0 108.544 169.289 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -111.32 139.33 46.82 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 114.636 1.347 . . . . 0.0 114.636 174.403 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -104.94 121.15 43.12 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.242 1.017 . . . . 0.0 108.98 168.754 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 43.8 m0 -107.07 111.61 24.15 Favored 'General case' 0 C--N 1.33 -0.239 0 C-N-CA 124.756 1.222 . . . . 0.0 108.352 -179.686 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 84.0 mm-40 -83.95 53.96 2.76 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-O 122.318 1.056 . . . . 0.0 111.561 -173.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 87.7 mt -85.53 165.86 16.76 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 126.957 2.103 . . . . 0.0 112.22 -179.704 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -96.29 157.0 16.1 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 123.98 0.912 . . . . 0.0 113.147 172.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 51.5 t0 -86.34 124.26 70.21 Favored Pre-proline 0 CA--C 1.542 0.665 0 C-N-CA 124.445 1.098 . . . . 0.0 110.266 173.021 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_exo -58.67 -24.4 70.57 Favored 'Trans proline' 0 CA--C 1.543 0.952 0 C-N-CA 122.925 2.417 . . . . 0.0 115.343 172.868 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -65.94 143.52 57.35 Favored 'General case' 0 CA--C 1.546 0.792 0 CA-C-N 119.444 1.02 . . . . 0.0 112.995 -178.771 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 80.95 5.95 89.78 Favored Glycine 0 CA--C 1.536 1.399 0 N-CA-C 115.176 0.83 . . . . 0.0 115.176 178.617 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 8.6 pt20 -142.17 168.3 20.07 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 125.378 1.471 . . . . 0.0 112.833 179.275 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 66.8 m -59.67 155.21 16.17 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 125.503 1.521 . . . . 0.0 114.085 -170.181 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 7.9 tt -60.51 -30.98 70.07 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.746 1.218 . . . . 0.0 113.569 -175.107 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -65.17 -23.96 67.25 Favored 'General case' 0 CA--C 1.546 0.81 0 O-C-N 121.059 -1.026 . . . . 0.0 112.899 173.544 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 11.3 t -72.84 -38.15 56.47 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 O-C-N 120.789 -1.195 . . . . 0.0 110.734 170.651 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -53.76 -45.73 70.69 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 118.78 0.718 . . . . 0.0 110.686 169.045 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 38.9 mtt180 -66.77 -39.08 87.71 Favored 'General case' 0 N--CA 1.482 1.159 0 N-CA-C 113.012 0.745 . . . . 0.0 113.012 175.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 28.9 m -58.89 -42.88 90.58 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 124.345 1.058 . . . . 0.0 110.946 172.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 77.6 t -67.99 -38.57 80.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 CA-C-O 117.894 -1.051 . . . . 0.0 111.083 177.361 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 65.9 mtm-85 -57.25 -43.82 83.34 Favored 'General case' 0 N--CA 1.487 1.413 0 CA-C-N 120.696 1.589 . . . . 0.0 112.208 170.169 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -59.37 -49.6 76.74 Favored Glycine 0 CA--C 1.536 1.403 0 CA-C-N 119.104 0.865 . . . . 0.0 113.253 176.522 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 55.5 mm-40 -64.57 -44.11 91.73 Favored 'General case' 0 N--CA 1.473 0.709 0 O-C-N 122.078 -0.66 . . . . 0.0 112.131 177.788 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 75.6 t -65.95 -37.38 79.72 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 124.203 1.001 . . . . 0.0 111.344 177.201 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 58.2 tttm -55.93 -51.9 66.0 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-N 119.81 1.186 . . . . 0.0 110.743 176.212 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -63.78 -40.82 97.6 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.119 0.568 . . . . 0.0 112.199 178.347 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -62.87 -44.08 97.07 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 124.583 1.153 . . . . 0.0 113.272 176.486 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 66.8 t -74.31 -35.8 40.93 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 124.188 0.995 . . . . 0.0 111.518 178.56 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -63.1 -39.76 95.65 Favored 'General case' 0 N--CA 1.471 0.58 0 O-C-N 121.138 -0.976 . . . . 0.0 111.679 169.809 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 11.6 m-80 -63.36 -44.94 93.36 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 118.976 0.807 . . . . 0.0 112.225 172.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 8.4 tt -51.49 -56.79 11.41 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 124.48 1.112 . . . . 0.0 110.306 174.334 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 62.8 mt -66.82 -44.24 89.23 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 O-C-N 121.848 -0.533 . . . . 0.0 111.174 -175.731 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -69.4 -10.53 58.38 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 114.102 1.149 . . . . 0.0 114.102 177.559 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 72.7 tttt -95.77 -48.26 5.83 Favored 'General case' 0 C--O 1.234 0.239 0 C-N-CA 125.811 1.644 . . . . 0.0 111.428 176.037 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 7.5 pt -93.71 -15.17 7.99 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 N-CA-C 114.375 1.25 . . . . 0.0 114.375 -172.798 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 73.8 m . . . . . 0 C--O 1.256 1.408 0 C-N-CA 125.606 1.562 . . . . 0.0 111.722 -176.464 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.8 ttt . . . . . 0 N--CA 1.502 2.166 0 N-CA-C 111.861 0.319 . . . . 0.0 111.861 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.72 164.99 28.88 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 125.371 1.468 . . . . 0.0 112.937 178.737 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 71.1 mttt -94.49 146.42 24.11 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 124.085 0.954 . . . . 0.0 112.872 175.58 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 14.5 t -123.51 134.45 66.31 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 C-N-CA 125.543 1.537 . . . . 0.0 111.998 175.019 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 48.6 tpp -102.81 123.48 46.54 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 168.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 72.4 m-85 -101.35 131.19 47.54 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 169.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -140.65 143.18 29.35 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 N-CA-C 114.012 1.116 . . . . 0.0 114.012 -169.379 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 46.4 t -145.14 160.11 41.94 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 127.473 2.309 . . . . 0.0 109.081 169.36 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 64.9 pttt -66.23 -42.67 88.32 Favored 'General case' 0 N--CA 1.485 1.311 0 N-CA-C 115.117 1.525 . . . . 0.0 115.117 -171.341 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 12.7 mmm180 -113.29 63.12 0.64 Allowed 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 126.758 2.023 . . . . 0.0 112.148 -175.705 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 47.2 t30 -45.42 -46.6 13.48 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 125.139 1.376 . . . . 0.0 113.834 -172.52 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 86.0 p -78.36 -10.2 59.59 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 115.717 1.747 . . . . 0.0 115.717 -175.674 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 88.6 p -133.36 0.34 3.35 Favored 'General case' 0 N--CA 1.479 1.003 0 N-CA-C 116.3 1.963 . . . . 0.0 116.3 179.401 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 2.4 tpt180 -112.82 -27.38 8.15 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 114.889 1.44 . . . . 0.0 114.889 178.766 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 3.0 t 63.77 166.63 0.14 Allowed 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 115.639 1.718 . . . . 0.0 115.639 -176.221 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -141.58 -50.06 0.41 Allowed 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 114.396 1.258 . . . . 0.0 114.396 -170.006 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 70.52 -38.78 0.43 Allowed 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 126.185 1.794 . . . . 0.0 114.096 -178.374 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -63.02 -30.79 71.88 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 113.992 1.108 . . . . 0.0 113.992 -173.73 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.2 pm0 -67.2 -42.42 84.18 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 119.568 1.077 . . . . 0.0 111.837 175.759 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -66.77 -41.31 93.75 Favored Glycine 0 C--N 1.335 0.48 0 N-CA-C 111.351 -0.7 . . . . 0.0 111.351 -178.324 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -70.89 -39.25 72.92 Favored 'General case' 0 N--CA 1.469 0.497 0 O-C-N 121.842 -0.799 . . . . 0.0 111.815 174.91 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -63.76 -35.92 82.19 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 119.375 0.989 . . . . 0.0 112.909 -176.08 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 7.5 pttp -82.72 -28.35 30.54 Favored 'General case' 0 N--CA 1.479 0.996 0 N-CA-C 113.972 1.101 . . . . 0.0 113.972 171.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 96.6 m -70.22 -35.74 74.08 Favored 'General case' 0 N--CA 1.486 1.341 0 CA-C-N 118.76 0.709 . . . . 0.0 111.937 175.093 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 74.1 mt -91.0 -38.03 13.08 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 125.92 1.688 . . . . 0.0 113.324 179.175 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -105.11 5.98 42.57 Favored Glycine 0 N--CA 1.471 1.008 0 N-CA-C 117.5 1.76 . . . . 0.0 117.5 -169.303 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.61 141.23 57.91 Favored 'General case' 0 CA--C 1.546 0.821 0 CA-C-N 121.149 2.474 . . . . 0.0 112.294 178.122 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 82.88 -16.93 24.46 Favored Glycine 0 CA--C 1.539 1.564 0 C-N-CA 124.868 1.223 . . . . 0.0 113.959 -169.539 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 62.7 mttp -104.0 -44.29 5.06 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 125.897 1.679 . . . . 0.0 112.172 171.808 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 38.1 pt -139.53 159.63 27.99 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 C-N-CA 125.323 1.449 . . . . 0.0 112.64 -178.257 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -107.85 149.23 28.52 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.378 1.471 . . . . 0.0 110.397 170.017 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 98.1 t -133.46 141.64 43.86 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 O-C-N 121.497 -0.752 . . . . 0.0 112.796 -176.173 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 38.8 m -134.91 153.33 52.1 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 125.732 1.613 . . . . 0.0 108.926 169.703 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 92.8 p -133.33 145.73 50.67 Favored 'General case' 0 CA--C 1.512 -0.497 0 CA-C-O 122.372 1.082 . . . . 0.0 112.179 167.774 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 54.4 p -145.97 166.53 25.77 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 113.714 -1.584 . . . . 0.0 112.199 -177.68 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -106.63 162.82 13.57 Favored Glycine 0 N--CA 1.467 0.753 0 C-N-CA 123.587 0.613 . . . . 0.0 112.754 172.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 9.0 mp -76.0 -32.27 59.33 Favored 'General case' 0 N--CA 1.479 1.024 0 O-C-N 122.144 -0.621 . . . . 0.0 111.819 172.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -134.29 27.23 3.8 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 125.734 1.614 . . . . 0.0 111.916 177.12 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 37.5 t -154.66 145.45 22.46 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 124.319 1.048 . . . . 0.0 112.796 -170.353 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 98.8 p -107.96 -13.04 15.05 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 116.853 2.168 . . . . 0.0 116.853 -169.679 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 71.7 ttt180 -134.38 149.12 50.79 Favored 'General case' 0 N--CA 1.483 1.217 0 CA-C-N 120.009 1.277 . . . . 0.0 111.072 -176.382 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 22.3 m -68.11 166.27 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.15 0 CA-C-O 122.908 1.337 . . . . 0.0 110.98 169.536 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 6.1 t-80 -57.04 129.87 79.18 Favored Pre-proline 0 N--CA 1.447 -0.586 0 CA-C-N 114.049 -1.432 . . . . 0.0 111.716 179.163 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_exo -61.1 -29.2 86.88 Favored 'Trans proline' 0 CA--C 1.549 1.25 0 CA-C-N 121.145 1.445 . . . . 0.0 112.3 177.506 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 99.3 m -67.64 -28.24 67.56 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 126.069 1.748 . . . . 0.0 112.656 172.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -59.68 -41.06 89.84 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 119.119 0.872 . . . . 0.0 111.748 -176.717 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.9 mp -54.17 -55.16 15.83 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 C-N-CA 123.976 0.91 . . . . 0.0 109.298 -177.585 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -65.83 -34.63 78.61 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 113.94 1.089 . . . . 0.0 113.94 -176.859 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -78.26 -20.57 51.38 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 113.676 0.991 . . . . 0.0 113.676 179.785 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 43.0 mtt -98.16 -26.78 14.45 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 125.032 1.333 . . . . 0.0 110.493 177.391 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -66.53 -13.82 61.47 Favored 'General case' 0 CA--C 1.544 0.717 0 O-C-N 120.662 -1.274 . . . . 0.0 111.784 168.525 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -61.83 -24.65 67.02 Favored 'General case' 0 N--CA 1.482 1.136 0 O-C-N 121.001 -1.062 . . . . 0.0 110.652 168.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 40.0 t -99.62 -6.77 9.15 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.882 0 C-N-CA 127.896 2.478 . . . . 0.0 111.275 175.358 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 81.68 20.82 62.95 Favored Glycine 0 CA--C 1.54 1.647 0 C-N-CA 125.293 1.425 . . . . 0.0 114.378 -173.44 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 85.7 mt -79.65 127.14 39.37 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 CA-C-N 118.485 1.143 . . . . 0.0 111.874 -173.51 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 20.7 t0 -89.15 93.73 9.68 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 123.538 0.735 . . . . 0.0 112.006 177.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 7.2 pt -118.27 11.08 7.03 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.082 0 C-N-CA 124.703 1.201 . . . . 0.0 113.957 170.761 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 72.7 m -60.42 -27.33 67.4 Favored 'General case' 0 N--CA 1.479 0.988 0 O-C-N 120.793 -1.192 . . . . 0.0 112.541 176.57 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -82.55 6.8 67.43 Favored Glycine 0 CA--C 1.538 1.472 0 C-N-CA 125.63 1.586 . . . . 0.0 116.031 174.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 26.5 mm100 -78.16 43.4 0.44 Allowed 'General case' 0 N--CA 1.478 0.969 0 CA-C-N 120.069 1.934 . . . . 0.0 113.599 -179.812 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 36.6 p -87.96 111.97 22.06 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 107.102 -1.444 . . . . 0.0 107.102 168.769 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 70.4 m -130.81 -160.59 1.05 Allowed 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 124.831 1.252 . . . . 0.0 111.374 -168.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -124.14 166.98 16.71 Favored Pre-proline 0 CA--C 1.546 0.797 0 C-N-CA 126.354 1.862 . . . . 0.0 108.464 169.543 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_endo -58.21 156.92 27.7 Favored 'Trans proline' 0 CA--C 1.539 0.761 0 C-N-CA 121.917 1.744 . . . . 0.0 112.38 169.573 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.492 HD11 ' CE3' ' A' ' 90' ' ' TRP . 9.8 tp -49.94 -34.02 9.51 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 C-N-CA 125.537 1.535 . . . . 0.0 112.363 174.183 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 12.7 mt-10 -64.32 -18.42 64.6 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.864 1.266 . . . . 0.0 113.126 -177.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -87.06 -13.9 43.01 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 124.994 1.318 . . . . 0.0 113.583 -173.255 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -104.67 -174.24 2.49 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 126.164 1.786 . . . . 0.0 112.686 -174.594 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 6.1 t30 -121.94 121.99 38.35 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 125.679 1.591 . . . . 0.0 109.519 175.035 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -64.11 -37.79 88.71 Favored 'General case' 0 C--N 1.333 -0.139 0 N-CA-C 114.943 1.46 . . . . 0.0 114.943 -169.617 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -73.64 -1.4 18.76 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 114.141 1.163 . . . . 0.0 114.141 -174.071 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -73.37 -14.87 61.36 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 123.392 0.677 . . . . 0.0 110.743 168.712 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 81.2 m-85 -112.44 140.57 47.07 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 127.315 2.246 . . . . 0.0 111.203 178.195 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -91.21 -22.58 20.55 Favored 'General case' 0 N--CA 1.477 0.879 0 CA-C-O 121.992 0.901 . . . . 0.0 112.303 176.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.714 HG22 ' HB ' ' A' ' 95' ' ' ILE . 90.5 t -134.5 138.1 50.26 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 C-N-CA 126.849 2.06 . . . . 0.0 108.948 -173.611 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 47.3 t -134.52 130.4 53.52 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 172.761 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 39.3 mm -119.0 104.83 16.51 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 C-N-CA 124.292 1.037 . . . . 0.0 109.717 -172.363 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 7.3 m -81.88 118.92 23.31 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 123.807 0.843 . . . . 0.0 109.634 171.359 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 90.5 mt -100.11 -7.23 25.13 Favored 'General case' 0 N--CA 1.478 0.929 0 N-CA-C 114.491 1.293 . . . . 0.0 114.491 -171.643 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 76.5 m -131.06 59.92 1.67 Allowed 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 125.217 1.407 . . . . 0.0 109.177 -169.745 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 82.4 -155.44 34.16 Favored Glycine 0 CA--C 1.536 1.354 0 C-N-CA 124.846 1.212 . . . . 0.0 111.602 -169.577 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 83.6 p -66.3 -29.91 70.22 Favored 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 113.483 0.92 . . . . 0.0 113.483 177.855 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 66.4 20.5 69.66 Favored Glycine 0 CA--C 1.534 1.247 0 C-N-CA 124.402 1.001 . . . . 0.0 114.11 -177.312 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 7.3 p -55.99 -9.89 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.34 0 N-CA-C 116.118 1.896 . . . . 0.0 116.118 -169.691 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -66.82 -22.18 66.01 Favored 'General case' 0 CA--C 1.554 1.124 0 N-CA-C 114.362 1.245 . . . . 0.0 114.362 169.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -67.82 154.51 93.41 Favored Pre-proline 0 N--CA 1.483 1.202 0 CA-C-N 120.903 1.683 . . . . 0.0 112.009 169.693 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.407 ' HA ' ' HD3' ' A' ' 88' ' ' PRO . 74.4 Cg_exo -57.71 148.51 73.86 Favored 'Trans proline' 0 CA--C 1.545 1.045 0 C-N-CA 122.698 2.265 . . . . 0.0 113.825 -175.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 87' ' ' PRO . 82.2 Cg_exo -56.04 -32.54 86.65 Favored 'Trans proline' 0 C--N 1.354 0.85 0 C-N-CA 123.12 2.547 . . . . 0.0 114.898 -171.755 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -60.51 -21.69 62.73 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 114.057 1.132 . . . . 0.0 114.057 179.411 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . 0.492 ' CE3' HD11 ' A' ' 65' ' ' ILE . 93.7 m95 -79.48 -21.52 45.29 Favored 'General case' 0 N--CA 1.47 0.529 0 O-C-N 120.695 -1.253 . . . . 0.0 113.169 175.0 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 14.2 m -92.42 -5.94 10.69 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 N-CA-C 113.481 0.919 . . . . 0.0 113.481 173.431 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 59.9 p -100.32 0.39 39.99 Favored 'General case' 0 N--CA 1.479 1.006 0 N-CA-C 115.29 1.589 . . . . 0.0 115.29 177.32 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 74.0 mm-40 -66.89 155.42 38.46 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-N 119.459 1.027 . . . . 0.0 110.722 169.789 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -54.78 -43.12 72.55 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 115.093 1.516 . . . . 0.0 115.093 -167.78 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.714 ' HB ' HG22 ' A' ' 75' ' ' VAL . 10.0 mm -116.53 66.39 0.23 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 C-N-CA 123.875 0.87 . . . . 0.0 109.579 176.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 12.2 t80 -77.04 108.71 10.3 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 168.595 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 9.1 mt-10 -107.62 142.58 37.34 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 114.321 1.23 . . . . 0.0 114.321 173.511 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -107.66 120.24 41.66 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 124.634 1.174 . . . . 0.0 108.23 168.381 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 37.3 m0 -103.84 133.67 48.44 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.545 1.138 . . . . 0.0 108.814 177.504 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 63.8 mt-30 -113.88 29.36 8.06 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 123.993 0.917 . . . . 0.0 111.987 -169.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -70.37 164.62 24.15 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 125.732 1.613 . . . . 0.0 112.292 170.621 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -73.63 158.71 34.25 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-O 121.773 0.797 . . . . 0.0 111.49 169.824 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -97.02 150.77 37.2 Favored Pre-proline 0 CA--C 1.542 0.653 0 C-N-CA 123.418 0.687 . . . . 0.0 110.055 169.797 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -88.59 -12.44 3.71 Favored 'Trans proline' 0 CA--C 1.547 1.152 0 CA-C-N 120.845 1.338 . . . . 0.0 115.072 -173.415 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -62.53 -50.27 72.04 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 114.928 1.455 . . . . 0.0 114.928 -170.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -77.24 16.69 5.63 Favored Glycine 0 CA--C 1.537 1.425 0 N-CA-C 115.256 0.862 . . . . 0.0 115.256 -169.825 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 7.9 pt20 -155.92 179.28 9.36 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 126.006 1.722 . . . . 0.0 112.63 -169.221 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 27.8 p -68.8 167.46 15.43 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 116.27 1.952 . . . . 0.0 116.27 -169.314 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 36.0 tp -59.88 -31.81 70.14 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.412 1.085 . . . . 0.0 112.46 172.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -63.46 -32.51 73.98 Favored 'General case' 0 N--CA 1.47 0.537 0 O-C-N 121.073 -1.017 . . . . 0.0 111.499 172.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 4.4 t -74.1 -35.07 40.21 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 O-C-N 121.2 -0.937 . . . . 0.0 112.069 171.54 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -55.59 -46.95 77.18 Favored 'General case' 0 N--CA 1.477 0.889 0 CA-C-N 120.424 1.466 . . . . 0.0 111.255 169.413 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 96.9 mtt180 -69.87 -33.91 72.87 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.75 0.82 . . . . 0.0 112.585 178.275 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 53.2 m -63.34 -42.89 98.98 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 123.787 0.835 . . . . 0.0 110.96 170.212 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 50.8 t -65.11 -40.56 89.28 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.475 0 CA-C-O 117.316 -1.326 . . . . 0.0 110.55 176.413 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 24.7 mtm105 -53.63 -47.38 70.34 Favored 'General case' 0 N--CA 1.484 1.248 0 CA-C-N 120.804 1.638 . . . . 0.0 112.287 170.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -61.36 -50.65 64.54 Favored Glycine 0 CA--C 1.537 1.417 0 CA-C-N 119.027 0.831 . . . . 0.0 113.644 177.743 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 65.2 mm-40 -63.49 -44.48 94.24 Favored 'General case' 0 N--CA 1.474 0.736 0 O-C-N 121.991 -0.711 . . . . 0.0 112.332 179.221 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 56.0 t -63.79 -43.73 98.02 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 C-N-CA 124.507 1.123 . . . . 0.0 110.603 176.485 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 59.5 tttm -53.56 -50.69 65.01 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-N 119.804 1.184 . . . . 0.0 111.295 179.602 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -63.58 -41.32 98.38 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 179.064 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 8.5 mtp85 -64.25 -42.12 96.65 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 113.145 0.794 . . . . 0.0 113.145 175.766 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 94.2 t -71.0 -36.44 63.53 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 C-N-CA 123.674 0.79 . . . . 0.0 111.156 178.71 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -63.31 -38.09 89.81 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 119.386 0.994 . . . . 0.0 111.606 170.724 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 12.5 m-80 -62.67 -48.02 81.12 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 118.914 0.779 . . . . 0.0 112.052 171.807 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 10.3 tt -50.45 -57.24 8.49 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 124.483 1.113 . . . . 0.0 110.07 173.809 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 75.3 mt -64.02 -42.57 96.1 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 CA-C-N 119.25 0.932 . . . . 0.0 111.56 -176.601 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -68.22 -10.46 54.62 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 114.535 1.309 . . . . 0.0 114.535 175.781 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 74.6 tttt -103.5 -45.78 4.75 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 126.049 1.74 . . . . 0.0 111.664 -179.813 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.573 HD13 HG21 ' A' ' 75' ' ' VAL . 5.4 pt -92.06 -16.53 7.88 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 N-CA-C 114.48 1.289 . . . . 0.0 114.48 -170.293 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 72.5 m . . . . . 0 C--O 1.253 1.281 0 CA-C-N 118.913 0.778 . . . . 0.0 112.9 -175.603 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.1 ttt . . . . . 0 N--CA 1.502 2.151 0 N-CA-C 111.615 0.228 . . . . 0.0 111.615 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.75 166.5 25.06 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 124.768 1.227 . . . . 0.0 113.654 177.266 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 44.2 mtmt -94.76 138.71 32.23 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 126.154 1.782 . . . . 0.0 112.954 -179.191 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 21.2 t -123.6 133.51 68.99 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 C-N-CA 126.036 1.734 . . . . 0.0 112.479 -179.151 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' MET . . . . . 0.494 ' HG3' HG13 ' A' ' 7' ' ' VAL . 41.8 tpp -104.66 125.51 50.85 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.562 0.745 . . . . 0.0 109.492 168.888 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 58.6 m-85 -102.81 127.72 49.86 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.266 1.026 . . . . 0.0 109.667 170.351 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.531 HG11 HD12 ' A' ' 65' ' ' ILE . 1.3 m -140.51 144.98 26.46 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.182 0 N-CA-C 114.414 1.265 . . . . 0.0 114.414 -168.862 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 41.7 t -157.06 159.65 38.15 Favored 'General case' 0 CA--C 1.556 1.18 0 C-N-CA 127.369 2.268 . . . . 0.0 111.974 177.443 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 17.9 ptpt -90.57 157.67 17.39 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 124.997 1.319 . . . . 0.0 111.638 169.522 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 34.1 mtp180 60.15 25.47 14.81 Favored 'General case' 0 N--CA 1.494 1.746 0 C-N-CA 126.074 1.75 . . . . 0.0 113.804 -169.098 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 5.8 t30 -52.95 -38.61 62.18 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 124.839 1.256 . . . . 0.0 114.045 -169.449 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 50.2 m -80.31 -8.34 59.44 Favored 'General case' 0 N--CA 1.478 0.96 0 N-CA-C 114.692 1.367 . . . . 0.0 114.692 -178.621 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 83.6 p -119.76 16.54 12.72 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 125.394 1.478 . . . . 0.0 112.996 170.672 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 19.5 ttm180 -139.49 156.06 47.17 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 125.653 1.581 . . . . 0.0 112.115 -175.78 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 73.0 m -94.76 138.08 33.03 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 125.015 1.326 . . . . 0.0 111.046 169.785 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 3.9 mp0 -113.71 -39.1 4.1 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 124.291 1.037 . . . . 0.0 112.497 -177.1 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . 0.43 ' HG2' ' SD ' ' A' ' 50' ' ' MET . 0.0 OUTLIER 68.96 -50.98 0.59 Allowed 'General case' 0 N--CA 1.478 0.954 0 N-CA-C 117.641 2.46 . . . . 0.0 117.641 169.212 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -56.73 -35.3 68.4 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 114.398 1.258 . . . . 0.0 114.398 -169.246 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 23.4 pm0 -61.13 -40.06 92.37 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.944 1.297 . . . . 0.0 112.711 177.137 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -69.91 -37.77 74.79 Favored Glycine 0 C--N 1.336 0.554 0 N-CA-C 111.377 -0.689 . . . . 0.0 111.377 178.46 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -70.43 -40.25 73.9 Favored 'General case' 0 N--CA 1.47 0.546 0 O-C-N 121.89 -0.771 . . . . 0.0 111.184 176.514 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.21 -41.79 97.46 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 119.024 0.829 . . . . 0.0 112.527 -175.567 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 10.5 pttp -79.49 -27.53 41.48 Favored 'General case' 0 N--CA 1.479 1.013 0 N-CA-C 113.662 0.986 . . . . 0.0 113.662 173.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 96.3 m -68.84 -36.59 78.34 Favored 'General case' 0 N--CA 1.486 1.342 0 O-C-N 121.185 -0.947 . . . . 0.0 111.636 172.81 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 72.1 mt -87.89 -29.67 20.7 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 125.656 1.582 . . . . 0.0 114.037 -178.489 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -146.03 28.95 1.69 Allowed Glycine 0 N--CA 1.473 1.129 0 N-CA-C 118.502 2.161 . . . . 0.0 118.502 -169.206 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -66.62 -20.2 65.94 Favored 'General case' 0 CA--C 1.546 0.813 0 CA-C-N 122.108 2.954 . . . . 0.0 115.197 -177.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -76.49 -7.73 85.5 Favored Glycine 0 CA--C 1.542 1.771 0 O-C-N 121.432 -0.793 . . . . 0.0 113.597 169.575 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 61.1 mttp -111.33 -40.73 4.32 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 127.088 2.155 . . . . 0.0 112.692 -178.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 28.3 pt -141.09 155.71 21.63 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 C-N-CA 125.366 1.466 . . . . 0.0 112.42 -172.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -103.06 136.6 42.56 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 124.678 1.191 . . . . 0.0 110.199 171.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 74.6 t -123.54 137.18 57.65 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 CA-C-N 118.814 0.734 . . . . 0.0 112.134 -175.327 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 41.4 m -129.59 153.71 47.8 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 125.566 1.547 . . . . 0.0 108.763 169.844 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 26.0 p -129.59 146.33 51.4 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.806 0.812 . . . . 0.0 111.991 168.671 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 59.4 p -145.78 148.17 32.66 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 114.247 -1.342 . . . . 0.0 112.117 177.45 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -82.32 152.66 31.16 Favored Glycine 0 CA--C 1.53 1.009 0 O-C-N 121.429 -0.794 . . . . 0.0 111.493 172.646 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.7 mp -69.4 -32.8 72.04 Favored 'General case' 0 N--CA 1.477 0.877 0 O-C-N 120.843 -1.387 . . . . 0.0 113.389 179.006 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -134.77 11.9 3.68 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 124.683 1.193 . . . . 0.0 113.027 178.641 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 23.6 p -152.73 173.89 14.71 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 125.227 1.411 . . . . 0.0 112.013 -174.71 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 62.6 m -99.0 -73.39 0.62 Allowed 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 113.738 1.014 . . . . 0.0 113.738 -169.838 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 30.3 ttt85 -86.18 165.89 16.18 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 125.906 1.682 . . . . 0.0 111.463 -169.397 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 21.3 m -82.57 166.38 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 C-N-CA 123.258 0.623 . . . . 0.0 111.316 170.356 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . 0.262 0.0 OUTLIER -67.67 137.76 93.12 Favored Pre-proline 0 CA--C 1.545 0.766 0 C-N-CA 118.971 -1.091 . . . . 0.0 109.879 169.752 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -61.38 -30.06 86.65 Favored 'Trans proline' 0 CA--C 1.537 0.67 0 C-N-CA 123.219 2.613 . . . . 0.0 116.148 -167.793 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 90.7 m -64.14 -23.96 67.51 Favored 'General case' 0 N--CA 1.481 1.075 0 O-C-N 120.969 -1.082 . . . . 0.0 111.86 -177.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -55.67 -38.62 69.85 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.117 0.967 . . . . 0.0 112.507 172.513 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 5.0 mp -60.22 -54.7 31.26 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 CA-C-N 119.588 1.085 . . . . 0.0 110.018 179.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.3 -32.09 73.41 Favored 'General case' 0 CA--C 1.542 0.656 0 N-CA-C 113.222 0.823 . . . . 0.0 113.222 -178.535 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 2.1 tpp -77.71 -25.6 49.48 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 113.679 0.992 . . . . 0.0 113.679 177.176 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . 0.43 ' SD ' ' HG2' ' A' ' 17' ' ' MET . 0.0 OUTLIER -88.01 -26.84 22.4 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-N 119.723 1.147 . . . . 0.0 111.04 174.145 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -65.12 -11.83 44.22 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 124.998 1.319 . . . . 0.0 113.219 169.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 17.9 mt-10 -61.7 -27.05 68.42 Favored 'General case' 0 N--CA 1.485 1.29 0 CA-C-N 120.012 1.278 . . . . 0.0 110.26 168.551 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 21.6 t -98.27 -1.52 10.17 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.958 0 C-N-CA 128.232 2.613 . . . . 0.0 110.829 178.774 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 77.04 20.13 76.3 Favored Glycine 0 CA--C 1.538 1.512 0 C-N-CA 125.041 1.305 . . . . 0.0 114.474 -176.036 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 70.5 mt -80.25 128.12 38.86 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 124.279 1.032 . . . . 0.0 111.72 -172.122 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 10.4 p-10 -88.22 100.35 12.91 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 124.372 1.069 . . . . 0.0 112.582 -179.734 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 12.9 pt -133.25 15.4 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.141 0 N-CA-C 114.934 1.457 . . . . 0.0 114.934 178.473 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 66.5 m -63.56 -19.77 65.09 Favored 'General case' 0 N--CA 1.481 1.09 0 O-C-N 120.32 -1.487 . . . . 0.0 113.293 177.514 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -85.41 10.08 65.3 Favored Glycine 0 CA--C 1.538 1.506 0 C-N-CA 125.993 1.759 . . . . 0.0 116.59 179.636 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 64.3 mt-30 -71.96 40.45 0.08 Allowed 'General case' 0 N--CA 1.486 1.34 0 CA-C-N 120.334 2.067 . . . . 0.0 114.699 -178.753 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 88.8 m -80.98 -4.56 55.51 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 119.788 -1.82 . . . . 0.0 112.662 177.198 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 70.5 m -45.11 146.4 0.87 Allowed 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 127.416 2.287 . . . . 0.0 114.323 176.332 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -67.69 171.51 5.18 Favored Pre-proline 0 CA--C 1.553 1.087 0 C-N-CA 127.169 2.188 . . . . 0.0 114.1 -175.558 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -59.03 160.06 19.8 Favored 'Trans proline' 0 C--N 1.353 0.798 0 C-N-CA 122.987 2.458 . . . . 0.0 113.621 169.73 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.531 HD12 HG11 ' A' ' 7' ' ' VAL . 7.6 tt -51.21 -37.6 18.11 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 C-N-CA 124.864 1.266 . . . . 0.0 111.854 174.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 14.1 mt-10 -64.61 -17.4 63.96 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.715 1.206 . . . . 0.0 113.111 -177.269 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -83.71 -12.3 56.01 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 124.927 1.291 . . . . 0.0 113.233 -178.31 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -106.94 -175.31 2.76 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 126.449 1.9 . . . . 0.0 112.723 -175.603 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 5.6 t30 -124.35 124.35 42.18 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 126.008 1.723 . . . . 0.0 109.103 174.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.74 -34.29 77.52 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 114.012 1.115 . . . . 0.0 114.012 -169.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . 0.264 0.0 OUTLIER -71.24 -4.58 26.49 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 114.06 1.133 . . . . 0.0 114.06 -177.752 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -72.94 -12.75 61.07 Favored 'General case' 0 CA--C 1.549 0.942 0 C-N-CA 123.4 0.68 . . . . 0.0 111.012 168.52 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 88.6 m-85 -118.19 138.5 52.27 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 126.806 2.042 . . . . 0.0 111.562 -177.713 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -89.08 -22.15 23.06 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-O 122.104 0.954 . . . . 0.0 112.38 176.404 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.712 HG22 ' HB ' ' A' ' 95' ' ' ILE . 77.9 t -131.44 138.59 52.74 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 C-N-CA 127.136 2.174 . . . . 0.0 108.908 -175.895 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 48.5 t -131.49 123.93 53.57 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 169.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 45.2 mm -109.42 103.72 15.95 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 C-N-CA 124.6 1.16 . . . . 0.0 109.536 -176.377 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 13.2 m -83.35 102.07 11.75 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 124.333 1.053 . . . . 0.0 109.439 169.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 92.4 mt -72.37 -36.25 68.69 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 112.755 0.65 . . . . 0.0 112.755 -177.371 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 36.4 m -112.05 122.27 47.3 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 125.61 1.564 . . . . 0.0 110.492 -169.221 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 62.9 -157.28 39.23 Favored Glycine 0 CA--C 1.537 1.455 0 C-N-CA 123.626 0.631 . . . . 0.0 114.055 -175.737 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 50.3 m -90.08 0.08 57.32 Favored 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 114.8 1.407 . . . . 0.0 114.8 -172.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 71.34 29.16 68.67 Favored Glycine 0 CA--C 1.535 1.315 0 O-C-N 121.478 -0.764 . . . . 0.0 114.609 179.249 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 60.0 t -90.46 -17.6 7.86 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.384 0 CA-C-N 118.216 1.008 . . . . 0.0 112.144 -179.69 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -84.23 12.63 6.26 Favored 'General case' 0 CA--C 1.555 1.144 0 C-N-CA 124.955 1.302 . . . . 0.0 113.641 -173.418 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -119.88 163.85 25.51 Favored Pre-proline 0 CA--C 1.552 1.047 0 C-N-CA 126.186 1.794 . . . . 0.0 112.464 177.671 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.415 ' HA ' ' HD3' ' A' ' 88' ' ' PRO . 52.0 Cg_exo -63.53 150.1 89.35 Favored 'Trans proline' 0 CA--C 1.545 1.064 0 C-N-CA 122.437 2.091 . . . . 0.0 113.981 -178.16 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 87' ' ' PRO . 74.7 Cg_exo -58.44 -27.96 83.63 Favored 'Trans proline' 0 C--N 1.353 0.789 0 C-N-CA 123.442 2.762 . . . . 0.0 115.559 -173.215 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -61.11 -24.14 66.03 Favored 'General case' 0 CA--C 1.544 0.725 0 O-C-N 120.976 -1.077 . . . . 0.0 113.214 177.059 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 89.6 m95 -82.96 -23.52 33.38 Favored 'General case' 0 N--CA 1.469 0.491 0 O-C-N 120.791 -1.193 . . . . 0.0 113.2 176.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 4.4 m -85.15 -18.98 8.91 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.228 0 CA-C-N 119.331 0.968 . . . . 0.0 113.142 173.084 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -88.53 -2.18 58.45 Favored 'General case' 0 N--CA 1.478 0.958 0 N-CA-C 114.847 1.425 . . . . 0.0 114.847 -177.517 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 73.0 mm-40 -66.33 157.07 32.65 Favored 'General case' 0 N--CA 1.481 1.08 0 O-C-N 120.963 -1.086 . . . . 0.0 111.575 171.126 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -59.28 -42.22 90.71 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 114.245 1.202 . . . . 0.0 114.245 -168.304 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.712 ' HB ' HG22 ' A' ' 75' ' ' VAL . 21.1 mm -117.88 61.75 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 C-N-CA 124.883 1.273 . . . . 0.0 108.949 179.273 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 19.9 t80 -78.18 110.42 13.15 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 168.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 24.9 mt-10 -114.54 137.3 52.04 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 114.047 1.129 . . . . 0.0 114.047 175.185 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -105.37 121.42 43.85 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 124.935 1.294 . . . . 0.0 108.852 169.176 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 42.9 m0 -100.52 -18.22 16.75 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 115.871 1.804 . . . . 0.0 115.871 -168.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 41.6 mm-40 55.11 30.61 14.69 Favored 'General case' 0 CA--C 1.555 1.158 0 N-CA-C 113.964 1.098 . . . . 0.0 113.964 174.19 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 30.0 mt -84.22 158.63 21.22 Favored 'General case' 0 N--CA 1.47 0.54 0 O-C-N 120.768 -1.208 . . . . 0.0 112.82 -170.3 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 9.7 tt0 -69.35 133.77 48.24 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.513 169.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 16.3 p-10 -90.46 137.66 27.3 Favored Pre-proline 0 CA--C 1.551 0.988 0 C-N-CA 126.011 1.724 . . . . 0.0 112.057 173.068 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_exo -67.79 -14.55 41.95 Favored 'Trans proline' 0 CA--C 1.551 1.333 0 C-N-CA 122.35 2.033 . . . . 0.0 115.358 178.225 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -59.25 136.73 58.05 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 124.773 1.229 . . . . 0.0 113.541 -175.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 76.46 8.99 86.11 Favored Glycine 0 CA--C 1.536 1.377 0 C-N-CA 124.449 1.023 . . . . 0.0 115.019 175.52 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 12.7 pt20 -141.17 168.92 18.62 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 125.53 1.532 . . . . 0.0 112.592 -179.131 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 28.1 p -66.54 166.08 13.36 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 115.453 1.649 . . . . 0.0 115.453 -169.407 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . 0.315 2.4 pp -68.72 -12.81 61.87 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 114.298 1.221 . . . . 0.0 114.298 173.887 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -70.81 -32.96 70.21 Favored 'General case' 0 CA--C 1.541 0.597 0 O-C-N 121.094 -1.004 . . . . 0.0 109.717 168.785 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 5.3 t -70.63 -40.18 76.8 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 CA-C-O 117.876 -1.059 . . . . 0.0 111.255 170.009 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 14.3 m-85 -54.05 -52.12 61.9 Favored 'General case' 0 N--CA 1.478 0.941 0 CA-C-N 120.287 1.403 . . . . 0.0 111.03 169.356 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 97.6 mtt180 -60.95 -38.69 86.77 Favored 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 124.03 0.932 . . . . 0.0 112.385 -179.138 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 75.2 m -64.84 -43.68 92.24 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.949 0.899 . . . . 0.0 111.341 172.776 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 54.5 t -66.72 -40.6 86.45 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 CA-C-O 117.739 -1.124 . . . . 0.0 111.213 177.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 47.8 mtm-85 -57.04 -41.06 77.95 Favored 'General case' 0 N--CA 1.482 1.153 0 CA-C-N 120.733 1.606 . . . . 0.0 111.295 174.13 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -60.92 -51.84 56.05 Favored Glycine 0 CA--C 1.537 1.462 0 CA-C-N 118.935 0.788 . . . . 0.0 113.597 173.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 60.6 mm-40 -63.89 -44.94 91.51 Favored 'General case' 0 N--CA 1.477 0.882 0 O-C-N 121.965 -0.727 . . . . 0.0 112.199 179.087 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 77.4 t -65.71 -40.61 88.35 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 C-N-CA 124.949 1.3 . . . . 0.0 110.711 178.201 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 36.2 ttmt -54.68 -50.3 68.58 Favored 'General case' 0 N--CA 1.478 0.948 0 CA-C-N 120.311 1.414 . . . . 0.0 110.41 175.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -61.8 -41.31 97.59 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 122.759 0.423 . . . . 0.0 112.119 178.821 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.63 -34.36 78.05 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 124.224 1.01 . . . . 0.0 113.561 176.824 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 97.3 t -80.19 -36.43 16.55 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 C-N-CA 125.353 1.461 . . . . 0.0 111.931 176.576 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -62.61 -39.56 94.19 Favored 'General case' 0 N--CA 1.47 0.536 0 O-C-N 120.885 -1.134 . . . . 0.0 110.97 170.09 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 14.2 m-80 -64.23 -44.72 90.98 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 118.747 0.703 . . . . 0.0 112.598 173.731 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 1.2 tt -48.22 -61.41 2.01 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 125.01 1.324 . . . . 0.0 109.702 172.233 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 82.9 mt -60.4 -44.98 97.28 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 C-N-CA 123.24 0.616 . . . . 0.0 110.648 -177.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -65.78 -12.76 56.66 Favored 'General case' 0 CA--C 1.547 0.853 0 N-CA-C 114.812 1.412 . . . . 0.0 114.812 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 21.1 ptmt -104.11 -27.13 12.27 Favored 'General case' 0 N--CA 1.477 0.904 0 N-CA-C 114.188 1.181 . . . . 0.0 114.188 172.494 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 16.3 pt -95.22 -12.88 8.42 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 N-CA-C 114.625 1.343 . . . . 0.0 114.625 178.618 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 70.1 m . . . . . 0 C--O 1.254 1.335 0 C-N-CA 125.146 1.379 . . . . 0.0 112.501 -179.742 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 36.4 ttm . . . . . 0 N--CA 1.501 2.083 0 N-CA-C 111.793 0.294 . . . . 0.0 111.793 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.0 163.17 30.47 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 125.151 1.38 . . . . 0.0 111.574 169.439 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 34.5 ttmt -101.63 144.17 30.69 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 124.639 1.175 . . . . 0.0 112.513 -179.044 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 21.7 t -124.15 135.09 64.79 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 125.33 1.452 . . . . 0.0 112.561 -176.358 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' MET . . . . . 0.53 ' HG3' HG13 ' A' ' 7' ' ' VAL . 49.8 tpp -103.74 125.91 50.53 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.396 0.678 . . . . 0.0 109.716 169.565 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 32.4 m-85 -108.73 121.96 46.13 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.917 1.287 . . . . 0.0 109.04 170.519 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.53 HG13 ' HG3' ' A' ' 5' ' ' MET . 2.8 m -140.5 159.32 24.9 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 N-CA-C 115.267 1.58 . . . . 0.0 115.267 -168.619 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.6 m -150.98 160.85 43.66 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 128.529 2.731 . . . . 0.0 110.693 169.68 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 64.8 pttt -82.77 138.38 34.03 Favored 'General case' 0 N--CA 1.48 1.031 0 O-C-N 121.061 -1.024 . . . . 0.0 112.4 171.283 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 20.5 tpt180 44.31 55.06 5.82 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 126.388 1.875 . . . . 0.0 112.729 -169.879 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 63.3 t30 -50.54 -22.12 1.83 Allowed 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 127.725 2.41 . . . . 0.0 113.475 175.012 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 31.1 m -53.2 -22.64 6.95 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 125.885 1.674 . . . . 0.0 113.929 170.473 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 58.7 m -112.35 157.52 20.91 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 126.212 1.805 . . . . 0.0 111.136 171.021 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 61.9 mtt85 61.26 168.9 0.1 Allowed 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 126.468 1.907 . . . . 0.0 114.728 -178.166 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 62.2 m -113.98 122.48 47.07 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 125.493 1.517 . . . . 0.0 110.165 -177.333 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 3.2 mp0 -97.21 -33.89 11.31 Favored 'General case' 0 N--CA 1.48 1.06 0 N-CA-C 115.748 1.759 . . . . 0.0 115.748 -168.647 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 70.1 -46.67 0.61 Allowed 'General case' 0 N--CA 1.482 1.158 0 N-CA-C 118.313 2.709 . . . . 0.0 118.313 168.804 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.69 -30.13 70.54 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 115.169 1.544 . . . . 0.0 115.169 -169.449 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 5.7 pm0 -61.76 -39.1 90.45 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 118.813 0.733 . . . . 0.0 111.854 172.045 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -69.45 -44.77 63.08 Favored Glycine 0 C--N 1.334 0.457 0 C-N-CA 124.216 0.912 . . . . 0.0 111.783 -177.467 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -68.67 -36.01 77.98 Favored 'General case' 0 N--CA 1.467 0.412 0 O-C-N 121.569 -0.959 . . . . 0.0 112.152 173.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -65.02 -34.97 79.7 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 119.345 0.975 . . . . 0.0 112.363 178.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 22.2 mtpp -67.26 -48.86 66.49 Favored 'General case' 0 N--CA 1.481 1.094 0 O-C-N 121.884 -0.51 . . . . 0.0 111.217 169.572 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 24.7 m -73.71 -28.12 61.55 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 113.239 0.829 . . . . 0.0 113.239 -169.568 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 56.8 mt -97.2 -35.14 10.86 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 125.612 1.565 . . . . 0.0 112.96 176.043 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -103.47 -10.44 35.9 Favored Glycine 0 N--CA 1.469 0.884 0 N-CA-C 117.243 1.657 . . . . 0.0 117.243 -169.157 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -62.81 140.04 58.75 Favored 'General case' 0 CA--C 1.544 0.726 0 CA-C-N 120.936 2.368 . . . . 0.0 112.06 179.805 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 89.88 -21.24 31.34 Favored Glycine 0 CA--C 1.541 1.688 0 C-N-CA 125.048 1.309 . . . . 0.0 113.374 -169.342 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -101.44 -50.71 3.67 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 125.942 1.697 . . . . 0.0 111.026 169.853 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 2.6 pp -131.35 155.93 42.24 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 C-N-CA 125.813 1.645 . . . . 0.0 111.721 179.225 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -103.24 151.62 22.44 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 124.783 1.233 . . . . 0.0 109.718 175.402 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 44.4 t -138.07 142.77 34.85 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.051 0 O-C-N 121.282 -0.886 . . . . 0.0 113.061 -173.716 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 29.6 m -132.93 152.69 51.87 Favored 'General case' 0 CA--C 1.513 -0.465 0 C-N-CA 125.478 1.511 . . . . 0.0 108.029 168.792 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 2.8 p -132.57 141.36 48.67 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 122.283 1.04 . . . . 0.0 111.533 169.638 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 59.9 p -152.3 -174.46 4.89 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 113.599 -1.637 . . . . 0.0 110.209 178.857 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -135.16 170.89 22.72 Favored Glycine 0 C--N 1.335 0.495 0 O-C-N 121.142 -0.974 . . . . 0.0 112.351 174.195 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 6.2 mp -89.86 124.07 34.37 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 105.556 -2.016 . . . . 0.0 105.556 168.633 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 60.25 26.96 16.46 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 124.852 1.261 . . . . 0.0 113.439 -175.018 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 26.9 p -169.51 156.82 6.88 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 125.876 1.671 . . . . 0.0 112.773 -174.474 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 88.6 p -110.16 -51.63 2.85 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 115.546 1.684 . . . . 0.0 115.546 178.396 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 56.6 ttt180 -115.58 139.69 49.85 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 126.779 2.031 . . . . 0.0 113.988 -168.527 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 10.7 m -51.61 148.99 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 126.636 1.975 . . . . 0.0 111.924 169.365 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -62.26 144.65 94.68 Favored Pre-proline 0 CA--C 1.551 1.01 0 CA-C-O 118.893 -0.575 . . . . 0.0 110.448 176.263 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_exo -47.93 -36.04 26.29 Favored 'Trans proline' 0 CA--C 1.538 0.719 0 C-N-CA 124.087 3.191 . . . . 0.0 118.319 -168.12 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 58.7 m -59.64 -27.03 65.99 Favored 'General case' 0 N--CA 1.483 1.187 0 CA-C-N 119.622 1.101 . . . . 0.0 112.166 -178.228 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -55.85 -37.64 69.01 Favored 'General case' 0 CA--C 1.535 0.365 0 C-N-CA 124.113 0.965 . . . . 0.0 113.059 175.247 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.6 mp -63.86 -54.28 33.86 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 CA-C-N 119.183 0.901 . . . . 0.0 108.628 -178.428 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -62.98 -35.44 80.17 Favored 'General case' 0 CA--C 1.544 0.729 0 N-CA-C 113.361 0.874 . . . . 0.0 113.361 -177.552 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -77.75 -23.77 49.21 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 113.923 1.083 . . . . 0.0 113.923 178.188 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -87.93 -29.71 20.63 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 118.948 0.794 . . . . 0.0 109.732 174.612 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -67.19 -13.14 61.68 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.315 1.446 . . . . 0.0 113.791 172.338 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 -60.09 -26.24 66.04 Favored 'General case' 0 N--CA 1.482 1.171 0 CA-C-N 120.452 1.478 . . . . 0.0 110.641 168.836 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 40.8 t -98.26 -0.42 10.36 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.02 0 C-N-CA 127.668 2.387 . . . . 0.0 111.232 178.471 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 78.28 18.62 75.92 Favored Glycine 0 CA--C 1.541 1.675 0 C-N-CA 125.076 1.322 . . . . 0.0 114.878 -176.529 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 77.1 mt -81.68 133.66 28.77 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 C-N-CA 124.929 1.291 . . . . 0.0 111.736 -172.514 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 31.6 t0 -98.21 116.95 31.51 Favored 'General case' 0 N--CA 1.473 0.725 0 CA-C-O 121.41 0.624 . . . . 0.0 111.96 169.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 19.4 pt -127.97 19.43 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 C-N-CA 126.24 1.816 . . . . 0.0 112.379 171.059 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 98.1 p -70.68 -16.23 62.78 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 115.39 1.626 . . . . 0.0 115.39 -173.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -82.69 -0.96 90.48 Favored Glycine 0 CA--C 1.537 1.466 0 C-N-CA 124.762 1.172 . . . . 0.0 115.922 -177.139 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 4.4 tt0 -68.36 -6.15 22.78 Favored 'General case' 0 CA--C 1.547 0.836 0 N-CA-C 116.402 2.001 . . . . 0.0 116.402 -170.29 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.3 m -67.53 -7.83 29.06 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 125.86 1.664 . . . . 0.0 114.6 -170.809 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 78.2 p -64.73 -78.9 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 115.524 1.676 . . . . 0.0 115.524 -170.541 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -148.59 157.85 40.91 Favored Pre-proline 0 CA--C 1.554 1.133 0 N-CA-C 115.459 1.651 . . . . 0.0 115.459 -169.283 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -69.55 163.71 37.08 Favored 'Trans proline' 0 C--N 1.354 0.865 0 C-N-CA 124.967 3.778 . . . . 0.0 114.921 170.107 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 6.0 tt -52.82 -44.69 48.88 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 C-N-CA 124.905 1.282 . . . . 0.0 111.851 178.054 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -66.93 -9.56 39.56 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 114.092 1.145 . . . . 0.0 114.092 -177.681 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 -81.12 -22.67 38.9 Favored 'General case' 0 CA--C 1.548 0.899 0 N-CA-C 113.129 0.789 . . . . 0.0 113.129 174.145 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 82.1 m-85 -94.19 -169.98 2.19 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 125.805 1.642 . . . . 0.0 112.159 -177.251 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -124.6 124.76 42.91 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 125.657 1.583 . . . . 0.0 109.791 176.375 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -67.42 -34.9 78.18 Favored 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 114.241 1.2 . . . . 0.0 114.241 -170.125 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . 0.252 0.0 OUTLIER -72.19 -5.09 33.24 Favored 'General case' 0 CA--C 1.545 0.778 0 N-CA-C 114.163 1.172 . . . . 0.0 114.163 -176.457 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -73.93 -11.39 60.34 Favored 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 123.833 0.853 . . . . 0.0 111.244 168.711 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 74.5 m-85 -117.36 139.57 50.69 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 127.379 2.272 . . . . 0.0 111.251 -179.664 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -92.17 -23.51 19.37 Favored 'General case' 0 N--CA 1.479 1.004 0 CA-C-O 122.359 1.076 . . . . 0.0 112.342 177.055 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.69 HG22 ' HB ' ' A' ' 95' ' ' ILE . 80.3 t -129.56 138.12 55.06 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 C-N-CA 127.252 2.221 . . . . 0.0 108.886 -176.429 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 83.0 t -131.94 127.82 58.82 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 N-CA-C 107.562 -1.273 . . . . 0.0 107.562 170.694 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 27.5 mm -119.31 117.07 52.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 C-N-CA 124.356 1.063 . . . . 0.0 109.251 -178.162 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 22.6 t -98.54 130.93 45.11 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 122.596 0.359 . . . . 0.0 110.553 169.609 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 8.3 mt -101.32 0.51 37.32 Favored 'General case' 0 N--CA 1.478 0.95 0 N-CA-C 113.779 1.029 . . . . 0.0 113.779 178.838 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 84.6 m -135.95 146.67 47.52 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.213 1.005 . . . . 0.0 113.186 -169.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 63.15 -146.57 50.45 Favored Glycine 0 CA--C 1.532 1.147 0 C-N-CA 124.547 1.07 . . . . 0.0 114.356 170.149 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 93.9 p -86.1 -16.61 37.48 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 125.212 1.405 . . . . 0.0 114.593 -178.907 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 76.68 6.83 85.43 Favored Glycine 0 CA--C 1.54 1.6 0 C-N-CA 124.32 0.962 . . . . 0.0 114.598 -170.278 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 58.6 t -88.68 -22.27 6.69 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.162 0 CA-C-N 119.017 1.408 . . . . 0.0 113.118 -175.377 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 34.2 m120 -71.62 -19.47 62.11 Favored 'General case' 0 CA--C 1.547 0.86 0 N-CA-C 114.545 1.313 . . . . 0.0 114.545 -174.452 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -79.19 148.01 70.31 Favored Pre-proline 0 CA--C 1.549 0.915 0 CA-C-N 118.929 0.786 . . . . 0.0 111.768 176.557 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -59.42 155.11 43.05 Favored 'Trans proline' 0 CA--C 1.543 0.974 0 C-N-CA 122.769 2.313 . . . . 0.0 114.151 -178.164 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_exo -55.01 -32.46 79.09 Favored 'Trans proline' 0 C--N 1.35 0.649 0 C-N-CA 123.46 2.773 . . . . 0.0 114.412 -177.318 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -63.62 -31.78 73.05 Favored 'General case' 0 N--CA 1.471 0.617 0 O-C-N 121.277 -0.889 . . . . 0.0 113.025 177.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 94.8 m95 -80.4 -32.34 37.51 Favored 'General case' 0 N--CA 1.473 0.68 0 O-C-N 121.071 -1.018 . . . . 0.0 111.989 175.428 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 75.8 t -67.57 -31.97 54.94 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 C-N-CA 124.499 1.12 . . . . 0.0 112.159 172.527 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -91.98 3.33 55.45 Favored 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 115.799 1.777 . . . . 0.0 115.799 -171.513 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 80.2 mm-40 -65.6 155.17 36.65 Favored 'General case' 0 N--CA 1.478 0.941 0 O-C-N 120.741 -1.224 . . . . 0.0 111.547 170.651 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -56.18 -41.28 75.25 Favored 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 114.466 1.284 . . . . 0.0 114.466 -167.638 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.69 ' HB ' HG22 ' A' ' 75' ' ' VAL . 18.7 mm -119.31 64.57 0.23 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 C-N-CA 125.089 1.356 . . . . 0.0 108.407 177.308 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 15.9 t80 -79.54 108.29 12.96 Favored 'General case' 0 CA--C 1.534 0.356 0 O-C-N 120.989 -1.07 . . . . 0.0 108.77 169.326 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 11.1 mt-10 -110.32 146.47 35.69 Favored 'General case' 0 CA--C 1.545 0.756 0 N-CA-C 114.627 1.343 . . . . 0.0 114.627 174.591 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -114.36 117.21 30.41 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 125.566 1.546 . . . . 0.0 110.022 169.914 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 39.4 m0 -104.96 106.94 17.65 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 124.63 1.172 . . . . 0.0 109.884 -176.482 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 11.2 mm100 -86.9 47.95 1.57 Allowed 'General case' 0 CA--C 1.547 0.862 0 CA-C-O 122.118 0.961 . . . . 0.0 111.843 -172.309 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 89.7 mt -75.36 162.65 28.2 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 126.22 1.808 . . . . 0.0 112.297 178.434 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -79.01 149.57 32.17 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-O 121.351 0.596 . . . . 0.0 112.457 170.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -83.19 127.57 68.41 Favored Pre-proline 0 CA--C 1.544 0.728 0 C-N-CA 123.96 0.904 . . . . 0.0 110.854 174.31 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -82.04 -16.42 8.65 Favored 'Trans proline' 0 CA--C 1.542 0.92 0 C-N-CA 121.335 1.357 . . . . 0.0 115.242 -170.701 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -72.62 -39.81 66.95 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 116.77 2.137 . . . . 0.0 116.77 -168.788 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -75.3 16.79 3.48 Favored Glycine 0 CA--C 1.539 1.559 0 C-N-CA 123.938 0.78 . . . . 0.0 114.679 -175.164 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 8.8 pt20 -157.98 174.44 15.24 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 126.876 2.07 . . . . 0.0 111.818 -169.321 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 70.4 m -63.29 159.29 18.25 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 114.721 1.378 . . . . 0.0 114.721 -169.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 42.3 tp -59.75 -27.15 66.26 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 124.905 1.282 . . . . 0.0 113.295 179.771 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -62.88 -30.7 71.72 Favored 'General case' 0 N--CA 1.473 0.711 0 O-C-N 120.733 -1.229 . . . . 0.0 112.008 171.753 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 3.0 t -75.69 -36.19 33.16 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 O-C-N 120.955 -1.091 . . . . 0.0 111.152 172.725 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -55.48 -48.01 75.24 Favored 'General case' 0 N--CA 1.479 0.978 0 CA-C-N 119.688 1.131 . . . . 0.0 110.548 169.086 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -67.01 -35.94 81.05 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 124.141 0.976 . . . . 0.0 112.382 178.907 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 31.2 m -61.16 -45.53 94.27 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 124.329 1.052 . . . . 0.0 111.239 169.724 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 56.2 t -67.14 -39.19 82.61 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 CA-C-O 117.638 -1.173 . . . . 0.0 111.339 178.2 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 67.4 mtm-85 -56.43 -43.02 79.04 Favored 'General case' 0 N--CA 1.484 1.249 0 CA-C-N 120.694 1.588 . . . . 0.0 111.724 169.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -59.61 -49.47 78.22 Favored Glycine 0 CA--C 1.537 1.417 0 CA-C-N 118.982 0.81 . . . . 0.0 113.871 174.529 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 52.4 mm-40 -65.66 -44.38 86.48 Favored 'General case' 0 N--CA 1.475 0.784 0 O-C-N 121.585 -0.95 . . . . 0.0 112.193 178.274 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 60.5 t -65.13 -40.15 87.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 C-N-CA 124.622 1.169 . . . . 0.0 110.789 177.816 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 61.4 tttm -54.71 -49.9 69.6 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 119.515 1.052 . . . . 0.0 110.932 175.796 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -64.48 -42.05 96.12 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 112.486 0.55 . . . . 0.0 112.486 177.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 16.5 mmm180 -61.26 -45.97 92.32 Favored 'General case' 0 N--CA 1.479 0.982 0 O-C-N 121.597 -0.689 . . . . 0.0 112.529 175.409 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 92.7 t -68.38 -40.95 83.11 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 C-N-CA 124.006 0.923 . . . . 0.0 111.268 179.49 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -62.48 -39.95 95.11 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 119.258 0.935 . . . . 0.0 111.593 173.165 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 13.9 m-80 -63.25 -46.7 85.67 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 118.982 0.81 . . . . 0.0 112.189 173.751 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -54.7 -55.21 32.17 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 124.607 1.163 . . . . 0.0 110.585 176.467 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 73.1 mt -59.82 -45.88 94.32 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 CA-C-O 119.079 -0.486 . . . . 0.0 110.084 178.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -67.89 -11.47 58.75 Favored 'General case' 0 CA--C 1.545 0.776 0 N-CA-C 115.318 1.599 . . . . 0.0 115.318 -179.215 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 21.0 ptmt -100.54 -24.13 14.53 Favored 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 113.798 1.036 . . . . 0.0 113.798 171.286 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 16.4 pt -97.78 -13.95 7.92 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 N-CA-C 114.592 1.33 . . . . 0.0 114.592 177.692 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 54.5 m . . . . . 0 C--O 1.254 1.293 0 C-N-CA 125.373 1.469 . . . . 0.0 112.032 -179.815 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.407 ' HA ' ' O ' ' A' ' 29' ' ' LYS . 22.6 ttt . . . . . 0 N--CA 1.503 2.207 0 N-CA-C 111.74 0.274 . . . . 0.0 111.74 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.21 164.06 31.28 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 125.089 1.355 . . . . 0.0 112.527 176.575 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 58.9 mttt -99.14 151.07 21.39 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 124.185 0.994 . . . . 0.0 112.46 177.731 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 12.5 t -129.2 138.49 54.29 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 C-N-CA 125.103 1.361 . . . . 0.0 112.674 179.019 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' MET . . . . . 0.503 ' HG3' HG13 ' A' ' 7' ' ' VAL . 62.0 tpp -107.75 120.94 43.65 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 123.726 0.81 . . . . 0.0 109.429 168.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 68.5 m-85 -100.73 127.09 47.29 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 124.27 1.028 . . . . 0.0 108.99 170.58 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.503 HG13 ' HG3' ' A' ' 5' ' ' MET . 1.0 OUTLIER -144.43 156.12 14.96 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.084 0 N-CA-C 114.769 1.396 . . . . 0.0 114.769 -168.177 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -151.38 169.29 22.36 Favored 'General case' 0 CA--C 1.552 1.043 0 C-N-CA 127.159 2.183 . . . . 0.0 110.939 173.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 61.8 mtpt -49.26 -62.74 1.37 Allowed 'General case' 0 N--CA 1.495 1.788 0 C-N-CA 126.126 1.77 . . . . 0.0 113.789 -173.762 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 28.8 mmt85 -127.68 106.3 9.05 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 126.164 1.785 . . . . 0.0 107.588 172.506 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 36.1 p-10 -74.32 -11.1 60.17 Favored 'General case' 0 CA--C 1.556 1.195 0 CA-C-N 119.458 1.027 . . . . 0.0 112.357 -176.831 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 69.8 m -80.13 -6.71 58.19 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 125.08 1.352 . . . . 0.0 112.855 169.464 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 72.8 m -108.18 -69.61 0.84 Allowed 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 124.71 1.204 . . . . 0.0 110.03 172.02 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 66.7 mtt85 -74.35 122.61 23.2 Favored 'General case' 0 N--CA 1.479 1.015 0 O-C-N 121.444 -0.785 . . . . 0.0 109.092 173.679 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 52.4 p -69.45 -28.29 65.98 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 115.644 1.72 . . . . 0.0 115.644 -168.784 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 7.6 mt-30 61.26 -177.81 0.11 Allowed 'General case' 0 CA--C 1.552 1.027 0 C-N-CA 124.633 1.173 . . . . 0.0 112.482 -170.07 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -175.12 -47.48 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 126.366 1.867 . . . . 0.0 110.947 -169.447 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -56.73 -32.16 65.26 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 115.331 1.604 . . . . 0.0 115.331 -169.398 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.3 pm0 -57.16 -41.68 79.66 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 123.528 0.731 . . . . 0.0 112.757 177.545 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -67.25 -43.79 87.95 Favored Glycine 0 C--N 1.334 0.436 0 C-N-CA 124.821 1.2 . . . . 0.0 112.071 -177.465 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -71.53 -35.36 70.65 Favored 'General case' 0 N--CA 1.47 0.534 0 O-C-N 121.542 -0.975 . . . . 0.0 112.005 174.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -64.09 -33.66 76.27 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 118.986 0.812 . . . . 0.0 112.034 -175.652 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 2.7 pttp -85.08 -36.43 21.19 Favored 'General case' 0 N--CA 1.479 1.024 0 N-CA-C 113.644 0.979 . . . . 0.0 113.644 169.686 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 56.3 m -68.88 -31.29 70.11 Favored 'General case' 0 N--CA 1.486 1.338 0 CA-C-N 119.455 1.025 . . . . 0.0 112.3 -178.642 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 70.8 mt -91.22 -37.85 13.07 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 126.131 1.772 . . . . 0.0 112.645 173.022 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -100.62 2.08 55.81 Favored Glycine 0 N--CA 1.472 1.06 0 N-CA-C 117.262 1.665 . . . . 0.0 117.262 -169.539 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -60.55 141.63 56.34 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-N 121.133 2.466 . . . . 0.0 112.303 177.648 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 82.91 -15.15 33.67 Favored Glycine 0 CA--C 1.54 1.643 0 C-N-CA 124.74 1.162 . . . . 0.0 113.657 -169.408 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.407 ' O ' ' HA ' ' A' ' 1' ' ' MET . 69.7 mttt -108.22 -43.7 4.31 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 126.309 1.844 . . . . 0.0 112.484 171.841 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 42.7 pt -139.93 160.02 26.66 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 C-N-CA 124.92 1.288 . . . . 0.0 113.416 -177.203 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -107.64 149.31 28.24 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 125.487 1.515 . . . . 0.0 110.724 169.747 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 98.8 t -137.78 141.11 39.79 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 O-C-N 121.197 -0.94 . . . . 0.0 113.085 -175.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 79.3 m -135.51 152.85 51.73 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 125.805 1.642 . . . . 0.0 109.28 169.521 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 88.9 p -133.21 142.7 48.71 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 122.419 1.104 . . . . 0.0 113.208 167.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 35.7 p -145.43 170.5 16.23 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 114.002 -1.453 . . . . 0.0 112.251 -173.863 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -92.82 152.83 21.24 Favored Glycine 0 N--CA 1.467 0.763 0 O-C-N 121.56 -0.713 . . . . 0.0 111.392 174.863 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 2.2 mp -65.97 -32.8 74.5 Favored 'General case' 0 N--CA 1.483 1.207 0 CA-C-N 118.807 1.303 . . . . 0.0 111.744 171.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -120.47 165.49 14.88 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 126.685 1.994 . . . . 0.0 108.93 169.089 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 52.2 m -53.95 100.19 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 125.281 1.432 . . . . 0.0 113.6 -169.703 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 24.0 p -156.97 156.44 33.0 Favored 'General case' 0 CA--C 1.548 0.897 0 N-CA-C 114.159 1.17 . . . . 0.0 114.159 -175.666 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 49.7 ttt180 -107.77 140.66 40.51 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 128.815 2.846 . . . . 0.0 109.199 174.781 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 18.5 m -53.65 117.97 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.36 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 173.477 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . 0.276 0.0 OUTLIER -58.25 143.75 78.67 Favored Pre-proline 0 CA--C 1.536 0.439 0 N-CA-C 112.699 0.629 . . . . 0.0 112.699 -167.901 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 81.5 Cg_exo -47.34 -36.25 22.59 Favored 'Trans proline' 0 CA--C 1.538 0.681 0 C-N-CA 123.449 2.766 . . . . 0.0 116.792 -168.121 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 56.3 m -64.18 -26.27 68.45 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.915 0.886 . . . . 0.0 112.552 -179.091 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -55.08 -49.53 71.43 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 119.517 1.053 . . . . 0.0 110.601 173.25 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.6 mp -54.2 -57.16 6.6 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 C-N-CA 124.189 0.996 . . . . 0.0 110.176 -173.41 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.95 -28.09 69.59 Favored 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 113.22 0.822 . . . . 0.0 113.22 -175.243 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -79.91 -28.51 39.8 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 113.6 0.963 . . . . 0.0 113.6 177.79 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 4.9 mmt -77.39 -36.49 53.35 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-N 119.142 0.883 . . . . 0.0 110.645 169.743 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -61.9 -16.39 50.3 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 125.095 1.358 . . . . 0.0 114.17 174.421 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -61.08 -29.79 69.96 Favored 'General case' 0 N--CA 1.479 0.984 0 CA-C-N 120.714 1.597 . . . . 0.0 111.747 169.508 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 59.1 t -89.89 -6.38 10.79 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.889 0 C-N-CA 126.627 1.971 . . . . 0.0 111.294 175.673 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 81.63 13.93 79.04 Favored Glycine 0 CA--C 1.539 1.554 0 C-N-CA 125.245 1.402 . . . . 0.0 114.281 -170.589 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 83.5 mt -77.91 142.04 14.7 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 124.618 1.167 . . . . 0.0 111.144 -178.016 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -101.05 131.3 47.01 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 123.517 0.727 . . . . 0.0 111.044 169.172 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 13.4 pt -135.3 8.25 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 C-N-CA 124.234 1.014 . . . . 0.0 113.33 169.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 51.8 m -77.65 152.06 34.0 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 125.228 1.411 . . . . 0.0 113.228 -171.004 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 67.89 20.61 72.68 Favored Glycine 0 N--CA 1.473 1.119 0 N-CA-C 116.035 1.174 . . . . 0.0 116.035 169.758 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 48.1 mt-30 -67.0 -69.98 0.28 Allowed 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 118.701 1.25 . . . . 0.0 112.158 -179.387 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 7.4 t -166.37 169.82 13.65 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 125.238 1.415 . . . . 0.0 112.323 -177.087 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 96.8 p -129.05 5.05 5.33 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 128.419 2.687 . . . . 0.0 112.379 169.474 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 32.5 m-20 -89.94 153.94 47.4 Favored Pre-proline 0 CA--C 1.543 0.676 0 C-N-CA 124.721 1.208 . . . . 0.0 113.299 -177.866 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -70.43 157.28 59.57 Favored 'Trans proline' 0 N--CA 1.458 -0.579 0 C-N-CA 123.089 2.526 . . . . 0.0 112.12 175.771 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 5.9 tt -50.57 -34.34 12.17 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 C-N-CA 124.991 1.316 . . . . 0.0 111.349 169.556 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 18.8 mt-10 -63.71 -17.91 63.47 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 125.547 1.539 . . . . 0.0 113.558 -178.758 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -83.61 -12.34 56.16 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 124.669 1.188 . . . . 0.0 113.659 -178.627 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 74.7 m-85 -106.64 -172.21 2.04 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 125.946 1.699 . . . . 0.0 111.733 -176.417 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 10.5 t30 -120.77 122.44 40.37 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 125.182 1.393 . . . . 0.0 110.274 177.328 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -68.05 -35.83 78.88 Favored 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 113.726 1.01 . . . . 0.0 113.726 -171.42 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -71.28 -4.98 28.83 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 114.409 1.262 . . . . 0.0 114.409 -175.155 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -73.08 -14.0 61.31 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 123.573 0.749 . . . . 0.0 111.691 168.823 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 39.2 m-85 -119.54 134.2 55.33 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 126.939 2.096 . . . . 0.0 111.068 -178.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -88.44 -19.64 26.26 Favored 'General case' 0 N--CA 1.48 1.058 0 CA-C-O 122.36 1.076 . . . . 0.0 112.672 -179.806 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.647 HG22 ' HB ' ' A' ' 95' ' ' ILE . 95.9 t -130.88 136.77 57.43 Favored 'Isoleucine or valine' 0 C--O 1.235 0.336 0 C-N-CA 127.722 2.409 . . . . 0.0 107.853 -175.411 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 65.3 t -134.13 127.07 50.79 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 170.384 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 48.3 mm -116.17 106.7 20.87 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.249 0 C-N-CA 124.454 1.101 . . . . 0.0 109.395 -171.873 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 4.0 m -92.38 108.2 19.78 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 123.049 0.54 . . . . 0.0 110.321 177.202 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 78.3 mt -78.07 -9.48 59.16 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 125.872 1.669 . . . . 0.0 113.406 -179.371 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 23.9 m -108.34 103.99 13.26 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 125.664 1.586 . . . . 0.0 110.733 -179.04 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 57.65 -139.66 46.72 Favored Glycine 0 CA--C 1.535 1.331 0 C-N-CA 124.325 0.964 . . . . 0.0 114.236 172.831 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 85.0 p -69.91 -14.28 62.65 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 124.84 1.256 . . . . 0.0 114.108 175.793 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 72.09 7.79 67.84 Favored Glycine 0 CA--C 1.528 0.902 0 N-CA-C 115.6 1.0 . . . . 0.0 115.6 178.872 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.3 p -72.51 -9.58 13.08 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.988 0 CA-C-N 119.593 1.696 . . . . 0.0 114.675 -169.89 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 -80.64 -16.71 53.34 Favored 'General case' 0 CA--C 1.547 0.857 0 N-CA-C 114.701 1.371 . . . . 0.0 114.701 -174.162 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -71.07 159.14 86.51 Favored Pre-proline 0 CA--C 1.551 0.985 0 CA-C-N 119.214 0.916 . . . . 0.0 112.317 170.926 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_exo -60.53 151.86 72.33 Favored 'Trans proline' 0 CA--C 1.544 1.014 0 C-N-CA 122.133 1.888 . . . . 0.0 113.321 -176.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_exo -54.35 -36.59 87.59 Favored 'Trans proline' 0 C--N 1.352 0.751 0 C-N-CA 123.458 2.772 . . . . 0.0 115.164 -169.816 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -63.71 -22.28 66.83 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 114.131 1.16 . . . . 0.0 114.131 179.723 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 77.7 m95 -82.99 -23.1 33.47 Favored 'General case' 0 N--CA 1.47 0.531 0 O-C-N 120.888 -1.133 . . . . 0.0 112.486 172.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 10.5 t -73.67 -30.37 29.01 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 C-N-CA 124.996 1.318 . . . . 0.0 110.91 170.336 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 76.5 p -91.14 3.33 55.06 Favored 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 116.252 1.945 . . . . 0.0 116.252 -174.869 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 80.4 mm-40 -66.36 149.62 50.11 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 119.503 1.047 . . . . 0.0 108.984 169.294 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -59.73 -37.97 80.41 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 114.577 1.325 . . . . 0.0 114.577 -167.154 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.647 ' HB ' HG22 ' A' ' 75' ' ' VAL . 16.2 mm -113.01 56.64 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 C-N-CA 124.715 1.206 . . . . 0.0 109.385 177.488 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 40.7 t80 -75.57 106.52 7.17 Favored 'General case' 0 CA--C 1.535 0.395 0 O-C-N 120.633 -1.292 . . . . 0.0 107.522 168.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.7 mt-10 -106.41 133.28 51.34 Favored 'General case' 0 CA--C 1.543 0.678 0 N-CA-C 113.556 0.947 . . . . 0.0 113.556 175.877 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -88.95 111.51 22.21 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.41 1.084 . . . . 0.0 109.339 169.432 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 15.2 m0 -97.99 101.22 12.65 Favored 'General case' 0 N--CA 1.462 0.158 0 C-N-CA 123.813 0.845 . . . . 0.0 109.48 -176.859 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 54.9 mm-40 -78.64 41.14 0.4 Allowed 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 125.995 1.718 . . . . 0.0 111.676 -177.291 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 33.1 mt -91.59 163.68 14.04 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 126.277 1.831 . . . . 0.0 113.19 -172.155 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -73.92 150.42 40.85 Favored 'General case' 0 CA--C 1.545 0.784 0 CA-C-N 114.857 -1.065 . . . . 0.0 111.715 169.728 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . 0.415 ' HA ' ' HD3' ' A' ' 104' ' ' PRO . 18.9 t70 -112.71 138.85 22.23 Favored Pre-proline 0 CA--C 1.549 0.923 0 C-N-CA 124.339 1.056 . . . . 0.0 111.108 169.564 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 103' ' ' ASP . 45.0 Cg_exo -66.81 -19.84 52.57 Favored 'Trans proline' 0 CA--C 1.54 0.822 0 C-N-CA 122.511 2.141 . . . . 0.0 116.61 -178.139 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -68.03 144.83 54.95 Favored 'General case' 0 CA--C 1.545 0.757 0 CA-C-N 120.375 1.443 . . . . 0.0 114.102 -170.424 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 77.69 6.52 86.98 Favored Glycine 0 CA--C 1.535 1.338 0 C-N-CA 124.815 1.198 . . . . 0.0 114.586 -177.936 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 13.3 pt20 -140.85 174.37 10.58 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 126.015 1.726 . . . . 0.0 112.165 179.832 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 25.0 p -67.71 164.73 18.72 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 117.395 2.369 . . . . 0.0 117.395 -168.659 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -53.5 -41.35 66.19 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 126.272 1.829 . . . . 0.0 111.961 169.767 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -60.01 -36.11 76.52 Favored 'General case' 0 CA--C 1.543 0.697 0 O-C-N 121.47 -0.769 . . . . 0.0 111.922 174.653 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 16.3 t -68.86 -40.8 81.68 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 O-C-N 121.177 -0.952 . . . . 0.0 111.463 171.141 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -52.31 -50.55 61.99 Favored 'General case' 0 N--CA 1.476 0.839 0 CA-C-N 119.56 1.073 . . . . 0.0 112.104 170.629 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 96.0 mtt180 -67.87 -35.17 78.06 Favored 'General case' 0 N--CA 1.477 0.883 0 O-C-N 121.399 -0.813 . . . . 0.0 112.751 179.428 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 79.4 m -63.67 -42.17 98.09 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.682 0.793 . . . . 0.0 110.957 172.229 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 71.5 t -67.9 -39.86 82.47 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 CA-C-O 117.914 -1.041 . . . . 0.0 111.215 176.603 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 27.1 mtm105 -54.56 -42.71 71.31 Favored 'General case' 0 N--CA 1.484 1.252 0 CA-C-N 120.52 1.509 . . . . 0.0 112.109 173.026 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -62.39 -51.34 57.08 Favored Glycine 0 CA--C 1.539 1.549 0 CA-C-N 119.052 0.842 . . . . 0.0 113.311 176.383 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 68.8 mm-40 -63.3 -44.42 95.08 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.234 0.614 . . . . 0.0 112.017 179.845 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 69.3 t -67.18 -41.16 86.51 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 C-N-CA 124.592 1.157 . . . . 0.0 111.028 177.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 34.6 ttmt -54.56 -49.9 69.21 Favored 'General case' 0 N--CA 1.478 0.971 0 CA-C-N 120.491 1.496 . . . . 0.0 110.773 177.645 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -61.1 -40.14 92.61 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 112.242 0.46 . . . . 0.0 112.242 177.492 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.11 -35.26 80.02 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 124.226 1.011 . . . . 0.0 113.228 176.947 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 99.6 t -77.34 -38.46 26.84 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 C-N-CA 125.195 1.398 . . . . 0.0 111.621 176.508 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -60.25 -40.2 89.45 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 119.198 0.908 . . . . 0.0 111.178 170.892 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 17.1 m-80 -64.35 -43.55 94.21 Favored 'General case' 0 CA--C 1.542 0.635 0 N-CA-C 112.56 0.578 . . . . 0.0 112.56 174.093 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 9.1 tt -53.69 -55.01 29.86 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 124.401 1.08 . . . . 0.0 110.477 173.148 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 76.4 mt -63.49 -41.81 93.98 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.625 0 C-N-CA 122.658 0.383 . . . . 0.0 110.589 -178.433 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -69.72 -12.68 61.82 Favored 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 114.578 1.325 . . . . 0.0 114.578 178.346 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 20.7 ptmt -101.27 -30.93 11.24 Favored 'General case' 0 N--CA 1.477 0.906 0 N-CA-C 113.915 1.08 . . . . 0.0 113.915 173.297 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 13.5 pt -94.09 -18.84 6.77 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 N-CA-C 114.528 1.307 . . . . 0.0 114.528 179.255 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 74.5 m . . . . . 0 C--O 1.253 1.26 0 C-N-CA 125.539 1.536 . . . . 0.0 111.708 -175.354 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 34.8 ttm . . . . . 0 N--CA 1.501 2.086 0 N-CA-C 112.087 0.403 . . . . 0.0 112.087 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.47 162.92 26.05 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 125.146 1.379 . . . . 0.0 111.247 169.234 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 69.0 mttt -96.99 147.44 23.99 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.648 0.779 . . . . 0.0 111.527 172.728 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 17.2 t -124.42 135.53 63.49 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 C-N-CA 125.297 1.439 . . . . 0.0 111.927 176.046 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' MET . . . . . 0.478 ' HG3' HG13 ' A' ' 7' ' ' VAL . 54.3 tpp -106.07 125.75 51.37 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 123.229 0.611 . . . . 0.0 109.501 168.724 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 67.1 m-85 -103.89 125.18 50.11 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.43 1.092 . . . . 0.0 108.918 172.846 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.478 HG13 ' HG3' ' A' ' 5' ' ' MET . 2.1 m -143.46 156.99 16.82 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.167 0 C-N-CA 124.661 1.184 . . . . 0.0 113.151 -169.175 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 18.2 t -153.65 141.7 20.33 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 126.304 1.842 . . . . 0.0 108.437 168.625 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . 0.263 60.7 pttt -73.79 -15.98 61.17 Favored 'General case' 0 N--CA 1.486 1.335 0 N-CA-C 116.385 1.994 . . . . 0.0 116.385 -169.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 16.2 ptm180 -121.08 49.68 1.46 Allowed 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 125.46 1.504 . . . . 0.0 112.645 169.899 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 5.8 t30 -46.79 -31.87 3.3 Favored 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 126.058 1.743 . . . . 0.0 114.582 -177.683 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 67.7 m -69.61 -23.78 63.56 Favored 'General case' 0 N--CA 1.479 1.0 0 N-CA-C 114.017 1.117 . . . . 0.0 114.017 178.131 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 36.9 m -89.9 -15.63 31.72 Favored 'General case' 0 N--CA 1.478 0.954 0 N-CA-C 114.247 1.203 . . . . 0.0 114.247 -176.244 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 55.7 mtp85 -135.5 159.03 42.88 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 125.607 1.563 . . . . 0.0 112.632 -169.847 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 26.1 t -100.25 145.59 27.9 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.234 1.414 . . . . 0.0 107.742 168.478 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 3.9 mp0 -108.76 -37.67 5.83 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 115.331 1.604 . . . . 0.0 115.331 -168.361 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . 0.4 ' HG2' ' SD ' ' A' ' 50' ' ' MET . 0.0 OUTLIER 66.07 -47.48 0.41 Allowed 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 126.996 2.118 . . . . 0.0 116.281 170.46 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.16 -35.81 76.15 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.649 1.18 . . . . 0.0 113.945 -169.824 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 3.9 pm0 -58.94 -38.31 78.72 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 125.049 1.339 . . . . 0.0 113.215 176.057 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -69.92 -45.03 59.4 Favored Glycine 0 N--CA 1.464 0.552 0 C-N-CA 123.688 0.661 . . . . 0.0 111.831 -177.737 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -69.29 -32.7 72.03 Favored 'General case' 0 N--CA 1.466 0.347 0 O-C-N 121.793 -0.828 . . . . 0.0 112.51 173.73 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -64.61 -36.71 85.12 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 119.347 0.976 . . . . 0.0 112.302 -174.804 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.23 -38.96 30.01 Favored 'General case' 0 N--CA 1.482 1.163 0 N-CA-C 112.904 0.705 . . . . 0.0 112.904 169.464 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 70.7 m -67.09 -32.46 73.63 Favored 'General case' 0 N--CA 1.485 1.286 0 CA-C-N 118.96 0.8 . . . . 0.0 112.24 -176.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 66.9 mt -91.85 -39.86 11.51 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 125.733 1.613 . . . . 0.0 112.926 173.858 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -99.02 3.43 58.5 Favored Glycine 0 N--CA 1.472 1.036 0 N-CA-C 117.444 1.738 . . . . 0.0 117.444 -169.431 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.24 142.02 57.11 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 121.034 2.417 . . . . 0.0 112.11 178.369 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 84.16 -21.65 9.74 Favored Glycine 0 CA--C 1.539 1.572 0 C-N-CA 125.092 1.33 . . . . 0.0 113.268 -169.442 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -98.88 -46.39 5.65 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 125.603 1.561 . . . . 0.0 111.985 171.609 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 43.0 pt -137.58 154.58 29.86 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 C-N-CA 124.96 1.304 . . . . 0.0 113.37 -175.375 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -102.59 142.37 33.87 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 124.757 1.223 . . . . 0.0 109.938 169.809 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 85.9 t -131.16 139.57 50.66 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 CA-C-N 118.928 0.785 . . . . 0.0 113.058 -176.455 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 27.5 m -139.69 154.24 47.44 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 125.815 1.646 . . . . 0.0 109.586 173.346 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 52.2 m -128.64 147.74 50.75 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.718 0.771 . . . . 0.0 110.841 168.448 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 3.8 m -142.69 151.76 41.68 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 113.926 -1.488 . . . . 0.0 110.981 177.119 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -89.59 174.08 40.97 Favored Glycine 0 CA--C 1.527 0.825 0 N-CA-C 110.383 -1.087 . . . . 0.0 110.383 169.166 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -84.47 -36.99 21.9 Favored 'General case' 0 N--CA 1.477 0.924 0 O-C-N 121.414 -1.05 . . . . 0.0 112.816 175.138 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -128.77 18.83 6.17 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 126.192 1.797 . . . . 0.0 111.628 175.02 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 34.7 p -142.86 153.13 42.87 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 126.069 1.747 . . . . 0.0 111.975 -173.768 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 98.5 p -95.8 -18.56 20.31 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 117.528 2.418 . . . . 0.0 117.528 -168.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 19.0 ttm105 -152.29 151.77 31.32 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 124.916 1.286 . . . . 0.0 111.789 -169.757 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 34.1 m -64.94 136.84 26.02 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 C-N-CA 123.328 0.651 . . . . 0.0 109.364 170.032 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -60.84 143.23 91.59 Favored Pre-proline 0 CA--C 1.551 1.005 0 N-CA-C 112.678 0.622 . . . . 0.0 112.678 -169.046 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_exo -46.59 -40.4 23.66 Favored 'Trans proline' 0 CA--C 1.538 0.718 0 C-N-CA 124.192 3.261 . . . . 0.0 118.731 -168.154 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 33.5 m -63.74 -27.25 69.07 Favored 'General case' 0 N--CA 1.484 1.249 0 CA-C-N 119.759 1.163 . . . . 0.0 111.936 -177.354 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -57.49 -50.15 73.99 Favored 'General case' 0 CA--C 1.537 0.448 0 O-C-N 121.373 -0.83 . . . . 0.0 111.548 173.705 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 4.6 mp -56.94 -50.94 74.22 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 CA-C-N 119.438 1.017 . . . . 0.0 111.126 -175.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -61.22 -27.9 68.77 Favored 'General case' 0 CA--C 1.546 0.804 0 N-CA-C 113.176 0.806 . . . . 0.0 113.176 -179.255 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -83.5 -24.0 31.91 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 113.963 1.098 . . . . 0.0 113.963 175.133 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . 0.4 ' SD ' ' HG2' ' A' ' 17' ' ' MET . 4.4 mmt -80.44 -30.5 37.57 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 119.758 1.163 . . . . 0.0 110.188 169.602 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -64.9 -14.92 61.24 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 125.345 1.458 . . . . 0.0 113.604 173.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -61.58 -27.0 68.32 Favored 'General case' 0 N--CA 1.482 1.173 0 CA-C-N 120.639 1.563 . . . . 0.0 110.918 169.104 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 61.0 t -95.8 -2.96 10.48 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.902 0 C-N-CA 127.574 2.349 . . . . 0.0 111.148 177.837 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 77.98 16.87 79.29 Favored Glycine 0 CA--C 1.54 1.598 0 O-C-N 120.699 -1.25 . . . . 0.0 114.397 -174.737 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 77.5 mt -72.34 137.32 23.79 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 124.687 1.195 . . . . 0.0 111.247 -177.456 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 18.0 t0 -105.29 105.41 15.43 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 124.331 1.052 . . . . 0.0 112.098 179.347 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 15.8 pt -137.32 18.99 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.309 0 N-CA-C 114.867 1.432 . . . . 0.0 114.867 -178.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 89.1 p -70.95 -36.87 72.76 Favored 'General case' 0 N--CA 1.479 0.982 0 O-C-N 120.138 -1.601 . . . . 0.0 112.691 175.33 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -77.54 39.16 1.7 Allowed Glycine 0 CA--C 1.538 1.471 0 C-N-CA 126.502 2.001 . . . . 0.0 114.788 177.443 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 5.9 mm-40 -83.42 65.78 8.53 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 125.621 1.568 . . . . 0.0 112.57 -172.427 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER 63.59 -30.79 0.1 Allowed 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 119.741 3.237 . . . . 0.0 119.741 169.11 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 71.2 m 59.37 32.3 21.73 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 125.387 1.475 . . . . 0.0 114.382 -179.622 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -150.95 145.92 18.7 Favored Pre-proline 0 CA--C 1.551 1.013 0 O-C-N 120.974 -1.079 . . . . 0.0 113.798 179.221 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -66.24 162.9 33.95 Favored 'Trans proline' 0 CA--C 1.54 0.795 0 C-N-CA 124.543 3.496 . . . . 0.0 114.599 171.095 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.432 HD11 ' CE3' ' A' ' 90' ' ' TRP . 9.3 tp -57.33 -35.1 47.9 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 C-N-CA 124.536 1.134 . . . . 0.0 112.113 177.924 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -68.21 -10.22 52.85 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 113.79 1.033 . . . . 0.0 113.79 -179.569 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 66.2 m-20 -95.27 11.72 31.53 Favored 'General case' 0 CA--C 1.555 1.157 0 N-CA-C 113.791 1.034 . . . . 0.0 113.791 178.892 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 76.8 m-85 -130.86 177.72 7.2 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 125.526 1.531 . . . . 0.0 114.514 -174.899 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 8.1 t30 -107.69 131.81 54.02 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 126.921 2.088 . . . . 0.0 109.975 172.858 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -73.89 -35.34 64.69 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 114.673 1.361 . . . . 0.0 114.673 -176.436 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . 0.273 0.0 OUTLIER -71.69 -6.38 40.74 Favored 'General case' 0 CA--C 1.544 0.734 0 N-CA-C 114.401 1.26 . . . . 0.0 114.401 -172.213 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -62.55 -27.73 69.37 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 124.28 1.032 . . . . 0.0 110.494 168.327 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 19.4 m-85 -113.77 121.65 44.71 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 125.65 1.58 . . . . 0.0 111.132 -172.213 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -73.0 -23.57 60.65 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-O 121.77 0.795 . . . . 0.0 112.555 175.851 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.51 HG22 ' HB ' ' A' ' 95' ' ' ILE . 90.8 t -126.9 136.41 60.87 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 C-N-CA 127.486 2.314 . . . . 0.0 109.299 -174.917 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 54.2 t -135.51 120.23 27.5 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 169.621 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 25.9 mm -106.82 117.97 53.65 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 C-N-CA 123.314 0.646 . . . . 0.0 109.498 -176.63 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 14.2 t -89.07 124.09 33.97 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 169.607 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 87.6 mt -100.08 13.58 33.61 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 125.147 1.379 . . . . 0.0 114.188 -170.044 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 20.8 p -149.19 1.74 0.55 Allowed 'General case' 0 CA--C 1.547 0.845 0 N-CA-C 114.926 1.454 . . . . 0.0 114.926 177.597 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 68.53 170.34 5.99 Favored Glycine 0 CA--C 1.541 1.682 0 C-N-CA 124.261 0.934 . . . . 0.0 114.161 -176.288 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 71.7 m 54.89 29.5 12.2 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 125.192 1.397 . . . . 0.0 113.685 178.342 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -73.4 18.02 1.77 Allowed Glycine 0 N--CA 1.474 1.213 0 C-N-CA 126.327 1.917 . . . . 0.0 114.688 -177.799 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 4.2 p -65.24 -5.46 2.57 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.881 0 C-N-CA 126.227 1.811 . . . . 0.0 114.482 -169.886 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 26.7 m120 -76.27 -18.43 58.99 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 125.072 1.349 . . . . 0.0 114.338 176.106 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -74.27 156.48 87.39 Favored Pre-proline 0 N--CA 1.483 1.179 0 CA-C-N 120.277 1.399 . . . . 0.0 112.144 169.918 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_exo -57.27 150.57 57.37 Favored 'Trans proline' 0 CA--C 1.544 1.01 0 C-N-CA 122.999 2.466 . . . . 0.0 114.087 179.308 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -62.22 -24.17 75.95 Favored 'Trans proline' 0 CA--C 1.536 0.586 0 C-N-CA 123.531 2.821 . . . . 0.0 113.814 -174.358 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -60.98 -24.14 65.88 Favored 'General case' 0 CA--C 1.54 0.578 0 O-C-N 121.056 -1.028 . . . . 0.0 113.534 176.052 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . 0.432 ' CE3' HD11 ' A' ' 65' ' ' ILE . 87.3 m95 -79.51 -35.88 39.38 Favored 'General case' 0 N--CA 1.473 0.719 0 O-C-N 120.818 -1.176 . . . . 0.0 112.668 175.364 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 3.9 m -79.34 -18.49 12.87 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.149 0 N-CA-C 113.164 0.802 . . . . 0.0 113.164 178.295 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -86.68 -1.38 57.66 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 114.406 1.262 . . . . 0.0 114.406 177.662 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 84.7 mm-40 -64.14 154.33 35.0 Favored 'General case' 0 N--CA 1.478 0.935 0 O-C-N 120.907 -1.12 . . . . 0.0 110.625 170.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -59.76 -38.25 81.29 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 114.007 1.114 . . . . 0.0 114.007 -168.281 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.51 ' HB ' HG22 ' A' ' 75' ' ' VAL . 17.0 mm -118.18 60.08 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 C-N-CA 125.078 1.351 . . . . 0.0 109.783 179.057 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 47.2 t80 -78.94 106.25 10.84 Favored 'General case' 0 CA--C 1.536 0.413 0 O-C-N 120.749 -1.219 . . . . 0.0 107.777 168.853 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -111.18 131.24 55.27 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 113.523 0.934 . . . . 0.0 113.523 -179.581 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 -92.08 113.01 25.17 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 124.977 1.311 . . . . 0.0 110.825 169.503 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 39.6 m0 -103.97 113.12 26.43 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 124.863 1.265 . . . . 0.0 109.459 174.341 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 34.6 mm-40 -78.98 59.69 2.72 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 124.58 1.152 . . . . 0.0 109.115 169.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 17.4 tp -79.32 145.58 33.39 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 126.068 1.747 . . . . 0.0 111.255 -169.76 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -69.2 125.3 26.27 Favored 'General case' 0 CA--C 1.542 0.645 0 O-C-N 122.146 -0.346 . . . . 0.0 111.068 169.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -75.45 134.78 72.86 Favored Pre-proline 0 CA--C 1.544 0.72 0 O-C-N 121.54 -0.725 . . . . 0.0 109.678 169.657 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -87.63 -17.12 2.83 Favored 'Trans proline' 0 CA--C 1.544 1.003 0 C-N-CA 121.441 1.427 . . . . 0.0 114.836 174.523 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -69.86 -40.45 75.74 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 115.032 1.493 . . . . 0.0 115.032 -169.852 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -68.33 -3.25 30.86 Favored Glycine 0 CA--C 1.54 1.631 0 N-CA-C 115.677 1.031 . . . . 0.0 115.677 -175.892 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -141.86 176.18 9.13 Favored 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 127.017 2.127 . . . . 0.0 112.148 -170.057 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 57.1 m -64.29 161.06 17.43 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 114.866 1.432 . . . . 0.0 114.866 -169.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 39.0 tp -59.02 -28.85 66.8 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 124.791 1.236 . . . . 0.0 113.409 -178.552 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -63.18 -32.42 73.81 Favored 'General case' 0 N--CA 1.473 0.717 0 O-C-N 120.641 -1.287 . . . . 0.0 112.004 172.448 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 4.9 t -72.76 -36.38 52.49 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 O-C-N 121.093 -1.005 . . . . 0.0 110.819 172.308 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -55.95 -49.15 74.31 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-N 119.944 1.247 . . . . 0.0 111.391 169.83 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -66.76 -38.27 86.26 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.586 0.755 . . . . 0.0 112.122 -179.63 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 84.4 m -63.52 -43.92 95.77 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.761 0.824 . . . . 0.0 111.394 172.139 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 52.8 t -69.23 -35.66 69.0 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 CA-C-O 117.704 -1.141 . . . . 0.0 111.186 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 72.3 mtm-85 -57.12 -41.41 78.94 Favored 'General case' 0 N--CA 1.484 1.229 0 CA-C-N 120.903 1.683 . . . . 0.0 111.322 169.76 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -58.66 -50.58 65.77 Favored Glycine 0 CA--C 1.541 1.695 0 CA-C-N 118.898 0.772 . . . . 0.0 113.531 173.401 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 41.3 mt-30 -65.12 -43.64 91.31 Favored 'General case' 0 N--CA 1.477 0.906 0 O-C-N 121.645 -0.915 . . . . 0.0 112.63 178.471 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 69.8 t -66.93 -40.58 86.0 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 C-N-CA 124.012 0.925 . . . . 0.0 110.726 179.325 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 63.7 tttm -54.39 -48.54 71.44 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 119.31 0.959 . . . . 0.0 110.802 175.176 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -61.87 -46.89 87.46 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 123.537 0.735 . . . . 0.0 112.242 177.004 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 12.7 mtp85 -61.74 -40.19 94.22 Favored 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 113.414 0.894 . . . . 0.0 113.414 176.831 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 69.2 t -76.26 -30.76 20.29 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 O-C-N 121.627 -0.671 . . . . 0.0 111.176 -179.44 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -64.63 -38.1 89.84 Favored 'General case' 0 CA--C 1.54 0.585 0 O-C-N 121.184 -0.948 . . . . 0.0 110.166 169.118 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 97.7 m-20 -63.74 -45.48 89.7 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 123.572 0.749 . . . . 0.0 112.493 174.099 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 8.1 tt -50.53 -58.92 4.65 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 125.464 1.505 . . . . 0.0 110.724 170.725 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 80.4 mt -62.62 -44.07 99.07 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 CA-C-O 118.692 -0.67 . . . . 0.0 110.457 -176.449 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -68.14 -14.0 62.65 Favored 'General case' 0 CA--C 1.546 0.816 0 N-CA-C 114.372 1.249 . . . . 0.0 114.372 179.058 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 18.2 ptmt -99.12 -32.31 11.31 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 113.793 1.034 . . . . 0.0 113.793 174.385 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 17.8 pt -90.1 -18.1 7.77 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 N-CA-C 114.109 1.151 . . . . 0.0 114.109 179.815 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 72.9 m . . . . . 0 C--O 1.254 1.319 0 CA-C-O 118.294 -0.86 . . . . 0.0 112.507 -179.783 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.4 ttt . . . . . 0 N--CA 1.501 2.12 0 N-CA-C 111.924 0.342 . . . . 0.0 111.924 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.2 164.25 31.27 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 124.868 1.267 . . . . 0.0 113.363 178.16 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 60.1 mtpt -90.44 142.71 27.46 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 125.059 1.344 . . . . 0.0 113.221 175.681 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 21.6 t -125.49 131.63 71.94 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 C-N-CA 125.791 1.637 . . . . 0.0 112.301 179.186 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' MET . . . . . 0.421 ' HG3' HG13 ' A' ' 7' ' ' VAL . 55.0 tpp -101.47 116.5 32.91 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.967 0.907 . . . . 0.0 109.828 169.912 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 51.2 m-85 -100.74 120.76 40.56 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 124.536 1.134 . . . . 0.0 108.908 171.452 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.421 HG13 ' HG3' ' A' ' 5' ' ' MET . 3.0 m -140.74 156.66 23.16 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 N-CA-C 115.062 1.504 . . . . 0.0 115.062 -168.774 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 39.4 t -151.82 164.67 36.55 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 128.324 2.65 . . . . 0.0 108.054 169.826 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 39.1 ttpt -56.07 -51.37 68.11 Favored 'General case' 0 N--CA 1.482 1.132 0 CA-C-N 119.532 1.06 . . . . 0.0 112.995 -172.079 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 10.0 tpt180 -103.23 133.38 48.41 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 124.734 1.214 . . . . 0.0 109.64 175.763 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 -90.89 -42.64 10.5 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-N 118.627 0.648 . . . . 0.0 110.661 171.787 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 94.0 p -66.25 158.35 29.17 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 124.426 1.09 . . . . 0.0 110.938 168.896 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 24.4 p 50.53 -19.48 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.467 0 C-N-CA 129.254 3.021 . . . . 0.0 119.015 -170.048 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 13.9 tpt180 -107.06 112.97 26.16 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 125.806 1.642 . . . . 0.0 112.062 -173.184 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 3.4 p -69.26 136.99 52.71 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 123.914 0.885 . . . . 0.0 110.914 169.756 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 16.0 mt-30 -122.14 -39.68 2.57 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 124.894 1.278 . . . . 0.0 112.263 -169.783 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 68.13 -43.55 0.48 Allowed 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 127.29 2.236 . . . . 0.0 116.357 169.511 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -65.2 -34.29 78.02 Favored 'General case' 0 CA--C 1.533 0.306 0 O-C-N 120.831 -1.168 . . . . 0.0 113.738 -172.206 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 3.1 pm0 -59.88 -40.67 89.48 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 118.919 0.781 . . . . 0.0 111.929 170.378 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -66.24 -52.3 37.21 Favored Glycine 0 C--N 1.335 0.525 0 C-N-CA 123.839 0.733 . . . . 0.0 111.813 178.138 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -64.73 -34.45 78.34 Favored 'General case' 0 N--CA 1.467 0.405 0 O-C-N 121.659 -0.907 . . . . 0.0 112.008 177.902 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -66.16 -32.1 73.35 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 119.568 1.076 . . . . 0.0 112.72 178.637 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 22.6 mtpp -68.42 -52.95 27.08 Favored 'General case' 0 N--CA 1.478 0.943 0 CA-C-N 118.496 0.589 . . . . 0.0 110.129 169.794 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 98.5 m -72.4 -22.76 61.07 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 113.841 1.052 . . . . 0.0 113.841 -170.81 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 49.9 mt -95.38 -37.25 11.03 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 125.472 1.509 . . . . 0.0 113.253 171.631 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -104.92 -4.5 41.97 Favored Glycine 0 N--CA 1.47 0.915 0 N-CA-C 117.848 1.899 . . . . 0.0 117.848 -168.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -62.66 137.66 58.31 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-N 121.526 2.663 . . . . 0.0 111.971 179.794 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 86.88 -14.0 57.74 Favored Glycine 0 CA--C 1.542 1.732 0 C-N-CA 124.92 1.248 . . . . 0.0 113.857 -169.365 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -108.35 -42.88 4.47 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 126.512 1.925 . . . . 0.0 111.768 170.776 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 34.3 pt -136.83 160.65 36.83 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 C-N-CA 126.18 1.792 . . . . 0.0 112.246 179.48 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -108.66 149.34 29.08 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 125.504 1.522 . . . . 0.0 109.893 169.822 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 84.7 t -138.25 141.18 38.63 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 O-C-N 121.471 -0.768 . . . . 0.0 111.916 -170.111 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 18.6 m -140.08 153.49 46.76 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 125.249 1.42 . . . . 0.0 109.936 174.796 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 38.8 p -137.74 138.99 39.86 Favored 'General case' 0 CA--C 1.516 -0.342 0 C-N-CA 124.505 1.122 . . . . 0.0 110.237 168.59 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 96.4 p -127.44 -62.45 1.09 Allowed 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 115.532 1.679 . . . . 0.0 115.532 -168.528 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 111.28 162.11 17.36 Favored Glycine 0 N--CA 1.469 0.841 0 C-N-CA 126.149 1.833 . . . . 0.0 110.6 -174.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -97.66 -20.01 17.9 Favored 'General case' 0 N--CA 1.482 1.16 0 CA-C-N 119.384 1.592 . . . . 0.0 113.66 171.801 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 61.0 mt-10 -132.37 -31.94 1.38 Allowed 'General case' 0 N--CA 1.48 1.039 0 N-CA-C 113.901 1.074 . . . . 0.0 113.901 -171.33 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 94.2 p -137.14 160.38 39.16 Favored 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 125.901 1.681 . . . . 0.0 110.875 -177.17 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 96.6 p -116.59 165.64 13.02 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 125.678 1.591 . . . . 0.0 112.995 -175.588 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 72.2 ttt180 62.87 133.39 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 128.161 2.585 . . . . 0.0 113.728 -171.647 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 26.5 m -61.98 135.13 26.92 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 170.675 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -59.88 144.98 85.22 Favored Pre-proline 0 CA--C 1.548 0.88 0 C-N-CA 120.274 -0.57 . . . . 0.0 112.536 -169.603 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -49.12 -40.93 41.92 Favored 'Trans proline' 0 CA--C 1.539 0.761 0 C-N-CA 123.23 2.62 . . . . 0.0 117.763 -167.762 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 59.8 m -65.75 -26.54 67.77 Favored 'General case' 0 N--CA 1.484 1.252 0 CA-C-N 119.475 1.034 . . . . 0.0 111.661 -176.471 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -57.12 -36.94 71.26 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 123.905 0.882 . . . . 0.0 112.199 177.279 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.8 mp -59.5 -60.15 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 CA-C-N 119.05 0.841 . . . . 0.0 109.269 -179.404 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -62.49 -31.25 71.97 Favored 'General case' 0 CA--C 1.544 0.734 0 N-CA-C 113.434 0.901 . . . . 0.0 113.434 -176.677 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -81.29 -6.15 58.57 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 124.815 1.246 . . . . 0.0 114.184 177.672 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 40.6 mtt -114.94 -22.9 9.36 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 125.383 1.473 . . . . 0.0 110.704 175.026 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -65.15 -19.2 65.87 Favored 'General case' 0 CA--C 1.541 0.628 0 O-C-N 120.594 -1.316 . . . . 0.0 111.729 168.751 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 11.7 mt-10 -60.73 -28.27 68.55 Favored 'General case' 0 N--CA 1.481 1.107 0 CA-C-N 119.558 1.072 . . . . 0.0 111.48 169.377 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 67.8 t -93.14 -5.43 10.69 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.946 0 C-N-CA 127.472 2.309 . . . . 0.0 111.021 177.893 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 82.22 16.87 70.67 Favored Glycine 0 CA--C 1.538 1.494 0 C-N-CA 125.16 1.362 . . . . 0.0 114.307 -175.224 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 78.5 mt -77.14 139.6 18.47 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 C-N-CA 124.645 1.178 . . . . 0.0 111.53 -173.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 20.0 t0 -103.7 106.68 17.26 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 124.614 1.166 . . . . 0.0 111.873 170.709 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 3.8 pt -131.54 13.71 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.212 0 C-N-CA 125.515 1.526 . . . . 0.0 113.811 178.048 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 72.7 m -73.37 119.56 17.78 Favored 'General case' 0 N--CA 1.472 0.628 0 O-C-N 120.834 -1.167 . . . . 0.0 112.119 -176.31 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 63.78 35.43 92.01 Favored Glycine 0 CA--C 1.537 1.416 0 N-CA-C 115.797 1.079 . . . . 0.0 115.797 169.831 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 41.0 mt-30 -59.99 -50.32 74.22 Favored 'General case' 0 N--CA 1.477 0.906 0 N-CA-C 113.887 1.069 . . . . 0.0 113.887 -172.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 76.1 p -139.13 154.18 48.08 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 125.267 1.427 . . . . 0.0 113.348 -169.065 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 69.5 m -122.99 5.86 9.3 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 125.664 1.586 . . . . 0.0 113.982 -176.829 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 -143.14 153.07 59.55 Favored Pre-proline 0 CA--C 1.55 0.976 0 C-N-CA 124.44 1.096 . . . . 0.0 113.562 -173.411 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_exo -66.07 167.11 18.81 Favored 'Trans proline' 0 C--N 1.353 0.808 0 C-N-CA 123.349 2.7 . . . . 0.0 113.84 170.085 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 8.3 tt -50.79 -30.36 8.52 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 C-N-CA 126.699 2.0 . . . . 0.0 111.498 169.073 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -53.44 -27.49 25.04 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 126.514 1.925 . . . . 0.0 113.347 177.123 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -88.34 -6.82 57.5 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 125.119 1.368 . . . . 0.0 113.72 -174.875 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 71.6 m-85 -109.04 179.95 4.02 Favored 'General case' 0 CA--C 1.55 0.981 0 C-N-CA 126.51 1.924 . . . . 0.0 111.485 -174.917 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 5.8 t30 -122.52 126.24 47.4 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 125.495 1.518 . . . . 0.0 109.757 175.023 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.59 -35.66 80.73 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 113.895 1.072 . . . . 0.0 113.895 -169.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . 0.254 0.0 OUTLIER -71.46 -5.34 32.17 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 114.085 1.142 . . . . 0.0 114.085 -177.02 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -76.08 -12.96 60.21 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 124.013 0.925 . . . . 0.0 111.463 169.245 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 86.5 m-85 -115.51 139.54 49.97 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 127.098 2.159 . . . . 0.0 111.167 178.676 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -91.14 -21.97 20.91 Favored 'General case' 0 N--CA 1.478 0.959 0 CA-C-O 122.078 0.942 . . . . 0.0 112.556 178.303 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.721 HG22 ' HB ' ' A' ' 95' ' ' ILE . 80.7 t -133.78 139.29 48.98 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 C-N-CA 126.957 2.103 . . . . 0.0 109.014 -174.547 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 45.1 t -131.71 124.07 53.19 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 169.789 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 44.8 mm -111.86 108.01 24.42 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 C-N-CA 124.578 1.151 . . . . 0.0 108.653 -179.486 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 46.8 m -93.64 114.97 27.42 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 123.201 0.6 . . . . 0.0 109.738 174.859 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 82.7 mt -86.77 -13.7 44.45 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.971 1.308 . . . . 0.0 114.059 -172.118 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 14.5 p -147.85 157.78 43.71 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 124.835 1.254 . . . . 0.0 111.29 -176.603 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 62.1 -143.08 48.49 Favored Glycine 0 CA--C 1.538 1.472 0 C-N-CA 123.431 0.538 . . . . 0.0 113.494 179.572 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 56.9 m -131.43 164.12 26.43 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 125.584 1.554 . . . . 0.0 111.209 179.067 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -72.67 63.97 1.49 Allowed Glycine 0 CA--C 1.538 1.517 0 C-N-CA 124.953 1.264 . . . . 0.0 113.525 177.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 10.0 p -141.6 -30.65 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 N-CA-C 114.492 1.293 . . . . 0.0 114.492 -171.597 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 10.9 t-20 -75.0 -29.25 60.83 Favored 'General case' 0 N--CA 1.477 0.882 0 CA-C-N 119.417 1.008 . . . . 0.0 112.193 176.525 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -83.18 150.93 62.12 Favored Pre-proline 0 CA--C 1.548 0.888 0 C-N-CA 125.024 1.329 . . . . 0.0 111.279 169.628 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -65.35 155.44 68.62 Favored 'Trans proline' 0 CA--C 1.541 0.828 0 C-N-CA 122.574 2.182 . . . . 0.0 111.655 178.141 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -59.41 -26.34 81.6 Favored 'Trans proline' 0 C--N 1.35 0.61 0 C-N-CA 123.474 2.782 . . . . 0.0 114.913 -169.157 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -59.59 -22.7 62.15 Favored 'General case' 0 N--CA 1.472 0.629 0 O-C-N 120.841 -1.162 . . . . 0.0 114.119 178.285 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 84.9 m95 -82.44 -16.99 46.93 Favored 'General case' 0 N--CA 1.471 0.616 0 O-C-N 120.79 -1.194 . . . . 0.0 113.593 174.904 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 10.3 m -93.33 -10.41 9.45 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 CA-C-N 119.299 0.954 . . . . 0.0 113.498 170.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 60.3 p -93.48 -1.35 55.75 Favored 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 114.771 1.397 . . . . 0.0 114.771 177.016 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 72.8 mm-40 -67.64 154.21 41.96 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 119.3 0.954 . . . . 0.0 110.909 169.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -56.62 -40.01 74.62 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 114.601 1.334 . . . . 0.0 114.601 -167.82 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.721 ' HB ' HG22 ' A' ' 75' ' ' VAL . 15.7 mm -120.89 61.64 0.23 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 C-N-CA 124.972 1.309 . . . . 0.0 109.357 178.822 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 13.3 t80 -77.29 110.83 12.34 Favored 'General case' 0 CA--C 1.536 0.404 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 168.849 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 16.3 mt-10 -114.66 138.56 50.54 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 113.988 1.107 . . . . 0.0 113.988 173.197 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -101.65 120.25 40.04 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 124.143 0.977 . . . . 0.0 108.518 168.603 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 35.8 m0 -103.56 134.81 46.29 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 123.722 0.809 . . . . 0.0 108.867 176.629 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 64.2 mt-30 -114.8 30.56 7.26 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 123.865 0.866 . . . . 0.0 112.554 -169.563 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -76.16 159.71 30.44 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 125.709 1.604 . . . . 0.0 112.579 174.783 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -73.44 156.18 38.52 Favored 'General case' 0 CA--C 1.539 0.53 0 O-C-N 121.88 -0.512 . . . . 0.0 111.906 170.029 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 64.2 m-20 -106.44 155.06 39.39 Favored Pre-proline 0 CA--C 1.549 0.918 0 C-N-CA 123.292 0.637 . . . . 0.0 111.111 173.096 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_exo -70.87 -21.59 28.12 Favored 'Trans proline' 0 CA--C 1.544 1.007 0 C-N-CA 122.464 2.109 . . . . 0.0 115.115 179.795 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -42.19 125.26 3.02 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 114.329 1.233 . . . . 0.0 114.329 172.756 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 81.54 3.24 90.67 Favored Glycine 0 CA--C 1.535 1.335 0 C-N-CA 124.39 0.995 . . . . 0.0 115.167 177.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 9.8 pt20 -137.81 172.8 12.41 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 124.938 1.295 . . . . 0.0 113.59 -178.595 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 51.9 p -71.67 169.75 14.95 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 117.666 2.469 . . . . 0.0 117.666 -168.442 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -54.84 -41.68 71.03 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 126.436 1.894 . . . . 0.0 112.17 170.129 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -57.25 -32.85 66.99 Favored 'General case' 0 N--CA 1.473 0.716 0 O-C-N 121.225 -0.922 . . . . 0.0 112.23 172.382 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 7.7 t -75.14 -36.2 36.77 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 O-C-N 121.051 -1.031 . . . . 0.0 112.05 171.101 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 12.1 m-85 -56.58 -42.77 79.23 Favored 'General case' 0 N--CA 1.478 0.949 0 CA-C-N 120.792 1.633 . . . . 0.0 111.132 169.229 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 83.2 mtp180 -64.82 -42.9 94.61 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 124.1 0.96 . . . . 0.0 112.11 175.063 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 53.1 m -60.45 -45.31 94.15 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 124.1 0.96 . . . . 0.0 111.283 175.398 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 74.3 t -68.16 -42.1 84.62 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 CA-C-O 117.929 -1.034 . . . . 0.0 110.643 177.66 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 18.0 mtp180 -52.91 -44.9 67.3 Favored 'General case' 0 N--CA 1.482 1.158 0 CA-C-N 120.283 1.401 . . . . 0.0 112.215 171.761 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -60.09 -51.49 58.57 Favored Glycine 0 CA--C 1.539 1.577 0 CA-C-N 119.243 0.928 . . . . 0.0 113.694 175.303 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 56.4 mm-40 -65.45 -44.48 87.12 Favored 'General case' 0 N--CA 1.477 0.883 0 O-C-N 121.797 -0.825 . . . . 0.0 112.221 179.873 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 52.9 t -63.21 -42.06 95.09 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 124.673 1.189 . . . . 0.0 110.496 177.022 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 60.0 tttm -54.81 -50.93 67.35 Favored 'General case' 0 N--CA 1.477 0.888 0 CA-C-N 119.689 1.132 . . . . 0.0 110.91 177.664 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -63.99 -41.77 97.4 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 112.458 0.54 . . . . 0.0 112.458 178.756 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 4.8 mtp85 -63.3 -43.97 96.35 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 113.254 0.835 . . . . 0.0 113.254 175.772 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 94.1 t -71.34 -37.76 66.68 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 C-N-CA 124.044 0.937 . . . . 0.0 111.105 179.407 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -61.24 -40.97 96.02 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 119.417 1.008 . . . . 0.0 111.682 170.409 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 11.6 m-80 -61.8 -48.59 79.93 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 118.727 0.694 . . . . 0.0 112.165 173.394 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -51.83 -56.61 12.96 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 125.33 1.452 . . . . 0.0 110.465 175.725 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 75.2 mt -61.25 -46.3 96.89 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 CA-C-O 119.124 -0.465 . . . . 0.0 110.138 -179.574 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -66.62 -12.04 56.27 Favored 'General case' 0 CA--C 1.546 0.795 0 N-CA-C 114.983 1.475 . . . . 0.0 114.983 -178.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -102.14 -26.45 13.35 Favored 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 113.824 1.046 . . . . 0.0 113.824 172.355 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 13.6 pt -97.45 -12.85 8.26 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 N-CA-C 114.866 1.432 . . . . 0.0 114.866 178.655 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 57.8 m . . . . . 0 C--O 1.252 1.199 0 C-N-CA 125.333 1.453 . . . . 0.0 112.255 -179.792 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.3 ttt . . . . . 0 N--CA 1.501 2.088 0 N-CA-C 111.937 0.347 . . . . 0.0 111.937 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.15 164.34 30.41 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 124.966 1.306 . . . . 0.0 112.886 175.922 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 41.5 mtpt -94.73 143.4 26.47 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 124.449 1.1 . . . . 0.0 112.136 178.141 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 18.9 t -124.71 133.86 68.33 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 C-N-CA 125.289 1.435 . . . . 0.0 112.749 -178.877 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' MET . . . . . 0.51 ' HG3' HG13 ' A' ' 7' ' ' VAL . 36.8 tpp -104.2 122.45 45.39 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 123.412 0.685 . . . . 0.0 109.257 168.717 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 68.6 m-85 -98.94 128.66 45.15 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.337 1.055 . . . . 0.0 108.993 170.22 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.58 HG11 HD12 ' A' ' 65' ' ' ILE . 0.4 OUTLIER -138.27 144.17 31.11 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 N-CA-C 114.363 1.245 . . . . 0.0 114.363 -168.778 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -141.18 166.81 23.76 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 127.131 2.173 . . . . 0.0 110.68 170.122 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -57.19 -49.15 76.87 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.263 -0.898 . . . . 0.0 112.928 -173.881 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 96.8 mtt180 -125.05 130.55 52.52 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 124.679 1.191 . . . . 0.0 110.088 169.559 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 35.5 t30 -81.54 -43.0 19.35 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-N 117.819 0.281 . . . . 0.0 111.498 -179.735 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 45.0 m -68.25 -32.23 72.28 Favored 'General case' 0 N--CA 1.478 0.954 0 N-CA-C 113.52 0.933 . . . . 0.0 113.52 -170.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 97.8 p -90.92 -5.7 55.12 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 114.855 1.428 . . . . 0.0 114.855 -175.138 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 60.2 mtt85 -134.93 156.64 48.64 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 124.583 1.153 . . . . 0.0 112.341 -175.917 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 37.2 m -105.47 103.83 13.44 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 124.565 1.146 . . . . 0.0 110.077 -179.893 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 3.1 mp0 -78.4 -34.51 48.03 Favored 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 114.162 1.171 . . . . 0.0 114.162 -169.206 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 68.74 -49.2 0.57 Allowed 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 126.474 1.91 . . . . 0.0 115.99 169.653 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.97 -33.57 73.41 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.185 0.994 . . . . 0.0 113.574 -171.131 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 3.4 pm0 -62.5 -46.3 89.05 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 123.978 0.911 . . . . 0.0 112.277 174.295 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -65.57 -39.87 95.74 Favored Glycine 0 C--N 1.335 0.49 0 C-N-CA 123.64 0.638 . . . . 0.0 111.66 178.849 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -69.92 -41.78 74.19 Favored 'General case' 0 N--CA 1.468 0.431 0 O-C-N 121.838 -0.801 . . . . 0.0 111.271 176.156 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -60.4 -43.36 96.75 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 119.626 1.103 . . . . 0.0 112.735 -176.446 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 8.8 pttp -77.91 -24.31 48.37 Favored 'General case' 0 N--CA 1.479 1.011 0 N-CA-C 113.65 0.981 . . . . 0.0 113.65 175.097 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 85.5 m -71.63 -36.01 70.6 Favored 'General case' 0 N--CA 1.48 1.071 0 O-C-N 121.401 -0.812 . . . . 0.0 111.623 171.682 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 61.4 mt -88.09 -31.73 19.09 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 125.711 1.604 . . . . 0.0 114.172 -177.698 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -145.8 30.97 1.65 Allowed Glycine 0 N--CA 1.474 1.219 0 N-CA-C 118.297 2.079 . . . . 0.0 118.297 -169.035 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -66.71 -19.75 65.82 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-N 121.794 2.797 . . . . 0.0 115.202 -178.238 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -75.36 -10.37 84.45 Favored Glycine 0 CA--C 1.541 1.711 0 O-C-N 121.293 -0.88 . . . . 0.0 113.18 169.586 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 76.0 mttt -108.64 -39.66 5.31 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 127.185 2.194 . . . . 0.0 113.375 179.873 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 22.6 pt -142.12 155.72 19.33 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 C-N-CA 124.966 1.306 . . . . 0.0 112.562 -173.235 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -104.27 142.68 34.11 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 124.156 0.982 . . . . 0.0 110.48 171.199 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 74.3 t -130.11 140.11 49.76 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 CA-C-N 119.186 0.903 . . . . 0.0 112.88 -171.776 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 36.4 m -137.59 154.18 49.82 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 126.302 1.841 . . . . 0.0 109.02 170.885 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 61.3 p -128.95 147.31 50.84 Favored 'General case' 0 CA--C 1.515 -0.366 0 CA-C-O 121.931 0.872 . . . . 0.0 112.506 167.464 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 25.8 p -144.79 157.44 44.17 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 114.353 -1.294 . . . . 0.0 112.378 -178.59 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -97.92 150.74 19.52 Favored Glycine 0 N--CA 1.468 0.814 0 CA-C-O 119.318 -0.712 . . . . 0.0 111.846 174.663 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 10.8 mp -66.44 -30.9 71.35 Favored 'General case' 0 N--CA 1.483 1.207 0 CA-C-N 119.299 1.55 . . . . 0.0 108.992 168.864 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 52.6 mt-10 -133.1 154.8 50.24 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 128.359 2.664 . . . . 0.0 107.201 168.214 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 27.0 p 64.46 161.38 0.12 Allowed 'General case' 0 N--CA 1.486 1.331 0 N-CA-C 117.504 2.409 . . . . 0.0 117.504 178.678 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 75.1 m -118.76 143.55 46.83 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 126.621 1.968 . . . . 0.0 113.18 -170.248 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 59.1 ttt-85 62.3 148.13 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.897 0 C-N-CA 127.612 2.365 . . . . 0.0 114.091 -176.381 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 24.9 m -61.38 166.18 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.255 0 CA-C-O 122.662 1.22 . . . . 0.0 111.824 169.782 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 2.7 t-80 -41.22 136.45 1.71 Allowed Pre-proline 0 C--N 1.327 -0.386 0 CA-C-N 113.761 -1.563 . . . . 0.0 113.243 169.426 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -60.36 -27.5 84.99 Favored 'Trans proline' 0 CA--C 1.546 1.12 0 CA-C-N 120.753 1.305 . . . . 0.0 112.252 170.647 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 99.0 m -67.89 -31.89 71.99 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 124.966 1.306 . . . . 0.0 112.077 174.566 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -57.39 -39.48 76.2 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 124.289 1.036 . . . . 0.0 111.636 -175.055 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.7 mp -57.45 -60.61 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 C-N-CA 124.226 1.01 . . . . 0.0 109.361 -178.908 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -61.82 -31.62 71.88 Favored 'General case' 0 CA--C 1.545 0.761 0 N-CA-C 113.384 0.883 . . . . 0.0 113.384 -177.17 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -82.25 -6.61 59.35 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 114.248 1.203 . . . . 0.0 114.248 177.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 39.1 mtt -112.52 -24.35 9.75 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 125.418 1.487 . . . . 0.0 110.464 174.604 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 27.0 mt-10 -65.46 -16.43 63.64 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 125.128 1.371 . . . . 0.0 111.519 168.559 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 11.5 mt-10 -60.21 -30.52 69.43 Favored 'General case' 0 N--CA 1.481 1.095 0 CA-C-N 119.726 1.148 . . . . 0.0 110.74 169.103 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 60.2 t -92.45 -4.99 10.79 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.955 0 C-N-CA 127.59 2.356 . . . . 0.0 111.017 178.721 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 80.1 18.3 72.37 Favored Glycine 0 CA--C 1.538 1.497 0 C-N-CA 125.073 1.32 . . . . 0.0 114.55 -173.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 73.8 mt -76.89 136.69 23.99 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 124.368 1.067 . . . . 0.0 111.661 -173.082 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 19.7 t0 -97.33 88.45 4.43 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.588 1.155 . . . . 0.0 112.061 -179.112 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 7.6 pt -125.8 8.66 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.33 0 N-CA-C 114.265 1.209 . . . . 0.0 114.265 174.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 97.7 p -59.28 -42.12 90.48 Favored 'General case' 0 N--CA 1.477 0.92 0 O-C-N 120.824 -1.173 . . . . 0.0 114.044 -171.59 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -93.35 15.39 63.07 Favored Glycine 0 CA--C 1.534 1.237 0 C-N-CA 125.18 1.371 . . . . 0.0 116.092 -176.533 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . 0.268 0.0 OUTLIER -77.51 62.07 2.4 Favored 'General case' 0 N--CA 1.478 0.93 0 CA-C-N 119.912 1.856 . . . . 0.0 114.481 -172.18 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 40.2 p -69.38 107.86 3.49 Favored 'General case' 0 N--CA 1.471 0.585 0 O-C-N 120.431 -1.418 . . . . 0.0 108.93 169.186 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 70.2 m -142.18 129.32 20.92 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.204 1.002 . . . . 0.0 111.456 -169.567 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -67.02 170.39 6.37 Favored Pre-proline 0 CA--C 1.549 0.922 0 C-N-CA 127.575 2.35 . . . . 0.0 114.496 -176.249 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -64.3 156.51 59.38 Favored 'Trans proline' 0 C--N 1.352 0.728 0 C-N-CA 122.665 2.243 . . . . 0.0 111.819 169.129 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.58 HD12 HG11 ' A' ' 7' ' ' VAL . 6.0 tt -51.59 -33.71 15.17 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 C-N-CA 125.874 1.669 . . . . 0.0 111.571 174.632 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 12.3 mt-10 -61.97 -24.18 66.85 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.748 1.219 . . . . 0.0 113.295 -178.044 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 71.1 m-20 -91.89 6.17 47.22 Favored 'General case' 0 CA--C 1.55 0.981 0 C-N-CA 124.378 1.071 . . . . 0.0 112.898 -175.408 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 -119.15 -175.55 2.94 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 126.833 2.053 . . . . 0.0 112.683 -179.76 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 9.6 p-10 -123.73 129.26 50.81 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 125.737 1.615 . . . . 0.0 109.728 172.474 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -64.72 -37.19 86.76 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 112.81 0.671 . . . . 0.0 112.81 -172.607 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -68.4 -4.39 14.52 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 114.291 1.219 . . . . 0.0 114.291 179.364 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -68.51 -21.39 64.58 Favored 'General case' 0 CA--C 1.549 0.916 0 CA-C-N 119.317 0.962 . . . . 0.0 109.932 168.449 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 76.6 m-85 -115.35 146.13 41.85 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 127.726 2.41 . . . . 0.0 111.842 -175.179 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -101.91 -18.12 15.84 Favored 'General case' 0 N--CA 1.481 1.088 0 CA-C-O 122.153 0.978 . . . . 0.0 112.614 178.584 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.657 HG22 ' HB ' ' A' ' 95' ' ' ILE . 76.0 t -128.62 138.64 54.05 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 C-N-CA 127.605 2.362 . . . . 0.0 108.022 177.731 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 48.7 t -132.82 124.98 51.68 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 169.836 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 46.2 mm -112.3 104.82 17.66 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.344 0 C-N-CA 124.275 1.03 . . . . 0.0 109.602 -175.054 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 3.6 m -80.28 106.69 12.49 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 123.494 0.718 . . . . 0.0 109.868 170.463 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 91.2 mt -83.58 -19.95 34.63 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 126.237 1.815 . . . . 0.0 113.852 -176.293 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 80.6 m -97.01 121.59 39.06 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 106.931 -1.507 . . . . 0.0 106.931 171.328 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -59.73 141.47 47.55 Favored Glycine 0 CA--C 1.535 1.337 0 CA-C-N 118.484 0.583 . . . . 0.0 113.199 -172.571 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 75.7 m 56.85 43.65 24.57 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.744 1.218 . . . . 0.0 111.114 -169.526 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -74.29 62.61 2.2 Favored Glycine 0 N--CA 1.471 1.002 0 C-N-CA 125.91 1.719 . . . . 0.0 111.802 176.331 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.3 p -113.17 -0.41 9.3 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 C-N-CA 126.119 1.768 . . . . 0.0 112.913 -170.074 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 29.0 m120 -74.46 -11.34 60.2 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 124.338 1.055 . . . . 0.0 113.252 174.844 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -65.77 158.96 72.46 Favored Pre-proline 0 CA--C 1.553 1.07 0 C-N-CA 124.274 1.03 . . . . 0.0 112.389 170.501 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -59.94 149.93 81.15 Favored 'Trans proline' 0 CA--C 1.543 0.975 0 C-N-CA 122.437 2.091 . . . . 0.0 113.11 178.721 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_exo -56.25 -33.4 90.88 Favored 'Trans proline' 0 C--N 1.351 0.694 0 C-N-CA 123.102 2.535 . . . . 0.0 114.948 -171.873 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -59.61 -22.49 61.89 Favored 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 114.019 1.118 . . . . 0.0 114.019 178.879 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 88.7 m95 -79.75 -15.82 56.76 Favored 'General case' 0 N--CA 1.469 0.511 0 O-C-N 120.685 -1.259 . . . . 0.0 113.487 176.439 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 8.2 m -96.35 -8.13 9.43 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 N-CA-C 113.711 1.004 . . . . 0.0 113.711 170.731 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 68.5 p -95.77 -2.85 46.86 Favored 'General case' 0 N--CA 1.48 1.044 0 N-CA-C 114.866 1.432 . . . . 0.0 114.866 178.206 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 68.6 mm-40 -65.93 155.09 37.51 Favored 'General case' 0 N--CA 1.477 0.916 0 CA-C-N 119.368 0.985 . . . . 0.0 110.236 169.553 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -56.78 -40.05 75.16 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 114.773 1.397 . . . . 0.0 114.773 -168.154 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.657 ' HB ' HG22 ' A' ' 75' ' ' VAL . 19.7 mm -120.26 65.92 0.26 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 C-N-CA 124.652 1.181 . . . . 0.0 109.147 -178.795 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 32.7 t80 -80.04 109.76 14.79 Favored 'General case' 0 C--O 1.236 0.375 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 168.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -110.2 135.19 51.36 Favored 'General case' 0 CA--C 1.545 0.76 0 N-CA-C 113.441 0.904 . . . . 0.0 113.441 174.478 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -102.06 103.71 14.32 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.435 1.094 . . . . 0.0 109.584 169.895 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 38.1 m0 -91.84 114.1 26.55 Favored 'General case' 0 N--CA 1.463 0.181 0 C-N-CA 124.275 1.03 . . . . 0.0 109.294 179.523 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 41.7 mt-30 -91.8 48.54 1.46 Allowed 'General case' 0 CA--C 1.544 0.749 0 CA-C-O 122.289 1.043 . . . . 0.0 111.26 -172.678 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 86.5 mt -78.39 166.25 22.87 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 127.115 2.166 . . . . 0.0 111.953 176.485 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -88.9 152.49 21.7 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-O 121.555 0.693 . . . . 0.0 112.415 169.573 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 13.4 p-10 -89.6 136.77 29.23 Favored Pre-proline 0 CA--C 1.55 0.968 0 C-N-CA 125.47 1.508 . . . . 0.0 112.008 176.214 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -70.25 -20.01 33.05 Favored 'Trans proline' 0 CA--C 1.547 1.126 0 C-N-CA 121.955 1.77 . . . . 0.0 115.491 -178.42 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -66.52 145.0 56.12 Favored 'General case' 0 N--CA 1.476 0.834 0 O-C-N 121.103 -0.998 . . . . 0.0 113.179 -175.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 78.36 4.81 87.37 Favored Glycine 0 CA--C 1.535 1.296 0 C-N-CA 123.943 0.782 . . . . 0.0 114.661 -179.156 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -141.61 166.83 23.67 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 125.465 1.506 . . . . 0.0 112.878 -179.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 66.9 m -63.86 163.23 12.23 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 115.698 1.74 . . . . 0.0 115.698 -169.239 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -51.82 -39.64 59.11 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 126.673 1.989 . . . . 0.0 112.837 171.911 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -55.27 -31.81 61.86 Favored 'General case' 0 N--CA 1.474 0.737 0 O-C-N 121.265 -0.897 . . . . 0.0 112.515 172.598 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 4.3 t -76.94 -37.27 26.7 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 O-C-N 121.163 -0.961 . . . . 0.0 111.75 173.575 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 21.4 m-85 -57.16 -42.66 81.49 Favored 'General case' 0 N--CA 1.477 0.88 0 CA-C-N 119.943 1.247 . . . . 0.0 111.221 169.302 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 97.7 mtt180 -68.45 -38.35 81.06 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.612 0.765 . . . . 0.0 112.474 176.158 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 45.8 m -61.71 -45.65 93.06 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 124.187 0.995 . . . . 0.0 111.37 172.638 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 72.1 t -67.77 -40.97 84.74 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 CA-C-O 118.266 -0.873 . . . . 0.0 110.463 178.324 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 20.4 mtp180 -54.45 -43.74 71.92 Favored 'General case' 0 N--CA 1.484 1.273 0 CA-C-N 120.239 1.381 . . . . 0.0 112.915 170.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -61.59 -50.02 70.69 Favored Glycine 0 CA--C 1.537 1.417 0 CA-C-N 119.45 1.023 . . . . 0.0 113.255 175.784 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 53.6 mm-40 -64.59 -44.13 91.65 Favored 'General case' 0 N--CA 1.476 0.837 0 O-C-N 122.043 -0.68 . . . . 0.0 112.012 178.478 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 58.8 t -63.92 -41.46 92.58 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 C-N-CA 124.91 1.284 . . . . 0.0 111.125 176.752 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 60.7 tttm -54.27 -49.75 68.84 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-N 120.13 1.332 . . . . 0.0 110.628 176.832 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -63.49 -44.79 93.33 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 112.557 0.577 . . . . 0.0 112.557 176.306 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.23 -35.38 80.86 Favored 'General case' 0 N--CA 1.481 1.105 0 N-CA-C 113.6 0.963 . . . . 0.0 113.6 -179.921 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 92.3 t -78.01 -40.55 26.61 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 C-N-CA 125.411 1.484 . . . . 0.0 110.992 177.008 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -61.43 -38.57 87.61 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 119.185 0.902 . . . . 0.0 111.542 172.257 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 11.1 m-80 -63.91 -44.96 91.37 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 118.846 0.748 . . . . 0.0 112.701 173.561 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -54.47 -56.32 20.0 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 124.223 1.009 . . . . 0.0 110.667 174.392 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 95.3 mt -61.76 -42.01 92.77 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 CA-C-O 119.199 -0.429 . . . . 0.0 110.51 -179.26 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -68.72 -14.38 62.99 Favored 'General case' 0 CA--C 1.545 0.763 0 N-CA-C 114.933 1.457 . . . . 0.0 114.933 179.072 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 21.1 ptmt -99.96 -27.96 13.32 Favored 'General case' 0 N--CA 1.479 0.986 0 N-CA-C 113.855 1.057 . . . . 0.0 113.855 173.523 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 16.6 pt -94.86 -20.54 6.03 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 N-CA-C 114.295 1.22 . . . . 0.0 114.295 177.338 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 74.7 m . . . . . 0 C--O 1.253 1.28 0 C-N-CA 125.074 1.349 . . . . 0.0 111.889 -173.788 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 32.9 ttm . . . . . 0 N--CA 1.502 2.133 0 N-CA-C 112.044 0.387 . . . . 0.0 112.044 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 3.5 mptp? -103.92 155.51 18.58 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 125.181 1.392 . . . . 0.0 112.688 169.812 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 44.7 mtpt -105.4 113.78 27.56 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 106.089 -1.819 . . . . 0.0 106.089 167.088 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 14.4 t -105.95 130.49 57.41 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 C-N-CA 125.247 1.419 . . . . 0.0 113.15 -178.788 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' MET . . . . . 0.52 ' HG3' HG13 ' A' ' 7' ' ' VAL . 61.3 tpp -101.65 117.74 35.51 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.501 0.72 . . . . 0.0 109.137 169.193 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 54.8 m-85 -98.79 128.09 44.91 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 169.744 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.52 HG13 ' HG3' ' A' ' 5' ' ' MET . 1.3 m -144.22 153.1 15.4 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.127 0 N-CA-C 113.527 0.936 . . . . 0.0 113.527 -169.195 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 44.0 t -146.2 137.66 24.71 Favored 'General case' 0 CA--C 1.552 1.024 0 C-N-CA 125.315 1.446 . . . . 0.0 113.052 -178.457 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -67.36 135.44 53.24 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 125.029 1.331 . . . . 0.0 111.718 172.439 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . 0.263 19.1 ttm180 47.24 56.36 6.99 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 126.693 1.997 . . . . 0.0 113.31 -174.53 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 -48.76 -29.93 5.07 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 126.746 2.018 . . . . 0.0 114.654 175.461 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 81.4 p -62.69 -19.17 63.61 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 114.558 1.318 . . . . 0.0 114.558 179.72 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 84.7 p -127.32 24.07 6.32 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.458 1.503 . . . . 0.0 113.872 175.019 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 72.2 mtt85 -139.32 150.44 45.4 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 124.846 1.259 . . . . 0.0 113.26 177.196 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 22.3 m -106.81 153.87 21.84 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 125.552 1.541 . . . . 0.0 111.147 172.499 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 30.7 mt-30 -110.15 -55.91 2.4 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 113.248 0.833 . . . . 0.0 113.248 -171.846 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . 0.433 ' HG2' ' SD ' ' A' ' 50' ' ' MET . 0.0 OUTLIER 73.28 -48.21 0.68 Allowed 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 126.608 1.963 . . . . 0.0 113.523 176.984 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.92 -33.31 74.02 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 113.552 0.945 . . . . 0.0 113.552 -175.1 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 5.4 pm0 -68.58 -42.3 78.45 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 123.846 0.859 . . . . 0.0 111.306 177.419 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -65.0 -40.59 97.23 Favored Glycine 0 C--N 1.336 0.581 0 N-CA-C 111.504 -0.638 . . . . 0.0 111.504 178.7 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -72.64 -38.93 67.54 Favored 'General case' 0 N--CA 1.466 0.366 0 O-C-N 121.809 -0.818 . . . . 0.0 112.054 177.403 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.9 -37.48 84.78 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 113.552 0.945 . . . . 0.0 113.552 -173.749 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 6.9 pttp -79.47 -31.16 42.37 Favored 'General case' 0 N--CA 1.481 1.102 0 N-CA-C 113.689 0.996 . . . . 0.0 113.689 172.115 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 59.0 m -70.74 -33.34 70.71 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.197 0.599 . . . . 0.0 111.498 178.583 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 68.3 mt -92.78 -37.5 12.3 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 125.864 1.666 . . . . 0.0 113.277 177.587 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -106.82 8.91 39.96 Favored Glycine 0 N--CA 1.472 1.055 0 N-CA-C 117.892 1.917 . . . . 0.0 117.892 -169.021 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.12 141.88 57.11 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-N 121.318 2.559 . . . . 0.0 112.203 177.407 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 83.91 -21.34 9.79 Favored Glycine 0 CA--C 1.538 1.495 0 C-N-CA 124.984 1.278 . . . . 0.0 113.749 -169.485 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 65.1 mttm -97.45 -48.22 5.37 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 125.786 1.635 . . . . 0.0 111.796 169.863 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 40.6 pt -135.39 150.13 29.03 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 C-N-CA 124.364 1.066 . . . . 0.0 113.085 -175.087 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -102.48 137.76 40.29 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 125.407 1.483 . . . . 0.0 108.921 169.769 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 99.4 t -126.49 140.67 48.16 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 C-N-CA 123.265 0.626 . . . . 0.0 111.976 -173.785 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 27.3 m -140.04 151.59 45.54 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 125.191 1.396 . . . . 0.0 109.626 174.745 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 53.0 p -138.37 145.75 41.46 Favored 'General case' 0 CA--C 1.516 -0.339 0 CA-C-O 122.486 1.136 . . . . 0.0 111.784 167.454 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 88.5 p -139.59 153.56 47.4 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 113.227 -1.806 . . . . 0.0 110.657 -171.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -75.98 162.82 53.0 Favored Glycine 0 CA--C 1.535 1.329 0 O-C-N 121.162 -0.961 . . . . 0.0 112.57 176.741 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.6 mp -95.5 -6.58 40.24 Favored 'General case' 0 N--CA 1.479 1.016 0 O-C-N 120.218 -1.754 . . . . 0.0 111.305 168.565 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -129.21 165.59 21.06 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 128.64 2.776 . . . . 0.0 107.386 169.799 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 70.1 m -77.24 59.7 1.82 Allowed 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 124.23 1.012 . . . . 0.0 113.159 -170.072 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 89.3 p -152.56 -179.63 7.76 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 125.748 1.619 . . . . 0.0 114.124 -169.685 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 58.8 ttt85 -94.8 163.17 13.46 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 128.798 2.839 . . . . 0.0 110.553 -174.571 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 21.2 m -78.51 178.49 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.235 0 C-N-CA 123.974 0.91 . . . . 0.0 110.056 169.238 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 2.1 t-80 -61.01 129.62 90.58 Favored Pre-proline 0 CA--C 1.534 0.344 0 CA-C-O 118.445 -0.788 . . . . 0.0 113.041 -177.06 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo -58.18 -28.01 82.42 Favored 'Trans proline' 0 CA--C 1.544 0.982 0 C-N-CA 121.728 1.618 . . . . 0.0 112.083 169.722 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 96.9 m -61.18 -32.32 72.06 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 125.5 1.52 . . . . 0.0 112.282 173.872 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -57.99 -47.24 83.59 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 118.98 0.809 . . . . 0.0 110.786 179.895 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.5 mp -53.42 -54.5 17.97 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 C-N-CA 124.222 1.009 . . . . 0.0 110.299 -174.596 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.24 -31.05 72.09 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 113.223 0.823 . . . . 0.0 113.223 -178.534 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -81.61 -21.72 38.13 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 113.761 1.022 . . . . 0.0 113.761 177.653 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . 0.433 ' SD ' ' HG2' ' A' ' 17' ' ' MET . 4.8 mmt -84.87 -31.27 23.83 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 119.491 1.042 . . . . 0.0 110.484 169.549 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -66.97 -15.05 63.46 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.752 1.221 . . . . 0.0 113.774 175.571 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 14.3 mt-10 -61.97 -25.7 67.77 Favored 'General case' 0 N--CA 1.482 1.137 0 CA-C-N 120.313 1.415 . . . . 0.0 110.797 168.864 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 48.6 t -98.44 -2.76 9.86 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.006 0 C-N-CA 127.69 2.396 . . . . 0.0 111.163 176.749 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 79.42 17.86 75.06 Favored Glycine 0 CA--C 1.539 1.591 0 C-N-CA 125.096 1.331 . . . . 0.0 114.498 -176.805 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 84.4 mt -79.49 136.16 24.17 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 C-N-CA 125.06 1.344 . . . . 0.0 111.523 -174.449 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 15.0 t0 -95.35 111.0 22.94 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 112.896 0.702 . . . . 0.0 112.896 175.29 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 6.7 pt -135.89 24.35 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.363 0 C-N-CA 124.77 1.228 . . . . 0.0 114.05 172.52 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 70.4 m -69.85 -20.47 63.42 Favored 'General case' 0 N--CA 1.48 1.048 0 O-C-N 120.153 -1.592 . . . . 0.0 114.608 -172.242 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -90.06 10.85 72.65 Favored Glycine 0 CA--C 1.537 1.416 0 N-CA-C 116.521 1.369 . . . . 0.0 116.521 -175.871 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 25.2 mt-30 -81.83 50.49 1.54 Allowed 'General case' 0 N--CA 1.482 1.154 0 CA-C-N 120.08 1.94 . . . . 0.0 114.97 -169.573 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 37.8 m -104.65 -7.15 19.82 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 125.501 1.52 . . . . 0.0 111.249 169.655 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 68.7 m -69.59 79.36 0.42 Allowed 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 115.921 1.823 . . . . 0.0 115.921 -169.299 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 34.8 m-20 65.35 158.91 0.13 Allowed Pre-proline 0 CA--C 1.552 1.039 0 C-N-CA 128.57 2.748 . . . . 0.0 117.48 169.116 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -73.04 158.47 49.49 Favored 'Trans proline' 0 CA--C 1.539 0.74 0 C-N-CA 122.656 2.237 . . . . 0.0 113.052 169.934 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.47 HD12 HG11 ' A' ' 7' ' ' VAL . 6.3 tt -51.22 -40.92 23.4 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 125.705 1.602 . . . . 0.0 112.065 174.336 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -69.54 -7.32 37.32 Favored 'General case' 0 CA--C 1.543 0.707 0 N-CA-C 113.999 1.111 . . . . 0.0 113.999 -179.331 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 -81.14 -19.92 42.45 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 123.682 0.793 . . . . 0.0 113.128 171.349 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -99.27 -173.04 2.38 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 126.104 1.762 . . . . 0.0 112.581 -176.201 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 14.7 t30 -117.75 124.87 49.52 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 125.363 1.465 . . . . 0.0 110.14 175.488 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.99 -38.29 88.13 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 113.694 0.998 . . . . 0.0 113.694 -172.237 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -72.72 -5.09 35.39 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 113.951 1.093 . . . . 0.0 113.951 -176.694 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -72.69 -16.05 61.68 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 123.485 0.714 . . . . 0.0 111.385 168.866 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 60.3 m-85 -115.11 132.11 56.71 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 126.348 1.859 . . . . 0.0 111.166 179.313 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -89.03 -20.6 24.18 Favored 'General case' 0 N--CA 1.476 0.875 0 CA-C-O 121.966 0.889 . . . . 0.0 112.73 -177.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.686 HG22 ' HB ' ' A' ' 95' ' ' ILE . 82.0 t -128.57 137.74 56.5 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 C-N-CA 127.488 2.315 . . . . 0.0 107.965 178.75 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 65.9 t -131.37 123.68 53.41 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 169.569 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 36.1 mm -109.77 104.46 17.11 Favored 'Isoleucine or valine' 0 C--O 1.234 0.287 0 C-N-CA 124.397 1.079 . . . . 0.0 108.462 -179.053 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 5.4 m -82.71 125.42 31.22 Favored 'General case' 0 N--CA 1.466 0.375 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 170.264 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 89.5 mt -102.33 -11.96 18.29 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 114.497 1.295 . . . . 0.0 114.497 -173.189 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 35.1 m -141.65 143.41 33.61 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 125.015 1.326 . . . . 0.0 110.426 -169.595 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 65.39 -133.4 35.85 Favored Glycine 0 CA--C 1.537 1.464 0 CA-C-N 118.083 0.402 . . . . 0.0 112.515 -176.762 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 88.4 p -131.02 13.84 5.21 Favored 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 115.143 1.534 . . . . 0.0 115.143 -175.212 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 67.57 69.17 1.43 Allowed Glycine 0 N--CA 1.475 1.276 0 CA-C-O 122.832 1.24 . . . . 0.0 111.968 -171.046 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 10.2 p -136.44 176.05 8.94 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 C-N-CA 127.876 2.47 . . . . 0.0 107.036 175.018 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 20.8 t-20 66.28 -36.93 0.26 Allowed 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 126.339 1.856 . . . . 0.0 114.844 -172.358 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -71.04 155.72 92.94 Favored Pre-proline 0 CA--C 1.554 1.106 0 CA-C-N 119.742 1.155 . . . . 0.0 111.592 169.18 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_exo -63.17 146.25 94.03 Favored 'Trans proline' 0 CA--C 1.548 1.183 0 C-N-CA 122.094 1.863 . . . . 0.0 113.169 179.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_exo -55.58 -28.8 66.98 Favored 'Trans proline' 0 C--N 1.352 0.738 0 C-N-CA 123.703 2.935 . . . . 0.0 115.804 -175.682 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 4.4 pm0 -62.61 -18.93 63.17 Favored 'General case' 0 CA--C 1.544 0.745 0 O-C-N 120.664 -1.273 . . . . 0.0 114.168 176.373 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 86.6 m95 -83.39 -24.11 32.1 Favored 'General case' 0 N--CA 1.471 0.578 0 O-C-N 120.552 -1.343 . . . . 0.0 112.934 175.708 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 9.7 m -86.21 -3.41 8.66 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.31 0 N-CA-C 113.608 0.966 . . . . 0.0 113.608 173.443 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -111.2 4.69 19.43 Favored 'General case' 0 N--CA 1.48 1.026 0 N-CA-C 114.581 1.326 . . . . 0.0 114.581 -177.957 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 85.9 mm-40 -64.56 158.35 24.47 Favored 'General case' 0 N--CA 1.478 0.956 0 O-C-N 120.863 -1.148 . . . . 0.0 111.976 170.882 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -57.52 -41.83 81.65 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 114.002 1.112 . . . . 0.0 114.002 -168.249 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.686 ' HB ' HG22 ' A' ' 75' ' ' VAL . 15.5 mm -116.03 58.97 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 C-N-CA 124.892 1.277 . . . . 0.0 109.049 174.401 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 27.0 t80 -74.17 110.12 8.2 Favored 'General case' 0 CA--C 1.534 0.356 0 O-C-N 120.441 -1.412 . . . . 0.0 107.666 168.8 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 9.1 mt-10 -107.67 129.43 55.01 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-O 121.586 0.708 . . . . 0.0 112.687 172.404 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -98.35 88.81 4.25 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 124.163 0.985 . . . . 0.0 110.215 174.287 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 29.2 m0 -81.09 102.09 10.03 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-O 122.031 0.919 . . . . 0.0 109.618 176.63 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 27.6 mt-30 -82.29 60.13 4.86 Favored 'General case' 0 CA--C 1.545 0.787 0 CA-C-O 122.527 1.156 . . . . 0.0 109.049 175.83 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 5.9 tt -95.13 156.31 16.37 Favored 'General case' 0 CA--C 1.539 0.519 0 C-N-CA 128.226 2.61 . . . . 0.0 112.87 -169.148 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -67.67 109.88 3.49 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 125.185 1.394 . . . . 0.0 112.398 177.473 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -71.63 123.9 90.12 Favored Pre-proline 0 CA--C 1.548 0.883 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 169.313 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -79.0 -8.57 15.5 Favored 'Trans proline' 0 CA--C 1.551 1.339 0 C-N-CA 122.092 1.861 . . . . 0.0 114.134 -172.456 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -72.82 155.0 40.37 Favored 'General case' 0 CA--C 1.549 0.934 0 CA-C-N 120.668 1.576 . . . . 0.0 113.338 176.416 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 76.57 5.94 83.65 Favored Glycine 0 CA--C 1.538 1.474 0 C-N-CA 124.428 1.013 . . . . 0.0 114.089 -178.12 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 -142.92 167.51 21.9 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 126.998 2.119 . . . . 0.0 111.226 179.284 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 70.6 m -59.83 157.16 12.78 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 115.081 1.511 . . . . 0.0 115.081 -169.42 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -51.1 -38.32 51.11 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 126.202 1.801 . . . . 0.0 112.689 172.304 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -55.11 -38.93 68.79 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 123.787 0.835 . . . . 0.0 112.107 172.7 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 14.6 t -67.96 -40.76 83.88 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 CA-C-O 118.674 -0.679 . . . . 0.0 111.071 173.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -53.7 -47.39 70.53 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 119.346 0.975 . . . . 0.0 112.339 169.821 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 96.9 mtt180 -69.01 -39.0 79.55 Favored 'General case' 0 N--CA 1.479 0.999 0 CA-C-N 118.842 0.746 . . . . 0.0 112.652 -179.603 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 30.7 m -62.18 -40.92 97.65 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 123.718 0.807 . . . . 0.0 111.306 170.432 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 41.8 t -65.69 -41.07 89.68 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 CA-C-O 117.407 -1.282 . . . . 0.0 111.19 176.57 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 75.5 mtm-85 -55.28 -43.52 74.82 Favored 'General case' 0 N--CA 1.485 1.315 0 CA-C-N 121.038 1.745 . . . . 0.0 112.26 172.576 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -60.85 -51.67 57.15 Favored Glycine 0 CA--C 1.537 1.429 0 CA-C-N 119.036 0.835 . . . . 0.0 113.514 176.269 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 57.6 mm-40 -64.81 -42.97 94.58 Favored 'General case' 0 N--CA 1.474 0.765 0 O-C-N 121.758 -0.848 . . . . 0.0 112.124 179.107 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 55.0 t -65.39 -42.54 93.78 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 C-N-CA 124.799 1.24 . . . . 0.0 110.957 177.378 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 62.9 tttm -53.57 -49.36 67.88 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-N 119.721 1.146 . . . . 0.0 111.147 176.629 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -63.68 -41.7 98.12 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 178.444 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 13.3 mtp85 -63.82 -43.5 96.04 Favored 'General case' 0 N--CA 1.478 0.952 0 N-CA-C 113.22 0.822 . . . . 0.0 113.22 175.435 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 86.2 t -69.06 -38.9 78.92 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 C-N-CA 123.453 0.701 . . . . 0.0 110.729 179.534 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -62.75 -37.63 87.36 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 118.897 0.771 . . . . 0.0 111.773 170.791 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 9.4 m-80 -63.29 -46.85 84.81 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 119.185 0.902 . . . . 0.0 112.549 173.495 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -52.98 -56.81 13.26 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 125.035 1.334 . . . . 0.0 110.253 173.696 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 75.4 mt -61.63 -40.53 87.0 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 O-C-N 122.004 -0.435 . . . . 0.0 110.603 -179.121 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -70.69 -12.11 61.36 Favored 'General case' 0 CA--C 1.545 0.779 0 N-CA-C 114.95 1.463 . . . . 0.0 114.95 178.695 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 20.9 ptmt -102.67 -25.9 13.38 Favored 'General case' 0 N--CA 1.478 0.952 0 N-CA-C 114.038 1.125 . . . . 0.0 114.038 172.882 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 16.7 pt -99.18 -19.16 6.01 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 N-CA-C 114.432 1.271 . . . . 0.0 114.432 177.733 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 68.8 m . . . . . 0 C--O 1.255 1.39 0 C-N-CA 125.132 1.373 . . . . 0.0 112.292 -174.777 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.8 ttt . . . . . 0 N--CA 1.503 2.22 0 N-CA-C 111.745 0.276 . . . . 0.0 111.745 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 3.3 mptp? -125.92 156.43 39.73 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 125.685 1.594 . . . . 0.0 112.681 175.759 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 30.5 ttmt -107.64 117.89 35.3 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 106.651 -1.611 . . . . 0.0 106.651 167.115 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 14.3 t -103.01 135.23 41.45 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 N-CA-C 114.239 1.2 . . . . 0.0 114.239 -179.376 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' MET . . . . . 0.511 ' HG3' HG13 ' A' ' 7' ' ' VAL . 42.4 tpp -104.48 124.37 49.14 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 123.886 0.874 . . . . 0.0 108.908 168.503 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 67.2 m-85 -105.03 126.09 51.69 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 123.839 0.856 . . . . 0.0 108.972 169.798 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.511 HG13 ' HG3' ' A' ' 5' ' ' MET . 1.5 m -141.95 150.6 19.03 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.194 0 N-CA-C 114.902 1.445 . . . . 0.0 114.902 -168.784 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 48.7 t -148.16 162.28 39.76 Favored 'General case' 0 CA--C 1.556 1.193 0 C-N-CA 127.501 2.32 . . . . 0.0 112.303 -179.432 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 21.9 ptmt -63.3 132.51 51.84 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 125.316 1.446 . . . . 0.0 112.298 172.597 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 6.9 mmm180 42.31 -135.84 0.32 Allowed 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 126.04 1.736 . . . . 0.0 112.255 -172.868 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 34.1 p-10 -154.39 -45.95 0.09 Allowed 'General case' 0 CA--C 1.549 0.942 0 N-CA-C 114.78 1.4 . . . . 0.0 114.78 172.715 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 67.5 m -56.73 -15.16 4.09 Favored 'General case' 0 N--CA 1.481 1.118 0 N-CA-C 117.685 2.476 . . . . 0.0 117.685 -169.067 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 97.7 p -102.17 -9.9 20.08 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 115.577 1.695 . . . . 0.0 115.577 -179.791 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 77.6 mtt85 -144.68 150.2 36.92 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 125.017 1.327 . . . . 0.0 113.468 -169.634 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 86.9 p -119.16 -5.07 10.49 Favored 'General case' 0 N--CA 1.478 0.944 0 N-CA-C 116.196 1.924 . . . . 0.0 116.196 -170.071 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 27.7 mt-30 64.25 -59.59 0.21 Allowed 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 128.013 2.525 . . . . 0.0 117.318 169.853 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 65.02 -43.88 0.33 Allowed 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 127.851 2.46 . . . . 0.0 116.597 -179.748 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.93 -28.34 68.87 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 115.137 1.532 . . . . 0.0 115.137 -169.212 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.0 pm0 -59.69 -37.1 77.87 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 119.132 0.878 . . . . 0.0 112.406 171.588 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -70.3 -50.45 27.17 Favored Glycine 0 C--O 1.224 -0.515 0 C-N-CA 124.408 1.004 . . . . 0.0 112.151 -169.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -66.4 -30.13 70.44 Favored 'General case' 0 N--CA 1.467 0.394 0 O-C-N 121.554 -0.968 . . . . 0.0 112.744 173.499 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -66.32 -35.86 81.46 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 118.499 0.59 . . . . 0.0 111.691 -176.001 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 13.4 ptmm? -82.1 -39.95 22.64 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 123.41 0.684 . . . . 0.0 112.319 169.227 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 16.9 m -76.02 -23.73 55.21 Favored 'General case' 0 N--CA 1.486 1.351 0 N-CA-C 112.905 0.706 . . . . 0.0 112.905 -169.255 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 85.3 mt -103.38 -30.61 10.48 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 125.378 1.471 . . . . 0.0 112.577 169.397 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -99.95 0.72 56.35 Favored Glycine 0 N--CA 1.471 1.026 0 N-CA-C 117.379 1.711 . . . . 0.0 117.379 -169.534 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -60.45 142.93 54.48 Favored 'General case' 0 CA--C 1.546 0.81 0 CA-C-N 121.09 2.445 . . . . 0.0 112.566 178.371 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 84.15 -23.51 7.0 Favored Glycine 0 CA--C 1.54 1.606 0 C-N-CA 124.822 1.201 . . . . 0.0 113.337 -169.48 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 62.1 mttp -96.93 -43.87 7.27 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 125.884 1.674 . . . . 0.0 111.883 169.834 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 43.7 pt -141.74 160.41 21.25 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 C-N-CA 125.178 1.391 . . . . 0.0 113.173 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -108.4 148.16 30.53 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 127.157 2.183 . . . . 0.0 109.17 169.831 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 58.7 t -136.02 143.85 34.95 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 CA-C-N 119.294 0.952 . . . . 0.0 113.165 -177.457 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 59.7 m -135.98 152.2 50.7 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 125.722 1.609 . . . . 0.0 109.539 169.821 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 96.7 p -136.06 142.32 44.36 Favored 'General case' 0 CA--C 1.514 -0.423 0 CA-C-O 121.942 0.877 . . . . 0.0 111.998 167.248 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 29.3 p -141.74 169.14 18.15 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 113.485 -1.689 . . . . 0.0 111.075 -176.707 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -106.02 164.23 13.76 Favored Glycine 0 CA--C 1.525 0.677 0 C-N-CA 123.731 0.681 . . . . 0.0 111.741 178.795 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -90.41 117.54 29.19 Favored 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 106.66 -1.608 . . . . 0.0 106.66 168.859 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 68.5 -41.57 0.46 Allowed 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 127.701 2.4 . . . . 0.0 113.955 -171.904 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 74.2 m -78.8 155.25 29.33 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 124.537 1.135 . . . . 0.0 111.142 169.547 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 67.9 p -90.74 -83.07 0.27 Allowed 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 114.394 1.257 . . . . 0.0 114.394 -179.273 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 52.1 ttt-85 -79.47 148.4 31.9 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 127.764 2.426 . . . . 0.0 110.457 -172.17 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 6.4 m -66.16 141.05 18.55 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 N-CA-C 109.214 -0.662 . . . . 0.0 109.214 171.739 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . 0.256 0.0 OUTLIER -65.36 144.35 98.96 Favored Pre-proline 0 CA--C 1.549 0.917 0 C-N-CA 119.636 -0.826 . . . . 0.0 111.103 -169.294 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_exo -46.32 -37.8 19.49 Favored 'Trans proline' 0 CA--C 1.54 0.792 0 C-N-CA 123.848 3.032 . . . . 0.0 118.331 -167.858 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 27.7 m -62.0 -26.59 68.31 Favored 'General case' 0 N--CA 1.485 1.299 0 O-C-N 120.702 -1.249 . . . . 0.0 112.206 -177.822 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.81 -21.96 66.69 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 113.538 0.94 . . . . 0.0 113.538 174.579 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.5 mp -74.91 -58.46 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 CA-C-N 119.527 1.058 . . . . 0.0 109.113 178.243 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.59 -33.89 76.97 Favored 'General case' 0 CA--C 1.545 0.752 0 N-CA-C 114.166 1.173 . . . . 0.0 114.166 -171.149 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.46 -25.54 57.48 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 124.268 1.027 . . . . 0.0 113.244 179.746 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -92.03 -32.63 15.13 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.578 1.151 . . . . 0.0 109.893 177.812 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -63.92 -12.18 34.83 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.092 1.357 . . . . 0.0 113.985 169.738 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -59.59 -19.68 50.51 Favored 'General case' 0 CA--C 1.553 1.087 0 CA-C-N 119.537 1.062 . . . . 0.0 110.458 168.041 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 16.5 t -108.75 -3.53 10.35 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.035 0 C-N-CA 128.548 2.739 . . . . 0.0 111.987 -179.585 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 73.99 34.41 55.72 Favored Glycine 0 CA--C 1.542 1.747 0 O-C-N 120.429 -1.419 . . . . 0.0 114.578 -177.137 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 9.4 mt -75.86 -19.17 15.53 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 N-CA-C 116.759 2.133 . . . . 0.0 116.759 -169.813 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 24.1 t0 43.7 72.28 0.2 Allowed 'General case' 0 CA--C 1.556 1.186 0 C-N-CA 126.747 2.019 . . . . 0.0 114.885 -179.185 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 35.3 pt -114.62 34.23 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 C-N-CA 125.569 1.548 . . . . 0.0 112.408 173.706 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 75.0 m -70.58 -34.0 71.7 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 114.594 1.331 . . . . 0.0 114.594 -170.104 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -84.41 -68.42 1.4 Allowed Glycine 0 CA--C 1.529 0.947 0 C-N-CA 123.477 0.561 . . . . 0.0 113.506 -179.62 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 8.0 mm100 54.46 -166.87 0.08 Allowed 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 126.527 1.931 . . . . 0.0 111.447 -169.091 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 64.2 p -73.21 138.19 45.48 Favored 'General case' 0 N--CA 1.473 0.701 0 O-C-N 121.141 -0.974 . . . . 0.0 112.56 -179.254 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 68.5 m -80.26 3.0 22.28 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.631 1.172 . . . . 0.0 113.012 169.782 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -144.72 157.35 55.26 Favored Pre-proline 0 CA--C 1.548 0.901 0 C-N-CA 125.87 1.668 . . . . 0.0 112.011 -176.365 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -64.89 165.99 19.63 Favored 'Trans proline' 0 CA--C 1.538 0.695 0 C-N-CA 124.183 3.255 . . . . 0.0 114.721 174.905 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.477 HD12 HG11 ' A' ' 7' ' ' VAL . 5.4 tt -49.83 -42.99 18.95 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.2 0 C-N-CA 124.59 1.156 . . . . 0.0 112.154 174.474 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -69.25 -10.69 58.99 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 113.524 0.935 . . . . 0.0 113.524 -174.83 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -77.39 -15.53 59.32 Favored 'General case' 0 CA--C 1.548 0.886 0 N-CA-C 112.807 0.669 . . . . 0.0 112.807 176.117 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 76.1 m-85 -107.28 -168.27 1.37 Allowed 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 126.53 1.932 . . . . 0.0 112.475 -174.868 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 8.9 p-10 -124.05 129.16 50.42 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 125.314 1.445 . . . . 0.0 109.921 176.629 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -64.55 -36.34 83.89 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 113.209 0.818 . . . . 0.0 113.209 -171.224 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -68.8 -4.55 16.55 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 114.067 1.136 . . . . 0.0 114.067 178.075 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -68.44 -16.68 63.99 Favored 'General case' 0 CA--C 1.549 0.913 0 CA-C-N 118.775 0.716 . . . . 0.0 110.296 168.286 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 79.6 m-85 -119.78 146.26 45.83 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 128.006 2.523 . . . . 0.0 111.709 -177.791 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -94.99 -29.06 14.82 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 124.838 1.255 . . . . 0.0 111.903 178.055 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.736 HG22 ' HB ' ' A' ' 95' ' ' ILE . 71.1 t -125.74 135.39 64.05 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 C-N-CA 126.067 1.747 . . . . 0.0 107.063 -177.212 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 69.0 t -127.04 121.39 57.83 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 169.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 45.1 mm -107.81 106.52 20.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 C-N-CA 124.703 1.201 . . . . 0.0 108.557 -177.597 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 8.1 m -90.68 111.85 23.36 Favored 'General case' 0 N--CA 1.463 0.222 0 C-N-CA 123.699 0.8 . . . . 0.0 109.829 176.611 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 89.9 mt -91.71 -11.32 37.18 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 124.855 1.262 . . . . 0.0 114.405 -170.539 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 57.3 m -139.94 156.27 46.75 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.565 1.146 . . . . 0.0 112.548 -168.927 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 60.62 -133.24 49.94 Favored Glycine 0 CA--C 1.536 1.377 0 N-CA-C 111.409 -0.677 . . . . 0.0 111.409 -175.326 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 75.3 m -125.19 26.87 6.79 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 124.305 1.042 . . . . 0.0 112.169 172.199 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 69.49 25.31 75.63 Favored Glycine 0 CA--C 1.533 1.172 0 O-C-N 121.344 -0.847 . . . . 0.0 114.905 -174.477 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 33.4 m -82.63 -178.54 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 C-N-CA 124.933 1.293 . . . . 0.0 110.254 169.713 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 12.5 t-20 66.18 -34.04 0.2 Allowed 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 127.182 2.193 . . . . 0.0 115.781 -179.35 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -71.85 142.36 85.55 Favored Pre-proline 0 CA--C 1.551 0.986 0 CA-C-N 120.271 1.396 . . . . 0.0 110.73 169.008 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -60.21 154.9 48.9 Favored 'Trans proline' 0 CA--C 1.543 0.946 0 C-N-CA 122.831 2.354 . . . . 0.0 114.492 -179.429 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_exo -56.03 -28.73 70.75 Favored 'Trans proline' 0 C--N 1.353 0.775 0 C-N-CA 123.733 2.955 . . . . 0.0 115.121 -177.483 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -62.11 -30.26 70.9 Favored 'General case' 0 CA--C 1.54 0.582 0 O-C-N 120.888 -1.132 . . . . 0.0 113.103 176.004 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 85.5 m95 -79.59 -29.83 41.33 Favored 'General case' 0 N--CA 1.476 0.846 0 O-C-N 120.942 -1.099 . . . . 0.0 111.998 174.303 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 48.8 t -68.91 -26.93 33.73 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.925 0 C-N-CA 125.216 1.406 . . . . 0.0 112.068 172.55 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -102.33 6.98 40.67 Favored 'General case' 0 N--CA 1.48 1.053 0 N-CA-C 116.051 1.871 . . . . 0.0 116.051 -170.894 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 89.7 mm-40 -65.49 160.33 22.45 Favored 'General case' 0 N--CA 1.481 1.112 0 O-C-N 120.633 -1.292 . . . . 0.0 112.255 172.537 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -51.35 -44.33 62.01 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 124.63 1.172 . . . . 0.0 113.849 -168.703 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.736 ' HB ' HG22 ' A' ' 75' ' ' VAL . 16.8 mm -123.19 69.1 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 C-N-CA 125.015 1.326 . . . . 0.0 108.343 177.781 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 57.1 t80 -78.58 107.55 11.33 Favored 'General case' 0 CA--C 1.534 0.356 0 O-C-N 120.796 -1.19 . . . . 0.0 108.58 169.399 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 9.1 mt-10 -105.92 132.7 51.7 Favored 'General case' 0 CA--C 1.545 0.778 0 N-CA-C 113.773 1.027 . . . . 0.0 113.773 174.551 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -93.75 104.39 16.48 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.648 1.179 . . . . 0.0 109.868 169.816 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 17.4 m0 -92.74 98.68 11.56 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.345 1.058 . . . . 0.0 110.002 -177.246 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 87.8 mm-40 -79.41 61.29 3.43 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 125.087 1.355 . . . . 0.0 109.985 172.833 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 6.2 tt -109.5 149.3 29.8 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 127.092 2.157 . . . . 0.0 113.054 -169.432 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -67.2 111.58 4.02 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 125.962 1.705 . . . . 0.0 111.912 176.444 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -84.0 129.88 57.06 Favored Pre-proline 0 CA--C 1.545 0.776 0 O-C-N 120.887 -1.133 . . . . 0.0 110.849 171.556 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -86.74 -9.63 6.52 Favored 'Trans proline' 0 CA--C 1.541 0.845 0 C-N-CA 121.955 1.77 . . . . 0.0 114.515 -169.957 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -60.39 -41.68 94.32 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 115.307 1.595 . . . . 0.0 115.307 -169.503 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -76.52 10.17 18.5 Favored Glycine 0 CA--C 1.537 1.444 0 C-N-CA 124.212 0.911 . . . . 0.0 114.755 -178.046 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 8.0 pt20 -146.69 -177.65 5.76 Favored 'General case' 0 CA--C 1.551 1.012 0 C-N-CA 126.848 2.059 . . . . 0.0 111.499 -169.877 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 10.5 p -66.76 164.68 16.6 Favored 'General case' 0 N--CA 1.478 0.947 0 N-CA-C 116.172 1.916 . . . . 0.0 116.172 -168.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 36.4 tp -63.02 -26.49 68.87 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 123.832 0.853 . . . . 0.0 112.338 170.591 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -69.39 -34.87 75.16 Favored 'General case' 0 CA--C 1.539 0.539 0 O-C-N 120.922 -1.111 . . . . 0.0 111.243 171.278 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 20.7 t -68.15 -38.94 80.48 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 CA-C-O 117.93 -1.034 . . . . 0.0 111.155 169.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 5.0 m-85 -54.72 -52.21 63.19 Favored 'General case' 0 N--CA 1.478 0.968 0 CA-C-N 120.664 1.574 . . . . 0.0 111.956 169.796 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -67.91 -34.33 76.41 Favored 'General case' 0 N--CA 1.479 0.992 0 CA-C-N 118.954 0.797 . . . . 0.0 112.221 -177.165 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 76.4 m -64.83 -46.42 82.04 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 123.871 0.868 . . . . 0.0 111.042 170.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 53.7 t -67.95 -35.21 71.17 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 CA-C-O 117.602 -1.19 . . . . 0.0 111.022 179.526 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 22.2 mtm105 -55.4 -46.71 76.59 Favored 'General case' 0 N--CA 1.481 1.112 0 CA-C-N 120.66 1.573 . . . . 0.0 111.031 170.629 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -58.47 -48.8 82.12 Favored Glycine 0 CA--C 1.542 1.765 0 CA-C-N 119.432 1.015 . . . . 0.0 113.848 175.188 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 15.5 mm100 -65.25 -44.9 86.63 Favored 'General case' 0 N--CA 1.474 0.742 0 O-C-N 121.778 -0.836 . . . . 0.0 112.02 179.846 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 78.6 t -66.97 -36.22 76.61 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 125.052 1.341 . . . . 0.0 111.308 177.255 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 78.1 tttt -54.64 -49.68 69.97 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-N 119.842 1.201 . . . . 0.0 110.207 174.472 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -64.23 -43.66 94.28 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 112.705 0.631 . . . . 0.0 112.705 175.873 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.57 -36.51 84.04 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 124.16 0.984 . . . . 0.0 112.894 179.47 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 94.4 t -77.48 -40.64 28.83 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 C-N-CA 125.515 1.526 . . . . 0.0 111.475 176.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -62.59 -31.84 72.73 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 119.567 1.076 . . . . 0.0 111.541 172.167 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 12.5 m-80 -67.28 -46.12 74.57 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-N 119.121 0.873 . . . . 0.0 112.867 171.294 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -50.83 -54.98 19.16 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 124.296 1.038 . . . . 0.0 110.138 171.259 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 74.3 mt -58.79 -49.53 82.51 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 CA-C-O 119.163 -0.446 . . . . 0.0 110.179 178.693 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -65.24 -11.26 39.26 Favored 'General case' 0 CA--C 1.544 0.743 0 N-CA-C 115.567 1.691 . . . . 0.0 115.567 -178.827 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 20.9 ptmt -103.23 -17.54 15.29 Favored 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 114.165 1.172 . . . . 0.0 114.165 171.823 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 14.3 pt -106.79 -12.22 10.16 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 N-CA-C 114.436 1.273 . . . . 0.0 114.436 177.153 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 73.8 m . . . . . 0 C--O 1.253 1.27 0 C-N-CA 125.185 1.394 . . . . 0.0 112.436 -176.763 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.9 ttt . . . . . 0 N--CA 1.503 2.185 0 N-CA-C 111.602 0.223 . . . . 0.0 111.602 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.28 163.71 32.9 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 124.828 1.251 . . . . 0.0 113.775 177.667 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 58.6 mtpt -89.72 141.82 28.26 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 125.226 1.41 . . . . 0.0 113.007 175.898 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 21.6 t -122.94 130.54 74.4 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 C-N-CA 125.971 1.708 . . . . 0.0 112.397 177.45 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 35.6 tpp -102.05 127.55 48.89 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 168.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 66.1 m-85 -104.68 132.32 51.06 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 123.728 0.811 . . . . 0.0 109.428 170.032 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -141.13 146.76 23.23 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 N-CA-C 114.584 1.327 . . . . 0.0 114.584 -169.441 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 41.8 t -151.19 176.32 11.31 Favored 'General case' 0 CA--C 1.552 1.056 0 C-N-CA 127.31 2.244 . . . . 0.0 110.853 171.472 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 54.1 mtpt -85.24 135.04 34.1 Favored 'General case' 0 N--CA 1.482 1.166 0 O-C-N 120.672 -1.267 . . . . 0.0 112.16 170.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 23.2 tpt180 47.58 56.45 7.05 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 127.507 2.323 . . . . 0.0 113.226 179.276 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -52.08 -28.56 17.94 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 113.857 1.058 . . . . 0.0 113.857 -179.422 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 67.2 m -63.69 -16.97 62.44 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-N 120.13 1.332 . . . . 0.0 112.661 -176.168 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 98.6 p -121.91 21.43 10.64 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 126.476 1.91 . . . . 0.0 113.767 171.11 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 73.6 mtt85 -137.73 151.32 48.08 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 125.762 1.625 . . . . 0.0 112.216 175.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 33.0 m -93.02 -31.93 14.69 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 114.977 1.473 . . . . 0.0 114.977 -169.729 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 59.89 -44.29 0.09 Allowed 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 127.887 2.475 . . . . 0.0 117.331 -179.043 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . 0.438 ' HG2' ' SD ' ' A' ' 50' ' ' MET . 0.0 OUTLIER 68.73 -46.55 0.55 Allowed 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 127.605 2.362 . . . . 0.0 115.907 172.389 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.08 -35.21 74.69 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 115.908 1.818 . . . . 0.0 115.908 -169.112 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.3 pm0 -64.36 -43.69 93.73 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 119.151 0.887 . . . . 0.0 112.426 -179.044 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -61.41 -38.04 95.09 Favored Glycine 0 C--N 1.336 0.57 0 C-N-CA 123.903 0.763 . . . . 0.0 112.123 175.12 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -73.58 -42.47 61.56 Favored 'General case' 0 N--CA 1.47 0.527 0 O-C-N 121.782 -0.834 . . . . 0.0 111.518 177.541 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -60.33 -40.97 92.57 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 119.243 0.929 . . . . 0.0 112.705 -175.613 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 11.7 pttp -78.77 -24.92 44.43 Favored 'General case' 0 N--CA 1.479 1.016 0 N-CA-C 113.787 1.032 . . . . 0.0 113.787 174.036 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 90.4 m -72.52 -34.98 67.98 Favored 'General case' 0 N--CA 1.486 1.329 0 O-C-N 121.432 -0.792 . . . . 0.0 111.779 171.896 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 82.4 mt -88.66 -28.58 20.52 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 125.625 1.57 . . . . 0.0 113.824 -177.026 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -148.23 29.24 1.36 Allowed Glycine 0 N--CA 1.473 1.102 0 N-CA-C 118.256 2.062 . . . . 0.0 118.256 -169.411 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -66.53 -20.39 66.01 Favored 'General case' 0 N--CA 1.477 0.919 0 CA-C-N 121.867 2.834 . . . . 0.0 115.301 -177.752 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -77.56 -4.59 85.0 Favored Glycine 0 CA--C 1.541 1.696 0 O-C-N 121.305 -0.872 . . . . 0.0 113.923 169.593 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 60.7 mttp -115.93 -40.58 3.3 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 126.981 2.112 . . . . 0.0 112.315 -177.286 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 19.8 pt -140.69 159.04 24.32 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 125.961 1.704 . . . . 0.0 112.558 -174.308 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -106.23 140.32 39.37 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.682 1.193 . . . . 0.0 110.209 171.099 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 69.5 t -125.15 140.92 46.75 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 CA-C-N 118.911 0.778 . . . . 0.0 111.819 -175.104 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 22.4 m -134.56 143.39 47.36 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 125.058 1.343 . . . . 0.0 109.95 173.815 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 78.6 p -97.39 144.38 27.2 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.846 0.831 . . . . 0.0 111.24 169.198 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 32.7 t -149.05 165.04 32.87 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 123.593 0.757 . . . . 0.0 110.311 169.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -134.67 161.61 24.53 Favored Glycine 0 C--O 1.229 -0.167 0 CA-C-O 121.808 0.671 . . . . 0.0 112.604 -178.547 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -95.0 111.28 23.1 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 106.351 -1.722 . . . . 0.0 106.351 169.58 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 19.0 mt-10 66.68 30.77 8.03 Favored 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 125.122 1.369 . . . . 0.0 114.392 -173.587 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 7.6 m -151.31 151.34 31.66 Favored 'General case' 0 N--CA 1.482 1.152 0 N-CA-C 114.681 1.364 . . . . 0.0 114.681 175.56 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 88.0 p -109.43 -15.34 14.25 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 126.985 2.114 . . . . 0.0 116.327 173.632 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 7.6 tpt180 -123.4 170.32 10.46 Favored 'General case' 0 N--CA 1.488 1.462 0 CA-C-N 120.497 1.499 . . . . 0.0 110.781 -178.512 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 27.0 m -111.93 163.84 8.45 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.266 0 C-N-CA 126.435 1.894 . . . . 0.0 109.57 169.481 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 3.1 t-80 -48.59 129.91 13.81 Favored Pre-proline 0 CA--C 1.536 0.408 0 N-CA-C 113.945 1.091 . . . . 0.0 113.945 -173.866 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 81.5 Cg_exo -59.93 -26.76 83.26 Favored 'Trans proline' 0 CA--C 1.549 1.23 0 CA-C-N 120.273 1.133 . . . . 0.0 112.5 173.231 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 55.0 m -70.91 -29.15 65.12 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 125.17 1.388 . . . . 0.0 112.363 174.033 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -55.45 -44.55 76.48 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 119.245 0.93 . . . . 0.0 111.226 -178.078 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.7 mp -47.2 -55.11 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 125.178 1.391 . . . . 0.0 110.483 -177.41 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.99 -30.89 71.91 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 113.486 0.921 . . . . 0.0 113.486 -176.748 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -82.73 -26.35 32.02 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 113.421 0.897 . . . . 0.0 113.421 179.064 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . 0.438 ' SD ' ' HG2' ' A' ' 17' ' ' MET . 3.9 mmt -80.3 -32.92 38.01 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.223 0.609 . . . . 0.0 110.8 170.266 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -66.01 -14.78 62.25 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 124.61 1.164 . . . . 0.0 113.348 172.845 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -60.56 -27.65 67.83 Favored 'General case' 0 N--CA 1.482 1.138 0 CA-C-N 120.106 1.321 . . . . 0.0 110.731 168.844 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 57.7 t -98.22 -6.5 9.35 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.939 0 C-N-CA 127.229 2.212 . . . . 0.0 111.282 176.894 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 81.14 19.36 67.22 Favored Glycine 0 CA--C 1.539 1.582 0 C-N-CA 124.951 1.263 . . . . 0.0 114.425 -174.506 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 83.0 mt -77.77 135.14 26.9 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 124.925 1.29 . . . . 0.0 111.266 -175.654 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 21.6 t0 -94.58 104.46 16.41 Favored 'General case' 0 CA--C 1.544 0.729 0 N-CA-C 113.236 0.828 . . . . 0.0 113.236 177.629 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 15.0 pt -130.56 23.25 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 C-N-CA 125.273 1.429 . . . . 0.0 112.338 169.688 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 72.2 m -87.69 153.53 21.29 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 124.729 1.212 . . . . 0.0 112.435 -178.379 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 65.68 18.5 66.1 Favored Glycine 0 CA--C 1.537 1.454 0 N-CA-C 115.28 0.872 . . . . 0.0 115.28 171.86 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -115.12 143.93 44.45 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 124.969 1.307 . . . . 0.0 111.957 -177.357 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 33.4 m -135.24 148.63 49.66 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 107.818 -1.179 . . . . 0.0 107.818 169.32 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 68.1 m -123.26 -161.45 0.97 Allowed 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 126.329 1.852 . . . . 0.0 109.916 -171.786 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -134.91 159.03 73.65 Favored Pre-proline 0 CA--C 1.54 0.567 0 C-N-CA 123.854 0.862 . . . . 0.0 110.923 179.332 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -62.17 157.27 45.63 Favored 'Trans proline' 0 N--CA 1.46 -0.476 0 C-N-CA 122.294 1.996 . . . . 0.0 112.311 171.77 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.426 HD11 ' CE3' ' A' ' 90' ' ' TRP . 6.7 tp -60.99 -30.21 47.16 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 O-C-N 121.667 -0.645 . . . . 0.0 112.423 -173.876 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -67.52 -12.5 60.49 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 114.341 1.237 . . . . 0.0 114.341 176.794 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 -79.95 -21.53 43.67 Favored 'General case' 0 CA--C 1.547 0.855 0 N-CA-C 113.22 0.822 . . . . 0.0 113.22 179.839 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 99.3 m-85 -102.39 -174.52 2.59 Favored 'General case' 0 CA--C 1.552 1.045 0 C-N-CA 126.216 1.806 . . . . 0.0 112.922 -173.319 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 5.9 t30 -123.6 126.7 47.1 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 126.21 1.804 . . . . 0.0 109.572 171.799 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.91 -35.9 81.05 Favored 'General case' 0 CA--C 1.53 0.184 0 N-CA-C 114.361 1.245 . . . . 0.0 114.361 -170.048 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . 0.256 0.0 OUTLIER -72.67 -3.63 26.18 Favored 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 114.221 1.193 . . . . 0.0 114.221 -175.672 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -75.21 -13.25 60.43 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 124.076 0.95 . . . . 0.0 111.543 168.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 87.8 m-85 -118.08 135.73 54.02 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 126.774 2.029 . . . . 0.0 111.574 -179.287 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -87.15 -24.23 24.56 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-O 122.297 1.046 . . . . 0.0 112.655 178.47 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.623 HG22 ' HB ' ' A' ' 95' ' ' ILE . 80.1 t -129.73 138.99 52.76 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 C-N-CA 127.28 2.232 . . . . 0.0 108.772 -176.569 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 59.2 t -135.15 122.66 37.29 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 171.509 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 45.1 mm -110.21 101.1 12.08 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 C-N-CA 124.255 1.022 . . . . 0.0 109.919 -174.693 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 8.8 m -86.15 94.43 9.28 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 124.224 1.01 . . . . 0.0 109.208 171.139 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -97.78 19.68 13.29 Favored 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 116.065 1.876 . . . . 0.0 116.065 -169.427 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 14.7 p -152.14 155.08 37.14 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 123.812 0.845 . . . . 0.0 110.941 170.695 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 62.06 -137.34 45.86 Favored Glycine 0 CA--C 1.535 1.334 0 C-N-CA 123.685 0.659 . . . . 0.0 113.948 177.571 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 83.4 p -93.21 -23.59 18.5 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.996 1.318 . . . . 0.0 114.552 179.544 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 77.07 4.44 83.4 Favored Glycine 0 CA--C 1.535 1.292 0 C-N-CA 124.555 1.074 . . . . 0.0 115.343 -169.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 48.9 t -88.73 -10.92 10.58 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 CA-C-N 119.564 1.682 . . . . 0.0 112.91 -172.373 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -72.65 -9.56 58.75 Favored 'General case' 0 CA--C 1.549 0.917 0 O-C-N 120.426 -1.421 . . . . 0.0 114.153 -176.168 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -95.06 158.43 34.9 Favored Pre-proline 0 CA--C 1.549 0.927 0 C-N-CA 124.791 1.236 . . . . 0.0 113.644 176.479 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_exo -61.18 152.92 68.56 Favored 'Trans proline' 0 CA--C 1.544 0.991 0 C-N-CA 122.96 2.44 . . . . 0.0 114.24 -179.198 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_exo -55.76 -29.66 72.59 Favored 'Trans proline' 0 C--N 1.354 0.824 0 C-N-CA 123.692 2.928 . . . . 0.0 115.082 -177.599 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -61.81 -29.31 70.07 Favored 'General case' 0 CA--C 1.539 0.551 0 O-C-N 121.077 -1.015 . . . . 0.0 112.888 177.02 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . 0.426 ' CE3' HD11 ' A' ' 65' ' ' ILE . 92.8 m95 -80.94 -33.79 33.75 Favored 'General case' 0 N--CA 1.473 0.698 0 O-C-N 121.202 -0.936 . . . . 0.0 112.119 174.269 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 25.0 t -63.25 -31.72 53.78 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 C-N-CA 124.679 1.192 . . . . 0.0 111.606 172.239 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -96.93 6.18 49.12 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 115.675 1.732 . . . . 0.0 115.675 -171.299 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 87.0 mm-40 -64.74 157.25 27.98 Favored 'General case' 0 N--CA 1.481 1.077 0 O-C-N 120.615 -1.303 . . . . 0.0 111.248 169.897 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -58.74 -39.53 81.2 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 113.967 1.099 . . . . 0.0 113.967 -168.092 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.623 ' HB ' HG22 ' A' ' 75' ' ' VAL . 19.1 mm -118.82 59.61 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 C-N-CA 124.958 1.303 . . . . 0.0 109.017 177.235 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 52.0 t80 -76.89 106.97 8.89 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 107.333 -1.358 . . . . 0.0 107.333 168.724 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 13.2 mt-10 -109.11 134.82 51.2 Favored 'General case' 0 N--CA 1.467 0.375 0 N-CA-C 113.11 0.781 . . . . 0.0 113.11 174.561 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -103.51 118.05 35.86 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.062 0.945 . . . . 0.0 109.453 169.089 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 28.4 m0 -109.96 114.34 27.8 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 107.672 -1.233 . . . . 0.0 107.672 176.415 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 19.3 mt-30 -85.22 49.07 1.67 Allowed 'General case' 0 CA--C 1.545 0.763 0 O-C-N 121.3 -0.875 . . . . 0.0 111.701 -175.003 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 82.7 mt -73.94 160.16 31.75 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 125.848 1.659 . . . . 0.0 111.918 175.54 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -88.34 155.22 19.83 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.846 169.286 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -94.14 143.86 27.1 Favored Pre-proline 0 CA--C 1.547 0.834 0 O-C-N 121.422 -0.799 . . . . 0.0 111.606 171.023 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -64.1 -18.5 63.75 Favored 'Trans proline' 0 CA--C 1.546 1.08 0 C-N-CA 122.661 2.241 . . . . 0.0 116.07 176.01 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -57.12 138.15 54.9 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 120.255 1.389 . . . . 0.0 113.583 -178.801 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 78.41 6.59 87.99 Favored Glycine 0 CA--C 1.535 1.311 0 C-N-CA 124.384 0.993 . . . . 0.0 115.058 177.19 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 11.7 pt20 -141.8 165.13 28.31 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 125.17 1.388 . . . . 0.0 113.499 -178.376 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 68.4 m -63.68 162.89 12.36 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 125.774 1.63 . . . . 0.0 115.393 -169.52 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 21.4 tp -59.75 -29.25 68.04 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 125.181 1.392 . . . . 0.0 113.445 178.518 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -62.1 -28.94 69.97 Favored 'General case' 0 N--CA 1.476 0.844 0 O-C-N 120.544 -1.348 . . . . 0.0 111.92 171.617 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 3.5 t -76.56 -37.39 29.64 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 O-C-N 120.86 -1.15 . . . . 0.0 111.427 172.628 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -56.34 -46.55 79.88 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-N 120.028 1.286 . . . . 0.0 110.531 168.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -66.85 -36.15 81.67 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.702 0.801 . . . . 0.0 112.002 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 25.5 m -60.85 -52.16 66.25 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 124.414 1.085 . . . . 0.0 111.162 170.43 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 69.3 t -64.54 -45.97 94.02 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 O-C-N 121.712 -0.617 . . . . 0.0 110.528 179.831 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 42.6 ttp85 -59.53 -38.59 81.41 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 125.359 1.463 . . . . 0.0 112.394 178.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -64.73 -50.5 58.33 Favored Glycine 0 CA--C 1.538 1.505 0 CA-C-N 119.156 0.889 . . . . 0.0 113.481 171.632 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 15.2 mm100 -63.7 -42.17 98.02 Favored 'General case' 0 N--CA 1.477 0.891 0 O-C-N 121.819 -0.812 . . . . 0.0 111.836 178.905 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 52.9 t -64.01 -42.07 94.5 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 C-N-CA 125.397 1.479 . . . . 0.0 110.887 175.437 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 82.4 tttt -53.24 -49.45 66.8 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 120.153 1.342 . . . . 0.0 110.478 176.854 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -64.96 -42.67 94.38 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 123.454 0.702 . . . . 0.0 112.788 178.689 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 16.1 mmm180 -60.29 -45.34 93.69 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 123.438 0.695 . . . . 0.0 112.649 175.278 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 87.2 t -71.4 -39.45 71.57 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 C-N-CA 124.147 0.979 . . . . 0.0 111.267 -178.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -61.15 -41.66 97.14 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 119.386 0.994 . . . . 0.0 111.638 171.151 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 14.4 m-80 -63.4 -46.26 87.26 Favored 'General case' 0 CA--C 1.539 0.519 0 CA-C-N 118.692 0.678 . . . . 0.0 112.275 174.911 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -54.1 -54.95 32.4 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 124.694 1.198 . . . . 0.0 110.766 175.492 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 97.1 mt -61.09 -44.48 98.37 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 CA-C-O 118.857 -0.592 . . . . 0.0 110.541 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -67.48 -14.47 62.96 Favored 'General case' 0 CA--C 1.543 0.681 0 N-CA-C 115.084 1.512 . . . . 0.0 115.084 -179.738 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 21.1 ptmt -100.17 -28.02 13.23 Favored 'General case' 0 N--CA 1.478 0.931 0 CA-C-N 119.298 0.953 . . . . 0.0 113.552 173.646 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 17.5 pt -92.27 -14.72 8.39 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 N-CA-C 114.491 1.293 . . . . 0.0 114.491 178.091 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 67.4 m . . . . . 0 C--O 1.254 1.291 0 C-N-CA 123.893 0.877 . . . . 0.0 112.892 179.573 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.1 ttt . . . . . 0 N--CA 1.501 2.123 0 N-CA-C 111.599 0.222 . . . . 0.0 111.599 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -123.74 160.39 27.38 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 125.844 1.658 . . . . 0.0 112.662 176.557 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 32.4 ttmt -110.91 113.68 26.43 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 167.588 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 16.2 t -103.7 133.65 47.07 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 N-CA-C 113.839 1.051 . . . . 0.0 113.839 -177.852 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 46.4 tpp -101.59 119.61 39.03 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.456 1.102 . . . . 0.0 109.58 169.093 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 56.3 m-85 -103.34 121.75 43.4 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 124.899 1.28 . . . . 0.0 109.134 173.433 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.419 HG11 HD12 ' A' ' 65' ' ' ILE . 4.2 m -144.57 162.32 14.27 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 C-N-CA 124.163 0.985 . . . . 0.0 113.002 -168.894 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 12.7 t -146.86 157.03 43.55 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 126.095 1.758 . . . . 0.0 110.749 169.807 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -30.59 -46.78 0.08 Allowed 'General case' 0 N--CA 1.489 1.476 0 C-N-CA 129.119 2.968 . . . . 0.0 117.126 -176.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 32.1 ttm180 -137.35 -26.01 1.01 Allowed 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 117.309 2.337 . . . . 0.0 117.309 -174.882 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 6.9 t30 60.34 -33.38 0.07 Allowed 'General case' 0 N--CA 1.485 1.319 0 N-CA-C 117.577 2.436 . . . . 0.0 117.577 -178.534 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 84.1 p -62.69 139.98 58.69 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 121.192 1.815 . . . . 0.0 111.946 175.049 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 69.7 m 49.85 31.39 4.54 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 125.943 1.697 . . . . 0.0 114.486 -175.115 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 77.0 mtt85 -141.61 162.75 34.71 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 126.631 1.972 . . . . 0.0 111.53 -175.576 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 4.0 m -124.16 149.32 46.42 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 125.766 1.626 . . . . 0.0 111.774 174.089 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 -112.71 -35.59 5.45 Favored 'General case' 0 N--CA 1.478 0.933 0 N-CA-C 114.347 1.24 . . . . 0.0 114.347 -178.185 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . 0.461 ' HG2' ' SD ' ' A' ' 50' ' ' MET . 0.0 OUTLIER 68.56 -47.78 0.55 Allowed 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 126.783 2.033 . . . . 0.0 115.681 173.887 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.17 -30.01 70.75 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 115.613 1.709 . . . . 0.0 115.613 -169.614 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 3.5 pm0 -62.7 -44.55 95.96 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 119.385 0.993 . . . . 0.0 112.096 178.062 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -64.77 -42.98 96.86 Favored Glycine 0 C--O 1.226 -0.402 0 C-N-CA 124.135 0.874 . . . . 0.0 111.736 179.405 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -68.6 -39.85 80.69 Favored 'General case' 0 N--CA 1.466 0.336 0 O-C-N 121.856 -0.791 . . . . 0.0 111.504 176.839 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -62.32 -41.41 98.52 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 119.226 0.921 . . . . 0.0 112.63 -177.837 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 10.5 pttp -81.17 -20.38 41.36 Favored 'General case' 0 N--CA 1.48 1.067 0 N-CA-C 114.037 1.125 . . . . 0.0 114.037 174.288 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 93.3 m -74.52 -36.13 63.18 Favored 'General case' 0 N--CA 1.483 1.224 0 O-C-N 121.561 -0.712 . . . . 0.0 111.645 170.806 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 74.4 mt -92.75 -30.83 15.31 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 125.374 1.47 . . . . 0.0 114.672 -174.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -137.21 25.71 3.01 Favored Glycine 0 N--CA 1.475 1.238 0 N-CA-C 118.224 2.049 . . . . 0.0 118.224 -169.002 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -66.69 -22.04 66.08 Favored 'General case' 0 N--CA 1.476 0.856 0 CA-C-N 121.895 2.848 . . . . 0.0 115.391 -174.459 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -72.74 -12.54 78.25 Favored Glycine 0 CA--C 1.542 1.748 0 O-C-N 121.18 -0.95 . . . . 0.0 113.632 169.576 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 53.2 mttm -107.34 -39.54 5.64 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 127.318 2.247 . . . . 0.0 113.161 -179.75 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 45.2 pt -144.41 154.46 15.0 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 C-N-CA 124.667 1.187 . . . . 0.0 114.094 -171.624 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -98.14 140.33 32.61 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 126.021 1.728 . . . . 0.0 109.247 169.548 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 92.3 t -127.27 139.02 53.08 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 CA-C-N 118.553 0.615 . . . . 0.0 111.735 -175.915 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 33.5 m -136.35 148.16 47.75 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 125.269 1.428 . . . . 0.0 109.432 172.182 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 86.1 p -136.02 143.19 44.62 Favored 'General case' 0 CA--C 1.514 -0.406 0 CA-C-O 122.249 1.023 . . . . 0.0 111.16 167.801 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 8.0 m -139.36 152.23 46.97 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 113.393 -1.731 . . . . 0.0 111.25 -169.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -81.33 163.76 45.1 Favored Glycine 0 CA--C 1.527 0.819 0 N-CA-C 110.382 -1.087 . . . . 0.0 110.382 169.222 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 8.2 mp -91.07 -23.09 20.43 Favored 'General case' 0 N--CA 1.477 0.911 0 O-C-N 120.885 -1.362 . . . . 0.0 112.895 174.173 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -148.8 29.68 0.82 Allowed 'General case' 0 CA--C 1.551 0.985 0 C-N-CA 125.734 1.614 . . . . 0.0 111.076 176.815 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 32.6 p -152.29 153.0 32.83 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 126.54 1.936 . . . . 0.0 112.16 -174.186 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 47.6 m -116.25 19.04 15.08 Favored 'General case' 0 N--CA 1.483 1.216 0 N-CA-C 116.198 1.925 . . . . 0.0 116.198 -169.003 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 7.8 tpt180 -159.3 144.76 15.98 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 124.702 1.201 . . . . 0.0 111.759 171.511 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 22.0 m -70.87 129.37 34.83 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.321 0 N-CA-C 105.92 -1.881 . . . . 0.0 105.92 167.847 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . 0.425 ' HA ' ' HD3' ' A' ' 44' ' ' PRO 0.271 0.0 OUTLIER -60.46 141.49 91.56 Favored Pre-proline 0 CA--C 1.552 1.05 0 N-CA-C 112.681 0.622 . . . . 0.0 112.681 -168.413 . . . . . . . . 4 4 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 43' ' ' HIS . 63.5 Cg_exo -46.49 -39.26 22.26 Favored 'Trans proline' 0 CA--C 1.54 0.778 0 C-N-CA 124.257 3.305 . . . . 0.0 118.567 -168.001 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 26.0 m -65.04 -24.3 67.44 Favored 'General case' 0 N--CA 1.484 1.242 0 CA-C-N 119.418 1.008 . . . . 0.0 112.802 -174.703 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -52.83 -48.77 66.74 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 123.673 0.789 . . . . 0.0 111.573 172.873 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.6 mp -54.01 -56.02 11.38 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 C-N-CA 124.373 1.069 . . . . 0.0 110.37 -171.764 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -62.4 -28.28 69.67 Favored 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 113.392 0.886 . . . . 0.0 113.392 -177.14 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -81.85 -20.64 38.53 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 113.69 0.996 . . . . 0.0 113.69 176.758 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . 0.461 ' SD ' ' HG2' ' A' ' 17' ' ' MET . 5.7 mmt -87.52 -32.55 19.35 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 119.465 1.03 . . . . 0.0 110.729 169.887 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -64.5 -15.29 60.58 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.752 1.221 . . . . 0.0 113.559 176.229 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 -61.15 -28.44 69.12 Favored 'General case' 0 N--CA 1.48 1.032 0 CA-C-N 120.225 1.375 . . . . 0.0 111.077 169.345 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 59.3 t -94.91 -3.65 10.58 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.047 0 C-N-CA 127.356 2.262 . . . . 0.0 111.253 178.03 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 79.4 17.54 75.83 Favored Glycine 0 CA--C 1.54 1.609 0 O-C-N 120.525 -1.359 . . . . 0.0 114.588 -174.572 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 67.2 mt -76.57 145.48 10.28 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 C-N-CA 125.09 1.356 . . . . 0.0 111.941 -174.445 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -106.3 53.16 0.71 Allowed 'General case' 0 CA--C 1.548 0.897 0 N-CA-C 115.11 1.522 . . . . 0.0 115.11 -170.092 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 12.0 pt -85.42 -0.12 6.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 120.017 -1.677 . . . . 0.0 114.252 173.334 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 84.5 p -67.09 -28.13 67.92 Favored 'General case' 0 N--CA 1.476 0.841 0 O-C-N 120.838 -1.163 . . . . 0.0 113.502 174.694 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -82.0 -6.95 88.47 Favored Glycine 0 CA--C 1.537 1.415 0 C-N-CA 125.075 1.321 . . . . 0.0 116.381 -177.112 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 14.8 pt20 -100.19 138.34 37.39 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 119.309 1.555 . . . . 0.0 112.077 179.364 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 58.8 p -106.38 -64.24 1.19 Allowed 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 125.701 1.6 . . . . 0.0 110.82 173.28 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 59.1 m 63.7 127.12 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 129.152 2.981 . . . . 0.0 116.639 173.621 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 24.6 m-20 -67.35 162.11 58.53 Favored Pre-proline 0 CA--C 1.548 0.87 0 C-N-CA 124.402 1.081 . . . . 0.0 111.012 169.555 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -58.1 157.95 23.44 Favored 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 122.627 2.218 . . . . 0.0 112.977 171.075 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.419 HD12 HG11 ' A' ' 7' ' ' VAL . 2.9 tt -57.1 -37.7 56.8 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 C-N-CA 123.778 0.831 . . . . 0.0 110.939 -178.506 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.98 -1.55 26.2 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 114.302 1.223 . . . . 0.0 114.302 -177.247 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -88.22 -6.85 57.59 Favored 'General case' 0 CA--C 1.555 1.167 0 C-N-CA 124.573 1.149 . . . . 0.0 111.9 169.242 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 77.2 m-85 -113.86 -174.93 2.56 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 126.796 2.038 . . . . 0.0 112.739 -178.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 13.3 p-10 -116.83 132.73 56.62 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 127.04 2.136 . . . . 0.0 109.915 174.607 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -67.45 -35.75 79.84 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 113.636 0.976 . . . . 0.0 113.636 -174.315 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -70.02 -3.45 16.37 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 114.429 1.27 . . . . 0.0 114.429 -179.334 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -69.96 -16.72 63.24 Favored 'General case' 0 CA--C 1.543 0.699 0 O-C-N 121.652 -0.655 . . . . 0.0 110.976 168.946 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 45.2 m-85 -120.42 131.14 54.66 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 126.661 1.985 . . . . 0.0 111.378 -172.724 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -80.69 -22.85 40.01 Favored 'General case' 0 N--CA 1.477 0.911 0 CA-C-O 122.234 1.016 . . . . 0.0 112.498 178.065 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.632 HG22 ' HB ' ' A' ' 95' ' ' ILE . 82.2 t -132.4 136.37 56.34 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 C-N-CA 127.501 2.32 . . . . 0.0 108.125 -175.113 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 59.7 t -131.92 127.3 58.19 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 169.561 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 41.8 mm -114.61 115.91 50.98 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 C-N-CA 123.777 0.831 . . . . 0.0 109.645 -174.93 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 10.5 t -89.18 122.46 32.49 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 169.208 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 92.7 mt -97.19 5.32 50.33 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 116.141 1.904 . . . . 0.0 116.141 -168.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 25.4 p -144.94 39.04 1.21 Allowed 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 123.273 0.629 . . . . 0.0 112.077 -174.435 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 110.53 -148.25 17.58 Favored Glycine 0 CA--C 1.531 1.08 0 C-N-CA 125.024 1.297 . . . . 0.0 112.992 -174.224 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 87.2 p -76.29 174.51 10.09 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 124.963 1.305 . . . . 0.0 113.502 -178.629 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -76.07 119.81 5.74 Favored Glycine 0 N--CA 1.469 0.889 0 CA-C-O 122.244 0.914 . . . . 0.0 111.317 169.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 7.6 p -148.0 151.73 13.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 C-N-CA 127.86 2.464 . . . . 0.0 106.471 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 51.7 t30 65.73 2.66 2.2 Favored 'General case' 0 CA--C 1.556 1.185 0 N-CA-C 115.996 1.85 . . . . 0.0 115.996 179.647 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -117.54 152.18 49.24 Favored Pre-proline 0 N--CA 1.479 0.996 0 C-N-CA 126.14 1.776 . . . . 0.0 111.681 169.679 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -71.89 160.36 47.97 Favored 'Trans proline' 0 CA--C 1.548 1.219 0 C-N-CA 122.407 2.071 . . . . 0.0 113.061 -179.082 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_exo -57.81 -25.77 70.59 Favored 'Trans proline' 0 C--N 1.354 0.834 0 C-N-CA 123.931 3.087 . . . . 0.0 116.363 -169.696 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -62.46 -25.78 68.17 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 114.024 1.12 . . . . 0.0 114.024 -178.711 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 93.8 m95 -81.13 -33.05 33.48 Favored 'General case' 0 N--CA 1.472 0.662 0 O-C-N 120.676 -1.265 . . . . 0.0 112.682 178.436 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 9.4 m -80.73 -6.2 9.36 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 N-CA-C 113.145 0.795 . . . . 0.0 113.145 176.046 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -106.82 6.01 29.06 Favored 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 114.741 1.386 . . . . 0.0 114.741 179.678 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 91.1 mm-40 -65.75 158.61 27.14 Favored 'General case' 0 N--CA 1.479 0.999 0 O-C-N 120.785 -1.197 . . . . 0.0 111.621 170.512 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -57.44 -43.47 83.91 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 114.224 1.194 . . . . 0.0 114.224 -168.15 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.632 ' HB ' HG22 ' A' ' 75' ' ' VAL . 22.0 mm -114.96 60.52 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 C-N-CA 124.93 1.292 . . . . 0.0 108.77 175.794 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 42.6 t80 -76.57 110.83 11.45 Favored 'General case' 0 CA--C 1.536 0.41 0 O-C-N 120.746 -1.221 . . . . 0.0 108.229 169.084 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 17.0 mt-10 -110.73 137.76 47.98 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 114.573 1.323 . . . . 0.0 114.573 175.7 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -97.71 114.74 26.79 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.99 1.316 . . . . 0.0 109.726 169.373 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 34.0 m0 -104.79 118.61 36.99 Favored 'General case' 0 N--CA 1.462 0.156 0 C-N-CA 124.438 1.095 . . . . 0.0 108.189 176.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 61.7 mt-30 -91.18 44.21 1.18 Allowed 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 124.508 1.123 . . . . 0.0 111.162 -169.627 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 90.1 mt -82.99 168.13 17.28 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 126.926 2.09 . . . . 0.0 112.222 -179.165 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -96.97 152.95 18.21 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 123.856 0.863 . . . . 0.0 113.108 172.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -77.7 121.62 84.52 Favored Pre-proline 0 CA--C 1.543 0.703 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 169.458 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -79.9 -9.06 14.42 Favored 'Trans proline' 0 CA--C 1.542 0.923 0 C-N-CA 121.403 1.402 . . . . 0.0 114.317 -178.798 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -72.89 -41.9 64.15 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 115.905 1.817 . . . . 0.0 115.905 -169.416 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -72.89 20.37 1.09 Allowed Glycine 0 CA--C 1.541 1.707 0 C-N-CA 124.387 0.994 . . . . 0.0 114.872 -177.471 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 7.3 pt20 -158.74 176.94 11.73 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 127.78 2.432 . . . . 0.0 110.876 -169.662 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 52.8 p -66.65 161.94 22.2 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 114.122 1.156 . . . . 0.0 114.122 -172.82 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . 0.32 2.9 pp -67.99 -11.97 59.88 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 114.194 1.183 . . . . 0.0 114.194 176.803 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -67.82 -30.07 69.39 Favored 'General case' 0 CA--C 1.543 0.682 0 O-C-N 120.968 -1.082 . . . . 0.0 109.953 168.845 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 3.4 t -74.35 -36.92 44.02 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 O-C-N 121.031 -1.043 . . . . 0.0 111.147 170.806 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 16.5 m-85 -58.05 -42.26 85.03 Favored 'General case' 0 N--CA 1.482 1.141 0 CA-C-N 120.229 1.377 . . . . 0.0 111.313 168.941 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -66.5 -37.51 85.22 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 124.19 0.996 . . . . 0.0 112.439 175.864 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 18.9 m -61.36 -50.53 72.53 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 124.491 1.116 . . . . 0.0 111.252 171.203 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 78.4 t -67.44 -37.73 79.44 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 C-N-CA 124.131 0.972 . . . . 0.0 111.098 -178.887 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 19.9 mtp180 -54.55 -43.38 71.93 Favored 'General case' 0 N--CA 1.48 1.052 0 CA-C-N 120.109 1.322 . . . . 0.0 112.467 170.255 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -61.74 -50.9 61.34 Favored Glycine 0 CA--C 1.535 1.332 0 CA-C-N 119.297 0.953 . . . . 0.0 112.954 175.239 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 52.4 mt-30 -61.03 -46.77 89.36 Favored 'General case' 0 N--CA 1.474 0.729 0 O-C-N 122.138 -0.625 . . . . 0.0 111.737 177.686 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 55.3 t -66.02 -41.02 88.88 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 C-N-CA 125.028 1.331 . . . . 0.0 111.144 -179.41 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -55.98 -48.15 76.36 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 120.117 1.326 . . . . 0.0 110.437 177.129 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -63.47 -44.66 93.8 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 112.682 0.623 . . . . 0.0 112.682 175.376 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.17 -33.72 76.67 Favored 'General case' 0 N--CA 1.478 0.967 0 N-CA-C 113.52 0.933 . . . . 0.0 113.52 179.188 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 82.4 t -78.99 -39.29 21.46 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 C-N-CA 125.698 1.599 . . . . 0.0 111.291 177.027 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -60.89 -40.11 91.79 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 119.58 1.082 . . . . 0.0 111.16 171.171 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 16.6 m-80 -63.96 -45.86 87.22 Favored 'General case' 0 CA--C 1.538 0.51 0 O-C-N 121.865 -0.522 . . . . 0.0 112.341 174.19 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -51.67 -57.9 7.9 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 124.729 1.212 . . . . 0.0 110.6 173.522 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 74.1 mt -62.59 -42.99 98.03 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 C-N-CA 122.827 0.451 . . . . 0.0 110.548 -177.11 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -72.92 -10.62 60.0 Favored 'General case' 0 CA--C 1.544 0.721 0 N-CA-C 114.86 1.43 . . . . 0.0 114.86 -178.854 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 20.7 ptmt -99.53 -29.93 12.44 Favored 'General case' 0 N--CA 1.479 0.976 0 N-CA-C 113.636 0.976 . . . . 0.0 113.636 170.198 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 12.7 pt -93.24 -8.91 9.93 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 N-CA-C 114.527 1.306 . . . . 0.0 114.527 178.313 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 27.1 p . . . . . 0 C--O 1.255 1.387 0 N-CA-C 114.663 1.357 . . . . 0.0 114.663 174.501 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.3 ttt . . . . . 0 N--CA 1.502 2.139 0 N-CA-C 111.501 0.186 . . . . 0.0 111.501 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.79 155.97 36.97 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 125.059 1.344 . . . . 0.0 112.774 173.951 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 30.8 ttmt -106.73 112.6 25.66 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 106.812 -1.551 . . . . 0.0 106.812 167.651 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 23.4 t -97.3 131.7 43.57 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 C-N-CA 125.38 1.472 . . . . 0.0 113.826 178.751 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' MET . . . . . 0.49 ' HG3' HG13 ' A' ' 7' ' ' VAL . 23.3 tpp -98.73 128.2 44.9 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 168.986 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 48.6 m-85 -109.46 121.35 44.99 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 125.784 1.633 . . . . 0.0 108.2 174.079 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.58 HG11 HD12 ' A' ' 65' ' ' ILE . 2.1 m -137.69 143.02 34.85 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 N-CA-C 113.926 1.084 . . . . 0.0 113.926 -168.823 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 5.3 t -131.03 147.45 52.63 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 126.41 1.884 . . . . 0.0 112.086 174.786 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 63.2 tttm -52.86 -39.71 62.82 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 126.477 1.911 . . . . 0.0 114.297 -177.641 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 53.4 ttt180 -101.95 -49.73 3.87 Favored 'General case' 0 N--CA 1.483 1.217 0 N-CA-C 113.719 1.007 . . . . 0.0 113.719 169.872 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 1.8 t30 63.63 -47.5 0.25 Allowed 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 127.232 2.213 . . . . 0.0 116.15 -173.515 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 59.6 p -64.85 145.97 55.54 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 119.044 0.838 . . . . 0.0 110.243 169.687 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 66.6 m 51.39 24.62 2.23 Favored 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 114.564 1.32 . . . . 0.0 114.564 -174.548 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 85.2 mtt180 -137.47 152.4 49.5 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 126.975 2.11 . . . . 0.0 110.399 176.403 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 61.1 m -97.01 -29.28 13.74 Favored 'General case' 0 N--CA 1.48 1.058 0 N-CA-C 115.771 1.767 . . . . 0.0 115.771 -169.295 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 3.9 mp0 59.96 -44.24 0.09 Allowed 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 128.596 2.758 . . . . 0.0 117.09 -178.517 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . 0.408 ' HG2' ' SD ' ' A' ' 50' ' ' MET . 0.0 OUTLIER 68.73 -46.38 0.55 Allowed 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 127.54 2.336 . . . . 0.0 115.753 171.931 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.86 -38.78 86.73 Favored 'General case' 0 C--O 1.222 -0.39 0 N-CA-C 115.494 1.665 . . . . 0.0 115.494 -169.605 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -69.15 -36.5 77.5 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-N 119.788 1.176 . . . . 0.0 112.134 -177.122 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -64.14 -40.16 97.81 Favored Glycine 0 N--CA 1.469 0.866 0 C-N-CA 124.135 0.874 . . . . 0.0 112.107 173.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -69.74 -38.32 76.77 Favored 'General case' 0 N--CA 1.47 0.533 0 O-C-N 121.75 -0.853 . . . . 0.0 111.686 172.404 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -64.59 -43.1 94.88 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 119.424 1.011 . . . . 0.0 112.402 -174.75 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 15.2 ptpt -64.75 -38.33 90.63 Favored 'General case' 0 N--CA 1.486 1.351 0 O-C-N 121.514 -0.741 . . . . 0.0 112.025 169.753 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 92.3 m -71.55 -34.07 69.67 Favored 'General case' 0 N--CA 1.479 1.001 0 O-C-N 121.632 -0.668 . . . . 0.0 112.475 -176.709 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 71.9 mt -88.66 -26.07 22.05 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 125.498 1.519 . . . . 0.0 113.84 -178.717 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -145.78 27.08 1.77 Allowed Glycine 0 N--CA 1.47 0.94 0 N-CA-C 118.487 2.155 . . . . 0.0 118.487 -169.083 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -65.82 -21.92 66.52 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-N 122.31 3.055 . . . . 0.0 115.329 -177.323 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -74.36 -5.17 71.47 Favored Glycine 0 CA--C 1.541 1.671 0 O-C-N 121.546 -0.721 . . . . 0.0 113.799 169.479 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 76.8 mttt -118.81 -39.81 2.93 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 127.339 2.256 . . . . 0.0 113.255 -177.506 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 43.7 pt -145.11 159.3 13.62 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 124.805 1.242 . . . . 0.0 113.399 -172.355 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -108.87 139.96 42.99 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 126.343 1.857 . . . . 0.0 108.65 169.752 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 4.2 m -129.55 148.83 33.23 Favored 'Isoleucine or valine' 0 C--O 1.234 0.273 0 CA-C-N 119.53 1.059 . . . . 0.0 111.067 -177.196 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 85.1 m -136.39 136.8 39.9 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 123.151 0.581 . . . . 0.0 110.781 179.0 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 11.5 t -88.51 133.67 34.08 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 124.329 1.052 . . . . 0.0 109.435 169.174 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 23.2 p -146.6 149.41 33.48 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 114.982 1.475 . . . . 0.0 114.982 169.935 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -98.22 152.11 19.75 Favored Glycine 0 C--N 1.338 0.643 0 C-N-CA 124.272 0.939 . . . . 0.0 113.725 -172.615 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 10.5 mp -96.12 99.51 11.24 Favored 'General case' 0 CA--C 1.536 0.41 0 O-C-N 120.604 -1.527 . . . . 0.0 108.956 176.616 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 25.9 mt-10 63.96 26.47 14.15 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 125.243 1.417 . . . . 0.0 113.324 -171.619 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 94.6 p -151.13 167.16 28.6 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 125.248 1.419 . . . . 0.0 113.705 -169.654 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 77.6 p -129.41 169.3 15.09 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 125.398 1.479 . . . . 0.0 113.911 173.05 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.454 ' HG3' ' H ' ' A' ' 42' ' ' VAL . 5.7 tpt180 60.94 -178.86 0.11 Allowed 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 128.636 2.775 . . . . 0.0 113.589 -179.143 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.454 ' H ' ' HG3' ' A' ' 41' ' ' ARG . 20.9 m -133.37 179.51 4.34 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 C-N-CA 129.808 3.243 . . . . 0.0 107.716 172.179 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 2.6 t-80 -58.77 130.75 85.89 Favored Pre-proline 0 C--N 1.325 -0.499 0 CA-C-O 118.052 -0.975 . . . . 0.0 112.127 178.482 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_exo -58.99 -27.2 84.33 Favored 'Trans proline' 0 CA--C 1.548 1.197 0 C-N-CA 121.337 1.358 . . . . 0.0 112.154 169.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 89.9 m -64.94 -29.66 70.61 Favored 'General case' 0 N--CA 1.482 1.175 0 C-N-CA 125.698 1.599 . . . . 0.0 112.452 173.209 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -56.65 -43.47 80.35 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 124.027 0.931 . . . . 0.0 111.114 -177.878 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.7 mp -51.74 -55.01 10.47 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 C-N-CA 124.233 1.013 . . . . 0.0 110.226 -176.564 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -62.95 -32.96 74.38 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 113.111 0.782 . . . . 0.0 113.111 -179.578 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -80.72 -20.68 42.29 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 113.719 1.007 . . . . 0.0 113.719 178.326 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . 0.408 ' SD ' ' HG2' ' A' ' 17' ' ' MET . 4.5 mmt -85.87 -32.51 21.64 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 119.54 1.064 . . . . 0.0 110.344 169.74 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -66.72 -15.75 63.75 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.953 1.301 . . . . 0.0 113.97 175.131 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 -62.29 -26.54 68.46 Favored 'General case' 0 N--CA 1.481 1.1 0 CA-C-N 120.367 1.439 . . . . 0.0 110.895 168.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 59.4 t -95.02 -5.77 10.24 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.82 0 C-N-CA 127.318 2.247 . . . . 0.0 111.348 175.613 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 80.22 18.4 71.83 Favored Glycine 0 CA--C 1.539 1.551 0 C-N-CA 125.165 1.364 . . . . 0.0 114.575 -174.65 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 94.6 mt -75.96 134.38 29.21 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 C-N-CA 124.843 1.257 . . . . 0.0 111.22 -176.727 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 21.8 t0 -94.68 108.71 20.69 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 123.231 0.612 . . . . 0.0 112.337 172.241 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 15.7 pt -129.82 12.68 2.39 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 C-N-CA 125.142 1.377 . . . . 0.0 113.284 169.641 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 72.5 m -69.67 138.24 52.82 Favored 'General case' 0 N--CA 1.47 0.57 0 O-C-N 120.603 -1.311 . . . . 0.0 111.93 -175.815 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 73.97 3.37 64.15 Favored Glycine 0 CA--C 1.537 1.429 0 N-CA-C 116.047 1.179 . . . . 0.0 116.047 176.468 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 9.2 pt20 -77.77 135.23 37.96 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 119.536 1.668 . . . . 0.0 110.903 177.414 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 24.1 p -77.36 -33.17 55.35 Favored 'General case' 0 N--CA 1.48 1.051 0 N-CA-C 114.853 1.427 . . . . 0.0 114.853 -173.196 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 31.8 m 47.85 54.27 10.21 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.804 1.242 . . . . 0.0 112.189 -170.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -54.04 159.02 3.12 Favored Pre-proline 0 CA--C 1.542 0.656 0 C-N-CA 124.306 1.042 . . . . 0.0 112.357 177.792 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -62.91 149.6 90.99 Favored 'Trans proline' 0 N--CA 1.457 -0.674 0 CA-C-N 120.312 1.147 . . . . 0.0 112.927 -176.489 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.58 HD12 HG11 ' A' ' 7' ' ' VAL . 7.7 tt -51.35 -32.22 12.72 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 125.246 1.418 . . . . 0.0 111.42 173.603 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 -65.73 -17.44 64.61 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 125.545 1.538 . . . . 0.0 113.35 -179.247 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -79.75 -9.29 59.63 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 125.103 1.361 . . . . 0.0 112.9 177.93 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 77.5 m-85 -117.35 -179.07 3.61 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 126.408 1.883 . . . . 0.0 112.254 -173.498 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 5.2 t30 -123.07 128.31 49.95 Favored 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 125.56 1.544 . . . . 0.0 109.711 175.015 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.33 -35.87 81.47 Favored 'General case' 0 CA--C 1.531 0.25 0 N-CA-C 114.205 1.187 . . . . 0.0 114.205 -169.861 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . 0.263 0.0 OUTLIER -72.18 -5.71 37.57 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 114.009 1.115 . . . . 0.0 114.009 -178.226 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -75.49 -10.39 59.4 Favored 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 124.082 0.953 . . . . 0.0 111.331 168.648 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 68.1 m-85 -116.55 145.09 43.6 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 127.167 2.187 . . . . 0.0 111.882 179.635 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -93.57 -26.25 17.2 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.892 1.277 . . . . 0.0 112.202 179.489 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.703 HG22 ' HB ' ' A' ' 95' ' ' ILE . 68.9 t -137.09 139.69 43.86 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 C-N-CA 126.99 2.116 . . . . 0.0 107.953 -169.923 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 61.0 t -130.9 126.39 59.78 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 170.268 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 45.5 mm -112.55 105.63 19.17 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 C-N-CA 125.331 1.452 . . . . 0.0 109.407 -177.137 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 9.5 m -84.44 117.93 23.96 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 123.976 0.91 . . . . 0.0 110.305 170.275 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 1.4 pp -130.91 168.93 16.5 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 125.79 1.636 . . . . 0.0 110.182 176.428 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER 65.84 -27.42 0.11 Allowed 'General case' 0 CA--C 1.553 1.075 0 C-N-CA 126.753 2.021 . . . . 0.0 114.982 -169.45 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -170.78 -173.09 37.68 Favored Glycine 0 CA--C 1.536 1.359 0 C-N-CA 126.395 1.95 . . . . 0.0 112.328 174.521 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 74.9 m -76.84 149.83 36.14 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.96 0.904 . . . . 0.0 112.51 -178.739 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -76.67 63.29 3.09 Favored Glycine 0 CA--C 1.535 1.336 0 C-N-CA 125.01 1.291 . . . . 0.0 113.625 176.461 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 58.2 t -105.09 -38.33 4.62 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.129 0 C-N-CA 124.284 1.034 . . . . 0.0 112.659 -176.284 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 62.7 t30 -91.31 33.16 0.99 Allowed 'General case' 0 CA--C 1.55 0.951 0 N-CA-C 113.344 0.868 . . . . 0.0 113.344 -178.772 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.1 pp -126.83 156.82 73.23 Favored Pre-proline 0 CA--C 1.55 0.976 0 C-N-CA 126.32 1.848 . . . . 0.0 111.853 172.41 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -61.65 149.0 91.74 Favored 'Trans proline' 0 CA--C 1.545 1.031 0 C-N-CA 122.315 2.01 . . . . 0.0 113.906 -179.581 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_exo -57.63 -26.03 70.55 Favored 'Trans proline' 0 C--N 1.354 0.827 0 C-N-CA 123.596 2.864 . . . . 0.0 115.244 -176.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -62.12 -22.8 66.13 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 113.695 0.998 . . . . 0.0 113.695 176.086 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 89.5 m95 -82.52 -28.65 30.95 Favored 'General case' 0 N--CA 1.473 0.681 0 O-C-N 120.821 -1.175 . . . . 0.0 113.193 176.932 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 6.4 m -80.25 -14.11 13.01 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.256 0 CA-C-N 119.232 0.924 . . . . 0.0 113.24 174.167 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -96.52 0.09 49.66 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 114.95 1.463 . . . . 0.0 114.95 -178.467 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 80.6 mm-40 -65.63 157.13 30.75 Favored 'General case' 0 N--CA 1.479 1.011 0 O-C-N 120.87 -1.144 . . . . 0.0 111.865 171.239 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -55.19 -42.54 73.37 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 114.392 1.256 . . . . 0.0 114.392 -167.872 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.703 ' HB ' HG22 ' A' ' 75' ' ' VAL . 14.0 mm -119.82 64.43 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 C-N-CA 124.63 1.172 . . . . 0.0 109.412 176.753 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 14.9 t80 -77.2 108.29 10.2 Favored 'General case' 0 CA--C 1.536 0.413 0 O-C-N 120.492 -1.38 . . . . 0.0 108.063 169.246 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -109.32 144.29 37.69 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 113.217 0.821 . . . . 0.0 113.217 172.788 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -121.42 115.54 23.09 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 124.13 0.972 . . . . 0.0 109.732 169.413 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 45.5 m0 -93.16 -19.78 21.13 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 113.903 1.075 . . . . 0.0 113.903 -169.859 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 66.5 mm-40 53.25 29.92 9.22 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 125.218 1.407 . . . . 0.0 113.177 -175.721 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.3 tt -80.83 132.73 35.5 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 125.428 1.491 . . . . 0.0 109.676 -174.599 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -65.74 151.98 45.34 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 113.131 0.789 . . . . 0.0 113.131 -179.43 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -92.9 148.82 36.61 Favored Pre-proline 0 CA--C 1.548 0.886 0 O-C-N 121.772 -0.58 . . . . 0.0 111.106 171.345 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -62.42 -19.19 66.63 Favored 'Trans proline' 0 CA--C 1.548 1.204 0 C-N-CA 122.779 2.32 . . . . 0.0 115.3 173.001 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -49.32 130.83 20.03 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 125.281 1.432 . . . . 0.0 114.582 175.761 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 79.29 7.95 88.13 Favored Glycine 0 CA--C 1.535 1.312 0 C-N-CA 124.736 1.16 . . . . 0.0 114.914 175.625 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 10.5 pt20 -143.36 173.2 11.82 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 125.098 1.359 . . . . 0.0 113.117 -177.122 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 26.5 p -68.3 167.46 14.41 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 116.61 2.078 . . . . 0.0 116.61 -168.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 41.7 tp -59.42 -30.8 68.73 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.516 1.126 . . . . 0.0 112.288 170.073 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -66.88 -31.76 72.57 Favored 'General case' 0 N--CA 1.47 0.536 0 O-C-N 120.818 -1.176 . . . . 0.0 111.487 173.849 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 7.6 t -71.49 -33.81 50.92 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 O-C-N 121.172 -0.955 . . . . 0.0 111.687 169.867 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -57.52 -48.34 79.55 Favored 'General case' 0 N--CA 1.477 0.893 0 CA-C-N 120.041 1.291 . . . . 0.0 111.261 169.34 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 2.8 mpt_? -63.35 -40.58 97.68 Favored 'General case' 0 N--CA 1.484 1.261 0 O-C-N 121.473 -0.767 . . . . 0.0 112.066 175.873 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 28.0 m -58.81 -46.5 87.45 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 124.095 0.958 . . . . 0.0 111.175 173.659 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 54.4 t -64.57 -43.19 96.77 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 CA-C-O 117.522 -1.228 . . . . 0.0 110.514 177.621 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 67.5 mtm-85 -57.3 -43.62 83.4 Favored 'General case' 0 N--CA 1.484 1.264 0 CA-C-N 121.076 1.762 . . . . 0.0 112.528 173.738 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -61.83 -51.21 58.79 Favored Glycine 0 CA--C 1.538 1.479 0 CA-C-N 119.046 0.839 . . . . 0.0 112.914 177.113 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 58.9 mm-40 -62.29 -45.36 93.6 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 123.742 0.817 . . . . 0.0 111.754 177.751 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 58.7 t -65.41 -40.59 88.84 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 C-N-CA 124.62 1.168 . . . . 0.0 111.375 178.342 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 82.3 tttt -56.02 -50.07 71.91 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 120.337 1.426 . . . . 0.0 110.131 177.594 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -62.81 -41.19 99.19 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 112.68 0.622 . . . . 0.0 112.68 176.64 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.77 -34.49 73.85 Favored 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 113.858 1.058 . . . . 0.0 113.858 -179.864 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 98.6 t -78.3 -38.53 23.3 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 C-N-CA 125.17 1.388 . . . . 0.0 110.926 175.744 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -62.3 -41.21 98.32 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 119.041 0.837 . . . . 0.0 111.506 171.661 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 15.2 m-80 -64.43 -42.13 96.18 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 119.249 0.931 . . . . 0.0 112.462 173.722 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -54.77 -57.23 12.38 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.234 0.614 . . . . 0.0 110.26 174.149 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 77.5 mt -63.32 -45.38 98.34 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 CA-C-O 118.995 -0.526 . . . . 0.0 111.251 -177.237 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -68.91 -10.84 59.31 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 114.222 1.193 . . . . 0.0 114.222 177.632 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 70.2 tttt -92.61 -45.63 7.99 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 125.425 1.49 . . . . 0.0 111.29 174.422 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 18.7 pt -91.89 -18.86 7.15 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 N-CA-C 114.41 1.263 . . . . 0.0 114.41 -174.257 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 73.7 m . . . . . 0 C--O 1.254 1.31 0 C-N-CA 125.783 1.633 . . . . 0.0 111.188 -175.878 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.8 ttt . . . . . 0 N--CA 1.503 2.183 0 N-CA-C 111.563 0.209 . . . . 0.0 111.563 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.9 164.35 30.33 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 125.061 1.344 . . . . 0.0 112.907 174.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 75.3 mttt -93.75 145.61 24.46 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 124.206 1.002 . . . . 0.0 112.193 177.269 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.408 HG13 ' CG1' ' A' ' 75' ' ' VAL . 21.5 t -129.06 131.57 67.91 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 125.569 1.548 . . . . 0.0 112.318 178.43 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 47.0 tpp -98.35 132.37 43.88 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 168.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 42.6 m-85 -115.61 127.32 55.13 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 124.441 1.096 . . . . 0.0 109.645 173.142 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 5.7 m -149.16 163.94 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 C-N-CA 124.398 1.079 . . . . 0.0 112.891 -169.779 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 47.1 t -132.25 165.52 23.96 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 127.312 2.245 . . . . 0.0 109.384 169.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -52.96 -37.6 61.26 Favored 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 124.547 1.139 . . . . 0.0 112.741 -178.529 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 82.3 mtt180 -141.18 150.73 43.11 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 127.203 2.201 . . . . 0.0 109.822 169.028 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 24.0 t30 -110.15 -27.11 9.31 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 124.341 1.056 . . . . 0.0 113.746 -173.222 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 60.5 m -56.29 126.54 26.69 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 118.769 0.713 . . . . 0.0 110.461 177.662 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 68.3 m 50.36 36.81 13.85 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 124.798 1.239 . . . . 0.0 113.945 -176.459 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -121.98 143.25 49.59 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 125.778 1.631 . . . . 0.0 109.478 171.082 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 15.8 m -97.02 -33.17 11.65 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 114.742 1.386 . . . . 0.0 114.742 -170.334 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 5.2 mt-30 60.75 -55.88 0.09 Allowed 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 128.578 2.751 . . . . 0.0 116.648 171.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 69.86 -42.67 0.52 Allowed 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 127.929 2.492 . . . . 0.0 117.498 169.599 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -59.9 -33.21 71.55 Favored 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 113.858 1.059 . . . . 0.0 113.858 -170.406 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.9 pm0 -61.56 -42.47 98.89 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.658 1.183 . . . . 0.0 112.275 173.767 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -68.75 -38.95 86.19 Favored Glycine 0 C--N 1.336 0.563 0 O-C-N 121.557 -0.715 . . . . 0.0 111.59 178.607 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -70.05 -41.65 73.91 Favored 'General case' 0 C--O 1.221 -0.414 0 O-C-N 121.834 -0.804 . . . . 0.0 111.258 175.865 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -60.16 -41.9 93.79 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 119.467 1.031 . . . . 0.0 113.008 -175.736 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 10.3 pttp -76.78 -29.28 55.99 Favored 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 113.502 0.927 . . . . 0.0 113.502 173.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 83.7 m -71.66 -31.29 66.65 Favored 'General case' 0 N--CA 1.485 1.281 0 O-C-N 121.585 -0.697 . . . . 0.0 111.842 175.241 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 78.2 mt -91.57 -30.82 16.17 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 125.923 1.689 . . . . 0.0 114.123 179.827 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -142.89 26.36 2.22 Favored Glycine 0 N--CA 1.475 1.292 0 N-CA-C 118.233 2.053 . . . . 0.0 118.233 -169.086 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -66.27 -20.3 66.07 Favored 'General case' 0 CA--C 1.547 0.833 0 CA-C-N 122.016 2.908 . . . . 0.0 114.952 -178.578 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -76.4 -4.18 79.21 Favored Glycine 0 CA--C 1.541 1.675 0 O-C-N 121.235 -0.916 . . . . 0.0 113.757 169.368 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -118.11 -40.94 2.91 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 127.178 2.191 . . . . 0.0 112.513 -175.536 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 29.4 pt -141.38 154.93 20.56 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 C-N-CA 125.919 1.687 . . . . 0.0 112.168 -175.103 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -97.3 137.53 36.17 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 123.872 0.869 . . . . 0.0 109.702 169.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 84.0 t -122.14 140.22 46.71 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 CA-C-N 118.996 0.817 . . . . 0.0 111.542 -178.769 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 20.4 m -135.68 151.2 49.95 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 124.923 1.289 . . . . 0.0 109.31 173.331 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 77.9 p -133.06 147.73 52.2 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 122.308 1.051 . . . . 0.0 110.913 168.32 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 88.7 p -144.2 157.9 44.03 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 114.066 -1.425 . . . . 0.0 112.461 -174.478 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -79.07 167.67 52.72 Favored Glycine 0 CA--C 1.527 0.818 0 N-CA-C 111.166 -0.774 . . . . 0.0 111.166 169.748 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 9.2 mp -100.91 -16.91 17.05 Favored 'General case' 0 N--CA 1.484 1.237 0 CA-C-N 120.27 2.035 . . . . 0.0 112.164 169.559 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -138.36 170.02 16.75 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 129.587 3.155 . . . . 0.0 107.095 172.331 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 69.0 m -57.46 110.17 0.82 Allowed 'General case' 0 N--CA 1.48 1.061 0 CA-C-N 119.759 1.163 . . . . 0.0 111.112 -178.461 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 91.2 p -158.51 175.02 14.21 Favored 'General case' 0 N--CA 1.478 0.966 0 N-CA-C 115.673 1.731 . . . . 0.0 115.673 -169.145 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 15.3 tpt180 -139.79 145.01 37.67 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 128.398 2.679 . . . . 0.0 108.852 171.76 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 35.5 m -56.21 163.98 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 CA-C-O 122.761 1.267 . . . . 0.0 111.155 169.598 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 1.6 t-80 -48.86 127.05 14.09 Favored Pre-proline 0 C--N 1.323 -0.543 0 CA-C-N 114.05 -1.432 . . . . 0.0 112.965 172.354 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_exo -60.64 -28.68 86.99 Favored 'Trans proline' 0 CA--C 1.542 0.907 0 CA-C-N 120.54 1.229 . . . . 0.0 111.904 171.497 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 88.6 m -65.6 -29.72 70.35 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 125.213 1.405 . . . . 0.0 112.238 173.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.32 -39.69 87.96 Favored 'General case' 0 N--CA 1.471 0.582 0 O-C-N 121.108 -0.995 . . . . 0.0 112.089 -175.714 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.9 mp -57.83 -56.03 18.09 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 -177.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.53 -33.62 76.33 Favored 'General case' 0 CA--C 1.542 0.656 0 N-CA-C 113.378 0.881 . . . . 0.0 113.378 -178.004 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -79.95 -21.19 44.07 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 114.13 1.159 . . . . 0.0 114.13 178.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -90.74 -28.01 18.57 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 118.96 0.8 . . . . 0.0 110.306 172.092 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -66.07 -13.12 59.47 Favored 'General case' 0 CA--C 1.543 0.692 0 O-C-N 120.641 -1.287 . . . . 0.0 113.247 171.248 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 13.3 mt-10 -61.41 -27.49 68.58 Favored 'General case' 0 N--CA 1.48 1.059 0 CA-C-N 120.233 1.378 . . . . 0.0 110.464 168.665 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 35.7 t -96.45 -2.29 10.4 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.032 0 C-N-CA 127.581 2.353 . . . . 0.0 111.135 176.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 78.93 21.26 68.66 Favored Glycine 0 CA--C 1.538 1.53 0 C-N-CA 125.35 1.452 . . . . 0.0 114.742 -176.606 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 77.8 mt -83.6 131.07 34.71 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 C-N-CA 124.798 1.239 . . . . 0.0 112.006 -171.436 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 19.4 t0 -96.06 107.14 19.41 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 112.895 0.702 . . . . 0.0 112.895 -178.616 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 15.6 pt -142.68 23.06 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.208 0 C-N-CA 125.302 1.441 . . . . 0.0 114.369 -177.286 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 95.2 p -48.15 -37.34 15.34 Favored 'General case' 0 N--CA 1.483 1.201 0 N-CA-C 116.567 2.062 . . . . 0.0 116.567 -169.341 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -142.97 40.04 1.28 Allowed Glycine 0 N--CA 1.474 1.179 0 C-N-CA 125.358 1.456 . . . . 0.0 113.01 -179.371 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 24.3 pt20 -66.5 -34.68 78.45 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 115.637 1.717 . . . . 0.0 115.637 -169.529 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 68.0 p -93.65 104.17 16.29 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 121.211 0.529 . . . . 0.0 111.352 173.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 95.9 p -108.94 -23.55 11.66 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 125.473 1.509 . . . . 0.0 114.278 178.316 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -145.46 155.34 53.53 Favored Pre-proline 0 CA--C 1.544 0.722 0 C-N-CA 124.722 1.209 . . . . 0.0 111.046 -171.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -74.37 155.13 46.07 Favored 'Trans proline' 0 CA--C 1.538 0.714 0 C-N-CA 122.561 2.174 . . . . 0.0 112.657 173.257 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 5.6 tt -54.44 -38.65 41.77 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 126.171 1.788 . . . . 0.0 111.615 179.74 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -68.34 -8.6 41.37 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 124.56 1.144 . . . . 0.0 113.763 178.785 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 -79.92 -21.73 43.54 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 124.085 0.954 . . . . 0.0 112.824 170.71 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 84.6 m-85 -93.62 -176.73 4.17 Favored 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 126.444 1.897 . . . . 0.0 111.879 -179.354 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 7.0 t30 -113.84 129.19 56.62 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 125.783 1.633 . . . . 0.0 109.695 171.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -69.38 -36.9 77.26 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 113.918 1.081 . . . . 0.0 113.918 -175.517 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . 0.272 0.0 OUTLIER -72.07 -7.82 51.11 Favored 'General case' 0 CA--C 1.544 0.744 0 N-CA-C 114.562 1.319 . . . . 0.0 114.562 -173.077 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -65.1 -26.35 68.18 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 123.664 0.786 . . . . 0.0 110.449 168.295 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 55.5 m-85 -108.4 120.75 43.31 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 125.834 1.654 . . . . 0.0 111.44 -173.307 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -74.0 -20.87 60.19 Favored 'General case' 0 CA--C 1.545 0.776 0 CA-C-O 122.195 0.998 . . . . 0.0 112.473 177.55 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.609 HG22 ' HB ' ' A' ' 95' ' ' ILE . 92.3 t -133.95 137.84 51.5 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 C-N-CA 127.381 2.272 . . . . 0.0 108.891 -173.407 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 63.0 t -133.91 118.61 29.65 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 169.685 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 44.8 mm -103.09 113.16 39.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 C-N-CA 123.818 0.847 . . . . 0.0 109.299 -177.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 15.5 m -92.78 114.12 26.59 Favored 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 169.531 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 90.7 mt -86.79 -3.16 59.02 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 125.644 1.577 . . . . 0.0 115.217 -169.548 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 77.5 m -130.34 40.32 3.54 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 125.359 1.463 . . . . 0.0 110.553 -169.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 80.51 -131.72 10.7 Favored Glycine 0 CA--C 1.532 1.109 0 C-N-CA 124.371 0.986 . . . . 0.0 111.174 -169.49 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 93.3 p -63.71 154.49 32.98 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 124.015 0.926 . . . . 0.0 113.479 176.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -75.35 -51.42 7.43 Favored Glycine 0 CA--C 1.534 1.269 0 O-C-N 121.739 -0.601 . . . . 0.0 112.339 176.009 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . 0.273 7.7 p 48.97 -47.54 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.677 1 C-N-CA 132.148 4.179 . . . . 0.0 119.021 169.883 . . . . . . . . 3 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 63.1 t30 -85.9 15.95 4.51 Favored 'General case' 0 CA--C 1.556 1.202 0 C-N-CA 126.734 2.014 . . . . 0.0 112.761 -179.834 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -122.87 160.45 49.13 Favored Pre-proline 0 CA--C 1.55 0.98 0 C-N-CA 127.589 2.356 . . . . 0.0 112.598 179.605 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -63.34 151.61 84.04 Favored 'Trans proline' 0 CA--C 1.546 1.084 0 C-N-CA 122.774 2.316 . . . . 0.0 113.948 178.721 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_exo -58.82 -27.05 82.8 Favored 'Trans proline' 0 C--N 1.352 0.728 0 C-N-CA 123.609 2.873 . . . . 0.0 115.309 -177.108 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -61.72 -21.24 64.32 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 113.74 1.015 . . . . 0.0 113.74 177.763 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 92.7 m95 -83.73 -28.95 27.88 Favored 'General case' 0 N--CA 1.474 0.733 0 O-C-N 120.83 -1.168 . . . . 0.0 113.318 177.32 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 6.4 m -82.88 -13.37 12.08 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.315 0 N-CA-C 113.36 0.874 . . . . 0.0 113.36 174.41 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -95.31 1.46 54.42 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 114.603 1.334 . . . . 0.0 114.603 -179.33 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 85.6 mm-40 -66.39 156.31 34.94 Favored 'General case' 0 N--CA 1.481 1.081 0 O-C-N 120.83 -1.169 . . . . 0.0 111.596 172.005 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -59.49 -42.54 92.37 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 114.196 1.184 . . . . 0.0 114.196 -168.183 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.609 ' HB ' HG22 ' A' ' 75' ' ' VAL . 16.3 mm -113.21 55.44 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 C-N-CA 125.083 1.353 . . . . 0.0 109.276 177.788 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 25.1 t80 -74.66 109.19 7.93 Favored 'General case' 0 CA--C 1.536 0.414 0 O-C-N 120.565 -1.334 . . . . 0.0 107.675 169.009 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 13.8 mt-10 -110.95 131.36 55.12 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 114.432 1.271 . . . . 0.0 114.432 176.657 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 12.5 p-10 -94.74 104.69 16.61 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 126.128 1.771 . . . . 0.0 110.053 169.214 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 34.2 m0 -93.35 124.56 37.42 Favored 'General case' 0 N--CA 1.464 0.236 0 C-N-CA 124.183 0.993 . . . . 0.0 109.089 174.703 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 32.5 mt-30 -91.95 42.3 1.1 Allowed 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 124.012 0.925 . . . . 0.0 111.574 -173.324 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 76.1 mt -81.28 164.07 22.5 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 125.271 1.428 . . . . 0.0 112.695 -178.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -87.2 163.74 16.75 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 124.901 1.28 . . . . 0.0 111.221 169.106 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -108.3 139.6 20.91 Favored Pre-proline 0 N--CA 1.474 0.755 0 O-C-N 121.33 -0.856 . . . . 0.0 110.526 169.748 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_exo -59.9 -17.13 42.27 Favored 'Trans proline' 0 CA--C 1.545 1.028 0 C-N-CA 123.006 2.471 . . . . 0.0 116.392 176.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -54.41 135.44 45.28 Favored 'General case' 0 CA--C 1.546 0.816 0 CA-C-N 120.13 1.332 . . . . 0.0 113.924 178.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 76.54 6.74 84.86 Favored Glycine 0 CA--C 1.538 1.48 0 C-N-CA 124.461 1.029 . . . . 0.0 115.007 178.453 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 -138.05 170.47 15.98 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 125.473 1.509 . . . . 0.0 113.033 -179.459 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 26.4 p -68.07 168.56 11.77 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 117.461 2.393 . . . . 0.0 117.461 -168.524 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 25.0 tp -60.18 -30.09 69.13 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 125.097 1.359 . . . . 0.0 112.483 169.801 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -65.58 -31.54 72.64 Favored 'General case' 0 CA--C 1.539 0.523 0 O-C-N 121.038 -1.039 . . . . 0.0 111.259 171.684 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 11.4 t -74.16 -38.52 48.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 CA-C-O 118.154 -0.927 . . . . 0.0 112.14 171.104 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 17.1 m-85 -56.25 -44.08 79.33 Favored 'General case' 0 N--CA 1.482 1.134 0 CA-C-N 120.698 1.59 . . . . 0.0 111.74 169.588 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -69.49 -37.5 77.26 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 124.351 1.06 . . . . 0.0 112.408 178.182 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 21.6 m -60.46 -48.04 83.48 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 124.507 1.123 . . . . 0.0 111.201 170.362 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 75.1 t -65.52 -43.52 94.28 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 CA-C-O 118.181 -0.914 . . . . 0.0 110.236 179.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 16.8 mtp180 -53.5 -45.48 69.69 Favored 'General case' 0 N--CA 1.481 1.118 0 CA-C-N 119.914 1.234 . . . . 0.0 112.716 172.091 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -60.57 -51.34 59.34 Favored Glycine 0 CA--C 1.538 1.482 0 CA-C-N 119.431 1.014 . . . . 0.0 113.218 176.432 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 58.9 mm-40 -63.37 -45.09 92.76 Favored 'General case' 0 N--CA 1.472 0.653 0 O-C-N 121.978 -0.719 . . . . 0.0 111.912 178.822 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 50.5 t -63.83 -41.72 93.48 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 C-N-CA 124.881 1.272 . . . . 0.0 111.237 177.818 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 78.1 tttt -56.77 -48.02 78.83 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 119.832 1.196 . . . . 0.0 110.425 178.407 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -64.35 -42.31 96.29 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 112.641 0.608 . . . . 0.0 112.641 177.523 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 16.6 mmm180 -61.14 -45.59 94.03 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.393 0.677 . . . . 0.0 112.696 175.144 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 79.3 t -69.45 -41.05 80.55 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 C-N-CA 124.5 1.12 . . . . 0.0 111.157 -179.392 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -62.51 -40.0 95.32 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 118.875 0.761 . . . . 0.0 111.647 172.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 13.0 m-80 -64.02 -46.11 85.95 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-N 118.782 0.719 . . . . 0.0 112.236 174.123 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -54.05 -54.78 34.53 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 124.734 1.213 . . . . 0.0 110.499 175.272 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 91.4 mt -59.88 -45.11 95.41 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 CA-C-O 119.024 -0.512 . . . . 0.0 110.393 179.255 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -68.83 -10.77 58.67 Favored 'General case' 0 CA--C 1.548 0.871 0 N-CA-C 115.245 1.572 . . . . 0.0 115.245 -179.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 21.4 ptmt -102.49 -24.18 13.84 Favored 'General case' 0 N--CA 1.479 1.01 0 N-CA-C 113.91 1.078 . . . . 0.0 113.91 171.271 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 14.7 pt -96.65 -7.97 9.4 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 N-CA-C 114.435 1.272 . . . . 0.0 114.435 176.179 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 83.4 p . . . . . 0 C--O 1.255 1.35 0 C-N-CA 125.075 1.35 . . . . 0.0 114.269 173.526 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.403 ' HG3' ' HA ' ' A' ' 30' ' ' ILE . 4.1 ttp . . . . . 0 N--CA 1.502 2.172 0 N-CA-C 112.087 0.403 . . . . 0.0 112.087 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 3.3 mptp? -86.03 159.91 19.46 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 124.602 1.161 . . . . 0.0 113.113 171.003 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 79.3 mttt -112.14 113.21 25.34 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 125.816 1.646 . . . . 0.0 106.577 167.671 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 18.9 t -102.91 132.5 48.95 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 C-N-CA 125.793 1.637 . . . . 0.0 113.579 -178.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . 0.538 ' HG3' HG13 ' A' ' 7' ' ' VAL . 36.6 tpp -107.05 119.86 40.53 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.567 0.747 . . . . 0.0 109.266 168.552 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 60.1 m-85 -97.16 125.08 41.42 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.232 1.013 . . . . 0.0 109.533 171.476 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.54 HG11 HD12 ' A' ' 65' ' ' ILE . 1.0 OUTLIER -140.99 147.78 22.25 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 N-CA-C 114.179 1.177 . . . . 0.0 114.179 -168.95 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 52.7 t -157.55 164.72 37.03 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 126.189 1.795 . . . . 0.0 112.417 172.298 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 53.4 mtmt -75.08 154.92 37.67 Favored 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 125.753 1.621 . . . . 0.0 112.628 171.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 6.4 tmm_? 49.3 84.45 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 127.377 2.271 . . . . 0.0 112.661 175.618 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 30.2 t-20 -79.69 -25.27 41.26 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 124.62 1.168 . . . . 0.0 113.132 -171.738 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 78.2 p -58.3 141.68 50.29 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.208 1.003 . . . . 0.0 111.567 170.092 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 66.9 m 56.23 -4.26 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.325 0 N-CA-C 116.647 2.091 . . . . 0.0 116.647 -170.598 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 58.8 ttm-85 -92.37 138.57 31.41 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 124.886 1.274 . . . . 0.0 113.372 -170.131 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 45.5 m -96.17 -38.16 10.26 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 114.578 1.325 . . . . 0.0 114.578 -176.64 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 60.82 -46.75 0.11 Allowed 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 127.622 2.369 . . . . 0.0 116.271 -177.132 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . 0.41 ' HG2' ' SD ' ' A' ' 50' ' ' MET . 0.0 OUTLIER 66.67 -50.54 0.45 Allowed 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 127.771 2.429 . . . . 0.0 116.579 169.619 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -56.17 -37.13 69.13 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 115.584 1.698 . . . . 0.0 115.584 -169.132 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.89 -34.94 77.62 Favored 'General case' 0 N--CA 1.476 0.864 0 O-C-N 121.412 -0.805 . . . . 0.0 112.774 -177.162 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -69.87 -42.83 68.53 Favored Glycine 0 N--CA 1.468 0.813 0 C-N-CA 123.692 0.663 . . . . 0.0 111.764 176.371 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -64.39 -36.94 85.79 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 117.884 0.842 . . . . 0.0 111.313 170.79 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -65.32 -39.12 92.03 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 119.449 1.022 . . . . 0.0 112.663 179.586 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 23.7 mtpp -62.05 -46.62 88.33 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 123.314 0.645 . . . . 0.0 110.978 169.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 69.6 m -68.15 -38.09 81.75 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 123.12 0.568 . . . . 0.0 112.245 -174.448 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 47.7 mt -85.49 -35.46 21.16 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 125.416 1.487 . . . . 0.0 113.362 -179.445 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -117.29 5.15 17.68 Favored Glycine 0 CA--C 1.528 0.867 0 N-CA-C 118.214 2.046 . . . . 0.0 118.214 -168.737 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -60.81 139.48 57.92 Favored 'General case' 0 CA--C 1.545 0.784 0 CA-C-N 122.064 2.932 . . . . 0.0 111.959 177.316 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 88.68 -21.38 26.56 Favored Glycine 0 CA--C 1.54 1.649 0 C-N-CA 124.797 1.189 . . . . 0.0 113.233 -169.206 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 72.4 mttt -101.77 -42.22 6.25 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 126.302 1.841 . . . . 0.0 112.015 169.531 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.403 ' HA ' ' HG3' ' A' ' 1' ' ' MET . 36.0 pt -135.12 146.11 30.92 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 C-N-CA 124.676 1.19 . . . . 0.0 113.126 -178.566 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -98.58 145.77 26.49 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 126.685 1.994 . . . . 0.0 108.337 169.197 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 71.3 t -141.38 139.01 32.9 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 O-C-N 121.781 -0.575 . . . . 0.0 112.435 -169.696 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 31.7 m -136.9 159.2 42.57 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 126.198 1.799 . . . . 0.0 108.745 169.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 26.5 p -133.98 148.55 51.15 Favored 'General case' 0 CA--C 1.515 -0.368 0 CA-C-O 121.742 0.782 . . . . 0.0 111.896 168.086 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 59.9 p -147.58 153.81 39.89 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 114.806 -1.088 . . . . 0.0 113.312 176.212 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -83.22 152.97 30.1 Favored Glycine 0 N--CA 1.473 1.138 0 O-C-N 121.735 -0.603 . . . . 0.0 111.987 173.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.4 mp -76.23 -20.43 57.45 Favored 'General case' 0 N--CA 1.481 1.088 0 CA-C-N 119.126 1.463 . . . . 0.0 113.973 176.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -138.31 -52.42 0.6 Allowed 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.934 0.893 . . . . 0.0 113.31 177.226 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 50.2 p -98.93 150.57 21.8 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 115.106 1.521 . . . . 0.0 115.106 -172.403 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 80.5 p -84.81 149.21 25.87 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 125.818 1.647 . . . . 0.0 114.23 -174.497 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 13.2 tpt180 57.61 137.58 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 129.483 3.113 . . . . 0.0 116.045 -178.662 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 15.6 m -67.49 156.48 6.79 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.354 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 168.695 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . 0.441 ' CE1' ' HB ' ' A' ' 45' ' ' THR 0.255 0.0 OUTLIER -68.19 140.18 92.98 Favored Pre-proline 0 CA--C 1.546 0.793 0 C-N-CA 118.188 -1.405 . . . . 0.0 110.943 178.08 . . . . . . . . 4 4 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -63.81 -31.01 68.69 Favored 'Trans proline' 0 CA--C 1.539 0.732 0 C-N-CA 123.254 2.636 . . . . 0.0 114.84 -168.291 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.441 ' HB ' ' CE1' ' A' ' 43' ' ' HIS . 51.7 m -65.46 -24.64 67.22 Favored 'General case' 0 N--CA 1.48 1.062 0 O-C-N 121.404 -0.81 . . . . 0.0 111.787 -176.334 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -50.51 -48.44 57.05 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.11 0.964 . . . . 0.0 111.67 169.796 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 4.7 mp -55.39 -53.26 37.61 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 CA-C-N 119.433 1.015 . . . . 0.0 111.015 -176.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -62.81 -25.55 68.3 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 113.648 0.981 . . . . 0.0 113.648 -177.709 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -81.08 -35.19 32.05 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 123.644 0.778 . . . . 0.0 112.808 174.859 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . 0.41 ' SD ' ' HG2' ' A' ' 17' ' ' MET . 4.5 mmt -72.49 -29.76 63.93 Favored 'General case' 0 N--CA 1.473 0.707 0 O-C-N 121.129 -0.982 . . . . 0.0 111.13 172.219 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -67.41 -9.08 38.2 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 125.339 1.456 . . . . 0.0 113.816 172.189 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -69.02 -29.74 67.96 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-N 120.325 1.421 . . . . 0.0 110.857 169.526 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . 0.295 2.2 p -109.66 8.25 8.95 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.815 0 C-N-CA 127.189 2.196 . . . . 0.0 111.955 -172.475 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 85.84 14.08 68.2 Favored Glycine 0 CA--C 1.538 1.497 0 C-N-CA 124.855 1.217 . . . . 0.0 115.369 171.673 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -76.19 138.39 20.83 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 C-N-CA 124.625 1.17 . . . . 0.0 109.698 -178.335 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 19.6 t0 -110.55 104.37 13.08 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 124.272 1.029 . . . . 0.0 111.767 175.088 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 21.4 pt -133.75 6.33 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.248 0 N-CA-C 116.289 1.959 . . . . 0.0 116.289 -175.727 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 72.3 m -60.21 -31.43 70.16 Favored 'General case' 0 N--CA 1.483 1.214 0 CA-C-N 120.438 1.472 . . . . 0.0 111.662 175.207 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -79.35 14.78 14.65 Favored Glycine 0 CA--C 1.539 1.559 0 C-N-CA 126.193 1.854 . . . . 0.0 115.934 175.863 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 70.6 mt-30 -62.38 157.21 20.46 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 119.434 1.617 . . . . 0.0 110.429 169.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 7.6 t -74.86 172.89 11.4 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 121.538 0.685 . . . . 0.0 112.061 169.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 73.4 m -118.09 -18.53 9.36 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 125.098 1.359 . . . . 0.0 114.211 -174.185 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 27.3 m-20 -86.11 158.68 55.29 Favored Pre-proline 0 CA--C 1.55 0.949 0 N-CA-C 114.691 1.367 . . . . 0.0 114.691 -169.703 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -63.98 160.91 35.38 Favored 'Trans proline' 0 C--N 1.353 0.787 0 C-N-CA 124.001 3.134 . . . . 0.0 114.371 172.268 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.54 HD12 HG11 ' A' ' 7' ' ' VAL . 8.4 tt -51.5 -36.47 17.93 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 C-N-CA 125.622 1.569 . . . . 0.0 112.103 173.092 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 17.8 mt-10 -65.0 -16.77 63.81 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.598 1.159 . . . . 0.0 112.825 -177.511 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -83.26 -8.18 59.49 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 124.815 1.246 . . . . 0.0 113.565 -178.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 69.7 m-85 -116.77 -175.44 2.77 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 126.221 1.808 . . . . 0.0 112.614 -172.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 11.2 t30 -120.69 125.81 48.61 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 125.603 1.561 . . . . 0.0 110.026 177.613 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -69.13 -35.4 76.34 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 114.021 1.119 . . . . 0.0 114.021 -173.363 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . 0.275 0.0 OUTLIER -71.92 -5.21 33.01 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 114.329 1.233 . . . . 0.0 114.329 -174.15 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -70.42 -25.73 63.34 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 122.968 0.507 . . . . 0.0 109.949 168.446 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 80.1 m-85 -99.23 148.67 23.88 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 126.473 1.909 . . . . 0.0 111.644 -179.205 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -107.04 -17.92 14.05 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 124.342 1.057 . . . . 0.0 112.176 176.011 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.662 HG22 ' HB ' ' A' ' 95' ' ' ILE . 71.7 t -129.94 137.81 55.64 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 C-N-CA 126.89 2.076 . . . . 0.0 107.959 177.454 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 60.2 t -132.93 123.46 48.48 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 169.591 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 41.5 mm -108.35 104.13 16.6 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 C-N-CA 124.496 1.119 . . . . 0.0 108.883 -176.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 3.6 m -81.78 107.48 14.54 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 169.646 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 75.4 mt -75.71 -18.72 59.51 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 114.945 1.461 . . . . 0.0 114.945 -170.062 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 28.7 p -136.66 30.81 2.83 Favored 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 114.935 1.457 . . . . 0.0 114.935 -168.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 152.03 -172.67 31.32 Favored Glycine 0 CA--C 1.532 1.096 0 N-CA-C 115.246 0.858 . . . . 0.0 115.246 177.685 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 97.0 p -79.01 160.64 27.08 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 125.295 1.438 . . . . 0.0 112.681 176.63 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -81.12 49.96 4.09 Favored Glycine 0 CA--C 1.534 1.267 0 C-N-CA 124.861 1.22 . . . . 0.0 114.951 -171.047 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 24.8 t -104.06 -33.17 3.01 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 CA-C-N 117.864 0.832 . . . . 0.0 112.88 -172.455 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 17.9 t-20 -84.84 -21.91 29.66 Favored 'General case' 0 CA--C 1.55 0.945 0 N-CA-C 113.865 1.061 . . . . 0.0 113.865 -179.239 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -82.42 160.49 62.02 Favored Pre-proline 0 CA--C 1.553 1.085 0 C-N-CA 124.0 0.92 . . . . 0.0 112.55 170.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_exo -61.47 149.75 88.23 Favored 'Trans proline' 0 CA--C 1.543 0.97 0 C-N-CA 122.79 2.327 . . . . 0.0 112.786 176.428 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -62.56 -29.04 77.87 Favored 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 122.95 2.433 . . . . 0.0 114.008 -170.356 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -60.64 -19.59 58.53 Favored 'General case' 0 CA--C 1.544 0.748 0 O-C-N 120.849 -1.157 . . . . 0.0 113.989 177.425 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 84.1 m95 -82.98 -14.71 53.53 Favored 'General case' 0 CA--C 1.542 0.662 0 O-C-N 120.659 -1.276 . . . . 0.0 113.324 175.667 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 14.5 m -93.49 -13.21 8.59 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.209 0 N-CA-C 113.729 1.011 . . . . 0.0 113.729 169.756 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 59.1 p -88.27 -5.46 58.35 Favored 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 114.48 1.289 . . . . 0.0 114.48 179.382 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 55.1 mm-40 -67.87 149.58 49.66 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-O 121.982 0.896 . . . . 0.0 110.275 169.63 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -53.88 -42.48 68.7 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 115.127 1.528 . . . . 0.0 115.127 -167.516 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.662 ' HB ' HG22 ' A' ' 75' ' ' VAL . 19.8 mm -117.44 63.83 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 C-N-CA 124.982 1.313 . . . . 0.0 109.232 179.21 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 33.0 t80 -76.11 111.86 11.96 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 168.799 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 9.0 mt-10 -108.97 130.92 55.47 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 114.15 1.167 . . . . 0.0 114.15 175.011 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 11.7 p-10 -93.89 109.7 21.4 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 125.016 1.326 . . . . 0.0 109.31 168.791 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 27.5 m0 -101.7 158.33 16.18 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.568 1.147 . . . . 0.0 108.943 169.627 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 8.3 mm-40 -128.41 65.84 1.39 Allowed 'General case' 0 CA--C 1.537 0.477 0 CA-C-O 122.875 1.321 . . . . 0.0 108.265 173.36 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.478 HD11 HG22 ' A' ' 119' ' ' VAL . 14.1 tp -77.11 150.63 35.61 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 126.608 1.963 . . . . 0.0 110.992 -174.344 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 29.4 tp10 -64.32 -43.01 96.01 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 113.681 0.993 . . . . 0.0 113.681 178.572 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 8.4 t0 62.88 126.39 0.02 OUTLIER Pre-proline 0 CA--C 1.558 1.257 0 C-N-CA 127.283 2.233 . . . . 0.0 113.596 -169.659 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_exo -62.61 -12.18 27.03 Favored 'Trans proline' 0 CA--C 1.55 1.301 0 C-N-CA 121.997 1.798 . . . . 0.0 114.499 172.189 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 8.6 t0 -23.99 107.47 0.03 OUTLIER 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 128.31 2.644 . . . . 0.0 116.068 169.629 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 72.16 10.59 74.08 Favored Glycine 0 CA--C 1.537 1.448 0 N-CA-C 116.379 1.312 . . . . 0.0 116.379 169.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 13.2 pt20 -128.73 166.5 18.84 Favored 'General case' 0 CA--C 1.545 0.753 0 CA-C-N 119.159 1.48 . . . . 0.0 113.999 -175.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 49.6 m -58.14 160.1 5.27 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 126.447 1.899 . . . . 0.0 115.63 -169.24 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 20.3 tp -59.41 -32.6 70.33 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.917 1.287 . . . . 0.0 113.069 178.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -61.76 -32.19 72.43 Favored 'General case' 0 N--CA 1.473 0.716 0 O-C-N 120.808 -1.183 . . . . 0.0 112.091 172.481 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 6.4 t -74.02 -37.62 47.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 CA-C-O 118.461 -0.78 . . . . 0.0 110.891 172.748 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 17.5 m-85 -57.08 -48.08 79.47 Favored 'General case' 0 N--CA 1.478 0.972 0 CA-C-N 120.273 1.397 . . . . 0.0 112.119 169.68 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 48.4 mtt-85 -60.12 -48.64 80.88 Favored 'General case' 0 N--CA 1.484 1.253 0 CA-C-N 119.185 0.902 . . . . 0.0 111.326 178.117 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 83.4 m -62.5 -46.13 89.85 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.884 0.873 . . . . 0.0 111.179 179.739 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 96.6 t -74.45 -41.19 49.58 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 CA-C-O 117.586 -1.197 . . . . 0.0 110.83 -175.307 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . 0.304 24.6 ptt85 -64.04 -28.65 69.94 Favored 'General case' 0 N--CA 1.483 1.225 0 CA-C-N 121.638 2.017 . . . . 0.0 113.12 177.487 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -65.15 -46.68 87.11 Favored Glycine 0 CA--C 1.542 1.772 0 CA-C-N 119.356 0.98 . . . . 0.0 112.938 169.279 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 15.0 mm100 -65.75 -41.32 92.25 Favored 'General case' 0 N--CA 1.475 0.824 0 O-C-N 121.387 -1.067 . . . . 0.0 112.151 177.014 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.478 HG22 HD11 ' A' ' 101' ' ' LEU . 77.7 t -60.82 -43.8 96.25 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 C-N-CA 125.416 1.487 . . . . 0.0 110.714 173.095 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 82.0 tttt -53.98 -49.68 68.24 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 119.205 0.911 . . . . 0.0 110.231 179.039 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -62.43 -41.65 98.88 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 112.742 0.645 . . . . 0.0 112.742 178.5 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 14.8 mtp85 -64.03 -43.6 95.08 Favored 'General case' 0 N--CA 1.479 1.01 0 N-CA-C 113.135 0.791 . . . . 0.0 113.135 176.024 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 94.2 t -70.91 -38.06 70.78 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 C-N-CA 123.181 0.592 . . . . 0.0 110.762 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -60.2 -38.52 83.56 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 118.613 0.642 . . . . 0.0 111.214 169.803 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 7.9 m-80 -62.48 -48.69 78.5 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 119.283 0.947 . . . . 0.0 112.153 174.112 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -52.89 -56.55 15.05 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.576 1.151 . . . . 0.0 110.699 174.076 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 85.4 mt -61.37 -42.15 92.59 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 O-C-N 122.017 -0.427 . . . . 0.0 111.08 -179.196 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -70.13 -13.18 62.08 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 114.755 1.391 . . . . 0.0 114.755 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -99.69 -28.5 13.15 Favored 'General case' 0 N--CA 1.479 0.998 0 N-CA-C 113.723 1.009 . . . . 0.0 113.723 172.24 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 19.1 pt -94.37 -21.43 5.84 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 N-CA-C 114.423 1.268 . . . . 0.0 114.423 177.755 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 66.6 m . . . . . 0 C--O 1.254 1.326 0 C-N-CA 125.074 1.35 . . . . 0.0 111.886 -174.085 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.8 ttt . . . . . 0 N--CA 1.503 2.196 0 N-CA-C 111.787 0.291 . . . . 0.0 111.787 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.67 161.3 30.92 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 126.336 1.855 . . . . 0.0 112.358 177.819 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 32.6 ttmt -114.5 116.49 28.91 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 107.136 -1.431 . . . . 0.0 107.136 167.73 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 16.0 t -106.17 134.6 47.27 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 C-N-CA 124.604 1.162 . . . . 0.0 114.085 -178.251 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 40.6 tpp -103.1 128.1 50.12 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 168.355 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 70.3 m-85 -108.97 131.8 54.71 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.984 0.914 . . . . 0.0 109.381 170.007 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.509 HG11 HD12 ' A' ' 65' ' ' ILE . 2.6 m -148.11 158.8 7.8 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.239 0 C-N-CA 124.179 0.992 . . . . 0.0 113.616 -171.666 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 35.1 t -152.31 156.48 39.72 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 126.941 2.096 . . . . 0.0 110.657 179.315 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 61.3 mtpt -72.62 138.83 47.0 Favored 'General case' 0 N--CA 1.484 1.275 0 C-N-CA 123.911 0.884 . . . . 0.0 110.42 169.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 69.9 mtp180 52.73 49.62 19.9 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 125.427 1.491 . . . . 0.0 113.571 -170.812 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -57.61 -26.51 61.64 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 115.134 1.531 . . . . 0.0 115.134 -176.812 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 77.1 p -80.2 -31.11 38.73 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 124.169 0.988 . . . . 0.0 112.857 176.725 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 16.4 m -77.79 -9.04 58.82 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.681 1.192 . . . . 0.0 112.79 173.743 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 74.6 mtt180 -131.5 157.96 42.16 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 125.491 1.516 . . . . 0.0 113.381 -169.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 71.0 m -105.22 129.74 53.53 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.979 0.912 . . . . 0.0 109.701 169.76 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 4.1 mp0 -98.67 -29.7 12.88 Favored 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 113.436 0.902 . . . . 0.0 113.436 -169.653 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . 0.467 ' HG2' ' SD ' ' A' ' 50' ' ' MET . 0.0 OUTLIER 67.1 -43.63 0.44 Allowed 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 127.104 2.162 . . . . 0.0 115.35 172.904 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -66.16 -32.64 74.2 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 114.073 1.138 . . . . 0.0 114.073 -169.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.2 pm0 -62.76 -37.14 85.45 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 119.032 0.833 . . . . 0.0 111.565 172.266 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -62.77 -61.82 6.11 Favored Glycine 0 C--N 1.336 0.548 0 N-CA-C 110.688 -0.965 . . . . 0.0 110.688 177.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -59.55 -33.09 70.97 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 117.584 0.692 . . . . 0.0 112.768 -179.449 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -67.56 -25.87 66.02 Favored 'General case' 0 CA--C 1.539 0.554 0 O-C-N 121.289 -0.882 . . . . 0.0 112.612 177.812 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 23.4 mtpp -77.57 -44.09 29.62 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.719 0.808 . . . . 0.0 110.665 169.464 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -67.31 -38.58 85.19 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 123.424 0.69 . . . . 0.0 112.738 -175.875 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 55.6 mt -93.21 -27.65 16.74 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 125.388 1.475 . . . . 0.0 112.774 -178.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -111.72 -4.93 26.16 Favored Glycine 0 N--CA 1.471 1.006 0 N-CA-C 117.556 1.782 . . . . 0.0 117.556 -169.058 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -62.84 139.54 58.72 Favored 'General case' 0 CA--C 1.545 0.78 0 CA-C-N 121.42 2.61 . . . . 0.0 112.327 178.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 86.41 -22.1 14.59 Favored Glycine 0 CA--C 1.541 1.671 0 C-N-CA 125.114 1.34 . . . . 0.0 113.437 -169.327 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 63.5 mttp -96.67 -44.28 7.18 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 125.981 1.712 . . . . 0.0 111.686 169.813 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 46.0 pt -141.18 157.01 22.17 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 C-N-CA 125.182 1.393 . . . . 0.0 113.009 -174.354 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -101.25 144.91 29.53 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 127.12 2.168 . . . . 0.0 108.796 169.405 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 73.7 t -140.3 137.6 37.11 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 C-N-CA 123.675 0.79 . . . . 0.0 111.578 -171.578 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 54.1 m -145.28 150.68 37.09 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 124.11 0.964 . . . . 0.0 110.852 177.738 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 93.5 p -133.21 137.98 46.35 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 124.52 1.128 . . . . 0.0 109.012 166.684 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 88.2 p -119.35 -70.05 0.81 Allowed 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 114.259 1.207 . . . . 0.0 114.259 -168.337 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 130.07 154.49 8.08 Favored Glycine 0 N--CA 1.465 0.597 0 C-N-CA 125.716 1.626 . . . . 0.0 113.346 173.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 10.3 mp -89.36 -13.21 38.35 Favored 'General case' 0 N--CA 1.474 0.754 0 O-C-N 121.797 -0.825 . . . . 0.0 113.173 -178.118 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -140.96 -57.06 0.5 Allowed 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 124.282 1.033 . . . . 0.0 112.444 179.322 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 39.7 m -108.44 155.91 20.05 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 124.714 1.206 . . . . 0.0 111.405 178.094 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 95.9 p -90.86 14.58 13.29 Favored 'General case' 0 N--CA 1.478 0.957 0 N-CA-C 116.694 2.109 . . . . 0.0 116.694 -170.042 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 64.3 ttt180 -130.87 157.12 43.77 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 125.541 1.536 . . . . 0.0 111.871 -177.075 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 24.1 m -111.77 165.27 6.95 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 C-N-CA 126.6 1.96 . . . . 0.0 109.55 170.765 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 5.1 t-80 -50.98 131.65 30.06 Favored Pre-proline 0 CA--C 1.532 0.275 0 CA-C-O 118.19 -0.91 . . . . 0.0 113.231 -170.698 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_exo -57.57 -27.94 78.99 Favored 'Trans proline' 0 CA--C 1.548 1.218 0 CA-C-N 120.612 1.254 . . . . 0.0 112.361 173.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 46.1 m -63.93 -32.5 74.05 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 126.08 1.752 . . . . 0.0 112.986 172.192 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -55.12 -45.23 75.55 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 123.977 0.911 . . . . 0.0 110.97 178.753 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.4 mp -53.95 -51.7 43.15 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 C-N-CA 124.09 0.956 . . . . 0.0 109.483 -176.854 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.4 -32.3 73.7 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 113.147 0.795 . . . . 0.0 113.147 -179.587 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -80.1 -30.15 39.11 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 113.452 0.908 . . . . 0.0 113.452 178.545 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . 0.467 ' SD ' ' HG2' ' A' ' 17' ' ' MET . 3.2 mmt -76.91 -30.77 56.29 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.42 0.688 . . . . 0.0 110.851 170.712 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -68.58 -13.25 62.21 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 124.41 1.084 . . . . 0.0 113.323 172.508 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -63.94 -29.71 70.85 Favored 'General case' 0 N--CA 1.481 1.124 0 CA-C-N 120.706 1.594 . . . . 0.0 110.695 168.705 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 61.5 t -91.62 -7.68 10.56 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.903 0 C-N-CA 126.896 2.078 . . . . 0.0 111.058 173.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 83.54 21.75 57.58 Favored Glycine 0 CA--C 1.539 1.56 0 C-N-CA 125.434 1.492 . . . . 0.0 114.447 -177.71 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 31.9 mt -88.82 135.73 25.08 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 C-N-CA 124.595 1.158 . . . . 0.0 111.505 -172.188 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 18.6 t0 -94.39 120.19 34.26 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 123.582 0.753 . . . . 0.0 112.332 171.492 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 9.2 pt -134.67 -1.94 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.358 0 N-CA-C 116.094 1.887 . . . . 0.0 116.094 179.257 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 83.5 p -73.28 -21.9 60.49 Favored 'General case' 0 N--CA 1.481 1.092 0 N-CA-C 115.175 1.546 . . . . 0.0 115.175 -169.638 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -78.44 0.86 73.87 Favored Glycine 0 CA--C 1.54 1.604 0 N-CA-C 116.39 1.316 . . . . 0.0 116.39 -173.81 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 33.4 mt-30 -78.65 -11.98 60.0 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 115.304 1.594 . . . . 0.0 115.304 -171.345 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 42.8 p -63.94 115.42 4.86 Favored 'General case' 0 N--CA 1.477 0.883 0 CA-C-N 119.537 1.062 . . . . 0.0 113.56 -169.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 89.2 p -152.35 -77.86 0.12 Allowed 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.765 1.226 . . . . 0.0 112.708 177.762 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -146.43 159.26 45.43 Favored Pre-proline 0 CA--C 1.554 1.112 0 C-N-CA 124.41 1.084 . . . . 0.0 113.522 -171.837 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_endo -61.71 161.04 26.24 Favored 'Trans proline' 0 C--N 1.352 0.742 0 C-N-CA 124.174 3.249 . . . . 0.0 114.133 169.745 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.509 HD12 HG11 ' A' ' 7' ' ' VAL . 11.6 tt -51.32 -35.68 16.28 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.128 0 C-N-CA 125.824 1.65 . . . . 0.0 112.444 172.484 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 17.5 mt-10 -64.42 -17.77 64.1 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 123.779 0.832 . . . . 0.0 112.961 -177.718 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -84.69 -10.67 57.07 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 124.792 1.237 . . . . 0.0 113.604 -175.898 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 76.6 m-85 -111.5 -168.32 1.29 Allowed 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 125.979 1.711 . . . . 0.0 112.348 -173.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 6.4 t30 -124.39 123.47 40.25 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 126.064 1.745 . . . . 0.0 109.864 178.673 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.81 -33.61 75.98 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 114.187 1.18 . . . . 0.0 114.187 -170.601 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . 0.269 0.0 OUTLIER -71.41 -4.62 27.4 Favored 'General case' 0 CA--C 1.544 0.721 0 N-CA-C 114.212 1.19 . . . . 0.0 114.212 -178.11 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -73.94 -12.33 60.62 Favored 'General case' 0 CA--C 1.549 0.904 0 C-N-CA 123.965 0.906 . . . . 0.0 111.348 168.752 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 58.3 m-85 -117.22 138.88 51.42 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 127.001 2.12 . . . . 0.0 111.268 179.128 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -90.5 -23.23 21.0 Favored 'General case' 0 N--CA 1.478 0.956 0 CA-C-O 122.207 1.003 . . . . 0.0 112.926 178.349 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.629 HG22 ' HB ' ' A' ' 95' ' ' ILE . 96.5 t -132.28 136.11 56.93 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 C-N-CA 126.988 2.115 . . . . 0.0 108.249 -174.12 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 91.0 t -131.8 125.76 56.04 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 170.104 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 45.1 mm -112.39 105.15 18.23 Favored 'Isoleucine or valine' 0 C--O 1.233 0.237 0 C-N-CA 124.257 1.023 . . . . 0.0 109.354 -176.239 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 24.4 m -86.66 98.79 11.31 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 123.667 0.787 . . . . 0.0 109.117 171.807 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 52.7 mt -69.69 178.62 2.49 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 125.499 1.52 . . . . 0.0 110.966 170.474 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 16.2 m 63.1 19.7 11.82 Favored 'General case' 0 CA--C 1.547 0.841 0 N-CA-C 114.784 1.401 . . . . 0.0 114.784 169.78 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 131.79 -120.43 2.81 Favored Glycine 0 CA--C 1.531 1.048 0 C-N-CA 124.512 1.053 . . . . 0.0 111.971 -172.152 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 9.2 t -135.96 157.99 45.48 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 124.908 1.283 . . . . 0.0 112.82 178.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -74.66 113.93 4.22 Favored Glycine 0 CA--C 1.531 1.087 0 C-N-CA 124.414 1.006 . . . . 0.0 112.261 -179.326 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 11.3 p -139.53 -39.06 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.26 0 N-CA-C 114.594 1.331 . . . . 0.0 114.594 -178.147 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 65.0 t30 -92.43 -15.63 26.92 Favored 'General case' 0 CA--C 1.549 0.911 0 N-CA-C 114.12 1.155 . . . . 0.0 114.12 -177.228 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -71.44 157.13 90.58 Favored Pre-proline 0 CA--C 1.552 1.024 0 O-C-N 121.309 -0.869 . . . . 0.0 111.843 169.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.41 ' HA ' ' HD3' ' A' ' 88' ' ' PRO . 43.3 Cg_exo -62.2 149.03 92.1 Favored 'Trans proline' 0 CA--C 1.545 1.047 0 C-N-CA 122.215 1.944 . . . . 0.0 113.352 -177.52 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 87' ' ' PRO . 88.8 Cg_exo -57.33 -33.63 96.5 Favored 'Trans proline' 0 C--N 1.351 0.707 0 C-N-CA 122.935 2.423 . . . . 0.0 115.144 -169.875 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -60.98 -21.4 63.5 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 114.284 1.216 . . . . 0.0 114.284 179.763 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 87.5 m95 -81.51 -22.2 38.1 Favored 'General case' 0 CA--C 1.535 0.388 0 O-C-N 120.637 -1.289 . . . . 0.0 112.663 176.302 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 10.6 m -89.77 -3.16 10.06 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 N-CA-C 113.463 0.912 . . . . 0.0 113.463 172.568 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 59.3 p -103.24 3.8 35.96 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 125.373 1.469 . . . . 0.0 114.888 176.251 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 80.6 mm-40 -66.86 156.66 35.07 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 119.351 0.978 . . . . 0.0 111.973 171.668 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -58.19 -42.01 85.2 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 114.278 1.214 . . . . 0.0 114.278 -167.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.629 ' HB ' HG22 ' A' ' 75' ' ' VAL . 20.1 mm -115.0 59.52 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 C-N-CA 124.822 1.249 . . . . 0.0 108.708 175.866 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 21.7 t80 -75.6 109.7 9.39 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 169.069 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 13.1 mt-10 -109.18 140.61 42.56 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 114.665 1.357 . . . . 0.0 114.665 174.252 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -98.23 121.05 39.67 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.985 1.314 . . . . 0.0 109.706 169.249 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 24.4 m0 -112.79 105.59 13.75 Favored 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 124.917 1.287 . . . . 0.0 109.063 -177.349 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -85.11 37.21 0.66 Allowed 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 124.933 1.293 . . . . 0.0 112.02 -171.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 73.9 mt -76.17 158.68 31.44 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 126.114 1.766 . . . . 0.0 111.934 178.561 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -81.41 152.08 27.6 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-O 121.559 0.695 . . . . 0.0 112.564 170.639 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 12.5 p-10 -88.02 136.87 31.73 Favored Pre-proline 0 CA--C 1.546 0.808 0 C-N-CA 125.0 1.32 . . . . 0.0 110.987 170.853 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -82.42 -9.22 11.43 Favored 'Trans proline' 0 CA--C 1.55 1.301 0 C-N-CA 121.57 1.513 . . . . 0.0 114.461 -174.785 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -65.29 146.14 55.32 Favored 'General case' 0 CA--C 1.547 0.837 0 CA-C-N 119.438 1.017 . . . . 0.0 112.47 175.675 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 77.78 5.58 86.54 Favored Glycine 0 CA--C 1.538 1.501 0 C-N-CA 123.829 0.728 . . . . 0.0 114.751 179.449 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -141.9 173.62 11.34 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 126.208 1.803 . . . . 0.0 112.015 178.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 24.4 p -65.78 164.97 13.62 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 116.161 1.911 . . . . 0.0 116.161 -169.274 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 43.7 tp -60.91 -27.91 68.53 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.171 0.988 . . . . 0.0 112.25 171.533 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -66.62 -32.14 73.28 Favored 'General case' 0 CA--C 1.54 0.575 0 O-C-N 120.681 -1.262 . . . . 0.0 111.508 172.597 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 4.4 t -72.49 -36.92 55.72 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 O-C-N 121.108 -0.995 . . . . 0.0 111.841 170.656 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -55.1 -47.57 74.79 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 119.724 1.147 . . . . 0.0 111.471 169.501 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -69.66 -32.59 71.32 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.658 0.783 . . . . 0.0 112.498 178.573 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 42.9 m -62.94 -43.89 97.55 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 123.883 0.873 . . . . 0.0 110.627 169.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 68.8 t -65.7 -41.01 89.53 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 CA-C-O 117.576 -1.202 . . . . 0.0 110.576 175.727 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 24.9 mtm105 -53.98 -49.48 68.71 Favored 'General case' 0 N--CA 1.484 1.24 0 CA-C-N 120.607 1.548 . . . . 0.0 111.592 169.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -59.22 -49.65 76.19 Favored Glycine 0 CA--C 1.538 1.505 0 CA-C-N 119.438 1.017 . . . . 0.0 113.641 179.326 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 56.7 mm-40 -63.58 -44.08 95.12 Favored 'General case' 0 N--CA 1.473 0.708 0 O-C-N 121.996 -0.708 . . . . 0.0 111.988 178.178 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 53.4 t -64.81 -39.71 86.58 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 C-N-CA 124.048 0.939 . . . . 0.0 111.186 176.791 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 12.3 tmtt? -56.07 -48.83 75.33 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 119.654 1.115 . . . . 0.0 110.312 179.041 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -65.15 -42.62 93.6 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 112.929 0.714 . . . . 0.0 112.929 176.792 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 15.5 mmm180 -62.03 -43.87 97.91 Favored 'General case' 0 N--CA 1.48 1.055 0 O-C-N 121.467 -0.771 . . . . 0.0 112.737 176.536 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 85.6 t -70.38 -37.75 71.75 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 123.776 0.83 . . . . 0.0 111.273 179.082 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 70.6 mt-10 -60.23 -41.91 94.12 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 119.537 1.062 . . . . 0.0 111.6 170.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 15.2 m-80 -63.33 -45.36 91.62 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 118.347 0.521 . . . . 0.0 112.151 175.432 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 8.6 tt -53.19 -55.9 20.63 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 124.604 1.162 . . . . 0.0 110.892 173.642 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 84.2 mt -63.27 -43.0 98.47 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 O-C-N 121.593 -0.692 . . . . 0.0 110.376 -177.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -68.07 -14.02 62.65 Favored 'General case' 0 CA--C 1.546 0.789 0 N-CA-C 114.822 1.415 . . . . 0.0 114.822 178.807 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 20.0 ptmt -102.04 -32.76 10.0 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 113.573 0.953 . . . . 0.0 113.573 174.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 13.5 pt -89.54 -17.3 8.18 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 N-CA-C 114.185 1.18 . . . . 0.0 114.185 -179.529 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 68.8 m . . . . . 0 C--O 1.255 1.365 0 N-CA-C 112.888 0.699 . . . . 0.0 112.888 -179.92 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.8 ttt . . . . . 0 N--CA 1.504 2.259 0 N-CA-C 111.493 0.183 . . . . 0.0 111.493 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 3.0 mptp? -121.91 160.31 25.05 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 125.683 1.593 . . . . 0.0 112.3 175.139 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 33.9 ttmt -111.03 116.92 32.0 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 106.647 -1.612 . . . . 0.0 106.647 167.146 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 16.8 t -104.41 132.05 51.91 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 C-N-CA 124.752 1.221 . . . . 0.0 113.831 -177.719 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . 0.406 ' HG3' HG13 ' A' ' 7' ' ' VAL . 48.5 tpp -100.43 123.4 44.6 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 123.882 0.873 . . . . 0.0 109.137 169.177 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 48.6 m-85 -108.18 121.07 44.09 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 124.574 1.15 . . . . 0.0 109.241 172.178 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.406 HG13 ' HG3' ' A' ' 5' ' ' MET . 5.1 m -144.14 165.64 13.51 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 C-N-CA 125.009 1.323 . . . . 0.0 112.369 -169.308 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -154.39 148.7 26.04 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 125.999 1.72 . . . . 0.0 110.301 175.165 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 39.5 ttpt -46.3 122.31 3.93 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 125.272 1.429 . . . . 0.0 111.968 175.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . 0.261 91.6 mtt180 52.67 -30.86 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 129.034 2.934 . . . . 0.0 118.896 -174.444 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 5.1 t30 61.81 -19.65 0.04 OUTLIER 'General case' 0 CA--C 1.558 1.261 0 N-CA-C 117.813 2.523 . . . . 0.0 117.813 169.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 75.7 m -50.41 121.27 5.44 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 126.525 1.93 . . . . 0.0 113.157 -177.3 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 66.5 m 51.41 41.07 27.95 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 125.006 1.323 . . . . 0.0 113.096 174.619 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 14.9 ttt180 -126.83 153.18 45.98 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 125.911 1.684 . . . . 0.0 110.023 177.171 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 33.1 m -102.94 126.87 50.28 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 124.062 0.945 . . . . 0.0 110.836 -179.455 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 3.9 mp0 -106.09 -36.16 7.01 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.793 0.837 . . . . 0.0 112.606 -172.523 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 68.78 -48.59 0.57 Allowed 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 126.823 2.049 . . . . 0.0 115.867 169.348 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -59.01 -36.23 74.58 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.59 1.156 . . . . 0.0 113.58 -171.13 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 6.3 pm0 -61.97 -41.63 98.23 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 124.739 1.216 . . . . 0.0 112.499 175.593 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -69.03 -40.23 83.94 Favored Glycine 0 C--N 1.335 0.483 0 N-CA-C 111.54 -0.624 . . . . 0.0 111.54 178.331 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -70.01 -40.41 75.27 Favored 'General case' 0 N--CA 1.468 0.434 0 O-C-N 121.947 -0.737 . . . . 0.0 111.493 177.489 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -60.19 -43.7 95.69 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 119.255 0.934 . . . . 0.0 112.941 -174.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 8.0 pttp -77.19 -26.61 53.05 Favored 'General case' 0 N--CA 1.481 1.115 0 N-CA-C 113.586 0.958 . . . . 0.0 113.586 174.253 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 94.2 m -72.47 -32.85 66.58 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.06 0.544 . . . . 0.0 111.754 174.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 72.3 mt -91.33 -34.36 14.94 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 125.847 1.659 . . . . 0.0 114.598 -179.221 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -135.41 28.04 3.05 Favored Glycine 0 N--CA 1.474 1.175 0 N-CA-C 118.789 2.275 . . . . 0.0 118.789 -168.711 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -65.05 -22.73 67.02 Favored 'General case' 0 CA--C 1.546 0.8 0 CA-C-N 122.108 2.954 . . . . 0.0 115.701 -176.315 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -72.62 -10.92 76.81 Favored Glycine 0 CA--C 1.542 1.77 0 O-C-N 121.209 -0.932 . . . . 0.0 113.868 169.639 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 54.8 mttm -109.56 -39.54 5.13 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 127.251 2.22 . . . . 0.0 112.98 -179.472 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 41.2 pt -145.49 155.43 13.32 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 C-N-CA 124.555 1.142 . . . . 0.0 113.942 -171.174 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -99.43 142.49 30.85 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 126.065 1.746 . . . . 0.0 108.916 169.295 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 97.6 t -130.4 140.11 49.66 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 O-C-N 121.439 -0.788 . . . . 0.0 111.704 -176.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 13.9 m -139.38 153.72 47.71 Favored 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 124.981 1.312 . . . . 0.0 109.698 175.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 91.4 p -128.59 155.58 44.71 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 123.803 0.841 . . . . 0.0 109.742 167.751 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 60.5 p -140.33 161.68 37.11 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 114.824 -1.08 . . . . 0.0 112.149 173.702 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -119.79 101.78 0.86 Allowed Glycine 0 C--N 1.339 0.696 0 N-CA-C 110.343 -1.103 . . . . 0.0 110.343 -169.731 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 10.6 mp -59.63 125.58 24.2 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.734 0.814 . . . . 0.0 109.512 -169.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 68.15 42.05 1.84 Allowed 'General case' 0 CA--C 1.553 1.074 0 C-N-CA 124.716 1.206 . . . . 0.0 113.02 -173.251 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 69.6 m 61.85 54.63 2.82 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 127.724 2.409 . . . . 0.0 113.776 169.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 79.2 p -114.39 164.77 13.5 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 115.587 1.699 . . . . 0.0 115.587 -171.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 22.2 tpt180 -113.38 144.85 42.08 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 126.363 1.865 . . . . 0.0 110.453 177.014 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 16.7 m -68.51 171.56 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.206 0 CA-C-O 122.002 0.906 . . . . 0.0 110.282 169.089 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 1.7 t-80 -59.37 131.02 87.73 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-O 118.431 -0.795 . . . . 0.0 112.659 179.617 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo -60.43 -27.69 85.33 Favored 'Trans proline' 0 CA--C 1.547 1.171 0 C-N-CA 121.35 1.367 . . . . 0.0 111.569 169.607 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 90.0 m -65.83 -30.83 71.51 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 125.278 1.431 . . . . 0.0 112.321 174.341 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -57.52 -39.42 76.5 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.365 1.066 . . . . 0.0 111.532 -175.163 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 2.3 mp -57.12 -60.38 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 C-N-CA 123.665 0.786 . . . . 0.0 109.311 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.19 -31.11 72.18 Favored 'General case' 0 CA--C 1.546 0.808 0 N-CA-C 113.616 0.969 . . . . 0.0 113.616 -177.04 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -81.55 -8.05 59.67 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 114.305 1.224 . . . . 0.0 114.305 177.373 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 41.3 mtt -109.88 -24.02 11.06 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 125.057 1.343 . . . . 0.0 110.211 173.606 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 24.3 mt-10 -64.98 -16.01 62.9 Favored 'General case' 0 CA--C 1.546 0.818 0 O-C-N 120.609 -1.307 . . . . 0.0 111.749 168.694 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 12.3 mt-10 -61.16 -29.33 69.73 Favored 'General case' 0 N--CA 1.482 1.173 0 CA-C-N 119.877 1.217 . . . . 0.0 110.92 169.108 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 48.1 t -92.27 -4.99 10.8 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.981 0 C-N-CA 127.437 2.295 . . . . 0.0 111.118 177.032 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 80.91 17.39 72.63 Favored Glycine 0 CA--C 1.538 1.494 0 C-N-CA 125.223 1.392 . . . . 0.0 114.566 -173.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 78.9 mt -77.64 139.92 17.87 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 C-N-CA 124.309 1.044 . . . . 0.0 111.893 -173.275 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -104.98 104.97 14.81 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.58 1.152 . . . . 0.0 111.761 175.598 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 3.5 pt -131.7 0.84 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 N-CA-C 115.696 1.739 . . . . 0.0 115.696 -178.283 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 93.6 p -70.74 -30.98 67.65 Favored 'General case' 0 N--CA 1.48 1.051 0 CA-C-N 120.012 1.278 . . . . 0.0 113.635 -177.541 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -79.74 13.16 25.26 Favored Glycine 0 CA--C 1.539 1.567 0 C-N-CA 125.743 1.64 . . . . 0.0 115.75 -179.201 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 32.0 mt-30 -80.9 167.98 19.26 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 118.886 1.343 . . . . 0.0 111.868 178.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 3.6 t -71.77 171.64 11.25 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 114.963 1.468 . . . . 0.0 114.963 -178.33 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 48.8 m -125.21 6.07 7.81 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 128.436 2.694 . . . . 0.0 111.66 169.475 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 23.7 m-20 -88.17 155.34 52.08 Favored Pre-proline 0 CA--C 1.546 0.818 0 C-N-CA 124.729 1.212 . . . . 0.0 113.746 179.22 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -78.43 158.78 29.23 Favored 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 123.49 2.793 . . . . 0.0 114.406 -177.685 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 8.5 tt -53.12 -38.98 31.62 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 C-N-CA 124.308 1.043 . . . . 0.0 112.486 174.781 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -70.16 -6.77 36.55 Favored 'General case' 0 CA--C 1.545 0.778 0 N-CA-C 114.116 1.154 . . . . 0.0 114.116 179.11 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -76.42 -15.13 60.0 Favored 'General case' 0 CA--C 1.547 0.83 0 O-C-N 121.429 -0.794 . . . . 0.0 112.569 170.691 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 61.5 m-85 -109.04 -171.61 1.88 Allowed 'General case' 0 CA--C 1.552 1.041 0 C-N-CA 126.921 2.088 . . . . 0.0 111.57 -179.175 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -125.79 126.57 44.76 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 125.337 1.455 . . . . 0.0 110.232 177.397 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.65 -35.88 82.06 Favored 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 113.641 0.978 . . . . 0.0 113.641 -170.1 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . 0.258 0.0 OUTLIER -72.67 -4.88 33.83 Favored 'General case' 0 CA--C 1.547 0.853 0 N-CA-C 113.718 1.007 . . . . 0.0 113.718 -177.559 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -74.47 -12.21 60.43 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 123.982 0.913 . . . . 0.0 111.142 168.588 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 65.7 m-85 -115.28 146.55 41.38 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 127.483 2.313 . . . . 0.0 110.989 178.345 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -105.25 -16.16 14.85 Favored 'General case' 0 N--CA 1.479 1.022 0 CA-C-O 121.97 0.891 . . . . 0.0 112.641 178.148 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.65 HG22 ' HB ' ' A' ' 95' ' ' ILE . 80.3 t -133.17 136.69 54.79 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 C-N-CA 127.306 2.242 . . . . 0.0 107.671 -179.881 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 60.0 t -132.35 126.9 56.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 N-CA-C 107.999 -1.111 . . . . 0.0 107.999 169.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 43.5 mm -114.31 118.37 58.3 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 C-N-CA 124.635 1.174 . . . . 0.0 108.815 -175.669 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 8.6 t -100.47 116.61 32.81 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 122.934 0.493 . . . . 0.0 111.462 173.672 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 49.9 mt -94.52 -13.38 26.13 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 125.724 1.61 . . . . 0.0 113.71 -172.291 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 1.5 p -156.63 147.45 21.82 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 124.075 0.95 . . . . 0.0 111.412 176.041 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 80.19 179.99 52.94 Favored Glycine 0 CA--C 1.539 1.567 0 C-N-CA 124.53 1.062 . . . . 0.0 114.528 -178.224 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 67.2 m -92.04 3.65 54.79 Favored 'General case' 0 N--CA 1.479 0.993 0 N-CA-C 114.719 1.377 . . . . 0.0 114.719 -170.01 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 79.67 23.59 62.02 Favored Glycine 0 CA--C 1.537 1.414 0 N-CA-C 115.164 0.826 . . . . 0.0 115.164 178.673 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 14.3 t -106.46 -12.0 10.09 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.374 0 C-N-CA 124.323 1.049 . . . . 0.0 112.855 -179.318 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 12.9 t-20 -81.35 6.62 13.79 Favored 'General case' 0 CA--C 1.552 1.023 0 C-N-CA 125.202 1.401 . . . . 0.0 113.397 -179.823 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -127.97 161.07 58.08 Favored Pre-proline 0 CA--C 1.552 1.032 0 C-N-CA 126.912 2.085 . . . . 0.0 112.058 178.165 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.404 ' HA ' ' HD3' ' A' ' 88' ' ' PRO . 38.4 Cg_exo -63.36 148.06 93.08 Favored 'Trans proline' 0 CA--C 1.546 1.11 0 C-N-CA 122.355 2.036 . . . . 0.0 112.773 177.344 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 87' ' ' PRO . 87.1 Cg_exo -56.83 -30.61 85.84 Favored 'Trans proline' 0 C--N 1.352 0.733 0 C-N-CA 123.051 2.5 . . . . 0.0 115.286 -174.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -59.77 -20.44 56.65 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 114.237 1.199 . . . . 0.0 114.237 178.458 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 89.1 m95 -81.88 -17.04 48.69 Favored 'General case' 0 CA--C 1.539 0.522 0 O-C-N 120.594 -1.316 . . . . 0.0 113.364 175.847 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 5.4 m -92.83 -8.38 10.16 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.105 0 CA-C-N 119.404 1.002 . . . . 0.0 113.398 170.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 72.5 p -98.24 -0.46 44.01 Favored 'General case' 0 N--CA 1.479 0.995 0 N-CA-C 114.873 1.434 . . . . 0.0 114.873 179.216 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 73.9 mm-40 -66.01 152.71 44.01 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 119.442 1.019 . . . . 0.0 111.202 169.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -55.38 -43.15 74.88 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 114.634 1.346 . . . . 0.0 114.634 -167.661 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.65 ' HB ' HG22 ' A' ' 75' ' ' VAL . 19.9 mm -114.49 61.15 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 C-N-CA 124.84 1.256 . . . . 0.0 109.003 176.832 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 41.7 t80 -77.23 108.16 10.14 Favored 'General case' 0 CA--C 1.535 0.393 0 O-C-N 120.639 -1.288 . . . . 0.0 108.22 169.119 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 9.4 mt-10 -108.23 136.86 47.18 Favored 'General case' 0 CA--C 1.545 0.758 0 N-CA-C 114.947 1.462 . . . . 0.0 114.947 177.071 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -91.54 114.1 26.54 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.916 1.287 . . . . 0.0 110.202 169.786 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 23.1 m0 -111.88 81.97 1.55 Allowed 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 125.047 1.339 . . . . 0.0 109.538 179.579 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 7.5 pt20 -75.88 55.77 0.91 Allowed 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 125.576 1.55 . . . . 0.0 112.279 176.709 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 73.4 mt -86.99 167.19 14.47 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 127.493 2.317 . . . . 0.0 112.481 -178.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -68.68 149.65 48.84 Favored 'General case' 0 CA--C 1.546 0.812 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.99 169.255 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . 0.454 ' HA ' ' HD3' ' A' ' 104' ' ' PRO . 0.8 OUTLIER -117.75 142.76 31.2 Favored Pre-proline 0 CA--C 1.553 1.085 0 C-N-CA 125.073 1.349 . . . . 0.0 112.148 175.544 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . 0.454 ' HD3' ' HA ' ' A' ' 103' ' ' ASP . 34.8 Cg_exo -75.26 -15.96 19.9 Favored 'Trans proline' 0 CA--C 1.547 1.126 0 N-CA-C 116.929 1.857 . . . . 0.0 116.929 -172.104 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -67.2 141.79 57.2 Favored 'General case' 0 N--CA 1.476 0.837 0 CA-C-N 120.313 1.415 . . . . 0.0 113.334 -170.296 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 77.33 8.59 87.04 Favored Glycine 0 CA--C 1.538 1.527 0 C-N-CA 124.635 1.112 . . . . 0.0 114.901 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 -141.58 164.64 29.68 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 125.033 1.333 . . . . 0.0 113.553 -178.127 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 66.4 m -63.49 164.07 9.96 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 116.161 1.911 . . . . 0.0 116.161 -169.129 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 25.8 tp -57.12 -31.38 65.26 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 125.686 1.594 . . . . 0.0 113.274 176.202 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -62.04 -30.52 71.03 Favored 'General case' 0 CA--C 1.541 0.628 0 O-C-N 121.002 -1.061 . . . . 0.0 111.988 172.662 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 4.2 t -75.89 -38.86 37.08 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 O-C-N 121.122 -0.986 . . . . 0.0 111.388 173.159 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 20.0 m-85 -56.85 -45.31 82.51 Favored 'General case' 0 N--CA 1.481 1.082 0 CA-C-N 120.169 1.349 . . . . 0.0 111.609 169.521 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -67.79 -37.29 81.82 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 124.179 0.991 . . . . 0.0 112.135 178.566 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 70.6 m -67.91 -42.62 80.83 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 123.793 0.837 . . . . 0.0 111.567 174.042 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 53.3 t -66.19 -41.41 89.23 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 CA-C-O 118.387 -0.816 . . . . 0.0 110.142 177.252 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 15.7 mtp180 -52.78 -46.89 67.78 Favored 'General case' 0 N--CA 1.479 1.022 0 CA-C-N 119.755 1.161 . . . . 0.0 112.507 170.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -59.69 -50.56 66.39 Favored Glycine 0 CA--C 1.54 1.6 0 CA-C-N 119.375 0.988 . . . . 0.0 113.427 176.352 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 60.3 mm-40 -65.89 -44.39 85.43 Favored 'General case' 0 N--CA 1.472 0.672 0 O-C-N 121.775 -0.838 . . . . 0.0 112.304 -179.682 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 65.6 t -64.25 -41.43 92.36 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 C-N-CA 124.782 1.233 . . . . 0.0 110.685 176.21 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 80.0 tttt -54.98 -50.06 69.89 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 120.18 1.355 . . . . 0.0 111.068 178.133 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -61.72 -40.67 95.87 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 112.205 0.446 . . . . 0.0 112.205 176.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.89 -35.91 81.96 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 124.354 1.062 . . . . 0.0 113.722 177.133 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 95.2 t -76.24 -40.92 36.64 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 C-N-CA 125.421 1.489 . . . . 0.0 111.284 176.228 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -61.47 -39.6 91.46 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 119.039 0.836 . . . . 0.0 111.39 172.373 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 13.6 m-80 -64.42 -43.57 93.95 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 118.69 0.677 . . . . 0.0 112.611 174.3 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -54.52 -56.58 17.39 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 124.256 1.023 . . . . 0.0 110.442 173.132 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 85.0 mt -61.04 -42.45 93.14 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 CA-C-O 119.166 -0.445 . . . . 0.0 110.532 -178.576 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -73.67 -10.77 60.04 Favored 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 115.073 1.508 . . . . 0.0 115.073 -179.449 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 20.7 ptmt -98.66 -27.16 14.11 Favored 'General case' 0 N--CA 1.479 0.997 0 CA-C-N 119.501 1.046 . . . . 0.0 113.388 169.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 14.3 pt -95.45 -7.6 9.75 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 N-CA-C 114.599 1.333 . . . . 0.0 114.599 176.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 27.3 p . . . . . 0 C--O 1.255 1.391 0 N-CA-C 114.774 1.398 . . . . 0.0 114.774 176.06 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.5 ttt . . . . . 0 N--CA 1.501 2.114 0 N-CA-C 111.725 0.269 . . . . 0.0 111.725 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.5 165.08 28.39 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 125.135 1.374 . . . . 0.0 112.684 175.573 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 67.9 mttt -95.75 145.02 25.64 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.996 0.918 . . . . 0.0 112.333 177.184 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 15.0 t -124.46 134.28 67.13 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 C-N-CA 125.301 1.44 . . . . 0.0 111.884 177.285 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 14.4 tpp -101.02 123.78 45.73 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.087 0.555 . . . . 0.0 109.894 169.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 48.4 m-85 -110.8 99.02 8.02 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 124.533 1.133 . . . . 0.0 110.509 175.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.603 HG11 HD12 ' A' ' 65' ' ' ILE . 1.4 m -111.7 165.21 6.94 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 C-N-CA 125.035 1.334 . . . . 0.0 112.042 -173.893 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 7.8 t -142.44 140.29 31.9 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 125.279 1.432 . . . . 0.0 111.041 179.444 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 37.5 ttmt -66.13 118.56 10.04 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.42 0.688 . . . . 0.0 110.499 175.231 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 28.6 mmt85 45.51 91.48 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 127.441 2.296 . . . . 0.0 113.14 -175.575 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 15.9 m120 -61.36 -17.46 54.04 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 115.839 1.792 . . . . 0.0 115.839 -171.692 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 70.8 m -50.48 138.65 17.04 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.489 1.116 . . . . 0.0 112.212 178.049 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 24.6 p 55.03 -10.62 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.246 0 N-CA-C 118.12 2.637 . . . . 0.0 118.12 -173.707 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 52.3 mtm-85 -93.6 157.22 16.29 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 125.985 1.714 . . . . 0.0 113.789 -174.678 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 5.5 m -113.94 -22.18 10.23 Favored 'General case' 0 N--CA 1.477 0.924 0 N-CA-C 116.457 2.021 . . . . 0.0 116.457 -169.463 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 26.0 mt-30 62.12 -64.0 0.09 Allowed 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 127.078 2.151 . . . . 0.0 116.674 -178.174 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . 0.434 ' HG2' ' SD ' ' A' ' 50' ' ' MET . 0.0 OUTLIER 74.13 -49.24 0.67 Allowed 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 127.209 2.203 . . . . 0.0 114.344 177.026 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.68 -34.57 74.54 Favored 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 114.602 1.334 . . . . 0.0 114.602 -170.337 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 20.3 pm0 -63.47 -38.18 90.16 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 124.783 1.233 . . . . 0.0 112.138 178.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -72.22 -37.67 59.37 Favored Glycine 0 C--N 1.337 0.593 0 C-N-CA 123.681 0.657 . . . . 0.0 111.794 178.834 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -73.36 -37.98 65.87 Favored 'General case' 0 N--CA 1.469 0.49 0 O-C-N 121.685 -0.891 . . . . 0.0 111.772 176.819 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -62.74 -35.86 81.15 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 113.403 0.89 . . . . 0.0 113.403 -173.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 6.2 pttp -79.48 -36.36 38.82 Favored 'General case' 0 N--CA 1.479 1.023 0 N-CA-C 113.269 0.84 . . . . 0.0 113.269 170.135 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 39.0 m -69.46 -31.06 69.13 Favored 'General case' 0 N--CA 1.484 1.253 0 O-C-N 121.8 -0.563 . . . . 0.0 111.977 -178.57 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 83.8 mt -91.74 -36.35 13.62 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 125.868 1.667 . . . . 0.0 112.889 174.529 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -104.11 3.03 44.11 Favored Glycine 0 N--CA 1.473 1.13 0 N-CA-C 117.574 1.789 . . . . 0.0 117.574 -169.529 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.49 140.76 58.03 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 121.356 2.578 . . . . 0.0 112.413 178.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 81.31 -11.48 43.89 Favored Glycine 0 CA--C 1.541 1.671 0 C-N-CA 124.783 1.182 . . . . 0.0 114.081 -169.673 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 63.5 mttp -110.01 -44.61 3.75 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 126.089 1.756 . . . . 0.0 111.69 172.771 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 44.5 pt -138.99 159.95 29.67 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 125.903 1.681 . . . . 0.0 112.408 179.497 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -106.52 148.21 28.49 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.092 1.357 . . . . 0.0 110.378 169.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 57.2 t -133.44 139.54 48.81 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 CA-C-N 119.002 0.819 . . . . 0.0 112.483 -177.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 85.9 m -133.14 150.85 52.01 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 125.696 1.598 . . . . 0.0 108.168 169.592 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 10.1 p -90.49 -73.97 0.51 Allowed 'General case' 0 N--CA 1.47 0.534 0 O-C-N 121.589 -0.695 . . . . 0.0 112.759 174.694 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 9.6 p 66.06 156.57 0.1 Allowed 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 127.925 2.49 . . . . 0.0 113.602 -169.645 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -106.61 156.33 16.2 Favored Glycine 0 N--CA 1.465 0.586 0 O-C-N 121.432 -0.793 . . . . 0.0 112.18 -175.052 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 9.7 mp -99.52 108.97 21.54 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 169.234 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 69.14 64.71 0.28 Allowed 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 126.44 1.896 . . . . 0.0 113.173 -176.661 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 67.5 m 48.51 48.39 19.47 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 126.968 2.107 . . . . 0.0 115.058 169.575 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 58.1 m -129.59 156.63 43.89 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 124.455 1.102 . . . . 0.0 113.172 -172.584 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 59.5 ttt-85 -115.78 153.55 31.23 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 128.232 2.613 . . . . 0.0 109.139 178.619 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 16.2 m -62.98 157.99 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.132 0 O-C-N 122.04 -0.412 . . . . 0.0 111.318 171.33 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . 0.477 ' CE1' ' HB ' ' A' ' 45' ' ' THR . 0.1 OUTLIER -63.74 142.91 98.08 Favored Pre-proline 0 CA--C 1.544 0.712 0 C-N-CA 119.755 -0.778 . . . . 0.0 110.318 174.871 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -60.97 -29.49 88.08 Favored 'Trans proline' 0 CA--C 1.539 0.768 0 C-N-CA 123.266 2.644 . . . . 0.0 114.758 -168.443 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.477 ' HB ' ' CE1' ' A' ' 43' ' ' HIS . 88.7 m -66.17 -22.67 66.37 Favored 'General case' 0 N--CA 1.475 0.813 0 O-C-N 121.273 -0.892 . . . . 0.0 111.924 -178.675 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -52.48 -50.28 63.02 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 118.948 0.795 . . . . 0.0 110.405 169.766 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.414 ' H ' HD12 ' A' ' 47' ' ' ILE . 4.5 mp -57.56 -48.64 82.65 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 C-N-CA 123.377 0.671 . . . . 0.0 110.728 -179.842 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -60.17 -32.42 71.04 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 113.102 0.779 . . . . 0.0 113.102 178.822 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -80.63 -30.43 36.69 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 113.87 1.063 . . . . 0.0 113.87 177.087 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . 0.434 ' SD ' ' HG2' ' A' ' 17' ' ' MET . 3.6 mmt -73.41 -32.63 64.54 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 118.789 0.722 . . . . 0.0 110.352 170.251 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -67.01 -13.25 61.73 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 124.806 1.242 . . . . 0.0 113.548 174.267 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 58.4 mt-10 -63.11 -27.57 69.47 Favored 'General case' 0 N--CA 1.48 1.073 0 CA-C-N 120.355 1.434 . . . . 0.0 110.666 168.517 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 60.8 t -95.02 -4.51 10.45 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.91 0 C-N-CA 127.041 2.136 . . . . 0.0 111.15 175.465 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 80.29 18.9 70.46 Favored Glycine 0 CA--C 1.539 1.547 0 C-N-CA 125.005 1.288 . . . . 0.0 114.272 -175.649 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 93.2 mt -77.31 132.86 31.92 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 C-N-CA 124.731 1.212 . . . . 0.0 111.28 -174.577 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 19.0 t0 -96.19 104.8 16.78 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.502 0.721 . . . . 0.0 112.627 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 14.1 pt -138.22 17.25 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.365 0 N-CA-C 114.727 1.38 . . . . 0.0 114.727 176.046 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 94.1 p -49.35 -41.73 39.81 Favored 'General case' 0 N--CA 1.484 1.259 0 N-CA-C 116.151 1.908 . . . . 0.0 116.151 -169.798 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -126.98 35.68 2.8 Favored Glycine 0 CA--C 1.534 1.248 0 C-N-CA 125.59 1.567 . . . . 0.0 113.179 -179.293 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 24.0 pt20 -64.88 -33.91 77.13 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 115.56 1.689 . . . . 0.0 115.56 -169.738 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 28.2 p -92.83 106.23 18.23 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 121.559 0.695 . . . . 0.0 111.68 179.633 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 67.4 m -104.57 -28.93 10.98 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 124.521 1.128 . . . . 0.0 113.311 176.469 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -147.75 158.2 43.06 Favored Pre-proline 0 CA--C 1.544 0.737 0 C-N-CA 124.514 1.125 . . . . 0.0 111.997 -176.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -64.49 156.41 60.75 Favored 'Trans proline' 0 CA--C 1.537 0.671 0 C-N-CA 122.42 2.08 . . . . 0.0 112.414 169.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.603 HD12 HG11 ' A' ' 7' ' ' VAL . 12.2 tt -50.12 -36.03 12.11 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.181 0 C-N-CA 124.016 0.926 . . . . 0.0 112.098 171.54 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 19.3 mt-10 -63.91 -18.08 63.86 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.153 0.981 . . . . 0.0 113.225 -176.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -85.1 -14.92 45.63 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 124.553 1.141 . . . . 0.0 113.785 -177.059 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -97.06 176.03 6.1 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 126.016 1.727 . . . . 0.0 112.304 -177.081 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 23.6 t30 -99.81 126.95 45.99 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 169.77 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.84 -46.52 74.82 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 112.433 0.531 . . . . 0.0 112.433 -175.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -72.57 -1.0 14.38 Favored 'General case' 0 CA--C 1.546 0.823 0 N-CA-C 114.796 1.406 . . . . 0.0 114.796 -173.169 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -70.24 -17.68 63.13 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 123.668 0.787 . . . . 0.0 110.245 168.255 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 58.6 m-85 -105.53 158.32 16.76 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 128.355 2.662 . . . . 0.0 111.14 174.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -116.94 -12.94 10.66 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 124.781 1.232 . . . . 0.0 112.874 179.465 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.631 HG22 ' HB ' ' A' ' 95' ' ' ILE . 87.3 t -142.54 136.49 27.82 Favored 'Isoleucine or valine' 0 C--O 1.236 0.384 0 C-N-CA 127.86 2.464 . . . . 0.0 107.699 -174.291 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 59.0 t -131.75 133.46 61.31 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 N-CA-C 108.431 -0.952 . . . . 0.0 108.431 169.799 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 43.6 mm -116.41 111.16 34.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 C-N-CA 124.832 1.253 . . . . 0.0 107.916 -177.069 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 4.3 m -95.61 101.36 13.06 Favored 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 123.521 0.728 . . . . 0.0 110.097 176.81 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 34.1 mt -79.15 176.73 9.4 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 126.495 1.918 . . . . 0.0 110.955 173.445 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 14.8 m 63.2 57.0 1.64 Allowed 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 124.408 1.083 . . . . 0.0 113.422 169.787 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 83.06 -137.14 16.07 Favored Glycine 0 CA--C 1.534 1.268 0 C-N-CA 123.863 0.744 . . . . 0.0 111.706 -171.437 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 98.9 p -83.82 163.29 20.22 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 113.26 0.837 . . . . 0.0 113.26 176.561 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -69.03 -88.85 0.08 OUTLIER Glycine 0 CA--C 1.528 0.892 0 N-CA-C 110.658 -0.977 . . . . 0.0 110.658 169.409 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 98.7 t 63.13 -48.17 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.239 0 C-N-CA 128.054 2.542 . . . . 0.0 116.571 170.139 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 29.3 t-20 -74.98 -30.84 61.3 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 124.883 1.273 . . . . 0.0 113.031 -179.545 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.4 ' HA ' ' HD3' ' A' ' 87' ' ' PRO . 2.5 pt? -68.25 146.77 98.15 Favored Pre-proline 0 CA--C 1.555 1.145 0 CA-C-O 118.709 -0.662 . . . . 0.0 112.373 174.412 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 86' ' ' LEU . 64.3 Cg_exo -62.05 156.87 47.16 Favored 'Trans proline' 0 CA--C 1.549 1.243 0 C-N-CA 122.775 2.317 . . . . 0.0 115.234 -176.773 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 80.6 Cg_exo -54.3 -36.44 86.7 Favored 'Trans proline' 0 C--N 1.355 0.869 0 C-N-CA 123.984 3.123 . . . . 0.0 115.119 -174.798 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -61.47 -15.86 41.66 Favored 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 115.052 1.501 . . . . 0.0 115.052 178.725 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 82.6 m95 -91.43 -34.51 14.81 Favored 'General case' 0 CA--C 1.539 0.552 0 O-C-N 121.029 -1.044 . . . . 0.0 112.314 172.702 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 6.7 m -84.73 -16.32 10.53 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.186 0 N-CA-C 113.588 0.958 . . . . 0.0 113.588 177.821 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 1.3 t -78.59 -5.8 53.81 Favored 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 114.627 1.343 . . . . 0.0 114.627 177.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 58.4 mt-30 -71.24 166.23 21.98 Favored 'General case' 0 N--CA 1.478 0.934 0 O-C-N 121.05 -1.031 . . . . 0.0 112.95 -172.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -60.0 -43.52 95.14 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 113.761 1.022 . . . . 0.0 113.761 -168.661 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.631 ' HB ' HG22 ' A' ' 75' ' ' VAL . 10.8 mm -121.23 62.0 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 C-N-CA 124.65 1.18 . . . . 0.0 109.186 176.052 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 17.2 t80 -75.02 113.16 12.02 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 107.394 -1.336 . . . . 0.0 107.394 168.727 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 14.0 mt-10 -108.19 126.72 53.12 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-O 122.26 1.029 . . . . 0.0 113.246 174.224 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -91.4 89.21 7.15 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 125.146 1.378 . . . . 0.0 109.197 176.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 20.4 m0 -81.8 90.97 6.43 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 124.621 1.168 . . . . 0.0 111.405 -173.021 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 70.2 mm-40 -71.55 41.64 0.07 Allowed 'General case' 0 CA--C 1.553 1.062 0 C-N-CA 127.212 2.205 . . . . 0.0 112.345 173.379 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 40.3 mt -84.06 161.94 20.52 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 125.917 1.687 . . . . 0.0 112.156 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -70.94 150.02 46.12 Favored 'General case' 0 CA--C 1.545 0.769 0 CA-C-N 114.757 -1.111 . . . . 0.0 112.222 169.729 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -116.28 142.63 29.67 Favored Pre-proline 0 CA--C 1.552 1.043 0 C-N-CA 124.66 1.184 . . . . 0.0 110.061 169.303 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -63.23 -4.83 7.01 Favored 'Trans proline' 0 CA--C 1.55 1.29 0 C-N-CA 123.107 2.538 . . . . 0.0 116.148 178.701 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -54.18 131.11 40.66 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 115.234 1.568 . . . . 0.0 115.234 -174.814 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 69.52 10.09 62.8 Favored Glycine 0 CA--C 1.538 1.496 0 N-CA-C 115.923 1.129 . . . . 0.0 115.923 175.379 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 16.1 pt20 -134.87 171.24 14.68 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 125.141 1.377 . . . . 0.0 113.909 -175.876 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 42.7 p -67.26 166.04 15.03 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 116.663 2.097 . . . . 0.0 116.663 -168.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 40.5 tp -57.66 -32.16 67.03 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 124.476 1.11 . . . . 0.0 112.375 172.431 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -62.71 -36.47 83.06 Favored 'General case' 0 CA--C 1.54 0.586 0 O-C-N 121.192 -0.942 . . . . 0.0 111.366 175.531 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 6.2 t -69.29 -40.26 80.01 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 O-C-N 121.482 -0.761 . . . . 0.0 111.477 172.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -53.8 -47.88 70.38 Favored 'General case' 0 N--CA 1.477 0.911 0 CA-C-N 119.298 0.954 . . . . 0.0 112.29 170.089 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 28.6 mmt85 -63.79 -44.41 93.44 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 124.221 1.008 . . . . 0.0 111.884 178.738 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 19.2 m -62.7 -40.99 98.89 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.776 0.831 . . . . 0.0 111.607 174.087 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 52.9 t -66.4 -42.35 90.32 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 CA-C-O 117.546 -1.216 . . . . 0.0 110.712 177.347 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 20.3 mtm105 -54.83 -44.18 73.67 Favored 'General case' 0 N--CA 1.483 1.224 0 CA-C-N 120.539 1.518 . . . . 0.0 111.708 171.647 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -60.4 -51.55 58.11 Favored Glycine 0 CA--C 1.538 1.499 0 CA-C-N 119.115 0.871 . . . . 0.0 113.797 176.411 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 60.2 mm-40 -65.48 -43.63 89.66 Favored 'General case' 0 N--CA 1.476 0.83 0 O-C-N 121.913 -0.757 . . . . 0.0 112.207 -179.426 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 69.3 t -66.58 -40.09 85.47 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 C-N-CA 124.737 1.215 . . . . 0.0 110.883 177.21 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -56.22 -49.48 73.97 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-N 120.163 1.347 . . . . 0.0 110.965 177.241 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -61.48 -41.99 98.11 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 122.92 0.488 . . . . 0.0 112.231 178.037 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -61.45 -42.98 99.6 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 124.824 1.25 . . . . 0.0 113.204 174.619 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 94.8 t -71.84 -39.46 67.81 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 C-N-CA 124.466 1.107 . . . . 0.0 111.663 177.72 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -62.54 -39.04 92.33 Favored 'General case' 0 N--CA 1.469 0.514 0 O-C-N 121.274 -0.891 . . . . 0.0 111.384 172.443 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 12.6 m-80 -63.78 -45.84 87.89 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 118.703 0.683 . . . . 0.0 112.487 173.155 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 9.8 tt -52.19 -54.39 31.5 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.935 1.294 . . . . 0.0 110.775 173.412 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 68.3 mt -63.87 -42.95 97.52 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 O-C-N 121.749 -0.594 . . . . 0.0 110.518 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -67.53 -10.97 56.66 Favored 'General case' 0 CA--C 1.548 0.866 0 N-CA-C 114.921 1.452 . . . . 0.0 114.921 177.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 20.2 ptmt -107.31 -30.93 8.43 Favored 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 113.942 1.089 . . . . 0.0 113.942 174.373 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . 0.263 7.1 pt -95.63 -11.57 8.73 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 N-CA-C 114.576 1.324 . . . . 0.0 114.576 -178.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 65.4 m . . . . . 0 C--O 1.253 1.246 0 C-N-CA 124.805 1.242 . . . . 0.0 112.78 177.846 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.421 ' HA ' ' O ' ' A' ' 29' ' ' LYS . 25.1 ttt . . . . . 0 N--CA 1.504 2.249 0 N-CA-C 112.133 0.42 . . . . 0.0 112.133 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 2.9 mptp? -126.12 158.0 36.61 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 125.729 1.612 . . . . 0.0 113.264 179.301 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 73.8 mttt -105.35 115.2 29.85 Favored 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 125.929 1.692 . . . . 0.0 106.629 167.39 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 10.7 t -105.81 130.89 56.56 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 C-N-CA 125.079 1.351 . . . . 0.0 113.9 178.62 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . 0.472 ' HG3' HG13 ' A' ' 7' ' ' VAL . 48.8 tpp -102.02 125.66 48.76 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 168.677 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 49.8 m-85 -108.62 119.29 39.1 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 124.362 1.065 . . . . 0.0 109.82 171.486 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.472 HG13 ' HG3' ' A' ' 5' ' ' MET . 3.4 m -140.3 149.74 21.62 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 C-N-CA 124.675 1.19 . . . . 0.0 111.788 -169.386 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 14.9 t -137.15 148.53 46.68 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 125.821 1.648 . . . . 0.0 111.283 -178.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 47.0 pttt -59.51 123.22 16.14 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 123.88 0.872 . . . . 0.0 111.922 177.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 74.5 mtp85 58.27 -33.9 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.784 0 C-N-CA 129.411 3.084 . . . . 0.0 116.718 -169.319 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 17.9 t-20 59.35 -48.82 0.07 Allowed 'General case' 0 CA--C 1.553 1.065 0 C-N-CA 129.382 3.073 . . . . 0.0 117.116 174.61 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 26.2 m -68.76 -8.6 44.64 Favored 'General case' 0 N--CA 1.482 1.167 0 CA-C-N 120.89 1.677 . . . . 0.0 114.023 -176.348 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 84.1 p -100.22 2.54 42.92 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 126.531 1.932 . . . . 0.0 114.506 170.028 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 83.7 mtt85 -140.86 173.83 11.1 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 126.682 1.993 . . . . 0.0 112.928 -169.645 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 35.1 t -114.92 174.9 5.74 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 125.176 1.391 . . . . 0.0 110.252 169.245 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 29.3 mt-30 -141.94 -49.28 0.38 Allowed 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 113.956 1.095 . . . . 0.0 113.956 -170.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . 0.434 ' HG2' ' SD ' ' A' ' 50' ' ' MET . 0.0 OUTLIER 71.67 -46.37 0.64 Allowed 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 126.231 1.812 . . . . 0.0 114.236 173.683 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.19 -32.53 73.18 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 114.258 1.207 . . . . 0.0 114.258 -169.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 7.3 pm0 -63.77 -38.39 90.92 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 123.289 0.635 . . . . 0.0 111.919 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -70.24 -42.84 65.24 Favored Glycine 0 C--N 1.335 0.492 0 C-N-CA 123.715 0.674 . . . . 0.0 111.726 -178.765 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -71.76 -36.25 70.33 Favored 'General case' 0 N--CA 1.468 0.46 0 O-C-N 121.662 -0.905 . . . . 0.0 112.13 177.151 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.89 -35.66 78.99 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 118.609 0.641 . . . . 0.0 112.467 -175.182 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 5.6 pttp -84.9 -35.39 22.18 Favored 'General case' 0 N--CA 1.481 1.093 0 N-CA-C 113.86 1.059 . . . . 0.0 113.86 170.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 75.8 m -67.86 -31.61 71.54 Favored 'General case' 0 N--CA 1.486 1.346 0 CA-C-N 118.828 0.74 . . . . 0.0 112.141 -179.266 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 72.4 mt -96.47 -37.26 10.5 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.801 1.64 . . . . 0.0 112.69 175.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -98.48 4.3 59.93 Favored Glycine 0 N--CA 1.471 1.024 0 N-CA-C 116.572 1.389 . . . . 0.0 116.572 -169.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.18 143.14 56.09 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-N 120.97 2.385 . . . . 0.0 112.524 177.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 83.53 -20.07 12.6 Favored Glycine 0 CA--C 1.542 1.732 0 C-N-CA 124.868 1.223 . . . . 0.0 113.251 -169.322 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.421 ' O ' ' HA ' ' A' ' 1' ' ' MET . 78.4 mttt -101.25 -44.52 5.64 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 125.889 1.676 . . . . 0.0 112.253 169.868 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 38.5 pt -139.33 158.12 28.2 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 C-N-CA 124.162 0.985 . . . . 0.0 113.627 -175.507 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -106.81 145.51 32.02 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 127.252 2.221 . . . . 0.0 109.7 169.846 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 72.7 t -134.3 141.96 42.19 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 CA-C-N 118.69 0.677 . . . . 0.0 112.759 -175.349 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 38.9 m -134.72 153.01 52.19 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 125.513 1.525 . . . . 0.0 109.075 169.589 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 55.4 p -130.03 146.83 51.72 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.845 0.831 . . . . 0.0 111.288 168.176 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 53.7 p -147.89 -173.63 4.35 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 114.704 -1.135 . . . . 0.0 111.708 175.833 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -135.96 170.11 23.31 Favored Glycine 0 N--CA 1.468 0.782 0 O-C-N 120.909 -1.119 . . . . 0.0 112.038 177.419 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 10.8 mp -91.68 -9.01 45.44 Favored 'General case' 0 N--CA 1.479 1.021 0 N-CA-C 114.967 1.469 . . . . 0.0 114.967 -169.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -142.13 63.9 1.4 Allowed 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 124.71 1.204 . . . . 0.0 110.934 -176.746 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.451 ' H ' ' HB3' ' A' ' 64' ' ' PRO . 72.7 m 49.53 45.8 23.88 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 126.194 1.798 . . . . 0.0 112.392 -175.456 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 16.6 p -123.26 165.88 16.2 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 126.078 1.751 . . . . 0.0 115.65 -168.812 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 29.3 ptt-85 -138.0 -171.62 3.06 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 127.695 2.398 . . . . 0.0 107.631 171.465 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 26.9 m -60.44 151.72 5.79 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.189 0 CA-C-N 120.369 1.44 . . . . 0.0 110.941 169.418 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -62.99 143.29 97.54 Favored Pre-proline 0 CA--C 1.55 0.975 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 168.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_exo -48.53 -37.11 33.15 Favored 'Trans proline' 0 CA--C 1.542 0.876 0 C-N-CA 123.421 2.748 . . . . 0.0 117.717 -168.195 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 93.9 m -63.23 -24.62 67.96 Favored 'General case' 0 N--CA 1.485 1.304 0 CA-C-N 119.721 1.146 . . . . 0.0 112.777 -174.695 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -51.97 -43.76 63.71 Favored 'General case' 0 CA--C 1.546 0.802 0 CA-C-O 118.352 -0.832 . . . . 0.0 111.034 170.697 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.6 mp -55.79 -54.05 30.71 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.297 0 CA-C-N 120.239 1.382 . . . . 0.0 110.1 178.159 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -62.27 -30.65 71.27 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 123.447 0.699 . . . . 0.0 112.736 -178.18 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . 0.41 ' HG2' ' CD1' ' A' ' 112' ' ' PHE . 0.0 OUTLIER -76.91 -33.5 57.76 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 113.119 0.785 . . . . 0.0 113.119 176.813 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . 0.434 ' SD ' ' HG2' ' A' ' 17' ' ' MET . 3.5 mmt -74.2 -32.5 63.07 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 118.877 0.762 . . . . 0.0 110.735 172.697 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -65.47 -14.05 60.14 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 124.534 1.134 . . . . 0.0 113.787 173.197 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 60.3 mt-10 -62.1 -27.18 68.74 Favored 'General case' 0 N--CA 1.482 1.161 0 CA-C-N 120.66 1.573 . . . . 0.0 110.896 168.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 56.5 t -96.5 -3.63 10.2 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.874 0 C-N-CA 127.54 2.336 . . . . 0.0 111.275 176.118 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 78.93 19.13 73.49 Favored Glycine 0 CA--C 1.541 1.677 0 C-N-CA 125.029 1.299 . . . . 0.0 114.374 -175.784 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 85.7 mt -77.88 135.3 26.53 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 C-N-CA 124.709 1.204 . . . . 0.0 111.638 -174.722 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 17.9 t0 -96.05 102.19 13.96 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 112.667 0.617 . . . . 0.0 112.667 178.133 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 8.6 pt -129.58 14.92 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.273 0 C-N-CA 125.214 1.406 . . . . 0.0 113.396 170.514 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 72.7 m -59.48 126.7 28.7 Favored 'General case' 0 N--CA 1.473 0.715 0 O-C-N 120.711 -1.243 . . . . 0.0 112.295 -172.592 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 80.15 -22.62 4.29 Favored Glycine 0 CA--C 1.538 1.48 0 C-N-CA 125.278 1.418 . . . . 0.0 115.938 179.653 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 70.8 mt-30 41.0 -96.12 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 127.482 2.313 . . . . 0.0 113.428 -175.535 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 9.1 t -145.63 163.95 33.24 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 126.655 1.982 . . . . 0.0 109.914 169.719 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 75.5 m -100.55 -2.52 32.75 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 125.904 1.682 . . . . 0.0 113.148 172.216 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 29.2 m-20 -111.05 146.79 35.22 Favored Pre-proline 0 CA--C 1.544 0.742 0 C-N-CA 124.053 0.941 . . . . 0.0 113.38 -174.523 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.451 ' HB3' ' H ' ' A' ' 39' ' ' SER . 57.6 Cg_endo -71.52 162.07 43.41 Favored 'Trans proline' 0 C--N 1.349 0.58 0 C-N-CA 122.541 2.16 . . . . 0.0 113.163 176.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 5.5 tt -48.74 -43.97 14.4 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 C-N-CA 124.465 1.106 . . . . 0.0 111.36 171.322 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -69.12 -5.64 23.53 Favored 'General case' 0 CA--C 1.546 0.813 0 N-CA-C 114.466 1.284 . . . . 0.0 114.466 -177.591 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 5.4 t-20 -84.27 -21.59 31.03 Favored 'General case' 0 CA--C 1.547 0.839 0 N-CA-C 113.312 0.856 . . . . 0.0 113.312 172.791 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 83.5 m-85 -91.3 -171.58 3.0 Favored 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 125.431 1.492 . . . . 0.0 111.838 -179.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 14.9 t30 -117.53 120.44 38.1 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.52 1.128 . . . . 0.0 109.351 175.804 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -64.97 -44.64 88.7 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 115.108 1.521 . . . . 0.0 115.108 -169.122 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -79.77 6.22 11.48 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 113.591 0.96 . . . . 0.0 113.591 -172.458 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -73.57 -26.66 60.93 Favored 'General case' 0 CA--C 1.545 0.783 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 167.617 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 76.4 m-85 -86.44 157.84 19.73 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 127.101 2.161 . . . . 0.0 110.244 169.635 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -116.07 -15.79 11.1 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 124.237 1.015 . . . . 0.0 112.355 174.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.632 HG22 ' HB ' ' A' ' 95' ' ' ILE . 91.6 t -129.33 135.27 62.13 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 C-N-CA 126.93 2.092 . . . . 0.0 107.648 174.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 66.7 t -131.8 123.42 51.65 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 169.471 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 45.7 mm -108.59 106.79 21.35 Favored 'Isoleucine or valine' 0 C--O 1.235 0.298 0 C-N-CA 124.645 1.178 . . . . 0.0 108.76 -175.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 4.1 m -85.42 92.26 8.44 Favored 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 123.983 0.913 . . . . 0.0 110.061 171.596 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 81.4 mt -67.34 172.52 4.77 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 126.259 1.823 . . . . 0.0 111.794 172.801 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 17.3 m 65.88 7.94 4.97 Favored 'General case' 0 CA--C 1.549 0.906 0 N-CA-C 114.868 1.433 . . . . 0.0 114.868 175.03 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 69.37 132.02 0.06 OUTLIER Glycine 0 CA--C 1.535 1.286 0 C-N-CA 126.793 2.14 . . . . 0.0 115.157 -179.801 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 38.2 m 60.18 43.48 13.98 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 125.84 1.656 . . . . 0.0 112.311 174.277 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -75.7 65.14 2.53 Favored Glycine 0 N--CA 1.472 1.058 0 C-N-CA 124.951 1.263 . . . . 0.0 111.281 174.44 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.9 p -112.81 -2.32 10.3 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 C-N-CA 125.263 1.425 . . . . 0.0 113.622 -169.647 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 62.0 t30 -77.26 -11.14 59.79 Favored 'General case' 0 CA--C 1.552 1.03 0 O-C-N 121.221 -0.924 . . . . 0.0 113.289 176.284 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -66.23 158.61 76.45 Favored Pre-proline 0 CA--C 1.556 1.19 0 C-N-CA 124.335 1.054 . . . . 0.0 112.494 170.282 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -60.1 151.27 73.91 Favored 'Trans proline' 0 CA--C 1.543 0.933 0 C-N-CA 122.776 2.317 . . . . 0.0 113.337 179.645 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -61.33 -26.54 81.8 Favored 'Trans proline' 0 C--N 1.35 0.656 0 C-N-CA 123.364 2.709 . . . . 0.0 113.863 -174.146 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -59.82 -22.2 61.9 Favored 'General case' 0 CA--C 1.541 0.596 0 CA-C-O 117.966 -1.016 . . . . 0.0 113.534 174.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 93.5 m95 -87.64 -12.97 43.97 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 125.025 1.33 . . . . 0.0 113.806 177.789 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 4.7 m -96.47 -7.75 9.48 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 CA-C-N 119.072 0.851 . . . . 0.0 112.946 171.736 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . 0.269 0.7 OUTLIER -96.47 -4.57 41.34 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 114.818 1.414 . . . . 0.0 114.818 -175.548 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 11.8 mp0 -61.05 156.89 16.86 Favored 'General case' 0 N--CA 1.487 1.384 0 CA-C-O 122.531 1.158 . . . . 0.0 111.183 168.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -61.83 -39.54 92.15 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 114.354 -1.294 . . . . 0.0 113.4 -168.831 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.632 ' HB ' HG22 ' A' ' 75' ' ' VAL . 16.6 mm -115.63 59.07 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 C-N-CA 125.321 1.448 . . . . 0.0 109.071 176.439 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 35.4 t80 -76.22 109.73 10.14 Favored 'General case' 0 CA--C 1.535 0.376 0 O-C-N 120.51 -1.369 . . . . 0.0 107.945 169.054 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 9.6 mt-10 -111.39 128.66 56.05 Favored 'General case' 0 N--CA 1.471 0.625 0 N-CA-C 113.214 0.82 . . . . 0.0 113.214 174.298 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -93.84 112.51 24.37 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 168.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 38.7 m0 -94.04 104.2 16.25 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 124.375 1.07 . . . . 0.0 108.983 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 73.7 mm-40 -74.73 54.82 0.64 Allowed 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 126.797 2.039 . . . . 0.0 110.342 173.32 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.1 tt -104.81 146.22 29.28 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 127.099 2.159 . . . . 0.0 110.624 -169.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -56.5 144.15 32.49 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 125.06 1.344 . . . . 0.0 113.848 174.289 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -97.34 119.77 62.31 Favored Pre-proline 0 CA--C 1.546 0.825 0 C-N-CA 124.661 1.184 . . . . 0.0 108.015 168.823 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -76.4 -11.22 19.03 Favored 'Trans proline' 0 CA--C 1.542 0.906 0 C-N-CA 122.067 1.845 . . . . 0.0 114.132 -173.671 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -74.72 155.87 37.23 Favored 'General case' 0 CA--C 1.546 0.795 0 CA-C-N 119.684 1.129 . . . . 0.0 113.689 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 76.47 8.41 85.83 Favored Glycine 0 CA--C 1.536 1.394 0 C-N-CA 124.712 1.149 . . . . 0.0 114.434 -177.667 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 15.0 pt20 -143.31 170.52 15.61 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 126.824 2.049 . . . . 0.0 111.196 179.239 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 15.9 m -56.77 154.32 9.34 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 125.031 1.332 . . . . 0.0 114.56 -169.568 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 60.2 tp -58.34 -30.05 66.42 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.902 0.881 . . . . 0.0 112.493 176.338 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -59.35 -31.93 69.64 Favored 'General case' 0 N--CA 1.475 0.793 0 O-C-N 121.351 -0.843 . . . . 0.0 113.268 170.559 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 14.0 t -74.12 -41.53 51.91 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 O-C-N 121.008 -1.058 . . . . 0.0 110.306 173.624 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.41 ' CD1' ' HG2' ' A' ' 49' ' ' MET . 0.3 OUTLIER -54.38 -47.26 72.87 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 119.097 0.862 . . . . 0.0 112.611 169.76 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -70.9 -34.21 71.33 Favored 'General case' 0 N--CA 1.477 0.902 0 O-C-N 121.395 -0.816 . . . . 0.0 112.726 179.191 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 53.3 m -64.98 -41.25 95.6 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.834 0.854 . . . . 0.0 111.13 170.686 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 54.7 t -68.34 -35.73 72.11 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 CA-C-O 117.371 -1.299 . . . . 0.0 111.029 175.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 28.6 mtm105 -56.23 -43.02 78.2 Favored 'General case' 0 N--CA 1.485 1.292 0 CA-C-N 121.275 1.852 . . . . 0.0 111.355 169.611 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -61.18 -49.98 72.12 Favored Glycine 0 CA--C 1.54 1.629 0 CA-C-N 119.132 0.878 . . . . 0.0 113.594 175.197 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 64.0 mm-40 -62.74 -46.73 86.7 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.537 0.735 . . . . 0.0 112.136 177.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 91.3 t -69.89 -34.71 61.4 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 C-N-CA 124.324 1.049 . . . . 0.0 111.262 -179.5 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 63.7 tttm -55.96 -51.85 66.23 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 120.44 1.473 . . . . 0.0 110.908 172.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -63.92 -42.07 97.48 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 123.303 0.641 . . . . 0.0 112.522 177.418 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -66.88 -34.8 78.58 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 125.446 1.498 . . . . 0.0 112.306 179.407 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 76.9 t -76.57 -40.89 34.18 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.089 0 C-N-CA 125.098 1.359 . . . . 0.0 111.511 173.716 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -62.6 -34.12 76.38 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 119.425 1.011 . . . . 0.0 111.604 173.156 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 9.6 m-80 -65.72 -44.4 86.17 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 119.056 0.844 . . . . 0.0 113.035 172.031 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -53.49 -55.48 25.0 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 123.884 0.874 . . . . 0.0 110.304 172.482 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 75.5 mt -61.39 -43.17 96.22 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 CA-C-O 119.164 -0.446 . . . . 0.0 110.666 -179.819 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -68.9 -13.58 62.51 Favored 'General case' 0 CA--C 1.544 0.744 0 N-CA-C 115.116 1.524 . . . . 0.0 115.116 179.704 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 21.4 ptmt -98.61 -28.17 13.68 Favored 'General case' 0 N--CA 1.477 0.887 0 CA-C-N 119.382 0.992 . . . . 0.0 113.541 172.767 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 18.5 pt -93.98 -22.57 5.55 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 N-CA-C 114.486 1.291 . . . . 0.0 114.486 177.581 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 75.6 m . . . . . 0 C--O 1.252 1.227 0 C-N-CA 125.418 1.487 . . . . 0.0 111.552 -173.77 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.3 ttt . . . . . 0 N--CA 1.504 2.234 0 N-CA-C 111.556 0.206 . . . . 0.0 111.556 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.14 166.0 25.9 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 125.018 1.327 . . . . 0.0 112.971 176.071 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 70.0 mttt -94.81 146.07 24.44 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 123.82 0.848 . . . . 0.0 112.629 174.466 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 16.7 t -124.28 138.13 54.85 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 125.645 1.578 . . . . 0.0 111.083 172.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -109.74 121.2 44.68 Favored 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 110.19 -0.3 . . . . 0.0 110.19 169.136 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 45.2 m-85 -96.52 125.19 40.83 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 170.608 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 28.8 m -140.49 151.57 21.0 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 N-CA-C 113.786 1.032 . . . . 0.0 113.786 -168.766 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 33.5 t -152.95 142.55 21.86 Favored 'General case' 0 CA--C 1.548 0.904 0 C-N-CA 124.711 1.204 . . . . 0.0 113.606 -172.717 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -80.79 140.52 35.44 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 124.779 1.232 . . . . 0.0 109.324 168.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 31.2 mtm180 52.54 47.34 24.91 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 125.48 1.512 . . . . 0.0 112.522 -169.12 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 23.4 t30 -57.32 -27.63 62.36 Favored 'General case' 0 CA--C 1.551 0.996 0 C-N-CA 125.581 1.552 . . . . 0.0 113.282 -179.786 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 72.8 m -73.32 -30.75 63.58 Favored 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 113.419 0.896 . . . . 0.0 113.419 172.041 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 48.8 m -80.66 -40.04 26.23 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 123.876 0.87 . . . . 0.0 112.082 179.458 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 11.7 mmt180 -101.88 163.34 12.3 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 124.645 1.178 . . . . 0.0 113.458 -173.844 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 3.7 m -106.92 134.96 49.3 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.148 0.979 . . . . 0.0 111.041 174.13 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 3.9 mp0 -105.11 -38.14 6.67 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 115.018 1.488 . . . . 0.0 115.018 -168.27 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . 0.438 ' HG2' ' SD ' ' A' ' 50' ' ' MET . 0.0 OUTLIER 67.16 -55.55 0.45 Allowed 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 126.71 2.004 . . . . 0.0 115.66 170.372 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -57.82 -37.04 73.09 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.923 1.289 . . . . 0.0 114.205 -169.577 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 7.5 pm0 -58.76 -31.97 68.84 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 125.391 1.476 . . . . 0.0 113.709 179.523 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -66.83 -68.06 1.79 Allowed Glycine 0 C--N 1.337 0.622 0 N-CA-C 110.588 -1.005 . . . . 0.0 110.588 174.506 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -50.65 -34.12 25.15 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 124.135 0.974 . . . . 0.0 113.449 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.47 ' HB1' HG21 ' A' ' 32' ' ' VAL . . . -60.24 -32.58 71.27 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 -177.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . 0.273 0.0 OUTLIER -98.84 -24.91 14.81 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 114.081 1.141 . . . . 0.0 114.081 169.947 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 1.3 m -64.51 -36.54 84.52 Favored 'General case' 0 N--CA 1.488 1.436 0 CA-C-N 120.33 1.423 . . . . 0.0 111.974 173.796 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 68.6 mt -98.96 -28.26 13.51 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 125.454 1.502 . . . . 0.0 113.206 178.778 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -111.93 2.77 27.2 Favored Glycine 0 N--CA 1.474 1.204 0 N-CA-C 118.112 2.005 . . . . 0.0 118.112 -169.389 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -66.34 -20.37 66.07 Favored 'General case' 0 N--CA 1.477 0.878 0 CA-C-N 122.548 3.174 . . . . 0.0 116.648 -169.684 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -75.69 -6.68 82.1 Favored Glycine 0 CA--C 1.542 1.748 0 O-C-N 121.339 -0.85 . . . . 0.0 113.881 169.627 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 61.1 mttp -119.87 -40.06 2.78 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 127.162 2.185 . . . . 0.0 113.101 -174.375 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 43.6 pt -144.27 157.22 15.31 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 C-N-CA 125.911 1.684 . . . . 0.0 112.686 -171.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -101.02 139.78 36.23 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.415 1.086 . . . . 0.0 109.39 169.486 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.47 HG21 ' HB1' ' A' ' 22' ' ' ALA . 30.2 t -130.79 136.46 58.14 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.076 0 CA-C-N 119.831 1.196 . . . . 0.0 113.179 177.632 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 37.1 m -131.02 154.91 47.7 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 125.969 1.708 . . . . 0.0 109.73 175.034 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 3.2 m -124.64 147.86 48.28 Favored 'General case' 0 CA--C 1.513 -0.458 0 CA-C-O 121.617 0.722 . . . . 0.0 112.42 168.358 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 2.2 m -142.74 149.74 39.15 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 113.688 -1.596 . . . . 0.0 111.167 172.636 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -79.82 165.21 49.23 Favored Glycine 0 CA--C 1.528 0.852 0 N-CA-C 110.888 -0.885 . . . . 0.0 110.888 169.484 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 9.1 mp -80.17 -11.51 59.74 Favored 'General case' 0 N--CA 1.48 1.036 0 O-C-N 121.653 -0.91 . . . . 0.0 112.809 169.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -132.03 165.5 23.84 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 126.973 2.109 . . . . 0.0 108.811 169.662 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 68.4 m -57.78 114.31 2.24 Favored 'General case' 0 N--CA 1.479 1.012 0 O-C-N 121.232 -0.917 . . . . 0.0 110.574 178.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 88.9 p -158.24 178.17 10.47 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 114.748 1.388 . . . . 0.0 114.748 -168.717 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 13.2 tpt180 -132.35 147.32 52.39 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 128.178 2.591 . . . . 0.0 108.631 174.296 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 33.0 m -62.28 154.91 5.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 CA-C-N 120.668 1.576 . . . . 0.0 109.425 168.394 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 11.9 t-80 -53.53 135.09 53.51 Favored Pre-proline 0 C--N 1.327 -0.389 0 CA-C-N 114.87 -1.059 . . . . 0.0 112.564 -170.13 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_exo -60.75 -26.11 82.37 Favored 'Trans proline' 0 CA--C 1.548 1.175 0 CA-C-N 121.01 1.397 . . . . 0.0 112.677 175.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 51.1 m -70.02 -33.94 72.65 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 125.296 1.438 . . . . 0.0 112.058 171.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -57.99 -43.2 86.44 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 124.018 0.927 . . . . 0.0 111.636 -178.474 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.7 mp -52.85 -54.15 17.82 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 CA-C-N 119.182 0.901 . . . . 0.0 109.425 -178.652 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -65.76 -32.28 73.73 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 113.351 0.871 . . . . 0.0 113.351 -177.406 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -79.19 -29.95 43.14 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 113.433 0.901 . . . . 0.0 113.433 178.683 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . 0.438 ' SD ' ' HG2' ' A' ' 17' ' ' MET . 1.0 OUTLIER -80.82 -29.57 35.95 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 123.521 0.728 . . . . 0.0 110.828 172.739 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -66.92 -12.27 58.93 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 124.719 1.208 . . . . 0.0 113.486 170.02 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -65.62 -26.23 67.73 Favored 'General case' 0 N--CA 1.481 1.076 0 CA-C-N 120.513 1.506 . . . . 0.0 110.892 169.06 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 56.7 t -93.72 -7.54 10.17 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.804 0 C-N-CA 126.996 2.119 . . . . 0.0 111.049 173.023 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 82.16 20.11 63.46 Favored Glycine 0 CA--C 1.538 1.501 0 C-N-CA 125.086 1.327 . . . . 0.0 114.22 -175.183 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.427 HG22 HG23 ' A' ' 57' ' ' ILE . 36.0 mt -85.68 126.13 40.51 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 CA-C-N 118.48 1.14 . . . . 0.0 110.805 -176.645 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 19.9 t0 -87.43 121.33 29.72 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.143 0.577 . . . . 0.0 111.537 170.692 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.427 HG23 HG22 ' A' ' 55' ' ' ILE . 29.2 pt -136.37 -1.72 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.24 0 N-CA-C 116.083 1.883 . . . . 0.0 116.083 -178.568 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 79.1 p -62.93 -25.61 68.42 Favored 'General case' 0 N--CA 1.482 1.17 0 N-CA-C 116.122 1.897 . . . . 0.0 116.122 -169.019 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -102.29 3.21 50.79 Favored Glycine 0 CA--C 1.537 1.431 0 N-CA-C 116.12 1.208 . . . . 0.0 116.12 -176.132 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 31.5 mt-30 -72.89 -44.3 61.46 Favored 'General case' 0 N--CA 1.48 1.05 0 CA-C-N 119.31 1.555 . . . . 0.0 113.639 -169.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 12.3 p -90.7 119.33 30.85 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 124.115 0.966 . . . . 0.0 112.382 -178.701 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 99.4 p -141.08 -12.17 0.95 Allowed 'General case' 0 N--CA 1.478 0.944 0 N-CA-C 114.884 1.439 . . . . 0.0 114.884 177.191 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -147.36 150.6 38.04 Favored Pre-proline 0 CA--C 1.546 0.821 0 C-N-CA 125.131 1.372 . . . . 0.0 111.58 179.522 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -63.15 155.71 59.66 Favored 'Trans proline' 0 C--N 1.35 0.624 0 C-N-CA 123.31 2.673 . . . . 0.0 112.168 169.543 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 10.3 tt -50.77 -33.84 12.47 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 C-N-CA 124.869 1.268 . . . . 0.0 112.291 171.261 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -62.41 -21.54 65.47 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.575 1.15 . . . . 0.0 112.87 -177.074 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 82.0 m-20 -91.7 4.7 52.14 Favored 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 124.452 1.101 . . . . 0.0 113.645 -176.264 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -116.48 -176.82 3.04 Favored 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 126.304 1.842 . . . . 0.0 112.377 179.283 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -119.76 125.0 47.56 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 125.874 1.67 . . . . 0.0 110.068 175.368 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -67.79 -34.91 77.7 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 113.921 1.082 . . . . 0.0 113.921 -171.201 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . 0.261 0.0 OUTLIER -71.6 -4.32 26.39 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 114.278 1.214 . . . . 0.0 114.278 -176.602 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -73.18 -15.96 61.44 Favored 'General case' 0 CA--C 1.548 0.871 0 O-C-N 121.711 -0.618 . . . . 0.0 111.136 168.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -112.45 138.5 49.11 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 127.074 2.15 . . . . 0.0 111.497 178.676 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -88.42 -23.68 23.25 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-O 122.112 0.958 . . . . 0.0 112.317 176.125 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.682 HG22 ' HB ' ' A' ' 95' ' ' ILE . 76.3 t -133.29 137.65 52.86 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 C-N-CA 126.679 1.992 . . . . 0.0 108.769 -175.487 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 78.8 t -133.56 131.92 57.3 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 173.184 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 43.3 mm -121.51 106.06 17.59 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 C-N-CA 124.243 1.017 . . . . 0.0 109.344 -171.378 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 4.1 m -88.75 109.79 20.45 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 123.631 0.772 . . . . 0.0 110.643 178.406 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 89.3 mt -90.76 -19.02 23.98 Favored 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 114.899 1.444 . . . . 0.0 114.899 -172.45 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 10.6 m -141.56 144.52 34.3 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.746 1.218 . . . . 0.0 110.703 -169.789 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 62.15 -125.37 35.97 Favored Glycine 0 CA--C 1.533 1.205 0 N-CA-C 110.632 -0.987 . . . . 0.0 110.632 -171.538 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 77.9 p -152.62 171.86 17.51 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.671 1.188 . . . . 0.0 111.527 169.719 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -66.41 65.0 0.16 Allowed Glycine 0 CA--C 1.538 1.512 0 C-N-CA 125.757 1.646 . . . . 0.0 114.691 176.043 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 7.7 p -143.79 -28.4 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.105 0 C-N-CA 125.633 1.573 . . . . 0.0 113.345 -178.324 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -91.19 22.95 3.51 Favored 'General case' 0 CA--C 1.554 1.121 0 C-N-CA 124.337 1.055 . . . . 0.0 112.447 178.115 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -133.54 159.28 73.15 Favored Pre-proline 0 CA--C 1.549 0.93 0 C-N-CA 126.338 1.855 . . . . 0.0 111.024 173.208 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -58.89 149.2 80.11 Favored 'Trans proline' 0 CA--C 1.543 0.937 0 C-N-CA 122.58 2.187 . . . . 0.0 112.695 178.229 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -61.77 -28.94 82.47 Favored 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 122.909 2.406 . . . . 0.0 113.626 -170.489 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -60.36 -20.95 61.4 Favored 'General case' 0 CA--C 1.544 0.723 0 N-CA-C 114.071 1.137 . . . . 0.0 114.071 177.704 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 88.6 m95 -80.34 -19.86 45.54 Favored 'General case' 0 N--CA 1.47 0.563 0 O-C-N 120.622 -1.299 . . . . 0.0 113.257 175.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 16.3 m -93.81 -8.21 9.98 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.125 0 N-CA-C 113.634 0.975 . . . . 0.0 113.634 172.213 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 67.5 p -96.98 -0.31 47.61 Favored 'General case' 0 N--CA 1.48 1.032 0 N-CA-C 114.796 1.406 . . . . 0.0 114.796 177.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 73.3 mm-40 -65.2 152.63 43.16 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 119.172 0.896 . . . . 0.0 111.213 169.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -54.01 -42.91 69.6 Favored 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 114.986 1.476 . . . . 0.0 114.986 -167.734 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.682 ' HB ' HG22 ' A' ' 75' ' ' VAL . 8.6 mm -118.26 65.16 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 C-N-CA 124.072 0.949 . . . . 0.0 109.224 173.41 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 23.3 t80 -75.31 109.46 8.85 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 106.909 -1.515 . . . . 0.0 106.909 168.645 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -104.58 130.45 52.55 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-O 121.797 0.808 . . . . 0.0 112.93 171.489 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -92.14 105.99 18.1 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 123.692 0.797 . . . . 0.0 109.399 169.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 19.0 m0 -94.47 99.26 11.46 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 124.571 1.148 . . . . 0.0 110.239 -176.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 99.9 mm-40 -79.13 53.7 1.5 Allowed 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 124.699 1.2 . . . . 0.0 110.514 170.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 5.0 tt -91.84 150.91 20.82 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 127.057 2.143 . . . . 0.0 111.9 -172.147 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -68.23 117.92 10.67 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 123.553 0.741 . . . . 0.0 112.868 179.029 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -74.43 133.25 77.62 Favored Pre-proline 0 CA--C 1.556 1.173 0 O-C-N 121.522 -0.736 . . . . 0.0 110.317 169.664 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -87.8 -6.96 6.57 Favored 'Trans proline' 0 CA--C 1.554 1.479 0 C-N-CA 122.295 1.997 . . . . 0.0 114.646 -178.597 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -64.38 146.91 53.69 Favored 'General case' 0 CA--C 1.547 0.864 0 CA-C-N 120.537 1.517 . . . . 0.0 113.188 176.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 75.77 8.62 84.65 Favored Glycine 0 CA--C 1.537 1.436 0 C-N-CA 123.869 0.747 . . . . 0.0 114.872 176.153 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 13.2 pt20 -140.75 165.46 27.44 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 125.893 1.677 . . . . 0.0 112.257 178.365 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 70.9 m -57.92 157.65 7.48 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 125.638 1.575 . . . . 0.0 114.843 -169.47 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 35.9 tp -59.25 -29.19 67.37 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 124.605 1.162 . . . . 0.0 113.001 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -61.9 -31.42 71.71 Favored 'General case' 0 N--CA 1.472 0.661 0 O-C-N 120.812 -1.18 . . . . 0.0 112.208 172.346 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 4.7 t -72.78 -40.49 60.97 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 O-C-N 121.146 -0.971 . . . . 0.0 111.114 171.73 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -55.16 -47.88 74.54 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 120.02 1.282 . . . . 0.0 112.056 169.857 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -69.13 -36.7 77.75 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.46 0.704 . . . . 0.0 112.506 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 79.0 m -63.86 -42.4 97.55 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 123.777 0.831 . . . . 0.0 110.832 171.593 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 44.1 t -65.96 -41.25 89.46 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 CA-C-O 117.567 -1.206 . . . . 0.0 110.803 176.429 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 30.8 mtm105 -55.73 -44.41 77.49 Favored 'General case' 0 N--CA 1.483 1.185 0 CA-C-N 120.841 1.655 . . . . 0.0 112.243 171.608 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -61.14 -50.85 62.75 Favored Glycine 0 CA--C 1.537 1.464 0 CA-C-N 118.979 0.809 . . . . 0.0 113.103 177.114 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 56.5 mm-40 -63.58 -45.0 92.42 Favored 'General case' 0 N--CA 1.473 0.689 0 O-C-N 121.996 -0.708 . . . . 0.0 112.217 178.387 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 70.4 t -64.78 -40.86 90.51 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 124.964 1.306 . . . . 0.0 111.301 177.679 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 84.3 tttt -54.44 -49.52 69.82 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 119.89 1.223 . . . . 0.0 110.474 176.215 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -63.64 -42.37 98.16 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 112.637 0.606 . . . . 0.0 112.637 176.268 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.24 -36.28 83.12 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 124.181 0.992 . . . . 0.0 112.897 177.803 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 92.5 t -78.44 -38.9 23.19 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 C-N-CA 125.521 1.529 . . . . 0.0 111.713 177.574 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -63.36 -35.43 80.38 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 119.546 1.066 . . . . 0.0 111.285 171.472 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 12.5 m-80 -64.89 -44.47 89.52 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 118.827 0.74 . . . . 0.0 112.52 172.328 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 9.8 tt -52.57 -57.18 10.81 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 124.237 1.015 . . . . 0.0 110.25 170.534 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 70.2 mt -60.58 -42.69 92.55 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 O-C-N 121.387 -0.821 . . . . 0.0 110.744 -177.805 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -68.45 -14.61 63.12 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 114.828 1.418 . . . . 0.0 114.828 178.263 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 19.0 ptmt -106.0 -32.75 8.16 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 113.596 0.961 . . . . 0.0 113.596 176.577 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.427 HD13 HG21 ' A' ' 75' ' ' VAL . 4.7 pt -88.98 -18.97 7.69 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 CA-C-O 118.038 -0.982 . . . . 0.0 113.619 -176.692 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 69.7 m . . . . . 0 C--O 1.253 1.274 0 N-CA-C 112.781 0.66 . . . . 0.0 112.781 -177.946 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.0 ttt . . . . . 0 N--CA 1.503 2.179 0 N-CA-C 111.774 0.287 . . . . 0.0 111.774 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.89 156.17 38.36 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 125.667 1.587 . . . . 0.0 113.207 179.422 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 44.1 mtmt -101.72 108.65 20.24 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 125.518 1.527 . . . . 0.0 107.342 167.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 16.3 t -95.18 131.92 40.64 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 125.981 1.713 . . . . 0.0 113.72 175.475 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . 0.558 ' HG3' HG13 ' A' ' 7' ' ' VAL . 37.6 tpp -102.98 120.2 40.22 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 123.765 0.826 . . . . 0.0 109.162 168.804 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 65.0 m-85 -99.0 118.93 36.9 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 125.68 1.592 . . . . 0.0 108.307 174.588 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.558 HG13 ' HG3' ' A' ' 5' ' ' MET . 1.5 m -137.91 151.44 25.56 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.143 0 N-CA-C 115.013 1.486 . . . . 0.0 115.013 -168.64 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 41.5 t -155.31 162.99 40.72 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 125.691 1.597 . . . . 0.0 111.028 169.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 40.2 ttmt -69.99 133.05 46.84 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 125.052 1.341 . . . . 0.0 110.855 169.827 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 98.2 mtt180 51.13 80.12 0.09 Allowed 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 126.88 2.072 . . . . 0.0 112.386 -176.541 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 21.9 t-20 -67.98 -32.99 73.78 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 113.828 1.047 . . . . 0.0 113.828 -174.174 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 60.4 p -76.29 157.45 32.51 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 125.008 1.323 . . . . 0.0 112.688 169.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 67.1 m 53.62 26.45 5.77 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 124.901 1.28 . . . . 0.0 114.242 -174.681 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 23.9 ttm180 -147.33 151.85 37.24 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 127.76 2.424 . . . . 0.0 110.048 -175.32 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 46.0 t -109.07 152.84 24.49 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.49 0.716 . . . . 0.0 111.248 170.157 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -139.98 -42.43 0.43 Allowed 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 125.887 1.675 . . . . 0.0 111.893 -169.52 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 65.91 -36.72 0.24 Allowed 'General case' 0 N--CA 1.478 0.975 0 N-CA-C 118.205 2.668 . . . . 0.0 118.205 169.238 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.27 -36.56 80.36 Favored 'General case' 0 C--O 1.224 -0.289 0 CA-C-N 119.278 0.944 . . . . 0.0 113.406 -171.26 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.5 pm0 -57.46 -34.37 68.94 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 124.361 1.064 . . . . 0.0 113.307 171.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -72.49 -57.03 5.73 Favored Glycine 0 C--N 1.332 0.332 0 C-N-CA 124.293 0.949 . . . . 0.0 111.425 177.437 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -59.34 -33.79 71.57 Favored 'General case' 0 N--CA 1.468 0.43 0 O-C-N 122.24 -0.565 . . . . 0.0 112.427 177.902 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -63.38 -40.16 96.47 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 119.198 0.908 . . . . 0.0 112.285 -178.825 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 33.7 mttm -58.3 -56.39 22.73 Favored 'General case' 0 N--CA 1.486 1.373 0 CA-C-O 121.544 0.688 . . . . 0.0 110.874 168.782 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 35.9 m -69.75 -24.15 63.48 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 125.186 1.394 . . . . 0.0 114.056 -169.392 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 76.7 mt -96.38 -19.15 19.41 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 125.066 1.347 . . . . 0.0 114.461 177.262 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -159.01 26.29 0.37 Allowed Glycine 0 C--N 1.344 0.979 0 N-CA-C 119.021 2.368 . . . . 0.0 119.021 -169.001 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -66.56 -21.28 66.15 Favored 'General case' 0 CA--C 1.546 0.812 0 CA-C-N 122.15 2.975 . . . . 0.0 115.37 -176.501 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -74.86 -5.47 75.03 Favored Glycine 0 CA--C 1.542 1.745 0 O-C-N 121.493 -0.755 . . . . 0.0 113.776 169.546 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 70.0 mttt -117.18 -37.24 3.58 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 127.536 2.335 . . . . 0.0 113.301 -178.565 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 40.1 pt -142.76 150.07 18.41 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 C-N-CA 124.386 1.074 . . . . 0.0 113.171 -174.619 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -99.53 139.23 35.5 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 125.813 1.645 . . . . 0.0 108.337 169.355 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 5.1 m -132.14 144.91 35.71 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.236 0 C-N-CA 124.033 0.933 . . . . 0.0 110.352 -173.578 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 72.3 m -138.42 138.91 38.65 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 123.522 0.729 . . . . 0.0 109.411 175.091 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 2.8 p -98.67 138.04 36.42 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 112.127 0.417 . . . . 0.0 112.127 168.755 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 24.4 p -149.18 162.29 40.28 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 113.274 0.842 . . . . 0.0 113.274 170.095 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -109.78 147.1 17.11 Favored Glycine 0 N--CA 1.473 1.165 0 C-N-CA 124.236 0.922 . . . . 0.0 113.89 -179.393 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 11.2 mp -68.32 -25.55 65.17 Favored 'General case' 0 N--CA 1.485 1.298 0 CA-C-N 119.395 1.597 . . . . 0.0 111.041 169.603 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -142.36 144.31 33.12 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 127.688 2.395 . . . . 0.0 106.955 169.06 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 25.5 p 58.05 171.42 0.05 Allowed 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 126.91 2.084 . . . . 0.0 116.172 -176.106 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 83.2 p -137.79 168.38 19.8 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 125.805 1.642 . . . . 0.0 114.34 178.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 24.5 ttt-85 61.74 124.24 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 129.494 3.117 . . . . 0.0 113.398 -169.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 32.0 m -57.89 144.8 9.97 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.32 0 C-N-CA 123.376 0.67 . . . . 0.0 109.557 169.696 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -65.13 147.68 98.39 Favored Pre-proline 0 CA--C 1.544 0.749 0 C-N-CA 119.369 -0.932 . . . . 0.0 112.332 -169.614 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo -48.27 -41.72 34.59 Favored 'Trans proline' 0 CA--C 1.538 0.707 0 C-N-CA 123.375 2.717 . . . . 0.0 117.51 -168.185 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 86.1 m -64.82 -24.0 67.41 Favored 'General case' 0 N--CA 1.485 1.32 0 O-C-N 121.211 -0.931 . . . . 0.0 112.267 -177.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -57.6 -34.25 69.06 Favored 'General case' 0 CA--C 1.536 0.406 0 O-C-N 121.315 -0.865 . . . . 0.0 112.153 173.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.7 mp -60.58 -57.88 9.94 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 CA-C-N 119.901 1.228 . . . . 0.0 109.312 175.564 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -61.31 -32.77 72.63 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 113.122 0.786 . . . . 0.0 113.122 -178.561 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 3.8 tpp -77.36 -24.14 50.7 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 113.209 0.818 . . . . 0.0 113.209 178.051 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -87.49 -27.35 22.71 Favored 'General case' 0 CA--C 1.541 0.615 0 O-C-N 121.136 -0.977 . . . . 0.0 110.876 172.464 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -65.62 -5.16 7.51 Favored 'General case' 0 CA--C 1.552 1.055 0 C-N-CA 125.166 1.386 . . . . 0.0 113.036 169.456 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 18.5 mt-10 -72.79 -29.26 63.13 Favored 'General case' 0 N--CA 1.484 1.263 0 CA-C-N 120.039 1.29 . . . . 0.0 111.082 171.284 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 8.5 p -113.21 12.94 8.34 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.798 0 C-N-CA 127.143 2.177 . . . . 0.0 111.26 -177.142 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 80.17 18.06 72.75 Favored Glycine 0 CA--C 1.533 1.202 0 C-N-CA 124.978 1.275 . . . . 0.0 115.861 170.668 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 2.4 mm -71.92 143.49 14.14 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 CA-C-N 119.549 1.674 . . . . 0.0 110.286 177.757 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -97.82 29.63 3.32 Favored 'General case' 0 CA--C 1.553 1.083 0 C-N-CA 125.986 1.714 . . . . 0.0 115.476 -176.825 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 11.6 pt -72.11 -2.75 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.384 0 N-CA-C 115.594 1.702 . . . . 0.0 115.594 -175.173 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 91.6 p -55.58 -32.35 62.98 Favored 'General case' 0 N--CA 1.479 1.016 0 CA-C-N 119.851 1.205 . . . . 0.0 113.828 179.453 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -82.44 3.61 81.27 Favored Glycine 0 CA--C 1.536 1.364 0 C-N-CA 125.237 1.399 . . . . 0.0 116.105 177.412 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 5.1 mt-30 -79.48 132.68 36.41 Favored 'General case' 0 C--N 1.343 0.319 0 CA-C-N 120.362 2.081 . . . . 0.0 112.33 -179.019 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 40.4 p -139.66 113.58 8.75 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 126.068 1.747 . . . . 0.0 107.051 168.747 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 59.7 p -114.61 -174.7 2.53 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 114.703 1.371 . . . . 0.0 114.703 -169.208 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -133.86 164.49 43.64 Favored Pre-proline 0 CA--C 1.546 0.812 0 C-N-CA 126.833 2.053 . . . . 0.0 109.628 176.798 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -60.78 155.95 46.03 Favored 'Trans proline' 0 CA--C 1.541 0.871 0 C-N-CA 122.193 1.928 . . . . 0.0 112.522 169.769 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.531 HD12 HG11 ' A' ' 7' ' ' VAL . 7.5 tt -53.55 -33.17 21.67 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 C-N-CA 125.428 1.491 . . . . 0.0 111.552 175.045 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 17.8 mt-10 -59.66 -20.58 57.08 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 125.315 1.446 . . . . 0.0 113.112 178.662 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -85.31 -9.96 57.01 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 125.294 1.438 . . . . 0.0 113.609 -179.015 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -108.27 178.77 4.4 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 126.334 1.854 . . . . 0.0 112.301 -176.312 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 20.3 t30 -114.58 126.08 54.5 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 125.208 1.403 . . . . 0.0 110.075 175.774 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -63.47 -43.34 97.6 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 114.515 1.302 . . . . 0.0 114.515 -169.756 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -75.26 -0.9 21.13 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 113.495 0.924 . . . . 0.0 113.495 -178.468 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -71.83 -12.96 61.54 Favored 'General case' 0 CA--C 1.544 0.724 0 O-C-N 121.572 -0.705 . . . . 0.0 110.784 168.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -116.21 141.81 47.65 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 126.175 1.79 . . . . 0.0 111.222 178.715 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -86.71 -31.73 20.85 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 125.464 1.505 . . . . 0.0 111.651 174.717 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.76 HG22 ' HB ' ' A' ' 95' ' ' ILE . 94.3 t -129.12 138.03 55.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 C-N-CA 125.446 1.498 . . . . 0.0 108.38 -171.366 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 37.3 t -130.56 125.15 58.49 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 173.488 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 44.3 mm -116.25 102.87 14.27 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 C-N-CA 125.052 1.341 . . . . 0.0 108.8 -173.403 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 15.8 m -86.31 106.77 17.61 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 124.041 0.936 . . . . 0.0 110.111 176.493 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 81.1 mt -82.04 -4.92 57.86 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 125.271 1.428 . . . . 0.0 114.647 -169.772 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 28.6 p -152.9 147.96 26.59 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 124.34 1.056 . . . . 0.0 112.121 -175.7 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 60.84 -160.39 25.61 Favored Glycine 0 CA--C 1.536 1.385 0 C-N-CA 124.585 1.088 . . . . 0.0 114.739 176.589 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 86.9 p -71.45 -22.69 61.8 Favored 'General case' 0 N--CA 1.475 0.782 0 O-C-N 121.305 -1.115 . . . . 0.0 113.575 175.454 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 72.58 10.0 75.02 Favored Glycine 0 CA--C 1.533 1.201 0 C-N-CA 124.968 1.27 . . . . 0.0 114.367 -176.39 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.0 p -77.07 -16.76 14.57 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 CA-C-N 119.36 1.58 . . . . 0.0 114.664 -169.702 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 36.4 m120 -80.44 -9.3 59.76 Favored 'General case' 0 CA--C 1.548 0.901 0 N-CA-C 114.984 1.475 . . . . 0.0 114.984 -170.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -75.59 159.64 81.1 Favored Pre-proline 0 CA--C 1.552 1.033 0 CA-C-N 119.323 0.965 . . . . 0.0 112.066 169.727 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_exo -58.43 142.97 98.26 Favored 'Trans proline' 0 CA--C 1.547 1.146 0 C-N-CA 122.607 2.205 . . . . 0.0 113.011 179.287 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_exo -54.85 -32.08 75.8 Favored 'Trans proline' 0 C--N 1.353 0.777 0 C-N-CA 123.358 2.706 . . . . 0.0 115.62 -171.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 2.9 pm0 -61.95 -16.82 54.04 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 114.239 1.2 . . . . 0.0 114.239 177.76 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 93.6 m95 -80.58 -24.01 39.49 Favored 'General case' 0 CA--C 1.542 0.669 0 O-C-N 120.45 -1.406 . . . . 0.0 112.908 171.728 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 11.8 m -85.98 -10.19 11.27 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.167 0 CA-C-N 119.909 1.231 . . . . 0.0 113.555 174.195 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 72.0 p -98.31 0.96 46.57 Favored 'General case' 0 N--CA 1.477 0.917 0 N-CA-C 115.225 1.565 . . . . 0.0 115.225 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 76.7 mm-40 -67.4 160.35 27.55 Favored 'General case' 0 N--CA 1.478 0.971 0 CA-C-N 119.482 1.037 . . . . 0.0 110.95 169.803 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -58.01 -36.04 72.12 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 116.09 1.885 . . . . 0.0 116.09 -168.34 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.76 ' HB ' HG22 ' A' ' 75' ' ' VAL . 12.1 mm -127.18 74.55 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 CA-C-N 119.605 1.093 . . . . 0.0 109.062 177.707 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 12.4 t80 -81.57 109.78 16.34 Favored 'General case' 0 CA--C 1.534 0.365 0 O-C-N 121.224 -0.922 . . . . 0.0 108.544 169.289 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -111.32 139.33 46.82 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 114.636 1.347 . . . . 0.0 114.636 174.403 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -104.94 121.15 43.12 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.242 1.017 . . . . 0.0 108.98 168.754 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 43.8 m0 -107.07 111.61 24.15 Favored 'General case' 0 C--N 1.33 -0.239 0 C-N-CA 124.756 1.222 . . . . 0.0 108.352 -179.686 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 84.0 mm-40 -83.95 53.96 2.76 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-O 122.318 1.056 . . . . 0.0 111.561 -173.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 87.7 mt -85.53 165.86 16.76 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 126.957 2.103 . . . . 0.0 112.22 -179.704 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -96.29 157.0 16.1 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 123.98 0.912 . . . . 0.0 113.147 172.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 51.5 t0 -86.34 124.26 70.21 Favored Pre-proline 0 CA--C 1.542 0.665 0 C-N-CA 124.445 1.098 . . . . 0.0 110.266 173.021 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_exo -58.67 -24.4 70.57 Favored 'Trans proline' 0 CA--C 1.543 0.952 0 C-N-CA 122.925 2.417 . . . . 0.0 115.343 172.868 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -65.94 143.52 57.35 Favored 'General case' 0 CA--C 1.546 0.792 0 CA-C-N 119.444 1.02 . . . . 0.0 112.995 -178.771 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 80.95 5.95 89.78 Favored Glycine 0 CA--C 1.536 1.399 0 N-CA-C 115.176 0.83 . . . . 0.0 115.176 178.617 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 8.6 pt20 -142.17 168.3 20.07 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 125.378 1.471 . . . . 0.0 112.833 179.275 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 66.8 m -59.67 155.21 16.17 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 125.503 1.521 . . . . 0.0 114.085 -170.181 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 7.9 tt -60.51 -30.98 70.07 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.746 1.218 . . . . 0.0 113.569 -175.107 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -65.17 -23.96 67.25 Favored 'General case' 0 CA--C 1.546 0.81 0 O-C-N 121.059 -1.026 . . . . 0.0 112.899 173.544 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 11.3 t -72.84 -38.15 56.47 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 O-C-N 120.789 -1.195 . . . . 0.0 110.734 170.651 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -53.76 -45.73 70.69 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 118.78 0.718 . . . . 0.0 110.686 169.045 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 38.9 mtt180 -66.77 -39.08 87.71 Favored 'General case' 0 N--CA 1.482 1.159 0 N-CA-C 113.012 0.745 . . . . 0.0 113.012 175.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 28.9 m -58.89 -42.88 90.58 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 124.345 1.058 . . . . 0.0 110.946 172.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 77.6 t -67.99 -38.57 80.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 CA-C-O 117.894 -1.051 . . . . 0.0 111.083 177.361 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 65.9 mtm-85 -57.25 -43.82 83.34 Favored 'General case' 0 N--CA 1.487 1.413 0 CA-C-N 120.696 1.589 . . . . 0.0 112.208 170.169 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -59.37 -49.6 76.74 Favored Glycine 0 CA--C 1.536 1.403 0 CA-C-N 119.104 0.865 . . . . 0.0 113.253 176.522 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 55.5 mm-40 -64.57 -44.11 91.73 Favored 'General case' 0 N--CA 1.473 0.709 0 O-C-N 122.078 -0.66 . . . . 0.0 112.131 177.788 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 75.6 t -65.95 -37.38 79.72 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 124.203 1.001 . . . . 0.0 111.344 177.201 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 58.2 tttm -55.93 -51.9 66.0 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-N 119.81 1.186 . . . . 0.0 110.743 176.212 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -63.78 -40.82 97.6 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.119 0.568 . . . . 0.0 112.199 178.347 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -62.87 -44.08 97.07 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 124.583 1.153 . . . . 0.0 113.272 176.486 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 66.8 t -74.31 -35.8 40.93 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 124.188 0.995 . . . . 0.0 111.518 178.56 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -63.1 -39.76 95.65 Favored 'General case' 0 N--CA 1.471 0.58 0 O-C-N 121.138 -0.976 . . . . 0.0 111.679 169.809 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 11.6 m-80 -63.36 -44.94 93.36 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 118.976 0.807 . . . . 0.0 112.225 172.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 8.4 tt -51.49 -56.79 11.41 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 124.48 1.112 . . . . 0.0 110.306 174.334 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 62.8 mt -66.82 -44.24 89.23 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 O-C-N 121.848 -0.533 . . . . 0.0 111.174 -175.731 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -69.4 -10.53 58.38 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 114.102 1.149 . . . . 0.0 114.102 177.559 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 72.7 tttt -95.77 -48.26 5.83 Favored 'General case' 0 C--O 1.234 0.239 0 C-N-CA 125.811 1.644 . . . . 0.0 111.428 176.037 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 7.5 pt -93.71 -15.17 7.99 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 N-CA-C 114.375 1.25 . . . . 0.0 114.375 -172.798 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 73.8 m . . . . . 0 C--O 1.256 1.408 0 C-N-CA 125.606 1.562 . . . . 0.0 111.722 -176.464 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.8 ttt . . . . . 0 N--CA 1.502 2.166 0 N-CA-C 111.861 0.319 . . . . 0.0 111.861 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.72 164.99 28.88 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 125.371 1.468 . . . . 0.0 112.937 178.737 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 71.1 mttt -94.49 146.42 24.11 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 124.085 0.954 . . . . 0.0 112.872 175.58 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 14.5 t -123.51 134.45 66.31 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 C-N-CA 125.543 1.537 . . . . 0.0 111.998 175.019 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 48.6 tpp -102.81 123.48 46.54 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 168.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 72.4 m-85 -101.35 131.19 47.54 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 169.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -140.65 143.18 29.35 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 N-CA-C 114.012 1.116 . . . . 0.0 114.012 -169.379 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 46.4 t -145.14 160.11 41.94 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 127.473 2.309 . . . . 0.0 109.081 169.36 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 64.9 pttt -66.23 -42.67 88.32 Favored 'General case' 0 N--CA 1.485 1.311 0 N-CA-C 115.117 1.525 . . . . 0.0 115.117 -171.341 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 12.7 mmm180 -113.29 63.12 0.64 Allowed 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 126.758 2.023 . . . . 0.0 112.148 -175.705 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 47.2 t30 -45.42 -46.6 13.48 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 125.139 1.376 . . . . 0.0 113.834 -172.52 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 86.0 p -78.36 -10.2 59.59 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 115.717 1.747 . . . . 0.0 115.717 -175.674 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 88.6 p -133.36 0.34 3.35 Favored 'General case' 0 N--CA 1.479 1.003 0 N-CA-C 116.3 1.963 . . . . 0.0 116.3 179.401 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 2.4 tpt180 -112.82 -27.38 8.15 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 114.889 1.44 . . . . 0.0 114.889 178.766 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 3.0 t 63.77 166.63 0.14 Allowed 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 115.639 1.718 . . . . 0.0 115.639 -176.221 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -141.58 -50.06 0.41 Allowed 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 114.396 1.258 . . . . 0.0 114.396 -170.006 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 70.52 -38.78 0.43 Allowed 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 126.185 1.794 . . . . 0.0 114.096 -178.374 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -63.02 -30.79 71.88 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 113.992 1.108 . . . . 0.0 113.992 -173.73 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.2 pm0 -67.2 -42.42 84.18 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 119.568 1.077 . . . . 0.0 111.837 175.759 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -66.77 -41.31 93.75 Favored Glycine 0 C--N 1.335 0.48 0 N-CA-C 111.351 -0.7 . . . . 0.0 111.351 -178.324 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -70.89 -39.25 72.92 Favored 'General case' 0 N--CA 1.469 0.497 0 O-C-N 121.842 -0.799 . . . . 0.0 111.815 174.91 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -63.76 -35.92 82.19 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 119.375 0.989 . . . . 0.0 112.909 -176.08 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 7.5 pttp -82.72 -28.35 30.54 Favored 'General case' 0 N--CA 1.479 0.996 0 N-CA-C 113.972 1.101 . . . . 0.0 113.972 171.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 96.6 m -70.22 -35.74 74.08 Favored 'General case' 0 N--CA 1.486 1.341 0 CA-C-N 118.76 0.709 . . . . 0.0 111.937 175.093 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 74.1 mt -91.0 -38.03 13.08 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 125.92 1.688 . . . . 0.0 113.324 179.175 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -105.11 5.98 42.57 Favored Glycine 0 N--CA 1.471 1.008 0 N-CA-C 117.5 1.76 . . . . 0.0 117.5 -169.303 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.61 141.23 57.91 Favored 'General case' 0 CA--C 1.546 0.821 0 CA-C-N 121.149 2.474 . . . . 0.0 112.294 178.122 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 82.88 -16.93 24.46 Favored Glycine 0 CA--C 1.539 1.564 0 C-N-CA 124.868 1.223 . . . . 0.0 113.959 -169.539 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 62.7 mttp -104.0 -44.29 5.06 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 125.897 1.679 . . . . 0.0 112.172 171.808 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 38.1 pt -139.53 159.63 27.99 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 C-N-CA 125.323 1.449 . . . . 0.0 112.64 -178.257 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -107.85 149.23 28.52 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.378 1.471 . . . . 0.0 110.397 170.017 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 98.1 t -133.46 141.64 43.86 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 O-C-N 121.497 -0.752 . . . . 0.0 112.796 -176.173 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 38.8 m -134.91 153.33 52.1 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 125.732 1.613 . . . . 0.0 108.926 169.703 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 92.8 p -133.33 145.73 50.67 Favored 'General case' 0 CA--C 1.512 -0.497 0 CA-C-O 122.372 1.082 . . . . 0.0 112.179 167.774 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 54.4 p -145.97 166.53 25.77 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 113.714 -1.584 . . . . 0.0 112.199 -177.68 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -106.63 162.82 13.57 Favored Glycine 0 N--CA 1.467 0.753 0 C-N-CA 123.587 0.613 . . . . 0.0 112.754 172.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 9.0 mp -76.0 -32.27 59.33 Favored 'General case' 0 N--CA 1.479 1.024 0 O-C-N 122.144 -0.621 . . . . 0.0 111.819 172.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -134.29 27.23 3.8 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 125.734 1.614 . . . . 0.0 111.916 177.12 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 37.5 t -154.66 145.45 22.46 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 124.319 1.048 . . . . 0.0 112.796 -170.353 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 98.8 p -107.96 -13.04 15.05 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 116.853 2.168 . . . . 0.0 116.853 -169.679 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 71.7 ttt180 -134.38 149.12 50.79 Favored 'General case' 0 N--CA 1.483 1.217 0 CA-C-N 120.009 1.277 . . . . 0.0 111.072 -176.382 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 22.3 m -68.11 166.27 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.15 0 CA-C-O 122.908 1.337 . . . . 0.0 110.98 169.536 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 6.1 t-80 -57.04 129.87 79.18 Favored Pre-proline 0 N--CA 1.447 -0.586 0 CA-C-N 114.049 -1.432 . . . . 0.0 111.716 179.163 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_exo -61.1 -29.2 86.88 Favored 'Trans proline' 0 CA--C 1.549 1.25 0 CA-C-N 121.145 1.445 . . . . 0.0 112.3 177.506 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 99.3 m -67.64 -28.24 67.56 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 126.069 1.748 . . . . 0.0 112.656 172.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -59.68 -41.06 89.84 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 119.119 0.872 . . . . 0.0 111.748 -176.717 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.9 mp -54.17 -55.16 15.83 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 C-N-CA 123.976 0.91 . . . . 0.0 109.298 -177.585 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -65.83 -34.63 78.61 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 113.94 1.089 . . . . 0.0 113.94 -176.859 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -78.26 -20.57 51.38 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 113.676 0.991 . . . . 0.0 113.676 179.785 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 43.0 mtt -98.16 -26.78 14.45 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 125.032 1.333 . . . . 0.0 110.493 177.391 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -66.53 -13.82 61.47 Favored 'General case' 0 CA--C 1.544 0.717 0 O-C-N 120.662 -1.274 . . . . 0.0 111.784 168.525 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -61.83 -24.65 67.02 Favored 'General case' 0 N--CA 1.482 1.136 0 O-C-N 121.001 -1.062 . . . . 0.0 110.652 168.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 40.0 t -99.62 -6.77 9.15 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.882 0 C-N-CA 127.896 2.478 . . . . 0.0 111.275 175.358 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 81.68 20.82 62.95 Favored Glycine 0 CA--C 1.54 1.647 0 C-N-CA 125.293 1.425 . . . . 0.0 114.378 -173.44 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 85.7 mt -79.65 127.14 39.37 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 CA-C-N 118.485 1.143 . . . . 0.0 111.874 -173.51 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 20.7 t0 -89.15 93.73 9.68 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 123.538 0.735 . . . . 0.0 112.006 177.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 7.2 pt -118.27 11.08 7.03 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.082 0 C-N-CA 124.703 1.201 . . . . 0.0 113.957 170.761 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 72.7 m -60.42 -27.33 67.4 Favored 'General case' 0 N--CA 1.479 0.988 0 O-C-N 120.793 -1.192 . . . . 0.0 112.541 176.57 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -82.55 6.8 67.43 Favored Glycine 0 CA--C 1.538 1.472 0 C-N-CA 125.63 1.586 . . . . 0.0 116.031 174.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 26.5 mm100 -78.16 43.4 0.44 Allowed 'General case' 0 N--CA 1.478 0.969 0 CA-C-N 120.069 1.934 . . . . 0.0 113.599 -179.812 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 36.6 p -87.96 111.97 22.06 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 107.102 -1.444 . . . . 0.0 107.102 168.769 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 70.4 m -130.81 -160.59 1.05 Allowed 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 124.831 1.252 . . . . 0.0 111.374 -168.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -124.14 166.98 16.71 Favored Pre-proline 0 CA--C 1.546 0.797 0 C-N-CA 126.354 1.862 . . . . 0.0 108.464 169.543 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_endo -58.21 156.92 27.7 Favored 'Trans proline' 0 CA--C 1.539 0.761 0 C-N-CA 121.917 1.744 . . . . 0.0 112.38 169.573 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.492 HD11 ' CE3' ' A' ' 90' ' ' TRP . 9.8 tp -49.94 -34.02 9.51 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 C-N-CA 125.537 1.535 . . . . 0.0 112.363 174.183 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 12.7 mt-10 -64.32 -18.42 64.6 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.864 1.266 . . . . 0.0 113.126 -177.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -87.06 -13.9 43.01 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 124.994 1.318 . . . . 0.0 113.583 -173.255 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -104.67 -174.24 2.49 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 126.164 1.786 . . . . 0.0 112.686 -174.594 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 6.1 t30 -121.94 121.99 38.35 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 125.679 1.591 . . . . 0.0 109.519 175.035 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -64.11 -37.79 88.71 Favored 'General case' 0 C--N 1.333 -0.139 0 N-CA-C 114.943 1.46 . . . . 0.0 114.943 -169.617 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -73.64 -1.4 18.76 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 114.141 1.163 . . . . 0.0 114.141 -174.071 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -73.37 -14.87 61.36 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 123.392 0.677 . . . . 0.0 110.743 168.712 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 81.2 m-85 -112.44 140.57 47.07 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 127.315 2.246 . . . . 0.0 111.203 178.195 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -91.21 -22.58 20.55 Favored 'General case' 0 N--CA 1.477 0.879 0 CA-C-O 121.992 0.901 . . . . 0.0 112.303 176.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.714 HG22 ' HB ' ' A' ' 95' ' ' ILE . 90.5 t -134.5 138.1 50.26 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 C-N-CA 126.849 2.06 . . . . 0.0 108.948 -173.611 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 47.3 t -134.52 130.4 53.52 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 172.761 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 39.3 mm -119.0 104.83 16.51 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 C-N-CA 124.292 1.037 . . . . 0.0 109.717 -172.363 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 7.3 m -81.88 118.92 23.31 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 123.807 0.843 . . . . 0.0 109.634 171.359 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 90.5 mt -100.11 -7.23 25.13 Favored 'General case' 0 N--CA 1.478 0.929 0 N-CA-C 114.491 1.293 . . . . 0.0 114.491 -171.643 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 76.5 m -131.06 59.92 1.67 Allowed 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 125.217 1.407 . . . . 0.0 109.177 -169.745 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 82.4 -155.44 34.16 Favored Glycine 0 CA--C 1.536 1.354 0 C-N-CA 124.846 1.212 . . . . 0.0 111.602 -169.577 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 83.6 p -66.3 -29.91 70.22 Favored 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 113.483 0.92 . . . . 0.0 113.483 177.855 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 66.4 20.5 69.66 Favored Glycine 0 CA--C 1.534 1.247 0 C-N-CA 124.402 1.001 . . . . 0.0 114.11 -177.312 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 7.3 p -55.99 -9.89 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.34 0 N-CA-C 116.118 1.896 . . . . 0.0 116.118 -169.691 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -66.82 -22.18 66.01 Favored 'General case' 0 CA--C 1.554 1.124 0 N-CA-C 114.362 1.245 . . . . 0.0 114.362 169.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -67.82 154.51 93.41 Favored Pre-proline 0 N--CA 1.483 1.202 0 CA-C-N 120.903 1.683 . . . . 0.0 112.009 169.693 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.407 ' HA ' ' HD3' ' A' ' 88' ' ' PRO . 74.4 Cg_exo -57.71 148.51 73.86 Favored 'Trans proline' 0 CA--C 1.545 1.045 0 C-N-CA 122.698 2.265 . . . . 0.0 113.825 -175.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 87' ' ' PRO . 82.2 Cg_exo -56.04 -32.54 86.65 Favored 'Trans proline' 0 C--N 1.354 0.85 0 C-N-CA 123.12 2.547 . . . . 0.0 114.898 -171.755 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -60.51 -21.69 62.73 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 114.057 1.132 . . . . 0.0 114.057 179.411 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . 0.492 ' CE3' HD11 ' A' ' 65' ' ' ILE . 93.7 m95 -79.48 -21.52 45.29 Favored 'General case' 0 N--CA 1.47 0.529 0 O-C-N 120.695 -1.253 . . . . 0.0 113.169 175.0 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 14.2 m -92.42 -5.94 10.69 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 N-CA-C 113.481 0.919 . . . . 0.0 113.481 173.431 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 59.9 p -100.32 0.39 39.99 Favored 'General case' 0 N--CA 1.479 1.006 0 N-CA-C 115.29 1.589 . . . . 0.0 115.29 177.32 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 74.0 mm-40 -66.89 155.42 38.46 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-N 119.459 1.027 . . . . 0.0 110.722 169.789 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -54.78 -43.12 72.55 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 115.093 1.516 . . . . 0.0 115.093 -167.78 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.714 ' HB ' HG22 ' A' ' 75' ' ' VAL . 10.0 mm -116.53 66.39 0.23 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 C-N-CA 123.875 0.87 . . . . 0.0 109.579 176.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 12.2 t80 -77.04 108.71 10.3 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 168.595 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 9.1 mt-10 -107.62 142.58 37.34 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 114.321 1.23 . . . . 0.0 114.321 173.511 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -107.66 120.24 41.66 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 124.634 1.174 . . . . 0.0 108.23 168.381 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 37.3 m0 -103.84 133.67 48.44 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.545 1.138 . . . . 0.0 108.814 177.504 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 63.8 mt-30 -113.88 29.36 8.06 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 123.993 0.917 . . . . 0.0 111.987 -169.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -70.37 164.62 24.15 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 125.732 1.613 . . . . 0.0 112.292 170.621 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -73.63 158.71 34.25 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-O 121.773 0.797 . . . . 0.0 111.49 169.824 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -97.02 150.77 37.2 Favored Pre-proline 0 CA--C 1.542 0.653 0 C-N-CA 123.418 0.687 . . . . 0.0 110.055 169.797 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -88.59 -12.44 3.71 Favored 'Trans proline' 0 CA--C 1.547 1.152 0 CA-C-N 120.845 1.338 . . . . 0.0 115.072 -173.415 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -62.53 -50.27 72.04 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 114.928 1.455 . . . . 0.0 114.928 -170.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -77.24 16.69 5.63 Favored Glycine 0 CA--C 1.537 1.425 0 N-CA-C 115.256 0.862 . . . . 0.0 115.256 -169.825 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 7.9 pt20 -155.92 179.28 9.36 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 126.006 1.722 . . . . 0.0 112.63 -169.221 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 27.8 p -68.8 167.46 15.43 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 116.27 1.952 . . . . 0.0 116.27 -169.314 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 36.0 tp -59.88 -31.81 70.14 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.412 1.085 . . . . 0.0 112.46 172.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -63.46 -32.51 73.98 Favored 'General case' 0 N--CA 1.47 0.537 0 O-C-N 121.073 -1.017 . . . . 0.0 111.499 172.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 4.4 t -74.1 -35.07 40.21 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 O-C-N 121.2 -0.937 . . . . 0.0 112.069 171.54 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -55.59 -46.95 77.18 Favored 'General case' 0 N--CA 1.477 0.889 0 CA-C-N 120.424 1.466 . . . . 0.0 111.255 169.413 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 96.9 mtt180 -69.87 -33.91 72.87 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.75 0.82 . . . . 0.0 112.585 178.275 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 53.2 m -63.34 -42.89 98.98 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 123.787 0.835 . . . . 0.0 110.96 170.212 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 50.8 t -65.11 -40.56 89.28 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.475 0 CA-C-O 117.316 -1.326 . . . . 0.0 110.55 176.413 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 24.7 mtm105 -53.63 -47.38 70.34 Favored 'General case' 0 N--CA 1.484 1.248 0 CA-C-N 120.804 1.638 . . . . 0.0 112.287 170.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -61.36 -50.65 64.54 Favored Glycine 0 CA--C 1.537 1.417 0 CA-C-N 119.027 0.831 . . . . 0.0 113.644 177.743 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 65.2 mm-40 -63.49 -44.48 94.24 Favored 'General case' 0 N--CA 1.474 0.736 0 O-C-N 121.991 -0.711 . . . . 0.0 112.332 179.221 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 56.0 t -63.79 -43.73 98.02 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 C-N-CA 124.507 1.123 . . . . 0.0 110.603 176.485 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 59.5 tttm -53.56 -50.69 65.01 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-N 119.804 1.184 . . . . 0.0 111.295 179.602 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -63.58 -41.32 98.38 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 179.064 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 8.5 mtp85 -64.25 -42.12 96.65 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 113.145 0.794 . . . . 0.0 113.145 175.766 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 94.2 t -71.0 -36.44 63.53 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 C-N-CA 123.674 0.79 . . . . 0.0 111.156 178.71 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -63.31 -38.09 89.81 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 119.386 0.994 . . . . 0.0 111.606 170.724 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 12.5 m-80 -62.67 -48.02 81.12 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 118.914 0.779 . . . . 0.0 112.052 171.807 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 10.3 tt -50.45 -57.24 8.49 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 124.483 1.113 . . . . 0.0 110.07 173.809 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 75.3 mt -64.02 -42.57 96.1 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 CA-C-N 119.25 0.932 . . . . 0.0 111.56 -176.601 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -68.22 -10.46 54.62 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 114.535 1.309 . . . . 0.0 114.535 175.781 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 74.6 tttt -103.5 -45.78 4.75 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 126.049 1.74 . . . . 0.0 111.664 -179.813 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.573 HD13 HG21 ' A' ' 75' ' ' VAL . 5.4 pt -92.06 -16.53 7.88 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 N-CA-C 114.48 1.289 . . . . 0.0 114.48 -170.293 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 72.5 m . . . . . 0 C--O 1.253 1.281 0 CA-C-N 118.913 0.778 . . . . 0.0 112.9 -175.603 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.1 ttt . . . . . 0 N--CA 1.502 2.151 0 N-CA-C 111.615 0.228 . . . . 0.0 111.615 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.75 166.5 25.06 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 124.768 1.227 . . . . 0.0 113.654 177.266 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 44.2 mtmt -94.76 138.71 32.23 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 126.154 1.782 . . . . 0.0 112.954 -179.191 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 21.2 t -123.6 133.51 68.99 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 C-N-CA 126.036 1.734 . . . . 0.0 112.479 -179.151 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . 0.494 ' HG3' HG13 ' A' ' 7' ' ' VAL . 41.8 tpp -104.66 125.51 50.85 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.562 0.745 . . . . 0.0 109.492 168.888 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 58.6 m-85 -102.81 127.72 49.86 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.266 1.026 . . . . 0.0 109.667 170.351 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.531 HG11 HD12 ' A' ' 65' ' ' ILE . 1.3 m -140.51 144.98 26.46 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.182 0 N-CA-C 114.414 1.265 . . . . 0.0 114.414 -168.862 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 41.7 t -157.06 159.65 38.15 Favored 'General case' 0 CA--C 1.556 1.18 0 C-N-CA 127.369 2.268 . . . . 0.0 111.974 177.443 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 17.9 ptpt -90.57 157.67 17.39 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 124.997 1.319 . . . . 0.0 111.638 169.522 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 34.1 mtp180 60.15 25.47 14.81 Favored 'General case' 0 N--CA 1.494 1.746 0 C-N-CA 126.074 1.75 . . . . 0.0 113.804 -169.098 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 5.8 t30 -52.95 -38.61 62.18 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 124.839 1.256 . . . . 0.0 114.045 -169.449 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 50.2 m -80.31 -8.34 59.44 Favored 'General case' 0 N--CA 1.478 0.96 0 N-CA-C 114.692 1.367 . . . . 0.0 114.692 -178.621 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 83.6 p -119.76 16.54 12.72 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 125.394 1.478 . . . . 0.0 112.996 170.672 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 19.5 ttm180 -139.49 156.06 47.17 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 125.653 1.581 . . . . 0.0 112.115 -175.78 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 73.0 m -94.76 138.08 33.03 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 125.015 1.326 . . . . 0.0 111.046 169.785 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 3.9 mp0 -113.71 -39.1 4.1 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 124.291 1.037 . . . . 0.0 112.497 -177.1 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . 0.43 ' HG2' ' SD ' ' A' ' 50' ' ' MET . 0.0 OUTLIER 68.96 -50.98 0.59 Allowed 'General case' 0 N--CA 1.478 0.954 0 N-CA-C 117.641 2.46 . . . . 0.0 117.641 169.212 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -56.73 -35.3 68.4 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 114.398 1.258 . . . . 0.0 114.398 -169.246 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 23.4 pm0 -61.13 -40.06 92.37 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.944 1.297 . . . . 0.0 112.711 177.137 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -69.91 -37.77 74.79 Favored Glycine 0 C--N 1.336 0.554 0 N-CA-C 111.377 -0.689 . . . . 0.0 111.377 178.46 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -70.43 -40.25 73.9 Favored 'General case' 0 N--CA 1.47 0.546 0 O-C-N 121.89 -0.771 . . . . 0.0 111.184 176.514 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.21 -41.79 97.46 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 119.024 0.829 . . . . 0.0 112.527 -175.567 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 10.5 pttp -79.49 -27.53 41.48 Favored 'General case' 0 N--CA 1.479 1.013 0 N-CA-C 113.662 0.986 . . . . 0.0 113.662 173.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 96.3 m -68.84 -36.59 78.34 Favored 'General case' 0 N--CA 1.486 1.342 0 O-C-N 121.185 -0.947 . . . . 0.0 111.636 172.81 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 72.1 mt -87.89 -29.67 20.7 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 125.656 1.582 . . . . 0.0 114.037 -178.489 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -146.03 28.95 1.69 Allowed Glycine 0 N--CA 1.473 1.129 0 N-CA-C 118.502 2.161 . . . . 0.0 118.502 -169.206 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -66.62 -20.2 65.94 Favored 'General case' 0 CA--C 1.546 0.813 0 CA-C-N 122.108 2.954 . . . . 0.0 115.197 -177.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -76.49 -7.73 85.5 Favored Glycine 0 CA--C 1.542 1.771 0 O-C-N 121.432 -0.793 . . . . 0.0 113.597 169.575 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 61.1 mttp -111.33 -40.73 4.32 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 127.088 2.155 . . . . 0.0 112.692 -178.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 28.3 pt -141.09 155.71 21.63 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 C-N-CA 125.366 1.466 . . . . 0.0 112.42 -172.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -103.06 136.6 42.56 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 124.678 1.191 . . . . 0.0 110.199 171.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 74.6 t -123.54 137.18 57.65 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 CA-C-N 118.814 0.734 . . . . 0.0 112.134 -175.327 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 41.4 m -129.59 153.71 47.8 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 125.566 1.547 . . . . 0.0 108.763 169.844 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 26.0 p -129.59 146.33 51.4 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.806 0.812 . . . . 0.0 111.991 168.671 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 59.4 p -145.78 148.17 32.66 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 114.247 -1.342 . . . . 0.0 112.117 177.45 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -82.32 152.66 31.16 Favored Glycine 0 CA--C 1.53 1.009 0 O-C-N 121.429 -0.794 . . . . 0.0 111.493 172.646 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.7 mp -69.4 -32.8 72.04 Favored 'General case' 0 N--CA 1.477 0.877 0 O-C-N 120.843 -1.387 . . . . 0.0 113.389 179.006 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -134.77 11.9 3.68 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 124.683 1.193 . . . . 0.0 113.027 178.641 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 23.6 p -152.73 173.89 14.71 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 125.227 1.411 . . . . 0.0 112.013 -174.71 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 62.6 m -99.0 -73.39 0.62 Allowed 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 113.738 1.014 . . . . 0.0 113.738 -169.838 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 30.3 ttt85 -86.18 165.89 16.18 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 125.906 1.682 . . . . 0.0 111.463 -169.397 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 21.3 m -82.57 166.38 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 C-N-CA 123.258 0.623 . . . . 0.0 111.316 170.356 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . 0.262 0.0 OUTLIER -67.67 137.76 93.12 Favored Pre-proline 0 CA--C 1.545 0.766 0 C-N-CA 118.971 -1.091 . . . . 0.0 109.879 169.752 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -61.38 -30.06 86.65 Favored 'Trans proline' 0 CA--C 1.537 0.67 0 C-N-CA 123.219 2.613 . . . . 0.0 116.148 -167.793 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 90.7 m -64.14 -23.96 67.51 Favored 'General case' 0 N--CA 1.481 1.075 0 O-C-N 120.969 -1.082 . . . . 0.0 111.86 -177.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -55.67 -38.62 69.85 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.117 0.967 . . . . 0.0 112.507 172.513 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 5.0 mp -60.22 -54.7 31.26 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 CA-C-N 119.588 1.085 . . . . 0.0 110.018 179.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.3 -32.09 73.41 Favored 'General case' 0 CA--C 1.542 0.656 0 N-CA-C 113.222 0.823 . . . . 0.0 113.222 -178.535 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 2.1 tpp -77.71 -25.6 49.48 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 113.679 0.992 . . . . 0.0 113.679 177.176 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . 0.43 ' SD ' ' HG2' ' A' ' 17' ' ' MET . 0.0 OUTLIER -88.01 -26.84 22.4 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-N 119.723 1.147 . . . . 0.0 111.04 174.145 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -65.12 -11.83 44.22 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 124.998 1.319 . . . . 0.0 113.219 169.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 17.9 mt-10 -61.7 -27.05 68.42 Favored 'General case' 0 N--CA 1.485 1.29 0 CA-C-N 120.012 1.278 . . . . 0.0 110.26 168.551 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 21.6 t -98.27 -1.52 10.17 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.958 0 C-N-CA 128.232 2.613 . . . . 0.0 110.829 178.774 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 77.04 20.13 76.3 Favored Glycine 0 CA--C 1.538 1.512 0 C-N-CA 125.041 1.305 . . . . 0.0 114.474 -176.036 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 70.5 mt -80.25 128.12 38.86 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 124.279 1.032 . . . . 0.0 111.72 -172.122 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 10.4 p-10 -88.22 100.35 12.91 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 124.372 1.069 . . . . 0.0 112.582 -179.734 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 12.9 pt -133.25 15.4 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.141 0 N-CA-C 114.934 1.457 . . . . 0.0 114.934 178.473 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 66.5 m -63.56 -19.77 65.09 Favored 'General case' 0 N--CA 1.481 1.09 0 O-C-N 120.32 -1.487 . . . . 0.0 113.293 177.514 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -85.41 10.08 65.3 Favored Glycine 0 CA--C 1.538 1.506 0 C-N-CA 125.993 1.759 . . . . 0.0 116.59 179.636 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 64.3 mt-30 -71.96 40.45 0.08 Allowed 'General case' 0 N--CA 1.486 1.34 0 CA-C-N 120.334 2.067 . . . . 0.0 114.699 -178.753 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 88.8 m -80.98 -4.56 55.51 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 119.788 -1.82 . . . . 0.0 112.662 177.198 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 70.5 m -45.11 146.4 0.87 Allowed 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 127.416 2.287 . . . . 0.0 114.323 176.332 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -67.69 171.51 5.18 Favored Pre-proline 0 CA--C 1.553 1.087 0 C-N-CA 127.169 2.188 . . . . 0.0 114.1 -175.558 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -59.03 160.06 19.8 Favored 'Trans proline' 0 C--N 1.353 0.798 0 C-N-CA 122.987 2.458 . . . . 0.0 113.621 169.73 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.531 HD12 HG11 ' A' ' 7' ' ' VAL . 7.6 tt -51.21 -37.6 18.11 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 C-N-CA 124.864 1.266 . . . . 0.0 111.854 174.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 14.1 mt-10 -64.61 -17.4 63.96 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.715 1.206 . . . . 0.0 113.111 -177.269 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -83.71 -12.3 56.01 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 124.927 1.291 . . . . 0.0 113.233 -178.31 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -106.94 -175.31 2.76 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 126.449 1.9 . . . . 0.0 112.723 -175.603 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 5.6 t30 -124.35 124.35 42.18 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 126.008 1.723 . . . . 0.0 109.103 174.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.74 -34.29 77.52 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 114.012 1.115 . . . . 0.0 114.012 -169.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . 0.264 0.0 OUTLIER -71.24 -4.58 26.49 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 114.06 1.133 . . . . 0.0 114.06 -177.752 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -72.94 -12.75 61.07 Favored 'General case' 0 CA--C 1.549 0.942 0 C-N-CA 123.4 0.68 . . . . 0.0 111.012 168.52 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 88.6 m-85 -118.19 138.5 52.27 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 126.806 2.042 . . . . 0.0 111.562 -177.713 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -89.08 -22.15 23.06 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-O 122.104 0.954 . . . . 0.0 112.38 176.404 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.712 HG22 ' HB ' ' A' ' 95' ' ' ILE . 77.9 t -131.44 138.59 52.74 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 C-N-CA 127.136 2.174 . . . . 0.0 108.908 -175.895 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 48.5 t -131.49 123.93 53.57 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 169.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 45.2 mm -109.42 103.72 15.95 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 C-N-CA 124.6 1.16 . . . . 0.0 109.536 -176.377 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 13.2 m -83.35 102.07 11.75 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 124.333 1.053 . . . . 0.0 109.439 169.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 92.4 mt -72.37 -36.25 68.69 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 112.755 0.65 . . . . 0.0 112.755 -177.371 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 36.4 m -112.05 122.27 47.3 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 125.61 1.564 . . . . 0.0 110.492 -169.221 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 62.9 -157.28 39.23 Favored Glycine 0 CA--C 1.537 1.455 0 C-N-CA 123.626 0.631 . . . . 0.0 114.055 -175.737 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 50.3 m -90.08 0.08 57.32 Favored 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 114.8 1.407 . . . . 0.0 114.8 -172.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 71.34 29.16 68.67 Favored Glycine 0 CA--C 1.535 1.315 0 O-C-N 121.478 -0.764 . . . . 0.0 114.609 179.249 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 60.0 t -90.46 -17.6 7.86 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.384 0 CA-C-N 118.216 1.008 . . . . 0.0 112.144 -179.69 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -84.23 12.63 6.26 Favored 'General case' 0 CA--C 1.555 1.144 0 C-N-CA 124.955 1.302 . . . . 0.0 113.641 -173.418 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -119.88 163.85 25.51 Favored Pre-proline 0 CA--C 1.552 1.047 0 C-N-CA 126.186 1.794 . . . . 0.0 112.464 177.671 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.415 ' HA ' ' HD3' ' A' ' 88' ' ' PRO . 52.0 Cg_exo -63.53 150.1 89.35 Favored 'Trans proline' 0 CA--C 1.545 1.064 0 C-N-CA 122.437 2.091 . . . . 0.0 113.981 -178.16 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 87' ' ' PRO . 74.7 Cg_exo -58.44 -27.96 83.63 Favored 'Trans proline' 0 C--N 1.353 0.789 0 C-N-CA 123.442 2.762 . . . . 0.0 115.559 -173.215 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -61.11 -24.14 66.03 Favored 'General case' 0 CA--C 1.544 0.725 0 O-C-N 120.976 -1.077 . . . . 0.0 113.214 177.059 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 89.6 m95 -82.96 -23.52 33.38 Favored 'General case' 0 N--CA 1.469 0.491 0 O-C-N 120.791 -1.193 . . . . 0.0 113.2 176.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 4.4 m -85.15 -18.98 8.91 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.228 0 CA-C-N 119.331 0.968 . . . . 0.0 113.142 173.084 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -88.53 -2.18 58.45 Favored 'General case' 0 N--CA 1.478 0.958 0 N-CA-C 114.847 1.425 . . . . 0.0 114.847 -177.517 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 73.0 mm-40 -66.33 157.07 32.65 Favored 'General case' 0 N--CA 1.481 1.08 0 O-C-N 120.963 -1.086 . . . . 0.0 111.575 171.126 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -59.28 -42.22 90.71 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 114.245 1.202 . . . . 0.0 114.245 -168.304 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.712 ' HB ' HG22 ' A' ' 75' ' ' VAL . 21.1 mm -117.88 61.75 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 C-N-CA 124.883 1.273 . . . . 0.0 108.949 179.273 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 19.9 t80 -78.18 110.42 13.15 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 168.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 24.9 mt-10 -114.54 137.3 52.04 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 114.047 1.129 . . . . 0.0 114.047 175.185 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -105.37 121.42 43.85 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 124.935 1.294 . . . . 0.0 108.852 169.176 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 42.9 m0 -100.52 -18.22 16.75 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 115.871 1.804 . . . . 0.0 115.871 -168.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 41.6 mm-40 55.11 30.61 14.69 Favored 'General case' 0 CA--C 1.555 1.158 0 N-CA-C 113.964 1.098 . . . . 0.0 113.964 174.19 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 30.0 mt -84.22 158.63 21.22 Favored 'General case' 0 N--CA 1.47 0.54 0 O-C-N 120.768 -1.208 . . . . 0.0 112.82 -170.3 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 9.7 tt0 -69.35 133.77 48.24 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.513 169.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 16.3 p-10 -90.46 137.66 27.3 Favored Pre-proline 0 CA--C 1.551 0.988 0 C-N-CA 126.011 1.724 . . . . 0.0 112.057 173.068 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_exo -67.79 -14.55 41.95 Favored 'Trans proline' 0 CA--C 1.551 1.333 0 C-N-CA 122.35 2.033 . . . . 0.0 115.358 178.225 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -59.25 136.73 58.05 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 124.773 1.229 . . . . 0.0 113.541 -175.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 76.46 8.99 86.11 Favored Glycine 0 CA--C 1.536 1.377 0 C-N-CA 124.449 1.023 . . . . 0.0 115.019 175.52 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 12.7 pt20 -141.17 168.92 18.62 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 125.53 1.532 . . . . 0.0 112.592 -179.131 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 28.1 p -66.54 166.08 13.36 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 115.453 1.649 . . . . 0.0 115.453 -169.407 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . 0.315 2.4 pp -68.72 -12.81 61.87 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 114.298 1.221 . . . . 0.0 114.298 173.887 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -70.81 -32.96 70.21 Favored 'General case' 0 CA--C 1.541 0.597 0 O-C-N 121.094 -1.004 . . . . 0.0 109.717 168.785 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 5.3 t -70.63 -40.18 76.8 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 CA-C-O 117.876 -1.059 . . . . 0.0 111.255 170.009 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 14.3 m-85 -54.05 -52.12 61.9 Favored 'General case' 0 N--CA 1.478 0.941 0 CA-C-N 120.287 1.403 . . . . 0.0 111.03 169.356 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 97.6 mtt180 -60.95 -38.69 86.77 Favored 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 124.03 0.932 . . . . 0.0 112.385 -179.138 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 75.2 m -64.84 -43.68 92.24 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.949 0.899 . . . . 0.0 111.341 172.776 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 54.5 t -66.72 -40.6 86.45 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 CA-C-O 117.739 -1.124 . . . . 0.0 111.213 177.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 47.8 mtm-85 -57.04 -41.06 77.95 Favored 'General case' 0 N--CA 1.482 1.153 0 CA-C-N 120.733 1.606 . . . . 0.0 111.295 174.13 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -60.92 -51.84 56.05 Favored Glycine 0 CA--C 1.537 1.462 0 CA-C-N 118.935 0.788 . . . . 0.0 113.597 173.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 60.6 mm-40 -63.89 -44.94 91.51 Favored 'General case' 0 N--CA 1.477 0.882 0 O-C-N 121.965 -0.727 . . . . 0.0 112.199 179.087 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 77.4 t -65.71 -40.61 88.35 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 C-N-CA 124.949 1.3 . . . . 0.0 110.711 178.201 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 36.2 ttmt -54.68 -50.3 68.58 Favored 'General case' 0 N--CA 1.478 0.948 0 CA-C-N 120.311 1.414 . . . . 0.0 110.41 175.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -61.8 -41.31 97.59 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 122.759 0.423 . . . . 0.0 112.119 178.821 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.63 -34.36 78.05 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 124.224 1.01 . . . . 0.0 113.561 176.824 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 97.3 t -80.19 -36.43 16.55 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 C-N-CA 125.353 1.461 . . . . 0.0 111.931 176.576 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -62.61 -39.56 94.19 Favored 'General case' 0 N--CA 1.47 0.536 0 O-C-N 120.885 -1.134 . . . . 0.0 110.97 170.09 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 14.2 m-80 -64.23 -44.72 90.98 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 118.747 0.703 . . . . 0.0 112.598 173.731 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 1.2 tt -48.22 -61.41 2.01 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 125.01 1.324 . . . . 0.0 109.702 172.233 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 82.9 mt -60.4 -44.98 97.28 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 C-N-CA 123.24 0.616 . . . . 0.0 110.648 -177.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -65.78 -12.76 56.66 Favored 'General case' 0 CA--C 1.547 0.853 0 N-CA-C 114.812 1.412 . . . . 0.0 114.812 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 21.1 ptmt -104.11 -27.13 12.27 Favored 'General case' 0 N--CA 1.477 0.904 0 N-CA-C 114.188 1.181 . . . . 0.0 114.188 172.494 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 16.3 pt -95.22 -12.88 8.42 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 N-CA-C 114.625 1.343 . . . . 0.0 114.625 178.618 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 70.1 m . . . . . 0 C--O 1.254 1.335 0 C-N-CA 125.146 1.379 . . . . 0.0 112.501 -179.742 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 36.4 ttm . . . . . 0 N--CA 1.501 2.083 0 N-CA-C 111.793 0.294 . . . . 0.0 111.793 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.0 163.17 30.47 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 125.151 1.38 . . . . 0.0 111.574 169.439 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 34.5 ttmt -101.63 144.17 30.69 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 124.639 1.175 . . . . 0.0 112.513 -179.044 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 21.7 t -124.15 135.09 64.79 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 125.33 1.452 . . . . 0.0 112.561 -176.358 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . 0.53 ' HG3' HG13 ' A' ' 7' ' ' VAL . 49.8 tpp -103.74 125.91 50.53 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.396 0.678 . . . . 0.0 109.716 169.565 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 32.4 m-85 -108.73 121.96 46.13 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.917 1.287 . . . . 0.0 109.04 170.519 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.53 HG13 ' HG3' ' A' ' 5' ' ' MET . 2.8 m -140.5 159.32 24.9 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 N-CA-C 115.267 1.58 . . . . 0.0 115.267 -168.619 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.6 m -150.98 160.85 43.66 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 128.529 2.731 . . . . 0.0 110.693 169.68 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 64.8 pttt -82.77 138.38 34.03 Favored 'General case' 0 N--CA 1.48 1.031 0 O-C-N 121.061 -1.024 . . . . 0.0 112.4 171.283 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 20.5 tpt180 44.31 55.06 5.82 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 126.388 1.875 . . . . 0.0 112.729 -169.879 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 63.3 t30 -50.54 -22.12 1.83 Allowed 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 127.725 2.41 . . . . 0.0 113.475 175.012 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 31.1 m -53.2 -22.64 6.95 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 125.885 1.674 . . . . 0.0 113.929 170.473 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 58.7 m -112.35 157.52 20.91 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 126.212 1.805 . . . . 0.0 111.136 171.021 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 61.9 mtt85 61.26 168.9 0.1 Allowed 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 126.468 1.907 . . . . 0.0 114.728 -178.166 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 62.2 m -113.98 122.48 47.07 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 125.493 1.517 . . . . 0.0 110.165 -177.333 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 3.2 mp0 -97.21 -33.89 11.31 Favored 'General case' 0 N--CA 1.48 1.06 0 N-CA-C 115.748 1.759 . . . . 0.0 115.748 -168.647 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 70.1 -46.67 0.61 Allowed 'General case' 0 N--CA 1.482 1.158 0 N-CA-C 118.313 2.709 . . . . 0.0 118.313 168.804 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.69 -30.13 70.54 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 115.169 1.544 . . . . 0.0 115.169 -169.449 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 5.7 pm0 -61.76 -39.1 90.45 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 118.813 0.733 . . . . 0.0 111.854 172.045 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -69.45 -44.77 63.08 Favored Glycine 0 C--N 1.334 0.457 0 C-N-CA 124.216 0.912 . . . . 0.0 111.783 -177.467 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -68.67 -36.01 77.98 Favored 'General case' 0 N--CA 1.467 0.412 0 O-C-N 121.569 -0.959 . . . . 0.0 112.152 173.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -65.02 -34.97 79.7 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 119.345 0.975 . . . . 0.0 112.363 178.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 22.2 mtpp -67.26 -48.86 66.49 Favored 'General case' 0 N--CA 1.481 1.094 0 O-C-N 121.884 -0.51 . . . . 0.0 111.217 169.572 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 24.7 m -73.71 -28.12 61.55 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 113.239 0.829 . . . . 0.0 113.239 -169.568 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 56.8 mt -97.2 -35.14 10.86 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 125.612 1.565 . . . . 0.0 112.96 176.043 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -103.47 -10.44 35.9 Favored Glycine 0 N--CA 1.469 0.884 0 N-CA-C 117.243 1.657 . . . . 0.0 117.243 -169.157 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -62.81 140.04 58.75 Favored 'General case' 0 CA--C 1.544 0.726 0 CA-C-N 120.936 2.368 . . . . 0.0 112.06 179.805 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 89.88 -21.24 31.34 Favored Glycine 0 CA--C 1.541 1.688 0 C-N-CA 125.048 1.309 . . . . 0.0 113.374 -169.342 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -101.44 -50.71 3.67 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 125.942 1.697 . . . . 0.0 111.026 169.853 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 2.6 pp -131.35 155.93 42.24 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 C-N-CA 125.813 1.645 . . . . 0.0 111.721 179.225 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -103.24 151.62 22.44 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 124.783 1.233 . . . . 0.0 109.718 175.402 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 44.4 t -138.07 142.77 34.85 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.051 0 O-C-N 121.282 -0.886 . . . . 0.0 113.061 -173.716 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 29.6 m -132.93 152.69 51.87 Favored 'General case' 0 CA--C 1.513 -0.465 0 C-N-CA 125.478 1.511 . . . . 0.0 108.029 168.792 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 2.8 p -132.57 141.36 48.67 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 122.283 1.04 . . . . 0.0 111.533 169.638 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 59.9 p -152.3 -174.46 4.89 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 113.599 -1.637 . . . . 0.0 110.209 178.857 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -135.16 170.89 22.72 Favored Glycine 0 C--N 1.335 0.495 0 O-C-N 121.142 -0.974 . . . . 0.0 112.351 174.195 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 6.2 mp -89.86 124.07 34.37 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 105.556 -2.016 . . . . 0.0 105.556 168.633 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 60.25 26.96 16.46 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 124.852 1.261 . . . . 0.0 113.439 -175.018 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 26.9 p -169.51 156.82 6.88 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 125.876 1.671 . . . . 0.0 112.773 -174.474 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 88.6 p -110.16 -51.63 2.85 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 115.546 1.684 . . . . 0.0 115.546 178.396 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 56.6 ttt180 -115.58 139.69 49.85 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 126.779 2.031 . . . . 0.0 113.988 -168.527 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 10.7 m -51.61 148.99 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 126.636 1.975 . . . . 0.0 111.924 169.365 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -62.26 144.65 94.68 Favored Pre-proline 0 CA--C 1.551 1.01 0 CA-C-O 118.893 -0.575 . . . . 0.0 110.448 176.263 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_exo -47.93 -36.04 26.29 Favored 'Trans proline' 0 CA--C 1.538 0.719 0 C-N-CA 124.087 3.191 . . . . 0.0 118.319 -168.12 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 58.7 m -59.64 -27.03 65.99 Favored 'General case' 0 N--CA 1.483 1.187 0 CA-C-N 119.622 1.101 . . . . 0.0 112.166 -178.228 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -55.85 -37.64 69.01 Favored 'General case' 0 CA--C 1.535 0.365 0 C-N-CA 124.113 0.965 . . . . 0.0 113.059 175.247 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.6 mp -63.86 -54.28 33.86 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 CA-C-N 119.183 0.901 . . . . 0.0 108.628 -178.428 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -62.98 -35.44 80.17 Favored 'General case' 0 CA--C 1.544 0.729 0 N-CA-C 113.361 0.874 . . . . 0.0 113.361 -177.552 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -77.75 -23.77 49.21 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 113.923 1.083 . . . . 0.0 113.923 178.188 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -87.93 -29.71 20.63 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 118.948 0.794 . . . . 0.0 109.732 174.612 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -67.19 -13.14 61.68 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.315 1.446 . . . . 0.0 113.791 172.338 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 -60.09 -26.24 66.04 Favored 'General case' 0 N--CA 1.482 1.171 0 CA-C-N 120.452 1.478 . . . . 0.0 110.641 168.836 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 40.8 t -98.26 -0.42 10.36 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.02 0 C-N-CA 127.668 2.387 . . . . 0.0 111.232 178.471 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 78.28 18.62 75.92 Favored Glycine 0 CA--C 1.541 1.675 0 C-N-CA 125.076 1.322 . . . . 0.0 114.878 -176.529 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 77.1 mt -81.68 133.66 28.77 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 C-N-CA 124.929 1.291 . . . . 0.0 111.736 -172.514 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 31.6 t0 -98.21 116.95 31.51 Favored 'General case' 0 N--CA 1.473 0.725 0 CA-C-O 121.41 0.624 . . . . 0.0 111.96 169.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 19.4 pt -127.97 19.43 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 C-N-CA 126.24 1.816 . . . . 0.0 112.379 171.059 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 98.1 p -70.68 -16.23 62.78 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 115.39 1.626 . . . . 0.0 115.39 -173.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -82.69 -0.96 90.48 Favored Glycine 0 CA--C 1.537 1.466 0 C-N-CA 124.762 1.172 . . . . 0.0 115.922 -177.139 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 4.4 tt0 -68.36 -6.15 22.78 Favored 'General case' 0 CA--C 1.547 0.836 0 N-CA-C 116.402 2.001 . . . . 0.0 116.402 -170.29 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.3 m -67.53 -7.83 29.06 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 125.86 1.664 . . . . 0.0 114.6 -170.809 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 78.2 p -64.73 -78.9 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 115.524 1.676 . . . . 0.0 115.524 -170.541 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -148.59 157.85 40.91 Favored Pre-proline 0 CA--C 1.554 1.133 0 N-CA-C 115.459 1.651 . . . . 0.0 115.459 -169.283 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -69.55 163.71 37.08 Favored 'Trans proline' 0 C--N 1.354 0.865 0 C-N-CA 124.967 3.778 . . . . 0.0 114.921 170.107 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 6.0 tt -52.82 -44.69 48.88 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 C-N-CA 124.905 1.282 . . . . 0.0 111.851 178.054 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -66.93 -9.56 39.56 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 114.092 1.145 . . . . 0.0 114.092 -177.681 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 -81.12 -22.67 38.9 Favored 'General case' 0 CA--C 1.548 0.899 0 N-CA-C 113.129 0.789 . . . . 0.0 113.129 174.145 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 82.1 m-85 -94.19 -169.98 2.19 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 125.805 1.642 . . . . 0.0 112.159 -177.251 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -124.6 124.76 42.91 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 125.657 1.583 . . . . 0.0 109.791 176.375 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -67.42 -34.9 78.18 Favored 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 114.241 1.2 . . . . 0.0 114.241 -170.125 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . 0.252 0.0 OUTLIER -72.19 -5.09 33.24 Favored 'General case' 0 CA--C 1.545 0.778 0 N-CA-C 114.163 1.172 . . . . 0.0 114.163 -176.457 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -73.93 -11.39 60.34 Favored 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 123.833 0.853 . . . . 0.0 111.244 168.711 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 74.5 m-85 -117.36 139.57 50.69 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 127.379 2.272 . . . . 0.0 111.251 -179.664 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -92.17 -23.51 19.37 Favored 'General case' 0 N--CA 1.479 1.004 0 CA-C-O 122.359 1.076 . . . . 0.0 112.342 177.055 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.69 HG22 ' HB ' ' A' ' 95' ' ' ILE . 80.3 t -129.56 138.12 55.06 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 C-N-CA 127.252 2.221 . . . . 0.0 108.886 -176.429 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 83.0 t -131.94 127.82 58.82 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 N-CA-C 107.562 -1.273 . . . . 0.0 107.562 170.694 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 27.5 mm -119.31 117.07 52.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 C-N-CA 124.356 1.063 . . . . 0.0 109.251 -178.162 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 22.6 t -98.54 130.93 45.11 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 122.596 0.359 . . . . 0.0 110.553 169.609 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 8.3 mt -101.32 0.51 37.32 Favored 'General case' 0 N--CA 1.478 0.95 0 N-CA-C 113.779 1.029 . . . . 0.0 113.779 178.838 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 84.6 m -135.95 146.67 47.52 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.213 1.005 . . . . 0.0 113.186 -169.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 63.15 -146.57 50.45 Favored Glycine 0 CA--C 1.532 1.147 0 C-N-CA 124.547 1.07 . . . . 0.0 114.356 170.149 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 93.9 p -86.1 -16.61 37.48 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 125.212 1.405 . . . . 0.0 114.593 -178.907 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 76.68 6.83 85.43 Favored Glycine 0 CA--C 1.54 1.6 0 C-N-CA 124.32 0.962 . . . . 0.0 114.598 -170.278 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 58.6 t -88.68 -22.27 6.69 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.162 0 CA-C-N 119.017 1.408 . . . . 0.0 113.118 -175.377 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 34.2 m120 -71.62 -19.47 62.11 Favored 'General case' 0 CA--C 1.547 0.86 0 N-CA-C 114.545 1.313 . . . . 0.0 114.545 -174.452 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -79.19 148.01 70.31 Favored Pre-proline 0 CA--C 1.549 0.915 0 CA-C-N 118.929 0.786 . . . . 0.0 111.768 176.557 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -59.42 155.11 43.05 Favored 'Trans proline' 0 CA--C 1.543 0.974 0 C-N-CA 122.769 2.313 . . . . 0.0 114.151 -178.164 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_exo -55.01 -32.46 79.09 Favored 'Trans proline' 0 C--N 1.35 0.649 0 C-N-CA 123.46 2.773 . . . . 0.0 114.412 -177.318 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -63.62 -31.78 73.05 Favored 'General case' 0 N--CA 1.471 0.617 0 O-C-N 121.277 -0.889 . . . . 0.0 113.025 177.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 94.8 m95 -80.4 -32.34 37.51 Favored 'General case' 0 N--CA 1.473 0.68 0 O-C-N 121.071 -1.018 . . . . 0.0 111.989 175.428 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 75.8 t -67.57 -31.97 54.94 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 C-N-CA 124.499 1.12 . . . . 0.0 112.159 172.527 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -91.98 3.33 55.45 Favored 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 115.799 1.777 . . . . 0.0 115.799 -171.513 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 80.2 mm-40 -65.6 155.17 36.65 Favored 'General case' 0 N--CA 1.478 0.941 0 O-C-N 120.741 -1.224 . . . . 0.0 111.547 170.651 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -56.18 -41.28 75.25 Favored 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 114.466 1.284 . . . . 0.0 114.466 -167.638 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.69 ' HB ' HG22 ' A' ' 75' ' ' VAL . 18.7 mm -119.31 64.57 0.23 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 C-N-CA 125.089 1.356 . . . . 0.0 108.407 177.308 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 15.9 t80 -79.54 108.29 12.96 Favored 'General case' 0 CA--C 1.534 0.356 0 O-C-N 120.989 -1.07 . . . . 0.0 108.77 169.326 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 11.1 mt-10 -110.32 146.47 35.69 Favored 'General case' 0 CA--C 1.545 0.756 0 N-CA-C 114.627 1.343 . . . . 0.0 114.627 174.591 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -114.36 117.21 30.41 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 125.566 1.546 . . . . 0.0 110.022 169.914 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 39.4 m0 -104.96 106.94 17.65 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 124.63 1.172 . . . . 0.0 109.884 -176.482 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 11.2 mm100 -86.9 47.95 1.57 Allowed 'General case' 0 CA--C 1.547 0.862 0 CA-C-O 122.118 0.961 . . . . 0.0 111.843 -172.309 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 89.7 mt -75.36 162.65 28.2 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 126.22 1.808 . . . . 0.0 112.297 178.434 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -79.01 149.57 32.17 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-O 121.351 0.596 . . . . 0.0 112.457 170.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -83.19 127.57 68.41 Favored Pre-proline 0 CA--C 1.544 0.728 0 C-N-CA 123.96 0.904 . . . . 0.0 110.854 174.31 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -82.04 -16.42 8.65 Favored 'Trans proline' 0 CA--C 1.542 0.92 0 C-N-CA 121.335 1.357 . . . . 0.0 115.242 -170.701 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -72.62 -39.81 66.95 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 116.77 2.137 . . . . 0.0 116.77 -168.788 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -75.3 16.79 3.48 Favored Glycine 0 CA--C 1.539 1.559 0 C-N-CA 123.938 0.78 . . . . 0.0 114.679 -175.164 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 8.8 pt20 -157.98 174.44 15.24 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 126.876 2.07 . . . . 0.0 111.818 -169.321 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 70.4 m -63.29 159.29 18.25 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 114.721 1.378 . . . . 0.0 114.721 -169.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 42.3 tp -59.75 -27.15 66.26 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 124.905 1.282 . . . . 0.0 113.295 179.771 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -62.88 -30.7 71.72 Favored 'General case' 0 N--CA 1.473 0.711 0 O-C-N 120.733 -1.229 . . . . 0.0 112.008 171.753 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 3.0 t -75.69 -36.19 33.16 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 O-C-N 120.955 -1.091 . . . . 0.0 111.152 172.725 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -55.48 -48.01 75.24 Favored 'General case' 0 N--CA 1.479 0.978 0 CA-C-N 119.688 1.131 . . . . 0.0 110.548 169.086 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -67.01 -35.94 81.05 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 124.141 0.976 . . . . 0.0 112.382 178.907 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 31.2 m -61.16 -45.53 94.27 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 124.329 1.052 . . . . 0.0 111.239 169.724 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 56.2 t -67.14 -39.19 82.61 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 CA-C-O 117.638 -1.173 . . . . 0.0 111.339 178.2 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 67.4 mtm-85 -56.43 -43.02 79.04 Favored 'General case' 0 N--CA 1.484 1.249 0 CA-C-N 120.694 1.588 . . . . 0.0 111.724 169.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -59.61 -49.47 78.22 Favored Glycine 0 CA--C 1.537 1.417 0 CA-C-N 118.982 0.81 . . . . 0.0 113.871 174.529 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 52.4 mm-40 -65.66 -44.38 86.48 Favored 'General case' 0 N--CA 1.475 0.784 0 O-C-N 121.585 -0.95 . . . . 0.0 112.193 178.274 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 60.5 t -65.13 -40.15 87.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 C-N-CA 124.622 1.169 . . . . 0.0 110.789 177.816 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 61.4 tttm -54.71 -49.9 69.6 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 119.515 1.052 . . . . 0.0 110.932 175.796 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -64.48 -42.05 96.12 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 112.486 0.55 . . . . 0.0 112.486 177.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 16.5 mmm180 -61.26 -45.97 92.32 Favored 'General case' 0 N--CA 1.479 0.982 0 O-C-N 121.597 -0.689 . . . . 0.0 112.529 175.409 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 92.7 t -68.38 -40.95 83.11 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 C-N-CA 124.006 0.923 . . . . 0.0 111.268 179.49 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -62.48 -39.95 95.11 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 119.258 0.935 . . . . 0.0 111.593 173.165 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 13.9 m-80 -63.25 -46.7 85.67 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 118.982 0.81 . . . . 0.0 112.189 173.751 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -54.7 -55.21 32.17 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 124.607 1.163 . . . . 0.0 110.585 176.467 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 73.1 mt -59.82 -45.88 94.32 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 CA-C-O 119.079 -0.486 . . . . 0.0 110.084 178.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -67.89 -11.47 58.75 Favored 'General case' 0 CA--C 1.545 0.776 0 N-CA-C 115.318 1.599 . . . . 0.0 115.318 -179.215 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 21.0 ptmt -100.54 -24.13 14.53 Favored 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 113.798 1.036 . . . . 0.0 113.798 171.286 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 16.4 pt -97.78 -13.95 7.92 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 N-CA-C 114.592 1.33 . . . . 0.0 114.592 177.692 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 54.5 m . . . . . 0 C--O 1.254 1.293 0 C-N-CA 125.373 1.469 . . . . 0.0 112.032 -179.815 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.407 ' HA ' ' O ' ' A' ' 29' ' ' LYS . 22.6 ttt . . . . . 0 N--CA 1.503 2.207 0 N-CA-C 111.74 0.274 . . . . 0.0 111.74 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.21 164.06 31.28 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 125.089 1.355 . . . . 0.0 112.527 176.575 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 58.9 mttt -99.14 151.07 21.39 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 124.185 0.994 . . . . 0.0 112.46 177.731 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 12.5 t -129.2 138.49 54.29 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 C-N-CA 125.103 1.361 . . . . 0.0 112.674 179.019 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . 0.503 ' HG3' HG13 ' A' ' 7' ' ' VAL . 62.0 tpp -107.75 120.94 43.65 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 123.726 0.81 . . . . 0.0 109.429 168.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 68.5 m-85 -100.73 127.09 47.29 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 124.27 1.028 . . . . 0.0 108.99 170.58 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.503 HG13 ' HG3' ' A' ' 5' ' ' MET . 1.0 OUTLIER -144.43 156.12 14.96 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.084 0 N-CA-C 114.769 1.396 . . . . 0.0 114.769 -168.177 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -151.38 169.29 22.36 Favored 'General case' 0 CA--C 1.552 1.043 0 C-N-CA 127.159 2.183 . . . . 0.0 110.939 173.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 61.8 mtpt -49.26 -62.74 1.37 Allowed 'General case' 0 N--CA 1.495 1.788 0 C-N-CA 126.126 1.77 . . . . 0.0 113.789 -173.762 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 28.8 mmt85 -127.68 106.3 9.05 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 126.164 1.785 . . . . 0.0 107.588 172.506 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 36.1 p-10 -74.32 -11.1 60.17 Favored 'General case' 0 CA--C 1.556 1.195 0 CA-C-N 119.458 1.027 . . . . 0.0 112.357 -176.831 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 69.8 m -80.13 -6.71 58.19 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 125.08 1.352 . . . . 0.0 112.855 169.464 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 72.8 m -108.18 -69.61 0.84 Allowed 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 124.71 1.204 . . . . 0.0 110.03 172.02 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 66.7 mtt85 -74.35 122.61 23.2 Favored 'General case' 0 N--CA 1.479 1.015 0 O-C-N 121.444 -0.785 . . . . 0.0 109.092 173.679 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 52.4 p -69.45 -28.29 65.98 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 115.644 1.72 . . . . 0.0 115.644 -168.784 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 7.6 mt-30 61.26 -177.81 0.11 Allowed 'General case' 0 CA--C 1.552 1.027 0 C-N-CA 124.633 1.173 . . . . 0.0 112.482 -170.07 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -175.12 -47.48 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 126.366 1.867 . . . . 0.0 110.947 -169.447 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -56.73 -32.16 65.26 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 115.331 1.604 . . . . 0.0 115.331 -169.398 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.3 pm0 -57.16 -41.68 79.66 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 123.528 0.731 . . . . 0.0 112.757 177.545 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -67.25 -43.79 87.95 Favored Glycine 0 C--N 1.334 0.436 0 C-N-CA 124.821 1.2 . . . . 0.0 112.071 -177.465 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -71.53 -35.36 70.65 Favored 'General case' 0 N--CA 1.47 0.534 0 O-C-N 121.542 -0.975 . . . . 0.0 112.005 174.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -64.09 -33.66 76.27 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 118.986 0.812 . . . . 0.0 112.034 -175.652 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 2.7 pttp -85.08 -36.43 21.19 Favored 'General case' 0 N--CA 1.479 1.024 0 N-CA-C 113.644 0.979 . . . . 0.0 113.644 169.686 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 56.3 m -68.88 -31.29 70.11 Favored 'General case' 0 N--CA 1.486 1.338 0 CA-C-N 119.455 1.025 . . . . 0.0 112.3 -178.642 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 70.8 mt -91.22 -37.85 13.07 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 126.131 1.772 . . . . 0.0 112.645 173.022 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -100.62 2.08 55.81 Favored Glycine 0 N--CA 1.472 1.06 0 N-CA-C 117.262 1.665 . . . . 0.0 117.262 -169.539 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -60.55 141.63 56.34 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-N 121.133 2.466 . . . . 0.0 112.303 177.648 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 82.91 -15.15 33.67 Favored Glycine 0 CA--C 1.54 1.643 0 C-N-CA 124.74 1.162 . . . . 0.0 113.657 -169.408 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.407 ' O ' ' HA ' ' A' ' 1' ' ' MET . 69.7 mttt -108.22 -43.7 4.31 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 126.309 1.844 . . . . 0.0 112.484 171.841 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 42.7 pt -139.93 160.02 26.66 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 C-N-CA 124.92 1.288 . . . . 0.0 113.416 -177.203 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -107.64 149.31 28.24 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 125.487 1.515 . . . . 0.0 110.724 169.747 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 98.8 t -137.78 141.11 39.79 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 O-C-N 121.197 -0.94 . . . . 0.0 113.085 -175.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 79.3 m -135.51 152.85 51.73 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 125.805 1.642 . . . . 0.0 109.28 169.521 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 88.9 p -133.21 142.7 48.71 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 122.419 1.104 . . . . 0.0 113.208 167.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 35.7 p -145.43 170.5 16.23 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 114.002 -1.453 . . . . 0.0 112.251 -173.863 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -92.82 152.83 21.24 Favored Glycine 0 N--CA 1.467 0.763 0 O-C-N 121.56 -0.713 . . . . 0.0 111.392 174.863 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 2.2 mp -65.97 -32.8 74.5 Favored 'General case' 0 N--CA 1.483 1.207 0 CA-C-N 118.807 1.303 . . . . 0.0 111.744 171.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -120.47 165.49 14.88 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 126.685 1.994 . . . . 0.0 108.93 169.089 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 52.2 m -53.95 100.19 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 125.281 1.432 . . . . 0.0 113.6 -169.703 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 24.0 p -156.97 156.44 33.0 Favored 'General case' 0 CA--C 1.548 0.897 0 N-CA-C 114.159 1.17 . . . . 0.0 114.159 -175.666 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 49.7 ttt180 -107.77 140.66 40.51 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 128.815 2.846 . . . . 0.0 109.199 174.781 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 18.5 m -53.65 117.97 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.36 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 173.477 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . 0.276 0.0 OUTLIER -58.25 143.75 78.67 Favored Pre-proline 0 CA--C 1.536 0.439 0 N-CA-C 112.699 0.629 . . . . 0.0 112.699 -167.901 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 81.5 Cg_exo -47.34 -36.25 22.59 Favored 'Trans proline' 0 CA--C 1.538 0.681 0 C-N-CA 123.449 2.766 . . . . 0.0 116.792 -168.121 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 56.3 m -64.18 -26.27 68.45 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.915 0.886 . . . . 0.0 112.552 -179.091 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -55.08 -49.53 71.43 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 119.517 1.053 . . . . 0.0 110.601 173.25 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.6 mp -54.2 -57.16 6.6 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 C-N-CA 124.189 0.996 . . . . 0.0 110.176 -173.41 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.95 -28.09 69.59 Favored 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 113.22 0.822 . . . . 0.0 113.22 -175.243 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -79.91 -28.51 39.8 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 113.6 0.963 . . . . 0.0 113.6 177.79 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 4.9 mmt -77.39 -36.49 53.35 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-N 119.142 0.883 . . . . 0.0 110.645 169.743 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -61.9 -16.39 50.3 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 125.095 1.358 . . . . 0.0 114.17 174.421 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -61.08 -29.79 69.96 Favored 'General case' 0 N--CA 1.479 0.984 0 CA-C-N 120.714 1.597 . . . . 0.0 111.747 169.508 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 59.1 t -89.89 -6.38 10.79 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.889 0 C-N-CA 126.627 1.971 . . . . 0.0 111.294 175.673 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 81.63 13.93 79.04 Favored Glycine 0 CA--C 1.539 1.554 0 C-N-CA 125.245 1.402 . . . . 0.0 114.281 -170.589 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 83.5 mt -77.91 142.04 14.7 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 124.618 1.167 . . . . 0.0 111.144 -178.016 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -101.05 131.3 47.01 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 123.517 0.727 . . . . 0.0 111.044 169.172 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 13.4 pt -135.3 8.25 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 C-N-CA 124.234 1.014 . . . . 0.0 113.33 169.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 51.8 m -77.65 152.06 34.0 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 125.228 1.411 . . . . 0.0 113.228 -171.004 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 67.89 20.61 72.68 Favored Glycine 0 N--CA 1.473 1.119 0 N-CA-C 116.035 1.174 . . . . 0.0 116.035 169.758 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 48.1 mt-30 -67.0 -69.98 0.28 Allowed 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 118.701 1.25 . . . . 0.0 112.158 -179.387 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 7.4 t -166.37 169.82 13.65 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 125.238 1.415 . . . . 0.0 112.323 -177.087 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 96.8 p -129.05 5.05 5.33 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 128.419 2.687 . . . . 0.0 112.379 169.474 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 32.5 m-20 -89.94 153.94 47.4 Favored Pre-proline 0 CA--C 1.543 0.676 0 C-N-CA 124.721 1.208 . . . . 0.0 113.299 -177.866 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -70.43 157.28 59.57 Favored 'Trans proline' 0 N--CA 1.458 -0.579 0 C-N-CA 123.089 2.526 . . . . 0.0 112.12 175.771 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 5.9 tt -50.57 -34.34 12.17 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 C-N-CA 124.991 1.316 . . . . 0.0 111.349 169.556 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 18.8 mt-10 -63.71 -17.91 63.47 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 125.547 1.539 . . . . 0.0 113.558 -178.758 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -83.61 -12.34 56.16 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 124.669 1.188 . . . . 0.0 113.659 -178.627 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 74.7 m-85 -106.64 -172.21 2.04 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 125.946 1.699 . . . . 0.0 111.733 -176.417 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 10.5 t30 -120.77 122.44 40.37 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 125.182 1.393 . . . . 0.0 110.274 177.328 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -68.05 -35.83 78.88 Favored 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 113.726 1.01 . . . . 0.0 113.726 -171.42 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -71.28 -4.98 28.83 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 114.409 1.262 . . . . 0.0 114.409 -175.155 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -73.08 -14.0 61.31 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 123.573 0.749 . . . . 0.0 111.691 168.823 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 39.2 m-85 -119.54 134.2 55.33 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 126.939 2.096 . . . . 0.0 111.068 -178.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -88.44 -19.64 26.26 Favored 'General case' 0 N--CA 1.48 1.058 0 CA-C-O 122.36 1.076 . . . . 0.0 112.672 -179.806 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.647 HG22 ' HB ' ' A' ' 95' ' ' ILE . 95.9 t -130.88 136.77 57.43 Favored 'Isoleucine or valine' 0 C--O 1.235 0.336 0 C-N-CA 127.722 2.409 . . . . 0.0 107.853 -175.411 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 65.3 t -134.13 127.07 50.79 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 170.384 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 48.3 mm -116.17 106.7 20.87 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.249 0 C-N-CA 124.454 1.101 . . . . 0.0 109.395 -171.873 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 4.0 m -92.38 108.2 19.78 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 123.049 0.54 . . . . 0.0 110.321 177.202 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 78.3 mt -78.07 -9.48 59.16 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 125.872 1.669 . . . . 0.0 113.406 -179.371 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 23.9 m -108.34 103.99 13.26 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 125.664 1.586 . . . . 0.0 110.733 -179.04 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 57.65 -139.66 46.72 Favored Glycine 0 CA--C 1.535 1.331 0 C-N-CA 124.325 0.964 . . . . 0.0 114.236 172.831 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 85.0 p -69.91 -14.28 62.65 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 124.84 1.256 . . . . 0.0 114.108 175.793 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 72.09 7.79 67.84 Favored Glycine 0 CA--C 1.528 0.902 0 N-CA-C 115.6 1.0 . . . . 0.0 115.6 178.872 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.3 p -72.51 -9.58 13.08 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.988 0 CA-C-N 119.593 1.696 . . . . 0.0 114.675 -169.89 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 -80.64 -16.71 53.34 Favored 'General case' 0 CA--C 1.547 0.857 0 N-CA-C 114.701 1.371 . . . . 0.0 114.701 -174.162 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -71.07 159.14 86.51 Favored Pre-proline 0 CA--C 1.551 0.985 0 CA-C-N 119.214 0.916 . . . . 0.0 112.317 170.926 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_exo -60.53 151.86 72.33 Favored 'Trans proline' 0 CA--C 1.544 1.014 0 C-N-CA 122.133 1.888 . . . . 0.0 113.321 -176.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_exo -54.35 -36.59 87.59 Favored 'Trans proline' 0 C--N 1.352 0.751 0 C-N-CA 123.458 2.772 . . . . 0.0 115.164 -169.816 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -63.71 -22.28 66.83 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 114.131 1.16 . . . . 0.0 114.131 179.723 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 77.7 m95 -82.99 -23.1 33.47 Favored 'General case' 0 N--CA 1.47 0.531 0 O-C-N 120.888 -1.133 . . . . 0.0 112.486 172.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 10.5 t -73.67 -30.37 29.01 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 C-N-CA 124.996 1.318 . . . . 0.0 110.91 170.336 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 76.5 p -91.14 3.33 55.06 Favored 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 116.252 1.945 . . . . 0.0 116.252 -174.869 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 80.4 mm-40 -66.36 149.62 50.11 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 119.503 1.047 . . . . 0.0 108.984 169.294 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -59.73 -37.97 80.41 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 114.577 1.325 . . . . 0.0 114.577 -167.154 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.647 ' HB ' HG22 ' A' ' 75' ' ' VAL . 16.2 mm -113.01 56.64 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 C-N-CA 124.715 1.206 . . . . 0.0 109.385 177.488 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 40.7 t80 -75.57 106.52 7.17 Favored 'General case' 0 CA--C 1.535 0.395 0 O-C-N 120.633 -1.292 . . . . 0.0 107.522 168.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.7 mt-10 -106.41 133.28 51.34 Favored 'General case' 0 CA--C 1.543 0.678 0 N-CA-C 113.556 0.947 . . . . 0.0 113.556 175.877 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -88.95 111.51 22.21 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.41 1.084 . . . . 0.0 109.339 169.432 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 15.2 m0 -97.99 101.22 12.65 Favored 'General case' 0 N--CA 1.462 0.158 0 C-N-CA 123.813 0.845 . . . . 0.0 109.48 -176.859 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 54.9 mm-40 -78.64 41.14 0.4 Allowed 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 125.995 1.718 . . . . 0.0 111.676 -177.291 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 33.1 mt -91.59 163.68 14.04 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 126.277 1.831 . . . . 0.0 113.19 -172.155 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -73.92 150.42 40.85 Favored 'General case' 0 CA--C 1.545 0.784 0 CA-C-N 114.857 -1.065 . . . . 0.0 111.715 169.728 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . 0.415 ' HA ' ' HD3' ' A' ' 104' ' ' PRO . 18.9 t70 -112.71 138.85 22.23 Favored Pre-proline 0 CA--C 1.549 0.923 0 C-N-CA 124.339 1.056 . . . . 0.0 111.108 169.564 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 103' ' ' ASP . 45.0 Cg_exo -66.81 -19.84 52.57 Favored 'Trans proline' 0 CA--C 1.54 0.822 0 C-N-CA 122.511 2.141 . . . . 0.0 116.61 -178.139 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -68.03 144.83 54.95 Favored 'General case' 0 CA--C 1.545 0.757 0 CA-C-N 120.375 1.443 . . . . 0.0 114.102 -170.424 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 77.69 6.52 86.98 Favored Glycine 0 CA--C 1.535 1.338 0 C-N-CA 124.815 1.198 . . . . 0.0 114.586 -177.936 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 13.3 pt20 -140.85 174.37 10.58 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 126.015 1.726 . . . . 0.0 112.165 179.832 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 25.0 p -67.71 164.73 18.72 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 117.395 2.369 . . . . 0.0 117.395 -168.659 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -53.5 -41.35 66.19 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 126.272 1.829 . . . . 0.0 111.961 169.767 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -60.01 -36.11 76.52 Favored 'General case' 0 CA--C 1.543 0.697 0 O-C-N 121.47 -0.769 . . . . 0.0 111.922 174.653 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 16.3 t -68.86 -40.8 81.68 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 O-C-N 121.177 -0.952 . . . . 0.0 111.463 171.141 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -52.31 -50.55 61.99 Favored 'General case' 0 N--CA 1.476 0.839 0 CA-C-N 119.56 1.073 . . . . 0.0 112.104 170.629 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 96.0 mtt180 -67.87 -35.17 78.06 Favored 'General case' 0 N--CA 1.477 0.883 0 O-C-N 121.399 -0.813 . . . . 0.0 112.751 179.428 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 79.4 m -63.67 -42.17 98.09 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.682 0.793 . . . . 0.0 110.957 172.229 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 71.5 t -67.9 -39.86 82.47 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 CA-C-O 117.914 -1.041 . . . . 0.0 111.215 176.603 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 27.1 mtm105 -54.56 -42.71 71.31 Favored 'General case' 0 N--CA 1.484 1.252 0 CA-C-N 120.52 1.509 . . . . 0.0 112.109 173.026 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -62.39 -51.34 57.08 Favored Glycine 0 CA--C 1.539 1.549 0 CA-C-N 119.052 0.842 . . . . 0.0 113.311 176.383 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 68.8 mm-40 -63.3 -44.42 95.08 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.234 0.614 . . . . 0.0 112.017 179.845 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 69.3 t -67.18 -41.16 86.51 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 C-N-CA 124.592 1.157 . . . . 0.0 111.028 177.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 34.6 ttmt -54.56 -49.9 69.21 Favored 'General case' 0 N--CA 1.478 0.971 0 CA-C-N 120.491 1.496 . . . . 0.0 110.773 177.645 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -61.1 -40.14 92.61 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 112.242 0.46 . . . . 0.0 112.242 177.492 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.11 -35.26 80.02 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 124.226 1.011 . . . . 0.0 113.228 176.947 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 99.6 t -77.34 -38.46 26.84 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 C-N-CA 125.195 1.398 . . . . 0.0 111.621 176.508 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -60.25 -40.2 89.45 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 119.198 0.908 . . . . 0.0 111.178 170.892 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 17.1 m-80 -64.35 -43.55 94.21 Favored 'General case' 0 CA--C 1.542 0.635 0 N-CA-C 112.56 0.578 . . . . 0.0 112.56 174.093 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 9.1 tt -53.69 -55.01 29.86 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 124.401 1.08 . . . . 0.0 110.477 173.148 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 76.4 mt -63.49 -41.81 93.98 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.625 0 C-N-CA 122.658 0.383 . . . . 0.0 110.589 -178.433 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -69.72 -12.68 61.82 Favored 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 114.578 1.325 . . . . 0.0 114.578 178.346 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 20.7 ptmt -101.27 -30.93 11.24 Favored 'General case' 0 N--CA 1.477 0.906 0 N-CA-C 113.915 1.08 . . . . 0.0 113.915 173.297 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 13.5 pt -94.09 -18.84 6.77 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 N-CA-C 114.528 1.307 . . . . 0.0 114.528 179.255 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 74.5 m . . . . . 0 C--O 1.253 1.26 0 C-N-CA 125.539 1.536 . . . . 0.0 111.708 -175.354 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 34.8 ttm . . . . . 0 N--CA 1.501 2.086 0 N-CA-C 112.087 0.403 . . . . 0.0 112.087 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.47 162.92 26.05 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 125.146 1.379 . . . . 0.0 111.247 169.234 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 69.0 mttt -96.99 147.44 23.99 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.648 0.779 . . . . 0.0 111.527 172.728 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 17.2 t -124.42 135.53 63.49 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 C-N-CA 125.297 1.439 . . . . 0.0 111.927 176.046 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . 0.478 ' HG3' HG13 ' A' ' 7' ' ' VAL . 54.3 tpp -106.07 125.75 51.37 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 123.229 0.611 . . . . 0.0 109.501 168.724 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 67.1 m-85 -103.89 125.18 50.11 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.43 1.092 . . . . 0.0 108.918 172.846 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.478 HG13 ' HG3' ' A' ' 5' ' ' MET . 2.1 m -143.46 156.99 16.82 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.167 0 C-N-CA 124.661 1.184 . . . . 0.0 113.151 -169.175 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 18.2 t -153.65 141.7 20.33 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 126.304 1.842 . . . . 0.0 108.437 168.625 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . 0.263 60.7 pttt -73.79 -15.98 61.17 Favored 'General case' 0 N--CA 1.486 1.335 0 N-CA-C 116.385 1.994 . . . . 0.0 116.385 -169.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 16.2 ptm180 -121.08 49.68 1.46 Allowed 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 125.46 1.504 . . . . 0.0 112.645 169.899 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 5.8 t30 -46.79 -31.87 3.3 Favored 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 126.058 1.743 . . . . 0.0 114.582 -177.683 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 67.7 m -69.61 -23.78 63.56 Favored 'General case' 0 N--CA 1.479 1.0 0 N-CA-C 114.017 1.117 . . . . 0.0 114.017 178.131 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 36.9 m -89.9 -15.63 31.72 Favored 'General case' 0 N--CA 1.478 0.954 0 N-CA-C 114.247 1.203 . . . . 0.0 114.247 -176.244 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 55.7 mtp85 -135.5 159.03 42.88 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 125.607 1.563 . . . . 0.0 112.632 -169.847 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 26.1 t -100.25 145.59 27.9 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.234 1.414 . . . . 0.0 107.742 168.478 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 3.9 mp0 -108.76 -37.67 5.83 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 115.331 1.604 . . . . 0.0 115.331 -168.361 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . 0.4 ' HG2' ' SD ' ' A' ' 50' ' ' MET . 0.0 OUTLIER 66.07 -47.48 0.41 Allowed 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 126.996 2.118 . . . . 0.0 116.281 170.46 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.16 -35.81 76.15 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.649 1.18 . . . . 0.0 113.945 -169.824 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 3.9 pm0 -58.94 -38.31 78.72 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 125.049 1.339 . . . . 0.0 113.215 176.057 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -69.92 -45.03 59.4 Favored Glycine 0 N--CA 1.464 0.552 0 C-N-CA 123.688 0.661 . . . . 0.0 111.831 -177.737 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -69.29 -32.7 72.03 Favored 'General case' 0 N--CA 1.466 0.347 0 O-C-N 121.793 -0.828 . . . . 0.0 112.51 173.73 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -64.61 -36.71 85.12 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 119.347 0.976 . . . . 0.0 112.302 -174.804 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.23 -38.96 30.01 Favored 'General case' 0 N--CA 1.482 1.163 0 N-CA-C 112.904 0.705 . . . . 0.0 112.904 169.464 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 70.7 m -67.09 -32.46 73.63 Favored 'General case' 0 N--CA 1.485 1.286 0 CA-C-N 118.96 0.8 . . . . 0.0 112.24 -176.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 66.9 mt -91.85 -39.86 11.51 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 125.733 1.613 . . . . 0.0 112.926 173.858 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -99.02 3.43 58.5 Favored Glycine 0 N--CA 1.472 1.036 0 N-CA-C 117.444 1.738 . . . . 0.0 117.444 -169.431 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.24 142.02 57.11 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 121.034 2.417 . . . . 0.0 112.11 178.369 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 84.16 -21.65 9.74 Favored Glycine 0 CA--C 1.539 1.572 0 C-N-CA 125.092 1.33 . . . . 0.0 113.268 -169.442 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -98.88 -46.39 5.65 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 125.603 1.561 . . . . 0.0 111.985 171.609 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 43.0 pt -137.58 154.58 29.86 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 C-N-CA 124.96 1.304 . . . . 0.0 113.37 -175.375 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -102.59 142.37 33.87 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 124.757 1.223 . . . . 0.0 109.938 169.809 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 85.9 t -131.16 139.57 50.66 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 CA-C-N 118.928 0.785 . . . . 0.0 113.058 -176.455 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 27.5 m -139.69 154.24 47.44 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 125.815 1.646 . . . . 0.0 109.586 173.346 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 52.2 m -128.64 147.74 50.75 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.718 0.771 . . . . 0.0 110.841 168.448 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 3.8 m -142.69 151.76 41.68 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 113.926 -1.488 . . . . 0.0 110.981 177.119 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -89.59 174.08 40.97 Favored Glycine 0 CA--C 1.527 0.825 0 N-CA-C 110.383 -1.087 . . . . 0.0 110.383 169.166 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -84.47 -36.99 21.9 Favored 'General case' 0 N--CA 1.477 0.924 0 O-C-N 121.414 -1.05 . . . . 0.0 112.816 175.138 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -128.77 18.83 6.17 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 126.192 1.797 . . . . 0.0 111.628 175.02 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 34.7 p -142.86 153.13 42.87 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 126.069 1.747 . . . . 0.0 111.975 -173.768 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 98.5 p -95.8 -18.56 20.31 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 117.528 2.418 . . . . 0.0 117.528 -168.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 19.0 ttm105 -152.29 151.77 31.32 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 124.916 1.286 . . . . 0.0 111.789 -169.757 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 34.1 m -64.94 136.84 26.02 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 C-N-CA 123.328 0.651 . . . . 0.0 109.364 170.032 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -60.84 143.23 91.59 Favored Pre-proline 0 CA--C 1.551 1.005 0 N-CA-C 112.678 0.622 . . . . 0.0 112.678 -169.046 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_exo -46.59 -40.4 23.66 Favored 'Trans proline' 0 CA--C 1.538 0.718 0 C-N-CA 124.192 3.261 . . . . 0.0 118.731 -168.154 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 33.5 m -63.74 -27.25 69.07 Favored 'General case' 0 N--CA 1.484 1.249 0 CA-C-N 119.759 1.163 . . . . 0.0 111.936 -177.354 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -57.49 -50.15 73.99 Favored 'General case' 0 CA--C 1.537 0.448 0 O-C-N 121.373 -0.83 . . . . 0.0 111.548 173.705 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 4.6 mp -56.94 -50.94 74.22 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 CA-C-N 119.438 1.017 . . . . 0.0 111.126 -175.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -61.22 -27.9 68.77 Favored 'General case' 0 CA--C 1.546 0.804 0 N-CA-C 113.176 0.806 . . . . 0.0 113.176 -179.255 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -83.5 -24.0 31.91 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 113.963 1.098 . . . . 0.0 113.963 175.133 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . 0.4 ' SD ' ' HG2' ' A' ' 17' ' ' MET . 4.4 mmt -80.44 -30.5 37.57 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 119.758 1.163 . . . . 0.0 110.188 169.602 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -64.9 -14.92 61.24 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 125.345 1.458 . . . . 0.0 113.604 173.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -61.58 -27.0 68.32 Favored 'General case' 0 N--CA 1.482 1.173 0 CA-C-N 120.639 1.563 . . . . 0.0 110.918 169.104 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 61.0 t -95.8 -2.96 10.48 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.902 0 C-N-CA 127.574 2.349 . . . . 0.0 111.148 177.837 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 77.98 16.87 79.29 Favored Glycine 0 CA--C 1.54 1.598 0 O-C-N 120.699 -1.25 . . . . 0.0 114.397 -174.737 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 77.5 mt -72.34 137.32 23.79 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 124.687 1.195 . . . . 0.0 111.247 -177.456 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 18.0 t0 -105.29 105.41 15.43 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 124.331 1.052 . . . . 0.0 112.098 179.347 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 15.8 pt -137.32 18.99 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.309 0 N-CA-C 114.867 1.432 . . . . 0.0 114.867 -178.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 89.1 p -70.95 -36.87 72.76 Favored 'General case' 0 N--CA 1.479 0.982 0 O-C-N 120.138 -1.601 . . . . 0.0 112.691 175.33 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -77.54 39.16 1.7 Allowed Glycine 0 CA--C 1.538 1.471 0 C-N-CA 126.502 2.001 . . . . 0.0 114.788 177.443 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 5.9 mm-40 -83.42 65.78 8.53 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 125.621 1.568 . . . . 0.0 112.57 -172.427 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER 63.59 -30.79 0.1 Allowed 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 119.741 3.237 . . . . 0.0 119.741 169.11 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 71.2 m 59.37 32.3 21.73 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 125.387 1.475 . . . . 0.0 114.382 -179.622 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -150.95 145.92 18.7 Favored Pre-proline 0 CA--C 1.551 1.013 0 O-C-N 120.974 -1.079 . . . . 0.0 113.798 179.221 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -66.24 162.9 33.95 Favored 'Trans proline' 0 CA--C 1.54 0.795 0 C-N-CA 124.543 3.496 . . . . 0.0 114.599 171.095 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.432 HD11 ' CE3' ' A' ' 90' ' ' TRP . 9.3 tp -57.33 -35.1 47.9 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 C-N-CA 124.536 1.134 . . . . 0.0 112.113 177.924 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -68.21 -10.22 52.85 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 113.79 1.033 . . . . 0.0 113.79 -179.569 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 66.2 m-20 -95.27 11.72 31.53 Favored 'General case' 0 CA--C 1.555 1.157 0 N-CA-C 113.791 1.034 . . . . 0.0 113.791 178.892 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 76.8 m-85 -130.86 177.72 7.2 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 125.526 1.531 . . . . 0.0 114.514 -174.899 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 8.1 t30 -107.69 131.81 54.02 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 126.921 2.088 . . . . 0.0 109.975 172.858 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -73.89 -35.34 64.69 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 114.673 1.361 . . . . 0.0 114.673 -176.436 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . 0.273 0.0 OUTLIER -71.69 -6.38 40.74 Favored 'General case' 0 CA--C 1.544 0.734 0 N-CA-C 114.401 1.26 . . . . 0.0 114.401 -172.213 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -62.55 -27.73 69.37 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 124.28 1.032 . . . . 0.0 110.494 168.327 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 19.4 m-85 -113.77 121.65 44.71 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 125.65 1.58 . . . . 0.0 111.132 -172.213 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -73.0 -23.57 60.65 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-O 121.77 0.795 . . . . 0.0 112.555 175.851 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.51 HG22 ' HB ' ' A' ' 95' ' ' ILE . 90.8 t -126.9 136.41 60.87 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 C-N-CA 127.486 2.314 . . . . 0.0 109.299 -174.917 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 54.2 t -135.51 120.23 27.5 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 169.621 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 25.9 mm -106.82 117.97 53.65 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 C-N-CA 123.314 0.646 . . . . 0.0 109.498 -176.63 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 14.2 t -89.07 124.09 33.97 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 169.607 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 87.6 mt -100.08 13.58 33.61 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 125.147 1.379 . . . . 0.0 114.188 -170.044 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 20.8 p -149.19 1.74 0.55 Allowed 'General case' 0 CA--C 1.547 0.845 0 N-CA-C 114.926 1.454 . . . . 0.0 114.926 177.597 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 68.53 170.34 5.99 Favored Glycine 0 CA--C 1.541 1.682 0 C-N-CA 124.261 0.934 . . . . 0.0 114.161 -176.288 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 71.7 m 54.89 29.5 12.2 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 125.192 1.397 . . . . 0.0 113.685 178.342 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -73.4 18.02 1.77 Allowed Glycine 0 N--CA 1.474 1.213 0 C-N-CA 126.327 1.917 . . . . 0.0 114.688 -177.799 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 4.2 p -65.24 -5.46 2.57 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.881 0 C-N-CA 126.227 1.811 . . . . 0.0 114.482 -169.886 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 26.7 m120 -76.27 -18.43 58.99 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 125.072 1.349 . . . . 0.0 114.338 176.106 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -74.27 156.48 87.39 Favored Pre-proline 0 N--CA 1.483 1.179 0 CA-C-N 120.277 1.399 . . . . 0.0 112.144 169.918 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_exo -57.27 150.57 57.37 Favored 'Trans proline' 0 CA--C 1.544 1.01 0 C-N-CA 122.999 2.466 . . . . 0.0 114.087 179.308 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -62.22 -24.17 75.95 Favored 'Trans proline' 0 CA--C 1.536 0.586 0 C-N-CA 123.531 2.821 . . . . 0.0 113.814 -174.358 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -60.98 -24.14 65.88 Favored 'General case' 0 CA--C 1.54 0.578 0 O-C-N 121.056 -1.028 . . . . 0.0 113.534 176.052 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . 0.432 ' CE3' HD11 ' A' ' 65' ' ' ILE . 87.3 m95 -79.51 -35.88 39.38 Favored 'General case' 0 N--CA 1.473 0.719 0 O-C-N 120.818 -1.176 . . . . 0.0 112.668 175.364 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 3.9 m -79.34 -18.49 12.87 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.149 0 N-CA-C 113.164 0.802 . . . . 0.0 113.164 178.295 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -86.68 -1.38 57.66 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 114.406 1.262 . . . . 0.0 114.406 177.662 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 84.7 mm-40 -64.14 154.33 35.0 Favored 'General case' 0 N--CA 1.478 0.935 0 O-C-N 120.907 -1.12 . . . . 0.0 110.625 170.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -59.76 -38.25 81.29 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 114.007 1.114 . . . . 0.0 114.007 -168.281 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.51 ' HB ' HG22 ' A' ' 75' ' ' VAL . 17.0 mm -118.18 60.08 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 C-N-CA 125.078 1.351 . . . . 0.0 109.783 179.057 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 47.2 t80 -78.94 106.25 10.84 Favored 'General case' 0 CA--C 1.536 0.413 0 O-C-N 120.749 -1.219 . . . . 0.0 107.777 168.853 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -111.18 131.24 55.27 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 113.523 0.934 . . . . 0.0 113.523 -179.581 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 -92.08 113.01 25.17 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 124.977 1.311 . . . . 0.0 110.825 169.503 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 39.6 m0 -103.97 113.12 26.43 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 124.863 1.265 . . . . 0.0 109.459 174.341 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 34.6 mm-40 -78.98 59.69 2.72 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 124.58 1.152 . . . . 0.0 109.115 169.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 17.4 tp -79.32 145.58 33.39 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 126.068 1.747 . . . . 0.0 111.255 -169.76 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -69.2 125.3 26.27 Favored 'General case' 0 CA--C 1.542 0.645 0 O-C-N 122.146 -0.346 . . . . 0.0 111.068 169.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -75.45 134.78 72.86 Favored Pre-proline 0 CA--C 1.544 0.72 0 O-C-N 121.54 -0.725 . . . . 0.0 109.678 169.657 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -87.63 -17.12 2.83 Favored 'Trans proline' 0 CA--C 1.544 1.003 0 C-N-CA 121.441 1.427 . . . . 0.0 114.836 174.523 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -69.86 -40.45 75.74 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 115.032 1.493 . . . . 0.0 115.032 -169.852 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -68.33 -3.25 30.86 Favored Glycine 0 CA--C 1.54 1.631 0 N-CA-C 115.677 1.031 . . . . 0.0 115.677 -175.892 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -141.86 176.18 9.13 Favored 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 127.017 2.127 . . . . 0.0 112.148 -170.057 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 57.1 m -64.29 161.06 17.43 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 114.866 1.432 . . . . 0.0 114.866 -169.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 39.0 tp -59.02 -28.85 66.8 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 124.791 1.236 . . . . 0.0 113.409 -178.552 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -63.18 -32.42 73.81 Favored 'General case' 0 N--CA 1.473 0.717 0 O-C-N 120.641 -1.287 . . . . 0.0 112.004 172.448 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 4.9 t -72.76 -36.38 52.49 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 O-C-N 121.093 -1.005 . . . . 0.0 110.819 172.308 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -55.95 -49.15 74.31 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-N 119.944 1.247 . . . . 0.0 111.391 169.83 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -66.76 -38.27 86.26 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.586 0.755 . . . . 0.0 112.122 -179.63 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 84.4 m -63.52 -43.92 95.77 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.761 0.824 . . . . 0.0 111.394 172.139 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 52.8 t -69.23 -35.66 69.0 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 CA-C-O 117.704 -1.141 . . . . 0.0 111.186 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 72.3 mtm-85 -57.12 -41.41 78.94 Favored 'General case' 0 N--CA 1.484 1.229 0 CA-C-N 120.903 1.683 . . . . 0.0 111.322 169.76 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -58.66 -50.58 65.77 Favored Glycine 0 CA--C 1.541 1.695 0 CA-C-N 118.898 0.772 . . . . 0.0 113.531 173.401 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 41.3 mt-30 -65.12 -43.64 91.31 Favored 'General case' 0 N--CA 1.477 0.906 0 O-C-N 121.645 -0.915 . . . . 0.0 112.63 178.471 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 69.8 t -66.93 -40.58 86.0 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 C-N-CA 124.012 0.925 . . . . 0.0 110.726 179.325 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 63.7 tttm -54.39 -48.54 71.44 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 119.31 0.959 . . . . 0.0 110.802 175.176 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -61.87 -46.89 87.46 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 123.537 0.735 . . . . 0.0 112.242 177.004 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 12.7 mtp85 -61.74 -40.19 94.22 Favored 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 113.414 0.894 . . . . 0.0 113.414 176.831 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 69.2 t -76.26 -30.76 20.29 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 O-C-N 121.627 -0.671 . . . . 0.0 111.176 -179.44 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -64.63 -38.1 89.84 Favored 'General case' 0 CA--C 1.54 0.585 0 O-C-N 121.184 -0.948 . . . . 0.0 110.166 169.118 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 97.7 m-20 -63.74 -45.48 89.7 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 123.572 0.749 . . . . 0.0 112.493 174.099 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 8.1 tt -50.53 -58.92 4.65 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 125.464 1.505 . . . . 0.0 110.724 170.725 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 80.4 mt -62.62 -44.07 99.07 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 CA-C-O 118.692 -0.67 . . . . 0.0 110.457 -176.449 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -68.14 -14.0 62.65 Favored 'General case' 0 CA--C 1.546 0.816 0 N-CA-C 114.372 1.249 . . . . 0.0 114.372 179.058 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 18.2 ptmt -99.12 -32.31 11.31 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 113.793 1.034 . . . . 0.0 113.793 174.385 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 17.8 pt -90.1 -18.1 7.77 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 N-CA-C 114.109 1.151 . . . . 0.0 114.109 179.815 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 72.9 m . . . . . 0 C--O 1.254 1.319 0 CA-C-O 118.294 -0.86 . . . . 0.0 112.507 -179.783 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.4 ttt . . . . . 0 N--CA 1.501 2.12 0 N-CA-C 111.924 0.342 . . . . 0.0 111.924 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.2 164.25 31.27 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 124.868 1.267 . . . . 0.0 113.363 178.16 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 60.1 mtpt -90.44 142.71 27.46 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 125.059 1.344 . . . . 0.0 113.221 175.681 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 21.6 t -125.49 131.63 71.94 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 C-N-CA 125.791 1.637 . . . . 0.0 112.301 179.186 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . 0.421 ' HG3' HG13 ' A' ' 7' ' ' VAL . 55.0 tpp -101.47 116.5 32.91 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.967 0.907 . . . . 0.0 109.828 169.912 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 51.2 m-85 -100.74 120.76 40.56 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 124.536 1.134 . . . . 0.0 108.908 171.452 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.421 HG13 ' HG3' ' A' ' 5' ' ' MET . 3.0 m -140.74 156.66 23.16 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 N-CA-C 115.062 1.504 . . . . 0.0 115.062 -168.774 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 39.4 t -151.82 164.67 36.55 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 128.324 2.65 . . . . 0.0 108.054 169.826 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 39.1 ttpt -56.07 -51.37 68.11 Favored 'General case' 0 N--CA 1.482 1.132 0 CA-C-N 119.532 1.06 . . . . 0.0 112.995 -172.079 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 10.0 tpt180 -103.23 133.38 48.41 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 124.734 1.214 . . . . 0.0 109.64 175.763 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 -90.89 -42.64 10.5 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-N 118.627 0.648 . . . . 0.0 110.661 171.787 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 94.0 p -66.25 158.35 29.17 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 124.426 1.09 . . . . 0.0 110.938 168.896 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 24.4 p 50.53 -19.48 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.467 0 C-N-CA 129.254 3.021 . . . . 0.0 119.015 -170.048 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 13.9 tpt180 -107.06 112.97 26.16 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 125.806 1.642 . . . . 0.0 112.062 -173.184 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 3.4 p -69.26 136.99 52.71 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 123.914 0.885 . . . . 0.0 110.914 169.756 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 16.0 mt-30 -122.14 -39.68 2.57 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 124.894 1.278 . . . . 0.0 112.263 -169.783 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 68.13 -43.55 0.48 Allowed 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 127.29 2.236 . . . . 0.0 116.357 169.511 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -65.2 -34.29 78.02 Favored 'General case' 0 CA--C 1.533 0.306 0 O-C-N 120.831 -1.168 . . . . 0.0 113.738 -172.206 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 3.1 pm0 -59.88 -40.67 89.48 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 118.919 0.781 . . . . 0.0 111.929 170.378 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -66.24 -52.3 37.21 Favored Glycine 0 C--N 1.335 0.525 0 C-N-CA 123.839 0.733 . . . . 0.0 111.813 178.138 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -64.73 -34.45 78.34 Favored 'General case' 0 N--CA 1.467 0.405 0 O-C-N 121.659 -0.907 . . . . 0.0 112.008 177.902 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -66.16 -32.1 73.35 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 119.568 1.076 . . . . 0.0 112.72 178.637 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 22.6 mtpp -68.42 -52.95 27.08 Favored 'General case' 0 N--CA 1.478 0.943 0 CA-C-N 118.496 0.589 . . . . 0.0 110.129 169.794 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 98.5 m -72.4 -22.76 61.07 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 113.841 1.052 . . . . 0.0 113.841 -170.81 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 49.9 mt -95.38 -37.25 11.03 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 125.472 1.509 . . . . 0.0 113.253 171.631 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -104.92 -4.5 41.97 Favored Glycine 0 N--CA 1.47 0.915 0 N-CA-C 117.848 1.899 . . . . 0.0 117.848 -168.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -62.66 137.66 58.31 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-N 121.526 2.663 . . . . 0.0 111.971 179.794 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 86.88 -14.0 57.74 Favored Glycine 0 CA--C 1.542 1.732 0 C-N-CA 124.92 1.248 . . . . 0.0 113.857 -169.365 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -108.35 -42.88 4.47 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 126.512 1.925 . . . . 0.0 111.768 170.776 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 34.3 pt -136.83 160.65 36.83 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 C-N-CA 126.18 1.792 . . . . 0.0 112.246 179.48 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -108.66 149.34 29.08 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 125.504 1.522 . . . . 0.0 109.893 169.822 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 84.7 t -138.25 141.18 38.63 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 O-C-N 121.471 -0.768 . . . . 0.0 111.916 -170.111 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 18.6 m -140.08 153.49 46.76 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 125.249 1.42 . . . . 0.0 109.936 174.796 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 38.8 p -137.74 138.99 39.86 Favored 'General case' 0 CA--C 1.516 -0.342 0 C-N-CA 124.505 1.122 . . . . 0.0 110.237 168.59 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 96.4 p -127.44 -62.45 1.09 Allowed 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 115.532 1.679 . . . . 0.0 115.532 -168.528 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 111.28 162.11 17.36 Favored Glycine 0 N--CA 1.469 0.841 0 C-N-CA 126.149 1.833 . . . . 0.0 110.6 -174.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -97.66 -20.01 17.9 Favored 'General case' 0 N--CA 1.482 1.16 0 CA-C-N 119.384 1.592 . . . . 0.0 113.66 171.801 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 61.0 mt-10 -132.37 -31.94 1.38 Allowed 'General case' 0 N--CA 1.48 1.039 0 N-CA-C 113.901 1.074 . . . . 0.0 113.901 -171.33 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 94.2 p -137.14 160.38 39.16 Favored 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 125.901 1.681 . . . . 0.0 110.875 -177.17 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 96.6 p -116.59 165.64 13.02 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 125.678 1.591 . . . . 0.0 112.995 -175.588 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 72.2 ttt180 62.87 133.39 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 128.161 2.585 . . . . 0.0 113.728 -171.647 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 26.5 m -61.98 135.13 26.92 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 170.675 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -59.88 144.98 85.22 Favored Pre-proline 0 CA--C 1.548 0.88 0 C-N-CA 120.274 -0.57 . . . . 0.0 112.536 -169.603 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -49.12 -40.93 41.92 Favored 'Trans proline' 0 CA--C 1.539 0.761 0 C-N-CA 123.23 2.62 . . . . 0.0 117.763 -167.762 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 59.8 m -65.75 -26.54 67.77 Favored 'General case' 0 N--CA 1.484 1.252 0 CA-C-N 119.475 1.034 . . . . 0.0 111.661 -176.471 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -57.12 -36.94 71.26 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 123.905 0.882 . . . . 0.0 112.199 177.279 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.8 mp -59.5 -60.15 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 CA-C-N 119.05 0.841 . . . . 0.0 109.269 -179.404 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -62.49 -31.25 71.97 Favored 'General case' 0 CA--C 1.544 0.734 0 N-CA-C 113.434 0.901 . . . . 0.0 113.434 -176.677 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -81.29 -6.15 58.57 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 124.815 1.246 . . . . 0.0 114.184 177.672 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 40.6 mtt -114.94 -22.9 9.36 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 125.383 1.473 . . . . 0.0 110.704 175.026 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -65.15 -19.2 65.87 Favored 'General case' 0 CA--C 1.541 0.628 0 O-C-N 120.594 -1.316 . . . . 0.0 111.729 168.751 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 11.7 mt-10 -60.73 -28.27 68.55 Favored 'General case' 0 N--CA 1.481 1.107 0 CA-C-N 119.558 1.072 . . . . 0.0 111.48 169.377 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 67.8 t -93.14 -5.43 10.69 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.946 0 C-N-CA 127.472 2.309 . . . . 0.0 111.021 177.893 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 82.22 16.87 70.67 Favored Glycine 0 CA--C 1.538 1.494 0 C-N-CA 125.16 1.362 . . . . 0.0 114.307 -175.224 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 78.5 mt -77.14 139.6 18.47 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 C-N-CA 124.645 1.178 . . . . 0.0 111.53 -173.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 20.0 t0 -103.7 106.68 17.26 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 124.614 1.166 . . . . 0.0 111.873 170.709 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 3.8 pt -131.54 13.71 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.212 0 C-N-CA 125.515 1.526 . . . . 0.0 113.811 178.048 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 72.7 m -73.37 119.56 17.78 Favored 'General case' 0 N--CA 1.472 0.628 0 O-C-N 120.834 -1.167 . . . . 0.0 112.119 -176.31 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 63.78 35.43 92.01 Favored Glycine 0 CA--C 1.537 1.416 0 N-CA-C 115.797 1.079 . . . . 0.0 115.797 169.831 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 41.0 mt-30 -59.99 -50.32 74.22 Favored 'General case' 0 N--CA 1.477 0.906 0 N-CA-C 113.887 1.069 . . . . 0.0 113.887 -172.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 76.1 p -139.13 154.18 48.08 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 125.267 1.427 . . . . 0.0 113.348 -169.065 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 69.5 m -122.99 5.86 9.3 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 125.664 1.586 . . . . 0.0 113.982 -176.829 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 -143.14 153.07 59.55 Favored Pre-proline 0 CA--C 1.55 0.976 0 C-N-CA 124.44 1.096 . . . . 0.0 113.562 -173.411 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_exo -66.07 167.11 18.81 Favored 'Trans proline' 0 C--N 1.353 0.808 0 C-N-CA 123.349 2.7 . . . . 0.0 113.84 170.085 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 8.3 tt -50.79 -30.36 8.52 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 C-N-CA 126.699 2.0 . . . . 0.0 111.498 169.073 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -53.44 -27.49 25.04 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 126.514 1.925 . . . . 0.0 113.347 177.123 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -88.34 -6.82 57.5 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 125.119 1.368 . . . . 0.0 113.72 -174.875 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 71.6 m-85 -109.04 179.95 4.02 Favored 'General case' 0 CA--C 1.55 0.981 0 C-N-CA 126.51 1.924 . . . . 0.0 111.485 -174.917 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 5.8 t30 -122.52 126.24 47.4 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 125.495 1.518 . . . . 0.0 109.757 175.023 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.59 -35.66 80.73 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 113.895 1.072 . . . . 0.0 113.895 -169.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . 0.254 0.0 OUTLIER -71.46 -5.34 32.17 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 114.085 1.142 . . . . 0.0 114.085 -177.02 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -76.08 -12.96 60.21 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 124.013 0.925 . . . . 0.0 111.463 169.245 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 86.5 m-85 -115.51 139.54 49.97 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 127.098 2.159 . . . . 0.0 111.167 178.676 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -91.14 -21.97 20.91 Favored 'General case' 0 N--CA 1.478 0.959 0 CA-C-O 122.078 0.942 . . . . 0.0 112.556 178.303 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.721 HG22 ' HB ' ' A' ' 95' ' ' ILE . 80.7 t -133.78 139.29 48.98 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 C-N-CA 126.957 2.103 . . . . 0.0 109.014 -174.547 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 45.1 t -131.71 124.07 53.19 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 169.789 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 44.8 mm -111.86 108.01 24.42 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 C-N-CA 124.578 1.151 . . . . 0.0 108.653 -179.486 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 46.8 m -93.64 114.97 27.42 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 123.201 0.6 . . . . 0.0 109.738 174.859 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 82.7 mt -86.77 -13.7 44.45 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.971 1.308 . . . . 0.0 114.059 -172.118 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 14.5 p -147.85 157.78 43.71 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 124.835 1.254 . . . . 0.0 111.29 -176.603 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 62.1 -143.08 48.49 Favored Glycine 0 CA--C 1.538 1.472 0 C-N-CA 123.431 0.538 . . . . 0.0 113.494 179.572 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 56.9 m -131.43 164.12 26.43 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 125.584 1.554 . . . . 0.0 111.209 179.067 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -72.67 63.97 1.49 Allowed Glycine 0 CA--C 1.538 1.517 0 C-N-CA 124.953 1.264 . . . . 0.0 113.525 177.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 10.0 p -141.6 -30.65 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 N-CA-C 114.492 1.293 . . . . 0.0 114.492 -171.597 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 10.9 t-20 -75.0 -29.25 60.83 Favored 'General case' 0 N--CA 1.477 0.882 0 CA-C-N 119.417 1.008 . . . . 0.0 112.193 176.525 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -83.18 150.93 62.12 Favored Pre-proline 0 CA--C 1.548 0.888 0 C-N-CA 125.024 1.329 . . . . 0.0 111.279 169.628 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -65.35 155.44 68.62 Favored 'Trans proline' 0 CA--C 1.541 0.828 0 C-N-CA 122.574 2.182 . . . . 0.0 111.655 178.141 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -59.41 -26.34 81.6 Favored 'Trans proline' 0 C--N 1.35 0.61 0 C-N-CA 123.474 2.782 . . . . 0.0 114.913 -169.157 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -59.59 -22.7 62.15 Favored 'General case' 0 N--CA 1.472 0.629 0 O-C-N 120.841 -1.162 . . . . 0.0 114.119 178.285 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 84.9 m95 -82.44 -16.99 46.93 Favored 'General case' 0 N--CA 1.471 0.616 0 O-C-N 120.79 -1.194 . . . . 0.0 113.593 174.904 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 10.3 m -93.33 -10.41 9.45 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 CA-C-N 119.299 0.954 . . . . 0.0 113.498 170.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 60.3 p -93.48 -1.35 55.75 Favored 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 114.771 1.397 . . . . 0.0 114.771 177.016 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 72.8 mm-40 -67.64 154.21 41.96 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 119.3 0.954 . . . . 0.0 110.909 169.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -56.62 -40.01 74.62 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 114.601 1.334 . . . . 0.0 114.601 -167.82 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.721 ' HB ' HG22 ' A' ' 75' ' ' VAL . 15.7 mm -120.89 61.64 0.23 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 C-N-CA 124.972 1.309 . . . . 0.0 109.357 178.822 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 13.3 t80 -77.29 110.83 12.34 Favored 'General case' 0 CA--C 1.536 0.404 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 168.849 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 16.3 mt-10 -114.66 138.56 50.54 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 113.988 1.107 . . . . 0.0 113.988 173.197 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -101.65 120.25 40.04 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 124.143 0.977 . . . . 0.0 108.518 168.603 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 35.8 m0 -103.56 134.81 46.29 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 123.722 0.809 . . . . 0.0 108.867 176.629 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 64.2 mt-30 -114.8 30.56 7.26 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 123.865 0.866 . . . . 0.0 112.554 -169.563 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -76.16 159.71 30.44 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 125.709 1.604 . . . . 0.0 112.579 174.783 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -73.44 156.18 38.52 Favored 'General case' 0 CA--C 1.539 0.53 0 O-C-N 121.88 -0.512 . . . . 0.0 111.906 170.029 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 64.2 m-20 -106.44 155.06 39.39 Favored Pre-proline 0 CA--C 1.549 0.918 0 C-N-CA 123.292 0.637 . . . . 0.0 111.111 173.096 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_exo -70.87 -21.59 28.12 Favored 'Trans proline' 0 CA--C 1.544 1.007 0 C-N-CA 122.464 2.109 . . . . 0.0 115.115 179.795 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -42.19 125.26 3.02 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 114.329 1.233 . . . . 0.0 114.329 172.756 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 81.54 3.24 90.67 Favored Glycine 0 CA--C 1.535 1.335 0 C-N-CA 124.39 0.995 . . . . 0.0 115.167 177.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 9.8 pt20 -137.81 172.8 12.41 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 124.938 1.295 . . . . 0.0 113.59 -178.595 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 51.9 p -71.67 169.75 14.95 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 117.666 2.469 . . . . 0.0 117.666 -168.442 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -54.84 -41.68 71.03 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 126.436 1.894 . . . . 0.0 112.17 170.129 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -57.25 -32.85 66.99 Favored 'General case' 0 N--CA 1.473 0.716 0 O-C-N 121.225 -0.922 . . . . 0.0 112.23 172.382 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 7.7 t -75.14 -36.2 36.77 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 O-C-N 121.051 -1.031 . . . . 0.0 112.05 171.101 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 12.1 m-85 -56.58 -42.77 79.23 Favored 'General case' 0 N--CA 1.478 0.949 0 CA-C-N 120.792 1.633 . . . . 0.0 111.132 169.229 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 83.2 mtp180 -64.82 -42.9 94.61 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 124.1 0.96 . . . . 0.0 112.11 175.063 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 53.1 m -60.45 -45.31 94.15 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 124.1 0.96 . . . . 0.0 111.283 175.398 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 74.3 t -68.16 -42.1 84.62 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 CA-C-O 117.929 -1.034 . . . . 0.0 110.643 177.66 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 18.0 mtp180 -52.91 -44.9 67.3 Favored 'General case' 0 N--CA 1.482 1.158 0 CA-C-N 120.283 1.401 . . . . 0.0 112.215 171.761 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -60.09 -51.49 58.57 Favored Glycine 0 CA--C 1.539 1.577 0 CA-C-N 119.243 0.928 . . . . 0.0 113.694 175.303 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 56.4 mm-40 -65.45 -44.48 87.12 Favored 'General case' 0 N--CA 1.477 0.883 0 O-C-N 121.797 -0.825 . . . . 0.0 112.221 179.873 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 52.9 t -63.21 -42.06 95.09 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 124.673 1.189 . . . . 0.0 110.496 177.022 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 60.0 tttm -54.81 -50.93 67.35 Favored 'General case' 0 N--CA 1.477 0.888 0 CA-C-N 119.689 1.132 . . . . 0.0 110.91 177.664 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -63.99 -41.77 97.4 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 112.458 0.54 . . . . 0.0 112.458 178.756 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 4.8 mtp85 -63.3 -43.97 96.35 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 113.254 0.835 . . . . 0.0 113.254 175.772 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 94.1 t -71.34 -37.76 66.68 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 C-N-CA 124.044 0.937 . . . . 0.0 111.105 179.407 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -61.24 -40.97 96.02 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 119.417 1.008 . . . . 0.0 111.682 170.409 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 11.6 m-80 -61.8 -48.59 79.93 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 118.727 0.694 . . . . 0.0 112.165 173.394 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -51.83 -56.61 12.96 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 125.33 1.452 . . . . 0.0 110.465 175.725 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 75.2 mt -61.25 -46.3 96.89 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 CA-C-O 119.124 -0.465 . . . . 0.0 110.138 -179.574 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -66.62 -12.04 56.27 Favored 'General case' 0 CA--C 1.546 0.795 0 N-CA-C 114.983 1.475 . . . . 0.0 114.983 -178.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -102.14 -26.45 13.35 Favored 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 113.824 1.046 . . . . 0.0 113.824 172.355 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 13.6 pt -97.45 -12.85 8.26 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 N-CA-C 114.866 1.432 . . . . 0.0 114.866 178.655 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 57.8 m . . . . . 0 C--O 1.252 1.199 0 C-N-CA 125.333 1.453 . . . . 0.0 112.255 -179.792 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.3 ttt . . . . . 0 N--CA 1.501 2.088 0 N-CA-C 111.937 0.347 . . . . 0.0 111.937 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.15 164.34 30.41 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 124.966 1.306 . . . . 0.0 112.886 175.922 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 41.5 mtpt -94.73 143.4 26.47 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 124.449 1.1 . . . . 0.0 112.136 178.141 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 18.9 t -124.71 133.86 68.33 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 C-N-CA 125.289 1.435 . . . . 0.0 112.749 -178.877 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . 0.51 ' HG3' HG13 ' A' ' 7' ' ' VAL . 36.8 tpp -104.2 122.45 45.39 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 123.412 0.685 . . . . 0.0 109.257 168.717 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 68.6 m-85 -98.94 128.66 45.15 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.337 1.055 . . . . 0.0 108.993 170.22 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.58 HG11 HD12 ' A' ' 65' ' ' ILE . 0.4 OUTLIER -138.27 144.17 31.11 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 N-CA-C 114.363 1.245 . . . . 0.0 114.363 -168.778 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -141.18 166.81 23.76 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 127.131 2.173 . . . . 0.0 110.68 170.122 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -57.19 -49.15 76.87 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.263 -0.898 . . . . 0.0 112.928 -173.881 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 96.8 mtt180 -125.05 130.55 52.52 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 124.679 1.191 . . . . 0.0 110.088 169.559 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 35.5 t30 -81.54 -43.0 19.35 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-N 117.819 0.281 . . . . 0.0 111.498 -179.735 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 45.0 m -68.25 -32.23 72.28 Favored 'General case' 0 N--CA 1.478 0.954 0 N-CA-C 113.52 0.933 . . . . 0.0 113.52 -170.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 97.8 p -90.92 -5.7 55.12 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 114.855 1.428 . . . . 0.0 114.855 -175.138 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 60.2 mtt85 -134.93 156.64 48.64 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 124.583 1.153 . . . . 0.0 112.341 -175.917 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 37.2 m -105.47 103.83 13.44 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 124.565 1.146 . . . . 0.0 110.077 -179.893 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 3.1 mp0 -78.4 -34.51 48.03 Favored 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 114.162 1.171 . . . . 0.0 114.162 -169.206 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 68.74 -49.2 0.57 Allowed 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 126.474 1.91 . . . . 0.0 115.99 169.653 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.97 -33.57 73.41 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.185 0.994 . . . . 0.0 113.574 -171.131 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 3.4 pm0 -62.5 -46.3 89.05 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 123.978 0.911 . . . . 0.0 112.277 174.295 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -65.57 -39.87 95.74 Favored Glycine 0 C--N 1.335 0.49 0 C-N-CA 123.64 0.638 . . . . 0.0 111.66 178.849 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -69.92 -41.78 74.19 Favored 'General case' 0 N--CA 1.468 0.431 0 O-C-N 121.838 -0.801 . . . . 0.0 111.271 176.156 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -60.4 -43.36 96.75 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 119.626 1.103 . . . . 0.0 112.735 -176.446 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 8.8 pttp -77.91 -24.31 48.37 Favored 'General case' 0 N--CA 1.479 1.011 0 N-CA-C 113.65 0.981 . . . . 0.0 113.65 175.097 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 85.5 m -71.63 -36.01 70.6 Favored 'General case' 0 N--CA 1.48 1.071 0 O-C-N 121.401 -0.812 . . . . 0.0 111.623 171.682 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 61.4 mt -88.09 -31.73 19.09 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 125.711 1.604 . . . . 0.0 114.172 -177.698 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -145.8 30.97 1.65 Allowed Glycine 0 N--CA 1.474 1.219 0 N-CA-C 118.297 2.079 . . . . 0.0 118.297 -169.035 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -66.71 -19.75 65.82 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-N 121.794 2.797 . . . . 0.0 115.202 -178.238 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -75.36 -10.37 84.45 Favored Glycine 0 CA--C 1.541 1.711 0 O-C-N 121.293 -0.88 . . . . 0.0 113.18 169.586 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 76.0 mttt -108.64 -39.66 5.31 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 127.185 2.194 . . . . 0.0 113.375 179.873 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 22.6 pt -142.12 155.72 19.33 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 C-N-CA 124.966 1.306 . . . . 0.0 112.562 -173.235 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -104.27 142.68 34.11 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 124.156 0.982 . . . . 0.0 110.48 171.199 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 74.3 t -130.11 140.11 49.76 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 CA-C-N 119.186 0.903 . . . . 0.0 112.88 -171.776 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 36.4 m -137.59 154.18 49.82 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 126.302 1.841 . . . . 0.0 109.02 170.885 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 61.3 p -128.95 147.31 50.84 Favored 'General case' 0 CA--C 1.515 -0.366 0 CA-C-O 121.931 0.872 . . . . 0.0 112.506 167.464 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 25.8 p -144.79 157.44 44.17 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 114.353 -1.294 . . . . 0.0 112.378 -178.59 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -97.92 150.74 19.52 Favored Glycine 0 N--CA 1.468 0.814 0 CA-C-O 119.318 -0.712 . . . . 0.0 111.846 174.663 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 10.8 mp -66.44 -30.9 71.35 Favored 'General case' 0 N--CA 1.483 1.207 0 CA-C-N 119.299 1.55 . . . . 0.0 108.992 168.864 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 52.6 mt-10 -133.1 154.8 50.24 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 128.359 2.664 . . . . 0.0 107.201 168.214 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 27.0 p 64.46 161.38 0.12 Allowed 'General case' 0 N--CA 1.486 1.331 0 N-CA-C 117.504 2.409 . . . . 0.0 117.504 178.678 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 75.1 m -118.76 143.55 46.83 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 126.621 1.968 . . . . 0.0 113.18 -170.248 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 59.1 ttt-85 62.3 148.13 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.897 0 C-N-CA 127.612 2.365 . . . . 0.0 114.091 -176.381 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 24.9 m -61.38 166.18 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.255 0 CA-C-O 122.662 1.22 . . . . 0.0 111.824 169.782 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 2.7 t-80 -41.22 136.45 1.71 Allowed Pre-proline 0 C--N 1.327 -0.386 0 CA-C-N 113.761 -1.563 . . . . 0.0 113.243 169.426 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -60.36 -27.5 84.99 Favored 'Trans proline' 0 CA--C 1.546 1.12 0 CA-C-N 120.753 1.305 . . . . 0.0 112.252 170.647 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 99.0 m -67.89 -31.89 71.99 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 124.966 1.306 . . . . 0.0 112.077 174.566 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -57.39 -39.48 76.2 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 124.289 1.036 . . . . 0.0 111.636 -175.055 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.7 mp -57.45 -60.61 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 C-N-CA 124.226 1.01 . . . . 0.0 109.361 -178.908 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -61.82 -31.62 71.88 Favored 'General case' 0 CA--C 1.545 0.761 0 N-CA-C 113.384 0.883 . . . . 0.0 113.384 -177.17 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -82.25 -6.61 59.35 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 114.248 1.203 . . . . 0.0 114.248 177.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 39.1 mtt -112.52 -24.35 9.75 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 125.418 1.487 . . . . 0.0 110.464 174.604 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 27.0 mt-10 -65.46 -16.43 63.64 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 125.128 1.371 . . . . 0.0 111.519 168.559 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 11.5 mt-10 -60.21 -30.52 69.43 Favored 'General case' 0 N--CA 1.481 1.095 0 CA-C-N 119.726 1.148 . . . . 0.0 110.74 169.103 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 60.2 t -92.45 -4.99 10.79 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.955 0 C-N-CA 127.59 2.356 . . . . 0.0 111.017 178.721 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 80.1 18.3 72.37 Favored Glycine 0 CA--C 1.538 1.497 0 C-N-CA 125.073 1.32 . . . . 0.0 114.55 -173.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 73.8 mt -76.89 136.69 23.99 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 124.368 1.067 . . . . 0.0 111.661 -173.082 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 19.7 t0 -97.33 88.45 4.43 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.588 1.155 . . . . 0.0 112.061 -179.112 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 7.6 pt -125.8 8.66 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.33 0 N-CA-C 114.265 1.209 . . . . 0.0 114.265 174.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 97.7 p -59.28 -42.12 90.48 Favored 'General case' 0 N--CA 1.477 0.92 0 O-C-N 120.824 -1.173 . . . . 0.0 114.044 -171.59 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -93.35 15.39 63.07 Favored Glycine 0 CA--C 1.534 1.237 0 C-N-CA 125.18 1.371 . . . . 0.0 116.092 -176.533 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . 0.268 0.0 OUTLIER -77.51 62.07 2.4 Favored 'General case' 0 N--CA 1.478 0.93 0 CA-C-N 119.912 1.856 . . . . 0.0 114.481 -172.18 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 40.2 p -69.38 107.86 3.49 Favored 'General case' 0 N--CA 1.471 0.585 0 O-C-N 120.431 -1.418 . . . . 0.0 108.93 169.186 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 70.2 m -142.18 129.32 20.92 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.204 1.002 . . . . 0.0 111.456 -169.567 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -67.02 170.39 6.37 Favored Pre-proline 0 CA--C 1.549 0.922 0 C-N-CA 127.575 2.35 . . . . 0.0 114.496 -176.249 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -64.3 156.51 59.38 Favored 'Trans proline' 0 C--N 1.352 0.728 0 C-N-CA 122.665 2.243 . . . . 0.0 111.819 169.129 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.58 HD12 HG11 ' A' ' 7' ' ' VAL . 6.0 tt -51.59 -33.71 15.17 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 C-N-CA 125.874 1.669 . . . . 0.0 111.571 174.632 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 12.3 mt-10 -61.97 -24.18 66.85 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.748 1.219 . . . . 0.0 113.295 -178.044 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 71.1 m-20 -91.89 6.17 47.22 Favored 'General case' 0 CA--C 1.55 0.981 0 C-N-CA 124.378 1.071 . . . . 0.0 112.898 -175.408 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 -119.15 -175.55 2.94 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 126.833 2.053 . . . . 0.0 112.683 -179.76 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 9.6 p-10 -123.73 129.26 50.81 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 125.737 1.615 . . . . 0.0 109.728 172.474 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -64.72 -37.19 86.76 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 112.81 0.671 . . . . 0.0 112.81 -172.607 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -68.4 -4.39 14.52 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 114.291 1.219 . . . . 0.0 114.291 179.364 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -68.51 -21.39 64.58 Favored 'General case' 0 CA--C 1.549 0.916 0 CA-C-N 119.317 0.962 . . . . 0.0 109.932 168.449 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 76.6 m-85 -115.35 146.13 41.85 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 127.726 2.41 . . . . 0.0 111.842 -175.179 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -101.91 -18.12 15.84 Favored 'General case' 0 N--CA 1.481 1.088 0 CA-C-O 122.153 0.978 . . . . 0.0 112.614 178.584 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.657 HG22 ' HB ' ' A' ' 95' ' ' ILE . 76.0 t -128.62 138.64 54.05 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 C-N-CA 127.605 2.362 . . . . 0.0 108.022 177.731 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 48.7 t -132.82 124.98 51.68 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 169.836 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 46.2 mm -112.3 104.82 17.66 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.344 0 C-N-CA 124.275 1.03 . . . . 0.0 109.602 -175.054 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 3.6 m -80.28 106.69 12.49 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 123.494 0.718 . . . . 0.0 109.868 170.463 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 91.2 mt -83.58 -19.95 34.63 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 126.237 1.815 . . . . 0.0 113.852 -176.293 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 80.6 m -97.01 121.59 39.06 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 106.931 -1.507 . . . . 0.0 106.931 171.328 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -59.73 141.47 47.55 Favored Glycine 0 CA--C 1.535 1.337 0 CA-C-N 118.484 0.583 . . . . 0.0 113.199 -172.571 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 75.7 m 56.85 43.65 24.57 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.744 1.218 . . . . 0.0 111.114 -169.526 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -74.29 62.61 2.2 Favored Glycine 0 N--CA 1.471 1.002 0 C-N-CA 125.91 1.719 . . . . 0.0 111.802 176.331 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.3 p -113.17 -0.41 9.3 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 C-N-CA 126.119 1.768 . . . . 0.0 112.913 -170.074 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 29.0 m120 -74.46 -11.34 60.2 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 124.338 1.055 . . . . 0.0 113.252 174.844 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -65.77 158.96 72.46 Favored Pre-proline 0 CA--C 1.553 1.07 0 C-N-CA 124.274 1.03 . . . . 0.0 112.389 170.501 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -59.94 149.93 81.15 Favored 'Trans proline' 0 CA--C 1.543 0.975 0 C-N-CA 122.437 2.091 . . . . 0.0 113.11 178.721 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_exo -56.25 -33.4 90.88 Favored 'Trans proline' 0 C--N 1.351 0.694 0 C-N-CA 123.102 2.535 . . . . 0.0 114.948 -171.873 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -59.61 -22.49 61.89 Favored 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 114.019 1.118 . . . . 0.0 114.019 178.879 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 88.7 m95 -79.75 -15.82 56.76 Favored 'General case' 0 N--CA 1.469 0.511 0 O-C-N 120.685 -1.259 . . . . 0.0 113.487 176.439 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 8.2 m -96.35 -8.13 9.43 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 N-CA-C 113.711 1.004 . . . . 0.0 113.711 170.731 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 68.5 p -95.77 -2.85 46.86 Favored 'General case' 0 N--CA 1.48 1.044 0 N-CA-C 114.866 1.432 . . . . 0.0 114.866 178.206 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 68.6 mm-40 -65.93 155.09 37.51 Favored 'General case' 0 N--CA 1.477 0.916 0 CA-C-N 119.368 0.985 . . . . 0.0 110.236 169.553 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -56.78 -40.05 75.16 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 114.773 1.397 . . . . 0.0 114.773 -168.154 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.657 ' HB ' HG22 ' A' ' 75' ' ' VAL . 19.7 mm -120.26 65.92 0.26 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 C-N-CA 124.652 1.181 . . . . 0.0 109.147 -178.795 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 32.7 t80 -80.04 109.76 14.79 Favored 'General case' 0 C--O 1.236 0.375 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 168.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -110.2 135.19 51.36 Favored 'General case' 0 CA--C 1.545 0.76 0 N-CA-C 113.441 0.904 . . . . 0.0 113.441 174.478 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -102.06 103.71 14.32 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.435 1.094 . . . . 0.0 109.584 169.895 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 38.1 m0 -91.84 114.1 26.55 Favored 'General case' 0 N--CA 1.463 0.181 0 C-N-CA 124.275 1.03 . . . . 0.0 109.294 179.523 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 41.7 mt-30 -91.8 48.54 1.46 Allowed 'General case' 0 CA--C 1.544 0.749 0 CA-C-O 122.289 1.043 . . . . 0.0 111.26 -172.678 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 86.5 mt -78.39 166.25 22.87 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 127.115 2.166 . . . . 0.0 111.953 176.485 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -88.9 152.49 21.7 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-O 121.555 0.693 . . . . 0.0 112.415 169.573 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 13.4 p-10 -89.6 136.77 29.23 Favored Pre-proline 0 CA--C 1.55 0.968 0 C-N-CA 125.47 1.508 . . . . 0.0 112.008 176.214 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -70.25 -20.01 33.05 Favored 'Trans proline' 0 CA--C 1.547 1.126 0 C-N-CA 121.955 1.77 . . . . 0.0 115.491 -178.42 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -66.52 145.0 56.12 Favored 'General case' 0 N--CA 1.476 0.834 0 O-C-N 121.103 -0.998 . . . . 0.0 113.179 -175.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 78.36 4.81 87.37 Favored Glycine 0 CA--C 1.535 1.296 0 C-N-CA 123.943 0.782 . . . . 0.0 114.661 -179.156 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -141.61 166.83 23.67 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 125.465 1.506 . . . . 0.0 112.878 -179.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 66.9 m -63.86 163.23 12.23 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 115.698 1.74 . . . . 0.0 115.698 -169.239 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -51.82 -39.64 59.11 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 126.673 1.989 . . . . 0.0 112.837 171.911 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -55.27 -31.81 61.86 Favored 'General case' 0 N--CA 1.474 0.737 0 O-C-N 121.265 -0.897 . . . . 0.0 112.515 172.598 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 4.3 t -76.94 -37.27 26.7 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 O-C-N 121.163 -0.961 . . . . 0.0 111.75 173.575 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 21.4 m-85 -57.16 -42.66 81.49 Favored 'General case' 0 N--CA 1.477 0.88 0 CA-C-N 119.943 1.247 . . . . 0.0 111.221 169.302 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 97.7 mtt180 -68.45 -38.35 81.06 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.612 0.765 . . . . 0.0 112.474 176.158 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 45.8 m -61.71 -45.65 93.06 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 124.187 0.995 . . . . 0.0 111.37 172.638 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 72.1 t -67.77 -40.97 84.74 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 CA-C-O 118.266 -0.873 . . . . 0.0 110.463 178.324 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 20.4 mtp180 -54.45 -43.74 71.92 Favored 'General case' 0 N--CA 1.484 1.273 0 CA-C-N 120.239 1.381 . . . . 0.0 112.915 170.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -61.59 -50.02 70.69 Favored Glycine 0 CA--C 1.537 1.417 0 CA-C-N 119.45 1.023 . . . . 0.0 113.255 175.784 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 53.6 mm-40 -64.59 -44.13 91.65 Favored 'General case' 0 N--CA 1.476 0.837 0 O-C-N 122.043 -0.68 . . . . 0.0 112.012 178.478 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 58.8 t -63.92 -41.46 92.58 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 C-N-CA 124.91 1.284 . . . . 0.0 111.125 176.752 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 60.7 tttm -54.27 -49.75 68.84 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-N 120.13 1.332 . . . . 0.0 110.628 176.832 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -63.49 -44.79 93.33 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 112.557 0.577 . . . . 0.0 112.557 176.306 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.23 -35.38 80.86 Favored 'General case' 0 N--CA 1.481 1.105 0 N-CA-C 113.6 0.963 . . . . 0.0 113.6 -179.921 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 92.3 t -78.01 -40.55 26.61 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 C-N-CA 125.411 1.484 . . . . 0.0 110.992 177.008 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -61.43 -38.57 87.61 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 119.185 0.902 . . . . 0.0 111.542 172.257 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 11.1 m-80 -63.91 -44.96 91.37 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 118.846 0.748 . . . . 0.0 112.701 173.561 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -54.47 -56.32 20.0 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 124.223 1.009 . . . . 0.0 110.667 174.392 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 95.3 mt -61.76 -42.01 92.77 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 CA-C-O 119.199 -0.429 . . . . 0.0 110.51 -179.26 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -68.72 -14.38 62.99 Favored 'General case' 0 CA--C 1.545 0.763 0 N-CA-C 114.933 1.457 . . . . 0.0 114.933 179.072 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 21.1 ptmt -99.96 -27.96 13.32 Favored 'General case' 0 N--CA 1.479 0.986 0 N-CA-C 113.855 1.057 . . . . 0.0 113.855 173.523 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 16.6 pt -94.86 -20.54 6.03 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 N-CA-C 114.295 1.22 . . . . 0.0 114.295 177.338 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 74.7 m . . . . . 0 C--O 1.253 1.28 0 C-N-CA 125.074 1.349 . . . . 0.0 111.889 -173.788 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 32.9 ttm . . . . . 0 N--CA 1.502 2.133 0 N-CA-C 112.044 0.387 . . . . 0.0 112.044 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 3.5 mptp? -103.92 155.51 18.58 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 125.181 1.392 . . . . 0.0 112.688 169.812 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 44.7 mtpt -105.4 113.78 27.56 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 106.089 -1.819 . . . . 0.0 106.089 167.088 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 14.4 t -105.95 130.49 57.41 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 C-N-CA 125.247 1.419 . . . . 0.0 113.15 -178.788 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . 0.52 ' HG3' HG13 ' A' ' 7' ' ' VAL . 61.3 tpp -101.65 117.74 35.51 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.501 0.72 . . . . 0.0 109.137 169.193 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 54.8 m-85 -98.79 128.09 44.91 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 169.744 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.52 HG13 ' HG3' ' A' ' 5' ' ' MET . 1.3 m -144.22 153.1 15.4 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.127 0 N-CA-C 113.527 0.936 . . . . 0.0 113.527 -169.195 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 44.0 t -146.2 137.66 24.71 Favored 'General case' 0 CA--C 1.552 1.024 0 C-N-CA 125.315 1.446 . . . . 0.0 113.052 -178.457 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -67.36 135.44 53.24 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 125.029 1.331 . . . . 0.0 111.718 172.439 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . 0.263 19.1 ttm180 47.24 56.36 6.99 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 126.693 1.997 . . . . 0.0 113.31 -174.53 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 -48.76 -29.93 5.07 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 126.746 2.018 . . . . 0.0 114.654 175.461 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 81.4 p -62.69 -19.17 63.61 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 114.558 1.318 . . . . 0.0 114.558 179.72 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 84.7 p -127.32 24.07 6.32 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.458 1.503 . . . . 0.0 113.872 175.019 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 72.2 mtt85 -139.32 150.44 45.4 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 124.846 1.259 . . . . 0.0 113.26 177.196 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 22.3 m -106.81 153.87 21.84 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 125.552 1.541 . . . . 0.0 111.147 172.499 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 30.7 mt-30 -110.15 -55.91 2.4 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 113.248 0.833 . . . . 0.0 113.248 -171.846 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . 0.433 ' HG2' ' SD ' ' A' ' 50' ' ' MET . 0.0 OUTLIER 73.28 -48.21 0.68 Allowed 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 126.608 1.963 . . . . 0.0 113.523 176.984 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.92 -33.31 74.02 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 113.552 0.945 . . . . 0.0 113.552 -175.1 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 5.4 pm0 -68.58 -42.3 78.45 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 123.846 0.859 . . . . 0.0 111.306 177.419 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -65.0 -40.59 97.23 Favored Glycine 0 C--N 1.336 0.581 0 N-CA-C 111.504 -0.638 . . . . 0.0 111.504 178.7 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -72.64 -38.93 67.54 Favored 'General case' 0 N--CA 1.466 0.366 0 O-C-N 121.809 -0.818 . . . . 0.0 112.054 177.403 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.9 -37.48 84.78 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 113.552 0.945 . . . . 0.0 113.552 -173.749 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 6.9 pttp -79.47 -31.16 42.37 Favored 'General case' 0 N--CA 1.481 1.102 0 N-CA-C 113.689 0.996 . . . . 0.0 113.689 172.115 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 59.0 m -70.74 -33.34 70.71 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.197 0.599 . . . . 0.0 111.498 178.583 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 68.3 mt -92.78 -37.5 12.3 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 125.864 1.666 . . . . 0.0 113.277 177.587 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -106.82 8.91 39.96 Favored Glycine 0 N--CA 1.472 1.055 0 N-CA-C 117.892 1.917 . . . . 0.0 117.892 -169.021 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.12 141.88 57.11 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-N 121.318 2.559 . . . . 0.0 112.203 177.407 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 83.91 -21.34 9.79 Favored Glycine 0 CA--C 1.538 1.495 0 C-N-CA 124.984 1.278 . . . . 0.0 113.749 -169.485 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 65.1 mttm -97.45 -48.22 5.37 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 125.786 1.635 . . . . 0.0 111.796 169.863 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 40.6 pt -135.39 150.13 29.03 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 C-N-CA 124.364 1.066 . . . . 0.0 113.085 -175.087 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -102.48 137.76 40.29 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 125.407 1.483 . . . . 0.0 108.921 169.769 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 99.4 t -126.49 140.67 48.16 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 C-N-CA 123.265 0.626 . . . . 0.0 111.976 -173.785 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 27.3 m -140.04 151.59 45.54 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 125.191 1.396 . . . . 0.0 109.626 174.745 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 53.0 p -138.37 145.75 41.46 Favored 'General case' 0 CA--C 1.516 -0.339 0 CA-C-O 122.486 1.136 . . . . 0.0 111.784 167.454 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 88.5 p -139.59 153.56 47.4 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 113.227 -1.806 . . . . 0.0 110.657 -171.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -75.98 162.82 53.0 Favored Glycine 0 CA--C 1.535 1.329 0 O-C-N 121.162 -0.961 . . . . 0.0 112.57 176.741 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.6 mp -95.5 -6.58 40.24 Favored 'General case' 0 N--CA 1.479 1.016 0 O-C-N 120.218 -1.754 . . . . 0.0 111.305 168.565 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -129.21 165.59 21.06 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 128.64 2.776 . . . . 0.0 107.386 169.799 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 70.1 m -77.24 59.7 1.82 Allowed 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 124.23 1.012 . . . . 0.0 113.159 -170.072 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 89.3 p -152.56 -179.63 7.76 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 125.748 1.619 . . . . 0.0 114.124 -169.685 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 58.8 ttt85 -94.8 163.17 13.46 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 128.798 2.839 . . . . 0.0 110.553 -174.571 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 21.2 m -78.51 178.49 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.235 0 C-N-CA 123.974 0.91 . . . . 0.0 110.056 169.238 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 2.1 t-80 -61.01 129.62 90.58 Favored Pre-proline 0 CA--C 1.534 0.344 0 CA-C-O 118.445 -0.788 . . . . 0.0 113.041 -177.06 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo -58.18 -28.01 82.42 Favored 'Trans proline' 0 CA--C 1.544 0.982 0 C-N-CA 121.728 1.618 . . . . 0.0 112.083 169.722 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 96.9 m -61.18 -32.32 72.06 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 125.5 1.52 . . . . 0.0 112.282 173.872 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -57.99 -47.24 83.59 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 118.98 0.809 . . . . 0.0 110.786 179.895 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.5 mp -53.42 -54.5 17.97 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 C-N-CA 124.222 1.009 . . . . 0.0 110.299 -174.596 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.24 -31.05 72.09 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 113.223 0.823 . . . . 0.0 113.223 -178.534 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -81.61 -21.72 38.13 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 113.761 1.022 . . . . 0.0 113.761 177.653 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . 0.433 ' SD ' ' HG2' ' A' ' 17' ' ' MET . 4.8 mmt -84.87 -31.27 23.83 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 119.491 1.042 . . . . 0.0 110.484 169.549 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -66.97 -15.05 63.46 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.752 1.221 . . . . 0.0 113.774 175.571 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 14.3 mt-10 -61.97 -25.7 67.77 Favored 'General case' 0 N--CA 1.482 1.137 0 CA-C-N 120.313 1.415 . . . . 0.0 110.797 168.864 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 48.6 t -98.44 -2.76 9.86 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.006 0 C-N-CA 127.69 2.396 . . . . 0.0 111.163 176.749 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 79.42 17.86 75.06 Favored Glycine 0 CA--C 1.539 1.591 0 C-N-CA 125.096 1.331 . . . . 0.0 114.498 -176.805 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 84.4 mt -79.49 136.16 24.17 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 C-N-CA 125.06 1.344 . . . . 0.0 111.523 -174.449 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 15.0 t0 -95.35 111.0 22.94 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 112.896 0.702 . . . . 0.0 112.896 175.29 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 6.7 pt -135.89 24.35 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.363 0 C-N-CA 124.77 1.228 . . . . 0.0 114.05 172.52 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 70.4 m -69.85 -20.47 63.42 Favored 'General case' 0 N--CA 1.48 1.048 0 O-C-N 120.153 -1.592 . . . . 0.0 114.608 -172.242 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -90.06 10.85 72.65 Favored Glycine 0 CA--C 1.537 1.416 0 N-CA-C 116.521 1.369 . . . . 0.0 116.521 -175.871 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 25.2 mt-30 -81.83 50.49 1.54 Allowed 'General case' 0 N--CA 1.482 1.154 0 CA-C-N 120.08 1.94 . . . . 0.0 114.97 -169.573 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 37.8 m -104.65 -7.15 19.82 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 125.501 1.52 . . . . 0.0 111.249 169.655 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 68.7 m -69.59 79.36 0.42 Allowed 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 115.921 1.823 . . . . 0.0 115.921 -169.299 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 34.8 m-20 65.35 158.91 0.13 Allowed Pre-proline 0 CA--C 1.552 1.039 0 C-N-CA 128.57 2.748 . . . . 0.0 117.48 169.116 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -73.04 158.47 49.49 Favored 'Trans proline' 0 CA--C 1.539 0.74 0 C-N-CA 122.656 2.237 . . . . 0.0 113.052 169.934 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.47 HD12 HG11 ' A' ' 7' ' ' VAL . 6.3 tt -51.22 -40.92 23.4 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 125.705 1.602 . . . . 0.0 112.065 174.336 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -69.54 -7.32 37.32 Favored 'General case' 0 CA--C 1.543 0.707 0 N-CA-C 113.999 1.111 . . . . 0.0 113.999 -179.331 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 -81.14 -19.92 42.45 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 123.682 0.793 . . . . 0.0 113.128 171.349 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -99.27 -173.04 2.38 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 126.104 1.762 . . . . 0.0 112.581 -176.201 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 14.7 t30 -117.75 124.87 49.52 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 125.363 1.465 . . . . 0.0 110.14 175.488 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.99 -38.29 88.13 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 113.694 0.998 . . . . 0.0 113.694 -172.237 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -72.72 -5.09 35.39 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 113.951 1.093 . . . . 0.0 113.951 -176.694 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -72.69 -16.05 61.68 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 123.485 0.714 . . . . 0.0 111.385 168.866 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 60.3 m-85 -115.11 132.11 56.71 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 126.348 1.859 . . . . 0.0 111.166 179.313 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -89.03 -20.6 24.18 Favored 'General case' 0 N--CA 1.476 0.875 0 CA-C-O 121.966 0.889 . . . . 0.0 112.73 -177.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.686 HG22 ' HB ' ' A' ' 95' ' ' ILE . 82.0 t -128.57 137.74 56.5 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 C-N-CA 127.488 2.315 . . . . 0.0 107.965 178.75 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 65.9 t -131.37 123.68 53.41 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 169.569 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 36.1 mm -109.77 104.46 17.11 Favored 'Isoleucine or valine' 0 C--O 1.234 0.287 0 C-N-CA 124.397 1.079 . . . . 0.0 108.462 -179.053 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 5.4 m -82.71 125.42 31.22 Favored 'General case' 0 N--CA 1.466 0.375 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 170.264 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 89.5 mt -102.33 -11.96 18.29 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 114.497 1.295 . . . . 0.0 114.497 -173.189 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 35.1 m -141.65 143.41 33.61 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 125.015 1.326 . . . . 0.0 110.426 -169.595 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 65.39 -133.4 35.85 Favored Glycine 0 CA--C 1.537 1.464 0 CA-C-N 118.083 0.402 . . . . 0.0 112.515 -176.762 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 88.4 p -131.02 13.84 5.21 Favored 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 115.143 1.534 . . . . 0.0 115.143 -175.212 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 67.57 69.17 1.43 Allowed Glycine 0 N--CA 1.475 1.276 0 CA-C-O 122.832 1.24 . . . . 0.0 111.968 -171.046 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 10.2 p -136.44 176.05 8.94 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 C-N-CA 127.876 2.47 . . . . 0.0 107.036 175.018 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 20.8 t-20 66.28 -36.93 0.26 Allowed 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 126.339 1.856 . . . . 0.0 114.844 -172.358 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -71.04 155.72 92.94 Favored Pre-proline 0 CA--C 1.554 1.106 0 CA-C-N 119.742 1.155 . . . . 0.0 111.592 169.18 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_exo -63.17 146.25 94.03 Favored 'Trans proline' 0 CA--C 1.548 1.183 0 C-N-CA 122.094 1.863 . . . . 0.0 113.169 179.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_exo -55.58 -28.8 66.98 Favored 'Trans proline' 0 C--N 1.352 0.738 0 C-N-CA 123.703 2.935 . . . . 0.0 115.804 -175.682 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 4.4 pm0 -62.61 -18.93 63.17 Favored 'General case' 0 CA--C 1.544 0.745 0 O-C-N 120.664 -1.273 . . . . 0.0 114.168 176.373 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 86.6 m95 -83.39 -24.11 32.1 Favored 'General case' 0 N--CA 1.471 0.578 0 O-C-N 120.552 -1.343 . . . . 0.0 112.934 175.708 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 9.7 m -86.21 -3.41 8.66 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.31 0 N-CA-C 113.608 0.966 . . . . 0.0 113.608 173.443 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -111.2 4.69 19.43 Favored 'General case' 0 N--CA 1.48 1.026 0 N-CA-C 114.581 1.326 . . . . 0.0 114.581 -177.957 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 85.9 mm-40 -64.56 158.35 24.47 Favored 'General case' 0 N--CA 1.478 0.956 0 O-C-N 120.863 -1.148 . . . . 0.0 111.976 170.882 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -57.52 -41.83 81.65 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 114.002 1.112 . . . . 0.0 114.002 -168.249 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.686 ' HB ' HG22 ' A' ' 75' ' ' VAL . 15.5 mm -116.03 58.97 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 C-N-CA 124.892 1.277 . . . . 0.0 109.049 174.401 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 27.0 t80 -74.17 110.12 8.2 Favored 'General case' 0 CA--C 1.534 0.356 0 O-C-N 120.441 -1.412 . . . . 0.0 107.666 168.8 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 9.1 mt-10 -107.67 129.43 55.01 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-O 121.586 0.708 . . . . 0.0 112.687 172.404 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -98.35 88.81 4.25 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 124.163 0.985 . . . . 0.0 110.215 174.287 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 29.2 m0 -81.09 102.09 10.03 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-O 122.031 0.919 . . . . 0.0 109.618 176.63 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 27.6 mt-30 -82.29 60.13 4.86 Favored 'General case' 0 CA--C 1.545 0.787 0 CA-C-O 122.527 1.156 . . . . 0.0 109.049 175.83 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 5.9 tt -95.13 156.31 16.37 Favored 'General case' 0 CA--C 1.539 0.519 0 C-N-CA 128.226 2.61 . . . . 0.0 112.87 -169.148 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -67.67 109.88 3.49 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 125.185 1.394 . . . . 0.0 112.398 177.473 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -71.63 123.9 90.12 Favored Pre-proline 0 CA--C 1.548 0.883 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 169.313 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -79.0 -8.57 15.5 Favored 'Trans proline' 0 CA--C 1.551 1.339 0 C-N-CA 122.092 1.861 . . . . 0.0 114.134 -172.456 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -72.82 155.0 40.37 Favored 'General case' 0 CA--C 1.549 0.934 0 CA-C-N 120.668 1.576 . . . . 0.0 113.338 176.416 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 76.57 5.94 83.65 Favored Glycine 0 CA--C 1.538 1.474 0 C-N-CA 124.428 1.013 . . . . 0.0 114.089 -178.12 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 -142.92 167.51 21.9 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 126.998 2.119 . . . . 0.0 111.226 179.284 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 70.6 m -59.83 157.16 12.78 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 115.081 1.511 . . . . 0.0 115.081 -169.42 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -51.1 -38.32 51.11 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 126.202 1.801 . . . . 0.0 112.689 172.304 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -55.11 -38.93 68.79 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 123.787 0.835 . . . . 0.0 112.107 172.7 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 14.6 t -67.96 -40.76 83.88 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 CA-C-O 118.674 -0.679 . . . . 0.0 111.071 173.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -53.7 -47.39 70.53 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 119.346 0.975 . . . . 0.0 112.339 169.821 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 96.9 mtt180 -69.01 -39.0 79.55 Favored 'General case' 0 N--CA 1.479 0.999 0 CA-C-N 118.842 0.746 . . . . 0.0 112.652 -179.603 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 30.7 m -62.18 -40.92 97.65 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 123.718 0.807 . . . . 0.0 111.306 170.432 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 41.8 t -65.69 -41.07 89.68 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 CA-C-O 117.407 -1.282 . . . . 0.0 111.19 176.57 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 75.5 mtm-85 -55.28 -43.52 74.82 Favored 'General case' 0 N--CA 1.485 1.315 0 CA-C-N 121.038 1.745 . . . . 0.0 112.26 172.576 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -60.85 -51.67 57.15 Favored Glycine 0 CA--C 1.537 1.429 0 CA-C-N 119.036 0.835 . . . . 0.0 113.514 176.269 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 57.6 mm-40 -64.81 -42.97 94.58 Favored 'General case' 0 N--CA 1.474 0.765 0 O-C-N 121.758 -0.848 . . . . 0.0 112.124 179.107 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 55.0 t -65.39 -42.54 93.78 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 C-N-CA 124.799 1.24 . . . . 0.0 110.957 177.378 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 62.9 tttm -53.57 -49.36 67.88 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-N 119.721 1.146 . . . . 0.0 111.147 176.629 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -63.68 -41.7 98.12 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 178.444 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 13.3 mtp85 -63.82 -43.5 96.04 Favored 'General case' 0 N--CA 1.478 0.952 0 N-CA-C 113.22 0.822 . . . . 0.0 113.22 175.435 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 86.2 t -69.06 -38.9 78.92 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 C-N-CA 123.453 0.701 . . . . 0.0 110.729 179.534 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -62.75 -37.63 87.36 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 118.897 0.771 . . . . 0.0 111.773 170.791 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 9.4 m-80 -63.29 -46.85 84.81 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 119.185 0.902 . . . . 0.0 112.549 173.495 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -52.98 -56.81 13.26 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 125.035 1.334 . . . . 0.0 110.253 173.696 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 75.4 mt -61.63 -40.53 87.0 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 O-C-N 122.004 -0.435 . . . . 0.0 110.603 -179.121 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -70.69 -12.11 61.36 Favored 'General case' 0 CA--C 1.545 0.779 0 N-CA-C 114.95 1.463 . . . . 0.0 114.95 178.695 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 20.9 ptmt -102.67 -25.9 13.38 Favored 'General case' 0 N--CA 1.478 0.952 0 N-CA-C 114.038 1.125 . . . . 0.0 114.038 172.882 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 16.7 pt -99.18 -19.16 6.01 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 N-CA-C 114.432 1.271 . . . . 0.0 114.432 177.733 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 68.8 m . . . . . 0 C--O 1.255 1.39 0 C-N-CA 125.132 1.373 . . . . 0.0 112.292 -174.777 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.8 ttt . . . . . 0 N--CA 1.503 2.22 0 N-CA-C 111.745 0.276 . . . . 0.0 111.745 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 3.3 mptp? -125.92 156.43 39.73 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 125.685 1.594 . . . . 0.0 112.681 175.759 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 30.5 ttmt -107.64 117.89 35.3 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 106.651 -1.611 . . . . 0.0 106.651 167.115 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 14.3 t -103.01 135.23 41.45 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 N-CA-C 114.239 1.2 . . . . 0.0 114.239 -179.376 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . 0.511 ' HG3' HG13 ' A' ' 7' ' ' VAL . 42.4 tpp -104.48 124.37 49.14 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 123.886 0.874 . . . . 0.0 108.908 168.503 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 67.2 m-85 -105.03 126.09 51.69 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 123.839 0.856 . . . . 0.0 108.972 169.798 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.511 HG13 ' HG3' ' A' ' 5' ' ' MET . 1.5 m -141.95 150.6 19.03 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.194 0 N-CA-C 114.902 1.445 . . . . 0.0 114.902 -168.784 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 48.7 t -148.16 162.28 39.76 Favored 'General case' 0 CA--C 1.556 1.193 0 C-N-CA 127.501 2.32 . . . . 0.0 112.303 -179.432 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 21.9 ptmt -63.3 132.51 51.84 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 125.316 1.446 . . . . 0.0 112.298 172.597 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 6.9 mmm180 42.31 -135.84 0.32 Allowed 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 126.04 1.736 . . . . 0.0 112.255 -172.868 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 34.1 p-10 -154.39 -45.95 0.09 Allowed 'General case' 0 CA--C 1.549 0.942 0 N-CA-C 114.78 1.4 . . . . 0.0 114.78 172.715 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 67.5 m -56.73 -15.16 4.09 Favored 'General case' 0 N--CA 1.481 1.118 0 N-CA-C 117.685 2.476 . . . . 0.0 117.685 -169.067 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 97.7 p -102.17 -9.9 20.08 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 115.577 1.695 . . . . 0.0 115.577 -179.791 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 77.6 mtt85 -144.68 150.2 36.92 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 125.017 1.327 . . . . 0.0 113.468 -169.634 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 86.9 p -119.16 -5.07 10.49 Favored 'General case' 0 N--CA 1.478 0.944 0 N-CA-C 116.196 1.924 . . . . 0.0 116.196 -170.071 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 27.7 mt-30 64.25 -59.59 0.21 Allowed 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 128.013 2.525 . . . . 0.0 117.318 169.853 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 65.02 -43.88 0.33 Allowed 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 127.851 2.46 . . . . 0.0 116.597 -179.748 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.93 -28.34 68.87 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 115.137 1.532 . . . . 0.0 115.137 -169.212 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.0 pm0 -59.69 -37.1 77.87 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 119.132 0.878 . . . . 0.0 112.406 171.588 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -70.3 -50.45 27.17 Favored Glycine 0 C--O 1.224 -0.515 0 C-N-CA 124.408 1.004 . . . . 0.0 112.151 -169.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -66.4 -30.13 70.44 Favored 'General case' 0 N--CA 1.467 0.394 0 O-C-N 121.554 -0.968 . . . . 0.0 112.744 173.499 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -66.32 -35.86 81.46 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 118.499 0.59 . . . . 0.0 111.691 -176.001 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 13.4 ptmm? -82.1 -39.95 22.64 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 123.41 0.684 . . . . 0.0 112.319 169.227 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 16.9 m -76.02 -23.73 55.21 Favored 'General case' 0 N--CA 1.486 1.351 0 N-CA-C 112.905 0.706 . . . . 0.0 112.905 -169.255 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 85.3 mt -103.38 -30.61 10.48 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 125.378 1.471 . . . . 0.0 112.577 169.397 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -99.95 0.72 56.35 Favored Glycine 0 N--CA 1.471 1.026 0 N-CA-C 117.379 1.711 . . . . 0.0 117.379 -169.534 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -60.45 142.93 54.48 Favored 'General case' 0 CA--C 1.546 0.81 0 CA-C-N 121.09 2.445 . . . . 0.0 112.566 178.371 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 84.15 -23.51 7.0 Favored Glycine 0 CA--C 1.54 1.606 0 C-N-CA 124.822 1.201 . . . . 0.0 113.337 -169.48 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 62.1 mttp -96.93 -43.87 7.27 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 125.884 1.674 . . . . 0.0 111.883 169.834 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 43.7 pt -141.74 160.41 21.25 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 C-N-CA 125.178 1.391 . . . . 0.0 113.173 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -108.4 148.16 30.53 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 127.157 2.183 . . . . 0.0 109.17 169.831 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 58.7 t -136.02 143.85 34.95 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 CA-C-N 119.294 0.952 . . . . 0.0 113.165 -177.457 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 59.7 m -135.98 152.2 50.7 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 125.722 1.609 . . . . 0.0 109.539 169.821 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 96.7 p -136.06 142.32 44.36 Favored 'General case' 0 CA--C 1.514 -0.423 0 CA-C-O 121.942 0.877 . . . . 0.0 111.998 167.248 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 29.3 p -141.74 169.14 18.15 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 113.485 -1.689 . . . . 0.0 111.075 -176.707 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -106.02 164.23 13.76 Favored Glycine 0 CA--C 1.525 0.677 0 C-N-CA 123.731 0.681 . . . . 0.0 111.741 178.795 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -90.41 117.54 29.19 Favored 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 106.66 -1.608 . . . . 0.0 106.66 168.859 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 68.5 -41.57 0.46 Allowed 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 127.701 2.4 . . . . 0.0 113.955 -171.904 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 74.2 m -78.8 155.25 29.33 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 124.537 1.135 . . . . 0.0 111.142 169.547 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 67.9 p -90.74 -83.07 0.27 Allowed 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 114.394 1.257 . . . . 0.0 114.394 -179.273 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 52.1 ttt-85 -79.47 148.4 31.9 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 127.764 2.426 . . . . 0.0 110.457 -172.17 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 6.4 m -66.16 141.05 18.55 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 N-CA-C 109.214 -0.662 . . . . 0.0 109.214 171.739 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . 0.256 0.0 OUTLIER -65.36 144.35 98.96 Favored Pre-proline 0 CA--C 1.549 0.917 0 C-N-CA 119.636 -0.826 . . . . 0.0 111.103 -169.294 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_exo -46.32 -37.8 19.49 Favored 'Trans proline' 0 CA--C 1.54 0.792 0 C-N-CA 123.848 3.032 . . . . 0.0 118.331 -167.858 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 27.7 m -62.0 -26.59 68.31 Favored 'General case' 0 N--CA 1.485 1.299 0 O-C-N 120.702 -1.249 . . . . 0.0 112.206 -177.822 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.81 -21.96 66.69 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 113.538 0.94 . . . . 0.0 113.538 174.579 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.5 mp -74.91 -58.46 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 CA-C-N 119.527 1.058 . . . . 0.0 109.113 178.243 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.59 -33.89 76.97 Favored 'General case' 0 CA--C 1.545 0.752 0 N-CA-C 114.166 1.173 . . . . 0.0 114.166 -171.149 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.46 -25.54 57.48 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 124.268 1.027 . . . . 0.0 113.244 179.746 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -92.03 -32.63 15.13 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.578 1.151 . . . . 0.0 109.893 177.812 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -63.92 -12.18 34.83 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.092 1.357 . . . . 0.0 113.985 169.738 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -59.59 -19.68 50.51 Favored 'General case' 0 CA--C 1.553 1.087 0 CA-C-N 119.537 1.062 . . . . 0.0 110.458 168.041 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 16.5 t -108.75 -3.53 10.35 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.035 0 C-N-CA 128.548 2.739 . . . . 0.0 111.987 -179.585 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 73.99 34.41 55.72 Favored Glycine 0 CA--C 1.542 1.747 0 O-C-N 120.429 -1.419 . . . . 0.0 114.578 -177.137 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 9.4 mt -75.86 -19.17 15.53 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 N-CA-C 116.759 2.133 . . . . 0.0 116.759 -169.813 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 24.1 t0 43.7 72.28 0.2 Allowed 'General case' 0 CA--C 1.556 1.186 0 C-N-CA 126.747 2.019 . . . . 0.0 114.885 -179.185 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 35.3 pt -114.62 34.23 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 C-N-CA 125.569 1.548 . . . . 0.0 112.408 173.706 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 75.0 m -70.58 -34.0 71.7 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 114.594 1.331 . . . . 0.0 114.594 -170.104 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -84.41 -68.42 1.4 Allowed Glycine 0 CA--C 1.529 0.947 0 C-N-CA 123.477 0.561 . . . . 0.0 113.506 -179.62 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 8.0 mm100 54.46 -166.87 0.08 Allowed 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 126.527 1.931 . . . . 0.0 111.447 -169.091 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 64.2 p -73.21 138.19 45.48 Favored 'General case' 0 N--CA 1.473 0.701 0 O-C-N 121.141 -0.974 . . . . 0.0 112.56 -179.254 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 68.5 m -80.26 3.0 22.28 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.631 1.172 . . . . 0.0 113.012 169.782 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -144.72 157.35 55.26 Favored Pre-proline 0 CA--C 1.548 0.901 0 C-N-CA 125.87 1.668 . . . . 0.0 112.011 -176.365 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -64.89 165.99 19.63 Favored 'Trans proline' 0 CA--C 1.538 0.695 0 C-N-CA 124.183 3.255 . . . . 0.0 114.721 174.905 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.477 HD12 HG11 ' A' ' 7' ' ' VAL . 5.4 tt -49.83 -42.99 18.95 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.2 0 C-N-CA 124.59 1.156 . . . . 0.0 112.154 174.474 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -69.25 -10.69 58.99 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 113.524 0.935 . . . . 0.0 113.524 -174.83 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -77.39 -15.53 59.32 Favored 'General case' 0 CA--C 1.548 0.886 0 N-CA-C 112.807 0.669 . . . . 0.0 112.807 176.117 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 76.1 m-85 -107.28 -168.27 1.37 Allowed 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 126.53 1.932 . . . . 0.0 112.475 -174.868 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 8.9 p-10 -124.05 129.16 50.42 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 125.314 1.445 . . . . 0.0 109.921 176.629 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -64.55 -36.34 83.89 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 113.209 0.818 . . . . 0.0 113.209 -171.224 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -68.8 -4.55 16.55 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 114.067 1.136 . . . . 0.0 114.067 178.075 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -68.44 -16.68 63.99 Favored 'General case' 0 CA--C 1.549 0.913 0 CA-C-N 118.775 0.716 . . . . 0.0 110.296 168.286 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 79.6 m-85 -119.78 146.26 45.83 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 128.006 2.523 . . . . 0.0 111.709 -177.791 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -94.99 -29.06 14.82 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 124.838 1.255 . . . . 0.0 111.903 178.055 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.736 HG22 ' HB ' ' A' ' 95' ' ' ILE . 71.1 t -125.74 135.39 64.05 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 C-N-CA 126.067 1.747 . . . . 0.0 107.063 -177.212 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 69.0 t -127.04 121.39 57.83 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 169.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 45.1 mm -107.81 106.52 20.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 C-N-CA 124.703 1.201 . . . . 0.0 108.557 -177.597 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 8.1 m -90.68 111.85 23.36 Favored 'General case' 0 N--CA 1.463 0.222 0 C-N-CA 123.699 0.8 . . . . 0.0 109.829 176.611 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 89.9 mt -91.71 -11.32 37.18 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 124.855 1.262 . . . . 0.0 114.405 -170.539 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 57.3 m -139.94 156.27 46.75 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.565 1.146 . . . . 0.0 112.548 -168.927 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 60.62 -133.24 49.94 Favored Glycine 0 CA--C 1.536 1.377 0 N-CA-C 111.409 -0.677 . . . . 0.0 111.409 -175.326 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 75.3 m -125.19 26.87 6.79 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 124.305 1.042 . . . . 0.0 112.169 172.199 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 69.49 25.31 75.63 Favored Glycine 0 CA--C 1.533 1.172 0 O-C-N 121.344 -0.847 . . . . 0.0 114.905 -174.477 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 33.4 m -82.63 -178.54 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 C-N-CA 124.933 1.293 . . . . 0.0 110.254 169.713 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 12.5 t-20 66.18 -34.04 0.2 Allowed 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 127.182 2.193 . . . . 0.0 115.781 -179.35 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -71.85 142.36 85.55 Favored Pre-proline 0 CA--C 1.551 0.986 0 CA-C-N 120.271 1.396 . . . . 0.0 110.73 169.008 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -60.21 154.9 48.9 Favored 'Trans proline' 0 CA--C 1.543 0.946 0 C-N-CA 122.831 2.354 . . . . 0.0 114.492 -179.429 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_exo -56.03 -28.73 70.75 Favored 'Trans proline' 0 C--N 1.353 0.775 0 C-N-CA 123.733 2.955 . . . . 0.0 115.121 -177.483 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -62.11 -30.26 70.9 Favored 'General case' 0 CA--C 1.54 0.582 0 O-C-N 120.888 -1.132 . . . . 0.0 113.103 176.004 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 85.5 m95 -79.59 -29.83 41.33 Favored 'General case' 0 N--CA 1.476 0.846 0 O-C-N 120.942 -1.099 . . . . 0.0 111.998 174.303 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 48.8 t -68.91 -26.93 33.73 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.925 0 C-N-CA 125.216 1.406 . . . . 0.0 112.068 172.55 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -102.33 6.98 40.67 Favored 'General case' 0 N--CA 1.48 1.053 0 N-CA-C 116.051 1.871 . . . . 0.0 116.051 -170.894 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 89.7 mm-40 -65.49 160.33 22.45 Favored 'General case' 0 N--CA 1.481 1.112 0 O-C-N 120.633 -1.292 . . . . 0.0 112.255 172.537 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -51.35 -44.33 62.01 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 124.63 1.172 . . . . 0.0 113.849 -168.703 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.736 ' HB ' HG22 ' A' ' 75' ' ' VAL . 16.8 mm -123.19 69.1 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 C-N-CA 125.015 1.326 . . . . 0.0 108.343 177.781 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 57.1 t80 -78.58 107.55 11.33 Favored 'General case' 0 CA--C 1.534 0.356 0 O-C-N 120.796 -1.19 . . . . 0.0 108.58 169.399 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 9.1 mt-10 -105.92 132.7 51.7 Favored 'General case' 0 CA--C 1.545 0.778 0 N-CA-C 113.773 1.027 . . . . 0.0 113.773 174.551 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -93.75 104.39 16.48 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.648 1.179 . . . . 0.0 109.868 169.816 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 17.4 m0 -92.74 98.68 11.56 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.345 1.058 . . . . 0.0 110.002 -177.246 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 87.8 mm-40 -79.41 61.29 3.43 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 125.087 1.355 . . . . 0.0 109.985 172.833 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 6.2 tt -109.5 149.3 29.8 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 127.092 2.157 . . . . 0.0 113.054 -169.432 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -67.2 111.58 4.02 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 125.962 1.705 . . . . 0.0 111.912 176.444 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -84.0 129.88 57.06 Favored Pre-proline 0 CA--C 1.545 0.776 0 O-C-N 120.887 -1.133 . . . . 0.0 110.849 171.556 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -86.74 -9.63 6.52 Favored 'Trans proline' 0 CA--C 1.541 0.845 0 C-N-CA 121.955 1.77 . . . . 0.0 114.515 -169.957 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -60.39 -41.68 94.32 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 115.307 1.595 . . . . 0.0 115.307 -169.503 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -76.52 10.17 18.5 Favored Glycine 0 CA--C 1.537 1.444 0 C-N-CA 124.212 0.911 . . . . 0.0 114.755 -178.046 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 8.0 pt20 -146.69 -177.65 5.76 Favored 'General case' 0 CA--C 1.551 1.012 0 C-N-CA 126.848 2.059 . . . . 0.0 111.499 -169.877 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 10.5 p -66.76 164.68 16.6 Favored 'General case' 0 N--CA 1.478 0.947 0 N-CA-C 116.172 1.916 . . . . 0.0 116.172 -168.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 36.4 tp -63.02 -26.49 68.87 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 123.832 0.853 . . . . 0.0 112.338 170.591 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -69.39 -34.87 75.16 Favored 'General case' 0 CA--C 1.539 0.539 0 O-C-N 120.922 -1.111 . . . . 0.0 111.243 171.278 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 20.7 t -68.15 -38.94 80.48 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 CA-C-O 117.93 -1.034 . . . . 0.0 111.155 169.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 5.0 m-85 -54.72 -52.21 63.19 Favored 'General case' 0 N--CA 1.478 0.968 0 CA-C-N 120.664 1.574 . . . . 0.0 111.956 169.796 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -67.91 -34.33 76.41 Favored 'General case' 0 N--CA 1.479 0.992 0 CA-C-N 118.954 0.797 . . . . 0.0 112.221 -177.165 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 76.4 m -64.83 -46.42 82.04 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 123.871 0.868 . . . . 0.0 111.042 170.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 53.7 t -67.95 -35.21 71.17 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 CA-C-O 117.602 -1.19 . . . . 0.0 111.022 179.526 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 22.2 mtm105 -55.4 -46.71 76.59 Favored 'General case' 0 N--CA 1.481 1.112 0 CA-C-N 120.66 1.573 . . . . 0.0 111.031 170.629 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -58.47 -48.8 82.12 Favored Glycine 0 CA--C 1.542 1.765 0 CA-C-N 119.432 1.015 . . . . 0.0 113.848 175.188 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 15.5 mm100 -65.25 -44.9 86.63 Favored 'General case' 0 N--CA 1.474 0.742 0 O-C-N 121.778 -0.836 . . . . 0.0 112.02 179.846 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 78.6 t -66.97 -36.22 76.61 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 125.052 1.341 . . . . 0.0 111.308 177.255 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 78.1 tttt -54.64 -49.68 69.97 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-N 119.842 1.201 . . . . 0.0 110.207 174.472 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -64.23 -43.66 94.28 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 112.705 0.631 . . . . 0.0 112.705 175.873 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.57 -36.51 84.04 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 124.16 0.984 . . . . 0.0 112.894 179.47 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 94.4 t -77.48 -40.64 28.83 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 C-N-CA 125.515 1.526 . . . . 0.0 111.475 176.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -62.59 -31.84 72.73 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 119.567 1.076 . . . . 0.0 111.541 172.167 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 12.5 m-80 -67.28 -46.12 74.57 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-N 119.121 0.873 . . . . 0.0 112.867 171.294 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -50.83 -54.98 19.16 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 124.296 1.038 . . . . 0.0 110.138 171.259 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 74.3 mt -58.79 -49.53 82.51 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 CA-C-O 119.163 -0.446 . . . . 0.0 110.179 178.693 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -65.24 -11.26 39.26 Favored 'General case' 0 CA--C 1.544 0.743 0 N-CA-C 115.567 1.691 . . . . 0.0 115.567 -178.827 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 20.9 ptmt -103.23 -17.54 15.29 Favored 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 114.165 1.172 . . . . 0.0 114.165 171.823 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 14.3 pt -106.79 -12.22 10.16 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 N-CA-C 114.436 1.273 . . . . 0.0 114.436 177.153 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 73.8 m . . . . . 0 C--O 1.253 1.27 0 C-N-CA 125.185 1.394 . . . . 0.0 112.436 -176.763 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.9 ttt . . . . . 0 N--CA 1.503 2.185 0 N-CA-C 111.602 0.223 . . . . 0.0 111.602 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.28 163.71 32.9 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 124.828 1.251 . . . . 0.0 113.775 177.667 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 58.6 mtpt -89.72 141.82 28.26 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 125.226 1.41 . . . . 0.0 113.007 175.898 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 21.6 t -122.94 130.54 74.4 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 C-N-CA 125.971 1.708 . . . . 0.0 112.397 177.45 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 35.6 tpp -102.05 127.55 48.89 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 168.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 66.1 m-85 -104.68 132.32 51.06 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 123.728 0.811 . . . . 0.0 109.428 170.032 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -141.13 146.76 23.23 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 N-CA-C 114.584 1.327 . . . . 0.0 114.584 -169.441 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 41.8 t -151.19 176.32 11.31 Favored 'General case' 0 CA--C 1.552 1.056 0 C-N-CA 127.31 2.244 . . . . 0.0 110.853 171.472 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 54.1 mtpt -85.24 135.04 34.1 Favored 'General case' 0 N--CA 1.482 1.166 0 O-C-N 120.672 -1.267 . . . . 0.0 112.16 170.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 23.2 tpt180 47.58 56.45 7.05 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 127.507 2.323 . . . . 0.0 113.226 179.276 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -52.08 -28.56 17.94 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 113.857 1.058 . . . . 0.0 113.857 -179.422 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 67.2 m -63.69 -16.97 62.44 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-N 120.13 1.332 . . . . 0.0 112.661 -176.168 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 98.6 p -121.91 21.43 10.64 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 126.476 1.91 . . . . 0.0 113.767 171.11 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 73.6 mtt85 -137.73 151.32 48.08 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 125.762 1.625 . . . . 0.0 112.216 175.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 33.0 m -93.02 -31.93 14.69 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 114.977 1.473 . . . . 0.0 114.977 -169.729 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 59.89 -44.29 0.09 Allowed 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 127.887 2.475 . . . . 0.0 117.331 -179.043 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . 0.438 ' HG2' ' SD ' ' A' ' 50' ' ' MET . 0.0 OUTLIER 68.73 -46.55 0.55 Allowed 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 127.605 2.362 . . . . 0.0 115.907 172.389 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.08 -35.21 74.69 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 115.908 1.818 . . . . 0.0 115.908 -169.112 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.3 pm0 -64.36 -43.69 93.73 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 119.151 0.887 . . . . 0.0 112.426 -179.044 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -61.41 -38.04 95.09 Favored Glycine 0 C--N 1.336 0.57 0 C-N-CA 123.903 0.763 . . . . 0.0 112.123 175.12 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -73.58 -42.47 61.56 Favored 'General case' 0 N--CA 1.47 0.527 0 O-C-N 121.782 -0.834 . . . . 0.0 111.518 177.541 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -60.33 -40.97 92.57 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 119.243 0.929 . . . . 0.0 112.705 -175.613 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 11.7 pttp -78.77 -24.92 44.43 Favored 'General case' 0 N--CA 1.479 1.016 0 N-CA-C 113.787 1.032 . . . . 0.0 113.787 174.036 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 90.4 m -72.52 -34.98 67.98 Favored 'General case' 0 N--CA 1.486 1.329 0 O-C-N 121.432 -0.792 . . . . 0.0 111.779 171.896 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 82.4 mt -88.66 -28.58 20.52 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 125.625 1.57 . . . . 0.0 113.824 -177.026 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -148.23 29.24 1.36 Allowed Glycine 0 N--CA 1.473 1.102 0 N-CA-C 118.256 2.062 . . . . 0.0 118.256 -169.411 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -66.53 -20.39 66.01 Favored 'General case' 0 N--CA 1.477 0.919 0 CA-C-N 121.867 2.834 . . . . 0.0 115.301 -177.752 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -77.56 -4.59 85.0 Favored Glycine 0 CA--C 1.541 1.696 0 O-C-N 121.305 -0.872 . . . . 0.0 113.923 169.593 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 60.7 mttp -115.93 -40.58 3.3 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 126.981 2.112 . . . . 0.0 112.315 -177.286 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 19.8 pt -140.69 159.04 24.32 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 125.961 1.704 . . . . 0.0 112.558 -174.308 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -106.23 140.32 39.37 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.682 1.193 . . . . 0.0 110.209 171.099 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 69.5 t -125.15 140.92 46.75 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 CA-C-N 118.911 0.778 . . . . 0.0 111.819 -175.104 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 22.4 m -134.56 143.39 47.36 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 125.058 1.343 . . . . 0.0 109.95 173.815 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 78.6 p -97.39 144.38 27.2 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.846 0.831 . . . . 0.0 111.24 169.198 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 32.7 t -149.05 165.04 32.87 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 123.593 0.757 . . . . 0.0 110.311 169.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -134.67 161.61 24.53 Favored Glycine 0 C--O 1.229 -0.167 0 CA-C-O 121.808 0.671 . . . . 0.0 112.604 -178.547 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -95.0 111.28 23.1 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 106.351 -1.722 . . . . 0.0 106.351 169.58 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 19.0 mt-10 66.68 30.77 8.03 Favored 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 125.122 1.369 . . . . 0.0 114.392 -173.587 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 7.6 m -151.31 151.34 31.66 Favored 'General case' 0 N--CA 1.482 1.152 0 N-CA-C 114.681 1.364 . . . . 0.0 114.681 175.56 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 88.0 p -109.43 -15.34 14.25 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 126.985 2.114 . . . . 0.0 116.327 173.632 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 7.6 tpt180 -123.4 170.32 10.46 Favored 'General case' 0 N--CA 1.488 1.462 0 CA-C-N 120.497 1.499 . . . . 0.0 110.781 -178.512 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 27.0 m -111.93 163.84 8.45 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.266 0 C-N-CA 126.435 1.894 . . . . 0.0 109.57 169.481 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 3.1 t-80 -48.59 129.91 13.81 Favored Pre-proline 0 CA--C 1.536 0.408 0 N-CA-C 113.945 1.091 . . . . 0.0 113.945 -173.866 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 81.5 Cg_exo -59.93 -26.76 83.26 Favored 'Trans proline' 0 CA--C 1.549 1.23 0 CA-C-N 120.273 1.133 . . . . 0.0 112.5 173.231 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 55.0 m -70.91 -29.15 65.12 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 125.17 1.388 . . . . 0.0 112.363 174.033 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -55.45 -44.55 76.48 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 119.245 0.93 . . . . 0.0 111.226 -178.078 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.7 mp -47.2 -55.11 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 125.178 1.391 . . . . 0.0 110.483 -177.41 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.99 -30.89 71.91 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 113.486 0.921 . . . . 0.0 113.486 -176.748 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -82.73 -26.35 32.02 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 113.421 0.897 . . . . 0.0 113.421 179.064 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . 0.438 ' SD ' ' HG2' ' A' ' 17' ' ' MET . 3.9 mmt -80.3 -32.92 38.01 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.223 0.609 . . . . 0.0 110.8 170.266 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -66.01 -14.78 62.25 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 124.61 1.164 . . . . 0.0 113.348 172.845 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -60.56 -27.65 67.83 Favored 'General case' 0 N--CA 1.482 1.138 0 CA-C-N 120.106 1.321 . . . . 0.0 110.731 168.844 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 57.7 t -98.22 -6.5 9.35 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.939 0 C-N-CA 127.229 2.212 . . . . 0.0 111.282 176.894 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 81.14 19.36 67.22 Favored Glycine 0 CA--C 1.539 1.582 0 C-N-CA 124.951 1.263 . . . . 0.0 114.425 -174.506 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 83.0 mt -77.77 135.14 26.9 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 124.925 1.29 . . . . 0.0 111.266 -175.654 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 21.6 t0 -94.58 104.46 16.41 Favored 'General case' 0 CA--C 1.544 0.729 0 N-CA-C 113.236 0.828 . . . . 0.0 113.236 177.629 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 15.0 pt -130.56 23.25 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 C-N-CA 125.273 1.429 . . . . 0.0 112.338 169.688 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 72.2 m -87.69 153.53 21.29 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 124.729 1.212 . . . . 0.0 112.435 -178.379 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 65.68 18.5 66.1 Favored Glycine 0 CA--C 1.537 1.454 0 N-CA-C 115.28 0.872 . . . . 0.0 115.28 171.86 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -115.12 143.93 44.45 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 124.969 1.307 . . . . 0.0 111.957 -177.357 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 33.4 m -135.24 148.63 49.66 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 107.818 -1.179 . . . . 0.0 107.818 169.32 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 68.1 m -123.26 -161.45 0.97 Allowed 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 126.329 1.852 . . . . 0.0 109.916 -171.786 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -134.91 159.03 73.65 Favored Pre-proline 0 CA--C 1.54 0.567 0 C-N-CA 123.854 0.862 . . . . 0.0 110.923 179.332 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -62.17 157.27 45.63 Favored 'Trans proline' 0 N--CA 1.46 -0.476 0 C-N-CA 122.294 1.996 . . . . 0.0 112.311 171.77 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.426 HD11 ' CE3' ' A' ' 90' ' ' TRP . 6.7 tp -60.99 -30.21 47.16 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 O-C-N 121.667 -0.645 . . . . 0.0 112.423 -173.876 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -67.52 -12.5 60.49 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 114.341 1.237 . . . . 0.0 114.341 176.794 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 -79.95 -21.53 43.67 Favored 'General case' 0 CA--C 1.547 0.855 0 N-CA-C 113.22 0.822 . . . . 0.0 113.22 179.839 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 99.3 m-85 -102.39 -174.52 2.59 Favored 'General case' 0 CA--C 1.552 1.045 0 C-N-CA 126.216 1.806 . . . . 0.0 112.922 -173.319 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 5.9 t30 -123.6 126.7 47.1 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 126.21 1.804 . . . . 0.0 109.572 171.799 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.91 -35.9 81.05 Favored 'General case' 0 CA--C 1.53 0.184 0 N-CA-C 114.361 1.245 . . . . 0.0 114.361 -170.048 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . 0.256 0.0 OUTLIER -72.67 -3.63 26.18 Favored 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 114.221 1.193 . . . . 0.0 114.221 -175.672 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -75.21 -13.25 60.43 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 124.076 0.95 . . . . 0.0 111.543 168.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 87.8 m-85 -118.08 135.73 54.02 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 126.774 2.029 . . . . 0.0 111.574 -179.287 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -87.15 -24.23 24.56 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-O 122.297 1.046 . . . . 0.0 112.655 178.47 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.623 HG22 ' HB ' ' A' ' 95' ' ' ILE . 80.1 t -129.73 138.99 52.76 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 C-N-CA 127.28 2.232 . . . . 0.0 108.772 -176.569 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 59.2 t -135.15 122.66 37.29 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 171.509 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 45.1 mm -110.21 101.1 12.08 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 C-N-CA 124.255 1.022 . . . . 0.0 109.919 -174.693 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 8.8 m -86.15 94.43 9.28 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 124.224 1.01 . . . . 0.0 109.208 171.139 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -97.78 19.68 13.29 Favored 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 116.065 1.876 . . . . 0.0 116.065 -169.427 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 14.7 p -152.14 155.08 37.14 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 123.812 0.845 . . . . 0.0 110.941 170.695 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 62.06 -137.34 45.86 Favored Glycine 0 CA--C 1.535 1.334 0 C-N-CA 123.685 0.659 . . . . 0.0 113.948 177.571 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 83.4 p -93.21 -23.59 18.5 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.996 1.318 . . . . 0.0 114.552 179.544 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 77.07 4.44 83.4 Favored Glycine 0 CA--C 1.535 1.292 0 C-N-CA 124.555 1.074 . . . . 0.0 115.343 -169.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 48.9 t -88.73 -10.92 10.58 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 CA-C-N 119.564 1.682 . . . . 0.0 112.91 -172.373 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -72.65 -9.56 58.75 Favored 'General case' 0 CA--C 1.549 0.917 0 O-C-N 120.426 -1.421 . . . . 0.0 114.153 -176.168 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -95.06 158.43 34.9 Favored Pre-proline 0 CA--C 1.549 0.927 0 C-N-CA 124.791 1.236 . . . . 0.0 113.644 176.479 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_exo -61.18 152.92 68.56 Favored 'Trans proline' 0 CA--C 1.544 0.991 0 C-N-CA 122.96 2.44 . . . . 0.0 114.24 -179.198 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_exo -55.76 -29.66 72.59 Favored 'Trans proline' 0 C--N 1.354 0.824 0 C-N-CA 123.692 2.928 . . . . 0.0 115.082 -177.599 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -61.81 -29.31 70.07 Favored 'General case' 0 CA--C 1.539 0.551 0 O-C-N 121.077 -1.015 . . . . 0.0 112.888 177.02 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . 0.426 ' CE3' HD11 ' A' ' 65' ' ' ILE . 92.8 m95 -80.94 -33.79 33.75 Favored 'General case' 0 N--CA 1.473 0.698 0 O-C-N 121.202 -0.936 . . . . 0.0 112.119 174.269 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 25.0 t -63.25 -31.72 53.78 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 C-N-CA 124.679 1.192 . . . . 0.0 111.606 172.239 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -96.93 6.18 49.12 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 115.675 1.732 . . . . 0.0 115.675 -171.299 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 87.0 mm-40 -64.74 157.25 27.98 Favored 'General case' 0 N--CA 1.481 1.077 0 O-C-N 120.615 -1.303 . . . . 0.0 111.248 169.897 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -58.74 -39.53 81.2 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 113.967 1.099 . . . . 0.0 113.967 -168.092 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.623 ' HB ' HG22 ' A' ' 75' ' ' VAL . 19.1 mm -118.82 59.61 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 C-N-CA 124.958 1.303 . . . . 0.0 109.017 177.235 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 52.0 t80 -76.89 106.97 8.89 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 107.333 -1.358 . . . . 0.0 107.333 168.724 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 13.2 mt-10 -109.11 134.82 51.2 Favored 'General case' 0 N--CA 1.467 0.375 0 N-CA-C 113.11 0.781 . . . . 0.0 113.11 174.561 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -103.51 118.05 35.86 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.062 0.945 . . . . 0.0 109.453 169.089 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 28.4 m0 -109.96 114.34 27.8 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 107.672 -1.233 . . . . 0.0 107.672 176.415 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 19.3 mt-30 -85.22 49.07 1.67 Allowed 'General case' 0 CA--C 1.545 0.763 0 O-C-N 121.3 -0.875 . . . . 0.0 111.701 -175.003 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 82.7 mt -73.94 160.16 31.75 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 125.848 1.659 . . . . 0.0 111.918 175.54 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -88.34 155.22 19.83 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.846 169.286 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -94.14 143.86 27.1 Favored Pre-proline 0 CA--C 1.547 0.834 0 O-C-N 121.422 -0.799 . . . . 0.0 111.606 171.023 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -64.1 -18.5 63.75 Favored 'Trans proline' 0 CA--C 1.546 1.08 0 C-N-CA 122.661 2.241 . . . . 0.0 116.07 176.01 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -57.12 138.15 54.9 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 120.255 1.389 . . . . 0.0 113.583 -178.801 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 78.41 6.59 87.99 Favored Glycine 0 CA--C 1.535 1.311 0 C-N-CA 124.384 0.993 . . . . 0.0 115.058 177.19 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 11.7 pt20 -141.8 165.13 28.31 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 125.17 1.388 . . . . 0.0 113.499 -178.376 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 68.4 m -63.68 162.89 12.36 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 125.774 1.63 . . . . 0.0 115.393 -169.52 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 21.4 tp -59.75 -29.25 68.04 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 125.181 1.392 . . . . 0.0 113.445 178.518 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -62.1 -28.94 69.97 Favored 'General case' 0 N--CA 1.476 0.844 0 O-C-N 120.544 -1.348 . . . . 0.0 111.92 171.617 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 3.5 t -76.56 -37.39 29.64 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 O-C-N 120.86 -1.15 . . . . 0.0 111.427 172.628 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -56.34 -46.55 79.88 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-N 120.028 1.286 . . . . 0.0 110.531 168.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -66.85 -36.15 81.67 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.702 0.801 . . . . 0.0 112.002 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 25.5 m -60.85 -52.16 66.25 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 124.414 1.085 . . . . 0.0 111.162 170.43 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 69.3 t -64.54 -45.97 94.02 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 O-C-N 121.712 -0.617 . . . . 0.0 110.528 179.831 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 42.6 ttp85 -59.53 -38.59 81.41 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 125.359 1.463 . . . . 0.0 112.394 178.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -64.73 -50.5 58.33 Favored Glycine 0 CA--C 1.538 1.505 0 CA-C-N 119.156 0.889 . . . . 0.0 113.481 171.632 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 15.2 mm100 -63.7 -42.17 98.02 Favored 'General case' 0 N--CA 1.477 0.891 0 O-C-N 121.819 -0.812 . . . . 0.0 111.836 178.905 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 52.9 t -64.01 -42.07 94.5 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 C-N-CA 125.397 1.479 . . . . 0.0 110.887 175.437 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 82.4 tttt -53.24 -49.45 66.8 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 120.153 1.342 . . . . 0.0 110.478 176.854 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -64.96 -42.67 94.38 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 123.454 0.702 . . . . 0.0 112.788 178.689 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 16.1 mmm180 -60.29 -45.34 93.69 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 123.438 0.695 . . . . 0.0 112.649 175.278 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 87.2 t -71.4 -39.45 71.57 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 C-N-CA 124.147 0.979 . . . . 0.0 111.267 -178.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -61.15 -41.66 97.14 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 119.386 0.994 . . . . 0.0 111.638 171.151 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 14.4 m-80 -63.4 -46.26 87.26 Favored 'General case' 0 CA--C 1.539 0.519 0 CA-C-N 118.692 0.678 . . . . 0.0 112.275 174.911 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -54.1 -54.95 32.4 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 124.694 1.198 . . . . 0.0 110.766 175.492 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 97.1 mt -61.09 -44.48 98.37 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 CA-C-O 118.857 -0.592 . . . . 0.0 110.541 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -67.48 -14.47 62.96 Favored 'General case' 0 CA--C 1.543 0.681 0 N-CA-C 115.084 1.512 . . . . 0.0 115.084 -179.738 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 21.1 ptmt -100.17 -28.02 13.23 Favored 'General case' 0 N--CA 1.478 0.931 0 CA-C-N 119.298 0.953 . . . . 0.0 113.552 173.646 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 17.5 pt -92.27 -14.72 8.39 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 N-CA-C 114.491 1.293 . . . . 0.0 114.491 178.091 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 67.4 m . . . . . 0 C--O 1.254 1.291 0 C-N-CA 123.893 0.877 . . . . 0.0 112.892 179.573 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.1 ttt . . . . . 0 N--CA 1.501 2.123 0 N-CA-C 111.599 0.222 . . . . 0.0 111.599 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -123.74 160.39 27.38 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 125.844 1.658 . . . . 0.0 112.662 176.557 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 32.4 ttmt -110.91 113.68 26.43 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 167.588 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 16.2 t -103.7 133.65 47.07 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 N-CA-C 113.839 1.051 . . . . 0.0 113.839 -177.852 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 46.4 tpp -101.59 119.61 39.03 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.456 1.102 . . . . 0.0 109.58 169.093 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 56.3 m-85 -103.34 121.75 43.4 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 124.899 1.28 . . . . 0.0 109.134 173.433 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.419 HG11 HD12 ' A' ' 65' ' ' ILE . 4.2 m -144.57 162.32 14.27 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 C-N-CA 124.163 0.985 . . . . 0.0 113.002 -168.894 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 12.7 t -146.86 157.03 43.55 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 126.095 1.758 . . . . 0.0 110.749 169.807 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -30.59 -46.78 0.08 Allowed 'General case' 0 N--CA 1.489 1.476 0 C-N-CA 129.119 2.968 . . . . 0.0 117.126 -176.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 32.1 ttm180 -137.35 -26.01 1.01 Allowed 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 117.309 2.337 . . . . 0.0 117.309 -174.882 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 6.9 t30 60.34 -33.38 0.07 Allowed 'General case' 0 N--CA 1.485 1.319 0 N-CA-C 117.577 2.436 . . . . 0.0 117.577 -178.534 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 84.1 p -62.69 139.98 58.69 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 121.192 1.815 . . . . 0.0 111.946 175.049 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 69.7 m 49.85 31.39 4.54 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 125.943 1.697 . . . . 0.0 114.486 -175.115 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 77.0 mtt85 -141.61 162.75 34.71 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 126.631 1.972 . . . . 0.0 111.53 -175.576 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 4.0 m -124.16 149.32 46.42 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 125.766 1.626 . . . . 0.0 111.774 174.089 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 -112.71 -35.59 5.45 Favored 'General case' 0 N--CA 1.478 0.933 0 N-CA-C 114.347 1.24 . . . . 0.0 114.347 -178.185 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . 0.461 ' HG2' ' SD ' ' A' ' 50' ' ' MET . 0.0 OUTLIER 68.56 -47.78 0.55 Allowed 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 126.783 2.033 . . . . 0.0 115.681 173.887 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.17 -30.01 70.75 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 115.613 1.709 . . . . 0.0 115.613 -169.614 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 3.5 pm0 -62.7 -44.55 95.96 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 119.385 0.993 . . . . 0.0 112.096 178.062 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -64.77 -42.98 96.86 Favored Glycine 0 C--O 1.226 -0.402 0 C-N-CA 124.135 0.874 . . . . 0.0 111.736 179.405 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -68.6 -39.85 80.69 Favored 'General case' 0 N--CA 1.466 0.336 0 O-C-N 121.856 -0.791 . . . . 0.0 111.504 176.839 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -62.32 -41.41 98.52 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 119.226 0.921 . . . . 0.0 112.63 -177.837 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 10.5 pttp -81.17 -20.38 41.36 Favored 'General case' 0 N--CA 1.48 1.067 0 N-CA-C 114.037 1.125 . . . . 0.0 114.037 174.288 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 93.3 m -74.52 -36.13 63.18 Favored 'General case' 0 N--CA 1.483 1.224 0 O-C-N 121.561 -0.712 . . . . 0.0 111.645 170.806 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 74.4 mt -92.75 -30.83 15.31 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 125.374 1.47 . . . . 0.0 114.672 -174.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -137.21 25.71 3.01 Favored Glycine 0 N--CA 1.475 1.238 0 N-CA-C 118.224 2.049 . . . . 0.0 118.224 -169.002 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -66.69 -22.04 66.08 Favored 'General case' 0 N--CA 1.476 0.856 0 CA-C-N 121.895 2.848 . . . . 0.0 115.391 -174.459 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -72.74 -12.54 78.25 Favored Glycine 0 CA--C 1.542 1.748 0 O-C-N 121.18 -0.95 . . . . 0.0 113.632 169.576 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 53.2 mttm -107.34 -39.54 5.64 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 127.318 2.247 . . . . 0.0 113.161 -179.75 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 45.2 pt -144.41 154.46 15.0 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 C-N-CA 124.667 1.187 . . . . 0.0 114.094 -171.624 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -98.14 140.33 32.61 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 126.021 1.728 . . . . 0.0 109.247 169.548 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 92.3 t -127.27 139.02 53.08 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 CA-C-N 118.553 0.615 . . . . 0.0 111.735 -175.915 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 33.5 m -136.35 148.16 47.75 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 125.269 1.428 . . . . 0.0 109.432 172.182 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 86.1 p -136.02 143.19 44.62 Favored 'General case' 0 CA--C 1.514 -0.406 0 CA-C-O 122.249 1.023 . . . . 0.0 111.16 167.801 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 8.0 m -139.36 152.23 46.97 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 113.393 -1.731 . . . . 0.0 111.25 -169.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -81.33 163.76 45.1 Favored Glycine 0 CA--C 1.527 0.819 0 N-CA-C 110.382 -1.087 . . . . 0.0 110.382 169.222 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 8.2 mp -91.07 -23.09 20.43 Favored 'General case' 0 N--CA 1.477 0.911 0 O-C-N 120.885 -1.362 . . . . 0.0 112.895 174.173 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -148.8 29.68 0.82 Allowed 'General case' 0 CA--C 1.551 0.985 0 C-N-CA 125.734 1.614 . . . . 0.0 111.076 176.815 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 32.6 p -152.29 153.0 32.83 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 126.54 1.936 . . . . 0.0 112.16 -174.186 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 47.6 m -116.25 19.04 15.08 Favored 'General case' 0 N--CA 1.483 1.216 0 N-CA-C 116.198 1.925 . . . . 0.0 116.198 -169.003 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 7.8 tpt180 -159.3 144.76 15.98 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 124.702 1.201 . . . . 0.0 111.759 171.511 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 22.0 m -70.87 129.37 34.83 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.321 0 N-CA-C 105.92 -1.881 . . . . 0.0 105.92 167.847 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . 0.425 ' HA ' ' HD3' ' A' ' 44' ' ' PRO 0.271 0.0 OUTLIER -60.46 141.49 91.56 Favored Pre-proline 0 CA--C 1.552 1.05 0 N-CA-C 112.681 0.622 . . . . 0.0 112.681 -168.413 . . . . . . . . 4 4 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 43' ' ' HIS . 63.5 Cg_exo -46.49 -39.26 22.26 Favored 'Trans proline' 0 CA--C 1.54 0.778 0 C-N-CA 124.257 3.305 . . . . 0.0 118.567 -168.001 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 26.0 m -65.04 -24.3 67.44 Favored 'General case' 0 N--CA 1.484 1.242 0 CA-C-N 119.418 1.008 . . . . 0.0 112.802 -174.703 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -52.83 -48.77 66.74 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 123.673 0.789 . . . . 0.0 111.573 172.873 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.6 mp -54.01 -56.02 11.38 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 C-N-CA 124.373 1.069 . . . . 0.0 110.37 -171.764 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -62.4 -28.28 69.67 Favored 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 113.392 0.886 . . . . 0.0 113.392 -177.14 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -81.85 -20.64 38.53 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 113.69 0.996 . . . . 0.0 113.69 176.758 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . 0.461 ' SD ' ' HG2' ' A' ' 17' ' ' MET . 5.7 mmt -87.52 -32.55 19.35 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 119.465 1.03 . . . . 0.0 110.729 169.887 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -64.5 -15.29 60.58 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.752 1.221 . . . . 0.0 113.559 176.229 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 -61.15 -28.44 69.12 Favored 'General case' 0 N--CA 1.48 1.032 0 CA-C-N 120.225 1.375 . . . . 0.0 111.077 169.345 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 59.3 t -94.91 -3.65 10.58 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.047 0 C-N-CA 127.356 2.262 . . . . 0.0 111.253 178.03 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 79.4 17.54 75.83 Favored Glycine 0 CA--C 1.54 1.609 0 O-C-N 120.525 -1.359 . . . . 0.0 114.588 -174.572 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 67.2 mt -76.57 145.48 10.28 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 C-N-CA 125.09 1.356 . . . . 0.0 111.941 -174.445 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -106.3 53.16 0.71 Allowed 'General case' 0 CA--C 1.548 0.897 0 N-CA-C 115.11 1.522 . . . . 0.0 115.11 -170.092 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 12.0 pt -85.42 -0.12 6.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 120.017 -1.677 . . . . 0.0 114.252 173.334 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 84.5 p -67.09 -28.13 67.92 Favored 'General case' 0 N--CA 1.476 0.841 0 O-C-N 120.838 -1.163 . . . . 0.0 113.502 174.694 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -82.0 -6.95 88.47 Favored Glycine 0 CA--C 1.537 1.415 0 C-N-CA 125.075 1.321 . . . . 0.0 116.381 -177.112 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 14.8 pt20 -100.19 138.34 37.39 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 119.309 1.555 . . . . 0.0 112.077 179.364 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 58.8 p -106.38 -64.24 1.19 Allowed 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 125.701 1.6 . . . . 0.0 110.82 173.28 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 59.1 m 63.7 127.12 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 129.152 2.981 . . . . 0.0 116.639 173.621 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 24.6 m-20 -67.35 162.11 58.53 Favored Pre-proline 0 CA--C 1.548 0.87 0 C-N-CA 124.402 1.081 . . . . 0.0 111.012 169.555 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -58.1 157.95 23.44 Favored 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 122.627 2.218 . . . . 0.0 112.977 171.075 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.419 HD12 HG11 ' A' ' 7' ' ' VAL . 2.9 tt -57.1 -37.7 56.8 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 C-N-CA 123.778 0.831 . . . . 0.0 110.939 -178.506 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.98 -1.55 26.2 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 114.302 1.223 . . . . 0.0 114.302 -177.247 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -88.22 -6.85 57.59 Favored 'General case' 0 CA--C 1.555 1.167 0 C-N-CA 124.573 1.149 . . . . 0.0 111.9 169.242 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 77.2 m-85 -113.86 -174.93 2.56 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 126.796 2.038 . . . . 0.0 112.739 -178.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 13.3 p-10 -116.83 132.73 56.62 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 127.04 2.136 . . . . 0.0 109.915 174.607 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -67.45 -35.75 79.84 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 113.636 0.976 . . . . 0.0 113.636 -174.315 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -70.02 -3.45 16.37 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 114.429 1.27 . . . . 0.0 114.429 -179.334 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -69.96 -16.72 63.24 Favored 'General case' 0 CA--C 1.543 0.699 0 O-C-N 121.652 -0.655 . . . . 0.0 110.976 168.946 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 45.2 m-85 -120.42 131.14 54.66 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 126.661 1.985 . . . . 0.0 111.378 -172.724 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -80.69 -22.85 40.01 Favored 'General case' 0 N--CA 1.477 0.911 0 CA-C-O 122.234 1.016 . . . . 0.0 112.498 178.065 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.632 HG22 ' HB ' ' A' ' 95' ' ' ILE . 82.2 t -132.4 136.37 56.34 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 C-N-CA 127.501 2.32 . . . . 0.0 108.125 -175.113 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 59.7 t -131.92 127.3 58.19 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 169.561 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 41.8 mm -114.61 115.91 50.98 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 C-N-CA 123.777 0.831 . . . . 0.0 109.645 -174.93 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 10.5 t -89.18 122.46 32.49 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 169.208 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 92.7 mt -97.19 5.32 50.33 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 116.141 1.904 . . . . 0.0 116.141 -168.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 25.4 p -144.94 39.04 1.21 Allowed 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 123.273 0.629 . . . . 0.0 112.077 -174.435 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 110.53 -148.25 17.58 Favored Glycine 0 CA--C 1.531 1.08 0 C-N-CA 125.024 1.297 . . . . 0.0 112.992 -174.224 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 87.2 p -76.29 174.51 10.09 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 124.963 1.305 . . . . 0.0 113.502 -178.629 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -76.07 119.81 5.74 Favored Glycine 0 N--CA 1.469 0.889 0 CA-C-O 122.244 0.914 . . . . 0.0 111.317 169.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 7.6 p -148.0 151.73 13.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 C-N-CA 127.86 2.464 . . . . 0.0 106.471 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 51.7 t30 65.73 2.66 2.2 Favored 'General case' 0 CA--C 1.556 1.185 0 N-CA-C 115.996 1.85 . . . . 0.0 115.996 179.647 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -117.54 152.18 49.24 Favored Pre-proline 0 N--CA 1.479 0.996 0 C-N-CA 126.14 1.776 . . . . 0.0 111.681 169.679 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -71.89 160.36 47.97 Favored 'Trans proline' 0 CA--C 1.548 1.219 0 C-N-CA 122.407 2.071 . . . . 0.0 113.061 -179.082 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_exo -57.81 -25.77 70.59 Favored 'Trans proline' 0 C--N 1.354 0.834 0 C-N-CA 123.931 3.087 . . . . 0.0 116.363 -169.696 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -62.46 -25.78 68.17 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 114.024 1.12 . . . . 0.0 114.024 -178.711 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 93.8 m95 -81.13 -33.05 33.48 Favored 'General case' 0 N--CA 1.472 0.662 0 O-C-N 120.676 -1.265 . . . . 0.0 112.682 178.436 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 9.4 m -80.73 -6.2 9.36 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 N-CA-C 113.145 0.795 . . . . 0.0 113.145 176.046 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -106.82 6.01 29.06 Favored 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 114.741 1.386 . . . . 0.0 114.741 179.678 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 91.1 mm-40 -65.75 158.61 27.14 Favored 'General case' 0 N--CA 1.479 0.999 0 O-C-N 120.785 -1.197 . . . . 0.0 111.621 170.512 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -57.44 -43.47 83.91 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 114.224 1.194 . . . . 0.0 114.224 -168.15 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.632 ' HB ' HG22 ' A' ' 75' ' ' VAL . 22.0 mm -114.96 60.52 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 C-N-CA 124.93 1.292 . . . . 0.0 108.77 175.794 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 42.6 t80 -76.57 110.83 11.45 Favored 'General case' 0 CA--C 1.536 0.41 0 O-C-N 120.746 -1.221 . . . . 0.0 108.229 169.084 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 17.0 mt-10 -110.73 137.76 47.98 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 114.573 1.323 . . . . 0.0 114.573 175.7 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -97.71 114.74 26.79 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.99 1.316 . . . . 0.0 109.726 169.373 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 34.0 m0 -104.79 118.61 36.99 Favored 'General case' 0 N--CA 1.462 0.156 0 C-N-CA 124.438 1.095 . . . . 0.0 108.189 176.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 61.7 mt-30 -91.18 44.21 1.18 Allowed 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 124.508 1.123 . . . . 0.0 111.162 -169.627 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 90.1 mt -82.99 168.13 17.28 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 126.926 2.09 . . . . 0.0 112.222 -179.165 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -96.97 152.95 18.21 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 123.856 0.863 . . . . 0.0 113.108 172.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -77.7 121.62 84.52 Favored Pre-proline 0 CA--C 1.543 0.703 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 169.458 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -79.9 -9.06 14.42 Favored 'Trans proline' 0 CA--C 1.542 0.923 0 C-N-CA 121.403 1.402 . . . . 0.0 114.317 -178.798 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -72.89 -41.9 64.15 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 115.905 1.817 . . . . 0.0 115.905 -169.416 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -72.89 20.37 1.09 Allowed Glycine 0 CA--C 1.541 1.707 0 C-N-CA 124.387 0.994 . . . . 0.0 114.872 -177.471 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 7.3 pt20 -158.74 176.94 11.73 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 127.78 2.432 . . . . 0.0 110.876 -169.662 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 52.8 p -66.65 161.94 22.2 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 114.122 1.156 . . . . 0.0 114.122 -172.82 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . 0.32 2.9 pp -67.99 -11.97 59.88 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 114.194 1.183 . . . . 0.0 114.194 176.803 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -67.82 -30.07 69.39 Favored 'General case' 0 CA--C 1.543 0.682 0 O-C-N 120.968 -1.082 . . . . 0.0 109.953 168.845 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 3.4 t -74.35 -36.92 44.02 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 O-C-N 121.031 -1.043 . . . . 0.0 111.147 170.806 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 16.5 m-85 -58.05 -42.26 85.03 Favored 'General case' 0 N--CA 1.482 1.141 0 CA-C-N 120.229 1.377 . . . . 0.0 111.313 168.941 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -66.5 -37.51 85.22 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 124.19 0.996 . . . . 0.0 112.439 175.864 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 18.9 m -61.36 -50.53 72.53 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 124.491 1.116 . . . . 0.0 111.252 171.203 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 78.4 t -67.44 -37.73 79.44 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 C-N-CA 124.131 0.972 . . . . 0.0 111.098 -178.887 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 19.9 mtp180 -54.55 -43.38 71.93 Favored 'General case' 0 N--CA 1.48 1.052 0 CA-C-N 120.109 1.322 . . . . 0.0 112.467 170.255 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -61.74 -50.9 61.34 Favored Glycine 0 CA--C 1.535 1.332 0 CA-C-N 119.297 0.953 . . . . 0.0 112.954 175.239 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 52.4 mt-30 -61.03 -46.77 89.36 Favored 'General case' 0 N--CA 1.474 0.729 0 O-C-N 122.138 -0.625 . . . . 0.0 111.737 177.686 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 55.3 t -66.02 -41.02 88.88 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 C-N-CA 125.028 1.331 . . . . 0.0 111.144 -179.41 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -55.98 -48.15 76.36 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 120.117 1.326 . . . . 0.0 110.437 177.129 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -63.47 -44.66 93.8 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 112.682 0.623 . . . . 0.0 112.682 175.376 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.17 -33.72 76.67 Favored 'General case' 0 N--CA 1.478 0.967 0 N-CA-C 113.52 0.933 . . . . 0.0 113.52 179.188 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 82.4 t -78.99 -39.29 21.46 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 C-N-CA 125.698 1.599 . . . . 0.0 111.291 177.027 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -60.89 -40.11 91.79 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 119.58 1.082 . . . . 0.0 111.16 171.171 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 16.6 m-80 -63.96 -45.86 87.22 Favored 'General case' 0 CA--C 1.538 0.51 0 O-C-N 121.865 -0.522 . . . . 0.0 112.341 174.19 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -51.67 -57.9 7.9 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 124.729 1.212 . . . . 0.0 110.6 173.522 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 74.1 mt -62.59 -42.99 98.03 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 C-N-CA 122.827 0.451 . . . . 0.0 110.548 -177.11 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -72.92 -10.62 60.0 Favored 'General case' 0 CA--C 1.544 0.721 0 N-CA-C 114.86 1.43 . . . . 0.0 114.86 -178.854 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 20.7 ptmt -99.53 -29.93 12.44 Favored 'General case' 0 N--CA 1.479 0.976 0 N-CA-C 113.636 0.976 . . . . 0.0 113.636 170.198 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 12.7 pt -93.24 -8.91 9.93 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 N-CA-C 114.527 1.306 . . . . 0.0 114.527 178.313 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 27.1 p . . . . . 0 C--O 1.255 1.387 0 N-CA-C 114.663 1.357 . . . . 0.0 114.663 174.501 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.3 ttt . . . . . 0 N--CA 1.502 2.139 0 N-CA-C 111.501 0.186 . . . . 0.0 111.501 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.79 155.97 36.97 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 125.059 1.344 . . . . 0.0 112.774 173.951 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 30.8 ttmt -106.73 112.6 25.66 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 106.812 -1.551 . . . . 0.0 106.812 167.651 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 23.4 t -97.3 131.7 43.57 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 C-N-CA 125.38 1.472 . . . . 0.0 113.826 178.751 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . 0.49 ' HG3' HG13 ' A' ' 7' ' ' VAL . 23.3 tpp -98.73 128.2 44.9 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 168.986 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 48.6 m-85 -109.46 121.35 44.99 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 125.784 1.633 . . . . 0.0 108.2 174.079 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.58 HG11 HD12 ' A' ' 65' ' ' ILE . 2.1 m -137.69 143.02 34.85 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 N-CA-C 113.926 1.084 . . . . 0.0 113.926 -168.823 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 5.3 t -131.03 147.45 52.63 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 126.41 1.884 . . . . 0.0 112.086 174.786 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 63.2 tttm -52.86 -39.71 62.82 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 126.477 1.911 . . . . 0.0 114.297 -177.641 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 53.4 ttt180 -101.95 -49.73 3.87 Favored 'General case' 0 N--CA 1.483 1.217 0 N-CA-C 113.719 1.007 . . . . 0.0 113.719 169.872 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 1.8 t30 63.63 -47.5 0.25 Allowed 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 127.232 2.213 . . . . 0.0 116.15 -173.515 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 59.6 p -64.85 145.97 55.54 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 119.044 0.838 . . . . 0.0 110.243 169.687 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 66.6 m 51.39 24.62 2.23 Favored 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 114.564 1.32 . . . . 0.0 114.564 -174.548 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 85.2 mtt180 -137.47 152.4 49.5 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 126.975 2.11 . . . . 0.0 110.399 176.403 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 61.1 m -97.01 -29.28 13.74 Favored 'General case' 0 N--CA 1.48 1.058 0 N-CA-C 115.771 1.767 . . . . 0.0 115.771 -169.295 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 3.9 mp0 59.96 -44.24 0.09 Allowed 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 128.596 2.758 . . . . 0.0 117.09 -178.517 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . 0.408 ' HG2' ' SD ' ' A' ' 50' ' ' MET . 0.0 OUTLIER 68.73 -46.38 0.55 Allowed 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 127.54 2.336 . . . . 0.0 115.753 171.931 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.86 -38.78 86.73 Favored 'General case' 0 C--O 1.222 -0.39 0 N-CA-C 115.494 1.665 . . . . 0.0 115.494 -169.605 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -69.15 -36.5 77.5 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-N 119.788 1.176 . . . . 0.0 112.134 -177.122 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -64.14 -40.16 97.81 Favored Glycine 0 N--CA 1.469 0.866 0 C-N-CA 124.135 0.874 . . . . 0.0 112.107 173.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -69.74 -38.32 76.77 Favored 'General case' 0 N--CA 1.47 0.533 0 O-C-N 121.75 -0.853 . . . . 0.0 111.686 172.404 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -64.59 -43.1 94.88 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 119.424 1.011 . . . . 0.0 112.402 -174.75 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 15.2 ptpt -64.75 -38.33 90.63 Favored 'General case' 0 N--CA 1.486 1.351 0 O-C-N 121.514 -0.741 . . . . 0.0 112.025 169.753 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 92.3 m -71.55 -34.07 69.67 Favored 'General case' 0 N--CA 1.479 1.001 0 O-C-N 121.632 -0.668 . . . . 0.0 112.475 -176.709 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 71.9 mt -88.66 -26.07 22.05 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 125.498 1.519 . . . . 0.0 113.84 -178.717 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -145.78 27.08 1.77 Allowed Glycine 0 N--CA 1.47 0.94 0 N-CA-C 118.487 2.155 . . . . 0.0 118.487 -169.083 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -65.82 -21.92 66.52 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-N 122.31 3.055 . . . . 0.0 115.329 -177.323 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -74.36 -5.17 71.47 Favored Glycine 0 CA--C 1.541 1.671 0 O-C-N 121.546 -0.721 . . . . 0.0 113.799 169.479 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 76.8 mttt -118.81 -39.81 2.93 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 127.339 2.256 . . . . 0.0 113.255 -177.506 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 43.7 pt -145.11 159.3 13.62 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 124.805 1.242 . . . . 0.0 113.399 -172.355 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -108.87 139.96 42.99 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 126.343 1.857 . . . . 0.0 108.65 169.752 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 4.2 m -129.55 148.83 33.23 Favored 'Isoleucine or valine' 0 C--O 1.234 0.273 0 CA-C-N 119.53 1.059 . . . . 0.0 111.067 -177.196 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 85.1 m -136.39 136.8 39.9 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 123.151 0.581 . . . . 0.0 110.781 179.0 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 11.5 t -88.51 133.67 34.08 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 124.329 1.052 . . . . 0.0 109.435 169.174 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 23.2 p -146.6 149.41 33.48 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 114.982 1.475 . . . . 0.0 114.982 169.935 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -98.22 152.11 19.75 Favored Glycine 0 C--N 1.338 0.643 0 C-N-CA 124.272 0.939 . . . . 0.0 113.725 -172.615 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 10.5 mp -96.12 99.51 11.24 Favored 'General case' 0 CA--C 1.536 0.41 0 O-C-N 120.604 -1.527 . . . . 0.0 108.956 176.616 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 25.9 mt-10 63.96 26.47 14.15 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 125.243 1.417 . . . . 0.0 113.324 -171.619 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 94.6 p -151.13 167.16 28.6 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 125.248 1.419 . . . . 0.0 113.705 -169.654 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 77.6 p -129.41 169.3 15.09 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 125.398 1.479 . . . . 0.0 113.911 173.05 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.454 ' HG3' ' H ' ' A' ' 42' ' ' VAL . 5.7 tpt180 60.94 -178.86 0.11 Allowed 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 128.636 2.775 . . . . 0.0 113.589 -179.143 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.454 ' H ' ' HG3' ' A' ' 41' ' ' ARG . 20.9 m -133.37 179.51 4.34 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 C-N-CA 129.808 3.243 . . . . 0.0 107.716 172.179 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 2.6 t-80 -58.77 130.75 85.89 Favored Pre-proline 0 C--N 1.325 -0.499 0 CA-C-O 118.052 -0.975 . . . . 0.0 112.127 178.482 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_exo -58.99 -27.2 84.33 Favored 'Trans proline' 0 CA--C 1.548 1.197 0 C-N-CA 121.337 1.358 . . . . 0.0 112.154 169.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 89.9 m -64.94 -29.66 70.61 Favored 'General case' 0 N--CA 1.482 1.175 0 C-N-CA 125.698 1.599 . . . . 0.0 112.452 173.209 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -56.65 -43.47 80.35 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 124.027 0.931 . . . . 0.0 111.114 -177.878 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.7 mp -51.74 -55.01 10.47 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 C-N-CA 124.233 1.013 . . . . 0.0 110.226 -176.564 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -62.95 -32.96 74.38 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 113.111 0.782 . . . . 0.0 113.111 -179.578 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -80.72 -20.68 42.29 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 113.719 1.007 . . . . 0.0 113.719 178.326 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . 0.408 ' SD ' ' HG2' ' A' ' 17' ' ' MET . 4.5 mmt -85.87 -32.51 21.64 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 119.54 1.064 . . . . 0.0 110.344 169.74 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -66.72 -15.75 63.75 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.953 1.301 . . . . 0.0 113.97 175.131 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 -62.29 -26.54 68.46 Favored 'General case' 0 N--CA 1.481 1.1 0 CA-C-N 120.367 1.439 . . . . 0.0 110.895 168.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 59.4 t -95.02 -5.77 10.24 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.82 0 C-N-CA 127.318 2.247 . . . . 0.0 111.348 175.613 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 80.22 18.4 71.83 Favored Glycine 0 CA--C 1.539 1.551 0 C-N-CA 125.165 1.364 . . . . 0.0 114.575 -174.65 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 94.6 mt -75.96 134.38 29.21 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 C-N-CA 124.843 1.257 . . . . 0.0 111.22 -176.727 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 21.8 t0 -94.68 108.71 20.69 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 123.231 0.612 . . . . 0.0 112.337 172.241 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 15.7 pt -129.82 12.68 2.39 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 C-N-CA 125.142 1.377 . . . . 0.0 113.284 169.641 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 72.5 m -69.67 138.24 52.82 Favored 'General case' 0 N--CA 1.47 0.57 0 O-C-N 120.603 -1.311 . . . . 0.0 111.93 -175.815 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 73.97 3.37 64.15 Favored Glycine 0 CA--C 1.537 1.429 0 N-CA-C 116.047 1.179 . . . . 0.0 116.047 176.468 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 9.2 pt20 -77.77 135.23 37.96 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 119.536 1.668 . . . . 0.0 110.903 177.414 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 24.1 p -77.36 -33.17 55.35 Favored 'General case' 0 N--CA 1.48 1.051 0 N-CA-C 114.853 1.427 . . . . 0.0 114.853 -173.196 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 31.8 m 47.85 54.27 10.21 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.804 1.242 . . . . 0.0 112.189 -170.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -54.04 159.02 3.12 Favored Pre-proline 0 CA--C 1.542 0.656 0 C-N-CA 124.306 1.042 . . . . 0.0 112.357 177.792 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -62.91 149.6 90.99 Favored 'Trans proline' 0 N--CA 1.457 -0.674 0 CA-C-N 120.312 1.147 . . . . 0.0 112.927 -176.489 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.58 HD12 HG11 ' A' ' 7' ' ' VAL . 7.7 tt -51.35 -32.22 12.72 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 125.246 1.418 . . . . 0.0 111.42 173.603 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 -65.73 -17.44 64.61 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 125.545 1.538 . . . . 0.0 113.35 -179.247 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -79.75 -9.29 59.63 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 125.103 1.361 . . . . 0.0 112.9 177.93 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 77.5 m-85 -117.35 -179.07 3.61 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 126.408 1.883 . . . . 0.0 112.254 -173.498 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 5.2 t30 -123.07 128.31 49.95 Favored 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 125.56 1.544 . . . . 0.0 109.711 175.015 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.33 -35.87 81.47 Favored 'General case' 0 CA--C 1.531 0.25 0 N-CA-C 114.205 1.187 . . . . 0.0 114.205 -169.861 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . 0.263 0.0 OUTLIER -72.18 -5.71 37.57 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 114.009 1.115 . . . . 0.0 114.009 -178.226 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -75.49 -10.39 59.4 Favored 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 124.082 0.953 . . . . 0.0 111.331 168.648 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 68.1 m-85 -116.55 145.09 43.6 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 127.167 2.187 . . . . 0.0 111.882 179.635 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -93.57 -26.25 17.2 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.892 1.277 . . . . 0.0 112.202 179.489 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.703 HG22 ' HB ' ' A' ' 95' ' ' ILE . 68.9 t -137.09 139.69 43.86 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 C-N-CA 126.99 2.116 . . . . 0.0 107.953 -169.923 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 61.0 t -130.9 126.39 59.78 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 170.268 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 45.5 mm -112.55 105.63 19.17 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 C-N-CA 125.331 1.452 . . . . 0.0 109.407 -177.137 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 9.5 m -84.44 117.93 23.96 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 123.976 0.91 . . . . 0.0 110.305 170.275 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 1.4 pp -130.91 168.93 16.5 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 125.79 1.636 . . . . 0.0 110.182 176.428 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER 65.84 -27.42 0.11 Allowed 'General case' 0 CA--C 1.553 1.075 0 C-N-CA 126.753 2.021 . . . . 0.0 114.982 -169.45 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -170.78 -173.09 37.68 Favored Glycine 0 CA--C 1.536 1.359 0 C-N-CA 126.395 1.95 . . . . 0.0 112.328 174.521 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 74.9 m -76.84 149.83 36.14 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.96 0.904 . . . . 0.0 112.51 -178.739 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -76.67 63.29 3.09 Favored Glycine 0 CA--C 1.535 1.336 0 C-N-CA 125.01 1.291 . . . . 0.0 113.625 176.461 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 58.2 t -105.09 -38.33 4.62 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.129 0 C-N-CA 124.284 1.034 . . . . 0.0 112.659 -176.284 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 62.7 t30 -91.31 33.16 0.99 Allowed 'General case' 0 CA--C 1.55 0.951 0 N-CA-C 113.344 0.868 . . . . 0.0 113.344 -178.772 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.1 pp -126.83 156.82 73.23 Favored Pre-proline 0 CA--C 1.55 0.976 0 C-N-CA 126.32 1.848 . . . . 0.0 111.853 172.41 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -61.65 149.0 91.74 Favored 'Trans proline' 0 CA--C 1.545 1.031 0 C-N-CA 122.315 2.01 . . . . 0.0 113.906 -179.581 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_exo -57.63 -26.03 70.55 Favored 'Trans proline' 0 C--N 1.354 0.827 0 C-N-CA 123.596 2.864 . . . . 0.0 115.244 -176.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -62.12 -22.8 66.13 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 113.695 0.998 . . . . 0.0 113.695 176.086 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 89.5 m95 -82.52 -28.65 30.95 Favored 'General case' 0 N--CA 1.473 0.681 0 O-C-N 120.821 -1.175 . . . . 0.0 113.193 176.932 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 6.4 m -80.25 -14.11 13.01 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.256 0 CA-C-N 119.232 0.924 . . . . 0.0 113.24 174.167 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -96.52 0.09 49.66 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 114.95 1.463 . . . . 0.0 114.95 -178.467 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 80.6 mm-40 -65.63 157.13 30.75 Favored 'General case' 0 N--CA 1.479 1.011 0 O-C-N 120.87 -1.144 . . . . 0.0 111.865 171.239 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -55.19 -42.54 73.37 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 114.392 1.256 . . . . 0.0 114.392 -167.872 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.703 ' HB ' HG22 ' A' ' 75' ' ' VAL . 14.0 mm -119.82 64.43 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 C-N-CA 124.63 1.172 . . . . 0.0 109.412 176.753 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 14.9 t80 -77.2 108.29 10.2 Favored 'General case' 0 CA--C 1.536 0.413 0 O-C-N 120.492 -1.38 . . . . 0.0 108.063 169.246 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -109.32 144.29 37.69 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 113.217 0.821 . . . . 0.0 113.217 172.788 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -121.42 115.54 23.09 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 124.13 0.972 . . . . 0.0 109.732 169.413 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 45.5 m0 -93.16 -19.78 21.13 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 113.903 1.075 . . . . 0.0 113.903 -169.859 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 66.5 mm-40 53.25 29.92 9.22 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 125.218 1.407 . . . . 0.0 113.177 -175.721 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.3 tt -80.83 132.73 35.5 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 125.428 1.491 . . . . 0.0 109.676 -174.599 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -65.74 151.98 45.34 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 113.131 0.789 . . . . 0.0 113.131 -179.43 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -92.9 148.82 36.61 Favored Pre-proline 0 CA--C 1.548 0.886 0 O-C-N 121.772 -0.58 . . . . 0.0 111.106 171.345 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -62.42 -19.19 66.63 Favored 'Trans proline' 0 CA--C 1.548 1.204 0 C-N-CA 122.779 2.32 . . . . 0.0 115.3 173.001 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -49.32 130.83 20.03 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 125.281 1.432 . . . . 0.0 114.582 175.761 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 79.29 7.95 88.13 Favored Glycine 0 CA--C 1.535 1.312 0 C-N-CA 124.736 1.16 . . . . 0.0 114.914 175.625 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 10.5 pt20 -143.36 173.2 11.82 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 125.098 1.359 . . . . 0.0 113.117 -177.122 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 26.5 p -68.3 167.46 14.41 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 116.61 2.078 . . . . 0.0 116.61 -168.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 41.7 tp -59.42 -30.8 68.73 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.516 1.126 . . . . 0.0 112.288 170.073 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -66.88 -31.76 72.57 Favored 'General case' 0 N--CA 1.47 0.536 0 O-C-N 120.818 -1.176 . . . . 0.0 111.487 173.849 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 7.6 t -71.49 -33.81 50.92 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 O-C-N 121.172 -0.955 . . . . 0.0 111.687 169.867 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -57.52 -48.34 79.55 Favored 'General case' 0 N--CA 1.477 0.893 0 CA-C-N 120.041 1.291 . . . . 0.0 111.261 169.34 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 2.8 mpt_? -63.35 -40.58 97.68 Favored 'General case' 0 N--CA 1.484 1.261 0 O-C-N 121.473 -0.767 . . . . 0.0 112.066 175.873 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 28.0 m -58.81 -46.5 87.45 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 124.095 0.958 . . . . 0.0 111.175 173.659 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 54.4 t -64.57 -43.19 96.77 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 CA-C-O 117.522 -1.228 . . . . 0.0 110.514 177.621 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 67.5 mtm-85 -57.3 -43.62 83.4 Favored 'General case' 0 N--CA 1.484 1.264 0 CA-C-N 121.076 1.762 . . . . 0.0 112.528 173.738 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -61.83 -51.21 58.79 Favored Glycine 0 CA--C 1.538 1.479 0 CA-C-N 119.046 0.839 . . . . 0.0 112.914 177.113 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 58.9 mm-40 -62.29 -45.36 93.6 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 123.742 0.817 . . . . 0.0 111.754 177.751 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 58.7 t -65.41 -40.59 88.84 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 C-N-CA 124.62 1.168 . . . . 0.0 111.375 178.342 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 82.3 tttt -56.02 -50.07 71.91 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 120.337 1.426 . . . . 0.0 110.131 177.594 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -62.81 -41.19 99.19 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 112.68 0.622 . . . . 0.0 112.68 176.64 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.77 -34.49 73.85 Favored 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 113.858 1.058 . . . . 0.0 113.858 -179.864 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 98.6 t -78.3 -38.53 23.3 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 C-N-CA 125.17 1.388 . . . . 0.0 110.926 175.744 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -62.3 -41.21 98.32 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 119.041 0.837 . . . . 0.0 111.506 171.661 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 15.2 m-80 -64.43 -42.13 96.18 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 119.249 0.931 . . . . 0.0 112.462 173.722 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -54.77 -57.23 12.38 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.234 0.614 . . . . 0.0 110.26 174.149 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 77.5 mt -63.32 -45.38 98.34 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 CA-C-O 118.995 -0.526 . . . . 0.0 111.251 -177.237 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -68.91 -10.84 59.31 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 114.222 1.193 . . . . 0.0 114.222 177.632 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 70.2 tttt -92.61 -45.63 7.99 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 125.425 1.49 . . . . 0.0 111.29 174.422 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 18.7 pt -91.89 -18.86 7.15 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 N-CA-C 114.41 1.263 . . . . 0.0 114.41 -174.257 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 73.7 m . . . . . 0 C--O 1.254 1.31 0 C-N-CA 125.783 1.633 . . . . 0.0 111.188 -175.878 . . . . . . . . 0 0 . 1 stop_ save_